PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Farrona, S; Hurtado, L; March-Diaz, R; Schmitz, RJ; Florencio, FJ; Turck, F; Amasino, RM; Reyes, JC				Farrona, Sara; Hurtado, Lidia; March-Diaz, Rosana; Schmitz, Robert J.; Florencio, Francisco J.; Turck, Franziska; Amasino, Richard M.; Reyes, Jose C.			Brahma Is Required for Proper Expression of the Floral Repressor FLC in Arabidopsis	PLOS ONE			English	Article							FLOWERING-LOCUS-C; CHROMATIN-REMODELING COMPLEXES; SWR1 COMPLEX; FT PROTEIN; GENE; ENCODES; TIME; CONSTANS; VERNALIZATION; INDUCTION	Background: BRAHMA (BRM) is a member of a family of ATPases of the SWI/SNF chromatin remodeling complexes from Arabidopsis. BRM has been previously shown to be crucial for vegetative and reproductive development. Methodology/Principal Findings: Here we carry out a detailed analysis of the flowering phenotype of brm mutant plants which reveals that, in addition to repressing the flowering promoting genes CONSTANS (CO), FLOWERING LOCUS T (FT) and SUPPRESSOR OF OVEREXPRESSION OF CO1 (SOC1), BRM also represses expression of the general flowering repressor FLOWERING LOCUS C (FLC). Thus, in brm mutant plants FLC expression is elevated, and FLC chromatin exhibits increased levels of histone H3 lysine 4 tri-methylation and decreased levels of H3 lysine 27 tri-methylation, indicating that BRM imposes a repressive chromatin configuration at the FLC locus. However, brm mutants display a normal vernalization response, indicating that BRM is not involved in vernalization-mediated FLC repression. Analysis of double mutants suggests that BRM is partially redundant with the autonomous pathway. Analysis of genetic interactions between BRM and the histone H2A. Z deposition machinery demonstrates that brm mutations overcome a requirement of H2A. Z for FLC activation suggesting that in the absence of BRM, a constitutively open chromatin conformation renders H2A. Z dispensable. Conclusions/Significance: BRM is critical for phase transition in Arabidopsis. Thus, BRM represses expression of the flowering promoting genes CO, FT and SOC1 and of the flowering repressor FLC. Our results indicate that BRM controls expression of FLC by creating a repressive chromatin configuration of the locus.	[Farrona, Sara; Turck, Franziska] Max Planck Inst Plant Breeding, Cologne, Germany; [Hurtado, Lidia; March-Diaz, Rosana; Reyes, Jose C.] CSIC, CABIMER, E-41080 Seville, Spain; [Schmitz, Robert J.; Amasino, Richard M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Florencio, Francisco J.] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Wisconsin System; University of Wisconsin Madison; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Farrona, S (corresponding author), Max Planck Inst Plant Breeding, Cologne, Germany.	farrona@mpipz.mpg.de	Turck, Franziska/G-1240-2013; IBIS, NEURONAL/O-9910-2015; Florencio, Francisco J/K-7716-2014; Schmitz, Robert/AAY-7659-2020; Reyes, Jose C/K-3699-2014; Hurtado, Lidia/G-5998-2015	Turck, Franziska/0000-0002-4982-5949; Florencio, Francisco J/0000-0002-2068-7861; Schmitz, Robert/0000-0001-7538-6663; Reyes, Jose C/0000-0002-8042-5142; Hurtado, Lidia/0000-0002-3193-3693; Farrona, Sara/0000-0002-6855-2237	Ministerio de Educacin y Ciencia [BFU2008-00238, CSD2006-00049]; Junta de Andaluca [P06-CVI-01400]; National Institutes of Health [1R01GM079525]; National Science Foundation [0446440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079525] Funding Source: NIH RePORTER	Ministerio de Educacin y Ciencia(Spanish Government); Junta de Andaluca(Junta de Andalucia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Ministerio de Educacin y Ciencia (BFU2008-00238, CSD2006-00049), and by Junta de Andaluca (P06-CVI-01400) to J.C.R. and by the National Institutes of Health (grant no. 1R01GM079525), and the National Science Foundation (grant no. 0446440) to R. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Bezhani S, 2007, PLANT CELL, V19, P403, DOI 10.1105/tpc.106.048272; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Choi K, 2005, PLANT CELL, V17, P2647, DOI 10.1105/tpc.105.035485; Choi K, 2007, DEVELOPMENT, V134, P1931, DOI 10.1242/dev.001891; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Deal RB, 2005, PLANT CELL, V17, P2633, DOI 10.1105/tpc.105.035196; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; DOYLE MR, 2009, PLANT PHYSL; Farrona S, 2007, J MOL BIOL, V373, P240, DOI 10.1016/j.jmb.2007.07.012; Farrona S, 2004, DEVELOPMENT, V131, P4965, DOI 10.1242/dev.01363; Farrona S, 2008, SEMIN CELL DEV BIOL, V19, P560, DOI 10.1016/j.semcdb.2008.07.015; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Hurtado L, 2006, PLANT MOL BIOL, V62, P291, DOI 10.1007/s11103-006-9021-2; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jiang D, 2007, PLANT CELL, V19, P2975, DOI 10.1105/tpc.107.052373; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Knizewski L, 2008, TRENDS PLANT SCI, V13, P557, DOI 10.1016/j.tplants.2008.08.004; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Kwon CS, 2006, DEVELOPMENT, V133, P3223, DOI 10.1242/dev.02508; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; March-Diaz R, 2008, PLANT J, V53, P475, DOI 10.1111/j.1365-313X.2007.03361.x; March-Diaz R, 2007, PLANT PHYSIOL, V143, P893, DOI 10.1104/pp.106.092270; March-Diaz R, 2009, MOL PLANT, V2, P565, DOI 10.1093/mp/ssp019; Martin-Trillo M, 2006, DEVELOPMENT, V133, P1241, DOI 10.1242/dev.02301; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mlynarova L, 2007, PLANT J, V51, P874, DOI 10.1111/j.1365-313X.2007.03185.x; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Ratcliffe OJ, 2001, PLANT PHYSIOL, V126, P122, DOI 10.1104/pp.126.1.122; Sanda SL, 1996, MOL GEN GENET, V251, P69; Sarnowski TJ, 2005, PLANT CELL, V17, P2454, DOI 10.1105/tpc.105.031203; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tang XR, 2008, PLANT PHYSIOL, V147, P1143, DOI 10.1104/pp.108.121996; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Wagner D, 2002, CURR BIOL, V12, P85, DOI 10.1016/S0960-9822(01)00651-0; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	58	39	41	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17997	10.1371/journal.pone.0017997	http://dx.doi.org/10.1371/journal.pone.0017997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445315	gold, Green Published			2022-12-27	WOS:000288613300027
J	van Wilderen, LJGW; Lincoln, CN; van Thor, JJ				van Wilderen, Luuk J. G. W.; Lincoln, Craig N.; van Thor, Jasper J.			Modelling Multi-Pulse Population Dynamics from Ultrafast Spectroscopy	PLOS ONE			English	Article							PHOTOACTIVE YELLOW PROTEIN; PATTERN SEARCH ALGORITHM; PUMP-DUMP-PROBE; TARGET ANALYSIS; STATE; PHOTOSELECTION; PHYTOCHROME; PHOTOLYSIS; ISOMERIZATION; PHOTOCYCLE	Current advanced laser, optics and electronics technology allows sensitive recording of molecular dynamics, from single resonance to multi-colour and multi-pulse experiments. Extracting the occurring (bio-) physical relevant pathways via global analysis of experimental data requires a systematic investigation of connectivity schemes. Here we present a Matlab-based toolbox for this purpose. The toolbox has a graphical user interface which facilitates the application of different reaction models to the data to generate the coupled differential equations. Any time-dependent dataset can be analysed to extract time-independent correlations of the observables by using gradient or direct search methods. Specific capabilities (i.e. chirp and instrument response function) for the analysis of ultrafast pump-probe spectroscopic data are included. The inclusion of an extra pulse that interacts with a transient phase can help to disentangle complex interdependent pathways. The modelling of pathways is therefore extended by new theory (which is included in the toolbox) that describes the finite bleach (orientation) effect of single and multiple intense polarised femtosecond pulses on an ensemble of randomly oriented particles in the presence of population decay. For instance, the generally assumed flat-top multimode beam profile is adapted to a more realistic Gaussian shape, exposing the need for several corrections for accurate anisotropy measurements. In addition, the (selective) excitation (photoselection) and anisotropy of populations that interact with single or multiple intense polarised laser pulses is demonstrated as function of power density and beam profile. Using example values of real world experiments it is calculated to what extent this effectively orients the ensemble of particles. Finally, the implementation includes the interaction with multiple pulses in addition to depth averaging in optically dense samples. In summary, we show that mathematical modelling is essential to model and resolve the details of physical behaviour of populations in ultrafast spectroscopy such as pump-probe, pump-dump-probe and pump-repump-probe experiments.	[van Wilderen, Luuk J. G. W.; Lincoln, Craig N.; van Thor, Jasper J.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London, England	Imperial College London	van Wilderen, LJGW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, S Kensington Campus, London, England.	j.vanthor@imperial.ac.uk	Lincoln, Craig N/L-8858-2013; van Wilderen, Luuk J/P-3923-2015; van Wilderen, Luuk/HGU-8072-2022	Lincoln, Craig N/0000-0003-3239-0114; van Wilderen, Luuk J/0000-0001-6462-5673; van Wilderen, Luuk/0000-0001-6462-5673	European Research Council [208650]; Biotechnology and Biological Sciences Research Council [BB/H004238/1] Funding Source: researchfish; BBSRC [BB/H004238/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LJGWvW is a long term FEBS research fellow. JvT acknowledges support from the European Research Council via Grant Agreement No 208650. JvT is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT AC, 1961, J MOL SPECTROSC, V6, P84, DOI 10.1016/0022-2852(61)90234-X; ANSARI A, 1993, BIOPHYS J, V64, P852, DOI 10.1016/S0006-3495(93)81446-2; Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Borisov VB, 2002, BIOCHEMISTRY-US, V41, P1654, DOI 10.1021/bi0158019; Bray T., 2008, EXTENSIBLE MARKUP LA; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; Changenet-Barret P, 2000, J PHYS CHEM B, V104, P9322, DOI 10.1021/jp001634v; Croce R, 2001, BIOPHYS J, V80, P901, DOI 10.1016/S0006-3495(01)76069-9; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Dietzek B, 2007, J AM CHEM SOC, V129, P13014, DOI 10.1021/ja072639+; Einax JW, 2008, ANAL BIOANAL CHEM, V390, P1225, DOI 10.1007/s00216-007-1786-x; Gai F, 1997, J AM CHEM SOC, V119, P6201, DOI 10.1021/ja9703685; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; HESTER RE, 1993, CHEM PHYS LETT, V208, P471, DOI 10.1016/0009-2614(93)87175-3; Heyne K, 2002, BIOPHYS J, V82, P1004, DOI 10.1016/S0006-3495(02)75460-X; HOLZWARTH AR, 1995, METHOD ENZYMOL, V246, P334; Hucka M., 2010, SYSTEMS BIOL MARKUP; Ihme M, 2008, NEURAL COMPUT, V20, P573, DOI 10.1162/neco.2007.08-06-316; Istratov AA, 1999, REV SCI INSTRUM, V70, P1233, DOI 10.1063/1.1149581; Joshi CP, 2006, BIOCHEMISTRY-US, V45, P7057, DOI 10.1021/bi0517335; Kennis JTM, 2004, P NATL ACAD SCI USA, V101, P17988, DOI 10.1073/pnas.0404262102; Kovalenko SA, 1999, PHYS REV A, V59, P2369, DOI 10.1103/PhysRevA.59.2369; Larsen DS, 2004, BIOPHYS J, V86, P2538, DOI 10.1016/S0006-3495(04)74309-X; Larsen DS, 2003, CHEM PHYS LETT, V381, P733, DOI 10.1016/j.cplett.2003.10.016; Lavine B, 2008, ANAL CHEM, V80, P4519, DOI 10.1021/ac800728t; Lim M, 2004, J AM CHEM SOC, V126, P7946, DOI 10.1021/ja035475f; Lim MH, 2002, B KOR CHEM SOC, V23, P865; Logunov SL, 2001, P NATL ACAD SCI USA, V98, P8475, DOI 10.1073/pnas.141220198; Middleton CT, 2007, J PHYS CHEM A, V111, P10460, DOI 10.1021/jp0740595; MOORE JN, 1988, P NATL ACAD SCI USA, V85, P5062, DOI 10.1073/pnas.85.14.5062; Mullen K.M., 2007, J STAT SOFTW, V18; Nibbering ETJ, 2000, APPL PHYS B-LASERS O, V71, P439, DOI 10.1007/s003400000420; Nicosia G, 2008, BIOPHYS J, V95, P4988, DOI 10.1529/biophysj.107.124016; Papagiannakis E, 2006, J PHYS CHEM B, V110, P512, DOI 10.1021/jp053094d; PIQUE JP, 1988, J CHEM PHYS, V88, P5972, DOI 10.1063/1.454510; QIAN J, 1995, CHEM PHYS LETT, V233, P9, DOI 10.1016/0009-2614(94)01445-2; ROELOFS TA, 1992, BIOPHYS J, V61, P1147, DOI 10.1016/S0006-3495(92)81924-0; Rupenyan A, 2009, J PHYS CHEM B, V113, P16251, DOI 10.1021/jp9065289; Satzger H, 2003, CHEM PHYS, V295, P287, DOI 10.1016/j.chemphys.2003.08.012; SCHARF LL, 1991, SIGNAL PROCESS, V25, P113, DOI 10.1016/0165-1684(91)90058-Q; Schmidt M, 2003, BIOPHYS J, V84, P2112, DOI 10.1016/S0006-3495(03)75018-8; STEINBERG IZ, 1974, J CHEM PHYS, V61, P3382, DOI 10.1063/1.1682501; Torczon V, 1997, SIAM J OPTIMIZ, V7, P1, DOI 10.1137/S1052623493250780; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; van Thor JJ, 2008, BIOPHYS J, V95, P1902, DOI 10.1529/biophysj.108.129957; van Thor JJ, 2007, J AM CHEM SOC, V129, P126, DOI 10.1021/ja0660709; van Thor JJ, 2005, J PHYS CHEM B, V109, P16099, DOI 10.1021/jp051315+; van Wilderen LJGW, 2009, J PHYS CHEM B, V113, P16354, DOI 10.1021/jp9038539; WIENKE D, 1992, ANAL CHIM ACTA, V265, P211, DOI 10.1016/0003-2670(92)85027-4; Wohlleben W, 2004, J PHYS CHEM B, V108, P3320, DOI 10.1021/jp036145k; WYNNE K, 1993, CHEM PHYS, V171, P179, DOI 10.1016/0301-0104(93)85142-U	51	79	79	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17373	10.1371/journal.pone.0017373	http://dx.doi.org/10.1371/journal.pone.0017373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445294	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300007
J	Fritzsching, B; Haas, J; Konig, F; Kunz, P; Fritzsching, E; Poschl, J; Krammer, PH; Bruck, W; Suri-Payer, E; Wildemann, B				Fritzsching, Benedikt; Haas, Juergen; Koenig, Fatima; Kunz, Pierre; Fritzsching, Eva; Poeschl, Johannes; Krammer, Peter H.; Brueck, Wolfgang; Suri-Payer, Elisabeth; Wildemann, Brigitte			Intracerebral Human Regulatory T Cells: Analysis of CD4(+)CD25(+)FOXP3(+) T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis Patients	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUPPRESSIVE FUNCTION; DIAGNOSTIC-CRITERIA; PROTEIN TRANSFER; APOPTOSIS; DEMYELINATION; LYMPHOCYTES; RECRUITMENT; EXPRESSION; GUIDELINES	Impaired suppressive capacity of CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) from peripheral blood of patients with multiple sclerosis (MS) has been reported by multiple laboratories. It is, however, currently unresolved whether Treg dysfunction in MS patients is limited to reduced control of peripheral T cell activation since most studies analyzed peripheral blood samples only. Here, we assessed early active MS lesions in brain biopsies obtained from 16 patients with MS by FOXP3 immunohistochemistry. In addition, we used six-color flow cytometry to determine numbers of Treg by analysis of FOXP3/CD127 expression in peripheral blood and cerebrospinal fluid (CSF) of 17 treatment-naive MS patients as well as quantities of apoptosis sensitive CD45RO(hi)CD95(hi) cells in circulating and CSF Treg subsets. Absolute numbers of FOXP3(+) and CD4(+) cells were rather low in MS brain lesions and Treg were not detectable in 30% of MS biopsies despite the presence of CD4(+) cell infiltrates. In contrast, Treg were detectable in all CSF samples and Treg with a CD45RO(hi)CD95(hi) phenotype previously shown to be highly apoptosis sensitive were found to be enriched in the CSF compared to peripheral blood of MS patients. We suggest a hypothetical model of intracerebral elimination of Treg by CD95L-mediated apoptosis within the MS lesion.	[Fritzsching, Benedikt; Fritzsching, Eva; Poeschl, Johannes] Univ Heidelberg Hosp, Ctr Child & Adolescent Med, Dept Neonatol, Heidelberg, Germany; [Haas, Juergen; Wildemann, Brigitte] Univ Heidelberg Hosp, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany; [Koenig, Fatima; Brueck, Wolfgang] Univ Med Ctr, Dept Neuropathol, Gottingen, Germany; [Kunz, Pierre] Univ Heidelberg Hosp, Dept Orthoped Surg, Heidelberg, Germany; [Krammer, Peter H.; Suri-Payer, Elisabeth] German Canc Res Ctr, Div Immunogenet, Heidelberg, Germany; [Koenig, Fatima] Univ Hosp, Dept Neuropathol, Giessen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Gottingen; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Fritzsching, B (corresponding author), Univ Heidelberg Hosp, Ctr Child & Adolescent Med, Dept Neonatol, Heidelberg, Germany.	brigitte.wildemann@med.uni-heidelberg.de	Suri-Payer, Elisabeth/ABC-2448-2021	Haas, Juergen/0000-0002-2314-7465	German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (Research Alliance "Understand MS", All). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Chen AS, 2007, CANCER RES, V67, P1291, DOI 10.1158/0008-5472.CAN-06-2622; Comi C, 2000, NEUROLOGY, V55, P921, DOI 10.1212/WNL.55.7.921; CVETANOVICH GL, 2010, CURR OPIN IMMUNOL; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Franz B, 2007, ARTHRITIS RHEUM-US, V56, P1910, DOI 10.1002/art.22699; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Fritzsching B, 2006, J NEUROL SCI, V251, P91, DOI 10.1016/j.jns.2006.09.006; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Gritzapis AD, 2010, CANCER RES, V70, P2686, DOI 10.1158/0008-5472.CAN-09-2517; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Haas J, 2008, BLOOD, V111, P761, DOI 10.1182/blood-2007-08-104877; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Huang YH, 2009, ANN NEUROL, V66, P171, DOI 10.1002/ana.21705; Klemke CD, 2006, LEUKEMIA, V20, P1123, DOI 10.1038/sj.leu.2404182; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Liu SR, 2007, J IMMUNOL, V178, P3301, DOI 10.4049/jimmunol.178.5.3301; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Macchi B, 1999, NEUROREPORT, V10, P399, DOI 10.1097/00001756-199902050-00034; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; NYLAND H, 1982, NEUROPATH APPL NEURO, V8, P403, DOI 10.1111/j.1365-2990.1982.tb00308.x; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Pender MP, 1998, LANCET, V351, P978; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Prineas JW., 1985, HDB CLIN NEUROLOGY, V3, P213; PULLEN AM, 1989, J IMMUNOL, V142, P3033; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schneider-Hohendorf T, 2010, EUR J IMMUNOL, V40, P3581, DOI 10.1002/eji.201040558; Sharief MK, 2000, J NEUROIMMUNOL, V109, P236, DOI 10.1016/S0165-5728(00)00325-8; Sonabend AM, 2008, ANTICANCER RES, V28, P1143; Stenner MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003319; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; VUKMANOVICSTEJI.M, J CLIN INVEST, V116, P2423; WOODROOFE MN, 1986, J NEUROL SCI, V74, P135, DOI 10.1016/0022-510X(86)90100-0	45	74	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17988	10.1371/journal.pone.0017988	http://dx.doi.org/10.1371/journal.pone.0017988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437244	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100053
J	Gasch, J; Reimann, M; Reichmann, H; Rudiger, H; Ziemssen, T				Gasch, Julia; Reimann, Manja; Reichmann, Heinz; Ruediger, Heinz; Ziemssen, Tjalf			Determination of Baroreflex Sensitivity during the Modified Oxford Maneuver by Trigonometric Regressive Spectral Analysis	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CARDIOVASCULAR REGULATION; PHENYLEPHRINE METHOD; ARTERIAL-PRESSURE; MORTALITY; RESPONSES; TIME; HYPERTENSION; INDEXES; REFLEX	Background: Differences in spontaneous and drug-induced baroreflex sensitivity (BRS) have been attributed to its different operating ranges. The current study attempted to compare BRS estimates during cardiovascular steady-state and pharmacologically stimulation using an innovative algorithm for dynamic determination of baroreflex gain. Methodology/Principal Findings: Forty-five volunteers underwent the modified Oxford maneuver in supine and 60 degrees tilted position with blood pressure and heart rate being continuously recorded. Drug-induced BRS-estimates were calculated from data obtained by bolus injections of nitroprusside and phenylephrine. Spontaneous indices were derived from data obtained during rest (stationary) and under pharmacological stimulation (non-stationary) using the algorithm of trigonometric regressive spectral analysis (TRS). Spontaneous and drug-induced BRS values were significantly correlated and display directionally similar changes under different situations. Using the Bland-Altman method, systematic differences between spontaneous and drug-induced estimates were found and revealed that the discrepancy can be as large as the gain itself. Fixed bias was not evident with ordinary least products regression. The correlation and agreement between the estimates increased significantly when BRS was calculated by TRS in non-stationary mode during the drug injection period. TRS-BRS significantly increased during phenylephrine and decreased under nitroprusside. Conclusions/Significance: The TRS analysis provides a reliable, non-invasive assessment of human BRS not only under static steady state conditions, but also during pharmacological perturbation of the cardiovascular system.	[Gasch, Julia; Reimann, Manja; Reichmann, Heinz; Ruediger, Heinz; Ziemssen, Tjalf] Tech Univ Dresden, Auton & Neuroendocrinol Lab, Dept Neurol, Univ Hosp Carl Gustav Carus, D-8027 Dresden, Germany; [Reimann, Manja; Ruediger, Heinz; Ziemssen, Tjalf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurol & Internal Med 3, Res Grp Neurometab, D-8027 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Gasch, J (corresponding author), Tech Univ Dresden, Auton & Neuroendocrinol Lab, Dept Neurol, Univ Hosp Carl Gustav Carus, D-8027 Dresden, Germany.	manjareimann@uniklinikum-dresden.de	Ziemssen, Tjalf/J-2017-2019	Ziemssen, Tjalf/0000-0001-8799-8202	University Hospital Carl Gustav Carus of the Dresden University of Technology	University Hospital Carl Gustav Carus of the Dresden University of Technology	The study was supported by the University Hospital Carl Gustav Carus of the Dresden University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Colombo R, 1999, CLIN SCI, V97, P503, DOI 10.1042/CS19990035; DI RIENZO M, 1991, AM J PHYSIOL, V261, pH1811, DOI 10.1152/ajpheart.1991.261.6.H1811; ECKBERG DL, 1982, AM J PHYSIOL, V242, pH638, DOI 10.1152/ajpheart.1982.242.4.H638; Friedrich C, 2008, J NEURAL TRANSM, V115, P1527, DOI 10.1007/s00702-008-0127-3; Friedrich C, 2010, MOVEMENT DISORD, V25, P315, DOI 10.1002/mds.22844; Gerritsen J, 2001, DIABETES CARE, V24, P1793, DOI 10.2337/diacare.24.10.1793; HULL SS, 1994, CIRCULATION, V89, P548, DOI 10.1161/01.CIR.89.2.548; IMAIZUMI T, 1984, HYPERTENSION, V6, P906, DOI 10.1161/01.HYP.6.6.906; JEWETT DL, 1964, J PHYSIOL-LONDON, V175, P321, DOI 10.1113/jphysiol.1964.sp007520; La Rovere MT, 1998, LANCET, V351, P478; La Rovere MT, 2000, Z KARDIOL, V89, P44; LaRovere MT, 1997, PACE, V20, P2602; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; Lipman RD, 2003, HYPERTENSION, V42, P481, DOI 10.1161/01.HYP.0000091370.83602.E6; Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x; Ludbrook J, 1997, CLIN EXP PHARMACOL P, V24, P193, DOI 10.1111/j.1440-1681.1997.tb01807.x; Maestri R, 1998, J AM COLL CARDIOL, V31, P344, DOI 10.1016/S0735-1097(97)00499-3; MENSE L, 2010, CIRC J; Musialek P, 1997, CIRC RES, V81, P60, DOI 10.1161/01.RES.81.1.60; Parati G, 2004, J HYPERTENS, V22, P1259, DOI 10.1097/01.hjh.0000125469.35523.32; Parati G, 2004, HYPERTENSION, V43, pE32, DOI 10.1161/01.HYP.0000126689.12940.cd; PARATI G, 1985, CLIN SCI, V69, P533, DOI 10.1042/cs0690533; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; PARATI G, 1994, HYPERTENSION, V23, P992, DOI 10.1161/01.HYP.23.6.992; Parati G, 1995, HIGH BLOOD PRESS, p[4, 186]; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; PEVELER RC, 1983, CLIN SCI, V64, P455, DOI 10.1042/cs0640455; PICKERING TG, 1973, CARDIOVASC RES, V7, P213, DOI 10.1093/cvr/7.2.213; Pitzalis MV, 1998, CIRCULATION, V97, P1362, DOI 10.1161/01.CIR.97.14.1362; Reimann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012187; Rudas L, 1999, AM J PHYSIOL-HEART C, V276, pH1691, DOI 10.1152/ajpheart.1999.276.5.H1691; Rudiger H, 1999, COMPUT METH PROG BIO, V58, P1, DOI 10.1016/S0169-2607(98)00070-4; Rudiger H, 2001, AUTON NEUROSCI-BASIC, V93, P71, DOI 10.1016/S1566-0702(01)00326-5; Ruediger H, 2004, J HUM HYPERTENS, V18, P307, DOI 10.1038/sj.jhh.1001671; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; Watkins LL, 1996, HYPERTENSION, V28, P238, DOI 10.1161/01.HYP.28.2.238; Westerhof BE, 2006, AM J PHYSIOL-HEART C, V291, pH2864, DOI 10.1152/ajpheart.01024.2005; Ziemssen Tjalf, 2008, J Clin Monit Comput, V22, P159, DOI 10.1007/s10877-008-9117-0	40	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18061	10.1371/journal.pone.0018061	http://dx.doi.org/10.1371/journal.pone.0018061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437258	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100067
J	Ulrich, PN; Jimenez, V; Park, M; Martins, VP; Atwood, J; Moles, K; Collins, D; Rohloff, P; Tarleton, R; Moreno, SNJ; Orlando, R; Docampo, R				Ulrich, Paul N.; Jimenez, Veronica; Park, Miyoung; Martins, Vicente P.; Atwood, James, III; Moles, Kristen; Collins, Dalis; Rohloff, Peter; Tarleton, Rick; Moreno, Silvia N. J.; Orlando, Ron; Docampo, Roberto			Identification of Contractile Vacuole Proteins in Trypanosoma cruzi	PLOS ONE			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; DICTYOSTELIUM-DISCOIDEUM; TRANSMEMBRANE TOPOLOGY; MEMBRANE TRAFFICKING; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; CA2+ TRANSPORT; CHAGAS-DISEASE; R-SNARES; COMPLEX	Contractile vacuole complexes are critical components of cell volume regulation and have been shown to have other functional roles in several free-living protists. However, very little is known about the functions of the contractile vacuole complex of the parasite Trypanosoma cruzi, the etiologic agent of Chagas disease, other than a role in osmoregulation. Identification of the protein composition of these organelles is important for understanding their physiological roles. We applied a combined proteomic and bioinfomatic approach to identify proteins localized to the contractile vacuole. Proteomic analysis of a T. cruzi fraction enriched for contractile vacuoles and analyzed by one-dimensional gel electrophoresis and LC-MS/MS resulted in the addition of 109 newly detected proteins to the group of expressed proteins of epimastigotes. We also identified different peptides that map to at least 39 members of the dispersed gene family 1 (DGF-1) providing evidence that many members of this family are simultaneously expressed in epimastigotes. Of the proteins present in the fraction we selected several homologues with known localizations in contractile vacuoles of other organisms and others that we expected to be present in these vacuoles on the basis of their potential roles. We determined the localization of each by expression as GFP-fusion proteins or with specific antibodies. Six of these putative proteins (Rab11, Rab32, AP180, ATPase subunit B, VAMP1, and phosphate transporter) predominantly localized to the vacuole bladder. TcSNARE2.1, TcSNARE2.2, and calmodulin localized to the spongiome. Calmodulin was also cytosolic. Our results demonstrate the utility of combining subcellular fractionation, proteomic analysis, and bioinformatic approaches for localization of organellar proteins that are difficult to detect with whole cell methodologies. The CV localization of the proteins investigated revealed potential novel roles of these organelles in phosphate metabolism and provided information on the potential participation of adaptor protein complexes in their biogenesis.	[Ulrich, Paul N.; Jimenez, Veronica; Park, Miyoung; Martins, Vicente P.; Moles, Kristen; Collins, Dalis; Rohloff, Peter; Tarleton, Rick; Moreno, Silvia N. J.; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Ulrich, Paul N.; Jimenez, Veronica; Park, Miyoung; Martins, Vicente P.; Moles, Kristen; Collins, Dalis; Rohloff, Peter; Tarleton, Rick; Moreno, Silvia N. J.; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Atwood, James, III; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ulrich, PN (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	rdocampo@uga.edu	de paulo martins, vicente/H-7182-2019; Martins, Vicente P/F-8395-2012; Tarleton, Rick/AES-8572-2022; Rohloff, Peter/P-8722-2017	de paulo martins, vicente/0000-0001-7611-861X; Martins, Vicente P/0000-0001-7611-861X; Rohloff, Peter/0000-0001-7274-8315; Tarleton, Rick/0000-0002-9589-5243; Collins, Dalis/0000-0003-2484-1640	U.S. National Institutes of Health [AI-068647]; American Heart Association; National Institutes of Health [RR-022685]; NATIONAL CENTER FOR RESEARCH RESOURCES [T35RR022685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health (grant AI-068647 to RD), and postdoctoral fellowships from the American Heart Association (to PNU and VJ). KM and DC were supported in part by a summer training grant from the National Institutes of Health (RR-022685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi A, 2010, J CELL SCI, V123, P3215, DOI 10.1242/jcs.063941; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Atwood JA, 2006, J PROTEOME RES, V5, P3376, DOI 10.1021/pr060364b; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; Becker M, 1999, EMBO J, V18, P3305, DOI 10.1093/emboj/18.12.3305; BENAIM G, 1991, BIOCHEM J, V280, P715, DOI 10.1042/bj2800715; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bridges DJ, 2008, PROTEOMICS, V8, P83, DOI 10.1002/pmic.200700607; CHUNG SH, 1990, NUCLEIC ACIDS RES, V18, P4561, DOI 10.1093/nar/18.15.4561; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; DEMENDONCA SM, 2000, CHARACTERIZATION, V243, P179; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Du F, 2008, EMBO J, V27, P2064, DOI 10.1038/emboj.2008.131; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; Field H, 2000, MOL BIOCHEM PARASIT, V106, P21, DOI 10.1016/S0166-6851(99)00192-9; Fok AK, 2008, J EUKARYOT MICROBIOL, V55, P481, DOI 10.1111/j.1550-7408.2008.00347.x; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gerald NJ, 2002, TRAFFIC, V3, P50, DOI 10.1034/j.1600-0854.2002.30107.x; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Harris E, 2001, J CELL SCI, V114, P3035; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Heazlewood JL, 2005, PLANT PHYSIOL, V139, P598, DOI 10.1104/pp.105.065532; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; HORTON P, P 4 ANN AS PAC BIOIN, P39; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Iwamoto M, 2004, J HISTOCHEM CYTOCHEM, V52, P557, DOI 10.1177/002215540405200501; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Kollien AH, 2001, J INSECT PHYSIOL, V47, P739, DOI 10.1016/S0022-1910(00)00170-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lefkir Y, 2003, MOL BIOL CELL, V14, P1835, DOI 10.1091/mbc.E02-10-0627; Lu HG, 1998, MOL CELL BIOL, V18, P2309, DOI 10.1128/MCB.18.4.2309; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; MADDY AH, 1976, J THEOR BIOL, V62, P315, DOI 10.1016/0022-5193(76)90123-5; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; Marchesini N, 2002, J BIOL CHEM, V277, P8146, DOI 10.1074/jbc.M111130200; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Moniakis J, 1999, J CELL SCI, V112, P405; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishihara E, 2008, BIOL CELL, V100, P179, DOI 10.1042/BC20070091; NOLTA KV, 1994, J BIOL CHEM, V269, P2225; OHALLORAN TJ, 1992, J CELL BIOL, V118, P1371, DOI 10.1083/jcb.118.6.1371; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Rohloff P, 2008, EXP PARASITOL, V118, P17, DOI 10.1016/j.exppara.2007.04.013; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Schilde C, 2006, TRAFFIC, V7, P440, DOI 10.1111/j.1600-0854.2006.00397.x; Schneider N, 2000, BIOL CELL, V92, P495, DOI 10.1016/S0248-4900(00)01102-3; Schoijet AC, 2011, MOL MICROBIOL, V79, P50, DOI 10.1111/j.1365-2958.2010.07429.x; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Sesaki H, 1997, J CELL BIOL, V138, P939, DOI 10.1083/jcb.138.4.939; Stavrou I, 2006, MOL BIOL CELL, V17, P5381, DOI 10.1091/mbc.E06-06-0531; Stenmark H, 2001, GENOME BIOL, V2; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; TELLEZINON MT, 1985, MOL BIOCHEM PARASIT, V17, P143, DOI 10.1016/0166-6851(85)90013-1; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wen YJ, 2009, MOL BIOL CELL, V20, P4278, DOI 10.1091/mbc.E09-03-0243; Xie YY, 1996, J CELL SCI, V109, P489; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347	86	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18013	10.1371/journal.pone.0018013	http://dx.doi.org/10.1371/journal.pone.0018013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437209	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100058
J	Yamamoto, Y; Takase, K; Kishino, J; Fujita, M; Okamura, N; Sakaeda, T; Fujimoto, M; Yagami, T				Yamamoto, Yasuhiro; Takase, Kenkichi; Kishino, Junji; Fujita, Megumi; Okamura, Noboru; Sakaeda, Toshiyuki; Fujimoto, Masafumi; Yagami, Tatsurou			Proteomic Identification of Protein Targets for 15-Deoxy-Delta(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; PROLIFERATOR-ACTIVATED RECEPTOR; ALZHEIMERS-DISEASE BRAIN; SMOOTH-MUSCLE-CELLS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; RAT-BRAIN; CYCLOPENTENONE PROSTAGLANDINS; GLYCOLYTIC-ENZYMES; TERMINAL FRAGMENTS; PRECURSOR PROTEIN	15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is one of factors contributed to the neurotoxicity of amyloid beta (A beta), a causative protein of Alzheimer's disease. Type 2 receptor for prostaglandin D-2 (DP2) and peroxysome-proliferator activated receptor gamma (PPAR gamma) are identified as the membrane receptor and the nuclear receptor for 15d-PGJ(2), respectively. Previously, we reported that the cytotoxicity of 15d-PGJ(2) was independent of DP2 and PPAR gamma, and suggested that 15d-PGJ(2) induced apoptosis through the novel specific binding sites of 15d-PGJ(2) different from DP2 and PPAR gamma. To relate the cytotoxicity of 15d-PGJ(2) to amyloidoses, we performed binding assay [H-3]15d-PGJ(2) and specified targets for 15d-PGJ(2) associated with cytotoxicity. In the various cell lines, there was a close correlation between the susceptibilities to 15d-PGJ(2) and fibrillar A beta. Specific binding sites of [H-3]15d-PGJ(2) were detected in rat cortical neurons and human bronchial smooth muscle cells. When the binding assay was performed in subcellular fractions of neurons, the specific binding sites of [H-3]15d-PGJ(2) were detected in plasma membrane, nuclear and cytosol, but not in microsome. A proteomic approach was used to identify protein targets for 15d-PGJ(2) in the plasma membrane. By using biotinylated 15d-PGJ(2), eleven proteins were identified as biotin-positive spots and classified into three different functional proteins: glycolytic enzymes (Enolase2, pyruvate kinase M1 (PKM1) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)), molecular chaperones (heat shock protein 8 and T-complex protein 1 subunit alpha), cytoskeletal proteins (Actin beta, F-actin-capping protein, Tubulin beta and Internexin alpha). GAPDH, PKM1 and Tubulin beta are A beta-interacting proteins. Thus, the present study suggested that 15d-PGJ(2) plays an important role in amyloidoses not only in the central nervous system but also in the peripheral tissues.	[Yamamoto, Yasuhiro; Takase, Kenkichi; Yagami, Tatsurou] Himeji Dokkyo Univ, Div Physiol, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo, Japan; [Kishino, Junji; Okamura, Noboru; Sakaeda, Toshiyuki; Fujimoto, Masafumi; Yagami, Tatsurou] Shionogi & Co Ltd, Discovery Res Labs, Osaka, Japan; [Fujita, Megumi; Okamura, Noboru] Mukogawa Womens Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Sakaeda, Toshiyuki] Kyoto Univ, Ctr Integrat Educ Pharm Frontier, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Fujimoto, Masafumi] Chiba Inst Sci, Lab Appl Pharmacol, Fac Pharm, Choshi, Japan	Himeji Dokkyo University; Shionogi & Company Limited; Mukogawa Women's University; Kyoto University	Yamamoto, Y (corresponding author), Himeji Dokkyo Univ, Div Physiol, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo, Japan.	yagami@himeji-du.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20500346]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors acknowledge the following sources of support: Grant-in-Aid 20500346 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JK, NO, TS, MF and TY are employed by Shionogi and Co., Ltd. The present study includes data provided by JK, NO, TS, MF and TY when at Shiogi and Co., Ltd. Since the data were not applied to pharmaceutical development, Shionogi approved the submission of the present study to contribute to the development of academic study.	Aldini G, 2007, BIOCHEMISTRY-US, V46, P2707, DOI 10.1021/bi0618565; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arias C, 2002, EXP NEUROL, V176, P163, DOI 10.1006/exnr.2002.7912; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Baumann MH, 1996, BIOCHEM BIOPH RES CO, V219, P238, DOI 10.1006/bbrc.1996.0211; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Bulliard C, 1997, BIOCHEM J, V324, P555, DOI 10.1042/bj3240555; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x; Ching GY, 1998, J CELL SCI, V111, P321; Chow SK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090035; Dale RC, 2006, J NEUROIMMUNOL, V172, P187, DOI 10.1016/j.jneuroim.2005.10.014; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Ishitani R, 1996, J NEUROCHEM, V66, P928; Islam K, 1997, AM J PATHOL, V151, P265; IWAMOTO N, 1989, J NEUROL, V236, P80, DOI 10.1007/BF00314401; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lovell MA, 2005, NEUROCHEM RES, V30, P113, DOI 10.1007/s11064-004-9692-5; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Oyama R, 2000, BBA-PROTEIN STRUCT M, V1479, P91, DOI 10.1016/S0167-4838(00)00057-1; Patel HJ, 2003, J IMMUNOL, V170, P2663, DOI 10.4049/jimmunol.170.5.2663; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; ROGALSKI AA, 1989, J BIOL CHEM, V264, P6438; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; SASAGURI T, 1992, EXP CELL RES, V200, P351, DOI 10.1016/0014-4827(92)90182-8; Schuller E, 2001, LIFE SCI, V69, P263, DOI 10.1016/S0024-3205(01)01126-2; SCHULZE H, 1993, J NEUROCHEM, V60, P1915, DOI 10.1111/j.1471-4159.1993.tb13420.x; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shibata T, 2003, J BIOL CHEM, V278, P26046, DOI 10.1074/jbc.M303690200; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; Tamaoka A, 1996, NEUROBIOL AGING, V17, P405, DOI 10.1016/0197-4580(96)00031-0; Toda Tosifusa, 1997, Japanese Journal of Electrophoresis, V41, P13; Ueta H, 2004, NEUROSCI RES, V48, P379, DOI 10.1016/j.neures.2003.12.006; Verdier Y, 2005, J NEUROCHEM, V94, P617, DOI 10.1111/j.1471-4159.2005.03158.x; Ward JE, 2004, BRIT J PHARMACOL, V141, P517, DOI 10.1038/sj.bjp.0705630; WHATLEY SA, 1986, J NEUROCHEM, V47, P1576, DOI 10.1111/j.1471-4159.1986.tb00797.x; Wright DH, 1999, EUR J PHARMACOL, V377, P101, DOI 10.1016/S0014-2999(99)00358-1; YAGAMI T, 1995, MOL PHARMACOL, V48, P849; YAGAMI T, 1990, JPN J PHARMACOL, V54, P365, DOI 10.1254/jjp.54.365; Yagami T, 2004, NEUROBIOL DIS, V16, P481, DOI 10.1016/j.nbd.2004.04.013; Yagami T, 2003, EXP CELL RES, V291, P212, DOI 10.1016/S0014-4827(03)00369-0; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114; Yagami T, 2001, BRIT J PHARMACOL, V134, P673, DOI 10.1038/sj.bjp.0704261	53	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17552	10.1371/journal.pone.0017552	http://dx.doi.org/10.1371/journal.pone.0017552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445266	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100016
J	Bollig-Fischer, A; Dewey, TG; Ethier, SP				Bollig-Fischer, Aliccia; Dewey, T. Gregory; Ethier, Stephen P.			Oncogene Activation Induces Metabolic Transformation Resulting in Insulin-Independence in Human Breast Cancer Cells	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; GROWTH-FACTOR INDEPENDENCE; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; GLUT4 TRAFFICKING; FACTOR-I; PROLIFERATION; DEHYDROGENASE; GLUTAMINE; MODEL	Normal breast epithelial cells require insulin and EGF for growth in serum-free media. We previously demonstrated that over expression of breast cancer oncogenes transforms MCF10A cells to an insulin-independent phenotype. Additionally, most breast cancer cell lines are insulin-independent for growth. In this study, we investigated the mechanism by which oncogene over expression transforms MCF10A cells to an insulin-independent phenotype. Analysis of the effects of various concentrations of insulin and/or IGF-I on proliferation of MCF10A cells demonstrated that some of the effects of insulin were independent from those of IGF-I, suggesting that oncogene over expression drives a true insulin-independent proliferative phenotype. To test this hypothesis, we examined metabolic functions of insulin signaling in insulin-dependent and insulin-independent cells. HER2 over expression in MCF10A cells resulted in glucose uptake in the absence of insulin at a rate equal to insulin-induced glucose uptake in non-transduced cells. We found that a diverse set of oncogenes induced the same result. To gain insight into how HER2 oncogene signaling affected increased insulin-independent glucose uptake we compared HER2-regulated gene expression signatures in MCF10A and HER2 over expressing MCF10A cells by differential analysis of time series gene expression data from cells treated with a HER2 inhibitor. This analysis identified genes specifically regulated by the HER2 oncogene, including VAMP8 and PHGDH, which have known functions in glucose uptake and processing of glycolytic intermediates, respectively. Moreover, these genes specifically implicated in HER2 oncogene-driven transformation are commonly altered in human breast cancer cells. These results highlight the diversity of oncogene effects on cell regulatory pathways and the importance of oncogene-driven metabolic transformation in breast cancer.	[Bollig-Fischer, Aliccia; Ethier, Stephen P.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; [Bollig-Fischer, Aliccia] Karmanos Canc Inst, Breast Canc Biol Program, Detroit, MI USA; [Dewey, T. Gregory] Univ La Verne, Los Angeles, CA USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; University of La Verne	Bollig-Fischer, A (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.	ethier@karmanos.org		Bollig-Fischer, Aliccia/0000-0003-4832-9457	Department of Defense; Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD [W81XWH-10-2-0068]	Department of Defense(United States Department of Defense); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD	This research and development project was conducted by the Barbara Ann Karmanos Cancer Institute and is made possible by a contract with the Department of Defense that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD, under Contract Number: W81XWH-10-2-0068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views, opinions and/or findings contained in this research/presentation/publication are those of the author(s)/company and do not necessarily reflect the views of the Department of Defense and should not be construed as an official DoD/Army position, policy or decision unless so designated by other documentation. No official endorsement should be made.	Blum R, 2005, CANCER RES, V65, P999; Bollig-Fischer A, 2010, CANCER RES, V70, P7862, DOI 10.1158/0008-5472.CAN-10-1529; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BRAND K, 1985, BIOCHEM J, V228, P353, DOI 10.1042/bj2280353; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Ethier SP, 1996, CANCER RES, V56, P899; ETHIER SP, 1993, CANCER RES, V53, P627; Flanagan L, 1999, BREAST CANCER RES TR, V58, P193, DOI 10.1023/A:1006331716981; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ignatoski KMW, 2005, NEOPLASIA, V7, P788, DOI 10.1593/neo.05106; Ignatoski KMW, 1999, ENDOCRINOLOGY, V140, P3615, DOI 10.1210/en.140.8.3615; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Mankoff DA, 2007, CLIN CANCER RES, V13, P3460, DOI 10.1158/1078-0432.CCR-07-0074; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Peters K, 2009, CELL PHYSIOL BIOCHEM, V24, P483, DOI 10.1159/000257490; POLLARI S, 2010, BREAST CANC RES TREA; PRESTON RSP, 2010, ONCOGENE; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; ROSENFELD RG, 1985, ENDOCRINOLOGY, V117, P2008, DOI 10.1210/endo-117-5-2008; SCHMIDT M, 2009, J CANC RES CLIN ONCO; SEMENZA GL, 2010, BIOCH BIOPHYS ACTA; Shirvani SM, 2007, PHYSIOL GENOMICS, V30, P61, DOI 10.1152/physiolgenomics.00277.2006; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2007, INT J CANCER, V121, P1265, DOI 10.1002/ijc.22831; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	47	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17959	10.1371/journal.pone.0017959	http://dx.doi.org/10.1371/journal.pone.0017959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437235	Green Submitted, Green Published, gold			2022-12-27	WOS:000288514600018
J	Lafforgue, G; Sardanyes, J; Elena, SF				Lafforgue, Guillaume; Sardanyes, Josep; Elena, Santiago F.			Differences in Accumulation and Virulence Determine the Outcome of Competition during Tobacco etch virus Coinfection	PLOS ONE			English	Article							EXPERIMENTAL EVOLUTION; LOCAL ADAPTATION; SPORE PRODUCTION; MOSAIC-VIRUS; PLANT; MODEL; TRANSMISSION; PATHOGENS; HOSTS	Understanding the evolution of virulence for RNA viruses is essential for developing appropriate control strategies. Although it has been usually assumed that virulence is a consequence of within-host replication of the parasite, viral strains may be highly virulent without experiencing large accumulation as a consequence of immunopathological host responses. Using two strains of Tobacco etch potyvirus (TEV) that show a negative relationship between virulence and accumulation rate, we first explored the evolution of virulence and fitness traits during simple and mixed infections. Short-term evolution experiments initiated with each strain independently confirmed the genetic and evolutionary stability of virulence and viral load, although infectivity significantly increased for both strains. Second, competition experiments between hypo- and hypervirulent TEV strains have shown that the outcome of competition is driven by differences in replication rate. A simple mathematical model has been developed to analyze the dynamics of these two strains during coinfection. The model qualitatively reproduced the experimental results using biologically meaningful parameters. Further analyses of the model also revealed a wide parametric region in which a low-fitness but hypovirulent virus can still outcompete a high-fitness but hypervirulent one. These results provide additional support to the observation that virulence and within-host replication may not necessarily be strongly tied in plant RNA viruses.	[Lafforgue, Guillaume; Sardanyes, Josep; Elena, Santiago F.] Consejo Super Invest Cientificas UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Lafforgue, G (corresponding author), Consejo Super Invest Cientificas UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain.	sfelena@ibmcp.upv.es	SARDANES, JOSEP/M-3799-2015; Elena, Santiago F./A-4191-2011; LAFFORGUE, Guillaume/M-2972-2019; Lafforgue, Guillaume/Q-7580-2016	SARDANES, JOSEP/0000-0001-7225-5158; Elena, Santiago F./0000-0001-8249-5593; Lafforgue, Guillaume/0000-0003-2215-2825	Human Frontier Science Program Organization [RGP12/2008]; Spanish Ministerio de Ciencia e Innovacion [BFU2009-06993]; Generalitat Valenciana [PROMETEO2010/019]; Santa Fe Institute	Human Frontier Science Program Organization(Human Frontier Science Program); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Santa Fe Institute	Funding: This work was funded by grants from the Human Frontier Science Program Organization (RGP12/2008), the Spanish Ministerio de Ciencia e Innovacion (BFU2009-06993) and the Generalitat Valenciana (PROMETEO2010/019). The authors also acknowledge support from the Santa Fe Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, THEOR POPUL BIOL, V74, P6, DOI 10.1016/j.tpb.2008.04.003; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; BREMERMANN HJ, 1983, J THEOR BIOL, V100, P411, DOI 10.1016/0022-5193(83)90438-1; Carr DE, 2006, HEREDITY, V96, P29, DOI 10.1038/sj.hdy.6800743; Carrasco P, 2007, J VIROL, V81, P12979, DOI 10.1128/JVI.00524-07; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; DOLJA VV, 1992, P NATL ACAD SCI USA, V89, P10208, DOI 10.1073/pnas.89.21.10208; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Elena SF, 2008, HEREDITY, V100, P478, DOI 10.1038/sj.hdy.6801088; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Escriu F, 2003, EVOLUTION, V57, P755, DOI 10.1111/j.0014-3820.2003.tb00287.x; FOX DT, 1984, CAN J PLANT PATHOL, V6, P175, DOI 10.1080/07060668409501580; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gal-On A, 2007, MOL PLANT PATHOL, V8, P139, DOI 10.1111/J.1364-3703.2007.00381.X; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaltz O, 2002, J EVOLUTION BIOL, V15, P850, DOI 10.1046/j.1420-9101.2002.00433.x; KLECZKOWSKI A, 1950, J GEN MICROBIOL, V4, P53, DOI 10.1099/00221287-4-1-53; LENSKI RE, 1994, J THEOR BIOL, V169, P253, DOI 10.1006/jtbi.1994.1146; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; Montarry J, 2006, J EVOLUTION BIOL, V19, P522, DOI 10.1111/j.1420-9101.2005.01005.x; Mosquera J, 1998, J THEOR BIOL, V195, P293, DOI 10.1006/jtbi.1998.0793; Pagan I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000786; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Roossinck MJ, 2003, CURR OPIN MICROBIOL, V6, P406, DOI 10.1016/S1369-5274(03)00087-0; Sole RV, 1999, J THEOR BIOL, V198, P47, DOI 10.1006/jtbi.1999.0901; Stewart AD, 2005, EVOLUTION, V59, P730, DOI 10.1111/j.0014-3820.2005.tb01749.x; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Zhan J, 2002, J EVOLUTION BIOL, V15, P634, DOI 10.1046/j.1420-9101.2002.00428.x	31	15	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17917	10.1371/journal.pone.0017917	http://dx.doi.org/10.1371/journal.pone.0017917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423618	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900044
J	Rieber, N; Graf, A; Hartl, D; Urschel, S; Belohradsky, BH; Liese, J				Rieber, Nikolaus; Graf, Anna; Hartl, Dominik; Urschel, Simon; Belohradsky, Bernd H.; Liese, Johannes			Acellular Pertussis Booster in Adolescents Induces Th1 and Memory CD8(+) T Cell Immune Response	PLOS ONE			English	Article							CHALLENGE IN-VITRO; WHOLE-CELL; BORDETELLA-PERTUSSIS; PRIMARY VACCINATION; INFANTS; VACCINES; DIPHTHERIA; CHILDREN; TETANUS; IMMUNOGENICITY	In a number of countries, whole cell pertussis vaccines (wcP) were replaced by acellular vaccines (aP) due to an improved reactogenicity profile. Pertussis immunization leads to specific antibody production with the help of CD4(+) T cells. In earlier studies in infants and young children, wcP vaccines selectively induced a Th1 dominated immune response, whereas aP vaccines led to a Th2 biased response. To obtain data on Th1 or Th2 dominance of the immune response in adolescents receiving an aP booster immunization after a wcP or aP primary immunization, we analyzed the concentration of Th1 (IL-2, TNF-alpha, INF-gamma) and Th2 (IL-4, IL-5, IL-10) cytokines in supernatants of lymphocyte cultures specifically stimulated with pertussis antigens. We also investigated the presence of cytotoxic T cell responses against the facultative intracellular bacterium Bordetella pertussis by quantifying pertussis-specific CD8(+) T cell activation following the aP booster immunization. Here we show that the adolescent aP booster vaccination predominantly leads to a Th1 immune response based on IFNgamma secretion upon stimulation with pertussis antigen, irrespective of a prior whole cell or acellular primary vaccination. The vaccination also induces an increase in peripheral CD8(+)CD69(+) activated pertussis-specific memory T cells four weeks after vaccination. The Th1 bias of this immune response could play a role for the decreased local reactogenicity of this adolescent aP booster immunization when compared to the preceding childhood acellular pertussis booster. Pertussis-specific CD8(+) memory T cells may contribute to protection against clinical pertussis.	[Rieber, Nikolaus; Graf, Anna; Hartl, Dominik; Urschel, Simon; Belohradsky, Bernd H.; Liese, Johannes] Univ Munich, Univ Childrens Hosp, Munich, Germany; [Rieber, Nikolaus; Hartl, Dominik] Univ Tubingen, Univ Childrens Hosp, Tubingen, Germany; [Liese, Johannes] Univ Wurzburg, Univ Childrens Hosp, Wurzburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Rieber, N (corresponding author), Univ Munich, Univ Childrens Hosp, Munich, Germany.	Nikolaus.Rieber@med.uni-muenchen.de; liese_j@klinik.uni-wuerzburg.de		Urschel, Simon/0000-0003-0820-6815	Sanofi Pasteur Inc., Swiftwater, PA, USA; German Research Foundation (DFG); Sanofi Pasteur Inc.	Sanofi Pasteur Inc., Swiftwater, PA, USA; German Research Foundation (DFG)(German Research Foundation (DFG)); Sanofi Pasteur Inc.	This work was supported by an unrestricted grant from Sanofi Pasteur Inc., Swiftwater, PA, USA. This publication was also funded by the German Research Foundation (DFG) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an unrestricted grant from Sanofi Pasteur Inc., Swiftwater, PA, USA to the senior author Johannes Liese. There are no conflicts of interest relating to employment, consultancy, patents, products in development or marketed products. The author confirms that the unrestricted grant from Sanofi Pasteur Inc. does not alter his adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. Johannes Liese has received travel grants and honoraria for speaking and participation at scientific meetings from Sanofi Pasteur Inc. The co-author Dominik Hartl is a member of the academic editorial board of PLoS ONE.	[Anonymous], 2018, PLOTKINS VACCINES; Ausiello CM, 1999, INFECT IMMUN, V67, P4064, DOI 10.1128/IAI.67.8.4064-4071.1999; Ausiello CM, 1997, INFECT IMMUN, V65, P2168, DOI 10.1128/IAI.65.6.2168-2174.1997; DEEN JL, 1995, CLIN INFECT DIS, V21, P1211, DOI 10.1093/clinids/21.5.1211; Dikopoulos N, 2003, J HEPATOL, V39, P910, DOI 10.1016/S0168-8278(03)00469-0; Esposito S, 2001, INFECT IMMUN, V69, P4516, DOI 10.1128/IAI.69.7.4516-4520.2001; Feunou PF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010178; Frey CR, 2003, J INFECT DIS, V188, P40, DOI 10.1086/375828; Liese JG, 1997, PEDIATR INFECT DIS J, V16, P1038, DOI 10.1097/00006454-199711000-00007; Liese JG, 2001, PEDIATR INFECT DIS J, V20, P981, DOI 10.1097/00006454-200110000-00012; LIESE JG, PEDIATR INFECT DIS J, DOI DOI 10.1097/INF.1090B1013E3181EA5866; Meyer CU, 2007, CLIN VACCINE IMMUNOL, V14, P288, DOI 10.1128/CVI.00364-06; MILLS KHG, 2001, IMMUNITY BORDETELLA, P655; Neal ZC, 1998, J VIROL, V72, P8052, DOI 10.1128/JVI.72.10.8052-8060.1998; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Pihlgren M, 1999, INT IMMUNOL, V11, P699, DOI 10.1093/intimm/11.5.699; Rieber N, 2008, VACCINE, V26, P6929, DOI 10.1016/j.vaccine.2008.09.064; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Rowe J, 2005, INFECT IMMUN, V73, P8130, DOI 10.1128/IAI.73.12.8130-8135.2005; Ryan M, 1998, IMMUNOLOGY, V93, P1, DOI 10.1046/j.1365-2567.1998.00401.x; SAUKKONEN K, 1991, J EXP MED, V173, P1143, DOI 10.1084/jem.173.5.1143; Vermeulen F, 2010, CLIN VACCINE IMMUNOL, V17, P258, DOI 10.1128/CVI.00328-09; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; WHO, 2005, Wkly Epidemiol Rec, V80, P31; Yano A, 2007, MICROBIOL IMMUNOL, V51, P685, DOI 10.1111/j.1348-0421.2007.tb03957.x; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C; Zorzeto TQ, 2009, CLIN VACCINE IMMUNOL, V16, P544, DOI 10.1128/CVI.00339-08	28	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17271	10.1371/journal.pone.0017271	http://dx.doi.org/10.1371/journal.pone.0017271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408149	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000019
J	Wang, L; Wu, XP; Zhang, W; Zhu, DH; Wang, Y; Li, YP; Tian, Y; Li, RC; Li, Z; Zhu, XL; Li, JH; Cai, J; Liu, L; Miao, XP; Liu, Y; Li, H				Wang, Li; Wu, Xiao-Pan; Zhang, Wei; Zhu, Da-Hai; Wang, Ying; Li, Yan-Ping; Tian, Yao; Li, Rong-Cheng; Li, Zhuo; Zhu, Xinlin; Li, Jun-Hong; Cai, Jun; Liu, Li; Miao, Xiao-Ping; Liu, Ying; Li, Hui			Evaluation of Genetic Susceptibility Loci for Chronic Hepatitis B in Chinese: Two Independent Case-Control Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VITAMIN-D-RECEPTOR; VIRUS INFECTION; TNF-ALPHA; HEPATOCELLULAR-CARCINOMA; PROMOTER POLYMORPHISMS; OUTCOMES; POPULATION; ALLELE; CLEARANCE	Background: A recent genome-wide scan has identified two genetic variants in the HLA-DP region strongly associated with hepatitis B infection in Japanese. This study evaluates the effects of these risk variants in Chinese, where the HBV infection is the most popular in the world. Methods and Findings: We have assessed the relationship between these two single nucleotide polymorphisms (rs3077 and rs9277535) and chronic hepatitis B infection in two independent case-control studies. The first population in Chinese Han included 736 patients and 782 spontaneously recovered controls. The second set was established in Chinese Zhuang minority of 177 patients and 208 controls. Both A alleles of rs3077 and rs9277535 significantly deceased the risk to CHB in Chinese Han (OR = 0.540, 95% CI: 0.464-0.628, P = 4.068x10(-16) and OR = 0.696, 95% CI: 0.601-0.806, P = 1.062x10(-26), respectively). Conceivably, rs9277535 was found to be associated with decreased risk of the disease in Chinese Zhuang, with an OR of 0.606 (95% CI, 0.441-0.833, P = 0.002). Conclusion: Chronic hepatitis B susceptibility loci in HLA-DP region (rs3077 and rs9277535) identified by genome-wide scan in Japanese population were validated in Chinese population. These findings might provide clues to develop screening and surveillance strategies.	[Wang, Li; Li, Hui] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Wu, Xiao-Pan; Tian, Yao; Liu, Ying] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Wei] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Wang, Ying; Liu, Li; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Wang, Ying; Liu, Li; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Li, Yan-Ping; Li, Rong-Cheng] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Li, Zhuo; Li, Jun-Hong] Capital Univ Med Sci, Affiliated Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Cai, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Dept Virol, Wuhan, Hubei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Capital Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Wang, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China.	miaoxp@mail.hust.edu.cn; liuyingpumc@yahoo.com; lihui99360@vip.sohu.com	wang, YA XING/K-9671-2016; li, yan/GTI-4638-2022; miao, xiaoping/C-4336-2011	wang, YA XING/0000-0003-2749-7793; miao, xiaoping/0000-0002-6818-9722	National Key Project of Infectious disease [2009ZX10004-903, 2008ZX10002-001]; National Basic Research Program of China (973 program) [2007CB512806]; National High Technology Research and Development Program of China (863 Program) [2006AA02A4100]; Science Fund for Creative Research Groups [30721063]; Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences [2009PY16]	National Key Project of Infectious disease; National Basic Research Program of China (973 program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences	This work was supported by National Key Project of Infectious disease (Grant number: 2009ZX10004-903 and 2008ZX10002-001); National Basic Research Program of China (973 program, Grant number: 2007CB512806); National High Technology Research and Development Program of China (863 Program, Grant number: 2006AA02A4100); Science Fund for Creative Research Groups (Grant number: 30721063); Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (Grant number: 2009PY16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cao TH, 2002, J GEN VIROL, V83, P3023, DOI 10.1099/0022-1317-83-12-3023; Cheong JY, 2006, J GASTROEN HEPATOL, V21, P1163, DOI 10.1111/j.1440-1746.2006.04304.x; Cho SW, 2008, J KOREAN MED SCI, V23, P838, DOI 10.3346/jkms.2008.23.5.838; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; Du T, 2006, J VIRAL HEPATITIS, V13, P618, DOI 10.1111/j.1365-2893.2006.00731.x; Gaston JSH, 1997, HUM IMMUNOL, V54, P40, DOI 10.1016/S0198-8859(97)00003-7; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Huang YW, 2010, GENES IMMUN, V11, P87, DOI 10.1038/gene.2009.65; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Koulentaki Meri, 2004, Eur J Intern Med, V15, P35, DOI 10.1016/j.ejim.2003.11.004; Kummee P, 2007, J VIRAL HEPATITIS, V14, P841, DOI 10.1111/j.1365-2893.2007.00880.x; Li HQ, 2006, BIOMED ENVIRON SCI, V19, P133; Li Jun-hong, 2006, Zhonghua Yi Xue Za Zhi, V86, P1952; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; LIN TM, 1989, ANTICANCER RES, V9, P737; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lu Liang-ping, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P427; Nicholson I, 1997, HUM IMMUNOL, V55, P163, DOI 10.1016/S0198-8859(97)00091-8; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Ramezani A, 2008, J GASTROEN HEPATOL, V23, P1716, DOI 10.1111/j.1440-1746.2008.05482.x; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suneetha PV, 2006, J HEPATOL, V44, P856, DOI 10.1016/j.jhep.2006.01.028; Thursz M, 2001, ANTIVIR RES, V52, P113, DOI 10.1016/S0166-3542(01)00175-9; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Urbani S, 2005, HEPATOLOGY, V41, P826, DOI 10.1002/hep.20614; Wang FS, 2003, WORLD J GASTROENTERO, V9, P641, DOI 10.3748/wjg.v9.i4.641; Wu Jiang, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P555; Xun Yun-hao, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P430; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008; Zheng MH, 2010, INT J INFECT DIS, V14, pE580, DOI 10.1016/j.ijid.2009.08.010	36	57	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17608	10.1371/journal.pone.0017608	http://dx.doi.org/10.1371/journal.pone.0017608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408128	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000046
J	Gill, A; Scanlon, TC; Osipovitch, DC; Madden, DR; Griswold, KE				Gill, Avinash; Scanlon, Thomas C.; Osipovitch, Daniel C.; Madden, Dean R.; Griswold, Karl E.			Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity	PLOS ONE			English	Article							ELECTROSTATIC INTERACTIONS; ANTIMICROBIAL ACTIVITY; PULMONARY INFECTIONS; F-ACTIN; PATHOPHYSIOLOGY; MANAGEMENT	Human lysozyme is a key component of the innate immune system, and recombinant forms of the enzyme represent promising leads in the search for therapeutic agents able to treat drug-resistant infections. The wild type protein, however, fails to participate effectively in clearance of certain infections due to inherent functional limitations. For example, wild type lysozymes are subject to electrostatic sequestration and inactivation by anionic biopolymers in the infected airway. A charge engineered variant of human lysozyme has recently been shown to possess improved antibacterial activity in the presence of disease associated inhibitory molecules. Here, the 2.04 angstrom crystal structure of this variant is presented along with an analysis that provides molecular level insights into the origins of the protein's enhanced performance. The charge engineered variant's two mutated amino acids exhibit stabilizing interactions with adjacent native residues, and from a global perspective, the mutations cause no gross structural perturbations or loss of stability. Importantly, the two substitutions dramatically expand the negative electrostatic potential that, in the wild type enzyme, is restricted to a small region near the catalytic residues. The net result is a reduction in the overall strength of the engineered enzyme's electrostatic potential field, and it appears that the specific nature of this remodeled field underlies the variant's reduced susceptibility to inhibition by anionic biopolymers.	[Gill, Avinash; Scanlon, Thomas C.; Griswold, Karl E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Osipovitch, Daniel C.] Dartmouth Coll, Program Expt & Mol Med, Hanover, NH 03755 USA; [Madden, Dean R.] Dartmouth Coll, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Madden, Dean R.; Griswold, Karl E.] Dartmouth Coll, Program Mol & Cellular Biol, Hanover, NH 03755 USA; [Griswold, Karl E.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Gill, A (corresponding author), Bioarchitecture Lab, Berkeley, CA USA.	Karl.E.Griswold@Dartmouth.edu	Griswold, Karl/B-3449-2012	Griswold, Karl/0000-0002-9835-3394	Wallace H. Coulter Foundation; Cystic Fibrosis Foundation [SCANLO08F0, P20RR018787-06]; National Center for Research Resources (NCRR), a component of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER	Wallace H. Coulter Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Center for Research Resources (NCRR), a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Wallace H. Coulter Foundation (http://www.whcf.org/) Early Career Award, a Cystic Fibrosis Foundation (http://www.cff.org/) Carol Basbaum Memorial Postdoctoral Fellowship (SCANLO08F0), and P20RR018787-06 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cole AM, 2002, J IMMUNOL, V169, P6985, DOI 10.4049/jimmunol.169.12.6985; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GOVAN JRW, 1992, BRIT MED BULL, V48, P912, DOI 10.1093/oxfordjournals.bmb.a072585; Higo J, 2002, J COMPUT CHEM, V23, P1323, DOI 10.1002/jcc.10100; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koshiba T, 2000, BIOCHEMISTRY-US, V39, P3248, DOI 10.1021/bi991525a; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Nash JA, 2006, J IMMUNOL, V177, P519, DOI 10.4049/jimmunol.177.1.519; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Projan SJ, 2007, ANTIMICROB AGENTS CH, V51, P1133, DOI 10.1128/AAC.01370-06; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rogers DF, 2007, RESP CARE, V52, P1134; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; Sanders LK, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108302; Sanders LK, 2007, P NATL ACAD SCI USA, V104, P15994, DOI 10.1073/pnas.0705898104; Scanlon TC, 2010, ACS CHEM BIOL, V5, P809, DOI 10.1021/cb1001119; SHIRE SJ, 1996, PHARM BIOTECHNOLOGY, P393; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; SONG HW, 1994, J MOL BIOL, V244, P522, DOI 10.1006/jmbi.1994.1750; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Ulmer JS, 1996, P NATL ACAD SCI USA, V93, P8225, DOI 10.1073/pnas.93.16.8225; Voynow JA, 2008, INT J BIOCHEM CELL B, V40, P1238, DOI 10.1016/j.biocel.2008.03.003; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC	32	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16788	10.1371/journal.pone.0016788	http://dx.doi.org/10.1371/journal.pone.0016788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408218	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800007
J	Gezen-Ak, D; Dursun, E; Yilmazer, S				Gezen-Ak, Duygu; Dursun, Erdinc; Yilmazer, Selma			The Effects of Vitamin D Receptor Silencing on the Expression of LVSCC-A1C and LVSCC-A1D and the Release of NGF in Cortical Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; D DEFICIENCY; D HORMONE; GENE; 1,25-DIHYDROXYVITAMIN-D3; NEUROTOXICITY; POLYMORPHISM; ASSOCIATION; VDR	Background: Recent studies have suggested that vitamin D can act on cells in the nervous system. Associations between polymorphisms in the vitamin D receptor (VDR), age-dependent cognitive decline, and insufficient serum 25 hydroxyvitamin D3 levels in Alzheimer's patients and elderly people with cognitive decline have been reported. We have previously shown that amyloid beta (A beta) treatment eliminates VDR protein in cortical neurons. These results suggest a potential role for vitamin D and vitamin D-mediated mechanisms in Alzheimer's disease (AD) and neurodegeneration. Vitamin D has been shown to down-regulate the L-type voltage-sensitive calcium channels, LVSCC-A1C and LVSCC-A1D, and up-regulate nerve growth factor (NGF). However, expression of these proteins when VDR is repressed is unknown. The aim of this study is to investigate LVSCC-A1C, LVSCC-A1D expression levels and NGF release in VDR-silenced primary cortical neurons prepared from Sprague-Dawley rat embryos. Methodology/Principal Findings: qRT-PCR and western blots were performed to determine VDR, LVSCC-A1C and -A1D expression levels. NGF and cytotoxicity levels were determined by ELISA. Apoptosis was determined by TUNEL. Our findings illustrate that LVSCC-A1C mRNA and protein levels increased rapidly in cortical neurons when VDR is down-regulated, whereas, LVSCC-A1D mRNA and protein levels did not change and NGF release decreased in response to VDR downregulation. Although vitamin D regulates LVSCC-A1C through VDR, it may not regulate LVSCC-A1D through VDR. Conclusions/Significance: Our results indicate that suppression of VDR disrupts LVSCC-A1C and NGF production. In addition, when VDR is suppressed, neurons could be vulnerable to aging and neurodegeneration, and when combined with Ab toxicity, it is possible to explain some of the events that occur during neurodegeneration.	[Gezen-Ak, Duygu; Dursun, Erdinc; Yilmazer, Selma] Istanbul Univ, Cerrahpasa Fac Med, Dept Med Biol, Istanbul, Turkey	Istanbul University; Istanbul University - Cerrahpasa	Gezen-Ak, D (corresponding author), Istanbul Univ, Cerrahpasa Fac Med, Dept Med Biol, Istanbul, Turkey.	selmayilmazer@mynet.com	Gezen-Ak, Duygu/D-2679-2019; Dursun, Erdinc/D-2666-2019; Dursun, Erdinc/AAH-9516-2019	Gezen-Ak, Duygu/0000-0001-7611-2111; Dursun, Erdinc/0000-0003-3701-6674; Dursun, Erdinc/0000-0003-3701-6674	Istanbul University [T-942/06102006, 548]; Scientific and Technological Research Council of Turkey-TUBITAK [107S041]	Istanbul University(Istanbul University); Scientific and Technological Research Council of Turkey-TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The present work was supported by the Research Fund of Istanbul University (http://bilimap.istanbul.edu.tr/en_index.htm) (Project No. T-942/06102006 and 548) and by the Scientific and Technological Research Council of Turkey-TUBITAK (http://www.tubitak.gov.tr/en/ot/10/;jsessionid=7858A45C2E6CB391140969EB6419650B) (Project No. 107S041).	Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Bouillon R, 1998, OSTEOPOROSIS INT, V8, pS13, DOI 10.1007/PL00022727; Brewer LD, 2006, CELL CALCIUM, V40, P277, DOI 10.1016/j.ceca.2006.04.001; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Cornet A, 1998, J NEUROSCI RES, V53, P742, DOI 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Dursun E, 2009, DEMENT GERIATR COGN, V27, P82, DOI 10.1159/000193627; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Fleet JC, 2004, J NUTR, V134, P3215, DOI 10.1093/jn/134.12.3215; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gezen-Ak D, 2007, TOHOKU J EXP MED, V212, P275, DOI 10.1620/tjem.212.275; HOLICK MF, 1995, BONE, V17, pS107, DOI 10.1016/8756-3282(95)00195-J; Kato S, 1998, J BONE MINER METAB, V16, P65, DOI 10.1007/s007740050028; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Khazai Natasha, 2008, Curr Rheumatol Rep, V10, P110, DOI 10.1007/s11926-008-0020-y; Kuningas M, 2009, NEUROBIOL AGING, V30, P466, DOI 10.1016/j.neurobiolaging.2007.07.001; Landfield PW, 1998, NEUROBIOL AGING, V19, P469, DOI 10.1016/S0197-4580(98)00079-7; Larrosa M, 2001, MED CLIN-BARCELONA, V117, P611, DOI 10.1016/S0025-7753(01)72195-1; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; Llewellyn DJ, 2009, J GERIATR PSYCH NEUR, V22, P188, DOI 10.1177/0891988708327888; LUINE V N, 1987, Steroids, V49, P133, DOI 10.1016/0039-128X(87)90082-1; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Peeraully MR, 2004, AM J PHYSIOL-ENDOC M, V287, pE331, DOI 10.1152/ajpendo.00076.2004; Price P., 1998, PROTOCOLS NEURAL CEL, P255; Rozema D. B., 2003, TARGETS, V2, P253; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; WION D, 1991, J NEUROSCI RES, V28, P110, DOI 10.1002/jnr.490280111; YAMAGUCHI M, 2002, ADV CELL AGING GERON, V10, P47; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	38	88	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17553	10.1371/journal.pone.0017553	http://dx.doi.org/10.1371/journal.pone.0017553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408608	gold, Green Published, Green Submitted			2022-12-27	WOS:000287965200024
J	Perini, F; Casabianca, A; Battocchi, C; Accoroni, S; Totti, C; Penna, A				Perini, Federico; Casabianca, Anna; Battocchi, Cecilia; Accoroni, Stefano; Totti, Cecilia; Penna, Antonella			New Approach Using the Real-Time PCR Method for Estimation of the Toxic Marine Dinoflagellate Ostreopsis cf. ovata in Marine Environment	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PALYTOXIN-LIKE; ALEXANDRIUM-MINUTUM; QUANTITATIVE PCR; QUANTIFICATION; ASSAY; DINOPHYCEAE; RDNA; SEA; IDENTIFICATION	Background: We describe the development and validation of a new quantitative real time PCR (qrt-PCR) method for the enumeration of the toxic benthic dinoflagellate Ostreopsis cf. ovata in marine environment. The benthic Ostreopsis sp. has a world-wide distribution and is associated during high biomass proliferation with the production of potent palytoxin-like compounds affecting human health and environment. Species-specific identification, which is relevant for the complex of different toxins production, by traditional methods of microscopy is difficult due to the high morphological variability, and thus different morphotypes can be easily misinterpreted. Methodology/Findings: The method is based on the SYBR I Green real-time PCR technology and combines the use of a plasmid standard curve with a "gold standard" created with pooled crude extracts from environmental samples collected during a bloom event of Ostreopsis cf. ovata in the Mediterranean Sea. Based on their similar PCR efficiencies (95% and 98%, respectively), the exact rDNA copy number per cell was obtained in cultured and environmental samples. Cell lysates were used as the templates to obtain total recovery of DNA. The analytical sensitivity of the PCR was set at two rDNA copy number and 8.0x10(-4) cell per reaction for plasmid and gold standards, respectively; the sensitivity of the assay was of cells g(-1) fw or 1(-1) in macrophyte and seawater samples, respectively. The reproducibility was determined on the total linear quantification range of both curves confirming the accuracy of the technical set-up in the complete ranges of quantification over time. Conclusions/Significance: We developed a qrt-PCR assay specific, robust and high sample throughput for the absolute quantification of the toxic dinoflagellate Ostreopsis cf. ovata in the environmental samples. This molecular approach may be considered alternative to traditional microscopy and applied for the monitoring of benthic toxic microalgal species in the marine ecosystems.	[Perini, Federico; Casabianca, Anna; Battocchi, Cecilia; Penna, Antonella] Univ Urbino, Dept Biomol Sci, Pesaro, Italy; [Accoroni, Stefano; Totti, Cecilia] Polytech Univ Marche, Dept Marine Sci, Ancona, Italy	University of Urbino; Marche Polytechnic University	Penna, A (corresponding author), Univ Urbino, Dept Biomol Sci, Pesaro, Italy.	antonella.penna@uniurb.it	Accoroni, Stefano/F-5818-2014; Totti, Cecilia Maria/A-9178-2016	Accoroni, Stefano/0000-0002-1134-7849; Totti, Cecilia Maria/0000-0002-1532-6009	Sixth Framework Programme [GOCE-003875]	Sixth Framework Programme(European Commission)	The work was supported by ISPRA Project "Ostreopsis ovata e Ostreopsis spp.: nuovi rischi di tossicita microalgale nei mari italiani"; PRIN 2007 Grant prot. FXSCL2; EC Contract No. GOCE-003875, funded by the Sixth Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligizaki K, 2008, TOXICON, V51, P418, DOI 10.1016/j.toxicon.2007.10.016; Battocchi C, 2010, MAR POLLUT BULL, V60, P1074, DOI 10.1016/j.marpolbul.2010.01.017; Casabianca A, 2007, MOL CELL PROBE, V21, P368, DOI 10.1016/j.mcp.2007.05.005; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Desire N, 2001, J CLIN MICROBIOL, V39, P1303, DOI 10.1128/JCM.39.4.1303-1310.2001; Edler L., 2010, MICROSCOPIC MOL METH, P13, DOI DOI 10.1016/J.RESP.2011.02.009; Erdner DL, 2010, DEEP-SEA RES PT II, V57, P279, DOI 10.1016/j.dsr2.2009.09.006; Galluzzi L, 2004, APPL ENVIRON MICROB, V70, P1199, DOI 10.1128/AEM.70.2.1199-1206.2004; Galluzzi L, 2010, J APPL PHYCOL, V22, P1, DOI 10.1007/s10811-009-9411-3; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Greenwood SJ, 2001, NUCLEIC ACIDS RES, V29, P2191, DOI 10.1093/nar/29.10.2191; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenoir S, 2004, J PHYCOL, V40, P1042, DOI 10.1111/j.1529-8817.2004.04016.x; Torres-Machorro AL, 2010, FEMS MICROBIOL REV, V34, P59, DOI 10.1111/j.1574-6976.2009.00196.x; Mangialajo L, 2008, MAR POLLUT BULL, V56, P1209, DOI 10.1016/j.marpolbul.2008.02.028; Maruyama S, 2007, J EUKARYOT MICROBIOL, V54, P333, DOI 10.1111/j.1550-7408.2007.00273.x; Penna A, 2005, J PHYCOL, V41, P212, DOI 10.1111/j.1529-8817.2005.04011.x; Penna A, 2010, J BIOGEOGR, V37, P830, DOI 10.1111/j.1365-2699.2009.02265.x; Riobo P, 2006, ANAL CHIM ACTA, V566, P217, DOI 10.1016/j.aca.2006.03.013; Rott E, 2007, HYDROBIOLOGIA, V578, P141, DOI 10.1007/s10750-006-0440-5; Saito K, 2002, APPL ENVIRON MICROB, V68, P5394, DOI 10.1128/AEM.68.11.5394-5407.2002; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Shears NT, 2009, HARMFUL ALGAE, V8, P916, DOI 10.1016/j.hal.2009.05.003; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; TOTTI C, 2004, MEDITERRANEAN MARINE, P247; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; Touzet N, 2009, FEMS MICROBIOL ECOL, V67, P329, DOI 10.1111/j.1574-6941.2008.00627.x; Vaitomaa J, 2003, APPL ENVIRON MICROB, V69, P7289, DOI 10.1128/AEM.69.12.7289-7297.2003; Vila M, 2001, AQUAT MICROB ECOL, V26, P51, DOI 10.3354/ame026051; YASUMOTO T, 1987, BIOL BULL, V172, P128, DOI 10.2307/1541612; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	33	67	69	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17699	10.1371/journal.pone.0017699	http://dx.doi.org/10.1371/journal.pone.0017699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408606	Green Submitted, Green Published, gold			2022-12-27	WOS:000287965200036
J	Shiroiwa, Y; Hayashi, T; Fujita, Y; Villar-Briones, A; Ikai, N; Takeda, K; Ebe, M; Yanagida, M				Shiroiwa, Yoshiharu; Hayashi, Takeshi; Fujita, Yohta; Villar-Briones, Alejandro; Ikai, Nobuyasu; Takeda, Kojiro; Ebe, Masahiro; Yanagida, Mitsuhiro			Mis17 Is a Regulatory Module of the Mis6-Mal2-Sim4 Centromere Complex That Is Required for the Recruitment of CenH3/CENP-A in Fission Yeast	PLOS ONE			English	Article							CELL-DIVISION CYCLE; CENP-A NUCLEOSOMES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; PROTEIN-KINASES; BUDDING YEAST; OUTER KINETOCHORE; GROWTH POLARITY; GENETIC-CONTROL	Background: The centromere is the chromosome domain on which the mitotic kinetochore forms for proper segregation. Deposition of the centromeric histone H3 (CenH3, CENP-A) is vital for the formation of centromere-specific chromatin. The Mis6-Mal2-Sim4 complex of the fission yeast S. pombe is required for the recruitment of CenH3 (Cnp1), but its function remains obscure. Methodology/Principal Findings: Mass spectrometry was performed on the proteins precipitated with Mis6- and Mis17-FLAG. The results together with the previously identified Sim4- and Mal2-TAP precipitated proteins indicated that the complex contains 12 subunits, Mis6, Sim4, Mal2, Mis15, Mis17, Cnl2, Fta1-4, Fta6-7, nine of which have human centromeric protein (CENP) counterparts. Domain dissection indicated that the carboxy-half of Mis17 is functional, while its amino-half is regulatory. Overproduction of the amino-half caused strong negative dominance, which led to massive chromosome missegregation and hypersensitivity to the histone deacetylase inhibitor TSA. Mis17 was hyperphosphorylated and overproduction-induced negative dominance was abolished in six kinase-deletion mutants, ssp2 (AMPK), ppk9 (AMPK), ppk15 (Yak1), ppk30 (Ark1), wis4 (Ssk2), and lsk1 (P-TEFb). Conclusions: Mis17 may be a regulatory module of the Mis6 complex. Negative dominance of the Mis17 fragment is exerted while the complex and CenH3 remain at the centromere, a result that differs from the mislocalization seen in the mis17-362 mutant. The known functions of the kinases suggest an unexpected link between Mis17 and control of the cortex actin, nutrition, and signal/transcription. Possible interpretations are discussed.	[Shiroiwa, Yoshiharu; Hayashi, Takeshi; Fujita, Yohta; Ikai, Nobuyasu; Ebe, Masahiro; Yanagida, Mitsuhiro] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan; [Hayashi, Takeshi; Villar-Briones, Alejandro; Takeda, Kojiro; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Promot Corp, Okinawa, Japan	Kyoto University; Okinawa Institute of Science & Technology Graduate University	Shiroiwa, Y (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan.	yanagida@kozo.lif.kyoto-ac.jp		Villar-Briones, Alejandro/0000-0002-4246-3877	Japan Science and Technology Corporation (JST); Okinawa Institute of Science and Technology	Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University)	The present work was supported by grants from the Japan Science and Technology Corporation (JST, CREST research project; http://www.jst.go.jp/kisoken/crest/en/index.html) and from the Initial Research Project for the Okinawa Institute of Science and Technology (http://www.oist.jp/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; CLARKE L, 1985, ANNU REV GENET, V19, P29, DOI 10.1146/annurev.ge.19.120185.000333; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Erler A, 2006, YEAST, V23, P813, DOI 10.1002/yea.1396; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hayashi A, 2006, MOL BIOL CELL, V17, P5173, DOI 10.1091/mbc.E06-05-0388; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kabir MA, 2005, YEAST, V22, P219, DOI 10.1002/yea.1210; Karagiannis J, 2005, MOL BIOL CELL, V16, P358, DOI 10.1091/mbc.E04-06-0502; Karagiannis J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000433; Kimata Y, 2008, J CELL SCI, V121, P1107, DOI 10.1242/jcs.024224; Koyano T, 2010, BIOSCI BIOTECH BIOCH, V74, P1129, DOI 10.1271/bbb.100223; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Smythe E, 2003, EMBO REP, V4, P246, DOI 10.1038/sj.embor.embor776; SPENCER F, 1990, GENETICS, V124, P237; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Toda T, 1996, J CELL SCI, V109, P2331; Tsuduki T, 2006, MOL CELL BIOL, V26, P7682, DOI 10.1128/MCB.00355-06; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yanagida M, 2005, PHILOS T R SOC B, V360, P609, DOI 10.1098/rstb.2004.1615; Yuzyuk T, 2002, MOL BIOL CELL, V13, P2869, DOI 10.1091/mbc.02-01-0004	61	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17761	10.1371/journal.pone.0017761	http://dx.doi.org/10.1371/journal.pone.0017761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445296	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300013
J	Crosio, C; Valle, C; Casciati, A; Iaccarino, C; Carri, MT				Crosio, Claudia; Valle, Cristiana; Casciati, Arianna; Iaccarino, Ciro; Carri, Maria Teresa			Astroglial Inhibition of NF-kappa B Does Not Ameliorate Disease Onset and Progression in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; REACTIVE ASTROCYTES; TRANSGENIC INHIBITION; INNATE IMMUNITY; NERVOUS-SYSTEM; CELL-DEATH; INFLAMMATION; EXPRESSION; SURVIVAL; ABLATION	Motor neuron death in amyotrophic lateral sclerosis (ALS) is considered a "non-cell autonomous" process, with astrocytes playing a critical role in disease progression. Glial cells are activated early in transgenic mice expressing mutant SOD1, suggesting that neuroinflammation has a relevant role in the cascade of events that trigger the death of motor neurons. An inflammatory cascade including COX2 expression, secretion of cytokines and release of NO from astrocytes may descend from activation of a NF-kappa B-mediated pathway observed in astrocytes from ALS patients and in experimental models. We have attempted rescue of transgenic mutant SOD1 mice through the inhibition of the NF-kappa B pathway selectively in astrocytes. Here we show that despite efficient inhibition of this major pathway, double transgenic mice expressing the mutant SOD1(G93A) ubiquitously and the dominant negative form of I kappa B alpha (I kappa B alpha AA) in astrocytes under control of the GFAP promoter show no benefit in terms of onset and progression of disease. Our data indicate that motor neuron death in ALS cannot be prevented by inhibition of a single inflammatory pathway because alternative pathways are activated in the presence of a persistent toxic stimulus.	[Crosio, Claudia; Iaccarino, Ciro] Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy; [Crosio, Claudia; Valle, Cristiana; Casciati, Arianna; Iaccarino, Ciro; Carri, Maria Teresa] Fdn Santa Lucia IRCCS, CERC, Rome, Italy; [Valle, Cristiana] CNR, Cell Biol & Neurobiol Inst, Monterotondo, Italy; [Carri, Maria Teresa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of Sassari; IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata	Crosio, C (corresponding author), Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy.	ccrosio@uniss.it	valle, cristiana/J-7302-2018; Carri, Maria Teresa/K-5480-2016	valle, cristiana/0000-0002-0914-6511; Carri, Maria Teresa/0000-0002-1789-1546	Telethon [GGP07018]; Sisal	Telethon(Fondazione Telethon); Sisal	This work was supported by Telethon (GGP07018) and Sisal to M.T.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Aggarwal S, 2008, NEUROTHERAPEUTICS, V5, P516, DOI 10.1016/j.nurt.2008.08.002; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brambilla R, 2009, J NEUROCHEM, V110, P765, DOI 10.1111/j.1471-4159.2009.06190.x; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAMPER SA, 1987, BIOTECHNIQUES, V5, P638; Carri MT, 2006, TRENDS PHARMACOL SCI, V27, P267, DOI 10.1016/j.tips.2006.03.009; Casciati A, 2002, J NEUROCHEM, V83, P1019, DOI 10.1046/j.1471-4159.2002.01232.x; Cereda C, 2008, J NEUROIMMUNOL, V194, P123, DOI 10.1016/j.jneuroim.2007.10.028; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Ekestern E, 2004, NEURODEGENER DIS, V1, P88, DOI 10.1159/000080049; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Ferri A, 2004, FASEB J, V18, P1261, DOI 10.1096/fj.03-1199fje; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Juttler E, 2007, J NEUROIMMUNOL, V189, P41, DOI 10.1016/j.jneuroim.2007.06.020; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; KEILHOFF G, 1991, NEUROSCIENCE, V43, P35, DOI 10.1016/0306-4522(91)90414-J; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; Li B, 2008, BRAIN RES, V1226, P199, DOI 10.1016/j.brainres.2008.06.024; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Migheli A, 1997, J NEUROPATH EXP NEUR, V56, P1314, DOI 10.1097/00005072-199712000-00006; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; MUCKE L, 1991, NEW BIOL, V3, P465; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Nolte C, 2001, GLIA, V33, P72; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Phulwani NK, 2008, J IMMUNOL, V181, P3841, DOI 10.4049/jimmunol.181.6.3841; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Qin LY, 2005, GLIA, V52, P78, DOI 10.1002/glia.20225; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Staats KA, 2009, J BIOL PHYS, V35, P337, DOI 10.1007/s10867-009-9141-4; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; TOLOSA L, 2010, MOL CELL NEUROSCI; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; WANG L, 2010, HUM MOL GENET; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004	61	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17187	10.1371/journal.pone.0017187	http://dx.doi.org/10.1371/journal.pone.0017187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445241	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100011
J	Ria, M; Lagercrantz, J; Samnegard, A; Boquist, S; Hamsten, A; Eriksson, P				Ria, Massimiliano; Lagercrantz, Jacob; Samnegard, Ann; Boquist, Susanna; Hamsten, Anders; Eriksson, Per			A Common Polymorphism in the Promoter Region of the TNFSF4 Gene Is Associated with Lower Allele-Specific Expression and Risk of Myocardial Infarction	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED T-CELLS; OX40 LIGAND; MAST-CELLS; ATHEROSCLEROSIS SUSCEPTIBILITY; RECEPTOR; TRANSCRIPTION; POPULATION; MICE; DIFFERENTIATION	Background: The TNFSF4/TNFRSF4 system, along with several other receptor-ligand pairs, is involved in the recruitment and activation of T-cells and is therefore tentatively implicated in atherosclerosis and acute coronary syndromes. We have previously shown that genetic variants in TNFSF4 are associated with myocardial infarction (MI) in women. This prompted functional studies of TNFSF4 expression. Methods and Results: Based on a screening of the TNFSF4 genomic region, a promoter polymorphism (rs45454293) and a haplotype were identified, conceivably involved in gene regulation. The rs45454293T-allele, in agreement with the linked rs3850641G-allele, proved to be associated with increased risk of MI in women. Haplotype-specific chromatin immunoprecipitation of activated polymerase II, as a measure of transcriptional activity in vivo, suggested that the haplotype including the rs45454293 and rs3850641 polymorphisms is functionally important, the rs45454293T- and rs3850641G-alleles being associated with lower transcriptional activity in cells heterozygous for both polymorphisms. The functional role of rs45454293 on transcriptional levels of TNFSF4 was clarified by luciferase reporter assays, where the rs45454293T-allele decreased gene expression when compared with the rs45454293C-allele, while the rs3850641 SNP did not have any effect on TNFSF4 promoter activity. Electromobility shift assay showed that the rs45454293 polymorphism, but not rs3850641, affects the binding of nuclear factors, thus suggesting that the lower transcriptional activity is attributed to binding of one or more transcriptional repressor(s) to the T-allele. Conclusions: Our data indicate that the TNFSF4 rs45454293T-allele is associated with lower TNFSF4 expression and increased risk of MI.	[Ria, Massimiliano; Lagercrantz, Jacob; Boquist, Susanna; Hamsten, Anders; Eriksson, Per] Karolinska Univ Hosp Solna, Atherosclerosis Res Unit, Ctr Mol Med, Dept Med, Stockholm, Sweden; [Samnegard, Ann] Danderyd Hosp, Div Cardiovasc Med, Dept Clin Sci, Karolinska Inst, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet	Ria, M (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England.	massimiliano.ria@well.ox.ac.uk		Eriksson, Per/0000-0002-5635-2692	Swedish Heart-Lung foundation; Swedish Medical Research Council [8691, 12660]; European Commission [LSHM-CT-2007-037273]; K&A Wallenberg Foundation; Leducq Foundation; AFA insurance; King Gustaf V 80th Birthday foundation; Stockholm County Council [550210, 560183]	Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Leducq Foundation(Leducq Foundation); AFA insurance; King Gustaf V 80th Birthday foundation; Stockholm County Council(Stockholm County Council)	This study was supported by grants from the Swedish Heart-Lung foundation, the Swedish Medical Research Council (8691, 12660), the European Commission (LSHM-CT-2007-037273), the K&A Wallenberg Foundation, the Leducq Foundation, AFA insurance, the King Gustaf V 80th Birthday foundation and the Stockholm County Council (projects 550210 and 560183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKSNIS M, 1991, J BIOL CHEM, V266, P10078; Andersen MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040005; [Anonymous], 2004, SCIENCE, V306, P636; Barbaro M, 2009, EUR J HUM GENET, V17, P1439, DOI 10.1038/ejhg.2009.70; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; Dehbi M, 1996, ONCOGENE, V13, P447; DUBOIS PC, NAT GENET, V42, P295; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hikami K, 2000, GENES IMMUN, V1, P521, DOI 10.1038/sj.gene.6363709; Holmberg K, 2005, CLIN CHEM, V51, P1549, DOI 10.1373/clinchem.2005.049932; Hori T, 2006, INT J HEMATOL, V83, P17, DOI 10.1532/IJH97.05151; Imura A, 1996, J EXP MED, V183, P2185, DOI 10.1084/jem.183.5.2185; KALB VF, 1977, ANAL BIOCHEM, V82, P362, DOI 10.1016/0003-2697(77)90173-7; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Koch W, 2008, NAT GENET, V40, P1386, DOI 10.1038/ng1208-1386; Malarstig A, 2008, CLIN CHEM, V54, P833, DOI 10.1373/clinchem.2007.096479; Nishimoto H, 2005, BLOOD, V106, P4241, DOI 10.1182/blood-2005-04-1358; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; QIAO JH, 1994, ARTERIOSCLER THROMB, V14, P1480, DOI 10.1161/01.ATV.14.9.1480; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Samnegard A, 2005, J INTERN MED, V258, P411, DOI 10.1111/j.1365-2796.2005.01561.x; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stopfer P, 2004, J IMMUNOL, V172, P7459, DOI 10.4049/jimmunol.172.12.7459; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; van Wanrooij EJA, 2007, ARTERIOSCL THROM VAS, V27, P204, DOI 10.1161/01.ATV.0000251007.07648.81; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Weinberg AD, 2002, TRENDS IMMUNOL, V23, P102, DOI 10.1016/S1471-4906(01)02127-5; Whatling C, 2004, J LIPID RES, V45, P1768, DOI 10.1194/jlr.M400195-JLR200; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhu CY, 2006, BIOCHEM BIOPH RES CO, V348, P1150, DOI 10.1016/j.bbrc.2006.07.174	36	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17652	10.1371/journal.pone.0017652	http://dx.doi.org/10.1371/journal.pone.0017652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445270	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100024
J	Sun, H; Clancy, HA; Kluz, T; Zavadil, J; Costa, M				Sun, Hong; Clancy, Harriet A.; Kluz, Thomas; Zavadil, Jiri; Costa, Max			Comparison of Gene Expression Profiles in Chromate Transformed BEAS-2B Cells	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; LUNG-CANCER; HEXAVALENT CHROMIUM; GROWTH-FACTOR; MICROSATELLITE INSTABILITY; DESMOSOMAL ADHESION; EXPOSED WORKERS; MISMATCH REPAIR; NUDE MICE; TGF-BETA	Background: Hexavalent chromium [Cr(VI)] is a potent human carcinogen. Occupational exposure has been associated with increased risk of respiratory cancer. Multiple mechanisms have been shown to contribute to Cr(VI) induced carcinogenesis, including DNA damage, genomic instability, and epigenetic modulation, however, the molecular mechanism and downstream genes mediating chromium's carcinogenicity remain to be elucidated. Methods/Results: We established chromate transformed cell lines by chronic exposure of normal human bronchial epithelial BEAS-2B cells to low doses of Cr(VI) followed by anchorage-independent growth. These transformed cell lines not only exhibited consistent morphological changes but also acquired altered and distinct gene expression patterns compared with normal BEAS-2B cells and control cell lines (untreated) that arose spontaneously in soft agar. Interestingly, the gene expression profiles of six Cr(VI) transformed cell lines were remarkably similar to each other yet differed significantly from that of either control cell lines or normal BEAS-2B cells. A total of 409 differentially expressed genes were identified in Cr(VI) transformed cells compared to control cells. Genes related to cell-to-cell junction were upregulated in all Cr(VI) transformed cells, while genes associated with the interaction between cells and their extracellular matrices were down-regulated. Additionally, expression of genes involved in cell proliferation and apoptosis were also changed. Conclusion: This study is the first to report gene expression profiling of Cr(VI) transformed cells. The gene expression changes across individual chromate exposed clones were remarkably similar to each other but differed significantly from the gene expression found in anchorage-independent clones that arose spontaneously. Our analysis identified many novel gene expression changes that may contribute to chromate induced cell transformation, and collectively this type of information will provide a better understanding of the mechanism underlying chromate carcinogenicity.	[Sun, Hong; Clancy, Harriet A.; Kluz, Thomas; Costa, Max] NYU, Sch Med, Nelson Inst Environm Med, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Dept Pathol, Inst Canc, New York, NY USA; [Zavadil, Jiri] NYU, Ctr Hlth Informat & Bioinformat, Langone Med Ctr, New York, NY USA	New York University; New York University; New York University; NYU Langone Medical Center	Sun, H (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, New York, NY 10016 USA.	Max.Costa@nyumc.org	Zavadil, Jiri/ABG-1780-2020; Rodriguez, Jan/I-2910-2012; costa, max/H-1754-2012	Zavadil, Jiri/0000-0003-0640-5562; Rodriguez, Jan/0000-0003-0367-2331; 	National Institutes of Environmental Health Sciences [ES000260, ES014454, ES005512, ES010344]; National Cancer Institute [CA16087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260, R01ES005512, R01ES014454] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant numbers ES000260, ES014454, ES005512, ES010344 from the National Institutes of Environmental Health Sciences, and grant number CA16087 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; Anumanthan G, 2005, BRIT J CANCER, V93, P1157, DOI 10.1038/sj.bjc.6602831; ARNAOUT MA, 2005, INTEGRIN STRUCTURE A; Boelens MC, 2007, J CLIN PATHOL, V60, P608, DOI 10.1136/jcp.2005.031443; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Costa AN, 2010, MOL CARCINOGEN, V49, P582, DOI 10.1002/mc.20624; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Den ZN, 2006, J CELL SCI, V119, P482, DOI 10.1242/jcs.02769; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Gavin IM, 2007, ENVIRON MOL MUTAGEN, V48, P650, DOI 10.1002/em.20331; GERWIN BI, 1992, P NATL ACAD SCI USA, V89, P2759, DOI 10.1073/pnas.89.7.2759; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Gupta S, 2003, INT J ONCOL, V22, P15; Hirose T, 2002, MOL CARCINOGEN, V33, P172, DOI 10.1002/mc.10035; Holmes AL, 2008, INDIAN J MED RES, V128, P353; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Katabami M, 2000, HUM PATHOL, V31, P973, DOI 10.1053/hupa.2000.9081; Klein CB, 2002, ENVIRON HEALTH PERSP, V110, P739, DOI 10.1289/ehp.02110s5739; Legembre P, 2004, J BIOL CHEM, V279, P46742, DOI 10.1074/jbc.M404334200; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; Monica V, 2009, MODERN PATHOL, V22, P709, DOI 10.1038/modpathol.2009.30; Nakada M, 2005, ACTA NEUROPATHOL, V110, P239, DOI 10.1007/s00401-005-1032-6; Raveh S, 2009, CANCER LETT, V282, P137, DOI 10.1016/j.canlet.2008.12.021; REDDEL RR, 1988, CANCER RES, V48, P1904; Rodrigues CFD, 2009, MUTAT RES-FUND MOL M, V670, P42, DOI 10.1016/j.mrfmmm.2009.07.004; Shi HL, 2004, FREE RADICAL BIO MED, V37, P582, DOI 10.1016/j.freeradbiomed.2004.03.012; Shimazui T, 2004, CANCER-AM CANCER SOC, V101, P963, DOI 10.1002/cncr.20479; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; STEARNS DM, 1994, CHEM RES TOXICOL, V7, P219, DOI 10.1021/tx00038a016; Sugden Kent D., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P215; Sun H, 2009, TOXICOL APPL PHARM, V237, P258, DOI 10.1016/j.taap.2009.04.008; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Twal WO, 2001, J CELL SCI, V114, P4587; Yamamoto H, 2008, BIOCHEM BIOPH RES CO, V365, P541, DOI 10.1016/j.bbrc.2007.11.013; Ye JP, 2001, MOL CELL BIOCHEM, V222, P189, DOI 10.1023/A:1017974415052; Zhitkovich A, 2005, CELL CYCLE, V4, P1050	44	39	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17982	10.1371/journal.pone.0017982	http://dx.doi.org/10.1371/journal.pone.0017982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437242	gold, Green Submitted, Green Published			2022-12-27	WOS:000288545100052
J	Thulin, E; Kesvatera, T; Linse, S				Thulin, Eva; Kesvatera, Tonu; Linse, Sara			Molecular Determinants of S100B Oligomer Formation	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; NEGATIVE REGULATORY DOMAIN; NMR-SPECTROSCOPY; RAGE ACTIVATION; PROTEINS; BINDING; P53; S100B(BETA-BETA); BRAIN; EXPRESSION	Background: S100B is a dimeric protein that can form tetramers, hexamers and higher order oligomers. These forms have been suggested to play a role in RAGE activation. Methodology/Principal Findings: Oligomerization was found to require a low molecular weight trigger/cofactor and could not be detected for highly pure dimer, irrespective of handling. Imidazol was identified as a substance that can serve this role. Oligomerization is dependent on both the imidazol concentration and pH, with optima around 90 mM imidazol and pH 7, respectively. No oligomerization was observed above pH 8, thus the protonated form of imidazol is the active species in promoting assembly of dimers to higher species. However, disulfide bonds are not involved and the process is independent of redox potential. The process was also found to be independent of whether Ca2+ is bound to the protein or not. Tetramers that are purified from dimers and imidazol by gel filtration are kinetically stable, but dissociate into dimers upon heating. Dimers do not revert to tetramer and higher oligomer unless imidazol is again added. Both tetramers and hexamers bind the target peptide from p53 with retained stoichiometry of one peptide per S100B monomer, and with high affinity (lgK = 7.3 +/- 0.2 and 7.2 +/- 0.2, respectively in 10 mM BisTris, 5 mM CaCl2, pH 7.0), which is less than one order of magnitude reduced compared to dimer under the same buffer conditions. Conclusion/Significance: S100B oligomerization requires protonated imidazol as a trigger/cofactor. Oligomers are kinetically stable after imidazol is removed but revert back to dimer if heated. The results underscore the importance of kinetic versus thermodynamic control of S100B protein aggregation.	[Thulin, Eva; Linse, Sara] Lund Univ, Dept Biochem, Lund, Sweden; [Kesvatera, Tonu] NICPB, Bioorgan Chem Lab, Tallinn, Estonia	Lund University; National Institute of Chemical Physics & Biophysics (NICPB)	Thulin, E (corresponding author), Lund Univ, Dept Biochem, Lund, Sweden.	sara.linse@biochemistry.lu.se		Linse, Sara/0000-0001-9629-7109	Swedish Research Council, VR; Crafoord Foundation; Estonian Ministry of Education and Research	Swedish Research Council, VR(Swedish Research Council); Crafoord Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by the Swedish Research Council, VR (SL), the Crafoord Foundation ( SL) and Estonian Ministry of Education and Research (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Drohat AC, 1996, BIOCHEMISTRY-US, V35, P11577, DOI 10.1021/bi9612226; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Drohat AC, 1997, PROTEIN SCI, V6, P1577, DOI 10.1002/pro.5560060721; Ferguson PL, 2004, J BIOL CHEM, V279, P18806, DOI 10.1074/jbc.M313948200; Hakansson M, 2001, PROTEIN SCI, V10, P927, DOI 10.1110/ps.47501; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; Jonsson H, 2003, RESTOR NEUROL NEUROS, V21, P151; Kilby PM, 1996, STRUCTURE, V4, P1041, DOI 10.1016/S0969-2126(96)00111-6; Kilby PM, 1997, PROTEIN SCI, V6, P2494; Laan W, 2006, BIOCHEMISTRY-US, V45, P51, DOI 10.1021/bi051367p; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Liu L, 2005, J NEUROCHEM, V92, P546, DOI 10.1111/j.1471-4159.2004.02909.x; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; McClintock KA, 2003, J BIOL CHEM, V278, P6251, DOI 10.1074/jbc.M210622200; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Smith SP, 1996, BIOCHEMISTRY-US, V35, P8805, DOI 10.1021/bi952698c; Smith SP, 1998, STRUCTURE, V6, P211, DOI 10.1016/S0969-2126(98)00022-7; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Wilder PT, 2005, BIOCHEMISTRY-US, V44, P5690, DOI 10.1021/bi0475830; Wilder PT, 2003, BIOCHEMISTRY-US, V42, P13410, DOI 10.1021/bi035334q	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14768	10.1371/journal.pone.0014768	http://dx.doi.org/10.1371/journal.pone.0014768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445240	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100004
J	Boyack, KW; Newman, D; Duhon, RJ; Klavans, R; Patek, M; Biberstine, JR; Schijvenaars, B; Skupin, A; Ma, NAL; Borner, K				Boyack, Kevin W.; Newman, David; Duhon, Russell J.; Klavans, Richard; Patek, Michael; Biberstine, Joseph R.; Schijvenaars, Bob; Skupin, Andre; Ma, Nianli; Boerner, Katy			Clustering More than Two Million Biomedical Publications: Comparing the Accuracies of Nine Text-Based Similarity Approaches	PLOS ONE			English	Article							INFORMATION; SEARCH; DECOMPOSITION; RETRIEVAL; MODELS; GRAPH	Background: We investigate the accuracy of different similarity approaches for clustering over two million biomedical documents. Clustering large sets of text documents is important for a variety of information needs and applications such as collection management and navigation, summary and analysis. The few comparisons of clustering results from different similarity approaches have focused on small literature sets and have given conflicting results. Our study was designed to seek a robust answer to the question of which similarity approach would generate the most coherent clusters of a biomedical literature set of over two million documents. Methodology: We used a corpus of 2.15 million recent (2004-2008) records from MEDLINE, and generated nine different document-document similarity matrices from information extracted from their bibliographic records, including titles, abstracts and subject headings. The nine approaches were comprised of five different analytical techniques with two data sources. The five analytical techniques are cosine similarity using term frequency-inverse document frequency vectors (tf-idf cosine), latent semantic analysis (LSA), topic modeling, and two Poisson-based language models - BM25 and PMRA (PubMed Related Articles). The two data sources were a) MeSH subject headings, and b) words from titles and abstracts. Each similarity matrix was filtered to keep the top-n highest similarities per document and then clustered using a combination of graph layout and average-link clustering. Cluster results from the nine similarity approaches were compared using (1) within-cluster textual coherence based on the Jensen-Shannon divergence, and (2) two concentration measures based on grant-to-article linkages indexed in MEDLINE. Conclusions: PubMed's own related article approach (PMRA) generated the most coherent and most concentrated cluster solution of the nine text-based similarity approaches tested, followed closely by the BM25 approach using titles and abstracts. Approaches using only MeSH subject headings were not competitive with those based on titles and abstracts.	[Boyack, Kevin W.] SciTech Strategies Inc, Albuquerque, NM USA; [Newman, David] Univ Calif Irvine, Irvine, CA USA; [Newman, David] NICTA Victorian Res Lab, Melbourne, Australia; [Duhon, Russell J.; Biberstine, Joseph R.; Ma, Nianli; Boerner, Katy] Indiana Univ, Sch Lib & Informat Sci, Bloomington, IN 47401 USA; [Klavans, Richard; Patek, Michael] SciTech Strategies Inc, Berwyn, PA USA; [Schijvenaars, Bob] Collexis Inc, Geldermalsen, Netherlands; [Skupin, Andre] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA	University of California System; University of California Irvine; Indiana University System; Indiana University Bloomington; California State University System; San Diego State University	Boyack, KW (corresponding author), SciTech Strategies Inc, Albuquerque, NM USA.	kboyack@mapofscience.com		Skupin, Andre/0000-0002-8398-8119; Boyack, Kevin/0000-0001-7814-8951; Schijvenaars, Bob/0000-0002-8508-3225	National Institutes of Health (NIH) SBIR [HHSN268200900053C]; James S. McDonnell Foundation; Australian Government; Australian Research Council through the ICT Centre of Excellence	National Institutes of Health (NIH) SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence(Australian Research Council)	This work was supported by National Institutes of Health (NIH) SBIR Contract HHSN268200900053C and a James S. McDonnell Foundation grant. NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren P, 2008, SCIENTOMETRICS, V76, P273, DOI 10.1007/s11192-007-1935-1; Ahlgren P, 2009, J INFORMETR, V3, P49, DOI 10.1016/j.joi.2008.11.003; Aphinyanaphongs Y, 2005, J AM MED INFORM ASSN, V12, P207, DOI 10.1197/jamia.M1641; BELKIN NJ, 1995, INFORM PROCESS MANAG, V31, P431, DOI 10.1016/0306-4573(94)00057-A; Berry MW, 1995, SIAM REV, V37, P573, DOI 10.1137/1037127; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Borner K, 2009, J INFORMETR, V3, P161, DOI 10.1016/j.joi.2009.03.008; Boyack KW, 2010, J AM SOC INF SCI TEC, V61, P2389, DOI 10.1002/asi.21419; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; BOYACK KW, 2009, 12 INT C INT SOC SCI, P730; Calado P, 2006, J AM SOC INF SCI TEC, V57, P208, DOI 10.1002/asi.20266; Cao MD, 2005, LECT NOTES ARTIF INT, V3809, P143; COOPER WS, 1973, J AM SOC INFORM SCI, V24, P87, DOI 10.1002/asi.4630240204; Couto T, 2006, OPENING INFORMATION HORIZONS, P75; GORRELL G, 2005, 9 EUR C SPEECH COMMM, P1325; Harman DK, 2006, ANNU REV INFORM SCI, V40, P113, DOI 10.1002/aris.1440400111; HEARST MA, 1996, P 19 ANN INT ACM SIG, P76; Hjaltason GR, 2003, ACM T DATABASE SYST, V28, P517, DOI 10.1145/958942.958948; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; JANACEK AGK, 2010, TEXT MINING APPL THE, P57; JANSSENS F, 2006, INT C MULT INF SCI T, P615; JARDINE N, 1971, INFORM STORAGE RET, V7, P217, DOI 10.1016/0020-0271(71)90051-9; Jarvelin K, 2002, ACM T INFORM SYST, V20, P422, DOI 10.1145/582415.582418; Jiang E.P., 2010, TEXT MINING APPL THE, P37; Jones K. S., 2000, Information Processing & Management, V36, P809, DOI 10.1016/S0306-4573(00)00016-9; Kassab Randa, 2008, Proceedings of the IASTED International Conference on Artificial Intelligence and Applications, P232; Klavans R, 2006, J AM SOC INF SCI TEC, V57, P251, DOI 10.1002/asi.20274; Kohonen T, 1995, SELF ORGANIZING MAPS; KOHONEN T, 1996, 31 HELS U TECHN LAB; Kolda TG, 1998, ACM T INFORM SYST, V16, P322, DOI 10.1145/291128.291131; Landauer TK, 2004, P NATL ACAD SCI USA, V101, P5214, DOI 10.1073/pnas.0400341101; Lewis J, 2006, BIOINFORMATICS, V22, P2298, DOI 10.1093/bioinformatics/btl388; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lin J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-423; MARTIN S, 2011, C VIS DAT AN 2011 SA; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; Newman DJ, 2006, J AM SOC INF SCI TEC, V57, P753, DOI 10.1002/asi.20342; Poulter GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-108; ROBERTSON SE, 1976, J AM SOC INFORM SCI, V27, P129, DOI 10.1002/asi.4630270302; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Sparck-Jones K, 2000, INFORM PROCESS MANAG, V36, P779, DOI 10.1016/S0306-4573(00)00015-7; Theodosiou T, 2008, BIOINFORMATICS, V24, P1935, DOI 10.1093/bioinformatics/btn318; Vanteru BC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S10; VOORHEES EM, 1986, INFORM PROCESS MANAG, V22, P465, DOI 10.1016/0306-4573(86)90097-X; Yamamoto Y, 2007, J BIOMED INFORM, V40, P114, DOI 10.1016/j.jbi.2006.07.004	47	162	169	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e18029	10.1371/journal.pone.0018029	http://dx.doi.org/10.1371/journal.pone.0018029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736SO	21437291	Green Published, gold			2022-12-27	WOS:000288514600022
J	Kaiser, R; Bunnell, R; Hightower, A; Kim, AA; Cherutich, P; Mwangi, M; Oluoch, T; Dadabhai, S; Mureithi, P; Mugo, N; Mermin, J				Kaiser, Reinhard; Bunnell, Rebecca; Hightower, Allen; Kim, Andrea A.; Cherutich, Peter; Mwangi, Mary; Oluoch, Tom; Dadabhai, Sufia; Mureithi, Patrick; Mugo, Nelly; Mermin, Jonathan		KAIS Study Grp	Factors Associated with HIV Infection in Married or Cohabitating Couples in Kenya: Results from a Nationally Representative Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MALE CIRCUMCISION; VIRAL LOAD; DISCORDANT COUPLES; CONTROLLED-TRIAL; UGANDA; TRANSMISSION; PREVENTION; MEN; ACQUISITION	Background: In order to inform prevention programming, we analyzed HIV discordance and concordance within couples in the Kenya AIDS Indicator Survey (KAIS) 2007. Methods: KAIS was a nationally representative population-based sero-survey that examined demographic and behavioral indicators and serologic testing for HIV, HSV-2, syphilis, and CD4 cell counts in 15,853 consenting adults aged 15-64 years. We analyzed interview and blood testing data at the sexual partnership level from married or cohabitating couples. Multivariable regression models were used to identify factors independently associated with HIV discordant and concordant status. Results: Of 3256 couples identified in the survey, 2748 (84.4%) had interview and blood testing data. Overall, 3.8% of couples were concordantly infected with HIV, and in 5.8% one partner was infected, translating to 338,000 discordant couples in Kenya. In 83.6% of HIV-infected Kenyans living in married or cohabitating couples neither partner knew their HIV status. Factors independently associated with HIV-discordance included young age in women (AOR 1.5, 95% CI: 1.2-1.8; p<0.0001), increasing number of lifetime sexual partners in women (AOR 1.5, 95% CI: 1.3-1.8; p<0.0001), HSV-2 infection in either or both partners (AOR 4.1, 95% CI: 2.3-7.2; p<0.0001), and lack of male circumcision (AOR 1.6, 95% CI: 1.0-2.5; p = 0.032). Independent factors for HIV-concordance included HSV-2 infection in both partners (AOR 6.5, 95% CI: 2.3-18.7; p = 0.001) and lack of male circumcision (AOR 1.8, 95% CI: 1.0-3.3; p = 0.043). Conclusions: Couple prevention interventions should begin early in relationships and include mutual knowledge of HIV status, reduction of outside sexual partners, and promotion of male circumcision among HIV-uninfected men. Mechanisms for effective prevention or suppression of HSV-2 infection are also needed.	[Kaiser, Reinhard; Bunnell, Rebecca; Hightower, Allen; Mwangi, Mary; Oluoch, Tom; Mermin, Jonathan] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Nairobi, Kenya; [Kim, Andrea A.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Cherutich, Peter] Natl AIDS STI Control Programme NASCOP, Nairobi, Kenya; [Dadabhai, Sufia] Univ California San Francisco, Nairobi, Kenya; [Mureithi, Patrick] Natl AIDS Control Council NACC, Nairobi, Kenya; [Mugo, Nelly] Kenyatta Natl Hosp, Nairobi, Kenya; [Mugo, Nelly] Univ Nairobi, Nairobi, Kenya; [Bunnell, Rebecca] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Adult & Community Hlth, Atlanta, GA USA; [Hightower, Allen] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Nairobi, Kenya; [Mermin, Jonathan] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Kenyatta National Hospital; University of Nairobi; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kaiser, R (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Nairobi, Kenya.	rkaiser@ke.cdc.gov	Oluoch, Tom/AGH-4170-2022; Oluoch, Tom/GPC-5771-2022; Mermin, Jonathan/J-9847-2012	Kim, Evelyn/0000-0002-9650-2093; Oluoch, Tom/0000-0001-9621-5900; Makokha, Ernest/0000-0002-3035-2491	Emergency Plan for AIDS Relief; Centers for Disease Control and Prevention (CDC), Department of Health and Human Services	Emergency Plan for AIDS Relief; Centers for Disease Control and Prevention (CDC), Department of Health and Human Services(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding: This study was funded through the United States President's Emergency Plan for AIDS Relief, through the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Several authors are employees of CDC and contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; Anand A, 2009, AIDS, V23, P1565, DOI 10.1097/QAD.0b013e32832cb10c; [Anonymous], REP GLOB AIDS EP 200; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baleta A, 2010, LANCET, V376, P320, DOI 10.1016/S0140-6736(10)61123-3; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Bunnell R, 2008, LANCET, V371, P2148, DOI 10.1016/S0140-6736(08)60929-0; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; CELUM C, 2010, N ENGL J MED; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; DONNELL D, 2010, C RETR OPP INF SAN F; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; NASCOP (National AIDS/ STI Control Programme) Kenya, 2009, KEN AIDS IND SURV; Olley BO, 2005, AIDS CARE, V17, P1, DOI 10.1080/095401204123315089; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; World Health Organization, 2007, GUID PROV IN HIV TES	30	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17842	10.1371/journal.pone.0017842	http://dx.doi.org/10.1371/journal.pone.0017842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423615	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900037
J	Darling, JA				Darling, John A.			Interspecific Hybridization and Mitochondrial Introgression in Invasive Carcinus Shore Crabs	PLOS ONE			English	Article							EUROPEAN GREEN CRAB; GENETIC-VARIATION; MULTIPLE INTRODUCTIONS; EVOLUTIONARY GENETICS; POPULATION-STRUCTURE; ADAPTIVE EVOLUTION; RANGE EXPANSION; MAENAS; HISTORY; SUCCESS	Interspecific hybridization plays an important role in facilitating adaptive evolutionary change. More specifically, recent studies have demonstrated that hybridization may dramatically influence the establishment, spread, and impact of invasive populations. In Japan, previous genetic evidence for the presence of two non-native congeners, the European green crab Carcinus maenas and the Mediterranean green crab C. aestuarii, has raised questions regarding the possibility of hybridization between these sister species. Here I present analysis based on both nuclear microsatellites and the mitochondrial cytochrome C oxidase subunit I (COI) gene which unambiguously argues for a hybrid origin of Japanese Carcinus. Despite the presence of mitochondrial lineages derived from both C. maenas and C. aestuarii, the Japanese population is panmictic at nuclear loci and has achieved cytonuclear equilibrium throughout the sampled range in Japan. Furthermore, analysis of admixture at nuclear loci indicates dramatic introgression of the C. maenas mitochondrial genome into a predominantly C. aestuarii nuclear background. These patterns, along with inferences drawn from the observational record, argue for a hybridization event pre-dating the arrival of Carcinus in Japan. The clarification of both invasion history and evolutionary history afforded by genetic analysis provides information that may be critically important to future studies aimed at assessing risks posed by invasive Carcinus populations to Japan and the surrounding region.	US EPA, Mol Ecol Res Branch, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	United States Environmental Protection Agency	Darling, JA (corresponding author), US EPA, Mol Ecol Res Branch, Natl Exposure Res Lab, Cincinnati, OH 45268 USA.	darling.john@epa.gov	Darling, John/B-5451-2014	Darling, John/0000-0002-4776-9533	Office of Research and Development; EPA Region 9; EPA Region 10	Office of Research and Development; EPA Region 9; EPA Region 10	This work was funded in part through an internal EPA Regional Applied Research Effort between Office of Research and Development and EPA Regions 9 and 10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Bagley MJ, 2000, MARINE BIOINVASIONS, P241; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basten CJ, 1997, GENETICS, V146, P1165; Bastrop R, 1998, MOL BIOL EVOL, V15, P97, DOI 10.1093/oxfordjournals.molbev.a025919; Belkhir K, 2004, GENETIX 4 05 LOGICIE; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; BERRILL M, 1982, B MAR SCI, V32, P632; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Carlton JT, 2003, J BIOGEOGR, V30, P1809, DOI 10.1111/j.1365-2699.2003.00962.x; Chan KMA, 2005, EVOLUTION, V59, P720; Chen RB, 2004, FISHERIES SCI, V70, P430, DOI 10.1111/j.1444-2906.2004.00822.x; Clark PF, 2001, J CRUSTACEAN BIOL, V21, P288, DOI 10.1651/0278-0372(2001)021[0288:AMAORV]2.0.CO;2; Compton TJ, 2010, DIVERS DISTRIB, V16, P243, DOI 10.1111/j.1472-4642.2010.00644.x; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Davidson SK, 1999, BIOL BULL, V196, P273, DOI 10.2307/1542952; DEMEUSY N, 1953, CR HEBD ACAD SCI, V236, P1088; Derivera CE, 2007, MAR BIOL, V150, P1275, DOI 10.1007/s00227-006-0451-9; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Geller JB, 1997, MOL ECOL, V6, P901, DOI 10.1046/j.1365-294X.1997.00256.x; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Goudet J., FSTAT PROGRAM ESTIMA; Hall RJ, 2009, BIOL INVASIONS, V11, P1217, DOI 10.1007/s10530-008-9387-y; Hanfling B, 2007, J FISH BIOL, V71, P115, DOI 10.1111/j.1095-8649.2007.01685.x; Holsbeek G, 2008, MOL ECOL, V17, P5023, DOI 10.1111/j.1365-294X.2008.03984.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hufbauer RA, 2008, DIVERS DISTRIB, V14, P252, DOI 10.1111/j.1472-4642.2007.00424.x; Koike F, 2011, BIOL INVASIONS, V13, P459, DOI 10.1007/s10530-010-9841-5; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Kolbe JJ, 2007, MOL ECOL, V16, P1579, DOI 10.1111/j.1365-294X.2006.03135.x; Largiader Carlo R., 2007, V193, P275; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; RAYMOND M, GENEPOP POPULATION G; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; See KE, 2010, BIOL INVASIONS, V12, P1305, DOI 10.1007/s10530-009-9548-7; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tepolt CK, 2006, MOL ECOL NOTES, V6, P343, DOI 10.1111/j.1471-8286.2006.01226.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vellend M, 2007, TRENDS ECOL EVOL, V22, P481, DOI 10.1016/j.tree.2007.02.017; Vila M., 2000, BIOL INVASIONS, V2, P207, DOI 10.1023/ A:1010003603310; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Wissemann V, 2007, SYST BIODIVERS, V5, P243, DOI 10.1017/S1477200007002381; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Yamada SB, 2001, J SHELLFISH RES, V20, P905; Yamada SB, 2000, GLOBAL INVADER EUROP	66	31	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17828	10.1371/journal.pone.0017828	http://dx.doi.org/10.1371/journal.pone.0017828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423759	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400031
J	Schiappacassi, M; Lovisa, S; Lovat, F; Fabris, L; Colombatti, A; Belletti, B; Baldassarre, G				Schiappacassi, Monica; Lovisa, Sara; Lovat, Francesca; Fabris, Linda; Colombatti, Alfonso; Belletti, Barbara; Baldassarre, Gustavo			Role of T198 Modification in the Regulation of p27(Kip1) Protein Stability and Function	PLOS ONE			English	Article							DEPENDENT DEGRADATION; INHIBITOR P27(KIP1); CDK INHIBITOR; PHOSPHORYLATION; CYCLE; MIGRATION; P27; UBIQUITINATION; STATHMIN; CASPASE	The tumor suppressor gene p27(Kip1) plays a fundamental role in human cancer progression. Its expression and/or functions are altered in almost all the different tumor histotype analyzed so far. Recently, it has been demonstrated that the tumor suppression function of p27 resides not only in the ability to inhibit Cyclins/CDKs complexes through its N-terminal domain but also in the capacity to modulate cell motility through its C-terminal portion. Particular interest has been raised by the last amino-acid, ( Threonine 198) in the regulation of both protein stability and cell motility. Here, we describe that the presence of Threonine in position 198 is of primary importance for the regulation of the protein stability and for the control of cell motility. However, while the control of cell motility is dependent on the phosphorylation of T198, the stability of the protein is specifically controlled by the steric hindrance of the last amino acid. The effects of T198 modification on protein stability are not linked to the capacity of p27 to bind Cyclins/CDKs complexes and/or the F-box protein Skp2. Conversely, our results support the hypothesis that conformational changes in the disordered structure of the C-terminal portion of p27 are important in its ability to be degraded via a proteasome-dependent mechanism. On the other hand T198 phosphorylation favors p27/stathmin interaction eventually contributing to the regulation of cell motility, supporting the hypothesis that the presence of T198 is fundamental for the regulation of p27 functions.	[Schiappacassi, Monica; Lovisa, Sara; Lovat, Francesca; Fabris, Linda; Colombatti, Alfonso; Belletti, Barbara; Baldassarre, Gustavo] Natl Canc Inst, Div Expt Oncol 2, Ctr Riferimento Oncol, Aviano, Italy	IRCCS Aviano (CRO)	Schiappacassi, M (corresponding author), Natl Canc Inst, Div Expt Oncol 2, Ctr Riferimento Oncol, Aviano, Italy.	gbaldassarre@cro.it	Belletti, Barbara/J-2028-2018; Schiappacassi, Monica/AAX-5505-2020; Lovisa, Sara/AAB-1141-2020; Baldassarre, Gustavo/K-1350-2016	Belletti, Barbara/0000-0003-2249-0285; Schiappacassi, Monica/0000-0003-4804-4291; Lovisa, Sara/0000-0001-7776-2896; Baldassarre, Gustavo/0000-0002-9750-8825; colombatti, alfonso/0000-0002-3676-2379	AICR [06-0319]	AICR	This work is supported by AICR grant 06-0319 to GB (http://www.aicr.org.uk/index.stm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Belletti B, 2005, CURR MED CHEM, V12, P1589, DOI 10.2174/0929867054367149; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; Berton S, 2009, MOL CELL BIOL, V29, P5031, DOI 10.1128/MCB.00144-09; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Frost V, 2001, ONCOGENE, V20, P2737, DOI 10.1038/sj.onc.1204367; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Medina-Palazon C, 2004, EUR J BIOCHEM, V271, P2716, DOI 10.1111/j.1432-1033.2004.04200.x; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Molatore S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-116; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Motti ML, 2004, CELL CYCLE, V3, P1074; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Schiappacassi M, 2008, MOL CANCER THER, V7, P1164, DOI 10.1158/1535-7163.MCT-07-2154; Tang PP, 2002, CELL SIGNAL, V14, P961, DOI 10.1016/S0898-6568(02)00043-8; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006	40	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17673	10.1371/journal.pone.0017673	http://dx.doi.org/10.1371/journal.pone.0017673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423803	gold, Green Published, Green Submitted			2022-12-27	WOS:000288512400019
J	Mouillot, D; Villeger, S; Scherer-Lorenzen, M; Mason, NWH				Mouillot, David; Villeger, Sebastien; Scherer-Lorenzen, Michael; Mason, Norman W. H.			Functional Structure of Biological Communities Predicts Ecosystem Multifunctionality	PLOS ONE			English	Article							PLANT DIVERSITY; GRASSLAND COMMUNITIES; EUROPEAN GRASSLANDS; CURRENT KNOWLEDGE; SPECIES RICHNESS; FISH COMMUNITIES; BIODIVERSITY; PRODUCTIVITY; EVENNESS; BIOMASS	The accelerating rate of change in biodiversity patterns, mediated by ever increasing human pressures and global warming, demands a better understanding of the relationship between the structure of biological communities and ecosystem functioning (BEF). Recent investigations suggest that the functional structure of communities, i.e. the composition and diversity of functional traits, is the main driver of ecological processes. However, the predictive power of BEF research is still low, the integration of all components of functional community structure as predictors is still lacking, and the multifunctionality of ecosystems (i.e. rates of multiple processes) must be considered. Here, using a multiple-processes framework from grassland biodiversity experiments, we show that functional identity of species and functional divergence among species, rather than species diversity per se, together promote the level of ecosystem multifunctionality with a predictive power of 80%. Our results suggest that primary productivity and decomposition rates, two key ecosystem processes upon which the global carbon cycle depends, are primarily sustained by specialist species, i.e. those that hold specialized combinations of traits and perform particular functions. Contrary to studies focusing on single ecosystem functions and considering species richness as the sole measure of biodiversity, we found a linear and non-saturating effect of the functional structure of communities on ecosystem multifunctionality. Thus, sustaining multiple ecological processes would require focusing on trait dominance and on the degree of community specialization, even in species-rich assemblages.	[Mouillot, David] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France; [Villeger, Sebastien] Univ Toulouse 3, Lab Evolut & Diversite Biol, UMR 5174, F-31062 Toulouse, France; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol Geobot, Freiburg, Germany; [Mason, Norman W. H.] Landcare Res, Hamilton, New Zealand	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Freiburg; Landcare Research - New Zealand	Mouillot, D (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France.	david.mouillot@univ-montp2.fr	Villéger, Sébastien/AAW-9949-2021; Villéger, Sébastien/C-6272-2011; Scherer-Lorenzen, Michael/AGB-4140-2022	Villéger, Sébastien/0000-0002-2362-7178; Villéger, Sébastien/0000-0002-2362-7178; Scherer-Lorenzen, Michael/0000-0001-9566-590X	European Commission [ENV-CT95-0008]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The BIODEPTH project ran from 1996 to 1998 and was funded by the European Commission within the Framework IV Environment and Climate programme (ENV-CT95-0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BURNHAM KP, 1998, MODEL SELECTION INFO; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fox J, 2008, APPL REGRESSION ANAL; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Halpern BS, 2008, MAR ECOL PROG SER, V364, P147, DOI 10.3354/meps07553; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Heisse K, 2007, OECOLOGIA, V152, P435, DOI 10.1007/s00442-007-0666-6; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Jenny H., 1941, FACTORS SOIL FORMATI; Legendre P., 2012, NUMERICAL ECOLOGY; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mouchet M, 2008, OIKOS, V117, P794, DOI 10.1111/j.0030-1299.2008.16594.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Posada JM, 2009, ANN BOT-LONDON, V103, P795, DOI 10.1093/aob/mcn265; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Scherer-Lorenzen M, 2008, FUNCT ECOL, V22, P547, DOI 10.1111/j.1365-2435.2008.01389.x; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; Sonohat G, 2002, PLANT CELL ENVIRON, V25, P529, DOI 10.1046/j.1365-3040.2002.00833.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Stevens MHH, 2001, OIKOS, V92, P291, DOI 10.1034/j.1600-0706.2001.920211.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	57	286	306	14	260	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17476	10.1371/journal.pone.0017476	http://dx.doi.org/10.1371/journal.pone.0017476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423747	Green Submitted, gold, Green Published			2022-12-27	WOS:000288219100009
J	McKinney, SM; Thien, TDV; Buxton, OM; Solet, JM; Ellenbogen, JM				McKinney, Scott M.; Thien Thanh Dang-Vu; Buxton, Orfeu M.; Solet, Jo M.; Ellenbogen, Jeffrey M.			Covert Waking Brain Activity Reveals Instantaneous Sleep Depth	PLOS ONE			English	Article							AROUSAL THRESHOLD; ALPHA OSCILLATIONS; EEG; PERFORMANCE; FREQUENCY; COHERENCE; POWER; FLUCTUATIONS; ALERTNESS; DYNAMICS	The neural correlates of the wake-sleep continuum remain incompletely understood, limiting the development of adaptive drug delivery systems for promoting sleep maintenance. The most useful measure for resolving early positions along this continuum is the alpha oscillation, an 8-13 Hz electroencephalographic rhythm prominent over posterior scalp locations. The brain activation signature of wakefulness, alpha expression discloses immediate levels of alertness and dissipates in concert with fading awareness as sleep begins. This brain activity pattern, however, is largely ignored once sleep begins. Here we show that the intensity of spectral power in the alpha band actually continues to disclose instantaneous responsiveness to noise-a measure of sleep depth-throughout a night of sleep. By systematically challenging sleep with realistic and varied acoustic disruption, we found that sleepers exhibited markedly greater sensitivity to sounds during moments of elevated alpha expression. This result demonstrates that alpha power is not a binary marker of the transition between sleep and wakefulness, but carries rich information about immediate sleep stability. Further, it shows that an empirical and ecologically relevant form of sleep depth is revealed in real-time by EEG spectral content in the alpha band, a measure that affords prediction on the order of minutes. This signal, which transcends the boundaries of classical sleep stages, could potentially be used for real-time feedback to novel, adaptive drug delivery systems for inducing sleep.	[McKinney, Scott M.; Thien Thanh Dang-Vu; Ellenbogen, Jeffrey M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Thien Thanh Dang-Vu; Buxton, Orfeu M.; Solet, Jo M.; Ellenbogen, Jeffrey M.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Thien Thanh Dang-Vu] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Buxton, Orfeu M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Solet, Jo M.] Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Liege; Harvard University; Brigham & Women's Hospital; Harvard University; Cambridge Health Alliance	McKinney, SM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	jeffrey_ellenbogen@hms.harvard.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604; Buxton, Orfeu/0000-0001-5057-633X; Dang Vu, Thien Thanh/0000-0002-7235-2721	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design; Massachusetts General Hospital	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design; Massachusetts General Hospital(General Electric)	This study was funded by the Academy of Architecture for Health, the Facilities Guidelines Institute, the Center for Health Design, and the Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1998, J SLEEP RES, V7, P36, DOI 10.1046/j.1365-2869.7.s1.6.x; AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Asyali MH, 2007, COMPUT BIOL MED, V37, P1600, DOI 10.1016/j.compbiomed.2007.03.001; BEATTY J, 1974, SCIENCE, V183, P871, DOI 10.1126/science.183.4127.871; BELYAVIN A, 1987, ELECTROEN CLIN NEURO, V66, P137, DOI 10.1016/0013-4694(87)90183-0; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BONNET MH, 1978, PSYCHOPHYSIOLOGY, V15, P412, DOI 10.1111/j.1469-8986.1978.tb01407.x; BORBELY AA, 1985, HUM NEUROBIOL, V4, P189; BRUNNER DP, 1991, PSYCHOPHARMACOLOGY, V104, P1, DOI 10.1007/BF02244546; BUSBY KA, 1994, PSYCHOPHYSIOLOGY, V31, P182, DOI 10.1111/j.1469-8986.1994.tb01038.x; Cantero JL, 1999, NEUROSCI LETT, V271, P167, DOI 10.1016/S0304-3940(99)00565-0; Cantero JL, 1999, NEUROPSYCHOBIOLOGY, V39, P110, DOI 10.1159/000026569; Cantero JL, 2002, NEUROPHYSIOL CLIN, V32, P54, DOI 10.1016/S0987-7053(01)00289-1; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; GATH I, 1983, INT J NEUROSCI, V20, P303, DOI 10.3109/00207458308986584; HOLM S, 1979, SCAND J STAT, V6, P65; Hori T., 1991, SLEEP RES, V20, P20; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Iber C., 2007, AASM MANUAL SCORING; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Lockley SW, 2006, SLEEP, V29, P161; Mackworth J, 1970, VIGILANCE ATTENTION; Magosso E, 2007, P ANN INT IEEE EMBS, P4006, DOI 10.1109/IEMBS.2007.4353212; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P23, DOI 10.1016/0013-4694(93)90064-3; Massimini M, 2003, J NEUROPHYSIOL, V89, P1205, DOI 10.1152/jn.00373.2002; Mitra P., 2007, OBSERVED BRAIN DYNAM; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; MORRELL LK, 1966, NEUROPSYCHOLOGIA, V4, P41, DOI 10.1016/0028-3932(66)90019-4; Muzet A, 2007, SLEEP MED REV, V11, P135, DOI 10.1016/j.smrv.2006.09.001; NECKELMANN D, 1993, SLEEP, V16, P467; Nikulin VV, 2006, NEUROSCIENCE, V137, P647, DOI 10.1016/j.neuroscience.2005.10.031; Ogilvie RD, 2001, SLEEP MED REV, V5, P247, DOI 10.1053/smrv.2001.0145; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Perlis ML, 2001, SLEEP MED REV, V5, P365, DOI 10.1053/smrv.2001.0151; Perlis ML, 2001, SLEEP, V24, P110, DOI 10.1093/sleep/24.1.110; Proakis J. G., 1996, DIGIT SIGNAL PROCESS; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; SCHEIBEL MADGE E., 1967, BRAIN RES, V6, P60, DOI 10.1016/0006-8993(67)90183-7; Smit CM, 2006, INT J PSYCHOPHYSIOL, V61, P235, DOI 10.1016/j.ijpsycho.2005.10.004; Smit DJA, 2005, PSYCHOPHYSIOLOGY, V42, P691, DOI 10.1111/j.1469-8986.2005.00352.x; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; Steriade M., 1991, NORMAL ALTERED STATE, V9, P279, DOI [10.1007/978-1-4615-6622-9_8, DOI 10.1007/978-1-4615-6622-9_8]; TOWNSEND RE, 1979, ELECTROEN CLIN NEURO, V47, P272, DOI 10.1016/0013-4694(79)90279-7; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; WILKINSON RT, 1984, J ACOUST SOC AM, V75, P468, DOI 10.1121/1.390470	51	42	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17351	10.1371/journal.pone.0017351	http://dx.doi.org/10.1371/journal.pone.0017351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408616	Green Published, Green Submitted, gold			2022-12-27	WOS:000287965200014
J	Rai, P; Shivaji, S				Rai, Priyanka; Shivaji, Sisinthy			The Role of DJ-1 in the Pathogenesis of Endometriosis	PLOS ONE			English	Article							EUTOPIC ENDOMETRIUM; OXIDATIVE STRESS; GENE-EXPRESSION; CELL-DEATH; IN-VITRO; IDENTIFICATION; PTEN; REGULATOR; CARCINOMA; MIGRATION	Background: Endometriosis is an estrogen-dependent disease causing pelvic pain and infertility in 10% of reproductive-aged women. Despite a long history of the disease the pathogenesis of endometriosis is poorly understood. It is known that the expression of several proteins is either up or down regulated during endometriosis, but their precise role remains to be determined. DJ-1 is one such protein that is upregulated in eutopic endometrium of women having endometriosis suggesting that DJ-1 may be involved in the pathogenesis of endometriosis. Methodology and Principal Findings: The role of DJ-1 in the pathogenesis of endometriosis was investigated. For this purpose the influence of DJ-1 on endometrial cell survival, attachment, proliferation, migration, and invasion either by overexpressing DJ-1 in normal endometrial cells or by knocking down DJ-1 expression in endometriotic cells using siRNA was investigated. The results indicated that DJ-1 protects endometrial cells from oxidative stress mediated apoptosis. Overexpression of DJ-1 in normal endometrial epithelial cells increases the adhesion on collagen type IV. However, no significant difference was observed incase of stromal cells. It was further demonstrated that DJ-1 regulates cell proliferation, migration, and invasion in normal endometrial and endometriotic epithelial cells whereas in the case of normal endometrial and endometriotic stromal cells, it regulates cell proliferation and invasion but not migration. Furthermore, the present study also indicated that DJ-1 regulates these cellular processes by modulating PI3K/Akt pathway by interacting and negatively regulating PTEN. Conclusions: Abnormally high levels of DJ-1 expression may be involved in endometriosis, possibly by stimulating endometrial cell survival, proliferation, migration, and invasion.	[Rai, Priyanka; Shivaji, Sisinthy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rai, P (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	shivas@ccmb.res.in		shivaji, sisinthy/0000-0003-0376-4658				Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168; Barbier CS, 2005, BIOL REPROD, V73, P106, DOI 10.1095/biolreprod.104.035063; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; DESAI NN, 1994, FERTIL STERIL, V61, P760; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Fowler PA, 2007, PROTEOMICS, V7, P130, DOI 10.1002/pmic.200600469; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HENKEL AW, 1994, ANAL BIOCHEM, V223, P329, DOI 10.1006/abio.1994.1595; Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu H, 2008, BIOCHEM BIOPH RES CO, V375, P477, DOI 10.1016/j.bbrc.2008.08.046; Lucidi RS, 2005, FERTIL STERIL, V84, P16, DOI 10.1016/j.fertnstert.2004.10.058; MacKeigan JP, 2003, CANCER RES, V63, P6928; Matsuzaki S, 2005, FERTIL STERIL, V84, P1180, DOI 10.1016/j.fertnstert.2005.04.041; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Rai P, 2010, J PROTEOME RES, V9, P4407, DOI 10.1021/pr100657s; Shen ZS, 2011, MED ONCOL, V28, P601, DOI 10.1007/s12032-010-9474-7; Shinbo YM, 2005, INT J ONCOL, V26, P641; Stephens AN, 2010, J PROTEOME RES, V9, P2438, DOI 10.1021/pr901131p; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Taira T, 2001, GENE, V263, P285, DOI 10.1016/S0378-1119(00)00590-4; Varma R, 2004, REPRODUCTION, V127, P293, DOI 10.1530/rep.1.00020; Vinatier D, 2000, EUR J OBSTET GYN R B, V91, P113, DOI 10.1016/S0301-2115(99)00263-8; Wu Y, 2006, ENDOCRINOLOGY, V147, P232, DOI 10.1210/en.2005-0426; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zeitvogel A, 2001, AM J PATHOL, V159, P1839, DOI 10.1016/S0002-9440(10)63030-1; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	34	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18074	10.1371/journal.pone.0018074	http://dx.doi.org/10.1371/journal.pone.0018074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445310	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300034
J	Nie, M; Wang, YJ; Yu, JY; Xiao, M; Jiang, LF; Yang, J; Fang, CM; Chen, JA; Li, B				Nie, Ming; Wang, Yijing; Yu, Jiayi; Xiao, Ming; Jiang, Lifen; Yang, Ji; Fang, Changming; Chen, Jiakuan; Li, Bo			Understanding Plant-Microbe Interactions for Phytoremediation of Petroleum-Polluted Soil	PLOS ONE			English	Article							NITROGEN MINERALIZATION; ORGANIC-MATTER; COMMUNITY; OIL; IMMOBILIZATION; DIVERSITY; ALFALFA; GROWTH; SLUDGE; GENES	Plant-microbe interactions are considered to be important processes determining the efficiency of phytoremediation of petroleum pollution, however relatively little is known about how these interactions are influenced by petroleum pollution. In this experimental study using a microcosm approach, we examined how plant ecophysiological traits, soil nutrients and microbial activities were influenced by petroleum pollution in Phragmites australis, a phytoremediating species. Generally, petroleum pollution reduced plant performance, especially at early stages of plant growth. Petroleum had negative effects on the net accumulation of inorganic nitrogen from its organic forms (net nitrogen mineralization (NNM)) most likely by decreasing the inorganic nitrogen available to the plants in petroleum-polluted soils. However, abundant dissolved organic nitrogen (DON) was found in petroleum-polluted soil. In order to overcome initial deficiency of inorganic nitrogen, plants by dint of high colonization of arbuscular mycorrhizal fungi might absorb some DON for their growth in petroleum-polluted soils. In addition, through using a real-time polymerase chain reaction method, we quantified hydrocarbon-degrading bacterial traits based on their catabolic genes (i.e. alkB (alkane monooxygenase), nah (naphthalene dioxygenase) and tol (xylene monooxygenase) genes). This enumeration of target genes suggests that different hydrocarbon-degrading bacteria experienced different dynamic changes during phytoremediation and a greater abundance of alkB was detected during vegetative growth stages. Because phytoremediation of different components of petroleum is performed by different hydrocarbon-degrading bacteria, plants' ability of phytoremediating different components might therefore vary during the plant life cycle. Phytoremediation might be most effective during the vegetative growth stages as greater abundances of hydrocarbon-degrading bacteria containing alkB and tol genes were observed at these stages. The information provided by this study enhances our understanding of the effects of petroleum pollution on plant-microbe interactions and the roles of these interactions in the phytoremediation of petroleum-polluted soil.	[Nie, Ming; Wang, Yijing; Yu, Jiayi; Jiang, Lifen; Yang, Ji; Fang, Changming; Chen, Jiakuan; Li, Bo] Fudan Univ, Inst Biodivers Sci, Coastal Ecosyst Res Stn Yangtze River Estuary, Minist Educ,Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China; [Jiang, Lifen; Fang, Changming; Chen, Jiakuan; Li, Bo] Fudan Univ, Inst Global Environm Change Res, Shanghai 200433, Peoples R China; [Nie, Ming; Chen, Jiakuan; Li, Bo] Nanchang Univ, Ctr Watershed Ecol, Inst Life Sci, Nanchang, Jiangxi, Peoples R China; [Nie, Ming; Chen, Jiakuan; Li, Bo] Nanchang Univ, Key Lab Poyang Lake Environm & Resource Utilizat, Nanchang, Jiangxi, Peoples R China; [Xiao, Ming] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China	Fudan University; Fudan University; Nanchang University; Nanchang University; Shanghai Normal University	Nie, M (corresponding author), Fudan Univ, Inst Biodivers Sci, Coastal Ecosyst Res Stn Yangtze River Estuary, Minist Educ,Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	bool@fudan.edu.cn	Li, Bo/B-8016-2010; Nie, Ming/F-1880-2010; Li, Bo/AAA-8968-2020; Nie, Ming/F-1880-2010	Li, Bo/0000-0002-0439-5666; Nie, Ming/0000-0003-0702-8009; Li, Bo/0000-0002-7294-6888; Nie, Ming/0000-0003-3898-5389	National Basic Research Program of China [2006CB403305, 2010CB950602]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (grant no. 2006CB403305 and 2010CB950602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaeda T, 2006, ENVIRON EXP BOT, V57, P9, DOI 10.1016/j.envexpbot.2005.03.006; Baldwin BR, 2003, APPL ENVIRON MICROB, V69, P3350, DOI 10.1128/AEM.69.6.3350-3358.2003; Baran S, 2004, GEODERMA, V118, P221, DOI 10.1016/S0016-7061(03)00205-2; CAI WM, 2004, THESIS CHINA AGR U B; Chalot M, 1998, FEMS MICROBIOL REV, V22, P21, DOI 10.1111/j.1574-6976.1998.tb00359.x; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; DeBruyn JM, 2007, ENVIRON SCI TECHNOL, V41, P5426, DOI 10.1021/es070406c; Dowty RA, 2001, MAR ENVIRON RES, V52, P195, DOI 10.1016/S0141-1136(00)00268-3; Finlay RD, 2008, J EXP BOT, V59, P1115, DOI 10.1093/jxb/ern059; FITTER AH, 1987, NEW PHYTOL, V106, P61, DOI 10.1111/j.1469-8137.1987.tb04683.x; Gerhardt KE, 2009, PLANT SCI, V176, P20, DOI 10.1016/j.plantsci.2008.09.014; Ghazali FM, 2004, INT BIODETER BIODEGR, V54, P61, DOI 10.1016/j.ibiod.2004.02.002; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gregory ST, 2005, ENVIRON SCI TECHNOL, V39, P5285, DOI 10.1021/es048028o; Haase J, 2008, ECOLOGY, V89, P3072, DOI 10.1890/07-1983.1; Harrison KA, 2008, SOIL BIOL BIOCHEM, V40, P228, DOI 10.1016/j.soilbio.2007.08.004; Herrmann AM, 2008, EUR J SOIL SCI, V59, P653, DOI 10.1111/j.1365-2389.2008.01023.x; Hutchinson SL, 2001, J ENVIRON QUAL, V30, P395, DOI 10.2134/jeq2001.302395x; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kirk JL, 2005, PLANT SOIL, V270, P23, DOI 10.1007/s11104-004-1013-x; Kirk JL, 2005, ENVIRON POLLUT, V133, P455, DOI 10.1016/j.envpol.2004.06.002; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; Langworthy DE, 1998, APPL ENVIRON MICROB, V64, P3422; Laurie AD, 2000, APPL ENVIRON MICROB, V66, P1814, DOI 10.1128/AEM.66.5.1814-1817.2000; Muratova AY, 2008, INT J PHYTOREMEDIAT, V10, P486, DOI 10.1080/15226510802114920; Muratova AY, 2003, APPL BIOCHEM MICRO+, V39, P599, DOI 10.1023/A:1026238720268; Newman LA, 2004, CURR OPIN BIOTECH, V15, P225, DOI 10.1016/j.copbio.2004.04.006; NIE M, 2010, EXPLORING RESPONSES; Nie M, 2011, ENVIRON POLLUT, V159, P157, DOI 10.1016/j.envpol.2010.09.013; Nie M, 2010, BIOL LETTERS, V6, P811, DOI 10.1098/rsbl.2010.0261; Nie M, 2009, SOIL BIOL BIOCHEM, V41, P2535, DOI 10.1016/j.soilbio.2009.09.012; PANSU M, 2006, HDB SOIL ANAL, P526; Peng SW, 2009, J HAZARD MATER, V168, P1490, DOI 10.1016/j.jhazmat.2009.03.036; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Powell SM, 2006, MICROB ECOL, V52, P523, DOI 10.1007/s00248-006-9131-z; Robertson SJ, 2007, BIOL REV, V82, P213, DOI 10.1111/j.1469-185X.2007.00012.x; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Siciliano SD, 2003, APPL ENVIRON MICROB, V69, P483, DOI 10.1128/AEM.69.1.483-489.2003; Susarla S, 2002, ECOL ENG, V18, P647, DOI 10.1016/S0925-8574(02)00026-5; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Thompson OA, 2008, WATER AIR SOIL POLL, V189, P37, DOI 10.1007/s11270-007-9552-4; Tordoff GM, 2000, CHEMOSPHERE, V41, P219, DOI 10.1016/S0045-6535(99)00414-2; Unterbrunner R, 2007, PLANT SOIL, V300, P117, DOI 10.1007/s11104-007-9394-2; van der Meer JR, 2006, FRONT ECOL ENVIRON, V4, P35, DOI 10.1890/1540-9295(2006)004[0035:EPPSOM]2.0.CO;2; Van Der Putten WH, 2003, ECOLOGY, V84, P2269, DOI 10.1890/02-0284; Walecka-Hutchison CM, 2007, BIODEGRADATION, V18, P133, DOI 10.1007/s10532-006-9049-7; Wenzel WW, 2009, PLANT SOIL, V321, P385, DOI 10.1007/s11104-008-9686-1; XIONG YS, 1993, GEOGR RES, V12, P23	51	64	65	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17961	10.1371/journal.pone.0017961	http://dx.doi.org/10.1371/journal.pone.0017961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437257	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100049
J	Theilacker, C; Kaczynski, Z; Kropec, A; Sava, I; Ye, LB; Bychowska, A; Holst, O; Huebner, J				Theilacker, Christian; Kaczynski, Zbigniew; Kropec, Andrea; Sava, Irina; Ye, Libin; Bychowska, Anna; Holst, Otto; Huebner, Johannes			Serodiversity of Opsonic Antibodies against Enterococcus faecalis -Glycans of the Cell Wall Revisited	PLOS ONE			English	Article							GROUP-D STREPTOCOCCI; O-SPECIFIC POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN-RESISTANT; PROLONGED BACTEREMIA; ANTIGEN; ACID; INFECTIONS; CLUSTER	In a typing system based on opsonic antibodies against carbohydrate antigens of the cell envelope, 60% of Enterococcus faecalis strains can be assigned to one of four serotypes (CPS-A to CPS-D). The structural basis for enterococcal serotypes, however, is still incompletely understood. Here we demonstrate that antibodies raised against lipoteichoic acid (LTA) from a CPS-A strain are opsonic to both CPS-A and CPS-B strains. LTA-specific antibodies also bind to LTA of CPS-C and CPS-D strains, but fail to opsonize them. From CPS-C and CPS-D strains resistant to opsonization by anti-LTA, we purified a novel diheteroglycan with a repeating unit of -> 6)-beta-Galf-(1 -> 3)-beta-D-Glcp-(1 -> with O-acetylation in position 5 and lactic acid substitution at position 3 of the Galf residue. The purified diheteroglycan, but not LTA absorbed opsonic antibodies from whole cell antiserum against E. faecalis type 2 (a CPS-C strain) and type 5 (CPS-D). Rabbit antiserum raised against purified diheteroglycan opsonized CPS-C and CPS-D strains and passive protection with diheteroglycan-specific antiserum reduced bacterial counts by 1.4 - 3.4 logs in mice infected with E. faecalis strains of the CPS-C and CPS-D serotype. Diheteroglycan-specific opsonic antibodies were absorbed by whole bacterial cells of E. faecalis FA2-2 (CPS-C) but not by its isogenic acapsular cpsI-mutant and on native PAGE purified diheteroglycan co-migrated with the gene product of the cps-locus, suggesting that it is synthesized by this locus. In summary, two polysaccharide antigens, LTA and a novel diheteroglycan, are targets of opsonic antibodies against typeable E. faecalis strains. These cell-wall associated polymers are promising candidates for active and passive vaccination and add to our armamentarium to fight this important nosocomial pathogen.	[Theilacker, Christian; Kropec, Andrea; Sava, Irina; Ye, Libin; Huebner, Johannes] Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, Freiburg, Germany; [Theilacker, Christian; Kropec, Andrea; Sava, Irina; Ye, Libin; Huebner, Johannes] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Kaczynski, Zbigniew; Bychowska, Anna] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Holst, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, Borstel, Germany	University of Freiburg; University of Freiburg; Fahrenheit Universities; University of Gdansk; Forschungszentrum Borstel	Theilacker, C (corresponding author), Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, Freiburg, Germany.	johannes.huebner@uniklinik-freiburg.de		Theilacker, Christian/0000-0003-0821-9202; Kaczynski, Zbigniew/0000-0002-4590-4690; Huebner, Johannes/0000-0003-1232-4646	Polish Ministry of Research and Higher Education [N N301 030134]	Polish Ministry of Research and Higher Education	ZK was supported by Polish Ministry of Research and Higher Education under grant no. N N301 030134. No other current external funding sources supported this this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beynon LM, 1997, EUR J BIOCHEM, V250, P163, DOI 10.1111/j.1432-1033.1997.00163.x; BLEIWEIS AS, 1965, J EXP MED, V122, P237, DOI 10.1084/jem.122.2.237; BLEIWEIS AS, 1967, J BACTERIOL, V94, P1381, DOI 10.1128/JB.94.5.1381-1387.1967; BRADFORD M, 1976, ANAL BIOCHEM, V28, P350; Burnie JP, 2000, INFECT IMMUN, V68, P3200, DOI 10.1128/IAI.68.6.3200-3209.2000; DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELLIOTT SD, 1960, J EXP MED, V111, P621, DOI 10.1084/jem.111.5.621; GOLD OG, 1975, ARCH ORAL BIOL, V20, P473, DOI 10.1016/0003-9969(75)90236-8; Hancock LE, 2003, J BACTERIOL, V185, P4393, DOI 10.1128/JB.185.15.4393-4401.2003; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Haseley SR, 1997, EUR J BIOCHEM, V244, P761, DOI 10.1111/j.1432-1033.1997.00761.x; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hsu CT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-62; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; KNIREL YA, 1994, CARBOHYD RES, V259, pC1, DOI 10.1016/0008-6215(94)84208-6; KNIREL YA, 1992, CARBOHYD RES, V235, pC19, DOI 10.1016/0008-6215(92)80105-A; Lee JC, 1997, INFECT IMMUN, V65, P4146, DOI 10.1128/IAI.65.10.4146-4151.1997; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; LOWRY OH, 1954, J BIOL CHEM, V207, P1; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; McNeely TB, 1998, INFECT IMMUN, V66, P3705, DOI 10.1128/IAI.66.8.3705-3710.1998; McNeil SA, 2006, CLIN INFECT DIS, V42, P195, DOI 10.1086/498903; PAZUR JH, 1973, J BIOL CHEM, V248, P279; PAZUR JH, 1971, J BIOL CHEM, V246, P1793; RHINEHART E, 1990, NEW ENGL J MED, V323, P1814, DOI 10.1056/NEJM199012273232606; RUOFF KL, 2010, PRINCIPLES PRACTICE, P2591; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; TENG F, 2009, INFECT IMMUN; Theilacker C, 2003, INFECT IMMUN, V71, P3875, DOI 10.1128/IAI.71.7.3875-3884.2003; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Thurlow LR, 2009, INFECT IMMUN, V77, P5551, DOI 10.1128/IAI.00576-09; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Vincent Jean-Louis, 2009, Crit Care Med, V37, pS296, DOI 10.1097/CCM.0b013e3181b6f1e1; WICKEN AJ, 1963, J GEN MICROBIOL, V31, P231, DOI 10.1099/00221287-31-2-231; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000	48	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17839	10.1371/journal.pone.0017839	http://dx.doi.org/10.1371/journal.pone.0017839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437253	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100038
J	Yang, CH; Chang, HW; Ho, CH; Chou, YC; Chuang, LY				Yang, Cheng-Hong; Chang, Hsueh-Wei; Ho, Chang-Hsuan; Chou, Yii-Cheng; Chuang, Li-Yeh			Conserved PCR Primer Set Designing for Closely-Related Species to Complete Mitochondrial Genome Sequencing Using a Sliding Window-Based PSO Algorithm	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MULTIPLE-ALIGNMENT; DNA; IDENTIFICATION; HYBRIDIZATION; PATTERNS; AVES	Background: Complete mitochondrial (mt) genome sequencing is becoming increasingly common for phylogenetic reconstruction and as a model for genome evolution. For long template sequencing, i.e., like the entire mtDNA, it is essential to design primers for Polymerase Chain Reaction (PCR) amplicons which are partly overlapping each other. The presented chromosome walking strategy provides the overlapping design to solve the problem for unreliable sequencing data at the 59 end and provides the effective sequencing. However, current algorithms and tools are mostly focused on the primer design for a local region in the genomic sequence. Accordingly, it is still challenging to provide the primer sets for the entire mtDNA. Methodology/Principal Findings: The purpose of this study is to develop an integrated primer design algorithm for entire mt genome in general, and for the common primer sets for closely-related species in particular. We introduce ClustalW to generate the multiple sequence alignment needed to find the conserved sequences in closely-related species. These conserved sequences are suitable for designing the common primers for the entire mtDNA. Using a heuristic algorithm particle swarm optimization (PSO), all the designed primers were computationally validated to fit the common primer design constraints, such as the melting temperature, primer length and GC content, PCR product length, secondary structure, specificity, and terminal limitation. The overlap requirement for PCR amplicons in the entire mtDNA is satisfied by defining the overlapping region with the sliding window technology. Finally, primer sets were designed within the overlapping region. The primer sets for the entire mtDNA sequences were successfully demonstrated in the example of two closely-related fish species. The pseudo code for the primer design algorithm is provided. Conclusions/Significance: In conclusion, it can be said that our proposed sliding window-based PSO algorithm provides the necessary primer sets for the entire mt genome amplification and sequencing.	[Yang, Cheng-Hong; Ho, Chang-Hsuan] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Yang, Cheng-Hong] Toko Univ, Dept Network Syst, Chiayi, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chou, Yii-Cheng] Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chung Hua University; I Shou University; I Shou University	Yang, CH (corresponding author), Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan.	changhw@kmu.edu.tw; chuang@isu.edu.tw	Chuang, Li-Yeh/E-5005-2011; Chang, Hsueh-Wei/C-9654-2009; Yang, Cheng-Hong/K-2438-2019; Yang, Cheng-Hong/M-7984-2013	Chang, Hsueh-Wei/0000-0003-0068-2366; Yang, Cheng-Hong/0000-0002-2741-0072	National Science Council in Taiwan [NSC97-2311-B-037-003-MY3, NSC97-2622-E-151-008-CC2, NSC96-2221-E-214-050-MY3, NSC96-2311-B037-002, NSC96-2622-E214-004-CC3, DOH99-TD-C-111-002, KMU-EM-99-1.4]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work is partly supported by the National Science Council in Taiwan under grants NSC97-2311-B-037-003-MY3, NSC97-2622-E-151-008-CC2, NSC96-2221-E-214-050-MY3, NSC96-2311-B037-002, NSC96-2622-E214-004-CC3, the funds DOH99-TD-C-111-002 and KMU-EM-99-1.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; AVISE JC, 1984, GENETICS, V108, P237; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BOLTON ET, 1962, P NATL ACAD SCI USA, V48, P1390, DOI 10.1073/pnas.48.8.1390; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chang HW, 2010, METHODS MOL BIOL, V628, P259, DOI 10.1007/978-1-60327-367-1_14; Chang HW, 2010, BIOCHEM SYST ECOL, V38, P195, DOI 10.1016/j.bse.2009.12.016; Chang HW, 2009, OMICS, V13, P253, DOI 10.1089/omi.2008.0058; Chen YF, 2009, COMPUT BIOL CHEM, V33, P181, DOI 10.1016/j.compbiolchem.2008.12.003; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chuang LY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-379; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Delisle I, 2002, MOL BIOL EVOL, V19, P357, DOI 10.1093/oxfordjournals.molbev.a004090; Fernandes Rohan J, 2002, Bioinformatics, V18 Suppl 1, pS128; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kim KG, 2009, MOL CELLS, V27, P429, DOI 10.1007/s10059-009-0064-5; KURABAYASHI A, 2010, MOL PHYLOGENET EVOL; Lamprecht AL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S13; Lee HP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-132; Li DM, 2009, GENE, V429, P31, DOI 10.1016/j.gene.2008.10.010; LIU WT, 2005, PRIMER SET SELECTION; Ma LL, 2010, MITOCHONDR DNA, V21, P5, DOI 10.3109/19401730903552026; May-Collado L, 2006, MOL PHYLOGENET EVOL, V38, P344, DOI 10.1016/j.ympev.2005.09.019; Moyle RG, 2006, MOL PHYLOGENET EVOL, V40, P687, DOI 10.1016/j.ympev.2006.04.015; Muller J, 2010, BIOINFORMATICS, V26, P263, DOI 10.1093/bioinformatics/btp651; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nakato R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-224; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Pang H, 2008, MITOCHONDR DNA, V19, P411, DOI 10.1080/19401730802389517; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Rao N, 2009, COMPUT BIOL MED, V39, P392, DOI 10.1016/j.compbiomed.2009.01.010; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Simmler H, 2004, CONCURR COMP-PRACT E, V16, P855, DOI 10.1002/cpe.810; Stone AC, 2010, PHILOS T R SOC B, V365, P3277, DOI 10.1098/rstb.2010.0096; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE RB, 1979, NUCLEIC ACIDS RES, V6, P3543, DOI 10.1093/nar/6.11.3543; Webb DM, 2005, MOL PHYLOGENET EVOL, V36, P233, DOI 10.1016/j.ympev.2005.03.015; Wu JS, 2004, BIOINFORMATICS, V20, P1710, DOI 10.1093/bioinformatics/bth147; Wu LC, 2007, SOFT COMPUT, V11, P855, DOI 10.1007/s00500-006-0137-8; Yang C.-H., 2010, INT J CHEM BIOL ENG, V3, P18; Yang CH, 2009, BIOTECHNOL PROGR, V25, P745, DOI 10.1002/btpr.169; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhang XY, 2009, MOL BIOL REP, V36, P981, DOI 10.1007/s11033-008-9271-y; Zsurka G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-270	53	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17729	10.1371/journal.pone.0017729	http://dx.doi.org/10.1371/journal.pone.0017729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445268	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100027
J	Paulmann, S; Ott, DVM; Kotz, SA				Paulmann, Silke; Ott, Derek V. M.; Kotz, Sonja A.			Emotional Speech Perception Unfolding in Time: The Role of the Basal Ganglia	PLOS ONE			English	Article							PARKINSONS-DISEASE; CORTICAL ACTIVATION; NEURAL MECHANISMS; BRAIN POTENTIALS; SEX-DIFFERENCES; ERP EVIDENCE; PROSODY; DISGUST; RECOGNITION; LESION	The basal ganglia (BG) have repeatedly been linked to emotional speech processing in studies involving patients with neurodegenerative and structural changes of the BG. However, the majority of previous studies did not consider that (i) emotional speech processing entails multiple processing steps, and the possibility that (ii) the BG may engage in one rather than the other of these processing steps. In the present study we investigate three different stages of emotional speech processing (emotional salience detection, meaning-related processing, and identification) in the same patient group to verify whether lesions to the BG affect these stages in a qualitatively different manner. Specifically, we explore early implicit emotional speech processing (probe verification) in an ERP experiment followed by an explicit behavioral emotional recognition task. In both experiments, participants listened to emotional sentences expressing one of four emotions (anger, fear, disgust, happiness) or neutral sentences. In line with previous evidence patients and healthy controls show differentiation of emotional and neutral sentences in the P200 component (emotional salience detection) and a following negative-going brain wave (meaning-related processing). However, the behavioral recognition (identification stage) of emotional sentences was impaired in BG patients, but not in healthy controls. The current data provide further support that the BG are involved in late, explicit rather than early emotional speech processing stages.	[Paulmann, Silke] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Ott, Derek V. M.; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	University of Essex; Max Planck Society	Paulmann, S (corresponding author), Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England.	paulmann@essex.ac.uk		Paulmann, Silke/0000-0003-4148-3806	German Research Foundation (DFG) [FOR 499]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG FOR 499 to S. A. Kotz). DFG website: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; BLONDER LX, 1989, BRAIN LANG, V36, P193, DOI 10.1016/0093-934X(89)90061-8; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; Breitenstein C, 2001, BRAIN COGNITION, V45, P277, DOI 10.1006/brcg.2000.1246; Breitenstein C, 1998, BEHAV NEUROL, V11, P29, DOI 10.1155/1998/579029; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; CANCELLIERE AEB, 1990, BRAIN COGNITION, V13, P133, DOI 10.1016/0278-2626(90)90046-Q; Dara C, 2008, BRAIN RES, V1188, P100, DOI 10.1016/j.brainres.2007.10.034; Friederici AD, 2003, NEUROPSYCHOLOGY, V17, P133, DOI 10.1037/0894-4105.17.1.133; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; KEPPEL G, 1991, DESIGN ANAL RESEARCH; Kiehl KA, 1999, PSYCHOPHYSIOLOGY, V36, P765, DOI 10.1111/1469-8986.3660765; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kotz SA, 2003, J INT NEUROPSYCH SOC, V9, P1053, DOI 10.1017/S1355617703970093; KOTZ SA, 2006, SPEECH PROSODY; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; Kotz SA, 2006, PROG BRAIN RES, V156, P285, DOI 10.1016/S0079-6123(06)56015-7; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Obleser J, 2006, CEREB CORTEX, V16, P1069, DOI 10.1093/cercor/bhj047; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; PAULMANN S, 2006, 12 ANN C ARCH MECH L; Paulmann S, 2008, BRAIN RES, V1217, P171, DOI 10.1016/j.brainres.2008.04.032; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Paulmann S, 2008, BRAIN LANG, V104, P262, DOI 10.1016/j.bandl.2007.03.002; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paulmann S, 2010, SOC NEUROSCI-UK, V5, P59, DOI 10.1080/17470910903135668; Paulmann S, 2009, BRAIN RES, V1295, P159, DOI 10.1016/j.brainres.2009.07.102; Pell ID, 1996, CORTEX, V32, P693, DOI 10.1016/S0010-9452(96)80039-6; Pell MD, 2003, COGN AFFECT BEHAV NE, V3, P275, DOI 10.3758/CABN.3.4.275; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; PFEIFER E, 1995, M PLANCK I COGNITIVE, P51; Pihan H, 2000, BRAIN, V123, P2338, DOI 10.1093/brain/123.11.2338; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2004, COGNITIVE BRAIN RES, V21, P269, DOI 10.1016/j.cogbrainres.2004.04.003; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schroder C, 2006, MOVEMENT DISORD, V21, P1774, DOI 10.1002/mds.21038; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; SCOTT S, 1984, J NEUROL NEUROSUR PS, V47, P840, DOI 10.1136/jnnp.47.8.840; Sidtis DV, 2006, BRAIN LANG, V97, P135, DOI 10.1016/j.bandl.2005.09.001; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 1997, P ROY SOC B-BIOL SCI, V264, P1767, DOI 10.1098/rspb.1997.0245; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; Tisch S, 2004, PSYCHIAT CLIN N AM, V27, P757, DOI 10.1016/j.psc.2004.06.004; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Wang K, 2003, NEUROPSYCHOLOGIA, V41, P527, DOI 10.1016/S0028-3932(02)00171-9; Wieser MJ, 2006, CLIN NEUROPHYSIOL, V117, P94, DOI 10.1016/j.clinph.2005.09.009; Wildgruber D., 2009, INT J SPEECH-LANG PA, V11, P277, DOI [10.1080/17549500902943043, DOI 10.1080/17549500902943043]; YIP JTH, 2003, MOV DIS, V18, P115; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	66	41	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17694	10.1371/journal.pone.0017694	http://dx.doi.org/10.1371/journal.pone.0017694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736SO	21437277	Green Published, gold, Green Accepted			2022-12-27	WOS:000288514600007
J	Chougule, MB; Patel, AR; Jackson, T; Singh, M				Chougule, Mahavir B.; Patel, Apurva R.; Jackson, Tanise; Singh, Mandip			Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; ANTICANCER ACTIVITY; LEUKEMIC-CELLS; MOUSE MODEL; APOPTOSIS; AGENTS; TUMORS; PROLIFERATION; FORMULATION; PROGRESSION	Background: The aim of this study was to investigate the anticancer activity and mechanism of action of Noscapine alone and in combination with Doxorubicin against triple negative breast cancer (TNBC). Methods: TNBC cells were pretreated with Noscapine or Doxorubicin or combination and combination index values were calculated using isobolographic method. Apoptosis was assessed by TUNEL staining. Female athymic Nu/nu mice were xenografted with MDA-MB-231 cells and the efficacy of Noscapine, Doxorubicin and combination was determined. Protein expression, immunohistochemical staining were evaluated in harvested tumor tissues. Results: Noscapine inhibited growth of MDA-MB-231 and MDA-MB-468 cells with the IC50 values of 36.16 +/- 3.76 and 42.7 +/- 4.3 mu M respectively. The CI values (<0.59) were suggestive of strong synergistic interaction between Noscapine and Doxorubicin and combination treatment showed significant increase in apoptotic cells. Noscapine showed dose dependent reduction in the tumor volumes at a dose of 150-550 mg/kg/day compared to controls. Noscapine (300 mg/kg), Doxorubicin (1.5 mg/kg) and combination treatment reduced tumor volume by 39.4 +/- 5.8, 34.2 +/- 5.7 and 82.9 +/- 4.5 percent respectively and showed decreased expression of NF-KB pathway proteins, VEGF, cell survival, and increased expression of apoptotic and growth inhibitory proteins compared to single-agent treatment and control groups. Conclusions: Noscapine potentiated the anticancer activity of Doxorubicin in a synergistic manner against TNBC tumors via inactivation of NF-KB and anti-angiogenic pathways while stimulating apoptosis. These findings suggest potential benefit for use of oral Noscapine and Doxorubicin combination therapy for treatment of more aggressive TNBC.	[Chougule, Mahavir B.] Univ Hawaii, Coll Pharm, Hilo, HI 96720 USA; [Patel, Apurva R.; Jackson, Tanise; Singh, Mandip] Florida A&M Univ, Coll Pharm, Tallahassee, FL 32307 USA	University of Hawaii System; University Hawaii Hilo; State University System of Florida; Florida A&M University	Chougule, MB (corresponding author), Univ Hawaii, Coll Pharm, Hilo, HI 96720 USA.	mandip.sachdeva@famu.edu			NIH [G12RR03020-11, 5S06GM008111-36]; NATIONAL CANCER INSTITUTE [SC1CA161676] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the financial support provided by RCMI grant (G12RR03020-11) and NIGMS/MBRS award (5S06GM008111-36) from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2005, J MED CHEM, V48, P7096, DOI 10.1021/jm050674q; Anderson JT, 2005, J MED CHEM, V48, P2756, DOI 10.1021/jm0494220; Aneja R, 2006, CANCER RES, V66, P3782, DOI 10.1158/0008-5472.CAN-05-2962; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Aneja R, 2007, CANCER RES, V67, P3862, DOI 10.1158/0008-5472.CAN-06-4282; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Barken I, 2008, ANTICANCER RES, V28, P3701; Buzdar AU, 2003, ONCOLOGIST, V8, P335, DOI 10.1634/theoncologist.8-4-335; Chougule M, 2010, LUNG CANC; DAHLSTROM B, 1982, EUR J CLIN PHARMACOL, V22, P535, DOI 10.1007/BF00609627; Ewens A, 2006, CANCER RES, V66, P5419, DOI 10.1158/0008-5472.CAN-05-3963; Hardenbergh PH, 1999, INT J RADIAT ONCOL, V45, P69, DOI 10.1016/S0360-3016(99)00127-3; Heidari N, 2007, ANTI-CANCER DRUG, V18, P1139, DOI 10.1097/CAD.0b013e3282eea257; Hiser L, 2008, LEUKEMIA LYMPHOMA, V49, P1603, DOI 10.1080/10428190802213480; Ichite N, 2009, CLIN CANCER RES, V15, P543, DOI 10.1158/1078-0432.CCR-08-1558; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z; Karna P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-93; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kawasaki H, 2001, CANCER, V91, P2026, DOI 10.1002/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E; Keam B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-203; Landen JW, 2004, CLIN CANCER RES, V10, P5187, DOI 10.1158/1078-0432.CCR-04-0360; Landen JW, 2002, CANCER RES, V62, P4109; Liu M, 2010, CANC CHEMOTHER PHARM; Mahmoudian M, 2009, RECENT PAT ANTI-CANC, V4, P92, DOI 10.2174/157489209787002524; Markman M, 2003, SUPPORT CARE CANCER, V11, P144, DOI 10.1007/s00520-002-0405-9; Menendez JA, 2001, EUR J CANCER, V37, P402, DOI 10.1016/S0959-8049(00)00408-1; Moulder S, 2008, CLIN PHARMACOL THER, V83, P26, DOI 10.1038/sj.clpt.6100449; Newcomb EW, 2008, INT J RADIAT ONCOL, V71, P1477, DOI 10.1016/j.ijrobp.2008.04.020; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Pan Q, 2003, MOL CANCER THER, V2, P617; Patlolla RR, 2010, J CONTROL RELEASE, V144, P233, DOI 10.1016/j.jconrel.2010.02.006; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Stockmans G, 2008, CURR OPIN ONCOL, V20, P614, DOI 10.1097/CCO.0b013e328312efba; Sung B, 2010, CANCER RES, V70, P3259, DOI 10.1158/0008-5472.CAN-09-4230; van Zuylen L, 2001, INVEST NEW DRUG, V19, P125, DOI 10.1023/A:1010618632738; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Yamamoto Y, 2010, INT J CLIN ONCOL; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zamorano J, 2001, INT IMMUNOL, V13, P1479, DOI 10.1093/intimm/13.12.1479; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200	45	82	86	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17733	10.1371/journal.pone.0017733	http://dx.doi.org/10.1371/journal.pone.0017733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423660	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900018
J	Hishiya, A; Salman, MN; Carra, S; Kampinga, HH; Takayama, S				Hishiya, Akinori; Salman, Mortada Najem; Carra, Serena; Kampinga, Harm H.; Takayama, Shinichi			BAG3 Directly Interacts with Mutated alphaB-Crystallin to Suppress Its Aggregation and Toxicity	PLOS ONE			English	Article							DESMIN-RELATED MYOPATHY; B-CRYSTALLIN; MYOFIBRILLAR MYOPATHY; CHAPERONE ACTIVITY; CELL-DEATH; CARDIOMYOPATHY; COMPLEX; PROTEIN; MICE; R120G-ALPHA-B-CRYSTALLIN	A homozygous disruption or genetic mutation of the bag3 gene causes progressive myofibrillar myopathy in mouse and human skeletal and cardiac muscle disorder while mutations in the small heat shock protein aB-crystallin gene ( CRYAB) are reported to be responsible for myofibrillar myopathy. Here, we demonstrate that BAG3 directly binds to wild-type alpha B-crystallin and the alpha B-crystallin mutant R120G, via the intermediate domain of BAG3. Peptides that inhibit this interaction in an in vitro binding assay indicate that two conserved Ile-Pro-Val regions of BAG3 are involved in the interaction with alpha B-crystallin, which is similar to results showing BAG3 binding to HspB8 and HspB6. BAG3 overexpression increased alpha B-crystallin R120G solubility and inhibited its intracellular aggregation in HEK293 cells. BAG3 suppressed cell death induced by alpha B-crystallin R120G overexpression in differentiating C2C12 mouse myoblast cells. Our findings indicate a novel function for BAG3 in inhibiting protein aggregation caused by the genetic mutation of CRYAB responsible for human myofibrillar myopathy.	[Hishiya, Akinori; Salman, Mortada Najem; Takayama, Shinichi] Boston Biomed Res Inst, Cardiovasc Grp, Watertown, MA 02472 USA; [Carra, Serena; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, Groningen, Netherlands	Boston Biomedical Research Institute; University of Groningen	Hishiya, A (corresponding author), Boston Biomed Res Inst, Cardiovasc Grp, Watertown, MA 02472 USA.	Takayama@bbri.org	Carra, Serena/O-2835-2015	Carra, Serena/0000-0003-0939-0140; Kampinga, Harm/0000-0002-8966-8466	National Institutes of Health (NIH) [AR052925]; Thoracic Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052925] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thoracic Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the National Institutes of Health (NIH) (AR052925) and the Thoracic Foundation for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Engel AG, 1999, ANN NEUROL, V46, P681, DOI 10.1002/1531-8249(199911)46:5<681::AID-ANA1>3.0.CO;2-B; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Hishiya A, 2008, ONCOGENE, V27, P6489, DOI 10.1038/onc.2008.314; Hishiya A, 2010, CIRCULATION IN PRESS; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Ito H, 2003, CELL MOL LIFE SCI, V60, P1217, DOI 10.1007/s00018-003-3024-9; Iwasaki M, 2010, BIOCHEM BIOPH RES CO, V400, P413, DOI 10.1016/j.bbrc.2010.08.092; Jana NR, 2005, NEUROSCI LETT, V378, P171, DOI 10.1016/j.neulet.2004.12.031; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Maloyan A, 2010, CIRC RES, V106, P1524, DOI 10.1161/CIRCRESAHA.109.212639; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Odgerel Z, 2010, NEUROMUSCULAR DISORD, V20, P438, DOI 10.1016/j.nmd.2010.05.004; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Reilich P, 2010, NEUROMUSCULAR DISORD, V20, P255, DOI 10.1016/j.nmd.2010.01.012; Rohde G, 2008, NEUROSCIENCE, V157, P844, DOI 10.1016/j.neuroscience.2008.09.055; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Selcen D, 2008, CURR OPIN NEUROL, V21, P585, DOI 10.1097/WCO.0b013e32830a752b; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Shelton GD, 2004, NEUROMUSCULAR DISORD, V14, P399, DOI 10.1016/j.nmd.2004.03.010; Takada H, 2003, MOL CELL BIOL, V23, P4026, DOI 10.1128/MCB.23.11.4026-4033.2003; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	36	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e16828	10.1371/journal.pone.0016828	http://dx.doi.org/10.1371/journal.pone.0016828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423662	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900004
J	Kaplan, F; Srinivasan, J; Mahanti, P; Ajredini, R; Durak, O; Nimalendran, R; Sternberg, PW; Teal, PEA; Schroeder, FC; Edison, AS; Alborn, HT				Kaplan, Fatma; Srinivasan, Jagan; Mahanti, Parag; Ajredini, Ramadan; Durak, Omer; Nimalendran, Rathika; Sternberg, Paul W.; Teal, Peter E. A.; Schroeder, Frank C.; Edison, Arthur S.; Alborn, Hans T.			Ascaroside Expression in Caenorhabditis elegans Is Strongly Dependent on Diet and Developmental Stage	PLOS ONE			English	Article							PHEROMONE; NEMATODE; TEMPERATURE	Background: The ascarosides form a family of small molecules that have been isolated from cultures of the nematode Caenorhabditis elegans. They are often referred to as "dauer pheromones" because most of them induce formation of long-lived and highly stress resistant dauer larvae. More recent studies have shown that ascarosides serve additional functions as social signals and mating pheromones. Thus, ascarosides have multiple functions. Until now, it has been generally assumed that ascarosides are constitutively expressed during nematode development. Methodology/Principal Findings: Cultures of C. elegans were developmentally synchronized on controlled diets. Ascarosides released into the media, as well as stored internally, were quantified by LC/MS. We found that ascaroside biosynthesis and release were strongly dependent on developmental stage and diet. The male attracting pheromone was verified to be a blend of at least four ascarosides, and peak production of the two most potent mating pheromone components, ascr#3 and asc#8 immediately preceded or coincided with the temporal window for mating. The concentration of ascr#2 increased under starvation conditions and peaked during dauer formation, strongly supporting ascr#2 as the main population density signal (dauer pheromone). After dauer formation, ascaroside production largely ceased and dauer larvae did not release any ascarosides. These findings show that both total ascaroside production and the relative proportions of individual ascarosides strongly correlate with these compounds' stage-specific biological functions. Conclusions/Significance: Ascaroside expression changes with development and environmental conditions. This is consistent with multiple functions of these signaling molecules. Knowledge of such differential regulation will make it possible to associate ascaroside production to gene expression profiles (transcript, protein or enzyme activity) and help to determine genetic pathways that control ascaroside biosynthesis. In conjunction with findings from previous studies, our results show that the pheromone system of C. elegans mimics that of insects in many ways, suggesting that pheromone signaling in C. elegans may exhibit functional homology also at the sensory level. In addition, our results provide a strong foundation for future behavioral modeling studies.	[Kaplan, Fatma; Teal, Peter E. A.; Alborn, Hans T.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Srinivasan, Jagan; Durak, Omer; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Srinivasan, Jagan; Durak, Omer; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mahanti, Parag; Nimalendran, Rathika; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Mahanti, Parag; Nimalendran, Rathika; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Ajredini, Ramadan; Edison, Arthur S.] Univ Florida, High Field Magnet Lab, Dept Biochem & Mol Biol, Gainesville, FL USA	United States Department of Agriculture (USDA); California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; State University System of Florida; University of Florida	Kaplan, F (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	hans.alborn@ars.usda.gov	Kaplan, Fatma/AAJ-7666-2020; Mahanti, Parag/AAK-8974-2021; Srinivasan, Jagan/B-6215-2015; Schroeder, Frank/H-5026-2012	Kaplan, Fatma/0000-0002-9565-0211; Durak, Omer/0000-0001-8426-6188; Schroeder, Frank/0000-0002-4420-0237; Srinivasan, Jagan/0000-0001-5449-7938; Edison, Arthur/0000-0002-5686-2350; Sternberg, Paul/0000-0002-7699-0173	National Institutes of Health [1R01GM085285-01A1, 3R01GM085285-01A1S1, GM088290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085285, R01GM088290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Partially funded by National Institutes of Health (1R01GM085285-01A1, 3R01GM085285-01A1S1, and GM088290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Edison AS, 2009, CURR OPIN NEUROBIOL, V19, P378, DOI 10.1016/j.conb.2009.07.007; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; HU PJ, 2007, COMMUNITY TCER, DOI DOI 10.1895/W0RMB00K.1891.1144.1891; JAFFE H, 1989, J CHEM ECOL, V15, P2031, DOI 10.1007/BF01207435; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Johnstone I.J., 1999, C ELEGANS PRACTICAL, P201; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; *PROTOCOLS, 2010, DAUER PUR SUCR FLOAT; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stiernagle T., 1999, C ELEGANS PRACTICAL, P51	19	65	72	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17804	10.1371/journal.pone.0017804	http://dx.doi.org/10.1371/journal.pone.0017804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423575	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000288513900032
J	Etienne, RS; Rosindell, J				Etienne, Rampal S.; Rosindell, James			The Spatial Limitations of Current Neutral Models of Biodiversity	PLOS ONE			English	Article							SPECIES-AREA CURVES; ZERO-SUM ASSUMPTION; DISPERSAL-LIMITATION; TROPICAL FORESTS; MULTIPLE SAMPLES; BETA-DIVERSITY; PARAMETERS; SPECIATION; ABUNDANCE; FORMULA	The unified neutral theory of biodiversity and biogeography is increasingly accepted as an informative null model of community composition and dynamics. It has successfully produced macro-ecological patterns such as species-area relationships and species abundance distributions. However, the models employed make many unrealistic auxiliary assumptions. For example, the popular spatially implicit version assumes a local plot exchanging migrants with a large panmictic regional source pool. This simple structure allows rigorous testing of its fit to data. In contrast, spatially explicit models assume that offspring disperse only limited distances from their parents, but one cannot as yet test the significance of their fit to data. Here we compare the spatially explicit and the spatially implicit model, fitting the most-used implicit model (with two levels, local and regional) to data simulated by the most-used spatially explicit model (where offspring are distributed about their parent on a grid according to either a radially symmetric Gaussian or a 'fat-tailed' distribution). Based on these fits, we express spatially implicit parameters in terms of spatially explicit parameters. This suggests how we may obtain estimates of spatially explicit parameters from spatially implicit ones. The relationship between these parameters, however, makes no intuitive sense. Furthermore, the spatially implicit model usually fits observed species-abundance distributions better than those calculated from the spatially explicit model's simulated data. Current spatially explicit neutral models therefore have limited descriptive power. However, our results suggest that a fatter tail of the dispersal kernel seems to improve the fit, suggesting that dispersal kernels with even fatter tails should be studied in future. We conclude that more advanced spatially explicit models and tools to analyze them need to be developed.	[Etienne, Rampal S.] Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Rosindell, James] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Groningen; University of Leeds	Etienne, RS (corresponding author), Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	r.s.etienne@rug.nl	Etienne, Rampal S./F-5835-2012	Etienne, Rampal S./0000-0003-2142-7612; Rosindell, James/0000-0002-5060-9346	Netherlands Organization for Scientific Research (NWO); Engineering and Physical Sciences Research Council (EPSRC) [EP/F043112/1]; Engineering and Physical Sciences Research Council [EP/F043112/1] Funding Source: researchfish; EPSRC [EP/F043112/1] Funding Source: UKRI	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	RSE and JR acknowledge the financial support of the Netherlands Organization for Scientific Research (NWO) and Engineering and Physical Sciences Research Council (EPSRC, grant number EP/F043112/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2001, NATURE, V412, P858, DOI 10.1038/35091120; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Allouche O, 2009, ECOL LETT, V12, P1287, DOI 10.1111/j.1461-0248.2009.01379.x; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Bengtsson J, 2002, ECOL ECON, V42, P497, DOI 10.1016/S0921-8009(02)00131-3; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Chisholm RA, 2009, ECOL LETT, V12, P1385, DOI 10.1111/j.1461-0248.2009.01389.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; de Mazancourt C, 2001, SCIENCE, V293, P1772; Durrett R, 1996, J THEOR BIOL, V179, P119, DOI 10.1006/jtbi.1996.0053; Economo EP, 2008, ECOL LETT, V11, P52, DOI 10.1111/j.1461-0248.2007.01126.x; Etienne RS, 2007, J STAT PHYS, V128, P485, DOI 10.1007/s10955-006-9163-2; Etienne RS, 2007, J THEOR BIOL, V248, P522, DOI 10.1016/j.jtbi.2007.06.010; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2007, OIKOS, V116, P241, DOI [10.1111/j.2007.0030-1299.15438.x, 10.1111/j.0030-1299.2007.15438.x]; Etienne RS, 2009, J THEOR BIOL, V257, P510, DOI 10.1016/j.jtbi.2008.12.016; Etienne RS, 2009, ECOLOGY, V90, P847, DOI 10.1890/08-0750.1; Etienne RS, 2006, SCIENCE, V311, p610B, DOI 10.1126/science.1121914; Etienne RS, 2005, ECOL LETT, V8, P1147, DOI 10.1111/j.1461-0248.2005.00817.x; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; ETIENNE RS, 2010, THEORETICAL ECOLOGY, V4, P87; FRIEDMAN M, 1953, ESSAYS POSITIVE EC C; Gray JS, 2006, J ANIM ECOL, V75, P752, DOI 10.1111/j.1365-2656.2006.01095.x; Haegeman B, 2008, J THEOR BIOL, V252, P288, DOI 10.1016/j.jtbi.2008.01.023; Haegeman B, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031911; Haegeman B, 2009, B MATH BIOL, V71, P1507, DOI 10.1007/s11538-009-9411-0; Hubbell Stephen P., 2001, V32, pi; Kimura M., 1983, NEUTRAL THEORY MOL E; Leigh E. G., 2010, SCHOLARPEDIA, V5, P8822; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Munoz F, 2008, AM NAT, V172, P116, DOI 10.1086/587842; Munoz F, 2007, ECOLOGY, V88, P2482, DOI 10.1890/07-0049.1; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Rosindell J, 2008, ECOL INFORM, V3, P259, DOI 10.1016/j.ecoinf.2008.05.001; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Rosindell J, 2010, ECOL LETT, V13, P716, DOI 10.1111/j.1461-0248.2010.01463.x; Rosindell J, 2009, ECOLOGY, V90, P1743, DOI 10.1890/08-0661.1; Vanpeteghem D, 2010, J MATH BIOL, V61, P323, DOI 10.1007/s00285-009-0303-6; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030	41	29	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14717	10.1371/journal.pone.0014717	http://dx.doi.org/10.1371/journal.pone.0014717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423724	gold, Green Published, Green Submitted			2022-12-27	WOS:000288512400001
J	Yang, HL; Wang, YP; Xiao, Y; Wang, Y; Wu, J; Liu, CB; Ye, HH; Li, FL; Yu, HN; Lai, R				Yang, Hailong; Wang, Yipeng; Xiao, Yao; Wang, Ying; Wu, Jing; Liu, Cunbao; Ye, Huahu; Li, Fengliang; Yu, Haining; Lai, Ren			A Bi-Functional Anti-Thrombosis Protein Containing Both Direct-Acting Fibrin(ogen)olytic and Plasminogen-Activating Activities	PLOS ONE			English	Article							HORSEFLY SALIVARY-GLANDS; FIBRINOLYTIC-ACTIVITY; SERINE-PROTEASE; PURIFICATION; COAGULATION; HEMORRHAGE; FLY; THROMBOLYSIS; UROKINASE; DIPTERA	Direct-acting fibrin(ogen)olytic agents such as plasmin have been proved to contain effective and safety thrombolytic potential. Unfortunately, plasmin is ineffective when administered by the intravenous route because it was neutralized by plasma antiplasmin. Direct-acting fibrin(ogen) olytic agents with resistance against antiplasmin will brighten the prospect of anti-thrombosis. As reported in 'Compendium of Materia Medica', the insect of Eupolyphaga sinensis Walker has been used as traditional anti-thrombosis medicine without bleeding risk for several hundreds years. Currently, we have identified a fibrin(ogen) olytic protein (Eupolytin1) containing both fibrin(ogen) olytic and plasminogen-activating (PA) activities from the beetle, E. sinensis. Objectives: To investigate the role of native and recombinant eupolytin1 in fibrin(ogen) olytic and plasminogen-activating processes. Methods and Results: Using thrombus animal model, eupolytin1 was proved to contain strong and rapid thrombolytic ability and safety in vivo, which are better than that of urokinase. Most importantly, no bleeding complications were appeared even the intravenous dose up to 0.12 mu mol/kg body weight (3 times of tested dose which could completely lyse experimental thrombi) in rabbits. It is the first report of thrombolytic agents containing both direct-acting fibrin(ogen) olytic and plasminogen-activating activities. Conclusions: The study identified novel thrombolytic agent with prospecting clinical potential because of its bi-functional merits containing both plasmin-and PA-like activities and unique pharmacological kinetics in vivo.	[Yang, Hailong; Wang, Yipeng; Xiao, Yao; Wang, Ying; Wu, Jing; Liu, Cunbao; Lai, Ren] Chinese Acad Sci, Biotoxin Units Key Lab Anim Models & Human Dis Me, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Lai, Ren] Nanjing Agr Univ, Life Sci Coll, Nanjing, Jiangsu, Peoples R China; [Yu, Haining] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China; [Li, Fengliang] First Peoples Hosp Yunnan Prov, Dept Lab Med, Kunming, Yunnan, Peoples R China; [Ye, Huahu] Acad Mil Med Sci, Inst Biotechnol, Beijing, Peoples R China; [Yang, Hailong; Wang, Yipeng; Xiao, Yao; Wang, Ying; Wu, Jing; Liu, Cunbao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Nanjing Agricultural University; Dalian University of Technology; Academy of Military Medical Sciences - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, HL (corresponding author), Chinese Acad Sci, Biotoxin Units Key Lab Anim Models & Human Dis Me, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	yuhaining@dlut.edu.cn; rlai@mail.kiz.ac.cn	Xiao, Yao/AAL-6013-2021; yang, hailong/GXH-9625-2022; Wang, Yipeng/AAA-1499-2020	Wang, Yipeng/0000-0003-1385-4470	Chinese National Natural Science Foundation [30830021, 41076098]; Chinese Academy of Sciences [KSCXZ-YW-R-088, KSCX2-YW-G-024]; Ministry of Science [2008AA02Z133, 2010CB529800]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Chinese National Natural Science Foundation (30830021, 41076098), Chinese Academy of Sciences (KSCXZ-YW-R-088, KSCX2-YW-G-024), and the Ministry of Science (2008AA02Z133, 2010CB529800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MY, 2003, THROMB RES, V112, P339, DOI 10.1016/j.thromres.2004.01.005; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; BEKEMEIER H, 1987, NATURWISSENSCHAFTEN, V74, P345, DOI 10.1007/BF00367934; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Dametto M, 2000, J PROTEIN CHEM, V19, P515, DOI 10.1023/A:1026557600429; Hahn BS, 1999, BBA-PROTEIN STRUCT M, V1430, P376, DOI 10.1016/S0167-4838(99)00024-2; Han Ya-Li, 2006, Zhong Yao Cai, V29, P765; Hindersin P, 1986, J Neurosurg Sci, V30, P183; HINDERSIN P, 1984, ACTA NEUR S IN PRESS; Kajimoto Y, 1997, NEUROSURGERY, V40, P572, DOI 10.1097/00006123-199703000-00029; Ma DY, 2009, MOL CELL PROTEOMICS, V8, P2071, DOI 10.1074/mcp.M900186-MCP200; Marder VJ, 2009, THROMB RES, V123, pS56, DOI 10.1016/S0049-3848(09)70145-8; Marder VJ, 2001, THROMB HAEMOSTASIS, V86, P739; RIBEIRO JMC, 1992, J EXP BIOL, V165, P61; SHERRY S, 1959, PHYSIOL REV, V39, P343, DOI 10.1152/physrev.1959.39.2.343; Sperzel M, 2007, J THROMB HAEMOST, V5, P2113, DOI 10.1111/j.1538-7836.2007.02717.x; Stewart D, 2003, BLOOD, V101, P3002, DOI 10.1182/blood-2002-08-2546; Sugimoto K, 2003, J VASC SURG, V37, P512, DOI 10.1067/mva.2003.41; Takac P, 2006, J EXP BIOL, V209, P343, DOI 10.1242/jeb.02003; WANG JD, 1989, CHEM PHARM BULL, V37, P2236; Xu XQ, 2008, MOL CELL PROTEOMICS, V7, P582, DOI 10.1074/mcp.M700497-MCP200	21	24	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17519	10.1371/journal.pone.0017519	http://dx.doi.org/10.1371/journal.pone.0017519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423730	Green Submitted, gold, Green Published			2022-12-27	WOS:000288512400012
J	Guyot, R; Garavito, A; Gavory, F; Samain, S; Tohme, J; Ghesquiere, A; Lorieux, M				Guyot, Romain; Garavito, Andrea; Gavory, Frederick; Samain, Sylvie; Tohme, Joe; Ghesquiere, Alain; Lorieux, Mathias			Patterns of Sequence Divergence and Evolution of the S-1 Orthologous Regions between Asian and African Cultivated Rice Species	PLOS ONE			English	Article							HYBRID STERILITY; REPRODUCTIVE BARRIER; GAMETE ELIMINATOR; ORYZA; GENE; NUCLEAR; RESOURCE; GENOMES; DOMESTICATION; ANNOTATION	A strong postzygotic reproductive barrier separates the recently diverged Asian and African cultivated rice species, Oryza sativa and O. glaberrima. Recently a model of genetic incompatibilities between three adjacent loci: S(1)A, S-1 and S1B (called together the S-1 regions) interacting epistatically, was postulated to cause the allelic elimination of female gametes in interspecific hybrids. Two candidate factors for the S-1 locus (including a putative F-box gene) were proposed, but candidates for S(1)A and S1B remained undetermined. Here, to better understand the basis of the evolution of regions involved in reproductive isolation, we studied the genic and structural changes accumulated in the S-1 regions between orthologous sequences. First, we established an 813 kb genomic sequence in O. glaberrima, covering completely the S(1)A, S-1 and the majority of the S1B regions, and compared it with the orthologous regions of O. sativa. An overall strong structural conservation was observed, with the exception of three isolated regions of disturbed collinearity: (1) a local invasion of transposable elements around a putative F-box gene within S-1, (2) the multiple duplication and subsequent divergence of the same F-box gene within S(1)A, (3) an interspecific chromosomal inversion in S1B, which restricts recombination in our O. sativa x O. glaberrima crosses. Beside these few structural variations, a uniform conservative pattern of coding sequence divergence was found all along the S-1 regions. Hence, the S-1 regions have undergone no drastic variation in their recent divergence and evolution between O. sativa and O. glaberrima, suggesting that a small accumulation of genic changes, following a Bateson-Dobzhansky-Muller (BDM) model, might be involved in the establishment of the sterility barrier. In this context, genetic incompatibilities involving the duplicated F-box genes as putative candidates, and a possible strengthening step involving the chromosomal inversion might participate to the reproductive barrier between Asian and African rice species.	[Guyot, Romain; Garavito, Andrea; Ghesquiere, Alain; Lorieux, Mathias] IRD, Plant Genome & Dev Lab, UMR 5096, CNRS,UPVD, Montpellier, France; [Tohme, Joe; Lorieux, Mathias] CIAT, Agrobiodivers & Biotechnol Project, Cali, Colombia; [Gavory, Frederick; Samain, Sylvie] Inst Genom, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Alliance; International Center for Tropical Agriculture - CIAT; UDICE-French Research Universities; Universite Paris Saclay	Guyot, R (corresponding author), IRD, UMR DIADE, Montpellier, France.	romain.guyot@ird.fr	GHESQUIERE, Alain/K-3068-2016; guyot, romain/AAE-2262-2021; Lorieux, Mathias J/A-9448-2011; guyot, romain/M-1118-2015	guyot, romain/0000-0002-7016-7485; guyot, romain/0000-0002-7016-7485; Garavito, Andrea/0000-0002-0864-8608; Gavory, Frederick/0000-0003-1534-5725	Generation Challenge Program; Departement Soutien et Formation (DSF) from Institut de Recherche pour le Developpement (IRD); Centro Internacional de Agricultura Tropical (CIAT)	Generation Challenge Program; Departement Soutien et Formation (DSF) from Institut de Recherche pour le Developpement (IRD); Centro Internacional de Agricultura Tropical (CIAT)	This work was supported by the Generation Challenge Program. The Departement Soutien et Formation (DSF) from Institut de Recherche pour le Developpement (IRD), and Centro Internacional de Agricultura Tropical (CIAT) provided the PhD scholarship of A. Garavito. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2000, BIOINFORMATICS, V16, P743, DOI 10.1093/bioinformatics/16.8.743; Ammiraju JSS, 2008, PLANT CELL, V20, P3191, DOI 10.1105/tpc.108.063727; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Bateson W., 1909, DARWIN MODERN SCI, P81; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chaparro C, 2007, NUCLEIC ACIDS RES, V35, pD66, DOI 10.1093/nar/gkl780; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; COYNE JA, 2004, SPECIATION SUNDERLAN; Dobzhansky T, 1936, GENETICS, V21, P113; Doi K., 2003, Advances in rice genetics, Los Banos, Laguna, Philippines, 22-27 October 2000, P149, DOI 10.1142/9789812814319_0059; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Garavito A, 2010, GENETICS, V185, P1425, DOI 10.1534/genetics.110.116772; Gusti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004780; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kim H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r45; Koide Y, 2008, NEW PHYTOL, V179, P888, DOI 10.1111/j.1469-8137.2008.02490.x; Kulathinal RJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000550; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Lu F, 2009, P NATL ACAD SCI USA, V106, P2071, DOI 10.1073/pnas.0812798106; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; MARTINEZ CP, 1994, JPN J GENET, V69, P513, DOI 10.1266/jjg.69.513; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; Muller HJ, 1942, BIOL S, V6, P71; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Orjuela J, 2010, THEOR APPL GENET, V120, P563, DOI 10.1007/s00122-009-1176-1; Osada N, 2005, GENETICS, V169, P259, DOI 10.1534/genetics.104.029231; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; PORTERES R, 1962, J AFR HIST, V3, P195, DOI 10.1017/S0021853700003030; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANO Y, 1990, GENETICS, V125, P183; SANO Y, 1994, J HERED, V85, P310, DOI 10.1093/oxfordjournals.jhered.a111465; Sarla N, 2005, CURR SCI INDIA, V89, P955; SECOND G, 1985, GENET SEL EVOL, V17, P89, DOI 10.1186/1297-9686-17-1-89; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Tang T, 2006, PLOS GENET, V2, P1824, DOI 10.1371/journal.pgen.0020199; Thibaud-Nissen F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-317; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Vaughan DA, 2005, BREEDING SCI, V55, P113, DOI 10.1270/jsbbs.55.113; Wang YX, 2006, PLANTA, V223, P613, DOI 10.1007/s00425-005-0154-3; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yamagata Y, 2010, P NATL ACAD SCI USA, V107, P1494, DOI 10.1073/pnas.0908283107; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; [No title captured]	62	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17726	10.1371/journal.pone.0017726	http://dx.doi.org/10.1371/journal.pone.0017726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423767	Green Submitted, Green Published, gold			2022-12-27	WOS:000288219100030
J	Botbol, M; Roubertoux, PL; Carlier, M; Trabado, S; Brailly-Tabard, S; Perez-Diaz, F; Bonnot, O; Bronsard, G; Tordjman, S				Botbol, Michel; Roubertoux, Pierre L.; Carlier, Michele; Trabado, Severine; Brailly-Tabard, Sylvie; Perez-Diaz, Fernando; Bonnot, Olivier; Bronsard, Guillaume; Tordjman, Sylvie			Modulation of Brain beta-Endorphin Concentration by the Specific Part of the Y Chromosome in Mice	PLOS ONE			English	Article							LARGE-SCALE SCREEN; PERIAQUEDUCTAL GRAY; OPIATE RECEPTORS; OPIOID RECEPTORS; INBRED STRAINS; AGGRESSION; MORPHINE; INVOLVEMENT; BEHAVIOR; STRESS	Background: Several studies in animal models suggest a possible effect of the specific part of the Y-chromosome (Y-NPAR) on brain opioid, and more specifically on brain beta-endorphin (BE). In humans, male prevalence is found in autistic disorder in which observation of abnormal peripheral or central BE levels are also reported. This suggests gender differences in BE associated with genetic factors and more precisely with Y-NPAR. Methodology/Principal Findings: Brain BE levels and plasma testosterone concentrations were measured in two highly inbred strains of mice, NZB/BlNJ (N) and CBA/HGnc (H), and their consomic strains for the Y-NPAR. An indirect effect of the Y-NPAR on brain BE level via plasma testosterone was also tested by studying the correlation between brain BE concentration and plasma testosterone concentration in eleven highly inbred strains. There was a significant and major effect (P < 0.0001) of the Y-NPAR in interaction with the genetic background on brain BE levels. Effect size calculated using Cohen's procedure was large (56% of the total variance). The variations of BE levels were not correlated with plasma testosterone which was also dependent of the Y-NPAR. Conclusions/Significance: The contribution of Y-NPAR on brain BE concentration in interaction with the genetic background is the first demonstration of Y-chromosome mediated control of brain opioid. Given that none of the genes encompassed by the Y-NPAR encodes for BE or its precursor, our results suggest a contribution of the sex-determining region (Sry, carried by Y-NPAR) to brain BE concentration. Indeed, the transcription of the Melanocortin 2 receptor gene (Mc2R gene, identified as the proopiomelanocortin receptor gene) depends on the presence of Sry and BE is derived directly from proopiomelanocortin. The results shed light on the sex dependent differences in brain functioning and the role of Sry in the BE system might be related to the higher frequency of autistic disorder in males.	[Botbol, Michel] INSERM, U669, Paris, France; [Roubertoux, Pierre L.] Aix Marseille Univ, INSERM, U910, Marseille, France; [Carlier, Michele] Inst Univ France, CNRS, UMR 6146, Lab Psychol Cognit, Marseille, France; [Trabado, Severine; Brailly-Tabard, Sylvie] Univ Paris Sud, CHU Bicetre, AP HP,Serv Genet Mol Pharmacogenet & Hormonol, INSERM,U693,Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France; [Perez-Diaz, Fernando] Grp Hosp Pitie Salpetriere, UFR Serv Hosp Univ Psychiat Enfant & Adolescent C, Ctr Emot, F-75634 Paris, France; [Bonnot, Olivier] Hop La Pitie Salpetriere, Serv Hosp Univ Psychiat Enfant & Adolescent, Paris, France; [Bronsard, Guillaume] Ecole Med LaTimone, Lab Sante Publ EA3279, Marseille, France; [Tordjman, Sylvie] CHGR, Serv Hosp Univ Psychiat Enfant & Adolescent Renne, Rennes, France; [Tordjman, Sylvie] Univ Rennes 1, Rennes, France; [Tordjman, Sylvie] Univ Paris 05, Lab Psychol Percept, Paris, France; [Tordjman, Sylvie] CNRS, UMR 8158, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; CHU Rennes; Universite de Rennes; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Botbol, M (corresponding author), INSERM, U669, Paris, France.	s.tordjman@yahoo.fr		Bonnot, Olivier/0000-0003-0005-4765; Trabado, Severine/0000-0002-1925-1999	INSERM [U910]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work is funded by INSERM U910. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELOGIANNI P, 1989, NEUROENDOCRINOLOGY, V50, P372, DOI 10.1159/000125251; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAILEY DW, 1985, J HERED, V76, P107, DOI 10.1093/oxfordjournals.jhered.a110033; Barraclough C A, 1966, Recent Prog Horm Res, V22, P503; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Canastar A, 2008, ARCH SEX BEHAV, V37, P2, DOI 10.1007/s10508-007-9257-1; Cohen J.E., 1988, STAT POWER ANAL BEHA; DIEZGUERRA FJ, 1987, BRAIN RES, V424, P225, DOI 10.1016/0006-8993(87)91465-X; ESPERT R, 1993, AGGRESSIVE BEHAV, V19, P377, DOI 10.1002/1098-2337(1993)19:5<377::AID-AB2480190507>3.0.CO;2-Y; GERRA G, 1992, PSYCHIAT RES, V41, P179, DOI 10.1016/0165-1781(92)90109-G; GUILLOT PV, 1995, BEHAV GENET, V25, P357, DOI 10.1007/BF02197285; HAMMER RP, 1984, BRAIN RES, V308, P172, DOI 10.1016/0006-8993(84)90932-6; HAMMER RP, 1985, BRAIN RES, V360, P65, DOI 10.1016/0006-8993(85)91221-1; HANEY M, 1989, PSYCHOPHARMACOLOGY, V98, P68, DOI 10.1007/BF00442008; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; HORTON RJE, 1989, J ENDOCRINOL, V122, P509, DOI 10.1677/joe.0.1220509; IBARRA P, 1994, J TRAUMA STRESS, V7, P303, DOI 10.1002/jts.2490070210; *JACKS LAB, 2009, MOUS GEN DAT MGD MOU; KJAER A, 1992, NEUROENDOCRINOLOGY, V56, P419, DOI 10.1159/000126258; Laarakker MC, 2008, BEHAV GENET, V38, P159, DOI 10.1007/s10519-007-9188-6; Le Roy I, 2001, GENETICS, V158, P333; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; MARTINI L, 1989, J STEROID BIOCHEM, V33, P673, DOI 10.1016/0022-4731(89)90477-9; MAXSON SC, 1989, BEHAV NEURAL BIOL, V52, P251, DOI 10.1016/S0163-1047(89)90369-5; MEITES J, 1979, LIFE SCI, V24, P1325, DOI 10.1016/0024-3205(79)90001-8; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; MINER LL, 1993, PSYCHOPHARMACOLOGY, V111, P17, DOI 10.1007/BF02257401; MOUTIER R, 1991, LAB ANIM-UK, V25, P303, DOI 10.1258/002367791780809986; Neidhardt L, 2000, MECH DEVELOP, V98, P77, DOI 10.1016/S0925-4773(00)00453-6; PFEIFFER DG, 1983, PEPTIDES, V4, P647, DOI 10.1016/0196-9781(83)90012-8; ROUBERTOUX PL, 1994, CR ACAD SCI III-VIE, V317, P523; Roubertoux PL, 1999, TEC BEHAV N, V13, P696; SHAIKH MB, 1991, BRAIN RES, V559, P109, DOI 10.1016/0006-8993(91)90293-5; SHAIKH MB, 1990, AGGRESSIVE BEHAV, V16, P191, DOI 10.1002/1098-2337(1990)16:3/4<191::AID-AB2480160306>3.0.CO;2-7; Sluyter F, 1996, BEHAV GENET, V26, P489, DOI 10.1007/BF02359753; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; TAYA K, 1989, J ENDOCRINOL, V120, P509, DOI 10.1677/joe.0.1200509; Tordjman S, 2003, BEHAV GENET, V33, P529, DOI 10.1023/A:1025774716976; TORDJMAN S, 1995, NEUROSCI LETT, V183, P190, DOI 10.1016/0304-3940(94)11148-C; TORDJMAN S, 2001, MOL PSYCHIATR, V5, P831; Tordjman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005289; TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153; WEINER S, 1991, PHYSIOL BEHAV, V49, P1099, DOI 10.1016/0031-9384(91)90337-N; Wertz K, 2000, MECH DEVELOP, V98, P51, DOI 10.1016/S0925-4773(00)00452-4; YONEKAWA H, 1982, DIFFERENTIATION, V22, P222, DOI 10.1111/j.1432-0436.1982.tb01255.x	49	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16704	10.1371/journal.pone.0016704	http://dx.doi.org/10.1371/journal.pone.0016704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408198	Green Submitted, gold, Green Published			2022-12-27	WOS:000288170000005
J	Gollo, LL; Mirasso, CR; Atienza, M; Crespo-Garcia, M; Cantero, JL				Gollo, Leonardo L.; Mirasso, Claudio R.; Atienza, Mercedes; Crespo-Garcia, Maite; Cantero, Jose L.			Theta Band Zero-Lag Long-Range Cortical Synchronization via Hippocampal Dynamical Relaying	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ENTORHINAL CORTEX; VISUAL-CORTEX; TIME-DELAY; OSCILLATIONS; RHYTHM; MODEL; BRAIN; PLASTICITY; NETWORKS	Growing evidence suggests that synchronization among distributed neuronal networks underlie functional integration in the brain. Neural synchronization is typically revealed by a consistent phase delay between neural responses generated in two separated sources. But the influence of a third neuronal assembly in that synchrony pattern remains largely unexplored. We investigate here the potential role of the hippocampus in determining cortico-cortical theta synchronization in different behavioral states during motor quiescent and while animals actively explore the environment. To achieve this goal, the two states were modeled with a recurrent network involving the hippocampus, as a relay element, and two distant neocortical sites. We found that cortico-cortical neural coupling accompanied higher hippocampal theta oscillations in both behavioral states, although the highest level of synchronization between cortical regions emerged during motor exploration. Local field potentials recorded from the same brain regions qualitatively confirm these findings in the two behavioral states. These results suggest that zero-lag long-range cortico-cortical synchronization is likely mediated by hippocampal theta oscillations in lower mammals as a function of cognitive demands and motor acts.	[Gollo, Leonardo L.; Mirasso, Claudio R.] CSIC UIB, IFISC, Palma de Mallorca, Spain; [Atienza, Mercedes; Crespo-Garcia, Maite; Cantero, Jose L.] Univ Pablo Olavide, Spanish Network Excellence Res Neurodegenerat Dis, Lab Funct Neurosci, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Universidad Pablo de Olavide	Gollo, LL (corresponding author), CSIC UIB, IFISC, Campus Univ Illes Balears, Palma de Mallorca, Spain.	claudio@ifisc.uib-csic.es	Gollo, Leonardo/K-6971-2014; Atienza, Mercedes/L-1805-2014; Crespo Garcia, Maite/K-9059-2014; Cantero, Jose L./ABG-6447-2020; Mirasso, Claudio R/B-8661-2008	Gollo, Leonardo/0000-0003-3505-9259; Atienza, Mercedes/0000-0002-6760-1252; Crespo Garcia, Maite/0000-0002-1170-0382; Mirasso, Claudio/0000-0003-2980-7038	European Commission [FP6-NEST, 043309]; Ministerio de Educacion y Ciencia (Spain); Fondo Europeo de Desarrollo Regional (FEDER) [FIS2007-60327]; Spanish Ministry of Science and Innovation [SAF2008-03300, PSI2008-06141]; Regional Ministry of Innovation, Science and Enterprise, Junta de Andalucia [CTS-4604]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Ministry of Innovation, Science and Enterprise, Junta de Andalucia(Junta de Andalucia)	The authors acknowledge the financial support from the European Commission Project GABA (FP6-NEST Contract 043309). LLG and CM also acknowledge the Ministerio de Educacion y Ciencia (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) under project FIS2007-60327 (FISICOS). This research was also supported by grants from the Spanish Ministry of Science and Innovation (SAF2008-03300, PSI2008-06141) to JLC and MA, respectively, and from the Regional Ministry of Innovation, Science and Enterprise, Junta de Andalucia (CTS-4604) to JLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Atay FM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.144101; Atay FM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.094101; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Budd JML, 2005, P ROY SOC B-BIOL SCI, V272, P101, DOI 10.1098/rspb.2004.2927; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Cantero JL, 2005, REV NEUROSCIENCE, V16, P69, DOI 10.1515/REVNEURO.2005.16.1.69; Cantero JL, 2003, J NEUROSCI, V23, P10897; Chawla D, 2001, NEURAL NETWORKS, V14, P727, DOI 10.1016/S0893-6080(01)00043-0; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Crespo-Garcia M, 2010, NEUROIMAGE, V50, P1258, DOI 10.1016/j.neuroimage.2010.01.018; D'Huys O, 2008, CHAOS, V18, DOI 10.1063/1.2953582; Dayan P, 2001, COMPUTATIONAL NEUROS; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074104; DOYERE V, 1993, NEUROPSYCHOLOGIA, V31, P1031, DOI 10.1016/0028-3932(93)90031-T; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Guderian S, 2005, HIPPOCAMPUS, V15, P901, DOI 10.1002/hipo.20125; Gutierrez R, 2010, J NEUROSCI, V30, P287, DOI 10.1523/JNEUROSCI.0855-09.2010; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Knoblauch A, 2003, NEUROCOMPUTING, V52-4, P301, DOI 10.1016/S0925-2312(02)00792-0; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Leung LS, 1998, NEUROSCI BIOBEHAV R, V22, P275; LEUNG LWS, 1987, BRAIN RES, V407, P68, DOI 10.1016/0006-8993(87)91220-0; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; MITCHELL SJ, 1980, BRAIN RES, V189, P49, DOI 10.1016/0006-8993(80)90006-2; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; NIEBUR E, 1991, PHYS REV LETT, V67, P2753, DOI 10.1103/PhysRevLett.67.2753; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; Pesaran B, 2010, CURR OPIN NEUROBIOL, V20, P166, DOI 10.1016/j.conb.2010.03.003; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Reddy DVR, 1998, PHYS REV LETT, V80, P5109, DOI 10.1103/PhysRevLett.80.5109; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Soteropoulos DS, 2006, J NEUROPHYSIOL, V95, P1194, DOI 10.1152/jn.00935.2005; Strogatz S. H., 2003, SYNC; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; Tejada S, 2010, NEUROSCIENCE, V165, P621, DOI 10.1016/j.neuroscience.2009.10.031; Tsanov M, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.032.2009; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; Wall PM, 2001, BEHAV BRAIN RES, V127, P99, DOI 10.1016/S0166-4328(01)00355-2; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yamaguchi Yoko, 2004, Journal of Integrative Neuroscience, V3, P143, DOI 10.1142/S0219635204000488; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	82	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17756	10.1371/journal.pone.0017756	http://dx.doi.org/10.1371/journal.pone.0017756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408082	gold, Green Published, Green Submitted			2022-12-27	WOS:000288170000058
J	Gosalbes, MJ; Durban, A; Pignatelli, M; Abellan, JJ; Jimenez-Hernandez, N; Perez-Cobas, AE; Latorre, A; Moya, A				Jose Gosalbes, Maria; Durban, Ana; Pignatelli, Miguel; Jose Abellan, Juan; Jimenez-Hernandez, Nuria; Elena Perez-Cobas, Ana; Latorre, Amparo; Moya, Andres			Metatranscriptomic Approach to Analyze the Functional Human Gut Microbiota	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HUMAN GASTROINTESTINAL-TRACT; METAGENOMIC ANALYSIS; BACTERIAL DIVERSITY; VIRAL COMMUNITY; NONCODING RNAS; MUCOSA; GROWTH; BIFIDOBACTERIA; METABOLISM	The human gut is the natural habitat for a large and dynamic bacterial community that has a great relevance for health. Metagenomics is increasing our knowledge of gene content as well as of functional and genetic variability in this microbiome. However, little is known about the active bacteria and their function(s) in the gastrointestinal tract. We performed a metatranscriptomic study on ten healthy volunteers to elucidate the active members of the gut microbiome and their functionality under conditions of health. First, the microbial cDNAs obtained from each sample were sequenced using 454 technology. The analysis of 16S transcripts showed the phylogenetic structure of the active microbial community. Lachnospiraceae, Ruminococcaceae, Bacteroidaceae, Prevotellaceae, and Rickenellaceae were the predominant families detected in the active microbiota. The characterization of mRNAs revealed a uniform functional pattern in healthy individuals. The main functional roles of the gut microbiota were carbohydrate metabolism, energy production and synthesis of cellular components. In contrast, housekeeping activities such as amino acid and lipid metabolism were underrepresented in the metatranscriptome. Our results provide new insights into the functionality of the complex gut microbiota in healthy individuals. In this RNA-based survey, we also detected small RNAs, which are important regulatory elements in prokaryotic physiology and pathogenicity.	[Jose Gosalbes, Maria; Durban, Ana; Pignatelli, Miguel; Jose Abellan, Juan; Jimenez-Hernandez, Nuria; Elena Perez-Cobas, Ana; Latorre, Amparo; Moya, Andres] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolutiva, Unidad Mixta Invest Genom & Salud, Ctr Super Invest Salud Publ Generalitat Valencian, Valencia, Spain; [Jose Gosalbes, Maria; Durban, Ana; Pignatelli, Miguel; Jose Abellan, Juan; Jimenez-Hernandez, Nuria; Latorre, Amparo; Moya, Andres] CIBER Epidemiol & Salud Publ, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Gosalbes, MJ (corresponding author), Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolutiva, Unidad Mixta Invest Genom & Salud, Ctr Super Invest Salud Publ Generalitat Valencian, Valencia, Spain.	andres.moya@uv.es	Hernández, Nuria Jiménez/H-1982-2015; Latorre, Amparo/E-4997-2015; Pérez Cobas, Ana Elena/GRY-4537-2022; Pérez-Cobas, Ana Elena/A-9471-2019; Moya, Andrés/A-8190-2008; Pérez-Cobas, Ana Elena/K-7881-2019; Gosalbes, Maria Jose/C-7194-2011	Hernández, Nuria Jiménez/0000-0002-9107-056X; Latorre, Amparo/0000-0002-9146-7284; Pérez-Cobas, Ana Elena/0000-0002-3995-5571; Moya, Andrés/0000-0002-2867-1119; Pérez-Cobas, Ana Elena/0000-0002-3995-5571; Gosalbes, Maria Jose/0000-0003-0460-1105; Abellan-Andres, Juan Jose/0000-0002-6517-0786	Ministerio de Ciencia e Innovacion, Spain [BFU2008-04501-E/BMC, SAF2009-13032-C02-01]; Instituto de Salud Carlos III, Spain; 'CIBER en Epidemiologia y Salud Publica' (CIBEResp), Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); 'CIBER en Epidemiologia y Salud Publica' (CIBEResp), Spain	This work has been funded by grant BFU2008-04501-E/BMC and SAF2009-13032-C02-01 from Ministerio de Ciencia e Innovacion, Spain. AD and AEPC are recipients of a fellowship from the Instituto de Salud Carlos III, Spain. MJG is recipient of a post-doctoral contract from 'CIBER en Epidemiologia y Salud Publica' (CIBEResp), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Bejerano-Sagie M, 2007, CURR OPIN MICROBIOL, V10, P189, DOI 10.1016/j.mib.2007.03.009; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Booijink CCGM, 2010, APPL ENVIRON MICROB, V76, P5533, DOI 10.1128/AEM.00502-10; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2000, STAT SINICA, V10, P227; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; GIBSON GR, 1994, J APPL BACTERIOL, V77, P412, DOI 10.1111/j.1365-2672.1994.tb03443.x; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lay C, 2005, ENVIRON MICROBIOL, V7, P933, DOI 10.1111/j.1462-2920.2005.00763.x; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Marounek M, 1999, LETT APPL MICROBIOL, V29, P429, DOI 10.1046/j.1472-765X.1999.00671.x; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; O'Sullivan DJ, 2001, J AGR FOOD CHEM, V49, P1751, DOI 10.1021/jf0012244; Papineau D, 2005, APPL ENVIRON MICROB, V71, P4822, DOI 10.1128/AEM.71.8.4822-4832.2005; Pignatelli M, 2009, ENV MICROBIOL REP, V1, P191, DOI 10.1111/j.1758-2229.2009.00030.x; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; RODE LM, 1981, APPL ENVIRON MICROB, V42, P20, DOI 10.1128/AEM.42.1.20-22.1981; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Takada T, 2004, J MICROBIOL METH, V58, P413, DOI 10.1016/j.mimet.2004.05.006; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Warnecke F, 2009, J BIOTECHNOL, V142, P91, DOI 10.1016/j.jbiotec.2009.03.022; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	67	234	261	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17447	10.1371/journal.pone.0017447	http://dx.doi.org/10.1371/journal.pone.0017447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408168	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000031
J	McMains, E; Krishnan, V; Prasad, S; Gleason, E				McMains, Emily; Krishnan, Vijai; Prasad, Sujitha; Gleason, Evanna			Expression and Localization of CLC Chloride Transport Proteins in the Avian Retina	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASE; DEVELOPING CHICK RETINA; SUBCELLULAR-LOCALIZATION; GLUTAMINE-SYNTHETASE; AMACRINE CELLS; HORIZONTAL CELLS; CHANNEL; KIDNEY; IMMUNOLOCALIZATION; LEADS	Members of the ubiquitously expressed CLC protein family of chloride channels and transporters play important roles in regulating cellular chloride and pH. The CLCs that function as Cl-/H+ antiporters, ClCs 3-7, are essential in particular for the acidification of endosomal compartments and protein degradation. These proteins are broadly expressed in the nervous system, and mutations that disrupt their expression are responsible for several human genetic diseases. Furthermore, knockout of ClC3 and ClC7 in the mouse result in the degeneration of the hippocampus and the retina. Despite this evidence of their importance in retinal function, the expression patterns of different CLC transporters in different retinal cell types are as yet undescribed. Previous work in our lab has shown that in chicken amacrine cells, internal Cl- can be dynamic. To determine whether CLCs have the potential to participate, we used PCR and immunohistochemical techniques to examine CLC transporter expression in the chicken retina. We observed a high level of variation in the retinal expression levels and patterns among the different CLC proteins examined. These findings, which represent the first systematic investigation of CLC transporter expression in the retina, support diverse functions for the different CLCs in this tissue.	[McMains, Emily; Krishnan, Vijai; Prasad, Sujitha; Gleason, Evanna] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	McMains, E (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	egleaso@lsu.edu	Gleason, Evanna/C-2778-2011	, Vijai/0000-0001-5979-1255; Abdulmagomedov, Suleiman/0000-0001-9162-5062	National Eye Institute, NIH [EY012204]; NATIONAL EYE INSTITUTE [R01EY012204, R29EY012204] Funding Source: NIH RePORTER	National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, NIH, EY012204 (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Bergmann M, 2002, J COMP NEUROL, V449, P231, DOI 10.1002/cne.10302; Bergmann M, 2000, J COMP NEUROL, V418, P361; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; Caminos E, 1999, DEV BRAIN RES, V118, P227, DOI 10.1016/S0165-3806(99)00156-X; Crousillac S, 2003, VISUAL NEUROSCI, V20, P453, DOI 10.1017/S0952523803204107; ELLIS JH, 1991, CELL TISSUE RES, V264, P197, DOI 10.1007/BF00313956; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 1998, J COMP NEUROL, V392, P273; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; GLEASON E, 1993, J NEUROSCI, V13, P2359, DOI 10.1523/JNEUROSCI.13-06-02359.1993; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hirano AA, 2005, J COMP NEUROL, V488, P70, DOI 10.1002/cne.20577; Hoffpauir B, 2006, J NEUROPHYSIOL, V95, P2866, DOI 10.1152/jn.01317.2005; Huang LQ, 2005, J BIOL CHEM, V280, P36150, DOI 10.1074/jbc.M507706200; Isnard-Bagnis C, 2003, AM J PHYSIOL-CELL PH, V284, pC220, DOI 10.1152/ajpcell.00374.2001; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Koulen P, 1997, J COMP NEUROL, V380, P520, DOI 10.1002/(SICI)1096-9861(19970421)380:4<520::AID-CNE8>3.0.CO;2-3; LINSER P, 1979, P NATL ACAD SCI USA, V76, P6476, DOI 10.1073/pnas.76.12.6476; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Luyckx VA, 1998, AM J PHYSIOL-RENAL, V275, pF761, DOI 10.1152/ajprenal.1998.275.5.F761; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; MILLAR T, 1985, NEUROSCI LETT, V61, P311, DOI 10.1016/0304-3940(85)90482-3; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; NORENBERG MD, 1980, J CELL BIOL, V84, P803, DOI 10.1083/jcb.84.3.803; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Plans V, 2009, PFLUG ARCH EUR J PHY, V458, P23, DOI 10.1007/s00424-008-0597-z; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Prada FA, 1998, GLIA, V22, P221, DOI 10.1002/(SICI)1098-1136(199803)22:3<221::AID-GLIA2>3.0.CO;2-8; Sakamoto H, 1999, AM J PHYSIOL-RENAL, V277, pF957, DOI 10.1152/ajprenal.1999.277.6.F957; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Sen M, 2006, VISUAL NEUROSCI, V23, P221, DOI 10.1017/S0952523806232073; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; Smith AJ, 2010, J PHYSIOL-LONDON, V588, P2033, DOI 10.1113/jphysiol.2010.188540; STAUBER T, 2010, J BIOL CHEM; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Vandewalle A, 2001, AM J PHYSIOL-CELL PH, V280, pC373, DOI 10.1152/ajpcell.2001.280.2.C373; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200	57	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17647	10.1371/journal.pone.0017647	http://dx.doi.org/10.1371/journal.pone.0017647			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408174	gold, Green Published, Green Submitted			2022-12-27	WOS:000288099800031
J	Fath, S; Bauer, AP; Liss, M; Spriestersbach, A; Maertens, B; Hahn, P; Ludwig, C; Schafer, F; Graf, M; Wagner, R				Fath, Stephan; Bauer, Asli Petra; Liss, Michael; Spriestersbach, Anne; Maertens, Barbara; Hahn, Peter; Ludwig, Christine; Schaefer, Frank; Graf, Marcus; Wagner, Ralf			Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIGH-LEVEL EXPRESSION; AU-RICH ELEMENTS; ESCHERICHIA-COLI; HETEROLOGOUS EXPRESSION; IMMEDIATELY DOWNSTREAM; EFFICIENT EXPRESSION; RECOMBINANT PROTEIN; INITIATION CODON; CPG CONTENT	Autologous expression of recombinant human proteins in human cells for biomedical research and product development is often hampered by low expression yields limiting subsequent structural and functional analyses. Following RNA and codon optimization, 50 candidate genes representing five classes of human proteins - transcription factors, ribosomal and polymerase subunits, protein kinases, membrane proteins and immunomodulators - all showed reliable, and 86% even elevated expression. Analysis of three representative examples showed no detrimental effect on protein solubility while unaltered functionality was demonstrated for JNK1, JNK3 and CDC2 using optimized constructs. Molecular analysis of a sequence-optimized transgene revealed positive effects at transcriptional, translational, and mRNA stability levels. Since improved expression was consistent in HEK293T, CHO and insect cells, it was not restricted to distinct mammalian cell systems. Additionally, optimized genes represent powerful tools in functional genomics, as demonstrated by the successful rescue of an siRNA-mediated knockdown using a sequence-optimized counterpart. This is the first large-scale study addressing the influence of multiparameter optimization on autologous human protein expression.	[Fath, Stephan; Liss, Michael; Ludwig, Christine; Graf, Marcus; Wagner, Ralf] Geneart AG, Regensburg, Germany; [Bauer, Asli Petra; Wagner, Ralf] Univ Regensburg, Mol Microbiol & Gene Therapy Unit, Inst Med Microbiol & Hyg, Regensburg, Germany; [Spriestersbach, Anne; Maertens, Barbara; Hahn, Peter; Schaefer, Frank] QIAGEN GmbH, Hilden, Germany	University of Regensburg; QIAGEN GmbH	Wagner, R (corresponding author), Geneart AG, BioPark, Regensburg, Germany.	ralf.wagner@geneart.com			Geneart AG; Qiagen GmbH; Bayerische Forschungsstiftung [288/02]; QIAGEN	Geneart AG; Qiagen GmbH; Bayerische Forschungsstiftung; QIAGEN	This work was funded by Geneart AG (primary funder) and in part by Qiagen GmbH. Assessment of Mip1a expression and analysis of underlying molecular mechanisms was funded by the Bayerische Forschungsstiftung, Grant 288/02 (ForImmun). The funders designed the study, collected and analysed data, decided to publish and prepared the manuscript. Geneart AG performed gene synthesis and codon and RNA optimized constructs, performed and analyzed mammalian gene expression experiments, performed and analyzed functionality of JNK1 expression, performed siRNA-mediated knockdown of optimized genes and wrote the manuscript. The molecular analysis of MIP1a-expression was performed by University of Regensburg, Germany. Qiagen GmbH performed and analyzed Sf9 expression experiments and performed and analyzed the CDC2 rescue study.; The authors declare competing financial interests: Geneart performed the gene design, optimization and synthesis; optimized genes are marketed as QIAgenes by QIAGEN. The authors also declare competing interests in the form of patent family WO04059556 including all national patents and pending applications. The authors declare that all other data and materials described in the manuscript adhere to all the PLoS ONE policies on sharing data and materials. S. F., M. L., C. L., M. G. and R. W. are employed by Geneart AG; A. S., B. M., P. H. and F. S. are employed by Qiagen GmbH and A. P. B. and R. W. are employed by the University of Regensburg.	ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Andre S, 1998, J VIROL, V72, P1497; Anson DS, 2005, MOL BIOTECHNOL, V31, P85, DOI 10.1385/MB:31:1:085; Bauer AP, 2010, NUCLEIC ACIDS RES, V38, P3891, DOI 10.1093/nar/gkq115; Brondyk WH, 2009, METHOD ENZYMOL, V463, P131, DOI 10.1016/S0076-6879(09)63011-1; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; FURTH PA, 1991, J VIROL, V65, P5806, DOI 10.1128/JVI.65.11.5806-5812.1991; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; Graf M, 2000, J VIROL, V74, P10822, DOI 10.1128/JVI.74.22.10822-10826.2000; GRAF M, 2009, SYSTEMS BIOL SYNTHET, P411, DOI DOI 10.1002/9780470437988.CH12; Graf Marcus, 2004, Methods Mol Med, V94, P197; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; IVANOV IG, 1992, EUR J BIOCHEM, V209, P151, DOI 10.1111/j.1432-1033.1992.tb17271.x; KINK JA, 1991, J PROTOZOOL, V38, P441, DOI 10.1111/j.1550-7408.1991.tb04814.x; KOSOVAC D, 2010, GENE THER, P1; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Levy JP, 1996, NAT BIOTECHNOL, V14, P610, DOI 10.1038/nbt0596-610; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; MALDARELLI F, 1991, J VIROL, V65, P5732, DOI 10.1128/JVI.65.11.5732-5743.1991; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Nishikubo T, 2005, J BIOTECHNOL, V120, P341, DOI 10.1016/j.jbiotec.2005.06.032; Nomura M, 1984, Nucleic Acids Symp Ser, P173; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Rao DVK, 2008, MOL BIOTECHNOL, V38, P221, DOI 10.1007/s12033-007-9018-3; Robinson F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001801; SALSER W, 1977, COLD SPRING HARB SYM, V42, P985; Schirrmann T, 2008, FRONT BIOSCI-LANDMRK, V13, P4576, DOI 10.2741/3024; Schmidt M, 2002, INT ARCH ALLERGY IMM, V128, P264, DOI 10.1159/000063865; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sokolowski M, 1998, J VIROL, V72, P1504, DOI 10.1128/JVI.72.2.1504-1515.1998; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; TAN W, 1995, J VIROL, V69, P5607, DOI 10.1128/JVI.69.9.5607-5620.1995; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Wells KD, 1999, TRANSGENIC RES, V8, P371, DOI 10.1023/A:1008952302539; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	53	114	163	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17596	10.1371/journal.pone.0017596	http://dx.doi.org/10.1371/journal.pone.0017596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408612	Green Published, gold			2022-12-27	WOS:000287965200032
J	Li, J; Jiang, DG; Zhou, H; Li, F; Yang, JW; Hong, LF; Fu, XA; Li, ZB; Liu, ZL; Li, JM; Zhuang, CX				Li, Jing; Jiang, Dagang; Zhou, Hai; Li, Feng; Yang, Jiawei; Hong, Laifa; Fu, Xiao; Li, Zhibin; Liu, Zhenlan; Li, Jianming; Zhuang, Chuxiong			Expression of RNA-Interference/Antisense Transgenes by the Cognate Promoters of Target Genes Is a Better Gene-Silencing Strategy to Study Gene Functions in Rice	PLOS ONE			English	Article							FLOWER PIGMENTATION; DOWN-REGULATION; CELL-DEATH; T-DNA; SEQUENCE; PLANTS; ARABIDOPSIS; FAMILY; METALLOTHIONEIN; TRANSFORMATION	Antisense and RNA interference (RNAi)-mediated gene silencing systems are powerful reverse genetic methods for studying gene function. Most RNAi and antisense experiments used constitutive promoters to drive the expression of RNAi/antisense transgenes; however, several reports showed that constitutive promoters were not expressed in all cell types in cereal plants, suggesting that the constitutive promoter systems are not effective for silencing gene expression in certain tissues/organs. To develop an alternative method that complements the constitutive promoter systems, we constructed RNAi and/or antisense transgenes for four rice genes using a constitutive promoter or a cognate promoter of a selected rice target gene and generated many independent transgenic lines. Genetic, molecular, and phenotypic analyses of these RNAi/antisense transgenic rice plants, in comparison to previously- reported transgenic lines that silenced similar genes, revealed that expression of the cognate promoter- driven RNAi/antisense transgenes resulted in novel growth/developmental defects that were not observed in transgenic lines expressing constitutive promoter- driven gene- silencing transgenes of the same target genes. Our results strongly suggested that expression of RNAi/antisense transgenes by cognate promoters of target genes is a better gene-silencing approach to discovery gene function in rice.	[Li, Jing; Jiang, Dagang; Zhou, Hai; Li, Feng; Yang, Jiawei; Hong, Laifa; Fu, Xiao; Li, Zhibin; Liu, Zhenlan; Zhuang, Chuxiong] S China Agr Univ, Key Lab Plant Funct Genom & Biotechnol, Educ Dept Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Li, Jianming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	South China Agricultural University; University of Michigan System; University of Michigan	Li, J (corresponding author), S China Agr Univ, Key Lab Plant Funct Genom & Biotechnol, Educ Dept Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	zhuangcx@scau.edu.cn	Li, Jianming/O-1772-2014; Zhou, Hai/AAY-8690-2020	Li, Jianming/0000-0003-3231-0778; 	National Basic Research Program of China [2005CB120802]; National High Technology Research and Development Program of China [2007AA10A144]; National Natural Science Foundation of China [30470983]; Genetically Modified Organisms breeding Major Projects [2008ZX08001-004]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms breeding Major Projects	This work was supported by the National Basic Research Program of China (2005CB120802, http://www.973.gov.cn/English/Index.aspx), the National High Technology Research and Development Program of China (2007AA10A144, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), the National Natural Science Foundation of China (30470983, http://www.973.gov.cn/English/Index.aspx) and Genetically Modified Organisms breeding Major Projects (2008ZX08001-004, http://www.most.gov.cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-ali T, 2003, PLANT BIOTECHNOL J, V1, P337, DOI 10.1046/j.1467-7652.2003.00030.x; An Gynheung, 2008, V62, P95; [Anonymous], RICE GENOME ANNOTATI; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bouchez D, 1998, PLANT PHYSIOL, V118, P725, DOI 10.1104/pp.118.3.725; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Cooper SR, 1999, PHARMACOL THERAPEUT, V82, P427, DOI 10.1016/S0163-7258(99)00002-9; Elomaa P, 1996, MOL BREEDING, V2, P41; Frantz JM, 2004, AGRON J, V96, P1172, DOI 10.2134/agronj2004.1172; Fu WQ, 2007, BIOCHEM BIOPH RES CO, V356, P843, DOI 10.1016/j.bbrc.2007.03.010; GATZ C, 1992, PLANT J, V2, P397, DOI 10.1046/j.1365-313X.1992.t01-37-00999.x; Good L, 2003, CELL MOL LIFE SCI, V60, P854, DOI 10.1007/s00018-003-3045-4; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirsche J, 2009, THEOR APPL GENET, V118, P235, DOI 10.1007/s00122-008-0892-2; Huang LM, 2007, PLANT PHYSIOL, V144, P1508, DOI 10.1104/pp.107.099473; Jan A, 2006, PLANT CELL PHYSIOL, V47, P244, DOI 10.1093/pcp/pci241; Leszczyszyn OI, 2007, PROTEINS, V68, P922, DOI 10.1002/prot.21463; Lin HN, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-18; Masclaux F, 2004, BIOCHEM BIOPH RES CO, V321, P364, DOI 10.1016/j.bbrc.2004.06.154; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; METT VL, 1993, P NATL ACAD SCI USA, V90, P4567, DOI 10.1073/pnas.90.10.4567; Nakatsuka T, 2007, PLANT BIOTECHNOL REP, V1, P251, DOI 10.1007/s11816-007-0039-y; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pastuglia M, 2003, CELL BIOL INT, V27, P249, DOI 10.1016/S1065-6995(02)00306-2; Praveen S, 2005, PLANT SCI, V168, P1011, DOI 10.1016/j.plantsci.2004.12.008; Rooke L, 2000, ANN APPL BIOL, V136, P167, DOI 10.1111/j.1744-7348.2000.tb00022.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Steffens B, 2009, PLANT CELL, V21, P184, DOI 10.1105/tpc.108.061887; Suwannaketchanatit C., 2006, Kasetsart Journal, Natural Sciences, V40, P934; The Arabidopsis Genome Initiative, 2000, NATURE, V408, P796; Upadhyaya N. M., 2007, RICE FUNCTIONAL GENO; VANDERKROL AR, 1990, PLANT MOL BIOL, V14, P457, DOI 10.1007/BF00027492; VASIL IK, 1999, MOL IMPROVEMENT CERE; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Yadetie F, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-12; YU SM, 1991, J BIOL CHEM, V266, P21131; Yuan J, 2008, PLANT PHYSIOL, V146, P1637, DOI 10.1104/pp.107.110304; Zuo JR, 2000, CURR OPIN BIOTECH, V11, P146, DOI 10.1016/S0958-1669(00)00073-2	41	25	31	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17444	10.1371/journal.pone.0017444	http://dx.doi.org/10.1371/journal.pone.0017444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408609	gold, Green Published, Green Submitted			2022-12-27	WOS:000287965200016
J	Grespi, F; Ottina, E; Yannoutsos, N; Geley, S; Villunger, A				Grespi, Francesca; Ottina, Eleonora; Yannoutsos, Nikolaos; Geley, Stephan; Villunger, Andreas			Generation and Evaluation of an IPTG-Regulated Version of Vav-Gene Promoter for Mouse Transgenesis	PLOS ONE			English	Article							COLI LAC REPRESSOR; HEMATOPOIETIC COMPARTMENT; FLUORESCENT PROTEIN; IN-VIVO; EXPRESSION; SYSTEM; CELLS; MICE; MUTAGENESIS; LINEAGES	Different bacteria-derived systems for regulatable gene expression have been developed for the use in mammalian cells and some were also successfully adopted for in vivo use in vertebrate model organisms. However, certain limitations apply to most of these systems, including leakiness of transgene expression, inefficient transgene silencing or activation, as well as limited tissue accessibility of transgene-inducers or their unfavourable pharmacokinetics. In this study, we evaluated the suitability of the lac-operon/lac-repressor (lacO/lacI) system for the regulation of the well-established Vav-gene promoter that allows inducible transgene expression in different haematopoietic lineages in mice. Using the fluorescence marker protein Venus as a reporter, we observed that the lacO/lacI system could be amended to modulate transgene-expression in haematopoietic cells. However, reporter expression was not uniform and the lacO elements introduced into the Vav-gene promoter only conferred limited repression and reversion of lacI-mediated gene silencing after administration of IPTG. Although further optimization of the system is required, the lacO-modified version of the Vav-gene promoter may be adopted as a tool where low basal gene-expression and limited transient induction of protein expression are desired, e. g. for the activation of oncogenes or transgenes that act in a dominant-negative manner.	[Grespi, Francesca; Ottina, Eleonora; Villunger, Andreas] Med Univ Innsbruck, Div Dev Immunol, Innsbruck, Austria; [Yannoutsos, Nikolaos] Med Univ Innsbruck, Div Cell Biol, Innsbruck, Austria; [Geley, Stephan] Med Univ Innsbruck, Innsbruck Bioctr, Div Mol Pathophysiol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Grespi, F (corresponding author), Med Univ Innsbruck, Div Dev Immunol, Innsbruck, Austria.	andreas.villunger@i-med.ac.at		Grespi, Francesca/0000-0002-0369-7793; Ottina, Eleonora/0000-0002-9630-496X	Austrian Science Fund (FWF) [SFB021]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Graduate School for Molecular Biology and Oncology (MCBO) and the SFB021, both funded by the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Campbell KJ, 2010, BLOOD; Corbel SY, 2002, CURR OPIN BIOTECH, V13, P448, DOI 10.1016/S0958-1669(02)00361-0; Cronin CA, 2001, GENE DEV, V15, P1506, DOI 10.1101/gad.892001; FIGGE J, 1988, CELL, V52, P713, DOI 10.1016/0092-8674(88)90409-6; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Ogilvy S, 1999, BLOOD, V94, P1855; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Robertson A, 2002, GENE, V282, P65, DOI 10.1016/S0378-1119(01)00793-4; Ryan Amy, 2004, Mol Imaging, V3, P33, DOI 10.1162/153535004773861705; Scrable H, 2002, SEMIN CELL DEV BIOL, V13, P109, DOI 10.1016/S1084-9521(02)00017-4; Scrable H, 1997, GENETICS, V147, P297; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Williams A, 2008, NUCLEIC ACIDS RES, V36, P2320, DOI 10.1093/nar/gkn085; WYBORSKI DL, 1991, NUCLEIC ACIDS RES, V19, P4647, DOI 10.1093/nar/19.17.4647	21	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18051	10.1371/journal.pone.0018051	http://dx.doi.org/10.1371/journal.pone.0018051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445314	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300031
J	Oudiette, D; Constantinescu, I; Leclair-Visonneau, L; Vidailhet, M; Schwartz, S; Arnulf, I				Oudiette, Delphine; Constantinescu, Irina; Leclair-Visonneau, Laurene; Vidailhet, Marie; Schwartz, Sophie; Arnulf, Isabelle			Evidence for the Re-Enactment of a Recently Learned Behavior during Sleepwalking	PLOS ONE			English	Article							SLOW-WAVE SLEEP; REM-SLEEP; MEMORY CONSOLIDATION; DISORDER; EXPERIENCE	Animal studies have shown that sequenced patterns of neuronal activity may be replayed during sleep. However, the existence of such replay in humans has not yet been directly demonstrated. Here we studied patients who exhibit overt behaviors during sleep to test whether sequences of movements trained during the day may be spontaneously reenacted by the patients during sleep. We recruited 19 sleepwalkers (who displayed complex and purposeful behaviors emerging from non REM sleep), 20 patients with REM sleep behavior disorder (who enacted their dreams in REM sleep) and 18 healthy controls. Continuous video sleep recordings were performed during sleep following intensive training on a sequence of large movements (learned during a variant of the serial reaction time task). Both patient groups showed learning of the intensively trained motor sequence after sleep. We report the re-enactment of a fragment of the recently trained motor behavior during one sleepwalking episode. This study provides, to our knowledge, the first evidence of a temporally-structured replay of a learned behavior during sleep in humans. Our observation also suggests that the study of such sleep disorders may provide unique and critical information about cognitive functions operating during sleep.	[Oudiette, Delphine; Leclair-Visonneau, Laurene; Arnulf, Isabelle] Hop La Pitie Salpetriere, APHP, Sleep Disorders Unit, Paris, France; [Vidailhet, Marie; Arnulf, Isabelle] INSERM, U975, Paris, France; [Oudiette, Delphine; Leclair-Visonneau, Laurene; Vidailhet, Marie; Arnulf, Isabelle] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Constantinescu, Irina; Schwartz, Sophie] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Constantinescu, Irina; Schwartz, Sophie] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland; [Constantinescu, Irina; Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci NCCR, Geneva, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Geneva; University of Geneva; University of Geneva	Oudiette, D (corresponding author), Hop La Pitie Salpetriere, APHP, Sleep Disorders Unit, Paris, France.	isabelle.arnulf@psl.aphp.fr	Leclair-Visonneau, Laurène/GZL-7934-2022; Oudiette, Delphine/AAE-1808-2019	Leclair-Visonneau, Laurène/0000-0001-6379-0765; Oudiette, Delphine/0000-0002-6598-4130; Schwartz, Sophie/0000-0001-7718-4053; Arnulf, Isabelle/0000-0002-2240-2516	Brain Research Federation (FRC); ADOREP (Association pour le Developpement et l'Organisation de la Recherche En Pneumologie); France Parkinson; French Sleep Society (SFRMS); Swiss National Science Foundation [310000-114008, 3200B0-104100]; European Sleep Research Society (ESRS)	Brain Research Federation (FRC); ADOREP (Association pour le Developpement et l'Organisation de la Recherche En Pneumologie); France Parkinson; French Sleep Society (SFRMS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Sleep Research Society (ESRS)	The study was funded by the Brain Research Federation (FRC) and ADOREP (Association pour le Developpement et l'Organisation de la Recherche En Pneumologie, grants to IA), France Parkinson and the French Sleep Society (SFRMS) (grants to DO), and by the Swiss National Science Foundation (grants # 310000-114008, # 3200B0-104100 to SS). IC was awarded a European Network of Sleep Training Laboratories (ENSTL) grant from the European Sleep Research Society (ESRS) for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; DECOCK VC, 2007, NAT NEUROSCI, V12, P919; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; EPSTEIN AW, 1985, AM J PSYCHIAT, V142, P123; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fosse MJ, 2003, J COGNITIVE NEUROSCI, V15, P1, DOI 10.1162/089892903321107774; Frauscher B, 2008, SLEEP, V31, P724, DOI 10.1093/sleep/31.5.724; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Leclair-Visonneau L, 2010, BRAIN, V133, P1737, DOI 10.1093/brain/awq110; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Olson EJ, 2000, BRAIN, V123, P331, DOI 10.1093/brain/123.2.331; Oudiette D, 2009, NEUROLOGY, V72, P551, DOI 10.1212/01.wnl.0000341936.78678.3a; OUDIETTE D, 2010, SLEEP MED; Oudiette D, 2009, SLEEP, V32, P1621, DOI 10.1093/sleep/32.12.1621; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; SCHENCKCH, 1986, SLEEP, V9, P293; Schwartz S, 2003, TRENDS COGN SCI, V7, P325, DOI 10.1016/S1364-6613(03)00162-1; Sforza E, 1997, Sleep Med Rev, V1, P57, DOI 10.1016/S1087-0792(97)90006-X; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wamsley EJ, 2010, CURR BIOL, V20, P850, DOI 10.1016/j.cub.2010.03.027; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	32	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18056	10.1371/journal.pone.0018056	http://dx.doi.org/10.1371/journal.pone.0018056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445313	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300032
J	Cui, JA; Li, F; Wang, GQ; Fang, XD; Puett, JD; Xu, Y				Cui, Juan; Li, Fan; Wang, Guoqing; Fang, Xuedong; Puett, J. David; Xu, Ying			Gene-Expression Signatures Can Distinguish Gastric Cancer Grades and Stages	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HISTOLOGICAL CLASSIFICATION; MICROARRAY DATABASE; CLAUDIN-7	Microarray gene-expression data of 54 paired gastric cancer and adjacent noncancerous gastric tissues were analyzed, with the aim to establish gene signatures for cancer grades (well-, moderately-, poorly-or un-differentiated) and stages (I, II, III and IV), which have been determined by pathologists. Our statistical analysis led to the identification of a number of gene combinations whose expression patterns serve well as signatures of different grades and different stages of gastric cancer. A 19-gene signature was found to have discerning power between high-and low-grade gastric cancers in general, with overall classification accuracy at 79.6%. An expanded 198-gene panel allows the stratification of cancers into four grades and control, giving rise to an overall classification agreement of 74.2% between each grade designated by the pathologists and our prediction. Two signatures for cancer staging, consisting of 10 genes and 9 genes, respectively, provide high classification accuracies at 90.0% and 84.0%, among early-, advanced-stage cancer and control. Functional and pathway analyses on these signature genes reveal the significant relevance of the derived signatures to cancer grades and progression. To the best of our knowledge, this represents the first study on identification of genes whose expression patterns can serve as markers for cancer grades and stages.	[Cui, Juan; Puett, J. David; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Li, Fan; Wang, Guoqing] Jilin Univ, Dept Pathogenobiol, Changchun 130023, Jilin, Peoples R China; [Fang, Xuedong] Jilin Univ, Affiliated Hosp 2, Changchun 130023, Jilin, Peoples R China; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China; [Cui, Juan; Puett, J. David; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Jilin University; Jilin University; Jilin University; University System of Georgia; University of Georgia	Cui, JA (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Puett, J. David/AIE-8612-2022		National Science Foundation [DEB-0830024, DBI-0542119]; National Institutes of Health [1R01GM075331]; Georgia Cancer Coalition; President's Venture Fund; Office of the Vice President for Research of the University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; President's Venture Fund; Office of the Vice President for Research of the University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Science Foundation (DEB-0830024, DBI-0542119), the National Institutes of Health (1R01GM075331), a "Distinguished Scholar" grant from the Georgia Cancer Coalition, and a seed fund jointly from the President's Venture Fund and the Office of the Vice President for Research of the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; *AM JOINT COMM CAN, 2002, AJCC CANC STAG MAN; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Chauhan SC, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-21; CUI J, 2010, NUCL ACIDS RES; de Souza BF, 2005, GENET MOL RES, V4, P599; Fontana MG, 2003, BRIT J CANCER, V88, P401, DOI 10.1038/sj.bjc.6600663; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; GOSEKI N, 1992, GUT, V33, P606, DOI 10.1136/gut.33.5.606; Hornsby CD, 2007, ARCH PATHOL LAB MED, V131, P1541; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kim S, 2007, MOL CELLS, V24, P200; LAUREN T, 1965, ACTA PATHOL MIC SC, P34; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Lee JW, 2005, GYNECOL ONCOL, V97, P53, DOI 10.1016/j.ygyno.2004.11.058; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Marchionni Luigi, 2007, Evid Rep Technol Assess (Full Rep), P1; MARTIN IG, 1994, GUT, V35, P758, DOI 10.1136/gut.35.6.758; OOTA K, 1977, INT HISTOLOGICAL CLA, V18; Park JY, 2007, ONCOL REP, V18, P377; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Shimamura T, 2005, CANCER SCI, V96, P265, DOI 10.1111/j.1349-7006.2005.00043.x; Silva EM, 2008, GASTRIC CANCER, V11, P149, DOI 10.1007/s10120-008-0468-5; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; TAKENO A, 2009, ANN SURG ONCOL; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x	34	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17819	10.1371/journal.pone.0017819	http://dx.doi.org/10.1371/journal.pone.0017819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445269	gold, Green Published			2022-12-27	WOS:000288545100033
J	Gosselin, F				Gosselin, Frederic			A New Calibrated Bayesian Internal Goodness-of-Fit Method: Sampled Posterior p-Values as Simple and General p-Values That Allow Double Use of the Data	PLOS ONE			English	Article							COMPOSITE NULL MODELS; ASYMPTOTIC-DISTRIBUTION; 2ND LEVELS; INFERENCE; CHECKING; TESTS	Background: Recent approaches mixing frequentist principles with Bayesian inference propose internal goodness-of-fit (GOF) p-values that might be valuable for critical analysis of Bayesian statistical models. However, GOF p-values developed to date only have known probability distributions under restrictive conditions. As a result, no known GOF p-value has a known probability distribution for any discrepancy function. Methodology/Principal Findings: We show mathematically that a new GOF p-value, called the sampled posterior p-value (SPP), asymptotically has a uniform probability distribution whatever the discrepancy function. In a moderate finite sample context, simulations also showed that the SPP appears stable to relatively uninformative misspecifications of the prior distribution. Conclusions/Significance: These reasons, together with its numerical simplicity, make the SPP a better canonical GOF p-value than existing GOF p-values.	Irstea, UR EFNO, Nogent Sur Vernisson, France	INRAE	Gosselin, F (corresponding author), Irstea, UR EFNO, Nogent Sur Vernisson, France.	frederic.gosselin@cemagref.fr		Gosselin, Frederic/0000-0003-3737-106X				ANSCOMBE FJ, 1963, J ROY STAT SOC B, V25, P81; Bayarri MJ, 2000, J AM STAT ASSOC, V95, P1127, DOI 10.2307/2669749; Bayarri MJ, 2004, STAT SCI, V19, P58, DOI 10.1214/088342304000000116; BOX GEP, 1980, J ROY STAT SOC A STA, V143, P383, DOI 10.2307/2982063; Christensen R, 2005, AM STAT, V59, P121, DOI 10.1198/000313005X20871; Cox DR, 2002, STAT IND TECHNOL, P3; DURBIN J, 1973, SIAM PUBLICATIONS, V9; Evans M, 2000, J AM STAT ASSOC, V95, P1160, DOI 10.2307/2669752; Evans M, 1997, COMMUN STAT-THEOR M, V26, P1125, DOI 10.1080/03610929708831972; Evans M, 2007, STAT SCI, V22, P344, DOI 10.1214/07-STS235C; Fraser DAS, 2008, BIOMETRIKA, V95, P1, DOI 10.1093/biomet/asm093; Gelman A, 1996, STAT SINICA, V6, P733; GELMAN A, 2004, BAYESIAN DATA ANAL B; Gelman A, 2007, STAT SCI, V22, P349, DOI 10.1214/07-STS235A; GUTTMAN I, 1967, J ROY STAT SOC B, V29, P83; Harrell FE, 2001, REGRESSION MODELING; Hjort NL, 2006, J AM STAT ASSOC, V101, P1157, DOI 10.1198/016214505000001393; Huber PJ, 2002, STAT IND TECHNOL, P25; JOHNSON RA, 1970, ANN MATH STAT, V41, P851, DOI 10.1214/aoms/1177696963; Johnson VE, 2007, BAYESIAN ANAL, V2, P719, DOI 10.1214/07-BA229; Johnson VE, 2004, ANN STAT, V32, P2361, DOI 10.1214/009053604000000616; Little RJ, 2006, AM STAT, V60, P213, DOI 10.1198/000313006X117837; McVinish R, 2009, SCAND J STAT, V36, P337, DOI 10.1111/j.1467-9469.2008.00620.x; Mentre F, 2006, J PHARMACOKINET PHAR, V33, P345, DOI 10.1007/s10928-005-0016-4; O'HAGAN A., 2003, HIGHLY STRUCTURED ST, V27, P423; PATIL GR, 1984, DICT CLASSIFIED BIBL, V1; Piccinato L, 2000, J AM STAT ASSOC, V95, P1166, DOI 10.2307/2669755; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2005, R LANG ENV STAT COMP; ROBERT CP, 2002, 02009 CEREMADE U PAR; Robins JM, 2000, J AM STAT ASSOC, V95, P1143, DOI 10.2307/2669750; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Shen XT, 2001, ANN STAT, V29, P687; STEPHENS MA, 1978, J ROY STAT SOC B MET, V40, P64; Verdinelli I, 1998, ANN STAT, V26, P1215; WALKER AM, 1969, J ROY STAT SOC B, V31, P80; Zhang J, 2002, J ROY STAT SOC B, V64, P281, DOI 10.1111/1467-9868.00337	37	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14770	10.1371/journal.pone.0014770	http://dx.doi.org/10.1371/journal.pone.0014770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445246	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100006
J	Salvagiotto, G; Burton, S; Daigh, CA; Rajesh, D; Slukvin, II; Seay, NJ				Salvagiotto, Giorgia; Burton, Sarah; Daigh, Christine A.; Rajesh, Deepika; Slukvin, Igor I.; Seay, Nicholas J.			A Defined, Feeder-Free, Serum-Free System to Generate In Vitro Hematopoietic Progenitors and Differentiated Blood Cells from hESCs and hiPSCs	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; CD34(+) CELLS; EFFICIENT DIFFERENTIATION; VASCULAR DEVELOPMENT; PLATELET PRODUCTION; STROMAL CELLS; MOUSE; EXPANSION; MESODERM	Human ESC and iPSC are an attractive source of cells of high quantity and purity to be used to elucidate early human development processes, for drug discovery, and in clinical cell therapy applications. To efficiently differentiate pluripotent cells into a pure population of hematopoietic progenitors we have developed a new 2-dimentional, defined and highly efficient protocol that avoids the use of feeder cells, serum or embryoid body formation. Here we showed that a single matrix protein in combination with growth factors and a hypoxic environment is sufficient to generate from pluripotent cells hematopoietic progenitors capable of differentiating further in mature cell types of different lineages of the blood system. We tested the differentiation method using hESCs and 9 iPSC lines generated from different tissues. These data indicate the robustness of the protocol providing a valuable tool for the generation of clinical-grade hematopoietic cells from pluripotent cells.	[Salvagiotto, Giorgia; Burton, Sarah; Daigh, Christine A.; Rajesh, Deepika; Seay, Nicholas J.] Cellular Dynam Int Inc, Dept Res & Dev, Madison, WI USA; [Slukvin, Igor I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Salvagiotto, G (corresponding author), Cellular Dynam Int Inc, Dept Res & Dev, Madison, WI USA.	giorgia.salvagiotto@gmail.com		Rajesh, Deepika/0000-0002-8820-4328	Cellular Dynamics International, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081962] Funding Source: NIH RePORTER	Cellular Dynamics International, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by research funding from Cellular Dynamics International, Inc. to all authors. The funder had a role in the decision to publish the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Bruno S, 2004, STEM CELLS, V22, P135, DOI 10.1634/stemcells.22-2-135; Bruno S, 2003, HAEMATOLOGICA, V88, P379; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Choi KD, 2009, J CLIN INVEST, V119, P2818, DOI 10.1172/JCI38591; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Decaudin D, 2004, BONE MARROW TRANSPL, V34, P1089, DOI 10.1038/sj.bmt.1704675; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gaur M, 2006, J THROMB HAEMOST, V4, P436, DOI 10.1111/j.1538-7836.2006.01744.x; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gerecht-Nir S, 2003, LAB INVEST, V83, P1811, DOI 10.1097/01.LAB.0000106502.41391.F0; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; KIM K, 2010, NATURE; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; KULKEAW K, 2010, STEM CELL REV; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Lengerke C, 2010, BLOOD REV, V24, P27, DOI 10.1016/j.blre.2009.10.001; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P219, DOI 10.1111/j.1749-6632.2009.04606.x; LU SJ, 2011, CELL RES; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mattia G, 2002, BLOOD, V99, P888, DOI 10.1182/blood.V99.3.888; Mattia G, 2008, EXP HEMATOL, V36, P244, DOI 10.1016/j.exphem.2007.09.006; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Perez LE, 2001, BLOOD, V97, P1635, DOI 10.1182/blood.V97.6.1635; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; Purpura KA, 2008, STEM CELLS, V26, P2832, DOI 10.1634/stemcells.2008-0237; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tijssen MR, 2008, LEUKEMIA, V22, P203, DOI 10.1038/sj.leu.2404979; van Hensbergen Y, 2006, EXP HEMATOL, V34, P943, DOI 10.1016/j.exphem.2006.04.009; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	56	47	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17829	10.1371/journal.pone.0017829	http://dx.doi.org/10.1371/journal.pone.0017829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445267	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100036
J	Shan, PF; Lu, Y; Cui, RR; Jiang, Y; Yuan, LQ; Liao, EY				Shan, Peng-Fei; Lu, Ying; Cui, Rong-Rong; Jiang, Yi; Yuan, Ling-Qing; Liao, Er-Yuan			Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							ENDOGENOUS LIGAND APELIN; ENDOTHELIAL-CELLS; PEPTIDE APELIN; APJ RECEPTOR; IN-VIVO; IMMUNOCYTOCHEMICAL LOCALIZATION; BETA-GLYCEROPHOSPHATE; CARDIAC CONTRACTILITY; TISSUE DISTRIBUTION; OXIDATIVE STRESS	Vascular calcification, which results from a process osteoblastic differentiation of vascular smooth muscle cells (VSMCs), is a major risk factor for cardiovascular morbidity and mortality. Apelin is a recently discovered peptide that is the endogenous ligand for the orphan G-protein-coupled receptor, APJ. Several studies have identified the protective effects of apelin on the cardiovascular system. However, the effects and mechanisms of apelin on the osteoblastic differentiation of VSMCs have not been elucidated. Using a culture of calcifying vascular smooth muscle cells (CVMSCs) as a model for the study of vascular calcification, the relationship between apelin and the osteoblastic differentiation of VSMCs and the signal pathway involved were investigated. Alkaline phosphatase (ALP) activity and osteocalcin secretion were examined in CVSMCs. The involved signal pathway was studied using the extracellular signal-regulated kinase (ERK) inhibitor, PD98059, the phosphatidylinositol 3-kinase (PI3-K) inhibitor, LY294002, and APJ siRNA. The results showed that apelin inhibited ALP activity, osteocalcin secretion, and the formation of mineralized nodules. APJ protein was detected in CVSMCs, and apelin activated ERK and AKT (a downstream effector of PI3-K). Suppression of APJ with siRNA abolished the apelin-induced activation of ERK and Akt. Furthermore, inhibition of APJ expression, and the activation of ERK or PI3-K, reversed the effects of apelin on ALP activity. These results showed that apelin inhibited the osteoblastic differentiation of CVSMCs through the APJ/ERK and APJ/PI3-K/AKT signaling pathway. Apelin appears to play a protective role against arterial calcification.	[Shan, Peng-Fei] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Ying] Peoples Hosp Zhongshan City, Dept Endocrinol & Metab, Zhongshan, Guangdong, Peoples R China; [Shan, Peng-Fei; Lu, Ying; Cui, Rong-Rong; Yuan, Ling-Qing; Liao, Er-Yuan] Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Cui, Rong-Rong] Cent S Univ, Xiang Ya Hosp 2, Dept Pediat, Changsha, Hunan, Peoples R China; [Jiang, Yi] Cent S Univ, Xiang Ya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China	Zhejiang University; Central South University; Central South University; Central South University	Yuan, LQ (corresponding author), Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.	allenylq@hotmail.com	; Yuan, Ling-Qing/D-2102-2019	Shan, Peng-Fei/0000-0002-6684-9395; Yuan, Ling-Qing/0000-0001-8602-7113; Yi, Jiang/0000-0002-7877-0561	Health Department of Zhejiang Province [2009QN012]; National Natural Science Foundation of China [30801203]; Ph. D. Programs Foundation of Ministry of Education of China [200805331017]; China Postdoctoral Science Foundation [20100471240]	Health Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph. D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funding from the Health Department of Zhejiang Province (2009QN012), the National Natural Science Foundation of China (30801203), the Ph. D. Programs Foundation of Ministry of Education of China (No. 200805331017) and China Postdoctoral Science Foundation (20100471240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Alexander MY, 2005, ARTERIOSCL THROM VAS, V25, P1851, DOI 10.1161/01.ATV.0000175750.94742.46; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Bear M, 2008, J CELL BIOCHEM, V105, P185, DOI 10.1002/jcb.21812; Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Cai Y, 2010, ACTA PHARMACOL SIN, V31, P1359, DOI 10.1038/aps.2010.89; Collett GDM, 2007, CIRC RES, V100, P502, DOI 10.1161/01.RES.0000258854.03388.02; Cui RR, 2010, AMINO ACIDS, V39, P1193, DOI 10.1007/s00726-010-0555-x; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Farkasfalvi K, 2007, BIOCHEM BIOPH RES CO, V357, P889, DOI 10.1016/j.bbrc.2007.04.017; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Hashimoto T, 2007, AM J PATHOL, V171, P1705, DOI 10.2353/ajpath.2007.070471; Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kanazawa I, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-51; Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee HL, 2010, EXP MOL MED, V42, P437, DOI 10.3858/emm.2010.42.6.045; Lee HL, 2010, BIOCHEM BIOPH RES CO, V391, P1087, DOI 10.1016/j.bbrc.2009.12.027; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Lee SK, 2009, BIOL PHARM BULL, V32, P1328, DOI 10.1248/bpb.32.1328; Liao XB, 2008, AMINO ACIDS, V34, P525, DOI 10.1007/s00726-007-0003-8; Liao XB, 2010, AMINO ACIDS, V39, P375, DOI 10.1007/s00726-009-0448-z; Lin IC, 2008, PLAST RECONSTR SURG, V121, P1554, DOI 10.1097/PRS.0b013e31816c3bd7; Liu CH, 2010, ACTA BIOCH BIOPH SIN, V42, P396, DOI 10.1093/abbs/gmq035; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Masri B, 2005, CELL SIGNAL, V17, P415, DOI 10.1016/j.cellsig.2004.09.018; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Nishiwaki-Yasuda K, 2007, ENDOCR J, V54, P103, DOI 10.1507/endocrj.K06-093; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Peltonen T, 2009, J HEART VALVE DIS, V18, P644; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Radcliff K, 2005, CIRC RES, V96, P398, DOI 10.1161/01.RES.0000157671.47477.71; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shi YL, 2009, J CELL BIOCHEM, V108, P1184, DOI 10.1002/jcb.22348; Shi Y, 2009, BIOMETALS, V22, P317, DOI 10.1007/s10534-008-9168-1; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205; Xie H, 2006, REGUL PEPTIDES, V134, P118, DOI 10.1016/j.regpep.2006.02.004; You HZ, 2009, RENAL FAILURE, V31, P313, DOI 10.1080/08860220902875182	58	49	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17938	10.1371/journal.pone.0017938	http://dx.doi.org/10.1371/journal.pone.0017938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437254	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100046
J	Wang, DP; Yu, J				Wang, Dapeng; Yu, Jun			Both Size and GC-Content of Minimal Introns Are Selected in Human Populations	PLOS ONE			English	Article							HUMAN GENOME; DROSOPHILA; EVOLUTION; LENGTH; POLYMORPHISM; EQUILIBRIUM; CONSTRAINTS; SEQUENCE; DYNAMICS; MODEL	Background: We previously have studied the insertion and deletion polymorphism by sequencing no more than one hundred introns in a mixed human population and found that the minimal introns tended to maintain length at an optimal size. Here we analyzed re-sequenced 179 individual genomes (from African, European, and Asian populations) from the data released by the 1000 Genome Project to study the size dynamics of minimal introns. Principal Findings: We not only confirmed that minimal introns in human populations are selected but also found two major effects in minimal intron evolution: (i) Size-effect: minimal introns longer than an optimal size (87 nt) tend to have a higher ratio of deletion to insertion than those that are shorter than the optimal size; (ii) GC-effect: minimal introns with lower GC content tend to be more frequently deleted than those with higher GC content. The GC-effect results in a higher GC content in minimal introns than their flanking exons as opposed to larger introns (>= 125 nt) that always have a lower GC content than that of their flanking exons. We also observed that the two effects are distinguishable but not completely separable within and between populations. Conclusions: We validated the unique mutation dynamics of minimal introns in keeping their near-optimal size and GC content, and our observations suggest potentially important functions of human minimal introns in transcript processing and gene regulation.	[Wang, Dapeng; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wang, Dapeng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, DP (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn	Wang, Dapeng/HGD-4818-2022; 郑, 征/C-8514-2011; Wang, Dapeng/AAK-5651-2020	Wang, Dapeng/0000-0002-9925-4574	National Science and Technology [2008ZX1004-013]; 863 Program [2009AA01A130]; Ministry of Science and Technology of the People's Republic of China [2011CB944101]	National Science and Technology; 863 Program(National High Technology Research and Development Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by grants from Key Project of National Science and Technology (2008ZX1004-013), 863 Program (2009AA01A130), and 973 Program (2011CB944101) of the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2010, GENOME RES; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Comeron JM, 2000, GENETICS, V156, P1175; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Fedorov A, 2003, GENOME RES, V13, P2236, DOI 10.1101/gr.1029803; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Haddrill PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r67; Johnson KP, 2004, MOL BIOL EVOL, V21, P599, DOI 10.1093/molbev/msh051; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Llopart A, 2002, P NATL ACAD SCI USA, V99, P8121, DOI 10.1073/pnas.122570299; Ometto L, 2005, GENETICS, V169, P1521, DOI 10.1534/genetics.104.037689; Parsch J, 2003, GENETICS, V165, P1843; Parsch J, 2010, MOL BIOL EVOL, V27, P1226, DOI 10.1093/molbev/msq046; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Presgraves DC, 2006, MOL BIOL EVOL, V23, P2203, DOI 10.1093/molbev/msl094; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Roy SW, 2005, P NATL ACAD SCI USA, V102, P713, DOI 10.1073/pnas.0408274102; Sjodin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008650; Sperling J, 2008, STRUCTURE, V16, P1605, DOI 10.1016/j.str.2008.08.011; Wang DP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-20; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang HF, 2007, BIOCHEM BIOPH RES CO, V354, P203, DOI 10.1016/j.bbrc.2006.12.184; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010144	31	11	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17945	10.1371/journal.pone.0017945	http://dx.doi.org/10.1371/journal.pone.0017945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437290	Green Published, gold, Green Submitted			2022-12-27	WOS:000288514600017
J	Shiheido, H; Takashima, H; Doi, N; Yanagawa, H				Shiheido, Hirokazu; Takashima, Hideaki; Doi, Nobuhide; Yanagawa, Hiroshi			mRNA Display Selection of an Optimized MDM2-Binding Peptide That Potently Inhibits MDM2-p53 Interaction	PLOS ONE			English	Article							IN-VITRO; HIGH-AFFINITY; CURRENT STRATEGIES; P53 PATHWAY; CELL-DEATH; PROTEIN; ACTIVATION; BINDING; DESIGN; TARGET	p53 is a tumor suppressor protein that prevents tumorigenesis through cell cycle arrest or apoptosis of cells in response to cellular stress such as DNA damage. Because the oncoprotein MDM2 interacts with p53 and inhibits its activity, MDM2-p53 interaction has been a major target for the development of anticancer drugs. While previous studies have used phage display to identify peptides (such as DI) that inhibit the MDM2-p53 interaction, these peptides were not sufficiently optimized because the size of the phage-displayed random peptide libraries did not cover all of the possible sequences. In this study, we performed selection of MDM2-binding peptides from large random peptide libraries in two stages using mRNA display. We identified an optimal peptide named MIP that inhibited the MDM2-p53 and MDMX-p53 interactions 29- and 13-fold more effectively than DI, respectively. Expression of MIP fused to the thioredoxin scaffold protein in living cells by adenovirus caused stabilization of p53 through its interaction with MDM2, resulting in activation of the p53 pathway. Furthermore, expression of MIP also inhibited tumor cell proliferation in a p53-dependent manner more potently than DI. These results show that two-stage, mRNA-displayed peptide selection is useful for the rapid identification of potent peptides that target oncoproteins.	[Shiheido, Hirokazu; Takashima, Hideaki; Doi, Nobuhide; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Shiheido, H (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	doi@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Shiheido, Hirokazu/0000-0002-1415-2019; Doi, Nobuhide/0000-0002-2402-6390	MEXT of Japan [19360377, 19657073, 22360351, S0801008]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: Financial support for this study was provided by a Grant-in-Aid for Scientific Research (19360377, 19657073, 22360351) and a Strategic Research Foundation Grant-aided Project for Private Universities (S0801008) from the MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Blagosklonny MV, 2002, INT J CANCER, V98, P161, DOI 10.1002/ijc.10158; Borghouts C, 2005, J PEPT SCI, V11, P713, DOI 10.1002/psc.717; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Bottger V, 1996, ONCOGENE, V13, P2141; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chen F, 2010, BIOCHEM PHARMACOL, V80, P724, DOI 10.1016/j.bcp.2010.04.031; Chene P, 2002, FEBS LETT, V529, P293, DOI 10.1016/S0014-5793(02)03362-8; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Frankel A, 2003, CHEM BIOL, V10, P1043, DOI 10.1016/j.chembiol.2003.11.004; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Guarracino DA, 2009, CHEM BIOL, V16, P919, DOI 10.1016/j.chembiol.2009.09.005; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Jackson MW, 2001, J BIOL CHEM, V276, P25336, DOI 10.1074/jbc.M010685200; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kanovsky M, 2001, P NATL ACAD SCI USA, V98, P12438, DOI 10.1073/pnas.211280698; Kawakami T, 2009, NAT CHEM BIOL, V5, P888, DOI 10.1038/nchembio.259; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Matsumura N, 2010, FASEB J, V24, P2201, DOI 10.1096/fj.09-143008; Matsuura T, 2006, J BIOSCI BIOENG, V101, P449, DOI 10.1263/jbb.101.449; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rosal R, 2005, ADV DRUG DELIVER REV, V57, P653, DOI 10.1016/j.addr.2004.10.008; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wasylyk C, 1999, ONCOGENE, V18, P1921, DOI 10.1038/sj.onc.1202528; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g	41	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17898	10.1371/journal.pone.0017898	http://dx.doi.org/10.1371/journal.pone.0017898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423613	gold, Green Published, Green Submitted			2022-12-27	WOS:000288513900043
J	Welham, NV; Yamashita, M; Choi, SH; Ling, CY				Welham, Nathan V.; Yamashita, Masaru; Choi, Seong Hee; Ling, Changying			Cross-Sample Validation Provides Enhanced Proteome Coverage in Rat Vocal Fold Mucosa	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; MASS-SPECTROMETRY; IMMUNOLOGICAL ARCHITECTURE; IDENTIFICATION; PROTEINS; PROTEOGLYCANS; EXPRESSION; MODEL; FIBROMODULIN; LARYNX	The vocal fold mucosa is a biomechanically unique tissue comprised of a densely cellular epithelium, superficial to an extracellular matrix (ECM)-rich lamina propria. Such ECM-rich tissues are challenging to analyze using proteomic assays, primarily due to extensive crosslinking and glycosylation of the majority of high M-r ECM proteins. In this study, we implemented an LC-MS/MS-based strategy to characterize the rat vocal fold mucosa proteome. Our sample preparation protocol successfully solubilized both proteins and certain high Mr glycoconjugates and resulted in the identification of hundreds of mucosal proteins. A straightforward approach to the treatment of protein identifications attributed to single peptide hits allowed the retention of potentially important low abundance identifications (validated by a cross-sample match and de novo interpretation of relevant spectra) while still eliminating potentially spurious identifications (global single peptide hits with no cross-sample match). The resulting vocal fold mucosa proteome was characterized by a wide range of cellular and extracellular proteins spanning 12 functional categories.	[Welham, Nathan V.; Yamashita, Masaru; Choi, Seong Hee; Ling, Changying] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Otolaryngol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Welham, NV (corresponding author), Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Otolaryngol, Madison, WI 53706 USA.	welham@sugery.wisc.edu	Yamashita, Masaru/B-2411-2009		National Institute on Deafness and Other Communication Disorders [R03 DC008884, R03 DC008884-S1, R01 DC10777]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010777, R03DC008884] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants R03 DC008884, R03 DC008884-S1 and R01 DC10777 from the National Institute on Deafness and Other Communication Disorders. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Barker E, 2006, CLIN EXP IMMUNOL, V143, P6, DOI 10.1111/j.1365-2249.2005.02950.x; Belluoccio D, 2006, PROTEOMICS, V6, P6549, DOI 10.1002/pmic.200600191; Bond MR, 2007, CURR OPIN CHEM BIOL, V11, P52, DOI 10.1016/j.cbpa.2006.11.032; Burton-Wurster N, 2003, OSTEOARTHR CARTILAGE, V11, P167, DOI 10.1053/S1063-4584(02)00349-7; Catterall JB, 2006, RHEUMATOLOGY, V45, P1101, DOI 10.1093/rheumatology/kel060; Cheng AL, 2008, CLIN CANCER RES, V14, P435, DOI 10.1158/1078-0432.CCR-07-1215; Connor NP, 2002, ANN OTO RHINOL LARYN, V111, P579, DOI 10.1177/000348940211100703; Domazet B, 2008, INT J CLIN EXP PATHO, V1, P475; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Gorti GK, 1999, TRANSPLANTATION, V68, P1638, DOI 10.1097/00007890-199912150-00006; GRAY SD, 1994, J VOICE, V8, P48, DOI 10.1016/S0892-1997(05)80318-2; Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115; Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001; Gray SD, 2000, OTOLARYNG CLIN N AM, V33, P679, DOI 10.1016/S0030-6665(05)70237-1; Gupta N, 2009, J PROTEOME RES, V8, P4173, DOI 10.1021/pr9004794; Hahn MS, 2005, ANN OTO RHINOL LARYN, V114, P451, DOI 10.1177/000348940511400607; Hansen KC, 2009, MOL CELL PROTEOMICS, V8, P1648, DOI 10.1074/mcp.M900039-MCP200; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Higdon R, 2007, BIOINFORMATICS, V23, P277, DOI 10.1093/bioinformatics/btl595; Hobbs CGL, 2006, CLIN EXP IMMUNOL, V145, P365, DOI 10.1111/j.1365-2249.2006.03125.x; Huttlin EL, 2007, J PROTEOME RES, V6, P392, DOI 10.1021/pr0603194; Inagi K, 1998, LARYNGOSCOPE, V108, P1048, DOI 10.1097/00005537-199807000-00018; Li ZB, 2005, PROTEOMICS, V5, P4764, DOI 10.1002/pmic.200401329; Lodewyck D, 2007, ARCH OTOLARYNGOL, V133, P557, DOI 10.1001/archotol.133.6.557; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Ohno T, 2009, LARYNGOSCOPE, V119, P1424, DOI 10.1002/lary.20497; Pawlak AS, 1996, ANN OTO RHINOL LARYN, V105, P6, DOI 10.1177/000348949610500102; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pflieger D, 2006, PROTEOMICS, V6, P5868, DOI 10.1002/pmic.200402040; Rees LEN, 2006, CLIN IMMUNOL, V118, P342, DOI 10.1016/j.clim.2005.10.015; Roughley PJ, 1996, OSTEOARTHR CARTILAGE, V4, P153, DOI 10.1016/S1063-4584(96)80011-2; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Sennels L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-179; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Sivasankar M, 2008, J VOICE, V22, P408, DOI 10.1016/j.jvoice.2006.11.005; Sivasankar M, 2007, J SPEECH LANG HEAR R, V50, P886, DOI 10.1044/1092-4388(2007/063); SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tateya I, 2006, ANN OTO RHINOL LARYN, V115, P135, DOI 10.1177/000348940611500210; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P215, DOI 10.1177/000348940611500310; Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183, DOI 10.1177/000348940511400303; Thibeault SL, 2003, J SPEECH LANG HEAR R, V46, P491, DOI 10.1044/1092-4388(2003/040); Thibeault Susan L, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P148, DOI 10.1097/01.moo.0000163450.90455.fb; Thomas H, 2008, PROTEOMICS, V8, P4173, DOI 10.1002/pmic.200800250; Vincourt JB, 2006, MOL CELL PROTEOMICS, V5, P1984, DOI 10.1074/mcp.T600007-MCP200; Welham NV, 2008, PROTEOMICS, V8, P1933, DOI 10.1002/pmic.200700859; Welham NV, 2006, J SPEECH LANG HEAR R, V49, P671, DOI 10.1044/1092-4388(2006/049); Welham NV, 2009, J SPEECH LANG HEAR R, V52, P1008, DOI 10.1044/1092-4388(2009/08-0049); Wilson R, 2008, METHODS, V45, P22, DOI 10.1016/j.ymeth.2008.01.008; Wilson R, 2008, MATRIX BIOL, V27, P709, DOI 10.1016/j.matbio.2008.07.007; Zaia J, 2004, MASS SPECTROM REV, V23, P161, DOI 10.1002/mas.10073	52	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17754	10.1371/journal.pone.0017754	http://dx.doi.org/10.1371/journal.pone.0017754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423617	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900021
J	Aimone, JA; Houser, D				Aimone, Jason A.; Houser, Daniel			Beneficial Betrayal Aversion	PLOS ONE			English	Article							TRUST; RISK; COOPERATION; INEQUALITY; FAIRNESS	Many studies demonstrate the social benefits of cooperation. Likewise, recent studies convincingly demonstrate that betrayal aversion hinders trust and discourages cooperation. In this respect, betrayal aversion is unlike socially "beneficial'' preferences including altruism, fairness and inequity aversion, all of which encourage cooperation and exchange. To our knowledge, other than the suggestion that it acts as a barrier to rash trust decisions, the benefits of betrayal aversion remain largely unexplored. Here we use laboratory experiments with human participants to show that groups including betrayal-averse agents achieve higher levels of reciprocity and more profitable social exchange than groups lacking betrayal aversion. These results are the first rigorous evidence on the benefits of betrayal aversion, and may help future research investigating cultural differences in betrayal aversion as well as future research on the evolutionary roots of betrayal aversion. Further, our results extend the understanding of how intentions affect social interactions and exchange and provide an effective platform for further research on betrayal aversion and its effects on human behavior.	[Aimone, Jason A.; Houser, Daniel] George Mason Univ, Interdisciplinary Ctr Econ Sci, Arlington, VA USA	George Mason University	Aimone, JA (corresponding author), George Mason Univ, Interdisciplinary Ctr Econ Sci, Arlington, VA USA.	jason.aimone@gmail.com		Houser, Daniel/0000-0003-3583-8201	International Foundation for Research in Experimental Economics; The Mercatus Center; National Science Foundation [SES-0851250]; Direct For Social, Behav & Economic Scie [0851250] Funding Source: National Science Foundation	International Foundation for Research in Experimental Economics; The Mercatus Center; National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	The authors gratefully acknowledge research support from the International Foundation for Research in Experimental Economics, The Mercatus Center, and the National Science Foundation Research Grant SES-0851250. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMONE JA, 2009, WHAT YOU DONT KNOW W; Ashraf N, 2006, EXP ECON, V9, P193, DOI 10.1007/s10683-006-9122-4; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bohnet I, 2004, J ECON BEHAV ORGAN, V55, P467, DOI 10.1016/j.jebo.2003.11.004; Bohnet I, 2008, AM ECON REV, V98, P294, DOI 10.1257/aer.98.1.294; Bohnet I, 2010, Q J ECON, V125, P811, DOI 10.1162/qjec.2010.125.2.811; Charness G, 2006, ECONOMETRICA, V74, P1579, DOI 10.1111/j.1468-0262.2006.00719.x; Dana J, 2007, ECON THEOR, V33, P67, DOI 10.1007/s00199-006-0153-z; Eckel CC, 2004, J ECON BEHAV ORGAN, V55, P447, DOI 10.1016/j.jebo.2003.11.003; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2009, J EUR ECON ASSOC, V7, P235, DOI 10.1162/JEEA.2009.7.2-3.235; HENRICH N, 2007, WHY HUMANS COOPERATE, P35; Hong K, 2007, J ECON PSYCHOL, V28, P197, DOI 10.1016/j.joep.2006.06.003; Houser D, 2010, J ECON BEHAV ORGAN, V74, P72, DOI 10.1016/j.jebo.2010.01.002; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; MCCABE KA, 2003, J ECON BEHAV ORGAN, V55, P447; Nesse RM, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P137; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Schechter L, 2007, J ECON BEHAV ORGAN, V62, P272, DOI 10.1016/j.jebo.2005.03.006; Snijders C, 1999, GAMES AND HUMAN BEHAVIOR, P355; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Winter E, 2005, JPN ECON REV, V56, P363, DOI 10.1111/j.1468-5876.2005.00329.x; Yamagishi T, 2009, P NATL ACAD SCI USA, V106, P11520, DOI 10.1073/pnas.0900636106	26	24	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17725	10.1371/journal.pone.0017725	http://dx.doi.org/10.1371/journal.pone.0017725			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736RS	21423732	Green Submitted, Green Published, gold			2022-12-27	WOS:000288512400022
J	Zhang, WY; Chen, JJ; Yang, Y; Tang, YF; Shang, J; Shen, BR				Zhang, Wenyu; Chen, Jiajia; Yang, Yang; Tang, Yifei; Shang, Jing; Shen, Bairong			A Practical Comparison of De Novo Genome Assembly Software Tools for Next-Generation Sequencing Technologies	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; READS; ALGORITHM; MILLIONS; ERROR	The advent of next-generation sequencing technologies is accompanied with the development of many whole-genome sequence assembly methods and software, especially for de novo fragment assembly. Due to the poor knowledge about the applicability and performance of these software tools, choosing a befitting assembler becomes a tough task. Here, we provide the information of adaptivity for each program, then above all, compare the performance of eight distinct tools against eight groups of simulated datasets from Solexa sequencing platform. Considering the computational time, maximum random access memory (RAM) occupancy, assembly accuracy and integrity, our study indicate that string-based assemblers, overlap-layout-consensus (OLC) assemblers are well-suited for very short reads and longer reads of small genomes respectively. For large datasets of more than hundred millions of short reads, De Bruijn graph-based assemblers would be more appropriate. In terms of software implementation, string-based assemblers are superior to graph-based ones, of which SOAPdenovo is complex for the creation of configuration file. Our comparison study will assist researchers in selecting a well-suited assembler and offer essential information for the improvement of existing assemblers or the developing of novel assemblers.	[Zhang, Wenyu; Chen, Jiajia; Yang, Yang; Tang, Yifei; Shang, Jing; Shen, Bairong] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Zhang, WY (corresponding author), Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China.	bairong.shen@suda.edu.cn	Zhang, Wenyu/H-5008-2013; Shen, Bairong/W-1254-2019; Shen, Bairong/E-6431-2012; Zhang, Wenyu/U-7261-2019	Shen, Bairong/0000-0003-2899-1531; Shen, Bairong/0000-0003-2899-1531; Zhang, Wenyu/0000-0002-2507-3033; Tang, Yifei/0000-0003-1979-9070	National Nature Science Foundation of China [31040020]; National 973 Programs of China [2007CB947002, 2010CB945600]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Programs of China(National Basic Research Program of China)	This work was supported by grants from the National Nature Science Foundation of China (31040020) and the National 973 Programs of China (2007CB947002, 2010CB945600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Bryant DW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-69; Cahill MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011518; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; GNERRE S, 2010, P NATL ACAD SCI US; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Nishito Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-243; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop Mihai, 2004, Methods Mol Biol, V255, P279; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Schatz MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-474; Schmidt B, 2009, BIOINFORMATICS, V25, P2279, DOI 10.1093/bioinformatics/btp374; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi HX, 2010, J COMPUT BIOL, V17, P603, DOI 10.1089/cmb.2009.0062; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Trapnell C, 2009, PARALLEL COMPUT, V35, P429, DOI 10.1016/j.parco.2009.05.002; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	32	134	152	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17915	10.1371/journal.pone.0017915	http://dx.doi.org/10.1371/journal.pone.0017915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423806	Green Published, gold, Green Submitted			2022-12-27	WOS:000288512400039
J	Mejias, JF; Torres, JJ				Mejias, Jorge F.; Torres, Joaquin J.			Emergence of Resonances in Neural Systems: The Interplay between Adaptive Threshold and Short-Term Synaptic Plasticity	PLOS ONE			English	Article							STOCHASTIC RESONANCE; COINCIDENCE DETECTION; FIRE MODEL; NOISE; NEURONS; DEPRESSION; INFORMATION; ADAPTATION; RELEASE; HETEROGENEITY	In this work we study the detection of weak stimuli by spiking (integrate-and-fire) neurons in the presence of certain level of noisy background neural activity. Our study has focused in the realistic assumption that the synapses in the network present activity-dependent processes, such as short-term synaptic depression and facilitation. Employing mean-field techniques as well as numerical simulations, we found that there are two possible noise levels which optimize signal transmission. This new finding is in contrast with the classical theory of stochastic resonance which is able to predict only one optimal level of noise. We found that the complex interplay between adaptive neuron threshold and activity-dependent synaptic mechanisms is responsible for this new phenomenology. Our main results are confirmed by employing a more realistic FitzHugh-Nagumo neuron model, which displays threshold variability, as well as by considering more realistic stochastic synaptic models and realistic signals such as poissonian spike trains.	[Mejias, Jorge F.] Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada; [Mejias, Jorge F.; Torres, Joaquin J.] Univ Granada, Dept Electromagnetism & Phys Matter, Granada, Spain	University of Ottawa; University of Granada	Mejias, JF (corresponding author), Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada.	jmejias@uottawa.ca	Torres, Joaquín J./AAE-6228-2019; Torres, Joaquín J./C-1385-2012	Torres, Joaquín J./0000-0001-6175-9676; Mejias, Jorge/0000-0002-8096-4891	MEyC-FEDER [FIS2009-08451]; Junta de Andalucia [P06-FQM-01505, P07-FQM-02725]	MEyC-FEDER; Junta de Andalucia(Junta de Andalucia)	This work was supported by the MEyC-FEDER project FIS2009-08451 and the Junta de Andalucia projects P06-FQM-01505 and P07-FQM-02725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Bulsara AR, 1996, PHYS REV E, V53, P3958, DOI 10.1103/PhysRevE.53.3958; Cardin JA, 2008, NEURON, V59, P150, DOI 10.1016/j.neuron.2008.05.002; Chacron MJ, 2004, PHYSICA D, V192, P138, DOI 10.1016/j.physd.2003.12.009; CHIALVO DR, 1993, J STAT PHYS, V70, P375, DOI 10.1007/BF01053974; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; de la Rocha J, 2005, J NEUROSCI, V25, P8416, DOI 10.1523/JNEUROSCI.0631-05.2005; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; FAUVE S, 1983, PHYS LETT A, V97, P5, DOI 10.1016/0375-9601(83)90086-5; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Fuentes MA, 2003, FLUCT NOISE LETT, V3, pL365, DOI 10.1142/S0219477503001440; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Garcia-Lazaro JA, 2007, EUR J NEUROSCI, V26, P2359, DOI 10.1111/j.1460-9568.2007.05847.x; Greenwood PE, 2000, PHYS REV LETT, V84, P4773, DOI 10.1103/PhysRevLett.84.4773; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hou ZH, 1999, J CHEM PHYS, V111, P1592, DOI 10.1063/1.479419; Ibanes M, 2000, EUR PHYS J B, V18, P663, DOI 10.1007/s100510070015; Kobayashi R, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.009.2009; Koch Christof, 1999, P1; Krawiecki A, 2009, EUR PHYS J B, V69, P81, DOI 10.1140/epjb/e2009-00082-x; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lindner B, 2009, J NEUROSCI, V29, P2076, DOI 10.1523/JNEUROSCI.3702-08.2009; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Manjarrez E, 2002, NEUROSCI LETT, V324, P213, DOI 10.1016/S0304-3940(02)00212-4; Mankin R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031120; Mato G, 1998, PHYS REV E, V58, P876, DOI 10.1103/PhysRevE.58.876; Mato G, 1999, PHYS REV E, V59, P3339, DOI 10.1103/PhysRevE.59.3339; MCNAMARA B, 1988, PHYS REV LETT, V60, P2626, DOI 10.1103/PhysRevLett.60.2626; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; Mejias JF, 2008, J COMPUT NEUROSCI, V24, P222, DOI 10.1007/s10827-007-0052-8; Mejias JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013651; Mejias JF, 2009, NEURAL COMPUT, V21, P851, DOI 10.1162/neco.2008.02-08-719; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; NOBLE D, 1966, PHYSIOL REV, V46, P1; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Rudolph M, 2001, J COMPUT NEUROSCI, V11, P19, DOI 10.1023/A:1011200713411; STANCEY WC, 2000, J NEUROPHYSIOL, V83, P1394; Stemmler M, 1996, NETWORK-COMP NEURAL, V7, P687, DOI 10.1088/0954-898X/7/4/005; Tessone CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.194101; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; VANDENBROECK C, 1994, PHYS REV LETT, V73, P3395, DOI 10.1103/PhysRevLett.73.3395; VandenBroeck C, 1997, PHYS REV E, V55, P4084, DOI 10.1103/PhysRevE.55.4084; Vilar JMG, 1997, PHYS REV LETT, V78, P2882, DOI 10.1103/PhysRevLett.78.2882; Volkov EI, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061112; Wang J, 2002, EUR PHYS J B, V29, P123, DOI 10.1140/epjb/e2002-00269-7; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WIESENFELD K, 1994, PHYS REV LETT, V72, P2125, DOI 10.1103/PhysRevLett.72.2125; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Yasuda H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118103; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zalanyi L, 2001, NEUROCOMPUTING, V38, P459, DOI 10.1016/S0925-2312(01)00383-6	62	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17255	10.1371/journal.pone.0017255	http://dx.doi.org/10.1371/journal.pone.0017255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408148	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170000018
J	Ouellette, SP; Dorsey, FC; Moshiach, S; Cleveland, JL; Carabeo, RA				Ouellette, Scot P.; Dorsey, Frank C.; Moshiach, Simon; Cleveland, John L.; Carabeo, Rey A.			Chlamydia Species-Dependent Differences in the Growth Requirement for Lysosomes	PLOS ONE			English	Article							TRACHOMATIS SEROVAR L2; COXIELLA-BURNETII; EPITHELIAL-CELLS; GENOME SEQUENCE; PNEUMONIAE; TRAFFICKING; INCLUSION; PHAGOSOMES; INFECTION; TRANSPORT	Genome reduction is a hallmark of obligate intracellular pathogens such as Chlamydia, where adaptation to intracellular growth has resulted in the elimination of genes encoding biosynthetic enzymes. Accordingly, chlamydiae rely heavily on the host cell for nutrients yet their specific source is unclear. Interestingly, chlamydiae grow within a pathogen-defined vacuole that is in close apposition to lysosomes. Metabolically-labeled uninfected host cell proteins were provided as an exogenous nutrient source to chlamydiae-infected cells, and uptake and subsequent labeling of chlamydiae suggested lysosomal degradation as a source of amino acids for the pathogen. Indeed, Bafilomycin A1 (BafA1), an inhibitor of the vacuolar H(+)/ATPase that blocks lysosomal acidification and functions, impairs the growth of C. trachomatis and C. pneumoniae, and these effects are especially profound in C. pneumoniae. BafA1 induced the marked accumulation of material within the lysosomal lumen, which was due to the inhibition of proteolytic activities, and this response inhibits chlamydiae rather than changes in lysosomal acidification per se, as cathepsin inhibitors also inhibit the growth of chlamydiae. Finally, the addition of cycloheximide, an inhibitor of eukaryotic protein synthesis, compromises the ability of lysosomal inhibitors to block chlamydial growth, suggesting chlamydiae directly access free amino acids in the host cytosol as a preferred source of these nutrients. Thus, chlamydiae co-opt the functions of lysosomes to acquire essential amino acids.	[Ouellette, Scot P.; Carabeo, Rey A.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, London, England; [Dorsey, Frank C.; Cleveland, John L.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Moshiach, Simon] St Jude Childrens Hosp, Dept Tumor Cell Biol & Genet, Memphis, TN 38105 USA	Imperial College London; Scripps Research Institute; St Jude Children's Research Hospital	Ouellette, SP (corresponding author), Inst Pasteur, Unite Biochim Interact Macromol, Paris, France.	r.carabeo@imperial.ac.uk		O, Scot/0000-0002-3721-6839; CARABEO, REY/0000-0002-5708-5493	National Institutes of Health [AI052252, AI065545, CA123777]; Medical Research Council [G0900213] Funding Source: researchfish; MRC [G0900213] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [F32CA123777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065545, K22AI052252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI052252 and AI065545 to R. A. C. and CA123777 to F. C. D. from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Al-Younes HM, 2004, INFECT IMMUN, V72, P4751, DOI 10.1128/IAI.72.8.4751-4762.2004; Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; BRUNHAM RC, 1985, J INFECT DIS, V152, P1275, DOI 10.1093/infdis/152.6.1275; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Byrne GI, 2001, INFECT IMMUN, V69, P5423, DOI 10.1128/IAI.69.9.5423-5429.2001; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; *CDCP, 2007, SEX TRANSM DIS SURV; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Doeven MK, 2008, BIOPHYS J, V94, P3956, DOI 10.1529/biophysj.107.120964; Dorsey FC, 2009, METHOD ENZYMOL, V453, P251, DOI 10.1016/S0076-6879(08)04012-3; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Gieffers J, 2002, INFECT IMMUN, V70, P5827, DOI 10.1128/IAI.70.10.5827-5834.2002; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757, DOI 10.1093/clind/15.5.757; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; HACKSTADT T, 1981, P NATL ACAD SCI-BIOL, V78, P3240, DOI 10.1073/pnas.78.5.3240; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; HAHN DL, 1995, J FAM PRACTICE, V41, P345; HATCH TP, 1975, INFECT IMMUN, V12, P211, DOI 10.1128/IAI.12.1.211-220.1975; Heinzen RA, 1997, INFECT IMMUN, V65, P1088, DOI 10.1128/IAI.65.3.1088-1094.1997; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Miyairi I, 2006, J INFECT DIS, V194, P350, DOI 10.1086/505432; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ouellette SP, 2006, MOL MICROBIOL, V62, P1387, DOI 10.1111/j.1365-2958.2006.05465.x; Pachikara N, 2009, FEMS MICROBIOL LETT, V292, P240, DOI 10.1111/j.1574-6968.2009.01494.x; PISONI RL, 1991, BIOCHIM BIOPHYS ACTA, V1071, P351, DOI 10.1016/0304-4157(91)90002-E; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; RIPA KT, 1977, J CLIN MICROBIOL, V6, P328; Rossi A, 2004, BIOL CHEM, V385, P363, DOI 10.1515/BC.2004.040; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schramm N, 1996, INFECT IMMUN, V64, P1208, DOI 10.1128/IAI.64.4.1208-1214.1996; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; TAYLORROBINSON D, 1992, LANCET, V340, P81, DOI 10.1016/0140-6736(92)90399-N; Thamotharan M, 1997, J BIOL CHEM, V272, P11786, DOI 10.1074/jbc.272.18.11786; WINKLER HH, 1982, INFECT IMMUN, V38, P109, DOI 10.1128/IAI.38.1.109-113.1982	53	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16783	10.1371/journal.pone.0016783	http://dx.doi.org/10.1371/journal.pone.0016783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408144	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000010
J	Shoval, Y; Berissi, H; Kimchi, A; Pietrokovski, S				Shoval, Yishay; Berissi, Hanna; Kimchi, Adi; Pietrokovski, Shmuel			New Modularity of DAP-Kinases: Alternative Splicing of the DRP-1 Gene Produces a ZIPk-Like Isoform	PLOS ONE			English	Article							INTERACTING PROTEIN-KINASE; REGULATORY LIGHT-CHAIN; CELL-DEATH; SERINE/THREONINE KINASE; APOPTOTIC ACTIVITY; TUMOR-SUPPRESSOR; REORGANIZATION; PHOSPHORYLATES; SIGNALS; GENOME	DRP-1 and ZIPk are two members of the Death Associated Protein Ser/Thr Kinase (DAP-kinase) family, which function in different settings of cell death including autophagy. DAP kinases are very similar in their catalytic domains but differ substantially in their extra-catalytic domains. This difference is crucial for the significantly different modes of regulation and function among DAP kinases. Here we report the identification of a novel alternatively spliced kinase isoform of the DRP-1 gene, termed DRP-1 beta. The alternative splicing event replaces the whole extra catalytic domain of DRP-1 with a single coding exon that is closely related to the sequence of the extra catalytic domain of ZIPk. As a consequence, DRP-1 beta lacks the calmodulin regulatory domain of DRP-1, and instead contains a leucine zipper-like motif similar to the protein binding region of ZIPk. Several functional assays proved that this new isoform retained the biochemical and cellular properties that are common to DRP-1 and ZIPk, including myosin light chain phosphorylation, and activation of membrane blebbing and autophagy. In addition, DRP-1 beta also acquired binding to the ATF4 transcription factor, a feature characteristic of ZIPk but not DRP-1. Thus, a splicing event of the DRP-1 produces a ZIPk like isoform. DRP-1 beta is highly conserved in evolution, present in all known vertebrate DRP-1 loci. We detected the corresponding mRNA and protein in embryonic mouse brains and in human embryonic stem cells thus confirming the in vivo utilization of this isoform. The discovery of module conservation within the DAPk family members illustrates a parsimonious way to increase the functional complexity within protein families. It also provides crucial data for modeling the expansion and evolution of DAP kinase proteins within vertebrates, suggesting that DRP-1 and ZIPk most likely evolved from their ancient ancestor gene DAPk by two gene duplication events that occurred close to the emergence of vertebrates.	[Shoval, Yishay; Berissi, Hanna; Kimchi, Adi; Pietrokovski, Shmuel] Weizmann Inst Sci, Dept Mol Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shoval, Y (corresponding author), Weizmann Inst Sci, Dept Mol Biol, IL-76100 Rehovot, Israel.	Adi.Kimchi@weizmann.ac.il; Shmuel.Pietrokovski@weizmann.ac.il		Pietrokovski, Shmuel/0000-0001-8573-5863	Flight Attendant Medical Research Institute (FAMRI); European Union; Israel Science Foundation (ISF)	Flight Attendant Medical Research Institute (FAMRI); European Union(European Commission); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by the Center of Excellence grant from the Flight Attendant Medical Research Institute (FAMRI), by a grant from the European Union FP7 consortium (APO-SYS), and by a grant from the Israel Science Foundation (ISF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bialik S, 2004, SEMIN CANCER BIOL, V14, P283, DOI 10.1016/j.semcancer.2004.04.008; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chen RH, 2006, J BIOMED SCI, V13, P193, DOI 10.1007/s11373-005-9063-5; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Inbal B, 2000, MOL CELL BIOL, V20, P1044, DOI 10.1128/MCB.20.3.1044-1054.2000; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kawai T, 1999, ONCOGENE, V18, P3471, DOI 10.1038/sj.onc.1202701; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kogel D, 2001, BRIT J CANCER, V85, P1801, DOI 10.1054/bjoc.2001.2158; Kogel D, 1999, ONCOGENE, V18, P7212, DOI 10.1038/sj.onc.1203169; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Murata-Hori M, 1999, FEBS LETT, V451, P81, DOI 10.1016/S0014-5793(99)00550-5; Murata-Hori M, 2001, ONCOGENE, V20, P8175, DOI 10.1038/sj.onc.1205055; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P3836, DOI 10.1093/nar/24.19.3836; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Raveh T, 2001, EXP CELL RES, V264, P185, DOI 10.1006/excr.2000.5134; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Shani G, 2004, MOL CELL BIOL, V24, P8611, DOI 10.1128/MCB.24.19.8611-8626.2004; Shani G, 2001, EMBO J, V20, P1099, DOI 10.1093/emboj/20.5.1099; Shohat G, 2002, BBA-PROTEINS PROTEOM, V1600, P45, DOI 10.1016/S1570-9639(02)00443-0; Shoval Y, 2007, PLOS GENET, V3, P1884, DOI 10.1371/journal.pgen.0030180; TANG HW, EMBO J; Tong A, 2009, P NATL ACAD SCI USA, V106, P1457, DOI 10.1073/pnas.0809339106; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050	35	14	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17344	10.1371/journal.pone.0017344	http://dx.doi.org/10.1371/journal.pone.0017344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408167	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000023
J	Tong, JS; Zhang, QH; Huang, X; Fu, XQ; Qi, ST; Wang, YP; Hou, Y; Sheng, J; Sun, QY				Tong, Jing-Shan; Zhang, Qing-Hua; Huang, Xin; Fu, Xue-Qi; Qi, Shu-Tao; Wang, Ya-Peng; Hou, Yi; Sheng, Jun; Sun, Qing-Yuan			Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; EMBRYONIC STEM-CELLS; SIGNALING PATHWAYS; ESTROGEN-RECEPTOR; MAP KINASES; DEATH; INHIBITION; TRANSIENT; STRESS; PHOSPHORYLATION	Icaritin, a compound from Epimedium Genus, has selective estrogen receptor (ER) modulating activities, and posses antitumor activity. Here, we examined icaritin effect on cell growth of human endometrial cancer Hec1A cells and found that icaritin potently inhibited proliferation of Hec1A cells. Icaritin-inhibited cell growth was associated with increased levels of p21 and p27 expression and reduced cyclinD1 and cdk 4 expression. Icaritin also induced cell apoptosis accompanied by activation of caspases as evidenced by the cleavage of endogenous substrate Poly (ADP-ribose) polymerase (PARP) and cytochrome c release, which was abrogated by pretreatment with the pan-caspase inhibitor z-VAD-fmk. Icaritin treatment also induced expression of pro-apoptotic protein Bax with a concomitant decrease of Bcl-2 expression. Furthermore, icaritin induced sustained phosphorylation of extracellular signal-regulated kinase1/2 (the MAPK/ERK1/2) in Hec1A cells and U0126, a specific MAP kinase kinase (MEK1/2) inhibitor, blocked the ERK1/2 activation by icaritin and abolished the icaritin-induced growth inhibition and apoptosis. Our results demonstrated that icaritin induced sustained ERK 1/2 activation and inhibited growth of endometrial cancer Hec1A cells, and provided a rational for preclinical and clinical evaluation of icaritin for endometrial cancer therapy.	[Tong, Jing-Shan; Zhang, Qing-Hua; Huang, Xin; Qi, Shu-Tao; Wang, Ya-Peng; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Tong, Jing-Shan; Fu, Xue-Qi; Sheng, Jun] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Sheng, Jun] Yunnan Agr Univ, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Jilin University; Yunnan Agricultural University	Tong, JS (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	shengjunpuer@qq.com; sunqy@ioz.ac.cn		Qi, Shutao/0000-0002-4073-1161; Tong, Jingshan/0000-0003-1640-5769	Major State Basic Research Program of China [2011CB94451]; NIH [DK070016]; Nebraska Tobacco Settlement Biomedical Research Program [LB-595, LB692]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070016] Funding Source: NIH RePORTER	Major State Basic Research Program of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Major State Basic Research Program of China to Q.Y. Sun (2011CB94451). This work was also supported by the NIH grant DK070016 to Z.Y. Wang and the Nebraska Tobacco Settlement Biomedical Research Program Awards (LB-595 and LB692) to Z.Y. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Brown J, 2010, CANCER-AM CANCER SOC, V116, P4973, DOI 10.1002/cncr.25498; Chaudhry P, 2009, ENDOCR-RELAT CANCER, V16, P363, DOI 10.1677/ERC-08-0266; Chen JR, 2005, J BIOL CHEM, V280, P4632, DOI 10.1074/jbc.M411530200; Chen MF, 2010, AMINO ACIDS, V38, P1505, DOI 10.1007/s00726-009-0366-0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Fan YM, 2007, MOL CELLS, V23, P30; Gehrig PA, 2010, GYNECOL ONCOL, V116, P187, DOI 10.1016/j.ygyno.2009.10.041; He J, 2010, PLANTA MED, V76, P1834, DOI 10.1055/s-0030-1250042; Heinrich A, 2009, TOXICOL LETT, V191, P260, DOI 10.1016/j.toxlet.2009.09.008; Holdenrieder S, 2001, CLIN CHEM LAB MED, V39, P596, DOI 10.1515/CCLM.2001.095; Huang J, 2007, LIFE SCI, V81, P832, DOI 10.1016/j.lfs.2007.07.015; Huang X, 2007, EUR J PHARMACOL, V564, P26, DOI 10.1016/j.ejphar.2007.02.039; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeon ES, 2007, J CELL BIOCHEM, V100, P1536, DOI 10.1002/jcb.21141; Kim BW, 2008, CANCER BIOL THER, V7, P1080, DOI 10.4161/cbt.7.7.6164; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Plataniotis G, 2010, ANN ONCOL, V21, pv41, DOI 10.1093/annonc/mdq245; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shtil AA, 1999, ONCOGENE, V18, P377, DOI 10.1038/sj.onc.1202305; Sorosky JI, 2008, OBSTET GYNECOL, V111, P436, DOI 10.1097/AOG.0b013e318162f690; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Stone AA, 2000, EXP CELL RES, V254, P110, DOI 10.1006/excr.1999.4731; Susnow N, 2009, SEMIN CANCER BIOL, V19, P42, DOI 10.1016/j.semcancer.2008.12.002; Tada-Oikawa S, 2009, PHOTOCHEM PHOTOBIOL, V85, P1391, DOI 10.1111/j.1751-1097.2009.00600.x; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang XD, 2001, GENE DEV, V15, P2922; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wang ZQ, 2009, CHEM-BIOL INTERACT, V179, P375, DOI 10.1016/j.cbi.2008.12.007; Wang ZQ, 2004, EUR J PHARMACOL, V504, P147, DOI 10.1016/j.ejphar.2004.10.002; Wo YB, 2008, J CELL BIOCHEM, V103, P1536, DOI 10.1002/jcb.21541; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yu CR, 2004, ONCOGENE, V23, P1364, DOI 10.1038/sj.onc.1207248; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035	48	121	132	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16781	10.1371/journal.pone.0016781	http://dx.doi.org/10.1371/journal.pone.0016781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408143	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000009
J	Hamilton, CK; Revay, T; Domander, R; Favetta, LA; King, WA				Hamilton, Christine K.; Revay, Tamas; Domander, Robin; Favetta, Laura A.; King, W. Allan			A Large Expansion of the HSFY Gene Family in Cattle Shows Dispersion across Yq and Testis-Specific Expression	PLOS ONE			English	Article							COPY NUMBER VARIATION; HEAT-SHOCK RESPONSE; HUMAN GENOME; MALE-INFERTILITY; CHROMOSOME; SEQUENCE; PROTEIN; REGION; TSPY; QUANTIFICATION	Heat shock transcription factor, Y-linked (HSFY) is a member of the heat shock transcriptional factor (HSF) family that is found in multiple copies on the Y chromosome and conserved in a number of species. Its function still remains unknown but in humans it is thought to play a role in spermatogenesis. Through real time polymerase chain reaction (PCR) analyses we determined that the HSFY family is largely expanded in cattle (similar to 70 copies) compared with human (2 functional copies, 4 HSFY-similar copies). Unexpectedly, we found that it does not vary among individual bulls as a copy number variant (CNV). Using fluorescence in situ hybridization (FISH) we found that the copies are dispersed along the long arm of the Y chromosome (Yq). HSFY expression in cattle appears restricted to the testis and its mRNA correlates positively with mRNA markers of spermatogonial and spermatocyte cells (UCHL1 and TRPC2, respectively) which suggests that HSFY is expressed (at least in part) in early germ cells.	[Hamilton, Christine K.; Revay, Tamas; Domander, Robin; Favetta, Laura A.; King, W. Allan] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Hamilton, CK (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	waking@uoguelph.ca	Laura, Favetta/AAN-3927-2021; Revay, Tamas/AAU-7731-2020		National Sciences Engineering and Research Council; Canadian Research Chair program; L'Alliance Boviteq Incorporated; OECD	National Sciences Engineering and Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Research Chair program(Canada Research Chairs); L'Alliance Boviteq Incorporated; OECD	This work was funded by the National Sciences Engineering and Research Council, Canadian Research Chair program and L'Alliance Boviteq Incorporated. CKH was funded with a fellowship from the National Sciences Engineering and Research Council. TR was supported with a fellowship under the OECD Co-operative Research Programme: Biological Resource Management for Sustainable Agricultural Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUHLER EM, 1980, HUM GENET, V55, P145, DOI 10.1007/BF00291764; Curry E, 2008, BIOCHEM INSIGHTS, V1, P35; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ferlin A, 2003, J MED GENET, V40, P18, DOI 10.1136/jmg.40.1.18; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Hamilton CK, 2009, SEX DEV, V3, P205, DOI 10.1159/000228721; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JAKUBICZKA S, 1993, GENOMICS, V17, P732, DOI 10.1006/geno.1993.1394; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Kinoshita K, 2006, J MED INVESTIG, V53, P117, DOI 10.2152/jmi.53.117; KOOPS WJ, 1995, J DAIRY SCI, V78, P921, DOI 10.3168/jds.S0022-0302(95)76707-8; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Li Z, 2008, J GENET GENOMICS, V35, P193, DOI 10.1016/S1673-8527(08)60027-2; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu W, 2010, REPROD GENOMICS DOME, P129; Liu WS, 2004, ANIM BIOTECHNOL, V15, P103, DOI 10.1081/labt-200032337; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; Nickkholgh B, 2010, FERTIL STERIL, V94, P1744, DOI 10.1016/j.fertnstert.2009.09.051; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Oatley JM, 2004, BIOL REPROD, V70, P625, DOI 10.1095/biolreprod.103.022483; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Raudsepp T, 2004, P NATL ACAD SCI USA, V101, P2386, DOI 10.1073/pnas.0308513100; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Rozen S, 2000, Methods Mol Biol, V132, P365; Shinka T, 2004, BIOL REPROD, V71, P297, DOI 10.1095/biolreprod.103.023580; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tessari A, 2004, MOL HUM REPROD, V10, P253, DOI 10.1093/molehr/gah036; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinci G, 2005, MOL HUM REPROD, V11, P295, DOI 10.1093/molehr/gah153; Wilkerson AJP, 2008, GENOMICS, V92, P329, DOI 10.1016/j.ygeno.2008.06.012; Wissenbach U, 1998, FEBS LETT, V429, P61, DOI 10.1016/S0014-5793(98)00561-4	41	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17790	10.1371/journal.pone.0017790	http://dx.doi.org/10.1371/journal.pone.0017790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408193	gold, Green Published, Green Submitted			2022-12-27	WOS:000288099800039
J	Nagabhushana, A; Bansal, M; Swarup, G				Nagabhushana, Ananthamurthy; Bansal, Megha; Swarup, Ghanshyam			Optineurin Is Required for CYLD-Dependent Inhibition of TNF alpha-Induced NF-kappa B Activation	PLOS ONE			English	Article							DEUBIQUITINATING ENZYME; OPTIC NEUROPATHY; UBIQUITINATION; BINDING; NEMO; A20; IDENTIFICATION; NEUROBIOLOGY; MUTATIONS; APOPTOSIS	The nuclear factor kappa B (NF-kappa B) regulates genes that function in diverse cellular processes like inflammation, immunity and cell survival. The activation of NF-kappa B is tightly controlled and the deubiquitinase CYLD has emerged as a key negative regulator of NF-kappa B signalling. Optineurin, mutated in certain glaucomas and amyotrophic lateral sclerosis, is also a negative regulator of NF-kappa B activation. It competes with NEMO (NF-kappa B essential modulator) for binding to ubiquitinated RIP (receptor interacting protein) to prevent NF-kappa B activation. Recently we identified CYLD as optineurin-interacting protein. Here we have analysed the functional significance of interaction of optineurin with CYLD. Our results show that a glaucoma-associated mutant of optineurin, H486R, is altered in its interaction with CYLD. Unlike wild-type optineurin, the H486R mutant did not inhibit tumour necrosis factor alpha (TNF alpha)-induced NF-kappa B activation. CYLD mediated inhibition of TNF alpha-induced NF-kappa B activation was abrogated by expression of the H486R mutant. Upon knockdown of optineurin, CYLD was unable to inhibit TNF alpha-induced NF-kappa B activation and showed drastically reduced interaction with ubiquitinated RIP. The level of ubiquitinated RIP was increased in optineurin knockdown cells. Deubiquitination of RIP by over-expressed CYLD was abrogated in optineurin knockdown cells. These results suggest that optineurin regulates NF-kappa B activation by mediating interaction of CYLD with ubiquitinated RIP thus facilitating deubiquitination of RIP.	[Nagabhushana, Ananthamurthy; Bansal, Megha; Swarup, Ghanshyam] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nagabhushana, A (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	gshyam@ccmb.res.in		Swarup, Ghanshyam/0000-0002-8098-0509	Department of Biotechnology, Government of India [BT/PR10130/BRB/10/614/2008]; UGC, India; CSIR, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); UGC, India(University Grants Commission, India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grant BT/PR10130/BRB/10/614/2008 from the Department of Biotechnology, Government of India, to GS. AN is recipient of Senior Research Fellowship of UGC, India. MB is recipient of Research Fellowship of CSIR, India. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Grus FH, 2008, J GLAUCOMA, V17, P79, DOI 10.1097/IJG.0b013e318156a592; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jain N, 2007, FEBS J, V274, P4396, DOI 10.1111/j.1742-4658.2007.05969.x; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000521; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Leung YF, 2003, INVEST OPHTH VIS SCI, V44, P3880, DOI 10.1167/iovs.02-0693; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Takahashi Y, 2007, NEUROPATH APPL NEURO, V33, P692, DOI 10.1111/j.1365-2990.2007.00862.x; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vrabec JP, 2007, EYE, V21, pS11, DOI 10.1038/sj.eye.6702880; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wax MB, 2002, MOL NEUROBIOL, V26, P45, DOI 10.1385/MN:26:1:045; Weisschuh N, 2007, EXP EYE RES, V85, P450, DOI 10.1016/j.exer.2007.06.012; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Willoughby CE, 2004, INVEST OPHTH VIS SCI, V45, P3122, DOI 10.1167/iovs.04-0107; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	47	83	85	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17477	10.1371/journal.pone.0017477	http://dx.doi.org/10.1371/journal.pone.0017477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408173	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800017
J	Senghor, MW; Faye, MN; Faye, B; Diarra, K; Elguero, E; Gaye, O; Banuls, AL; Niang, AA				Senghor, Massila W.; Faye, Malick N.; Faye, Babacar; Diarra, Karamoko; Elguero, Eric; Gaye, Oumar; Banuls, Anne-Laure; Niang, Abdoul A.			Ecology of Phlebotomine Sand Flies in the Rural Community of Mont Rolland (Thies Region, Senegal): Area of Transmission of Canine Leishmaniasis	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; INFANTUM; SANDFLIES; DIPTERA; FOCUS; IDENTIFICATION; PERNICIOSUS; VECTORS; GAMBIA	Background: Different epidemiological studies previously indicated that canine leishmaniasis is present in the region of Thies (Senegal). However, the risks to human health, the transmission cycle and particularly the implicated vectors are unknown. Methodology/Principal Findings: To improve our knowledge on the population of phlebotomine sand flies and the potential vectors of canine leishmaniasis, sand flies were collected using sticky traps, light traps and indoor spraying method using pyrethroid insecticides in 16 villages of the rural community of Mont Rolland (Thies region) between March and July 2005. The 3788 phlebotomine sand flies we collected (2044 males, 1744 females) were distributed among 9 species of which 2 belonged to the genus Phlebotomus: P. duboscqi (vector of cutaneous leishmaniasis in Senegal) and P. rodhaini. The other species belonged to the genus Sergentomyia: S. adleri, S. clydei, S. antennata, S. buxtoni, S. dubia, S. schwetzi and S. magna. The number of individuals and the species composition differed according to the type of trap, suggesting variable, species-related degrees of endophily or exophily. The two species of the genus Phlebotomus were markedly under-represented in comparison to the species of the genus Sergentomyia. This study also shows a heterogeneous spatial distribution within the rural community that could be explained by the different ecosystems and particularly the soil characteristics of this community. Finally, the presence of the S. dubia species appeared to be significantly associated with canine leishmaniasis seroprevalence in dogs. Conclusions/Significance: Our data allow us to hypothesize that the species of the genus Sergentomyia and particularly the species S. dubia and S. schwetzi might be capable of transmitting canine leishmaniasis. These results challenge the dogma that leishmaniasis is exclusively transmitted by species of the genus Phlebotomus in the Old World. This hypothesis should be more thoroughly evaluated.	[Senghor, Massila W.; Faye, Malick N.; Niang, Abdoul A.] Univ Cheikh Anta Diop, Inst Fondamental Afr Noire Cheikh Anta Diop, Lab Zool Invertebres Terr, Dakar, Senegal; [Faye, Malick N.; Diarra, Karamoko] Univ Cheikh Anta Diop, Fac Sci, Dept Biol Anim, Dakar, Senegal; [Faye, Babacar; Gaye, Oumar] Univ Cheikh Anta Diop, Serv Parasitol Mycol Med, Dakar, Senegal; [Senghor, Massila W.; Elguero, Eric; Banuls, Anne-Laure] Univ Montpellier I, CNRS 5290, Lab MIVEGEC, UMR IRD 224, Montpellier, France	University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Senghor, MW (corresponding author), Univ Cheikh Anta Diop, Inst Fondamental Afr Noire Cheikh Anta Diop, Lab Zool Invertebres Terr, Dakar, Senegal.	mawasen@yahoo.fr	Elguero, Eric/J-3014-2012	Banuls, Anne-Laure/0000-0002-2106-8667	IFAN; Cheikh Anta Diop University of Dakar; AUF; French cooperation; ANR; SEST IAEL; IRD; CNRS	IFAN; Cheikh Anta Diop University of Dakar; AUF; French cooperation; ANR(French National Research Agency (ANR)); SEST IAEL; IRD; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by IFAN, Cheikh Anta Diop University of Dakar, AUF, French cooperation, ANR SEST IAEL, 2006-20 01, IRD and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABONNENC E., 1972, Mem. O. R. S. T. O. M.; [Anonymous], LEISHMANIASES BIOL M; Aransay AM, 2000, APPL ENVIRON MICROB, V66, P1933, DOI 10.1128/AEM.66.5.1933-1938.2000; Azizi K, 2006, ANN TROP MED PARASIT, V100, P63, DOI 10.1179/136485906X78454; Ba Y, 1999, B SOC PATHOL EXOT, V92, P131; Blanchot M., 1984, Medecine Tropicale, V44, P35; By Y, 1998, PARASITE, V5, P143, DOI 10.1051/parasite/1998052143; CONTEH S, 1983, T ROY SOC TROP MED H, V77, P298, DOI 10.1016/0035-9203(83)90147-5; DEDET JP, 1980, B SOC PATHOL EXOT, V73, P266; Desjeux P., 1981, Afrique Medicale, V20, P347; DESJEUX P, 1983, T ROY SOC TROP MED H, V77, P143, DOI 10.1016/0035-9203(83)90052-4; DESJEUX P., 1981, Afrique Medicale, V20, P427; DESJEUX P, 1982, B SOC PATHOL EXOT, V75, P620; Faye B, 2010, MICROBES INFECT, V12, P1219, DOI 10.1016/j.micinf.2010.09.003; Izri MA, 1996, T ROY SOC TROP MED H, V90, P114, DOI 10.1016/S0035-9203(96)90104-2; IZRI MA, 1992, B SOC PATHOL EXOT, V85, P385; IZRI MA, 1990, ANN PARASIT HUM COMP, V65, P151; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; MORRISON AC, 1993, AM J TROP MED HYG, V49, P68, DOI 10.4269/ajtmh.1993.49.68; Niang AA, 1998, PARASITE, V5, P51, DOI 10.1051/parasite/1998051051; *R DEV COR, 2009, R LANG ENV STAT COMP; Ranque P., 1978, Medecine Tropicale, V38, P413; Ranque P, 1970, Bull Acad Natl Med, V154, P510; RANQUE P, 1971, Medecine d'Afrique Noire, V18, P761; RIOUX JA, 1984, ANN PARASIT HUM COMP, V59, P331, DOI 10.1051/parasite/1984594331; Trouillet J., 1994, Bulletin de l'Institut Fondamental d'Afrique Noire. Serie A, Sciences Naturelles, V47, P73; TROUILLET J, 1993, ANN PARASIT HUM COMP, V68, P101; TROUILLET J, 1990, Journal of African Zoology, V104, P477; TROUILLET J, 1983, B ECOL, V14, P1; TROUILLET J, 1995, PARASITE, V2, P289, DOI 10.1051/parasite/1995023289; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Waroqw L, 1981, AFRIQUE MED, V19, P439	32	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e14773	10.1371/journal.pone.0014773	http://dx.doi.org/10.1371/journal.pone.0014773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445295	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300003
J	Brown, NF; Coombes, BK; Bishop, JL; Wickham, ME; Lowden, MJ; Gal-Mor, O; Goode, DL; Boyle, EC; Sanderson, KL; Finlay, BB				Brown, Nat F.; Coombes, Brian K.; Bishop, Jenna L.; Wickham, Mark E.; Lowden, Michael J.; Gal-Mor, Ohad; Goode, David L.; Boyle, Erin C.; Sanderson, Kristy L.; Finlay, B. Brett			Salmonella Phage ST64B Encodes a Member of the SseK/NleB Effector Family	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; ESCHERICHIA-COLI; HOST-CELLS; IN-VIVO; EPITHELIAL-CELLS; VIRULENCE GENES; PROTEINS; MACROPHAGES	Salmonella enterica is a species of bacteria that is a major cause of enteritis across the globe, while certain serovars cause typhoid, a more serious disease associated with a significant mortality rate. Type III secreted effectors are major contributors to the pathogenesis of Salmonella infections. Genes encoding effectors are acquired via horizontal gene transfer, and a subset are encoded within active phage lysogens. Because the acquisition of effectors is in flux, the complement of effectors possessed by various Salmonella strains frequently differs. By comparing the genome sequences of S. enterica serovar Typhimurium strain SL1344 with LT2, we identified a gene with significant similarity to SseK/NleB type III secreted effector proteins within a phage ST64B lysogen that is absent from LT2. We have named this gene sseK3. SseK3 was co-regulated with the SPI-2 type III secretion system in vitro and inside host cells, and was also injected into infected host cells. While no role for SseK3 in virulence could be identified, a role for the other family members in murine typhoid was found. SseK3 and other phage-encoded effectors were found to have a significant but sparse distribution in the available Salmonella genome sequences, indicating the potential for more uncharacterised effectors to be present in less studied serovars. These phage-encoded effectors may be principle subjects of contemporary selective processes shaping Salmonella-host interactions.	[Brown, Nat F.; Sanderson, Kristy L.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Brown, Nat F.; Coombes, Brian K.; Bishop, Jenna L.; Wickham, Mark E.; Lowden, Michael J.; Gal-Mor, Ohad; Goode, David L.; Boyle, Erin C.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	Griffith University; University of British Columbia	Brown, NF (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	nfbrown@unimelb.edu.au; bfinlay@interchange.ubc.ca	Wickham, Mark/A-1396-2009; Gal-Mor, Ohad/U-5025-2017; Brown, Nat/HHN-8551-2022; Wickham, Mark E/HCI-4959-2022; Coombes, Brian K/A-1727-2009	Wickham, Mark/0000-0002-3473-7196; Gal-Mor, Ohad/0000-0002-2540-6790; Wickham, Mark E/0000-0002-3473-7196; Boyle, Erin C./0000-0002-5963-3633; Coombes, Brian/0000-0001-9883-1010; Goode, David/0000-0002-3277-6562	Michael Smith Foundation for Health Research; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council (NHMRC); Howard Hughes Medical Institute	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	NFB, BKC, MEW and OG-M were supported by the Michael Smith Foundation for Health Research. BKC and MEW were also supported by Canadian Institutes of Health Research (CIHR) postdoctoral fellowships and NFB is supported by a National Health and Medical Research Council (NHMRC) Howard Florey Centenary fellowship. Research in NFB's laboratory is supported by a grant from NHMRC and research in BBF's laboratory is supported by grants from CIHR and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bishop JL, 2008, INFECT IMMUN, V76, P2913, DOI 10.1128/IAI.01596-07; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Brown NF, 2006, MICROBIOL-SGM, V152, P2323, DOI 10.1099/mic.0.28995-0; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2005, J MOL BIOL, V348, P817, DOI 10.1016/j.jmb.2005.03.024; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; Davis MA, 2002, J LAB CLIN MED, V140, P135, DOI 10.1067/mlc.2002.126411; Figueroa-Bossi N, 2004, J BACTERIOL, V186, P4038, DOI 10.1128/JB.186.12.4038-4041.2004; FRETER R, 1981, INFECT IMMUN, V34, P234, DOI 10.1128/IAI.34.1.234-240.1981; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gauthier A, 2000, INFECT IMMUN, V68, P4344, DOI 10.1128/IAI.68.7.4344-4348.2000; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Jiang XJ, 2004, MOL MICROBIOL, V54, P1186, DOI 10.1111/j.1365-2958.2004.04344.x; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Mmolawa PT, 2003, J BACTERIOL, V185, P6481, DOI 10.1128/JB.185.21.6481-6485.2003; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Pelludat C, 2003, J BACTERIOL, V185, P5182, DOI 10.1128/JB.185.17.5182-5191.2003; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; YU XJ, 2010, SCIENCE; Zhang SP, 2002, FEMS MICROBIOL LETT, V217, P243, DOI 10.1111/j.1574-6968.2002.tb11482.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	53	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17824	10.1371/journal.pone.0017824	http://dx.doi.org/10.1371/journal.pone.0017824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445262	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100034
J	Lacruz, RS; Lakshminarayanan, R; Bromley, KM; Hacia, JG; Bromage, TG; Snead, ML; Moradian-Oldak, J; Paine, ML				Lacruz, Rodrigo S.; Lakshminarayanan, Rajamani; Bromley, Keith M.; Hacia, Joseph G.; Bromage, Timothy G.; Snead, Malcolm L.; Moradian-Oldak, Janet; Paine, Michael L.			Structural Analysis of a Repetitive Protein Sequence Motif in Strepsirrhine Primate Amelogenin	PLOS ONE			English	Article							MALAGASY LEMURS; GENETIC-BASIS; EVOLUTION; BIOMINERALIZATION; MICROSTRUCTURE; CHROMOSOMES; PEPTIDE; REGIONS; TEETH; LOCI	Strepsirrhines are members of a primate suborder that has a distinctive set of features associated with the development of the dentition. Amelogenin (AMEL), the better known of the enamel matrix proteins, forms 90% of the secreted organic matrix during amelogenesis. Although AMEL has been sequenced in numerous mammalian lineages, the only reported strepsirrhine AMEL sequences are those of the ring-tailed lemur and galago, which contain a set of additional proline-rich tandem repeats absent in all other primates species analyzed to date, but present in some non-primate mammals. Here, we first determined that these repeats are present in AMEL from three additional lemur species and thus are likely to be widespread throughout this group. To evaluate the functional relevance of these repeats in strepsirrhines, we engineered a mutated murine amelogenin sequence containing a similar proline-rich sequence to that of Lemur catta. In the monomeric form, the MQP insertions had no influence on the secondary structure or refolding properties, whereas in the assembled form, the insertions increased the hydrodynamic radii. We speculate that increased AMEL nanosphere size may influence enamel formation in strepsirrhine primates.	[Lacruz, Rodrigo S.; Bromley, Keith M.; Snead, Malcolm L.; Moradian-Oldak, Janet; Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Lakshminarayanan, Rajamani] Singapore Eye Res Inst, Singapore, Singapore; [Hacia, Joseph G.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA	University of Southern California; National University of Singapore; Singapore National Eye Center; University of Southern California; New York University; New York University	Lacruz, RS (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	rodrigo@usc.edu; paine@usc.edu	Lacruz, Rodrigo/AGY-8090-2022; Rajamani, Lakshminarayanan/AAG-5541-2019; bromage, timothy/H-8621-2015	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Bromley, Keith/0000-0002-8001-3818; LACRUZ, RODRIGO/0000-0002-0776-6143; bromage, timothy/0000-0002-9843-7993	NIH-NIDCR [DE013404, DE019629, DE20099, DE13414]; NIH-NIGMS [GM072447]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414, R01DE019629, R01DE020099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072447, R01GM072477] Funding Source: NIH RePORTER	NIH-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH-NIDCR grants to: M.L.P. (DE013404; DE019629); J.M.O. (DE20099; DE13414) and NIH-NIGMS grant to J.G.H (GM072447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Delgado S, 2005, J MOL EVOL, V60, P12, DOI 10.1007/s00239-003-0070-8; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fleagle J.G., 1998, PRIMATE ADAPTATION E; Godfrey LR, 2005, FOLIA PRIMATOL, V76, P77, DOI 10.1159/000083615; Jin TQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000262; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Kawasaki K, 2005, P NATL ACAD SCI USA, V102, P18063, DOI 10.1073/pnas.0509263102; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Lacruz RS, 2007, AM J PHYS ANTHROPOL, V132, P175, DOI 10.1002/ajpa.20506; Lakshminarayanan R, 2010, J BIOL CHEM, V285, P40593, DOI 10.1074/jbc.M110.131136; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 1998, BIOPOLYMERS, V46, P225, DOI 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Moradian-Oldak J., 2010, AMELOGENINS MULTIFAC; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Paine ML, 1998, J DENT RES, V77, P496, DOI 10.1177/00220345980770030901; Papagerakis P, 2005, J DENT RES, V84, P613, DOI 10.1177/154405910508400706; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Schwartz GT, 2002, P NATL ACAD SCI USA, V99, P6124, DOI 10.1073/pnas.092685099; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Sire JY, 2005, ARCH ORAL BIOL, V50, P205, DOI 10.1016/j.archoralbio.2004.09.004; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Warotayanont R, 2009, BIOCHEM BIOPH RES CO, V387, P558, DOI 10.1016/j.bbrc.2009.07.058; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Zhang B, 2000, BIOPOLYMERS, V54, P464, DOI 10.1002/1097-0282(200011)54:6<464::AID-BIP90>3.0.CO;2-N; Zhu DH, 2006, J BIOL CHEM, V281, P21173, DOI 10.1074/jbc.M510757200; Zou Y, 2007, BIOCHEM J, V408, P347, DOI 10.1042/BJ20070881	38	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18028	10.1371/journal.pone.0018028	http://dx.doi.org/10.1371/journal.pone.0018028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437261	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100064
J	Keaton, MA; Taylor, CM; Layer, RM; Dutta, A				Keaton, Mignon A.; Taylor, Christopher M.; Layer, Ryan M.; Dutta, Anindya			Nuclear Scaffold Attachment Sites within ENCODE Regions Associate with Actively Transcribed Genes	PLOS ONE			English	Article							GENOME-TILING ARRAYS; DNA-REPLICATION; HISTONE MODIFICATIONS; MAMMALIAN-CELLS; PROTEIN MATRIX; CHROMATIN LOOP; HELA-CELLS; IDENTIFICATION; ORGANIZATION; CHROMOSOME	The human genome must be packaged and organized in a functional manner for the regulation of DNA replication and transcription. The nuclear scaffold/matrix, consisting of structural and functional nuclear proteins, remains after extraction of nuclei and anchors loops of DNA. In the search for cis-elements functioning as chromatin domain boundaries, we identified 453 nuclear scaffold attachment sites purified by lithium-3,5-iodosalicylate extraction of HeLa nuclei across 30 Mb of the human genome studied by the ENCODE pilot project. The scaffold attachment sites mapped predominately near expressed genes and localized near transcription start sites and the ends of genes but not to boundary elements. In addition, these regions were enriched for RNA polymerase II and transcription factor binding sites and were located in early replicating regions of the genome. We believe these sites correspond to genome-interactions mediated by transcription factors and transcriptional machinery immobilized on a nuclear substructure.	[Keaton, Mignon A.; Dutta, Anindya] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Taylor, Christopher M.] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA; [Layer, Ryan M.] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA	University of Virginia; University of Louisiana System; University of New Orleans; University of Virginia	Keaton, MA (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	ad8q@virginia.edu	Taylor, Christopher M./AAF-5480-2020; Dutta, Anindya/P-3203-2016	Taylor, Christopher M./0000-0002-7983-5275; Dutta, Anindya/0000-0002-4319-0073	National Research Service Awards [F32GM087843]; National Institutes of Health [R01 GM084465]; NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084465, F32GM087843] Funding Source: NIH RePORTER	National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by a National Research Service Awards fellowship F32GM087843 to MA Keaton and National Institutes of Health R01 GM084465 to A Dutta. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; BEREZNEY R, 1975, SCIENCE, V189, P291, DOI 10.1126/science.1145202; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bode J, 2003, CHROMOSOME RES, V11, P435, DOI 10.1023/A:1024918525818; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dijkwel PA, 1999, METHODS, V18, P418, DOI 10.1006/meth.1999.0800; Djeliova V, 2001, NUCLEIC ACIDS RES, V29, P3181, DOI 10.1093/nar/29.15.3181; Donev RM, 2000, MOL CELL BIOCHEM, V214, P103; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; GAVRILOV AA, 2010, NUCL ACIDS RES; GERDES MG, 1994, J CELL BIOL, V126, P289, DOI 10.1083/jcb.126.2.289; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gluch A., 2008, V186, P67, DOI 10.1007/978-3-540-72843-6_4; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hancock R, 2000, CHROMOSOMA, V109, P219, DOI 10.1007/s004120000077; Iarovaia OV, 2005, NUCLEIC ACIDS RES, V33, P4157, DOI 10.1093/nar/gki733; Iarovaia OV, 2004, NUCLEIC ACIDS RES, V32, P2079, DOI 10.1093/nar/gkh532; Jackson DA, 1996, NUCLEIC ACIDS RES, V24, P1212, DOI 10.1093/nar/24.7.1212; JACKSON DA, 1988, EMBO J, V7, P3667, DOI 10.1002/j.1460-2075.1988.tb03248.x; JACKSON DA, 1981, NATURE, V292, P552, DOI 10.1038/292552a0; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; JACKSON DA, 1990, NUCLEIC ACIDS RES, V18, P4385, DOI 10.1093/nar/18.15.4385; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVYWILSON B, 1989, J BIOL CHEM, V264, P21196; Linnemann AK, 2009, HUM MOL GENET, V18, P645, DOI 10.1093/hmg/ddn394; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MESNER LD, 2011, GENOME RES; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Purbowasito N, 2004, DNA RES, V11, P391, DOI 10.1093/dnares/11.6.391; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Shaposhnikov SA, 2007, GENOMICS, V89, P354, DOI 10.1016/j.ygeno.2006.11.003; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; VAUGHN JP, 1990, NUCLEIC ACIDS RES, V18, P1965, DOI 10.1093/nar/18.8.1965; VERHEIJEN R, 1988, J CELL SCI, V90, P11; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhang SB, 2002, CELL RES, V12, P411, DOI 10.1038/sj.cr.7290144; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z	62	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17912	10.1371/journal.pone.0017912	http://dx.doi.org/10.1371/journal.pone.0017912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423757	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400038
J	Panova, M; Blakeslee, AMH; Miller, AW; Makinen, T; Ruiz, GM; Johannesson, K; Andre, C				Panova, Marina; Blakeslee, April M. H.; Miller, A. Whitman; Maekinen, Tuuli; Ruiz, Gregory M.; Johannesson, Kerstin; Andre, Carl			Glacial History of the North Atlantic Marine Snail, Littorina saxatilis, Inferred from Distribution of Mitochondrial DNA Lineages	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION; POPULATION-STRUCTURE; INTERGLACIAL CYCLE; GENETIC DIVERSITY; LARVAL DISPERSAL; ENGLISH-CHANNEL; PHYLOGEOGRAPHY; REFUGIA; MIGRATION; GROWTH	The North Atlantic intertidal gastropod, Littorina saxatilis (Olivi, 1792), exhibits extreme morphological variation between and within geographic regions and has become a model for studies of local adaptation; yet a comprehensive analysis of the species' phylogeography is lacking. Here, we examine phylogeographic patterns of the species' populations in the North Atlantic and one remote Mediterranean population using sequence variation in a fragment of the mitochondrial cytochrome b gene (607 bp). We found that, as opposed to many other rocky intertidal species, L. saxatilis has likely had a long and continuous history in the Northwest Atlantic, including survival during the last glacial maximum (LGM), possibly in two refugia. In the Northeast Atlantic, several areas likely harboured refugial populations that recolonized different parts of this region after glacial retreat, resulting in strong population structure. However, the outlying monomorphic Venetian population is likely a recent anthropogenic introduction from northern Europe and not a remnant of an earlier wider distribution in the Mediterranean Sea. Overall, our detailed phylogeography of L. saxatilis adds an important piece to the understanding of Pleistocene history in North Atlantic marine biota as well as being the first study to describe the species' evolutionary history in its natural range. The latter contribution is noteworthy because the snail has recently become an important model species for understanding evolutionary processes of speciation; thus our work provides integral information for such endeavours.	[Panova, Marina; Johannesson, Kerstin; Andre, Carl] Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden; [Blakeslee, April M. H.; Miller, A. Whitman; Ruiz, Gregory M.] Smithsonian Environm Res Ctr, Marine Invas Lab, Edgewater, MD 21037 USA; [Maekinen, Tuuli] S African Inst Aquat Biodivers, Grahamstown, South Africa	University of Gothenburg; Smithsonian Institution; Smithsonian Environmental Research Center; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Panova, M (corresponding author), Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden.	marina.panova@marecol.gu.se	Johannesson, Kerstin/B-5528-2013; Johannesson, Kerstin/X-7994-2019; Panova, Marina/D-2633-2015; Panova, Marina/V-3533-2019; Andre, Carl/B-4237-2010; Miller, Whitman/C-7811-2017	Johannesson, Kerstin/0000-0003-0176-7986; Johannesson, Kerstin/0000-0003-0176-7986; Panova, Marina/0000-0002-4147-6473; Panova, Marina/0000-0002-4147-6473; Andre, Carl/0000-0003-4404-7292; Ruiz, Gregory/0000-0003-2499-441X; Blakeslee, April/0000-0001-9667-2175; Miller, Whitman/0000-0003-0484-182X; Makinen, Tuuli Elina/0000-0001-5163-8459	Centre for Theoretical Biology at Gothenburg University; Swedish Royal Academy of Science; Swedish Research Council; Smithsonian Institution postdoctoral fellowship program; Helge Ax:son Johnson Foundation; Swedish Research Council VR; Swedish Research Council Formas	Centre for Theoretical Biology at Gothenburg University; Swedish Royal Academy of Science; Swedish Research Council(Swedish Research CouncilEuropean Commission); Smithsonian Institution postdoctoral fellowship program(Smithsonian Institution); Helge Ax:son Johnson Foundation; Swedish Research Council VR(Swedish Research Council); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Financial support was provided by the Centre for Theoretical Biology at Gothenburg University (MP, CA, KJ), the Swedish Royal Academy of Science (MP), the Swedish Research Council (KJ, CA), the Smithsonian Institution postdoctoral fellowship program (AMHB) and a grant from the Helge Ax:son Johnson Foundation (TM). This work was partly performed within the Linnaeus Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se/) supported by a Linnaeus-grant from the Swedish Research Councils VR and Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1973, VENICE MARITIME REPU, P241; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Blakeslee AMH, 2008, MOL ECOL, V17, P3684, DOI 10.1111/j.1365-294X.2008.03865.x; Blakeslee AMH, 2008, ECOLOGY, V89, P1068, DOI 10.1890/07-0832.1; Bowen DQ, 2002, QUATERNARY SCI REV, V21, P89, DOI 10.1016/S0277-3791(01)00102-0; Brawley SH, 2009, P NATL ACAD SCI USA, V106, P8239, DOI 10.1073/pnas.0812300106; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; Carlton James T., 1992, Journal of Shellfish Research, V11, P489; Carlton JT, 1998, VELIGER, V41, P333; Charbit S, 2007, CLIM PAST, V3, P15, DOI 10.5194/cp-3-15-2007; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Dahlgren TG, 2000, MAR BIOL, V137, P487, DOI 10.1007/s002270000342; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hoarau G, 2007, MOL ECOL, V16, P3606, DOI 10.1111/j.1365-294X.2007.03408.x; INGOLFSSON A, 1992, J BIOGEOGR, V19, P705, DOI 10.2307/2845711; Ingolfsson A, 2009, ZOOL SCR, V38, P663, DOI 10.1111/j.1463-6409.2009.00405.x; JANSON K, 1983, OECOLOGIA, V59, P58, DOI 10.1007/BF00388072; JANSON K, 1985, BIOL J LINN SOC, V24, P51, DOI 10.1111/j.1095-8312.1985.tb00159.x; JANSON K, 1982, MAR BIOL, V69, P73, DOI 10.1007/BF00396963; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jesus FF, 2006, GENET MOL RES, V5, P466; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; KNIGHT AJ, 1987, BIOL J LINN SOC, V32, P417, DOI 10.1111/j.1095-8312.1987.tb00441.x; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Olsen JL, 2010, J BIOGEOGR, V37, P842, DOI 10.1111/j.1365-2699.2009.02262.x; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Provan J, 2005, MOL ECOL, V14, P793, DOI 10.1111/j.1365-294X.2005.02447.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Reid DG, 1996, PHILOS T R SOC B, V351, P877, DOI 10.1098/rstb.1996.0082; Reid DG, 1996, SYSTEMATIC EVOLUTION; Remerie T, 2009, J BIOGEOGR, V36, P39, DOI 10.1111/j.1365-2699.2008.01970.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Sejrup HP, 2005, MAR PETROL GEOL, V22, P1111, DOI 10.1016/j.marpetgeo.2004.09.007; Small MP, 2000, MOL ECOL, V9, P39, DOI 10.1046/j.1365-294x.2000.00824.x; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsai YHE, 2010, P NATL ACAD SCI USA, V107, P17035, DOI 10.1073/pnas.1006225107; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Wares JP, 2001, EVOLUTION, V55, P2455; Wilding CS, 1999, J MOL EVOL, V48, P348, DOI 10.1007/PL00006479	60	70	72	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17511	10.1371/journal.pone.0017511	http://dx.doi.org/10.1371/journal.pone.0017511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412417	Green Published, gold			2022-12-27	WOS:000288247800009
J	Han, HJ; Kuwae, A; Abe, A; Arakawa, Y; Kamachi, K				Han, Hyun-Ja; Kuwae, Asaomi; Abe, Akio; Arakawa, Yoshichika; Kamachi, Kazunari			Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; VIRULENCE FACTORS; SECRETION SYSTEM; ANTIGENIC DIVERGENCE; UNITED-STATES; IN-VITRO; TOXIN; PERTACTIN; VACCINE; BRONCHISEPTICA	Background: Bordetella pertussis is the primary etiologic agent of the disease pertussis. Universal immunization programs have contributed to a significant reduction in morbidity and mortality of pertussis; however, incidence of the disease, especially in adolescents and adults, has increased in several countries despite high vaccination coverage. During the last three decades, strains of Bordetella pertussis in circulation have shifted from the vaccine-type to the nonvaccine-type in many countries. A comparative proteomic analysis of the strains was performed to identify protein(s) involved in the type shift. Methodology/Principal Finding: Proteomic analysis identified one differentially expressed protein in the B. pertussis strains: the type III cytotoxic effector protein BteA, which is responsible for host cell death in Bordetella bronchiseptica infections. Immunoblot analysis confirmed the prominent expression of BteA protein in the nonvaccine-type strains but not in the vaccine-type strains. Sequence analysis of the vaccine-type strains revealed an IS481 insertion in the 5' untranslated region of bteA, -136 bp upstream of the bteA start codon. A high level of bteA transcripts from the IS481 promoter was detected in the vaccine-type strains, indicating that the transcript might be an untranslatable form. Furthermore, BteA mutant studies demonstrated that BteA expression in the vaccine-type strains is down-regulated by the IS481 insertion. Conclusion/Significance: The cytotoxic effector BteA protein is expressed at higher levels in B. pertussis nonvaccine-type strains than in vaccine-type strains. This type-dependent expression is due to an insertion of IS481 in B. pertussis clinical strains, suggesting that augmented expression of BteA protein might play a key role in the type shift of B. pertussis.	[Han, Hyun-Ja; Arakawa, Yoshichika; Kamachi, Kazunari] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Kuwae, Asaomi; Abe, Akio] Kitasato Univ, Lab Bacterial Infect, Kitasato Inst Life Sci, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Kitasato University	Han, HJ (corresponding author), Natl Fisheries Res & Dev Inst, Pusan, South Korea.	kamachi@nih.go.jp	Arakawa, Yoshichika/P-5997-2015; Abe, Akio/AAQ-2464-2020	Kamachi, Kazunari/0000-0001-5259-1744	Ministry of Health, Labor and Welfare of Japan [09158691, 09158699]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by grants for Research on Emerging and Re-emerging Infectious Diseases (09158691 and 09158699) from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 1997, Commun Dis Intell, V21, P145; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Caro V, 2008, J CLIN MICROBIOL, V46, P2125, DOI 10.1128/JCM.02484-07; Caro V, 2006, MICROBES INFECT, V8, P2228, DOI 10.1016/j.micinf.2006.04.014; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; Craig NL, 2002, MOBILE DNA 2; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; DESHAZER D, 1994, MOL MICROBIOL, V14, P123, DOI 10.1111/j.1365-2958.1994.tb01272.x; Fennelly NK, 2008, INFECT IMMUN, V76, P1257, DOI 10.1128/IAI.00836-07; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Han HJ, 2008, VACCINE, V26, P1530, DOI 10.1016/j.vaccine.2008.01.020; He QS, 2003, J INFECT DIS, V187, P1200, DOI 10.1086/368412; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Hellenbrand W, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-22; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; KOZAK NA, 2007, BORDETELLA MOL MICRO, P119; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mattoo S, 2004, MOL MICROBIOL, V52, P1201, DOI 10.1111/j.1365-2958.2004.04053.x; Medhekar B, 2009, MOL MICROBIOL, V71, P492, DOI 10.1111/j.1365-2958.2008.06543.x; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nogawa H, 2004, J BACTERIOL, V186, P3806, DOI 10.1128/JB.186.12.3806-3813.2004; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Vidakovics ML, 2007, J PROTEOME RES, V6, P2518, DOI 10.1021/pr060681i; Pradel E, 2000, INFECT IMMUN, V68, P1919, DOI 10.1128/IAI.68.4.1919-1927.2000; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shrivastava R, 2009, CURR OPIN MICROBIOL, V12, P88, DOI 10.1016/j.mib.2009.01.001; Stefanelli P, 2006, J CLIN MICROBIOL, V44, P3397, DOI 10.1128/JCM.00247-06; Stibitz S, 1998, J BACTERIOL, V180, P4963, DOI 10.1128/JB.180.18.4963-4966.1998; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Tsang RSW, 2004, J CLIN MICROBIOL, V42, P5364, DOI 10.1128/JCM.42.11.5364-5367.2004; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x	44	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17797	10.1371/journal.pone.0017797	http://dx.doi.org/10.1371/journal.pone.0017797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423776	Green Submitted, gold, Green Published			2022-12-27	WOS:000288219100034
J	Hocher, B; Heiden, S; von Websky, K; Arafat, AM; Rahnenfuhrer, J; Alter, M; Kalk, P; Ziegler, D; Fischer, Y; Pfab, T				Hocher, Berthold; Heiden, Susi; von Websky, Karoline; Arafat, Ayman M.; Rahnenfuehrer, Jan; Alter, Markus; Kalk, Philipp; Ziegler, Dieter; Fischer, Yvan; Pfab, Thiemo			Renal Effects of the Novel Selective Adenosine A(1) Receptor Blocker SLV329 in Experimental Liver Cirrhosis in Rats	PLOS ONE			English	Article							HEPATORENAL REFLEX; ANTAGONIST; HYPERTENSION; EXCRETION; FAILURE; KIDNEY	Liver cirrhosis is often complicated by an impaired renal excretion of water and sodium. Diuretics tend to further deteriorate renal function. It is unknown whether chronic selective adenosine A(1) receptor blockade, via inhibition of the hepatorenal reflex and the tubuloglomerular feedback, might exert diuretic and natriuretic effects without a reduction of the glomerular filtration rate. In healthy animals intravenous treatment with the novel A(1) receptor antagonist SLV329 resulted in a strong dose-dependent diuretic (up to 3.4-fold) and natriuretic (up to 13.5-fold) effect without affecting creatinine clearance. Male Wistar rats with thioacetamide-induced liver cirrhosis received SLV329, vehicle or furosemide for 12 weeks. The creatinine clearance of cirrhotic animals decreased significantly (-36.5%, p < 0.05), especially in those receiving furosemide (-41.9%, p < 0.01). SLV329 was able to prevent this decline of creatinine clearance. Mortality was significantly lower in cirrhotic animals treated with SLV329 in comparison to animals treated with furosemide (17% vs. 54%, p < 0.05). SLV329 did not relevantly influence the degree of liver fibrosis, kidney histology or expression of hepatic or renal adenosine receptors. In conclusion, chronic treatment with SLV329 prevented the decrease of creatinine clearance in a rat model of liver cirrhosis. Further studies will have to establish whether adenosine A(1) receptor antagonists are clinically beneficial at different stages of liver cirrhosis.	[Hocher, Berthold; von Websky, Karoline; Rahnenfuehrer, Jan] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Hocher, Berthold; Heiden, Susi; von Websky, Karoline; Rahnenfuehrer, Jan; Alter, Markus; Kalk, Philipp; Pfab, Thiemo] Charite, Cardiovasc Res Ctr, Inst Pharmacol, Berlin, Germany; [Arafat, Ayman M.] Charite Campus Benjamin Franklin, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Arafat, Ayman M.] German Inst Human Nutr, Dept Clin Nutr, Potsdam, Nuthetal, Germany; [Alter, Markus; Kalk, Philipp; Pfab, Thiemo] Charite Campus Benjamin Franklin, Dept Nephrol, Berlin, Germany; [Ziegler, Dieter; Fischer, Yvan] Abbott Prod GmbH, Hannover, Germany	University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.	berthold.hocher@charite.de	Hocher, Berthold/AAC-3510-2020	Heiden, Susi/0000-0001-8993-7120; Arafat, Ayman/0000-0003-3069-8385; Hocher, Berthold/0000-0001-8143-0579	Solvay Pharmaceuticals (now Abbott Products GmbH)	Solvay Pharmaceuticals (now Abbott Products GmbH)	This study was partially supported by a grant of the Dr. Werner Jackstadt-Stiftung to Markus Alter. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by Solvay Pharmaceuticals (now Abbott Products GmbH). Dieter Ziegler and Yvan Fischer are employees of Abbott Products GmbH and played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. The study design was set up together with Solvay Pharmaceuticals. Solvay Pharmaceuticals agreed to publish the manuscript.	Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gottlieb SS, 2002, CIRCULATION, V105, P1348, DOI 10.1161/hc1102.105264; Hocher B, 2010, KIDNEY INT, V78, P438, DOI 10.1038/ki.2010.204; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Jackson EK, 2007, J PHARMACOL EXP THER, V320, P117, DOI 10.1124/jpet.106.112748; Jackson EK, 2002, AM J PHYSIOL-RENAL, V283, pF41, DOI 10.1152/ajprenal.00232.2001; Kalk P, 2007, BRIT J PHARMACOL, V151, P1025, DOI 10.1038/sj.bjp.0707319; KNIGHT RJ, 1993, BRIT J PHARMACOL, V109, P271, DOI 10.1111/j.1476-5381.1993.tb13564.x; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Ming Z, 2005, J HEPATOL, V42, P680, DOI 10.1016/j.jhep.2004.12.023; Ming Z, 2002, HEPATOLOGY, V35, P167, DOI 10.1053/jhep.2002.30425; Ming Z, 2006, CAN J PHYSIOL PHARM, V84, P1177, DOI 10.1139/Y06-063; Miracle CM, 2007, KIDNEY BLOOD PRESS R, V30, P388, DOI 10.1159/000108625; Pfab T, 2006, J AM SOC NEPHROL, V17, P1082, DOI 10.1681/ASN.2005080833; Quaschning T, 2007, J AM SOC NEPHROL, V18, P730, DOI 10.1681/ASN.2006050541; REYES AJ, 1993, J CARDIOVASC PHARM, V22, pS11, DOI 10.1097/00005344-199322003-00003; Sansoe G, 2005, DIGEST DIS SCI, V50, P955, DOI 10.1007/s10620-005-2671-0; Stanley AJ, 1998, GASTROENTEROLOGY, V115, P406, DOI 10.1016/S0016-5085(98)70207-0; TOYA Y, 1993, KIDNEY INT, V43, P928, DOI 10.1038/ki.1993.130; Vallon V, 2006, PHYSIOL REV, V86, P901, DOI 10.1152/physrev.00031.2005; Wilcox CS, 1999, J AM SOC NEPHROL, V10, P714	22	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17891	10.1371/journal.pone.0017891	http://dx.doi.org/10.1371/journal.pone.0017891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423778	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100044
J	Lammers, AJJ; Hoekstra, JBL; Speelman, P; Lombarts, KMJMH				Lammers, A. J. Jolanda; Hoekstra, Joost B. L.; Speelman, Peter; Lombarts, Kiki M. J. M. H.			Physicians Report Barriers to Deliver Best Practice Care for Asplenic Patients: A Cross-Sectional Survey	PLOS ONE			English	Article							VACCINATION COVERAGE; RESPONSE RATES; PROPHYLAXIS; INFECTION; SPLENECTOMY; GUIDELINES; KNOWLEDGE; PATTERNS; ABSENT; RISKS	Background: Current management of asplenic patients is not in compliance with best practice standards, such as defined by the British Committee for Standards in Haematology. To improve quality of care, factors inhibiting best practice care delivery need to be identified first. With this study, we aimed to identify and quantify physicians' barriers to adhere to best practice management of asplenic patients in the Netherlands. Methods and Principal Findings: A cross-sectional survey, preceded by multiple focus group discussions, was performed among Dutch physicians responsible for prevention of infections in asplenic patients, including specialists ( of Internal medicine and Surgery) and general practitioners (GPs). Forty seven GPs and seventy three hospital specialists returned the questionnaire, yielding response rates of 47% and 36,5% respectively. Physicians reported several barriers to deliver best practice. For both GPs and specialists, the most frequently listed barriers were: poor patient knowledge (> 80% of hospital specialists and GPs) and lack of clarity about which physician is responsible for the management of asplenic patients (50% of Internists, 46% of Surgeons, 55% of GPs). Both GPs and hospital specialists expressed to experience a lack of mutual trust: specialists were uncertain whether the GP would follow their advice given on patient discharge (33-59%), whereas half of GPs was not convinced that specialists' discharge letters contained the correct recommendations. Almost all physicians (> 90%) indicated that availability of a national guideline would improve adherence to best practice, especially if accessible online. Conclusion: This study showed that, in accordance with reports on international performance, care delivery for asplenic patients in the Netherlands is suboptimal. We identified and quantified perceived barriers by physicians that prevent adherence to post-splenectomy guidelines for the first time. Better transmural collaboration and better informed patients are likely to improve the quality of care of the asplenic patient population. A national, online-available guideline is urgently required.	[Lammers, A. J. Jolanda; Hoekstra, Joost B. L.; Speelman, Peter] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Lombarts, Kiki M. J. M. H.] Univ Amsterdam, Dept Qual & Proc Innovat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Lammers, AJJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.	a.j.lammers@amc.uva.nl		Lombarts, Kiki/0000-0001-6167-0620	Netherlands Organisation of Scientific Research (NWO) [945-17-001]	Netherlands Organisation of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This project was supported by a ZonMw Grant form the Netherlands Organisation of Scientific Research (NWO, grant number 945-17-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour RS, 2005, MED EDUC, V39, P742, DOI 10.1111/j.1365-2929.2005.02200.x; Brigden ML, 2001, CAN J SURG, V44, P210; Bruni L, 2006, EPIDEMIOL INFECT, V134, P837, DOI 10.1017/S0950268805005704; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cavill I, 1996, BRIT MED J, V312, P430; Davies JM, 2002, CLIN MED, V2, P440, DOI 10.7861/clinmedicine.2-5-440; Deodhar M, 2004, J CLIN PATHOL, V57, P407, DOI 10.1136/jcp.2003.013896; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Ejstrud P, 2000, SCAND J INFECT DIS, V32, P521, DOI 10.1080/003655400458811; El-Alfy MS, 2004, HEMATOL J, V5, P77, DOI 10.1038/sj.thj.6200328; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Halasa NB, 2007, CLIN INFECT DIS, V44, P1428, DOI 10.1086/516781; Hasse B, 2005, SWISS MED WKLY, V135, P291; HOLDSWORTH RJ, 1991, BRIT J SURG, V78, P1031, DOI 10.1002/bjs.1800780904; Kyaw MH, 2002, J CLIN PATHOL, V55, P472, DOI 10.1136/jcp.55.6.472; Lammers AJJ, 2010, EUR J CLIN MICROBIOL, V29, P399, DOI 10.1007/s10096-009-0870-x; Maue SK, 2004, AM J MANAG CARE, V10, P383; Meerveld-Eggink A, 2008, VACCINE, V26, P6975, DOI 10.1016/j.vaccine.2008.09.052; Mourtzoukou EG, 2008, BRIT J SURG, V95, P273, DOI 10.1002/bjs.6106; Ramachandra J, 2003, ANN ROY COLL SURG, V85, P252, DOI 10.1308/003588403766274962; Solberg LI, 1997, J FAM PRACTICE, V44, P451; STYRT B, 1990, AM J MED, V88, pN33; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17302	10.1371/journal.pone.0017302	http://dx.doi.org/10.1371/journal.pone.0017302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423748	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100005
J	Vazao, H; das Neves, RP; Graos, M; Ferreira, L				Vazao, Helena; das Neves, Ricardo Pires; Graos, Mario; Ferreira, Lino			Towards the Maturation and Characterization of Smooth Muscle Cells Derived from Human Embryonic Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; PROGENITOR CELLS; GROWTH; EXPRESSION; MATRIX; CA2+; HETEROGENEITY; PROLIFERATION; MONOLAYER; INDUCTION	In this study we demonstrate that CD34(+) cells derived from human embryonic stem cells (hESCs) have higher smooth muscle cell (SMC) potential than CD34(-) cells. We report that from all inductive signals tested, retinoic acid (RA) and platelet derived growth factor (PDGF(BB)) are the most effective agents in guiding the differentiation of CD34(+) cells into smooth muscle progenitor cells (SMPCs) characterized by the expression of SMC genes and proteins, secretion of SMC-related cytokines, contraction in response to depolarization agents and vasoactive peptides and expression of SMC-related genes in a 3D environment. These cells are also characterized by a low organization of the contractile proteins and the contractility response is mediated by Ca2+, which involves the activation of Rho A/Rho kinase-and Ca2+/calmodulin (CaM)/myosin light chain kinase (MLCK)-dependent pathways. We further show that SMPCs obtained from the differentiation of CD34(+) cells with RA, but not with PDGF(BB), can be maturated in medium supplemented with endothelin-1 showing at the end individualized contractile filaments. Overall the hESC-derived SMCs presented in this work might be an unlimited source of SMCs for tissue engineering and regenerative medicine.	[Vazao, Helena; das Neves, Ricardo Pires; Ferreira, Lino] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Vazao, Helena; das Neves, Ricardo Pires; Graos, Mario; Ferreira, Lino] Biocant, Ctr Innovat Biotechnol, Cantanhede, Portugal	Universidade de Coimbra	Vazao, H (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	lino@biocant.pt	Neves, Ricardo/GXM-6159-2022; Grãos, Mário/O-7273-2017; Neves, Ricardo N Pires das/A-3322-2009; neves, ricardo/AAU-7959-2021	Grãos, Mário/0000-0002-2707-1488; Neves, Ricardo N Pires das/0000-0003-2291-6610; neves, ricardo/0000-0003-2291-6610; ferreira, lino/0000-0001-8985-9302; Vazao, Helena/0000-0002-5955-4804	Marie Curie-Reintegration Grant; MIT-Portugal program; Crioestaminal; Associacao Viver a Ciencia; Fundacao para a Ciencia e a Tecnologia [PTDC/SA-BEB/098468/2008, PTDC/CTM/099659/2008, SFRH/BD/40077/2007]	Marie Curie-Reintegration Grant(European Commission); MIT-Portugal program; Crioestaminal; Associacao Viver a Ciencia; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by a Marie Curie-Reintegration Grant, MIT-Portugal program, Crioestaminal, Associacao Viver a Ciencia and Fundacao para a Ciencia e a Tecnologia (PTDC/SA-BEB/098468/2008 and PTDC/CTM/099659/2008 to L.F.; SFRH/BD/40077/2007 to H.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; Deb A, 2004, CIRCULATION, V110, P2673, DOI 10.1161/01.CIR.0000139842.15651.B2; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dora KA, 2003, AM J PHYSIOL-HEART C, V285, pH119, DOI 10.1152/ajpheart.00643.2002; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; FRAMPTON JE, 1992, J PHYSIOL-LONDON, V453, P385, DOI 10.1113/jphysiol.1992.sp019234; FRID MG, 1992, DEV BIOL, V153, P185, DOI 10.1016/0012-1606(92)90104-O; Gerecht-Nir S, 2003, LAB INVEST, V83, P1811, DOI 10.1097/01.LAB.0000106502.41391.F0; Gerthoffer William T, 2002, Mol Interv, V2, P447, DOI 10.1124/mi.2.7.447; GRAIER WF, 1994, BIOCHEM J, V300, P637, DOI 10.1042/bj3000637; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Harnett KM, 2003, AM J MED, V115, p24S, DOI 10.1016/S0002-9343(03)00232-8; HATHAWAY DR, 1991, CIRCULATION, V83, P382, DOI 10.1161/01.CIR.83.2.382; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Hill KL, 2010, EXP HEMATOL, V38, P246, DOI 10.1016/j.exphem.2010.01.001; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Kansui Y, 2008, CELL CALCIUM, V44, P135, DOI 10.1016/j.ceca.2007.11.012; Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5; KIM MR, 2008, STEM CELLS; Le Ricousse-Roussanne S, 2004, CARDIOVASC RES, V62, P176, DOI 10.1016/j.cardiores.2004.01.017; Lee TH, 2010, CIRC RES, V106, P120, DOI 10.1161/CIRCRESAHA.109.207902; MAJACK RA, 1986, P NATL ACAD SCI USA, V83, P9050, DOI 10.1073/pnas.83.23.9050; Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a; Mayr M, 2008, CIRC RES, V102, P1046, DOI 10.1161/CIRCRESAHA.108.174623; MONTIEL M, 2003, SIGNAL T, V3, P201; Naito M, 1996, THROMB RES, V84, P129, DOI 10.1016/0049-3848(96)00168-5; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha Sanjay, 2009, V482, P345, DOI 10.1007/978-1-59745-060-7_22; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKEDA T, 1992, J CELL SCI, V101, P745; VO E, 2010, STEM CELL REV REP; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Walsh MJ, 2003, FASEB J, V17, pA1007; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1	55	25	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17771	10.1371/journal.pone.0017771	http://dx.doi.org/10.1371/journal.pone.0017771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423769	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100032
J	Guo, J; Gong, T; Gao, XD				Guo, Jia; Gong, Ting; Gao, Xiang-Dong			Identification of an Amphipathic Helix Important for the Formation of Ectopic Septin Spirals and Axial Budding in Yeast Axial Landmark Protein Bud3p	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL POLARITY; MEMBRANE-BINDING; SITE-SELECTION; HYDROPHOBIC RESIDUES; LOCALIZATION; CYCLE; ESTABLISHMENT; GENE; RING	Correct positioning of polarity axis in response to internal or external cues is central to cellular morphogenesis and cell fate determination. In the budding yeast Saccharomyces cerevisiae, Bud3p plays a key role in the axial bud-site selection (axial budding) process in which cells assemble the new bud next to the preceding cell division site. Bud3p is thought to act as a component of a spatial landmark. However, it is not clear how Bud3p interacts with other components of the landmark, such as the septins, to control axial budding. Here, we report that overexpression of Bud3p causes the formation of small septin rings (similar to 1 mu m in diameter) and arcs aside from previously reported spiral-like septin structures. Bud3p closely associates with the septins in vivo as Bud3p colocalizes with these aberrant septin structures and forms a complex with two septins, Cdc10p and Cdc11p. The interaction of Bud3p with the septins may involve multiple regions of Bud3p including 1-858, 850-1220, and 1221-1636 a. a. since they all target to the bud neck but exhibit different effects on septin organization when overexpressed. In addition, our study reveals that the axial budding function of Bud3p is mediated by the N-terminal region 1-858. This region shares an amphipathic helix (850-858) crucial for bud neck targeting with the middle portion 850-1103 involved in the formation of ectopic septin spirals and rings. Interestingly, the Dbl-homology domain located in 1-858 is dispensable for axial bud-site selection. Our findings suggest that multiple regions of Bud3p ensure efficient targeting of Bud3p to the bud neck in the assembly of the axial landmark and distinct domains of Bud3p are involved in axial bud-site selection and other cellular processes.	[Guo, Jia; Gong, Ting; Gao, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Guo, J (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	xdgao@whu.edu.cn		Gao, Xiang-Dong/0000-0002-1008-2324; Guo, Jia/0000-0002-9110-5574	National Natural Science Foundation of China [30770017, 30871347]; Chinese 111 Project [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (Grants Nos. 30770017 and 30871347 to XDG) and the Chinese 111 Project (No. B06018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Bailly E, 2003, J CELL SCI, V116, P4119, DOI 10.1242/jcs.00706; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Bouquin N, 2000, J CELL SCI, V113, P1435; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; Demay BS, 2009, MOL BIOL CELL, V20, P2311, DOI 10.1091/mbc.E08-12-1169; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; FLESCHER EG, 1993, J CELL BIOL, V122, P373, DOI 10.1083/jcb.122.2.373; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Fujita A, 2004, GENE, V327, P161, DOI 10.1016/j.gene.2003.11.021; Gale C, 2001, MOL BIOL CELL, V12, P3538, DOI 10.1091/mbc.12.11.3538; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Guthrie C, 1991, GUIDE YEAST GENETICS; Halme A, 1996, CURR BIOL, V6, P570, DOI 10.1016/S0960-9822(02)00543-2; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Kang PJ, 2004, MOL BIOL CELL, V15, P5145, DOI 10.1091/mbc.E04-07-0600; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lord M, 2002, CURR BIOL, V12, P1347, DOI 10.1016/S0960-9822(02)01042-4; Lord M, 2000, J CELL BIOL, V151, P1501, DOI 10.1083/jcb.151.7.1501; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; Orlando K, 2008, J BIOL CHEM, V283, P14205, DOI 10.1074/jbc.M708178200; Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Schmidt K, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-43; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Wendland J, 2003, EMBO REP, V4, P200, DOI 10.1038/sj.embor.embor727; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003	42	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16744	10.1371/journal.pone.0016744	http://dx.doi.org/10.1371/journal.pone.0016744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408200	gold, Green Published, Green Submitted			2022-12-27	WOS:000288170000006
J	Gutteling, TP; Kenemans, JL; Neggers, SFW				Gutteling, Tjerk P.; Kenemans, J. Leon; Neggers, Sebastiaan F. W.			Grasping Preparation Enhances Orientation Change Detection	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUOSPATIAL ATTENTION; VISUAL-SEARCH; SELECTION; FMRI; TMS; PERCEPTION; MECHANISM; FEEDBACK; FIELDS	Preparing a goal directed movement often requires detailed analysis of our environment. When picking up an object, its orientation, size and relative distance are relevant parameters when preparing a successful grasp. It would therefore be beneficial if the motor system is able to influence early perception such that information processing needs for action control are met at the earliest possible stage. However, only a few studies reported (indirect) evidence for action-induced visual perception improvements. We therefore aimed to provide direct evidence for a feature-specific perceptual modulation during the planning phase of a grasping action. Human subjects were instructed to either grasp or point to a bar while simultaneously performing an orientation discrimination task. The bar could slightly change its orientation during grasping preparation. By analyzing discrimination response probabilities, we found increased perceptual sensitivity to orientation changes when subjects were instructed to grasp the bar, rather than point to it. As a control experiment, the same experiment was repeated using bar luminance changes, a feature that is not relevant for either grasping or pointing. Here, no differences in visual sensitivity between grasping and pointing were found. The present results constitute first direct evidence for increased perceptual sensitivity to a visual feature that is relevant for a certain skeletomotor act during the movement preparation phase. We speculate that such action-induced perception improvements are controlled by neuronal feedback mechanisms from cortical motor planning areas to early visual cortex, similar to what was recently established for spatial perception improvements shortly before eye movements.	[Gutteling, Tjerk P.; Neggers, Sebastiaan F. W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Kenemans, J. Leon] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Gutteling, TP (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	T.Gutteling@umcutrecht.nl	Gutteling, Tjerk/J-3440-2012	Gutteling, Tjerk/0000-0002-0934-418X	Netherlands Foundation for Scientific Research (NWO) [NWO 400-05-134]	Netherlands Foundation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Netherlands Foundation for Scientific Research (NWO, http://www.nwo.nl/) Open Competition Grant NWO 400-05-134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT A, 1987, SELECTION ACTION SOM, P395; Bekkering H, 2002, PSYCHOL SCI, V13, P370, DOI 10.1111/1467-9280.00466; Cohen NR, 2009, NEUROPSYCHOLOGIA, V47, P1553, DOI 10.1016/j.neuropsychologia.2008.12.034; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Fagioli S, 2007, PSYCHOL RES-PSYCH FO, V71, P22, DOI 10.1007/s00426-005-0033-3; Grabowska A, 1996, PSYCHOL BULL, V120, P434, DOI 10.1037/0033-2909.120.3.434; Gutteling TP, 2010, J COGNITIVE NEUROSCI, V22, P1931, DOI 10.1162/jocn.2009.21342; Hannus A, 2005, ACTA PSYCHOL, V118, P171, DOI 10.1016/j.actpsy.2004.10.010; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Macmillan N.A, DETECTION THEORY USE; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Neggers SFW, 2007, J NEUROPHYSIOL, V98, P2765, DOI 10.1152/jn.00357.2007; Neggers SFW, 1999, EXP BRAIN RES, V125, P97, DOI 10.1007/s002210050663; Neuman O., 1987, PERSPECTIVES PERCEPT, P361; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRINZ W, 1997, EUROPEAN J COGNITIVE, P129; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Symes E, 2008, J EXP PSYCHOL HUMAN, V34, P854, DOI 10.1037/0096-1523.34.4.854; van Elk M, 2010, J NEUROPHYSIOL, V104, P972, DOI 10.1152/jn.01079.2009; Van Ettinger-Veenstra HM, 2009, J NEUROPHYSIOL, V102, P3469, DOI 10.1152/jn.00350.2009	24	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17675	10.1371/journal.pone.0017675	http://dx.doi.org/10.1371/journal.pone.0017675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FI	21408131	Green Published, gold			2022-12-27	WOS:000288170000052
J	Roy, B; Copenhaver, GP; von Arnim, AG				Roy, Bijoyita; Copenhaver, Gregory P.; von Arnim, Albrecht G.			Fluorescence-Tagged Transgenic Lines Reveal Genetic Defects in Pollen Growth-Application to the Eif3 Complex	PLOS ONE			English	Article							MALE GAMETOPHYTE DEVELOPMENT; TRANSLATION INITIATION; ARABIDOPSIS-THALIANA; MATURE POLLEN; VISUAL ASSAY; PROTEIN; SUBUNIT; TRANSCRIPTOME; TOBACCO; REINITIATION	Background: Mutations in several subunits of eukaryotic translation initiation factor 3 (eIF3) cause male transmission defects in Arabidopsis thaliana. To identify the stage of pollen development at which eIF3 becomes essential it is desirable to examine viable pollen and distinguish mutant from wild type. To accomplish this we have developed a broadly applicable method to track mutant alleles that are not already tagged by a visible marker gene through the male lineage of Arabidopsis. Methodology/Principal Findings: Fluorescence tagged lines (FTLs) harbor a transgenic fluorescent protein gene (XFP) expressed by the pollen-specific LAT52 promoter at a defined chromosomal position. In the existing collection of FTLs there are enough XFP marker genes to track nearly every nuclear gene by virtue of its genetic linkage to a transgenic marker gene. Using FTLs in a quartet mutant, which yields mature pollen tetrads, we determined that the pollen transmission defect of the eif3h-1 allele is due to a combination of reduced pollen germination and reduced pollen tube elongation. We also detected reduced pollen germination for eif3e. However, neither eif3h nor eif3e, unlike other known gametophytic mutations, measurably disrupted the early stages of pollen maturation. Conclusion/Significance: eIF3h and eIF3e both become essential during pollen germination, a stage of vigorous translation of newly transcribed mRNAs. These data delimit the end of the developmental window during which paternal rescue is still possible. Moreover, the FTL collection of mapped fluorescent protein transgenes represents an attractive resource for elucidating the pollen development phenotypes of any fine-mapped mutation in Arabidopsis.	[Roy, Bijoyita; von Arnim, Albrecht G.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN USA; [Copenhaver, Gregory P.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Copenhaver, Gregory P.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Copenhaver, Gregory P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Roy, B (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Mol Genet, Worcester, MA 01605 USA.	vonarnim@utk.edu	Copenhaver, Gregory/AFL-9831-2022; Copenhaver, Gregory/AAH-2031-2022; Copenhaver, Gregory P/A-7549-2014	Copenhaver, Gregory/0000-0002-7962-3862; Copenhaver, Gregory/0000-0002-7962-3862; Copenhaver, Gregory P/0000-0002-7962-3862; von Arnim, Albrecht/0000-0003-3472-3357; Roy, Bijoyita/0000-0003-1061-5482	DOE [DE-FG02-96ER20223, DE-FGO2-05ER15651]; NSF [DBI-0820047, MCB-0618691]	DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This work was supported by a grant from the DOE Energy Biosciences Program (DE-FG02-96ER20223) and the NSF Arabidopsis 2010 project DBI-0820047 to AGV. GPC thanks NSF (MCB-0618691) and the DOE (DE-FGO2-05ER15651) for financial support. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Belostotsky DA, 1996, PLANT CELL, V8, P1261, DOI 10.1105/tpc.8.8.1261; Berchowitz LE, 2008, NAT PROTOC, V3, P41, DOI 10.1038/nprot.2007.491; Berchowitz LE, 2009, METHODS MOL BIOL, V557, P99, DOI 10.1007/978-1-59745-527-5_8; Boavida LC, 2009, GENETICS, V181, P1369, DOI 10.1534/genetics.108.090852; Borg M, 2009, J EXP BOT, V60, P1465, DOI 10.1093/jxb/ern355; BRANDER KA, 1995, PLANT MOL BIOL, V27, P637, DOI 10.1007/BF00020219; Burks EA, 2001, J BIOL CHEM, V276, P2122, DOI 10.1074/jbc.M007236200; Francis KE, 2007, P NATL ACAD SCI USA, V104, P3913, DOI 10.1073/pnas.0608936104; Francis KE, 2006, PLANT PHYSIOL, V142, P1004, DOI 10.1104/pp.106.085274; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Hasegawa Y, 2009, NEW PHYTOL, V182, P994, DOI 10.1111/j.1469-8137.2009.02806.x; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Holmes-Davis R, 2005, PROTEOMICS, V5, P4864, DOI 10.1002/pmic.200402011; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Honys D, 2009, J PROTEOME RES, V8, P2015, DOI 10.1021/pr8009897; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Kim BH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r60; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; Lalanne E, 2002, PLANT PHYSIOL, V129, P865, DOI 10.1104/pp.003301; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; Noir S, 2005, BIOCHEM BIOPH RES CO, V337, P1257, DOI 10.1016/j.bbrc.2005.09.185; op den Camp RGL, 1998, NUCLEIC ACIDS RES, V26, P2058, DOI 10.1093/nar/26.9.2058; PREUSS D, 1994, SCIENCE, V264, P1458, DOI 10.1126/science.8197459; Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Yahalom A, 2008, PLANT J, V53, P300, DOI 10.1111/j.1365-313X.2007.03347.x; Zhou F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-193	36	10	10	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17640	10.1371/journal.pone.0017640	http://dx.doi.org/10.1371/journal.pone.0017640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408229	Green Submitted, Green Published, gold			2022-12-27	WOS:000288099800030
J	Wang, D; Jones, LM; Urwin, PE; Atkinson, HJ				Wang, Dong; Jones, Laura M.; Urwin, Peter E.; Atkinson, Howard J.			A Synthetic Peptide Shows Retro- and Anterograde Neuronal Transport before Disrupting the Chemosensation of Plant-Pathogenic Nematodes	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CAENORHABDITIS-ELEGANS; INTRAFLAGELLAR TRANSPORT; BEHAVIOR; IDENTIFICATION; CHEMOTAXIS; RESISTANCE; DYNAMICS; MOTORS; MOBILE	Cyst nematodes are a group of plant pathogens each with a defined host range that cause major losses to crops including potato, soybean and sugar beet. The infective mobile stage hatches from dormant eggs and moves a short distance through the soil to plant roots, which it then invades. A novel strategy for control has recently been proposed in which the plant is able to secrete a peptide which disorientates the infective stage and prevents invasion of the pathogen. This study provides indirect evidence to support the mechanism by which one such peptide disrupts chemosensory function in nematodes. The peptide is a disulphide-constrained 7-mer with the amino acid sequence CTTMHPRLC that binds to nicotinic acetylcholine receptors. A fluorescently tagged version of this peptide with both epifluorescent and confocal microscopy was used to demonstrate that retrograde transport occurs from an aqueous environment along bare-ending primary cilia of chemoreceptive sensilla. The peptide is transported to the cell bodies of these neurons and on to a limited number of other neurons to which they connect. It appears to be localised in both neuronal processes and organelles adjacent to nuclei of some neurons suggesting it could be transported through the Golgi apparatus. The peptide takes 2.5 h to reach the neuronal cell bodies. Comparative studies established that similar but less abundant uptake occurs for Caenorhabditis elegans along its well studied dye-filling chemoreceptive neurons. Incubation in peptide solution or root-exudate from transgenic plants that secrete the peptide disrupted normal orientation of infective cyst nematodes to host root diffusate. The peptide probably undergoes transport along the dye-filling non-cholinergic chemoreceptive neurons to their synapses where it is taken up by the interneurons to which they connect. Coordinated responses to chemoreception are disrupted when the sub-set of cholinergic interneurons secrete the peptide at synapses that have post-synaptic nicotinic acetylcholine receptors.	[Wang, Dong; Jones, Laura M.; Urwin, Peter E.; Atkinson, Howard J.] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Wang, D (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.e.urwin@leeds.ac.uk		Urwin, Peter Edward/0000-0003-0398-2372	NERC/BP; Biotechnology and Biological Sciences Research Council [BB/D001749/1, BB/F004001/1] Funding Source: researchfish; BBSRC [BB/D001749/1, BB/F004001/1] Funding Source: UKRI	NERC/BP(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a Dorothy Hodgkin Postgraduate Award (NERC/BP, http://www.rcuk.ac.uk/hodgkin/dorothy.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton FT, 1999, VET PARASITOL, V84, P297, DOI 10.1016/S0304-4017(99)00037-0; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Brown LA, 2006, INT J PARASITOL, V36, P617, DOI 10.1016/j.ijpara.2006.01.016; Bumbarger DJ, 2009, J COMP NEUROL, V512, P271, DOI 10.1002/cne.21882; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; CLEMENS CD, 1994, FUND APPL NEMATOL, V17, P569; Costa JC, 2009, INT J PARASITOL, V39, P849, DOI 10.1016/j.ijpara.2008.12.007; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; GRAY GM, 2005, PNAS, V102, P3184; GRUNDLER F, 1991, PARASITOLOGY, V103, P149, DOI 10.1017/S0031182000059394; Hao LM, 2009, METHOD CELL BIOL, V93, P235, DOI 10.1016/S0091-679X(08)93013-2; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Inglis P. N., 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.126.2; Liu B, 2005, PLANT BIOTECHNOL J, V3, P487, DOI 10.1111/j.1467-7652.2005.00139.x; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; Qian H, 2008, FASEB J, V22, P3247, DOI 10.1096/fj.08-110502; Rand JB, 2000, FASEB J, V14, P2414, DOI 10.1096/fj.00-0313rev; Roy S, 2008, J NEUROSCI, V28, P5248, DOI 10.1523/JNEUROSCI.0309-08.2008; Roy S, 2007, J NEUROSCI, V27, P3131, DOI 10.1523/JNEUROSCI.4999-06.2007; SASSER JN, 1986, J NEMATOL, V18, P596; Sattelle DB, 2009, J PESTIC SCI, V34, P233, DOI 10.1584/jpestics.R09-02; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Trivedi N, 2007, J NEUROSCI, V27, P507, DOI 10.1523/JNEUROSCI.4227-06.2007; URWIN PE, 1995, PLANT J, V8, P121, DOI 10.1046/j.1365-313X.1995.08010121.x; Winter MD, 2002, PARASITOLOGY, V125, P561, DOI 10.1017/S0031182002002482; Yassin L, 2001, MOL CELL NEUROSCI, V17, P589, DOI 10.1006/mcne.2000.0944; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17475	10.1371/journal.pone.0017475	http://dx.doi.org/10.1371/journal.pone.0017475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408216	gold, Green Published, Green Submitted			2022-12-27	WOS:000288099800016
J	Eddy, DR; Clarke, JA				Eddy, Drew R.; Clarke, Julia A.			New Information on the Cranial Anatomy of Acrocanthosaurus atokensis and Its Implications for the Phylogeny of Allosauroidea (Dinosauria: Theropoda)	PLOS ONE			English	Article							CRETACEOUS THEROPOD; CARCHARODONTOSAURID DINOSAURIA; CARNOSAUR DINOSAURIA; COMPUTED-TOMOGRAPHY; STRATIGRAPHIC FIT; CRESTED THEROPOD; EVOLUTION; OSTEOLOGY; SIZE; TYRANNOSAURUS	Background: Allosauroidea has a contentious taxonomic and systematic history. Within this group of theropod dinosaurs, considerable debate has surrounded the phylogenetic position of the large-bodied allosauroid Acrocanthosaurus atokensis from the Lower Cretaceous Antlers Formation of North America. Several prior analyses recover Acrocanthosaurus atokensis as sister taxon to the smaller-bodied Allosaurus fragilis known from North America and Europe, and others nest Acrocanthosaurus atokensis within Carcharodontosauridae, a large-bodied group of allosauroids that attained a cosmopolitan distribution during the Early Cretaceous. Methodology/Principal Findings: Re-evaluation of a well-preserved skull of Acrocanthosaurus atokensis (NCSM 14345) provides new information regarding the palatal complex and inner surfaces of the skull and mandible. Previously inaccessible internal views and articular surfaces of nearly every element of the skull are described. Twenty-four new morphological characters are identified as variable in Allosauroidea, combined with 153 previously published characters, and evaluated for eighteen terminal taxa. Systematic analysis of this dataset recovers a single most parsimonious topology placing Acrocanthosaurus atokensis as a member of Allosauroidea, in agreement with several recent analyses that nest the taxon well within Carcharodontosauridae. Conclusions/Significance: A revised diagnosis of Acrocanthosaurus atokensis finds that the species is distinguished by four primary characters, including: presence of a knob on the lateral surangular shelf; enlarged posterior surangular foramen; supraoccipital protruding as a double-boss posterior to the nuchal crest; and pneumatic recess within the medial surface of the quadrate. Furthermore, the recovered phylogeny more closely agrees with the stratigraphic record than hypotheses that place Acrocanthosaurus atokensis as more closely related to Allosaurus fragilis. Fitch optimization of body size is also more consistent with the placement of Acrocanthosaurus atokensis within a clade of larger carcharodontosaurid taxa than with smaller-bodied taxa near the base of Allosauroidea. This placement of Acrocanthosaurus atokensis supports previous hypotheses of a global carcharodontosaurid radiation during the Early Cretaceous.	[Eddy, Drew R.; Clarke, Julia A.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Eddy, DR (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	dreddy@mail.utexas.edu			North Carolina State University	North Carolina State University	This work was supported by North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2002, J VERTEBR PALEONTOL, V22, P548, DOI 10.1671/0272-4634(2002)022[0548:DOMDTI]2.0.CO;2; Alroy J, 2000, PALEOBIOLOGY, V26, P319, DOI 10.1666/0094-8373(2000)026<0319:UTDOTW>2.0.CO;2; [Anonymous], 2000, GAIA; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Bell Christopher J., 2009, Records of the Western Australian Museum, V25, P201; BENSON RBJ, 2010, ZOOL J LINN SOC-LOND, P1; Benson RBJ, 2008, GEOL MAG, V145, P778, DOI 10.1017/S0016756808005475; Benson RBJ, 2008, PALAEONTOLOGY, V51, P419, DOI 10.1111/j.1475-4983.2008.00751.x; Benson RBJ, 2008, ZOOTAXA, P57, DOI 10.11646/zootaxa.1931.1.5; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Bonner JT, 1965, SIZE CYCLE ESSAY STR; Boyd CA, 2011, CLADISTICS, V27, P52, DOI 10.1111/j.1096-0031.2010.00320.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; BROCHU C. A., 2002, MEMOIR SOC VERTEBRAT, V22, P1; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P902, DOI 10.1671/0272-4634(2007)27[902:ANSOCD]2.0.CO;2; Brusatte SL, 2010, ZOOTAXA, P1; Brusatte SL, 2010, ZOOL J LINN SOC-LOND, V158, P573, DOI 10.1111/j.1096-3642.2009.00563.x; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; Buckland W., 1824, T GEOLOGICAL SOC LON, V1, P390, DOI DOI 10.1144/TRANSGSLB.1.2.390; CARR T, 2005, PHYLOGENY TYRANNOSAU; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; CHARIG AJ, 1986, NATURE, V324, P359, DOI 10.1038/324359a0; CHURE DJ, 2000, NEW SPECIES ALLOSAUR; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; COPE E.D, 1871, P AM PHILOS SOC, V12, P41; COPE ED, 1887, AM NAT, V21, P367, DOI DOI 10.1086/274464; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P802, DOI 10.1671/0272-4634(2002)022[0802:TBOGCD]2.0.CO;2; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; DeCourten FL., 1991, GEOLOGY E CENTRAL UT, P311; DEPERET CH, 1927, BULL SOC GEOL FRANCE, V27, P257; DONG ZM, 1978, KEXUE TONGBAO, V23, P298; EDDY DE, 2008, 14345 NCSM N CAR STA; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Forster CA, 1999, J AFR EARTH SCI, V28, P169, DOI 10.1016/S0899-5362(99)00023-8; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; FVON H, 1920, Z INDUKT ABSTAMM VER, V22, P209; Gaudin Timothy J., 2006, P1; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; GILMORE CW, 1920, P US NATL MUS, V54, P383; Goloboff P, 2008, CLADISTICS, V24, P91; HAMMER WR, 1994, SCIENCE, V264, P828, DOI 10.1126/science.264.5160.828; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harris JD, 1998, NEW MEXICO MUSEUM NA, V13, P1, DOI DOI 10.1080/0022293460865417; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; HOLTZ TR, 1995, J VERTEBE PALEONTO S, V15, pA35; Hu S. y., 1964, Vertebrata Palasiatica, V8, P42; HUELSENBECK JP, 1994, PALEOBIOLOGY, V20, P470, DOI 10.1017/S009483730001294X; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; HUTT S, 1996, NEUES JB GEOLOGIE PA, P635; HVON M, 1861, PALAEONTOGR, V7, P253; Canudo JI, 2009, B SOC GEOL FR, V180, P5, DOI 10.2113/gssgfbull.180.1.5; *INT COMM STRAT, 2008, INT STRAT CHART; Jablonski David, 1996, P256; KIRKLAND JI, 1995, J VERT PALEONTOL S, V15, pA39; Langston W. Jr., 1974, Geoscience Man, V8, P77; Larsson Hans C.E., 2001, P19; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Linneaus C., 1758, SYSTEMA NATURAE REGN, VI; Lipka, 1998, NEW MEXICO MUSEUM NA, V14, P229; Maddison W.P., MESQUITE MODULAR SYS; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Madsen Jr J.H., 2000, CERATOSAURUS DINOSAU, V00-2, P1; Marsh O.C, 1884, AM J SCI, V27, P329, DOI DOI 10.2475/AJS.S3-27.160.329; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Marsh OC., 1877, AM J SCI, V3, P514, DOI DOI 10.2475/AJS.S3-14.84.514; Mateus Octavio, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P111; McIntosh J. S., 1981, BULL CARNEG MUS NAT, V18, P1; *MERC COMP SYST, 2007, AV VERS 5 0 1; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; NAISH D, 2001, DINOSAURS ISLE WIGHT, P242; Naish D, 2007, J GEOL SOC LONDON, V164, P493, DOI 10.1144/0016-76492006-032; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; NOVAS FE, 1992, PALAEONTOLOGY, V35, P51; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Olshevsky G., 1991, SAN DIEGO CALIFORNIA, P1; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Padian K, 1999, J VERTEBR PALEONTOL, V19, P69, DOI 10.1080/02724634.1999.10011123; PADIAN K, 1997, ENCY DINOSAURS, P6; Paul G., 1988, PREDATORY DINOSAURS; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; Pol D, 2004, CLADISTICS, V20, P64, DOI 10.1111/j.1096-0031.2003.00002.x; Pol D, 2001, CLADISTICS, V17, P285, DOI 10.1111/j.1096-0031.2001.tb00125.x; Pol D, 2006, SYST BIOL, V55, P512, DOI 10.1080/10635150600755446; Prendini L, 2001, SYST BIOL, V50, P290, DOI 10.1080/10635150118650; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Reig O. A., 1963, Ameghiniana, V3, P3; Rogers SW, 1998, NEURON, V21, P673, DOI 10.1016/S0896-6273(00)80585-1; Rogers SW, 1999, ANAT RECORD, V257, P162; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; RUSSELL DA, 1970, NATL MUS NAT HIST PU, V1, P1; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Siddall ME, 1996, SYST BIOL, V45, P111, DOI 10.2307/2413516; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Smith David K., 1999, P135; Smith DK, 1998, J VERTEBR PALEONTOL, V18, P126, DOI 10.1080/02724634.1998.10011039; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; Stromer E., 1931, Abh bayer Akad Wiss Munchen (nf), V9, P1; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; SWOFFORD DL, PAUP PHYLOGENETIC AN; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; von HUENE FRIEDRICH, 1933, MEM GEOL SURV INDIA PALAEONT INDICA, V21, P1; Wagner A., 1861, ABHANDLUNGEN BAYERIS, V9, P30; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; WILLS M, GHOSTS SIGNIFICANCE; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1; ZHAO XJ, 1993, CAN J EARTH SCI, V30, P2027, DOI 10.1139/e93-178; [No title captured]	140	56	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17932	10.1371/journal.pone.0017932	http://dx.doi.org/10.1371/journal.pone.0017932			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445312	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300023
J	Reikvam, DH; Erofeev, A; Sandvik, A; Grcic, V; Jahnsen, FL; Gaustad, P; McCoy, KD; Macpherson, AJ; Meza-Zepeda, LA; Johansen, FE				Reikvam, Dag Henrik; Erofeev, Alexander; Sandvik, Anders; Grcic, Vedrana; Jahnsen, Frode Lars; Gaustad, Peter; McCoy, Kathy D.; Macpherson, Andrew J.; Meza-Zepeda, Leonardo A.; Johansen, Finn-Eirik			Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene Expression	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IMMUNE-RESPONSES; SYMBIOTIC BACTERIA; RECOGNITION; HOMEOSTASIS; RESISTANCE; CATALOG; A(2)	Background: Inappropriate cross talk between mammals and their gut microbiota may trigger intestinal inflammation and drive extra-intestinal immune-mediated diseases. Epithelial cells constitute the interface between gut microbiota and host tissue, and may regulate host responses to commensal enteric bacteria. Gnotobiotic animals represent a powerful approach to study bacterial-host interaction but are not readily accessible to the wide scientific community. We aimed at refining a protocol that in a robust manner would deplete the cultivable intestinal microbiota of conventionally raised mice and that would prove to have significant biologic validity. Methodology/Principal Findings: Previously published protocols for depleting mice of their intestinal microbiota by administering broad-spectrum antibiotics in drinking water were difficult to reproduce. We show that twice daily delivery of antibiotics by gavage depleted mice of their cultivable fecal microbiota and reduced the fecal bacterial DNA load by 400 fold while ensuring the animals' health. Mice subjected to the protocol for 17 days displayed enlarged ceca, reduced Peyer's patches and small spleens. Antibiotic treatment significantly reduced the expression of antimicrobial factors to a level similar to that of germ-free mice and altered the expression of 517 genes in total in the colonic epithelium. Genes involved in cell cycle were significantly altered concomitant with reduced epithelial proliferative activity in situ assessed by Ki-67 expression, suggesting that commensal microbiota drives cellular proliferation in colonic epithelium. Conclusion: We present a robust protocol for depleting conventionally raised mice of their cultivatable intestinal microbiota with antibiotics by gavage and show that the biological effect of this depletion phenocopies physiological characteristics of germ-free mice.	[Reikvam, Dag Henrik; Erofeev, Alexander; Sandvik, Anders; Grcic, Vedrana; Jahnsen, Frode Lars; Johansen, Finn-Eirik] Univ Oslo, Dept Pathol, Oslo, Norway; [Reikvam, Dag Henrik; Erofeev, Alexander; Sandvik, Anders; Grcic, Vedrana; Jahnsen, Frode Lars; Johansen, Finn-Eirik] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Gaustad, Peter] Univ Oslo, Inst Microbiol, Oslo, Norway; [Jahnsen, Frode Lars; Johansen, Finn-Eirik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Dept Clin Res, Maurice Muller Labs, Bern, Switzerland; [Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway; [Meza-Zepeda, Leonardo A.] Univ Oslo, Dept Mol Biosci, Norwegian Microarray Consortium, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Bern; University of Oslo; University of Oslo	Reikvam, DH (corresponding author), Univ Oslo, Dept Pathol, Oslo, Norway.	dag.henrik.reikvam@rr-research.no	McCoy, Kathy/ABD-5814-2021; Meza-Zepeda, Leonardo Andres/CAG-5229-2022	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X	Norwegian Cancer Society; Research Council of Norway; FUGE	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); FUGE	The project was funded by the Norwegian Cancer Society and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Linda Manley for technical assistance with the laboratory animals, Linda Solfjell for molecular bioengineering, Aaste Aursjo for immunohistochemistry handcraft, Anne Kilsund Axelssen for all bacteriological work, and the FUGE funded Microarray Core Facility for providing gene expression services.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Birts CN, 2010, TRENDS BIOCHEM SCI, V35, P28, DOI 10.1016/j.tibs.2009.08.003; Bollyky PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005063; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Dann SM, 2007, CURR OPIN GASTROEN, V23, P115, DOI 10.1097/MOG.0b013e32803cadf4; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Fukushima K, 2003, SCAND J GASTROENTERO, V38, P626, DOI 10.1080/00365510310000376; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Kollef MH, 2005, CRIT CARE, V9, P459, DOI 10.1186/cc3757; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nevalainen TJ, 2008, BBA-MOL CELL BIOL L, V1781, P1, DOI 10.1016/j.bbalip.2007.12.001; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Underwood KW, 1998, J BIOL CHEM, V273, P21926, DOI 10.1074/jbc.273.34.21926; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Van de Craen M, 1998, CELL DEATH DIFFER, V5, P838, DOI 10.1038/sj.cdd.4400444; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336	44	311	320	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17996	10.1371/journal.pone.0017996	http://dx.doi.org/10.1371/journal.pone.0017996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445311	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300026
J	Tanaka, J; Yanagawa, H; Doi, N				Tanaka, Junko; Yanagawa, Hiroshi; Doi, Nobuhide			Comparison of the Frequency of Functional SH3 Domains with Different Limited Sets of Amino Acids Using mRNA Display	PLOS ONE			English	Article							RANDOM-SEQUENCE PROTEINS; IN-VITRO SELECTION; DE-NOVO PROTEINS; DIRECTED EVOLUTION; GENETIC-CODE; SUPERFAMILY; MUTAGENESIS; LIBRARIES; LIGANDS; ENZYME	Although modern proteins consist of 20 different amino acids, it has been proposed that primordial proteins consisted of a small set of amino acids, and additional amino acids have gradually been recruited into the genetic code. This hypothesis has recently been supported by comparative genome sequence analysis, but no direct experimental approach has been reported. Here, we utilized a novel experimental approach to test a hypothesis that native-like globular proteins might be easily simplified by a set of putative primitive amino acids with retention of its structure and function than by a set of putative new amino acids. We performed in vitro selection of a functional SH3 domain as a model from partially randomized libraries with different sets of amino acids using mRNA display. Consequently, a library rich in putative primitive amino acids included a larger number of functional SH3 sequences than a library rich in putative new amino acids. Further, the functional SH3 sequences were enriched from the primitive library slightly earlier than from a randomized library with the full set of amino acids, while the function and structure of the selected SH3 proteins with the primitive alphabet were comparable with those from the 20 amino acid alphabet. Application of this approach to various combinations of codons in protein sequences may be useful not only for clarifying the precise order of the amino acid expansion in the early stages of protein evolution but also for efficiently creating novel functional proteins in the laboratory.	[Tanaka, Junko; Yanagawa, Hiroshi; Doi, Nobuhide] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Tanaka, J (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	doi@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Tanaka, Junko/0000-0003-2802-1797; Doi, Nobuhide/0000-0002-2402-6390	JSPS (Japan Society for the Promotion of Science) [19657073]; MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (19657073) from the JSPS (Japan Society for the Promotion of Science) and a Grant-in- Aid for the Keio University Global Center of Excellence (G-COE) Program entitled 'Center of Human Metabolomic Systems Biology' from the MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma S, 2002, P NATL ACAD SCI USA, V99, P13549, DOI 10.1073/pnas.222243999; Babajide A, 1997, FOLD DES, V2, P261, DOI 10.1016/S1359-0278(97)00037-0; CHEN JK, 1993, J AM CHEM SOC, V115, P12591, DOI 10.1021/ja00079a051; Cho G, 2000, J MOL BIOL, V297, P309, DOI 10.1006/jmbi.2000.3571; Cronin J R, 1983, Adv Space Res, V3, P5, DOI 10.1016/0273-1177(83)90036-4; Crowhurst KA, 2002, J MOL BIOL, V322, P163, DOI 10.1016/S0022-2836(02)00741-6; Doi N, 2005, PROTEIN ENG DES SEL, V18, P279, DOI 10.1093/protein/gzi034; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Go A, 2008, PROTEIN SCI, V17, P821, DOI 10.1110/ps.073377908; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Jumawid MT, 2009, PROTEIN SCI, V18, P384, DOI 10.1002/pro.41; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Knapp S, 1998, PROTEINS, V31, P309, DOI 10.1002/(SICI)1097-0134(19980515)31:3<309::AID-PROT7>3.0.CO;2-D; Koonin EV, 2009, IUBMB LIFE, V61, P99, DOI 10.1002/iub.146; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; MILLER SL, 1987, COLD SPRING HARB SYM, V52, P17, DOI 10.1101/SQB.1987.052.01.005; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Silverman JA, 2001, P NATL ACAD SCI USA, V98, P3092, DOI 10.1073/pnas.041613598; Tanaka J, 2010, PROTEIN SCI, V19, P786, DOI 10.1002/pro.358; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Walter KU, 2005, J BIOL CHEM, V280, P37742, DOI 10.1074/jbc.M507210200; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208; Wu S, 2010, P NATL ACAD SCI USA, V107, P2775, DOI 10.1073/pnas.0911656107	29	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18034	10.1371/journal.pone.0018034	http://dx.doi.org/10.1371/journal.pone.0018034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445307	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300029
J	Li, A; Lim, TS; Shi, H; Yin, J; Tan, SJ; Li, ZJ; Low, BC; Tan, KSW; Lim, CT				Li, Ang; Lim, Tong Seng; Shi, Hui; Yin, Jing; Tan, Swee Jin; Li, Zhengjun; Low, Boon Chuan; Tan, Kevin Shyong Wei; Lim, Chwee Teck			Molecular Mechanistic Insights into the Endothelial Receptor Mediated Cytoadherence of Plasmodium falciparum-Infected Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; HUMAN CEREBRAL MALARIA; PARASITIZED ERYTHROCYTES; MEMBRANE GLYCOPROTEIN; FORCE; ADHESION; CD36; IDENTIFICATION; SELECTIN; LIGAND	Cytoadherence or sequestration is essential for the pathogenesis of the most virulent human malaria species, Plasmodium falciparum (P. falciparum). Similar to leukocyte-endothelium interaction in response to inflammation, cytoadherence of P. falciparum infected red blood cells (IRBCs) to endothelium occurs under physiological shear stresses in blood vessels and involves an array of molecule complexes which cooperate to form stable binding. Here, we applied single-molecule force spectroscopy technique to quantify the dynamic force spectra and characterize the intrinsic kinetic parameters for specific ligand-receptor interactions involving two endothelial receptor proteins: thrombospondin (TSP) and CD36. It was shown that CD36 mediated interaction was much more stable than that mediated by TSP at single molecule level, although TSP-IRBC interaction appeared stronger than CD36-IRBC interaction in the high pulling rate regime. This suggests that TSP-mediated interaction may initiate cell adhesion by capturing the fast flowing IRBCs whereas CD36 functions as the 'holder' for providing stable binding.	[Li, Ang; Shi, Hui] SMART, Singapore, Singapore; [Lim, Tong Seng] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore; [Yin, Jing; Tan, Kevin Shyong Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Tan, Swee Jin; Lim, Chwee Teck] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Li, Zhengjun; Low, Boon Chuan; Lim, Chwee Teck] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Tan, Kevin Shyong Wei] Natl Univ Singapore, Inst Life Sci, Program Infect Dis, Singapore 117548, Singapore	Singapore-MIT Alliance for Research & Technology Centre (SMART); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Li, A (corresponding author), SMART, Singapore, Singapore.	mictank@nus.edu.sg; ctlim@nus.edu.sg	Low, Boon Chuan/AAU-7685-2021; Tan, Kevin/C-9653-2014; Low, Boon Chuan/H-8049-2012; Lim, chwee Teck/B-3307-2011	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Lim, chwee Teck/0000-0003-4019-9782; /0000-0002-7437-5687				AIKAWA M, 1992, MEM I OSWALDO CRUZ, V87, P297, DOI 10.1590/S0074-02761992000700051; [Anonymous], REFORMA MED; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Baenziger N L, 1974, Methods Enzymol, V31, P149; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Baruch DI, 1999, BLOOD, V94, P2121, DOI 10.1182/blood.V94.6.2121.418k09_2121_2127; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; COOKE BM, 1995, EXP PARASITOL, V80, P116, DOI 10.1006/expr.1995.1013; Cooke BM, 1998, MOL MICROBIOL, V30, P83, DOI 10.1046/j.1365-2958.1998.01040.x; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; DAVIET L, 1995, BIOCHEM J, V305, P221, DOI 10.1042/bj3050221; Dobrowsky TM, 2008, J VIROL, V82, P7022, DOI 10.1128/JVI.00053-08; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Ebner A, 2007, ULTRAMICROSCOPY, V107, P922, DOI 10.1016/j.ultramic.2007.02.035; Eda S, 2002, CELL PHYSIOL BIOCHEM, V12, P373, DOI 10.1159/000067908; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Hanley W, 2003, J BIOL CHEM, V278, P10556, DOI 10.1074/jbc.M213233200; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Korn C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.138103; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Li A, 2006, J MICROBIOL METH, V66, P434, DOI 10.1016/j.mimet.2006.01.009; Liu F, 2003, CELL BIOCHEM BIOPHYS, V38, P251, DOI 10.1385/CBB:38:3:251; LUSE SA, 1971, AM J TROP MED HYG, V20, P655, DOI 10.4269/ajtmh.1971.20.655; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MILLER LH, 1969, AM J TROP MED HYG, V18, P860, DOI 10.4269/ajtmh.1969.18.860; Nagao E, 2000, J STRUCT BIOL, V130, P34, DOI 10.1006/jsbi.2000.4236; O'Connell D, 2007, NAT REV MICROBIOL, V5, P655, DOI 10.1038/nrmicro1737; OCKENHOUSE CF, 1993, INFECT IMMUN, V61, P2229, DOI 10.1128/IAI.61.5.2229-2232.1993; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Riener CK, 2003, ANAL CHIM ACTA, V479, P59, DOI 10.1016/S0003-2670(02)01373-9; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UDEINYA IJ, 1981, SCIENCE, V213, P555, DOI 10.1126/science.7017935; Winograd E, 2004, MOL BIOCHEM PARASIT, V136, P243, DOI 10.1016/j.molbiopara.2004.04.005; Yipp BG, 2007, MICROCIRCULATION, V14, P593, DOI 10.1080/10739680701404705	52	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e16929	10.1371/journal.pone.0016929	http://dx.doi.org/10.1371/journal.pone.0016929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437286	Green Published, Green Submitted, gold			2022-12-27	WOS:000288514600002
J	Brett, CL; Kallay, L; Hua, ZL; Green, R; Chyou, A; Zhang, YQ; Graham, TR; Donowitz, M; Rao, R				Brett, Christopher L.; Kallay, Laura; Hua, Zhaolin; Green, Richard; Chyou, Anthony; Zhang, Yongqiang; Graham, Todd R.; Donowitz, Mark; Rao, Rajini			Genome-Wide Analysis Reveals the Vacuolar pH-Stat of Saccharomyces cerevisiae	PLOS ONE			English	Article							ORGANELLE ACIDIFICATION; TRANSLOCASE ACTIVITY; PROTEIN TRAFFICKING; PLASMA-MEMBRANE; YEAST MUTANT; PROTON PUMPS; C DISEASE; H+-ATPASE; GOLGI; TRANSPORT	Protons, the smallest and most ubiquitous of ions, are central to physiological processes. Transmembrane proton gradients drive ATP synthesis, metabolite transport, receptor recycling and vesicle trafficking, while compartmental pH controls enzyme function. Despite this fundamental importance, the mechanisms underlying pH homeostasis are not entirely accounted for in any organelle or organism. We undertook a genome-wide survey of vacuole pH (pH(v)) in 4,606 single-gene deletion mutants of Saccharomyces cerevisiae under control, acid and alkali stress conditions to reveal the vacuolar pH-stat. Median pHv (5.27 +/- 0.13) was resistant to acid stress (5.28 +/- 0.14) but shifted significantly in response to alkali stress (5.83 +/- 0.13). Of 107 mutants that displayed aberrant pHv under more than one external pH condition, functional categories of transporters, membrane biogenesis and trafficking machinery were significantly enriched. Phospholipid flippases, encoded by the family of P4-type ATPases, emerged as pH regulators, as did the yeast ortholog of Niemann Pick Type C protein, implicated in sterol trafficking. An independent genetic screen revealed that correction of pHv dysregulation in a neo1(ts) mutant restored viability whereas cholesterol accumulation in human NPC1(-/-) fibroblasts diminished upon treatment with a proton ionophore. Furthermore, while it is established that lumenal pH affects trafficking, this study revealed a reciprocal link with many mutants defective in anterograde pathways being hyperacidic and retrograde pathway mutants with alkaline vacuoles. In these and other examples, pH perturbations emerge as a hitherto unrecognized phenotype that may contribute to the cellular basis of disease and offer potential therapeutic intervention through pH modulation.	[Brett, Christopher L.; Kallay, Laura; Chyou, Anthony; Zhang, Yongqiang; Donowitz, Mark; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Hua, Zhaolin; Green, Richard; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Vanderbilt University; Johns Hopkins University	Brett, CL (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	cbrett@alcor.concordia.ca; rrao@jhmi.edu		Hua, Zhaolin/0000-0001-9242-1387	National Institutes of Health [R01 DK54214, GM62367, DK26523]; Johns Hopkins University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214, R01DK026523, R01DK061765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 DK54214 to R.R., GM62367 to T.R.G. and DK26523 to M.D. C.L.B. was a predoctoral fellow of the American Heart Association. A.C. received support from a Provost's Undergraduate Research Award of the Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Battisti C, 2003, MOVEMENT DISORD, V18, P1405, DOI 10.1002/mds.10541; Berger AC, 2005, TRAFFIC, V6, P907, DOI 10.1111/j.1600-0854.2005.00327.x; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Borrelly G, 2001, P NATL ACAD SCI USA, V98, P9660, DOI 10.1073/pnas.161215198; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2006, FEBS LETT, V580, P717, DOI 10.1016/j.febslet.2005.12.103; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Jacobs NL, 1997, J LIPID RES, V38, P1973; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kaufmann SHE, 2008, NAT IMMUNOL, V9, P705, DOI 10.1038/ni0708-705; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Lin M, 2009, FEBS J, V276, P7253, DOI 10.1111/j.1742-4658.2009.07433.x; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; MELLMAN I, 1992, J EXP BIOL, V172, P39; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Muthusamy BP, 2009, MOL BIOL CELL, V20, P2920, DOI 10.1091/mbc.E08-10-1036; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nieland TJF, 2004, TRAFFIC, V5, P478, DOI 10.1111/j.1398-9219.2004.00193.x; NIKAWA J, 1983, EUR J BIOCHEM, V131, P223, DOI 10.1111/j.1432-1033.1983.tb07253.x; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ohgaki R, 2010, MOL BIOL CELL, V21, P1293, DOI 10.1091/mbc.E09-09-0767; Palma M, 2009, FEMS YEAST RES, V9, P526, DOI 10.1111/j.1567-1364.2009.00511.x; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; PRESTON RA, 1992, GENETICS, V131, P551; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Sakano K, 1998, PLANT CELL PHYSIOL, V39, P467, DOI 10.1093/oxfordjournals.pcp.a029393; Schellmann S, 2009, CURR OPIN PLANT BIOL, V12, P670, DOI 10.1016/j.pbi.2009.09.005; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; WALLS KC, J BIOL CHEM, V285, P10497; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	55	60	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17619	10.1371/journal.pone.0017619	http://dx.doi.org/10.1371/journal.pone.0017619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423800	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000288512400017
J	Papoiu, ADP; Tey, HL; Coghill, RC; Wang, H; Yosipovitch, G				Papoiu, Alexandru D. P.; Tey, Hong Liang; Coghill, Robert C.; Wang, Hui; Yosipovitch, Gil			Cowhage-Induced Itch as an Experimental Model for Pruritus. A Comparative Study with Histamine-Induced Itch	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; ATOPIC-DERMATITIS; PAIN MEASUREMENT; SEVERITY; PROTEINASE; SENSATION; PATHWAYS; HEAT; SKIN	Background: Histamine is the prototypical pruritogen used in experimental itch induction. However, in most chronic pruritic diseases, itch is not predominantly mediated by histamine. Cowhage-induced itch, on the other hand, seems more characteristic of itch occurring in chronic pruritic diseases. Objectives: We tested the validity of cowhage as an itch-inducing agent by contrasting it with the classical itch inducer, histamine, in healthy subjects and atopic dermatitis (AD) patients. We also investigated whether there was a cumulative effect when both agents were combined. Methods: Fifteen healthy individuals and fifteen AD patients were recruited. Experimental itch induction was performed in eczema-free areas on the volar aspects of the forearm, using different itch inducers: histamine, cowhage and their combination thereof. Itch intensity was assessed continuously for 5.5 minutes after stimulus application using a computer-assisted visual analogue scale (COVAS). Results: In both healthy and AD subjects, the mean and peak intensity of itch were higher after the application of cowhage compared to histamine, and were higher after the combined application of cowhage and histamine, compared to histamine alone (p < 0.0001 in all cases). Itch intensity ratings were not significantly different between healthy and AD subjects for the same itch inducer used; however AD subjects exhibited a prolonged itch response in comparison to healthy subjects (p < 0.001). Conclusions: Cowhage induced a more intense itch sensation compared to histamine. Cowhage was the dominant factor in itch perception when both pathways were stimulated in the same time. Cowhage-induced itch is a suitable model for the study of itch in AD and other chronic pruritic diseases, and it can serve as a new model for testing antipruritic drugs in humans.	[Papoiu, Alexandru D. P.; Tey, Hong Liang; Wang, Hui; Yosipovitch, Gil] Wake Forest Univ, Bowman Gray Sch Med, Dept Dermatol, Winston Salem, NC 27103 USA; [Coghill, Robert C.; Yosipovitch, Gil] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27103 USA; [Yosipovitch, Gil] Wake Forest Univ, Bowman Gray Sch Med, Dept Regenerat Med, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Papoiu, ADP (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Dermatol, Winston Salem, NC 27103 USA.	gyosipov@wfubmc.edu	Yosipovitch, Gil/K-3517-2019; Tey, Hong Liang/GON-9676-2022		NIH (NIAMS) [5R01AR055902]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055902] Funding Source: NIH RePORTER	NIH (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The current work was supported by NIH (NIAMS) award 5R01AR055902 to Dr. Gil Yosipovitch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Dawn A, 2009, BRIT J DERMATOL, V160, P642, DOI 10.1111/j.1365-2133.2008.08941.x; Goon ATJ, 2007, INT J DERMATOL, V46, P1023, DOI 10.1111/j.1365-4632.2007.03152.x; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Ikoma A, 2003, ARCH DERMATOL, V139, P1455, DOI 10.1001/archderm.139.11.1455; Ishiuji Y, 2008, BRIT J DERMATOL, V158, P78, DOI 10.1111/j.1365-2133.2007.08281.x; Ishiuji Y, 2009, BRIT J DERMATOL, V161, P1072, DOI 10.1111/j.1365-2133.2009.09308.x; Johanek LM, 2007, J NEUROSCI, V27, P7490, DOI 10.1523/JNEUROSCI.1249-07.2007; Koyama Y, 2004, PAIN, V107, P256, DOI 10.1016/j.pain.2003.11.007; LaMotte RH, 2009, J NEUROPHYSIOL, V101, P1430, DOI 10.1152/jn.91268.2008; MELTON FM, 1950, J INVEST DERMATOL, V15, P325, DOI 10.1038/jid.1950.106; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Reddy VB, 2010, J INVEST DERMATOL, V130, P1468, DOI 10.1038/jid.2009.430; Rosier EM, 2002, PAIN, V98, P205, DOI 10.1016/S0304-3959(02)00048-9; Schmelz M, 2010, NEUROSCI BIOBEHAV R, V34, P171, DOI 10.1016/j.neubiorev.2008.12.004; SHELLEY WB, 1957, ARCH DERMATOL, V76, P296, DOI 10.1001/archderm.1957.01550210020004; SHELLEY WB, 1955, ARCH DERMATOL, V72, P399, DOI 10.1001/archderm.1955.03730350001001; Sikand P, 2009, PAIN, V144, P66, DOI 10.1016/j.pain.2009.03.001; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Wang H, 2010, BRIT J DERMATOL, V162, P1023, DOI 10.1111/j.1365-2133.2009.09628.x; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yang HJ, 2010, ASIAN PAC J ALLERGY, V28, P130	25	70	72	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17786	10.1371/journal.pone.0017786	http://dx.doi.org/10.1371/journal.pone.0017786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423808	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400028
J	Martin, S; Herder, C; Schloot, NC; Koenig, W; Heise, T; Heinemann, L; Kolb, H				Martin, Stephan; Herder, Christian; Schloot, Nanette C.; Koenig, Wolfgang; Heise, Tim; Heinemann, Lutz; Kolb, Hubert		DIATOR Study Grp	Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; COENZYME-A REDUCTASE; SOLUBLE FORMS; STATINS; INTERFERON; DISEASE; ONSET; IMMUNOMODULATION; INHIBITION	Background: Recent evidence suggests that the lipid-lowering agent atorvastatin is also a potent immunomodulator. The aim of this study was to investigate the possible effect of atorvastatin on the decline of residual beta cell function in recent-onset type 1 diabetes. Methods and Findings: The randomised placebo-controlled Diabetes and Atorvastatin (DIATOR) Trial included 89 patients with newly diagnosed type 1 diabetes and islet autoantibodies (mean age 30 years, 40% females), in 12 centres in Germany. Patients received placebo or 80 mg/d atorvastatin for 18 months. As primary outcome stimulated serum C-peptide levels were determined 90 min after a standardized liquid mixed meal. An intent-to-treat analysis was performed. Fasting and stimulated C-peptide levels were not significantly different between groups at 18 months. However, median fasting serum C-peptide levels dropped from baseline to 12 and 18 months in the placebo group (from 0. 34 to 0.23 and 0.20 nmol/l, p<0.001) versus a nonsignificant decline in the atorvastatin group (from 0.34 to 0.27 and 0.30 nmol/l, ns). Median stimulated C-peptide concentrations declined between baseline and 12 months (placebo from 0.89 to 0.71 nmol/l, atorvastatin from 0.88 to 0.73 nmol/l, p<0.01 each) followed by a major loss by month 18 in the placebo group (to 0.48 nmol/l, p = 0.047) but not in the atorvastatin group (to 0.71 nmol/l, ns). Median levels of total cholesterol and Creactive protein decreased in the atorvastatin group only (p<0.001 and p = 0.04). Metabolic control was similar between groups. Conclusions: Atorvastatin treatment did not significantly preserve beta cell function although there may have been a slower decline of beta-cell function which merits further study.	[Martin, Stephan; Herder, Christian; Schloot, Nanette C.; Kolb, Hubert] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Schloot, Nanette C.] Univ Hosp, Dept Med, Dusseldorf, Germany; [Schloot, Nanette C.] Univ Hosp, Dept Metab Dis, Dusseldorf, Germany; [Koenig, Wolfgang] Univ Ulm, Dept Internal Med 2, Med Ctr, D-7900 Ulm, Germany; [Heise, Tim; Heinemann, Lutz] Profil Inst Metab Res, Neuss, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ulm University; Profil	Martin, S (corresponding author), Verbund Katholischer Kliniken Dusseldorf, W German Ctr Diabet & Hlth, Dusseldorf, Germany.	stephan.martin@uni-duesseldorf.de		Koenig, Wolfgang/0000-0002-2064-9603; Nowotny, Bettina/0000-0002-0671-9644	Pfizer Pharma GmbH, Berlin, Germany	Pfizer Pharma GmbH, Berlin, Germany	The trial was supported by an unrestricted grant from Pfizer Pharma GmbH, Berlin, Germany. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. T. Heise and Lutz Heinemann are employees of the clinical research organization Profil Institute of Metabolic Research who organized and handled the trial, collected and analyzed data as defined in the study protocol, but did not participate in the decision to publish or the preparation of the manuscript, except for contributing to the final revision.	[Anonymous], 1988, Diabetes, V37, P1574; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Baker WL, 2010, DIABETES RES CLIN PR, V87, P98, DOI 10.1016/j.diabres.2009.10.008; Birnbaum G, 2008, NEUROLOGY, V71, P1390, DOI 10.1212/01.wnl.0000319698.40024.1c; Blank N, 2007, J IMMUNOL, V179, P3613, DOI 10.4049/jimmunol.179.6.3613; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bonnet J, 2008, CLIN THER, V30, P2298, DOI 10.1016/j.clinthera.2008.12.023; Bu DX, 2010, J CLIN INVEST, V120, P1961, DOI 10.1172/JCI41384; Contreras JL, 2002, TRANSPLANTATION, V74, P1063, DOI 10.1097/00007890-200210270-00001; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Hakamada-Taguchi R, 2003, CIRC RES, V93, P948, DOI 10.1161/01.RES.0000101298.76864.14; Hanifi-Moghaddam P, 2003, DIABETES, V52, P1137, DOI 10.2337/diabetes.52.5.1137; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2009, DIABETOLOGIA, V52, P433, DOI 10.1007/s00125-008-1243-1; Kim YC, 2010, IMMUNOLOGY, V130, P484, DOI 10.1111/j.1365-2567.2010.03269.x; Kolb H, 2001, DIABETOLOGIA, V44, P1349, DOI 10.1007/s001250100636; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; LAMPETER ER, 1992, DIABETES, V41, P1668, DOI 10.2337/diabetes.41.12.1668; Lanzillo R, 2010, MULT SCLER J, V16, P450, DOI 10.1177/1352458509358909; Lozanoska-Ochser B, 2006, DIABETES, V55, P1004, DOI 10.2337/diabetes.55.04.06.db05-1261; Marchand KC, 2010, AM J PHYSIOL-ENDOC M, V299, pE92, DOI 10.1152/ajpendo.00132.2010; Martin S, 1998, DIABETOLOGIA, V41, P1298, DOI 10.1007/s001250051068; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Montecucco F, 2009, RHEUMATOLOGY, V48, P233, DOI 10.1093/rheumatology/ken466; Palomer X, 2005, DIABETOLOGIA, V48, P1671, DOI 10.1007/s00125-005-1834-z; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; ROEP BO, 1994, LANCET, V343, P1590, DOI 10.1016/S0140-6736(94)93055-4; Rudick RA, 2009, NEUROLOGY, V72, P1989, DOI 10.1212/WNL.0b013e3181a92b96; Rydgren T, 2007, J PHARMACOL EXP THER, V323, P180, DOI 10.1124/jpet.107.122655; Sosenko JM, 2004, DIABETES, V53, pA425; Waldron-Lynch F, 2009, ENDOCRIN METAB CLIN, V38, P303, DOI 10.1016/j.ecl.2009.01.005; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zhang Song, 2008, Zhonghua Yi Xue Za Zhi, V88, P568	36	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17554	10.1371/journal.pone.0017554	http://dx.doi.org/10.1371/journal.pone.0017554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412424	Green Published, gold, Green Submitted			2022-12-27	WOS:000288247800015
J	Cortese, MS; Etxebeste, O; Garzia, A; Espeso, EA; Ugalde, U				Cortese, Marc S.; Etxebeste, Oier; Garzia, Aitor; Espeso, Eduardo A.; Ugalde, Unai			Elucidation of Functional Markers from Aspergillus nidulans Developmental Regulator FlbB and Their Phylogenetic Distribution	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FLBB; INTRINSICALLY UNSTRUCTURED PROTEINS; NUCLEAR EXPORT SIGNAL; DNA-BINDING ACTIVITY; ASEXUAL DEVELOPMENT; LEUCINE-ZIPPER; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; REDOX REGULATION; STRUCTURAL BASIS	Aspergillus nidulans is a filamentous fungus widely used as a model for biotechnological and clinical research. It is also used as a platform for the study of basic eukaryotic developmental processes. Previous studies identified and partially characterized a set of proteins controlling cellular transformations in this ascomycete. Among these proteins, the bZip type transcription factor FlbB is a key regulator of reproduction, stress responses and cell-death. Our aim here was the prediction, through various bioinformatic methods, of key functional residues and motifs within FlbB in order to inform the design of future laboratory experiments and further the understanding of the molecular mechanisms that control fungal development. A dataset of FlbB orthologs and those of its key interaction partner FlbE was assembled from 40 members of the Pezizomycotina. Unique features were identified in each of the three structural domains of FlbB. The N-terminal region encoded a bZip transcription factor domain with a novel histidine-containing DNA binding motif while the dimerization determinants exhibited two distinct profiles that segregated by class. The C-terminal region of FlbB showed high similarity with the AP-1 family of stress response regulators but with variable patterns of conserved cysteines that segregated by class and order. Motif conservation analysis revealed that nine FlbB orthologs belonging to the Eurotiales order contained a motif in the central region that could mediate interaction with FlbE. The key residues and motifs identified here provide a basis for the design of follow-up experimental investigations. Additionally, the presence or absence of these residues and motifs among the FlbB orthologs could help explain the differences in the developmental programs among fungal species as well as define putative complementation groups that could serve to extend known functional characterizations to other species.	[Cortese, Marc S.; Etxebeste, Oier; Garzia, Aitor; Ugalde, Unai] Univ Basque Country, Fac Chem, Dept Appl Chem, San Sebastian, Spain; [Cortese, Marc S.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Espeso, Eduardo A.] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid, Spain	University of Basque Country; Basque Foundation for Science; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Cortese, MS (corresponding author), Univ Basque Country, Fac Chem, Dept Appl Chem, San Sebastian, Spain.	marc_cortese@ehu.es	Espeso, Eduardo A/C-5259-2011; Espeso, Eduardo A/AAC-7238-2022; Etxebeste, Oier/H-8064-2019; Cortese, Marc/G-4026-2010	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Etxebeste, Oier/0000-0002-9786-6091; Garzia, Aitor/0000-0002-6270-1369; Cortese, Marc/0000-0002-5903-0525	Basque Government [IT393-10]; Spanish Ministerio de Educacion y Ciencia [BFU2009-08701]; University of the Basque Country	Basque Government(Basque Government); Spanish Ministerio de Educacion y Ciencia(Spanish Government); University of the Basque Country	This work was supported by the Basque Government (http://www.hezkuntza.ejgv.euskadi.net) through grant IT393-10 to U.U. and by the Spanish Ministerio de Educacion y Ciencia (www.mec.es) through grant BFU2009-08701 to E.A.E. M.S.C. was a contract researcher of the Ikerbasque program of the Basque Government (www.ikerbasque.net). O.E. was a contract researcher of the University of the Basque Country (www.ehu.es). A.G. held a predoctoral fellowship from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Acharya A, 2002, BIOCHEMISTRY-US, V41, P14122, DOI 10.1021/bi020486r; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Amoutzias GD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-107; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Asano Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1800, DOI 10.1271/bbb.70133; Bayram O, 2008, FUNGAL GENET BIOL, V45, P127, DOI 10.1016/j.fgb.2007.06.001; Bedard JEJ, 2007, HUM MOL GENET, V16, P187, DOI 10.1093/hmg/ddl461; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; de Bakker PIW, 2001, BIOINFORMATICS, V17, P748, DOI 10.1093/bioinformatics/17.8.748; Deppmann CD, 2003, BIOCHEM J, V374, P423, DOI 10.1042/BJ20030455; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Durbin R., 1998, BIOL SEQUENCE ANAL P; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eddy Sean R, 2009, Genome Inform, V23, P205; Etxebeste O, 2008, EUKARYOT CELL, V7, P38, DOI 10.1128/EC.00207-07; Etxebeste O, 2010, TRENDS MICROBIOL, V18, P569, DOI 10.1016/j.tim.2010.09.007; Etxebeste O, 2009, MOL MICROBIOL, V73, P775, DOI 10.1111/j.1365-2958.2009.06804.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fleck CB, 2009, FUNGAL GENET BIOL, V46, P473, DOI 10.1016/j.fgb.2009.03.004; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Garzia A, 2010, MOL MICROBIOL, V75, P1314, DOI 10.1111/j.1365-2958.2010.07063.x; Garzia A, 2009, MOL MICROBIOL, V71, P172, DOI 10.1111/j.1365-2958.2008.06520.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hesse SJA, 2002, EUR J BIOCHEM, V269, P3485, DOI 10.1046/j.1432-1033.2002.03042.x; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Irimia M, 2007, TRENDS GENET, V23, P321, DOI 10.1016/j.tig.2007.04.001; Isoyama T, 2001, J BIOL CHEM, V276, P21863, DOI 10.1074/jbc.M009258200; KAFER E, 1965, GENETICS, V52, P217; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; KUES M, 2006, MYCOTA GROWTH DIFFER, P263; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Kwon NJ, 2010, FUNGAL GENET BIOL, V47, P981, DOI 10.1016/j.fgb.2010.08.009; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MARTINELLI SD, 1994, ASPERGILLUS 50 YEARS; Maruyama JI, 2005, BIOCHEM BIOPH RES CO, V331, P1081, DOI 10.1016/j.bbrc.2005.03.233; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; MIMS C, 1988, PROTOPLASMA, V244, P132; Momany M, 2005, MED MYCOL, V43, pS23, DOI 10.1080/13693780400024263; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; POGGELER M, 2006, MYCOTA GROWTH DIFFER, P325; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Puttick J, 2008, BBA-PROTEINS PROTEOM, V1784, P100, DOI 10.1016/j.bbapap.2007.07.008; SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731; Sharon Itai, 2009, V541, P61, DOI 10.1007/978-1-59745-243-4_4; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Shen WC, 1998, GENETICS, V148, P1031; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Tanaka A, 2002, BBA-GENE STRUCT EXPR, V1576, P176, DOI 10.1016/S0167-4781(02)00286-5; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Umeda M, 2005, GENETICS, V171, P7, DOI 10.1534/genetics.105.042598; Vandenbussche M, 2003, NUCLEIC ACIDS RES, V31, P4401, DOI 10.1093/nar/gkg642; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Virag A, 2007, MOL MICROBIOL, V66, P1579, DOI 10.1111/j.1365-2958.2007.06021.x; WIESER J, 1994, CURR GENET, V27, P62, DOI 10.1007/BF00326580; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xiao P, 2010, EUKARYOT CELL, V9, P1711, DOI 10.1128/EC.00198-10; Yamada T, 2006, MED MYCOL, V44, P243, DOI 10.1080/13693780500410909; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004	81	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17505	10.1371/journal.pone.0017505	http://dx.doi.org/10.1371/journal.pone.0017505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423749	Green Submitted, Green Published, gold			2022-12-27	WOS:000288219100010
J	Town, SM; McCabe, BJ				Town, Stephen Michael; McCabe, Brian John			Neuronal Plasticity and Multisensory Integration in Filial Imprinting	PLOS ONE			English	Article							SUPERIOR COLLICULUS; DOMESTIC CHICK; MEMORY SYSTEM; BRAIN; FAMILIARITY; TRACE	Many organisms sample their environment through multiple sensory systems and the integration of multisensory information enhances learning. However, the mechanisms underlying multisensory memory formation and their similarity to unisensory mechanisms remain unclear. Filial imprinting is one example in which experience is multisensory, and the mechanisms of unisensory neuronal plasticity are well established. We investigated the storage of audiovisual information through experience by comparing the activity of neurons in the intermediate and medial mesopallium of imprinted and naive domestic chicks (Gallus gallus domesticus) in response to an audiovisual imprinting stimulus and novel object and their auditory and visual components. We find that imprinting enhanced the mean response magnitude of neurons to unisensory but not multisensory stimuli. Furthermore, imprinting enhanced responses to incongruent audiovisual stimuli comprised of mismatched auditory and visual components. Our results suggest that the effects of imprinting on the unisensory and multisensory responsiveness of IMM neurons differ and that IMM neurons may function to detect unexpected deviations from the audiovisual imprinting stimulus.	[Town, Stephen Michael; McCabe, Brian John] Univ Cambridge, Subdept Anim Behav, Dept Zool, Cambridge CB3 8AA, England	University of Cambridge	Town, SM (corresponding author), Univ Cambridge, Subdept Anim Behav, Dept Zool, Cambridge CB3 8AA, England.	stephentown42@gmail.com		McCabe, Brian/0000-0003-4669-1364; Town, Stephen/0000-0003-1375-7769	BBSRC; Balfour Trust; BBSRC [BB/H018948/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [S18043, BB/H018948/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Balfour Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a BBSRC studentship and a research grant from the Balfour Trust fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; BRADLEY P, 1985, J ANAT, V140, P577; BROWN MW, 1994, EUR J NEUROSCI, V6, P1479, DOI 10.1111/j.1460-9568.1994.tb01009.x; CIPOLLANETO J, 1979, J PHYSIOL-LONDON, V295, pP8; DAVIES DC, 1983, DEV BRAIN RES, V10, P251, DOI 10.1016/0165-3806(83)90141-4; DiCarlo JJ, 1996, J NEUROSCI METH, V64, P75, DOI 10.1016/0165-0270(95)00113-1; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Hein G, 2007, J NEUROSCI, V27, P7881, DOI 10.1523/JNEUROSCI.1740-07.2007; Horn G, 2001, P NATL ACAD SCI USA, V98, P5282, DOI 10.1073/pnas.091094798; Horn G, 2004, NAT REV NEUROSCI, V5, P108, DOI 10.1038/nrn1324; Jackson C, 2008, CURR BIOL, V18, P393, DOI 10.1016/j.cub.2008.01.062; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; Kim RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001532; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; MCCABE BJ, 1981, BRAIN RES, V205, P29, DOI 10.1016/0006-8993(81)90717-4; McCabe BJ, 2001, NEUROSCIENCE, V105, P317, DOI 10.1016/S0306-4522(01)00186-5; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Nakamori T, 2010, J NEUROSCI, V30, P4467, DOI 10.1523/JNEUROSCI.3532-09.2010; Naumer MJ, 2009, CEREB CORTEX, V19, P1641, DOI 10.1093/cercor/bhn200; NICOL AU, 1995, EUR J NEUROSCI, V7, P766, DOI 10.1111/j.1460-9568.1995.tb00680.x; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Sluckin W, 1972, IMPRINTING EARLY LEA; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein BE., 1993, MERGING SENSES; Tanabe HC, 2005, J NEUROSCI, V25, P6409, DOI 10.1523/JNEUROSCI.0636-05.2005; TAYLOR A, 1967, ANIM BEHAV, V15, P514, DOI 10.1016/0003-3472(67)90052-8; VANKAMPEN HS, 1991, BEHAVIOUR, V117, P303, DOI 10.1163/156853991X00607; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Zahar Y, 2009, J NEUROPHYSIOL, V101, P2380, DOI 10.1152/jn.91193.2008	33	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17777	10.1371/journal.pone.0017777	http://dx.doi.org/10.1371/journal.pone.0017777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423770	Green Submitted, Green Published, gold			2022-12-27	WOS:000288219100033
J	Twiner, MJ; Fire, S; Schwacke, L; Davidson, L; Wang, ZH; Morton, S; Roth, S; Balmer, B; Rowles, TK; Wells, RS				Twiner, Michael J.; Fire, Spencer; Schwacke, Lori; Davidson, Leigh; Wang, Zhihong; Morton, Steve; Roth, Stephen; Balmer, Brian; Rowles, Teresa K.; Wells, Randall S.			Concurrent Exposure of Bottlenose Dolphins (Tursiops truncatus) to Multiple Algal Toxins in Sarasota Bay, Florida, USA	PLOS ONE			English	Article							SENSITIVE SODIUM-CHANNELS; IN-VITRO EXPOSURE; DOMOIC ACID; KARENIA-BREVIS; RED-TIDE; SEA LIONS; BREVETOXIN METABOLITES; MONTEREY BAY; FOOD-WEB; CALIFORNIA	Sentinel species such as bottlenose dolphins (Tursiops truncatus) can be impacted by large-scale mortality events due to exposure to marine algal toxins. In the Sarasota Bay region (Gulf of Mexico, Florida, USA), the bottlenose dolphin population is frequently exposed to harmful algal blooms (HABs) of Karenia brevis and the neurotoxic brevetoxins (PbTx; BTX) produced by this dinoflagellate. Live dolphins sampled during capture-release health assessments performed in this region tested positive for two HAB toxins; brevetoxin and domoic acid (DA). Over a ten-year study period (2000-2009) we have determined that bottlenose dolphins are exposed to brevetoxin and/or DA on a nearly annual basis (i.e., DA: 2004, 2005, 2006, 2008, 2009; brevetoxin: 2000, 2004, 2005, 2008, 2009) with 36% of all animals testing positive for brevetoxin (n = 118) and 53% positive for DA (n = 83) with several individuals (14%) testing positive for both neurotoxins in at least one tissue/fluid. To date there have been no previously published reports of DA in southwestern Florida marine mammals, however the May 2008 health assessment coincided with a Pseudo-nitzschia pseudodelicatissima bloom that was the likely source of DA observed in seawater and live dolphin samples. Concurrently, both DA and brevetoxin were observed in common prey fish. Although no Pseudo-nitzschia bloom was identified the following year, DA was identified in seawater, fish, sediment, snails, and dolphins. DA concentrations in feces were positively correlated with hematologic parameters including an increase in total white blood cell (p = 0.001) and eosinophil (p < 0.001) counts. Our findings demonstrate that dolphins within Sarasota Bay are commonly exposed to two algal toxins, and provide the impetus to further explore the potential long-term impacts on bottlenose dolphin health.	[Twiner, Michael J.; Fire, Spencer; Davidson, Leigh; Wang, Zhihong; Morton, Steve] Natl Ocean Serv, Marine Biotoxins Program, Natl Ocean & Atmospher Adm, Charleston, SC USA; [Twiner, Michael J.] Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA; [Schwacke, Lori] Natl Ocean Serv, Ctr Human Hlth Risks, Hollings Marine Lab, Natl Ocean & Atmospher Adm, Charleston, SC USA; [Roth, Stephen] Natl Ocean Serv, Coastal Ecol Program, Natl Ocean & Atmospher Adm, Charleston, SC USA; [Balmer, Brian; Wells, Randall S.] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Rowles, Teresa K.] Natl Ocean & Atmospher Adm Fisheries, Off Protected Resources, Silver Spring, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of Michigan System; University of Michigan; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Mote Marine Laboratory & Aquarium; National Oceanic Atmospheric Admin (NOAA) - USA	Twiner, MJ (corresponding author), Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA.	mtwiner@umd.umich.edu	Fire, Spencer/P-6040-2014	Fire, Spencer/0000-0002-1657-790X; Balmer, Brian/0000-0001-9734-4042	NOAA; NOAA Fisheries; Batchelor Foundation; Dolphin Quest; Georgia Aquarium; Disney's Animal Programs; International Whaling Commission; National Marine Fisheries Service	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); Batchelor Foundation; Dolphin Quest; Georgia Aquarium; Disney's Animal Programs; International Whaling Commission; National Marine Fisheries Service	The authors would like to acknowledge their funding sources, including the NOAA Marine Biotoxins Program (www.chbr.noaa.gov/habar/default.aspx), NOAA Fisheries (www.nmfs.noaa.gov), the Batchelor Foundation, Dolphin Quest (www.dolphinquest.com), the Georgia Aquarium (www.georgiaaquarium.org), Disney's Animal Programs (disney.go.com/index), and the International Whaling Commission (iwcoffice.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sample collection during bottlenose dolphin health assessments in Sarasota Bay were made possible by the efforts of the staff, students, and volunteers of the Chicago Zoological Society's Sarasota Dolphin Research Program along with collaborating scientists and veterinarians from a number of institutions. Funding for health assessments and fish collections was provided by the National Marine Fisheries Service, Dolphin Quest, and Disney's Animal Programs. The authors would like to thank Dr. Gary Kirkpatrick of the Phytoplankton Ecology Program, Mote Marine Laboratory, Sarasota, FL for generously supplying cell count data, Hannah Giddens, Jen Maucher, Tod Leighfield, Seana Powers, Liz Symon, and Valeriy Palubok for technical help, and Larry Fulford for dolphin capturerelease and fish collections. Disclaimer: This publication does not constitute an endorsement of any commercial product or intend to be an opinion beyond scientific or other results obtained by the National Oceanic and Atmospheric Administration (NOAA). No reference shall be made to NOAA, or this publication furnished by NOAA, to any advertising or sales promotion which would indicate or imply that NOAA recommends or endorses any proprietary product mentioned herein, or which has as its purpose an interest to cause the advertised product to be used or purchased because of this publication.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; BADEN DG, 1982, TOXICON, V20, P457, DOI 10.1016/0041-0101(82)90009-5; BADEN DG, 1984, SEAFOOD TOXINS, P359; Bargu S, 2002, MAR ECOL PROG SER, V237, P209, DOI 10.3354/meps237209; Barros N.B., 1990, P309; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Blanco J, 2002, AQUAT TOXICOL, V60, P111, DOI 10.1016/S0166-445X(01)00274-0; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; Burns JM, 2007, J ENVIRON MONITOR, V9, P1373, DOI 10.1039/b713101a; CATTERALL WA, 1981, MOL PHARMACOL, V19, P345; CATTET M, 1993, TOXICON, V31, P1483, DOI 10.1016/0041-0101(93)90214-4; DARCY G, SYNOPSIS BIOL DATA P; DAVIS CC, 1948, BOT GAZ, V109, P358, DOI 10.1086/335488; Dawes C.J., 1985, P S SUBTR TROP SEAGR, P25; DICKEY RW, 1992, TOXICON, V30, P355, DOI 10.1016/0041-0101(92)90877-8; Ferdin ME, 2002, TOXICON, V40, P1259, DOI 10.1016/S0041-0101(02)00129-0; FIRE SE, COOCCURRENC IN PRESS; Fire SE, 2008, MAR ECOL PROG SER, V368, P283, DOI 10.3354/meps07643; Fire SE, 2008, MAR MAMMAL SCI, V24, P831, DOI 10.1111/j.1748-7692.2008.00221.x; Fire SE, 2007, MAR BIOL, V152, P827, DOI 10.1007/s00227-007-0733-x; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FRYXELL GA, 1990, NOVA HEDWIGIA S, V100, P171; Gannon DP, 2009, MAR ECOL PROG SER, V378, P171, DOI 10.3354/meps07853; Gulland FMD, 2002, VET REC, V150, P475; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hampson David R., 1998, Natural Toxins, V6, P153, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<153::AID-NT16>3.0.CO;2-1; Hasle G.R., 1978, PHYTOPLANKTON MANUAL, VVolume 6, P88; Hinton M, 2008, MAR ECOL PROG SER, V356, P251, DOI 10.3354/meps07267; HUANG JMC, 1984, J PHARMACOL EXP THER, V229, P615; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kvitek RG, 2008, MAR ECOL PROG SER, V367, P35, DOI 10.3354/meps07569; Leandro LF, 2010, MAR ECOL PROG SER, V398, P287, DOI 10.3354/meps08321; Lefebvre KA, 2002, TOXICON, V40, P971, DOI 10.1016/S0041-0101(02)00093-4; Lefebvre KA, 2001, MAR BIOL, V138, P693, DOI 10.1007/s002270000509; Lefebvre KA, 1999, NAT TOXINS, V7, P85, DOI 10.1002/(SICI)1522-7189(199905/06)7:3<85::AID-NT39>3.0.CO;2-Q; Lefebvre KA, 2009, TOXICOL SCI, V107, P65, DOI 10.1093/toxsci/kfn207; Levin M, 2010, J WILDLIFE DIS, V46, P541, DOI 10.7589/0090-3558-46.2.541; Levin M, 2008, MAR DRUGS, V6, P636, DOI 10.3390/md6040636; Liefer JD, 2009, HARMFUL ALGAE, V8, P706, DOI 10.1016/j.hal.2009.02.003; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; MASE B, EPIZOOTIC BOTTLENOSE; Maucher JA, 2005, TOXICON, V45, P607, DOI 10.1016/j.toxicon.2005.01.002; Maucher JM, 2007, ENVIRON SCI TECHNOL, V41, P563, DOI 10.1021/es0612605; McFARREN E. F., 1965, TOXICON, V3, P111, DOI 10.1016/0041-0101(65)90005-X; Mendoza WG, 2008, CHEMOSPHERE, V73, P1373, DOI 10.1016/j.chemosphere.2008.07.089; Morton SL, 1998, BOT MAR, V41, P565, DOI 10.1515/botm.1998.41.1-6.565; MOTTA PJ, 1995, B MAR SCI, V56, P185; MOYLE PB, 1988, INTRO ICHTHYOLOGY, P559; Murrell RN, 2009, ARCH TOXICOL, V83, P1009, DOI 10.1007/s00204-009-0443-x; Naar JP, 2007, TOXICON, V50, P707, DOI 10.1016/j.toxicon.2007.06.005; Nelson J.S., 1994, FISHES WORLD, P600; Odum W. E., 1970, MARINE FOOD CHAINS, P222; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pan YL, 2001, MAR ECOL PROG SER, V220, P83, DOI 10.3354/meps220083; Parsons ML, 1999, J PHYCOL, V35, P1368, DOI 10.1046/j.1529-8817.1999.3561368.x; Plakas SM, 2004, TOXICON, V44, P677, DOI 10.1016/j.toxicon.2004.07.027; Plakas SM, 2008, TOXICON, V52, P32, DOI 10.1016/j.toxicon.2008.04.174; POLI MA, 1995, J AOAC INT, V78, P538; Poli MA, 2000, TOXICON, V38, P981, DOI 10.1016/S0041-0101(99)00191-9; POLI MA, 1986, MOL PHARMACOL, V30, P129; QUILLIAM MA, 1989, ANAL CHEM, V61, pA1053, DOI 10.1021/ac00193a745; Ramsdell John S., 2008, P519; Roth PB, 2007, TOXICON, V50, P1175, DOI 10.1016/j.toxicon.2007.08.003; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwacke LH, 2002, ENVIRON TOXICOL CHEM, V21, P2752, DOI 10.1897/1551-5028(2002)021<2752:PRAORE>2.0.CO;2; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Schwacke LH, 2009, AM J VET RES, V70, P973, DOI 10.2460/ajvr.70.8.973; Sekula-Wood E, 2009, NAT GEOSCI, V2, P272, DOI 10.1038/NGEO472; STEIDINGER K, 1972, MARINE PHARMACOGNOSY, P179; Steidinger K.A., 1998, PHYSL ECOLOGY HARMFU, P133; SUZUKI CAM, 1993, FOOD CHEM TOXICOL, V31, P701, DOI 10.1016/0278-6915(93)90140-T; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Van Dolah F. M., 1994, Natural Toxins, V2, P189, DOI 10.1002/nt.2620020407; Van Dolah FM, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P85; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vigilant VL, 2007, MAR BIOL, V151, P2053, DOI 10.1007/s00227-007-0634-z; Virnstein R.W., 1983, Florida Scientist, V46, P363; Walsh CJ, 2008, MAR DRUGS, V6, P291, DOI 10.3390/md20080014; Wang ZH, 2004, TOXICON, V43, P455, DOI 10.1016/j.toxicon.2004.02.017; Wang ZH, 2007, J CHROMATOGR A, V1163, P169, DOI 10.1016/j.chroma.2007.06.054; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2005, SCI TOTAL ENVIRON, V349, P106, DOI 10.1016/j.scitotenv.2005.01.010; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; WOODCOCK AH, 1948, J MAR RES, V7, P56; Woofter R, 2003, ENVIRON HEALTH PERSP, V111, P1595, DOI 10.1289/ehp.6166; Woofter RT, 2005, ENVIRON HEALTH PERSP, V113, P11, DOI 10.1289/ehp.7274; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54	89	44	44	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17394	10.1371/journal.pone.0017394	http://dx.doi.org/10.1371/journal.pone.0017394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423740	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100008
J	Schmieder, R; Edwards, R				Schmieder, Robert; Edwards, Robert			Fast Identification and Removal of Sequence Contamination from Genomic and Metagenomic Datasets	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; HUMAN MICROBIOME PROJECT; SHORT READ ALIGNMENT; GENERATION; TOOL; BLAST	High-throughput sequencing technologies have strongly impacted microbiology, providing a rapid and cost-effective way of generating draft genomes and exploring microbial diversity. However, sequences obtained from impure nucleic acid preparations may contain DNA from sources other than the sample. Those sequence contaminations are a serious concern to the quality of the data used for downstream analysis, causing misassembly of sequence contigs and erroneous conclusions. Therefore, the removal of sequence contaminants is a necessary and required step for all sequencing projects. We developed DeconSeq, a robust framework for the rapid, automated identification and removal of sequence contamination in longer-read datasets (>150 bp mean read length). DeconSeq is publicly available as standalone and web-based versions. The results can be exported for subsequent analysis, and the databases used for the web-based version are automatically updated on a regular basis. DeconSeq categorizes possible contamination sequences, eliminates redundant hits with higher similarity to non-contaminant genomes, and provides graphical visualizations of the alignment results and classifications. Using DeconSeq, we conducted an analysis of possible human DNA contamination in 202 previously published microbial and viral metagenomes and found possible contamination in 145 (72%) metagenomes with as high as 64% contaminating sequences. This new framework allows scientists to automatically detect and efficiently remove unwanted sequence contamination from their datasets while eliminating critical limitations of current methods. DeconSeq's web interface is simple and user-friendly. The standalone version allows offline analysis and integration into existing data processing pipelines. DeconSeq's results reveal whether the sequencing experiment has succeeded, whether the correct sample was sequenced, and whether the sample contains any sequence contamination from DNA preparation or host. In addition, the analysis of 202 metagenomes demonstrated significant contamination of the non-human associated metagenomes, suggesting that this method is appropriate for screening all metagenomes. DeconSeq is available at http://deconseq.sourceforge.net/.	[Schmieder, Robert; Edwards, Robert] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Schmieder, Robert] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Edwards, Robert] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	California State University System; San Diego State University; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Schmieder, R (corresponding author), San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA.	rschmied@sciences.sdsu.edu; redwards@cs.sdsu.edu	Edwards, Robert/Q-1691-2019	Edwards, Robert/0000-0001-8383-8949	National Science Foundation [DBI 0850356]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant DBI 0850356 Advances in Bioinformatics from the National Science Foundation (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YR, 2009, NAT BIOTECHNOL, V27, P820, DOI 10.1038/nbt0909-820; Manzini G, 2000, P 41 ANN S FDN COMP; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McCarthy A, 2010, CHEM BIOL, V17, P675, DOI 10.1016/j.chembiol.2010.07.004; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rosen GL, 2009, CURR GENOMICS, V10, P493, DOI 10.2174/138920209789208255; Schmieder R, 2011, BIOINFORMATICS; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner DJ, 2009, MAMM GENOME, V20, P327, DOI 10.1007/s00335-009-9187-4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667	51	469	517	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17288	10.1371/journal.pone.0017288	http://dx.doi.org/10.1371/journal.pone.0017288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408061	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900009
J	Luo, JY; Flynn, JM; Solnick, RE; Ecklund, EH; Matthews, KRW				Luo, Jingyuan; Flynn, Jesse M.; Solnick, Rachel E.; Ecklund, Elaine Howard; Matthews, Kirstin R. W.			International Stem Cell Collaboration: How Disparate Policies between the United States and the United Kingdom Impact Research	PLOS ONE			English	Article							CITATION; SINGLE	As the scientific community globalizes, it is increasingly important to understand the effects of international collaboration on the quality and quantity of research produced. While it is generally assumed that international collaboration enhances the quality of research, this phenomenon is not well examined. Stem cell research is unique in that it is both politically charged and a research area that often generates international collaborations, making it an ideal case through which to examine international collaborations. Furthermore, with promising medical applications, the research area is dynamic and responsive to a globalizing science environment. Thus, studying international collaborations in stem cell research elucidates the role of existing international networks in promoting quality research, as well as the effects that disparate national policies might have on research. This study examined the impact of collaboration on publication significance in the United States and the United Kingdom, world leaders in stem cell research with disparate policies. We reviewed publications by US and UK authors from 2008, along with their citation rates and the political factors that may have contributed to the number of international collaborations. The data demonstrated that international collaborations significantly increased an article's impact for UK and US investigators. While this applied to UK authors whether they were corresponding or secondary, this effect was most significant for US authors who were corresponding authors. While the UK exhibited a higher proportion of international publications than the US, this difference was consistent with overall trends in international scientific collaboration. The findings suggested that national stem cell policy differences and regulatory mechanisms driving international stem cell research in the US and UK did not affect the frequency of international collaborations, or even the countries with which the US and UK most often collaborated. Geographical and traditional collaborative relationships were the predominate considerations in establishing international collaborations.	[Luo, Jingyuan; Solnick, Rachel E.; Matthews, Kirstin R. W.] Rice Univ, James A Baker III Inst Publ Policy, Sci & Technol Policy Program, Houston, TX 77251 USA; [Flynn, Jesse M.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ecklund, Elaine Howard] Rice Univ, Dept Sociol, Houston, TX USA	Rice University; University of Texas System; UTMD Anderson Cancer Center; Rice University	Luo, JY (corresponding author), Rice Univ, James A Baker III Inst Publ Policy, Sci & Technol Policy Program, Houston, TX 77251 USA.	krwm@rice.edu	Matthews, Kirstin RW/D-2496-2017	Matthews, Kirstin RW/0000-0002-3702-0414; Solnick, Rachel E./0000-0002-2565-5690	Baker Institute; Richard Lounsbery Foundation; Rice University School of Social Sciences	Baker Institute; Richard Lounsbery Foundation; Rice University School of Social Sciences	This work was funded by the Baker Institute International Stem Cell Policy Program through an endowment from the State of Qatar and a grant from the Richard Lounsbery Foundation. EHE was supported by a Social Science Research Initiative Grant from the Rice University School of Social Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABT HA, 1984, PUBL ASTRON SOC PAC, V96, P746, DOI 10.1086/131415; *BRIT BROADC CORP, SWISS END STEM CELL; Corrigan O, 2006, ETHICAL LEGAL SOCIAL; Cyranoski D, 2004, NAT MED, V10, P763, DOI 10.1038/nm0804-763b; Druml C, 2009, CELL, V139, P649, DOI 10.1016/j.cell.2009.10.043; *EUR COMM, 2008, COOP 7; *EUR COMM, 2005, PROP COUNC DEC CONC, P440; *EUR COMM, 2008, STEM CELLS EUR RES I; Flynn JM, 2010, STEM CELL REV REP, V6, P143, DOI 10.1007/s12015-010-9133-6; GIBBONS D, 2009, GERMANY CALIFORNIA A; Glanzel W, 2005, SCIENTOMETRICS, V65, P323, DOI 10.1007/s11192-005-0277-0; Glanzel W, 2002, LIBR TRENDS, V50, P461; Goldfinch S, 2003, SCIENTOMETRICS, V57, P321, DOI 10.1023/A:1025048516769; Gottweis H, 2009, HEALTH TECHNOL SOC, P1, DOI 10.1057/9780230594364; HERBERTZ H, 1995, SCIENTOMETRICS, V33, P117, DOI 10.1007/BF02020777; *HUM EMBR STEM CEL, CELL; *INT SOC STEM CELL, 2010, FUND CORN; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; MARRIOT B, 2006, SCI ENG TECHNOLOGIST; MATTHEWS K, 2009, STEM CELL POLICY OBA; MATTHEWS KR, 2009, STEM CELL RES SCI PO; *MRC, 2010, RES FUND STEM CELL R; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; *NAT ASS CONF SWIT, 2003, LOI FED REL RECH CEL; *NAT SCI FDN DIV S, 2003, SCI ENG STAT DAT SYS; National Science Board, 2010, SCI ENG IND; National Science Board, 2010, SCI ENG IND 2010, P21; *OFF NAT STAT, POP EST UK POP GROWS; Russo E, 2005, PLOS BIOL, V3, P1167, DOI 10.1371/journal.pbio.0030234; Salter B, 2008, REGEN MED, V3, P597, DOI 10.2217/17460751.3.4.597; SMART JC, 1986, SCIENTOMETRICS, V10, P297, DOI 10.1007/BF02016776; *UK DEP HLTH, 2005, UK STEM CELL IN REP; *UK STEM CELL IN, 2005, GLOB POSIT STEM CELL; *UK STEM CELL IN, 2005, GLOB POS STEM CELL R; *US CENS BUR, 2010, US POP CLOCK PROJ; *US NAT I HLTH, 2010, STEM CELL DIS; *US NAT I HLTH, 2010, EST FUND VAR RES CON; Warnock M., 1984, REP COMM INQ HUM FER; WIDERMANN P, 2004, EMBO REP, V5, P927; 2001, PRESIDENT GW BUSHS A	40	18	18	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17684	10.1371/journal.pone.0017684	http://dx.doi.org/10.1371/journal.pone.0017684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FI	21408134	gold, Green Published, Green Submitted			2022-12-27	WOS:000288170000054
J	Nemeth, D; Janacsek, K; Csifcsak, G; Szvoboda, G; Howard, JH; Howard, DV				Nemeth, Dezso; Janacsek, Karolina; Csifcsak, Gabor; Szvoboda, Gabor; Howard, James H., Jr.; Howard, Darlene V.			Interference between Sentence Processing and Probabilistic Implicit Sequence Learning	PLOS ONE			English	Article							MEMORY-SYSTEMS; LANGUAGE; FACULTY	Background: During sentence processing we decode the sequential combination of words, phrases or sentences according to previously learned rules. The computational mechanisms and neural correlates of these rules are still much debated. Other key issue is whether sentence processing solely relies on language-specific mechanisms or is it also governed by domain-general principles. Methodology/Principal Findings: In the present study, we investigated the relationship between sentence processing and implicit sequence learning in a dual-task paradigm in which the primary task was a non-linguistic task (Alternating Serial Reaction Time Task for measuring probabilistic implicit sequence learning), while the secondary task were a sentence comprehension task relying on syntactic processing. We used two control conditions: a non-linguistic one (math condition) and a linguistic task (word processing task). Here we show that the sentence processing interfered with the probabilistic implicit sequence learning task, while the other two tasks did not produce a similar effect. Conclusions/Significance: Our findings suggest that operations during sentence processing utilize resources underlying non-domain-specific probabilistic procedural learning. Furthermore, it provides a bridge between two competitive frameworks of language processing. It appears that procedural and statistical models of language are not mutually exclusive, particularly for sentence processing. These results show that the implicit procedural system is engaged in sentence processing, but on a mechanism level, language might still be based on statistical computations.	[Nemeth, Dezso; Janacsek, Karolina; Csifcsak, Gabor; Szvoboda, Gabor] Univ Szeged, Inst Psychol, Szeged, Hungary; [Howard, James H., Jr.] Catholic Univ Amer, Dept Psychol, Washington, DC 20064 USA; [Howard, James H., Jr.; Howard, Darlene V.] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Szeged University; Catholic University of America; Georgetown University	Nemeth, D (corresponding author), Univ Szeged, Inst Psychol, Szeged, Hungary.	nemethd@edpsy.u-szeged.hu	Janacsek, Karolina/H-8639-2017; Nemeth, Dezso/B-9142-2009; Janacsek, Karolina/P-2957-2019	Janacsek, Karolina/0000-0001-7829-8220; Nemeth, Dezso/0000-0002-9629-5856; Janacsek, Karolina/0000-0001-7829-8220; Csifcsak, Gabor/0000-0001-7719-7073	Hungarian Scientific Research Fund [OTKA K82068]; Bolyai Scholarship; NATIONAL INSTITUTE ON AGING [R01AG036863] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Scholarship(Hungarian Academy of Sciences); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to the Hungarian Scientific Research Fund (OTKA K82068) and Bolyai Scholarship Program for supporting their work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Bates E., 1989, CROSSLINGUISTIC STUD, P3; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Christiansen MH, 2010, COGNITION, V116, P382, DOI 10.1016/j.cognition.2010.05.015; CONWAY C, 2009, IMPLICIT STAT LEARNI; DAMASIO AR, 1992, SCI AM, V267, P89; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P1322, DOI 10.1037/0278-7393.21.5.1322; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Elman JL, 1996, RETHINKING INNATENES; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Fodor J, 1983, MODULARITY MIND; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; FRAZIER L, 1987, ATTENTION PERFORM, P559; Gomez RL, 1999, COGNITION, V70, P109, DOI 10.1016/S0010-0277(99)00003-7; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Howard JH, 2008, J EXP PSYCHOL LEARN, V34, P1139, DOI 10.1037/a0012797; Howard JH, 1997, PSYCHOL AGING, V12, P634, DOI 10.1037/0882-7974.12.4.634; Jackendoff R, 2005, COGNITION, V97, P211, DOI 10.1016/j.cognition.2005.04.006; Kineses ZT, 2008, NEUROIMAGE, V39, P1950, DOI 10.1016/j.neuroimage.2007.09.070; McClelland JL, 2002, TRENDS COGN SCI, V6, P465, DOI 10.1016/S1364-6613(02)01993-9; McMurray B, 2009, DEVELOPMENTAL SCI, V12, P369, DOI 10.1111/j.1467-7687.2009.00822.x; MISYAK JB, 2009, FRONTIERS PSYCHOL, V1, P12; Nemeth D, 2010, EXP BRAIN RES, V201, P351, DOI 10.1007/s00221-009-2024-x; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker Steven, 1994, LANGUAGE INSTINCT; Poldrack RA, 2005, J NEUROSCI, V25, P5356, DOI 10.1523/JNEUROSCI.3880-04.2005; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; RUMELHART DE, 1986, PARALLEL DISTRIBUTED, V2, P272; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Seidenberg MS, 1997, SCIENCE, V275, P1599, DOI 10.1126/science.275.5306.1599; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; SQUIRE LR, 2000, NEW COGNITIVE NEUROS, P765; Tomasello M., 2003, CONSTRUCTING LANGUAG; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558	40	38	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17577	10.1371/journal.pone.0017577	http://dx.doi.org/10.1371/journal.pone.0017577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FI	21408117	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000288170000040
J	Shamu, S; Abrahams, N; Temmerman, M; Musekiwa, A; Zarowsky, C				Shamu, Simukai; Abrahams, Naeemah; Temmerman, Marleen; Musekiwa, Alfred; Zarowsky, Christina			A Systematic Review of African Studies on Intimate Partner Violence against Pregnant Women: Prevalence and Risk Factors	PLOS ONE			English	Review							ATTENDING ANTENATAL CLINICS; CONFLICT-TACTICS-SCALES; GENDER-BASED VIOLENCE; CHILD SEXUAL-ABUSE; LOW-BIRTH-WEIGHT; DOMESTIC VIOLENCE; REFERRAL CENTER; SOUTH-AFRICA; HIV; HEALTH	Background: Intimate partner violence (IPV) is very high in Africa. However, information obtained from the increasing number of African studies on IPV among pregnant women has not been scientifically analyzed. This paper presents a systematic review summing up the evidence from African studies on IPV prevalence and risk factors among pregnant women. Methods: A key-word defined search of various electronic databases, specific journals and reference lists on IPV prevalence and risk factors during pregnancy resulted in 19 peer-reviewed journal articles which matched our inclusion criteria. Quantitative articles about pregnant women from Africa published in English between 2000 and 2010 were reviewed. At least two reviewers assessed each paper for quality and content. We conducted meta-analysis of prevalence data and reported odds ratios of risk factors. Results: The prevalence of IPV during pregnancy ranges from 2% to 57% (n = 13 studies) with meta-analysis yielding an overall prevalence of 15.23% (95% CI: 14.38 to 16.08%). After adjustment for known confounders, five studies retained significant associations between HIV and IPV during pregnancy (OR1.48-3.10). Five studies demonstrated strong evidence that a history of violence is significantly associated with IPV in pregnancy and alcohol abuse by a partner also increases a woman's chances of being abused during pregnancy (OR 2.89-11.60). Other risk factors include risky sexual behaviours, low socioeconomic status and young age. Conclusion: The prevalence of IPV among pregnant women in Africa is one of the highest reported globally. The major risk factors included HIV infection, history of violence and alcohol and drug use. This evidence points to the importance of further research to both better understand IPV during pregnancy and feed into interventions in reproductive health services to prevent and minimize the impact of such violence.	[Shamu, Simukai; Zarowsky, Christina] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Abrahams, Naeemah] Med Res Council Cape Town, Gender & Hlth Unit, Cape Town, South Africa; [Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Musekiwa, Alfred] MRC, Biostat Unit, Cape Town, South Africa	University of the Western Cape; Ghent University	Shamu, S (corresponding author), Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa.	shamuts@yahoo.com	Abrahams, Naeemah/AAF-1144-2020; Abrahams, Naeemah/C-5577-2013	Shamu, Simukai/0000-0002-2290-0515; Musekiwa, Alfred/0000-0001-5880-3680; Zarowsky, Christina/0000-0002-0850-6212; Abrahams, Naeemah/0000-0002-6138-6256	VLIR-UOS	VLIR-UOS	The first author received a VLIR-UOS PhD bursary for his studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhabib S, 2010, J FAM VIOLENCE, V25, P369, DOI 10.1007/s10896-009-9298-4; Ameh N, 2009, NIGER J CLIN PRACT, V12, P179; AMEH NA, 2004, ANN AFRICAN MED, V3, P1596; Bacchus L, 2006, VIOLENCE AGAINST WOM, V12, P588, DOI 10.1177/1077801206289131; BEITCHMAN JH, 1992, CHILD ABUSE NEGLECT, V16, P101, DOI 10.1016/0145-2134(92)90011-F; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; CHIRAWU S, 2006, CARDOZO WOMENS LAW J, V13, P23; Dunkle KL, 2004, AM J EPIDEMIOL, V160, P230, DOI 10.1093/aje/kwh194; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Efetie ER, 2007, J OBSTET GYNAECOL, V27, P379, DOI 10.1080/01443610701327552; Ezechi O C, 2004, J Obstet Gynaecol, V24, P652, DOI 10.1080/01443610400007901; Ezechi OC, 2009, ARCH GYNECOL OBSTET, V280, P745, DOI 10.1007/s00404-009-0956-9; Fanslow J, 2008, AUST NZ J OBSTET GYN, V48, P398, DOI 10.1111/j.1479-828X.2008.00890.x; Fawole AO, 2008, AUST NZ J OBSTET GYN, V48, P405, DOI 10.1111/j.1479-828X.2008.00868.x; Fonck K, 2005, AIDS BEHAV, V9, P335, DOI 10.1007/s10461-005-9007-0; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; Gyuse ANI, 2009, S AFR FAM PRACT, V51, P343, DOI 10.1080/20786204.2009.10873877; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoque M. E., 2009, Southern African Journal of Epidemiology & Infection, V24, P34; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; Kaye D, 2002, Cent Afr J Med, V48, P64; Kaye DK, 2006, TROP MED INT HEALTH, V11, P1576, DOI 10.1111/j.1365-3156.2006.01711.x; Kaye Dan K, 2004, Afr Health Sci, V4, P67; Koenig LJ, 2002, AM J PUBLIC HEALTH, V92, P367, DOI 10.2105/AJPH.92.3.367; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martin SL, 2007, TRAUMA VIOLENCE ABUS, V8, P135, DOI 10.1177/1524838007301223; Mbokota M, 2003, SAMJ S AFR MED J, V93, P455; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; Messman TL, 1996, CLIN PSYCHOL REV, V16, P397, DOI 10.1016/0272-7358(96)00019-0; MULLEN PE, 1994, BRIT J PSYCHIAT, V165, P35, DOI 10.1192/bjp.165.1.35; Ntaganira J, 2009, RURAL REMOTE HEALTH, V9; Ntaganira Joseph, 2008, BMC Womens Health, V8, P17, DOI 10.1186/1472-6874-8-17; Olagbuji B, 2010, INT J GYNECOL OBSTET, V108, P101, DOI 10.1016/j.ijgo.2009.09.024; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Reichenheim ME, 2004, J EPIDEMIOL COMMUN H, V58, P523, DOI 10.1136/jech.2003.011742; Roelens K, 2008, EUR J OBSTET GYN R B, V137, P37, DOI 10.1016/j.ejogrb.2007.04.013; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; *STATACORP2, 2009, STAT STAT SOFTW REL; STEWART DE, 1993, CAN MED ASSOC J, V149, P1257; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; TEMMERMAN M, 1995, LANCET, V345, P969, DOI 10.1016/S0140-6736(95)90707-6; TOWNSEND L, 2010, AIDS BEHAV, P1, DOI DOI 10.1080/0954012.2010.482128; Umeora OUJ, 2008, J OBSTET GYNAECOL, V28, P769, DOI 10.1080/01443610802463819; Valladares E, 2002, OBSTET GYNECOL, V100, P700, DOI 10.1016/S0029-7844(02)02093-8; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; WHO, 2005, MULT STUD WOM HLTH D; *WHO, 2000, MILL DEV GOALS; *WHO UNAIDS, 2008, WORLD REP AIDS; World Health Organization UNAIDS, 2004, INF B SER, P1; Xu X, 2005, AM J PUBLIC HEALTH, V95, P78, DOI 10.2105/AJPH.2003.023978	58	257	260	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17591	10.1371/journal.pone.0017591	http://dx.doi.org/10.1371/journal.pone.0017591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FI	21408120	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170000042
J	Suckale, J; Wendling, O; Masjkur, J; Jager, M; Munster, C; Anastassiadis, K; Stewart, F; Solimena, M				Suckale, Jakob; Wendling, Olivia; Masjkur, Jimmy; Jaeger, Melanie; Muenster, Carla; Anastassiadis, Konstantinos; Stewart, Francis; Solimena, Michele			PTBP1 Is Required for Embryonic Development before Gastrulation	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; POLYPYRIMIDINE TRACT; MESSENGER-RNA; MOUSE DEVELOPMENT; GENE-EXPRESSION; REGULATORY ROLE; PROMOTES; CELLS; DIFFERENTIATION; RECOGNITION	Polypyrimidine-tract binding protein 1 (PTBP1) is an important cellular regulator of messenger RNAs influencing the alternative splicing profile of a cell as well as its mRNA stability, location and translation. In addition, it is diverted by some viruses to facilitate their replication. Here, we used a novel PTBP1 knockout mouse to analyse the tissue expression pattern of PTBP1 as well as the effect of its complete removal during development. We found evidence of strong PTBP1 expression in embryonic stem cells and throughout embryonic development, especially in the developing brain and spinal cord, the olfactory and auditory systems, the heart, the liver, the kidney, the brown fat and cartilage primordia. This widespread distribution points towards a role of PTBP1 during embryonic development. Homozygous offspring, identified by PCR and immunofluorescence, were able to implant but were arrested or retarded in growth. At day 7.5 of embryonic development (E7.5) the null mutants were about 5x smaller than the control littermates and the gap in body size widened with time. At mid-gestation, all homozygous embryos were resorbed/degraded. No homozygous mice were genotyped at E12 and the age of weaning. Embryos lacking PTBP1 did not display differentiation into the 3 germ layers and cavitation of the epiblast, which are hallmarks of gastrulation. In addition, homozygous mutants displayed malformed ectoplacental cones and yolk sacs, both early supportive structure of the embryo proper. We conclude that PTBP1 is not required for the earliest isovolumetric divisions and differentiation steps of the zygote up to the formation of the blastocyst. However, further post-implantation development requires PTBP1 and stalls in homozygous null animals with a phenotype of dramatically reduced size and aberration in embryonic and extra-embryonic structures.	[Suckale, Jakob; Masjkur, Jimmy; Jaeger, Melanie; Muenster, Carla; Solimena, Michele] Tech Univ Dresden, Paul Langerhans Inst Dresden, Sch Med, D-8027 Dresden, Germany; [Suckale, Jakob; Masjkur, Jimmy; Jaeger, Melanie; Muenster, Carla; Solimena, Michele] Tech Univ Dresden, Univ Clin Carl Gustav Carus, D-8027 Dresden, Germany; [Wendling, Olivia] IGBMC, Dept Funct Gen, Illkirch Graffenstaden, France; [Suckale, Jakob] ICS, Illkirch Graffenstaden, France; [Anastassiadis, Konstantinos] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, BioInnovat Zentrum, D-8027 Dresden, Germany; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Technische Universitat Dresden; Max Planck Society	Suckale, J (corresponding author), Tech Univ Dresden, Paul Langerhans Inst Dresden, Sch Med, D-8027 Dresden, Germany.	Michele.Solimena@tu-dresden.de	Anastassiadis, Konstantinos/A-8944-2010; Solimena, Michele/E-1275-2011; Stewart, A. Francis/E-7789-2010; Solimena, Michele/GVS-5990-2022	Anastassiadis, Konstantinos/0000-0002-9814-0559; 	German Federal Ministry of Education and Research (BMBF); German Center for Diabetes Research (DZD); Max Planck Society; Center for Regenerative Therapies Dresden (CRTD); Medical School of the Dresden University of Technology	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Center for Diabetes Research (DZD); Max Planck Society(Max Planck Society); Center for Regenerative Therapies Dresden (CRTD); Medical School of the Dresden University of Technology	These studies have been supported with funds from the German Federal Ministry of Education and Research (BMBF; www.bmbf.de) to the Network of Competence for Diabetes (KKNDm), from the German Center for Diabetes Research (DZD), from the Max Planck Society (www.mpg.de) to MS, and from the Center for Regenerative Therapies Dresden (CRTD; www.crt-dresden.de) to KA. JS was the recipient of a MedDrive Grant from the Medical School of the Dresden University of Technology (www.medizin.tu-dresden.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashiya M, 1997, RNA, V3, P996; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Brunel F, 1996, NUCLEIC ACIDS RES, V24, P1608, DOI 10.1093/nar/24.9.1608; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Cross JC, 2005, PLACENTA, V26, pA6; Davis MB, 2002, MECH DEVELOP, V111, P143, DOI 10.1016/S0925-4773(01)00595-0; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Ehehalt F, 2010, ISLETS, V2, P30, DOI 10.4161/isl.2.1.10098; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Gooding C, 2003, J BIOL CHEM, V278, P15201, DOI 10.1074/jbc.M210131200; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kafasla P, 2009, MOL CELL, V34, P556, DOI 10.1016/j.molcel.2009.04.015; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Motallebipour M, 2010, MOL BIOL REP, V37, P2021, DOI 10.1007/s11033-009-9653-9; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829	46	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16992	10.1371/journal.pone.0016992	http://dx.doi.org/10.1371/journal.pone.0016992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21423341	Green Published, gold			2022-12-27	WOS:000287482300026
J	Kettle, CJ; Maycock, CR; Ghazoul, J; Hollingsworth, PM; Khoo, E; Sukri, RSH; Burslem, DFRP				Kettle, Chris J.; Maycock, Colin R.; Ghazoul, Jaboury; Hollingsworth, Pete M.; Khoo, Eyen; Sukri, Rahayu Sukmaria Haji; Burslem, David F. R. P.			Ecological Implications of a Flower Size/Number Trade-Off in Tropical Forest Trees	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; EICHHORNIA-PANICULATA PONTEDERIACEAE; EARLY-LIFE STAGES; POLLEN DISPERSAL; FLORAL DISPLAY; COMPUTER-PROGRAM; SEED DISPERSAL; DIPTEROCARPACEAE; SHOREA; SIZE	Background: In angiosperms, flower size commonly scales negatively with number. The ecological consequences of this trade-off for tropical trees remain poorly resolved, despite their potential importance for tropical forest conservation. We investigated the flower size number trade-off and its implications for fecundity in a sample of tree species from the Dipterocarpaceae on Borneo. Methodology/Principal Findings: We combined experimental exclusion of pollinators in 11 species, with direct and indirect estimates of contemporary pollen dispersal in two study species and published estimates of pollen dispersal in a further three species to explore the relationship between flower size, pollinator size and mean pollen dispersal distance. Maximum flower production was two orders of magnitude greater in small-flowered than large-flowered species of Dipterocarpaceae. In contrast, fruit production was unrelated to flower size and did not differ significantly among species. Small-flowered species had both smaller-sized pollinators and lower mean pollination success than large-flowered species. Average pollen dispersal distances were lower and frequency of mating between related individuals was higher in a smaller-flowered species than a larger-flowered confamilial. Our synthesis of pollen dispersal estimates across five species of dipterocarp suggests that pollen dispersal scales positively with flower size. Conclusions and Their Significance: Trade-offs embedded in the relationship between flower size and pollination success contribute to a reduction in the variance of fecundity among species. It is therefore plausible that these processes could delay competitive exclusion and contribute to maintenance of species coexistence in this ecologically and economically important family of tropical trees. These results have practical implications for tree species conservation and restoration. Seed collection from small-flowered species may be especially vulnerable to cryptic genetic erosion. Our findings also highlight the potential for differential vulnerability of tropical tree species to the deleterious consequences of forest fragmentation.	[Kettle, Chris J.; Ghazoul, Jaboury] ETH, Inst Terr Ecosyst, Zurich, Switzerland; [Kettle, Chris J.; Maycock, Colin R.; Sukri, Rahayu Sukmaria Haji; Burslem, David F. R. P.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Hollingsworth, Pete M.] Royal Bot Gardens, Edinburgh, Midlothian, Scotland; [Khoo, Eyen] Sabah Forest Dept, Forest Res Ctr, Sabah, Malaysia	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Aberdeen; Royal Botanic Gardens, Kew; Pusat Penyelidikan Hutan	Kettle, CJ (corresponding author), ETH, Inst Terr Ecosyst, Zurich, Switzerland.	chris.kettle@env.ethz.ch	Sukri, Rahayu/AAJ-9640-2020; Burslem, David FRP/F-1204-2019; Maycock, Colin Ruzelion/H-3556-2013; Kettle, Chris/A-6160-2011; Ghazoul, Jaboury/B-2121-2018	Sukri, Rahayu/0000-0002-2662-399X; Burslem, David FRP/0000-0001-6033-0990; Maycock, Colin Ruzelion/0000-0002-4368-2545; Hollingsworth, Peter/0000-0003-0602-0654	British Ecological Society; Natural Environment Research Council [NER/A/S/2001/00835, NE/D003822/1]; NERC [NE/D003822/1] Funding Source: UKRI	British Ecological Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support was provided by the British Ecological Society (http://www.britishecologicalsociety.org/) "Overseas Research Programme" and the Natural Environment Research Council (http://www.nerc.ac.uk/) grant numbers NER/A/S/2001/00835 and NE/D003822/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Aldrich PR, 1998, MOL ECOL, V7, P933, DOI 10.1046/j.1365-294x.1998.00396.x; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Ashton PS., 2004, TREE FLORA SABAH SAR, P63; Austerlitz F, 2007, HEREDITY, V99, P193, DOI 10.1038/sj.hdy.6800983; BAGCHI R, 2009, ECOLOGY LETT, V9999; BAWA KS, 1998, REV DIPTEROCARPS TAX; de Lacerda AEB, 2008, BIOTROPICA, V40, P462, DOI 10.1111/j.1744-7429.2008.00402.x; Blundell AG, 1998, OECOLOGIA, V117, P151, DOI 10.1007/s004420050643; Blundell AG, 2004, J TROP ECOL, V20, P229, DOI 10.1017/S0266467403001123; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chambers J, 2009, EVOL ECOL, V23, P737, DOI 10.1007/s10682-008-9269-x; CHARLESWORTH D, 1989, TRENDS ECOL EVOL, V4, P289, DOI 10.1016/0169-5347(89)90023-2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cloutier D, 2007, MOL ECOL, V16, P797, DOI 10.1111/j.1365-294X.2006.03193.x; Colpaert N, 2005, SILVAE GENET, V54, P265, DOI 10.1515/sg-2005-0038; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Dayanandan S.C, 1990, REPROD ECOLOGY TROPI; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FOX JED, 1973, HDB KABILI SEPILOK; Fukue Y, 2007, J PLANT RES, V120, P413, DOI 10.1007/s10265-007-0078-z; Gamage DT, 2006, GENES GENET SYST, V81, P1, DOI 10.1266/ggs.81.1; Ghazoul J, 1998, J ECOL, V86, P462, DOI 10.1046/j.1365-2745.1998.00270.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Ghazoul J, 1997, J NAT HIST, V31, P901, DOI 10.1080/00222939700770441; Ghazoul J, 2009, ECOLOGY, V90, P369, DOI 10.1890/07-1436.1; Goodwillie C, 2010, NEW PHYTOL, V185, P311, DOI 10.1111/j.1469-8137.2009.03043.x; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Harder LD, 2010, PHILOS T R SOC B, V365, P529, DOI 10.1098/rstb.2009.0226; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 2008, BIOL J LINN SOC, V93, P465, DOI 10.1111/j.1095-8312.2007.00898.x; Harrison Rhett D., 2005, Malayan Nature Journal, V57, P67; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; Hubbell S.P., 2001, MG POP BIOL, V32; Hufford KM, 2003, EVOLUTION, V57, P518, DOI 10.1111/j.0014-3820.2003.tb01543.x; Hufford KM, 2009, INT J PLANT SCI, V170, P724, DOI 10.1086/599075; Jones FA, 2008, P ROY SOC B-BIOL SCI, V275, P2759, DOI 10.1098/rspb.2008.0894; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamiya K, 2005, AM J BOT, V92, P775, DOI 10.3732/ajb.92.5.775; Kenta T, 2004, MOL ECOL, V13, P3575, DOI 10.1111/j.1365-294X.2004.02345.x; Kettle CJ, 2008, BIOL CONSERV, V141, P1953, DOI 10.1016/j.biocon.2008.05.008; KETTLE CJ, PERSPECTIVE IN PRESS; Kohyama T, 2009, J ECOL, V97, P463, DOI 10.1111/j.1365-2745.2009.01490.x; Konuma A, 2000, MOL ECOL, V9, P1843, DOI 10.1046/j.1365-294x.2000.01081.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lee SL, 2006, BIOL CONSERV, V131, P72, DOI 10.1016/j.biocon.2006.02.005; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MARTIN EP, 2004, COMPARE VERSION 4 6B; Maycock CR, 2005, J VEG SCI, V16, P635, DOI 10.1111/j.1654-1103.2005.tb02406.x; Momose Kuniyasu, 1996, Plant Species Biology, V11, P189, DOI 10.1111/j.1442-1984.1996.tb00145.x; Naito Y, 2005, J PLANT RES, V118, P423, DOI 10.1007/s10265-005-0245-z; Naito Y, 2008, FOREST ECOL MANAG, V256, P375, DOI 10.1016/j.foreco.2008.04.031; Ng KKS, 2006, TREE GENET GENOMES, V2, P121, DOI 10.1007/s11295-006-0035-3; Ng KKS, 2004, MOL ECOL, V13, P657, DOI 10.1046/j.1365-294X.2004.02094.x; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Osada N, 2001, J TROP ECOL, V17, P911, DOI 10.1017/S0266467401001687; PRIMACK RB, 1987, ANNU REV ECOL SYST, V18, P409, DOI 10.1146/annurev.ecolsys.18.1.409; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Richards SA, 2009, AM NAT, V174, P382, DOI 10.1086/603626; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Robledo-Arnuncio JJ, 2007, MOL ECOL NOTES, V7, P763, DOI 10.1111/j.1471-8286.2007.01706.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Sakai S, 1999, AM J BOT, V86, P62, DOI 10.2307/2656955; SAKAI S, 1995, AM NAT, V145, P918, DOI 10.1086/285776; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai Satoki, 2000, Plant Species Biology, V15, P261, DOI 10.1046/j.1442-1984.2000.00045.x; Sargent RD, 2008, INT J PLANT SCI, V169, P39, DOI 10.1086/523359; Sargent RD, 2007, AM J BOT, V94, P2059, DOI 10.3732/ajb.94.12.2059; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Smouse PE, 2001, EVOLUTION, V55, P260; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Stone GN, 1998, ECOLOGY, V79, P2808, DOI 10.1890/0012-9658(1998)079[2808:POPDFI]2.0.CO;2; Takeuchi Y, 2004, HEREDITY, V92, P323, DOI 10.1038/sj.hdy.6800411; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Verhulst J, 2008, OECOLOGIA, V156, P95, DOI 10.1007/s00442-008-0980-7; Wells K, 2005, RAFFLES B ZOOL, V53, P281; WOOD GHS, 1964, DIPTEROCARPS SABAH; Worley AC, 2000, EVOLUTION, V54, P1533, DOI 10.1111/j.0014-3820.2000.tb00699.x; Worley AC, 2001, J EVOLUTION BIOL, V14, P469, DOI 10.1046/j.1420-9101.2001.00296.x; Worley AC, 2000, INT J PLANT SCI, V161, P69, DOI 10.1086/314225	91	31	32	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2011	6	2							e16111	10.1371/journal.pone.0016111	http://dx.doi.org/10.1371/journal.pone.0016111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UR	21408110	Green Submitted, Green Published, gold			2022-12-27	WOS:000286835000003
J	Lee, CM; Yang, PL; Chen, LC; Chen, CC; Wu, SC; Cheng, HY; Chang, YS				Lee, Chiou-Mei; Yang, Polung; Chen, Lih-Chyang; Chen, Chia-Chun; Wu, Shinn-Chih; Cheng, Hsiao-Yun; Chang, Yu-Sun			A Novel Role of RASSF9 in Maintaining Epidermal Homeostasis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; DOMAIN-CONTAINING PROTEINS; TERMINAL DIFFERENTIATION; MOUSE KERATINOCYTES; ACTIVATION; CALCIUM; GROWTH; PATHWAY; FAMILY; ALPHA	The physiological role of RASSF9, a member of the Ras-association domain family (RASSF), is currently unclear. Here, we report a mouse line in which an Epstein-Barr virus Latent Membrane Protein 1 (LMP1) transgene insertion has created a 7.2-kb chromosomal deletion, which abolished RASSF9 gene expression. The RASSF9-null mice exhibited interesting phenotypes that resembled human ageing, including growth retardation, short lifespan, less subcutaneous adipose layer and alopecia. In the wild-type mice, RASSF9 is predominantly expressed in the epidermal keratinocytes of skin, as determined by quantitative reverse-transcription PCR, immunofluorescence and in situ hybridization. In contrast, RASSF9-/- mice presented a dramatic change in epithelial organization of skin with increased proliferation and aberrant differentiation as detected by bromodeoxyuridine incorporation assays and immunofluorescence analyses. Furthermore, characteristic functions of RASSF9-/- versus wild type (WT) mouse primary keratinocytes showed significant proliferation linked to a reduction of p21Cip1 expression under growth or early differentiation conditions. Additionally, in RASSF9-/- keratinocytes there was a drastic down-modulation of terminal differentiation markers, which could be rescued by infection with a recombinant adenovirus, Adv/HA-RASSF9. Our results indicate a novel and significant role of RASSF9 in epidermal homeostasis.	[Lee, Chiou-Mei] Chang Gung Mem Hosp Lin Kou, Dept Med Res & Dev, Tao Yuan, Taiwan; [Lee, Chiou-Mei; Chen, Lih-Chyang; Chang, Yu-Sun] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Yang, Polung; Chen, Chia-Chun; Cheng, Hsiao-Yun; Chang, Yu-Sun] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan; [Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University	Lee, CM (corresponding author), Chang Gung Mem Hosp Lin Kou, Dept Med Res & Dev, Tao Yuan, Taiwan.	lcm5132@mail.cgu.edu.tw		Chang, Yu-Sun/0000-0002-6457-3890; Wu, Shinn-Chih/0000-0001-8881-1550	Ministry of Education, Taiwan; Chang Gung University; Chang Gung Memorial Hospital [CMRPD 160053, BMRP021]	Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung University; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by the grant from the Ministry of Education, Taiwan (to Chang Gung University), and grants from Chang Gung University and the Chang Gung Memorial Hospital (CMRPD 160053 and BMRP021 to YSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; CALLARD RE, 1988, IMMUNOLOGY, V65, P379; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chang MH, 1997, DNA CELL BIOL, V16, P829, DOI 10.1089/dna.1997.16.829; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chen LH, 1998, J BIOL CHEM, V273, P33524, DOI 10.1074/jbc.273.50.33524; CHEN ML, 1992, ONCOGENE, V7, P2131; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dirksen WP, 2003, J BIOL CHEM, V278, P9722, DOI 10.1074/jbc.M207969200; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Fang NX, 2007, VIROLOGY, V365, P187, DOI 10.1016/j.virol.2007.03.038; Fitzsimons C, 2002, BIOCHEM PHARMACOL, V63, P1785, DOI 10.1016/S0006-2952(02)00975-9; Fuchs E, 1990, CURR OPIN CELL BIOL, V2, P1028, DOI 10.1016/0955-0674(90)90152-5; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Hovhannisyan RH, 2005, MOL CELL BIOL, V25, P250, DOI 10.1128/MCB.25.1.250-263.2005; Karlsson T, 2010, J DERMATOL SCI, V57, P207, DOI 10.1016/j.jdermsci.2009.12.013; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Liu BG, 2009, CELL CYCLE, V8, P527, DOI 10.4161/cc.8.4.7598; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; OCHMAN H, 1988, GENETICS, V120, P621; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Rahkonen O, 2004, CIRC RES, V94, P83, DOI 10.1161/01.RES.0000108263.74520.15; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Scamborova P, 2004, MOL CELL BIOL, V24, P1855, DOI 10.1128/MCB.24.5.1855-1869.2004; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Takahashi K, 1998, GENOMICS, V53, P170, DOI 10.1006/geno.1998.5476; Todd C, 1998, AM J PATHOL, V153, P39, DOI 10.1016/S0002-9440(10)65543-5; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Tscharntke M, 2005, FASEB J, V19, P1836, DOI 10.1096/fj.04-3327fje; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vaughan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007908; Wagner EJ, 2005, J BIOL CHEM, V280, P14017, DOI 10.1074/jbc.M414492200; Wang XJ, 2000, MOL CARCINOGEN, V27, P200, DOI 10.1002/(SICI)1098-2744(200003)27:3<200::AID-MC7>3.3.CO;2-0; Xie ZJ, 2005, MOL BIOL CELL, V16, P3236, DOI 10.1091/mbc.E05-02-0109; Yeh TS, 1997, DNA CELL BIOL, V16, P1311, DOI 10.1089/dna.1997.16.1311; YUSPA SH, 1981, NATURE, V293, P72, DOI 10.1038/293072a0	48	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17867	10.1371/journal.pone.0017867	http://dx.doi.org/10.1371/journal.pone.0017867			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445300	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300018
J	Karling, P; Danielsson, A; Wikgren, M; Soderstrom, I; Del-Favero, J; Adolfsson, R; Norrback, KF				Karling, Pontus; Danielsson, Ake; Wikgren, Mikael; Soderstrom, Ingegerd; Del-Favero, Jurgen; Adolfsson, Rolf; Norrback, Karl-Fredrik			The Relationship between the Val158Met Catechol-o-Methyltransferase (COMT) Polymorphism and Irritable Bowel Syndrome	PLOS ONE			English	Article							GENE POLYMORPHISM; DEPRESSION SCALE; HOSPITAL ANXIETY; PAIN; ASSOCIATION; DISORDERS; SYMPTOMS; METAANALYSIS; INDIVIDUALS; POPULATION	Background: The catechol-O-methyltransferase (COMT) enzyme has a key function in the degradation of catecholamines and a functional polymorphism is val158met. The val/val genotype results in a three to fourfold higher enzymatic activity compared with the met/met genotype, with the val/met genotype exhibiting intermediate activity. Since pain syndromes as well as anxiety and depression are associated to low and high COMT activity respectively and these conditions are all associated with irritable bowel syndrome (IBS) we wanted for the first time to explore the relationship between the polymorphism and IBS. Methodology/Principal Findings: 867 subjects (445 women) representative of the general population and 70 consecutively sampled patients with IBS (61 women) were genotyped for the val158met polymorphism and the IBS patients filled out the Hospital-Anxiety-and-Depression-Scale (HADS) questionnaire, and an IBS symptom diary. Results: There was a significantly higher occurrence of the val/val genotype in patients compared with controls (30% vs 20%; Chi(2) (1) 3.98; p = 0.046) and a trend toward a lower occurrence of the val/met genotype in IBS patients compared with controls (39% vs 49%; Chi(2) (1) 2.89; p = 0.089). Within the IBS patients the val/val carriers exhibited significantly increased bowel frequency (2.6 vs 1.8 stools per day; Chi(2) (1) 5.3; p = 0.03) and a smaller proportion of stools with incomplete defecation (41% vs 68%; Chi(2) (1) 4.3; p = 0.04) compared with the rest (val/met+ met/met carriers). The val/val carriers also showed a trend for a smaller proportion of hard stools (0% vs 15%; Chi(2) (1) 3.2; p = 0.08) and a higher frequency of postprandial defecation (26% vs 21%; Chi(2) (1) 3.0; p = 0.08). Conclusions/Significance: In this study we found an association between the val/val genotype of the val158met COMT gene and IBS as well as to specific IBS related bowel pattern in IBS patients.	[Karling, Pontus; Danielsson, Ake; Soderstrom, Ingegerd] Umea Univ, Div Med, Dept Publ Hlth & Clin Med, Umea, Sweden; [Wikgren, Mikael; Adolfsson, Rolf; Norrback, Karl-Fredrik] Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden; [Del-Favero, Jurgen] VIB, Dept Mol Genet, Appl Mol Genom Grp, Antwerp, Belgium; [Del-Favero, Jurgen] Univ Antwerp, B-2020 Antwerp, Belgium	Umea University; Umea University; Flanders Institute for Biotechnology (VIB); University of Antwerp	Karling, P (corresponding author), Umea Univ, Div Med, Dept Publ Hlth & Clin Med, Umea, Sweden.	pontus.karling@vll.se		Adolfsson, Rolf/0000-0001-9785-8473; Del Favero, jurgen/0000-0002-7427-7489	Swedish Research Council [2003-5158, 2006-4472]; Medical faculty, Umea University; County Council of Norrbotten, Sweden; County Council of Vasterbotten, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical faculty, Umea University; County Council of Norrbotten, Sweden; County Council of Vasterbotten, Sweden	The research was funded by the Swedish Research Council (grants 2003-5158 and 2006-4472), the Medical faculty, Umea University, and the County Councils of Vasterbotten and Norrbotten, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo MA, 2010, ALIMENT PHARM THER, V32, P738, DOI 10.1111/j.1365-2036.2010.04409.x; Armero P, 2005, EUR J PAIN, V9, P229, DOI 10.1016/j.ejpain.2004.06.005; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cervero F, 1999, LANCET, V353, P2145, DOI 10.1016/S0140-6736(99)01306-9; DELVAUX MM, 1999, CAN J GASTROENTEL SA, V13, pS32; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Domschke K, 2007, AM J MED GENET B, V144B, P667, DOI 10.1002/ajmg.b.30494; Garakani Amir, 2003, Am J Ther, V10, P61, DOI 10.1097/00045391-200301000-00014; Geeraerts B, 2005, GASTROENTEROLOGY, V129, P1437, DOI 10.1053/j.gastro.2005.08.020; Gursoy S, 2003, RHEUMATOL INT, V23, P104, DOI 10.1007/s00296-002-0260-5; Hagen K, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-34; Hagen K, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-40; Hagen Knut, 2006, J Headache Pain, V7, P70, DOI 10.1007/s10194-006-0281-7; Jones MP, 2006, NEUROGASTROENT MOTIL, V18, P91, DOI 10.1111/j.1365-2982.2005.00730.x; Karling P, 2007, NEUROGASTROENT MOTIL, V19, P896, DOI 10.1111/j.1365-2982.2007.00967.x; Karling P, 2007, SCAND J GASTROENTERO, V42, P1294, DOI 10.1080/00365520701395945; Keogh E, 2001, PAIN, V91, P91, DOI 10.1016/S0304-3959(00)00422-X; Lachman HM, 1996, AM J MED GENET, V67, P468, DOI 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; MARBACH JJ, 1976, J DENT RES, V55, P711, DOI 10.1177/00220345760550043801; Mayer EA, 2000, GUT, V47, P861, DOI 10.1136/gut.47.6.861; MAYER EA, 2001, J CLIN PSYCHIAT, V62, pS28; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Ragnarsson G, 1998, EUR J GASTROEN HEPAT, V10, P415, DOI 10.1097/00042737-199805000-00011; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; TAHARA T, 2008, HEPATO-GASTROENTEROL, V55, P879; Tornblom H, 2005, SCAND J GASTROENTERO, V40, P1140, DOI 10.1080/00365520510023657; Van Den Bogaert A, 2006, PSYCHIAT GENET, V16, P209, DOI 10.1097/01.ypg.0000218623.03752.e4; Weiss EM, 2007, J INT NEUROPSYCH SOC, V13, P881; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; WICHERS M, 2007, NEUROPSYCHOPHARMACOL, V8, P1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	33	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18035	10.1371/journal.pone.0018035	http://dx.doi.org/10.1371/journal.pone.0018035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437260	Green Published, gold			2022-12-27	WOS:000288545100066
J	Mead, GE; Graham, C; Dorman, P; Slot, KB; Lewis, SC; Dennis, MS; Sandercock, PAG				Mead, Gillian E.; Graham, Catriona; Dorman, Paul; Slot, Karsten Bruins; Lewis, Steff C.; Dennis, Martin S.; Sandercock, Peter A. G.		UK Collaborators IST	Fatigue after Stroke: Baseline Predictors and Influence on Survival. Analysis of Data from UK Patients Recruited in the International Stroke Trial	PLOS ONE			English	Article							POSTSTROKE FATIGUE; FOLLOW-UP; EUROQOL; SF-36; ADULTS	Background and Purpose: Little is known about the associations of post-stroke fatigue or its influence on survival. The vitality component of the Short Form 36 (SF-36) is a valid and reliable measure of post-stroke fatigue. We sought to identify associates of post-stroke fatigue and determine whether fatigue predicted survival. Methods: We used SF-36 vitality scores obtained by postal questionnaires from 1080 UK patients randomised in the International Stroke Trial, at a mean of 64 weeks after stroke onset. We used logistic regression to explore factors at randomisation which predicted SF-36 vitality at follow-up, and the relationship between SF-36 vitality and both SF-36 mental health and SF-36 emotional role function at follow-up. We used Cox proportional hazards to explore the influence of SF-36 vitality at follow-up on subsequent survival, using four different statistical models for handling missing data. Results: Female sex, increasing age, lower mental health and lower emotional role function scores were associated with greater degrees of fatigue after stroke (i.e. lower vitality scores) but these factors explained < 30% of the variance (R-2) in fatigue. In two models, fatigue at follow-up was associated with shorter subsequent survival. Conclusion: Increasing age, female sex, emotional role function and mental health were associated with increased fatigue at a mean of 64 weeks after stroke onset, but explained less than 30% of the variance. Fatigue was associated with reduced subsequent long-term survival in 2/4 models. Further work is needed to identify the biological substrate of fatigue and to clarify its influence on survival.	[Mead, Gillian E.; Graham, Catriona] Univ Edinburgh, Wellcome Trust Clin Res Facil, Edinburgh, Midlothian, Scotland; [Dorman, Paul] Newcastle Acute Hosp NHS Fdn Trust, Dept Neurol, Newcastle Upon Tyne, Tyne & Wear, England; [Slot, Karsten Bruins] Univ Oslo, Ulleval Hosp, Div Med, Oslo, Norway	University of Edinburgh; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Oslo	Mead, GE (corresponding author), Univ Edinburgh, Wellcome Trust Clin Res Facil, Edinburgh, Midlothian, Scotland.	Gillian.e.mead@ed.ac.uk	Mead, Gillian E/F-7648-2011	Sandercock, Peter/0000-0001-8484-0135; Lewis, Steff/0000-0003-1210-2314	Chief Scientist Office Scottish Government [CZG/2/387]; MRC [G0800803] Funding Source: UKRI; Medical Research Council [G0800803] Funding Source: researchfish; Chief Scientist Office [CZG/2/387] Funding Source: researchfish	Chief Scientist Office Scottish Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This analysis was funded by Chief Scientist Office Scottish Government CZG/2/387. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784; Dorman P, 1998, STROKE, V29, P63, DOI 10.1161/01.STR.29.1.63; Dorman PJ, 1999, STROKE, V30, P2146, DOI 10.1161/01.STR.30.10.2146; Dorman PJ, 1997, BRIT MED J, V315, P461, DOI 10.1136/bmj.315.7106.461; Flinn NA, 2010, OCCUP THER INT, V17, P81, DOI 10.1002/oti.286; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; Harbison JA, 2009, QJM-INT J MED, V102, P109, DOI 10.1093/qjmed/hcn146; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; LEEGAARD OF, 1983, ACTA NEUROL SCAND, V67, P348; Lynch J, 2007, J PSYCHOSOM RES, V63, P539, DOI 10.1016/j.jpsychores.2007.08.004; McGeough E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007030.pub2; Mead G, 2007, STROKE, V38, P2090, DOI 10.1161/STROKEAHA.106.478941; Morley W, 2005, AGE AGEING, V34, P313, DOI 10.1093/ageing/afi082; Naess H, 2005, CEREBROVASC DIS, V20, P245, DOI 10.1159/000087706; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Sandercock P, 1997, LANCET, V349, P1569; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Slot KB, 2008, BRIT MED J, V336, P376, DOI 10.1136/bmj.39456.688333.BE; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; van der Werf SP, 2001, EUR NEUROL, V45, P28, DOI 10.1159/000052085; Walters SJ, 2001, AGE AGEING, V30, P337, DOI 10.1093/ageing/30.4.337; Ware J., 1993, SF 36 HLTH SURVEY MA; Winward C, 2009, STROKE, V40, P757, DOI 10.1161/STROKEAHA.108.527101	23	71	75	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e16988	10.1371/journal.pone.0016988	http://dx.doi.org/10.1371/journal.pone.0016988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445242	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100009
J	Suga, T; Kimura, E; Morioka, Y; Ikawa, M; Li, S; Uchino, K; Uchida, Y; Yamashita, S; Maeda, Y; Chamberlain, JS; Uchino, M				Suga, Tomohiro; Kimura, En; Morioka, Yuka; Ikawa, Masahito; Li, Sheng; Uchino, Katsuhisa; Uchida, Yuji; Yamashita, Satoshi; Maeda, Yasushi; Chamberlain, Jeffrey S.; Uchino, Makoto			Muscle Fiber Type-Predominant Promoter Activity in Lentiviral-Mediated Transgenic Mouse	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GENE-TRANSFER; SKELETAL-MUSCLE; MDX MICE; STABLE TRANSDUCTION; HEMATOPOIETIC-CELLS; ADENOVIRUS VECTOR; SATELLITE CELLS; LIFE-SPAN; EXPRESSION	Variations in gene promoter/enhancer activity in different muscle fiber types after gene transduction was noticed previously, but poorly analyzed. The murine stem cell virus (MSCV) promoter drives strong, stable gene expression in hematopoietic stem cells and several other cells, including cerebellar Purkinje cells, but it has not been studied in muscle. We injected a lentiviral vector carrying an MSCV-EGFP cassette (LvMSCV-EGFP) into tibialis anterior muscles and observed strong EGFP expression in muscle fibers, primary cultured myoblasts, and myotubes isolated from injected muscles. We also generated lentiviral-mediated transgenic mice carrying the MSCV-EGFP cassette and detected transgene expression in striated muscles. LvMSCV-EGFP transgenic mice showed fiber type-dependent variations in expression: highest in types I and IIA, intermediate in type IID/X, and lowest in type IIB fibers. The soleus and diaphragm muscles, consisting mainly of types I and IIA, are most severely affected in the mdx mouse model of muscular dystrophy. Further analysis of this promoter may have the potential to achieve certain gene expression in severely affected muscles of mdx mice. The Lv-mediated transgenic mouse may prove a useful tool for assessing the enhancer/promoter activities of a variety of different regulatory cassettes.	[Suga, Tomohiro; Kimura, En; Uchino, Katsuhisa; Uchida, Yuji; Yamashita, Satoshi; Maeda, Yasushi; Uchino, Makoto] Kumamoto Univ, Dept Neurol, Grad Sch Med Sci, Kumamoto, Japan; [Morioka, Yuka] Hokkaido Univ, Res Ctr, Infect Associated Canc, Div Dis Model Innovat,Inst Genet Med, Sapporo, Hokkaido, Japan; [Morioka, Yuka; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Kimura, En; Li, Sheng; Chamberlain, Jeffrey S.] Univ Washington, Sch Med, Dept Neurol Med & Biochem, Seattle, WA USA; [Uchida, Yuji] Sojo Univ, Pharmacol Lab, Div Life Sci, Fac Pharmaceut Sci, Kumamoto, Japan	Kumamoto University; Hokkaido University; Osaka University; University of Washington; University of Washington Seattle; Sojo University	Suga, T (corresponding author), Kumamoto Univ, Dept Neurol, Grad Sch Med Sci, Kumamoto, Japan.	enkimura@kumamoto-u.ac.jp	Kimura, En/B-3869-2010; ikawa, masahito/A-5315-2009	Kimura, En/0000-0002-7865-5918; ikawa, masahito/0000-0001-9859-6217; Yamashita, Satoshi/0000-0001-9315-3492; Chamberlain, Jeffrey/0000-0001-5299-0059	Gene Technology Center; Center for Animal Resources and Development of Kumamoto University; Japan Society for the Promotion of Science [20591004, 20591003]; Ministry of Health, Labour and Welfare [19A-7]; Kanae Foundation for the Promotion of Medical Science [37-C12]; Terumo Life Science Foundation [09-328]; National Institutes of Health [NS046788]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS046788] Funding Source: NIH RePORTER	Gene Technology Center; Center for Animal Resources and Development of Kumamoto University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Kanae Foundation for the Promotion of Medical Science; Terumo Life Science Foundation(Terumo Life Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Luigi Naldini (San Raffaele Telethon Institute for Gene Therapy, HSR-TIGET), William Osborne (University of Washington, UW), and Hiroyuki Miyoshi (RIKEN) for providing their Lentiviral vector backbones, Dusty Miller (Fred Hutchinson Cancer Research Center) for 293D cells, Stephen Hauschka (UW) for the primary culture conditions, and Glen Banks and Yutaka Ohsawa for technical advice about fiber type specific immunostaining. We acknowledge the support of the Gene Technology Center and Center for Animal Resources and Development of Kumamoto University.; Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to E.K. (20591004) and M.U. (20591003) URL: http://www.jsps.go.jp/english/e-grants/grants.html. Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare (19A-7) URL: http://www.ncnp.go.jp/research/cost.html. The Kanae Foundation for the Promotion of Medical Science to E.K. (37-C12) URL: http://kanae.sanofi-aventis.co.jp/english/index.html. The Terumo Life Science Foundation to E.K. (09-328) URL: http://www.terumozaidan.or.jp/. National Institutes of Health grant to J.S.C. (NS046788) URL: http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcaitis S, 2005, GLIA, V50, P48, DOI 10.1002/glia.20146; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; CHAMBERLAIN JS, 1985, MOL CELL BIOL, V5, P484, DOI 10.1128/MCB.5.3.484; Chinnasamy D, 2000, BLOOD, V96, P1309, DOI 10.1182/blood.V96.4.1309.h8001309_1309_1316; Choi JK, 2001, STEM CELLS, V19, P236, DOI 10.1634/stemcells.19-3-236; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; Dardalhon V, 2001, GENE THER, V8, P190, DOI 10.1038/sj.gt.3301378; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Foster H, 2008, MOL THER, V16, P1825, DOI 10.1038/mt.2008.186; GILGOFF I, 1989, CHEST, V95, P519, DOI 10.1378/chest.95.3.519; GORZA L, 1990, J HISTOCHEM CYTOCHEM, V38, P257, DOI 10.1177/38.2.2137154; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Gregory LG, 2004, GENE THER, V11, P1117, DOI 10.1038/sj.gt.3302268; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hauser MA, 2000, MOL THER, V2, P16, DOI 10.1006/mthe.2000.0089; HAWLEY RG, 1994, GENE THER, V1, P136; HEMATOPOIETIC C, STEM CELLS, V19, P236; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; Ikemoto M, 2007, MOL THER, V15, P2178, DOI 10.1038/sj.mt.6300295; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kawano R, 2008, MOL THER, V16, P825, DOI 10.1038/mt.2008.23; Kimura E, 2001, GENE THER, V8, P20, DOI 10.1038/sj.gt.3301359; Kimura E, 2008, HUM MOL GENET, V17, P2507, DOI 10.1093/hmg/ddn151; Kimura E, 2010, MOL THER, V18, P206, DOI 10.1038/mt.2009.253; Kobinger GP, 2003, HUM GENE THER, V14, P1441, DOI 10.1089/104303403769211655; Kootstra NA, 2003, MOL THER, V7, P623, DOI 10.1016/S1525-0016(03)00073-X; Li S, 2005, GENE THER, V12, P1099, DOI 10.1038/sj.gt.3302505; Lynch GS, 1997, AM J PHYSIOL-CELL PH, V272, pC2063, DOI 10.1152/ajpcell.1997.272.6.C2063; MacKenzie TC, 2005, J GENE MED, V7, P50, DOI 10.1002/jgm.649; MINETTI C, 1991, NEUROLOGY, V41, P1977, DOI 10.1212/WNL.41.12.1977; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; NAITO K, 1992, HUM REPROD, V7, P281, DOI 10.1093/oxfordjournals.humrep.a137633; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; Osborne CS, 1999, J VIROL, V73, P5490, DOI 10.1128/JVI.73.7.5490-5496.1999; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Sakamoto T, 2008, NEUROMUSCULAR DISORD, V18, P382, DOI 10.1016/j.nmd.2008.02.004; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; SHER J, 1976, ACTA NEUROL SCAND, V54, P45, DOI 10.1111/j.1600-0404.1976.tb07619.x; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Uchida Y, 2005, J GENE MED, V7, P1010, DOI 10.1002/jgm.745; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e16908	10.1371/journal.pone.0016908	http://dx.doi.org/10.1371/journal.pone.0016908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445245	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100008
J	de Langavant, LC; Remy, P; Trinkler, I; McIntyre, J; Dupoux, E; Berthoz, A; Bachoud-Levi, AC				de Langavant, Laurent Cleret; Remy, Philippe; Trinkler, Iris; McIntyre, Joseph; Dupoux, Emmanuel; Berthoz, Alain; Bachoud-Levi, Anne-Catherine			Behavioral and Neural Correlates of Communication via Pointing	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; EXTERNALLY TRIGGERED MOVEMENTS; VISUAL PERSPECTIVE; JOINT ATTENTION; BODY; PERCEPTION; LANGUAGE; CORTEX; BRAIN; SELF	Communicative pointing is a human specific gesture which allows sharing information about a visual item with another person. It sets up a three-way relationship between a subject who points, an addressee and an object. Yet psychophysical and neuroimaging studies have focused on non-communicative pointing, which implies a two-way relationship between a subject and an object without the involvement of an addressee, and makes such gesture comparable to touching or grasping. Thus, experimental data on the communicating function of pointing remain scarce. Here, we examine whether the communicative value of pointing modifies both its behavioral and neural correlates by comparing pointing with or without communication. We found that when healthy participants pointed repeatedly at the same object, the communicative interaction with an addressee induced a spatial reshaping of both the pointing trajectories and the endpoint variability. Our finding supports the hypothesis that a change in reference frame occurs when pointing conveys a communicative intention. In addition, measurement of regional cerebral blood flow using H2O15 PET-scan showed that pointing when communicating with an addressee activated the right posterior superior temporal sulcus and the right medial prefrontal cortex, in contrast to pointing without communication. Such a right hemisphere network suggests that the communicative value of pointing is related to processes involved in taking another person's perspective. This study brings to light the need for future studies on communicative pointing and its neural correlates by unraveling the three-way relationship between subject, object and an addressee.	[de Langavant, Laurent Cleret; Trinkler, Iris; Bachoud-Levi, Anne-Catherine] Inst Mondor Rech Biomed, INSERM, Equipe 1, U955, Creteil, France; [de Langavant, Laurent Cleret; Trinkler, Iris; Dupoux, Emmanuel; Bachoud-Levi, Anne-Catherine] ENS, Dept Etudes Cognit, F-75230 Paris 05, France; [de Langavant, Laurent Cleret; Remy, Philippe; Trinkler, Iris; Bachoud-Levi, Anne-Catherine] Univ Paris Est, Fac Med, Creteil, France; [de Langavant, Laurent Cleret; Remy, Philippe; Bachoud-Levi, Anne-Catherine] CHU Henri Mondor, AP HP, Serv Neurol, F-94010 Creteil, France; [Remy, Philippe] SHFJ, URA CNRS CEA 2210, Orsay, France; [McIntyre, Joseph; Berthoz, Alain] Coll France, LPPA, F-75231 Paris, France; [McIntyre, Joseph] Univ Paris 05, Inst Neurosci & Cognit, CESeM, UMR 8194, Paris, France; [McIntyre, Joseph] CNRS, Paris, France; [Dupoux, Emmanuel] ENS EHESS CNRS, Dept Etudes Cognit, LSCP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	de Langavant, LC (corresponding author), Inst Mondor Rech Biomed, INSERM, Equipe 1, U955, Creteil, France.	bachoud@gmail.com	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; McIntyre, Joseph/K-6395-2015	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; McIntyre, Joseph/0000-0003-4974-4257; Remy, Philippe/0000-0003-2150-2563; Trinkler, Iris/0000-0002-0405-161X; Cleret de Langavant, Laurent/0000-0001-6551-4641; Dupoux, Emmanuel/0000-0002-7814-2952				Abraham A, 2008, CONSCIOUS COGN, V17, P438, DOI 10.1016/j.concog.2008.03.011; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1989, BRIT J DEV PSYCHOL, V7, P113, DOI 10.1111/j.2044-835X.1989.tb00793.x; BARONCOHEN S, 2005, EMPATHIZING SYSTEM R; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; BOOKSTEIN FL, 1992, BEHAV BRAIN SCI, V15, P327, DOI 10.1017/S0140525X00068886; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Carrozzo M, 2002, EXP BRAIN RES, V147, P426, DOI 10.1007/s00221-002-1232-4; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Charman T., 2006, SOCIAL COMMUNICATION; Cook RD, 1982, RESIDUALS INFLUENCE; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; de Langavant LC, 2009, NEUROPSYCHOLOGIA, V47, P1745, DOI 10.1016/j.neuropsychologia.2009.02.016; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Degos JD, 1997, NEUROCASE, V3, P31, DOI 10.1080/13554799708404032; Diedrichsen J, 2004, PERCEPT PSYCHOPHYS, V66, P89, DOI 10.3758/BF03194864; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Felician O, 2003, NEUROPSYCHOLOGIA, V41, P1307, DOI 10.1016/S0028-3932(03)00046-0; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Franco F, 1996, J CHILD LANG, V23, P307, DOI 10.1017/S0305000900008813; FRANCO F, 2005, JOINT ATTENTION COMM, P129, DOI DOI 10.1093/ACPROF:OSO/9780199245635.003.0007; Frith U, 2005, CONSCIOUS COGN, V14, P719, DOI 10.1016/j.concog.2005.04.006; Ganesan V, 2005, AM J PSYCHIAT, V162, P1545, DOI 10.1176/appi.ajp.162.8.1545; Gomez J. C., 2005, JOINT ATTENTION COMM, P65; Gomez JC, 1996, BEHAV BRAIN SCI, V19, P129, DOI 10.1017/S0140525X00041881; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Henderson LM, 2002, INT J DEV NEUROSCI, V20, P449, DOI 10.1016/S0736-5748(02)00038-2; HOBSON R, 2005, JOINT ATTENTION COMM, P129; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jellema T, 2004, CEREB CORTEX, V14, P781, DOI 10.1093/cercor/bhh038; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; LACQUANITI F, 1997, HANDB NEUR, V11, P27; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; Liszkowski U, 2004, DEVELOPMENTAL SCI, V7, P297, DOI 10.1111/j.1467-7687.2004.00349.x; Liszkowski U, 2008, INFANT BEHAV DEV, V31, P157, DOI 10.1016/j.infbeh.2007.10.011; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Pelphrey KA, 2003, NEUROPSYCHOLOGIA, V41, P156, DOI 10.1016/S0028-3932(02)00146-X; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; Phillips W, 1995, J CHILD PSYCHOL PSYC, V36, P1383, DOI 10.1111/j.1469-7610.1995.tb01670.x; Pick A, 1922, PSYCHOL FORSCH, V1, P303, DOI 10.1007/BF00410392; Puce A, 1998, J NEUROSCI, V18, P2188; Ramnani N, 2004, NAT NEUROSCI, V7, P85, DOI 10.1038/nn1168; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Simon O, 2004, NEUROIMAGE, V23, P1192, DOI 10.1016/j.neuroimage.2004.09.023; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Soechting J F, 1990, J Cogn Neurosci, V2, P32, DOI 10.1162/jocn.1990.2.1.32; Spence SA, 2002, COGN NEUROPSYCHIATRY, P211, DOI 10.1080/13546800244000094; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; Vindras P, 1998, J EXP PSYCHOL HUMAN, V24, P569, DOI 10.1037/0096-1523.24.2.569; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	72	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17719	10.1371/journal.pone.0017719	http://dx.doi.org/10.1371/journal.pone.0017719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736SH	21423659	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900017
J	Li, Y; Zhu, Z; Zhang, SH; Yu, DH; Yu, HY; Liu, LN; Cao, XZ; Wang, L; Gao, HJ; Zhu, MH				Li, Yongmei; Zhu, Zhi; Zhang, Shuhui; Yu, Danghui; Yu, Hongyu; Liu, Lina; Cao, Xiaozhe; Wang, Li; Gao, Hengjun; Zhu, Minghua			ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; CELL-CYCLE; CENP-A; CLINICOPATHOLOGICAL SIGNIFICANCE; NASOPHARYNGEAL CARCINOMA; NEGATIVE REGULATOR; COLORECTAL-CANCER; KINETOCHORE; EXPRESSION; OVEREXPRESSION	Background: Centromere protein A (CENP-A) plays important roles in cell-cycle regulation and genetic stability. Herein, we aimed to investigate its expression pattern, clinical significance, and biological function in hepatocellular carcinoma (HCC). Methodology/Principal Findings: CENP-A expression at the mRNA and protein levels was examined in 20 pairs of fresh HCCs and corresponding nontumor liver tissues. Immunohistochemistry for CENP-A was performed on 80 paraffin-embedded HCC specimens, and the clinical significance of its expression was analyzed. A human HCC cell line HepG2 with high abundance of CENP-A was used to study the effects of manipulating CENP-A on HCC growth. Quantitative real-time polymerase chain reaction arrays and Western blot analysis were employed to identify the cell-cycle control-and apoptosis-related genes regulated by CENP-A. The results showed that CENP-A was aberrantly overexpressed in HCCs relative to adjacent nontumor tissues. This overexpression was significantly associated with positive serum HBsAg status, increased histological grade, high Ki-67 index and P53 immunopositivity. Knockdown of CENP-A in HepG2 cells reduced cell proliferation, blocked cell cycle at the G1 phase, and increased apoptosis. The antiproliferative effects of CENP-A silencing were also observed in vivo. Conversely, CENP-A overexpression promoted HCC cell growth and reduced apoptosis. Furthermore, many genes implicated in cell-cycle regulation and apoptosis, including CHK2, P21waf1, P27 Kip1, SKP2, cyclin G1, MDM2, Bcl-2, and Bax, were deregulated by manipulating CENP-A. Conclusions/Significance: Overexpression of CENP-A is frequently observed in HCC. Targeting CENP-A can inhibit HCC growth, likely through the regulation of a large number genes involved in cell-cycle progression and apoptosis, and thereby represents a potential therapeutic strategy for this malignancy.	[Li, Yongmei; Zhu, Zhi; Yu, Danghui; Yu, Hongyu; Liu, Lina; Cao, Xiaozhe; Wang, Li; Zhu, Minghua] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Zhu, Minghua] Second Mil Med Univ, Inst Liver Dis, Shanghai, Peoples R China; [Zhang, Shuhui] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Dept Pathol, Shanghai, Peoples R China; [Li, Yongmei] Tongji Univ, Coll Med, Dept Pathol, Shanghai 200092, Peoples R China; [Gao, Hengjun] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Shanghai University of Traditional Chinese Medicine; Tongji University	Li, Y (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China.	mhzhu2000@hotmail.com	liu, li/HGC-0900-2022		National Natural Science Foundation of China [30870976]; National Science Fund for Creative Research Groups [30921006]; Shanghai Natural Science Foundation of China [08ZR1419600]; Key Research Foundation of Shanghai Municipal Education Commission of China [08ZZ123]; Research Foundation from Shanghai Municipal Health Bureau, China [2007086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Foundation of Shanghai Municipal Education Commission of China; Research Foundation from Shanghai Municipal Health Bureau, China	Funding: Funding was provided by National Natural Science Foundation of China (no. 30870976) and National Science Fund for Creative Research Groups (no. 30921006) to MZ; Shanghai Natural Science Foundation of China (No. 08ZR1419600) and Key Research Foundation of Shanghai Municipal Education Commission of China (No. 08ZZ123) to SZ; Research Foundation from Shanghai Municipal Health Bureau, China (2007086) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Cao JY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-237; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Chehab NH, 2000, GENE DEV, V14, P278; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; de la Guardia C, 2001, HEAD NECK-J SCI SPEC, V23, P104; Ecker K, 2009, NAT CELL BIOL, V11, P377, DOI [10.1038/ncb1859, 10.1038/ncb0409-377]; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; HAMILTON S, 2000, WHO CLASSIFICATION T, P167; Henning W, 2003, TOXICOLOGY, V193, P91, DOI 10.1016/S0300-483X(03)00291-9; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Li Yong-mei, 2008, Chinese Journal of Pathology, V37, P124; Liao WT, 2007, CLIN CANCER RES, V13, P508, DOI 10.1158/1078-0432.CCR-06-1512; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JX, 2006, P NATL ACAD SCI USA, V103, P383, DOI 10.1073/pnas.0509810102; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Marshall OJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000370; McIntyre M, 1999, ONCOGENE, V18, P4577, DOI 10.1038/sj.onc.1202815; Mellone BG, 2009, CELL, V137, P409, DOI 10.1016/j.cell.2009.04.035; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Orthaus S, 2006, BIOCHEM BIOPH RES CO, V348, P36, DOI 10.1016/j.bbrc.2006.06.187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podhraski V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010120; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Sanyal K, 2002, P NATL ACAD SCI USA, V99, P12969, DOI 10.1073/pnas.162488299; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Tomonaga T, 2003, CANCER RES, V63, P3511; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Xian ZH, 2006, MODERN PATHOL, V19, P280, DOI 10.1038/modpathol.3800530; Zeindl-Eberhart E, 2004, HEPATOLOGY, V39, P540, DOI 10.1002/hep.20060; Zeindl-Eberhart E, 2001, ELECTROPHORESIS, V22, P3009, DOI 10.1002/1522-2683(200108)22:14<3009::AID-ELPS3009>3.0.CO;2-V; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zhang SH, 2008, HUM PATHOL, V39, P1827, DOI 10.1016/j.humpath.2008.06.003; Zhu Z, 2009, HEPATOLOGY, V49, P504, DOI 10.1002/hep.22675	55	80	83	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17794	10.1371/journal.pone.0017794	http://dx.doi.org/10.1371/journal.pone.0017794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423629	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900030
J	Tia, B; Saimpont, A; Paizis, C; Mourey, F; Fadiga, L; Pozzo, T				Tia, Banty; Saimpont, Arnaud; Paizis, Christos; Mourey, France; Fadiga, Luciano; Pozzo, Thierry			Does Observation of Postural Imbalance Induce a Postural Reaction?	PLOS ONE			English	Article							BIOLOGICAL MOTION; UTILIZATION BEHAVIOR; MUSCLE-STIFFNESS; MOTOR IMAGERY; PERCEPTION; MOVEMENT; MODULATION; IMITATION; BALANCE; PICTURES	Background: Several studies bring evidence that action observation elicits contagious responses during social interactions. However automatic imitative tendencies are generally inhibited and it remains unclear in which conditions mere action observation triggers motor behaviours. In this study, we addressed the question of contagious postural responses when observing human imbalance. Methodology/Principal Findings: We recorded participants' body sway while they observed a fixation cross (control condition), an upright point-light display of a gymnast balancing on a rope, and the same point-light display presented upside down. Our results showed that, when the upright stimulus was displayed prior to the inverted one, centre of pressure area and antero-posterior path length were significantly greater in the upright condition compared to the control and upside down conditions. Conclusions/Significance: These results demonstrate a contagious postural reaction suggesting a partial inefficiency of inhibitory processes. Further, kinematic information was sufficient to trigger this reaction. The difference recorded between the upright and upside down conditions indicates that the contagion effect was dependent on the integration of gravity constraints by body kinematics. Interestingly, the postural response was sensitive to habituation, and seemed to disappear when the observer was previously shown an inverted display. The motor contagion recorded here is consistent with previous work showing vegetative output during observation of an effortful movement and could indicate that lower level control facilitates contagion effects.	[Tia, Banty; Saimpont, Arnaud; Paizis, Christos; Mourey, France; Pozzo, Thierry] Univ Bourgogne, INSERM, U887, Dijon, France; [Tia, Banty; Saimpont, Arnaud; Mourey, France] Ctr Hosp Univ Dijon, Dijon, France; [Paizis, Christos] Univ Bourgogne, UFR STAPS, Ctr Expertise Performance Gilles Cometti, Dijon, France; [Fadiga, Luciano] Univ Ferrara, Fac Med, Dept SBTA, Sect Human Physiol, I-44100 Ferrara, Italy; [Fadiga, Luciano; Pozzo, Thierry] Italian Inst Technol, RBCS Robot Brain & Cognit Sci Dept, Genoa, Italy; [Pozzo, Thierry] Univ Bourgogne, UFR STAPS, Inst Univ France, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; University of Ferrara; Istituto Italiano di Tecnologia - IIT; Institut Universitaire de France; Universite de Bourgogne	Tia, B (corresponding author), Univ Bourgogne, INSERM, U887, Dijon, France.	banty.tia@u-bourgogne.fr	PAIZIS, CHRISTOS/P-1848-2019; Mourey, France/AAF-1784-2020; Fadiga, Luciano/AAC-7404-2022	fadiga, luciano/0000-0001-5691-5080; Pozzo, Thierry/0000-0002-0585-7965	French Agence Nationale de la Recherche (ANR); Conseil Regional de Bourgogne	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte)	Funding: This study was supported by the French Agence Nationale de la Recherche (ANR TecSan projet SimAction) and the Conseil Regional de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo TM, 2005, PSYCHOPHYSIOLOGY, V42, P255, DOI 10.1111/j.1469-8986.2005.00287.x; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Bisio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013506; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bove M, 2009, BRAIN RES BULL, V80, P122, DOI 10.1016/j.brainresbull.2009.04.008; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Chang DHF, 2009, J VISION, V9, DOI [10.1167/9.1.19, 10.1167/9.5.8]; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Courtine G, 2002, NEUROSCI LETT, V332, P70, DOI 10.1016/S0304-3940(02)00909-6; DeRenzi E, 1996, J NEUROL NEUROSUR PS, V61, P396, DOI 10.1136/jnnp.61.4.396; Ehrenfried T, 2003, COGNITIVE BRAIN RES, V17, P140, DOI 10.1016/S0926-6410(03)00088-0; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Guillot A, 2007, INT J PSYCHOPHYSIOL, V66, P18, DOI 10.1016/j.ijpsycho.2007.05.009; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LIPPS T, 2006, AESTHETIC PSYCHOL SC; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; Morasso PG, 2002, J NEUROPHYSIOL, V88, P2157, DOI 10.1152/jn.2002.88.4.2157; Mulder T, 2005, EXP BRAIN RES, V163, P344, DOI 10.1007/s00221-004-2179-4; Paccalin C, 2000, BRAIN RES, V862, P194, DOI 10.1016/S0006-8993(00)02145-4; Paillard J., 1976, TRAITE PHYSL, VII, P521; Papaxanthis C, 2003, NEUROSCIENCE, V117, P779, DOI 10.1016/S0306-4522(02)00964-8; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pozzo T, 2006, BEHAV BRAIN RES, V169, P75, DOI 10.1016/j.bbr.2005.12.005; Shiffrar M., 2007, SENSORIMOTOR FDN HIG, V22, P267; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Thirioux B, 2009, BRAIN COGNITION, V70, P191, DOI 10.1016/j.bandc.2009.02.006; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211	43	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17799	10.1371/journal.pone.0017799	http://dx.doi.org/10.1371/journal.pone.0017799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736SH	21423622	gold, Green Submitted, Green Published			2022-12-27	WOS:000288513900031
J	Alfaro, C; Suarez, N; Martinez-Forero, I; Palazon, A; Rouzaut, A; Solano, S; Feijoo, E; Gurpide, A; Bolanos, E; Erro, L; Dubrot, J; Hervas-Stubbs, S; Gonzalez, A; Perez-Gracia, JL; Melero, I				Alfaro, Carlos; Suarez, Natalia; Martinez-Forero, Ivan; Palazon, Asis; Rouzaut, Ana; Solano, Sarai; Feijoo, Esperanza; Gurpide, Alfonso; Bolanos, Elixabet; Erro, Lorena; Dubrot, Juan; Hervas-Stubbs, Sandra; Gonzalez, Alvaro; Luis Perez-Gracia, Jose; Melero, Ignacio			Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation	PLOS ONE			English	Article							INTRATUMORAL INJECTION; TUMOR MICROENVIRONMENT; CANCER-IMMUNOTHERAPY; ANTITUMOR IMMUNITY; MELANOMA PATIENTS; GROWTH-FACTOR; CHEMOKINES; RECEPTOR; INFLAMMATION; EXPRESSION	Background: Interleukin-8 (IL-8, CXCL8) is readily produced by human malignant cells. Dendritic cells (DC) both produce IL-8 and express the IL-8 functional receptors CXCR1 and CXCR2. Most human colon carcinomas produce IL-8. IL-8 importance in malignancies has been ascribed to angiogeneis promotion. Principal Findings: IL-8 effects on human monocyte-derived DC biology were explored upon DC exposure to recombinant IL-8 and with the help of an IL-8 neutralizing mAb. In vivo experiments were performed in immunodeficient mice xenografted with IL-8-producing human colon carcinomas and comparatively with cell lines that do not produce IL-8. Allogenic T lymphocyte stimulation by DC was explored under the influence of IL-8. DC and neutrophil chemotaxis were measured by transwell-migration assays. Sera from tumor-xenografted mice contained increasing concentrations of IL-8 as the tumors progress. IL-8 production by carcinoma cells can be modulated by low doses of cyclophosphamide at the transcription level. If human DC are injected into HT29 or CaCo2 xenografted tumors, DC are retained intratumorally in an IL-8-dependent fashion. However, IL-8 did not modify the ability of DC to stimulate T cells. Interestingly, pre-exposure of DC to IL-8 desensitizes such cells for IL-8-mediated in vitro or in vivo chemoattraction. Thereby DC become disoriented to subsequently follow IL-8 chemotactic gradients towards malignant or inflamed tissue. Conclusions: IL-8 as produced by carcinoma cells changes DC migration cues, without directly interfering with DC-mediated T-cell stimulation.	[Alfaro, Carlos; Suarez, Natalia; Martinez-Forero, Ivan; Palazon, Asis; Rouzaut, Ana; Solano, Sarai; Feijoo, Esperanza; Bolanos, Elixabet; Erro, Lorena; Dubrot, Juan; Hervas-Stubbs, Sandra; Melero, Ignacio] CIMA, Gene Therapy & Hepatol Div, Pamplona, Spain; [Suarez, Natalia; Gonzalez, Alvaro] Univ Navarra Clin, Dept Biochem, Pamplona, Spain; [Gurpide, Alfonso; Bolanos, Elixabet; Luis Perez-Gracia, Jose; Melero, Ignacio] Univ Navarra Clin, Dept Med Oncol, Pamplona, Spain	University of Navarra; University of Navarra	Alfaro, C (corresponding author), CIMA, Gene Therapy & Hepatol Div, Pamplona, Spain.	imelero@unav.es	Dubrot, Juan/ABI-1676-2020; González, Álvaro/T-8122-2018; Perez-Gracia, Jose Luis/I-8372-2017; Palazon, Asis/ABI-1748-2020; Melero, Ignacio/T-7600-2019; Alfaro, Carlos/K-3566-2014; Rouzaut, Ana/I-2576-2017; Bolaños, Elixabet/I-8225-2017; Hervas-Stubbs, Sandra/C-9053-2018	Dubrot, Juan/0000-0002-8093-2208; González, Álvaro/0000-0002-1423-273X; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Palazon, Asis/0000-0002-7172-7229; Melero, Ignacio/0000-0002-1360-348X; Alfaro, Carlos/0000-0002-4812-7153; Rouzaut, Ana/0000-0003-3226-9162; Bolaños, Elixabet/0000-0003-3780-9244; Hervas-Stubbs, Sandra/0000-0003-3391-1516	MEC/MICINN [SAF2005-03131, SAF2008-03294]; Departamento de Educacion del Gobierno de Navarra; Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri); Redes tematicas de investigacion cooperativa RETIC [RD06/0020/0065]; Fondo de investigacion sanitaria [FIS PI060932]; European commission; SUDOE-IMMUNONET; Fundacion Mutua Madrilena; "UTE for project FIMA"; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC); Ministerio de Educacion y Ciencia; FIS	MEC/MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departamento de Educacion del Gobierno de Navarra; Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri); Redes tematicas de investigacion cooperativa RETIC; Fondo de investigacion sanitaria(Instituto de Salud Carlos III); European commission(European CommissionEuropean Commission Joint Research Centre); SUDOE-IMMUNONET; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); "UTE for project FIMA"; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC); Ministerio de Educacion y Ciencia(Spanish Government); FIS(Instituto de Salud Carlos III)	Financial support was from MEC/MICINN (SAF2005-03131 and SAF2008-03294), Departamento de Educacion del Gobierno de Navarra, Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri), Redes tematicas de investigacion cooperativa RETIC (RD06/0020/0065), Fondo de investigacion sanitaria (FIS PI060932), European commission 7th framework program (ENCITE) and SUDOE-IMMUNONET, Fundacion Mutua Madrilena, and "UTE for project FIMA". CA is supported by Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC). SH-S receives a Ramon y Cajal contract from Ministerio de Educacion y Ciencia and AP a scholarship from FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Baggiolini M, 2000, IMMUNOL TODAY, V21, P418, DOI 10.1016/S0167-5699(00)01672-8; BAGGIOLINI M, 1994, CHEST, V105, pS95, DOI 10.1378/chest.105.3_Supplement.95S; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Feijoo E, 2005, INT J CANCER, V116, P275, DOI 10.1002/ijc.21046; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gasparini G, 2001, LANCET ONCOL, V2, P733, DOI 10.1016/S1470-2045(01)00587-3; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Gross MD, 2001, J NUCL MED, V42, P1656; Guo J, 2007, INT J CANCER, V120, P2418, DOI 10.1002/ijc.22551; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; HUANG D, CANC RES, V70, P1063; Huarte E, 2005, EXPERT OPIN BIOL TH, V5, P7, DOI 10.1517/14712598.5.1.7; Kikuchi T, 2000, BLOOD, V96, P91, DOI 10.1182/blood.V96.1.91.013k19_91_99; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; Mazzolini G, 2005, J CLIN ONCOL, V23, P999, DOI 10.1200/JCO.2005.00.463; Melero I, 1999, GENE THER, V6, P1779, DOI 10.1038/sj.gt.3301010; Melero I, 2006, CLIN CANCER RES, V12, P2385, DOI 10.1158/1078-0432.CCR-06-0314; Melero I, 2000, GENE THER, V7, P1167, DOI 10.1038/sj.gt.3301234; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Meyer TPH, 2005, J IMMUNOL METHODS, V307, P150, DOI 10.1016/j.jim.2005.10.004; Miller PW, 2000, HUM GENE THER, V11, P53, DOI 10.1089/10430340050016157; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Murillo O, 2009, EUR J IMMUNOL, V39, P2424, DOI 10.1002/eji.200838958; Nishioka Y, 1999, CANCER RES, V59, P4035; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rolny C, 2008, J EXP MED, V205, P1155, DOI 10.1084/jem.20072509; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Schraufstatter IU, 2003, J IMMUNOL, V171, P6714, DOI 10.4049/jimmunol.171.12.6714; Sozzani S, 1997, J IMMUNOL, V159, P1993; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; SUAREZ N, INT J CANC; Tirapu I, 2006, CANCER RES, V66, P2442, DOI 10.1158/0008-5472.CAN-05-1681; Tirapu I, 2004, INT J CANCER, V110, P51, DOI 10.1002/ijc.20093; Triozzi PL, 2000, CANCER-AM CANCER SOC, V89, P2646, DOI 10.1002/1097-0142(20001215)89:12<2646::AID-CNCR18>3.0.CO;2-A; UEDA T, 1994, J GASTROENTEROL, V29, P423, DOI 10.1007/BF02361238; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Verdijk P, 2008, EXPERT OPIN BIOL TH, V8, P865, DOI [10.1517/14712598.8.7.865, 10.1517/14712598.8.7.865 ]; Verdijk P, 2009, CLIN CANCER RES, V15, P2531, DOI 10.1158/1078-0432.CCR-08-2729; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	56	28	31	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17922	10.1371/journal.pone.0017922	http://dx.doi.org/10.1371/journal.pone.0017922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423807	Green Submitted, gold, Green Published			2022-12-27	WOS:000288512400040
J	Fairhurst, GD; Frey, MD; Reichert, JF; Szelest, I; Kelly, DM; Bortolotti, GR				Fairhurst, Graham D.; Frey, Matthew D.; Reichert, James F.; Szelest, Izabela; Kelly, Debbie M.; Bortolotti, Gary R.			Does Environmental Enrichment Reduce Stress? An Integrated Measure of Corticosterone from Feathers Provides a Novel Perspective	PLOS ONE			English	Article							FURNISHED CAGES; IMMUNE FUNCTION; BODY CONDITION; BATTERY CAGES; EXPLORATION; RESPONSES; BEHAVIOR; WELFARE; NEOPHOBIA; PARAMETERS	Enrichment is widely used as tool for managing fearfulness, undesirable behaviors, and stress in captive animals, and for studying exploration and personality. Inconsistencies in previous studies of physiological and behavioral responses to enrichment led us to hypothesize that enrichment and its removal are stressful environmental changes to which the hormone corticosterone and fearfulness, activity, and exploration behaviors ought to be sensitive. We conducted two experiments with a captive population of wild-caught Clark's nutcrackers (Nucifraga columbiana) to assess responses to short- (10-d) and long-term (3-mo) enrichment, their removal, and the influence of novelty, within the same animal. Variation in an integrated measure of corticosterone from feathers, combined with video recordings of behaviors, suggests that how individuals perceive enrichment and its removal depends on the duration of exposure. Short- and long-term enrichment elicited different physiological responses, with the former acting as a stressor and birds exhibiting acclimation to the latter. Non-novel enrichment evoked the strongest corticosterone responses of all the treatments, suggesting that the second exposure to the same objects acted as a physiological cue, and that acclimation was overridden by negative past experience. Birds showed weak behavioral responses that were not related to corticosterone. By demonstrating that an integrated measure of glucocorticoid physiology varies significantly with changes to enrichment in the absence of agonistic interactions, our study sheds light on potential mechanisms driving physiological and behavioral responses to environmental change.	[Fairhurst, Graham D.; Frey, Matthew D.; Bortolotti, Gary R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Reichert, James F.; Szelest, Izabela; Kelly, Debbie M.] Univ Saskatchewan, Dept Psychol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan	Fairhurst, GD (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	graham.fairhurst@usask.ca	Fairhurst, Graham/ABB-1218-2020; Fairhurst, Graham/E-1639-2011	Fairhurst, Graham/0000-0001-8731-1298	Natural Sciences and Engineering Research Council of Canada [312379-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by Natural Sciences and Engineering Research Council of Canada grant #312379-2009 (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Balcombe JP, 2006, LAB ANIM-UK, V40, P217, DOI 10.1258/002367706777611488; Barnett JL, 2009, POULTRY SCI, V88, P456, DOI 10.3382/ps.2008-00168; Bateson M, 2007, ANIM WELFARE, V16, P33; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Boinski S, 1999, AM J PRIMATOL, V48, P49, DOI 10.1002/(SICI)1098-2345(1999)48:1<49::AID-AJP4>3.3.CO;2-Y; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bolhuis JE, 2005, APPL ANIM BEHAV SCI, V93, P213, DOI 10.1016/j.applanim.2005.01.006; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2010, ECOL APPL, V20, P1766, DOI 10.1890/09-1473.1; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Bortolotti GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004983; Bosson CO, 2009, PHYSIOL BIOCHEM ZOOL, V82, P291, DOI 10.1086/597530; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Carlsson HE, 2007, RES VET SCI, V82, P423, DOI 10.1016/j.rvsc.2006.09.005; Carlstead K, 2000, BIOLOGY OF ANIMAL STRESS, P337, DOI 10.1079/9780851993591.0337; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Cockrem JF, 2002, GEN COMP ENDOCR, V125, P248, DOI 10.1006/gcen.2001.7749; Cornelius JM, 2010, P ROY SOC B-BIOL SCI, V277, P2399, DOI 10.1098/rspb.2010.0164; Cummings D, 2007, ZOO BIOL, V26, P331, DOI 10.1002/zoo.20138; de Azevedo CS, 2007, APPL ANIM BEHAV SCI, V102, P329, DOI 10.1016/j.applanim.2006.05.034; deMonte M, 1997, ANIM WELFARE, V6, P53; DOBRAKOVOVA M, 1993, PSYCHONEUROENDOCRINO, V18, P163, DOI 10.1016/0306-4530(93)90001-2; DOBSON H, 1995, J REPROD FERTIL, P451; DYBKJAER L, 1992, APPL ANIM BEHAV SCI, V35, P135, DOI 10.1016/0168-1591(92)90004-U; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Fox RA, 2004, APPL ANIM BEHAV SCI, V89, P117, DOI 10.1016/j.applanim.2004.05.002; Fox RA, 2007, APPL ANIM BEHAV SCI, V104, P107, DOI 10.1016/j.applanim.2006.04.033; Fox RA, 2009, ANIM BEHAV, V77, P1441, DOI 10.1016/j.anbehav.2009.02.022; Gagliano H, 2008, BEHAV BRAIN RES, V187, P239, DOI 10.1016/j.bbr.2007.09.006; Gardner JM, 2001, APPL ANIM BEHAV SCI, V74, P135, DOI 10.1016/S0168-1591(01)00158-7; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Harms NJ, 2010, ENVIRON POLLUT, V158, P841, DOI 10.1016/j.envpol.2009.09.025; Hemsworth PH, 2003, APPL ANIM BEHAV SCI, V81, P185, DOI 10.1016/S0168-1591(02)00280-0; Ishiwata T, 2006, ANIM SCI J, V77, P352, DOI 10.1111/j.1740-0929.2006.00359.x; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; Kells A, 2001, ANIM WELFARE, V10, P347; LEMAHO Y, 1992, AM J PHYSIOL, V263, pR775, DOI 10.1152/ajpregu.1992.263.4.R775; Leone EH, 2008, POULTRY SCI, V87, P14, DOI 10.3382/ps.2007-00154; Lutz CK, 2005, ILAR J, V46, P178, DOI 10.1093/ilar.46.2.178; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; Meehan CL, 2002, APPL ANIM BEHAV SCI, V79, P75, DOI 10.1016/S0168-1591(02)00118-1; Menargues A, 2008, ANIM WELFARE, V17, P305; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mettke-Hofmann C, 2006, J ZOOL, V268, P405, DOI 10.1111/j.1469-7998.2005.00037.x; Mettke-Hofmann C, 2005, BEHAV ECOL, V16, P247, DOI 10.1093/beheco/arh159; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Mettke-Hofmann C, 2007, ETHOLOGY, V113, P174, DOI 10.1111/j.1439-0310.2006.01307.x; Moncek F, 2004, J NEUROENDOCRINOL, V16, P423, DOI 10.1111/j.1365-2826.2004.01173.x; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pena Y, 2009, PSYCHONEUROENDOCRINO, V34, P1390, DOI 10.1016/j.psyneuen.2009.04.019; Pohle K, 2009, POULTRY SCI, V88, P2042, DOI 10.3382/ps.2009-00171; Pohle K, 2009, POULTRY SCI, V88, P1559, DOI 10.3382/ps.2009-00045; Renner M.J., 1987, ENRICHED IMPOVERISHE; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Rushen J, 2000, BIOLOGY OF ANIMAL STRESS, P23, DOI 10.1079/9780851993591.0023; Sabbatini G, 2007, AM J PRIMATOL, V69, P457, DOI 10.1002/ajp.20365; Saino N, 2003, BEHAV ECOL, V14, P318, DOI 10.1093/beheco/14.3.318; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Staley AM, 2007, J COMP PHYSIOL B, V177, P609, DOI 10.1007/s00360-007-0159-2; Tomback Diana F., 1998, Birds of North America, V331, P1; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Veissier I, 1997, J ANIM SCI, V75, P356; Wasser SK, 2005, ANN NY ACAD SCI, V1046, P109, DOI 10.1196/annals.1343.010; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wayland M, 2002, ENVIRON RES, V90, P47, DOI 10.1006/enrs.2002.4384; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P600, DOI 10.1093/icb/42.3.600; Wingfield John C., 1999, P1; Wolfle TL, 2000, BIOLOGY OF ANIMAL STRESS, P355, DOI 10.1079/9780851993591.0355; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046	77	57	59	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17663	10.1371/journal.pone.0017663	http://dx.doi.org/10.1371/journal.pone.0017663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412426	gold, Green Published, Green Submitted			2022-12-27	WOS:000288247800022
J	Knower, KC; Kelly, S; Ludbrook, LM; Bagheri-Fam, S; Sim, H; Bernard, P; Sekido, R; Lovell-Badge, R; Harley, VR				Knower, Kevin C.; Kelly, Sabine; Ludbrook, Louisa M.; Bagheri-Fam, Stefan; Sim, Helena; Bernard, Pascal; Sekido, Ryohei; Lovell-Badge, Robin; Harley, Vincent R.			Failure of SOX9 Regulation in 46XY Disorders of Sex Development with SRY, SOX9 and SF1 Mutations	PLOS ONE			English	Article							STEROIDOGENIC FACTOR-I; CAMPOMELIC DYSPLASIA; GONADAL-DYSGENESIS; MISSENSE MUTATIONS; DETERMINING REGION; TESTIS DEVELOPMENT; DETERMINING GENES; DNA-BINDING; BOX REGION; CELL LINE	Background: In human embryogenesis, loss of SRY (sex determining region on Y), SOX9 (SRY-related HMG box 9) or SF1 (steroidogenic factor 1) function causes disorders of sex development (DSD). A defining event of vertebrate sex determination is male-specific upregulation and maintenance of SOX9 expression in gonadal pre-Sertoli cells, which is preceded by transient SRY expression in mammals. In mice, Sox9 regulation is under the transcriptional control of SRY, SF1 and SOX9 via a conserved testis-specific enhancer of Sox9 (TES). Regulation of SOX9 in human sex determination is however poorly understood. Methodology/Principal Findings: We show that a human embryonal carcinoma cell line (NT2/D1) can model events in presumptive Sertoli cells that initiate human sex determination. SRY associates with transcriptionally active chromatin in NT2/D1 cells and over-expression increases endogenous SOX9 expression. SRY and SF1 co-operate to activate the human SOX9 homologous TES (hTES), a process dependent on phosphorylated SF1. SOX9 also activates hTES, augmented by SF1, suggesting a mechanism for maintenance of SOX9 expression by auto-regulation. Analysis of mutant SRY, SF1 and SOX9 proteins encoded by thirteen separate 46, XY DSD gonadal dysgenesis individuals reveals a reduced ability to activate hTES. Conclusions/Significance: We demonstrate how three human sex-determining factors are likely to function during gonadal development around SOX9 as a hub gene, with different genetic causes of 46, XY DSD due a common failure to upregulate SOX9 transcription.	[Knower, Kevin C.; Kelly, Sabine; Ludbrook, Louisa M.; Bagheri-Fam, Stefan; Sim, Helena; Bernard, Pascal; Harley, Vincent R.] Prince Henrys Inst, Melbourne, Vic, Australia; [Bagheri-Fam, Stefan] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Harley, Vincent R.] Monash Univ, Dept Mol Biol & Biochem, Melbourne, Vic 3004, Australia; [Sekido, Ryohei; Lovell-Badge, Robin] MRC Natl Inst Med Res, Div Dev Genet, Ridgeway, London, England	Prince Henry's Institute of Medical Research; Monash University; Monash University	Knower, KC (corresponding author), Prince Henrys Inst, Melbourne, Vic, Australia.	vincent.harley@princehenrys.org	Knower, Kevin/C-2869-2014; Harley, Vincent/B-8092-2018; Bernard, Pascal/G-7615-2011	Harley, Vincent/0000-0002-2405-1262; Lovell-Badge, Robin/0000-0001-9364-4179; Sekido, Ryohei/0000-0003-2364-1882	National Health and Medical Research Council of Australia (NHMRC) [334314, 546517]; Victorian Government; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) Program Grant number 334314 (2004-2009) and number 546517 (2010-2014); and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Albrecht KH, 2003, GENETICS, V164, P277; Assumpcao JG, 2002, J MOL MED, V80, P782, DOI 10.1007/s00109-002-0376-9; Bagheri-Fam S, 2010, INT J BIOCHEM CELL B, V42, P472, DOI 10.1016/j.biocel.2009.07.001; BARBOSA AS, 1995, HUM GENET, V95, P63; Benasayag S, 2001, J PEDIATR ENDOCR MET, V14, P797; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bernard P, 2008, INT J BIOCHEM CELL B, V40, P2889, DOI 10.1016/j.biocel.2008.06.006; Bilbao JR, 1996, HUM GENET, V97, P537, DOI 10.1007/s004390050088; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Bullejos M, 2005, DEV BIOL, V278, P473, DOI 10.1016/j.ydbio.2004.11.030; Burgoyne PS, 2001, INT J DEV BIOL, V45, P509; Cameron FJ, 1997, HUM MUTAT, V9, P388; Canto P, 2000, J CLIN ENDOCR METAB, V85, P1908, DOI 10.1210/jc.85.5.1908; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; COHEN DR, 1994, P NATL ACAD SCI USA, V91, P4372, DOI 10.1073/pnas.91.10.4372; Correa RV, 2004, J CLIN ENDOCR METAB, V89, P1767, DOI 10.1210/jc.2003-031240; Crawford PA, 1997, MOL ENDOCRINOL, V11, P1626, DOI 10.1210/me.11.11.1626; Desclozeaux M, 1998, J BIOL CHEM, V273, P7988, DOI 10.1074/jbc.273.14.7988; Domenice S, 1998, HUM GENET, V102, P213, DOI 10.1007/s004390050680; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; Eicher EM, 1996, NAT GENET, V14, P206, DOI 10.1038/ng1096-206; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FRIEDMAN AD, 1988, NATURE, V335, P452, DOI 10.1038/335452a0; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hageman RM, 1998, HUM MUTAT, pS112; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hanley NA, 2000, MECH DEVELOP, V91, P403, DOI 10.1016/S0925-4773(99)00307-X; HARLEY VR, 2003, P NATL ACAD SCI US; Hines RS, 1997, FERTIL STERIL, V67, P675, DOI 10.1016/S0015-0282(97)81365-9; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hughes IA., 2006, J PEDIATR UROL, V2, P148, DOI [DOI 10.1016/J.JPUROL.2006.03.004, 10.1101/gr.247007.118]; Ito M, 2000, J BIOL CHEM, V275, P31708, DOI 10.1074/jbc.M002892200; JUST W, 1995, NAT GENET, V11, P117, DOI 10.1038/ng1095-117; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; Knower KC, 2007, SEX DEV, V1, P114, DOI 10.1159/000100033; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lau YFC, 2009, J GENET GENOMICS, V36, P193, DOI 10.1016/S1673-8527(08)60107-1; Lee CH, 2001, GENESIS, V30, P7, DOI 10.1002/gene.1026; LI B, 2001, J BIOL CHEM; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Lovell-Badge R, 2002, NOVART FDN SYMP, V244, P4; LOVELLBADGE R, 1993, PHILOS T R SOC B, V339, P159, DOI 10.1098/rstb.1993.0012; Matoba S, 2005, J CELL SCI, V118, P1449, DOI 10.1242/jcs.01738; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; McElreavey K, 1999, AM J MED GENET, V89, P176, DOI 10.1002/(SICI)1096-8628(19991229)89:4<176::AID-AJMG2>3.0.CO;2-B; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Moreno-Mendoza N, 1999, J EXP ZOOL, V284, P705, DOI 10.1002/(SICI)1097-010X(19991101)284:6<705::AID-JEZ12>3.0.CO;2-1; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Oreal E, 1998, DEV DYNAM, V212, P522, DOI 10.1002/(SICI)1097-0177(199808)212:4<522::AID-AJA5>3.0.CO;2-J; Polanco JC, 2009, BIOL CELL, V101, P55, DOI 10.1042/BC20080061; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; Preiss S, 2001, J BIOL CHEM, V276, P27864, DOI 10.1074/jbc.M101278200; Refai O, 2010, AM J MED GENET A, V152A, P422, DOI 10.1002/ajmg.a.33201; ROSSI P, 1993, MOL REPROD DEV, V34, P369, DOI 10.1002/mrd.1080340404; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schmahl J, 2000, DEVELOPMENT, V127, P65; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tremblay JJ, 2003, J BIOL CHEM, V278, P42637, DOI 10.1074/jbc.M305485200; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Western PS, 1999, DEV DYNAM, V214, P171, DOI 10.1002/(SICI)1097-0177(199903)214:3<171::AID-AJA1>3.3.CO;2-J; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0	77	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17751	10.1371/journal.pone.0017751	http://dx.doi.org/10.1371/journal.pone.0017751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412441	Green Published, Green Submitted, gold			2022-12-27	WOS:000288247800029
J	Gaudeul, M; Giraud, T; Kiss, L; Shykoff, JA				Gaudeul, Myriam; Giraud, Tatiana; Kiss, Levente; Shykoff, Jacqui A.			Nuclear and Chloroplast Microsatellites Show Multiple Introductions in the Worldwide Invasion History of Common Ragweed, Ambrosia artemisiifolia	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-STRUCTURE; ADAPTIVE EVOLUTION; INFERENCE; DIFFERENTIATION; DISPERSAL; DIVERSITY; INCREASES; PROGRAM; WEEDS	Background: Ambrosia artemisiifolia is a North American native that has become one of the most problematic invasive plants in Europe and Asia. We studied its worldwide population genetic structure, using both nuclear and chloroplast microsatellite markers and an unprecedented large population sampling. Our goals were (i) to identify the sources of the invasive populations; (ii) to assess whether all invasive populations were founded by multiple introductions, as previously found in France; (iii) to examine how the introductions have affected the amount and structure of genetic variation in Europe; (iv) to document how the colonization of Europe proceeded; (v) to check whether populations exhibit significant heterozygote deficiencies, as previously observed. Principal Findings: We found evidence for multiple introductions of A. artemisiifolia, within regions but also within populations in most parts of its invasive range, leading to high levels of diversity. In Europe, introductions probably stem from two different regions of the native area: populations established in Central Europe appear to have originated from eastern North America, and Eastern European populations from more western North America. This may result from differential commercial exchanges between these geographic regions. Our results indicate that the expansion in Europe mostly occurred through long-distance dispersal, explaining the absence of isolation by distance and the weak influence of geography on the genetic structure in this area in contrast to the native range. Last, we detected significant heterozygote deficiencies in most populations. This may be explained by partial selfing, biparental inbreeding and/or a Wahlund effect and further investigation is warranted. Conclusions: This insight into the sources and pathways of common ragweed expansion may help to better understand its invasion success and provides baseline data for future studies on the evolutionary processes involved during range expansion in novel environments.	[Gaudeul, Myriam] Museum Natl Hist Nat, UMR CNRS Origine Struct & Evolut Biodiversite 720, F-75231 Paris, France; [Giraud, Tatiana; Shykoff, Jacqui A.] Univ Paris 11, UMR CNRS Ecol Systemat & Evolut 8079, Orsay, France; [Kiss, Levente] Hungarian Acad Sci, Dept Plant Pathol, Inst Plant Protect, Budapest, Hungary	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Saclay; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Gaudeul, M (corresponding author), Museum Natl Hist Nat, UMR CNRS Origine Struct & Evolut Biodiversite 720, F-75231 Paris, France.	gaudeul@mnhn.fr	Kiss, Levente/Q-3786-2018	Kiss, Levente/0000-0002-4785-4308; Giraud, Tatiana/0000-0002-2685-6478	Museum National d'Histoire Naturelle (Paris, France); Universite Paris-Sud (Orsay, France); Plant Protection Institute of the Hungarian Academy of Sciences (Budapest, Hungary);  [ANR 07-BDIV-003]	Museum National d'Histoire Naturelle (Paris, France); Universite Paris-Sud (Orsay, France); Plant Protection Institute of the Hungarian Academy of Sciences (Budapest, Hungary); 	This work was funded by the Museum National d'Histoire Naturelle (Paris, France), the Universite Paris-Sud (Orsay, France) and the Plant Protection Institute of the Hungarian Academy of Sciences (Budapest, Hungary). TG acknowledges the grant ANR 07-BDIV-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie LG, 2009, MOL ECOL RESOUR, V9, P1375, DOI 10.1111/j.1755-0998.2009.02746.x; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett S.C.H., 1986, P21; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Bass DJ, 2000, AEROBIOLOGIA, V16, P107, DOI DOI 10.1023/A:1007696112953; BASSETT IJ, 1975, CAN J PLANT SCI, V55, P463, DOI 10.4141/cjps75-072; BOHREN C, 2008, AMBROSIA ARTEMISIIFO; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Bryan GJ, 1999, THEOR APPL GENET, V99, P859, DOI 10.1007/s001220051306; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Chen H, 2007, LECT NOTES GEOINF CA, P105, DOI 10.1007/978-3-540-71318-0_8; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Colautti RI, 2010, P ROY SOC B-BIOL SCI, V277, P1799, DOI 10.1098/rspb.2009.2231; CORNUET JM, 1996, GENETICS, V163; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; ElMousadik A, 1996, MOL ECOL, V5, P547, DOI 10.1046/j.1365-294X.1996.00123.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Falush D, 2003, GENETICS, V164, P1567; Friedman J, 2008, ANN BOT-LONDON, V101, P1303, DOI 10.1093/aob/mcn039; Fumanal B, 2007, ANN BOT-LONDON, V100, P305, DOI 10.1093/aob/mcm108; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Genton BJ, 2005, OECOLOGIA, V146, P404, DOI 10.1007/s00442-005-0234-x; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Gladieux P, 2011, BIOL INVASIONS, V13, P933, DOI 10.1007/s10530-010-9880-y; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Hufbauer RA, 2008, DIVERS DISTRIB, V14, P252, DOI 10.1111/j.1472-4642.2007.00424.x; Jahodova S, 2007, DIVERS DISTRIB, V13, P99, DOI 10.1111/j.1366-9516.2006.00305.x; Jakobsson M, 2007, THEOR APPL GENET, V114, P223, DOI 10.1007/s00122-006-0425-9; JONES KL, 1936, L AM MIDL NAT, V17, P673; Kang M, 2007, MOL ECOL, V16, P4662, DOI 10.1111/j.1365-294X.2007.03536.x; Kiss L, 2006, J BIOGEOGR, V33, P2156, DOI 10.1111/j.1365-2699.2006.01633.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LEWIS AJ, 1973, B TORREY BOT CLUB, V100, P333, DOI 10.2307/2484099; LI XM, 2009, INT C BIOL INV ICBI; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; Martin MD, 2009, AM J BOT, V96, P1703, DOI 10.3732/ajb.0800407; MCFADYEN R, 2008, 1 INT RAGW C 10 13 S; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Olivieri I, 2009, TRENDS ECOL EVOL, V24, P289, DOI 10.1016/j.tree.2009.01.015; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pons O, 1996, GENETICS, V144, P1237; Prentis PJ, 2009, DIVERS DISTRIB, V15, P822, DOI 10.1111/j.1472-4642.2009.00592.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Protopopova VV, 2006, EUPHYTICA, V148, P17, DOI 10.1007/s10681-006-5938-4; Pysek Petr, 2003, Biological Invasions, V5, P337, DOI 10.1023/B:BINV.0000005572.47560.1c; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REZNIK S, 2008, 1 INT RAGW C 10 13 S; Rohlf F.J., 1993, NTSYS PC; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SHIN HD, 2008, 1 INT RAGW C 10 13 S; SKJOTH CA, 2009, EARTH ENV SCI, V6; Taramarcaz P, 2005, SWISS MED WKLY, V135, P538; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Thuillet AC, 2002, MOL BIOL EVOL, V19, P122, DOI 10.1093/oxfordjournals.molbev.a003977; Torok K., 2003, Biological Invasions, V5, P349, DOI 10.1023/B:BINV.0000005570.19429.73; Valliant MT, 2007, AM J BOT, V94, P1156, DOI 10.3732/ajb.94.7.1156; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868	73	83	83	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17658	10.1371/journal.pone.0017658	http://dx.doi.org/10.1371/journal.pone.0017658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423697	Green Published, Green Accepted, gold			2022-12-27	WOS:000288219100021
J	Hakansson, AP; Roche-Hakansson, H; Mossberg, AK; Svanborg, C				Hakansson, Anders P.; Roche-Hakansson, Hazeline; Mossberg, Ann-Kristin; Svanborg, Catharina			Apoptosis-Like Death in Bacteria Induced by HAMLET, a Human Milk Lipid-Protein Complex	PLOS ONE			English	Article							PNEUMOCOCCAL SURFACE PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION; PHARYNGEAL EPITHELIAL-CELLS; HUMAN ALPHA-LACTALBUMIN; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; CALCIUM REGULATION; ELICIT PROTECTION; FOLDING VARIANT; TRANSFORMATION	Background: Apoptosis is the primary means for eliminating unwanted cells in multicellular organisms in order to preserve tissue homeostasis and function. It is characterized by distinct changes in the morphology of the dying cell that are orchestrated by a series of discrete biochemical events. Although there is evidence of primitive forms of programmed cell death also in prokaryotes, no information is available to suggest that prokaryotic death displays mechanistic similarities to the highly regulated programmed death of eukaryotic cells. In this study we compared the characteristics of tumor and bacterial cell death induced by HAMLET, a human milk complex of alpha-lactalbumin and oleic acid. Methodology/Principal Findings: We show that HAMLET-treated bacteria undergo cell death with mechanistic and morphologic similarities to apoptotic death of tumor cells. In Jurkat cells and Streptococcus pneumoniae death was accompanied by apoptosis-like morphology such as cell shrinkage, DNA condensation, and DNA degradation into high molecular weight fragments of similar sizes, detected by field inverse gel electrophoresis. HAMLET was internalized into tumor cells and associated with mitochondria, causing a rapid depolarization of the mitochondrial membrane and bound to and induced depolarization of the pneumococcal membrane with similar kinetic and magnitude as in mitochondria. Membrane depolarization in both systems required calcium transport, and both tumor cells and bacteria were found to require serine protease activity (but not caspase activity) to execute cell death. Conclusions/Significance: Our results suggest that many of the morphological changes and biochemical responses associated with apoptosis are present in prokaryotes. Identifying the mechanisms of bacterial cell death has the potential to reveal novel targets for future antimicrobial therapy and to further our understanding of core activation mechanisms of cell death in eukaryote cells.	[Hakansson, Anders P.; Roche-Hakansson, Hazeline] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA; [Mossberg, Ann-Kristin; Svanborg, Catharina] Lund Univ, Sect Microbiol Immunol & Glycobiol MIG, Dept Lab Med, Lund, Sweden; [Svanborg, Catharina] ASTAR, Singapore Immunol Network, Singapore, Singapore	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Lund University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Hakansson, AP (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	andersh@buffalo.edu	Hakansson, Anders/H-8190-2014; Hakansson, Anders P/AAX-1225-2020	Hakansson, Anders/0000-0002-2834-6009; Hakansson, Anders P/0000-0002-2834-6009	Bill and Melinda Gates Foundation [53085]; JR Oishei Foundation; Royal Physiographic Society, Lund, Sweden; Swedish Society for Medical Research, Stockholm, Sweden; John and Augusta Perssons Foundation for Scientific Medical Research, Lund, Sweden; Anna-Lisa and Sven-Eric Lundgrens Foundation for Medical Research, Malmo, Sweden; Gunnar, Arvid and Elisabeth Nilssons Foundation for Fighting Cancer, Helsingborg, Sweden; Maggie Stephen's Foundation, Lund, Sweden; Swedish Cancer Foundation [3807-B97-01XAB, 96-1719]; American Cancer Society [RPG 97-157-01]; Swedish Heart and Lung Foundation; American Lung Association [RG-123721-N]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JR Oishei Foundation; Royal Physiographic Society, Lund, Sweden; Swedish Society for Medical Research, Stockholm, Sweden; John and Augusta Perssons Foundation for Scientific Medical Research, Lund, Sweden; Anna-Lisa and Sven-Eric Lundgrens Foundation for Medical Research, Malmo, Sweden; Gunnar, Arvid and Elisabeth Nilssons Foundation for Fighting Cancer, Helsingborg, Sweden; Maggie Stephen's Foundation, Lund, Sweden; Swedish Cancer Foundation; American Cancer Society(American Cancer Society); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); American Lung Association	This study was supported by grants from Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/, Grant 53085; AH), the JR Oishei Foundation (http://www.oisheifdt.org/, AH), The Royal Physiographic Society, Lund, Sweden (http://www.fysiografen.se/AH), The Swedish Society for Medical Research, Stockholm, Sweden (http://www.ssmf.se/AH), John and Augusta Perssons Foundation for Scientific Medical Research, Lund, Sweden (AH), Anna-Lisa and Sven-Eric Lundgrens Foundation for Medical Research, Malmo, Sweden (AH), Gunnar, Arvid and Elisabeth Nilssons Foundation for Fighting Cancer, Helsingborg, Sweden (AH), Maggie Stephen's Foundation, Lund, Sweden (AH), The Swedish Cancer Foundation (http://www.cancerfonden.se/ Grants no. 3807-B97-01XAB and 96-1719, CS), The American Cancer Society (http://www.cancer.org/ Grant no. RPG 97-157-01, CS), The Swedish Heart and Lung Foundation (http://www.hjart-lungfonden.se/ CS) and the American Lung Association (Grant RG-123721-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER HE, 1951, J EXP MED, V93, P345, DOI 10.1084/jem.93.4.345; Ameisen JC, 1996, SCIENCE, V272, P1278, DOI 10.1126/science.272.5266.1278; ANDERSSON B, 1981, INFECT IMMUN, V32, P311, DOI 10.1128/IAI.32.1.311-317.1981; ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Ankarcrona M, 1996, NEUROREPORT, V7, P2659, DOI 10.1097/00001756-199611040-00050; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dave S, 2004, J IMMUNOL, V173, P471, DOI 10.4049/jimmunol.173.1.471; Davis MK, 1998, INT J CANCER, V78, P29; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Giorgi C, 2008, CURR MOL MED, V8, P119; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson A, 2001, INFECT IMMUN, V69, P3372, DOI 10.1128/IAI.69.5.3372-3381.2001; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; HEINE WE, 1991, J NUTR, V121, P277, DOI 10.1093/jn/121.3.277; JORGENSEN JH, 1992, J CLIN MICROBIOL, V30, P961, DOI 10.1128/JCM.30.4.961-966.1992; Kohler C, 1999, EXP CELL RES, V249, P260, DOI 10.1006/excr.1999.4472; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lawrence Robert M, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P7, DOI 10.1016/j.cppeds.2006.10.002; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; LINDAHL L, 1984, ANAL BIOCHEM, V140, P394, DOI 10.1016/0003-2697(84)90184-2; Lysenko E, 2000, MOL MICROBIOL, V35, P234, DOI 10.1046/j.1365-2958.2000.01707.x; MAJNO G, 1995, AM J PATHOL, V146, P3; MCDANIEL LS, 1992, MICROB PATHOGENESIS, V13, P261, DOI 10.1016/0882-4010(92)90036-N; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; PUYET A, 1990, J MOL BIOL, V213, P727, DOI 10.1016/S0022-2836(05)80259-1; PUYET A, 1989, J BACTERIOL, V171, P2278, DOI 10.1128/jb.171.5.2278-2286.1989; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003; Smith AW, 2002, MOL MICROBIOL, V44, P431, DOI 10.1046/j.1365-2958.2002.02883.x; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TOMASZ A, 1988, J BACTERIOL, V170, P5931, DOI 10.1128/jb.170.12.5931-5934.1988; TROMBE MC, 1993, J GEN MICROBIOL, V139, P433, DOI 10.1099/00221287-139-3-433; TROMBE MC, 1992, J GEN MICROBIOL, V138, P77, DOI 10.1099/00221287-138-1-77; YOTHER J, 1992, J BACTERIOL, V174, P610, DOI 10.1128/jb.174.2.610-618.1992; YOTHER J, 1986, J BACTERIOL, V168, P1463, DOI 10.1128/jb.168.3.1463-1465.1986	60	83	85	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17717	10.1371/journal.pone.0017717	http://dx.doi.org/10.1371/journal.pone.0017717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423701	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100028
J	Dai, DH; Beck, B; Wang, XF; Howk, C; Li, Y				Dai, Donghai; Beck, Brandon; Wang, Xiaofang; Howk, Cory; Li, Yi			Quantitative Interpretation of a Genetic Model of Carcinogenesis Using Computer Simulations	PLOS ONE			English	Article							METASTATIC INEFFICIENCY; CELL-POPULATIONS; STEM-CELLS; CANCER; GROWTH; EVOLUTIONARY; DISEASE	The genetic model of tumorigenesis by Vogelstein et al. (V theory) and the molecular definition of cancer hallmarks by Hanahan and Weinberg (W theory) represent two of the most comprehensive and systemic understandings of cancer. Here, we develop a mathematical model that quantitatively interprets these seminal cancer theories, starting from a set of equations describing the short life cycle of an individual cell in uterine epithelium during tissue regeneration. The process of malignant transformation of an individual cell is followed and the tissue (or tumor) is described as a composite of individual cells in order to quantitatively account for intra-tumor heterogeneity. Our model describes normal tissue regeneration, malignant transformation, cancer incidence including dormant/transient tumors, and tumor evolution. Further, a novel mechanism for the initiation of metastasis resulting from substantial cell death is proposed. Finally, model simulations suggest two different mechanisms of metastatic inefficiency for aggressive and less aggressive cancer cells. Our work suggests that cellular de-differentiation is one major oncogenic pathway, a hypothesis based on a numerical description of a cell's differentiation status that can effectively and mathematically interpret some major concepts in V/W theories such as progressive transformation of normal cells, tumor evolution, and cancer hallmarks. Our model is a mathematical interpretation of cancer phenotypes that complements the well developed V/W theories based upon description of causal biological and molecular events. It is possible that further developments incorporating patient-and tissue-specific variables may build an even more comprehensive model to explain clinical observations and provide some novel insights for understanding cancer.	[Dai, Donghai; Beck, Brandon; Wang, Xiaofang; Howk, Cory] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Li, Yi] Univ Iowa, Dept Math, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Dai, DH (corresponding author), Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.	donghai-dai@uiowa.edu	Li, Yi/D-5381-2017	Li, Yi/0000-0002-7148-0019; Dai, Donghai/0000-0002-9670-7822	ACS [RSG-06-105-01-CCE]; UI College of Medicine	ACS(American Cancer Society); UI College of Medicine	This work is supported by ACS Research Scholar Award RSG-06-105-01-CCE (DD) and UI College of Medicine Basic Reproductive Science Research Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2010, CANC FACTS FIG; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bru A, 2006, J THEOR BIOL, V243, P171, DOI 10.1016/j.jtbi.2006.05.020; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Enderling H, 2009, CANCER RES, V69, P8814, DOI 10.1158/0008-5472.CAN-09-2115; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gatenby RA, 2003, CANCER RES, V63, P6212; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; LAIRD AK, 1969, NATL CANCER I MONOGR, P15; Lloyd, 1979, ADV CANCER CHEMOTHER, V1, P205; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Riester M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000777; SMITH JR, 1974, J CELL BIOL, V62, P48, DOI 10.1083/jcb.62.1.48; SMITH JR, 1980, SCIENCE, V207, P82; Spencer SL, 2004, J THEOR BIOL, V231, P515, DOI 10.1016/j.jtbi.2004.07.006; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; SWEENEY E, 1995, HUM PATHOL, V26, P691, DOI 10.1016/0046-8177(95)90180-9; Weinberg RA, 2007, BIOL CANC; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Wong CW, 2001, CANCER RES, V61, P333; ZHANG G, 2011, ONCOLOGY RE IN PRESS	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16859	10.1371/journal.pone.0016859	http://dx.doi.org/10.1371/journal.pone.0016859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408146	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000011
J	Reyes, LH; Almario, MP; Kao, KC				Reyes, Luis H.; Almario, Maria P.; Kao, Katy C.			Genomic Library Screens for Genes Involved in n-Butanol Tolerance in Escherichia coli	PLOS ONE			English	Article							ORGANIC-SOLVENT TOLERANCE; CLOSTRIDIUM-ACETOBUTYLICUM; STRESS; IDENTIFICATION; RESISTANCE; EXPRESSION; BACTERIA; PROTEIN; MECHANISMS; REGULON	Background: n-Butanol is a promising emerging biofuel, and recent metabolic engineering efforts have demonstrated the use of several microbial hosts for its production. However, most organisms have very low tolerance to n-butanol (up to 2% (v/v)), limiting the economic viability of this biofuel. The rational engineering of more robust n-butanol production hosts relies upon understanding the mechanisms involved in tolerance. However, the existing knowledge of genes involved in n-butanol tolerance is limited. The goal of this study is therefore to identify E. coli genes that are involved in n-butanol tolerance. Methodology/Principal Findings: Using a genomic library enrichment strategy, we identified approximately 270 genes that were enriched or depleted in n-butanol challenge. The effects of these candidate genes on n-butanol tolerance were experimentally determined using overexpression or deletion libraries. Among the 55 enriched genes tested, 11 were experimentally shown to confer enhanced tolerance to n-butanol when overexpressed compared to the wild-type. Among the 84 depleted genes tested, three conferred increased n-butanol resistance when deleted. The overexpressed genes that conferred the largest increase in n-butanol tolerance were related to iron transport and metabolism, entC and feoA, which increased the n-butanol tolerance by 32.8 +/- 4.0% and 49.1 +/- 3.3%, respectively. The deleted gene that resulted in the largest increase in resistance to n-butanol was astE, which enhanced n-butanol tolerance by 48.7 +/- 6.3%. Conclusions/Significance: We identified and experimentally verified 14 genes that decreased the inhibitory effect of n-butanol tolerance on E. coli. From the data, we were able to expand the current knowledge on the genes involved in n-butanol tolerance; the results suggest that an increased iron transport and metabolism and decreased acid resistance may enhance n-butanol tolerance. The genes and mechanisms identified in this study will be helpful in the rational engineering of more robust biofuel producers.	[Reyes, Luis H.; Almario, Maria P.; Kao, Katy C.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Reyes, LH (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	katy@chemail.tamu.edu	Reyes, Luis/J-8334-2017	Reyes, Luis/0000-0001-7251-5298; Kao, Katy/0000-0002-1184-276X	US NSF [CBET-1032487]; Texas Engineering Experimental Station (TEES); Div Of Chem, Bioeng, Env, & Transp Sys [1032487] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); Texas Engineering Experimental Station (TEES); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors wish to acknowledge financial support from US NSF grant CBET-1032487 and the Texas Engineering Experimental Station (TEES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BEESCH SC, 1953, APPL MICROBIOL, V1, P85, DOI 10.1128/AEM.1.2.85-95.1953; BEESCH SC, 1952, IND ENG CHEM, V44, P1677, DOI 10.1021/ie50511a054; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Berezina OV, 2010, APPL MICROBIOL BIOT, V87, P635, DOI 10.1007/s00253-010-2480-z; Borden JR, 2007, APPL ENVIRON MICROB, V73, P3061, DOI 10.1128/AEM.02296-06; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Brynildsen MP, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.34; BURTON K, 1977, BIOCHEM J, V168, P195, DOI 10.1042/bj1680195; BURTON K, 1994, P ROY SOC B-BIOL SCI, V255, P153, DOI 10.1098/rspb.1994.0022; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demple B, 1996, GENE, V179, P53, DOI 10.1016/S0378-1119(96)00329-0; Dupont M, 2007, ANTIMICROB AGENTS CH, V51, P3190, DOI 10.1128/AAC.01481-06; Fajardo DA, 1998, J BACTERIOL, V180, P4452, DOI 10.1128/JB.180.17.4452-4459.1998; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; GAVIN JJ, 1965, J BACTERIOL, V89, P437, DOI 10.1128/JB.89.2.437-443.1965; Han XL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-35; HEIPIEPER HJ, 1994, TRENDS BIOTECHNOL, V12, P409, DOI 10.1016/0167-7799(94)90029-9; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Kieboom J, 1998, J BIOL CHEM, V273, P85, DOI 10.1074/jbc.273.1.85; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lee JH, 2009, J BACTERIOL, V191, P4441, DOI 10.1128/JB.01474-08; Lewis C, 2008, MICROBIOL-SGM, V154, P979, DOI 10.1099/mic.0.2007/011999-0; LIN YL, 1983, APPL ENVIRON MICROB, V45, P966, DOI 10.1128/AEM.45.3.966-973.1983; Ma Z, 2002, J BACTERIOL, V184, P7001, DOI 10.1128/JB.184.24.7001-7012.2002; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Ng B, 2008, ANAL BIOCHEM, V376, P131, DOI 10.1016/j.ab.2008.01.026; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Nielsen LE, 2005, APPL ENVIRON MICROB, V71, P5171, DOI 10.1128/AEM.71.9.5171-5176.2005; Pinkart HC, 1996, APPL ENVIRON MICROB, V62, P1129, DOI 10.1128/AEM.62.3.1129-1132.1996; Qin ZHS, 2003, NAT BIOTECHNOL, V21, P435, DOI 10.1038/nbt802; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramos JL, 1997, J BIOL CHEM, V272, P3887, DOI 10.1074/jbc.272.7.3887; RON EZ, 1990, ANTON LEEUW INT J G, V58, P169, DOI 10.1007/BF00548929; Rowbury RJ, 1999, J APPL MICROBIOL, V86, P325, DOI 10.1046/j.1365-2672.1999.00676.x; Ruhl J, 2009, APPL ENVIRON MICROB, V75, P4653, DOI 10.1128/AEM.00225-09; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sambrook J, 2001, MOL CLONING LAB MANU; Sardessai Y, 2002, RES MICROBIOL, V153, P263, DOI 10.1016/S0923-2508(02)01319-0; Semchyshyn H, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1238, DOI 10.1007/s10541-005-0253-6; Shimizu K, 2005, J BIOSCI BIOENG, V99, P72, DOI 10.1263/jbb.99.72; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Sugai R, 2001, J BACTERIOL, V183, P5523, DOI 10.1128/JB.183.19.5523-5528.2001; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Tomas CA, 2004, J BACTERIOL, V186, P2006, DOI 10.1128/JB.186.7.2006-2018.2004; Tomas Christopher A., 2005, P813; Tsukagoshi N, 2000, J BACTERIOL, V182, P4803, DOI 10.1128/JB.182.17.4803-4810.2000; Weber FJ, 1996, BBA-REV BIOMEMBRANES, V1286, P225, DOI 10.1016/S0304-4157(96)00010-X; WHITE CB, 1995, J BIOL CHEM, V270, P12990, DOI 10.1074/jbc.270.22.12990; White DG, 1997, J BACTERIOL, V179, P6122, DOI 10.1128/jb.179.19.6122-6126.1997; WINKLER J, 2010, TRANSCRIPTIONA UNPUB; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Yang YH, 2001, PROC SPIE, V4266, P141, DOI 10.1117/12.427982; Yoshimura M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-69; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	63	103	118	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17678	10.1371/journal.pone.0017678	http://dx.doi.org/10.1371/journal.pone.0017678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408113	Green Submitted, gold, Green Published			2022-12-27	WOS:000288170000053
J	Sesti, G; Folli, F; Perego, L; Hribal, ML; Pontiroli, AE				Sesti, Giorgio; Folli, Franco; Perego, Lucia; Hribal, Marta Letizia; Pontiroli, Antonio E.			Effects of Weight Loss in Metabolically Healthy Obese Subjects after Laparoscopic Adjustable Gastric Banding and Hypocaloric Diet	PLOS ONE			English	Article							RISK; INFLAMMATION; INDIVIDUALS; PREVALENCE; PROFILE; WOMEN	Weight loss in metabolically healthy obese (MHO) subjects may result in deterioration of cardio-metabolic risk profile. We analyzed the effects of weight loss induced by laparoscopic adjustable gastric banding (LAGB) on cardio-metabolic risk factors in MHO and insulin resistant obese (IRO) individuals. This study included 190 morbidly obese non-diabetic subjects. Obese individuals were stratified on the basis of their insulin sensitivity index (ISI), estimated from an OGTT, into MHO (ISI index in the upper quartile) and IRO (ISI in the three lower quartiles). Anthropometric and cardio-metabolic variables were measured at baseline and 6-months after LAGB. Six months after LAGB, anthropometric measures were significantly reduced in both MHO and IRO. Percent changes in body weight, BMI, and waist circumference did not differ between the two groups. Fasting glucose and insulin levels, triglycerides, AST, and ALT were significantly reduced, and HDL cholesterol significantly increased, in both MHO and IRO subjects with no differences in percent changes from baseline. Insulin sensitivity increased in both MHO and IRO group. Insulin secretion was significantly reduced in the IRO group only. However, the disposition index significantly increased in both MHO and IRO individuals with no differences in percent changes from baseline between the two groups. The change in insulin sensitivity correlated with the change in BMI (r = -0.43; P< 0.0001). In conclusion, our findings reinforce the recommendation that weight loss in response to LAGB intervention should be considered an appropriate treatment option for morbidly obese individuals regardless of their metabolic status, i.e. MHO vs. IRO subjects.	[Sesti, Giorgio; Hribal, Marta Letizia] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Perego, Lucia; Pontiroli, Antonio E.] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	Magna Graecia University of Catanzaro; University of Texas System; University of Texas Health San Antonio; University of Milan	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	folli@uthscsa.edu	folli, franco/J-2795-2018; Sesti, Giorgio/B-1509-2012; pontiroli, antonio e/AAI-5575-2020	folli, franco/0000-0001-9824-5222; Sesti, Giorgio/0000-0002-1618-7688				Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Janiszewski PM, 2010, DIABETES CARE, V33, P1957, DOI 10.2337/dc10-0547; Kantartzis K, 2011, DIABETOLOGIA, V54, P864, DOI 10.1007/s00125-010-2006-3; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Pontiroli AE, 2005, DIABETES CARE, V28, P2703, DOI 10.2337/diacare.28.11.2703; Pontiroli AE, 2002, J CLIN ENDOCR METAB, V87, P3555, DOI 10.1210/jc.87.8.3555; Sesti G, 2005, J CLIN ENDOCR METAB, V90, P5064, DOI 10.1210/jc.2005-0404; Sesti G, 2011, NUTR METAB CARDIOVAS, V21, P933, DOI 10.1016/j.numecd.2010.02.008; Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Succurro E, 2008, OBESITY, V16, P1881, DOI 10.1038/oby.2008.308; Succurro E, 2010, CLIN J AM SOC NEPHRO, V5, P1922, DOI 10.2215/CJN.03240410; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	22	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17737	10.1371/journal.pone.0017737	http://dx.doi.org/10.1371/journal.pone.0017737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408112	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000056
J	Gabrieli, P; Gomulski, LM; Bonomi, A; Siciliano, P; Scolari, F; Franz, G; Jessup, A; Malacrida, AR; Gasperi, G				Gabrieli, Paolo; Gomulski, Ludvik M.; Bonomi, Angelica; Siciliano, Paolo; Scolari, Francesca; Franz, Gerald; Jessup, Andrew; Malacrida, Anna R.; Gasperi, Giuliano			Interchromosomal Duplications on the Bactrocera oleae Y Chromosome Imply a Distinct Evolutionary Origin of the Sex Chromosomes Compared to Drosophila	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; CERATITIS-CAPITATA; NUCLEAR IMPORT; SEGMENTAL DUPLICATIONS; TRANSPOSABLE ELEMENT; CYTOGENETIC ANALYSIS; DNA-SEQUENCES; DIPTERA; GENOME; SR	Background: Diptera have an extraordinary variety of sex determination mechanisms, and Drosophila melanogaster is the paradigm for this group. However, the Drosophila sex determination pathway is only partially conserved and the family Tephritidae affords an interesting example. The tephritid Y chromosome is postulated to be necessary to determine male development. Characterization of Y sequences, apart from elucidating the nature of the male determining factor, is also important to understand the evolutionary history of sex chromosomes within the Tephritidae. We studied the Y sequences from the olive fly, Bactrocera oleae. Its Y chromosome is minute and highly heterochromatic, and displays high heteromorphism with the X chromosome. Methodology/Principal Findings: A combined Representational Difference Analysis (RDA) and fluorescence in-situ hybridization (FISH) approach was used to investigate the Y chromosome to derive information on its sequence content. The Y chromosome is strewn with repetitive DNA sequences, the majority of which are also interdispersed in the pericentromeric regions of the autosomes. The Y chromosome appears to have accumulated small and large repetitive interchromosomal duplications. The large interchromosomal duplications harbour an importin-4-like gene fragment. Apart from these importin-4-like sequences, the other Y repetitive sequences are not shared with the X chromosome, suggesting molecular differentiation of these two chromosomes. Moreover, as the identified Y sequences were not detected on the Y chromosomes of closely related tephritids, we can infer divergence in the repetitive nature of their sequence contents. Conclusions/Significance: The identification of Y-linked sequences may tell us much about the repetitive nature, the origin and the evolution of Y chromosomes. We hypothesize how these repetitive sequences accumulated and were maintained on the Y chromosome during its evolutionary history. Our data reinforce the idea that the sex chromosomes of the Tephritidae may have distinct evolutionary origins with respect to those of the Drosophilidae and other Dipteran families.	[Gabrieli, Paolo; Gomulski, Ludvik M.; Bonomi, Angelica; Siciliano, Paolo; Scolari, Francesca; Malacrida, Anna R.; Gasperi, Giuliano] Univ Pavia, Dept Anim Biol, I-27100 Pavia, Italy; [Franz, Gerald; Jessup, Andrew] IAEA, Joint FAO IAEA Programme, Entomol Unit, FAO IAEA Agr & Biotechnol Lab, A-1400 Vienna, Austria	University of Pavia; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Gabrieli, P (corresponding author), Univ Pavia, Dept Anim Biol, Via Palestro 3, I-27100 Pavia, Italy.	gasperi@unipv.it	Scolari, Francesca/ABC-2285-2020; Gasperi, Giuliano/Y-1894-2019; Gabrieli, Paolo/A-3206-2016; Gomulski, Ludvik/AFK-3930-2022; Jessup, Andrew J/B-2510-2016; Gomulski, Ludvik/AAG-2709-2022	Scolari, Francesca/0000-0003-3085-9038; Gasperi, Giuliano/0000-0001-6972-8591; Gabrieli, Paolo/0000-0002-4996-2468; Jessup, Andrew J/0000-0003-2318-7835; malacrida, anna/0000-0003-4566-8795; GOMULSKI, LUDVIK/0000-0002-1506-7051; Jessup, Andrew/0000-0002-0479-7489	University of Pavia [15642/R0]	University of Pavia	This research was supported by a FAR grant from the University of Pavia in the framework of the IAEA Research Agreement No. 15642/R0 to G. Gasperi, concerning the Research Project: "Identification of Molecular and Transgenic Tools for Sexing Strategies and Development of Strain and Sperm Marking Systems for Fruitfly Pests.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANLEITNER JE, 1992, CHROMOSOMA, V101, P271, DOI 10.1007/BF00346005; [Anonymous], FRUIT FLIES EC IMPOR; BARUFFI L, 1995, HEREDITY, V74, P425, DOI 10.1038/hdy.1995.60; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; Bueno AM, 2002, IOBC WPRS B, V25, P1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carvalho AB, 2009, TRENDS GENET, V25, P270, DOI 10.1016/j.tig.2009.04.002; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Charlesworth B, 1997, GENETICS, V147, P1993; Charlesworth B, 2001, CURR BIOL, V11, pR182, DOI 10.1016/S0960-9822(01)00089-6; Donnison IS, 1996, GENETICS, V144, P1893; DREW AC, 1995, MOL BIOCHEM PARASIT, V71, P173, DOI 10.1016/0166-6851(95)00048-6; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fujisawa M, 2001, GENETICS, V159, P981; Gabrieli P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-12; Garcia-Martinez V, 2009, GENOME, V52, P20, DOI 10.1139/G08-099; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Groot PC, 1998, NUCLEIC ACIDS RES, V26, P4476, DOI 10.1093/nar/26.19.4476; Gvozdev VA, 2005, BIOESSAYS, V27, P1256, DOI 10.1002/bies.20321; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Kalmykova AI, 1997, P NATL ACAD SCI USA, V94, P6297, DOI 10.1073/pnas.94.12.6297; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Khila A, 2003, INSECT BIOCHEM MOLEC, V33, P691, DOI 10.1016/S0965-1748(03)00063-8; Kirsch S, 2005, GENOME RES, V15, P195, DOI 10.1101/gr.3302705; Kounatidis I, 2008, GENOME, V51, P479, DOI 10.1139/G08-032; KWIATOWSKI J, 1994, J MOL EVOL, V38, P443, DOI 10.1007/BF00178844; LABRADOR M, 1994, MOL GEN GENET, V245, P661, DOI 10.1007/BF00297273; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Luijten M, 2000, EUR J HUM GENET, V8, P209, DOI 10.1038/sj.ejhg.5200434; Mavragani-Tsipidou P, 2002, GENETICA, V116, P45, DOI 10.1023/A:1020907624816; MAVRAGANITSIPIDOU P, 1992, GENOME, V35, P373, DOI 10.1139/g92-056; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pantazidis A, 1999, MOL BIOL EVOL, V16, P909, DOI 10.1093/oxfordjournals.molbev.a026180; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; POWELL JR, 1993, GENETICS, V133, P291; Premi S, 2010, CHROMOSOME RES, V18, P419, DOI 10.1007/s10577-010-9123-1; ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0; Rozen S, 2000, Methods Mol Biol, V132, P365; Saccone G, 2002, GENETICA, V116, P15, DOI 10.1023/A:1020903523907; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Steinemann S, 2005, BIOESSAYS, V27, P1076, DOI 10.1002/bies.20288; Stratikopoulos EE, 2008, GENETICA, V133, P147, DOI 10.1007/s10709-007-9195-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torti C, 2000, CHROMOSOMA, V108, P523, DOI 10.1007/s004120050404; TZANAKAKIS ME, 1966, Z ANGREW ENTOMOL, V59, P127; WERMAN SD, 1990, J MOL EVOL, V30, P281, DOI 10.1007/BF02099998; Willhoeft U, 1996, GENETICS, V144, P737; Willhoeft U, 1996, GENOME, V39, P884, DOI 10.1139/g96-111; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhao JT, 1998, GENOME, V41, P510, DOI 10.1139/gen-41-4-510; Zhou Q, 2000, GENOME, V43, P434, DOI 10.1139/gen-43-3-434	62	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17747	10.1371/journal.pone.0017747	http://dx.doi.org/10.1371/journal.pone.0017747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408187	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800036
J	Grabowski, TB; Thorsteinsson, V; McAdam, BJ; Marteinsdottir, G				Grabowski, Timothy B.; Thorsteinsson, Vilhjalmur; McAdam, Bruce J.; Marteinsdottir, Gudrun			Evidence of Segregated Spawning in a Single Marine Fish Stock: Sympatric Divergence of Ecotypes in Icelandic Cod?	PLOS ONE			English	Article							GADUS-MORHUA L.; NORTH-SEA COD; ATLANTIC COD; LIFE-HISTORY; POPULATION-STRUCTURE; MIGRATORY BEHAVIOR; SPATIAL VARIATION; COASTAL COD; FISHERIES; PATTERNS	There is increasing recognition of intraspecific diversity and population structure within marine fish species, yet there is little direct evidence of the isolating mechanisms that maintain it or documentation of its ecological extent. We analyzed depth and temperature histories collected by electronic data storage tags retrieved from 104 Atlantic cod at liberty >= 1 year to evaluate a possible isolating mechanisms maintaining population structure within the Icelandic cod stock. This stock consists of two distinct behavioral types, resident coastal cod and migratory frontal cod, each occurring within two geographically distinct populations. Despite being captured together on the same spawning grounds, we show the behavioral types seem reproductively isolated by fine-scale differences in spawning habitat selection, primarily depth. Additionally, the different groups occupied distinct seasonal thermal and bathymetric niches that generally demonstrated low levels of overlap throughout the year. Our results indicate that isolating mechanisms, such as differential habitat selection during spawning, might contribute to maintaining diversity and fine-scale population structure in broadcast-spawning marine fishes.	[Grabowski, Timothy B.; McAdam, Bruce J.; Marteinsdottir, Gudrun] Univ Iceland, Inst Biol, Reykjavik, Iceland; [Grabowski, Timothy B.] Texas Tech Univ, US Geol Survey, Texas Cooperat Fish & Wildlife Res Unit, Lubbock, TX 79409 USA; [Thorsteinsson, Vilhjalmur] Marine Res Inst Hafrannsoknastofnunin, Reykjavik, Iceland	University of Iceland; Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; Marine & Freshwater Research Institute (MFRI)	Grabowski, TB (corresponding author), Univ Iceland, Inst Biol, Reykjavik, Iceland.	t.grabowski@ttu.edu		Grabowski, Timothy/0000-0001-9763-8948; Marteinsdottir, Gudrun/0000-0001-6939-2434	Marine Research Institute, Iceland; University of Iceland; EU [Q5RS-2002-00813, Q5RS-2001-00953]; Icelandic Research Fund [070019023]; Icelandic Ministry of Fisheries and Agriculture	Marine Research Institute, Iceland; University of Iceland; EU(European Commission); Icelandic Research Fund; Icelandic Ministry of Fisheries and Agriculture	Funding for this project was provided by the Marine Research Institute, Iceland; the University of Iceland Research Fund; the EU projects "CODYSSEY" (Q5RS-2002-00813; 2003-2006) and "METACOD" (Q5RS-2001-00953; 2002-2005); the Icelandic Research Fund (070019023); and the Fisheries Project Fund of the Icelandic Ministry of Fisheries and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005529; Begg GA, 2002, MAR ECOL PROG SER, V229, P263, DOI 10.3354/meps229263; BRANDER K, 2005, 274 ICES COOP RES RE; BRAWN VIVIEN M., 1961, BEHAVIOUR, V18, P177, DOI 10.1163/156853961X00114; BRAWN VIVIEN M., 1961, BEHAVIOUR, V18, P107, DOI 10.1163/156853961X00295; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Fudge SB, 2009, ICES J MAR SCI, V66, P1259, DOI 10.1093/icesjms/fsp097; Grabowski TB, 2009, ENVIRON BIOL FISH, V86, P361, DOI 10.1007/s10641-009-9534-z; Harrald M, 2010, CAN J FISH AQUAT SCI, V67, P866, DOI 10.1139/F10-030; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hiddink JG, 2008, FISH RES, V90, P6, DOI 10.1016/j.fishres.2007.11.025; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hutchings JA, 1999, CAN J FISH AQUAT SCI, V57, P1011; Hutchings JA, 2007, P ROY SOC B-BIOL SCI, V274, P1693, DOI 10.1098/rspb.2007.0263; Hutchinson WF, 2008, BIOL LETTERS, V4, P693, DOI 10.1098/rsbl.2008.0443; Jonsdottir IG, 2006, J FISH BIOL, V69, P136, DOI 10.1111/j.1095-8649.2006.01271.x; Jonsdottir IG, 2006, ICES J MAR SCI, V63, P1501, DOI 10.1016/j.icesjms.2006.05.006; JONSSON E, 1982, RIT FISKIDEILDAR, V6; Jorgensen C, 2008, ECOLOGY, V89, P3436, DOI 10.1890/07-1469.1; Kjesbu OS, 2010, CAN J FISH AQUAT SCI, V67, P605, DOI 10.1139/F10-011; Lawson GL, 2000, CAN J FISH AQUAT SCI, V57, P1011, DOI 10.1139/cjfas-57-5-1011; McIntyre TM, 2003, CAN J FISH AQUAT SCI, V60, P1111, DOI 10.1139/F03-090; Neuheimer AB, 2007, CAN J FISH AQUAT SCI, V64, P375, DOI 10.1139/F07-003; Nordeide JT, 2000, FISH FISH, V1, P90, DOI 10.1046/j.1467-2979.2000.00005.x; Nordeide JT, 1998, ICES J MAR SCI, V55, P134, DOI 10.1006/jmsc.1997.0261; Nordeide JT, 1998, SARSIA, V83, P373, DOI 10.1080/00364827.1998.10413696; Palsson OK, 2003, CAN J FISH AQUAT SCI, V60, P1409, DOI 10.1139/F03-117; Pampoulie C, 2008, BEHAV GENET, V38, P76, DOI 10.1007/s10519-007-9175-y; Pampoulie C, 2006, CAN J FISH AQUAT SCI, V63, P2660, DOI 10.1139/F06-150; Pardoe H, 2009, J FISH BIOL, V75, P282, DOI 10.1111/j.1095-8649.2009.02273.x; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Pogson GH, 2001, EVOLUTION, V55, P131, DOI 10.1111/j.0014-3820.2001.tb01279.x; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Righton D, 2001, NATURE, V411, P156, DOI 10.1038/35075667; Robichaud D, 2004, FISH FISH, V5, P185, DOI 10.1111/j.1467-2679.2004.00141.x; ROSE GA, 1993, NATURE, V366, P458, DOI 10.1038/366458a0; Ruzzante DE, 2000, J FISH BIOL, V56, P431, DOI 10.1111/j.1095-8649.2000.tb02116.x; Salvanes AGV, 2004, MAR ECOL PROG SER, V267, P241, DOI 10.3354/meps267241; Svedang H, 2006, J FISH BIOL, V69, P151, DOI 10.1111/j.1095-8649.2006.01272.x; Svedang H, 2007, MAR ECOL PROG SER, V345, P1, DOI 10.3354/meps07140; Syrjala SE, 1996, ECOLOGY, V77, P75, DOI 10.2307/2265656; THORSTEINSSON V, 1998, SIZE SPECIFIC TIME D; Westgaard JI, 2007, FISH RES, V85, P306, DOI 10.1016/j.fishres.2007.04.001; Wright PJ, 2006, J FISH BIOL, V69, P181, DOI 10.1111/j.1095-8649.2006.01262.x	46	54	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17528	10.1371/journal.pone.0017528	http://dx.doi.org/10.1371/journal.pone.0017528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408180	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800022
J	Lyman, SK; Crawley, SC; Gong, R; Adamkewicz, JI; McGrath, G; Chew, JY; Choi, J; Holst, CR; Goon, LH; Detmer, SA; Vaclavikova, J; Gerritsen, ME; Blake, RA				Lyman, Susan K.; Crawley, Suzanne C.; Gong, Ruoyu; Adamkewicz, Joanne I.; McGrath, Garth; Chew, Jason Y.; Choi, Jennifer; Holst, Charles R.; Goon, Leanne H.; Detmer, Scott A.; Vaclavikova, Jana; Gerritsen, Mary E.; Blake, Robert A.			High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888	PLOS ONE			English	Article							BREAST-CANCER CELLS; POLO-LIKE KINASE-1; SHOCK-PROTEIN 90; MITOTIC ENTRY; MUTANT P53; IN-VITRO; HEAT-SHOCK-PROTEIN-90 INHIBITOR; SPINDLE FORMATION; DOWN-REGULATION; P21 EXPRESSION	Background: Many proteins that are dysregulated or mutated in cancer cells rely on the molecular chaperone HSP90 for their proper folding and activity, which has led to considerable interest in HSP90 as a cancer drug target. The diverse array of HSP90 client proteins encompasses oncogenic drivers, cell cycle components, and a variety of regulatory factors, so inhibition of HSP90 perturbs multiple cellular processes, including mitogenic signaling and cell cycle control. Although many reports have investigated HSP90 inhibition in the context of the cell cycle, no large-scale studies have examined potential correlations between cell genotype and the cell cycle phenotypes of HSP90 inhibition. Methodology/Principal Findings: To address this question, we developed a novel high-content, high-throughput cell cycle assay and profiled the effects of two distinct small molecule HSP90 inhibitors (XL888 and 17-AAG [17-allylamino-17-demethoxygeldanamycin]) in a large, genetically diverse panel of cancer cell lines. The cell cycle phenotypes of both inhibitors were strikingly similar and fell into three classes: accumulation in M-phase, G2-phase, or G1-phase. Accumulation in M-phase was the most prominent phenotype and notably, was also correlated with TP53 mutant status. We additionally observed unexpected complexity in the response of the cell cycle-associated client PLK1 to HSP90 inhibition, and we suggest that inhibitor-induced PLK1 depletion may contribute to the striking metaphase arrest phenotype seen in many of the M-arrested cell lines. Conclusions/Significance: Our analysis of the cell cycle phenotypes induced by HSP90 inhibition in 25 cancer cell lines revealed that the phenotypic response was highly dependent on cellular genotype as well as on the concentration of HSP90 inhibitor and the time of treatment. M-phase arrest correlated with the presence of TP53 mutations, while G2 or G1 arrest was more commonly seen in cells bearing wt TP53. We draw upon previous literature to suggest an integrated model that accounts for these varying observations.	[Lyman, Susan K.; Crawley, Suzanne C.; Gong, Ruoyu; Adamkewicz, Joanne I.; McGrath, Garth; Chew, Jason Y.; Choi, Jennifer; Holst, Charles R.; Goon, Leanne H.; Detmer, Scott A.; Vaclavikova, Jana; Gerritsen, Mary E.; Blake, Robert A.] Exelixis Inc, Dept Mol & Cellular Pharmacol, San Francisco, CA USA; [Choi, Jennifer; Vaclavikova, Jana] Exelixis Inc, Dept Genome Biol, San Francisco, CA USA	Exelixis, Inc.; Exelixis, Inc.	Lyman, SK (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	xl888.mail@gmail.com		Holst, Charles/0000-0001-8010-1677; McGrath, Garth/0000-0002-4924-6269	Exelixis, Inc	Exelixis, Inc	This work (study design, data collection and analysis, manuscript preparation) was carried out at Exelixis, Inc. Permission to publish was granted by Exelixis, Inc.	Archambault V, 2008, MOL CELL, V30, P541, DOI 10.1016/j.molcel.2008.05.012; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arlander SJH, 2003, J BIOL CHEM, V278, P52572, DOI 10.1074/jbc.M309054200; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Basto R, 2007, J CELL SCI, V120, P1278, DOI 10.1242/jcs.000604; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Biamonte MA, 2010, J MED CHEM, V53, P3, DOI 10.1021/jm9004708; Borysov SI, 2008, MOL BIOL CELL, V19, P2907, DOI 10.1091/mbc.E07-07-0679; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Burrows F, 2004, CELL CYCLE, V3, P1530, DOI 10.4161/cc.3.12.1277; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Dai Chengkai, 2005, Future Oncol, V1, P529; Davies AE, 2010, J CELL BIOL, V189, P261, DOI 10.1083/jcb.200910036; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Elbendary AA, 1996, CLIN CANCER RES, V2, P1571; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Garcia-Morales P, 2007, ONCOGENE, V26, P7185, DOI 10.1038/sj.onc.1210534; Georgakis GV, 2006, BRIT J HAEMATOL, V135, P68, DOI 10.1111/j.1365-2141.2006.06247.x; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hostein I, 2001, CANCER RES, V61, P4003; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Lesko E, 2007, ANTI-CANCER DRUG, V18, P1173, DOI 10.1097/CAD.0b013e3282ef532d; Lin K, 2008, ONCOGENE, V27, P2445, DOI 10.1038/sj.onc.1210893; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martins T, 2009, EMBO J, V28, P234, DOI 10.1038/emboj.2008.283; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Moran DM, 2008, ONCOGENE, V27, P5567, DOI 10.1038/onc.2008.172; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Muller P, 2005, J BIOL CHEM, V280, P6682, DOI 10.1074/jbc.M412767200; Munster PN, 2001, CLIN CANCER RES, V7, P2228; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; OConnor PM, 1997, CANCER RES, V57, P4285; Okamoto J, 2008, J THORAC ONCOL, V3, P1089, DOI 10.1097/JTO.0b013e3181839693; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Rakitina TV, 2007, BIOCHEM PHARMACOL, V73, P1715, DOI 10.1016/j.bcp.2007.01.037; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Senju M, 2006, J CANCER RES CLIN, V132, P150, DOI 10.1007/s00432-005-0047-7; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Spankuch B, 2006, CANCER RES, V66, P5836, DOI 10.1158/0008-5472.CAN-06-0343; Srethapakdi M, 2000, CANCER RES, V60, P3940; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Sugimoto K, 2008, ONCOGENE, V27, P3091, DOI 10.1038/sj.onc.1210978; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Tse AN, 2009, MOL PHARMACOL, V75, P124, DOI 10.1124/mol.108.050807; Uchiumi T, 1997, J BIOL CHEM, V272, P9166; Usmani SZ, 2009, CURR MOL MED, V9, P654, DOI 10.2174/156652409788488757; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wellcome Trust Sanger Institute, CAT SOM MUT CANC; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Workman P, 2007, NAT CHEM BIOL, V3, P455, DOI 10.1038/nchembio0807-455; Zajac M, 2008, MOL CANCER THER, V7, P2358, DOI 10.1158/1535-7163.MCT-08-0327; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	74	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17692	10.1371/journal.pone.0017692	http://dx.doi.org/10.1371/journal.pone.0017692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408192	Green Submitted, gold, Green Published			2022-12-27	WOS:000288099800033
J	Xu, WH; Han, L; Lin, ZL				Xu, Wanghui; Han, Lu; Lin, Zhanglin			Screening of Random Peptide Library of Hemagglutinin from Pandemic 2009 A(H1N1) Influenza Virus Reveals Unexpected Antigenically Important Regions	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; NEUTRALIZING ANTIBODIES; RECEPTOR-BINDING; SURFACE DISPLAY; SITES; PROTEIN; BROAD; H5N1; IDENTIFICATION	The antigenic structure of the membrane protein hemagglutinin (HA) from the 2009 A(H1N1) influenza virus was dissected with a high-throughput screening method using complex antisera. The approach involves generating yeast cell libraries displaying a pool of random peptides of controllable lengths on the cell surface, followed by one round of fluorescence-activated cell sorting (FACS) against antisera from mouse, goat and human, respectively. The amino acid residue frequency appearing in the antigenic peptides at both the primary sequence and structural level was determined and used to identify "hot spots'' or antigenically important regions. Unexpectedly, different antigenic structures were seen for different antisera. Moreover, five antigenic regions were identified, of which all but one are located in the conserved HA stem region that is responsible for membrane fusion. Our findings are corroborated by several recent studies on cross-neutralizing H1 subtype antibodies that recognize the HA stem region. The antigenic peptides identified may provide clues for creating peptide vaccines with better accessibility to memory B cells and better induction of cross-neutralizing antibodies than the whole HA protein. The scheme used in this study enables a direct mapping of the antigenic regions of viral proteins recognized by antisera, and may be useful for dissecting the antigenic structures of other viral proteins.	[Xu, Wanghui; Han, Lu; Lin, Zhanglin] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China	Tsinghua University	Xu, WH (corresponding author), Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.	zhanglinlin@mail.tsinghua.edu.cn	Lin, Zhanglin/A-7232-2011		National Basic Research program of China [2009CB724700]; Tsinghua University [20091081428]	National Basic Research program of China(National Basic Research Program of China); Tsinghua University	This work was supported by a National Basic Research program of China grant (2009CB724700) and an innovative research grant from Tsinghua University (20091081428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banki MR, 2005, NAT METHODS, V2, P659, DOI 10.1038/nmeth787; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Bowley DR, 2009, P NATL ACAD SCI USA, V106, P1380, DOI 10.1073/pnas.0812291106; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Christmann A, 2001, J IMMUNOL METHODS, V257, P163, DOI 10.1016/S0022-1759(01)00461-6; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Li J, 2009, EUR J IMMUNOL, V39, P3498, DOI 10.1002/eji.200939532; Liang YF, 2005, CLIN CHEM, V51, P1382, DOI 10.1373/clinchem.2005.051045; Lin Zhanglin, 2009, V515, P261, DOI 10.1007/978-1-59745-559-6_18; Mischo Axel, 2003, Cancer Immun, V3, P5; NAKAJIMA S, 1983, VIROLOGY, V131, P116, DOI 10.1016/0042-6822(83)90538-X; Prodromou C, 2007, DRUG DISCOV TODAY, V12, P931, DOI 10.1016/j.drudis.2007.08.012; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SMITH CA, 1991, J EXP MED, V173, P953, DOI 10.1084/jem.173.4.953; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WALTER G, 1981, NATURE, V290, P713; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILLIAMSON RA, 1993, P NATL ACAD SCI USA, V90, P4141, DOI 10.1073/pnas.90.9.4141; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	41	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18016	10.1371/journal.pone.0018016	http://dx.doi.org/10.1371/journal.pone.0018016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437206	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100059
J	Ding, VMY; Boersema, PJ; Foong, LY; Preisinger, C; Koh, G; Natarajan, S; Lee, DY; Boekhorst, J; Snel, B; Lemeer, S; Heck, AJR; Choo, A				Ding, Vanessa M. Y.; Boersema, Paul J.; Foong, Leong Yan; Preisinger, Christian; Koh, Geoffrey; Natarajan, Subaashini; Lee, Dong-Yup; Boekhorst, Jos; Snel, Berend; Lemeer, Simone; Heck, Albert J. R.; Choo, Andre			Tyrosine Phosphorylation Profiling in FGF-2 Stimulated Human Embryonic Stem Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GROWTH-FACTOR; SELF-RENEWAL; GENE-EXPRESSION; SRC; MAINTENANCE; PROTEINS; RECEPTOR; DYNAMICS; FAMILY	The role of fibroblast growth factor-2 (FGF-2) in maintaining undifferentiated human embryonic stem cells (hESC) was investigated using a targeted phosphoproteomics approach to specifically profile tyrosine phosphorylation events following FGF-2 stimulation. A cumulative total number of 735 unique tyrosine phosphorylation sites on 430 proteins were identified, by far the largest inventory to date for hESC. Early signaling events in FGF-2 stimulated hESC were quantitatively monitored using stable isotope dimethyl labeling, resulting in temporal tyrosine phosphorylation profiles of 316 unique phosphotyrosine peptides originating from 188 proteins. Apart from the rapid activation of all four FGF receptors, trans-activation of several other receptor tyrosine kinases (RTKs) was observed as well as induced tyrosine phosphorylation of downstream proteins such as PI3-K, MAPK and several Src family members. Both PI3-K and MAPK have been linked to hESC maintenance through FGF-2 mediated signaling. The observed activation of the Src kinase family members by FGF-2 and loss of pluripotent marker expression post Src kinase inhibition may point to the regulation of cytoskeletal and actin depending processes to maintain undifferentiated hESC.	[Ding, Vanessa M. Y.; Foong, Leong Yan; Koh, Geoffrey; Natarajan, Subaashini; Lee, Dong-Yup; Choo, Andre] ASTAR, Bioproc Technol Inst, Stem Cell Grp, Singapore, Singapore; [Ding, Vanessa M. Y.; Lee, Dong-Yup] NUS Grad Sch Integrat Sci & Engn NGS, Ctr Life Sci CeLS, Singapore, Singapore; [Boersema, Paul J.; Preisinger, Christian; Lemeer, Simone; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Boersema, Paul J.; Preisinger, Christian; Lemeer, Simone; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Boersema, Paul J.; Preisinger, Christian; Lemeer, Simone; Heck, Albert J. R.] Netherlands Prote Ctr, Utrecht, Netherlands; [Boekhorst, Jos; Snel, Berend; Choo, Andre] Univ Utrecht, Dept Biol, Fac Sci, Utrecht, Netherlands; [Heck, Albert J. R.] Ctr Biomed Genet, Utrecht, Netherlands; [Choo, Andre] Natl Univ Singapore, Fac Engn, Div Bioengn, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; Utrecht University; Utrecht University; Utrecht University; National University of Singapore	Ding, VMY (corresponding author), ASTAR, Bioproc Technol Inst, Stem Cell Grp, Singapore, Singapore.	a.j.r.heck@uu.nl; andre_choo@bti.a-star.edu.sg	Lemeer, Simone/I-4363-2016; Lee, Dong-Yup/D-6650-2011; Heck, Albert/D-7098-2011; Snel, Berend/B-8886-2011	Lee, Dong-Yup/0000-0003-0901-708X; Heck, Albert/0000-0002-2405-4404; Snel, Berend/0000-0002-5804-8547; Boekhorst, Jos/0000-0002-4807-7838; Choo, Andre/0000-0001-9648-0755	Agency for Science Technology and Research (A*STAR), Singapore; Netherlands Proteomics Centre	Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Netherlands Proteomics Centre	This work is supported by the Agency for Science Technology and Research (A*STAR), Singapore and the Netherlands Proteomics Centre (http://www.netherlandsproteomicscentre.nl), a program embedded in the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Avery S, 2006, STEM CELLS DEV, V15, P729, DOI 10.1089/scd.2006.15.729; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Boersema PJ, 2008, PROTEOMICS, V8, P4624, DOI 10.1002/pmic.200800297; BOERSEMA PJ, 2009, MOL CELL PROTEOMICS, V9, P1; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Chae JI, 2009, PROTEOMICS, V9, P1128, DOI 10.1002/pmic.200800234; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Ding V, 2006, BIOTECHNOL LETT, V28, P491, DOI 10.1007/s10529-006-0005-8; DING V, 2010, J CELL PHYS IN PRESS; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Esposito CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001643; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; LIVIA E, 2009, STEM CELLS, V8, P1847; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Nichols Amy M., 2009, V492, P143, DOI 10.1007/978-1-59745-493-3_8; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saito K, 2008, BIOCHEM BIOPH RES CO, V366, P969, DOI 10.1016/j.bbrc.2007.12.055; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stewart MH, 2008, J MOL MED, V86, P875, DOI 10.1007/s00109-008-0356-9; Suzuki E, 2007, EXP CELL RES, V313, P2451, DOI 10.1016/j.yexcr.2007.03.041; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; van Breukelen B, 2009, BIOINFORMATICS, V25, P1472, DOI 10.1093/bioinformatics/btp181; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	61	51	52	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17538	10.1371/journal.pone.0017538	http://dx.doi.org/10.1371/journal.pone.0017538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437283	Green Submitted, gold, Green Published			2022-12-27	WOS:000288514600005
J	Cairns, S; Thomas, JG; Hooper, SJ; Wise, MP; Frost, PJ; Wilson, MJ; Lewis, MAO; Williams, DW				Cairns, Scott; Thomas, John Gilbert; Hooper, Samuel James; Wise, Matthew Peter; Frost, Paul John; Wilson, Melanie Julia; Lewis, Michael Alexander Oxenham; Williams, David Wynne			Molecular Analysis of Microbial Communities in Endotracheal Tube Biofilms	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; VENTILATOR-ASSOCIATED PNEUMONIA; CANDIDA-ALBICANS; BACTERIAL-COLONIZATION; STREPTOCOCCUS-MUTANS; ORAL DECONTAMINATION; IDENTIFICATION; DGGE; PCR; SILVER	Background: Ventilator-associated pneumonia is the most prevalent acquired infection of patients on intensive care units and is associated with considerable morbidity and mortality. Evidence suggests that an improved understanding of the composition of the biofilm communities that form on endotracheal tubes may result in the development of improved preventative strategies for ventilator-associated pneumonia. Methodology/Principal Findings: The aim of this study was to characterise microbial biofilms on the inner luminal surface of extubated endotracheal tubes from ICU patients using PCR and molecular profiling. Twenty-four endotracheal tubes were obtained from twenty mechanically ventilated patients. Denaturing gradient gel electrophoresis (DGGE) profiling of 16S rRNA gene amplicons was used to assess the diversity of the bacterial population, together with species specific PCR of key marker oral microorganisms and a quantitative assessment of culturable aerobic bacteria. Analysis of culturable aerobic bacteria revealed a range of colonisation from no growth to 2.1x10(8) colony forming units (cfu)/cm(2) of endotracheal tube (mean 1.4x10(7) cfu/cm(2)). PCR targeting of specific bacterial species detected the oral bacteria Streptococcus mutans (n = 5) and Porphyromonas gingivalis (n = 5). DGGE profiling of the endotracheal biofilms revealed complex banding patterns containing between 3 and 22 (mean 6) bands per tube, thus demonstrating the marked complexity of the constituent biofilms. Significant inter-patient diversity was evident. The number of DGGE bands detected was not related to total viable microbial counts or the duration of intubation. Conclusions/Significance: Molecular profiling using DGGE demonstrated considerable biofilm compositional complexity and inter-patient diversity and provides a rapid method for the further study of biofilm composition in longitudinal and interventional studies. The presence of oral microorganisms in endotracheal tube biofilms suggests that these may be important in biofilm development and may provide a therapeutic target for the prevention of ventilator-associated pneumonia.	[Cairns, Scott; Wise, Matthew Peter; Frost, Paul John] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales; [Thomas, John Gilbert] W Virginia Univ, Morgantown, WV 26506 USA; [Hooper, Samuel James; Wilson, Melanie Julia; Lewis, Michael Alexander Oxenham; Williams, David Wynne] Cardiff Univ, Sch Dent, Cardiff, S Glam, Wales	Cardiff University; West Virginia University; Cardiff University	Cairns, S (corresponding author), Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales.	wilsonmj@cf.ac.uk	Williams, David/E-5506-2012	Williams, David/0000-0002-7351-5131; Wise, Matt/0000-0002-2763-4316				Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; Amin A, 2009, CLIN INFECT DIS, V49, pS36, DOI 10.1086/599814; Azoulay E, 2006, CHEST, V129, P110, DOI 10.1378/chest.129.1.110; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Bauer T T, 2002, Monaldi Arch Chest Dis, V57, P84; Berra L, 2004, ANESTHESIOLOGY, V100, P1446, DOI 10.1097/00000542-200406000-00017; Berra L, 2008, INTENS CARE MED, V34, P1020, DOI 10.1007/s00134-008-1099-3; Berra L, 2008, INTENS CARE MED, V34, P1030, DOI 10.1007/s00134-008-1100-1; BRANTING C, 1989, ARCH ORAL BIOL, V34, P347, DOI 10.1016/0003-9969(89)90108-8; Brennan MT, 2004, ORAL SURG ORAL MED O, V98, P665, DOI 10.1016/j.tripleo.2004.06.005; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Chan EY, 2009, AUST CRIT CARE, V22, P3, DOI 10.1016/j.aucc.2008.12.001; Chen Z, 2007, FEMS MICROBIOL LETT, V272, P154, DOI 10.1111/j.1574-6968.2007.00756.x; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; de Oliveira JCM, 2007, ORAL MICROBIOL IMMUN, V22, P14, DOI 10.1111/j.1399-302X.2007.00311.x; De Sordi L, 2009, FEMS YEAST RES, V9, P990, DOI 10.1111/j.1567-1364.2009.00573.x; Dijk F, 2000, J BIOMED MATER RES, V51, P408, DOI 10.1002/1097-4636(20000905)51:3<408::AID-JBM15>3.3.CO;2-D; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Forestier C, 2008, CRIT CARE, V12, DOI 10.1186/cc6907; Fujimoto C, 2003, J PERIODONTAL RES, V38, P440, DOI 10.1034/j.1600-0765.2003.02607.x; Gafan GP, 2005, FEMS MICROBIOL LETT, V253, P303, DOI 10.1016/j.femsle.2005.09.048; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Jackson Colin R., 2000, Molecular Biology Today, V1, P49; Jackson WL, 2006, CURR OPIN ANESTHESIO, V19, P117, DOI 10.1097/01.aco.0000192770.01904.dd; Koeman M, 2006, AM J RESP CRIT CARE, V173, P1348, DOI 10.1164/rccm.200505-820OC; Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805; Kulekci G, 2008, ANAEROBE, V14, P49, DOI 10.1016/J.anaerobe.2007.08.001; Lavenir R, 2007, J MICROBIOL METH, V70, P20, DOI 10.1016/j.mimet.2007.03.008; Le Berre R, 2006, MED MALADIES INFECT, V36, P349, DOI 10.1016/j.medmal.2006.01.008; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Liu ZM, 2007, DIAGN MICR INFEC DIS, V59, P379, DOI 10.1016/j.diagmicrobio.2007.06.011; Lopez-Ribot JL, 2005, CURR BIOL, V15, pR453, DOI 10.1016/j.cub.2005.06.020; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nseir S, 2007, INTENS CARE MED, V33, P137, DOI 10.1007/s00134-006-0422-0; O'keefe-McCarthy Sheila, 2006, Dynamics, V17, P8; Olson ME, 2002, CHEST, V121, P863, DOI 10.1378/chest.121.3.863; Palmer LB, 2009, CURR OPIN PULM MED, V15, P230, DOI 10.1097/MCP.0b013e3283292650; Park David R, 2005, Respir Care, V50, P742; Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014; Pfaller MA, 1996, J CLIN MICROBIOL, V34, P58, DOI 10.1128/JCM.34.1.58-61.1996; Pneumatikos IA, 2009, ANESTHESIOLOGY, V110, P673, DOI 10.1097/ALN.0b013e31819868e0; Ramirez P, 2007, CURR OPIN INFECT DIS, V20, P190, DOI 10.1097/QCO.0b013e328014daac; Rocas IN, 2004, ORAL SURG ORAL MED O, V98, P741, DOI 10.1016/j.tripleo.2004.09.006; Rolleke S, 1996, APPL ENVIRON MICROB, V62, P2059; Ruffell Alison, 2008, Nurs Crit Care, V13, P44, DOI 10.1111/j.1478-5153.2007.00248.x; Scannapieco FA, 2006, J AM DENT ASSOC, V137, p21S, DOI 10.14219/jada.archive.2006.0400; Schabereiter-Gurtner C, 2001, INVEST OPHTH VIS SCI, V42, P1164; Sheppard DC, 1998, J CLIN MICROBIOL, V36, P3726, DOI 10.1128/JCM.36.12.3726-3727.1998; Shinada K, 1995, Kokubyo Gakkai Zasshi, V62, P281; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001; Tantipong H, 2008, INFECT CONT HOSP EP, V29, P131, DOI 10.1086/526438; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682; Zijnge V, 2003, ORAL MICROBIOL IMMUN, V18, P59, DOI 10.1034/j.1399-302X.2003.180110.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	58	40	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14759	10.1371/journal.pone.0014759	http://dx.doi.org/10.1371/journal.pone.0014759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423727	Green Published, gold			2022-12-27	WOS:000288512400005
J	Karim, R; Meyers, C; Backendorf, C; Ludigs, K; Offringa, R; van Ommen, GJB; Melief, CJM; van der Burg, SH; Boer, JM				Karim, Rezaul; Meyers, Craig; Backendorf, Claude; Ludigs, Kristina; Offringa, Rienk; van Ommen, Gert-Jan B.; Melief, Cornelis J. M.; van der Burg, Sjoerd H.; Boer, Judith M.			Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; SQUAMOUS INTRAEPITHELIAL LESIONS; CERVICAL-CANCER; RIG-I; HUMAN KERATINOCYTES; INNATE IMMUNITY; EPIDERMAL-KERATINOCYTES; CD4+T-CELL IMMUNITY; E7 ONCOPROTEIN	Despite the presence of intracellular pathogen recognition receptors that allow infected cells to attract the immune system, undifferentiated keratinocytes (KCs) are the main targets for latent infection with high-risk human papilloma viruses (hrHPVs). HPV infections are transient but on average last for more than one year suggesting that HPV has developed means to evade host immunity. To understand how HPV persists, we studied the innate immune response of undifferentiated human KCs harboring episomal copies of HPV16 and 18 by genome-wide expression profiling. Our data showed that the expression of the different virus-sensing receptors was not affected by the presence of HPV. Poly(I: C) stimulation of the viral RNA receptors TLR3, PKR, MDA5 and RIG-I, the latter of which indirectly senses viral DNA through non-self RNA polymerase III transcripts, showed dampening in downstream signalling of these receptors by HPVs. Many of the genes downregulated in HPV-positive KCs involved components of the antigen presenting pathway, the inflammasome, the production of antivirals, pro-inflammatory and chemotactic cytokines, and components downstream of activated pathogen receptors. Notably, gene and/or protein interaction analysis revealed the downregulation of a network of genes that was strongly interconnected by IL-1 beta, a crucial cytokine to activate adaptive immunity. In summary, our comprehensive expression profiling approach revealed that HPV16 and 18 coordinate a broad deregulation of the keratinocyte's inflammatory response, and contributes to the understanding of virus persistence.	[Karim, Rezaul; van Ommen, Gert-Jan B.; Boer, Judith M.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [Karim, Rezaul; Ludigs, Kristina; Offringa, Rienk; Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Karim, Rezaul; van der Burg, Sjoerd H.] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Meyers, Craig] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [Backendorf, Claude] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, Mol Genet Lab, NL-2300 RA Leiden, Netherlands; [Boer, Judith M.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Leiden University; Leiden University - Excl LUMC	Karim, R (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands.	j.m.boer@lumc.nl	van der Burg, Sjoerd H/T-1875-2017	van der Burg, Sjoerd H/0000-0002-6556-0354; Boer, Judith/0000-0003-4848-7789	Centre for Medical Systems Biology; Netherlands Genomics Initiative; Public Health Service Grant [AI057988]; Netherlands Organization for Health Research (NWO/ZonMw) [91209012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	Centre for Medical Systems Biology; Netherlands Genomics Initiative; Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Netherlands Organization for Health Research (NWO/ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centre for Medical Systems Biology, a Centre of Excellence supported by the Netherlands Genomics Initiative. CJMM was supported by Public Health Service Grant AI057988. SHvdB and JMB were supported by the Netherlands Organization for Health Research (NWO/ZonMw) TOP grant 91209012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; An J, 2008, CANCER CELL, V14, P394, DOI 10.1016/j.ccr.2008.10.007; Andersen JM, 2006, BIOL REPROD, V74, P824, DOI 10.1095/biolreprod.105.048629; Barnard P, 1999, VIROLOGY, V259, P305, DOI 10.1006/viro.1999.9771; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chang YJE, 2000, J VIROL, V74, P4174, DOI 10.1128/JVI.74.9.4174-4182.2000; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; de Jong A, 2004, CANCER RES, V64, P5449, DOI 10.1158/0008-5472.CAN-04-0831; de Jong A, 2002, CANCER RES, V62, P472; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ferlay J, 2010, INT J CANC; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Huang SM, 2002, J VIROL, V76, P8710, DOI 10.1128/JVI.76.17.8710-8721.2002; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; McLaughlin-Drubin ME, 2004, VIROLOGY, V322, P213, DOI 10.1016/j.virol.2004.02.011; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pivarcsi A, 2004, ARCH DERMATOL RES, V296, P120, DOI 10.1007/s00403-004-0475-2; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Sankar S, 2006, CELL SIGNAL, V18, P982, DOI 10.1016/j.cellsig.2005.08.006; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Spitkovsky D, 2002, J BIOL CHEM, V277, P25576, DOI 10.1074/jbc.M201884200; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; van Poelgeest MIE, 2005, CLIN CANCER RES, V11, P5273, DOI 10.1158/1078-0432.CCR-05-0616; van Steenwijk PJD, 2008, CLIN CANCER RES, V14, P7188, DOI 10.1158/1078-0432.CCR-08-0994; Welters MJP, 2003, CANCER RES, V63, P636; Woo YL, 2008, BJOG-INT J OBSTET GY, V115, P1616, DOI 10.1111/j.1471-0528.2008.01936.x; Woo YL, 2010, INT J CANCER, V126, P133, DOI 10.1002/ijc.24804; WOODWORTH CD, 1992, ONCOGENE, V7, P619; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhang JZ, 2003, NUCLEIC ACIDS RES, V31, P602, DOI 10.1093/nar/gkg157; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	62	111	115	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17848	10.1371/journal.pone.0017848	http://dx.doi.org/10.1371/journal.pone.0017848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423754	Green Submitted, Green Published, gold			2022-12-27	WOS:000288512400033
J	Sahay, S; Gupte, N; Brahme, RG; Nirmalkar, A; Bembalkar, S; Bollinger, RC; Mehendale, S				Sahay, Seema; Gupte, Nikhil; Brahme, Radhika G.; Nirmalkar, Amit; Bembalkar, Shilpa; Bollinger, Robert C.; Mehendale, Sanjay			Predictors of Retention among Men Attending STI Clinics in HIV Prevention Programs and Research: A Case Control Study in Pune, India	PLOS ONE			English	Article							TRANSMITTED-DISEASE CLINICS; SEX WORKERS; INFECTION; TRIAL; COHORT; WOMEN; PREVALENCE; ENROLLMENT; ATTRITION; DROPOUTS	Background: Retention is critical in HIV prevention programs and clinical research. We studied retention in the three modeled scenarios of primary prevention programs, cohort studies and clinical trials to identify predictors of retention. Methodology/Principal Findings: Men attending Sexually Transmitted Infection (STI) clinics (n = 10, 801) were followed in a cohort study spanning over a ten year period (1993-2002) in Pune, India. Using pre-set definitions, cases with optimal retention in prevention program (n = 1286), cohort study (n = 940) and clinical trial (n = 896) were identified from this cohort. Equal number of controls matched for age and period of enrollment were selected. A case control analysis using conditional logistic regression was performed. Being employed was a predictor of lower retention in all the three modeled scenarios. Presence of genital ulcer disease (GUD), history of commercial sex work and living away from the family were predictors of lower retention in primary prevention, cohort study and clinical trial models respectively. Alcohol consumption predicted lower retention in cohort study and clinical trial models. Married monogamous men were less likely to be retained in the primary prevention and cohort study models. Conclusions/Significance: Predicting potential drop-outs among the beneficiaries or research participants at entry point in the prevention programs and research respectively is possible. Suitable interventions might help in optimizing retention. Customized counseling to prepare the clients properly may help in their retention.	[Sahay, Seema] Natl AIDS Res Inst, Div Social & Behav Res, Pune, Maharashtra, India; [Gupte, Nikhil] Byramjee Jeejeebhoy Med Coll, Clin Trial Unit, Pune, Maharashtra, India; [Brahme, Radhika G.; Nirmalkar, Amit; Bembalkar, Shilpa] Natl AIDS Res Inst, Div Epidemiol & Biostat, Pune, Maharashtra, India; [Bollinger, Robert C.] Johns Hopkins Univ, Johns Hopkins Ctr Clin Global Hlth Educ, Baltimore, MD USA; [Mehendale, Sanjay] Natl Inst Epidemiol, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Johns Hopkins University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE)	Sahay, S (corresponding author), Natl AIDS Res Inst, Div Social & Behav Res, Pune, Maharashtra, India.	ssahay@nariindia.org		Sahay, Seema/0000-0001-6064-827X; Bollinger, Robert/0000-0002-6798-6834	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [A1 41369]; NIAID, NIH through Family Health International (FHI) [A1 35173, A1 33879, RR-00722]; Indian Council Medical Research, New Delhi, India; Sassoon General Hospitals; Dr. Kotnis Municipal Dispensary; National Institute of Virology; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI035173, U01AI047968, R01AI041369, R21AI033879] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH through Family Health International (FHI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Indian Council Medical Research, New Delhi, India; Sassoon General Hospitals; Dr. Kotnis Municipal Dispensary; National Institute of Virology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding support was received from grants from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (A1 41369), and through a contract from the NIAID, NIH through Family Health International (FHI) (A1 35173, A1 33879 and RR-00722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Indian Council Medical Research, New Delhi, India. We thank the Director, National AIDS Research Institute (NARI) for continued support. We acknowledge the support received from the NARI institutional staff and the project staff of the PAVE, HIVNET and Acute Pathogenesis studies for counseling, clinical care of study participants, community work, laboratory work, data management, and statistical support from National AIDS Research Institute, Pune and Johns Hopkins University, Baltimore. We also thank B.J. Medical College, Pune, and Pune Municipal Corporation for facilitating clinical collaborations to conduct these studies. We acknowledge the support from Sassoon General Hospitals, Dr. Kotnis Municipal Dispensary and National Institute of Virology where the study clinics were situated in Pune. Finally we sincerely thank the participants who took part in the study.	A Kumar, 2008, Indian J Community Med, V33, P156, DOI 10.4103/0970-0218.42051; Brahme R, 2006, JAIDS-J ACQ IMM DEF, V41, P107, DOI 10.1097/01.qai.0000179428.49907.6d; Brahme RG, 2005, AIDS CARE, V17, P377, DOI 10.1080/09540120412331299771; CAMPSMITH ML, 1995, SEX TRANSM DIS, V22, P312, DOI 10.1097/00007435-199509000-00008; Clark O., 2001, FOREST PLOTS EXCEL S; De Weert-Van Oene GH, 2001, J SUBST ABUSE TREAT, V20, P253, DOI 10.1016/S0740-5472(01)00160-X; DENYER S, 1998, MENS HLTH C BUND DON; DUDLEY J, 1995, AM J EPIDEMIOL, V142, P323, DOI 10.1093/oxfordjournals.aje.a117638; El-Khorazaty MN, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-233; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; Honas JJ, 2003, OBES RES, V11, P888, DOI 10.1038/oby.2003.122; IIPS & ORC Macro, 2007, NATL FAMILY HLTH SUR; Jaggarajamma K, 2009, Indian J Tuberc, V56, P185; Janson SL, 2001, CONTROL CLIN TRIALS, V22, p236S, DOI 10.1016/S0197-2456(01)00171-4; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kim YJ, 2006, INT J NURS STUD, V43, P527, DOI 10.1016/j.ijnurstu.2005.07.005; LEVINE J, 2010, NEWS LETT; Mehendale SM, 2007, JAIDS-J ACQ IMM DEF, V45, P564, DOI 10.1097/QAI.0b013e3180d0a6ba; Mehendale SM, 1996, INDIAN J MED RES, V104, P327; Moser DK, 2000, NURS RES, V49, P109, DOI 10.1097/00006199-200003000-00008; *NACO, DEP AIDS CONTR MIN H; Naik Eknath, 2005, BMC Int Health Hum Rights, V5, P1, DOI 10.1186/1472-698X-5-1; *NHMP TRIAL, 1997, AIDS S, V11, pS13; Orellana ER, 2006, AIDS EDUC PREV, V18, P348, DOI 10.1521/aeap.2006.18.4.348; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Radwan I., 2005, INDIA PRIVATE HLTH S; RAO S, 2009, J INDIAN MED ASSOC, V107, P274; RODRIGUES JJ, 1995, BRIT MED J, V311, P283, DOI 10.1136/bmj.311.7000.283; Rutledge S. E., 2002, AIDS BEHAV, V6, P69, DOI DOI 10.1023/A:1014580629524; Saharabuddhe V, 2008, PROSTITUTION, P239; Shepherd ME, 2003, J HEALTH POPUL NUTR, V21, P251; Shinde S, 2009, INDIAN J DERMATOL VE, V75, P41, DOI 10.4103/0378-6323.45219; Talukdar A, 2008, AIDS BEHAV, V12, P613, DOI 10.1007/s10461-007-9338-0; US Center for Disease Control and Prevention, 2001, MMWR, V50, P13; Villacorta V, 2007, CLIN TRIALS, V4, P32, DOI 10.1177/1740774506075869; *WHO NACO, 2008, TECHN CONS REV HIV S; Wu E, 2005, AIDS EDUC PREV, V17, P41, DOI 10.1521/aeap.17.1.41.58685	39	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17448	10.1371/journal.pone.0017448	http://dx.doi.org/10.1371/journal.pone.0017448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	733FF	21412414	Green Published, Green Submitted, gold			2022-12-27	WOS:000288247800006
J	Kulkarni, A; Dangat, K; Kale, A; Sable, P; Chavan-Gautam, P; Joshi, S				Kulkarni, Asmita; Dangat, Kamini; Kale, Anvita; Sable, Pratiksha; Chavan-Gautam, Preeti; Joshi, Sadhana			Effects of Altered Maternal Folic Acid, Vitamin B-12 and Docosahexaenoic Acid on Placental Global DNA Methylation Patterns in Wistar Rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; S-ADENOSYLHOMOCYSTEINE; TOTAL HOMOCYSTEINE; FOLATE-DEFICIENCY; GENE-EXPRESSION; PLASMA; NUTRITION; SUPPLEMENTATION; METABOLISM; PREGNANCY	Potential adverse effects of excess maternal folic acid supplementation on a vegetarian population deficient in vitamin B-12 are poorly understood. We have previously shown in a rat model that maternal folic acid supplementation at marginal protein levels reduces brain omega-3 fatty acid levels in the adult offspring. We have also reported that reduced docosahexaenoic acid (DHA) levels may result in diversion of methyl groups towards DNA in the one carbon metabolic pathway ultimately resulting in DNA methylation. This study was designed to examine the effect of normal and excess folic acid in the absence and presence of vitamin B-12 deficiency on global methylation patterns in the placenta. Further, the effect of maternal omega 3 fatty acid supplementation on the above vitamin B-12 deficient diets was also examined. Our results suggest maternal folic acid supplementation in the absence of vitamin B-12 lowers plasma and placental DHA levels (p < 0.05) and reduces global DNA methylation levels (p < 0.05). When this group was supplemented with omega 3 fatty acids there was an increase in placental DHA levels and subsequently DNA methylation levels revert back to the levels of the control group. Our results suggest for the first time that DHA plays an important role in one carbon metabolism thereby influencing global DNA methylation in the placenta.	[Kulkarni, Asmita; Dangat, Kamini; Kale, Anvita; Sable, Pratiksha; Chavan-Gautam, Preeti; Joshi, Sadhana] Bharati Vidyapeeth Univ, Dept Med Nutr, Interact Res Sch Hlth Affairs, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University	Kulkarni, A (corresponding author), Bharati Vidyapeeth Univ, Dept Med Nutr, Interact Res Sch Hlth Affairs, Pune, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001; Chavan-Gautam, Preeti/0000-0001-8514-3171	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was partially funded by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHON M, 2000, WORKSH METH MET MOL, P303; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Bromberg A, 2008, SCHIZOPHR RES, V101, P50, DOI 10.1016/j.schres.2008.01.009; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; DANGAT K, 2011, METABOLISM IN PRESS; Dangat KD, 2010, NEONATOLOGY, V97, P190, DOI 10.1159/000252971; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; DuttaRoy AK, 1997, J NUTR BIOCHEM, V8, P548, DOI 10.1016/S0955-2863(97)00087-9; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Friso S, 2005, CLIN CHEM LAB MED, V43, P1158, DOI 10.1515/CCLM.2005.201; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Grenier E, 2008, FASEB J, V22; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Hertrampf E, 2003, J NUTR, V133, P3166, DOI 10.1093/jn/133.10.3166; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kilari AS, 2009, J PERINAT MED, V37, P513, DOI 10.1515/JPM.2009.096; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; KULKARNI A, 2010, DNA CELL BI IN PRESS; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; LEE DSC, 1985, CLIN BIOCHEM, V18, P261, DOI 10.1016/S0009-9120(85)80028-X; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; MANKU MS, 1983, LIPIDS, V18, P906, DOI 10.1007/BF02534572; McCabe DC, 2005, NUTR REV, V63, P183, DOI [10.1301/nr.2005.Jun.183-195, 10.1111/j.1753-4887.2005.tb00136.x]; Min H, 2009, NUTR RES PRACT, V3, P122, DOI 10.4162/nrp.2009.3.2.122; Nelen WLDM, 2000, OBSTET GYNECOL, V95, P519, DOI 10.1016/S0029-7844(99)00610-9; Owens S, 2008, T ROY SOC TROP MED H, V102, P103, DOI 10.1016/j.trstmh.2007.09.018; Pita ML, 2000, THROMB HAEMOSTASIS, V84, P420; Rao S, 2006, METABOLISM, V55, P628, DOI 10.1016/j.metabol.2005.12.008; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; ROY S, 2011, BRAIN DEV IN PRESS; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Selley ML, 2007, NEUROBIOL AGING, V28, P1834, DOI 10.1016/j.neurobiolaging.2006.08.003; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Uekawa A, 2009, J NUTRIGENET NUTRIGE, V2, P29, DOI 10.1159/000165374; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Whalley LJ, 2004, AM J CLIN NUTR, V80, P1650, DOI 10.1093/ajcn/80.6.1650; Windham GC, 2000, AM J MED GENET, V90, P261, DOI 10.1002/(SICI)1096-8628(20000131)90:3<261::AID-AJMG18>3.0.CO;2-L; Wyrwoll CS, 2006, ENDOCRINOLOGY, V147, P599, DOI 10.1210/en.2005-0748; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Zighetti ML, 2002, HAEMATOLOGICA, V87, P89	52	157	161	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17706	10.1371/journal.pone.0017706	http://dx.doi.org/10.1371/journal.pone.0017706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423696	gold, Green Published, Green Submitted			2022-12-27	WOS:000288219100027
J	Osborne, K; Dolman, AM; Burgess, SC; Johns, KA				Osborne, Kate; Dolman, Andrew M.; Burgess, Scott C.; Johns, Kerryn A.			Disturbance and the Dynamics of Coral Cover on the Great Barrier Reef (1995-2009)	PLOS ONE			English	Article							ACANTHASTER-PLANCI; FISH ASSEMBLAGES; WATER-QUALITY; PHASE-SHIFTS; RESILIENCE; RECOVERY; BIODIVERSITY; DEGRADATION; COMMUNITIES; DECLINE	Coral reef ecosystems worldwide are under pressure from chronic and acute stressors that threaten their continued existence. Most obvious among changes to reefs is loss of hard coral cover, but a precise multi-scale estimate of coral cover dynamics for the Great Barrier Reef (GBR) is currently lacking. Monitoring data collected annually from fixed sites at 47 reefs across 1300 km of the GBR indicate that overall regional coral cover was stable (averaging 29% and ranging from 23% to 33% cover across years) with no net decline between 1995 and 2009. Subregional trends (10-100 km) in hard coral were diverse with some being very dynamic and others changing little. Coral cover increased in six subregions and decreased in seven subregions. Persistent decline of corals occurred in one subregion for hard coral and Acroporidae and in four subregions in non-Acroporidae families. Change in Acroporidae accounted for 68% of change in hard coral. Crown-of-thorns starfish (Acanthaster planci) outbreaks and storm damage were responsible for more coral loss during this period than either bleaching or disease despite two mass bleaching events and an increase in the incidence of coral disease. While the limited data for the GBR prior to the 1980's suggests that coral cover was higher than in our survey, we found no evidence of consistent, system-wide decline in coral cover since 1995. Instead, fluctuations in coral cover at subregional scales (10-100 km), driven mostly by changes in fast-growing Acroporidae, occurred as a result of localized disturbance events and subsequent recovery.	[Osborne, Kate; Dolman, Andrew M.; Burgess, Scott C.; Johns, Kerryn A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Osborne, K (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	k.osborne@aims.gov.au	Dolman, Andrew/G-2399-2011	Dolman, Andrew/0000-0002-6481-966X; Burgess, Scott/0000-0002-0348-3453	Australian Institute of Marine Science; The Australian Federal Government's Marine and Tropical Scientific Reseach Facility [1.1.2]	Australian Institute of Marine Science; The Australian Federal Government's Marine and Tropical Scientific Reseach Facility	This study was supported by the Australian Institute of Marine Science and by The Australian Federal Government's Marine and Tropical Scientific Reseach Facility (Project 1.1.2; www.rrrc.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADBO D, 2004, SURVEYS BENTHIC REEF; Ayling A. M., 2005, DYNAMICS CAIRNS CENT; AYLING AM, 1995, PRELIMINARY SURVEY B; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R., 2009, V205, P103; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burgess SC, 2010, GLOBAL ECOL BIOGEOGR, V19, P363, DOI 10.1111/j.1466-8238.2009.00516.x; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2002, CORAL REEFS, V21, P131, DOI 10.1007/s00338-002-0227-8; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; DAVIDSON J, 1997, OPTIMISING USE VIDEO; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Done TJ, 2010, CORAL REEFS, V29, P815, DOI 10.1007/s00338-010-0637-y; DONE TJ, 1991, BROADSCALE SURVEY IM; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Gomez E.D., 1982, Proceedings of the International Coral Reef Symposium, P275; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2009, BIODIVERS CONSERV, V18, P3325, DOI 10.1007/s10531-009-9633-3; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lough J., 2007, CLIMATE CHANGE GREAT, P15; Lough J, 2006, B AUST METEOROL OCEA, V19, P53, DOI DOI 10.1201/9781420041675.CH17; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; MILLER I, 2002, P 10 INT COR REEF S, V2, P1273; Miller Ian, 2002, P1273; MILLER IR, 2003, CROWN THORNS STARFIS; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; OLIVER JK, 2009, CORAL BLEACHING PATT; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinheiro J, 2008, R PACKAGE VERSION, V57, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pratchett MS, 2010, CORAL REEFS, V29, P717, DOI 10.1007/s00338-010-0602-9; Schaffelke B., 2010, REEF RESCUE MARINE M; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Somerfield PJ, 2008, CORAL REEFS, V27, P951, DOI 10.1007/s00338-008-0390-7; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H.H., 2008, 8 AUSTR I MAR SCI; Thompson A., 2010, REEF RESCUE MARINE M; Thompson AA, 2010, CORAL REEFS, V29, P637, DOI 10.1007/s00338-009-0562-0; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; Wilkinson C, 2008, STATUS CORAL REEFS W; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	69	170	172	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17516	10.1371/journal.pone.0017516	http://dx.doi.org/10.1371/journal.pone.0017516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423742	Green Submitted, Green Published, gold			2022-12-27	WOS:000288219100013
J	Zhao, X; Rodland, EA; Sorlie, T; Naume, B; Langerod, A; Frigessi, A; Kristensen, VN; Borresen-Dale, AL; Lingjaerde, OC				Zhao, Xi; Rodland, Einar Andreas; Sorlie, Therese; Naume, Bjorn; Langerod, Anita; Frigessi, Arnoldo; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise; Lingjaerde, Ole Christian			Combining Gene Signatures Improves Prediction of Breast Cancer Survival	PLOS ONE			English	Article							EXPRESSION DATA; BONE-MARROW; METASTASIS; RECURRENCE; SUBTYPES; CELLS	Background: Several gene sets for prediction of breast cancer survival have been derived from whole-genome mRNA expression profiles. Here, we develop a statistical framework to explore whether combination of the information from such sets may improve prediction of recurrence and breast cancer specific death in early-stage breast cancers. Microarray data from two clinically similar cohorts of breast cancer patients are used as training (n = 123) and test set (n = 81), respectively. Gene sets from eleven previously published gene signatures are included in the study. Principal Findings: To investigate the relationship between breast cancer survival and gene expression on a particular gene set, a Cox proportional hazards model is applied using partial likelihood regression with an L2 penalty to avoid overfitting and using cross-validation to determine the penalty weight. The fitted models are applied to an independent test set to obtain a predicted risk for each individual and each gene set. Hierarchical clustering of the test individuals on the basis of the vector of predicted risks results in two clusters with distinct clinical characteristics in terms of the distribution of molecular subtypes, ER, PR status, TP53 mutation status and histological grade category, and associated with significantly different survival probabilities (recurrence: p = 0.005; breast cancer death: p = 0.014). Finally, principal components analysis of the gene signatures is used to derive combined predictors used to fit a new Cox model. This model classifies test individuals into two risk groups with distinct survival characteristics (recurrence: p = 0.003; breast cancer death: p = 0.001). The latter classifier outperforms all the individual gene signatures, as well as Cox models based on traditional clinical parameters and the Adjuvant! Online for survival prediction. Conclusion: Combining the predictive strength of multiple gene signatures improves prediction of breast cancer survival. The presented methodology is broadly applicable to breast cancer risk assessment using any new identified gene set.	[Zhao, Xi; Sorlie, Therese; Langerod, Anita; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Dept Genet, Inst Canc Res, Oslo, Norway; [Zhao, Xi; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Oslo, Norway; [Rodland, Einar Andreas; Lingjaerde, Ole Christian] Univ Oslo, Dept Informat, Biomed Res Grp, Fac Math & Nat Sci, N-0316 Oslo, Norway; [Rodland, Einar Andreas; Lingjaerde, Ole Christian] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Naume, Bjorn] Oslo Univ Hosp, Canc Clin, Oslo, Norway; [Frigessi, Arnoldo] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Frigessi, Arnoldo] Norwegian Comp Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Zhao, X (corresponding author), Oslo Univ Hosp, Radiumhosp, Dept Genet, Inst Canc Res, Oslo, Norway.	xi.zhao@medisin.uio.no	li, jie/A-3133-2011; Sørlie, Therese/B-1413-2015	Sørlie, Therese/0000-0002-5995-2319; Lingjaerde, Ole Christian/0000-0003-3565-4912; Frigessi, Arnoldo/0000-0001-7103-7589	Norwegian Research Council (NFR) [175240]; NFR Cancer program [193387]	Norwegian Research Council (NFR)(Research Council of Norway); NFR Cancer program	This study was supported by Norwegian Research Council (NFR) FUGE program, Grant 175240 and NFR Cancer program, Grant 193387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; GOEMAN J, 2010, PENALIZED R PACKAGE; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hastie T, 2001, ELEMENTS STAT LEARNI, V1.8, P371; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; SCHEMPER M, 1993, STAT MED, V12, P2377, DOI 10.1002/sim.4780122413; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VERWEIJ PJM, 1993, STAT MED, V12, P2305, DOI 10.1002/sim.4780122407; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182	31	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17845	10.1371/journal.pone.0017845	http://dx.doi.org/10.1371/journal.pone.0017845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423775	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100039
J	Lee, TY; Chen, SA; Hung, HY; Ou, YY				Lee, Tzong-Yi; Chen, Shu-An; Hung, Hsin-Yi; Ou, Yu-Yen			Incorporating Distant Sequence Features and Radial Basis Function Networks to Identify Ubiquitin Conjugation Sites	PLOS ONE			English	Article							FUNCTION NEURAL-NETWORK; PROTEIN; PREDICTION; IDENTIFICATION; DEGRADATION; DATABASE; BLAST; LOGO	Ubiquitin (Ub) is a small protein that consists of 76 amino acids about 8.5 kDa. In ubiquitin conjugation, the ubiquitin is majorly conjugated on the lysine residue of protein by Ub-ligating (E3) enzymes. Three major enzymes participate in ubiquitin conjugation. They are - E1, E2 and E3 which are responsible for activating, conjugating and ligating ubiquitin, respectively. Ubiquitin conjugation in eukaryotes is an important mechanism of the proteasome-mediated degradation of a protein and regulating the activity of transcription factors. Motivated by the importance of ubiquitin conjugation in biological processes, this investigation develops a method, UbSite, which uses utilizes an efficient radial basis function (RBF) network to identify protein ubiquitin conjugation (ubiquitylation) sites. This work not only investigates the amino acid composition but also the structural characteristics, physicochemical properties, and evolutionary information of amino acids around ubiquitylation (Ub) sites. With reference to the pathway of ubiquitin conjugation, the substrate sites for E3 recognition, which are distant from ubiquitylation sites, are investigated. The measurement of F-score in a large window size (-20 similar to+20) revealed a statistically significant amino acid composition and position-specific scoring matrix (evolutionary information), which are mainly located distant from Ub sites. The distant information can be used effectively to differentiate Ub sites from non-Ub sites. As determined by five-fold cross-validation, the model that was trained using the combination of amino acid composition and evolutionary information performs best in identifying ubiquitin conjugation sites. The prediction sensitivity, specificity, and accuracy are 65.5%, 74.8%, and 74.5%, respectively. Although the amino acid sequences around the ubiquitin conjugation sites do not contain conserved motifs, the cross-validation result indicates that the integration of distant sequence features of Ub sites can improve predictive performance. Additionally, the independent test demonstrates that the proposed method can outperform other ubiquitylation prediction tools.	[Lee, Tzong-Yi; Chen, Shu-An; Hung, Hsin-Yi; Ou, Yu-Yen] Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan	Yuan Ze University	Lee, TY (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan.	francis@saturn.yzu.edu.tw; yien@csie.org	Ou, Yu-Yen/AAA-1716-2022	Ou, Yu-Yen/0000-0002-9894-926X	National Science Council (NSC) of Taiwan [NSC99-2320-B155-001, NSC99-2221-E155-073]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by National Science Council (NSC) of Taiwan, NSC99-2320-B155-001 to TYL, and NSC99-2221-E155-073 to YYO. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; CHARTON M, 1982, J THEOR BIOL, V99, P629, DOI 10.1016/0022-5193(82)90191-6; Chen SA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-536; Chernorudskiy AL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-126; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hu ZJ, 2004, NUCLEIC ACIDS RES, V32, pW235, DOI 10.1093/nar/gkh483; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Lin C-J, 2003, NIPS 2003 FEATURE SE, P1; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Ou CY, 2003, TRENDS GENET, V19, P382, DOI 10.1016/S0168-9525(03)00146-X; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; OU YY, 2005, P IEEE INT C NEURAL, V3, P1383; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Yang ZR, 2005, IEEE T NEURAL NETWOR, V16, P263, DOI 10.1109/TNN.2004.836196; Zanzoni A, 2007, NUCLEIC ACIDS RES, V35, pD229, DOI 10.1093/nar/gkl922; Zhang GZ, 2004, J COMPUT AID MOL DES, V18, P797, DOI 10.1007/s10822-005-0578-7	38	63	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17331	10.1371/journal.pone.0017331	http://dx.doi.org/10.1371/journal.pone.0017331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408064	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900010
J	Buchowski, MS; Meade, NN; Charboneau, E; Park, S; Dietrich, MS; Cowan, RL; Martin, PR				Buchowski, Maciej S.; Meade, Natalie N.; Charboneau, Evonne; Park, Sohee; Dietrich, Mary S.; Cowan, Ronald L.; Martin, Peter R.			Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; CIGARETTE CRAVINGS; PHYSICAL-ACTIVITY; RAT; ACTIVATION; DEPRESSION; RECOVERY; BINDING	Background: Cannabis dependence is a significant public health problem. Because there are no approved medications for this condition, treatment must rely on behavioral approaches empirically complemented by such lifestyle change as exercise. Aims: To examine the effects of moderate aerobic exercise on cannabis craving and use in cannabis dependent adults under normal living conditions. Design: Participants attended 10 supervised 30-min treadmill exercise sessions standardized using heart rate (HR) monitoring (60-70% HR reserve) over 2 weeks. Exercise sessions were conducted by exercise physiologists under medical oversight. Participants: Sedentary or minimally active non-treatment seeking cannabis-dependent adults (n = 12, age 25 +/- 63 years, 8 females) met criteria for primary cannabis dependence using the Substance Abuse module of the Structured Clinical Interview for DSM-IV (SCID). Measurements: Self-reported drug use was assessed for 1-week before, during, and 2-weeks after the study. Participants viewed visual cannabis cues before and after exercise in conjunction with assessment of subjective cannabis craving using the Marijuana Craving Questionnaire (MCQ-SF). Findings: Daily cannabis use within the run-in period was 5.9 joints per day (SD = 3.1, range 1.8-10.9). Average cannabis use levels within the exercise (2.8 joints, SD = 1.6, range 0.9-5.4) and follow-up (4.1 joints, SD = 2.5, range 1.1-9.5) periods were lower than during the run-in period (both P <.005). Average MCQ factor scores for the pre- and post-exercise craving assessments were reduced for compulsivity (P = .006), emotionality (P = .002), expectancy (P = .002), and purposefulness (P = .002). Conclusions: The findings of this pilot study warrant larger, adequately powered controlled trials to test the efficacy of prescribed moderate aerobic exercise as a component of cannabis dependence treatment. The neurobiological mechanisms that account for these beneficial effects on cannabis use may lead to understanding of the physical and emotional underpinnings of cannabis dependence and recovery from this disorder.	[Buchowski, Maciej S.; Meade, Natalie N.] Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Energy Balance Lab, Nashville, TN 37203 USA; [Charboneau, Evonne; Dietrich, Mary S.; Cowan, Ronald L.; Martin, Peter R.] Vanderbilt Univ, Dept Psychiat, Addict Ctr, Nashville, TN USA; [Charboneau, Evonne; Dietrich, Mary S.; Cowan, Ronald L.; Martin, Peter R.] Vanderbilt Univ, Dept Psychiat, Psychiat Neuroimaging Program, Nashville, TN USA; [Park, Sohee; Cowan, Ronald L.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Dietrich, Mary S.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Cowan, Ronald L.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN USA; [Cowan, Ronald L.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Buchowski, MS (corresponding author), Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Energy Balance Lab, Nashville, TN 37203 USA.	maciej.buchowski@vanderbilt.edu	Buchowski, Maciej S./A-2683-2008; Martin, Peter R/A-7738-2008	Buchowski, Maciej S./0000-0002-0566-1743; Park, Sohee/0000-0003-3797-4776	National Center for Research Resources (NCRR/NIH), Vanderbilt Institute for Clinical and Translational Research (VICTR) [1UL1 RR024975]; National Institute on Drug Abuse (NIDA/NIH) [R01 DA01537, R21 DA020149, 1R01 DA015713]; Vanderbilt Addiction Center;  [DK69465]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA020149, R01DA015713] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR/NIH), Vanderbilt Institute for Clinical and Translational Research (VICTR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Drug Abuse (NIDA/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Vanderbilt Addiction Center; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported in part by the Vanderbilt Institute for Clinical and Translational Research (VICTR) grant 1UL1 RR024975 from the National Center for Research Resources (NCRR/NIH), and from grants R01 DA01537 and R21 DA020149 from the National Institute on Drug Abuse (NIDA/NIH) (to RLC), 1R01 DA015713 from NIDA/NIH (to PRM), and from the Vanderbilt Addiction Center. MSB was supported in part by DK69465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, DRUG ALCOHOL DEPEN, V95, P107, DOI 10.1016/j.drugalcdep.2007.12.017; American College of Sports Medicine, 2008, ACSMS GUID EX TEST P; ARPANA A, 2008, ADDICTION, V103, P1896; Brown Richard A, 2010, Ment Health Phys Act, V3, P27; Brown RA, 2009, BEHAV MODIF, V33, P220, DOI 10.1177/0145445508329112; BUDNEY A, 2007, ADDICTION SCI CLIN P, V4, P1; Cowan RL, 2006, PHARMACOL BIOCHEM BE, V84, P219, DOI 10.1016/j.pbb.2006.04.024; Cowan RL, 2008, SYNAPSE, V62, P268, DOI 10.1002/syn.20491; Cowan RL, 2007, PSYCHIAT RES-NEUROIM, V155, P179, DOI 10.1016/j.pscychresns.2007.01.008; Cowan RL, 2009, PHARMACOL BIOCHEM BE, V92, P105, DOI 10.1016/j.pbb.2008.10.022; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; First M. B., 1997, STRUCTURED CLIN INTE; Fisher BE, 2004, J NEUROSCI RES, V77, P378, DOI 10.1002/jnr.20162; GILLIAM PE, 1984, PHARMACOL BIOCHEM BE, V20, P863, DOI 10.1016/0091-3057(84)90008-X; HATTORI S, 1994, BRAIN RES BULL, V35, P41, DOI 10.1016/0361-9230(94)90214-3; Heishman SJ, 2006, METH MOLEC MED, V123, P209; Heishman SJ, 2009, DRUG ALCOHOL DEPEN, V102, P35, DOI 10.1016/j.drugalcdep.2008.12.010; Johnson PL, 2008, NEUROPSYCHOPHARMACOL, V33, P2093, DOI 10.1038/sj.npp.1301621; LYNCH WJ, 2010, BIOL PSYCHI IN PRESS; MACRAE PG, 1987, PSYCHOPHARMACOLOGY, V92, P236; Martin PR, 2005, AM J ADDICTION, V14, P1, DOI 10.1080/10550490590899808; Matthews CE, 2005, MED SCI SPORT EXER, V37, P986, DOI 10.1249/01.mss.0000171615.76521.69; Meeusen R, 1997, ACTA PHYSIOL SCAND, V159, P335, DOI 10.1046/j.1365-201X.1997.00118.x; MORGAN, 1982, BEHAV MED UPDATE, V4, P25; Muller SM, 2006, PERCEPT MOTOR SKILL, V103, P717, DOI 10.2466/PMS.103.3.717-725; NORRIS R, 1992, J PSYCHOSOM RES, V36, P55, DOI 10.1016/0022-3999(92)90114-H; NORRIS R, 1990, J PSYCHOSOM RES, V34, P367, DOI 10.1016/0022-3999(90)90060-H; Parfitt G, 2006, BRIT J HEALTH PSYCH, V11, P39, DOI 10.1348/135910705X43606; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; ROESSLER K, 2010, SCAND J PUBLIC  0621; Smith MA, 2008, DRUG ALCOHOL DEPEN, V98, P129, DOI 10.1016/j.drugalcdep.2008.05.006; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Ussher MH, 2008, COCHRANE DB SYST REV, V4; Ussher M, 2009, ADDICTION, V104, P1251, DOI 10.1111/j.1360-0443.2009.02605.x; Van Rensburg KJ, 2008, HUM PSYCHOPHARM CLIN, V23, P193, DOI 10.1002/hup.925; VEALE D, 1992, J ROY SOC MED, V85, P541; Waade NR, 2004, AUST J PHYSIOTHER, V50, P117, DOI 10.1016/S0004-9514(14)60106-9; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	38	86	92	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17465	10.1371/journal.pone.0017465	http://dx.doi.org/10.1371/journal.pone.0017465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FI	21408154	gold, Green Published			2022-12-27	WOS:000288170000032
J	Carola, V; Mirabeau, O; Gross, CT				Carola, Valeria; Mirabeau, Olivier; Gross, Cornelius T.			Hidden Markov Model Analysis of Maternal Behavior Patterns in Inbred and Reciprocal Hybrid Mice	PLOS ONE			English	Article							EMOTIONAL REACTIVITY; RESPONSES; ANXIETY; STRESS; MOUSE; ENVIRONMENT; EXPRESSION; STRAINS; MAZE; CARE	Individual variation in maternal care in mammals shows a significant heritable component, with the maternal behavior of daughters resembling that of their mothers. In laboratory mice, genetically distinct inbred strains show stable differences in maternal care during the first postnatal week. Moreover, cross fostering and reciprocal breeding studies demonstrate that differences in maternal care between inbred strains persist in the absence of genetic differences, demonstrating a nongenetic or epigenetic contribution to maternal behavior. In this study we applied a mathematical tool, called hidden Markov model (HMM), to analyze the behavior of female mice in the presence of their young. The frequency of several maternal behaviors in mice has been previously described, including nursing/grooming pups and tending to the nest. However, the ordering, clustering, and transitions between these behaviors have not been systematically described and thus a global description of maternal behavior is lacking. Here we used HMM to describe maternal behavior patterns in two genetically distinct mouse strains, C57BL/6 and BALB/c, and their genetically identical reciprocal hybrid female offspring. HMM analysis is a powerful tool to identify patterns of events that cluster in time and to determine transitions between these clusters, or hidden states. For the HMM analysis we defined seven states: arched-backed nursing, blanket nursing, licking/grooming pups, grooming, activity, eating, and sleeping. By quantifying the frequency, duration, composition, and transition probabilities of these states we were able to describe the pattern of maternal behavior in mouse and identify aspects of these patterns that are under genetic and nongenetic inheritance. Differences in these patterns observed in the experimental groups (inbred and hybrid females) were detected only after the application of HMM analysis whereas classical statistical methods and analyses were not able to highlight them.	[Carola, Valeria; Mirabeau, Olivier; Gross, Cornelius T.] EMBL, Mouse Biol Unit, Monterotondo, Italy; [Carola, Valeria] European Ctr Brain Res CERC, Santa Lucia Fdn, Rome, Italy	European Molecular Biology Laboratory (EMBL); IRCCS Santa Lucia	Carola, V (corresponding author), EMBL, Mouse Biol Unit, Monterotondo, Italy.	carola@embl.it; gross@embl.it	carola, valeria/J-9724-2014		Santa Lucia Foundation; Fritz Thyssen Stiftung; NARSAD; European Molecular Biology Laboratory	Santa Lucia Foundation; Fritz Thyssen Stiftung; NARSAD(NARSAD); European Molecular Biology Laboratory	This work was supported by grants from the Santa Lucia Foundation (V. C.), Fritz Thyssen Stiftung (C. G.), NARSAD (C. G.), and funds from European Molecular Biology Laboratory (O.M. and C. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Benjamini Y, 2001, ANN STAT, V29, P1165; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Calatayud F, 2001, PHYSIOL BEHAV, V74, P355, DOI 10.1016/S0031-9384(01)00566-2; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Carola V, 2006, GENES BRAIN BEHAV, V5, P189, DOI 10.1111/j.1601-183X.2005.00152.x; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Carola V, 2008, BIOL PSYCHIAT, V63, P840, DOI 10.1016/j.biopsych.2007.08.013; CHEVALET P, 1989, BEHAV PROCESS, V20, P93, DOI 10.1016/0376-6357(89)90015-6; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Hastie T., 2009, UNSUPERVISED LEARNIN; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Maubourguet N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000229; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Prakash P, 2006, BRAIN RES, V1111, P122, DOI 10.1016/j.brainres.2006.06.089; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Roy V, 2007, BEHAV BRAIN RES, V185, P49, DOI 10.1016/j.bbr.2007.07.008; Sargin ME, 2008, IEEE T PATTERN ANAL, V30, P1330, DOI 10.1109/TPAMI.2007.70797; Shoji H, 2006, PHYSIOL BEHAV, V89, P320, DOI 10.1016/j.physbeh.2006.06.012; VETROV D, 2008, P 6 INT C METH TECHN; Weaver ICG, 2002, ENDOCR RES, V28, P699, DOI 10.1081/ERC-120016989; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130; Zhang TY, 2004, ANN NY ACAD SCI, V1032, P85, DOI 10.1196/annals.1314.007	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e14753	10.1371/journal.pone.0014753	http://dx.doi.org/10.1371/journal.pone.0014753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408086	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000002
J	Feng, Y; Cao, CM; Vikram, M; Park, S; Kim, HJ; Hong, JC; Cisneros-Zevallos, L; Koiwa, H				Feng, Yue; Cao, Cong-Mei; Vikram, Meenu; Park, Sunghun; Kim, Hye Jin; Hong, Jong Chan; Cisneros-Zevallos, Luis; Koiwa, Hisashi			A Three-Component Gene Expression System and Its Application for Inducible Flavonoid Overproduction in Transgenic Arabidopsis thaliana	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; FUNCTIONAL GENOMICS; ROOT DEVELOPMENT; OVER-EXPRESSION; HUMAN HEALTH; STRESS; ANTHOCYANIN; BIOSYNTHESIS; TOBACCO; PLANTS	Inducible gene expression is a powerful tool to study and engineer genes whose overexpression could be detrimental for the host organisms. However, only limited systems have been adopted in plant biotechnology. We have developed an osmotically inducible system using three components of plant origin, RD29a (Responsive to Dehydration 29A) promoter, CBF3 (C-repeat Binding Factor 3) transcription factor and cpl1-2 (CTD phosphatase-like 1) mutation. The osmotic stress responsible RD29a promoter contains the CBF3 binding sites and thus RD29A-CBF3 feedforward cassette enhances induction of RD29a promoter under stress. The cpl1-2 mutation in a host repressor CPL1 promotes stress responsible RD29a promoter expression. The efficacy of this system was tested using PAP1 (Production of Anthocyanin Pigment 1) transgene, a model transcription factor that regulates the anthocyanin pathway in Arabidopsis. While transgenic plants with only one or two of three components did not reproducibly accumulate anthocyanin pigments above the control level, transgenic cpl1 plants containing homozygous RD29a-PAP1 and RD29a-CBF3 transgenes produced 30-fold higher level of total anthocyanins than control plants upon cold treatment. Growth retardation and phytochemical production of transgenic plants were minimum under normal conditions. The flavonoid profile in cold-induced transgenic plants was determined by LC/MS/MS, which resembled that of previously reported pap1-D plants but enriched for kaempferol derivatives. These results establish the functionality of the inducible three-component gene expression system in plant metabolic engineering. Furthermore, we show that PAP1 and environmental signals synergistically regulate the flavonoid pathway to produce a unique flavonoid blend that has not been produced by PAP1 overexpression or cold treatment alone.	[Feng, Yue; Cao, Cong-Mei; Vikram, Meenu; Cisneros-Zevallos, Luis; Koiwa, Hisashi] Texas A&M Univ, Dept Hort Sci, Vegetable & Fruit Improvement Ctr, College Stn, TX 77843 USA; [Park, Sunghun] Kansas State Univ, Dept Hort Forestry & Recreat Sources, Manhattan, KS 66506 USA; [Kim, Hye Jin; Hong, Jong Chan] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci & Plant Mol Biol, Program BK21, Jinju, South Korea; [Kim, Hye Jin; Hong, Jong Chan] Gyeongsang Natl Univ, Grad Sch, Biotechnol Res Ctr, Jinju, South Korea	Texas A&M University System; Texas A&M University College Station; Kansas State University; Gyeongsang National University; Gyeongsang National University	Feng, Y (corresponding author), Texas A&M Univ, Dept Hort Sci, Vegetable & Fruit Improvement Ctr, College Stn, TX 77843 USA.	koiwa@neo.tamu.edu	Cao, Congmei/M-5720-2014; Koiwa, Hisashi/AAO-6512-2020; Koiwa, Hisashi/AAA-8182-2019	Koiwa, Hisashi/0000-0002-7421-340X; 	National Science Foundation [MCB0421889, MCB0950459]; USDA-CSREES [2008-34402-19195, 2009-34402-19831]; National Research Foundation of Korea, MEST [2010-0012801]	National Science Foundation(National Science Foundation (NSF)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Research Foundation of Korea, MEST(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the National Science Foundation (http://www.nsf.gov, MCB0421889 and MCB0950459), USDA-CSREES (http://www.csrees.usda.gov, 2008-34402-19195 and 2009-34402-19831) "Designing Food for Health'', and a Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.go.kr/html/en/) MEST (2010-0012801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; FULEKI T, 1968, J FOOD SCI, V33, P78, DOI 10.1111/j.1365-2621.1968.tb00888.x; Geekiyanage S, 2007, PLANT BIOTECHNOL REP, V1, P11, DOI 10.1007/s11816-006-0001-4; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x; Iriti M, 2009, NAT PROD COMMUN, V4, P611; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Koiwa H, 2002, P NATL ACAD SCI USA, V99, P10893, DOI 10.1073/pnas.112276199; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Li X, 2010, J AGR FOOD CHEM, V58, P1639, DOI 10.1021/jf903527y; Liu CJ, 2002, P NATL ACAD SCI USA, V99, P14578, DOI 10.1073/pnas.212522099; Marczak L, 2008, RAPID COMMUN MASS SP, V22, P3949, DOI 10.1002/rcm.3819; Matsuda O, 2009, PLANT J, V57, P96, DOI 10.1111/j.1365-313X.2008.03663.x; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Piao HL, 2001, PLANT J, V27, P305, DOI 10.1046/j.1365-313x.2001.01099.x; Sanchez-Calderon L, 2006, PLANT PHYSIOL, V140, P879, DOI 10.1104/pp.105.073825; Shadle GL, 2003, PHYTOCHEMISTRY, V64, P153, DOI 10.1016/S0031-9422(03)00151-1; Shi MZ, 2010, PLANTA, V231, P1385, DOI 10.1007/s00425-010-1142-9; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Zhou LL, 2008, PLANTA, V229, P37, DOI 10.1007/s00425-008-0809-y; Zuo Jianru, 2006, V323, P329	30	5	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17603	10.1371/journal.pone.0017603	http://dx.doi.org/10.1371/journal.pone.0017603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408135	gold, Green Published, Green Submitted			2022-12-27	WOS:000288170000044
J	Hsing, CH; Lin, MC; Choi, PC; Huang, WC; Kai, JI; Tsai, CC; Cheng, YL; Hsieh, CY; Wang, CY; Chang, YP; Chen, YH; Chen, CL; Lin, CF				Hsing, Chung-Hsi; Lin, Ming-Chung; Choi, Pui-Ching; Huang, Wei-Ching; Kai, Jui-In; Tsai, Cheng-Chieh; Cheng, Yi-Lin; Hsieh, Chia-Yuan; Wang, Chi-Yun; Chang, Yu-Ping; Chen, Yu-Hong; Chen, Chia-Ling; Lin, Chiou-Feng			Anesthetic Propofol Reduces Endotoxic Inflammation by Inhibiting Reactive Oxygen Species-regulated Akt/IKK beta/NF-kappa B Signaling	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; INFUSION SYNDROME; GENE-EXPRESSION; CONSCIOUS RATS; LIPOPOLYSACCHARIDE; ACTIVATION; SEPSIS; CELLS; PATHOPHYSIOLOGY	Background: Anesthetic propofol has immunomodulatory effects, particularly in the area of anti-inflammation. Bacterial endotoxin lipopolysaccharide (LPS) induces inflammation through toll-like receptor (TLR) 4 signaling. We investigated the molecular actions of propofol against LPS/TLR4-induced inflammatory activation in murine RAW264.7 macrophages. Methodology/Principal Findings: Non-cytotoxic levels of propofol reduced LPS-induced inducible nitric oxide synthase (iNOS) and NO as determined by western blotting and the Griess reaction, respectively. Propofol also reduced the production of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, and IL-10 as detected by enzyme-linked immunosorbent assays. Western blot analysis showed propofol inhibited LPS-induced activation and phosphorylation of IKK beta (Ser180) and nuclear factor (NF)-kappa B (Ser536); the subsequent nuclear translocation of NF-kappa B p65 was also reduced. Additionally, propofol inhibited LPS-induced Akt activation and phosphorylation (Ser473) partly by reducing reactive oxygen species (ROS) generation; inter-regulation that ROS regulated Akt followed by NF-kappa B activation was found to be crucial for LPS-induced inflammatory responses in macrophages. An in vivo study using C57BL/6 mice also demonstrated the anti-inflammatory properties against LPS in peritoneal macrophages. Conclusions/Significance: These results suggest that propofol reduces LPS-induced inflammatory responses in macrophages by inhibiting the interconnected ROS/Akt/IKK beta/NF-kappa B signaling pathways.	[Hsing, Chung-Hsi; Lin, Ming-Chung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Hsing, Chung-Hsi] Taipei Med Univ, Coll Med, Dept Anesthesiol, Taipei, Taiwan; [Lin, Ming-Chung; Choi, Pui-Ching; Huang, Wei-Ching; Kai, Jui-In; Tsai, Cheng-Chieh; Cheng, Yi-Lin; Hsieh, Chia-Yuan; Wang, Chi-Yun; Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Huang, Wei-Ching; Tsai, Cheng-Chieh; Wang, Chi-Yun; Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tsai, Cheng-Chieh] Chung Hwa Univ Med Technol, Dept Nursing, Tainan, Taiwan; [Cheng, Yi-Lin] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chen, Yu-Hong; Chen, Chia-Ling; Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan	Chi Mei Hospital; Taipei Medical University; National Cheng Kung University; National Cheng Kung University; Chung Hua University; National Cheng Kung University; National Cheng Kung University	Hsing, CH (corresponding author), Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan.	hsing@mail.chimei.org.tw; cflin@mail.ncku.edu.tw		Wang, Chi-Yun/0000-0003-0317-5378	National Cheng Kung University [CMNCKU9809]; Chi Mei Medical Center, Taiwan; National Science Council, Taiwan [NSC 96-2320-B-006-018-MY3]	National Cheng Kung University; Chi Mei Medical Center, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the cooperation project CMNCKU9809 of National Cheng Kung University and Chi Mei Medical Center, Taiwan and by grant NSC 96-2320-B-006-018-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Brasil LJ, 2006, TOXICOLOGY, V227, P53, DOI 10.1016/j.tox.2006.07.013; Chen HI, 2008, CRIT CARE MED, V36, P1214, DOI 10.1097/CCM.0b013e31816a0607; Chen RM, 2005, ANN NY ACAD SCI, V1042, P262, DOI 10.1196/annals.1338.030; Chiu WT, 2009, CHEM-BIOL INTERACT, V181, P430, DOI 10.1016/j.cbi.2009.06.011; Fudickar A, 2009, MINERVA ANESTESIOL, V75, P339; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haddad JJ, 2002, CYTOKINES CELL MOL T, V7, P1, DOI 10.1080/13684730216401; HSING CH, 2010, NEPHROL DIA IN PRESS; Hsu BG, 2005, CLIN EXP PHARMACOL P, V32, P24, DOI 10.1111/j.1440-1681.2005.04155.x; Huang WC, 2009, IMMUNOLOGY, V128, pe275, DOI 10.1111/j.1365-2567.2008.02959.x; Inada T, 2009, CAN J ANAESTH, V56, P222, DOI 10.1007/s12630-008-9035-0; Jang SI, 2006, EUR J PHARMACOL, V542, P1, DOI 10.1016/j.ejphar.2006.04.044; Jawan B, 2008, TOXICOL APPL PHARM, V229, P362, DOI 10.1016/j.taap.2008.01.044; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Koay MA, 2001, INFECT IMMUN, V69, P5991, DOI 10.1128/IAI.69.10.5991-5996.2001; Kwak SH, 2004, J KOREAN MED SCI, V19, P55, DOI 10.3346/jkms.2004.19.1.55; Lawton JA, 2003, CURR OPIN CHEM BIOL, V7, P446, DOI 10.1016/S1367-5931(03)00077-2; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Ma L, 2010, ACTA ANAESTH SCAND, V54, P362, DOI 10.1111/j.1399-6576.2009.02127.x; Macdonald J, 2003, BRIT J ANAESTH, V90, P221, DOI 10.1093/bja/aeg034; MACKENZIE N, 1987, ANAESTHESIA, V42, P3, DOI 10.1111/j.1365-2044.1987.tb02936.x; Marik PE, 2005, PHARMACOTHERAPY, V25, p28S, DOI 10.1592/phco.2005.25.5_Part_2.28S; Nomellini V, 2009, SHOCK, V31, P11, DOI 10.1097/SHK.0b013e318180f508; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rinaldi S, 2009, CURR DRUG TARGETS, V10, P872, DOI 10.2174/138945009789108774; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Song XM, 2009, MOL BIOL REP, V36, P2345, DOI 10.1007/s11033-009-9456-z; Takaono M, 2002, ACTA ANAESTH SCAND, V46, P176, DOI 10.1034/j.1399-6576.2002.460209.x; Takemoto Yasuhiro, 2005, J Anesth, V19, P40, DOI 10.1007/s00540-004-0267-z; Taniguchi T, 2003, TOHOKU J EXP MED, V200, P85, DOI 10.1620/tjem.200.85; Tsao CM, 2008, CRIT CARE MED, V36, P887, DOI 10.1097/CCM.0B013E318165395E; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Victor Victor M., 2009, Infectious Disorders - Drug Targets, V9, P376; Wu GJ, 2009, CHEM-BIOL INTERACT, V180, P465, DOI 10.1016/j.cbi.2009.05.003; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630	38	75	86	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17598	10.1371/journal.pone.0017598	http://dx.doi.org/10.1371/journal.pone.0017598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408125	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000043
J	Burkett-Cadena, ND; McClure, CJW; Ligon, RA; Graham, SP; Guyer, C; Hill, GE; Ditchkoff, SS; Eubanks, MD; Hassan, HK; Unnasch, TR				Burkett-Cadena, Nathan D.; McClure, Christopher J. W.; Ligon, Russell A.; Graham, Sean P.; Guyer, Craig; Hill, Geoffrey E.; Ditchkoff, Stephen S.; Eubanks, Micky D.; Hassan, Hassan K.; Unnasch, Thomas R.			Host Reproductive Phenology Drives Seasonal Patterns of Host Use in Mosquitoes	PLOS ONE			English	Article							EQUINE ENCEPHALOMYELITIS VIRUS; WHITE-TAILED DEER; BLOOD-FEEDING PATTERNS; VERTEBRATE HOSTS; CENTRAL ALABAMA; CULEX-TARSALIS; VECTORS; IDENTIFICATION; TRANSMISSION; ENCEPHALITIS	Seasonal shifts in host use by mosquitoes from birds to mammals drive the timing and intensity of annual epidemics of mosquito-borne viruses, such as West Nile virus, in North America. The biological mechanism underlying these shifts has been a matter of debate, with hypotheses falling into two camps: (1) the shift is driven by changes in host abundance, or (2) the shift is driven by seasonal changes in the foraging behavior of mosquitoes. Here we explored the idea that seasonal changes in host use by mosquitoes are driven by temporal patterns of host reproduction. We investigated the relationship between seasonal patterns of host use by mosquitoes and host reproductive phenology by examining a seven-year dataset of blood meal identifications from a site in Tuskegee National Forest, Alabama USA and data on reproduction from the most commonly utilized endothermic (white-tailed deer, great blue heron, yellow-crowned night heron) and ectothermic (frogs) hosts. Our analysis revealed that feeding on each host peaked during periods of reproductive activity. Specifically, mosquitoes utilized herons in the spring and early summer, during periods of peak nest occupancy, whereas deer were fed upon most during the late summer and fall, the period corresponding to the peak in births for deer. For frogs, however, feeding on early-and late-season breeders paralleled peaks in male vocalization. We demonstrate for the first time that seasonal patterns of host use by mosquitoes track the reproductive phenology of the hosts. Peaks in relative mosquito feeding on each host during reproductive phases are likely the result of increased tolerance and decreased vigilance to attacking mosquitoes by nestlings and brooding adults (avian hosts), quiescent young (avian and mammalian hosts), and mate-seeking males (frogs).	[Burkett-Cadena, Nathan D.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [McClure, Christopher J. W.; Ligon, Russell A.; Graham, Sean P.; Guyer, Craig; Hill, Geoffrey E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Ditchkoff, Stephen S.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Hassan, Hassan K.; Unnasch, Thomas R.] Univ S Florida, Dept Global Hlth, Tampa, FL USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of South Florida	Burkett-Cadena, ND (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	urkend@auburn.edu	McClure, Christopher/J-2712-2019; Hill, Geoffrey E./R-7354-2019; Ligon, Russell/M-1233-2013	McClure, Christopher/0000-0003-1216-7425; Hill, Geoffrey E./0000-0001-8864-6495; Ligon, Russell/0000-0002-0195-8275; Burkett-Cadena, Nathan/0000-0001-6168-1637; Ditchkoff, Stephen/0000-0002-7414-5777	National Institute of Allergy and Infectious Diseases [R01AI049724]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049724] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from the National Institute of Allergy and Infectious Diseases, Project # R01AI049724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander K, 1997, J AVIAN BIOL, V28, P325, DOI 10.2307/3676946; Bernal XE, 2006, BEHAV ECOL, V17, P709, DOI 10.1093/beheco/arl003; BLACKMORE JOHN S., 1958, MOSQUITO NEWS, V18, P15; Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809; Burkett-Cadena ND, 2008, J AM MOSQUITO CONTR, V24, P228, DOI 10.2987/5662.1; BURKETTCADENA ND, 2010, AM J TROP MED HYG, P10, DOI DOI 10.4269/AJTMH.PP; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; Cohen SB, 2009, AM J TROP MED HYG, V81, P452, DOI 10.4269/ajtmh.2009.81.452; CUNNINGHAM R. A., 2006, CANBERRA BIRD NOTES, V31, P73; Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272; Cupp EW, 2003, AM J TROP MED HYG, V68, P495, DOI 10.4269/ajtmh.2003.68.495; DALRYMPLE JM, 1972, AM J EPIDEMIOL, V96, P129, DOI 10.1093/oxfordjournals.aje.a121439; EDMAN JD, 1968, SCIENCE, V161, P67, DOI 10.1126/science.161.3836.67; EDMAN JD, 1974, J MED ENTOMOL, V11, P95, DOI 10.1093/jmedent/11.1.95; Hamilton R.J., 1985, PROC ANN CONF SOUTHE, V9, P389; Hassan HK, 2003, AM J TROP MED HYG, V69, P641, DOI 10.4269/ajtmh.2003.69.641; JACKSON RM, 1972, ECOLOGY, V53, P262, DOI 10.2307/1934080; KALE HW, 1972, MOSQ NEWS, V32, P343; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Lee JH, 2002, AM J TROP MED HYG, V66, P599, DOI 10.4269/ajtmh.2002.66.599; Ligon JD, 1999, EVOLUTION AVIAN BREE; Linnell JDC, 1995, WILDLIFE BIOL, V1, P209, DOI 10.2981/wlb.1995.0026; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MCKEEVER S, 1977, MOSQ NEWS, V37, P522; MILLER AJ, 1992, SUBSET SELECTION REG; NELSON RL, 1976, AM J TROP MED HYG, V25, P644, DOI 10.4269/ajtmh.1976.25.644; Pyle P, 2004, WILSON BULL, V116, P287, DOI 10.1676/04-012; R Core Team, 2018, R LANG ENV STAT COMP; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; RYAN MJ, 1988, AM ZOOL, V28, P885; Saalfeld ST, 2007, J WILDLIFE MANAGE, V71, P940, DOI 10.2193/2006-116; TEMPELIS CH, 1965, AM J TROP MED HYG, V14, P170, DOI 10.4269/ajtmh.1965.14.170; Toma Takako, 2005, Medical Entomology and Zoology, V56, P65; TUTTLE ND, 1981, SCIENCE, V214, P677; WALKER ED, 1985, J MED ENTOMOL, V22, P4370; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; WEINMANN CJ, 1975, J PARASITOL, V61, P317, DOI 10.2307/3279012; WRIGHT RE, 1970, ANN ENTOMOL SOC AM, V63, P777, DOI 10.1093/aesa/63.3.777; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	40	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17681	10.1371/journal.pone.0017681	http://dx.doi.org/10.1371/journal.pone.0017681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408172	gold, Green Published			2022-12-27	WOS:000288099800032
J	Hagemann, S; Heil, O; Lyko, F; Brueckner, B				Hagemann, Sabine; Heil, Oliver; Lyko, Frank; Brueckner, Bodo			Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; HISTONE DEACETYLASE; GENOMIC DNA; METHYLATION; 5-AZA-2'-DEOXYCYTIDINE; METHYLTRANSFERASE; EPIGENOMICS; INHIBITION; RESISTANCE; DNMT1	The DNA methyltransferase inhibitors azacytidine and decitabine represent archetypal drugs for epigenetic cancer therapy. To characterize the demethylating activity of azacytidine and decitabine we treated colon cancer and leukemic cells with both drugs and used array-based DNA methylation analysis of more than 14,000 gene promoters. Additionally, drug-induced demethylation was compared to methylation patterns of isogenic colon cancer cells lacking both DNA methyltransferase 1 (DNMT1) and DNMT3B. We show that drug-induced demethylation patterns are highly specific, non-random and reproducible, indicating targeted remethylation of specific loci after replication. Correspondingly, we found that CG dinucleotides within CG islands became preferentially remethylated, indicating a role for DNA sequence context. We also identified a subset of genes that were never demethylated by drug treatment, either in colon cancer or in leukemic cell lines. These demethylation-resistant genes were enriched for Polycomb Repressive Complex 2 components in embryonic stem cells and for transcription factor binding motifs not present in demethylated genes. Our results provide detailed insights into the DNA methylation patterns induced by azacytidine and decitabine and suggest the involvement of complex regulatory mechanisms in drug-induced DNA demethylation.	[Hagemann, Sabine; Lyko, Frank; Brueckner, Bodo] Deutsch Krebsforschungszentrum, Div Epigenet, D-6900 Heidelberg, Germany; [Heil, Oliver] Deutsch Krebsforschungszentrum, Genom & Prote Core Facil, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Hagemann, S (corresponding author), Deutsch Krebsforschungszentrum, Div Epigenet, D-6900 Heidelberg, Germany.	b.brueckner@dkfz.de			Deutsche Forschungsgemeinschaft [SPP1463]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SPP1463) to FL (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CM, 1998, CANCER RES, V58, P95; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; MOMPARLER RL, 1984, CANCER CHEMOTH PHARM, V13, P191, DOI 10.1007/BF00269027; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; Mund C, 2005, CANCER RES, V65, P7086, DOI 10.1158/0008-5472.CAN-05-0695; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; SAKAI T, 1991, AM J HUM GENET, V48, P880; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Sarkar D, 2008, USE R, P1; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; Stach D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng002; STRESEMANN C, 2008, MOL CANC THER; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3; Team RDC, 2010, R LANG ENV STAT COMP; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	46	103	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17388	10.1371/journal.pone.0017388	http://dx.doi.org/10.1371/journal.pone.0017388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408221	Green Published, gold, Green Submitted			2022-12-27	WOS:000288099800011
J	Ito, M; Johansson, J; Stromberg, R; Nilsson, L				Ito, Mika; Johansson, Jan; Stromberg, Roger; Nilsson, Lennart			Unfolding of the Amyloid beta-Peptide Central Helix: Mechanistic Insights from Molecular Dynamics Simulations	PLOS ONE			English	Article							FIBRIL-FORMING PROTEINS; ALZHEIMERS-DISEASE; SECONDARY-STRUCTURE; FORCE-FIELDS; IN-SILICO; AGGREGATION; PREDICTION; WATER; A-BETA(1-42); SEQUENCE	Alzheimer's disease (AD) pathogenesis is associated with formation of amyloid fibrils caused by polymerization of the amyloid beta-peptide (A beta), which is a process that requires unfolding of the native helical structure of A beta. According to recent experimental studies, stabilization of the A beta central helix is effective in preventing A beta polymerization into toxic assemblies. To uncover the fundamental mechanism of unfolding of the A beta central helix, we performed molecular dynamics simulations for wild-type (WT), V18A/F19A/F20A mutant (MA), and V18L/F19L/F20L mutant (ML) models of the A beta central helix. It was quantitatively demonstrated that the stability of the alpha-helical conformation of both MA and ML is higher than that of WT, indicating that the alpha-helical propensity of the three nonpolar residues (18, 19, and 20) is the main factor for the stability of the whole A beta central helix and that their hydrophobicity plays a secondary role. WT was found to completely unfold by a three-step mechanism: 1) loss of alpha-helical backbone hydrogen bonds, 2) strong interactions between nonpolar sidechains, and 3) strong interactions between polar sidechains. WT did not completely unfold in cases when any of the three steps was omitted. MA and ML did not completely unfold mainly due to the lack of the first step. This suggests that disturbances in any of the three steps would be effective in inhibiting the unfolding of the A beta central helix. Our findings would pave the way for design of new drugs to prevent or retard AD.	[Ito, Mika; Stromberg, Roger; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Johansson, Jan] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Johansson, Jan] Karolinska Inst, Alzheimer Dis Res Ctr, Dept Neurobiol Care Sci & Soc NVS, Huddinge, Sweden	Karolinska Institutet; Swedish University of Agricultural Sciences; Karolinska Institutet	Ito, M (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	lennart.nilsson@ki.se	Nilsson, Lennart/B-7208-2009; Stromberg, Roger/C-2960-2013	Nilsson, Lennart/0000-0002-5067-6397; Johansson, Jan/0000-0002-8719-4703	Swedish Research Council [621-2009-4590]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grant (621-2009-4590) from the Swedish Research Council (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INS 2 VERS 2000; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Caballero-Herrera A, 2005, BIOPHYS J, V89, P842, DOI 10.1529/biophysj.105.061978; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; DELOOF H, 1992, J AM CHEM SOC, V114, P4028, DOI 10.1021/ja00037a002; ELOFSSON A, 1993, J MOL BIOL, V233, P766, DOI 10.1006/jmbi.1993.1551; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; GAVEL Y, 1988, FEBS LETT, V235, P173, DOI 10.1016/0014-5793(88)81257-2; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gnanakaran S, 2006, J AM CHEM SOC, V128, P2158, DOI 10.1021/ja0548337; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh SG, 2008, J PHYS CHEM B, V112, P2767, DOI 10.1021/jp712170h; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Masman MF, 2009, J PHYS CHEM B, V113, P11710, DOI 10.1021/jp901057w; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mousseau N, 2005, ACCOUNTS CHEM RES, V38, P885, DOI 10.1021/ar050045a; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nilsson L, 2009, J COMPUT CHEM, V30, P1490, DOI 10.1002/jcc.21169; Nordling E, 2008, J COMPUT AID MOL DES, V22, P53, DOI 10.1007/s10822-007-9155-6; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shen L, 2008, J PHYS CHEM B, V112, P3164, DOI 10.1021/jp7108237; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; TIRADORIVES J, 1991, BIOCHEMISTRY-US, V30, P3864, DOI 10.1021/bi00230a009; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; Triguero L, 2008, J PHYS CHEM B, V112, P7123, DOI 10.1021/jp801168v; Triguero L, 2008, J PHYS CHEM B, V112, P2159, DOI 10.1021/jp0771872; Watanabe K, 2002, BIOCHEM BIOPH RES CO, V290, P121, DOI 10.1006/bbrc.2001.6191; Watanabe K, 2001, J PEPT RES, V58, P342, DOI 10.1034/j.1399-3011.2001.00920.x; Wolf MG, 2008, J AM CHEM SOC, V130, P15772, DOI 10.1021/ja806606y; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288	58	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17587	10.1371/journal.pone.0017587	http://dx.doi.org/10.1371/journal.pone.0017587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408230	Green Submitted, Green Published, gold			2022-12-27	WOS:000288099800026
J	Koprich, JB; Johnston, TH; Huot, P; Reyes, MG; Espinosa, M; Brotchie, JM				Koprich, James B.; Johnston, Tom H.; Huot, Philippe; Reyes, M. Gabriela; Espinosa, Maria; Brotchie, Jonathan M.			Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein	PLOS ONE			English	Article							TRANSGENIC MICE; RAT MODEL; OVEREXPRESSION; MUTATION; PHOSPHORYLATION; DUPLICATION; EXPRESSION; RESISTANT; NEURONS	The pathological hallmarks of Parkinson's disease (PD) are degeneration of dopamine (DA) neurons of the substantia nigra (SN) and the presence of alpha-synuclein (alpha-syn)-rich Lewy bodies in DA cells that remain. To model these aspects of the disease, we previously showed that high titer (5.1610exp12 gp/ml) AAV1/2 driven expression of A53T alpha-syn in the SN of rats caused nigrostriatal pathology including a loss of DA neurons, but also with toxicity in the GFP control group. In the current study, we evaluate the effects of two lower titers by dilution of the vector (1: 3 [1.7x10exp12] and 1: 10 [5.1x10exp11]) to define a concentration that produced pathology specific for alpha-syn. In GFP and empty vector groups there were no behavioural or post-mortem changes at 3 or 6 weeks post-administration at either vector dose. Dilution of the AAV1/2 A53T alpha-syn (1: 3) produced significant paw use asymmetry, reductions in striatal tyrosine hydroxylase (TH), and increases in DA turnover at 3 weeks in the absence of overt pathology. By 6 weeks greater evidence of pathology was observed and included, reductions in SN DA neurons, striatal DA, TH and DA-transporter, along with a sustained behavioural deficit. In contrast, the 1: 10 AAV1/2 A53T alpha-syn treated animals showed normalization between 3 and 6 weeks in paw use asymmetry, reductions in striatal TH, and increased DA turnover. Progression of dopaminergic deficits using the 1: 3 titer of AAV1/2 A53T alpha-syn provides a platform for evaluating treatments directed at preventing and/or reversing synucleinopathy. Use of the 1: 10 titer of AAV1/2 A53T alpha-syn provides an opportunity to study mechanisms of endogenous compensation. Furthermore, these data highlight the need to characterize the titer of vector being utilized, when using AAV to express pathogenic proteins and model disease process, to avoid producing non-specific effects.	[Koprich, James B.; Johnston, Tom H.; Huot, Philippe; Reyes, M. Gabriela; Espinosa, Maria; Brotchie, Jonathan M.] Toronto Western Hosp, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Koprich, JB (corresponding author), Toronto Western Hosp, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON M5T 2S8, Canada.	jkoprich@uhnres.utoronto.ca	Johnston, Tom H/D-2531-2018	Johnston, Tom H/0000-0002-1537-8175; Brotchie, Jonathan/0000-0003-2337-0816	Cure Parkinson's Trust; Krembil Foundation	Cure Parkinson's Trust; Krembil Foundation	This study was supported by The Cure Parkinson's Trust and the Krembil Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2010, MOVEMENT DISORD, V25, pS21, DOI 10.1002/mds.22722; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hauck B, 2003, MOL THER, V7, P419, DOI 10.1016/S1525-0016(03)00012-1; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Koprich JB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-43; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Madine J, 2008, MOL MEMBR BIOL, V25, P518, DOI 10.1080/09687680802467977; Maingay M, 2006, NEUROBIOL DIS, V23, P522, DOI 10.1016/j.nbd.2006.04.007; MARIEFRANCOISE C, 2008, PARKINSONISM RELAT D, V14, pS84; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Mendritzki S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/375462; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; PAXINOS CWG, 1998, RAT BRAIN STEROTAXIC; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P742, DOI 10.1093/jnen/63.7.742; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TANJI K, 2010, ACTA NEUROPATHOL; Whishaw Ian Q., 2005, BEHAV LAB RAT HDB TE; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	41	68	68	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17698	10.1371/journal.pone.0017698	http://dx.doi.org/10.1371/journal.pone.0017698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408191	Green Submitted, gold, Green Published			2022-12-27	WOS:000288099800034
J	Rozovics, JM; Virgen-Slane, R; Semler, BL				Rozovics, Janet M.; Virgen-Slane, Richard; Semler, Bert L.			Engineered Picornavirus VPg-RNA Substrates: Analysis of a Tyrosyl-RNA Phosphodiesterase Activity	PLOS ONE			English	Article							GENOME-LINKED PROTEIN; POLIOVIRUS-INFECTED CELLS; DNA PHOSPHODIESTERASE; MESSENGER-RNA; VIRION RNA; INVITRO TRANSLATION; RETICULOCYTE LYSATE; COVALENT COMPLEXES; POLYRIBOSOMAL RNA; 5 END	Using poliovirus, the prototypic member of Picornaviridae, we have further characterized a host cell enzymatic activity found in uninfected cells, termed "unlinkase,'' that recognizes and cleaves the unique 5' tyrosyl-RNA phosphodiester bond found at the 5' end of picornavirus virion RNAs. This bond connects VPg, a viral-encoded protein primer essential for RNA replication, to the viral RNA; it is cleaved from virion RNA prior to its engaging in protein synthesis as mRNA. Due to VPg retention on nascent RNA strands and replication templates, but not on viral mRNA, we hypothesize that picornaviruses utilize unlinkase activity as a means of controlling the ratio of viral RNAs that are translated versus those that either serve as RNA replication templates or are encapsidated. To test our hypothesis and further characterize this enzyme, we have developed a novel assay to detect unlinkase activity. We demonstrate that unlinkase activity can be detected using this assay, that this unique activity remains unchanged over the course of a poliovirus infection in HeLa cells, and that unlinkase activity is unaffected by the presence of exogenous VPg or anti-VPg antibodies. Furthermore, we have determined that unlinkase recognizes and cleaves a human rhinovirus-poliovirus chimeric substrate with the same efficiency as the poliovirus substrate.	[Rozovics, Janet M.; Virgen-Slane, Richard; Semler, Bert L.] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine	Rozovics, JM (corresponding author), Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	blsemler@uci.edu	Semler, Bert/AAV-8795-2020	Semler, Bert/0000-0002-2424-5155; Virgen-Slane, Richard/0000-0002-0011-3844	American Asthma Foundation	American Asthma Foundation	This work was supported, in part, by research funds provided by the American Asthma Foundation, http://www.americanasthmafoundation.org/. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER SP, 1975, J BIOL CHEM, V250, P6264; AMBROS V, 1980, J BIOL CHEM, V255, P6739; AMBROS V, 1978, CELL, V15, P1439, DOI 10.1016/0092-8674(78)90067-3; AMBROS V, 1978, J BIOL CHEM, V253, P5263; ARABSHAHI A, 1986, BIOCHEMISTRY-US, V25, P5583, DOI 10.1021/bi00367a036; BALTIMOR.D, 1966, VIROLOGY, V29, P179, DOI 10.1016/0042-6822(66)90024-9; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Brunner JE, 2010, VIROLOGY, V400, P240, DOI 10.1016/j.virol.2010.01.031; CALIGUIRI LA, 1973, J GEN VIROL, V21, P99, DOI 10.1099/0022-1317-21-1-99; Cheney IW, 2003, J VIROL, V77, P7434, DOI 10.1128/JVI.77.13.7434-7443.2003; DEVARENNES A, 1986, J GEN VIROL, V67, P2347, DOI 10.1099/0022-1317-67-11-2347; DILDINE SL, 1992, J VIROL, V66, P4364, DOI 10.1128/JVI.66.7.4364-4376.1992; DOERSEN CJ, 1979, P NATL ACAD SCI USA, V76, P4549, DOI 10.1073/pnas.76.9.4549; DORNER AJ, 1981, FEBS LETT, V132, P219, DOI 10.1016/0014-5793(81)81164-7; DORNER AJ, 1984, J VIROL, V50, P507, DOI 10.1128/JVI.50.2.507-514.1984; Drygin Iu F, 1986, Biokhimiia, V51, P249; DRYGIN Y, 1988, FEBS LETT, V239, P343, DOI 10.1016/0014-5793(88)80948-7; Drygin YF, 1998, NUCLEIC ACIDS RES, V26, P4791, DOI 10.1093/nar/26.21.4791; FERNANDEZMUNOZ R, 1976, J VIROL, V18, P719, DOI 10.1128/JVI.18.2.719-726.1976; FERNANDEZMUNOZ R, 1977, J VIROL, V21, P820; FLANEGAN JB, 1977, P NATL ACAD SCI USA, V74, P961, DOI 10.1073/pnas.74.3.961; Geeganage S, 1998, BIOCHEMISTRY-US, V37, P14500, DOI 10.1021/bi9815546; GOLINI F, 1980, NATURE, V287, P600, DOI 10.1038/287600a0; Gulevich AY, 2002, BIOCHEMISTRY-MOSCOW+, V67, P615, DOI 10.1023/A:1016124202274; Haller AA, 1996, J VIROL, V70, P1467, DOI 10.1128/JVI.70.3.1467-1474.1996; HEWLETT MJ, 1976, P NATL ACAD SCI USA, V73, P327, DOI 10.1073/pnas.73.2.327; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; KITAMURA N, 1981, NATURE, V291, P547, DOI 10.1038/291547a0; KUHN RJ, 1988, J VIROL, V62, P4207, DOI 10.1128/JVI.62.11.4207-4215.1988; KUHN RJ, 1988, P NATL ACAD SCI USA, V85, P519, DOI 10.1073/pnas.85.2.519; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; LEE YF, 1977, P NATL ACAD SCI USA, V74, P59, DOI 10.1073/pnas.74.1.59; Liu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001066; LLOYD RE, 1993, VIROLOGY, V194, P200, DOI 10.1006/viro.1993.1250; LOZZIO CB, 1973, J NATL CANCER I, V50, P535, DOI 10.1093/jnci/50.2.535; NOMOTO A, 1977, NATURE, V268, P208, DOI 10.1038/268208a0; NOMOTO A, 1977, P NATL ACAD SCI USA, V74, P5345, DOI 10.1073/pnas.74.12.5345; NOMOTO A, 1976, P NATL ACAD SCI USA, V73, P375, DOI 10.1073/pnas.73.2.375; NOVAK JE, 1994, GENE DEV, V8, P1726, DOI 10.1101/gad.8.14.1726; Nugent CI, 1999, J VIROL, V73, P427, DOI 10.1128/JVI.73.1.427-435.1999; OSHEROFF N, 1989, PHARMACOL THERAPEUT, V41, P223, DOI 10.1016/0163-7258(89)90108-3; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; PETTERSSON RF, 1977, NATURE, V268, P270, DOI 10.1038/268270a0; PETTERSSON RF, 1978, J VIROL, V27, P357, DOI 10.1128/JVI.27.2.357-365.1978; PFISTER T, 1992, VIROLOGY, V188, P676, DOI 10.1016/0042-6822(92)90522-Q; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; PUCK TT, 1956, J EXP MED, V103, P273, DOI 10.1084/jem.103.2.273; ROTHBERG PG, 1978, P NATL ACAD SCI USA, V75, P4868, DOI 10.1073/pnas.75.10.4868; SANGAR DV, 1981, J VIROL, V39, P67, DOI 10.1128/JVI.39.1.67-74.1981; Shabanov AA, 1996, BIOCHEMISTRY-MOSCOW+, V61, P794; TOYODA H, 1987, J VIROL, V61, P2816, DOI 10.1128/JVI.61.9.2816-2822.1987; Walter BL, 2002, J VIROL, V76, P12008, DOI 10.1128/JVI.76.23.12008-12022.2002; WIMMER E, 1982, CELL, V28, P199, DOI 10.1016/0092-8674(82)90335-X; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	54	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16559	10.1371/journal.pone.0016559	http://dx.doi.org/10.1371/journal.pone.0016559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408223	Green Published, gold			2022-12-27	WOS:000288099800004
J	Fiorenza, L; Benazzi, S; Tausch, J; Kullmer, O; Bromage, TG; Schrenk, F				Fiorenza, Luca; Benazzi, Stefano; Tausch, Jeremy; Kullmer, Ottmar; Bromage, Timothy G.; Schrenk, Friedemann			Molar Macrowear Reveals Neanderthal Eco-Geographic Dietary Variation	PLOS ONE			English	Article							NITROGEN STABLE-ISOTOPES; TOOTH WEAR; JAW MOVEMENTS; KEBARA CAVE; MIDDLE; MORPHOLOGY; MAMMALS; ISRAEL; SITE; EXPLOITATION	Neanderthal diets are reported to be based mainly on the consumption of large and medium sized herbivores, while the exploitation of other food types including plants has also been demonstrated. Though some studies conclude that early Homo sapiens were active hunters, the analyses of faunal assemblages, stone tool technologies and stable isotopic studies indicate that they exploited broader dietary resources than Neanderthals. Whereas previous studies assume taxon-specific dietary specializations, we suggest here that the diet of both Neanderthals and early Homo sapiens is determined by ecological conditions. We analyzed molar wear patterns using occlusal fingerprint analysis derived from optical 3D topometry. Molar macrowear accumulates during the lifespan of an individual and thus reflects diet over long periods. Neanderthal and early Homo sapiens maxillary molar macrowear indicates strong eco-geographic dietary variation independent of taxonomic affinities. Based on comparisons with modern hunter-gatherer populations with known diets, Neanderthals as well as early Homo sapiens show high dietary variability in Mediterranean evergreen habitats but a more restricted diet in upper latitude steppe/coniferous forest environments, suggesting a significant consumption of high protein meat resources.	[Fiorenza, Luca; Kullmer, Ottmar; Schrenk, Friedemann] Senckenberg Res Inst, Dept Palaeoanthropol & Messel Res, Frankfurt, Germany; [Fiorenza, Luca] Univ New England, Palaeoanthropol Dept, Fac Arts & Sci, Armidale, NSW, Australia; [Benazzi, Stefano] Univ Vienna, Dept Anthropol, Vienna, Austria; [Tausch, Jeremy] Borough Manhattan Community Coll, Dept Sci, New York, NY USA; [Tausch, Jeremy; Schrenk, Friedemann] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Bromage, Timothy G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA	Senckenberg Gesellschaft fur Naturforschung (SGN); University of New England; University of Vienna; Goethe University Frankfurt; New York University; New York University	Fiorenza, L (corresponding author), Senckenberg Res Inst, Dept Palaeoanthropol & Messel Res, Frankfurt, Germany.	lfiorenza@senckenberg.de	Benazzi, Stefano/AAH-3923-2020; bromage, timothy/H-8621-2015	Kullmer, Ottmar/0000-0002-5929-8070; Benazzi, Stefano/0000-0003-4305-6920; bromage, timothy/0000-0002-9843-7993; Fiorenza, Luca/0000-0001-7110-3398	EU Marie Curie Training Network [MRTN-CT-2005-019564 EVAN]; Max Planck Society; Alexander von Humboldt Foundation; German Research Foundation (DFG); Research Unit 771	EU Marie Curie Training Network(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); Research Unit 771	Funding was obtained from EU Marie Curie Training Network MRTN-CT-2005-019564 EVAN. Research support from the 2010 Max Planck Research Award to TGB was provided by the Max Planck Society and the Alexander von Humboldt Foundation in respect to the Hard Tissue Research Program in Human Paleobiomics, and from the German Research Foundation (DFG) and the Research Unit 771. Function and performance enhancement in the mammalian dentition - phylogenetic and ontogenetic impact on the masticatory apparatus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy M, 2006, MG ORAL SCI, V20, P17, DOI 10.1159/000093348; Albert RM, 2000, J ARCHAEOL SCI, V27, P931, DOI 10.1006/jasc.2000.0507; Ames K. M., 1999, PEOPLES NW COAST THE; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bailey S, 2002, THESIS ARIZONA STATE; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bailey S, 2006, PERIOD BIOL, V108, P253; Barton Nick, 2000, P211; Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; Benazzi S, 2011, AM J PHYS ANTHROPOL, V144, P309, DOI 10.1002/ajpa.21413; Bocherens H, 1999, J ARCHAEOL SCI, V26, P599, DOI 10.1006/jasc.1998.0377; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Bocherens H, 2001, J HUM EVOL, V40, P497, DOI 10.1006/jhev.2000.0452; BOSINSKI G, 2000, HUNTERS GOLDEN AGE M, V30, P271; Brand-Miller JC, 1998, NUTR RES REV, V11, P5, DOI 10.1079/NRR19980003; Bridges E. Lucas, 1948, UTTERMOST PART EARTH; Burke A, 2004, INT J OSTEOARCHAEOL, V14, P155, DOI 10.1002/oa.752; Butler PM., 1981, DENT ANATOMY EMBRYOL; Caspari R, 2004, P NATL ACAD SCI USA, V101, P10895, DOI 10.1073/pnas.0402857101; CROMPTON AW, 1970, L ZOOL J LINN SOC, V49, P21; Douglas G. D., 1997, SCI PRACTICE OCCLUSI, P69; Drucker D, 2004, INT J OSTEOARCHAEOL, V14, P162, DOI 10.1002/oa.753; ELZAATARI S, 2007, THESIS BROOK U; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Fiorenza L, 2011, ANAT REC, V294, P453, DOI 10.1002/ar.21325; Fiorenza L, 2010, AM J PHYS ANTHROPOL, V143, P306, DOI 10.1002/ajpa.21311; Fiorenza L, 2009, J ANTHROPOL SCI, V87, P211; FIZET M, 1995, J ARCHAEOL SCI, V22, P67, DOI 10.1016/S0305-4403(95)80163-4; FRAYER DW, 1987, AM J PHYS ANTHROPOL, V74, P393, DOI 10.1002/ajpa.1330740311; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; GORDON KD, 1984, ARCH ORAL BIOL, V29, P783, DOI 10.1016/0003-9969(84)90007-4; Grippo JO, 2004, J AM DENT ASSOC, V135, P1109, DOI 10.14219/jada.archive.2004.0369; HAHN J, 2000, HUNTERS GOLDEN AGE M; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hardy BL, 2004, ANTIQUITY, V78, P547, DOI 10.1017/S0003598X00113213; Hastorf Christine A., 1988, CURRENT PALEOETHNOBO, P119; Heinbecker P, 1928, J BIOL CHEM, V80, P461; HENRY GA, 2008, PALEOANTRHOPOLOGY 20, pA11; Hiiemae K.M., 1978, P359; Hillson S, 2003, DENT ANTHR; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; HYLANDER WL, 1980, AM J PHYS ANTHROPOL, V52, P239; Janis C.M., 1990, P241; JANIS CM, 1979, PALEOBIOLOGY, V5, P50, DOI 10.1017/S0094837300006291; Kaidonis JA, 2008, CLIN ORAL INVEST, V12, pS21, DOI 10.1007/s00784-007-0154-8; Kaifu Y, 2003, YEARB PHYS ANTHROPOL, V46, P47, DOI 10.1002/ajpa.10329; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; KAY RF, 1977, AM J PHYS ANTHROPOL, V46, P327, DOI 10.1002/ajpa.1330460213; KAY RF, 1978, BIOL ARBOREAL FOLIVO, P173; Kraus B. S., 1969, DENT ANATOMY OCCLUSI; Krueger KL, 2008, AM J PHYS ANTHROPOL, V137, P485, DOI 10.1002/ajpa.20928; Kullmer Ottmar, 2002, BAR International Series, V1049, P71; Kullmer O, 2009, AM J PHYS ANTHROPOL, V139, P600, DOI 10.1002/ajpa.21086; Lalueza C, 1996, AM J PHYS ANTHROPOL, V100, P367, DOI 10.1002/(SICI)1096-8644(199607)100:3<367::AID-AJPA5>3.0.CO;2-R; LEE R B, 1973, Ecology of Food and Nutrition, V2, P307; LEE RB, 1978, BUSHMEN SAN HUNTERS, P98; Lee RB., 1976, KALAHARI HUNTER GATH; Lev E, 2005, J ARCHAEOL SCI, V32, P475, DOI 10.1016/j.jas.2004.11.006; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lucas P., 2004, DENT FUNCTIONAL MORP; Madella M, 2002, J ARCHAEOL SCI, V29, P703, DOI 10.1006/jasc.2001.0743; MAIER W, 1981, Zeitschrift fuer Morphologie und Anthropologie, V72, P127; Maier W., 1980, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, P1; Mann A.E., 1981, P10; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; MILLS JRE, 1967, ARCH ORAL BIOL, V12, P645, DOI 10.1016/0003-9969(67)90083-0; MOLNAR S, 1972, CURR ANTHROPOL, V13, P511, DOI 10.1086/201284; ODEA K, 1991, PHILOS T ROY SOC B, V334, P233, DOI 10.1098/rstb.1991.0112; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Patou-Mathis M, 2000, INT J OSTEOARCHAEOL, V10, P379, DOI 10.1002/1099-1212(200009/10)10:5<379::AID-OA558>3.0.CO;2-4; Perez-Perez A, 2003, J HUM EVOL, V44, P497, DOI 10.1016/S0047-2484(03)00030-7; PERLES C, 2000, HUNTERS GOLDEN AGE M, P375; Popowics TE, 1997, ANN ZOOL FENN, V34, P73; Richards MP, 2008, J HUM EVOL, V55, P179, DOI 10.1016/j.jhevol.2008.02.007; Richards M, 2008, J ARCHAEOL SCI, V35, P1251, DOI 10.1016/j.jas.2007.08.018; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; SAHLINS M, 1968, MAN HUNTER, P85; Schulz D., 2003, NAT NATURGEMASSE A 1; SCHULZ D, 2004, BASISWISSEN DATENUBE; Silberbauer GeorgeB., 1981, HUNTER HABITAT CENTR; SINCLAIR HM, 1953, P NUTR SOC, V12, P69, DOI 10.1079/PNS19530016; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Stewart JR, 2004, INT J OSTEOARCHAEOL, V14, P178, DOI 10.1002/oa.754; Stiner MC, 1994, HONOR THIEVES; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; SVOBODA J, 2000, HUNTERS GOLDEN AGE M; Teaford M. F., 2007, EVOLUTION HOMININ DI, P106; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Ulhaas L, 2004, ANN ANAT, V186, P487, DOI 10.1016/S0940-9602(04)80090-6; Ulhaas L, 2007, VERTEBR PALEOBIOL PA, P369, DOI 10.1007/978-1-4020-5845-5_24; UNGAR PS, 2000, PALAEONTOLOGIA ELECT, V3; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; Wall CE, 2006, AM J PHYS ANTHROPOL, V129, P215, DOI 10.1002/ajpa.20290; White T.D., 2005, HUMAN BONE MANUAL, DOI [DOI 10.1016/B978-0-12-088467-4.50018-1, 10.1016/B978-0-12-088467-4.50018-1]; [No title captured]	98	84	85	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14769	10.1371/journal.pone.0014769	http://dx.doi.org/10.1371/journal.pone.0014769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	737CD	21445243	gold, Green Published			2022-12-27	WOS:000288545100005
J	Miyazawa, S				Miyazawa, Sanzo			Selective Constraints on Amino Acids Estimated by a Mechanistic Codon Substitution Model with Multiple Nucleotide Changes	PLOS ONE			English	Article							ESTIMATING EVOLUTIONARY RATES; DNA-SEQUENCES; PROTEIN; TRANSITION; PHYLOGENY; FREQUENCY; MATRICES; SITES	Background: Empirical substitution matrices represent the average tendencies of substitutions over various protein families by sacrificing gene-level resolution. We develop a codon-based model, in which mutational tendencies of codon, a genetic code, and the strength of selective constraints against amino acid replacements can be tailored to a given gene. First, selective constraints averaged over proteins are estimated by maximizing the likelihood of each 1-PAM matrix of empirical amino acid (JTT, WAG, and LG) and codon (KHG) substitution matrices. Then, selective constraints specific to given proteins are approximated as a linear function of those estimated from the empirical substitution matrices. Results: Akaike information criterion (AIC) values indicate that a model allowing multiple nucleotide changes fits the empirical substitution matrices significantly better. Also, the ML estimates of transition-transversion bias obtained from these empirical matrices are not so large as previously estimated. The selective constraints are characteristic of proteins rather than species. However, their relative strengths among amino acid pairs can be approximated not to depend very much on protein families but amino acid pairs, because the present model, in which selective constraints are approximated to be a linear function of those estimated from the JTT/WAG/LG/KHG matrices, can provide a good fit to other empirical substitution matrices including cpREV for chloroplast proteins and mtREV for vertebrate mitochondrial proteins. Conclusions/Significance: The present codon-based model with the ML estimates of selective constraints and with adjustable mutation rates of nucleotide would be useful as a simple substitution model in ML and Bayesian inferences of molecular phylogenetic trees, and enables us to obtain biologically meaningful information at both nucleotide and amino acid levels from codon and protein sequences.	Gunma Univ, Grad Sch Engn, Gunma, Japan	Gunma University	Miyazawa, S (corresponding author), Gunma Univ, Grad Sch Engn, Gunma, Japan.	miyazawa@smlab.sci.gunma-u.ac.jp	Miyazawa, Sanzo/V-5550-2017	Miyazawa, Sanzo/0000-0002-5063-3661	Gunma University	Gunma University	This work was supported by Gunma University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Adachi J, 1996, J MOL EVOL, V42, P459; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; Choi SC, 2007, MOL BIOL EVOL, V24, P1769, DOI 10.1093/molbev/msm097; Conant GC, 2007, MOL PHYLOGENET EVOL, V42, P298, DOI 10.1016/j.ympev.2006.07.006; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Delport W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011587; Dimmic M W, 2000, Pac Symp Biocomput, P18; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huelsenbeck JP, 2008, PHILOS T R SOC B, V363, P3941, DOI 10.1098/rstb.2008.0175; JIN L, 1990, MOL BIOL EVOL, V7, P82; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kinjo AR, 2004, BIOINFORMATICS, V20, P2504, DOI 10.1093/bioinformatics/bth297; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; MIYAZAWA S, 1993, PROTEIN ENG, V6, P267, DOI 10.1093/protein/6.3.267; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Rodrigue N, 2008, GENETICS, V180, P1579, DOI 10.1534/genetics.108.092254; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; Seo TK, 2008, SYST BIOL, V57, P367, DOI 10.1080/10635150802158670; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Smith NGC, 2003, MOL BIOL EVOL, V20, P47, DOI 10.1093/molbev/msg003; TAKAHATA N, 1987, GENETICS, V116, P169; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2004, GENETICS, V167, P2027, DOI 10.1534/genetics.103.023226; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284	45	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17244	10.1371/journal.pone.0017244	http://dx.doi.org/10.1371/journal.pone.0017244			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445250	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100012
J	Tan, CYQ; Ninove, L; Gaudart, J; Nougairede, A; Zandotti, C; Thirion-Perrier, L; Charrel, RN; de Lamballerie, X				Tan, Charlene Y. Q.; Ninove, Laetitia; Gaudart, Jean; Nougairede, Antoine; Zandotti, Christine; Thirion-Perrier, Laurence; Charrel, Remi N.; de Lamballerie, Xavier			A Retrospective Overview of Enterovirus Infection Diagnosis and Molecular Epidemiology in the Public Hospitals of Marseille, France (1985-2005)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ASEPTIC-MENINGITIS; FREQUENT RECOMBINATION; DIRECT IDENTIFICATION; ECHOVIRUS TYPE-30; EVOLUTION; VP1; OUTBREAK; SEQUENCE; GENOME	Human enteroviruses (HEV) are frequent human pathogens and, associated in particular with large outbreaks of aseptic meningitis. Here, we have compiled a database of clinical HEV isolates from the Public Hospitals of Marseille, from 1985 to 2005. Amongst 654 isolates that could be characterized by complete sequencing of the VP1 gene, 98% belonged to species HEV-B; the most frequently isolated serotypes were Echovirus E30, E11, E7, E6 and E4. The high incidence of E30 and the recent emergence of E13 are consistent with reports worldwide and peak HEV isolation occurred mostly in the late spring and summer months. The proportion of echoviruses has decreased across the years, while that of coxsackieviruses has increased. Stool (the most frequent sample type) allowed detection of all identified serotypes. MRC5 (Human lung fibroblasts) cell line was the most conducive cell line for HEV isolation (84.9% of 10 most common serotype isolates, 96.3% in association with BGM (Buffalo green monkey kidney cells)). Previous seroneutralization-based serotype identification demonstrated 55.4% accuracy when compared with molecular VP1 analysis. Our analysis of a large number of clinical strains over 20 years reinforced the validity of VP1 serotyping and showed that comparative p-distance scores can be coupled with phylogenetic analysis to provide non-ambiguous serotype identification. Phylogenetic analysis in the VP1, 2C and 3D regions also provided evidence for recombination events amongst clinical isolates. In particular, it identified isolates with dissimilar VP1 but almost identical nonstructural regions.	[Tan, Charlene Y. Q.; Ninove, Laetitia; Nougairede, Antoine; Thirion-Perrier, Laurence; Charrel, Remi N.; de Lamballerie, Xavier] Univ Mediterranee, Inst Rech Dev, Unite Virus Emergents UMR190, Marseille, France; [Ninove, Laetitia; Nougairede, Antoine; Zandotti, Christine; Charrel, Remi N.; de Lamballerie, Xavier] Assistance Publ Hop Marseille, Marseille, France; [Gaudart, Jean] Univ Mediterranee, Biostat Res Unit, LERTIM EA3283, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Tan, CYQ (corresponding author), Univ Mediterranee, Inst Rech Dev, Unite Virus Emergents UMR190, Marseille, France.	charlene.tanyq@gmail.com	gaudart, jean/D-9071-2013	gaudart, jean/0000-0001-9006-5729; Charrel, Remi/0000-0002-7675-8251	Universite de la Mediterranee - Institut de Recherche pour le Developpement	Universite de la Mediterranee - Institut de Recherche pour le Developpement	This study was funded by Universite de la Mediterranee - Institut de Recherche pour le Developpement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antona D, 2007, EUR J CLIN MICROBIOL, V26, P403, DOI 10.1007/s10096-007-0306-4; Avellon A, 2003, EMERG INFECT DIS, V9, P934; Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Bernit E, 2004, MEDICINE, V83, P245, DOI 10.1097/01.md.0000133623.27828.27; Breiman L., 1984, CLASSIFICATION REGRE; Cabrerizo M, 2008, J MED VIROL, V80, P1018, DOI 10.1002/jmv.21197; Chen TC, 2008, J ANTIMICROB CHEMOTH, V62, P1169, DOI 10.1093/jac/dkn424; CHERRY JD, 1992, TXB PEDIAT INFECT DI, P1705; Davies M, 2003, LANCET, V361, P1187, DOI 10.1016/S0140-6736(03)12919-4; deLamballerie X, 1997, J GEN VIROL, V78, P45, DOI 10.1099/0022-1317-78-1-45; DIEDRICH S, 1995, J MED VIROL, V46, P148, DOI 10.1002/jmv.1890460212; dos Santos GPL, 2006, J MED VIROL, V78, P98, DOI 10.1002/jmv.20509; *GLOB POL ER IN, 2009, STRAT PLAN 2009 2013; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEWLETT MJ, 1980, P NATL ACAD SCI-BIOL, V77, P303, DOI 10.1073/pnas.77.1.303; Hyypia T, 1997, J GEN VIROL, V78, P1; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitch ECM, 2009, J CLIN VIROL, V44, P119, DOI 10.1016/j.jcv.2008.11.015; LIM KA, 1960, J IMMUNOL, V84, P309; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Malvy Denis J.-M., 1993, Public Health Reviews, V21, P41; Melnick J, 1996, FIELDS VIROLOGY, P655; Mirand A, 2008, J CLIN MICROBIOL, V46, P87, DOI 10.1128/JCM.01020-07; Mizuta K, 2003, J INFECTION, V47, P243, DOI 10.1016/S0163-4453(03)00081-1; *MMWR, 2006, MMWR-MORBID MORTAL W, V55, P153; Montgomery DC., 2000, INTRO STAT QUALITY C; Mullins JA, 2004, CLIN INFECT DIS, V38, P70, DOI 10.1086/380462; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Ozkaya E, 2003, EUR J EPIDEMIOL, V18, P823, DOI 10.1023/A:1025334116364; Pallansch M., 2007, FIELDS VIROLOGY, P840; Poyry T, 1996, J GEN VIROL, V77, P1699, DOI 10.1099/0022-1317-77-8-1699; Rotbart HA, 2000, SEMIN NEUROL, V20, P277, DOI 10.1055/s-2000-9427; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Scrucca L, 2004, R NEWS, V4, P22; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Tebruegge M, 2009, SEMIN FETAL NEONAT M, V14, P222, DOI 10.1016/j.siny.2009.02.002; TRABELSI A, 1995, J CLIN MICROBIOL, V33, P2454, DOI 10.1128/JCM.33.9.2454-2457.1995; Trallero G, 2010, J CLIN VIROL, V47, P170, DOI 10.1016/j.jcv.2009.11.013; Wang JR, 2002, J CLIN MICROBIOL, V40, P4439, DOI 10.1128/JCM.40.12.4439-4444.2002; Watkins-Riedel T, 2002, DIAGN MICR INFEC DIS, V42, P99, DOI 10.1016/S0732-8893(01)00330-3; WINCKEL P, 2007, STAT DEV QUALITY MED; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	53	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18022	10.1371/journal.pone.0018022	http://dx.doi.org/10.1371/journal.pone.0018022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437207	gold, Green Submitted, Green Published			2022-12-27	WOS:000288545100061
J	Ungerback, J; Elander, N; Grunberg, J; Sigvardsson, M; Soderkvist, P				Ungerback, Jonas; Elander, Nils; Grunberg, John; Sigvardsson, Mikael; Soderkvist, Peter			The Notch-2 Gene Is Regulated by Wnt Signaling in Cultured Colorectal Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR LEF-1; BETA-CATENIN; TUMOR-SUPPRESSOR; PROGENITOR CELLS; COLON-CANCER; STEM-CELLS; TUMORIGENESIS; ACTIVATION; EXPRESSION; INTESTINE	Background: Notch and Wnt pathways are key regulators of intestinal homeostasis and alterations in these pathways may lead to the development of colorectal cancer (CRC). In CRC the Apc/beta-catenin genes in the Wnt signaling pathway are frequently mutated and active Notch signaling contributes to tumorigenesis by keeping the epithelial cells in a proliferative state. These pathways are simultaneously active in proliferative adenoma cells and a crosstalk between them has previously been suggested in normal development as well as in cancer. Principal Findings: In this study, in silico analysis of putative promoters involved in transcriptional regulation of genes coding for proteins in the Notch signaling pathway revealed several putative LEF-1/TCF sites as potential targets for beta-catenin and canonical Wnt signaling. Further results from competitive electrophoretic mobility-shift assay (EMSA) studies suggest binding of several putative sites in Notch pathway gene promoters to in vitro translated beta-catenin/Lef-1. Wild type (wt)-Apc negatively regulates beta-catenin. By induction of wt-Apc or beta-catenin silencing in HT29 cells, we observed that several genes in the Notch pathway, including Notch-2, were downregulated. Finally, active Notch signaling was verified in the Apc(Min/+) mouse model where Hes-1 mRNA levels were found significantly upregulated in intestinal tumors compared to normal intestinal mucosa. Luciferase assays showed an increased activity for the core and proximal Notch-2 promoter upon co-transfection of HCT116 cells with high expression recombinant Tcf-4, Lef-1 or beta-catenin. Conclusions: In this paper, we identified Notch-2 as a novel target for beta-catenin-dependent Wnt signaling. Furthermore our data supports the notion that additional genes in the Notch pathway might be transcriptionally regulated by Wnt signaling in colorectal cancer.	[Ungerback, Jonas; Elander, Nils; Grunberg, John; Sigvardsson, Mikael; Soderkvist, Peter] Linkoping Univ, Fac Hlth Sci, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Ungerback, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden.	jonas.ungerback@liu.se		Grunberg, John/0000-0002-7839-2302; Sigvardsson, Mikael/0000-0001-8527-7276	Swedish Research Council; Ostergotland County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ostergotland County Council	This work was funded by the Swedish Research Council and Ostergotland County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ambler CA, 2007, DEV DYNAM, V236, P1595, DOI 10.1002/dvdy.21151; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; CHU D, 2009, ANN SURG ONCOL; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Elander N, 2008, BIOCHEM BIOPH RES CO, V372, P249, DOI 10.1016/j.bbrc.2008.05.026; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Grego-Bessa J, 2004, CELL CYCLE, V3, P718; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jin YH, 2009, BBA-MOL CELL RES, V1793, P290, DOI 10.1016/j.bbamcr.2008.10.002; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schilham MW, 1998, SEMIN IMMUNOL, V10, P127, DOI 10.1006/smim.1998.0114; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sikandar S.S., CANC RES, V70, P1469; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Zhang MQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S3	67	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17957	10.1371/journal.pone.0017957	http://dx.doi.org/10.1371/journal.pone.0017957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437251	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100048
J	Varanese, S; Perfetti, B; Ghilardi, MF; Di Rocco, A				Varanese, Sara; Perfetti, Bernardo; Ghilardi, Maria Felice; Di Rocco, Alessandro			Apathy, but Not Depression, Reflects Inefficient Cognitive Strategies in Parkinson's Disease	PLOS ONE			English	Article							VERBAL-LEARNING TEST; RATING-SCALES; DYSFUNCTION; DEMENTIA; CRITIQUE	Background: The relationship between apathy, depression and cognitive impairment in Parkinson's disease (PD) is still controversial. The objective of this study is to investigate whether apathy and depression are associated with inefficient cognitive strategies in PD. Methods: In this prospective clinical cohort study conducted in a university-based clinical and research movement disorders center we studied 48 PD patients. Based on clinical evaluation, they were classified in two groups: PD with apathy (PD-A group, n = 23) and PD without apathy (PD-NA group, n = 25). Patients received clinical and neuropsychological evaluations. The clinical evaluation included: Apathy Evaluation Scale-patient version, Hamilton Depression Rating Scale-17 items, the Unified Parkinson's Disease Rating Scale and the Hoehn and Yahr staging system; the neuropsychological evaluation explored speed information processing, attention, working memory, executive function, learning abilities and memory, which included several measures of recall (immediate free, short delay free, long delay free and cued, and total recall). Findings: PD-A and PD-NA groups did not differ in age, disease duration, treatment, and motor condition, but differed in recall (p < 0.001) and executive tasks (p < 0.001). Immediate free recall had the highest predictive value for apathy (F = 10.94; p = 0.002). Depression and apathy had a weak correlation (Pearson index = 0.3; p < 0.07), with three items of the depression scale correlating with apathy (Pearson index between.3 and. 4; p < 0.04). The depressed and non-depressed PD patients within the non-apathetic group did not differ. Conclusion: Apathy, but not depression, is associated with deficit in implementing efficient cognitive strategies. As the implementation of efficient strategies relies on the fronto-striatal circuit, we conclude that apathy, unlike depression, is an early expression of executive impairment in PD.	[Varanese, Sara; Di Rocco, Alessandro] NYU, Dept Neurol, Sch Med, Div Movement Disorders, New York, NY 10016 USA; [Varanese, Sara; Perfetti, Bernardo] Univ G DAnnunzio, Dept Neurosci & Imaging, ITAB Inst Adv Biomed Technol, Chieti, Italy; [Perfetti, Bernardo; Ghilardi, Maria Felice] CUNY City Coll, Dept Physiol & Pharmacol, Sophie Davis Sch Med, New York, NY 10031 USA	New York University; G d'Annunzio University of Chieti-Pescara; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education	Varanese, S (corresponding author), NYU, Dept Neurol, Sch Med, Div Movement Disorders, New York, NY 10016 USA.	sara78_96@yahoo.it		Di Rocco (also publications under DiRocco), Alessandro/0000-0002-5508-5043				Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; Butterfield LC, 2010, NEUROPSYCHOLOGY, V24, P721, DOI 10.1037/a0019650; CZERMECKI V, 2007, MOVEMENT DISORD, V22, P778; Delis C, 2001, DELISKAPLAN EXECUTIV; Delis C. E., 2002, CALIFORNIA VERBAL LE; Dujardin K, 2009, MOVEMENT DISORD, V24, P2391, DOI 10.1002/mds.22843; FANH S, 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Isella V, 2002, MOVEMENT DISORD, V17, P366, DOI 10.1002/mds.10041; Kirsch-Darrow L, 2006, NEUROLOGY, V67, P33, DOI 10.1212/01.wnl.0000230572.07791.22; Kongs SK, 2000, WISCONSIN CARD SORTI; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2004, DOI 10.1002/mds.22229; Levy G, 2000, NEUROLOGY, V55, P539, DOI 10.1212/WNL.55.4.539; Levy ML, 1998, J NEUROPSYCH CLIN N, V10, P314, DOI 10.1176/jnp.10.3.314; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Pedersen KF, 2009, J NEUROL NEUROSUR PS, V80, P1279, DOI 10.1136/jnnp.2008.170043; Pedersen KF, 2009, PARKINSONISM RELAT D, V15, P295, DOI 10.1016/j.parkreldis.2008.07.006; Perfetti B, 2009, HUM BRAIN MAPP, V30, P497, DOI 10.1002/hbm.20519; Pluck GC, 2002, J NEUROL NEUROSUR PS, V73, P636, DOI 10.1136/jnnp.73.6.636; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Shulman LM, 2000, INT REV PSYCHIATR, V12, P298, DOI 10.1080/09540260020002523; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Zgaljardic DJ, 2007, COGN BEHAV NEUROL, V20, P184, DOI 10.1097/WNN.0b013e318145a6f6	33	64	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17846	10.1371/journal.pone.0017846	http://dx.doi.org/10.1371/journal.pone.0017846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	737CD	21437255	gold, Green Published			2022-12-27	WOS:000288545100039
J	Cheng, HY; Zhang, LN; Cogdell, DE; Zheng, H; Schetter, AJ; Nykter, M; Harris, CC; Chen, KX; Hamilton, SR; Zhang, W				Cheng, Hanyin; Zhang, Lina; Cogdell, David E.; Zheng, Hong; Schetter, Aaron J.; Nykter, Matti; Harris, Curtis C.; Chen, Kexin; Hamilton, Stanley R.; Zhang, Wei			Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; COLORECTAL-CANCER; EXPRESSION; MICRORNAS; TARGETS; CELLS; ZEB1	Background: Colorectal cancer (CRC) remains one of the major cancer types and cancer related death worldwide. Sensitive, non-invasive biomarkers that can facilitate disease detection, staging and prediction of therapeutic outcome are highly desirable to improve survival rate and help to determine optimized treatment for CRC. The small non-coding RNAs, microRNAs (miRNAs), have recently been identified as critical regulators for various diseases including cancer and may represent a novel class of cancer biomarkers. The purpose of this study was to identify and validate circulating microRNAs in human plasma for use as such biomarkers in colon cancer. Methodology/Principal Findings: By using quantitative reverse transcription-polymerase chain reaction, we found that circulating miR-141 was significantly associated with stage IV colon cancer in a cohort of 102 plasma samples. Receiver operating characteristic (ROC) analysis was used to evaluate the sensitivity and specificity of candidate plasma microRNA markers. We observed that combination of miR-141 and carcinoembryonic antigen (CEA), a widely used marker for CRC, further improved the accuracy of detection. These findings were validated in an independent cohort of 156 plasma samples collected at Tianjin, China. Furthermore, our analysis showed that high levels of plasma miR-141 predicted poor survival in both cohorts and that miR-141 was an independent prognostic factor for advanced colon cancer. Conclusions/Significance: We propose that plasma miR-141 may represent a novel biomarker that complements CEA in detecting colon cancer with distant metastasis and that high levels of miR-141 in plasma were associated with poor prognosis.	[Cheng, Hanyin; Cogdell, David E.; Hamilton, Stanley R.; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zhang, Lina; Zheng, Hong; Chen, Kexin] Tianjin Med Univ Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Schetter, Aaron J.; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Nykter, Matti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland	University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tampere University	Cheng, HY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	chenkexin1963@yahoo.com; shamilto@mdanderson.org; wzhang@mdanderson.org		Chen, Kexin/0000-0003-4248-7681; Nykter, Matti/0000-0001-6956-2843	National Foundation for Cancer Research; Tianjin Cancer Institute and Hospital; NIH [R90 DK071505-05]; M. D. Anderson University; Center for Clinical and Translational Sciences of the University of Texas Health Science Center at Houston; NIH Cancer Center [CA16672]; TexGen Research; NATIONAL CANCER INSTITUTE [ZIABC010878, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071505] Funding Source: NIH RePORTER	National Foundation for Cancer Research; Tianjin Cancer Institute and Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson University; Center for Clinical and Translational Sciences of the University of Texas Health Science Center at Houston; NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TexGen Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by a grant from the National Foundation for Cancer Research (WZ and SRH) and Tianjin Cancer Institute and Hospital (KC). Hanyin Cheng was supported by a Pharmacoinformatic Training Grant fellowship from NIH (NIH Grant No. R90 DK071505-05). Data and sample collection were supported by the M. D. Anderson University Cancer Fund, the Center for Clinical and Translational Sciences of the University of Texas Health Science Center at Houston, and NIH Cancer Center Support Grant CA16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ms. Elizabeth G. Thompson for her help with the handling of the samples and TexGen Research for its support and permission to use its data and samples. The authors would also like to thank Ms. Kate Newberry from the Department of Scientific Publications for editing this manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Alwan A, 2007, DISASTER MED PUBLIC, V1, P7, DOI 10.1097/DMP.0b013e3180676d32; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Fakih MG, 2006, ONCOLOGY-NY, V20, P579; Hegde Sanjay R, 2008, Expert Rev Gastroenterol Hepatol, V2, P135, DOI 10.1586/17474124.2.1.135; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; LIU CJ, ORAL DIS; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Price ND, 2007, P NATL ACAD SCI USA, V104, P3414, DOI 10.1073/pnas.0611373104; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tan E, 2009, SURG ONCOL, V18, P15, DOI 10.1016/j.suronc.2008.05.008; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Zhang Y, MOL CELL, V39, P133; Zhang YL, 2002, WORLD J GASTROENTERO, V8, P21, DOI 10.3748/wjg.v8.i1.21; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	24	342	379	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17745	10.1371/journal.pone.0017745	http://dx.doi.org/10.1371/journal.pone.0017745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21445232	gold, Green Published, Green Submitted			2022-12-27	WOS:000288514600012
J	Everett, DB; Mukaka, M; Denis, B; Gordon, SB; Carrol, ED; van Oosterhout, JJ; Molyneux, EM; Molyneux, M; French, N; Heyderman, RS				Everett, Dean B.; Mukaka, Mavuto; Denis, Brigitte; Gordon, Stephen B.; Carrol, Enitan D.; van Oosterhout, Joep J.; Molyneux, Elizabeth M.; Molyneux, Malcolm; French, Neil; Heyderman, Robert S.			Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; PNEUMOCOCCAL CONJUGATE VACCINE; BACTERIAL-MENINGITIS; ANTIMICROBIAL RESISTANCE; TRIMETHOPRIM-SULFAMETHOXAZOLE; SUSCEPTIBILITY PATTERNS; HIV-INFECTION; SOUTH-AFRICA; ADULTS; DISEASE	Objective: To document trends in invasive pneumococcal disease (IPD) in a central hospital in Malawi during the period of national scale-up of antiretroviral therapy (ART) and cotrimoxazole prophylaxis. Methods: Between 1 January 2000 and 31 December 2009 almost 100,000 blood cultures and 40,000 cerebrospinal fluid (CSF) cultures were obtained from adults and children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi with suspected severe bacterial infection. Results: 4,445 pneumococcal isolates were obtained over the 10 year period. 1,837 were from children: 885 (19.9%) from blood and 952 (21.4%) from CSF. 2,608 were from adults: 1,813 (40.8%) from blood and 795 (17.9%) from CSF. At the start of the surveillance period cotrimoxazole resistance was 73.8% and at the end was 92.6%. Multidrug resistance (MDR) was present in almost one third of isolates and was constant over time. Free ART was introduced in Malawi in 2004. From 2005 onwards there was a decline in invasive pneumococcal infections with a negative correlation between ART scale-up and the decline in IPD (Pearson's correlation r = -0.91; p<0.001). Conclusion: During 2004-2009, national ART scale-up in Malawi was associated with a downward trend in IPD at QECH. The introduction of cotrimoxazole prophylaxis in HIV-infected groups has not coincided with a further increase in pneumococcal cotrimoxazole or multidrug resistance. These data highlight the importance of surveillance for high disease burden infections such as IPD in the region, which will be vital for monitoring pneumococcal conjugate vaccine introduction into national immunisation programmes.	[Everett, Dean B.; Mukaka, Mavuto; Denis, Brigitte; Gordon, Stephen B.; Carrol, Enitan D.; Molyneux, Malcolm; Heyderman, Robert S.] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Gordon, Stephen B.; Molyneux, Malcolm; Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Carrol, Enitan D.] Univ Liverpool, Inst Child Hlth, Liverpool L69 3BX, Merseyside, England; [van Oosterhout, Joep J.] Coll Med, Dept Med, Blantyre, Malawi; [Molyneux, Elizabeth M.] Coll Med, Dept Pediat, Blantyre, Malawi; [French, Neil] London Sch Hyg & Trop Med, London WC1, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; University of Malawi; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Everett, DB (corresponding author), Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	Dean.Everett@liverpool.ac.uk	French, Neil/A-2994-2012	Carrol, Enitan/0000-0001-8357-7726; Gordon, Stephen/0000-0001-6576-1116; French, Neil/0000-0003-4814-8293; Everett, Dean/0000-0002-8458-6779	Wellcome Trust [084679/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: The invasive bacterial surveillance service is supported by the Wellcome Trust Major Overseas programme award (award no: 084679/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World, 2008, BRIT PARL, P1; Anglaret X, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a304; [Anonymous], 2001, BSAC DISC DIFFUSION; [Anonymous], 2008, EP FACT SHEET HIV AI; Barrow G.I., 1993, MANUAL IDENTIFICATIO, V3rd; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; CreweBrown HH, 1997, CLIN INFECT DIS, V25, P1165, DOI 10.1086/516104; Dagan R, 2009, CLIN MICROBIOL INFEC, V15, P16, DOI 10.1111/j.1469-0691.2009.02726.x; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Dowell SF, 2000, NEW ENGL J MED, V342, P1399, DOI 10.1056/NEJM200005113421904; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; French N, 2004, 4 INT S PNEUM PNEUM; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gill CJ, 2008, J INFECT DIS, V197, P1000, DOI 10.1086/528806; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Government of Malawi, 2008, MAL MILL DEV GOAL RE; Grimwade K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003508.pub2; Grimwade K, 2001, CURR OPIN INFECT DIS, V14, P507, DOI 10.1097/00001432-200110000-00002; Gwanzura L, 2003, INT J ANTIMICROB AG, V21, P557, DOI 10.1016/S0924-8579(03)00052-9; Harries AD, 2009, JAIDS-J ACQ IMM DEF, V52, pS14, DOI 10.1097/QAI.0b013e3181bbc99e; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Jahn A, 2010, DATA ARV SCALE COTRI; Jones RN, INT J ANTIMICROB AGE; Kariuki S, 2003, East Afr Med J, V80, P213; Klein DL, 1999, MICROB DRUG RESIST, V5, P147, DOI 10.1089/mdr.1999.5.147; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Klugman KP, 2005, EMERG INFECT DIS, V11, P802, DOI 10.3201/eid1106.050147; Klugman KP, 2001, CLIN INFECT DIS, V33, P489, DOI 10.1086/322736; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Liebowitz LD, 2003, J CLIN PATHOL, V56, P344, DOI 10.1136/jcp.56.5.344; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P210, DOI 10.1055/s-0029-1202939; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; Malawi Antiretroviral Treatment Programme, 2010, Q REP RES 31 DEC 200, P1; [MalawiGo Health Mo], 2010, Q HIV PROGR REP; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Medina MJ, 2005, MICROB DRUG RESIST, V11, P9, DOI 10.1089/mdr.2005.11.9; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mtunthama N, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-137; Mudhune S, 2009, CLIN INFECT DIS, V48, pS147, DOI 10.1086/596494; Nunes MC, 2010, IMPACT ANTIRETROVIRA; Poland GA, 1999, VACCINE, V17, P1674, DOI 10.1016/S0264-410X(98)00435-6; Reinert RR, 2009, CLIN MICROBIOL INFEC, V15, P7, DOI 10.1111/j.1469-0691.2009.02724.x; Riou JY, 1996, B WORLD HEALTH ORGAN, V74, P181; Rogerson SR, 2004, T ROY SOC TROP MED H, V98, P544, DOI 10.1016/j.trstmh.2003.12.011; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Siira L, 2009, ANTIMICROB AGENTS CH, V53, P2066, DOI 10.1128/AAC.01464-08; Spratt BG, 2004, PNEUMOCCOCUS, P119; Talbot TR, 2005, AM J MED, V118, P285, DOI 10.1016/j.amjmed.2004.09.016; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Watera C, 2006, JAIDS-J ACQ IMM DEF, V42, P373, DOI 10.1097/01.qai.0000221679.14445.1b; Wolter N, 2008, INT J ANTIMICROB AG, V32, P62, DOI 10.1016/j.ijantimicag.2008.01.013	59	57	57	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17765	10.1371/journal.pone.0017765	http://dx.doi.org/10.1371/journal.pone.0017765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423577	Green Published, Green Accepted, gold			2022-12-27	WOS:000288513900026
J	Li, HH; Bradbury, P; Ersoz, E; Buckler, ES; Wang, JK				Li, Huihui; Bradbury, Peter; Ersoz, Elhan; Buckler, Edward S.; Wang, Jiankang			Joint QTL Linkage Mapping for Multiple-Cross Mating Design Sharing One Common Parent	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FLOWERING-TIME; GENETIC ARCHITECTURE; INBRED LINES; COMPLEX TRAITS; ASSOCIATION; MAIZE; POPULATIONS; GENOME; FAMILIES	Background: Nested association mapping (NAM) is a novel genetic mating design that combines the advantages of linkage analysis and association mapping. This design provides opportunities to study the inheritance of complex traits, but also requires more advanced statistical methods. In this paper, we present the detailed algorithm of a QTL linkage mapping method suitable for genetic populations derived from NAM designs. This method is called joint inclusive composite interval mapping (JICIM). Simulations were designed on the detected QTL in a maize NAM population and an Arabidopsis NAM population so as to evaluate the efficiency of the NAM design and the JICIM method. Principal Findings: Fifty-two QTL were identified in the maize population, explaining 89% of the phenotypic variance of days to silking, and nine QTL were identified in the Arabidopsis population, explaining 83% of the phenotypic variance of flowering time. Simulations indicated that the detection power of these identified QTL was consistently high, especially for large-effect QTL. For rare QTL having significant effects in only one family, the power of correct detection within the 5 cM support interval was around 80% for 1-day effect QTL in the maize population, and for 3-day effect QTL in the Arabidopsis population. For smaller-effect QTL, the power diminished, e. g., it was around 50% for maize QTL with an effect of 0.5 day. When QTL were linked at a distance of 5 cM, the likelihood of mapping them as two distinct QTL was about 70% in the maize population. When the linkage distance was 1 cM, they were more likely mapped as one single QTL at an intermediary position. Conclusions: Because it takes advantage of the large genetic variation among parental lines and the large population size, NAM is a powerful multiple-cross design for complex trait dissection. JICIM is an efficient and specialty method for the joint QTL linkage mapping of genetic populations derived from the NAM design.	[Li, Huihui; Wang, Jiankang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Li, Huihui; Wang, Jiankang] Chinese Acad Agr Sci, CIMMYT China, Beijing, Peoples R China; [Li, Huihui; Ersoz, Elhan; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Bradbury, Peter; Buckler, Edward S.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Cornell University; United States Department of Agriculture (USDA)	Li, HH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	wangjk@caas.net.cn	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; 	Natural Science Foundation of China [31000540]; United States National Science Foundation [DBI-0321467, DBI-0820619]; USDA-ARS; Consultative Group for International Agricultural Research (CGIAR)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Consultative Group for International Agricultural Research (CGIAR)(CGIAR)	This work was supported by the Natural Science Foundation of China (No. 31000540), the United States National Science Foundation (DBI-0321467 and DBI-0820619), the USDA-ARS, and the Generation Challenge Program of the Consultative Group for International Agricultural Research (CGIAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Beavis W.D., 1994, P 49 ANN CORN SORGH, P250; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Chen L, 2006, GENETICS, V173, P2371, DOI 10.1534/genetics.105.052506; CHRISTIE BR, 1992, PLANT BREED REV, V9, P9; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Crepieux S, 2004, GENETICS, V168, P1737, DOI 10.1534/genetics.104.028993; DARVASI A, 1993, GENETICS, V134, P943; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Fang M, 2008, GENETICA, V134, P367, DOI 10.1007/s10709-008-9244-z; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Guo BH, 2010, GENETICS, V186, P373, DOI 10.1534/genetics.110.115782; Hayashi T, 2009, HEREDITY, V102, P497, DOI 10.1038/hdy.2009.6; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jannink JL, 2001, GENETICS, V157, P445; Jourjon MF, 2005, BIOINFORMATICS, V21, P128, DOI 10.1093/bioinformatics/bth481; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li H, 2010, HEREDITY, V105, P257, DOI 10.1038/hdy.2010.56; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Liu YF, 2000, GENET RES, V75, P345, DOI 10.1017/S0016672300004493; Lynch M., 1998, GENETICS ANAL QUANTI; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Rebai A, 2000, GENET RES, V75, P243, DOI 10.1017/S0016672399004358; REBAI A, 1993, THEOR APPL GENET, V86, P1014, DOI 10.1007/BF00211055; Roux F, 2006, TRENDS PLANT SCI, V11, P375, DOI 10.1016/j.tplants.2006.06.006; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Wang JianKang, 2009, Acta Agronomica Sinica, V35, P239, DOI 10.3724/SP.J.1006.2009.00239; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Xu SZ, 1998, GENETICS, V148, P517; Yi NJ, 2002, GENETICA, V114, P217, DOI 10.1023/A:1016296225065; Yi NJ, 2001, GENETICS, V157, P1759; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang LY, 2008, GENETICS, V180, P1177, DOI 10.1534/genetics.108.092122; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z	43	75	79	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17573	10.1371/journal.pone.0017573	http://dx.doi.org/10.1371/journal.pone.0017573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423655	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900012
J	Ye, CT; Abraham, S; Wu, HQ; Shankar, P; Manjunath, N				Ye, Chunting; Abraham, Sojan; Wu, Haoquan; Shankar, Premlata; Manjunath, N.			Silencing Early Viral Replication in Macrophages and Dendritic Cells Effectively Suppresses Flavivirus Encephalitis	PLOS ONE			English	Article							WEST-NILE-VIRUS; RNA INTERFERENCE; DISSEMINATED INFECTION; BLOOD-TRANSFUSION; IMMUNITY; INNATE	West Nile (WN) and St. Louis encephalitis (SLE) viruses can cause fatal neurological infection and currently there is neither a specific treatment nor an approved vaccine for these infections. In our earlier studies, we have reported that siRNAs can be developed as broad-spectrum antivirals for the treatment of infection caused by related viruses and that a small peptide called RVG-9R can deliver siRNA to neuronal cells as well as macrophages. To increase the repertoire of broad-spectrum antiflaviviral siRNAs, we screened 25 siRNAs targeting conserved regions in the viral genome. Five siRNAs were found to inhibit both WNV and SLE replication in vitro reflecting broad-spectrum antiviral activity and one of these was also validated in vivo. In addition, we also show that RVG-9R delivers siRNA to macrophages and dendritic cells, resulting in effective suppression of virus replication. Mice were challenged intraperitoneally (i.p.) with West Nile virus (WNV) and treated i.v. with siRNA/peptide complex. The peritoneal macrophages isolated on day 3 post infection were isolated and transferred to new hosts. Mice receiving macrophages from the anti-viral siRNA treated mice failed to develop any disease while the control mice transferred with irrelevant siRNA treated mice all died of encephalitis. These studies suggest that early suppression of viral replication in macrophages and dendritic cells by RVG-9R-mediated siRNA delivery is key to preventing the development of a fatal neurological disease.	[Ye, Chunting; Abraham, Sojan; Wu, Haoquan; Shankar, Premlata; Manjunath, N.] Texas Tech Univ Hlth Sci Ctr, Ctr Excellence Infect Dis, Paul L Foster Sch Med, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University Health Science Center	Ye, CT (corresponding author), Texas Tech Univ Hlth Sci Ctr, Ctr Excellence Infect Dis, Paul L Foster Sch Med, El Paso, TX 79905 USA.	Manjunath.swamy@ttuhsc.edu		Wu, Haoquan/0000-0001-9386-3187	NIH [U01AI075419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075419] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by NIH grant U01AI075419 to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI F, J INFECT DIS, V202, P1804; Bai FW, 2005, J INFECT DIS, V191, P1148, DOI 10.1086/428507; Biggerstaff BJ, 2003, TRANSFUSION, V43, P1007, DOI 10.1046/j.1537-2995.2003.00480.x; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; FIELDS BN, FIELDS VIROLOGY, P931; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; KIM SS, MOL THER, V18, P993; Kirchhoff F, 2008, CELL, V134, P566, DOI 10.1016/j.cell.2008.08.004; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lares MR, TRENDS BIOTECHNOL, V28, P570; LIM PY, VIROLOGY, V400, P93; Manjunath N, 2006, TRENDS IMMUNOL, V27, P328, DOI 10.1016/j.it.2006.05.006; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; SU X, J IMMUNOL, V184, P401; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; Tyler KL, 2004, ARCH NEUROL-CHICAGO, V61, P1190, DOI 10.1001/archneur.61.8.1190; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07	23	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17889	10.1371/journal.pone.0017889	http://dx.doi.org/10.1371/journal.pone.0017889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423625	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900042
J	Tyack, PL; Zimmer, WMX; Moretti, D; Southall, BL; Claridge, DE; Durban, JW; Clark, CW; D'Amico, A; DiMarzio, N; Jarvis, S; McCarthy, E; Morrissey, R; Ward, J; Boyd, IL				Tyack, Peter L.; Zimmer, Walter M. X.; Moretti, David; Southall, Brandon L.; Claridge, Diane E.; Durban, John W.; Clark, Christopher W.; D'Amico, Angela; DiMarzio, Nancy; Jarvis, Susan; McCarthy, Elena; Morrissey, Ronald; Ward, Jessica; Boyd, Ian L.			Beaked Whales Respond to Simulated and Actual Navy Sonar	PLOS ONE			English	Article							KILLER WHALES; ORCINUS-ORCA; NOISE; BEHAVIOR	Beaked whales have mass stranded during some naval sonar exercises, but the cause is unknown. They are difficult to sight but can reliably be detected by listening for echolocation clicks produced during deep foraging dives. Listening for these clicks, we documented Blainville's beaked whales, Mesoplodon densirostris, in a naval underwater range where sonars are in regular use near Andros Island, Bahamas. An array of bottom-mounted hydrophones can detect beaked whales when they click anywhere within the range. We used two complementary methods to investigate behavioral responses of beaked whales to sonar: an opportunistic approach that monitored whale responses to multi-day naval exercises involving tactical mid-frequency sonars, and an experimental approach using playbacks of simulated sonar and control sounds to whales tagged with a device that records sound, movement, and orientation. Here we show that in both exposure conditions beaked whales stopped echolocating during deep foraging dives and moved away. During actual sonar exercises, beaked whales were primarily detected near the periphery of the range, on average 16 km away from the sonar transmissions. Once the exercise stopped, beaked whales gradually filled in the center of the range over 2-3 days. A satellite tagged whale moved outside the range during an exercise, returning over 2-3 days post-exercise. The experimental approach used tags to measure acoustic exposure and behavioral reactions of beaked whales to one controlled exposure each of simulated military sonar, killer whale calls, and band-limited noise. The beaked whales reacted to these three sound playbacks at sound pressure levels below 142 dB re 1 mu Pa by stopping echolocation followed by unusually long and slow ascents from their foraging dives. The combined results indicate similar disruption of foraging behavior and avoidance by beaked whales in the two different contexts, at exposures well below those used by regulators to define disturbance.	[Tyack, Peter L.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Zimmer, Walter M. X.] N Atlantic Treaty Org Undersea Res Ctr, La Spezia, Italy; [Moretti, David; DiMarzio, Nancy; Jarvis, Susan; McCarthy, Elena; Morrissey, Ronald; Ward, Jessica] USN, Undersea Warfare Ctr Div, Newport, RI USA; [Southall, Brandon L.] Southall Environm Associates, Aptos, CA USA; [Southall, Brandon L.] Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95064 USA; [Claridge, Diane E.] Bahamas Marine Mammal Res Org, Marsh Harbour, Abaco, Bahamas; [Durban, John W.] Natl Ocean & Atmospher Adm, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Clark, Christopher W.] Cornell Univ, Bioacoust Res Program, Cornell Lab Ornithol, Ithaca, NY USA; [D'Amico, Angela] Space & Naval Warfare Syst Ctr Pacific, San Diego, CA USA; [Boyd, Ian L.] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews KY16 9AJ, Fife, Scotland	Woods Hole Oceanographic Institution; United States Department of Defense; United States Navy; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; Cornell University; Naval Information Warfare Center Pacific; University of St Andrews	Tyack, PL (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	ptyack@whoi.edu	Tyack, Peter/AAC-4513-2019; Tyack, Peter L/D-6209-2013	Tyack, Peter/0000-0002-8409-4790; Tyack, Peter L/0000-0002-8409-4790	United States (U.S.) Office of Naval Research [N00014-07-10988, N00014-07-11023, N00014-08-10990]; U.S. Strategic Environmental Research and Development Program [SI-1539]; Environmental Readiness Division of the U.S. Navy; U.S. Naval Operations Submarine Warfare Division (Undersea Surveillance); U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology); U.S. National Oceanic and Atmospheric Administration; International Association of Oil and Gas Producers; U.S. Navy; Natural Environment Research Council [smru10001] Funding Source: researchfish	United States (U.S.) Office of Naval Research(Office of Naval Research); U.S. Strategic Environmental Research and Development Program; Environmental Readiness Division of the U.S. Navy; U.S. Naval Operations Submarine Warfare Division (Undersea Surveillance); U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology)(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); International Association of Oil and Gas Producers; U.S. Navy; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research reported here was financially supported by the United States (U.S.) Office of Naval Research (www.onr.navy.mil) Grants N00014-07-10988, N00014-07-11023, N00014-08-10990; the U.S. Strategic Environmental Research and Development Program (www.serdp.org) Grant SI-1539, the Environmental Readiness Division of the U.S. Navy (http://www.navy.mil/local/n45/), the U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance), the U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology) (http://www.st.nmfs.noaa.gov/), U.S. National Oceanic and Atmospheric Administration Ocean Acoustics Program (http://www.nmfs.noaa.gov/pr/acoustics/), and the Joint Industry Program on Sound and Marine Life of the International Association of Oil and Gas Producers (www.soundandmarinelife.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; While the sponsors of this study come from an international mix of sound producers and a United States regulatory agency, the majority of funding for the research reported here comes from different divisions of the U.S. Navy, and all of the authors have had at least some of the research reported here partially funded by different divisions of the U.S. Navy. The following authors are employed by the U.S. Navy: David Moretti, Angela D'Amico, Nancy DiMarzio, Susan Jarvis, Elena McCarthy, Ronald Morrissey, and Jessica Ward. Their primary involvement was in designing, installing, and helping to operate the passive acoustic marine mammal monitoring system at the AUTEC range; providing the sound sources used in the experiments; and with analyzing and writing up the data. During the time period covered by this research the following authors were employed by the National Marine Fisheries Service of the U.S. National Oceanic and Atmospheric Administration, which acts as the federal regulatory agency for protection of marine mammals: Brandon Southall and John Durban. The following authors have been asked by the U.S. Department of Justice to act as expert witnesses in cases involving the effects of naval sonar on marine mammals: Christopher Clark, Brandon Southall, and Peter Tyack. Peter Tyack is a member of Natural Resources Defense Council, which is an advocacy organization that has sued the Navy concerning effects of sonar on marine mammals. None of the analysis nor write up of the paper involved or was influenced by the sponsors of the research.	Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; [Anonymous], 2008, CANADIAN ACOUSTICS; BALSIGER J, 2008, FED REGISTER, V73, P60877; Boyd I. L., 2007, BEHAV RESPONSE STUDY; Claridge D. E, 2006, THESIS U ABERDEEN AB; Cook MLH, 2006, J COMP PHYSIOL A, V192, P489, DOI 10.1007/s00359-005-0086-1; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; D'Amico Angela, 2009, Aquatic Mammals, V35, P452, DOI 10.1578/AM.35.4.2009.452; D'Spain Gerald L., 2005, Journal of Cetacean Research and Management, V7, P223; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P435, DOI 10.1578/AM.35.4.2009.435; Finneran JJ, 2009, J ACOUST SOC AM, V126, P484, DOI 10.1121/1.3133241; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Gillespie D, 2009, J ACOUST SOC AM, V125, P3428, DOI 10.1121/1.3110832; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Lengagne T, 2008, BIOL CONSERV, V141, P2023, DOI 10.1016/j.biocon.2008.05.017; Madsen PT, 2006, J ACOUST SOC AM, V120, P2366, DOI 10.1121/1.2229287; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; MORETTI D, 2010, MAR MAMM SCI UNPUB; MYRBERG AA, 1990, ENVIRON INT, V16, P575, DOI 10.1016/0160-4120(90)90028-5; NOTARBARTOLODISCIARA G, 1987, MAR MAMMAL SCI, V3, P356, DOI 10.1111/j.1748-7692.1987.tb00324.x; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; ROLT KD, 1990, J ACOUST SOC AM, V87, P1340, DOI 10.1121/1.399507; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Ward J., 2008, CAN ACOUST, V36, P60; Wartzok D, 2005, MARINE MAMMAL POPULA; Weinberg H, 1996, J ACOUST SOC AM, V100, P1421, DOI 10.1121/1.415989; Zimmer WMX, 2007, MAR MAMMAL SCI, V23, P888, DOI 10.1111/j.1748-7692.2007.00152.x; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	37	233	240	7	227	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17009	10.1371/journal.pone.0017009	http://dx.doi.org/10.1371/journal.pone.0017009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423729	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400008
J	Zele, AJ; Feigl, B; Smith, SS; Markwell, EL				Zele, Andrew J.; Feigl, Beatrix; Smith, Simon S.; Markwell, Emma L.			The Circadian Response of Intrinsically Photosensitive Retinal Ganglion Cells	PLOS ONE			English	Article							PUPILLARY LIGHT REFLEX; MELANOPSIN; SLEEP; PHASE; MELATONIN; RHYTHMS; MODELS; DRIVEN; ONSET	Intrinsically photosensitive retinal ganglion cells (ipRGC) signal environmental light level to the central circadian clock and contribute to the pupil light reflex. It is unknown if ipRGC activity is subject to extrinsic (central) or intrinsic (retinal) network-mediated circadian modulation during light entrainment and phase shifting. Eleven younger persons (18-30 years) with no ophthalmological, medical or sleep disorders participated. The activity of the inner (ipRGC) and outer retina (cone photoreceptors) was assessed hourly using the pupil light reflex during a 24 h period of constant environmental illumination (10 lux). Exogenous circadian cues of activity, sleep, posture, caffeine, ambient temperature, caloric intake and ambient illumination were controlled. Dim-light melatonin onset (DLMO) was determined from salivary melatonin assay at hourly intervals, and participant melatonin onset values were set to 14 h to adjust clock time to circadian time. Here we demonstrate in humans that the ipRGC controlled post-illumination pupil response has a circadian rhythm independent of external light cues. This circadian variation precedes melatonin onset and the minimum ipRGC driven pupil response occurs post melatonin onset. Outer retinal photoreceptor contributions to the inner retinal ipRGC driven post-illumination pupil response also show circadian variation whereas direct outer retinal cone inputs to the pupil light reflex do not, indicating that intrinsically photosensitive (melanopsin) retinal ganglion cells mediate this circadian variation.	[Zele, Andrew J.; Feigl, Beatrix; Smith, Simon S.; Markwell, Emma L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Zele, Andrew J.; Feigl, Beatrix; Markwell, Emma L.] Queensland Univ Technol, Sch Optometry, Brisbane, Qld 4001, Australia; [Smith, Simon S.] Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Zele, AJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	andrew.zele@qut.edu.au; b.feigl@qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045; Feigl, Beatrix/0000-0001-7198-7373; Zele, Andrew/0000-0003-0291-9929	Australian Research Council [ARC-DP1096354]; QUT	Australian Research Council(Australian Research Council); QUT	This work was supported by Australian Research Council Discovery Projects ARC-DP1096354 (AJZ) and a QUT Vice Chancellor's Research Fellowship (BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Archer SN, 2008, SLEEP, V31, P608, DOI 10.1093/sleep/31.5.608; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Borgmann H, 1966, Ber Zusammenkunft Dtsch Ophthalmol Ges, V67, P123; Burgess HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003055; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cameron M, 2008, J GENET, V87, P459, DOI 10.1007/s12041-008-0068-5; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Figueiro Mariana G, 2005, J Circadian Rhythms, V3, P14, DOI 10.1186/1740-3391-3-14; FOSNAUGH JS, 1992, METHOD FIND EXP CLIN, V14, P545; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Kankipati L, 2010, INVEST OPHTH VIS SCI, V51, P2764, DOI 10.1167/iovs.09-4717; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kraemer S, 2000, BIOL PSYCHIAT, V48, P1069, DOI 10.1016/S0006-3223(00)00908-2; LOEWENFELD IE, 1999, PUPIL ANATOMY PHYSL, P11; Loving RT, 1996, AM J PHYSIOL-REG I, V271, pR320, DOI 10.1152/ajpregu.1996.271.2.R320; LOWENSTEIN O, 1964, ANN NY ACAD SCI, V117, P142, DOI 10.1111/j.1749-6632.1964.tb48169.x; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Markwell EL, 2010, CLIN EXP OPTOM, V93, P137, DOI 10.1111/j.1444-0938.2010.00479.x; Mathes A, 2007, J NEUROENDOCRINOL, V19, P952, DOI 10.1111/j.1365-2826.2007.01608.x; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; MONK TH, 1994, J SLEEP RES, V3, P111, DOI 10.1111/j.1365-2869.1994.tb00114.x; Pandi-Perumal SR, 2007, PROG NEURO-PSYCHOPH, V31, P1, DOI 10.1016/j.pnpbp.2006.06.020; Pigolotti S, 2007, P NATL ACAD SCI USA, V104, P6533, DOI 10.1073/pnas.0610759104; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ranzijn R, 1997, PSYCHOPHYSIOLOGY, V34, P17, DOI 10.1111/j.1469-8986.1997.tb02411.x; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; TIEDT N, 1963, PFLUGERS ARCH GESAMT, V277; Tsujimura S, 2010, P ROY SOC B-BIOL SCI, V277, P2485, DOI 10.1098/rspb.2010.0330; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; van Someren EJW, 2007, SLEEP MED, V8, P590, DOI 10.1016/j.sleep.2007.03.012; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Wilhelm B, 1998, SLEEP, V21, P258; Wilhelm B, 2001, J SLEEP RES, V10, P1, DOI 10.1046/j.1365-2869.2001.00239.x; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751	53	118	119	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17860	10.1371/journal.pone.0017860	http://dx.doi.org/10.1371/journal.pone.0017860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423755	Green Submitted, Green Published, gold			2022-12-27	WOS:000288512400035
J	Jensen, RA; Agardh, E; Lernmark, A; Gudbjornsdottir, S; Smith, NL; Siscovick, DS; Torn, C				Jensen, Richard A.; Agardh, Elisabet; Lernmark, Ake; Gudbjornsdottir, Soffia; Smith, Nicholas L.; Siscovick, David S.; Torn, Carina		DISS Grp	HLA Genes, Islet Autoantibodies and Residual C-Peptide at the Clinical Onset of Type 1 Diabetes Mellitus and the Risk of Retinopathy 15 Years Later	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; BETA-CELL FUNCTION; INSULIN-DEPENDENT DIABETICS; PROTEIN-TYROSINE-PHOSPHATASE; GAMMA-AMINOBUTYRIC ACID; PROLIFERATIVE RETINOPATHY; COMPLICATIONS TRIAL; GAD AUTOANTIBODY; MULTIPLE FACTORS; HIGH PREVALENCE	Aims/Hypothesis: HLA genes, islet autoantibodies and residual C-peptide were studied to determine the independent association of each exposure with diabetic retinopathy (DR), 15 years after the clinical onset of type 1 diabetes in 15-34 year old individuals. Methods: The cohort was identified in 1992 and 1993 by the Diabetes Incidence Study in Sweden (DISS), which investigates incident cases of diabetes for patients between 15 and 34 years of age. Blood samples at diagnosis were analyzed to determine HLA genotype, islet autoantibodies and serum C-peptide. In 2009, fundus photographs were obtained from patient records. Study measures were supplemented with data from the Swedish National Diabetes Registry. Results: The prevalence of DR was 60.2% (148/246). Autoantibodies against the 65 kD isoform of glutamate decarboxylase (GADA) at the onset of clinical diabetes increased the risk of DR 15 years later, relative risk 1.12 for each 100 WHO units/ml, [95% CI 1.02 to 1.23]. This equates to risk estimates of 1.27, [95% CI 1.04 to 1.62] and 1.43, [95% CI 1.06 to 1.94] for participants in the highest 25(th) (GADA. 233 WHO units/ml) and 5(th) percentile (GADA. 319 WHO units/ml) of GADA, respectively. These were adjusted for duration of diabetes, HbA(1c), treated hypertension, sex, age at diagnosis, HLA and C-peptide. Islet cell autoantibodies, insulinoma-antigen 2 autoantibodies, residual C-peptide and the type 1 diabetes associated haplotypes DQ2, DQ8 and DQ6 were not associated with DR. Conclusions: Increased levels of GADA at the onset of type 1 diabetes were associated with DR 15 years later. These results, if confirmed, could provide additional insights into the pathogenesis of the most common microvascular complication of diabetes and lead to better risk stratification for both patient screenings and DR treatment trials.	[Jensen, Richard A.; Smith, Nicholas L.; Siscovick, David S.] Univ Washington, Sch Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Jensen, Richard A.; Smith, Nicholas L.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Agardh, Elisabet] Univ Hosp MAS, Dept Clin Sci, Malmo, Sweden; [Lernmark, Ake; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Lernmark, Ake; Torn, Carina] Lund Univ, Clin Res Ctr, Dept Clin Sci, Malmo, Sweden; [Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden; [Smith, Nicholas L.] Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Smith, Nicholas L.] Off Res & Dev, Dept Vet Affairs, Seattle, WA USA; [Smith, Nicholas L.] Grp Hlth Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Lund University; Skane University Hospital; University of Washington; University of Washington Seattle; Lund University; Sahlgrenska University Hospital; University of Gothenburg	Jensen, RA (corresponding author), Univ Washington, Sch Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.	richaj@uw.edu	Kockum, Ingrid/O-8781-2018; Lernmark, Åke/F-8140-2015	Kockum, Ingrid/0000-0002-0867-4726; Lernmark, Åke/0000-0003-1735-0499; Landin-Olsson, Mona/0000-0003-0510-9112	Knut and Alice Wallenberg Foundation; Jarnhardt Foundation; Foundation for Visually Impaired in Former Malmohus Lan; Lund University; Skane County Council; National Heart, Lung, And Blood Institute [T32HL007902]; Magnuson Scholars Program; National Institutes of Health [DK42654]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042654] Funding Source: NIH RePORTER	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Jarnhardt Foundation; Foundation for Visually Impaired in Former Malmohus Lan; Lund University; Skane County Council; National Heart, Lung, And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Magnuson Scholars Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The Knut and Alice Wallenberg Foundation (CT, AL), The Jarnhardt Foundation (EA), The Foundation for Visually Impaired in Former Malmohus Lan (EA), Lund University and Skane County Council (EA, AL), National Heart, Lung, And Blood Institute Training Grant T32HL007902 (RAJ), The Magnuson Scholars Program (RAJ), The National Institutes of Health, DK42654 (AL). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, And Blood Institute or the National Institutes of Health.	Agardh D, 1998, DIABETES RES CLIN PR, V40, P9, DOI 10.1016/S0168-8227(98)00007-2; Agardh D, 1996, DIABETOLOGIA, V39, P1313, DOI 10.1007/s001250050575; AGARDH E, 1987, J COMP NEUROL, V258, P622, DOI 10.1002/cne.902580411; Agardh E, 2004, J DIABETES COMPLICAT, V18, P32, DOI 10.1016/S1056-8727(03)00040-0; AGARDH E, 1987, HISTOCHEMISTRY, V86, P485, DOI 10.1007/BF00500621; [Anonymous], 1993, NEW ENGL J MED, V329, P977; [Anonymous], 1998, LANCET, V352, P837; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BAKER RS, 1986, AM J OPHTHALMOL, V102, P693, DOI 10.1016/0002-9394(86)90395-8; Balme M, 2002, DIABETIC MED, V19, P602, DOI 10.1046/j.1464-5491.2002.00739.x; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; BECKER B, 1977, DIABETES, V26, P997, DOI 10.2337/diabetes.26.10.997; BINGLEY PJ, 1994, DIABETES, V43, P1304, DOI 10.2337/diabetes.43.11.1304; Birinci A, 2002, EUR J OPHTHALMOL, V12, P89, DOI 10.1177/112067210201200203; BONIFACIO E, 1990, LANCET, V335, P147, DOI 10.1016/0140-6736(90)90013-U; Borg H, 2002, DIABETES, V51, P1754, DOI 10.2337/diabetes.51.6.1754; BOTTAZZO GF, 1974, LANCET, V2, P1279, DOI 10.1016/S0140-6736(74)90140-8; DORNAN TL, 1982, DIABETES, V31, P226, DOI 10.2337/diabetes.31.3.226; ERDO SL, 1990, J NEUROCHEM, V54, P363, DOI 10.1111/j.1471-4159.1990.tb01882.x; Falck AAK, 1997, J DIABETES COMPLICAT, V11, P203, DOI 10.1016/S1056-8727(96)00051-7; FALORNI A, 1995, J IMMUNOL METHODS, V186, P89, DOI 10.1016/0022-1759(95)00139-2; Graham J, 2002, DIABETES, V51, P1346, DOI 10.2337/diabetes.51.5.1346; GRAY RS, 1982, BRIT J OPHTHALMOL, V66, P280, DOI 10.1136/bjo.66.5.280; GROOP LC, 1986, DIABETES, V35, P1397, DOI 10.2337/diabetes.35.12.1397; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; HAWRAMI K, 1991, DIABETOLOGIA, V34, P441, DOI 10.1007/BF00403184; Henricsson M, 2003, DIABETES CARE, V26, P349, DOI 10.2337/diacare.26.2.349; Hoeldtke RD, 2000, J CLIN ENDOCR METAB, V85, P3297, DOI 10.1210/jc.85.9.3297; Huber PJ, 1967, BERK S MATH STAT PRO, V1, P221; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Jensen R, 2007, DIABETIC MED, V24, P1221, DOI 10.1111/j.1464-5491.2007.02235.x; Jensen RA, 2007, J DIABETES COMPLICAT, V21, P205, DOI 10.1016/j.jdiacomp.2006.01.004; Jeppsson JO, 1996, DIABETES CARE, V19, P142, DOI 10.2337/diacare.19.2.142; KARLSEN AE, 1992, DIABETES, V41, P1355, DOI 10.2337/diabetes.41.10.1355; KARLSEN AE, 1991, P NATL ACAD SCI USA, V88, P8337, DOI 10.1073/pnas.88.19.8337; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; Kupila A, 2001, DIABETOLOGIA, V44, P290, DOI 10.1007/s001250051616; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; LANDINOLSSON M, 1987, DIABETOLOGIA, V30, P327; LARKINS RG, 1978, BRIT MED J, V1, P1111, DOI 10.1136/bmj.1.6120.1111; LERNMARK A, 1978, NEW ENGL J MED, V299, P375, DOI 10.1056/NEJM197808242990802; Littorin B, 1996, DIABETES RES CLIN PR, V33, P129, DOI 10.1016/0168-8227(96)01282-X; MACCUISH AC, 1974, LANCET, V2, P1529; MALONE JI, 1984, PEDIATRICS, V73, P756; McCulloch D, 2007, UPTODATE; MIDDLETON D, 1985, INT OPHTHALMOL, V8, P33, DOI 10.1007/BF00136459; Mimura T, 2004, DIABETIC MED, V21, P559, DOI 10.1111/j.1464-5491.2004.01204.x; Mimura T, 2004, BRIT J OPHTHALMOL, V88, P303, DOI 10.1136/bjo.2003.023945; Mimura T, 2003, AM J OPHTHALMOL, V135, P844, DOI 10.1016/S0002-9394(02)02291-2; MIMURA T, 2005, OPHTHALMOLOGY; Mueller Patricia W, 2002, Diabetes Technol Ther, V4, P397, DOI 10.1089/152091502760098537; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; OLERUP O, 1993, TISSUE ANTIGENS, V41, P55; OSTMAN J, 1986, ACTA MED SCAND, V220, P437; Padmos RC, 2004, BIOL PSYCHIAT, V56, P476, DOI 10.1016/j.biopsych.2004.07.003; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; PAYTON MA, 1995, J CLIN INVEST, V96, P1506, DOI 10.1172/JCI118188; PUGLIESE A, 1995, DIABETES, V44, P608, DOI 10.2337/diabetes.44.6.608; Quiroz-Mercado H, 2002, ARCH MED RES, V33, P123, DOI 10.1016/S0188-4409(01)00378-2; RABIN DU, 1994, J IMMUNOL, V152, P3183; Rakocevic G, 2004, ARCH NEUROL-CHICAGO, V61, P902, DOI 10.1001/archneur.61.6.902; RAND LI, 1985, NEW ENGL J MED, V313, P1433, DOI 10.1056/NEJM198512053132302; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Rolandsson O, 2003, J INTERN MED, V253, P447, DOI 10.1046/j.1365-2796.2003.01115.x; Schenker M, 1999, DIABETOLOGIA, V42, P671, DOI 10.1007/s001250051214; Schranz DB, 1998, J IMMUNOL METHODS, V213, P87, DOI 10.1016/S0022-1759(98)00025-8; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Sterky G, 1986, Acta Paediatr Scand Suppl, V327, P1; Torn C, 2000, J CLIN ENDOCR METAB, V85, P4619, DOI 10.1210/jc.85.12.4619; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; WEBER B, 1986, DIABETOLOGIA, V29, P23, DOI 10.1007/BF02427276; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2002, OPHTHALMOLOGY, V109, P275, DOI 10.1016/S0161-6420(01)00925-3; World Health Organization, 2008, DIAB FACT SHEET 312; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275; ZIEGLER AG, 1993, DIABETOLOGIA, V36, P402, DOI 10.1007/BF00402275	82	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17569	10.1371/journal.pone.0017569	http://dx.doi.org/10.1371/journal.pone.0017569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412422	gold, Green Published, Green Submitted			2022-12-27	WOS:000288247800016
J	Chen, YJ; Tsai, WH; Chen, YL; Ko, YC; Chou, SP; Chen, JY; Lin, SF				Chen, Yen-Ju; Tsai, Wan-Hua; Chen, Yu-Lian; Ko, Ying-Chieh; Chou, Sheng-Ping; Chen, Jen-Yang; Lin, Su-Fang			Epstein-Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells	PLOS ONE			English	Article							BINDING-PROTEIN-ALPHA; EPITHELIAL-CELLS; GENE-EXPRESSION; CELLULAR SENESCENCE; CYCLE ARREST; C-MYC; FATE DETERMINATION; VIRAL GENE; B-CELLS; REPLICATION	Epstein-Barr virus (EBV) Rta belongs to a lytic switch gene family that is evolutionarily conserved in all gamma-herpesviruses. Emerging evidence indicates that cell cycle arrest is a common means by which herpesviral immediate-early protein hijacks the host cell to advance the virus's lytic cycle progression. To examine the role of Rta in cell cycle regulation, we recently established a doxycycline (Dox)-inducible Rta system in 293 cells. In this cell background, inducible Rta modulated the levels of signature G1 arrest proteins, followed by induction of the cellular senescence marker, SA-beta-Gal. To delineate the relationship between Rta-induced cell growth arrest and EBV reactivation, recombinant viral genomes were transferred into Rta-inducible 293 cells. Somewhat unexpectedly, we found that Dox-inducible Rta reactivated both EBV and Kaposi's sarcoma-associated herpesvirus (KSHV), to similar efficacy. As a consequence, the Rta-mediated EBV and KSHV lytic replication systems, designated as EREV8 and ERKV, respectively, were homogenous, robust, and concurrent with cell death likely due to permissive lytic replication. In addition, the expression kinetics of EBV lytic genes in Dox-treated EREV8 cells was similar to that of their KSHV counterparts in Dox-induced ERKV cells, suggesting that a common pathway is used to disrupt viral latency in both cell systems. When the time course was compared, cell cycle arrest was achieved between 6 and 48 h, EBV or KSHV reactivation was initiated abruptly at 48 h, and the cellular senescence marker was not detected until 120 h after Dox treatment. These results lead us to hypothesize that in 293 cells, Rta-induced G1 cell cycle arrest could provide (1) an ideal environment for virus reactivation if EBV or KSHV coexists and (2) a preparatory milieu for cell senescence if no viral genome is available. The latter is hypothetical in a transient-lytic situation.	[Chen, Yen-Ju; Chen, Jen-Yang] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Chen, Yen-Ju; Tsai, Wan-Hua; Chen, Yu-Lian; Ko, Ying-Chieh; Chou, Sheng-Ping; Chen, Jen-Yang; Lin, Su-Fang] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli Cty, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan	Chen, YJ (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan.	cjy@nhri.org.tw; sflin@nhri.org.tw		Lin, Su-Fang/0000-0001-8706-2439	Taiwan NHRI [CA-099-PP-17]; Department of Health [DOH99-TD-C-111-004]; NHRI [CA-099-PP-13]; National Science Council [NSC98-3112-B-400-002, NSC99-3112-B-400-009]	Taiwan NHRI; Department of Health; NHRI(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by Taiwan NHRI CA-099-PP-17 and Department of Health DOH99-TD-C-111-004 to S.-F. Lin; NHRI CA-099-PP-13, National Science Council NSC98-3112-B-400-002, and NSC99-3112-B-400-009 to J.-Y. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cayrol C, 1996, EMBO J, V15, P2748, DOI 10.1002/j.1460-2075.1996.tb00635.x; Chen LW, 2005, J VIROL, V79, P9635, DOI 10.1128/JVI.79.15.9635-9650.2005; Chen YL, 2009, CELL CYCLE, V8, P58, DOI 10.4161/cc.8.1.7411; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Feederle R, 2007, INT J CANCER, V121, P588, DOI 10.1002/ijc.22727; Flemington EK, 2001, J VIROL, V75, P4475, DOI 10.1128/JVI.75.10.4475-4481.2001; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; GRUFFAT H, 1994, NUCLEIC ACIDS RES, V22, P1172, DOI 10.1093/nar/22.7.1172; Guo QW, 2010, MOL IMMUNOL, V47, P1783, DOI 10.1016/j.molimm.2010.02.017; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Harrington W, 1997, LANCET, V349, P774; Hobbs WE, 1999, J VIROL, V73, P8245, DOI 10.1128/JVI.73.10.8245-8255.1999; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang ES, 2002, MECH AGEING DEV, V123, P1681, DOI 10.1016/S0047-6374(02)00102-1; Inman GJ, 2001, J VIROL, V75, P2400, DOI 10.1128/JVI.75.5.2400-2410.2001; Izumiya Y, 2003, J VIROL, V77, P9652, DOI 10.1128/JVI.77.17.9652-9661.2003; Johnson AS, 2005, J VIROL, V79, P13769, DOI 10.1128/JVI.79.21.13769-13777.2005; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Kudoh A, 2003, J VIROL, V77, P851, DOI 10.1128/JVI.77.2.851-861.2003; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; LI X, 2010, J VIROL; Li YL, 2004, J VIROL, V78, P11778, DOI 10.1128/JVI.78.21.11778-11785.2004; Li YL, 2004, J VIROL, V78, P4197, DOI 10.1128/JVI.78.8.4197-4206.2004; LIN CT, 1993, LAB INVEST, V68, P716; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Noris E, 2002, J VIROL, V76, P12135, DOI 10.1128/JVI.76.23.12135-12148.2002; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; Rodriguez A, 2001, J VIROL, V75, P4482, DOI 10.1128/JVI.75.10.4482-4489.2001; Schultz J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-53; Sekeri-Pataryas KE, 2007, ANN NY ACAD SCI, V1100, P361, DOI 10.1196/annals.1395.039; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sun CC, 2007, J VIROL, V81, P13566, DOI 10.1128/JVI.01055-07; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Swenson JJ, 1999, J VIROL, V73, P6540, DOI 10.1128/JVI.73.8.6540-6550.1999; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; Turk SM, 2006, J VIROL, V80, P9628, DOI 10.1128/JVI.00622-06; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wells R, 2009, J VIROL, V83, P4695, DOI 10.1128/JVI.02241-08; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Wells SI, 2003, P NATL ACAD SCI USA, V100, P7093, DOI 10.1073/pnas.1232309100; Wilson SJ, 2007, J VIROL, V81, P13578, DOI 10.1128/JVI.01663-07; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Wu FY, 2003, J VIROL, V77, P1481, DOI 10.1128/JVI.77.2.1481-1500.2003; Wu FY, 2002, P NATL ACAD SCI USA, V99, P10683, DOI 10.1073/pnas.162352299; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991; Zacny VL, 1998, J VIROL, V72, P8043, DOI 10.1128/JVI.72.10.8043-8051.1998; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	60	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17809	10.1371/journal.pone.0017809	http://dx.doi.org/10.1371/journal.pone.0017809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423768	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100036
J	Doehring, A; Kusener, N; Fluhr, K; Neddermeyer, TJ; Schneider, G; Lotsch, J				Doehring, Alexandra; Kuesener, Nele; Fluehr, Karin; Neddermeyer, Till J.; Schneider, Gaby; Loetsch, Joern			Effect Sizes in Experimental Pain Produced by Gender, Genetic Variants and Sensitization Procedures	PLOS ONE			English	Article							SEX-DIFFERENCES; GTP CYCLOHYDROLASE; ION-CHANNEL; RECEPTOR; SENSITIVITY; COLD; STIMULI; HUMANS; MU; POLYMORPHISM	Background: Various effects on pain have been reported with respect to their statistical significance, but a standardized measure of effect size has been rarely added. Such a measure would ease comparison of the magnitude of the effects across studies, for example the effect of gender on heat pain with the effect of a genetic variant on pressure pain. Methodology/Principal Findings: Effect sizes on pain thresholds to stimuli consisting of heat, cold, blunt pressure, punctuate pressure and electrical current, administered to 125 subjects, were analyzed for 29 common variants in eight human genes reportedly modulating pain, gender and sensitization procedures using capsaicin or menthol. The genotype explained 0-5.9% of the total interindividual variance in pain thresholds to various stimuli and produced mainly small effects (Cohen's d 0-1.8). The largest effect had the TRPA1 rs13255063T/rs11988795G haplotype explaining > 5% of the variance in electrical pain thresholds and conferring lower pain sensitivity to homozygous carriers. Gender produced larger effect sizes than most variant alleles (1-14.8% explained variance, Cohen's d 0.2-0.8), with higher pain sensitivity in women than in men. Sensitization by capsaicin or menthol explained up to 63% of the total variance (4.7-62.8%) and produced largest effects according to Cohen's d (0.4-2.6), especially heat sensitization by capsaicin (Cohen's d = 2.6). Conclusions: Sensitization, gender and genetic variants produce effects on pain in the mentioned order of effect sizes. The present report may provide a basis for comparative discussions of factors influencing pain.	[Doehring, Alexandra; Fluehr, Karin; Neddermeyer, Till J.; Loetsch, Joern] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Clin Pharmacol, Frankfurt, Germany; [Kuesener, Nele; Schneider, Gaby] Goethe Univ Frankfurt, Dept Math & Comp Sci, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Doehring, A (corresponding author), Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Clin Pharmacol, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958				Al'Absi M, 2004, PSYCHOSOM MED, V66, P198, DOI 10.1097/01.psy.0000116250.81254.5d; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BEECHER HK, 1957, PHARMACOL REV, V9, P59; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DERBYSHIRE SW, 2008, PAIN CLIN UPDATES; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Fillingim RB, 2005, J PAIN, V6, P159, DOI 10.1016/j.jpain.2004.11.008; Fillingim Roger B, 2005, Curr Rheumatol Rep, V7, P342, DOI 10.1007/s11926-005-0018-7; Fluhr K, 2009, CLIN J PAIN, V25, P128, DOI 10.1097/AJP.0b013e3181817aa2; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hatem S, 2006, PAIN, V122, P190, DOI 10.1016/j.pain.2006.01.026; HUSKISSON EC, 1982, J RHEUMATOL, V9, P768; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; KIM H, 2005, GENETICS PAIN ANALGE, P8; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Kowalczyk WJ, 2006, J PAIN, V7, P151, DOI 10.1016/j.jpain.2005.10.004; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lenth RV, 2001, AM STAT, V55, P187, DOI 10.1198/000313001317098149; Lotsch J, 2006, BEHAV NEUROSCI, V120, P1218, DOI 10.1037/0735-7044.120.6.1218; Lotsch J, 2010, TRENDS PHARMACOL SCI, V31, P312, DOI 10.1016/j.tips.2010.04.002; Lotsch J, 2010, PHARMACOGENET GENOM, V20, P291, DOI 10.1097/FPC.0b013e3283386bda; Lotsch J, 2010, PAIN, V148, P103, DOI 10.1016/j.pain.2009.10.021; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mogil JS, 2009, PAIN, V146, P231, DOI 10.1016/j.pain.2009.07.023; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Neddermeyer TJ, 2008, PAIN, V138, P286, DOI 10.1016/j.pain.2007.12.015; Nielsen CS, 2008, PAIN, V136, P21, DOI 10.1016/j.pain.2007.06.008; Nishizawa D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007060; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; RAO S S, 1987, Indian Journal of Physiology and Pharmacology, V31, P250; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; SNIDVONGS S, 2008, GENDER DIFFERENCES R; Solovieva S, 2004, PAIN, V109, P8, DOI 10.1016/j.pain.2003.10.020; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TEGEDER I, 2009, J CELL MOL MED; Tegeder I, 2008, EUR J PAIN, V12, P1069, DOI 10.1016/j.ejpain.2008.02.004; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Tershner SA, 2000, PAIN, V85, P153, DOI 10.1016/S0304-3959(99)00257-2; Thompson B, 2007, PSYCHOL SCHOOLS, V44, P423, DOI 10.1002/pits.20234; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	54	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17724	10.1371/journal.pone.0017724	http://dx.doi.org/10.1371/journal.pone.0017724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423693	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100029
J	Gaida, A; Becker, MM; Schmid, CD; Buhlmann, T; Louis, EJ; Beck, HP				Gaida, Annette; Becker, Marion M.; Schmid, Christoph D.; Buehlmann, Tobias; Louis, Edward J.; Beck, Hans-Peter			Cloning of the Repertoire of Individual Plasmodium falciparum var Genes Using Transformation Associated Recombination (TAR)	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; DIFFERENTIAL EXPRESSION; ANTIGENIC VARIATION; GENOME SEQUENCE; MALARIA; YEAST; VIRULENCE; DNA; IDENTIFICATION; SURFACE	One of the major virulence factors of the malaria causing parasite is the Plasmodium falciparum encoded erythrocyte membrane protein 1 (PfEMP1). It is translocated to It the membrane of infected erythrocytes and expressed from approximately 60 var genes in a mutually exclusive manner. Switching of var genes allows the parasite to alter functional and antigenic properties of infected erythrocytes, to escape the immune defense and to establish chronic infections. We have developed an efficient method for isolating VAR genes from telomeric and other genome locations by adapting transformation-associated recombination (TAR) cloning, which can then be analyzed and sequenced. For this purpose, three plasmids each containing a homologous sequence representing the upstream regions of the group A, B, and C var genes and a sequence homologous to the conserved acidic terminal segment (ATS) of var genes were generated. Co-transfection with P. falciparum strain ITG2F6 genomic DNA in yeast cells yielded 200 TAR clones. The relative frequencies of clones from each group were not biased. Clones were screened by PCR, as well as Southern blotting, which revealed clones missed by PCR due to sequence mismatches with the primers. Selected clones were transformed into E. coli and further analyzed by RFLP and end sequencing. Physical analysis of 36 clones revealed 27 distinct types potentially representing 50% of the var gene repertoire. Three clones were selected for sequencing and assembled into single var gene containing contigs. This study demonstrates that it is possible to rapidly obtain the repertoire of var genes from P. falciparum within a single set of cloning experiments. This technique can be applied to individual isolates which will provide a detailed picture of the diversity of var genes in the field. This is a powerful tool to overcome the obstacles with cloning and assembly of multi-gene families by simultaneously cloning each member.	[Gaida, Annette; Schmid, Christoph D.; Buehlmann, Tobias; Beck, Hans-Peter] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Gaida, Annette; Schmid, Christoph D.; Buehlmann, Tobias; Beck, Hans-Peter] Univ Basel, Basel, Switzerland; [Becker, Marion M.; Louis, Edward J.] Univ Nottingham, Ctr Genet & Genom, Queens Med Ctr, Nottingham NG7 2RD, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Nottingham	Gaida, A (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.	ed.louis@nottingham.ac.uk	Louis, Edward/B-7920-2008	Louis, Edward/0000-0003-1157-3608; Beck, Hans-Peter/0000-0001-8326-4834	Swiss National Science Foundation [3100A0-118456]; Wellcome Trust	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Swiss National Science Foundation [grant number 3100A0-118456] for AG and HPB, and by the Wellcome Trust for MMB and EJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Beck Hans-Peter, 2002, Methods Mol Med, V72, P159, DOI 10.1385/1-59259-271-6:159; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Blythe JE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-140; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cancilla MR, 1998, GENOMICS, V47, P399, DOI 10.1006/geno.1997.5129; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Chookajorn T, 2008, TRENDS PARASITOL, V24, P455, DOI 10.1016/j.pt.2008.07.005; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Falk N, 2009, J INFECT DIS, V200, P347, DOI 10.1086/600071; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kouprina N, 2003, EMBO REP, V4, P257, DOI 10.1038/sj.embor.embor766; Kouprina N, 2003, NUCLEIC ACIDS RES, V31, P922, DOI 10.1093/nar/gkg182; Kouprina N, 1997, GENE, V197, P269, DOI 10.1016/S0378-1119(97)00271-0; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Larionov V, 1996, P NATL ACAD SCI USA, V93, P491, DOI 10.1073/pnas.93.1.491; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Raymond CK, 2002, GENOME RES, V12, P190, DOI 10.1101/gr.205201; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rowe JA, 2004, MOL MICROBIOL, V53, P1011, DOI 10.1111/j.1365-2958.2004.04256.x; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; SILVERMAN GA, 1989, P NATL ACAD SCI USA, V86, P7485, DOI 10.1073/pnas.86.19.7485; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; WHO, 2008, PHARMAFORUM 0121; Young R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-385	41	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17782	10.1371/journal.pone.0017782	http://dx.doi.org/10.1371/journal.pone.0017782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408186	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800038
J	Kumar, K; Desai, V; Cheng, L; Khitrov, M; Grover, D; Satya, RV; Yu, CG; Zavaljevski, N; Reifman, J				Kumar, Kamal; Desai, Valmik; Cheng, Li; Khitrov, Maxim; Grover, Deepak; Satya, Ravi Vijaya; Yu, Chenggang; Zavaljevski, Nela; Reifman, Jaques			AGeS: A Software System for Microbial Genome Sequence Annotation	PLOS ONE			English	Article							RAPID ANNOTATION; PREDICTION; RESOURCE; INTERPRO; PROGRAM; SERVER; GENES; DNA	Background: The annotation of genomes from next-generation sequencing platforms needs to be rapid, high-throughput, and fully integrated and automated. Although a few Web-based annotation services have recently become available, they may not be the best solution for researchers that need to annotate a large number of genomes, possibly including proprietary data, and store them locally for further analysis. To address this need, we developed a standalone software application, the Annotation of microbial Genome Sequences (AGeS) system, which incorporates publicly available and in-house-developed bioinformatics tools and databases, many of which are parallelized for high-throughput performance. Methodology: The AGeS system supports three main capabilities. The first is the storage of input contig sequences and the resulting annotation data in a central, customized database. The second is the annotation of microbial genomes using an integrated software pipeline, which first analyzes contigs from high-throughput sequencing by locating genomic regions that code for proteins, RNA, and other genomic elements through the Do-It-Yourself Annotation (DIYA) framework. The identified protein-coding regions are then functionally annotated using the in-house-developed Pipeline for Protein Annotation (PIPA). The third capability is the visualization of annotated sequences using GBrowse. To date, we have implemented these capabilities for bacterial genomes. AGeS was evaluated by comparing its genome annotations with those provided by three other methods. Our results indicate that the software tools integrated into AGeS provide annotations that are in general agreement with those provided by the compared methods. This is demonstrated by a > 94% overlap in the number of identified genes, a significant number of identical annotated features, and a > 90% agreement in enzyme function predictions.	[Kumar, Kamal; Desai, Valmik; Cheng, Li; Khitrov, Maxim; Grover, Deepak; Satya, Ravi Vijaya; Yu, Chenggang; Zavaljevski, Nela; Reifman, Jaques] USA, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, DoD Biotechnol High Performance Comp Software App, Ft Detrick, MD USA		Kumar, K (corresponding author), USA, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, DoD Biotechnol High Performance Comp Software App, Ft Detrick, MD USA.	jaques.reifman@us.army.mil		Kumar, Kamal/0000-0002-9470-6682	United States Department of Defense High-Performance Computing Modernization Program (HPCMP) office, under the High-Performance Computing Software Applications Institutes (HSAI) Initiative	United States Department of Defense High-Performance Computing Modernization Program (HPCMP) office, under the High-Performance Computing Software Applications Institutes (HSAI) Initiative	This work was partially sponsored by the United States Department of Defense High-Performance Computing Modernization Program (HPCMP) office, under the High-Performance Computing Software Applications Institutes (HSAI) Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrett Alan J., 1997, European Journal of Biochemistry, V250, P1; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Donlin Maureen J, 2009, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0909s28; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Glasner JD, 2008, NUCLEIC ACIDS RES, V36, pD519, DOI 10.1093/nar/gkm973; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mulder NJ, 2008, MOL BIOTECHNOL, V38, P165, DOI 10.1007/s12033-007-9003-x; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Paulson LD, 2005, COMPUTER, V38, P14, DOI 10.1109/MC.2005.330; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Warren AS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-35; Yu CG, 2009, PROTEINS, V74, P449, DOI 10.1002/prot.22167; Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52	37	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17469	10.1371/journal.pone.0017469	http://dx.doi.org/10.1371/journal.pone.0017469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408217	Green Submitted, Green Published, gold			2022-12-27	WOS:000288099800014
J	Ramanathan, R; Campbell, JL; Soni, SK; Bhargava, SK; Bansal, V				Ramanathan, Rajesh; Campbell, Jos L.; Soni, Sarvesh K.; Bhargava, Suresh K.; Bansal, Vipul			Cationic Amino Acids Specific Biomimetic Silicification in Ionic Liquid: A Quest to Understand the Formation of 3-D Structures in Diatoms	PLOS ONE			English	Article							FUNGUS FUSARIUM-OXYSPORUM; SILICA STRUCTURES; BIOINSPIRED SYNTHESIS; AMORPHOUS SILICA; BIOSYNTHESIS; BIOSILICIFICATION; NANOPARTICLES; PROTEIN; NANOTECHNOLOGY; BIOSILICA	The intricate, hierarchical, highly reproducible, and exquisite biosilica structures formed by diatoms have generated great interest to understand biosilicification processes in nature. This curiosity is driven by the quest of researchers to understand nature's complexity, which might enable reproducing these elegant natural diatomaceous structures in our laboratories via biomimetics, which is currently beyond the capabilities of material scientists. To this end, significant understanding of the biomolecules involved in biosilicification has been gained, wherein cationic peptides and proteins are found to play a key role in the formation of these exquisite structures. Although biochemical factors responsible for silica formation in diatoms have been studied for decades, the challenge to mimic biosilica structures similar to those synthesized by diatoms in their natural habitats has not hitherto been successful. This has led to an increasingly interesting debate that physico-chemical environment surrounding diatoms might play an additional critical role towards the control of diatom morphologies. The current study demonstrates this proof of concept by using cationic amino acids as catalyst/template/scaffold towards attaining diatom-like silica morphologies under biomimetic conditions in ionic liquids.	[Ramanathan, Rajesh; Campbell, Jos L.; Soni, Sarvesh K.; Bhargava, Suresh K.; Bansal, Vipul] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Bhargava, SK (corresponding author), RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia.	suresh.bhargava@rmit.edu.au; vipul.bansal@rmit.edu.au	Soni, Sarvesh/H-4007-2012; Ramanathan, Rajesh/H-1617-2011; Bansal, Vipul/B-2485-2008; Bhargava, Suresh K./AAQ-2675-2020; Bhargava, Suresh K./C-5783-2011	Bansal, Vipul/0000-0002-3354-4317; Bhargava, Suresh K./0000-0002-3127-8166; Bhargava, Suresh K./0000-0002-3127-8166; Ramanathan, Rajesh/0000-0002-8500-9148	Australian Research Council (ARC) [DP0988099, DP110105125, LP100200859]; Commonwealth of Australia	Australian Research Council (ARC)(Australian Research Council); Commonwealth of Australia(Australian Government)	VB thanks the Australian Research Council (ARC) for APD Fellowship and financial support through the ARC Discovery Projects DP0988099 and DP110105125, and ARC Linkage Project LP100200859. VB also acknowledges the support of Ian Potter Foundation in establishing a multimode advanced spectroscopy facility at RMIT University. RR thanks the Commonwealth of Australia for an Australian Postgraduate Award (APA) towards his PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Bansal V, 2005, ADV MATER, V17, P889, DOI 10.1002/adma.200401176; Bansal V, 2004, J MATER CHEM, V14, P3303, DOI 10.1039/b407904c; Bansal V, 2006, J AM CHEM SOC, V128, P11958, DOI 10.1021/ja063011m; Bansal V, 2007, LANGMUIR, V23, P4993, DOI 10.1021/la062535x; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; BARR TL, 1983, APPL SURF SCI, V15, P1, DOI 10.1016/0378-5963(83)90003-X; Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f; Bharde A, 2006, SMALL, V2, P135, DOI 10.1002/smll.200500180; Bradbury J, 2004, PLOS BIOL, V2, P1512, DOI 10.1371/journal.pbio.0020306; Brutchey RL, 2008, CHEM REV, V108, P4915, DOI 10.1021/cr078256b; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328; Drum RW, 2003, TRENDS BIOTECHNOL, V21, P325, DOI 10.1016/S0167-7799(03)00169-0; Estroff LA, 2001, CHEM MATER, V13, P3227, DOI 10.1021/cm010110k; Foo CWP, 2004, TRENDS BIOTECHNOL, V22, P577, DOI 10.1016/j.tibtech.2004.09.011; Greaves TL, 2008, CHEM SOC REV, V37, P1709, DOI 10.1039/b801395k; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Iler R. K, 1979, CHEM SILICA; IMAI H, 2007, SELF ORGANIZED FORMA, P43; Kr?ger N., 2004, BIOMINERALIZATION PR, P137; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; Lopez PJ, 2005, CURR NANOSCI, V1, P73, DOI 10.2174/1573413052953156; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Parkinson J, 1999, BBA-MOL CELL RES, V1452, P89, DOI 10.1016/S0167-4889(99)00116-0; Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c; Patwardhan SV, 2003, CHEM COMMUN, P1122, DOI 10.1039/b302056h; Patwardhan SV, 2001, J INORG ORGANOMET P, V11, P117, DOI 10.1023/A:1014403932692; Pearson A, 2010, CHEM COMMUN, V46, P731, DOI 10.1039/b918866e; Pearson A, 2011, INORG CHEM, V50, P1705, DOI 10.1021/ic1021752; Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130; Ryu J. Hyung, 2008, ANGEW CHEM INT EDIT, V47, P7639; Schiffrin A, 2007, P NATL ACAD SCI USA, V104, P5279, DOI 10.1073/pnas.0607867104; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; SIMPSON TL, 1981, SILICON SILICEOUS ST; Soni SK, 2010, LANGMUIR, V26, P16020, DOI 10.1021/la101965j; Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k; Vrieling EG, 2007, P NATL ACAD SCI USA, V104, P10441, DOI 10.1073/pnas.0608980104	42	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17707	10.1371/journal.pone.0017707	http://dx.doi.org/10.1371/journal.pone.0017707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408611	Green Published, gold, Green Submitted			2022-12-27	WOS:000287965200037
J	Nakamura, H; Ikeda, N; Stickley, A; Mori, R; Shibuya, K				Nakamura, Haruyo; Ikeda, Nayu; Stickley, Andrew; Mori, Rintaro; Shibuya, Kenji			Achieving MDG 4 in Sub-Saharan Africa: What Has Contributed to the Accelerated Child Mortality Decline in Ghana?	PLOS ONE			English	Article							UNDER-5 MORTALITY; SURVIVAL; ASSOCIATION; COUNTRIES	Background: Recent analyses have suggested an accelerated decline in child mortality in Ghana since 2000. This study examines the long-term child mortality trends in the country, relates them to changes in the key drivers of mortality decline, and assesses the feasibility of the country's MDG 4 attainment. Methodology: Data from five Demographic and Health Surveys (DHS) between 1988 and 2008 and the Maternal Health Survey 2007 were used to generate two-year estimates of under-five mortality rates back to 1967. Lowess regression fitted past and future trends towards 2015. A modified Poisson approach was applied on the person-period data created from the DHS 2003 and 2008 to examine determinants of under-five mortality and their contributions to the change in mortality. A policy-modelling system assessed the feasibility of the country's MDG 4 attainment. Findings: The under-five mortality rate has steadily declined over the past 40 years with acceleration since 2000, and is projected to reach between 45 and 69 per 1000 live births in 2015. Preceding birth interval (reference: 36+ months, relative risk [RR] increased as the interval shortened), bed net use (RR 0.71, 95% confidence interval [CI]: 0.52-0.95), maternal education (reference: secondary/higher, RR 1.71, 95% CI: 1.18-2.47 for primary), and maternal age at birth (reference: 17+ years, RR 2.13, 95% CI: 1.12-4.05) were primarily associated with under-five mortality. Increased bed-net use made a substantial contribution to the mortality decline. The scale-up of key interventions will allow the possibility of Ghana's MDG 4 attainment. Conclusions: National and global efforts for scaling up key child survival interventions in Ghana are paying off _ these concerted efforts need to be sustained in order to achieve MDG 4.	[Nakamura, Haruyo] JICA, Tokyo, Japan; [Ikeda, Nayu; Stickley, Andrew; Mori, Rintaro; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Tokyo, Japan; [Stickley, Andrew] London Sch Hyg & Trop Med, London WC1, England	University of Tokyo; University of London; London School of Hygiene & Tropical Medicine	Nakamura, H (corresponding author), JICA, Tokyo, Japan.	fv5h-smz@asahi-net.or.jp	Ikeda, Nayu/J-9890-2019	Ikeda, Nayu/0000-0002-3424-1991; Mori, Rintaro/0000-0001-7656-6156; Shibuya, Kenji/0000-0003-2528-7530	Japan Ministry of Health, Labour and Welfare	Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was in part funded by a research grant from the Japan Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo Victor M., 2005, Food and Nutrition Bulletin, V26, P348; Aguayo VM, 2005, PUBLIC HEALTH NUTR, V8, P29, DOI 10.1079/PHN2004664; [Anonymous], 2009, WORLD EC OUTL; [Anonymous], WORLD FACTB; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bryce J, 2010, INT J EPIDEMIOL, V39, P40, DOI 10.1093/ije/dyq020; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; Cleveland W.S., 1996, P STAT THEORY COMPUT, P10; FORT AL, 2006, POSTPARTUM CARE LEVE, V15; *GHAN STAT SERV, 2004, GHAN DEM HLTH SURV 2; *GHAN STAT SERV GH, 2009, GHAN MAT HLTH SURV; Ghana Statistical Service. Ghana Health Service, 2009, GHAN DEM HLTH SURV 2; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Int Mon Fund, 2011, WOR ECON OUTLOOK, P1; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Mahy M., 2003, MEASURING CHILD MORT; MEASURE DHS, 2009, DEM HLTH SURV QUAL I; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; ORC Macro, 2006, DEM HLTH SURV INT MA; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; PLOSKY WD, 2009, LIVES SAVED TOOL EAS; Ploslcy WD, 2009, LIVES SAVED TOOL COM; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rutstein S. O., 2004, DHS WEALTH INDEX; Rutstein SO, 2006, GUIDE DHS STAT; SHIMIZU H, 2003, PROGR REPORT PROJECT; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; *UNICEF, 2009, MOTH NEWB HLTH; Unicef, 2008, TRACK PROGR MAT NEWB; UNICEF, 2006, GHAN INT CHILD HLTH; United Nations, 2009, MILL DEV GOALS REP 2; W.H. Organization, 2009, WORLD HLTH STAT 2009; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17774	10.1371/journal.pone.0017774	http://dx.doi.org/10.1371/journal.pone.0017774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445299	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300014
J	Li, XA; Hu, Z; Qu, XS; Zhu, JD; Li, L; Ring, BZ; Su, L				Li, Xiang; Hu, Zheng; Qu, Xinshun; Zhu, Jiadong; Li, Lin; Ring, Brian Z.; Su, Li			Putative EPHX1 Enzyme Activity Is Related with Risk of Lung and Upper Aerodigestive Tract Cancers: A Comprehensive Meta-Analysis	PLOS ONE			English	Article							MICROSOMAL EPOXIDE HYDROLASE; GLUTATHIONE-S-TRANSFERASE; SQUAMOUS-CELL-CARCINOMA; XENOBIOTIC-METABOLIZING ENZYMES; GENE-ENVIRONMENT INTERACTION; CIGARETTE-SMOKING; COLORECTAL-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; TYR113HIS POLYMORPHISM	Background: EPHX1 is a key enzyme in metabolizing some exogenous carcinogens such as products of cigarette-smoking. Two functional polymorphisms in the EPHX1 gene, Tyr113His and His139Arg can alter the enzyme activity, suggesting their possible association with carcinogenesis risk, particularly of some tobacco-related cancers. Methodology/Principal Findings: A comprehensive systematic review and meta-analysis was performed of available studies on these two polymorphisms and cancer risk published up to November 2010, consisting of 84 studies (31144 cases and 42439 controls) for Tyr113His and 77 studies (28496 cases and 38506 controls) for His139Arg primarily focused on lung cancer, upper aerodigestive tract (UADT) cancers (including oral, pharynx, larynx and esophagus cancers), colorectal cancer or adenoma, bladder cancer and breast cancer. Results showed that Y113H low activity allele (H) was significantly associated with decreased risk of lung cancer (OR = 0.88, 95%Cl = 0.80-0.96) and UADT cancers (OR = 0.86, 95%Cl = 0.77-0.97) and H139R high activity allele (R) with increased risk of lung cancer (OR = 1.18, 95%Cl = 1.04-1.33) but not of UADT cancers (OR = 1.05, 95%Cl = 0.93-1.17). Pooled analysis of lung and UADT cancers revealed that low EPHX1 enzyme activity, predicted by the combination of Y113H and H139R showed decreased risk of these cancers (OR = 0.83, 95%Cl = 0.75-0.93) whereas high EPHX1 activity increased risk of the cancers (OR = 1.20, 95% Cl = 0.98-1.46). Furthermore, modest difference for the risk of lung and UADT cancers was found between cigarette smokers and nonsmokers both in single SNP analyses (low activity allele H: OR = 0.77/0.85 for smokers/nonsmokers; high activity allele R: OR = 1.20/1.09 for smokers/nonsmokers) and in combined double SNP analyses (putative low activity: OR = 0.73/0.88 for smokers/nonsmokers; putative high activity: OR = 1.02/0.93 for smokers/nonsmokers). Conclusions/Significance: Putative low EPHX1 enzyme activity may have a potential protective effect on tobacco-related carcinogenesis of lung and UADT cancers, whereas putative high EPHX1 activity may have a harmful effect. Moreover, cigarette-smoking status may influence the association of EPHX1 enzyme activity and the related cancer risk.	[Li, Xiang; Zhu, Jiadong; Li, Lin; Su, Li] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ,Sino France Joint Ctr Drug Res & Scre, Sch Life Sci & Technol, Wuhan 430074, Peoples R China; [Hu, Zheng] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Qu, Xinshun] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; [Ring, Brian Z.] Yigene Inc, Beijing, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Li, XA (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ,Sino France Joint Ctr Drug Res & Scre, Sch Life Sci & Technol, Wuhan 430074, Peoples R China.	lisu@mail.hust.edu.cn			Ministry of Science and Technology, China [2009DFA31940, 2009ZX10001-017-06]	Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was funded in part by a grant 2009DFA31940 and 2009ZX10001-017-06 from The Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Ring is employed by Yigene Inc. and helped to prepare the manuscript. Yigene Inc. did have a role in the preparation of the manuscript.	Abbas S, 2010, BREAST CANCER RES TR, V120, P737, DOI 10.1007/s10549-009-0490-2; Agudo A, 2006, CANCER EPIDEM BIOMAR, V15, P2427, DOI 10.1158/1055-9965.EPI-06-0072; Amador AG, 2002, ORAL SURG ORAL MED O, V93, P440, DOI 10.1067/moe.2002.122586; Baxter SW, 2002, CANCER LETT, V177, P75, DOI 10.1016/S0304-3835(01)00782-0; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benhamou S, 1998, CANCER RES, V58, P5291; Boccia S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-206; Boccia S, 2008, J CANCER RES CLIN, V134, P93, DOI 10.1007/s00432-007-0254-5; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Brockmoller J, 1996, PHARMACOGENETICS, V6, P535, DOI 10.1097/00008571-199612000-00007; Cajas-Salazar N, 2003, CANCER GENET CYTOGEN, V145, P97, DOI 10.1016/S0165-4608(03)00058-X; Casson AG, 2003, CANCER DETECT PREV, V27, P139, DOI 10.1016/S0361-090X(03)00033-3; Casson AG, 2006, CANCER DETECT PREV, V30, P423, DOI 10.1016/j.cdp.2006.09.005; CHAUHAN PS, 2010, DNA CELL BIOL   0823; Clavel J, 2005, EUR J CANCER PREV, V14, P531, DOI 10.1097/00008469-200512000-00007; Cleary SP, 2010, AM J EPIDEMIOL, V172, P1000, DOI 10.1093/aje/kwq245; Cortessis V, 2001, CANCER RES, V61, P2381; Cotterchio M, 2008, CANCER EPIDEM BIOMAR, V17, P3098, DOI 10.1158/1055-9965.EPI-08-0341; de Assis S, 2002, CANCER EPIDEM BIOMAR, V11, P1697; De Roos AJ, 2006, NEURO-ONCOLOGY, V8, P145, DOI 10.1215/15228517-2005-003; De Roos AJ, 2006, CANCER EPIDEM BIOMAR, V15, P1647, DOI 10.1158/1055-9965.EPI-06-0193; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Figueroa JD, 2008, CARCINOGENESIS, V29, P1955, DOI 10.1093/carcin/bgn163; Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6; Gemignani F, 2007, CARCINOGENESIS, V28, P1287, DOI 10.1093/carcin/bgm021; Gold LS, 2009, CANCER EPIDEMIOL, V33, P276, DOI 10.1016/j.canep.2009.08.005; Graziano C, 2009, LUNG CANCER, V63, P187, DOI 10.1016/j.lungcan.2008.05.004; Gsur A, 2003, BRIT J CANCER, V89, P702, DOI 10.1038/sj.bjc.6601142; Harrison DJ, 1999, BRIT J CANCER, V79, P168, DOI 10.1038/sj.bjc.6690028; Hassett C, 1997, ARCH BIOCHEM BIOPHYS, V337, P275, DOI 10.1006/abbi.1996.9794; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Hlavata I, 2010, ONCOL REP, V24, P1347, DOI 10.3892/or_0000992; Hsu LI, 2008, TOXICOL APPL PHARM, V228, P144, DOI 10.1016/j.taap.2007.12.003; Huang WY, 2005, CANCER EPIDEM BIOMAR, V14, P152; *IARC, 2004, TOB SMOK INV SM; Ihsan R, 2010, J GASTROEN HEPATOL, V25, P1456, DOI 10.1111/j.1440-1746.2010.06354.x; Jourenkova-Mironova N, 2000, CANCER RES, V60, P534; Justenhoven C, 2008, BREAST CANCER RES TR, V108, P137, DOI 10.1007/s10549-007-9586-8; Khedhaier A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-109; Kiran M, 2008, DNA CELL BIOL, V27, P687, DOI 10.1089/dna.2008.0805; Kiran M, 2009, DNA CELL BIOL, V28, P573, DOI 10.1089/dna.2009.0921; Kirk GD, 2005, CANCER EPIDEM BIOMAR, V14, P373, DOI 10.1158/1055-9965.EPI-04-0161; Kiss I, 2007, ANTICANCER RES, V27, P2931; Kiyohara C, 2006, EPIDEMIOLOGY, V17, P89, DOI 10.1097/01.ede.0000187627.70026.23; Lacko M, 2008, HEAD NECK-J SCI SPEC, V30, P836, DOI 10.1002/hed.20781; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Lebailly P, 2002, BRIT J HAEMATOL, V116, P587, DOI 10.1046/j.0007-1048.2001.03320.x; Lin YC, 2006, CANCER LETT, V237, P281, DOI 10.1016/j.canlet.2005.06.010; Lincz LF, 2007, LEUKEMIA RES, V31, P759, DOI 10.1016/j.leukres.2006.07.012; London SJ, 2000, LUNG CANCER, V28, P147, DOI 10.1016/S0169-5002(99)00130-0; Mckay JD, 2008, CANCER EPIDEM BIOMAR, V17, P141, DOI 10.1158/1055-9965.EPI-07-0553; Minelli C, 2005, STAT MED, V24, P3845, DOI 10.1002/sim.2393; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Mitrou PN, 2007, CARCINOGENESIS, V28, P875, DOI 10.1093/carcin/bgl194; Mittal RD, 2007, DNA CELL BIOL, V26, P791, DOI 10.1089/dna.2007.0630; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Nishino K, 2008, J OBSTET GYNAECOL RE, V34, P994, DOI 10.1111/j.1447-0756.2008.00798.x; Northwood EL, 2010, PHARMACOGENET GENOM, V20, P315, DOI 10.1097/FPC.0b013e3283395c6a; Ockenga J, 2009, PANCREAS, V38, pE97, DOI 10.1097/MPA.0b013e31819feeed; OESCH F, 1973, XENOBIOTICA, V3, P305, DOI 10.3109/00498257309151525; Park JH, 2003, TRANSPORT RES E-LOG, V39, P1, DOI 10.1016/S1366-5545(02)00023-6; Park JY, 2005, EUR J CANCER PREV, V14, P223, DOI 10.1097/00008469-200506000-00005; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Persson I, 1999, INT J CANCER, V81, P325, DOI 10.1002/(SICI)1097-0215(19990505)81:3<325::AID-IJC2>3.0.CO;2-S; PETITI DB, 1994, METAANALYSIS DECISIO, V24; Robien K, 2005, CANCER EPIDEM BIOMAR, V14, P1350, DOI 10.1158/1055-9965.EPI-04-0877; Rosenberger A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-60; Rotunno M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005652; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sangrajrang S, 2009, INT J CANCER, V125, P837, DOI 10.1002/ijc.24434; Sarmanova J, 2004, EUR J HUM GENET, V12, P848, DOI 10.1038/sj.ejhg.5201249; Sarmanova J, 2001, HUM MOL GENET, V10, P1265, DOI 10.1093/hmg/10.12.1265; SEIDEGARD J, 1983, BIOCHIM BIOPHYS ACTA, V695, P251, DOI 10.1016/0304-419X(83)90014-8; Sierra-Torres CH, 2003, ENVIRON MOL MUTAGEN, V41, P69, DOI 10.1002/em.10132; Silveira VD, 2010, ENVIRON MOL MUTAGEN, V51, P48, DOI 10.1002/em.20510; SIMS P, 1974, NATURE, V252, P326, DOI 10.1038/252326a0; Skjelbred CF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-228; Smith CAD, 1997, LANCET, V350, P630, DOI 10.1016/S0140-6736(96)08061-0; Soucek P, 2010, NEOPLASMA, V57, P415, DOI 10.4149/neo_2010_05_415; Spurdle AB, 2001, MOL CARCINOGEN, V30, P71, DOI 10.1002/1098-2744(200101)30:1<71::AID-MC1015>3.0.CO;2-9; Spurdle AB, 2007, CANCER EPIDEM BIOMAR, V16, P769, DOI 10.1158/1055-9965.EPI-06-0776; Srivastava DS, 2008, ARCH TOXICOL, V82, P633, DOI 10.1007/s00204-007-0276-4; Taioli E, 2008, CARCINOGENESIS, V29, P1467, DOI 10.1093/carcin/bgn062; Tiemersma EW, 2004, INT J CANCER, V108, P97, DOI 10.1002/ijc.11533; Tiemersma EW, 2001, CANCER EPIDEM BIOMAR, V10, P785; Timofeeva M, 2010, INT J CANCER, V127, P1547, DOI 10.1002/ijc.25175; To-Figueras J, 2002, CANCER LETT, V187, P95, DOI 10.1016/S0304-3835(02)00406-8; To-Figueras J, 2001, CANCER LETT, V173, P155, DOI 10.1016/S0304-3835(01)00626-7; Tranah GJ, 2004, CARCINOGENESIS, V25, P1211, DOI 10.1093/carcin/bgh126; Tranah GJ, 2005, MOL CARCINOGEN, V44, P21, DOI 10.1002/mc.20112; Tsai YY, 2003, LUNG CANCER, V41, P269, DOI 10.1016/S0169-5002(03)00238-1; Ulrich CM, 2001, CANCER EPIDEM BIOMAR, V10, P875; van der Logt EMJ, 2006, MUTAT RES-FUND MOL M, V593, P39, DOI 10.1016/j.mrfmmm.2005.06.018; Varela-Lema L, 2008, J ONCOL, V2008, DOI 10.1155/2008/741310; Voho A, 2006, CANCER LETT, V237, P102, DOI 10.1016/j.canlet.2005.05.029; Wenghoefer M, 2003, ARCH TOXICOL, V77, P37, DOI 10.1007/s00204-002-0414-y; Wong NACS, 2000, TOXICOL LETT, V115, P17, DOI 10.1016/S0378-4274(00)00166-1; Wu XF, 2001, CARCINOGENESIS, V22, P923, DOI 10.1093/carcin/22.6.923; Yin L, 2001, LUNG CANCER-J IASLC, V33, P133, DOI 10.1016/S0169-5002(01)00182-9; Yoshikawa M, 2000, INT J MOL MED, V5, P49; Zhang JH, 2003, WORLD J GASTROENTERO, V9, P2654; Zhao H, 2002, MOL CARCINOGEN, V33, P99, DOI 10.1002/mc.10023; Zhou W, 2001, CANCER EPIDEM BIOMAR, V10, P461; Zienolddiny S, 2008, CARCINOGENESIS, V29, P1164, DOI 10.1093/carcin/bgn020	110	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14749	10.1371/journal.pone.0014749	http://dx.doi.org/10.1371/journal.pone.0014749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445251	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100001
J	Olling, A; Goy, S; Hoffmann, F; Tatge, H; Just, I; Gerhard, R				Olling, Alexandra; Goy, Sebastian; Hoffmann, Florian; Tatge, Helma; Just, Ingo; Gerhard, Ralf			The Repetitive Oligopeptide Sequences Modulate Cytopathic Potency but Are Not Crucial for Cellular Uptake of Clostridium difficile Toxin A	PLOS ONE			English	Article							BINDING DOMAINS; RECEPTOR; SYSTEM; MODEL; GENE	The pathogenicity of Clostridium difficile is primarily linked to secretion of the intracellular acting toxins A (TcdA) and B (TcdB) which monoglucosylate and thereby inactivate Rho GTPases of host cells. Although the molecular mode of action of TcdA and TcdB is well understood, far less is known about toxin binding and uptake. It is acknowledged that the C-terminally combined repetitive oligopeptides (CROPs) of the toxins function as receptor binding domain. The current study evaluates the role of the CROP domain with respect to functionality of TcdA and TcdB. Therefore, we generated truncated TcdA devoid of the CROPs (TcdA(1-1874)) and found that this mutant was still cytopathic. However, TcdA(1-1874) possesses about 5 to 10-fold less potency towards 3T3 and HT29 cells compared to the full length toxin. Interestingly, CHO-C6 cells even showed almost identical susceptibility towards truncated and full length TcdA concerning Rac1 glucosylation or cell rounding, respectively. FACS and Western blot analyses elucidated these differences and revealed a correlation between CROP-binding to the cell surface and toxin potency. These findings refute the accepted opinion of solely CROP-mediated toxin internalization. Competition experiments demonstrated that presence neither of TcdA CROPs nor of full length TcdA reduced binding of truncated TcdA(1-1874) to HT29 cells. We assume that toxin uptake might additionally occur through alternative receptor structures and/or other associated endocytotic pathways. The second assumption was substantiated by TER measurements showing that basolaterally applied TcdA(1-1874) exhibits considerably higher cytotoxic potency than apically applied mutant or even full length TcdA, the latter being almost independent of the side of application. Thus, different routes for cellular uptake might enable the toxins to enter a broader repertoire of cell types leading to the observed multifarious pathogenesis of C. difficile.	[Olling, Alexandra; Goy, Sebastian; Hoffmann, Florian; Tatge, Helma; Just, Ingo; Gerhard, Ralf] Hannover Med Sch, Inst Toxikol, D-30623 Hannover, Germany	Hannover Medical School	Olling, A (corresponding author), Hannover Med Sch, Inst Toxikol, D-30623 Hannover, Germany.	Gerhard.ralf@mh-hannover.de			Deutsche Forschungsgemeinschaft [SFB 621, B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB 621 (Project B5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amimoto K, 2007, MICROBIOL-SGM, V153, P1198, DOI 10.1099/mic.0.2006/002287-0; BARROSO LA, 1994, MICROB PATHOGENESIS, V16, P297, DOI 10.1006/mpat.1994.1030; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Demarest SJ, 2005, J MOL BIOL, V346, P1197, DOI 10.1016/j.jmb.2004.12.059; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Kato H, 1999, FEMS MICROBIOL LETT, V175, P197, DOI [10.1016/S0378-1097(99)00196-2, 10.1111/j.1574-6968.1999.tb13620.x]; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; Teichert M, 2006, INFECT IMMUN, V74, P6006, DOI 10.1128/IAI.00545-06; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; van den Berg RJ, 2004, J CLIN MICROBIOL, V42, P1035, DOI 10.1128/JCM.42.3.1035-1041.2004; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	29	57	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17623	10.1371/journal.pone.0017623	http://dx.doi.org/10.1371/journal.pone.0017623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445253	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100021
J	Wang, W; Hansbro, PM; Foster, PS; Yang, M				Wang, Wan; Hansbro, Philip M.; Foster, Paul S.; Yang, Ming			An Alternate STAT6-Independent Pathway Promotes Eosinophil Influx into Blood during Allergic Airway Inflammation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; T-CELLS; NK CELLS; INTERLEUKIN-5 PRODUCTION; EXPERIMENTAL ASTHMA; IL-5 PRODUCTION; BALB/C MICE; HYPERREACTIVITY; EOTAXIN; HYPERRESPONSIVENESS	Background: Enhanced eosinophil responses have critical roles in the development of allergic diseases. IL-5 regulates the maturation, migration and survival of eosinophils, and IL-5 and eotaxins mediate the trafficking and activation of eosinophils in inflamed tissues. CD4(+) Th2 cells are the main producers of IL-5 and other cells such as NK also release this cytokine. Although multiple signalling pathways may be involved, STAT6 critically regulates the differentiation and cytokine production of Th2 cells and the expression of eotaxins. Nevertheless, the mechanisms that mediate different parts of the eosinophilic inflammatory process in different tissues in allergic airway diseases remain unclear. Furthermore, the mechanisms at play may vary depending on the context of inflammation and microenvironment of the involved tissues. Methodology/Principal Findings: We employed a model of allergic airway disease in wild type and STAT6-deficient mice to explore the roles of STAT6 and IL-5 in the development of eosinophilic inflammation in this context. Quantitative PCR and ELISA were used to examine IL-5, eotaxins levels in serum and lungs. Eosinophils in lung, peripheral blood and bone marrow were characterized by morphological properties. CD4(+) T cell and NK cells were identified by flow cytometry. Antibodies were used to deplete CD4(+) and NK cells. We showed that STAT6 is indispensible for eosinophilic lung inflammation and the induction of eotaxin-1 and -2 during allergic airway inflammation. In the absence of these chemokines eosinophils are not attracted into lung and accumulate in peripheral blood. We also demonstrate the existence of an alternate STAT6-independent pathway of IL-5 production by CD4(+) and NK cells that mediates the development of eosinophils in bone marrow and their subsequent movement into the circulation. Conclusions: These results suggest that different points of eosinophilic inflammatory processes in allergic airway disease may be differentially regulated by the activation of STAT6-dependent and -independent pathways.	[Wang, Wan] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; Hunter Med Res Inst, Callaghan, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Wang, W (corresponding author), Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	Paul.Foster@newcastle.edu.au; Ming.Yang@newcastle.edu.au	Hansbro, Phil/G-7486-2013; Foster, Paul/G-5057-2013	Hansbro, Phil/0000-0002-4741-3035; , Paul/0000-0002-0827-8299	National Health & Medical Research Council of Australia; Cooperative Research Centre for Asthma and Airways	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding: This work was supported by project grants from the National Health & Medical Research Council of Australia (P. S. Foster and M. Yang) and the Cooperative Research Centre for Asthma and Airways (P. S. Foster and M. Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Chong LK, 2008, EUR J IMMUNOL, V38, P995, DOI 10.1002/eji.200737687; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Foster PS, 2002, PHARMACOL THERAPEUT, V94, P253, DOI 10.1016/S0163-7258(02)00220-6; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hoeck J, 2001, J IMMUNOL, V166, P4507, DOI 10.4049/jimmunol.166.7.4507; Hogan SP, 1997, IMMUNOL CELL BIOL, V75, P284, DOI 10.1038/icb.1997.43; Hogan SP, 1998, J IMMUNOL, V161, P1501; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Katsumoto T, 2004, J IMMUNOL, V173, P4967, DOI 10.4049/jimmunol.173.8.4967; Kiss A, 2007, J ALLERGY CLIN IMMUN, V120, P334, DOI 10.1016/j.jaci.2007.04.025; Kon OM, 1998, LANCET, V352, P1109, DOI 10.1016/S0140-6736(97)12261-9; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; OWEN WF, 1989, J EXP MED, V170, P343, DOI 10.1084/jem.170.1.343; Radinger M, 2009, PHARMACOL THERAPEUT, V121, P174, DOI 10.1016/j.pharmthera.2008.10.008; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sakamoto Y, 2004, IMMUNOLOGY, V112, P615, DOI 10.1046/j.1365-2567.2004.01909.x; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Schwarze J, 1999, J IMMUNOL, V162, P4207; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Soderstrom K, 2010, P NATL ACAD SCI USA, V107, P13028, DOI 10.1073/pnas.1000546107; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TING CC, 1987, CELL IMMUNOL, V104, P115, DOI 10.1016/0008-8749(87)90012-8; Tomkinson A, 1999, AM J RESP CRIT CARE, V160, P1283, DOI 10.1164/ajrccm.160.4.9809065; Walker C, 1998, J IMMUNOL, V161, P1962; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; WARREN HS, 1995, J IMMUNOL, V154, P5144; Yang M, 2003, J ALLERGY CLIN IMMUN, V112, P935, DOI 10.1016/j.jaci.2003.08.010; Yang M, 2001, AM J RESP CELL MOL, V25, P522, DOI 10.1165/ajrcmb.25.4.4620; Yang M, 2006, J IMMUNOL, V177, P5595, DOI 10.4049/jimmunol.177.8.5595; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zimmermann N, 2000, J IMMUNOL, V165, P5839, DOI 10.4049/jimmunol.165.10.5839; Zimmermann N, 2004, J IMMUNOL, V172, P1815, DOI 10.4049/jimmunol.172.3.1815	52	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17766	10.1371/journal.pone.0017766	http://dx.doi.org/10.1371/journal.pone.0017766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423619	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900027
J	Eto, D; Lao, C; DiToro, D; Barnett, B; Escobar, TC; Kageyama, R; Yusuf, I; Crotty, S				Eto, Danelle; Lao, Christopher; DiToro, Daniel; Barnett, Burton; Escobar, Tania C.; Kageyama, Robin; Yusuf, Isharat; Crotty, Shane			IL-21 and IL-6 Are Critical for Different Aspects of B Cell Immunity and Redundantly Induce Optimal Follicular Helper CD4 T Cell (Tfh) Differentiation	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; CHRONIC VIRAL-INFECTION; IMMUNOGLOBULIN PRODUCTION; MULTIPLE-MYELOMA; PLASMA-CELLS; ANTIBODY-PRODUCTION; HUMORAL IMMUNITY; BCL-6 EXPRESSION; DOWN-REGULATION; GROWTH-FACTOR	Cytokines are important modulators of lymphocytes, and both interleukin-21 (IL-21) and IL-6 have proposed roles in T follicular helper (Tfh) differentiation, and directly act on B cells. Here we investigated the absence of IL-6 alone, IL-21 alone, or the combined lack of IL-6 and IL-21 on Tfh differentiation and the development of B cell immunity in vivo. C57BL/6 or IL-21(-/-) mice were treated with a neutralizing monoclonal antibody against IL-6 throughout the course of an acute viral infection (lymphocytic choriomeningitis virus, LCMV). The combined absence of IL-6 and IL-21 resulted in reduced Tfh differentiation and reduced Bcl6 protein expression. In addition, we observed that these cytokines had a large impact on antigen-specific B cell responses. IL-6 and IL-21 collaborate in the acute T-dependent antiviral antibody response (90% loss of circulating antiviral IgG in the absence of both cytokines). In contrast, we observed reduced germinal center formation only in the absence of IL-21. Absence of IL-6 had no impact on germinal centers, and combined absence of both IL-21 and IL-6 revealed no synergistic effect on germinal center B cell development. Studying CD4 T cells in vitro, we found that high IL-21 production was not associated with high Bcl6 or CXCR5 expression. TCR stimulation of purified naive CD4 T cells in the presence of IL-6 also did not result in Tfh differentiation, as determined by Bcl6 or CXCR5 protein expression. Cumulatively, our data indicates that optimal Tfh formation requires IL-21 and IL-6, and that cytokines alone are insufficient to drive Tfh differentiation.	[Eto, Danelle; Lao, Christopher; DiToro, Daniel; Barnett, Burton; Escobar, Tania C.; Kageyama, Robin; Yusuf, Isharat; Crotty, Shane] La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA USA	La Jolla Institute for Immunology	Eto, D (corresponding author), La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA USA.	shane@liai.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 	Pew Scholar Award; LIAI; NIH NIAID [R01 072543]	Pew Scholar Award; LIAI; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pew Scholar Award, LIAI Institutional Funds, and NIH NIAID R01 072543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; BATAILLE R, 1995, BLOOD, V86, P685, DOI 10.1182/blood.V86.2.685.bloodjournal862685; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; CROTTY S, 2011, ANN REV IMMUNOL; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gonzalez-Garcia I, 2006, J IMMUNOL, V176, P4042, DOI 10.4049/jimmunol.176.7.4042; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hotson AN, 2009, J IMMUNOL, V182, P7558, DOI 10.4049/jimmunol.0803666; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jego G, 2001, BLOOD, V97, P1817, DOI 10.1182/blood.V97.6.1817; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kashiwakuma D, 2010, J IMMUNOL, V185, P2730, DOI 10.4049/jimmunol.0903839; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; SUTO A, 2008, DEVELOPMENT, V205, P1369; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; vanZaanen HCT, 1996, J CLIN INVEST, V98, P1441, DOI 10.1172/JCI118932; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	77	375	392	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17739	10.1371/journal.pone.0017739	http://dx.doi.org/10.1371/journal.pone.0017739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423809	Green Published, gold, Green Submitted			2022-12-27	WOS:000288512400024
J	Niibe, K; Kawamura, Y; Araki, D; Morikawa, S; Miura, K; Suzuki, S; Shimmura, S; Sunabori, T; Mabuchi, Y; Nagai, Y; Nakagawa, T; Okano, H; Matsuzaki, Y				Niibe, Kunimichi; Kawamura, Yoshimi; Araki, Daisuke; Morikawa, Satoru; Miura, Kyoko; Suzuki, Sadafumi; Shimmura, Shigeto; Sunabori, Takehiko; Mabuchi, Yo; Nagai, Yasuo; Nakagawa, Taneaki; Okano, Hideyuki; Matsuzaki, Yumi			Purified Mesenchymal Stem Cells Are an Efficient Source for iPS Cell Induction	PLOS ONE			English	Article							HUMAN FIBROBLASTS; ES CELLS; PLURIPOTENCY; MOUSE; GENERATION; EXPRESSION; CHIMERAS; NANOG	Background: Induced pluripotent stem (iPS) cells are generated from mouse and human somatic cells by the forced expression of defined transcription factors. Although most somatic cells are capable of acquiring pluripotency with minimal gene transduction, the poor efficiency of cell reprogramming and the uneven quality of iPS cells are still important problems. In particular, the choice of cell type most suitable for inducing high-quality iPS cells remains unclear. Methodology/Principal Findings: Here, we generated iPS cells from PDGFR alpha(+) Sca-1(+) (P alpha S) adult mouse mesenchymal stem cells (MSCs) and PDGFR alpha(-) Sca-1(-) osteo-progenitors (OP cells), and compared the induction efficiency and quality of individual iPS clones. MSCs had a higher reprogramming efficiency compared with OP cells and Tail Tip Fibroblasts (TTFs). The iPS cells induced from MSCs by Oct3/4, Sox2, and Klf4 appeared to be the closest equivalent to ES cells by DNA microarray gene profile and germline-transmission efficiency. Conclusions/Significance: Our findings suggest that a purified source of undifferentiated cells from adult tissue can produce high-quality iPS cells. In this context, prospectively enriched MSCs are a promising candidate for the efficient generation of high-quality iPS cells.	[Niibe, Kunimichi; Kawamura, Yoshimi; Araki, Daisuke; Miura, Kyoko; Suzuki, Sadafumi; Sunabori, Takehiko; Mabuchi, Yo; Nagai, Yasuo; Okano, Hideyuki; Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Niibe, Kunimichi; Araki, Daisuke; Morikawa, Satoru; Nakagawa, Taneaki] Keio Univ, Sch Med, Dept Dent & Oral Surg, Tokyo, Japan; [Shimmura, Shigeto] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Keio University; Keio University; Keio University	Niibe, K (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan.	penguin@a8.keio.jp	Mabuchi, Yo/L-1535-2013; Morikawa, Satoru/AFL-5621-2022; Miura, Kyoko/L-1750-2013; Okano, Hideyuki/I-7584-2019; Shimmura, Shigeto/J-4678-2013; Kawamura, Yoshimi/L-1289-2013	Mabuchi, Yo/0000-0001-8008-3966; Morikawa, Satoru/0000-0001-8859-2888; Miura, Kyoko/0000-0003-2208-149X; Matsuzaki, Yumi/0000-0002-3729-2997; Kawamura, Yoshimi/0000-0002-9864-7974	Japan Society for the Promotion of Science (JSPS); Ministry of Education, and Science and Culture of Japan of Keio University; Grants-in-Aid for Scientific Research [23791446] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, and Science and Culture of Japan of Keio University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by a grant from the Japan Society for the Promotion of Science (JSPS), and partly by a grant-in-aid from the Global Century COE program of the Ministry of Education, and Science and Culture of Japan of Keio University. K.N. is supported by a Research Fellowship for Young Scientists from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarkowski AK, 1998, INT J DEV BIOL, V42, P903; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882	27	40	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17610	10.1371/journal.pone.0017610	http://dx.doi.org/10.1371/journal.pone.0017610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412425	Green Published, Green Submitted, gold			2022-12-27	WOS:000288247800018
J	Sharon, H; Amar, D; Levdansky, E; Mircus, G; Shadkchan, Y; Shamir, R; Osherov, N				Sharon, Haim; Amar, David; Levdansky, Emma; Mircus, Gabriel; Shadkchan, Yana; Shamir, Ron; Osherov, Nir			PrtT-Regulated Proteins Secreted by Aspergillus fumigatus Activate MAPK Signaling in Exposed A549 Lung Cells Leading to Necrotic Cell Death	PLOS ONE			English	Article							CANDIDA-ALBICANS; EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; P38 MAPK; KAPPA-B; KINASE; MACROPHAGES; INDUCTION; INFECTION; INTERLEUKIN-8	Aspergillus fumigatus is the most commonly encountered mold pathogen of humans, predominantly infecting the respiratory system. Colonization and penetration of the lung alveolar epithelium is a key but poorly understood step in the infection process. This study focused on identifying the transcriptional and cell-signaling responses activated in A549 alveolar carcinoma cells incubated in the presence of A. fumigatus wild-type and Delta PrtT protease-deficient germinating conidia and culture filtrates (CF). Microarray analysis of exposed A549 cells identified distinct classes of genes whose expression is altered in the presence of germinating conidia and CF and suggested the involvement of both NFkB and MAPK signaling pathways in mediating the cellular response. Phosphoprotein analysis of A549 cells confirmed that JNK and ERK1/2 are phosphorylated in response to CF from wild-type A. fumigatus and not phosphorylated in response to CF from the Delta PrtT protease-deficient strain. Inhibition of JNK or ERK1/2 kinase activity substantially decreased CF-induced cell damage, including cell peeling, actin-cytoskeleton damage, and reduction in metabolic activity and necrotic death. These results suggest that inhibition of MAPK-mediated host responses to treatment with A. fumigatus CF decreases cellular damage, a finding with possible clinical implications.	[Sharon, Haim; Levdansky, Emma; Mircus, Gabriel; Shadkchan, Yana; Osherov, Nir] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Amar, David; Shamir, Ron] Tel Aviv Univ, Dept Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Sharon, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	nosherov@post.tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870	Israel Ministry of Health [3-5201]; Israel Cancer Research Fund (ICRF) [05-502 RCDA]; Israel Science Foundation [802/08]; Tel Aviv University	Israel Ministry of Health; Israel Cancer Research Fund (ICRF); Israel Science Foundation(Israel Science Foundation); Tel Aviv University	This work was supported by the Israel Ministry of Health grant 3-5201 and Israel Cancer Research Fund (ICRF) grant 05-502 RCDA to N.O. R.S. was supported in part by the Israel Science Foundation (grant 802/08). D.A. was supported in part by a fellowship from the Edmond J. Safra Bioinformatics program at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Balloy V, 2008, J BIOL CHEM, V283, P30513, DOI 10.1074/jbc.M803149200; Bergmann A, 2009, INFECT IMMUN, V77, P4041, DOI 10.1128/IAI.00425-09; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; BRUNS S, PLOS PATHOG, V6; Copping VMS, 2005, J ANTIMICROB CHEMOTH, V55, P645, DOI 10.1093/jac/dki088; Daly P, 2002, MED MYCOL, V40, P27, DOI 10.1080/mmy.40.1.27.33; Daly P, 1999, MYCOPATHOLOGIA, V146, P67, DOI 10.1023/A:1007092112873; DeHart DJ, 1997, J INFECT DIS, V175, P146, DOI 10.1093/infdis/175.1.146; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Deva R, 2003, J IMMUNOL, V171, P3047, DOI 10.4049/jimmunol.171.6.3047; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Hargett D, 2005, J VIROL, V79, P8348, DOI 10.1128/JVI.79.13.8348-8360.2005; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kimberg M, 2008, MED MYCOL, V46, P631, DOI 10.1080/13693780802140907; Kogan TV, 2004, J INFECT DIS, V189, P1965, DOI 10.1086/420850; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lamaris GA, 2008, J INFECT DIS, V198, P186, DOI 10.1086/589305; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Lee HS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2661; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Mans Jeffrey J., 2006, Infectious Disorders - Drug Targets, V6, P299, DOI 10.2174/187152606778249926; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Monick MM, 2001, J IMMUNOL, V166, P2681, DOI 10.4049/jimmunol.166.4.2681; Moriyuki K, 2008, REGUL PEPTIDES, V145, P42, DOI 10.1016/j.regpep.2007.08.002; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; MULLINS J, 1976, CLIN ALLERGY, V6, P209, DOI 10.1111/j.1365-2222.1976.tb01899.x; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Roeder A, 2004, J INFECT DIS, V190, P1318, DOI 10.1086/423854; Rydkina E, 2005, CELL MICROBIOL, V7, P1519, DOI 10.1111/j.1462-5822.2005.00574.x; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Segal BH, 2007, ONCOLOGIST, V12, P7, DOI 10.1634/theoncologist.12-S2-7; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Sharon H, 2009, INFECT IMMUN, V77, P4051, DOI 10.1128/IAI.00426-09; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS157, DOI 10.1086/376523; Stergiopoulou T, 2007, AM J CLIN PATHOL, V127, P349, DOI 10.1309/UJRV9DLC11RM3G8R; Tang NF, 2004, INFECT IMMUN, V72, P2513, DOI 10.1128/IAI.72.5.2513-2520.2004; Tang P, 1998, INFECT IMMUN, V66, P1106, DOI 10.1128/IAI.66.3.1106-1112.1998; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Unezaki S, 2007, GENES CELLS, V12, P773, DOI 10.1111/j.1365-2443.2007.01084.x; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x	54	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17509	10.1371/journal.pone.0017509	http://dx.doi.org/10.1371/journal.pone.0017509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412410	Green Published, Green Submitted, gold			2022-12-27	WOS:000288247800008
J	Perez-Losada, M; Jobes, DV; Sinangil, F; Crandall, KA; Arenas, M; Posada, D; Berman, PW				Perez-Losada, Marcos; Jobes, David V.; Sinangil, Faruk; Crandall, Keith A.; Arenas, Miguel; Posada, David; Berman, Phillip W.			Phylodynamics of HIV-1 from a Phase III AIDS Vaccine Trial in Bangkok, Thailand	PLOS ONE			English	Article							INJECTING DRUG-USERS; ESTIMATING EVOLUTIONARY RATES; MOLECULAR EPIDEMIOLOGY; SUBTYPE-B; TRANSMISSION CLUSTERS; GENOTYPIC CHARACTERIZATION; CIRCULATING RECOMBINANT; CRF01-AE/B RECOMBINANT; TYPE-1; INFECTION	Background: In 2003, a phase III placebo-controlled trial (VAX003) was completed in Bangkok, Thailand. Of the 2,546 individuals enrolled in the trial based on high risk for infection through injection drug use (IDU), we obtained clinical samples and HIV-1 sequence data (envelope glycoprotein gene gp120) from 215 individuals who became infected during the trial. Here, we used these data in combination with other publicly available gp120 sequences to perform a molecular surveillance and phylodynamic analysis of HIV-1 in Thailand. Methodology and Findings: Phylogenetic and population genetic estimators were used to assess HIV-1 gp120 diversity as a function of vaccination treatment, viral load (VL) and CD4(+) counts, to indentify transmission clusters and to investigate the timescale and demographics of HIV-1 in Thailand. Three HIV-1 subtypes were identified: CRF01_AE (85% of the infections), subtype B (13%) and CRF15_AE (2%). The Bangkok IDU cohort showed more gp120 diversity than other Asian IDU cohorts and similar diversity to that observed in sexually infected individuals. Moreover, significant differences (P < 0.02) in genetic diversity were observed in CRF01_AE IDU with different VL and CD4(+) counts. No phylogenetic structure was detected regarding any of the epidemiological and clinical factors tested, although high proportions (35% to 50%) of early infections fell into clusters, which suggests that transmission chains associated with acute infection play a key role on HIV-1 spread among IDU. CRF01_AE was estimated to have emerged in Thailand in 1984.5 (1983-1986), 3-6 years before the first recognition of symptomatic patients (1989). The relative genetic diversity of the HIV-1 population has remained high despite decreasing prevalence rates since the mid 1990s. Conclusions: Our study and recent epidemiological reports indicate that HIV-1 is still a major threat in Thailand and suggest that HIV awareness and prevention needs to be strengthened to avoid AIDS resurgence.	[Perez-Losada, Marcos] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Jobes, David V.] Jobes Consulting Serv, Rockville, MD USA; [Sinangil, Faruk] Global Solut Infect Dis, San Francisco, CA USA; [Crandall, Keith A.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Arenas, Miguel; Posada, David] Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo 36310, Spain; [Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Universidade do Porto; Brigham Young University; Universidade de Vigo; University of California System; University of California Santa Cruz	Perez-Losada, M (corresponding author), Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal.	mlosada323@gmail.com	Posada, David/C-4502-2008; Perez-Losada, Marcos/I-4407-2013; Crandall, Keith A./H-2789-2019; Arenas, Miguel/C-4831-2009	Posada, David/0000-0003-1407-3406; Perez-Losada, Marcos/0000-0002-2585-4657; Crandall, Keith A./0000-0002-0836-3389; Arenas, Miguel/0000-0002-0516-2717	VaxGen; Bill and Melinda Gates Foundation	VaxGen; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The data collection, clinical and genetic, for this study was funded by VaxGen as part of their Vax003 Phase III vaccine trial. The analysis of the DNA sequence data presented in this paper was supported by funding from the Bill and Melinda Gates Foundation to the non-profit organization Global Solutions for Infectious Diseases (GSID). The funders had no role in study design, data analysis, decision to publish, or preparation of this manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2003, GENETICS, V164, P1229; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Cheng Chun-Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P720; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; Crandall KA, 1999, EVOLUTION OF HIV, P153; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Silva UC, 2010, AIDS RES HUM RETROV, V26, P223, DOI 10.1089/aid.2009.0213; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009, 2009, AIDS EP UPD DEC 2009; KALISH ML, 1995, AIDS, V9, P851, DOI 10.1097/00002030-199508000-00004; Kato K, 2001, AIDS RES HUM RETROV, V17, P113, DOI 10.1089/08892220150217201; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kretzschmar M, 1998, AIDS, V12, P801, DOI 10.1097/00002030-199807000-00017; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; MARAIS H, 2004, THAILAND RESPONSE HI; MARJORAM P, 1994, GENETICS, V136, P673; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McCutchan FE, 1998, AIDS RES HUM RETROV, V14, P329, DOI 10.1089/aid.1998.14.329; MCCUTCHAN FE, 1992, AIDS RES HUM RETROV, V8, P1887, DOI 10.1089/aid.1992.8.1887; McVean G, 2002, GENETICS, V160, P1231; Migasena S, 2000, AIDS RES HUM RETROV, V16, P655, DOI 10.1089/088922200308882; Nguyen L, 2002, J ACQ IMMUN DEF SYND, V30, P248, DOI [10.1097/00042560-200206010-00014, 10.1097/01.QAI.0000014769.35851.92]; *NIAID, 2004, HIV CAUS AIDS US NAT; Oelrichs RB, 2003, CURR HIV RES, V1, P239, DOI 10.2174/1570162033485302; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Over M, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000279713.39675.1c; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Papathanasopoulos MA, 2003, VIRUS GENES, V26, P151, DOI 10.1023/A:1023435429841; Perez-Losada M, 2010, MOL BIOL EVOL, V27, P417, DOI 10.1093/molbev/msp254; Perez-Losada M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-67; PHANUPHAK P, 1985, ASIAN PAC J ALLERGY, V3, P195; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Punyacharoensin N, 2009, AIDS, V23, P1143, DOI 10.1097/QAD.0b013e32832baa1c; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rambaut A., 2009, TRACER MCMC TRACE AN; Ramos A, 2003, AIDS RES HUM RETROV, V19, P667, DOI 10.1089/088922203322280892; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2003, GENETICS, V164, P1677; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Saengdidtha Boonterm, 2005, J Med Assoc Thai, V88 Suppl 3, pS378; Saengwonloey O, 2003, JAIDS-J ACQ IMM DEF, V32, pS63, DOI 10.1097/00126334-200302011-00010; Saidel T. J., 2003, International Journal of Drug Policy, V14, P63, DOI 10.1016/S0955-3959(02)00209-8; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Seo TK, 2002, BIOINFORMATICS, V18, P115, DOI 10.1093/bioinformatics/18.1.115; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Smith D G, 1990, Lancet, V335, P781, DOI 10.1016/0140-6736(90)90883-7; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Subbarao S, 2000, AIDS RES HUM RETROV, V16, P699, DOI 10.1089/088922200308693; Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; *THAIL MIN PUBL HL, 1984, ACQ IMM SYNDR AIDS; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; Tovanabutra S, 2001, AIDS, V15, P1063, DOI 10.1097/00002030-200105250-00018; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2004, AIDS RES HUM RETROV, V20, P465, DOI 10.1089/088922204323087705; *UNAIDS, 2008, REP GLOB HIV AIDS EP; UNAIDS/WHO, 2008, EP FACT SHEET HIV AI; *USAID, 2008, HIV AIDS HLTH PROF S; Utachee P, 2009, AIDS RES HUM RETROV, V25, P229, DOI 10.1089/aid.2008.0232; Vaccari M, 2010, EXPERT REV VACCINES, V9, P997, DOI [10.1586/erv.10.104, 10.1586/ERV.10.104]; van Griensven F, 2004, AIDS, V18, P295, DOI 10.1097/00002030-200401230-00020; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vanichseni S, 2004, AIDS, V18, P311, DOI 10.1097/00002030-200401230-00022; Viputtijul K, 2002, AIDS RES HUM RETROV, V18, P1235, DOI 10.1089/08892220260387986; WASI C, 1995, AIDS, V9, P843, DOI 10.1097/00002030-199508000-00003; Watanaveeradej V, 2006, AIDS RES HUM RETROV, V22, P801, DOI 10.1089/aid.2006.22.801; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Wirachsilp Piyanot, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P814; Xiridou M, 2007, JAIDS-J ACQ IMM DEF, V45, P468, DOI 10.1097/QAI.0b013e318093dea5; YANG Z, 2001, PAML PHYLOGENETIC AN; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; [No title captured]	106	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e16902	10.1371/journal.pone.0016902	http://dx.doi.org/10.1371/journal.pone.0016902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423744	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100004
J	Goni, J; Aznarez-Sanado, M; Arrondo, G; Fernandez-Seara, M; Loayza, FR; Heukamp, FH; Pastor, MA				Goni, Joaquin; Aznarez-Sanado, Maite; Arrondo, Gonzalo; Fernandez-Seara, Maria; Loayza, Francis R.; Heukamp, Franz H.; Pastor, Maria A.			The Neural Substrate and Functional Integration of Uncertainty in Decision Making: An Information Theory Approach	PLOS ONE			English	Article							PREFRONTAL CORTEX; ANTERIOR CINGULATE; INSULAR CORTEX; PROBABILITY; VALIDATION; ACTIVATION; NETWORKS; PARIETAL; CONTEXT	Decision making can be regarded as the outcome of cognitive processes leading to the selection of a course of action among several alternatives. Borrowing a central measurement from information theory, Shannon entropy, we quantified the uncertainties produced by decisions of participants within an economic decision task under different configurations of reward probability and time. These descriptors were used to obtain blood oxygen level-dependent (BOLD) signal correlates of uncertainty and two clusters codifying the Shannon entropy of task configurations were identified: a large cluster including parts of the right middle cingulate cortex (MCC) and left and right pre-supplementary motor areas (pre-SMA) and a small cluster at the left anterior thalamus. Subsequent functional connectivity analyses using the psycho-physiological interactions model identified areas involved in the functional integration of uncertainty. Results indicate that clusters mostly located at frontal and temporal cortices experienced an increased connectivity with the right MCC and left and right pre-SMA as the uncertainty was higher. Furthermore, pre-SMA was also functionally connected to a rich set of areas, most of them associative areas located at occipital and parietal lobes. This study provides a map of the human brain segregation and integration (i.e., neural substrate and functional connectivity respectively) of the uncertainty associated to an economic decision making paradigm.	[Goni, Joaquin; Aznarez-Sanado, Maite; Arrondo, Gonzalo; Fernandez-Seara, Maria; Loayza, Francis R.; Pastor, Maria A.] Univ Navarra, Neuroimaging Lab, Dept Neurosci, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Arrondo, Gonzalo; Heukamp, Franz H.] Univ Navarra, IESE Business Sch, Barcelona, Spain	University of Navarra; University of Navarra; IESE Business School	Goni, J (corresponding author), Univ Navarra, Neuroimaging Lab, Dept Neurosci, Ctr Appl Med Res, E-31080 Pamplona, Spain.	mapastor@unav.es	Loayza, Francis R./AAR-7985-2021; Fernandez-Seara, Maria A./K-1246-2014; Pastor, Maria A./C-7851-2009; Arrondo, Gonzalo/U-9534-2017	Loayza, Francis R./0000-0002-6283-3679; Fernandez-Seara, Maria A./0000-0001-8536-6295; Pastor, Maria A./0000-0003-2404-9346; Arrondo, Gonzalo/0000-0003-3085-8959; Aznarez-Sanado, Maite/0000-0002-4368-548X	FIMA of the University of Navarra; IESE Business School of the University of Navarra; CIBERNED	FIMA of the University of Navarra; IESE Business School of the University of Navarra; CIBERNED(Instituto de Salud Carlos III)	This work was funded by FIMA of the University of Navarra, IESE Business School of the University of Navarra and by CIBERNED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Aziz-Zadeh L, 2009, HUM BRAIN MAPP, V30, P908, DOI 10.1002/hbm.20554; BAUCELLS M, 2007, PROBABILITY TIME TRA; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bischoff-Grethe A, 2001, J COGNITIVE NEUROSCI, V13, P986, DOI 10.1162/089892901753165881; Blackwood N, 2004, COGNITIVE BRAIN RES, V20, P46, DOI 10.1016/j.cogbrainres.2003.12.009; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elliott R, 1999, NEUROPSYCHOLOGIA, V37, P403, DOI 10.1016/S0028-3932(98)00107-9; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; FORTSMANN BU, 2008, P NATL ACAD SCI USA, V105, P17538; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Harrison LM, 2006, NEURAL NETWORKS, V19, P535, DOI 10.1016/j.neunet.2005.11.002; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031; Paulus MP, 2001, NEUROIMAGE, V13, P91, DOI 10.1006/nimg.2000.0667; Penny W., 2003, HUMAN BRAIN FUNCTION; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Reynolds SM, 2005, J NEUROSCI, V25, P11757, DOI 10.1523/JNEUROSCI.3432-05.2005; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stephan KE, 2004, J ANAT, V205, P443, DOI 10.1111/j.0021-8782.2004.00359.x; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; STOODLEY C, 2010, CORTEX IN PRESS; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; STRANGE BA, 1999, NEUROIMAGE, V9, P36; Volz KG, 2005, BRAIN RES BULL, V67, P403, DOI 10.1016/j.brainresbull.2005.06.011; Volz KG, 2004, NEUROIMAGE, V21, P848, DOI 10.1016/j.neuroimage.2003.10.028; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y	38	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17408	10.1371/journal.pone.0017408	http://dx.doi.org/10.1371/journal.pone.0017408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408065	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900015
J	Pan, YQ; Ouyang, ZQ; Wong, WH; Baker, JC				Pan, Yuqiong; Ouyang, Zhengqing; Wong, Wing Hung; Baker, Julie C.			A New FACS Approach Isolates hESC Derived Endoderm Using Transcription Factors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION ANALYSIS; FLOW-CYTOMETRY; DIFFERENTIATION; RNA; FIXATION; MOUSE	We show that high quality microarray gene expression profiles can be obtained following FACS sorting of cells using combinations of transcription factors. We use this transcription factor FACS (tfFACS) methodology to perform a genomic analysis of hESC-derived endodermal lineages marked by combinations of SOX17, GATA4, and CXCR4, and find that triple positive cells have a much stronger definitive endoderm signature than other combinations of these markers. Additionally, SOX17(+) GATA4(+) cells can be obtained at a much earlier stage of differentiation, prior to expression of CXCR4(+) cells, providing an important new tool to isolate this earlier definitive endoderm subtype. Overall, tfFACS represents an advancement in FACS technology which broadly crosses multiple disciplines, most notably in regenerative medicine to redefine cellular populations.	[Pan, Yuqiong; Wong, Wing Hung] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Pan, Yuqiong; Baker, Julie C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pan, Yuqiong] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Ouyang, Zhengqing; Wong, Wing Hung] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Wong, Wing Hung] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Pan, YQ (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	whwong@stanford.edu; jbaker@stanford.edu			California Institute of Regenerative Medicine (CIRM) [RC1-00100, RC1-00133]; National Institutes of Health [1U01HL100397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the California Institute of Regenerative Medicine (CIRM) Grants RC1-00100 (J.C.B., W.H.W.) and RC1-00133 (W.H.W.), National Institutes of Health grant 1U01HL100397 (W.H.W.). Z.O. was supported by a CIRM predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afouda BA, 2005, DEVELOPMENT, V132, P763, DOI 10.1242/dev.01647; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Chiao E, 2008, STEM CELLS, V26, P2032, DOI 10.1634/stemcells.2007-0964; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; De Rosa SC, 2003, NAT MED, V9, P112, DOI 10.1038/nm0103-112; Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li JX, 2000, GENE DEV, V14, P464; LIU H, 2007, P LSS COMPUT SYST BI, V6, P79; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Mossman AK, 2005, STEM CELLS DEV, V14, P656, DOI 10.1089/scd.2005.14.656; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Preffer F, 2009, CYTOM PART B-CLIN CY, V76B, P295, DOI 10.1002/cyto.b.20480; Ravo M, 2008, LAB INVEST, V88, P430, DOI 10.1038/labinvest.2008.11; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szaniszlo P, 2004, CYTOM PART A, V59A, P191, DOI 10.1002/cyto.a.20055; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	29	18	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17536	10.1371/journal.pone.0017536	http://dx.doi.org/10.1371/journal.pone.0017536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408072	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900026
J	Schmidt, AJ; Rockstroh, JK; Vogel, M; Heiden, MAD; Baillot, A; Krznaric, I; Radun, D				Schmidt, Axel J.; Rockstroh, Juergen K.; Vogel, Martin; Heiden, Matthias An Der; Baillot, Armin; Krznaric, Ivanka; Radun, Doris			Trouble with Bleeding: Risk Factors for Acute Hepatitis C among HIV-Positive Gay Men from Germany-A Case-Control Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED INFECTION; HOMOSEXUAL-MEN; HETEROSEXUAL TRANSMISSION; COINFECTED PATIENTS; SEMINAL PLASMA; SEX; HCV; PREVALENCE; INCREASE	Objectives: To identify risk factors for hepatitis C among HIV-positive men who have sex with men (MSM), focusing on potential sexual, nosocomial, and other non-sexual determinants. Background: Outbreaks of hepatitis C virus (HCV) infections among HIV-positive MSM have been reported by clinicians in post-industrialized countries since 2000. The sexual acquisition of HCV by gay men who are HIV positive is not, however, fully understood. Methods: Between 2006 and 2008, a case-control study was embedded into a behavioural survey of MSM in Germany. Cases were HIV-positive and acutely HCV-co-infected, with no history of injection drug use. HIV-positive MSM without known HCV infection, matched for age group, served as controls. The HCV-serostatus of controls was assessed by serological testing of dried blood specimens. Univariable and multivariable regression analyses were used to identify factors independently associated with HCV-co-infection. Results: 34 cases and 67 controls were included. Sex-associated rectal bleeding, receptive fisting and snorting cocaine/amphetamines, combined with group sex, were independently associated with case status. Among cases, surgical interventions overlapped with sex-associated rectal bleeding. Conclusions: Sexual practices leading to rectal bleeding, and snorting drugs in settings of increased HCV-prevalence are risk factors for acute hepatitis C. We suggest that sharing snorting equipment as well as sharing sexual partners might be modes of sexual transmission. Condoms and gloves may not provide adequate protection if they are contaminated with blood. Public health interventions for HIV-positive gay men should address the role of blood in sexual risk behaviour. Further research is needed into the interplay of proctosurgery and sex-associated rectal bleeding.	[Schmidt, Axel J.; Heiden, Matthias An Der; Radun, Doris] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany; [Rockstroh, Juergen K.; Vogel, Martin] Univ Bonn, Med Clin 1, D-5300 Bonn, Germany; [Baillot, Armin] Govt Inst Publ Hlth Lower Saxony, Hannover, Germany	Robert Koch Institute; University of Bonn	Schmidt, AJ (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	a.j.schmidt@rki.de	Schmidt, Axel J/J-1855-2019	Schmidt, Axel J/0000-0002-6910-4399; an der Heiden, Matthias/0000-0001-5863-4549	Robert Koch Institute; University of Bonn; German MOH; Roche; Essex; Abbott; Gilead; Boehringer Ingelheim; GSK; ViiV; Pfizer; MSD; Tibotec; BMS	Robert Koch Institute; University of Bonn; German MOH; Roche(Roche Holding); Essex; Abbott(Abbott Laboratories); Gilead(Gilead Sciences); Boehringer Ingelheim(Boehringer Ingelheim); GSK(GlaxoSmithKline); ViiV; Pfizer(Pfizer); MSD; Tibotec; BMS(Bristol-Myers Squibb)	The embedded case-control study was funded by the Robert Koch Institute and the University of Bonn; the KABaSTI study was supported by the German MOH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Axel J. Schmidt, Matthias An der Heiden, Armin Baillot, Ivanka Krznaric, and Doris Radun do not have any financial disclosures. Jurgen K. Rockstroh and Martin Vogel have received lecture fees and congress travel grants from Roche, Essex, Abbott, Gilead, Boehringer Ingelheim, GSK, ViiV, Pfizer, MSD, Tibotec, and BMS, but none of these were related to the case-control-study presented here.	Aaron S, 2008, CLIN INFECT DIS, V47, P931, DOI 10.1086/591699; Alary M, 2005, AM J PUBLIC HEALTH, V95, P502, DOI 10.2105/AJPH.2003.020388; Aral SO, 2002, SEX TRANSM INFECT, V78, pI3, DOI 10.1136/sti.78.suppl_1.i3; Blaise G, 2007, J EUR ACAD DERMATOL, V21, P1262, DOI 10.1111/j.1468-3083.2007.02155.x; BOCHOW M, 2004, GAY MEN AIDS RISK MA, V48; BOCHOW M, 2010, GAY MEN AIDS SEXUAL, V55; Bollepalli S, 2007, SEX TRANSM DIS, V34, P367, DOI 10.1097/01.olq.0000240295.35457.b1; Bourlet T, 2003, J CLIN MICROBIOL, V41, P789, DOI 10.1128/JCM.41.2.789-793.2003; Bourlet T, 2002, J CLIN MICROBIOL, V40, P3252, DOI 10.1128/JCM.40.9.3252-3255.2002; Bouvet Elisabeth, 2005, Euro Surveill, V10, P74; Briat A, 2005, AIDS, V19, P1827, DOI 10.1097/01.aids.0000189847.98569.2d; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Carey JW, 2009, AIDS BEHAV, V13, P1084, DOI 10.1007/s10461-008-9403-3; Cassuto NG, 2002, HUM REPROD, V17, P3153, DOI 10.1093/humrep/17.12.3153; Clarke A, 2006, INT J STD AIDS, V17, P74, DOI 10.1258/095646206775455685; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; *EACS, 2007, GUID CLIN MAN TREAT; Farias A, 2010, HEPATO-GASTROENTEROL, V57, P300; Fierer D, 2009, 16 C RETR OPP INF MO; Filippini P, 2001, SEX TRANSM DIS, V28, P725, DOI 10.1097/00007435-200112000-00010; GAMBOTTI L, 2005, EUROSURVEILLANCE, V10, P74; Ghosn J, 2006, SEX TRANSM INFECT, V82, P458, DOI 10.1136/sti.2006.021493; Ghosn J, 2004, HIV MED, V5, P303, DOI 10.1111/j.1468-1293.2004.00225.x; GHOSN J, 2009, 16 C RETR OPP INF MO; Ghosn J, 2008, AIDS, V22, P658, DOI 10.1097/QAD.0b013e3282f4e86f; Giuliani M, 1997, SEX TRANSM DIS, V24, P533, DOI 10.1097/00007435-199710000-00007; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Hisada M, 2000, J INFECT DIS, V181, P1475, DOI 10.1086/315396; Jin FY, 2007, JAIDS-J ACQ IMM DEF, V46, P245, DOI 10.1097/QAI.0b013e3181565db5; Jin FY, 2007, SEX TRANSM INFECT, V83, P397, DOI 10.1136/sti.2007.025684; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Jin FY, 2005, AUST NZ J PUBL HEAL, V29, P536, DOI 10.1111/j.1467-842X.2005.tb00246.x; Kamili S, 2007, INFECT CONT HOSP EP, V28, P519, DOI 10.1086/513727; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Leruez-Ville M, 2000, LANCET, V356, P42, DOI 10.1016/S0140-6736(00)02435-1; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; MARCUS U, 2011, SEX HLTH IN PRESS; Marcus U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-180; Minola E, 2006, EUR J EPIDEMIOL, V21, P293, DOI 10.1007/s10654-006-0016-8; Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea; Mudrikova T, 2008, NETH J MED, V66, P98; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Neumayr G, 1999, QJM-INT J MED, V92, P505, DOI 10.1093/qjmed/92.9.505; Nowicki MJ, 2005, J INFECT DIS, V192, P1557, DOI 10.1086/491742; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Owen G, 2008, CULT HEALTH SEX, V10, P601, DOI 10.1080/13691050802061673; Page-Shafer KA, 2002, AM J PUBLIC HEALTH, V92, P670, DOI 10.2105/AJPH.92.4.670; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Pasquier C, 2003, J MED VIROL, V69, P344, DOI 10.1002/jmv.10295; *R KOCH I, 2009, EP B, V20, P197; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P112; Ruys Th A, 2004, Ned Tijdschr Geneeskd, V148, P2309; Schmidt A.J., 2007, KABASTI STUDY KNOWLE; SCHMIDT AJ, 2009, 16 C RETR OPP INF MO; Serpaggi J, 2006, AIDS, V20, P233, DOI 10.1097/01.aids.0000200541.40633.56; Tahan V, 2005, AM J GASTROENTEROL, V100, P821, DOI 10.1111/j.1572-0241.2005.40879.x; Terrault NA, 2002, HEPATOLOGY, V36, pS99, DOI 10.1053/jhep.2002.36797; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Tortu S, 2004, SUBST USE MISUSE, V39, P211, DOI 10.1081/JA-120028488; Trimarchi M, 2006, AM J RHINOL, V20, P160, DOI 10.1177/194589240602000207; Tuaillon E, 2010, HEPATOLOGY, V51, P752, DOI 10.1002/hep.23407; Turner J, 2010, 2 JOINT BHIVA BASHH; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; VANDENBERG G, 2009, 16 C RETR OPP INF MO; Vogel M, 2009, CLIN INFECT DIS, V49, DOI 10.1086/600058; Walter J, 2005, GESUNDHEITSWESEN, V67, P441, DOI 10.1055/s-2005-858519; Wienecke R, 2006, HAUTARZT, V57, P994, DOI 10.1007/s00105-006-1236-2; Wyld R, 1997, J INFECTION, V35, P163, DOI 10.1016/S0163-4453(97)91677-7; Young RM, 2005, AM J PUBLIC HEALTH, V95, P1144, DOI 10.2105/AJPH.2004.046714	79	109	111	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17781	10.1371/journal.pone.0017781	http://dx.doi.org/10.1371/journal.pone.0017781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408083	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000288170000059
J	Garbuzova-Davis, S; Louis, MK; Haller, EM; Derasari, HM; Rawls, AE; Sanberg, PR				Garbuzova-Davis, Svitlana; Louis, Michael K.; Haller, Edward M.; Derasari, Hiranya M.; Rawls, Ashley E.; Sanberg, Paul R.			Blood-Brain Barrier Impairment in an Animal Model of MPS III B	PLOS ONE			English	Article							SANFILIPPO-SYNDROME; MUCOPOLYSACCHARIDOSE-IIIB; PERIVASCULAR MACROPHAGES; STORAGE DISORDERS; MOUSE MODELS; MICROGLIA; PERICYTES; CELLS; GANGLIOSIDES; MECHANISMS	Background: Sanfilippo syndrome type B (MPS III B) is caused by a deficiency of alpha-N-acetylglucosaminidase enzyme, leading to accumulation of heparan sulfate within lysosomes and eventual progressive cerebral and systemic multiple organ abnormalities. However, little is known about the competence of the blood-brain barrier (BBB) in MPS III B. BBB dysfunction in this devastating disorder could contribute to neuropathological disease manifestations. Methodology/Principal Findings: In the present study, we investigated structural (electron microscope) and functional (vascular leakage) integrity of the BBB in a mouse model of MPS III B at different stages of disease, focusing on brain structures known to experience neuropathological changes. Major findings of our study were: (1) endothelial cell damage in capillary ultrastructure, compromising the BBB and resulting in vascular leakage, (2) formation of numerous large vacuoles in endothelial cells and perivascular cells (pericytes and perivascular macrophages) in the large majority of vessels, (3) edematous space around microvessels, (4) microaneurysm adjacent to a ruptured endothelium, (6) Evans Blue and albumin microvascular leakage in various brain structures, (7) GM3 ganglioside accumulation in endothelium of the brain microvasculature. Conclusions/Significance: These new findings of BBB structural and function impairment in MPS III B mice even at early disease stage may have implications for disease pathogenesis and should be considered in current and future development of treatments for MPS III B.	[Garbuzova-Davis, Svitlana; Louis, Michael K.; Derasari, Hiranya M.; Rawls, Ashley E.; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL USA; [Garbuzova-Davis, Svitlana] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Haller, Edward M.] Univ S Florida, Dept Integrat Biol, Tampa, FL USA; [Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Garbuzova-Davis, Svitlana/Q-3687-2019	Sanberg, Paul/0000-0001-9130-4592; Haller, Edward/0000-0002-8535-2181	Children's Medical Research Foundation	Children's Medical Research Foundation	This study was supported by the Children's Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barone R, 1999, NEUROPEDIATRICS, V30, P270, DOI 10.1055/s-2007-973503; Beesley GE, 1998, J MED GENET, V35, P910, DOI 10.1136/jmg.35.11.910; Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; Begley DJ, 2003, PROG DRUG RES, V61, P39; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; DAMORE PA, 1992, AM J RESP CELL MOL, V6, P1; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; FERRER I, 1988, NEUROPATH APPL NEURO, V14, P315, DOI 10.1111/j.1365-2990.1988.tb00891.x; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hamano K, 2008, ACTA NEUROPATHOL, V115, P547, DOI 10.1007/s00401-007-0325-3; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; KIDA SY, 1993, ACTA NEUROPATHOL, V85, P646, DOI 10.1007/BF00334675; Kutcher ME, 2009, MICROVASC RES, V77, P235, DOI 10.1016/j.mvr.2009.01.007; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Sasaki A, 1996, PATHOL INT, V46, P15, DOI 10.1111/j.1440-1827.1996.tb03528.x; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; Weber B, 1999, EUR J HUM GENET, V7, P34, DOI 10.1038/sj.ejhg.5200242; Zafeiriou DI, 2001, BRAIN DEV-JPN, V23, P385, DOI 10.1016/S0387-7604(01)00242-X	30	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16601	10.1371/journal.pone.0016601	http://dx.doi.org/10.1371/journal.pone.0016601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408219	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800005
J	Mukherjee, S; Santilli, G; Blundell, MP; Navarro, S; Bueren, JA; Thrasher, AJ				Mukherjee, Sayandip; Santilli, Giorgia; Blundell, Michael P.; Navarro, Susana; Bueren, Juan A.; Thrasher, Adrian J.			Generation of Functional Neutrophils from a Mouse Model of X-Linked Chronic Granulomatous Disorder Using Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC LINEAGES; EFFICIENT PRODUCTION; DEFINED FACTORS; GENE-THERAPY; DISEASE; FIBROBLASTS; PROGENITORS; ACTIVATION; INDUCTION; CULTURE	Murine models of human genetic disorders provide a valuable tool for investigating the scope for application of induced pluripotent stem cells (iPSC). Here we present a proof-of-concept study to demonstrate generation of iPSC from a mouse model of X-linked chronic granulomatous disease (X-CGD), and their successful differentiation into haematopoietic progenitors of the myeloid lineage. We further demonstrate that additive gene transfer using lentiviral vectors encoding gp91(phox) is capable of restoring NADPH-oxidase activity in mature neutrophils derived from X-CGD iPSC. In the longer term, correction of iPSC from human patients with CGD has therapeutic potential not only through generation of transplantable haematopoietic stem cells, but also through production of large numbers of autologous functional neutrophils.	[Mukherjee, Sayandip; Santilli, Giorgia; Blundell, Michael P.; Thrasher, Adrian J.] UCL Inst Child Hlth, Ctr Immunodeficiency, London, England; [Navarro, Susana; Bueren, Juan A.] Ctr Invest Energet Medioambient & Tecnol CIEMAT, Hematopoiesis & Gene Therapy Div, Madrid, Spain; [Thrasher, Adrian J.] Great Ormond St Hosp NHS Trust, London, England	University of London; University College London; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Thrasher, AJ (corresponding author), UCL Inst Child Hlth, Ctr Immunodeficiency, London, England.	a.thrasher@ich.ucl.ac.uk	Blundell, Michael P/M-1276-2015; Bueren, Juan/L-6112-2014; Navarro, Susana/L-9300-2014	Bueren, Juan/0000-0002-3228-7013; Navarro, Susana/0000-0002-0764-5384; Thrasher, Adrian/0000-0002-6097-6115; Blundell, Michael/0000-0002-9179-6870	European Program "7FWP, Health" [222878]; Chronic Granulomatous Disorder Research Trust [J4G/04B/GT09]; Biotechnology and Biological Sciences Research Council, UK [BB/F015526/1]; Wellcome Trust [090233/Z/09/Z]; GOSH Children's Charity; Ministry of Science and Innovation for Programa de Fomento de Cooperacion Cientifica Internacional [110-90.1]; Plan Nacional de Salud y Farmacia [SAF 2009-07164]; Fondo de Investigaciones Sanitarias, ISCIII [RETICS-RD06/0010/0015]; BBSRC [BB/F015526/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F015526/1] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1223] Funding Source: researchfish	European Program "7FWP, Health"; Chronic Granulomatous Disorder Research Trust; Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); GOSH Children's Charity; Ministry of Science and Innovation for Programa de Fomento de Cooperacion Cientifica Internacional; Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias, ISCIII(Instituto de Salud Carlos III); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Great Ormond Street Hospital Childrens Charity	This work was supported by generous funding from the following: European Program "7FWP, Health" (PERSIST; Ref Grant Agreement no: 222878); Chronic Granulomatous Disorder Research Trust (J4G/04B/GT09); Biotechnology and Biological Sciences Research Council, UK (BB/F015526/1); Wellcome Trust (090233/Z/09/Z); GOSH Children's Charity; Ministry of Science and Innovation for Programa de Fomento de Cooperacion Cientifica Internacional (110-90.1); Plan Nacional de Salud y Farmacia (SAF 2009-07164); Fondo de Investigaciones Sanitarias, ISCIII (Programa RETICS-RD06/0010/0015); Fundacion Marcelino Botin for promoting translational research at the Division de Hematopoyesis y Terapia Genica at the CIEMAT-CIBERER. CIBERER is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Alton E, 2007, GENE THER, V14, P1439, DOI 10.1038/sj.gt.3303001; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; GREZ M, 2010, MOL THER; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MORISHIMA T, 2010, J CELL PHYSL; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; OKADA M, 2010, BIOCH BIOPHYS ACTA; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Saeki K, 2009, STEM CELLS, V27, P59, DOI 10.1634/stemcells.2007-0980; SANTILLI G, 2010, MOL THER; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yokoyama Y, 2009, BLOOD, V113, P6584, DOI 10.1182/blood-2008-06-160838	29	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17565	10.1371/journal.pone.0017565	http://dx.doi.org/10.1371/journal.pone.0017565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408614	gold, Green Published, Green Submitted			2022-12-27	WOS:000287965200027
J	Buhler, S; Sanchez-Mazas, A				Buhler, Stephane; Sanchez-Mazas, Alicia			HLA DNA Sequence Variation among Human Populations: Molecular Signatures of Demographic and Selective Events	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I LOCI; HUMAN MITOCHONDRIAL-DNA; GENE CONVERSION; OVERDOMINANT SELECTION; NUCLEOTIDE SUBSTITUTION; BALANCING SELECTION; NATURAL-SELECTION; HLA-DRB1 ALLELES; MHC EVOLUTION	Molecular differences between HLA alleles vary up to 57 nucleotides within the peptide binding coding region of human Major Histocompatibility Complex (MHC) genes, but it is still unclear whether this variation results from a stochastic process or from selective constraints related to functional differences among HLA molecules. Although HLA alleles are generally treated as equidistant molecular units in population genetic studies, DNA sequence diversity among populations is also crucial to interpret the observed HLA polymorphism. In this study, we used a large dataset of 2,062 DNA sequences defined for the different HLA alleles to analyze nucleotide diversity of seven HLA genes in 23,500 individuals of about 200 populations spread worldwide. We first analyzed the HLA molecular structure and diversity of these populations in relation to geographic variation and we further investigated possible departures from selective neutrality through Tajima's tests and mismatch distributions. All results were compared to those obtained by classical approaches applied to HLA allele frequencies. Our study shows that the global patterns of HLA nucleotide diversity among populations are significantly correlated to geography, although in some specific cases the molecular information reveals unexpected genetic relationships. At all loci except HLA-DPB1, populations have accumulated a high proportion of very divergent alleles, suggesting an advantage of heterozygotes expressing molecularly distant HLA molecules (asymmetric overdominant selection model). However, both different intensities of selection and unequal levels of gene conversion may explain the heterogeneous mismatch distributions observed among the loci. Also, distinctive patterns of sequence divergence observed at the HLA-DPB1 locus suggest current neutrality but old selective pressures on this gene. We conclude that HLA DNA sequences advantageously complement HLA allele frequencies as a source of data used to explore the genetic history of human populations, and that their analysis allows a more thorough investigation of human MHC molecular evolution.	[Buhler, Stephane; Sanchez-Mazas, Alicia] Univ Geneva, Lab Anthropol Genet & Peopling Hist, Dept Anthropol, Geneva, Switzerland	University of Geneva	Buhler, S (corresponding author), Univ Geneva, Lab Anthropol Genet & Peopling Hist, Dept Anthropol, Geneva, Switzerland.	stephane.buhler@unige.ch		Buhler, Stephane/0000-0001-6675-5287; SANCHEZ-MAZAS, Alicia/0000-0002-7714-2432	Swiss National Science Foundation [FNS 3100-49771.96, 3100A0-112651]; European Science Foundation [ESF COST Action BM0803 HLA-NET]; Swiss State Secretariat for Education and Research (SER) [C08.0131];  [PBGEA-119280]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); Swiss State Secretariat for Education and Research (SER); 	This work was supported by grants from the Swiss National Science Foundation (FNS 3100-49771.96 and 3100A0-112651 to A. Sanchez-Mazas and fellowship for prospective researcher PBGEA-119280 to S. Buhler) and by the European Science Foundation (ESF COST Action BM0803 HLA-NET) and the Swiss State Secretariat for Education and Research (SER grant C08.0131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x; Arnaiz-Villena A, 2000, TISSUE ANTIGENS, V56, P405, DOI 10.1034/j.1399-0039.2000.560503.x; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Beck S, 2000, ANNU REV GENOM HUM G, V1, P117, DOI 10.1146/annurev.genom.1.1.117; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; Bergstrom TF, 1999, IMMUNOL REV, V167, P351, DOI 10.1111/j.1600-065X.1999.tb01404.x; Bergstrom TF, 1998, NAT GENET, V18, P237, DOI 10.1038/ng0398-237; BODMER J, 1997, P 12 INT HIST WORKSH, P269; Bontrop RE, 2006, HUM IMMUNOL, V67, P388, DOI 10.1016/j.humimm.2006.03.007; Bradshaw D, 2002, TISSUE ANTIGENS, V59, P325, DOI 10.1034/j.1399-0039.2002.590413.x; Buhler S, 2006, TISSUE ANTIGENS, V68, P44, DOI 10.1111/j.1399-0039.2006.00621.x; Buhler S, 2002, TISSUE ANTIGENS, V59, P525, DOI 10.1034/j.1399-0039.2002.590611.x; Buhler S, 2010, TISSUE ANTIGENS, V75, P500, DOI 10.1111/j.1399-0039.2010.01469.x; Bunce M, 1997, TRANSPLANTATION, V64, P1505, DOI 10.1097/00007890-199712150-00001; Bunce M., 1997, Tissue Antigens, V50, P100, DOI 10.1111/j.1399-0039.1997.tb02847.x; Cadavid LF, 1997, TISSUE ANTIGENS, V50, P209, DOI 10.1111/j.1399-0039.1997.tb02865.x; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cereb N, 1997, IMMUNOGENETICS, V47, P30, DOI 10.1007/s002510050323; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DI D, AM J PHYS A IN PRESS; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fukami-Kobayashi K, 2005, P NATL ACAD SCI USA, V102, P9230, DOI 10.1073/pnas.0500770102; GAO X, 1997, P 12 INT HIST WORKSH, P298; Garrigan D, 2003, EVOLUTION, V57, P1707; Gaudieri S, 2000, GENOME RES, V10, P1579, DOI 10.1101/gr.127200; Gibert M, 2003, EUR J IMMUNOGENET, V30, P361, DOI 10.1046/j.1365-2370.2003.00418.x; Grundschober C, 1997, TISSUE ANTIGENS, V49, P612, DOI 10.1111/j.1399-0039.1997.tb02809.x; Guenounou BA, 2006, INT J IMMUNOGENET, V33, P93, DOI 10.1111/j.1744-313X.2006.00577.x; Hao L, 2005, GENE, V347, P149, DOI 10.1016/j.gene.2004.12.012; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hedrick PW, 1998, GENETICA, V104, P207, DOI 10.1023/A:1026494212540; HOLLENBACH JA, 2010, ANTHR COMP 15 INT HI; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Jakobsen IB, 1998, IMMUNOGENETICS, V48, P312, DOI 10.1007/s002510050438; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; KWOK WW, 1993, J IMMUNOL, V150, P2263; KWOK WW, 1995, J IMMUNOL, V155, P2468; Little AM, 1996, TISSUE ANTIGENS, V48, P113, DOI 10.1111/j.1399-0039.1996.tb02615.x; MACK S, 2006, IMMUNOBIOLOGY HUMAN, P747; Mack S. J., 2006, IMMUNOBIOLOGY HUMAN, P580; Mack SJ, 2006, IMMUNOBIOLOGY HUMAN, P564; Marsh S. G. E., 2000, HLA FACTSBOOK; MARSH SG, 2008, HUM IMMUNOL; Marsh SGE, 2005, TISSUE ANTIGENS, V65, P301, DOI 10.1111/j.1399-0039.2005.00379.x; Martinsohn JT, 1999, IMMUNOGENETICS, V50, P168, DOI 10.1007/s002510050593; MEDHI SQ, 1997, P 12 INT HIST WORKSH, P321; Meyer D, 2006, IMMUNOBIOLOGY HUMAN, P653; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Mytilineos J, 1997, TISSUE ANTIGENS, V50, P395, DOI 10.1111/j.1399-0039.1997.tb02893.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NUNES J, HUM BIOL IN PRESS; Nunes J, 2006, IMMUNOBIOLOGY HUMAN, P143; Nunes J, 2005, THESIS U PORTO; Nunes JM, 2006, GENERATE TOOLS ANAL; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Parham P, 1997, TISSUE ANTIGENS, V50, P219, DOI 10.1111/j.1399-0039.1997.tb02866.x; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; Perrier P, 2000, TISSUE ANTIGENS, V56, P556, DOI 10.1034/j.1399-0039.2000.560612.x; PETZLERLER ML, 1997, P 12 IHWC HLA GEN HI, P337; PIAZZA A, 1997, P 12 INT HIST WORKSH, P374; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ray N., 2002, GEODIST; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; REYNOLDS J, 1983, GENETICS, V105, P767; RICCIO M, HUM BIOL IN PRESS; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Robinson James, 2007, V409, P43, DOI 10.1007/978-1-60327-118-9_3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohlf F.J., 2000, NTSYSPC NUMERICAL TA; Salamon H, 1999, GENETICS, V152, P393; Sanchez-Mazas A, 2000, TISSUE ANTIGENS, V56, P303, DOI 10.1034/j.1399-0039.2000.560402.x; Sanchez-Mazas A, 2001, HUM IMMUNOL, V62, P937, DOI 10.1016/S0198-8859(01)00293-2; Sanchez-Mazas A., 2006, IMMUNOBIOLOGY HUMAN, P758; Sanchez-Mazas A, 2007, TISSUE ANTIGENS, V69, P198, DOI 10.1111/j.1399-0039.2006.00802.x; Satta Y, 1997, HEREDITAS, V127, P105, DOI 10.1111/j.1601-5223.1997.00105.x; SATTA Y, 1994, P NATL ACAD SCI USA, V91, P7184, DOI 10.1073/pnas.91.15.7184; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SAWYER S, 1999, GENECONVC COMPUTER P; Schierup MH, 2000, GENETICS, V156, P879; Schierup MH, 2001, GENETICS, V159, P1833; Schneider S, 1999, GENETICS, V152, P1079; Silvera-Redondo C, 2000, IMMUNOGENETICS, V51, P1053, DOI 10.1007/s002510000238; Slatkin M, 2000, GENETICS, V156, P2119; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Takahata N, 1998, GENETICA, V102-3, P157, DOI 10.1023/A:1017029613342; Tavoularis S, 2001, TISSUE ANTIGENS, V57, P390, DOI 10.1034/j.1399-0039.2001.570420.x; TIERCY JM, 1992, AM J HUM GENET, V51, P592; TSAI Y, 2006, IMMUNOBIOLOGY HUMAN, P199; Turner S, 1998, J IMMUNOL, V161, P1406; Valdes AM, 1999, ANN HUM GENET, V63, P27, DOI 10.1046/j.1469-1809.1999.6310027.x; van Oosterhout Cock, 2009, Communicative & Integrative Biology, V2, P408; van Oosterhout C, 2009, P ROY SOC B-BIOL SCI, V276, P657, DOI 10.1098/rspb.2008.1299; von Salome J, 2007, IMMUNOGENETICS, V59, P261, DOI 10.1007/s00251-007-0196-8; Wang H, 1997, TISSUE ANTIGENS, V49, P134, DOI 10.1111/j.1399-0039.1997.tb02727.x; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; WATTERSON GA, 1978, GENETICS, V88, P405; Wiuf C, 2000, GENETICS, V155, P451; Wiuf C, 2000, THEOR POPUL BIOL, V57, P357, DOI 10.1006/tpbi.2000.1462; WRIGHT S, 1951, ANN EUGENIC, V15, P323	109	94	96	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2011	6	2							e14643	10.1371/journal.pone.0014643	http://dx.doi.org/10.1371/journal.pone.0014643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UR	21408106	Green Published, Green Submitted, gold			2022-12-27	WOS:000286835000002
J	Biadgilign, S; Deribew, A; Amberbir, A; Escudero, HR; Deribe, K				Biadgilign, Sibhatu; Deribew, Amare; Amberbir, Alemayehu; Escudero, Horacio Ruisenor; Deribe, Kebede			Factors Associated with HIV/AIDS Diagnostic Disclosure to HIV Infected Children Receiving HAART: A Multi-Center Study in Addis Ababa, Ethiopia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MATERNAL DISCLOSURE; OLDER CHILDREN; DISCUSSING HIV; ADOLESCENTS; MOTHERS; AIDS; PERSPECTIVES; CAREGIVERS; ADHERENCE	Background: Diagnostic disclosure of HIV/AIDS to a child is becoming an increasingly common issue in clinical practice. Nevertheless, some parents and health care professionals are reluctant to inform children about their HIV infection status. The objective of this study was to identify the proportion of children who have knowledge of their serostatus and factors associated with disclosure in HIV-infected children receiving HAART in Addis Ababa, Ethiopia. Methods: A cross-sectional study was conducted in five hospitals in Addis Ababa from February 18, 2008-April 28, 2008. The study populations were parents/caretakers and children living with HIV/AIDS who were receiving Highly Active Antiretroviral Therapy (HAART) in selected hospitals in Addis Ababa. Univariate and multivariate logistic regression analysis were carried out using SPSS 12.0.1 statistical software. Results: A total of 390 children/caretaker pairs were included in the study. Two hundred forty three children (62.3%) were between 6-9 years of age. HIV/AIDS status was known by 68 (17.4%) children, 93 (29%) caretakers reported knowing the child's serostatus two years prior to our survey, 180 (46.2%) respondents said that the child should be told about his/her HIV/AIDS status when he/she is older than 14 years of age. Children less than 9 years of age and those living with educated caregivers are less likely to know their results than their counterparts. Children referred from hospital's in-patient ward before attending the HIV clinic and private clinic were more likely to know their results than those from community clinic. Conclusion: The proportion of disclosure of HIV/AIDS diagnosis to HIV-infected children is low. Strengthening referral linkage and health education tailored to educated caregivers are recommended to increase the rate of disclosure.	[Biadgilign, Sibhatu; Deribew, Amare] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol & Biostat, Jimma, Ethiopia; [Escudero, Horacio Ruisenor] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Amberbir, Alemayehu] Univ Addis Ababa, Addis Ababa, Ethiopia; [Deribe, Kebede] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Gen Publ Hlth, Jimma, Ethiopia	Jimma University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Addis Ababa University; Jimma University	Biadgilign, S (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol & Biostat, Jimma, Ethiopia.	sibhatu2005@yahoo.com	Amberbir, Alemayehu/HGC-2647-2022; Deribe, Kebede/K-7055-2019; Deribe, Kebede/I-5422-2019	Deribe, Kebede/0000-0002-8526-6996; Biadgilign, Sibhatu/0000-0002-7582-5977; Deribew, Amare/0000-0003-2031-6080	Jimma University	Jimma University	This study was funded by Jimma University. The university had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armistead L, 2001, J PEDIATR PSYCHOL, V26, P11, DOI 10.1093/jpepsy/26.1.11; Biadgilign S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-53; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Blasini I, 2004, J DEV BEHAV PEDIATR, V25, P181, DOI 10.1097/00004703-200406000-00007; BOR R, 1996, AIDS CARE, V9, P49; Brown LK, 2000, J CHILD PSYCHOL PSYC, V41, P81, DOI 10.1111/1469-7610.00550; Butler AM, 2009, PEDIATRICS, V123, P935, DOI 10.1542/peds.2008-1290; Cohen J, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e8; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; Flanagan-Klygis E, 2002, AIDS PUBLIC POLICY J, V17, P3; FunckBrentano I, 1997, ARCH PEDIAT ADOL MED, V151, P978, DOI 10.1001/archpedi.1997.02170470012002; GRUBMAN S, 1995, PEDIATRICS, V95, P657; Herek GM, 1999, AM BEHAV SCI, V42, P1106, DOI 10.1177/00027649921954787; Kirshenbaum SB, 2002, AIDS EDUC PREV, V14, P1, DOI 10.1521/aeap.14.1.1.24331; Landau G, 2004, HEALTH SOC WORK, V29, P116, DOI 10.1093/hsw/29.2.116; Ledlie SW, 1999, NURS RES, V48, P141, DOI 10.1097/00006199-199905000-00004; Lee CL, 1999, AIDS PATIENT CARE ST, V13, P41, DOI 10.1089/apc.1999.13.41; Lesch A, 2007, AIDS CARE, V19, P811, DOI 10.1080/09540120601129301; LESTER P, 2002, CLIN CHILD PSYCHOL P, V7, P85, DOI DOI 10.1177/1359104502007001007; LIPSON M, 1994, J DEV BEHAV PEDIATR, V15, pS61; Lipson M., 1993, AIDS Clinical Care, V5, P43; Mellins C.A., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [https://doi.org/10.1177/1359104502007001008, DOI 10.1177/1359104502007001008, 10.1177/1359104502007001008]; *MIN HLTH ETH FED, 2008, GUID PAED HIV AI JUL; Moodley K, 2006, SAMJ S AFR MED J, V96, pA201; Murphy DA, 2001, J FAM PSYCHOL, V15, P441, DOI 10.1037/0893-3200.15.3.441; Myer L, 2006, J TROP PEDIATRICS, V52, P293, DOI 10.1093/tropej/fml004; NAEEMSHEIK A, 2005, S AFR J HIV MED, V21, P46; NISHI EA, 2004, INT C AIDS JUL 11 16, V15; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Peretti-Watel P, 2006, AIDS CARE, V18, P254, DOI 10.1080/09540120500456193; SEMPLE SJ, 1993, WOMEN HEALTH, V20, P15, DOI 10.1300/J013v20n04_02; Thorne C, 2002, J ACQ IMMUN DEF SYND, V29, P396, DOI 10.1097/00126334-200204010-00011; Thorne C, 2000, CHILD CARE HLTH DEV, V26, P29, DOI 10.1046/j.1365-2214.2000.00128.x; TOMPKINS TL, 1999, CULTURAL DIVERSITY E, V5, P197, DOI DOI 10.1037/1099-9809.5.3.197; UNAIDS, 2010, GLOB AIDS EP UPD REP; WALSH ME, 1991, J PEDIATR PSYCHOL, V16, P273, DOI 10.1093/jpepsy/16.3.273; Weiner L., 1996, PEDIATR AIDS HIV INF, V7, P310; WHO UNICEF, 2008, SCAL HIV REL PREV DI; Wilfert C, 1999, PEDIATRICS, V103, P164	39	69	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17572	10.1371/journal.pone.0017572	http://dx.doi.org/10.1371/journal.pone.0017572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	738BC	21445289	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000288613300009
J	Kawazu, M; Saso, K; Tong, KI; McQuire, T; Goto, K; Son, DO; Wakeham, A; Miyagishi, M; Mak, TW; Okada, H				Kawazu, Masahito; Saso, Kayoko; Tong, Kit I.; McQuire, Tracy; Goto, Kouichiro; Son, Dong-Ok; Wakeham, Andrew; Miyagishi, Makoto; Mak, Tak W.; Okada, Hitoshi			Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development	PLOS ONE			English	Article							ANDROGEN-RECEPTOR; CHROMATIN STATE; GENE-EXPRESSION; BINDING-SITES; H3 LYSINE-9; TRANSCRIPTION; GENOME; CELLS; METHYLATION; ALPHA	Estrogen is a key regulator of normal function of female reproductive system and plays a pivotal role in the development and progression of breast cancer. Here, we demonstrate that JMJD2B (also known as KDM4B) constitutes a key component of the estrogen signaling pathway. JMJD2B is expressed in a high proportion of human breast tumors, and that expression levels significantly correlate with estrogen receptor (ER) positivity. In addition, 17-beta-estradiol (E2) induces JMJD2B expression in an ER alpha dependent manner. JMJD2B interacts with ER alpha and components of the SWI/SNF-B chromatin remodeling complex. JMJD2B is recruited to ER alpha target sites, demethylates H3K9me3 and facilitates transcription of ER responsive genes including MYB, MYC and CCND1. As a consequence, knockdown of JMJD2B severely impairs estrogen-induced cell proliferation and the tumor formation capacity of breast cancer cells. Furthermore, Jmjd2b-deletion in mammary epithelial cells exhibits delayed mammary gland development in female mice. Taken together, these findings suggest an essential role for JMJD2B in the estrogen signaling, and identify JMJD2B as a potential therapeutic target in breast cancer.	[Kawazu, Masahito; Saso, Kayoko; Tong, Kit I.; McQuire, Tracy; Goto, Kouichiro; Son, Dong-Ok; Wakeham, Andrew; Mak, Tak W.; Okada, Hitoshi] Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Miyagishi, Makoto] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Japan; [Mak, Tak W.; Okada, Hitoshi] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Mak, Tak W.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Institute of Advanced Industrial Science & Technology (AIST); University of Toronto; University of Toronto	Kawazu, M (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada.	mkawz-tky@umin.ac.jp; hokada@uhnres.utoronto.ca	Kawazu, Masahito/AAE-6143-2022; Miyagishi, Makoto/L-8174-2016	Kawazu, Masahito/0000-0003-4146-3629; Miyagishi, Makoto/0000-0001-7654-3616	Canadian Institute for Health Reserach [MOP84353]; Uehara Memorial Foundation; CIHR Institute of Cancer Research; Ontario Ministry of Health and Long Term Care	Canadian Institute for Health Reserach(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); CIHR Institute of Cancer Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	The project was supported by Canadian Institute for Health Reserach (http://www.cihr-irsc.gc.ca/e/193.html; MOP84353); Uehara Memorial Foundation (http://www.ueharazaidan.com/) for Research Fellowship Program to MK and Postdoctoral Fellowship Program to KG; CIHR Institute of Cancer Research (Bridge Funding) to HO. This research was funded in part by the Ontario Ministry of Health and Long Term Care (http://www.health.gov.on.ca/en/). The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; GOMES NP, GENES DEV, V24, P1022; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MOSAMMAPARAST N, ANN REV BIOCH; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; MULLERTIDOW C, BLOOD; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; YANG J, 2002, CANCER RES, V70, P6456	56	140	148	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17830	10.1371/journal.pone.0017830	http://dx.doi.org/10.1371/journal.pone.0017830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445275	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100037
J	Lambert, N; Lambot, MA; Bilheu, A; Albert, V; Englert, Y; Libert, F; Noel, JC; Sotiriou, C; Holloway, AK; Pollard, KS; Detours, V; Vanderhaeghen, P				Lambert, Nelle; Lambot, Marie-Alexandra; Bilheu, Angeline; Albert, Valerie; Englert, Yvon; Libert, Frederick; Noel, Jean-Christophe; Sotiriou, Christos; Holloway, Alisha K.; Pollard, Katherine S.; Detours, Vincent; Vanderhaeghen, Pierre			Genes Expressed in Specific Areas of the Human Fetal Cerebral Cortex Display Distinct Patterns of Evolution	PLOS ONE			English	Article							ACCELERATED EVOLUTION; BRAIN EVOLUTION; TRANSCRIPTION; SCHIZOPHRENIA; ASYMMETRY; MIGRATION; INSIGHTS; NEURONS; SYSTEM; NURR1	The developmental mechanisms through which the cerebral cortex increased in size and complexity during primate evolution are essentially unknown. To uncover genetic networks active in the developing cerebral cortex, we combined three-dimensional reconstruction of human fetal brains at midgestation and whole genome expression profiling. This novel approach enabled transcriptional characterization of neurons from accurately defined cortical regions containing presumptive Broca and Wernicke language areas, as well as surrounding associative areas. We identified hundreds of genes displaying differential expression between the two regions, but no significant difference in gene expression between left and right hemispheres. Validation by qRTPCR and in situ hybridization confirmed the robustness of our approach and revealed novel patterns of area-and layer-specific expression throughout the developing cortex. Genes differentially expressed between cortical areas were significantly associated with fast-evolving non-coding sequences harboring human-specific substitutions that could lead to divergence in their repertoires of transcription factor binding sites. Strikingly, while some of these sequences were accelerated in the human lineage only, many others were accelerated in chimpanzee and/or mouse lineages, indicating that genes important for cortical development may be particularly prone to changes in transcriptional regulation across mammals. Genes differentially expressed between cortical regions were also enriched for transcriptional targets of FoxP2, a key gene for the acquisition of language abilities in humans. Our findings point to a subset of genes with a unique combination of cortical areal expression and evolutionary patterns, suggesting that they play important roles in the transcriptional network underlying human-specific neural traits.	[Lambert, Nelle; Lambot, Marie-Alexandra; Bilheu, Angeline; Libert, Frederick; Detours, Vincent; Vanderhaeghen, Pierre] Univ Libre Bruxelles, Inst Rech Biol Humaine & Mol IRIBHM, Brussels, Belgium; [Lambert, Nelle] Hop Univ Enfants Reine Fabiola, Child Psychiat Dept, Brussels, Belgium; [Albert, Valerie; Englert, Yvon] Univ Libre Bruxelles, Dept Obstet & Gynaecol, Brussels, Belgium; [Noel, Jean-Christophe] Univ Libre Bruxelles, Erasme Hosp, Dept Pathol, Brussels, Belgium; [Sotiriou, Christos] Univ Libre Bruxelles, Bordet Canc Inst, Brussels, Belgium; [Holloway, Alisha K.; Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lambert, N (corresponding author), Univ Libre Bruxelles, Inst Rech Biol Humaine & Mol IRIBHM, Brussels, Belgium.	pierre.vanderhaeghen@ulb.ac.be	Holloway, Alisha/H-9574-2013	Holloway, Alisha/0000-0001-9810-389X; , Nelle/0000-0003-1137-9725; Vanderhaeghen, Pierre/0000-0001-7899-5720	Belgian FRS/FNRS; Belgian FRSM; Queen Elizabeth Medical Foundation; Interuniversity Attraction Poles Programme; Belgian State; Federal Office for Scientific, Technical and Cultural Affairs; Fondation Pierre Clerdent; Walloon Region Excellence Programme Cibles; Welbio Programme; Fonds Erasme; Belgian Kid's Fund; National Institute of General Medical Sciences [GM82901]	Belgian FRS/FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian FRSM(Fonds de la Recherche Scientifique - FNRS); Queen Elizabeth Medical Foundation; Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State; Federal Office for Scientific, Technical and Cultural Affairs; Fondation Pierre Clerdent; Walloon Region Excellence Programme Cibles; Welbio Programme(WELBIO); Fonds Erasme; Belgian Kid's Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the Belgian FRS/FNRS, the Belgian FRSM, the Queen Elizabeth Medical Foundation, the Interuniversity Attraction Poles Programme, Belgian State, Federal Office for Scientific, Technical and Cultural Affairs, The Fondation Pierre Clerdent, the Walloon Region Excellence Programme Cibles, The Welbio Programme, the Fonds Erasme and the Belgian Kid's Fund (to PV, NL, MA), and the National Institute of General Medical Sciences (grant GM82901) (to KSP). PV is a Research Director and NL a clinician-scientist of the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Amadio JP, 2006, CELL, V126, P1033, DOI 10.1016/j.cell.2006.09.007; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; CHEUNG AF, 2009, CEREB CORTEX; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; FIETZ SA, 2010, NAT NEUROSCI; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gil-Da-Costa R, 2006, NAT NEUROSCI, V9, P1064, DOI 10.1038/nn1741; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; HANSEN DV, 2010, NATURE; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Hoerder-Suabedissen A, 2009, CEREB CORTEX, V19, P1738, DOI 10.1093/cercor/bhn195; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lambot MA, 2005, J NEUROSCI, V25, P7232, DOI 10.1523/JNEUROSCI.0802-05.2005; Lambot MAH, 2009, ANAT REC, V292, P595, DOI 10.1002/ar.20883; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Rojas P, 2007, MOL PSYCHIATR, V12, P756, DOI 10.1038/sj.mp.4001993; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Sun T, 2006, CEREB CORTEX, V16, pI18, DOI 10.1093/cercor/bhk026; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Taher L, 2009, BIOINFORMATICS, V25, P578, DOI 10.1093/bioinformatics/btp043; Takeuchi A, 2006, J NEUROSCI, V26, P4460, DOI 10.1523/JNEUROSCI.4935-05.2006; TAYLOR J, CURR PROTOC BIOINFOR, pCH10; *TEAM DC, 2009, LANG ENV STAT COMP; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VALDESDAPENA M, 1983, PATHOLOGY; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xing GQ, 2006, SCHIZOPHR RES, V84, P36, DOI 10.1016/j.schres.2005.11.006; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459	64	55	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17753	10.1371/journal.pone.0017753	http://dx.doi.org/10.1371/journal.pone.0017753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445258	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100030
J	Wu, DY; Wu, M; Halpern, A; Rusch, DB; Yooseph, S; Frazier, M; Venter, JC; Eisen, JA				Wu, Dongying; Wu, Martin; Halpern, Aaron; Rusch, Douglas B.; Yooseph, Shibu; Frazier, Marvin; Venter, J. Craig; Eisen, Jonathan A.			Stalking the Fourth Domain in Metagenomic Data: Searching for, Discovering, and Interpreting Novel, Deep Branches in Marker Gene Phylogenetic Trees	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MULTIPLE SEQUENCE ALIGNMENT; MICROBIAL DIVERSITY; PROTEIN; GENOME; EVOLUTION; IDENTIFICATION; PHOTOTROPHY; ALGORITHM; RESOURCE	Background: Most of our knowledge about the ancient evolutionary history of organisms has been derived from data associated with specific known organisms (i.e., organisms that we can study directly such as plants, metazoans, and culturable microbes). Recently, however, a new source of data for such studies has arrived: DNA sequence data generated directly from environmental samples. Such metagenomic data has enormous potential in a variety of areas including, as we argue here, in studies of very early events in the evolution of gene families and of species. Methodology/Principal Findings: We designed and implemented new methods for analyzing metagenomic data and used them to search the Global Ocean Sampling (GOS) Expedition data set for novel lineages in three gene families commonly used in phylogenetic studies of known and unknown organisms: small subunit rRNA and the recA and rpoB superfamilies. Though the methods available could not accurately identify very deeply branched ss-rRNAs (largely due to difficulties in making robust sequence alignments for novel rRNA fragments), our analysis revealed the existence of multiple novel branches in the recA and rpoB gene families. Analysis of available sequence data likely from the same genomes as these novel recA and rpoB homologs was then used to further characterize the possible organismal source of the novel sequences. Conclusions/Significance: Of the novel recA and rpoB homologs identified in the metagenomic data, some likely come from uncharacterized viruses while others may represent ancient paralogs not yet seen in any cultured organism. A third possibility is that some come from novel cellular lineages that are only distantly related to any organisms for which sequence data is currently available. If there exist any major, but so-far-undiscovered, deeply branching lineages in the tree of life, we suggest that methods such as those described herein currently offer the best way to search for them.	[Wu, Dongying; Wu, Martin; Eisen, Jonathan A.] Univ Calif Davis, Univ Calif Davis Genome Ctr, Dept Med Microbiol & Immunol, Dept Ecol & Evolut, Davis, CA 95616 USA; [Halpern, Aaron; Rusch, Douglas B.; Yooseph, Shibu; Frazier, Marvin; Venter, J. Craig] J Craig Venter Inst, Rockville, MD USA; [Halpern, Aaron; Rusch, Douglas B.; Yooseph, Shibu; Frazier, Marvin; Venter, J. Craig] J Craig Venter Inst, La Jolla, CA USA; [Wu, Martin] Univ Virginia, Charlottesville, VA USA	University of California System; University of California Davis; J. Craig Venter Institute; J. Craig Venter Institute; University of Virginia	Wu, DY (corresponding author), Univ Calif Davis, Univ Calif Davis Genome Ctr, Dept Med Microbiol & Immunol, Dept Ecol & Evolut, Davis, CA 95616 USA.	jaeisen@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Wu, Martin/0000-0003-3093-4077; Yooseph, Shibu/0000-0001-5581-5002	National Science Foundation [0228651]; Gordon and Betty Moore Foundation [0000951, 0001660]	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	The development and main work on this project was supported by the National Science Foundation via an "Assembling the Tree of Life'' grant (number 0228651) to to Jonathan A. Eisen and Naomi Ward. The final work on this project was funded by the Gordon and Betty Moore Foundation (through grants 0000951 and 0001660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; BALCH WE, 1977, J MOL EVOL, V9, P305, DOI 10.1007/BF01796092; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devulder G, 2003, J CLIN MICROBIOL, V41, P1785, DOI 10.1128/JCM.41.4.1785-1787.2003; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 1995, J MOL EVOL, V41, P1105; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HASEGAWA M, 1993, NATURE, V361, P23, DOI 10.1038/361023b0; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KING KW, 1994, GENE, V139, P111, DOI 10.1016/0378-1119(94)90532-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; La Scola B, 2003, SCIENCE, V299, P2033; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; LLOYD AT, 1993, J MOL EVOL, V37, P399; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Oxelman B, 2004, MOL PHYLOGENET EVOL, V32, P462, DOI 10.1016/j.ympev.2004.01.014; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Poole AM, 2007, ASTROBIOLOGY, V7, P801, DOI 10.1089/ast.2006.0094; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sandler SJ, 1999, J BACTERIOL, V181, P907, DOI 10.1128/JB.181.3.907-915.1999; SHARPTON TJR, 2011, PLOS COMPUTATI UNPUB; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; STAHL DA, 1985, APPL ENVIRON MICROB, V49, P1379, DOI 10.1128/AEM.49.6.1379-1384.1985; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; TOMMASINO M, 1988, NUCLEIC ACIDS RES, V16, P5863, DOI 10.1093/nar/16.13.5863; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward N, 2006, FEMS MICROBIOL ECOL, V55, P331, DOI 10.1111/j.1574-6941.2005.00055.x; Ward N, 2005, CURR OPIN MICROBIOL, V8, P564, DOI 10.1016/j.mib.2005.08.011; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	81	63	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18011	10.1371/journal.pone.0018011	http://dx.doi.org/10.1371/journal.pone.0018011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437252	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100056
J	Mukherjee, DV; Tonry, JH; Kim, KS; Ramarao, N; Popova, TG; Bailey, C; Popov, S; Chung, MC				Mukherjee, Dhritiman V.; Tonry, Jessica H.; Kim, Kwang Sik; Ramarao, Nalini; Popova, Taissia G.; Bailey, Charles; Popov, Serguei; Chung, Myung-Chul			Bacillus anthracis Protease InhA Increases Blood-Brain Barrier Permeability and Contributes to Cerebral Hemorrhages	PLOS ONE			English	Article							TOXIN; EXPRESSION; METALLOPROTEASES; ACTIVATION; ADHESION; MATRIX; EDEMA; CELLS	Hemorrhagic meningitis is a fatal complication of anthrax, but its pathogenesis remains poorly understood. The present study examined the role of B. anthracis-secreted metalloprotease InhA on monolayer integrity and permeability of human brain microvasculature endothelial cells (HBMECs) which constitute the blood-brain barrier (BBB). Treatment of HBMECs with purified InhA resulted in a time-dependent decrease in trans-endothelial electrical resistance (TEER) accompanied by zonula occluden-1 (ZO-1) degradation. An InhA-expressing B. subtilis exhibited increased permeability of HBMECs, which did not occur with the isogenic inhA deletion mutant (Delta inhA) of B. anthracis, compared with the corresponding wild-type strain. Mice intravenously administered with purified InhA or nanoparticles-conjugated to InhA demonstrated a time-dependent Evans Blue dye extravasation, leptomeningeal thickening, leukocyte infiltration, and brain parenchymal distribution of InhA indicating BBB leakage and cerebral hemorrhage. Mice challenged with vegetative bacteria of the Delta inhA strain of B. anthracis exhibited a significant decrease in leptomeningeal thickening compared to the wildtype strain. Cumulatively, these findings indicate that InhA contributes to BBB disruption associated with anthrax meningitis through proteolytic attack on the endothelial tight junctional protein zonula occluden (ZO)-1.	[Mukherjee, Dhritiman V.; Tonry, Jessica H.; Popova, Taissia G.; Bailey, Charles; Popov, Serguei; Chung, Myung-Chul] George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Kim, Kwang Sik] Johns Hopkins Univ, Sch Med, Div Pediat Infect Dis, Baltimore, MD USA; [Ramarao, Nalini] INRA, Unite MICALIS GME, La Miniere, Guyancourt, France	George Mason University; Johns Hopkins University; INRAE	Mukherjee, DV (corresponding author), Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY 10027 USA.	spopov@gmu.edu; mchung3@gmu.edu	Rama Rao, Nalini/GRR-7800-2022		U.S. Department of Defense [DAMD 17-03-C-01220]; U.S. Department of Energy [DE-FC52-FC04NA25455]	U.S. Department of Defense(United States Department of Defense); U.S. Department of Energy(United States Department of Energy (DOE))	This work has been supported by the U.S. Department of Defense grant DAMD 17-03-C-01220 and the U.S. Department of Energy grant DE-FC52-FC04NA25455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruscato TJ, 2002, J PHARM SCI-US, V91, P2525, DOI 10.1002/jps.10256; ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chung MC, 2008, J BIOL CHEM, V283, P9531, DOI 10.1074/jbc.M705871200; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Chung MC, 2009, J MED MICROBIOL, V58, P737, DOI 10.1099/jmm.0.007427-0; Chung MC, 2008, FEMS IMMUNOL MED MIC, V54, P309, DOI 10.1111/j.1574-695X.2008.00480.x; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kastrup CJ, 2008, NAT CHEM BIOL, V4, P742, DOI 10.1038/nchembio.124; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Lanska DJ, 2002, NEUROLOGY, V59, P327, DOI 10.1212/WNL.59.3.327; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Meyer MA, 2003, ARCH NEUROL-CHICAGO, V60, P483, DOI 10.1001/archneur.60.4.483; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Okamoto T, 1997, J BIOL CHEM, V272, P6059, DOI 10.1074/jbc.272.9.6059; Popov SG, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-25; Popova T, 2009, FEMS IMMUNOL MED MIC, V56, P129, DOI 10.1111/j.1574-695X.2009.00558.x; Popova TG, 2011, FEMS IMMUNOL MED MIC, V61, P15, DOI 10.1111/j.1574-695X.2010.00740.x; Popova TG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-8; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; Sakata Y, 1996, MICROBIOL IMMUNOL, V40, P415, DOI 10.1111/j.1348-0421.1996.tb01088.x; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Supuran CT, 2002, MED RES REV, V22, P329, DOI 10.1002/med.10007; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	39	33	34	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17921	10.1371/journal.pone.0017921	http://dx.doi.org/10.1371/journal.pone.0017921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437287	Green Submitted, gold, Green Published			2022-12-27	WOS:000288514600016
J	Zaragoza, B; Evaristo, C; Kissenpfennig, A; Libri, V; Malissen, B; Rocha, B; Freitas, AA; Almeida, ARM				Zaragoza, Bruno; Evaristo, Cesar; Kissenpfennig, Adrien; Libri, Valentina; Malissen, Bernard; Rocha, Benedita; Freitas, Antonio A.; Almeida, Afonso R. M.			Cell-to-Cell Interactions and Signals Involved in the Reconstitution of Peripheral CD8(+) T-CM and T-EM Cell Pools	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; HOMEOSTATIC PROLIFERATION; IN-VIVO; LYMPHOPENIC HOSTS; REGULATORY-CELLS; CUTTING EDGE; MEMORY; CD4(+); EXPANSION; IMMUNE	We here describe novel aspects of CD8(+) and CD4(+) T cell subset interactions that may be clinically relevant and provide new tools for regulating the reconstitution of the peripheral CD8(+) T cell pools in immune-deficient states. We show that the reconstitution capacity of transferred isolated naive CD8(+) T cells and their differentiation of effector functions is limited, but both dramatically increase upon the co-transfer of CD4(+) T cells. This helper effect is complex and determined by multiple factors. It was directly correlated to the number of helper cells, required the continuous presence of the CD4(+) T cells, dependent on host antigen-presenting cells (APCs) expressing CD40 and on the formation of CD4/CD8/APC cell clusters. By comparing the recovery of (CD44(+)CD62L(high)) T-CM and (CD44(+)CD62L(low)) T-EM CD8(+) T cells, we found that the accumulation of TCM and TEM subsets is differentially regulated. T-CM-cell accumulation depended mainly on type I interferons, interleukin (IL)-6, and IL-15, but was independent of CD4(+) T-cell help. In contrast, TEM-cell expansion was mainly determined by CD4(+) T-cell help and dependent on the expression of IL-2R beta by CD8 cells, on IL-2 produced by CD4(+) T-cells, on IL-15 and to a minor extent on IL-6.	[Zaragoza, Bruno; Freitas, Antonio A.; Almeida, Afonso R. M.] Inst Pasteur, Lymphocyte Populat Biol Unit, CNRS, URA 1961, Paris, France; [Evaristo, Cesar; Rocha, Benedita] Univ Paris 05, INSERM, U591, Inst Federatif Rech 94, Paris, France; [Kissenpfennig, Adrien; Malissen, Bernard] Univ Mediterranne, INSERM, U631, CNRS,UMR6102,Ctr Immunol Marseille Luminy, Marseille, France; [Libri, Valentina] Inst Pasteur, U Signalisat Cytokines, CNRS, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zaragoza, B (corresponding author), Inst Pasteur, Lymphocyte Populat Biol Unit, CNRS, URA 1961, Paris, France.	antonio.freitas@pasteur.fr; afonsoalmeida@fm.ul.pt	freitas, antonio/A-2482-2013; Evaristo, Cesar/O-8430-2016; Malissen, Bernard/AAK-4659-2020	Libri, Valentina/0000-0002-2080-1089; Evaristo, Cesar/0000-0002-2281-1045; freitas, antonio/0000-0001-6392-7178; Kissenpfennig, Adrien/0000-0002-9633-3111; Almeida, Afonso/0000-0002-4292-8558; Malissen, Bernard/0000-0003-1340-9342	European Research Council (ERC); Ligue Nationale Contre le Cancer; Association pour la Recherche Contre le Cancer (ARC); Agence Nationale de la Recherche Contre le SIDA (ANRS); Agence Nationale pour la Recherche (ANR); Association Francaise des Myopathies (AFM); Centre National de la Recherche Scientifique (CNRS); Institut Pasteur; MRT; ARC, France; FCT, Portugal	European Research Council (ERC)(European Research Council (ERC)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale de la Recherche Contre le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise des Myopathies (AFM)(Association Francaise contre les Myopathies); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); MRT; ARC, France; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the European Research Council (ERC), Ligue Nationale Contre le Cancer, Association pour la Recherche Contre le Cancer (ARC), Agence Nationale de la Recherche Contre le SIDA (ANRS), Agence Nationale pour la Recherche (ANR), Association Francaise des Myopathies (AFM), Centre National de la Recherche Scientifique (CNRS) and the Institut Pasteur. BZ was supported by the MRT and ARC, France and ARMA by the FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Cho JH, 2007, J EXP MED, V204, P1787, DOI 10.1084/jem.20070740; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hagen KA, 2004, J IMMUNOL, V173, P3909, DOI 10.4049/jimmunol.173.6.3909; Hamilton SE, 2008, P NATL ACAD SCI USA, V105, P18484, DOI 10.1073/pnas.0806487105; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hao Y, 2006, J EXP MED, V203, P1643, DOI 10.1084/jem.20052174; Helft J, 2008, BLOOD, V112, P1249, DOI 10.1182/blood-2007-09-114389; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kursar M, 2002, J EXP MED, V196, P1585, DOI 10.1084/jem.20011347; La Gruta NL, 2000, EUR J IMMUNOL, V30, P3380; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; ROCHA B, 1989, IMMUNOLOGY, V19, P905; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 2002, J IMMUNOL, V168, P5042, DOI 10.4049/jimmunol.168.10.5042; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17423	10.1371/journal.pone.0017423	http://dx.doi.org/10.1371/journal.pone.0017423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423804	Green Published, gold, Green Submitted			2022-12-27	WOS:000288512400010
J	Dulik, MC; Osipova, LP; Schurr, TG				Dulik, Matthew C.; Osipova, Ludmila P.; Schurr, Theodore G.			Y-Chromosome Variation in Altaian Kazakhs Reveals a Common Paternal Gene Pool for Kazakhs and the Influence of Mongolian Expansions	PLOS ONE			English	Article							CENTRAL-ASIAN POPULATIONS; SHORT TANDEM REPEATS; SIBERIAN POPULATIONS; HUNTER-GATHERER; HAPLOGROUP C; EAST-ASIA; DIVERSITY; DIVERGENCE; RESOLUTION; ADMIXTURE	Kazakh populations have traditionally lived as nomadic pastoralists that seasonally migrate across the steppe and surrounding mountain ranges in Kazakhstan and southern Siberia. To clarify their population history from a paternal perspective, we analyzed the non-recombining portion of the Y-chromosome from Kazakh populations living in southern Altai Republic, Russia, using a high-resolution analysis of 60 biallelic markers and 17 STRs. We noted distinct differences in the patterns of genetic variation between maternal and paternal genetic systems in the Altaian Kazakhs. While they possess a variety of East and West Eurasian mtDNA haplogroups, only three East Eurasian paternal haplogroups appear at significant frequencies (C3*, C3c and O3a3c*). In addition, the Y-STR data revealed low genetic diversity within these lineages. Analysis of the combined biallelic and STR data also demonstrated genetic differences among Kazakh populations from across Central Asia. The observed differences between Altaian Kazakhs and indigenous Kazakhs were not the result of admixture between Altaian Kazakhs and indigenous Altaians. Overall, the shared paternal ancestry of Kazakhs differentiates them from other Central Asian populations. In addition, all of them showed evidence of genetic influence by the 13(th) century CE Mongol Empire. Ultimately, the social and cultural traditions of the Kazakhs shaped their current pattern of genetic variation.	[Dulik, Matthew C.; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Osipova, Ludmila P.] Russian Acad Sci SB RAS, Siberian Branch, Inst Cytol & Genet, Novosibirsk, Russia	University of Pennsylvania; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Dulik, MC (corresponding author), Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA.	tgschurr@sas.upenn.edu	Osipova, Ludmila P/O-6480-2014	Osipova, Ludmila P/0000-0001-7602-1156	University of Pennsylvania; National Science Foundation [BCS-0726623]; Social Sciences and Humanities Research Council of Canada [MCRI 412-2005-1004]; Russian Basic Fund for Research	University of Pennsylvania; National Science Foundation(National Science Foundation (NSF)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Russian Basic Fund for Research	This project was supported by the University of Pennsylvania (TGS), the National Science Foundation (BCS-0726623) (TGS, MCD), the Social Sciences and Humanities Research Council of Canada (MCRI 412-2005-1004) (TGS) and the Russian Basic Fund for Research (LPO). TGS would also like to acknowledge the infrastructural support provided by the National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Chaix R, 2007, CURR BIOL, V17, P43, DOI 10.1016/j.cub.2006.10.058; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; Cox MP, 2006, ANTHROPOL SCI, V114, P69, DOI 10.1537/ase.050712; de Knijff P, 2000, AM J HUM GENET, V67, P1055; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; Di Benedetto G, 2001, AM J PHYS ANTHROPOL, V115, P144, DOI 10.1002/ajpa.1064; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; GOKCUMEN O, 2010, AM ANTHR IN PRESS; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; Golden P. B., 1998, NOMADS SEDENTARY SOC; Golden Peter B, 1992, INTRO HIST TURKIC PE; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Heyer E, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-49; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Katoh T, 2005, GENE, V346, P63, DOI 10.1016/j.gene.2004.10.023; Keyser C, 2009, HUM GENET, V126, P395, DOI 10.1007/s00439-009-0683-0; Kim K, 2010, AM J PHYS ANTHROPOL, V142, P429, DOI 10.1002/ajpa.21242; Krader Lawrence, 1963, SOCIAL ORG MONGOL TU; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Menges K.H., 1995, VER FFENTLICHUNGEN S; Oktyabrskaya I.V., 2006, ARCHAEOLOGY ETHNOLOG, V25, P132; Olcott MB, 1995, KAZAKHS; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; RENFREW C, 1989, SCI AM, V261, P106, DOI 10.1038/scientificamerican1089-106; RENFREW C, 1987, ARCHAEOLOGY LANGUAGE; Segurel L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000200; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Sinor D., 1990, CAMBRIDGE HIST EARLY; SOUCEK S, 2000, HIST INNER ASIA, pR13; SPSS Inc, 2001, SPSS WIND REL 11 0 0; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue Y., 2008, SIMULATIONS GENETICS, P79; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Xue YL, 2005, AM J HUM GENET, V77, P1112, DOI 10.1086/498583; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	52	46	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17548	10.1371/journal.pone.0017548	http://dx.doi.org/10.1371/journal.pone.0017548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412412	Green Published, gold, Green Submitted			2022-12-27	WOS:000288247800014
J	Moura, RS; Coutinho-Borges, JP; Pacheco, AP; daMota, PO; Correia-Pinto, J				Moura, Rute S.; Coutinho-Borges, Jose P.; Pacheco, Ana P.; daMota, Paulo O.; Correia-Pinto, Jorge			FGF Signaling Pathway in the Developing Chick Lung: Expression and Inhibition Studies	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTORS; BRANCHING MORPHOGENESIS; EMBRYONIC-DEVELOPMENT; MOUSE ORGANOGENESIS; FACTOR FAMILY; RAT LUNG; SPROUTY; SYSTEM; GENES; FETAL	Background: Fibroblast growth factors (FGF) are essential key players during embryonic development. Through their specific cognate receptors (FGFR) they activate intracellular cascades, finely regulated by modulators such as Sprouty. Several FGF ligands (FGF1, 2, 7, 9, 10 and 18) signaling through the four known FGFRs, have been implicated in lung morphogenesis. Although much is known about mammalian lung, so far, the avian model has not been explored for lung studies. Methodology/Principal Findings: In this study we provide the first description of fgf10, fgfr1-4 and spry2 expression patterns in early stages of chick lung development by in situ hybridization and observe that they are expressed similarly to their mammalian counterparts. Furthermore, aiming to determine a role for FGF signaling in chick lung development, in vitro FGFR inhibition studies were performed. Lung explants treated with an FGF receptor antagonist (SU5402) presented an impairment of secondary branch formation after 48 h of culture; moreover, abnormal lung growth with a cystic appearance of secondary bronchi and reduction of the mesenchymal tissue was observed. Branching and morphometric analysis of lung explants confirmed that FGFR inhibition impaired branching morphogenesis and induced a significant reduction of the mesenchyme. Conclusions/Significance: This work demonstrates that FGFRs are essential for the epithelial-mesenchymal interactions that determine epithelial branching and mesenchymal growth and validate the avian embryo as a good model for pulmonary studies, namely to explore the FGF pathway as a therapeutic target.	[Moura, Rute S.; Coutinho-Borges, Jose P.; Pacheco, Ana P.; daMota, Paulo O.; Correia-Pinto, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal	Universidade do Minho	Moura, RS (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	rutemoura@ecsaude.uminho.pt	Moura, Rute S/B-4208-2011; Moura, Rute/GYV-3259-2022; Correia-Pinto, Jorge/B-3344-2012	Moura, Rute S/0000-0003-1763-9014; Correia-Pinto, Jorge/0000-0002-9265-6896; Mota, Paulo/0000-0002-2316-373X	Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-OBD/108051/2008]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/15408/2005]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-OBD/108051/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This project was funded by Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-OBD/108051/2008). RSM was supported by Fundacao para a Ciencia e Tecnologia (grant number SFRH/BPD/15408/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Del Moral PM, 2006, DEV BIOL, V290, P177, DOI 10.1016/j.ydbio.2005.11.022; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gonzaga S, 2008, AM J RESP CELL MOL, V39, P346, DOI 10.1165/rcmb.2007-0290OC; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Krejci P, 2009, HUM MUTAT, V30, P1245, DOI 10.1002/humu.21067; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Maina JN, 2003, TISSUE CELL, V35, P375, DOI 10.1016/S0040-8166(03)00058-2; Maina JN, 2006, BIOL REV, V81, P545, DOI 10.1017/S1464793106007111; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Miura T, 2002, MECH DEVELOP, V116, P29, DOI 10.1016/S0925-4773(02)00132-6; Miura T, 2009, MECH DEVELOP, V126, P160, DOI 10.1016/j.mod.2008.11.006; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Muehlethaler V, 2008, AM J PHYSIOL-LUNG C, V294, pL110, DOI 10.1152/ajplung.00407.2007; Nakazawa F, 2006, BLOOD, V108, P3335, DOI 10.1182/blood-2006-05-021386; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; PETERS KG, 1992, DEVELOPMENT, V114, P233; Powell PP, 1998, AM J RESP CELL MOL, V19, P563, DOI 10.1165/ajrcmb.19.4.2994; Sakiyama J, 2000, DEV BIOL, V227, P12, DOI 10.1006/dbio.2000.9880; Sakiyama J, 2003, DEVELOPMENT, V130, P1225, DOI 10.1242/dev.00345; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sun L, 1998, J MED CHEM, V41, P2588, DOI 10.1021/jm980123i; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Wang O, 2001, DEVELOPMENT, V128, P3867; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	36	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17660	10.1371/journal.pone.0017660	http://dx.doi.org/10.1371/journal.pone.0017660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412430	Green Published, gold			2022-12-27	WOS:000288247800021
J	Warren, RJ; Skelly, DK; Schmitz, OJ; Bradford, MA				Warren, Robert J., II; Skelly, David K.; Schmitz, Oswald J.; Bradford, Mark A.			Universal Ecological Patterns in College Basketball Communities	PLOS ONE			English	Article							SPECIES ABUNDANCE DISTRIBUTIONS; NEUTRAL THEORY; RELATIVE ABUNDANCE; DIVERSITY	The rank abundance of common and rare species within ecological communities is remarkably consistent from the tropics to the tundra. This invariant patterning provides one of ecology's most enduring and unified tenets: most species rare and a few very common. Increasingly, attention is focused upon elucidating biological mechanisms that explain these species abundance distributions (SADs), but these evaluations remain controversial. We show that college basketball wins generate SADs just like those observed in ecological communities. Whereas college basketball wins are structured by competitive interactions, the result produces a SAD pattern indistinguishable from random wins. We also show that species abundance data for tropical trees exhibits a significant-digit pattern consistent with data derived from complex structuring forces. These results cast doubt upon the ability of SAD analysis to resolve ecological mechanism, and their patterning may reflect statistical artifact as much as biological processes.	[Warren, Robert J., II; Skelly, David K.; Schmitz, Oswald J.; Bradford, Mark A.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Yale University	Warren, RJ (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	hexastylis@gmail.com	Bradford, Mark A/G-3850-2012; Skelly, David/D-3878-2013	Bradford, Mark A/0000-0002-2022-8331; 	National Science Foundation [DEB-0823293]; Yale School of Forestry and Environmental Studies	National Science Foundation(National Science Foundation (NSF)); Yale School of Forestry and Environmental Studies	This work was supported by funds from the National Science Foundation (award DEB-0823293) to the Coweeta Long Term Ecological Research Program and by the Yale School of Forestry and Environmental Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Bates D., 1988, NONLINEAR REGRESSION; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Clark JS, 2009, TRENDS ECOL EVOL, V24, P8, DOI 10.1016/j.tree.2008.09.004; FIZEL J, 2004, EC COLL SPORTS, P3; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUBBELL SP, 2006, BARRO COLORADO ISLAN; Hubbell Stephen P., 2001, V32, pi; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; MACARTHUR RH, 1966, ECOLOGY, V47, P1074; Magurran A.E, 2004, MEASURING BIOL DIVER; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Magurran AE, 2005, FUNCT ECOL, V19, P177, DOI 10.1111/j.0269-8463.2005.00930.x; May R.M., 1975, P81; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; MILLER M, 2010, GREATEST PROGRAMS AL; Morlon H, 2009, ECOL LETT, V12, P488, DOI 10.1111/j.1461-0248.2009.01318.x; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; Nekola JC, 2007, ECOL LETT, V10, P188, DOI 10.1111/j.1461-0248.2006.01003.x; Newcomb S., 1881, AM J MATH, V4, P39, DOI [10.2307/2369148, DOI 10.2307/2369148]; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; R Development Core Team, 2005, R LANG ENV STAT COMP; Rosindell J, 2010, ECOL LETT, V13, P716, DOI 10.1111/j.1461-0248.2010.01463.x; STAUDOHAR PD, 2004, EC COLL SPORTS; Tokeshi M., 1999, SPECIES COEXISTENCE; VANRIPER T, 2010, HIGHEST PAID COLL BA; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Williams C. B., 1964, PATTERNS BALANCE NAT	34	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17342	10.1371/journal.pone.0017342	http://dx.doi.org/10.1371/journal.pone.0017342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408063	gold, Green Published			2022-12-27	WOS:000288170900011
J	Agarwal, G; Mahajan, S; Srinivasan, N; de Brevern, AG				Agarwal, Garima; Mahajan, Swapnil; Srinivasan, Narayanaswamy; de Brevern, Alexandre G.			Identification of Local Conformational Similarity in Structurally Variable Regions of Homologous Proteins Using Protein Blocks	PLOS ONE			English	Article							STRUCTURE ALIGNMENT; CRYSTAL-STRUCTURE; FUNCTIONAL CONSTRAINTS; SEQUENCE ALIGNMENT; TERTIARY STRUCTURE; EVOLUTION; CLASSIFICATION; PREDICTION; ALPHABET; DATABASE	Structure comparison tools can be used to align related protein structures to identify structurally conserved and variable regions and to infer functional and evolutionary relationships. While the conserved regions often superimpose well, the variable regions appear non superimposable. Differences in homologous protein structures are thought to be due to evolutionary plasticity to accommodate diverged sequences during evolution. One of the kinds of differences between 3-D structures of homologous proteins is rigid body displacement. A glaring example is not well superimposed equivalent regions of homologous proteins corresponding to a-helical conformation with different spatial orientations. In a rigid body superimposition, these regions would appear variable although they may contain local similarity. Also, due to high spatial deviation in the variable region, one-to-one correspondence at the residue level cannot be determined accurately. Another kind of difference is conformational variability and the most common example is topologically equivalent loops of two homologues but with different conformations. In the current study, we present a refined view of the "structurally variable" regions which may contain local similarity obscured in global alignment of homologous protein structures. As structural alphabet is able to describe local structures of proteins precisely through Protein Blocks approach, conformational similarity has been identified in a substantial number of 'variable' regions in a large data set of protein structural alignments; optimal residue-residue equivalences could be achieved on the basis of Protein Blocks which led to improved local alignments. Also, through an example, we have demonstrated how the additional information on local backbone structures through protein blocks can aid in comparative modeling of a loop region. In addition, understanding on sequence-structure relationships can be enhanced through our approach. This has been illustrated through examples where the equivalent regions in homologous protein structures share sequence similarity to varied extent but do not preserve local structure.	[Agarwal, Garima; Mahajan, Swapnil; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Mahajan, Swapnil] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [de Brevern, Alexandre G.] INSERM, U665, Paris, France; [de Brevern, Alexandre G.] Univ Paris 07, UMR S665, Paris, France; [de Brevern, Alexandre G.] Inst Natl Transfus Sanguine, F-75015 Paris, France	Indian Institute of Science (IISC) - Bangalore; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Agarwal, G (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in	Mahajan, Swapnil/J-4732-2019; de Brevern, Alexandre G./B-4788-2009	Mahajan, Swapnil/0000-0003-2136-1801; de Brevern, Alexandre G./0000-0001-7112-5626	Council of Scientific and Industrial Research; Department of Biotechnology; CEFIPRA [3903-E]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; CEFIPRA	GA and SM are supported by fellowships from Council of Scientific and Industrial Research and Department of Biotechnology respectively. NS and AdB acknowledge the support from CEFIPRA collaborative grant (number 3903-E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen GR, 2000, J MOL BIOL, V297, P421, DOI 10.1006/jmbi.2000.3564; Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Balaji S, 2001, PROTEIN ENG, V14, P219, DOI 10.1093/protein/14.4.219; BRADY RL, 1993, SCIENCE, V260, P979, DOI 10.1126/science.8493535; BRUCCOLERI RE, 1987, BIOPOLYMERS, V26, P137, DOI 10.1002/bip.360260114; Carpentier M, 2005, PROTEINS, V61, P137, DOI 10.1002/prot.20517; Chothia C, 1997, NATURE, V385, P579, DOI 10.1038/385579a0; De Brevern AG, 2007, J BIOSCIENCES, V32, P51, DOI 10.1007/s12038-007-0006-3; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern Alexandre G., 2005, In Silico Biology, V5, P283; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; FAURE G, 2009, BIOCHIMIE; Fetrow JS, 1998, J MOL BIOL, V282, P703, DOI 10.1006/jmbi.1998.2061; FINE R M, 1986, Proteins Structure Function and Genetics, V1, P342, DOI 10.1002/prot.340010408; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2002, ACCOUNTS CHEM RES, V35, P413, DOI 10.1021/ar010061h; Fourrier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-58; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Ghozlane A, 2009, BIOINFORMATION, V3, P367, DOI 10.6026/97320630003367; Godzik A, 1996, PROTEIN SCI, V5, P1325, DOI 10.1002/pro.5560050711; GREER J, 1980, P NATL ACAD SCI-BIOL, V77, P3393, DOI 10.1073/pnas.77.6.3393; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; JAKONCIC J, 2010, CRYSTAL STR IN PRESS; JOHNSON MS, 1990, J MOL EVOL, V30, P43, DOI 10.1007/BF02102452; JOHNSON MS, 1990, METHOD ENZYMOL, V183, P670; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; Joseph Agnel Praveen, 2010, Biophys Rev, V2, P137, DOI 10.1007/s12551-010-0036-1; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MOULT J, 1986, Proteins Structure Function and Genetics, V1, P146, DOI 10.1002/prot.340010207; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; Oliva B, 1997, J MOL BIOL, V266, P814, DOI 10.1006/jmbi.1996.0819; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Orengo CA, 2001, J STRUCT BIOL, V134, P145, DOI 10.1006/jsbi.2001.4398; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Parmeggiani A, 2006, BIOCHEMISTRY-US, V45, P6846, DOI 10.1021/bi0525122; PASCARELLA S, 1992, J MOL BIOL, V224, P461, DOI 10.1016/0022-2836(92)91008-D; Pisanti N, 2009, J COMPUT BIOL, V16, P1635, DOI 10.1089/cmb.2008.0019; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Sandhya S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004981; Shatsky M, 2004, J COMPUT BIOL, V11, P83, DOI 10.1089/106652704773416902; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SRINIVASAN N, 1993, PROTEIN ENG, V6, P501, DOI 10.1093/protein/6.5.501; Swindells MB, 1998, BIOESSAYS, V20, P884; TAYLOR WR, 1989, J MOL BIOL, V208, P1, DOI 10.1016/0022-2836(89)90084-3; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Thomas A, 2006, PROTEINS, V65, P889, DOI 10.1002/prot.21151; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JM, 1999, J MOL BIOL, V293, P333, DOI 10.1006/jmbi.1999.3054; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, NUCLEIC ACIDS RES, V34, pW119, DOI 10.1093/nar/gkl199; Tyagi M, 2006, PROTEINS, V65, P32, DOI 10.1002/prot.21087; vanVlijmen HWT, 1997, J MOL BIOL, V267, P975, DOI 10.1006/jmbi.1996.0857; Williams SG, 2009, MOL BIOL EVOL, V26, P1055, DOI 10.1093/molbev/msp020; Worth CL, 2009, NAT REV MOL CELL BIO, V10, P709, DOI 10.1038/nrm2762; Wu CY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq478; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; ZHU ZY, 1992, PROTEIN ENG, V5, P43, DOI 10.1093/protein/5.1.43	81	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17826	10.1371/journal.pone.0017826	http://dx.doi.org/10.1371/journal.pone.0017826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445259	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100035
J	Hemmert, AC; Otto, TC; Chica, RA; Wierdl, M; Edwards, JS; Lewis, SL; Edwards, CC; Tsurkan, L; Cadieux, CL; Kasten, SA; Cashman, JR; Mayo, SL; Potter, PM; Cerasoli, DM; Redinbo, MR				Hemmert, Andrew C.; Otto, Tamara C.; Chica, Roberto A.; Wierdl, Monika; Edwards, Jonathan S.; Lewis, Steven L.; Edwards, Carol C.; Tsurkan, Lyudmila; Cadieux, C. Linn; Kasten, Shane A.; Cashman, John R.; Mayo, Stephen L.; Potter, Philip M.; Cerasoli, Douglas M.; Redinbo, Matthew R.			Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme	PLOS ONE			English	Article							ANHYDRIDE HYDROLASE ACTIVITY; INHIBITION; REACTIVATION; EXPRESSION; CATALYSIS; KINETICS; TARGETS	Organophosphorus (OP) nerve agents are potent suicide inhibitors of the essential neurotransmitter-regulating enzyme acetylcholinesterase. Due to their acute toxicity, there is significant interest in developing effective countermeasures to OP poisoning. Here we impart nerve agent hydrolysis activity into the human drug metabolism enzyme carboxylesterase 1. Using crystal structures of the target enzyme in complex with nerve agent as a guide, a pair of histidine and glutamic acid residues were designed proximal to the enzyme's native catalytic triad. The resultant variant protein demonstrated significantly increased rates of reactivation following exposure to sarin, soman, and cyclosarin. Importantly, the addition of these residues did not alter the high affinity binding of nerve agents to this protein. Thus, using two amino acid substitutions, a novel enzyme was created that efficiently converted a group of hemisubstrates, compounds that can start but not complete a reaction cycle, into bona fide substrates. Such approaches may lead to novel countermeasures for nerve agent poisoning.	[Hemmert, Andrew C.; Edwards, Jonathan S.; Lewis, Steven L.; Redinbo, Matthew R.] Univ N Carolina, Dept Biochem Biophys & Chem, Chapel Hill, NC 27515 USA; [Otto, Tamara C.; Cadieux, C. Linn; Kasten, Shane A.; Cerasoli, Douglas M.] USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA; [Chica, Roberto A.; Mayo, Stephen L.] CALTECH, Dept Biol & Chem, Pasadena, CA 91125 USA; [Wierdl, Monika; Edwards, Carol C.; Tsurkan, Lyudmila; Potter, Philip M.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Cashman, John R.] Human BioMol Res Inst, San Diego, CA USA	University of North Carolina; University of North Carolina Chapel Hill; Research Institute of Chemical Defense - China; California Institute of Technology; St Jude Children's Research Hospital	Hemmert, AC (corresponding author), Univ N Carolina, Dept Biochem Biophys & Chem, Chapel Hill, NC 27515 USA.	redinbo@unc.edu	; Potter, Philip/J-4515-2013	Cadieux, C. Linn/0000-0002-1440-2284; Potter, Philip/0000-0001-8922-8535; Kasten, Shane/0000-0003-1986-8064	National Institutes of Health through National Institute of Neurological Disorders and Stroke [UO1 NS58089, UO1 NS058038]; American Lebanese and Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058038, U01NS058089] Funding Source: NIH RePORTER	National Institutes of Health through National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Lebanese and Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health CounterACT Program through the National Institute of Neurological Disorders and Stroke (UO1 NS58089, MRR; UO1 NS058038, JRC). This work was also supported by the American Lebanese and Syrian Associated Charities (ALSAC) and St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurbek N, 2006, TOXICOLOGY, V224, P91, DOI 10.1016/j.tox.2006.04.030; Casida JE, 2005, CHEM-BIOL INTERACT, V157, P277, DOI 10.1016/j.cbi.2005.10.036; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Dixon M., 1979, ENZYMES, Vthird; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Elcock AH, 1999, J MOL BIOL, V291, P149, DOI 10.1006/jmbi.1999.2919; Fleming CD, 2007, BIOCHEMISTRY-US, V46, P5063, DOI 10.1021/bi700246n; Gilley C, 2009, CHEM RES TOXICOL, V22, P1680, DOI 10.1021/tx900090m; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Hemmert AC, 2010, MOL PHARMACOL, V77, P508, DOI 10.1124/mol.109.062356; HOVANEC JW, 1977, BIOCHIM BIOPHYS ACTA, V483, P312, DOI 10.1016/0005-2744(77)90059-6; Jett DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000752; Kuca K, 2007, DRUG CHEM TOXICOL, V30, P31, DOI 10.1080/01480540601017637; Lenz D. E., 2008, Chemical warfare agents: chemistry, pharmacology, toxicology and therapeutics, P175; Lockridge O, 1997, BIOCHEMISTRY-US, V36, P786, DOI 10.1021/bi961412g; Marcel V, 2000, J BIOL CHEM, V275, P11603, DOI 10.1074/jbc.275.16.11603; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Millard CB, 1995, BIOCHEMISTRY-US, V34, P15925, DOI 10.1021/bi00049a007; Millard CB, 1998, BIOCHEMISTRY-US, V37, P237, DOI 10.1021/bi972057c; Morton CL, 2000, MOL BIOTECHNOL, V16, P193, DOI 10.1385/MB:16:3:193; Newmark J, 2007, NEUROLOGIST, V13, P20, DOI 10.1097/01.nrl.0000252923.04894.53; Ohbu S, 1997, SOUTHERN MED J, V90, P587, DOI 10.1097/00007611-199706000-00002; QIAN NF, 1993, FEBS LETT, V336, P263, DOI 10.1016/0014-5793(93)80816-D; Redinbo MR, 2005, DRUG DISCOV TODAY, V10, P313, DOI 10.1016/S1359-6446(05)03383-0; Shortle D, 2003, PROTEIN SCI, V12, P1298, DOI 10.1110/ps.0306903; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wadkins RM, 2001, MOL PHARMACOL, V60, P355, DOI 10.1124/mol.60.2.355; Wierdl M, 2008, CANCER GENE THER, V15, P183, DOI 10.1038/sj.cgt.7701112; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y	30	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17441	10.1371/journal.pone.0017441	http://dx.doi.org/10.1371/journal.pone.0017441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445272	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000288545100014
J	Muendlein, A; Saely, CH; Geller-Rhomberg, S; Sonderegger, G; Rein, P; Winder, T; Beer, S; Vonbank, A; Drexel, H				Muendlein, Axel; Saely, Christoph H.; Geller-Rhomberg, Simone; Sonderegger, Gudrun; Rein, Philipp; Winder, Thomas; Beer, Stefan; Vonbank, Alexander; Drexel, Heinz			Single Nucleotide Polymorphisms of TCF7L2 Are Linked to Diabetic Coronary Atherosclerosis	PLOS ONE			English	Article							BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; GENE; RISK; GLUCOSE; CHOLESTEROL; EXPRESSION; PREVENTION; RECEPTORS	Background: Coronary artery disease (CAD) shares common risk factors with type 2 diabetes (T2DM). Variations in the transcription factor 7-like 2 (TCF7L2) gene, particularly rs7903146, increase T2DM risk. Potential links between genetic variants of the TCF7L2 locus and coronary atherosclerosis are uncertain. We therefore investigated the association between TCF7L2 polymorphisms and angiographically determined CAD in diabetic and non-diabetic patients. Methodology/Principal Findings: We genotyped TCF7L2 variants rs7903146, rs12255372, and rs11196205 in a cross-sectional study including 1,650 consecutive patients undergoing coronary angiography for the evaluation of established or suspected stable CAD. Significant CAD was diagnosed in the presence of coronary stenoses >= 50%. Variant rs7903146 in the total study cohort was significantly associated with significant CAD (adjusted additive OR = 1.29 [1.09-1.53]; p = 0.003). This association was strong and significant in T2DM patients (n = 393; OR = 1.91 [1.32-2.75]; p = 0.001) but not in non-diabetic subjects (OR = 1.09 [0.90-1.33]; p = 0.370). The interaction risk allele by T2DM was significant (p(interaction) = 0.002), indicating a significantly stronger impact of the polymorphism on CAD in T2DM patients than in non-diabetic subjects. TCF7L2 polymorphisms rs12255372 and rs11196205 were also significantly associated with CAD in diabetic patients (adjusted additive OR = 1.90 [1.31-2.74]; p = 0.001 and OR = 1.75 [1.22-2.50]; p = 0.002, respectively). Further, haplotype analysis demonstrated that haplotypes including the rare alleles of all investigated variants were significantly associated with CAD in the whole cohort as well as in diabetic subjects (OR = 1.22 [1.04-1.43]; p = 0.013 and OR = 1.67 [1.19-2.22]; p = 0.003, respectively). Conclusions/Significance: These results suggest that TCF7L2 variants rs7903146 rs12255372, and rs11196205 are significantly associated with angiographically diagnosed CAD, specifically in patients with T2DM. TCF7L2 therefore appears as a genetic link between diabetes and atherosclerosis.	[Muendlein, Axel; Saely, Christoph H.; Geller-Rhomberg, Simone; Sonderegger, Gudrun; Rein, Philipp; Winder, Thomas; Beer, Stefan; Vonbank, Alexander; Drexel, Heinz] Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria; [Muendlein, Axel; Saely, Christoph H.; Geller-Rhomberg, Simone; Rein, Philipp; Winder, Thomas; Beer, Stefan; Vonbank, Alexander; Drexel, Heinz] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Saely, Christoph H.; Rein, Philipp; Winder, Thomas; Beer, Stefan; Vonbank, Alexander; Drexel, Heinz] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Drexel, Heinz] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Muendlein, A (corresponding author), Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria.	vivit@lkhf.at	Muendlein, Axel/AAS-5313-2021	Vonbank, Alexander/0000-0001-5648-5623; Muendlein, Axel/0000-0002-5582-4125	Kurt und Senta Herrmann Stiftung (Liechtenstein); Land Vorarlberg; Europaeischer Fonds fuer regionale Entwicklung (EFRE)	Kurt und Senta Herrmann Stiftung (Liechtenstein); Land Vorarlberg; Europaeischer Fonds fuer regionale Entwicklung (EFRE)	Funding: The study was part-financed by the 'Kurt und Senta Herrmann Stiftung' (Liechtenstein), the 'Land Vorarlberg' and the 'Europaeischer Fonds fuer regionale Entwicklung' (EFRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x; Bielinski SJ, 2008, DIABETOLOGIA, V51, P968, DOI 10.1007/s00125-008-1004-1; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Drexel H, 2005, DIABETES CARE, V28, P101, DOI 10.2337/diacare.28.1.101; DREXEL H, 1994, CIRCULATION, V90, P2230, DOI 10.1161/01.CIR.90.5.2230; Duval A, 2000, CYTOGENET CELL GENET, V88, P264, DOI 10.1159/000015534; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Gable DR, 2006, ATHEROSCLEROSIS, V188, P231, DOI 10.1016/j.atherosclerosis.2006.02.010; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Genuth S, 2003, DIABETES CARE, V26, P3160; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; JUDKINS MP, 1967, RADIOLOGY, V89, P815, DOI 10.1148/89.5.815; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1956, DOI 10.1210/jc.2006-2514; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Marz W, 2004, CIRCULATION, V109, P2844, DOI 10.1161/01.CIR.0000129306.44085.C4; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Mulnier HE, 2008, DIABETOLOGIA, V51, P1639, DOI 10.1007/s00125-008-1076-y; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Pearson ER, 2009, DIABETOLOGIA, V52, P1227, DOI 10.1007/s00125-009-1356-1; Piga R, 2007, ATHEROSCLEROSIS, V193, P328, DOI 10.1016/j.atherosclerosis.2006.09.016; Quasnichka H, 2006, CIRC RES, V99, P1329, DOI 10.1161/01.RES.0000253533.65446.33; Saegusa M, 2007, J PATHOL, V213, P35, DOI 10.1002/path.2198; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Sousa AGP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007697; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; XIE X, 1993, AM J HUM GENET, V53, P1107; YAN SD, 1994, J BIOL CHEM, V269, P9889	38	50	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17978	10.1371/journal.pone.0017978	http://dx.doi.org/10.1371/journal.pone.0017978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423583	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900049
J	Shoji, A; Elliott, KH; Aris-Brosou, S; Crump, D; Gaston, AJ				Shoji, Akiko; Elliott, Kyle H.; Aris-Brosou, Stephane; Crump, Doug; Gaston, Anthony J.			Incubation Patterns in a Central-Place Forager Affect Lifetime Reproductive Success: Scaling of Patterns from a Foraging Bout to a Lifetime	PLOS ONE			English	Article							FULMARS FULMARUS-GLACIALIS; GUILLEMOTS URIA-LOMVIA; BODY CONDITION; EGG NEGLECT; ENERGY-EXPENDITURE; NORTHERN FULMARS; EUDYPTULA-MINOR; CASSINS AUKLET; COMMON EIDERS; STORM-PETRELS	Background: Long-lived seabirds face a conflict between current and lifelong reproductive success. During incubation shifts, egg neglect is sometimes necessary to avoid starvation, but may compromise the current reproductive attempt. However, factors underlying this decision process are poorly understood. We focus on the ancient murrelet, Synthliboramphus antiquus, an alcid with exceptionally long incubation shift lengths, and test the impact of environmental factors on incubation shift length in relation to reproductive success. Methodology/Principal Findings: Using an information theoretic approach, we show that incubation shift length was a strong predictor of reproductive success for ancient murrelets at Reef Island, Haida Gwaii, British Columbia, Canada during the 2007 and 2008 breeding seasons. The most important factors explaining an individual's shift length were egg size, wind speed and the length of the mate's previous shift. Wind speed and tide height were the two most important factors for determining foraging behavior, as measured by dive frequency and depth. Conclusions/Significance: Our study demonstrates that (i) species-specific reproductive strategies interact with environmental conditions such as wind speed to form multiple incubation patterns and (ii) maintaining regular incubation shifts is an essential component of reproductive success.	[Shoji, Akiko; Aris-Brosou, Stephane; Gaston, Anthony J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Shoji, Akiko; Crump, Doug; Gaston, Anthony J.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Elliott, Kyle H.] Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada	University of Ottawa; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of Manitoba	Shoji, A (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	akikosho@gmail.com	Elliott, Kyle/S-9185-2019	Aris-Brosou, Stephane/0000-0003-4987-0296; Elliott, Kyle/0000-0001-5304-3993	Environment Canada; Natural Sciences and Engineering Research Council of Canada; Foundation For International Education Exchange	Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Foundation For International Education Exchange	This project was funded by Environment Canada; SAB was partially supported by the Natural Sciences and Engineering Research Council of Canada. AS received the full scholarship from Ito Foundation For International Education Exchange for the MSc program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2007, AUK, V124, P63, DOI 10.1642/0004-8038(2007)124[63:TPFCRT]2.0.CO;2; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Amundsen T, 1996, J ANIM ECOL, V65, P545, DOI 10.2307/5735; Ashmole N.P., 1971, AVIAN BIOL, P224; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; BIRKHEAD TR, 1976, BRIT BIRDS, V69, P490; Blight LK, 1999, CONDOR, V101, P871, DOI 10.2307/1370079; BURGER AE, 1990, CAN J ZOOL, V68, P1572, DOI 10.1139/z90-232; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chastel O, 1995, AUK, V112, P964, DOI 10.2307/4089027; CHAURAND T, 1994, IBIS, V136, P285, DOI 10.1111/j.1474-919X.1994.tb01097.x; CODY ML, 1973, ECOLOGY, V54, P31, DOI 10.2307/1934372; Cresswell W, 2004, BEHAV ECOL, V15, P498, DOI 10.1093/beheco/arh042; Dale S, 1996, BEHAV ECOL SOCIOBIOL, V39, P31, DOI 10.1007/s002650050264; DAVIS LS, 1988, AUK, V105, P428, DOI 10.1093/auk/105.3.428; DeForest LN, 1996, ECOLOGY, V77, P1501, DOI 10.2307/2265547; DRENT RH, 1980, ARDEA, V68, P225; Egloff C, 2009, MOL ECOL RESOUR, V9, P19, DOI 10.1111/j.1755-0998.2008.02214.x; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Elliott KH, 2010, AQUAT BIOL, V8, P221, DOI 10.3354/ab00236; Elliott KH, 2009, WATERBIRDS, V32, P183, DOI 10.1675/063.032.0123; Elliott KH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1773, DOI 10.1007/s00265-009-0801-y; Falk K, 1997, IBIS, V139, P270, DOI 10.1111/j.1474-919X.1997.tb04625.x; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Gaston, 1992, ANCIENT MURRELET NAT; Gaston A.J., 1998, AUKS ALCIDAE; Gaston A.J., 2004, SEABIRDS NATURAL HIS; GASTON AJ, 1988, COLON WATERBIRD, V11, P58, DOI 10.2307/1521170; Gaston AJ, 2006, J AVIAN BIOL, V37, P101; Gaston AJ, 2006, IBIS, V148, P106, DOI 10.1111/j.1474-919X.2006.00489.x; GASTON AJ, 1992, CONDOR, V94, P1019, DOI 10.2307/1369303; GASTON AJ, 1989, AUK, V106, P653; GASTON AJ, 1989, AUK, V106, P433; GASTON AJ, 1990, CONDOR, V92, P998, DOI 10.2307/1368736; Gaston AJ, 1996, COLON WATERBIRD, V19, P116, DOI 10.2307/1521814; GASTON AJ, 1994, BIRDS N AM, V132; Gray CM, 2005, J AVIAN BIOL, V36, P374, DOI 10.1111/j.0908-8857.2005.03597.x; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Guigueno MF, 2010, CONDOR, V112, P399, DOI 10.1525/cond.2010.090135; HAMER KC, 1994, J AVIAN BIOL, V25, P198, DOI 10.2307/3677075; Hamer KC, 1997, IBIS, V139, P31, DOI 10.1111/j.1474-919X.1997.tb04501.x; HARRIS SW, 1974, CONDOR, V76, P249, DOI 10.2307/1366338; Hatch JJ, 2011, IBIS, V153, P185, DOI 10.1111/j.1474-919X.2010.01076.x; Heath JP, 2007, ANIM BEHAV, V73, P877, DOI 10.1016/j.anbehav.2006.10.015; Heath JP, 2006, J EXP BIOL, V209, P3974, DOI 10.1242/jeb.02482; Heath JP, 2008, WATERBIRDS, V31, P71; Hipfner JM, 1997, J AVIAN BIOL, V28, P271, DOI 10.2307/3676939; Holm HJ, 2002, WATERBIRDS, V25, P312; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; IMBER M J, 1975, Notornis, V22, P302; JONES IL, 1990, CAN J ZOOL, V68, P433, DOI 10.1139/z90-064; Kato A, 2008, AUK, V125, P588, DOI 10.1525/auk.2008.06273; Keitt Bradford S., 2004, Marine Ornithology, V32, P173; Lack D., 1968, pvii; Litzow MA, 2004, J ANIM ECOL, V73, P1149, DOI 10.1111/j.0021-8790.2004.00890.x; LLOYD CS, 1979, IBIS, V121, P165, DOI 10.1111/j.1474-919X.1979.tb04959.x; Lovvorn JR, 2010, AQUAT BIOL, V8, P203, DOI 10.3354/ab00210; Mallory ML, 2008, MAR BIOL, V154, P1031, DOI 10.1007/s00227-008-0994-z; Martin TE, 1999, AM NAT, V153, P131, DOI 10.1086/303153; Michl G, 2000, ANIM BEHAV, V59, P623, DOI 10.1006/anbe.1999.1352; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; Ojowski U, 2001, MAR BIOL, V139, P1193; PRINCE PA, 1994, IBIS, V136, P50, DOI 10.1111/j.1474-919X.1994.tb08131.x; R Development Core Team, 2009, LANG ENV STAT COMP V; Reid JM, 2002, AUK, V119, P54, DOI 10.1642/0004-8038(2002)119[0054:ECOCTA]2.0.CO;2; Riou S, 2008, ANIM BEHAV, V76, P1743, DOI 10.1016/j.anbehav.2008.08.012; Ronconi RA, 2009, CAN J ZOOL, V87, P415, DOI 10.1139/Z09-027; SEALY SG, 1975, CAN J ZOOL, V53, P418, DOI 10.1139/z75-055; SEALY SG, 1976, CONDOR, V78, P294, DOI 10.2307/1367688; Shoji AM, 2010, WATERBIRDS, V33, P260, DOI 10.1675/063.033.0217; Smith PA, 2009, CONDOR, V111, P414, DOI 10.1525/cond.2009.090002; Smith PA, 2007, CONDOR, V109, P15; Stearns S.C., 1992, pi; Tveraa T, 1997, BEHAV ECOL, V8, P465, DOI 10.1093/beheco/8.5.465; WANLESS S, 1993, IBIS, V135, P19, DOI 10.1111/j.1474-919X.1993.tb02805.x; WARHAM J, 1990, PETRELS THEIR ECOLOG; WATANUKI Y, 1986, AUK, V103, P14, DOI 10.1093/auk/103.1.14; Weimerskirch H, 2002, J EXP BIOL, V205, P475; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Wilson RP, 2001, J AVIAN BIOL, V32, P83, DOI 10.1034/j.1600-048X.2001.320113.x; [No title captured], DOI DOI 10.2307/1367282	82	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17760	10.1371/journal.pone.0017760	http://dx.doi.org/10.1371/journal.pone.0017760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423631	gold, Green Submitted, Green Published			2022-12-27	WOS:000288513900023
J	Srinivasan, D; Muthukrishnan, N; Johnson, GA; Erazo-Oliveras, A; Lim, J; Simanek, EE; Pellois, JP				Srinivasan, Divyamani; Muthukrishnan, Nandhini; Johnson, Gregory A.; Erazo-Oliveras, Alfredo; Lim, Jongdoo; Simanek, Eric E.; Pellois, Jean-Philippe			Conjugation to the Cell-Penetrating Peptide TAT Potentiates the Photodynamic Effect of Carboxytetramethylrhodamine	PLOS ONE			English	Article							ARGININE-RICH PEPTIDES; BIOLOGICAL-MEMBRANES; INDUCED ENDOCYTOSIS; LIPID-PEROXIDATION; MECHANISM; THERAPY; PROTEOGLYCANS; TRANSLOCATION; EXPRESSION; LYSOSOMES	Background: Cell-penetrating peptides (CPPs) can transport macromolecular cargos into live cells. However, the cellular delivery efficiency of these reagents is often suboptimal because CPP-cargo conjugates typically remain trapped inside endosomes. Interestingly, irradiation of fluorescently labeled CPPs with light increases the release of the peptide and its cargos into the cytosol. However, the mechanism of this phenomenon is not clear. Here we investigate the molecular basis of the photo-induced endosomolytic activity of the prototypical CPPs TAT labeled to the fluorophore 5(6)carboxytetramethylrhodamine (TMR). Methodology/Principal Findings: We report that TMR-TAT acts as a photosensitizer that can destroy membranes. TMR-TAT escapes from endosomes after exposure to moderate light doses. However, this is also accompanied by loss of plasma membrane integrity, membrane blebbing, and cell-death. In addition, the peptide causes the destruction of cells when applied extracellularly and also triggers the photohemolysis of red blood cells. These photolytic and photocytotoxic effects were inhibited by hydrophobic singlet oxygen quenchers but not by hydrophilic quenchers. Conclusions/Significance: Together, these results suggest that TAT can convert an innocuous fluorophore such as TMR into a potent photolytic agent. This effect involves the targeting of the fluorophore to cellular membranes and the production of singlet oxygen within the hydrophobic environment of the membranes. Our findings may be relevant for the design of reagents with photo-induced endosomolytic activity. The photocytotoxicity exhibited by TMR-TAT also suggests that CPP-chromophore conjugates could aid the development of novel Photodynamic Therapy agents.	[Srinivasan, Divyamani; Muthukrishnan, Nandhini; Johnson, Gregory A.; Erazo-Oliveras, Alfredo; Pellois, Jean-Philippe] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Lim, Jongdoo; Simanek, Eric E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Srinivasan, D (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pellois@tamu.edu	Muthukrishnan, Nandhini/P-8906-2018; Johnson, Gregory/F-3793-2012	Pellois, Jean-Philippe/0000-0001-8528-4652; Johnson, Gregory/0000-0001-6917-4322	National Institute of General Medical Sciences [R01GM087227]; National Institutes of Health (NIH) [R01GM087227, T32GM065088, T32 GM008523]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008523, R01GM087227, T32GM065088] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Award Number R01GM087227 from the National Institute of General Medical Sciences. G.J. was supported by the National Institutes of Health (NIH) Molecular Biophysics training grant T32GM065088 and by grant R01GM087227. A.E.-O. was supported by the NIH Chemistry-Biology Interface training grant T32 GM008523. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1966, NATURE, V209, P874, DOI 10.1038/209874a0; Bagdonas S, 2005, PHOTOCH PHOTOBIO SCI, V4, P497, DOI 10.1039/b503790e; BERG K, 1994, INT J CANCER, V59, P814, DOI 10.1002/ijc.2910590618; BIRCHMEIER W, 1979, J BIOL CHEM, V254, P9298; BLUM A, 1985, PHOTOCHEM PHOTOBIOL, V41, P27, DOI 10.1111/j.1751-1097.1985.tb03443.x; Bourre L, 2010, PHOTOCH PHOTOBIO SCI, V9, P1613, DOI 10.1039/c0pp00146e; Brown SB, 2004, LANCET ONCOL, V5, P497, DOI 10.1016/S1470-2045(04)01529-3; Choi Y, 2006, CHEMMEDCHEM, V1, P458, DOI 10.1002/cmdc.200500036; Ciobanasu C, 2009, BIOCHEMISTRY-US, V48, P4728, DOI 10.1021/bi900365s; COLIN FC, 1991, AM J HEMATOL, V37, P34, DOI 10.1002/ajh.2830370108; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; DOLEIDEN FH, 1974, PHOTOCHEM PHOTOBIOL, V20, P519, DOI 10.1111/j.1751-1097.1974.tb06613.x; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Drzeniek Z, 1999, BLOOD, V93, P2884; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Eggeling C, 1998, ANAL CHEM, V70, P2651, DOI 10.1021/ac980027p; EISENBERG WC, 1984, PHOTOCHEM PHOTOBIOL, V40, P55, DOI 10.1111/j.1751-1097.1984.tb04553.x; Endoh T, 2009, J CONTROL RELEASE, V137, P241, DOI 10.1016/j.jconrel.2009.04.015; EVANS EA, 1974, BIOPHYS J, V14, P923, DOI 10.1016/S0006-3495(74)85959-X; Geissbuehler M, 2010, BIOPHYS J, V98, P339, DOI 10.1016/j.bpj.2009.10.006; Grossweiner L I, 1984, Prog Clin Biol Res, V170, P391; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Hong SB, 2005, PHOTODERMATOL PHOTO, V21, P322, DOI 10.1111/j.1600-0781.2005.00181.x; JAY AWL, 1975, J PHYSIOL-LONDON, V252, P817, DOI 10.1113/jphysiol.1975.sp011172; Maiolo JR, 2004, J AM CHEM SOC, V126, P15376, DOI 10.1021/ja044867z; Matsushita M, 2004, FEBS LETT, V572, P221, DOI 10.1016/j.febslet.2004.07.033; MORLIERE P, 1991, BIOCHIM BIOPHYS ACTA, V1084, P261, DOI 10.1016/0005-2760(91)90068-S; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Ouedraogo GD, 2003, PHOTOCHEM PHOTOBIOL, V77, P192, DOI 10.1562/0031-8655(2003)077<0192:SROSET>2.0.CO;2; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; REYFTMANN JP, 1986, PHOTOCHEM PHOTOBIOL, V44, P461, DOI 10.1111/j.1751-1097.1986.tb04693.x; RUBEN S, 1989, J VIROL, V63, P1; Schmidt-Erfurth U, 1999, ARCH OPHTHALMOL-CHIC, V117, P1177; Sehgal I, 2008, J MED CHEM, V51, P6014, DOI 10.1021/jm800444c; SEVANIAN A, 1985, ANNU REV NUTR, V5, P365, DOI 10.1146/annurev.nu.05.070185.002053; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; VALENZENO DP, 1987, PHOTOCHEM PHOTOBIOL, V46, P147, DOI 10.1111/j.1751-1097.1987.tb04749.x; Vogt AM, 2004, BIOCHEM J, V381, P593, DOI 10.1042/BJ20040762; WILSON PD, 1987, J CELL BIOL, V104, P1223, DOI 10.1083/jcb.104.5.1223; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	44	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17732	10.1371/journal.pone.0017732	http://dx.doi.org/10.1371/journal.pone.0017732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423812	Green Published, gold, Green Submitted			2022-12-27	WOS:000288512400023
J	Yu, XL; Yuan, L; Huang, Y; Xu, WS; Fang, ZM; Liu, SW; Shao, YM; Jiang, SB; Ma, LY				Yu, Xiaoling; Yuan, Lin; Huang, Yang; Xu, Weisi; Fang, Zhiming; Liu, Shuwen; Shao, Yiming; Jiang, Shibo; Ma, Liying			Susceptibility of HIV-1 Subtypes B ', CRF07_BC and CRF01_AE that Are Predominantly Circulating in China to HIV-1 Entry Inhibitors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANT HIV-1; CCR5 ANTAGONIST MARAVIROC; FUSION INHIBITOR; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; ANTIVIRAL ACTIVITY; GP41; ENFUVIRTIDE; PEPTIDE	Background: The B', CRF07_BC and CRF01_AE are the predominant HIV-1 subtypes in China. It is essential to determine their baseline susceptibility to HIV entry inhibitors before these drugs are used in China. Methodology/Principal Findings: The baseline susceptibility of 14 representative HIV-1 isolates (5 CRF07_BC, 4 CRF01_AE, and 5 B'), most of which were R5 viruses, obtained from drug-naive patients to HIV entry inhibitors, including two fusion inhibitors (enfuvirtide and C34), two CCR5 antagonists (maraviroc and TAK779) and one CXCR4 antagonist (AMD3100), were determined by virus inhibition assay. The sequences of their env genes were amplified and analyzed. These isolates possessed similar susceptibility to C34, but they exhibited different sensitivity to enfuvirtide, maraviroc or TAK779. CRF07_BC isolates, which carried polymorphisms of A578T and V583I in the N-terminal heptad repeat and E630Q, E662A, K665S, A667K and S668N in the C-terminal heptad repeat of gp41, were about 5-fold less sensitive than B' and CRF01_AE isolates to enfuvirtide. Subtype B' isolates with a unique polymorphism site of F317W in V3 loop, were about 4- to 5-fold more sensitive than CRF07_BC and CRF01_AE isolates to maraviroc and TAK779. AMD3100 at the concentration as high as 5 mu M exhibited no significant inhibitory activity against any of the isolates tested. Conclusion: Our results suggest that there are significant differences in baseline susceptibility to HIV entry inhibitors among the predominant HIV-1 subtypes in China and the differences may partly result from the naturally occurring polymorphisms in these subtypes. This study provides useful information for rational design of optimal therapeutic regimens for HIV-1-infected patients in China.	[Yu, Xiaoling; Yuan, Lin; Huang, Yang; Xu, Weisi; Fang, Zhiming; Shao, Yiming; Ma, Liying] Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yu, Xiaoling; Liu, Shuwen; Jiang, Shibo] So Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Southern Medical University - China; New York Blood Center; Fudan University; Fudan University	Yu, XL (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao@bbn.cn; sjiang@nybloodcenter.org; liyingma5566@chinaaids.cn	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135; Liu, Shuwen/0000-0001-6346-5006	National Nature Science Foundation of China [30872232, U0832001]; National Science and Technology Major Project [2008ZX10001-004, 2008ZX10001-013, 2008ZX10001-015]; United States National Institutes of Health [AI046221]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046221, R01AI046221] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from National Nature Science Foundation of China (30872232, U0832001) and National Science and Technology Major Project (2008ZX10001-004, 2008ZX10001-013 and 2008ZX10001-015) and a United States National Institutes of Health grant (AI046221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Cai LF, 2010, CHEMMEDCHEM, V5, P1813, DOI 10.1002/cmdc.201000289; Carmona R, 2005, J CLIN VIROL, V32, P248, DOI 10.1016/j.jcv.2004.11.009; Chong HH, 2008, JAIDS-J ACQ IMM DEF, V47, P535, DOI 10.1097/QAI.0b013e3181663967; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Han J, 2009, INT J STD AIDS, V20, P249, DOI 10.1258/ijsa.2008.008480; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Izumi K, 2009, J BIOL CHEM, V284, P4914, DOI 10.1074/jbc.M807169200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Leung PHM, 2010, J CLIN VIROL, V47, P273, DOI 10.1016/j.jcv.2010.01.002; LEVIN J, 2010, 17 CROI C RETR OPP I; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; LIU Z, 2010, J BIOL CHEM; Lobritz MA, 2007, J VIROL, V81, P8258, DOI 10.1128/JVI.02739-06; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Luo MQ, 2009, JAIDS-J ACQ IMM DEF, V50, P1, DOI 10.1097/QAI.0b013e31818ffcdc; Ma LY, 2007, JAIDS-J ACQ IMM DEF, V44, P14, DOI 10.1097/01.qai.0000243049.27580.cc; Ma LY, 2010, AIDS RES HUM RETROV, V26, P1007, DOI 10.1089/aid.2009.0252; Ma LY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-45; McCutchan FE, 2000, AIDS, V14, pS31; Ogert RA, 2008, VIROLOGY, V373, P387, DOI 10.1016/j.virol.2007.12.009; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Pang Wei, 2009, Antivir Chem Chemother, V20, P1, DOI 10.3851/IMP1369; Princen Katrien, 2004, Retrovirology, V1, P2, DOI 10.1186/1742-4690-1-2; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Schurmann D, 2007, AIDS, V21, P1293, DOI 10.1097/QAD.0b013e3280f00f9f; Shao YM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-87; SHIMURA K, 2010, J BIOL CHEM; Simon V, 2002, AIDS, V16, P1511, DOI 10.1097/00002030-200207260-00008; Sun JP, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-201; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Toma J, 2010, AIDS, V24, P2181, DOI 10.1097/QAD.0b013e32833c543f; Tsibris AMN, 2008, J VIROL, V82, P8210, DOI 10.1128/JVI.00444-08; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang M, 2008, JPN J INFECT DIS, V61, P361	50	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17605	10.1371/journal.pone.0017605	http://dx.doi.org/10.1371/journal.pone.0017605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412427	Green Submitted, gold, Green Published			2022-12-27	WOS:000288247800017
J	Galeote, V; Bigey, F; Beyne, E; Novo, M; Legras, JL; Casaregola, S; Dequin, S				Galeote, Virginie; Bigey, Frederic; Beyne, Emmanuelle; Novo, Maite; Legras, Jean-Luc; Casaregola, Serge; Dequin, Sylvie			Amplification of a Zygosaccharomyces bailii DNA Segment in Wine Yeast Genomes by Extrachromosomal Circular DNA Formation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HORIZONTAL-GENE-TRANSFER; SACCHAROMYCES-CEREVISIAE; EVOLUTION; SEQUENCE; REPAIR; POLYMORPHISM; DIVERSITY; PLASMIDS; PATHWAYS	We recently described the presence of large chromosomal segments resulting from independent horizontal gene transfer (HGT) events in the genome of Saccharomyces cerevisiae strains, mostly of wine origin. We report here evidence for the amplification of one of these segments, a 17 kb DNA segment from Zygosaccharomyces bailii, in the genome of S. cerevisiae strains. The copy number, organization and location of this region differ considerably between strains, indicating that the insertions are independent and that they are post-HGT events. We identified eight different forms in 28 S. cerevisiae strains, mostly of wine origin, with up to four different copies in a single strain. The organization of these forms and the identification of an autonomously replicating sequence functional in S. cerevisiae, strongly suggest that an extrachromosomal circular DNA (eccDNA) molecule serves as an intermediate in the amplification of the Z. bailii region in yeast genomes. We found little or no sequence similarity at the breakpoint regions, suggesting that the insertions may be mediated by nonhomologous recombination. The diversity between these regions in S. cerevisiae represents roughly one third the divergence among the genomes of wine strains, which confirms the recent origin of this event, posterior to the start of wine strain expansion. This is the first report of a circle-based mechanism for the expansion of a DNA segment, mediated by nonhomologous recombination, in natural yeast populations.	[Galeote, Virginie; Bigey, Frederic; Beyne, Emmanuelle; Novo, Maite; Legras, Jean-Luc; Dequin, Sylvie] INRA, Sci OEnol UMR1083, F-34060 Montpellier, France; [Casaregola, Serge] AgroParisTech, CIRM Levures, INRA, Micalis UMR1319, Thiverval Grignon, France	INRAE; Universite de Montpellier; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Galeote, V (corresponding author), INRA, Sci OEnol UMR1083, F-34060 Montpellier, France.	sylvie.dequin@supagro.inra.fr	Bigey, Frédéric/F-2517-2010; Legras, Jean-Luc/A-7589-2008; Novo, Maite/G-2002-2016	Bigey, Frédéric/0000-0002-6240-3038; Legras, Jean-Luc/0000-0002-4006-4389; Novo, Maite/0000-0002-2454-1990	French Agence Nationale de la Recherche (ANR) [ANR-07-BLAN-0205]; French National Institute for Agricultural Research (INRA); Generalitat de Catalunya	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French National Institute for Agricultural Research (INRA); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the French Agence Nationale de la Recherche (ANR Project GENYEASTRAIT, ANR-07-BLAN-0205) and post doc fellowships of French National Institute for Agricultural Research (INRA) to EB and of the Generalitat de Catalunya to MN, http://www.international.inra.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAKI H, 1985, J MOL BIOL, V182, P191, DOI 10.1016/0022-2836(85)90338-9; ARGUESO JL, 2009, GENOME RES, V7, P7; BIDENNE C, 1992, CURR GENET, V22, P1, DOI 10.1007/BF00351734; Borneman AR, 2008, FEMS YEAST RES, V8, P1185, DOI 10.1111/j.1567-1364.2008.00434.x; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; Cohen Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006126; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; DAMON C, ISME J IN PRESS; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Frank AC, 2009, EUKARYOT CELL, V8, P1521, DOI 10.1128/EC.00110-09; Galeote V, 2010, MICROBIOL-SGM, V156, P3754, DOI 10.1099/mic.0.041673-0; Gresham D, 2010, P NATL ACAD SCI USA, V107, P18551, DOI 10.1073/pnas.1014023107; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HOROWITZ H, 1985, MOL CELL BIOL, V5, P2369, DOI 10.1128/MCB.5.9.2369; HOURCADE D, 1973, P NATL ACAD SCI USA, V70, P2926, DOI 10.1073/pnas.70.10.2926; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Kavanaugh LA, 2006, MOL BIOL EVOL, V23, P1879, DOI 10.1093/molbev/msl070; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Koszul R, 2009, CR BIOL, V332, P254, DOI 10.1016/j.crvi.2008.07.005; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kuttler F, 2007, SEMIN CANCER BIOL, V17, P56, DOI 10.1016/j.semcancer.2006.10.007; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Moore IK, 2000, ENVIRON MOL MUTAGEN, V36, P113, DOI 10.1002/1098-2280(2000)36:2<113::AID-EM5>3.0.CO;2-T; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Rolland T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006515; Sacerdot C, 2008, FEMS YEAST RES, V8, P846, DOI 10.1111/j.1567-1364.2008.00409.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOHE A, 1985, NUCLEIC ACIDS RES, V13, P4267, DOI 10.1093/nar/13.12.4267; UTATSU I, 1987, J BACTERIOL, V169, P5537, DOI 10.1128/jb.169.12.5537-5545.1987; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917; VANLOON N, 1994, NUCLEIC ACIDS RES, V22, P2447, DOI 10.1093/nar/22.13.2447; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17872	10.1371/journal.pone.0017872	http://dx.doi.org/10.1371/journal.pone.0017872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423766	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100042
J	Leclerc, EA; Gazeilles, L; Serre, G; Guerrin, M; Jonca, N				Leclerc, Emilie A.; Gazeilles, Leila; Serre, Guy; Guerrin, Marina; Jonca, Nathalie			The Ubiquitous Dermokine Delta Activates Rab5 Function in the Early Endocytic Pathway	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SMALL GTPASE RAB5; IDENTIFICATION; GENE; LOCALIZATION; TRAFFICKING; ENDOSOMES; NETWORKS; PROTEINS; GROWTH	The expression of the recently identified dermokine (Dmkn) gene leads to four families of proteins with as yet unknown functions. The secreted alpha, beta and gamma isoforms share an epidermis-restricted expression pattern, whereas the delta isoform is intracellular and ubiquitous. To get an insight into Dmkn delta function, we performed yeast two-hybrid screening and identified the small GTPases Rab5 as partners for Dmkn delta. The Rab5 proteins are known to regulate membrane docking and fusion in the early endocytic pathway. GST pull-down assays confirmed the direct interaction between Rab5 and Dmkn delta. Transient expression of Dmkn delta in HeLa cells led to the formation of punctate structures colocalized with endogenous Rab5 and clathrin, indicating Dmkn delta involvement in the early steps of endocytosis. Dmkn delta indeed colocalized with transferrin at early stages of endocytosis, but did not modulate its endocytosis or recycling kinetics. We also showed that Dmkn delta was able to bind both inactive (GDP-bound) and active (GTP-bound) forms of Rab5 in vitro but preferentially targeted GDP-bound form in HeLa cells. Interestingly, Dmkn delta expression rescued the Rab5S34N-mediated inhibition of endosome fusion. Moreover, Dmkn delta caused the enlargement of vesicles positive for Rab5 by promoting GTP loading onto the small GTPase. Together our data reveal that Dmkn delta activates Rab5 function and thus is involved in the early endosomal trafficking.	[Leclerc, Emilie A.; Gazeilles, Leila; Serre, Guy; Guerrin, Marina; Jonca, Nathalie] Univ Toulouse 3, UMR 516,Epidermis Differentiat & Rheumatoid Autoi, CNRS,IFR 150,INSERM, CHU,CHU Purpan, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Leclerc, EA (corresponding author), Univ Toulouse 3, UMR 516,Epidermis Differentiat & Rheumatoid Autoi, CNRS,IFR 150,INSERM, CHU,CHU Purpan, F-31062 Toulouse, France.	Nathalie.Jonca@udear.cnrs.fr	Jonca, Nathalie/AAX-3870-2020	Jonca, Nathalie/0000-0003-3602-0102	"Centre National de la Recherche Scientifique" (CNRS); Toulouse III University	"Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Toulouse III University	This work was supported by grants from the "Centre National de la Recherche Scientifique" (CNRS) and Toulouse III University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Bazzi H, 2007, DEV DYNAM, V236, P961, DOI 10.1002/dvdy.21099; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Callaghan L, 1999, EUR J BIOCHEM, V265, P361; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHEN PI, 2009, J BIOL CHEM; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Moffatt P, 2004, GENE, V334, P123, DOI 10.1016/j.gene.2004.03.010; Naso MF, 2007, J INVEST DERMATOL, V127, P1622, DOI 10.1038/sj.jid.5700779; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Toulza E, 2006, J INVEST DERMATOL, V126, P503, DOI 10.1038/sj.jid.5700033; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Wakamatsu A, 2009, DNA RES, V16, P371, DOI 10.1093/dnares/dsp022; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100	36	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17816	10.1371/journal.pone.0017816	http://dx.doi.org/10.1371/journal.pone.0017816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423773	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100038
J	Reis, M; Sousa-Guimaraes, S; Vieira, CP; Sunkel, CE; Vieira, J				Reis, Micael; Sousa-Guimaraes, Sofia; Vieira, Cristina P.; Sunkel, Claudio E.; Vieira, Jorge			Drosophila Genes That Affect Meiosis Duration Are among the Meiosis Related Genes That Are More Often Found Duplicated	PLOS ONE			English	Article							CONCERTED EVOLUTION; VIRILIS GROUP; POLO KINASE; GENOME; YEAST; COMPLEX; MELANOGASTER; MECHANISMS; SOFTWARE; PROTEINS	Using a phylogenetic approach, the examination of 33 meiosis/meiosis-related genes in 12 Drosophila species, revealed nine independent gene duplications, involving the genes cav, mre11, meiS332, polo and mtrm. Evidence is provided that at least eight out of the nine gene duplicates are functional. Therefore, the rate at which Drosophila meiosis/meiosis-related genes are duplicated and retained is estimated to be 0.0012 per gene per million years, a value that is similar to the average for all Drosophila genes. It should be noted that by using a phylogenetic approach the confounding effect of concerted evolution, that is known to lead to overestimation of the duplication and retention rate, is avoided. This is an important issue, since even in our moderate size sample, evidence for long-term concerted evolution ( lasting for more than 30 million years) was found for the meiS332 gene pair in species of the Drosophila subgenus. Most striking, in contrast to theoretical expectations, is the finding that genes that encode proteins that must follow a close stoichiometric balance, such as polo, mtrm and meiS332 have been found duplicated. The duplicated genes may be examples of gene neofunctionalization. It is speculated that meiosis duration may be a trait that is under selection in Drosophila and that it has different optimal values in different species.	[Reis, Micael; Sousa-Guimaraes, Sofia; Vieira, Cristina P.; Sunkel, Claudio E.; Vieira, Jorge] Univ Porto, IBMC, P-4100 Oporto, Portugal	Universidade do Porto	Reis, M (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jbvieira@ibmc.up.pt	Vieira, Cristina P./K-1775-2013; Vieira, Jorge/J-7477-2013; Sunkel, Claudio E/J-3352-2013	Vieira, Cristina P./0000-0002-7139-2107; Vieira, Jorge/0000-0001-7032-5220; Sunkel, Claudio E/0000-0002-2963-9380; Reis, Micael/0000-0002-2601-0886	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BDE/66765/2006, PTDC/BIA-BEC/099933/2008]; Programa Operacional para a Ciencia e Inovacao [POCI-2010]; Fundo Europeu para o Desenvolvimento Regional (FEDER); Programa Operacional para a Promocao da competividade (COMPETE)	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional para a Ciencia e Inovacao; Fundo Europeu para o Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional para a Promocao da competividade (COMPETE)	This work was funded by the Fundacao para a Ciencia e Tecnologia (FCT) through research projects PTDC/BIA-BDE/66765/2006 and PTDC/BIA-BEC/099933/2008 and through PhD grants attributed to MR and SG, funded by Programa Operacional para a Ciencia e Inovacao (POCI-2010), co-funded by Fundo Europeu para o Desenvolvimento Regional (FEDER) and Programa Operacional para a Promocao da competividade (COMPETE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2009, GENETICS, V181, P177, DOI 10.1534/genetics.108.093807; Badugu R, 2003, J BIOL CHEM, V278, P34491, DOI 10.1074/jbc.M305262200; Beisswanger S, 2008, P NATL ACAD SCI USA, V105, P5447, DOI 10.1073/pnas.0710892105; BENNETT MD, 1977, PHILOS T R SOC B, V277, P201, DOI 10.1098/rstb.1977.0012; Bi XL, 2004, CURR BIOL, V14, P1348, DOI 10.1016/j.cub.2004.06.063; Carmon A, 2010, J MOL EVOL, V70, P260, DOI 10.1007/s00239-010-9327-1; Clarke AS, 2005, DEV CELL, V8, P53, DOI 10.1016/j.devcel.2004.12.003; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Gao GJ, 2009, P NATL ACAD SCI USA, V106, P10728, DOI 10.1073/pnas.0902707106; Gao LZ, 2004, SCIENCE, V306, P1367, DOI 10.1126/science.1102033; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; HICKEY DA, 1991, P NATL ACAD SCI USA, V88, P1611, DOI 10.1073/pnas.88.5.1611; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kahn T, 2000, MOL CELL BIOL, V20, P7634, DOI 10.1128/MCB.20.20.7634-7642.2000; KLASTERSKA I, 1990, GENETICA, V80, P181, DOI 10.1007/BF00137324; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2000, GENETICS, V154, P459; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Osada N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000305; Page SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000194; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Reis M, 2008, GENE, V425, P48, DOI 10.1016/j.gene.2008.08.010; Reynolds N, 2003, J CELL SCI, V116, P1377, DOI 10.1242/jcs.00314; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Shareef MM, 2003, GENETICA, V117, P127; Smith SK, 2008, CELL CYCLE, V7, P698, DOI 10.4161/cc.7.6.5568; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Soyer OS, 2010, J EVOLUTION BIOL, V23, P2410, DOI 10.1111/j.1420-9101.2010.02101.x; TAJIMA F, 1993, GENETICS, V135, P599; Vieira CP, 2006, GENET RES, V87, P163, DOI 10.1017/S0016672306008147; Villasante A, 2007, GENOME RES, V17, P1909, DOI 10.1101/gr.6365107; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wang SJ, 1999, MOL BIOL EVOL, V16, P1117, DOI 10.1093/oxfordjournals.molbev.a026202; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Yang J, 2004, GENE, V340, P237, DOI 10.1016/j.gene.2004.06.057	41	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17512	10.1371/journal.pone.0017512	http://dx.doi.org/10.1371/journal.pone.0017512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423746	Green Submitted, Green Published, gold			2022-12-27	WOS:000288219100012
J	Steelandt, S; Dufour, V; Broihanne, MH; Thierry, B				Steelandt, Sophie; Dufour, Valerie; Broihanne, Marie-Helene; Thierry, Bernard			Can Monkeys Make Investments Based on Maximized Pay-off?	PLOS ONE			English	Article							SEQUENTIALLY PRESENTED SETS; BY-ONE ADDITION; RHESUS MACAQUES; DEMAND DETERMINE; SMALL NUMBERS; CHIMPANZEES; SUMMATION; FOOD; REPRESENTATION; TROGLODYTES	Animals can maximize benefits but it is not known if they adjust their investment according to expected pay-offs. We investigated whether monkeys can use different investment strategies in an exchange task. We tested eight capuchin monkeys (Cebus apella) and thirteen macaques (Macaca fascicularis, Macaca tonkeana) in an experiment where they could adapt their investment to the food amounts proposed by two different experimenters. One, the doubling partner, returned a reward that was twice the amount given by the subject, whereas the other, the fixed partner, always returned a constant amount regardless of the amount given. To maximize pay-offs, subjects should invest a maximal amount with the first partner and a minimal amount with the second. When tested with the fixed partner only, one third of monkeys learned to remove a maximal amount of food for immediate consumption before investing a minimal one. With both partners, most subjects failed to maximize pay-offs by using different decision rules with each partner' quality. A single Tonkean macaque succeeded in investing a maximal amount to one experimenter and a minimal amount to the other. The fact that only one of over 21 subjects learned to maximize benefits in adapting investment according to experimenters' quality indicates that such a task is difficult for monkeys, albeit not impossible.	[Steelandt, Sophie; Dufour, Valerie; Thierry, Bernard] CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Steelandt, Sophie; Dufour, Valerie; Thierry, Bernard] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Dufour, Valerie] Univ St Andrews, Scottish Primate Res Grp, Ctr Social Learning & Cognit Evolut, Sch Psychol, St Andrews KY16 9AJ, Fife, Scotland; [Broihanne, Marie-Helene] Univ Strasbourg, Lab Rech Gest & Econ, EM Strasbourg Business Sch, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of St Andrews; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Steelandt, S (corresponding author), CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France.	sophie.steelandt@c-strasbourg.fr		Broihanne, Marie-Helene/0000-0002-3651-2740	Agence Nationale de la Recherche [ANR-08-BLAN-0042-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The research was supported by a grant from the Agence Nationale de la Recherche (ANR-08-BLAN-0042-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESSI E, 2007, P ROY SOC LOND B BIO, V274, P2709; Addessi E, 2008, ANIM COGN, V11, P275, DOI 10.1007/s10071-007-0111-6; Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Anderson US, 2005, J COMP PSYCHOL, V119, P285, DOI 10.1037/0735-7036.119.3.285; Barrett L, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P209, DOI 10.1007/3-540-28277-7_12; Beran MJ, 2008, AM J PRIMATOL, V70, P191, DOI 10.1002/ajp.20474; Beran MJ, 2008, ANIM COGN, V11, P109, DOI 10.1007/s10071-007-0094-3; Beran MJ, 2004, J COMP PSYCHOL, V118, P25, DOI 10.1037/0735-7036.118.1.25; Beran MJ, 2004, PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2004.01502004.x; Beran MJ, 2002, J GEN PSYCHOL, V129, P49, DOI 10.1080/00221300209602032; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; Blaye A, 2001, BRIT J DEV PSYCHOL, V19, P395, DOI 10.1348/026151001166173; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Brosnan SF, 2009, INT J PRIMATOL, V30, P663, DOI 10.1007/s10764-009-9366-x; Brosnan SF, 2005, PRIMATES, V46, P173, DOI 10.1007/s10329-005-0125-0; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; Call J, 2000, J COMP PSYCHOL, V114, P136, DOI 10.1037/0735-7036.114.2.136; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Cantlon JF, 2005, P NATL ACAD SCI USA, V102, P16507, DOI 10.1073/pnas.0506463102; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Cordes S, 2007, CURR DIR PSYCHOL SCI, V16, P156, DOI 10.1111/j.1467-8721.2007.00495.x; Drapier M, 2005, PRIMATES, V46, P241, DOI 10.1007/s10329-005-0132-1; Dufour V, 2007, J COMP PSYCHOL, V121, P145, DOI 10.1037/0735-7036.121.2.145; Dufour V, 2009, BIOL LETTERS, V5, P172, DOI 10.1098/rsbl.2008.0644; Evans TA, 2007, J GEN PSYCHOL, V134, P199, DOI 10.3200/GENP.134.2.199-216; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Hare B, 2003, ANIM BEHAV, V65, P131, DOI 10.1006/anbe.2002.2017; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 2003, COGNITIVE PSYCHOL, V47, P367, DOI 10.1016/S0010-0285(03)00050-1; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P1441, DOI 10.1098/rspb.2003.2414; Hyatt CW, 1998, BEHAV PROCESS, V42, P177, DOI 10.1016/S0376-6357(97)00075-2; Judge PG, 2005, J EXP PSYCHOL-ANIM B, V31, P79, DOI 10.1037/0097-7403.31.1.79; Lakshminaryanan V, 2008, PHILOS T R SOC B, V363, P3837, DOI 10.1098/rstb.2008.0149; McNamara JM, 1996, AM ZOOL, V36, P484; Mitchell RW, 1997, J COMP PSYCHOL, V111, P351, DOI 10.1037/0735-7036.111.4.351; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Nofsinger JR, 2005, PSYCHOL INVESTMENT; Pele M, 2010, ANIM COGN, V13, P263, DOI 10.1007/s10071-009-0264-6; PERUSSE R, 1990, INT J PRIMATOL, V11, P425, DOI 10.1007/BF02196130; POVINELLI DJ, 1991, J COMP PSYCHOL, V105, P318, DOI 10.1037/0735-7036.105.4.318; Ramseyer A, 2006, P ROY SOC B-BIOL SCI, V273, P179, DOI 10.1098/rspb.2005.3300; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Rumbaugh D.M., 1984, P569; RUMBAUGH DM, 1987, J EXP PSYCHOL ANIM B, V13, P107, DOI 10.1037/0097-7403.13.2.107; Silk JB, 2007, ADV STUD BEHAV, V37, P1, DOI 10.1016/S0065-3454(07)37001-0; STEELANDT S, ARE MONKEYS SE UNPUB; Stephens D., 2007, FORAGING BEHAV ECOLO; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Sulkowski GM, 2001, COGNITION, V79, P239, DOI 10.1016/S0010-0277(00)00112-8; THOMAS RK, 1993, DEV NUMERICAL COMPET, P127; Tomasello M, 1997, PRIMATE COGNITION; vanMarle K, 2006, J COMP PSYCHOL, V120, P416, DOI 10.1037/0735-7036.120.4.416; Westergaard GC, 2004, ANIM COGN, V7, P19, DOI 10.1007/s10071-003-0181-z; Wood JN, 2008, COGNITION, V106, P207, DOI 10.1016/j.cognition.2007.01.004; Zelazo PD, 2003, MONOGR SOC RES CHILD, V68, P1, DOI 10.1111/j.0037-976X.2003.00261.x; [No title captured]	61	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17801	10.1371/journal.pone.0017801	http://dx.doi.org/10.1371/journal.pone.0017801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732VZ	21423777	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100035
J	Belo, NO; Pinheiro, RT; Reis, ES; Ricklefs, RE; Braga, EM				Belo, Nayara O.; Pinheiro, Renato T.; Reis, Elivania S.; Ricklefs, Robert E.; Braga, Erika M.			Prevalence and Lineage Diversity of Avian Haemosporidians from Three Distinct Cerrado Habitats in Brazil	PLOS ONE			English	Article							BLOOD PARASITES; ANOPHELES-DARLINGI; MALARIA PARASITES; HOST; PLASMODIUM; FOREST; VECTOR; RISK; INFECTION; BIRDS	Habitat alteration can disrupt host-parasite interactions and lead to the emergence of new diseases in wild populations. The cerrado habitat of Brazil is being fragmented and degraded rapidly by agriculture and urbanization. We screened 676 wild birds from three habitats (intact cerrado, disturbed cerrado and transition area Amazonian rainforest-cerrado) for the presence of haemosporidian parasites (Plasmodium and Haemoproteus) to determine whether different habitats were associated with differences in the prevalence and diversity of infectious diseases in natural populations. Twenty one mitochondrial lineages, including 11 from Plasmodium and 10 from Haemoproteus were identified. Neither prevalence nor diversity of infections by Plasmodium spp. or Haemoproteus spp. differed significantly among the three habitats. However, 15 of the parasite lineages had not been previously described and might be restricted to these habitats or to the region. Six haemosporidian lineages previously known from other regions, particularly the Caribbean Basin, comprised 50-80% of the infections in each of the samples, indicating a regional relationship between parasite distribution and abundance.	[Belo, Nayara O.; Braga, Erika M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Pinheiro, Renato T.; Reis, Elivania S.] Univ Fed Tocantins, Palmas, Brazil; [Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Universidade Federal de Minas Gerais; Universidade Federal do Tocantins (UFT); University of Missouri System; University of Missouri Saint Louis	Belo, NO (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	embraga@icb.ufmg.br	Braga, Erika Martins/A-6776-2008; Belo, Nayara/ABE-3106-2021; Belo, nayara Oliveira/H-1657-2012; Pinheiro, Renato/D-9567-2013	Braga, Erika Martins/0000-0001-5550-7157; , nayara/0000-0003-1719-7404	Conselho Nacional de Pesquisa e Tecnologia (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPQ; Curators of the University of Missouri	Conselho Nacional de Pesquisa e Tecnologia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Curators of the University of Missouri	This work was supported by Conselho Nacional de Pesquisa e Tecnologia (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The CNPQ granted a scholarship to Ms. Nayara O. Belo. Some laboratory work was supported by funds from the Curators of the University of Missouri to R. E. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 2002, CONSERVATION MEDICINE, P79; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Belo NO, 2009, PREV VET MED, V88, P220, DOI 10.1016/j.prevetmed.2008.09.007; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2003, J PARASITOL, V89, P388, DOI 10.1645/0022-3395(2003)089[0388:TASVOH]2.0.CO;2; Bonneaud C, 2009, J TROP ECOL, V25, P439, DOI 10.1017/S0266467409006178; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; COLWELL R. K., 2008, ESTIMATES STAT ESTIM; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; Cunha RV, 1999, T ROY SOC TROP MED H, V93, P247, DOI 10.1016/S0035-9203(99)90008-1; de Morais SA, 2010, MEM I OSWALDO CRUZ, V105, P672, DOI 10.1590/S0074-02762010000500012; Fallon SM, 2005, AM NAT, V165, P466, DOI 10.1086/428430; Fallon SM, 2003, EVOLUTION, V57, P606, DOI 10.1111/j.0014-3820.2003.tb01552.x; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Jarvi SI, 2002, J PARASITOL, V88, P153, DOI 10.1645/0022-3395(2002)088[0153:PDUTPO]2.0.CO;2; KNOWLES SC, 2010, MOL ECOL IN PRESS; Kotze DJ, 2001, BIODIVERS CONSERV, V10, P443, DOI 10.1023/A:1016606209906; Lafferty KD, 1997, PARASITOL TODAY, V13, P251, DOI 10.1016/S0169-4758(97)01072-7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Povoa MM, 2003, J MED ENTOMOL, V40, P379, DOI 10.1603/0022-2585-40.4.379; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; SCHALL JJ, 1995, J ANIM ECOL, V64, P177, DOI 10.2307/5753; SCOTT TW, 1991, BIRD PARASITE INTERA, P179; Sehgal RNM, 2005, J VET MED SCI, V67, P295, DOI 10.1292/jvms.67.295; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; *UN FAO, 2007, STAT WORLDS FOR 2007; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; ENV SITUATION	45	60	63	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17654	10.1371/journal.pone.0017654	http://dx.doi.org/10.1371/journal.pone.0017654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408114	Green Published, gold			2022-12-27	WOS:000288170000051
J	Ho, PL; Lo, WU; Yeung, MK; Lin, CH; Chow, KH; Ang, I; Tong, AHY; Bao, JYJ; Lok, S; Lo, JYC				Ho, Pak Leung; Lo, Wai U.; Yeung, Man Kiu; Lin, Chi Ho; Chow, Kin Hung; Ang, Irene; Tong, Amy Hin Yan; Bao, Jessie Yun-Juan; Lok, Si; Lo, Janice Yee Chi			Complete Sequencing of pNDM-HK Encoding NDM-1 Carbapenemase from a Multidrug-Resistant Escherichia coli Strain Isolated in Hong Kong	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; COMPLETE NUCLEOTIDE-SEQUENCE; KLEBSIELLA-PNEUMONIAE; AMINOGLYCOSIDE-RESISTANCE; BLA(CTX-M) GENES; PLASMIDS; EMERGENCE; ELEMENTS; SYSTEMS; SPREAD	Background: The emergence of plasmid-mediated carbapenemases, such as NDM-1 in Enterobacteriaceae is a major public health issue. Since they mediate resistance to virtually all beta-lactam antibiotics and there is often co-resistance to other antibiotic classes, the therapeutic options for infections caused by these organisms are very limited. Methodology: We characterized the first NDM-1 producing E. coli isolate recovered in Hong Kong. The plasmid encoding the metallo-beta-lactamase gene was sequenced. Principal Findings: The plasmid, pNDM-HK readily transferred to E. coli J53 at high frequencies. It belongs to the broad host range IncL/M incompatibility group and is 88803 bp in size. Sequence alignment showed that pNDM-HK has a 55 kb backbone which shared 97% homology with pEL60 originating from the plant pathogen, Erwina amylovora in Lebanon and a 28.9 kb variable region. The plasmid backbone includes the mucAB genes mediating ultraviolet light resistance. The 28.9 kb region has a composite transposon-like structure which includes intact or truncated genes associated with resistance to beta-lactams (bla(TEM-1), bla(NDM-1), Delta bla(DHA-1)), aminoglycosides (aacC2, armA), sulphonamides (sul1) and macrolides (mel, mph2). It also harbors the following mobile elements: IS26, ISCR1, tnpU, tnpAcp2, tnpD, Delta tnpATn1 and insL. Certain blocks within the 28.9 kb variable region had homology with the corresponding sequences in the widely disseminated plasmids, pCTX-M3, pMUR050 and pKP048 originating from bacteria in Poland in 1996, in Spain in 2002 and in China in 2006, respectively. Significance: The genetic support of NDM-1 gene suggests that it has evolved through complex pathways. The association with broad host range plasmid and multiple mobile genetic elements explain its observed horizontal mobility in multiple bacterial taxa.	[Ho, Pak Leung; Lo, Wai U.; Yeung, Man Kiu; Chow, Kin Hung; Ang, Irene] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Ho, Pak Leung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China; [Lin, Chi Ho; Tong, Amy Hin Yan; Bao, Jessie Yun-Juan; Lok, Si] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Lo, Janice Yee Chi] Ctr Hlth Protect, Publ Hlth Lab Serv Branch, Hong Kong, Hong Kong, Peoples R China; [Lo, Janice Yee Chi] Ctr Hlth Protect, Dept Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Ho, PL (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	plho@hkucc.hku.hk	何栢良, Pak-Leung HO/C-4310-2009; Lo, Wai U/J-3053-2019; CHOW, Kin Hung/AAZ-3739-2020	何栢良, Pak-Leung HO/0000-0002-8811-1308; Lo, Wai U/0000-0002-2182-0222; /0000-0002-7386-8236	Health and Food Bureau of the Hong Kong, Special Administrative Region government	Health and Food Bureau of the Hong Kong, Special Administrative Region government	This work was supported by a commission grant from the Research Fund for the Control of Infectious Diseases (RFCID) of the Health and Food Bureau of the Hong Kong, Special Administrative Region government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bertini A, 2007, ANTIMICROB AGENTS CH, V51, P2324, DOI 10.1128/AAC.01502-06; BRADLEY DE, 1980, J BACTERIOL, V143, P1466, DOI 10.1128/JB.143.3.1466-1470.1980; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; CASTANHEIRA M, 2010, ANTIMICROB AGENTS CH; Chu YW, 2011, EMERG INFECT DIS, V17, P130, DOI 10.3201/eid1701.101443; Clinical and Laboratory Standards Institute, 2010, M100S20U CLIN LAB ST; Cullik A, 2010, J MED MICROBIOL, V59, P580, DOI 10.1099/jmm.0.016188-0; Foster GC, 2004, APPL ENVIRON MICROB, V70, P7539, DOI 10.1128/AEM.70.12.7539-7544.2004; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; Gonzalez-Zorn B, 2005, EMERG INFECT DIS, V11, P954; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Ho PL, 2007, J ANTIMICROB CHEMOTH, V60, P140, DOI 10.1093/jac/dkm144; Ho PL, 2010, J MED MICROBIOL, V59, P702, DOI 10.1099/jmm.0.015032-0; Ho PL, 2005, J ANTIMICROB CHEMOTH, V55, P326, DOI 10.1093/jac/dki010; Jiang Y, 2010, ANTIMICROB AGENTS CH, V54, P3967, DOI 10.1128/AAC.00137-10; Kac G, 2010, INFECT CONT HOSP EP, V31, P165, DOI 10.1086/649794; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Literacka E, 2009, ANTIMICROB AGENTS CH, V53, P1630, DOI 10.1128/AAC.01431-08; Lo WU, 2010, J INFECTION, V60, P286, DOI 10.1016/j.jinf.2010.02.002; Loli A, 2006, J ANTIMICROB CHEMOTH, V58, P669, DOI 10.1093/jac/dkl302; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Muir A, 2010, J HOSP INFECT, V75, P239, DOI 10.1016/j.jhin.2010.02.005; POIREL L, 2010, ANTIMICROB AGENTS CH; SAMUELSEN O, 2010, J ANTIMICROB CHEMOTH; Shahid M, 2010, J CLIN MICROBIOL, V48, P1833, DOI 10.1128/JCM.01467-09; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Yu WL, 2006, CLIN MICROBIOL INFEC, V12, P806, DOI 10.1111/j.1469-0691.2006.01488.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhu WH, 2009, ANTIMICROB AGENTS CH, V53, P5291, DOI 10.1128/AAC.00032-09	36	146	173	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17989	10.1371/journal.pone.0017989	http://dx.doi.org/10.1371/journal.pone.0017989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445317	gold, Green Published, Green Submitted			2022-12-27	WOS:000288613300025
J	Madzivhandila, M; Adrian, PV; Cutland, CL; Kuwanda, L; Schrag, SJ; Madhi, SA				Madzivhandila, Mashudu; Adrian, Peter V.; Cutland, Clare L.; Kuwanda, Locadiah; Schrag, Stephanie J.; Madhi, Shabir A.			Serotype Distribution and Invasive Potential of Group B Streptococcus Isolates Causing Disease in Infants and Colonizing Maternal-Newborn Dyads	PLOS ONE			English	Article							PREGNANT-WOMEN; CARRIAGE; IMMUNIZATION; COLONIZATION; EPIDEMIOLOGY; PNEUMONIAE; MOTHERS; ASSAY	Background: Serotype-specific polysaccharide based group B streptococcus (GBS) vaccines are being developed. An understanding of the serotype epidemiology associated with maternal colonization and invasive disease in infants is necessary to determine the potential coverage of serotype-specific GBS vaccines. Methods: Colonizing GBS isolates were identified by vaginal swabbing of mothers during active labor and from skin of their newborns post-delivery. Invasive GBS isolates from infants were identified through laboratory-based surveillance. GBS serotyping was done by latex agglutination. Serologically non-typeable isolates were typed by a serotype-specific PCR method. The invasive potential of GBS serotypes associated with sepsis within seven days of birth was evaluated in association to maternal colonizing serotypes. Results: GBS was identified in 289 (52.4%) newborns born to 551 women with GBS-vaginal colonization and from 113 (5.6%) newborns born to 2,010 mothers in whom GBS was not cultured from vaginal swabs. The serotype distribution among vaginal-colonizing isolates was as follows: III (37.3%), Ia (30.1%), and II (11.3%), V (10.2%), Ib (6.7%) and IV (3.7%). There were no significant differences in serotype distribution between vaginal and newborn colonizing isolates (P = 0.77). Serotype distribution of invasive GBS isolates were significantly different to that of colonizing isolates (P < 0.0001). Serotype III was the most common invasive serotype in newborns less than 7 days (57.7%) and in infants 7 to 90 days of age (84.3%; P < 0.001). Relative to serotype III, other serotypes showed reduced invasive potential: Ia (0.49; 95% CI 0.31-0.77), II (0.30; 95% CI 0.13-0.67) and V (0.38; 95% CI 0.17-0.83). Conclusion: In South Africa, an anti-GBS vaccine including serotypes Ia, Ib and III has the potential of preventing 74.1%, 85.4% and 98.2% of GBS associated with maternal vaginal-colonization, invasive disease in neonates less than 7 days and invasive disease in infants between 7-90 days of age, respectively.	[Madzivhandila, Mashudu; Adrian, Peter V.; Cutland, Clare L.; Kuwanda, Locadiah; Madhi, Shabir A.] Univ Witwatersrand, Vaccine Preventable Dis & Resp & Meningeal Pathog, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa; [Schrag, Stephanie J.] Ctr Dis Control & Prevent, Atlanta, GA USA	National Research Foundation - South Africa; University of Witwatersrand; Centers for Disease Control & Prevention - USA	Madzivhandila, M (corresponding author), Univ Witwatersrand, Vaccine Preventable Dis & Resp & Meningeal Pathog, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa.	madhis@rmpru.co.za	Cutland, Clare L./GXE-9967-2022	Cutland, Clare L./0000-0001-8250-8307	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (Vaccine Preventable Diseases Research Chair Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sweih Noura, 2005, Archives of Gynecology and Obstetrics, V272, P131, DOI 10.1007/s00404-004-0705-z; Amin A, 2002, J INFECTION, V45, P42, DOI 10.1053/jinf.2001.0990; BAIDI MS, 1977, J INFECT DIS, V135, P308; Baker CJ, 1999, J INFECT DIS, V179, P142, DOI 10.1086/314574; Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0; Baker CJ, 2003, ARCH DIS CHILD, V88, P375, DOI 10.1136/adc.88.5.375; Beal S., 2006, REV GYNAECOL P RINAT, V6, P218, DOI [10.1016/j.rigapp.2006.05.006, DOI 10.1016/J.RIGAPP.2006.05.006]; BEHRMAN RE, 1973, FETAL NEONATAL MED, V82, P703; Berg S, 2000, CLIN MICROBIOL INFEC, V6, P9, DOI 10.1046/j.1469-0691.2000.00007.x; Bisharat N, 2005, MICROBIOL-SGM, V151, P1875, DOI 10.1099/mic.0.27826-0; BLACK RE, 2010, LANCET, V6736, P39; Brimil N, 2006, INT J MED MICROBIOL, V296, P39, DOI 10.1016/j.ijmm.2005.11.001; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Buttery J, 2002, BRIT MED BULL, V61, P63, DOI 10.1093/bmb/61.1.63; CUTLAND CL, 2009, LANCET, V6736, P1; DILLON HC, 1982, J INFECT DIS, V145, P794, DOI 10.1093/infdis/145.6.794; Eren A, 2005, TURKISH J PEDIATR, V47, P28; Fluegge K, 2005, CLIN INFECT DIS, V40, P760, DOI 10.1086/427942; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Harrison LH, 1998, J INFECT DIS, V177, P998, DOI 10.1086/515260; HOOGKAMPKORSTANJE JAA, 1982, J INFECT DIS, V145, P800, DOI 10.1093/infdis/145.6.800; Kovavisarach Ekachai, 2007, Journal of the Medical Association of Thailand, V90, P1710; Lancefield RC, 1934, J EXP MED, V59, P459, DOI 10.1084/jem.59.4.459; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; Moore MR, 2003, LANCET INFECT DIS, V3, P201, DOI 10.1016/S1473-3099(03)00577-2; Moyo SR, 2002, J MED MICROBIOL, V51, P595, DOI 10.1099/0022-1317-51-7-595; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; QINLAN JD, 2000, J MED MICROBIOL, V49, P447; QUINLAN JD, 2000, J FAMILY PRACTICE, V49, P448; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Slotved HC, 2003, J CLIN MICROBIOL, V41, P4445, DOI 10.1128/JCM.41.9.4445-4447.2003; Strus M, 2009, J MED MICROBIOL, V58, P228, DOI 10.1099/jmm.0.002865-0; SUARA RO, 1994, J INFECT DIS, V170, P1316, DOI 10.1093/infdis/170.5.1316; van Elzakker E, 2009, EUR J CLIN MICROBIOL, V28, P921, DOI 10.1007/s10096-009-0726-4; Weisner AM, 2004, CLIN INFECT DIS, V38, P1203, DOI 10.1086/382881; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; 2006, WEEKLY EPIDEMIOL REC, V81, P198	41	72	79	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17861	10.1371/journal.pone.0017861	http://dx.doi.org/10.1371/journal.pone.0017861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445302	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300017
J	Uraki, R; Sakudo, A; Michibata, K; Ano, Y; Kono, J; Yukawa, M; Onodera, T				Uraki, Ryuta; Sakudo, Akikazu; Michibata, Kosuke; Ano, Yasuhisa; Kono, Jyuri; Yukawa, Masayoshi; Onodera, Takashi			Blocking of FcR Suppresses the Intestinal Invasion of Scrapie Agents	PLOS ONE			English	Article							PRION PROTEIN; LAMININ RECEPTOR; DENDRITIC CELLS; MICE; PATHOGENESIS; TRANSPORT; BINDING; MUCOSA; SHEEP	Prion diseases are a family of neurodegenerative zoonotic foodborne disorders. Although prions can be transmitted orally, the mechanism by which prions are incorporated into the intestine remains unclear. Our previous studies have shown that an abnormal isoform of prion protein (PrP(Sc)), which is the main component of prions, was efficiently incorporated into the intestine in suckling mice but not in weaned mice. Furthermore, suckling SCID mice lacking maternal antibodies showed decreased uptake of PrP(Sc) into the intestine compared with suckling wild-type mice, while the lack of PrP(Sc) uptake into the intestine of suckling SCID mice was rescued by the oral administration of IgG. These findings raise the possibility that the neonatal Fc receptor (nFcR), which contributes to the uptake of maternal antibodies into the intestine, plays a role in PrP(Sc) incorporation into the intestine. The present immunohistochemical study further showed that the FcR blocker Z-epsilon-aminocaproic acid (ZAA) inhibited PrP(Sc) incorporation into the intestinal villi of suckling mice, supporting the above mentioned concept. Therefore, our findings provide strong evidence that nFcR and maternal antibodies are involved in PrP(Sc) incorporation into the intestine before the weaning period.	[Uraki, Ryuta; Michibata, Kosuke; Ano, Yasuhisa; Onodera, Takashi] Univ Tokyo, Sch Agr & Life Sci, Dept Mol Immunol, Tokyo, Japan; [Sakudo, Akikazu] Univ Ryukyus, Sch Hlth Sci, Fac Med, Lab Biometab Chem, Okinawa, Japan; [Kono, Jyuri; Yukawa, Masayoshi] Nihon Univ, Coll Bioresource Sci, Dept Vet Sci, Kanagawa, Japan	University of Tokyo; University of the Ryukyus; Nihon University	Uraki, R (corresponding author), Univ Tokyo, Sch Agr & Life Sci, Dept Mol Immunol, Tokyo, Japan.	aonoder@mail.ecc.u-tokyo.ac.jp	Sakudo, Akikazu/B-1368-2014		Japanese Food Safety Commission [0503]	Japanese Food Safety Commission	Funding was provided by a Grant-in-Aid from the Japanese Food Safety Commission (no. 0503; http://www.fsc.go.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano Y, 2010, INT J MOL MED, V26, P845, DOI 10.3892/ijmm_00000533; Beekes M, 2000, NEUROSCI LETT, V278, P181, DOI 10.1016/S0304-3940(99)00934-9; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Ghosh S, 2004, ADV DRUG DELIVER REV, V56, P915, DOI 10.1016/j.addr.2003.10.035; Heppner FL, 2001, NAT MED, V7, P976, DOI 10.1038/nm0901-976; Hirogari Y, 2003, MICROBIOL IMMUNOL, V47, P871, DOI 10.1111/j.1348-0421.2003.tb03453.x; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; KRAMER DR, 1995, J IMMUNOL, V154, P2051; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Oda M, 2003, INT IMMUNOL, V15, P417, DOI 10.1093/intimm/dxg036; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Rodewald HR, 1999, P NATL ACAD SCI USA, V96, P15068, DOI 10.1073/pnas.96.26.15068; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P775, DOI 10.1093/jnen/63.7.775; Shmakov AN, 2000, J PATHOL, V191, P318, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH640>3.0.CO;2-4; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007	19	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17928	10.1371/journal.pone.0017928	http://dx.doi.org/10.1371/journal.pone.0017928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437246	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100044
J	Fleming, EJ; Langdon, AE; Martinez-Garcia, M; Stepanauskas, R; Poulton, NJ; Masland, EDP; Emerson, D				Fleming, Emily J.; Langdon, Amy E.; Martinez-Garcia, Manuel; Stepanauskas, Ramunas; Poulton, Nicole J.; Masland, E. Dashiell P.; Emerson, David			What's New Is Old: Resolving the Identity of Leptothrix ochracea Using Single Cell Genomics, Pyrosequencing and FISH	PLOS ONE			English	Article							IRON-OXIDIZING BACTERIA; FRESH-WATER HABITATS; RNA-TARGETED PROBES; FILAMENTOUS BACTERIA; SPHAEROTILUS-NATANS; ACTIVATED-SLUDGE; MARINE-BACTERIA; NEUTRAL PH; IN-SITU; MANGANESE	Leptothrix ochracea is a common inhabitant of freshwater iron seeps and iron-rich wetlands. Its defining characteristic is copious production of extracellular sheaths encrusted with iron oxyhydroxides. Surprisingly, over 90% of these sheaths are empty, hence, what appears to be an abundant population of iron-oxidizing bacteria, consists of relatively few cells. Because L. ochracea has proven difficult to cultivate, its identification is based solely on habitat preference and morphology. We utilized cultivation-independent techniques to resolve this long-standing enigma. By selecting the actively growing edge of a Leptothrix-containing iron mat, a conventional SSU rRNA gene clone library was obtained that had 29 clones (42% of the total library) related to the Leptothrix/Sphaerotilus group (<= 96% identical to cultured representatives). A pyrotagged library of the V4 hypervariable region constructed from the bulk mat showed that 7.2% of the total sequences also belonged to the Leptothrix/Sphaerotilus group. Sorting of individual L. ochracea sheaths, followed by whole genome amplification (WGA) and PCR identified a SSU rRNA sequence that clustered closely with the putative Leptothrix clones and pyrotags. Using these data, a fluorescence in-situ hybridization (FISH) probe, Lepto175, was designed that bound to ensheathed cells. Quantitative use of this probe demonstrated that up to 35% of microbial cells in an actively accreting iron mat were L. ochracea. The SSU rRNA gene of L. ochracea shares 96% homology with its closet cultivated relative, L. cholodnii, This establishes that L. ochracea is indeed related to this group of morphologically similar, filamentous, sheathed microorganisms.	[Fleming, Emily J.; Langdon, Amy E.; Martinez-Garcia, Manuel; Stepanauskas, Ramunas; Poulton, Nicole J.; Masland, E. Dashiell P.; Emerson, David] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Langdon, Amy E.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	Bigelow Laboratory for Ocean Sciences; Swarthmore College	Fleming, EJ (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA.	efleming@bigelow.org	t, lf/AAJ-4924-2020; Fleming, Emily/I-8927-2012; Martínez-García, Manuel/AAT-1935-2021	Martínez-García, Manuel/0000-0001-5056-1525; Stepanauskas, Ramunas/0000-0003-4458-3108; Langdon, Amy/0000-0002-0797-8939; Poulton, Nicole/0000-0003-3020-4509	NSF [IOS 0951077]; NASA Astrobiology Institute; Swarthmore College; NSF MRI [OCE-821374, OCE-1019242]; Maine Technology Institute; NSF SGER [EF-0633142, MCB-738232]; Division Of Integrative Organismal Systems [0951077] Funding Source: National Science Foundation; Division Of Ocean Sciences [0755142] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA Astrobiology Institute; Swarthmore College; NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); Maine Technology Institute; NSF SGER(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	EJF and DE were funded in part by NSF grant IOS 0951077 (http://www.nsf.gov/) and the NASA Astrobiology Institute (http://astrobiology.nasa.gov/nai/). AEL was funded by Bigelow Laboratory NSF REU program and a Swarthmore College summer HHMI grant (http://www.swarthmore.edu/hhmi.xml). Instrumentation and infrastructure for the Bigelow Laboratory Single Cell Genomics Center were sponsored by the NSF MRI grants OCE-821374 and OCE-1019242 to RS and by the Maine Technology Institute (http://www.mainetechnology.org/). The development of single cell genomics methods was supported by NSF SGER grants EF-0633142 and MCB-738232 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; ADAMS LF, 1987, J BACTERIOL, V169, P1279, DOI 10.1128/jb.169.3.1279-1285.1987; ADAMS LF, 1985, APPL ENVIRON MICROB, V49, P556, DOI 10.1128/AEM.49.3.556-562.1985; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Blothe M, 2009, APPL ENVIRON MICROB, V75, P468, DOI 10.1128/AEM.01817-08; Bruun AM, 2010, GEOMICROBIOL J, V27, P15, DOI 10.1080/01490450903232165; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CORSTJENS P, 1993, SYST APPL MICROBIOL, V16, P219; CORSTJENS PLAM, 1992, APPL ENVIRON MICROB, V58, P450, DOI 10.1128/AEM.58.2.450-454.1992; Crump BC, 2005, LIMNOL OCEANOGR, V50, P1718, DOI 10.4319/lo.2005.50.6.1718; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Druschel GK, 2008, GEOCHIM COSMOCHIM AC, V72, P3358, DOI 10.1016/j.gca.2008.04.035; Duckworth OW, 2009, CHEM GEOL, V260, P149, DOI 10.1016/j.chemgeo.2008.08.027; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emerson D, 2005, METHOD ENZYMOL, V397, P112, DOI 10.1016/S0076-6879(05)97006-7; Emerson D, 2004, GEOMICROBIOL J, V21, P405, DOI 10.1080/01490450490485881; EMERSON D, 1994, APPL ENVIRON MICROB, V60, P4022, DOI 10.1128/AEM.60.11.4022-4031.1994; EMERSON D, 1997, APPL ENVIRON MICROB, V68, P3085; EMERSON D, 1994, APPL ENVIRON MICROB, P4032; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Fuchs BM., 2007, METHODS GEN MOL MICR, V5, P886; GHIORSE WC, 1984, ANNU REV MICROBIOL, V38, P515, DOI 10.1146/annurev.mi.38.100184.002503; GHIORSE WC, 1993, CATENA S21, V21; Haaijer SCM, 2008, ISME J, V2, P1231, DOI 10.1038/ismej.2008.75; HALLBECK L, 1991, J GEN MICROBIOL, V137, P2657, DOI 10.1099/00221287-137-11-2657; Harder EC, 1915, SCIENCE, V42, P310, DOI 10.1126/science.42.1079.310; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Katsoylannis IA, 2006, WATER QUAL RES J CAN, V41, P117, DOI 10.2166/wqrj.2006.014; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; KUTZING FT, 1843, PHYCOLOGIA GEN ORDER; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LANE DJ, 1992, J BACTERIOL, V174, P269, DOI 10.1128/jb.174.1.269-278.1992; Langley S, 2009, CHEM GEOL, V262, P217, DOI 10.1016/j.chemgeo.2009.01.019; Little BJ., 2007, MICROBIOLOGICALLY IN; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; MOUCHET P, 1992, J AM WATER WORKS ASS, V84, P158; MULDER EG, 1963, ANTON VAN LEE J M S, V29, P121, DOI 10.1007/BF02046045; MULDER EG, 1964, J APPL BACTERIOL, V27, P151, DOI 10.1111/j.1365-2672.1964.tb04824.x; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Neubauer SC, 2002, APPL ENVIRON MICROB, V68, P3988, DOI 10.1128/AEM.68.8.3988-3995.2002; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Polz MF, 2003, BIOL BULL-US, V204, P196, DOI 10.2307/1543558; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rentz JA, 2009, WATER RES, V43, P2029, DOI 10.1016/j.watres.2009.02.021; Roden EE, 2004, GEOMICROBIOL J, V21, P379, DOI 10.1080/01490450490485872; Schauer M, 2005, APPL ENVIRON MICROB, V71, P1931, DOI 10.1128/AEM.71.4.1931-1940.2005; Siering PL, 1997, APPL ENVIRON MICROB, V63, P644, DOI 10.1128/AEM.63.2.644-651.1997; Siering PL, 1996, INT J SYST BACTERIOL, V46, P173, DOI 10.1099/00207713-46-1-173; Spring S, 2004, INT J SYST EVOL MICR, V54, P99, DOI 10.1099/ijs.0.02727-0; SPRING S, 2006, BERGEYS MANUAL DETER, P740; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; STOKES JL, 1954, J BACTERIOL, V67, P278, DOI 10.1128/JB.67.3.278-291.1954; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Thomsen TR, 2002, ENVIRON MICROBIOL, V4, P383, DOI 10.1046/j.1462-2920.2002.00316.x; VANVEEN WL, 1978, MICROBIOL REV, V42, P329, DOI 10.1128/MMBR.42.2.329-356.1978; WALLNER G, 1995, APPL ENVIRON MICROB, V61, P1859, DOI 10.1128/AEM.61.5.1859-1866.1995; Wallner G, 1997, APPL ENVIRON MICROB, V63, P4223, DOI 10.1128/AEM.63.11.4223-4231.1997; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; WILLEMS A, 1991, INT J SYST BACTERIOL, V41, P65, DOI 10.1099/00207713-41-1-65; Winogradsky S., 1888, BOTANISHE ZEITUNG, V46, P261; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995	67	78	84	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17769	10.1371/journal.pone.0017769	http://dx.doi.org/10.1371/journal.pone.0017769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437234	gold, Green Published, Green Submitted			2022-12-27	WOS:000288514600013
J	Zhang, JS; Ye, JM; Altafaj, A; Cardona, M; Bahi, N; Llovera, M; Canas, X; Cook, SA; Comella, JX; Sanchis, D				Zhang, Jisheng; Ye, Junmei; Altafaj, Albert; Cardona, Maria; Bahi, Nuria; Llovera, Marta; Canas, Xavier; Cook, Stuart A.; Comella, Joan X.; Sanchis, Daniel			EndoG Links Bnip3-Induced Mitochondrial Damage and Caspase-Independent DNA Fragmentation in Ischemic Cardiomyocytes	PLOS ONE			English	Article							CARDIAC MYOCYTE DEATH; CELL-DEATH; ENDONUCLEASE-G; GENE-TRANSFER; BNIP3; APOPTOSIS; EXPRESSION; HYPOXIA; HEART; PROTECTS	Mitochondrial dysfunction, caspase activation and caspase-dependent DNA fragmentation are involved in cell damage in many tissues. However, differentiated cardiomyocytes repress the expression of the canonical apoptotic pathway and their death during ischemia is caspase-independent. The atypical BH3-only protein Bnip3 is involved in the process leading to caspase-independent DNA fragmentation in cardiomyocytes. However, the pathway by which DNA degradation ensues following Bnip3 activation is not resolved. To identify the mechanism involved, we analyzed the interdependence of Bnip3, Nix and EndoG in mitochondrial damage and DNA fragmentation during experimental ischemia in neonatal rat ventricular cardiomyocytes. Our results show that the expression of EndoG and Bnip3 increases in the heart throughout development, while the caspase-dependent machinery is silenced. TUNEL-positive DNA damage, which depends on caspase activity in other cells, is caspase-independent in ischemic cardiomyocytes and ischemia-induced DNA high and low molecular weight fragmentation is blocked by repressing EndoG expression. Ischemia-induced EndoG translocation and DNA degradation are prevented by silencing the expression of Bnip3, but not Nix, or by overexpressing Bcl-x(L). These data establish a link between Bnip3 and EndoG-dependent, TUNEL-positive, DNA fragmentation in ischemic cardiomyocytes in the absence of caspases, defining an alternative cell death pathway in postmitotic cells.	[Zhang, Jisheng; Ye, Junmei; Cardona, Maria; Bahi, Nuria; Llovera, Marta; Sanchis, Daniel] Columbia Univ, Irving Comprehens Canc Ctr, Med Ctr, New York, NY 10027 USA; [Zhang, Jisheng; Ye, Junmei; Cardona, Maria; Bahi, Nuria; Llovera, Marta; Sanchis, Daniel] Univ Lleida, Inst Recerca Biomed Lleida IRBLLEIDA, Lleida, Spain; [Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Med Res Council Clin Sci Ctr, London, England; [Comella, Joan X.] UAB, Hosp Vall Hebro, Inst Neurociencies, Ciberned, Barcelona, Spain	Columbia University; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Autonomous University of Barcelona; CIBERNED; Hospital Universitari Vall d'Hebron	Zhang, JS (corresponding author), Columbia Univ, Irving Comprehens Canc Ctr, Med Ctr, New York, NY 10027 USA.	daniel.sanchis@cmb.udl.cat	Zhang, Jisheng/AAT-6495-2020; Pla, Nuria Bahi/B-8022-2009; Llovera, Marta/B-5585-2009; Llovera, Marta/AAE-4230-2021; Comella, Joan/GQA-4279-2022; Cook, Stuart/G-9567-2011; Zhang, Jisheng/A-1928-2010; Cañas, Xavier/D-7656-2015; Sanchis, Daniel/C-8077-2009; Comella, Joan X/D-7333-2012; Bahi, Nuria/ABE-9680-2021	Pla, Nuria Bahi/0000-0003-2845-0313; Llovera, Marta/0000-0001-8399-6867; Cañas, Xavier/0000-0002-0512-2248; Sanchis, Daniel/0000-0003-0047-8533; Comella, Joan X/0000-0002-6218-0786; Bahi, Nuria/0000-0003-2845-0313; Cook, Stuart/0000-0001-6628-194X	Ministry of Science and Innovation of Spain [SAF2005-02197, SAF2008-02271]; Government of Catalonia (AGAUR) [SGR2005-00628]; Spanish Government; Instituto de Salud Carlos III -Ministerio de Sanidad y Consumo (FIS) [PI04/2537, PS09/00140]; Ministry of Education and Science of Spain; Universitat de Lleida; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120085815] Funding Source: researchfish; MRC [MC_U120085815] Funding Source: UKRI	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Catalonia (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Spanish Government(Spanish GovernmentEuropean Commission); Instituto de Salud Carlos III -Ministerio de Sanidad y Consumo (FIS)(Instituto de Salud Carlos III); Ministry of Education and Science of Spain(Spanish Government); Universitat de Lleida; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Ministry of Science and Innovation of Spain (SAF2005-02197 and SAF2008-02271) to DS and Programa de Suport a Grups de Recerca de Catalunya from the Government of Catalonia (AGAUR) (SGR2005-00628) and Ciberned from the Spanish Government to JXC, Instituto de Salud Carlos III -Ministerio de Sanidad y Consumo (FIS) (PI04/2537 and PS09/00140) to ML. JZ was recipient of a pre-doctoral fellowship (FPI program) from the Ministry of Education and Science of Spain and JY is recipient of a fellowship from the Universitat de Lleida. URLs: Ministry of Science and Innovation of Spain: http://www.micinn.es; AGAUR: http://www10.gencat.cat/agaur_web/AppJava/catala/index.jsp; Ministry of Education: http://www.educacion.es/portada.html; Instituto de Salud Carlos III: http://www.isciii.es/htdocs/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; Bahi N, 2006, J BIOL CHEM, V281, P22943, DOI 10.1074/jbc.M601025200; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Chatterjee S, 2002, CIRCULATION, V106, pI212, DOI 10.1161/01.cir.0000032907.33237.55; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Donovan M, 2002, CELL DEATH DIFFER, V9, P1220, DOI 10.1038/sj.cdd.4401105; French CJ, 2009, FASEB J, V23, P1177, DOI 10.1096/fj.08-116509; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; GERSCHENSON M, 1995, NUCLEIC ACIDS RES, V23, P88, DOI 10.1093/nar/23.1.88; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Huang JH, 2003, BIOCHEM BIOPH RES CO, V311, P64, DOI 10.1016/j.bbrc.2003.09.160; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; Ishihara Y, 2006, J BIOL CHEM, V281, P6726, DOI 10.1074/jbc.M510382200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Lamy L, 2003, J BIOL CHEM, V278, P23915, DOI 10.1074/jbc.M301869200; Lee P, 2003, AM J PHYSIOL-HEART C, V284, pH456, DOI 10.1152/ajpheart.00777.2002; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Nakagawa Y, 2009, CIRC RES, V105, P746, DOI 10.1161/CIRCRESAHA.109.206037; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Ohno M, 1998, CIRCULATION, V98, P1422, DOI 10.1161/01.CIR.98.14.1422; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Saraste A, 1997, CIRCULATION, V95, P320; Sowter HM, 2001, CANCER RES, V61, P6669; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; Zhang JS, 2007, FEBS LETT, V581, P5781, DOI 10.1016/j.febslet.2007.11.046; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129; Zhao ST, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-113	43	26	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17998	10.1371/journal.pone.0017998	http://dx.doi.org/10.1371/journal.pone.0017998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437288	Green Published, gold, Green Submitted			2022-12-27	WOS:000288514600021
J	French, SS; Gonzalez-Suarez, M; Young, JK; Durham, S; Gerber, LR				French, Susannah S.; Gonzalez-Suarez, Manuela; Young, Julie K.; Durham, Susan; Gerber, Leah R.			Human Disturbance Influences Reproductive Success and Growth Rate in California Sea Lions (Zalophus californianus)	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; STRESS-RESPONSE; BODY-SIZE; CORTICOSTERONE; PATTERNS; EXPOSURE; PENGUINS; IMMUNITY; BEHAVIOR; HORMONE	The environment is currently undergoing changes at both global (e. g., climate change) and local (e. g., tourism, pollution, habitat modification) scales that have the capacity to affect the viability of animal and plant populations. Many of these changes, such as human disturbance, have an anthropogenic origin and therefore may be mitigated by management action. To do so requires an understanding of the impact of human activities and changing environmental conditions on population dynamics. We investigated the influence of human activity on important life history parameters (reproductive rate, and body condition, and growth rate of neonate pups) for California sea lions (Zalophus californianus) in the Gulf of California, Mexico. Increased human presence was associated with lower reproductive rates, which translated into reduced long-term population growth rates and suggested that human activities are a disturbance that could lead to population declines. We also observed higher body growth rates in pups with increased exposure to humans. Increased growth rates in pups may reflect a density dependent response to declining reproductive rates (e. g., decreased competition for resources). Our results highlight the potentially complex changes in life history parameters that may result from human disturbance, and their implication for population dynamics. We recommend careful monitoring of human activities in the Gulf of California and emphasize the importance of management strategies that explicitly consider the potential impact of human activities such as ecotourism on vertebrate populations.	[French, Susannah S.; Durham, Susan] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [French, Susannah S.; Durham, Susan] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Gonzalez-Suarez, Manuela; Young, Julie K.; Gerber, Leah R.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Gonzalez-Suarez, Manuela] Univ Paris 06, CNRS, Lab Ecol & Evolut, UMR 7625, Paris, France	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	French, SS (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	sfrench@biology.usu.edu	González-Suárez, Manuela/B-9740-2008	González-Suárez, Manuela/0000-0001-5069-8900; Young, Julie/0000-0003-4522-0157; Gerber, Leah/0000-0002-6763-6842	National Science Foundation [0347960]; European Community [235897]; Spanish Ministry of Science and Innovation [CGL2009-07301/BOS]	National Science Foundation(National Science Foundation (NSF)); European Community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by a grant to LRG from the National Science Foundation (Animal Behavior, Biological Oceanography, and International Programs; Award # 0347960; www.nsf.gov) and a grant to MGS by the European Community's Seventh Framework Programme (FP7/2007-2013; http://cordis.europa.eu/fp7) under grant agreement nu 235897, and the Spanish Ministry of Science and Innovation (Project: CGL2009-07301/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; BARLOW SM, 1978, TERATOLOGY, V18, P211, DOI 10.1002/tera.1420180206; Bliese PD, 2002, ORGAN RES METHODS, V5, P362, DOI 10.1177/109442802237116; BONESS DJ, 1991, PINNIPEDS EL NINO RE, P173; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Carabias-Lillo J, 2000, PROGRAMA MANEJO AREA; CASTELLINI MA, 1993, MAR MAMMAL SCI, V9, P48, DOI 10.1111/j.1748-7692.1993.tb00425.x; CASTELLINI MA, 1990, MAR MAMMAL SCI, V6, P75, DOI 10.1111/j.1748-7692.1990.tb00227.x; Caswell, 2000, MATRIX POPULATION MO; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Crone EE, 2001, EVOLUTION, V55, P2611; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Demas GE, 2003, P ROY SOC B-BIOL SCI, V270, P905, DOI 10.1098/rspb.2003.2341; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Dendrinos P, 2007, MAR MAMMAL SCI, V23, P615, DOI 10.1111/j.1748-7692.2007.00121.x; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Flather Curtis H., 1995, P3; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; Garcia-Aguilar Maria Concepcion, 2003, Aquatic Mammals, V29, P67, DOI 10.1578/016754203101024086; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; GERRODETTE T, 1990, CONSERV BIOL, V4, P423, DOI 10.1111/j.1523-1739.1990.tb00317.x; Gonzalez-Suarez M, 2006, ANIM CONSERV, V9, P219, DOI 10.1111/j.1469-1795.2006.00022.x; Gonzalez-Suarez M, 2009, MOL ECOL, V18, P1088, DOI 10.1111/j.1365-294X.2009.04093.x; Gonzalez-Suarez M, 2008, J MAMMAL, V89, P1521, DOI 10.1644/08-MAMM-A-109.1; HARRINGTON FH, 1992, ARCTIC, V45, P213; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hurlbert SH, 2009, ANN ZOOL FENN, V46, P311, DOI 10.5735/086.046.0501; Jacobs DF, 2008, J MAMMAL, V89, P1212, DOI 10.1644/07-MAMM-A-171.1; KENYON KW, 1972, J MAMMAL, V53, P687, DOI 10.2307/1379207; Kight CR, 2007, BIOL CONSERV, V138, P189, DOI 10.1016/j.biocon.2007.04.014; Labrada-Martagon Vanessa, 2005, Latin American Journal of Aquatic Mammals, V4, P175; LABRADAMARTAGON V, 2003, INFLUENCIA TURISMO C; le Boeuf B.J., 1983, Proceedings of the California Academy of Sciences, V43, P77; Lourdais O, 2003, J ZOOL, V259, P123, DOI 10.1017/S0952836902003059; Luque SP, 2001, MAR MAMMAL SCI, V17, P147, DOI 10.1111/j.1748-7692.2001.tb00985.x; Moore IT, 2003, HORM BEHAV, V43, P39, DOI 10.1016/S0018-506X(02)00038-7; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; Ono KA, 1996, BEHAV ECOL SOCIOBIOL, V38, P31, DOI 10.1007/s002650050214; Pauli JN, 2007, J APPL ECOL, V44, P1219, DOI 10.1111/j.1365-2664.2007.01337.x; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; PICKERING AD, 1991, GEN COMP ENDOCR, V83, P86, DOI 10.1016/0016-6480(91)90108-I; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Robertson KL, 2008, CAN J ZOOL, V86, P237, DOI 10.1139/Z07-136; Rode KD, 2007, J WILDLIFE MANAGE, V71, P929, DOI 10.2193/2006-075; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Romero LM, 2002, BIOL CONSERV, V108, P371, DOI 10.1016/S0006-3207(02)00128-3; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Salvante KG, 2003, GEN COMP ENDOCR, V130, P205, DOI 10.1016/S0016-6480(02)00637-8; SEGGIE JA, 1975, CAN J PHYSIOL PHARM, V53, P629, DOI 10.1139/y75-087; Szteren D, 2006, LOW WAKE FI, P369; Taylor EN, 2005, OECOLOGIA, V144, P206, DOI 10.1007/s00442-005-0056-x; Tershy BR, 1997, ENVIRON CONSERV, V24, P261, DOI 10.1017/S0376892997000349; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/ror.0.0050105; *UNESCO, UNESCO DEC 29COM 8B; VELARDE E, 1994, ICBP TECHNICAL PUBLI, P229; Walker BG, 2006, CONSERV BIOL, V20, P146, DOI 10.1111/j.1523-1739.2005.00271.x; Walker BG, 2005, CONSERV BIOL, V19, P1571, DOI 10.1111/j.1523-1739.2005.00104.x; WHITE CM, 1985, CONDOR, V87, P14, DOI 10.2307/1367125; Wielgus J, 2008, ECOL APPL, V18, P1287, DOI 10.1890/07-0892.1; Wikelski M, 1997, ECOLOGY, V78, P2204, DOI 10.2307/2265956; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; YARMOLOY C, 1988, CAN FIELD NAT, V102, P425; Young JK, 2008, BEHAVIOUR, V145, P1797, DOI 10.1163/156853908786279646	66	59	61	0	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17686	10.1371/journal.pone.0017686	http://dx.doi.org/10.1371/journal.pone.0017686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436887	Green Published, gold			2022-12-27	WOS:000288514000006
J	Lu, HY; Liu, XF; Wei, SP; Zhang, YM				Lue, Hai-Yan; Liu, Xiao-Fen; Wei, Shi-Ping; Zhang, Yuan-Ming			Epistatic Association Mapping in Homozygous Crop Cultivars	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MARKER-ASSISTED SELECTION; HASEMAN-ELSTON REGRESSION; INBRED LINES; POPULATION-STRUCTURE; GENETIC ASSOCIATION; VARIANCE-COMPONENTS; MOLECULAR MARKERS; GENERAL PEDIGREES; LINKAGE ANALYSIS	The genetic dissection of complex traits plays a crucial role in crop breeding. However, genetic analysis and crop breeding have heretofore been performed separately. In this study, we designed a new approach that integrates epistatic association analysis in crop cultivars with breeding by design. First, we proposed an epistatic association mapping (EAM) approach in homozygous crop cultivars. The phenotypic values of complex traits, along with molecular marker information, were used to perform EAM. In our EAM, all the main-effect quantitative trait loci (QTLs), environmental effects, QTL-by-environment interactions and QTL-by-QTL interactions were included in a full model and estimated by empirical Bayes approach. A series of Monte Carlo simulations was performed to confirm the reliability of the new method. Next, the information from all detected QTLs was used to mine novel alleles for each locus and to design elite cross combination. Finally, the new approach was adopted to dissect the genetic basis of seed length in 215 soybean cultivars obtained, by stratified random sampling, from 6 geographic ecotypes in China. As a result, 19 main-effect QTLs and 3 epistatic QTLs were identified, more than 10 novel alleles were mined and 3 elite parental combinations, such as Daqingdou and Zhengzhou790034, were predicted.	[Lue, Hai-Yan; Liu, Xiao-Fen; Wei, Shi-Ping; Zhang, Yuan-Ming] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Sect Stat Gen, Nanjing, Jiangsu, Peoples R China; [Lue, Hai-Yan] Henan Agr Univ, Coll Informat & Management Sci, Zhengzhou, Henan, Peoples R China	Nanjing Agricultural University; Henan Agricultural University	Zhang, YM (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Sect Stat Gen, Nanjing, Jiangsu, Peoples R China.	soyzhang@njau.edu.cn	Zhang, Yuan-Ming/AAT-2899-2021; Zhang, Yuan-Ming/AFQ-8637-2022	Zhang, Yuan-Ming/0000-0003-2317-2190	National Basic Research Program of China [2011CB109300]; National Natural Science Foundation of China [30971848, 30671333]; Fundamental Research Funds for the Central Universities [KYT201002]; 111 Project [B08025]; Specialized Research Fund for the Doctoral Program of Higher Education [20100097110035]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Funding: This work was supported by grant 2011CB109300 from the National Basic Research Program of China, grants 30971848 and 30671333 from the National Natural Science Foundation of China, grant KYT201002 from the Fundamental Research Funds for the Central Universities, grant B08025 from the 111 Project, and grant 20100097110035 from Specialized Research Fund for the Doctoral Program of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AM, 2001, THEOR APPL GENET, V102, P222, DOI 10.1007/s001220051639; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chen WM, 2004, GENET EPIDEMIOL, V26, P265, DOI 10.1002/gepi.10315; Chen X, 2007, P NATL ACAD SCI USA, V104, P19199, DOI 10.1073/pnas.0709868104; CHO YG, 1994, THEOR APPL GENET, V89, P54, DOI 10.1007/BF00226982; Diao G, 2005, AM J HUM GENET, V77, P97, DOI 10.1086/431683; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Dong YS, 2001, THEOR APPL GENET, V103, P98, DOI 10.1007/s001220000522; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Dwivedi SL, 2007, ADV AGRON, V95, P163, DOI 10.1016/S0065-2113(07)95003-8; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Forrest WF, 2001, HUM HERED, V52, P47, DOI 10.1159/000053353; Friesen ML, 2010, CURR OPIN PLANT BIOL, V13, P119, DOI 10.1016/j.pbi.2009.11.003; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; He XH, 2008, HEREDITY, V101, P39, DOI 10.1038/hdy.2008.23; He XH, 2011, THEOR APPL GENET, V122, P33, DOI 10.1007/s00122-010-1420-8; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; HOLLAND JB, 2004, P 4 INT CROP SCI C 2; Hoti F, 2006, HEREDITY, V97, P4, DOI 10.1038/sj.hdy.6800817; Iwata H, 2007, THEOR APPL GENET, V114, P1437, DOI 10.1007/s00122-007-0529-x; Iwata H, 2009, THEOR APPL GENET, V118, P865, DOI 10.1007/s00122-008-0945-6; Jahufer MZZ, 2002, AUST J AGR RES, V53, P239, DOI 10.1071/AR01110; [李灿东 Li Candong], 2008, [分子植物育种, Molecular Plant Breeding], V6, P1091; Li MY, 2010, BIOINFORMATICS, V26, P798, DOI 10.1093/bioinformatics/btq025; Liang HZ, 2008, HENAN AGR SCI, V45, P54; Lipp M, 1999, J AOAC INT, V82, P923; Liu YF, 2000, GENET RES, V75, P345, DOI 10.1017/S0016672300004493; Lu HY, 2009, HEREDITY, V103, P346, DOI 10.1038/hdy.2009.66; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Milne RI, 2000, MOL ECOL, V9, P541, DOI 10.1046/j.1365-294x.2000.00906.x; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; Peleman JD, 2003, TRENDS PLANT SCI, V8, P330, DOI 10.1016/S1360-1385(03)00134-1; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2005, THEOR APPL GENET, V111, P906, DOI 10.1007/s00122-005-0016-1; Ribaut JM, 1999, MOL BREEDING, V5, P531, DOI 10.1023/A:1009631718036; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Salas P, 2006, THEOR APPL GENET, V113, P1459, DOI 10.1007/s00122-006-0392-1; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sax K, 1923, GENETICS, V8, P552; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; SMOUSE PE, 1990, CAN J FISH AQUAT SCI, V47, P620, DOI 10.1139/f90-070; STUBER CW, 1995, TRENDS GENET, V11, P477, DOI 10.1016/S0168-9525(00)89156-8; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; Verhoeven KJF, 2006, HEREDITY, V96, P139, DOI 10.1038/sj.hdy.6800763; Wan X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-13; Wang T, 2005, GENET EPIDEMIOL, V29, P12, DOI 10.1002/gepi.20075; WANG YS, 2002, CHIN J APPL ECOL, V13, P71; Warburton ML, 2006, EUPHYTICA, V149, P289, DOI 10.1007/s10681-005-9077-0; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Xu Y, 2011, THEOR APPL GENET, V122, P581, DOI 10.1007/s00122-010-1471-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; ZHANG XQ, 2002, CHINESE ACAD CANON 2, P25; Zhang YM, 2005, HEREDITY, V95, P96, DOI 10.1038/sj.hdy.6800702; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zhang YM, 2008, THEOR APPL GENET, V117, P683, DOI 10.1007/s00122-008-0809-0; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863	71	38	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17773	10.1371/journal.pone.0017773	http://dx.doi.org/10.1371/journal.pone.0017773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423630	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900028
J	Manji, SSM; Williams, LH; Miller, KA; Ooms, LM; Bahlo, M; Mitchell, CA; Dahl, HHM				Manji, Shehnaaz S. M.; Williams, Louise H.; Miller, Kerry A.; Ooms, Lisa M.; Bahlo, Melanie; Mitchell, Christina A.; Dahl, Hans-Henrik M.			A Mutation in Synaptojanin 2 Causes Progressive Hearing Loss in the ENU-Mutagenised Mouse Strain Mozart	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 5-PHOSPHATASES; HAIR-CELLS; TARGETED DISRUPTION; SUPPORTING CELLS; PHOSPHATASE; PHOSPHOINOSITIDES; MECHANISM; COCHLEA; MICE; INS(1,4,5)P-3	Background: Hearing impairment is the most common sensory impairment in humans, affecting 1:1,000 births. We have identified an ENU generated mouse mutant, Mozart, with recessively inherited, non-syndromic progressive hearing loss caused by a mutation in the synaptojanin 2 (Synj2), a central regulatory enzyme in the phosphoinositide-signaling cascade. Methodology/Principal Findings: The hearing loss in Mozart is caused by a p.Asn538Lys mutation in the catalytic domain of the inositol polyphosphate 5-phosphatase synaptojanin 2. Within the cochlea, Synj2 mRNA expression was detected in the inner and outer hair cells but not in the spiral ganglion. Synj2(N538K) mutant protein showed loss of lipid phosphatase activity, and was unable to degrade phosphoinositide signaling molecules. Mutant Mozart mice (Synj2(N538K/N538K)) exhibited progressive hearing loss and showed signs of hair cell degeneration as early as two weeks of age, with fusion of stereocilia followed by complete loss of hair bundles and ultimately loss of hair cells. No changes in vestibular or neurological function, or other clinical or behavioral manifestations were apparent. Conclusions/Significance: Phosphoinositides are membrane associated signaling molecules that regulate many cellular processes including cell death, proliferation, actin polymerization and ion channel activity. These results reveal Synj2 as a critical regulator of hair cell survival that is essential for hair cell maintenance and hearing function.	[Manji, Shehnaaz S. M.; Williams, Louise H.; Miller, Kerry A.; Dahl, Hans-Henrik M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Melbourne Hosp, Dept Pediat, Parkville, Vic, Australia; [Ooms, Lisa M.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat, Parkville, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Melbourne Hospital; University of Melbourne; Monash University; Walter & Eliza Hall Institute	Manji, SSM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	hdahl@bigpond.net.au	Ooms, Lisa/AGZ-7420-2022	Ooms, Lisa Michelle/0000-0002-8918-9932; Mitchell, Christina A/0000-0001-9372-3192; Bahlo, Melanie/0000-0001-5132-0774	HEARingCRC; NHMRC [284550, 436944]; J. & J. Calvert-Jones	HEARingCRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); J. & J. Calvert-Jones	This work was supported by the The HEARingCRC, NHMRC Project grants 284550 and 436944, and by J. & J. Calvert-Jones. HHMD is a NHMRC Principal Research Fellow (ID 334313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwardt BA, 2001, J NEUROSCI, V21, P2330, DOI 10.1523/JNEUROSCI.21-07-02330.2001; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Astle MV, 2007, BIOCHEM SOC SYMP, V74, P161, DOI 10.1042/BSS2007c15; Astle MV, 2006, IUBMB LIFE, V58, P451, DOI 10.1080/15216540600871159; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bruzzone R, 2005, NAT CELL BIOL, V7, P14, DOI 10.1038/ncb0105-14; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hellsten E, 2002, BIOL REPROD, V66, P1522, DOI 10.1095/biolreprod66.5.1522; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Jiang H, 2006, J NEUROCHEM, V99, P269, DOI 10.1111/j.1471-4159.2006.04117.x; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Khvotchev M, 1998, J BIOL CHEM, V273, P2306, DOI 10.1074/jbc.273.4.2306; Kim CH, 1999, J CLIN INVEST, V104, P1751, DOI 10.1172/JCI7310; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lesniak W, 2005, CHEM RES TOXICOL, V18, P357, DOI 10.1021/tx0496946; Maison SF, 2006, J NEUROSCI, V26, P10315, DOI 10.1523/JNEUROSCI.2395-06.2006; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Mitchell CA, 2002, IUBMB LIFE, V53, P25, DOI 10.1080/15216540210815; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nemoto Y, 1997, J BIOL CHEM, V272, P30817, DOI 10.1074/jbc.272.49.30817; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Ooms Lisa M., 2009, V462, P223, DOI 10.1007/978-1-60327-115-8_15; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Piazza V, 2007, CELL CALCIUM, V41, P77, DOI 10.1016/j.ceca.2006.05.005; Prestwich GD, 2004, CHEM BIOL, V11, P619, DOI 10.1016/j.chembiol.2004.03.025; Sasaki J, 2010, NATURE, V465, P497, DOI 10.1038/nature09023; SCHACHT J, 1986, HEARING RES, V22, P297, DOI 10.1016/0378-5955(86)90105-X; Schimenti JC, 2005, P NATL ACAD SCI USA, V102, P3342, DOI 10.1073/pnas.0407970102; Sha SH, 2010, HEARING RES, V264, P86, DOI 10.1016/j.heares.2009.09.002; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; Van Epps HA, 2004, J NEUROSCI, V24, P8641, DOI 10.1523/JNEUROSCI.2892-04.2004; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Volpicelli-Daley L, 2007, NAT MED, V13, P784, DOI 10.1038/nm0707-784; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Whisstock JC, 2000, J BIOL CHEM, V275, P37055, DOI 10.1074/jbc.M006244200; Whisstock JC, 2002, IUBMB LIFE, V53, P15, DOI 10.1080/15216540210814; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102	62	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17607	10.1371/journal.pone.0017607	http://dx.doi.org/10.1371/journal.pone.0017607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423608	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900013
J	Su, TX; Das, SK; Xiao, M; Purohit, PK				Su, Tianxiang; Das, Somes K.; Xiao, Ming; Purohit, Prashant K.			Transition between Two Regimes Describing Internal Fluctuation of DNA in a Nanochannel	PLOS ONE			English	Article							NANOFLUIDIC CHANNELS; SINGLE-MOLECULE; STATISTICS; DYNAMICS; CONFINEMENT; MECHANICS; POLYMERS; TUBE	We measure the thermal fluctuation of the internal segments of a piece of DNA confined in a nanochannel about 50-100 nm wide. This local thermodynamic property is key to accurate measurement of distances in genomic analysis. For DNA in similar to 100 nm channels, we observe a critical length scale similar to 10 mu m for the mean extension of internal segments, below which the de Gennes' theory describes the fluctuations with no fitting parameters, and above which the fluctuation data falls into Odijk's deflection theory regime. By analyzing the probability distributions of the extensions of the internal segments, we infer that folded structures of length 150-250 nm, separated by similar to 10 mu m exist in the confined DNA during the transition between the two regimes. For similar to 50 nm channels we find that the fluctuation is significantly reduced since the Odijk regime appears earlier. This is critical for genomic analysis. We further propose a more detailed theory based on small fluctuations and incorporating the effects of confinement to explicitly calculate the statistical properties of the internal fluctuations. Our theory is applicable to polymers with heterogeneous mechanical properties confined in non-uniform channels. We show that existing theories for the end-to-end extension/fluctuation of polymers can be used to study the internal fluctuations only when the contour length of the polymer is many times larger than its persistence length. Finally, our results suggest that introducing nicks in the DNA will not change its fluctuation behavior when the nick density is below 1 nick per kbp DNA.	[Su, Tianxiang; Purohit, Prashant K.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Das, Somes K.; Xiao, Ming] BioNanomatrix Inc, Philadelphia, PA USA	University of Pennsylvania	Su, TX (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.	purohit@seas.upenn.edu	Xiao, Ming/E-7448-2012		NSF [CMMI-0953548]; Nano/Bio Interface Center at the University of Pennsylvania [NSF NSEC DMR08-32802]	NSF(National Science Foundation (NSF)); Nano/Bio Interface Center at the University of Pennsylvania	Mr. Tianxiang Su is supported by the start-up funds of Dr. Prashant K. Purohit. Dr. S. K. Das and Dr. M. Xiao are employees of the commercial company BioNanomatrix. Dr. Prashant K. Purohit acknowledges partial support from grant NSF CMMI-0953548 and the Nano/Bio Interface Center at the University of Pennsylvania through grant NSF NSEC DMR08-32802. Funder's role: The experiments were carried out at the premises of BioNanomatrix.	Bonthuis DJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108303; Burkhardt TW, 1997, J PHYS A-MATH GEN, V30, pL167, DOI 10.1088/0305-4470/30/7/004; Cao H, 2002, APPL PHYS LETT, V81, P174, DOI 10.1063/1.1489102; Cao H, 2002, APPL PHYS LETT, V81, P3058, DOI 10.1063/1.1515115; Cifra P, 2008, FARADAY DISCUSS, V139, P377, DOI 10.1039/b716546c; DAOUD M, 1977, J PHYS-PARIS, V38, P85, DOI 10.1051/jphys:0197700380108500; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; DEGENNES PG, 1979, SCALING CONCEPTS POL, pCH3; Doi M., 1986, THEORY POLYM DYNAMIC; Douville N, 2008, ANAL BIOANAL CHEM, V391, P2395, DOI 10.1007/s00216-008-1995-y; Jun S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.138101; Jung Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061912; ODIJK T, 1983, MACROMOLECULES, V16, P1340, DOI 10.1021/ma00242a015; Odijk T, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2400227; Odijk T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060901; Persson F, 2010, CHEM SOC REV, V39, P985, DOI 10.1039/b912918a; Persson F, 2009, SMALL, V5, P190, DOI 10.1002/smll.200800423; Purohita PK, 2008, INT J NONLIN MECH, V43, P1056, DOI 10.1016/j.ijnonlinmec.2008.05.009; Reisner W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196101; Reisner W, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058302; Riehn R, 2005, P NATL ACAD SCI USA, V102, P10012, DOI 10.1073/pnas.0503809102; SCHAEFER DW, 1980, MACROMOLECULES, V13, P1280, DOI 10.1021/ma60077a048; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; Su TX, 2010, J MECH PHYS SOLIDS, V58, P164, DOI 10.1016/j.jmps.2009.10.007; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Wang J, 2007, J MATER SCI, V42, P8838, DOI 10.1007/s10853-007-1846-9; Wang YM, 2005, P NATL ACAD SCI USA, V102, P9796, DOI 10.1073/pnas.0502917102; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Yang YZ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011804; Zhang YL, 2003, BIOPHYS J, V84, P136, DOI 10.1016/S0006-3495(03)74838-3	30	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e16890	10.1371/journal.pone.0016890	http://dx.doi.org/10.1371/journal.pone.0016890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423606	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900005
J	Giagulli, C; Marsico, S; Magiera, AK; Bruno, R; Caccuri, F; Barone, I; Fiorentini, S; Ando, S; Caruso, A				Giagulli, Cinzia; Marsico, Stefania; Magiera, Anna K.; Bruno, Rosalinda; Caccuri, Francesca; Barone, Ines; Fiorentini, Simona; Ando, Sebastiano; Caruso, Arnaldo			Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells	PLOS ONE			English	Article							MATRIX PROTEIN P17; VIRUS; PHOSPHORYLATION; BINDING; PATHWAY; CANCER; PROLIFERATION; MECHANISMS; ANTIBODIES; INHIBITOR	The HIV-1 matrix protein p17 is a structural protein that can act in the extracellular environment to deregulate several functions of immune cells, through the interaction of its NH2-terminal region with a cellular surface receptor (p17R). The intracellular events triggered by p17/p17R interaction have been not completely characterized yet. In this study we analyze the signal transduction pathways induced by p17/p17R interaction and show that in Raji cells, a human B cell line stably expressing p17R on its surface, p17 induces a transient activation of the transcriptional factor AP-1. Moreover, it was found to upregulate pERK1/2 and downregulate pAkt, which are the major intracellular signalling components involved in AP-1 activation. These effects are mediated by the COOH-terminal region of p17, which displays the capability of keeping PTEN, a phosphatase that regulates the PI3K/Akt pathway, in an active state through the serin/threonin (Ser/Thr) kinase ROCK. Indeed, the COOH-terminal truncated form of p17 (p17 Delta 36) induced activation of the PI3K/Akt pathway by maintaining PTEN in an inactive phosphorylated form. Interestingly, we show that among different p17s, a variant derived from a Ugandan HIV-1 strain, named S75X, triggers an activation of PI3K/Akt signalling pathway, and leads to an increased B cell proliferation and malignant transformation. In summary, this study shows the role of the COOH-terminal region in modulating the p17 signalling pathways so highlighting the complexity of p17 binding to and signalling through its receptor(s). Moreover, it provides the first evidence on the presence of a p17 natural variant mimicking the p17 Delta 36-induced signalling in B cells and displaying the capacity of promoting B cell growth and tumorigenesis.	[Giagulli, Cinzia; Caccuri, Francesca; Fiorentini, Simona; Caruso, Arnaldo] Univ Brescia, Dept Expt & Appl Med, Brescia, Italy; [Marsico, Stefania; Bruno, Rosalinda] Univ Calabria, Dept Pharmaco Biol, I-87036 Cosenza, Italy; [Barone, Ines; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87036 Cosenza, Italy; [Magiera, Anna K.] Medestea Res, Turin, Italy	University of Brescia; University of Calabria; University of Calabria	Giagulli, C (corresponding author), Univ Brescia, Dept Expt & Appl Med, Brescia, Italy.	caruso@med.unibs.it	Caruso, Arnaldo/H-7818-2014; Caccuri, Francesca/AAC-1281-2022; MARSICO, Stefania/J-9938-2019	Caccuri, Francesca/0000-0002-1923-9033; MARSICO, Stefania/0000-0003-1598-0526; FIORENTINI, SIMONA/0000-0002-1866-314X; BARONE, Ines/0000-0002-9769-1615; CARUSO, Arnaldo/0000-0001-5178-566X	Italian Ministry of University and Scientific Research; Istituto Superiore di Sanita [40G.16]; Bonino-Pulejo Foundation (Messina, Italy)	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; Bonino-Pulejo Foundation (Messina, Italy)	This work was supported by the Italian Ministry of University and Scientific Research (Programmi di Ricerca di Rilevante Interesse Nazionale projects) and Istituto Superiore di Sanita (AIDS Grant 40G.16). This work was also supported in part by the Bonino-Pulejo Foundation (Messina, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey NB, 2000, CANCER RES, V60, P35; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; BUDKA H, 1990, ACTA NEUROPATHOL, V79, P611, DOI 10.1007/BF00294238; Bukrinskaya AG, 1996, P NATL ACAD SCI USA, V93, P367, DOI 10.1073/pnas.93.1.367; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Ehrlich LS, 1996, BIOCHEMISTRY-US, V35, P3933, DOI 10.1021/bi952337x; Fiorentini S, 2006, NEW MICROBIOL, V29, P1; Fiorentini S, 2008, VACCINE, V26, P4758, DOI 10.1016/j.vaccine.2008.06.082; Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105; Fiorentini S, 2010, PHARMACOL THERAPEUT, V128, P433, DOI 10.1016/j.pharmthera.2010.08.005; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gucalp A, 2010, CURR OPIN HEMATOL, V17, P362, DOI 10.1097/MOH.0b013e328338f6b6; Haffar O, 2005, J VIROL, V79, P13028, DOI 10.1128/JVI.79.20.13028-13036.2005; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kozikowski AP, 2003, J AM CHEM SOC, V125, P1144, DOI 10.1021/ja0285159; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li L, 2005, PROSTATE CANCER P D, V8, P108, DOI 10.1038/sj.pcan.4500776; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Marini E, 2008, CELL MICROBIOL, V10, P655, DOI 10.1111/j.1462-5822.2007.01073.x; Massiah MA, 1996, PROTEIN SCI, V5, P2391, DOI 10.1002/pro.5560051202; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Tiberio GAM, 2007, HEPATO-GASTROENTEROL, V54, P878; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Meili R, 2005, NAT CELL BIOL, V7, P334, DOI 10.1038/ncb0405-334; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; PAPSIDERO LD, 1989, J VIROL, V63, P267, DOI 10.1128/JVI.63.1.267-272.1989; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shin S, 2009, MOL CANCER RES, V7, P745, DOI 10.1158/1541-7786.MCR-08-0462; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Tiberio L, 2006, CYTOKINE, V34, P131, DOI 10.1016/j.cyto.2006.04.009; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vandergeeten C, 2007, BIOCHEM PHARMACOL, V73, P1738, DOI 10.1016/j.bcp.2007.02.011; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Verli H, 2007, J MOL GRAPH MODEL, V26, P62, DOI 10.1016/j.jmgm.2006.09.009; Vitale M, 2003, BRIT J HAEMATOL, V120, P337, DOI 10.1046/j.1365-2141.2003.04053.x; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587	58	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17831	10.1371/journal.pone.0017831	http://dx.doi.org/10.1371/journal.pone.0017831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423810	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400032
J	Sule, S; Rosen, A; Petri, M; Akhter, E; Andrade, F				Sule, Sangeeta; Rosen, Antony; Petri, Michelle; Akhter, Ehtisham; Andrade, Felipe			Abnormal Production of Pro- and Anti-Inflammatory Cytokines by Lupus Monocytes in Response to Apoptotic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; SYSTEMIC AUTOIMMUNE-DISEASE; BLOOD MONONUCLEAR-CELLS; IN-VITRO PRODUCTION; TOLL-LIKE RECEPTORS; FACTOR-ALPHA; TNF-ALPHA; RHEUMATOID-ARTHRITIS; HUMAN KERATINOCYTES	Monocytes are a key component of the innate immune system involved in the regulation of the adaptive immune response. Previous studies have focused on apoptotic cell clearance abnormalities in systemic lupus erythematosus (SLE) monocytes. However, whether SLE monocytes might express unique patterns of cytokine secretion in response to apoptotic cells is still unknown. Here, we used monocytes from healthy controls and SLE patients to evaluate the production of TNF-alpha and TGF-beta in response to apoptotic cells. Upon recognition of apoptotic material, monocytes from healthy controls showed prominent TGF-beta secretion (mean +/- SD: 824.6 +/- 144.3 pg/ml) and minimal TNF-alpha production (mean +/- SD: 32.6 +/- 2.1 pg/ml). In contrast, monocytes from SLE patients had prominent TNF-alpha production (mean +/- SD: 302.2 +/- 337.5 pg/ml) and diminished TGF-beta secretion (mean +/- SD: 685.9 +/- 615.9 pg/ml), a difference that was statistically significant compared to normal monocytes (p <= 10(-6) for TNF-alpha secretion, and p = 0.0031 for TGF-beta, respectively). Interestingly, the unique cytokine response by SLE monocytes was independent of their phagocytic clearance efficiency, opsonizing autoantibodies and disease activity. We further showed that nucleic acids from apoptotic cells play important role in the induction of TNF-alpha by lupus monocytes. Together, these observations suggest that, in addition to potential clearance defects, monocytes from SLE patients have an abnormal balance in the secretion of anti-and pro-inflammatory cytokines in response to apoptotic cells. Since the abnormal cytokine response to apoptotic material in SLE is not related to disease activity and opsonizing autoantibodies, it is possible that this response might be an intrinsic property of lupus monocytes. The studies focus attention on toll-like receptors (TLRs) and their downstream pathways as mediators of this response.	[Sule, Sangeeta] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Rosen, Antony; Petri, Michelle; Akhter, Ehtisham; Andrade, Felipe] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Rosen, Antony] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sule, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	andrade@jhmi.edu			NIH [AR43727, DE12354]; Johns Hopkins University School of Medicine General Clinical Research Center [M01-RR00052]; Dana Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043727, R55AR043727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE012354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Dana Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The Hopkins Lupus Cohort is supported by NIH grant AR43727 and the Johns Hopkins University School of Medicine General Clinical Research Center (M01-RR00052). A.R. was supported by NIH grant DE12354. F.A is a Lowe Family Scholar in the Johns Hopkins Bayview Center for Innovative Medicine and was supported by the Dana Foundation Scholars Program in Human Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade F, 2005, ARTHRITIS RHEUM, V52, P1160, DOI 10.1002/art.20992; Andrade F, 2000, RHEUM DIS CLIN N AM, V26, P215, DOI 10.1016/S0889-857X(05)70136-8; Aringer M, 2005, LUPUS, V14, P13, DOI 10.1191/0961203305lu2053oa; Aringer M, 2004, ARTHRITIS RHEUM-US, V50, P3161, DOI 10.1002/art.20576; Aringer M, 2002, LUPUS, V11, P102, DOI 10.1191/0961203302lu160oa; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bijl M, 2006, ANN RHEUM DIS, V65, P57, DOI 10.1136/ard.2005.035733; BOSWELL JM, 1988, J IMMUNOL, V141, P3050; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; CasciolaRosen L, 1997, LUPUS, V6, P175, DOI 10.1177/096120339700600213; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.3.CO;2-4; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Demirci FYK, 2007, J RHEUMATOL, V34, P1708; DUCLOS TW, 1994, CLIN IMMUNOL IMMUNOP, V70, P22, DOI 10.1006/clin.1994.1005; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FURUKAWA F, 1990, J INVEST DERMATOL, V94, P77, DOI 10.1111/1523-1747.ep12873930; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hepburn AL, 2007, ANN RHEUM DIS, V66, P1106, DOI 10.1136/ard.2006.065003; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; HORWITZ DA, 1994, LUPUS, V3, P423, DOI 10.1177/096120339400300511; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; Jones BM, 1999, AUTOIMMUNITY, V31, P117, DOI 10.3109/08916939908994055; KASHIWA H, 1987, J IMMUNOL, V138, P1383; Kelley J, 2007, ARTHRITIS RHEUM, V56, P3375, DOI 10.1002/art.22916; Lee YH, 2006, EUR J HUM GENET, V14, P364, DOI 10.1038/sj.ejhg.5201566; LEFEBER WP, 1984, J CLIN INVEST, V74, P1545, DOI 10.1172/JCI111569; Lemay S, 1996, KIDNEY INT, V50, P85, DOI 10.1038/ki.1996.290; Liou LB, 2001, CLIN EXP RHEUMATOL, V19, P515; Liou LB, 2003, CLIN EXP RHEUMATOL, V21, P437; MALAVE I, 1989, INT ARCH ALLER A IMM, V89, P355, DOI 10.1159/000234975; MALIDE D, 1995, HUM PATHOL, V26, P558, DOI 10.1016/0046-8177(95)90253-8; Manfredi AA, 1998, ARTHRITIS RHEUM-US, V41, P205; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; MAURY CPJ, 1989, ARTHRITIS RHEUM, V32, P146, DOI 10.1002/anr.1780320206; MEIJER C, 1993, LUPUS, V2, P359, DOI 10.1177/096120339300200605; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Paul E, 2002, EUR J IMMUNOL, V32, P2672, DOI 10.1002/1521-4141(200209)32:9<2672::AID-IMMU2672>3.0.CO;2-X; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Robak E, 2004, EUR CYTOKINE NETW, V15, P222; Robak Ewa, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P375; Rodriguez W, 2005, ARTHRITIS RHEUM-US, V52, P642, DOI 10.1002/art.20846; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Steinbach F, 2000, ANN RHEUM DIS, V59, P283, DOI 10.1136/ard.59.4.283; StudnickaBenke A, 1996, BRIT J RHEUMATOL, V35, P1067; Sullivan KE, 2007, CLIN IMMUNOL, V123, P74, DOI 10.1016/j.clim.2006.12.008; Szalai AJ, 2003, ARTHRITIS RHEUM-US, V48, P1602, DOI 10.1002/art.11026; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wong CK, 2010, CLIN EXP IMMUNOL, V159, P11, DOI 10.1111/j.1365-2249.2009.04036.x; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Zou YF, 2010, AUTOIMMUNITY, V43, P264, DOI 10.3109/08916930903509049; ZOU YF, 2010, RHEUMATOL INT 2 0324	62	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17495	10.1371/journal.pone.0017495	http://dx.doi.org/10.1371/journal.pone.0017495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423726	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400011
J	Badhai, J; Schuster, J; Gidlof, O; Dahl, N				Badhai, Jitendra; Schuster, Jens; Gidlof, Olof; Dahl, Niklas			5 ' UTR Variants of Ribosomal Protein S19 Transcript Determine Translational Efficiency: Implications for Diamond-Blackfan Anemia and Tissue Variability	PLOS ONE			English	Article							5' UNTRANSLATED REGIONS; RPS19 GENE; MESSENGER-RNAS; MUTATION; EXPRESSION; DISEASE; HETEROGENEITY; BIOGENESIS; INITIATION; DISORDER	Background: Diamond-Blackfan anemia (DBA) is a lineage specific and congenital erythroblastopenia. The disease is associated with mutations in genes encoding ribosomal proteins resulting in perturbed ribosomal subunit biosynthesis. The RPS19 gene is mutated in approximately 25% of DBA patients and a variety of coding mutations have been described, all presumably leading to haploinsufficiency. A subset of patients carries rare polymorphic sequence variants within the 5'untranslated region (5'UTR) of RPS19. The functional significance of these variants remains unclear. Methodology/Principal Findings: We analyzed the distribution of transcriptional start sites (TSS) for RPS19 mRNAs in testis and K562 cells. Twenty-nine novel RPS19 transcripts were identified with different 5'UTR length. Quantification of expressed w.t. 5'UTR variants revealed that a short 5'UTR correlates with high levels of RPS19. The total levels of RPS19 transcripts showed a broad variation between tissues. We also expressed three polymorphic RPS19 5'UTR variants identified in DBA patients. The sequence variants include two insertions (c.-147_-146insGCCA and c.-147_-146insAGCC) and one deletion (c.-144_-141delTTTC). The three 5'UTR polymorphisms are associated with a 20-30% reduction in RPS19 protein levels when compared to the wild-type (w.t.) 5'UTR of corresponding length. Conclusions: The RPS19 gene uses a broad range of TSS and a short 5'UTR is associated with increased levels of RPS19. Comparisons between tissues showed a broad variation in the total amount of RPS19 mRNA and in the distribution of TSS used. Furthermore, our results indicate that rare polymorphic 5'UTR variants reduce RPS19 protein levels with implications for Diamond-Blackfan anemia.	Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; Uppsala Univ, Rudbeck Lab, Uppsala, Sweden	Uppsala University; Uppsala University	Badhai, J (corresponding author), Netherlands Canc Inst NKI, Div Med Genet, Amsterdam, Netherlands.	niklas.dahl@igp.uu.se	Schuster, Jens/D-2005-2010	Schuster, Jens/0000-0002-4383-9880; Badhai, Jitendra/0000-0002-9526-3748; Gidlof, Olof/0000-0002-7402-3139	Swedish Research Council; Uppsala University; 272 National Institutes of Health USA [5R01-HL079567-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079567] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University; 272 National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Swedish Research Council, Uppsala University and the 272 National Institutes of Health USA (grant number 5R01-HL079567-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badhai J, 2009, BBA-MOL BASIS DIS, V1792, P1036, DOI 10.1016/j.bbadis.2009.08.002; Barrio AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006172; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; CHEN TR, 1988, CYTOGENET CELL GENET, V48, P19, DOI 10.1159/000132579; Choesmel V, 2008, HUM MOL GENET, V17, P1253, DOI 10.1093/hmg/ddn015; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Cretien A, 2010, AM J HEMATOL, V85, P111, DOI 10.1002/ajh.21601; Dahlqvist J, 2010, AM J HUM GENET, V86, P596, DOI 10.1016/j.ajhg.2010.02.018; Devlin EE, 2010, BLOOD, V116, P2826, DOI 10.1182/blood-2010-03-275776; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ellis SR, 2006, MED HYPOTHESES, V66, P643, DOI 10.1016/j.mehy.2005.09.010; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Flygare J, 2007, BLOOD, V109, P980, DOI 10.1182/blood-2006-07-038232; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; Gregory LA, 2007, NUCLEIC ACIDS RES, V35, P5913, DOI 10.1093/nar/gkm626; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Huang QL, 2006, BRIT J HAEMATOL, V135, P745, DOI 10.1111/j.1365-2141.2006.06368.x; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; KONDOH N, 1992, CANCER RES, V52, P791; Landers JE, 1997, CANCER RES, V57, P3562; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Martineau Y, 2004, MOL CELL BIOL, V24, P7622, DOI 10.1128/MCB.24.17.7622-7635.2004; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Proust Alexis, 2003, Hematol J, V4, P132, DOI 10.1038/sj.thj.6200230; Ramenghi U, 2000, BLOOD CELL MOL DIS, V26, P417, DOI 10.1006/bcmd.2000.0324; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; Roberts AG, 2005, FEBS LETT, V579, P1061, DOI 10.1016/j.febslet.2004.12.080; Schuster J, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-58; Schuster J, 2010, BLOOD CELL MOL DIS, V45, P23, DOI 10.1016/j.bcmd.2010.03.007; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Stoneley M, 2003, CURR MOL MED, V3, P597, DOI 10.2174/1566524033479474; Strausberg R. L., 2002, Pharmacogenomics Journal, V2, P156, DOI 10.1038/sj.tpj.6500103; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17672	10.1371/journal.pone.0017672	http://dx.doi.org/10.1371/journal.pone.0017672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412415	Green Published, gold, Green Submitted			2022-12-27	WOS:000288247800024
J	Bagnaud-Baule, A; Reynard, O; Perret, M; Berland, JL; Maache, M; Peyrefitte, C; Vernet, G; Volchkov, V; Paranhos-Baccala, G				Bagnaud-Baule, Audrey; Reynard, Olivier; Perret, Magali; Berland, Jean-Luc; Maache, Mimoun; Peyrefitte, Christophe; Vernet, Guy; Volchkov, Viktor; Paranhos-Baccala, Glaucia			The Human Metapneumovirus Matrix Protein Stimulates the Inflammatory Immune Response In Vitro	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; DENDRITIC CELLS; EPITHELIAL-CELLS; TRACT DISEASE; TAT PROTEIN; INFECTION; CHEMOKINES; CHILDREN; NUCLEOCAPSIDS; INTERFERONS	Each year, during winter months, human Metapneumovirus (hMPV) is associated with epidemics of bronchiolitis resulting in the hospitalization of many infants. Bronchiolitis is an acute illness of the lower respiratory tract with a consequent inflammation of the bronchioles. The rapid onset of inflammation suggests the innate immune response may have a role to play in the pathogenesis of this hMPV infection. Since, the matrix protein is one of the most abundant proteins in the Paramyxoviridae family virion, we hypothesized that the inflammatory modulation observed in hMPV infected patients may be partly associated with the matrix protein (M-hMPV) response. By western blot analysis, we detected a soluble form of M-hMPV released from hMPV infected cell as well as from M-hMPV transfected HEK 293T cells suggesting that M-hMPV may be directly in contact with antigen presenting cells (APCs) during the course of infection. Moreover, flow cytometry and confocal microscopy allowed determining that M-hMPV was taken up by dendritic cells (moDCs) and macrophages inducing their activation. Furthermore, these moDCs enter into a maturation process inducing the secretion of a broad range of inflammatory cytokines when exposed to M-hMPV. Additionally, M-hMPV activated DCs were shown to stimulate IL-2 and IFN-gamma production by allogeneic T lymphocytes. This M-hMPV-mediated activation and antigen presentation of APCs may in part explain the marked inflammatory immune response observed in pathology induced by hMPV in patients.	[Bagnaud-Baule, Audrey; Maache, Mimoun; Paranhos-Baccala, Glaucia] Inst Federatif Rech 128 BioSci Lyon Gerland, Emerging Pathogens Dept, bioMerieux, Lyon, France; [Bagnaud-Baule, Audrey; Perret, Magali; Berland, Jean-Luc; Peyrefitte, Christophe; Vernet, Guy; Paranhos-Baccala, Glaucia] Fdn Merieux, Lab Pathogenes Emergents, Lyon, France; [Reynard, Olivier; Volchkov, Viktor] INSERM, U758, IFR128, F-69008 Lyon, France; [Peyrefitte, Christophe] Inst Rech Biomed Armees, Grenoble, France	bioMerieux; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bagnaud-Baule, A (corresponding author), Inst Federatif Rech 128 BioSci Lyon Gerland, Emerging Pathogens Dept, bioMerieux, Lyon, France.	glaucia.baccala@fondation-merieux.org	reynard, olivier AJ/M-8069-2014; Volchkov, Viktor/M-7846-2014	reynard, olivier AJ/0000-0001-7536-355X; Volchkov, Viktor/0000-0001-7896-8706; Berland, Jean-Luc/0000-0002-6337-3715	bioMerieux S.A; French Ministry of the Economy, Finance and Employment (DEMINAP); bioMerieux	bioMerieux S.A; French Ministry of the Economy, Finance and Employment (DEMINAP); bioMerieux	This work was supported by bioMerieux S.A and by grants from the French Ministry of the Economy, Finance and Employment (DEMINAP). The authors, hereby, declare that bioMerieux financed Audrey Bagnaud-Baule for her PhD study, Mimoun Maache for his post-doctoral position and Glaucia Paranhos-Baccala as the research director of the lab and Audrey Bagnaud-Baule's PhD supervisor. bioMerieux provided funding to support the cost of a part of the materials used for this study. The study design has been done by GPB, ABB, OR and VV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribillaga L, 2002, VACCINE, V21, P202, DOI 10.1016/S0264-410X(02)00456-5; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; BILYK N, 1995, IMMUNOLOGY, V86, P231; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Coronel EC, 2001, J VIROL, V75, P1117, DOI 10.1128/JVI.75.3.1117-1123.2001; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ghildyal R, 2002, J GEN VIROL, V83, P753, DOI 10.1099/0022-1317-83-4-753; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grayson MH, 2007, J MOL MED, V85, P1057, DOI 10.1007/s00109-007-0212-3; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Henderson G, 2002, VIROLOGY, V300, P244, DOI 10.1006/viro.2002.1540; KAPTUR PE, 1991, J VIROL, V65, P1057, DOI 10.1128/JVI.65.3.1057-1065.1991; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Latiff K, 2004, CLIN MICROBIOL INFEC, V10, P945, DOI 10.1111/j.1469-0691.2004.00980.x; Lenard J, 1996, VIROLOGY, V216, P289, DOI 10.1006/viro.1996.0064; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Principi N, 2006, CLIN MICROBIOL INFEC, V12, P301, DOI 10.1111/j.1469-0691.2005.01325.x; Rodriguez L, 2004, J GEN VIROL, V85, P709, DOI 10.1099/vir.0.19707-0; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Tan MC, 2007, VIROLOGY, V357, P1, DOI 10.1016/j.virol.2006.08.004; Taub D D, 1994, Ther Immunol, V1, P229; Taub DD, 1996, J LEUKOCYTE BIOL, V59, P81, DOI 10.1002/jlb.59.1.81; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Veyret R, 2005, ANAL BIOCHEM, V346, P59, DOI 10.1016/j.ab.2005.07.036; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001	45	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17818	10.1371/journal.pone.0017818	http://dx.doi.org/10.1371/journal.pone.0017818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412439	gold, Green Submitted, Green Published			2022-12-27	WOS:000288247800032
J	Ivie, SE; Fennessey, CM; Sheng, JS; Rubin, DH; McClain, MS				Ivie, Susan E.; Fennessey, Christine M.; Sheng, Jinsong; Rubin, Donald H.; McClain, Mark S.			Gene-Trap Mutagenesis Identifies Mammalian Genes Contributing to Intoxication by Clostridium perfringens epsilon-Toxin	PLOS ONE			English	Article							PORE-FORMING TOXINS; HEPATITIS-A VIRUS; CAVEOLIN-1 BINDING MOTIF; INJURY MOLECULE-1 KIM1; CANINE KIDNEY-CELLS; ALPHA-HEMOLYSIN; ANTHRAX TOXIN; CELLULAR RECEPTOR; PROTEIN LRP6; GAS-GANGRENE	The Clostridium perfringens epsilon-toxin is an extremely potent toxin associated with lethal toxemias in domesticated ruminants and may be toxic to humans. Intoxication results in fluid accumulation in various tissues, most notably in the brain and kidneys. Previous studies suggest that the toxin is a pore-forming toxin, leading to dysregulated ion homeostasis and ultimately cell death. However, mammalian host factors that likely contribute to epsilon-toxin-induced cytotoxicity are poorly understood. A library of insertional mutant Madin Darby canine kidney (MDCK) cells, which are highly susceptible to the lethal affects of epsilon-toxin, was used to select clones of cells resistant to epsilon-toxin-induced cytotoxicity. The genes mutated in 9 surviving resistant cell clones were identified. We focused additional experiments on one of the identified genes as a means of validating the experimental approach. Gene expression microarray analysis revealed that one of the identified genes, hepatitis A virus cellular receptor 1 (HAVCR1, KIM-1, TIM1), is more abundantly expressed in human kidney cell lines than it is expressed in human cells known to be resistant to epsilon-toxin. One human kidney cell line, ACHN, was found to be sensitive to the toxin and expresses a larger isoform of the HAVCR1 protein than the HAVCR1 protein expressed by other, toxin-resistant human kidney cell lines. RNA interference studies in MDCK and in ACHN cells confirmed that HAVCR1 contributes to epsilon-toxin-induced cytotoxicity. Additionally, epsilon-toxin was shown to bind to HAVCR1 in vitro. The results of this study indicate that HAVCR1 and the other genes identified through the use of gene-trap mutagenesis and RNA interference strategies represent important targets for investigation of the process by which epsilon-toxin induces cell death and new targets for potential therapeutic intervention.	[Ivie, Susan E.; Fennessey, Christine M.; Sheng, Jinsong; Rubin, Donald H.; McClain, Mark S.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA; [Rubin, Donald H.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Rubin, Donald H.] VA Tennessee Valley Healthcare Syst, Res Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ivie, SE (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.	mark.mcclain@vanderbilt.edu	McClain, Mark S/A-6942-2009	McClain, Mark S/0000-0002-9857-4883	National Institutes of Health [R21-AI065435, R01-AI079123]; Vanderbilt University Digestive Disease Research Center [P30-DK058404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079123, R21AI065435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants R21-AI065435 and R01-AI079123 to MSM. Cell imaging studies were supported by core resources of the Vanderbilt University Digestive Disease Research Center (P30-DK058404). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, or the National Institutes of Health. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Banks DJ, 2007, NAT METHODS, V4, P51, DOI 10.1038/NMETH991; Beal DR, 2003, HUM EXP TOXICOL, V22, P593, DOI 10.1191/0960327103ht397oa; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; BUXTON D, 1976, J COMP PATHOL, V86, P67, DOI 10.1016/0021-9975(76)90029-3; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; de Souza AJ, 2008, J IMMUNOL, V180, P6518, DOI 10.4049/jimmunol.180.10.6518; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; FERNANDEZMIYAKA.ME, 2007, INFECT IMMUN; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Ghabriel MN, 2000, ACTA NEUROCHIR SUPPL, V76, P231; GLEESONWHITE MH, 1955, LANCET, V1, P384; Goldstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007065; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Graves PE, 2005, J ALLERGY CLIN IMMUN, V116, P650, DOI 10.1016/j.jaci.2005.05.004; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hauer P J, 1999, Dev Biol Stand, V101, P85; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; KOHN J, 1955, LANCET, V1, P385; Kotsis F, 2007, PFLUG ARCH EUR J PHY, V453, P819, DOI 10.1007/s00424-006-0168-0; Kuehn EW, 2007, BIOCHEM BIOPH RES CO, V364, P861, DOI 10.1016/j.bbrc.2007.10.103; Lewis M, 2010, TOXINS, V2, P1825, DOI 10.3390/toxins2071825; Lindsay CD, 1996, HUM EXP TOXICOL, V15, P904, DOI 10.1177/096032719601501107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClain MS, 2007, INFECT IMMUN, V75, P1785, DOI 10.1128/IAI.01643-06; Miller C, 2004, LIVER TRANSPLANT, V10, P1315, DOI 10.1002/lt.20227; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; MORINAGA G, 1965, J BACTERIOL, V90, P826, DOI 10.1128/JB.90.3.826-826.1965; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Nagahama M, 1998, J NAT TOXINS, V7, P291; NAGAHAMA M, 1991, FEMS MICROBIOL LETT, V84, P41, DOI [10.1111/j.1574-6968.1991.tb04566.x, 10.1016/S0378-1097(99)00655-2]; Nakajima T, 2005, GENES IMMUN, V6, P398, DOI 10.1038/sj.gene.6364215; NOPHAR Y, 1988, J IMMUNOL, V140, P3456; Osipovich AB, 2004, NUCLEIC ACIDS RES, V32, P2912, DOI 10.1093/nar/gkh604; Oyston PCF, 1998, MICROBIOL-SGM, V144, P333, DOI 10.1099/00221287-144-2-333; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Pany S, 2007, BIOCHEM BIOPH RES CO, V363, P197, DOI 10.1016/j.bbrc.2007.08.132; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; PELISH TM, 2009, J BIOL CHEM; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; RYU SE, 1994, STRUCTURE, V2, P59, DOI 10.1016/S0969-2126(00)00008-3; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; SCHROEDER SA, 1995, NAT MED, V1, P703, DOI 10.1038/nm0795-703; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Shimamoto S, 2005, MICROBIOL IMMUNOL, V49, P245, DOI 10.1111/j.1348-0421.2005.tb03726.x; Shortt SJ, 2000, HUM EXP TOXICOL, V19, P108, DOI 10.1191/096032700678815710; SIDORENKO GI, 1967, J HYG EPID MICROB IM, V11, P171; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Smith LDS, 1984, PATHOGENIC ANAEROBIC, V3rd; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; Soletti RC, 2010, ANTICANCER RES, V30, P1209; Song C, 2007, J VIROL, V81, P11946, DOI 10.1128/JVI.00620-07; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thompson P, 1998, J VIROL, V72, P3751, DOI 10.1128/JVI.72.5.3751-3761.1998; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2002, J COMP PATHOL, V126, P71, DOI 10.1053/jcpa.2001.0514; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1124, DOI 10.1016/j.bbrc.2004.09.165; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; WORTHINGTON R W, 1975, Onderstepoort Journal of Veterinary Research, V42, P25; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	78	52	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17787	10.1371/journal.pone.0017787	http://dx.doi.org/10.1371/journal.pone.0017787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412435	Green Submitted, Green Published, gold			2022-12-27	WOS:000288247800030
J	Lowry, JE; Isaak, DD; Leonhardt, JA; Vernati, G; Pate, JC; Andrews, GP				Lowry, Jake E.; Isaak, Dale D.; Leonhardt, Jack A.; Vernati, Giulia; Pate, Jessie C.; Andrews, Gerard P.			Vaccination with Brucella abortus Recombinant In Vivo-Induced Antigens Reduces Bacterial Load and Promotes Clearance in a Mouse Model for Infection	PLOS ONE			English	Article							STRAIN RB51 VACCINATION; IV SECRETION SYSTEM; IMMUNE-RESPONSES; BALB/C MICE; SUPEROXIDE-DISMUTASE; YERSINIA-PESTIS; PREGNANT MOUSE; PROTECTS MICE; CHALLENGE; VACCINES	Current vaccines used for the prevention of brucellosis are ineffective in inducing protective immunity in animals that are chronically infected with Brucella abortus, such as elk. Using a gene discovery approach, in vivo-induced antigen technology (IVIAT) on B. abortus, we previously identified ten loci that encode products up-regulated during infection in elk and consequently may play a role in virulence. In our present study, five of the loci (D15, 0187, VirJ, Mdh, AfuA) were selected for further characterization and compared with three additional antigens with virulence potential (Hia, PrpA, MltA). All eight genes were PCR-amplified from B. abortus and cloned into E. coli. The recombinant products were then expressed, purified, adjuvanted, and delivered subcutaneously to BALB/c mice. After primary immunization and two boosts, mice were challenged i.p. with 5 x 10(4) CFU of B. abortus strain 19. Spleens from challenged animals were harvested and bacterial loads determined by colony count at various time points. While vaccination with four of the eight individual proteins appeared to have some effect on clearance kinetics, mice vaccinated with recombinant Mdh displayed the most significant reduction in bacterial colonization. Furthermore, mice immunized with Mdh maintained higher levels of IFN-c in spleens compared to other treatment groups. Collectively, our in vivo data gathered from the S19 murine colonization model suggest that vaccination with at least three of the IVIAT antigens conferred an enhanced ability of the host to respond to infection, reinforcing the utility of this methodology for the identification of potential vaccine candidates against brucellosis. Mechanisms for immunity to one protein, Mdh, require further in vitro exploration and evaluation against wild-type B. abortus challenge in mice, as well as other hosts. Additional studies are being undertaken to clarify the role of Mdh and other IVI antigens in B. abortus virulence and induction of protective immunity.	[Lowry, Jake E.; Leonhardt, Jack A.; Vernati, Giulia; Pate, Jessie C.; Andrews, Gerard P.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Isaak, Dale D.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Lowry, Jake E.] Colorado State Univ, Coll Vet Med & Biomed Sci, Profess Vet Med Program, Ft Collins, CO 80523 USA	University of Wyoming; University of Wyoming; Colorado State University	Lowry, JE (corresponding author), Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA.	jake.lowry@colostate.edu; Gandrews@uwyo.edu		Lowry, John/0000-0003-2382-9594	U.S. Department of Agriculture (USDA) [CSRE45229]	U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	This study was supported by the U.S. Department of Agriculture (USDA) Special Projects Grant, CSRE45229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mariri A, 2001, INFECT IMMUN, V69, P4816, DOI 10.1128/IAI.69.8.4816-4822.2001; Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; Andrews GP, 2010, VECTOR-BORNE ZOONOT, V10, P749, DOI 10.1089/vbz.2009.0179; Baldwin C L, 1994, Immunol Ser, V60, P363; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; BOSSERAY N, 1992, DEV BIOL STAND, V79, P121; BOSSERAY N, 1990, VACCINE, V8, P462, DOI 10.1016/0264-410X(90)90247-J; Cassataro J, 2007, CLIN VACCINE IMMUNOL, V14, P869, DOI 10.1128/CVI.00472-06; CHEERS C, 1984, DEV BIOL STAND, V56, P237; Chirhart-Gilleland RL, 1998, INFECT IMMUN, V66, P4000, DOI 10.1128/IAI.66.8.4000-4003.1998; Cook WE, 2002, J WILDLIFE DIS, V38, P18, DOI 10.7589/0090-3558-38.1.18; Davis DS, 2002, VET MICROBIOL, V90, P533, DOI 10.1016/S0378-1135(02)00233-X; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; Elzer PH, 1998, J WILDLIFE DIS, V34, P825, DOI 10.7589/0090-3558-34.4.825; Elzer PH, 1998, AM J VET RES, V59, P1575; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; He YQ, 2002, INFECT IMMUN, V70, P2535, DOI 10.1128/IAI.70.5.2535-2543.2002; Kaushik P, 2010, VET RES COMMUN, V34, P119, DOI 10.1007/s11259-009-9337-x; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Kreeger TJ, 2002, J WILDLIFE DIS, V38, P27, DOI 10.7589/0090-3558-38.1.27; Lowry JE, 2010, VET MICROBIOL, V142, P367, DOI 10.1016/j.vetmic.2009.10.010; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Olsen SC, 2006, CLIN VACCINE IMMUNOL, V13, P1098, DOI 10.1128/CVI.00213-06; Olsen SC, 2009, CLIN VACCINE IMMUNOL, V16, P535, DOI 10.1128/CVI.00419-08; Olsen SC, 2003, J WILDLIFE DIS, V39, P824, DOI 10.7589/0090-3558-39.4.824; Olsen SC, 1999, AM J VET RES, V60, P905; Palmer MV, 1996, VET PATHOL, V33, P682, DOI 10.1177/030098589603300607; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Sofer-Podesta C, 2009, INFECT IMMUN, V77, P1561, DOI 10.1128/IAI.00856-08; TOBIAS L, 1992, RES VET SCI, V53, P179, DOI 10.1016/0034-5288(92)90107-D; TOBIAS L, 1993, VET PATHOL, V30, P119, DOI 10.1177/030098589303000204; Vemulapalli R, 2004, VET MICROBIOL, V102, P237, DOI 10.1016/j.vetmic.2004.07.001; Wang YF, 2010, FEMS MICROBIOL LETT, V303, P92, DOI 10.1111/j.1574-6968.2009.01866.x; Zhong ZJ, 2009, MICROBIOL-SGM, V155, P3392, DOI 10.1099/mic.0.030619-0	36	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17425	10.1371/journal.pone.0017425	http://dx.doi.org/10.1371/journal.pone.0017425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412420	Green Published, Green Submitted, gold			2022-12-27	WOS:000288247800005
J	Rao, LL; Zhou, YA; Xu, LJ; Liang, ZY; Jiang, TZ; Li, S				Rao, Li-Lin; Zhou, Yuan; Xu, Lijuan; Liang, Zhu-Yuan; Jiang, Tianzi; Li, Shu			Are Risky Choices Actually Guided by a Compensatory Process? New Insights from fMRI	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DECISION-MAKING; PROSPECT-THEORY; PREFRONTAL CORTEX; NEURAL RESPONSES; REWARD; GIGERENZER; CONFLICT; BRANDSTATTER; POSTSCRIPT	The dominant theories about risky decision-making assume that decision conflicts are solved by a compensatory process involving a trade-off of probability against payoff, but it is unclear whether these theories actually represent the events that occur when people make a risky decision. By contrasting a preferential choice with a judgment-based choice that required a compensatory process, we explored the mechanisms underlying risky decision-making. First, using parametric analyses, we identified the dorsomedial prefrontal cortex (dMPFC) as the specific region in charge of task-related conflict in risky decision-making tasks. We also showed that the dMPFC was activated less when judgment-based choices were being made, implying that the conflict experienced during a judgment-based choice was not as strong as the conflict that was experienced during the preferential choice. Our results provide neural evidence that preferential choice cannot be characterized solely as a compensatory process. Thus, questions were raised about whether existing compensatory theories could adequately describe individual risky decisions.	[Rao, Li-Lin; Zhou, Yuan; Liang, Zhu-Yuan; Li, Shu] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Xu, Lijuan; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Sino French Lab Comp Sci Automat & Appl Math LIAM, Beijing, Peoples R China; [Xu, Lijuan; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS	Rao, LL (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	jiangtz@nlpr.ia.ac.cn; lishu@psych.ac.cn	Zhou, Yuan/AAI-6570-2021; Zhou, Yuan/N-5569-2017; Jiang, Tianzi/I-4256-2012	Zhou, Yuan/0000-0001-6378-1711; Zhou, Yuan/0000-0001-6378-1711; Jiang, Tianzi/0000-0001-9531-291X; li, shu/0000-0003-4402-1674	National Natural Science Foundation of China [70871110, 60675033, 30730035]; National Basic Research Program of China (973 Program) [2011CB711000]; China Postdoctoral Science Foundation [20070420545]; CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); CAS(Chinese Academy of Sciences)	This work was partially supported by the National Natural Science Foundation of China (No. 70871110; 60675033; 30730035), National Basic Research Program of China (973 Program, No. 2011CB711000), the China Postdoctoral Science Foundation (No. 20070420545), and the "Graduate Science and Social Practice Special Funding In'vative Research Program'' of CAS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2003, PSYCHOL BULL, V129, P139, DOI 10.1037//0033-2909.129.1.139; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Birnbaum M, 2008, PSYCHOL REV, V115, P260, DOI 10.1037/0033-295X.115.1.260; Birnbaum MH, 2008, PSYCHOL REV, V115, P463, DOI 10.1037/0033-295X.115.2.463; Birnbaum MH, 2008, PSYCHOL REV, V115, P253, DOI 10.1037/0033-295X.115.1.253; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brandstatter E, 2008, PSYCHOL REV, V115, P281, DOI 10.1037/0033-295X.115.1.281; Brandstatter E, 2008, PSYCHOL REV, V115, P289, DOI 10.1037/0033-295X.115.1.289; Brandstatter E, 2006, PSYCHOL REV, V113, P409, DOI 10.1037/0033-295X.113.2.409; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brown JW, 2008, BRAIN RES, V1202, P99, DOI 10.1016/j.brainres.2007.06.080; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Chu PC, 2003, ORGAN BEHAV HUM DEC, V91, P203, DOI 10.1016/S0749-5978(03)00056-6; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fennema H, 1998, J RISK UNCERTAINTY, V17, P277, DOI 10.1023/A:1007739018615; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; HOGARTH R, 1987, JUDGMENT CHOICE; Hsu M, 2009, J NEUROSCI, V29, P2231, DOI 10.1523/JNEUROSCI.5296-08.2009; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Johnson EJ, 2008, PSYCHOL REV, V115, P263, DOI 10.1037/0033-295X.115.1.263; Johnson EJ, 2008, PSYCHOL REV, V115, P272, DOI 10.1037/0033-295X.115.1.272; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Li LB, 2009, INT J APPROX REASON, V50, P515, DOI 10.1016/j.ijar.2008.10.004; Li S, 2004, APPL INTELL, V20, P147, DOI 10.1023/B:APIN.0000013337.01711.c7; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Payne J. W., 1993, ADAPTIVE DECISION MA; PAYNE JW, 1976, ORGAN BEHAV HUM PERF, V16, P366, DOI 10.1016/0030-5073(76)90022-2; Rieger MO, 2008, PSYCHOL REV, V115, P274, DOI 10.1037/0033-295X.115.1.274; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; RUBINSTEIN A, 1988, J ECON THEORY, V46, P145, DOI 10.1016/0022-0531(88)90154-8; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schmidt U, 2008, J RISK UNCERTAINTY, V36, P203, DOI 10.1007/s11166-008-9040-2; Smith BW, 2009, NEUROIMAGE, V44, P600, DOI 10.1016/j.neuroimage.2008.08.016; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; THURSTON DL, 1993, STRUCT OPTIMIZATION, V5, P240, DOI 10.1007/BF01743586; Trepel C, 2005, COGNITIVE BRAIN RES, V23, P34, DOI 10.1016/j.cogbrainres.2005.01.016; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; TVERSKY A, 1988, PSYCHOL REV, V95, P371, DOI 10.1037/0033-295X.95.3.371; Venkatraman V, 2009, J NEUROSCI, V29, P13158, DOI 10.1523/JNEUROSCI.2708-09.2009; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Weber BJ, 2008, BRAIN RES, V1234, P104, DOI 10.1016/j.brainres.2008.07.105	56	12	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e14756	10.1371/journal.pone.0014756	http://dx.doi.org/10.1371/journal.pone.0014756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412409	gold, Green Submitted, Green Published			2022-12-27	WOS:000288247800002
J	Lim, YH; Charette, JM; Baserga, SJ				Lim, Young H.; Charette, J. Michael; Baserga, Susan J.			Assembling a Protein-Protein Interaction Map of the SSU Processome from Existing Datasets	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; SMALL-SUBUNIT PROCESSOME; INTERACTION NETWORK; FUNCTIONAL-CHARACTERIZATION; INTERACTION DATABASE; 2-HYBRID ANALYSIS; U3 SNORNP; IN-VIVO; YEAST; DOMAIN	Background: The small subunit (SSU) processome is a large ribonucleoprotein complex involved in small ribosomal subunit assembly. It consists of the U3 snoRNA and similar to 72 proteins. While most of its components have been identified, the protein-protein interactions (PPIs) among them remain largely unknown, and thus the assembly, architecture and function of the SSU processome remains unclear. Methodology: We queried PPI databases for SSU processome proteins to quantify the degree to which the three genome-wide high-throughput yeast two-hybrid (HT-Y2H) studies, the genome-wide protein fragment complementation assay (PCA) and the literature-curated (LC) datasets cover the SSU processome interactome. Conclusions: We find that coverage of the SSU processome PPI network is remarkably sparse. Two of the three HT-Y2H studies each account for four and six PPIs between only six of the 72 proteins, while the third study accounts for as little as one PPI and two proteins. The PCA dataset has the highest coverage among the genome-wide studies with 27 PPIs between 25 proteins. The LC dataset was the most extensive, accounting for 34 proteins and 38 PPIs, many of which were validated by independent methods, thereby further increasing their reliability. When the collected data were merged, we found that at least 70% of the predicted PPIs have yet to be determined and 26 proteins (36%) have no known partners. Since the SSU processome is conserved in all Eukaryotes, we also queried HT-Y2H datasets from six additional model organisms, but only four orthologues and three previously known interologous interactions were found. This provides a starting point for further work on SSU processome assembly, and spotlights the need for a more complete genome-wide Y2H analysis.	[Lim, Young H.; Charette, J. Michael; Baserga, Susan J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Charette, J. Michael; Baserga, Susan J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Lim, YH (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.	Susan.Baserga@Yale.edu			National Institutes of Health [GM052581]; Yale University; NIH-Ruth L. Kirschstein National Research Service Award, Institutional Research Training Grant [T32 CA009259]; NATIONAL CANCER INSTITUTE [T32CA009259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052581, R29GM052581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NIH-Ruth L. Kirschstein National Research Service Award, Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (www.nih.gov) grant GM052581 (to SJB), the Science, Technology and Research Scholars II (STARS II) program (http://yalecollege.yale.edu/content/stars-ii-program) at Yale University (to YHL) and a post-doctoral NIH-Ruth L. Kirschstein National Research Service Award, Institutional Research Training Grant: Radiation Therapy, Biology, Physics (http://grants.nih.gov/training/nrsa.htm) T32 CA009259 (to JMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2010, MOL BIOSYST, V6, P2296, DOI 10.1039/c004430j; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Blow N, 2009, NATURE, V460, P415, DOI 10.1038/460415a; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Cagney G, 2001, PHYSIOL GENOMICS, V7, P27, DOI 10.1152/physiolgenomics.2001.7.1.27; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Charette JM, 2010, RNA, V16, P2156, DOI 10.1261/rna.2359810; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FREED EF, 2010, NUCL ACIDS RES; Gallagher JEG, 2004, NUCLEIC ACIDS RES, V32, P1404, DOI 10.1093/nar/gkh318; Gentleman R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-112; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldfeder MB, 2010, FEBS J, V277, P2838, DOI 10.1111/j.1742-4658.2010.07701.x; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2006, NUCLEIC ACIDS RES, V34, P3189, DOI 10.1093/nar/gkl419; Grigoriev A, 2003, NUCLEIC ACIDS RES, V31, P4157, DOI 10.1093/nar/gkg466; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Huang YC, 2010, BIOCHEM BIOPH RES CO, V393, P297, DOI 10.1016/j.bbrc.2010.02.003; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jensen LJ, 2008, SCIENCE, V322, P56, DOI 10.1126/science.1164801; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lebaron S, 2005, MOL CELL BIOL, V25, P9269, DOI 10.1128/MCB.25.21.9269-9282.2005; Lebaron S, 2009, EMBO J, V28, P3808, DOI 10.1038/emboj.2009.335; Lee SM, 1999, MRS INTERNET J N S R, V4; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; Pandit S, 2009, GENETICS, V183, P195, DOI 10.1534/genetics.109.106955; Pang EL, 2010, MOL BIOSYST, V6, P2164, DOI 10.1039/c0mb00038h; Park YU, 2002, BIOCHEM BIOPH RES CO, V293, P733, DOI 10.1016/S0006-291X(02)00288-7; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Rajagopala SV, 2009, METHODS MOL BIOL, V548, P223, DOI 10.1007/978-1-59745-540-4_13; Rajagopala SV, 2008, BIOINFORMATICS, V24, P2622, DOI 10.1093/bioinformatics/btn481; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Salwinski L, 2009, NAT METHODS, V6, P860, DOI 10.1038/nmeth1209-860; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Schwartz AS, 2009, NAT METHODS, V6, P55, DOI [10.1038/nmeth.1283, 10.1038/NMETH.1283]; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Uetz P, 2005, FEBS LETT, V579, P1821, DOI 10.1016/j.febslet.2005.02.001; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Wiles AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-36; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536; Wu XM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S16; Xin XF, 2009, GENOME RES, V19, P1262, DOI 10.1101/gr.090019.108; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	89	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17701	10.1371/journal.pone.0017701	http://dx.doi.org/10.1371/journal.pone.0017701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423703	gold, Green Submitted, Green Published			2022-12-27	WOS:000288219100026
J	Moller, IE; Licht, HHDF; Harholt, J; Willats, WGT; Boomsma, JJ				Moller, Isabel E.; Licht, Henrik H. De Fine; Harholt, Jesper; Willats, William G. T.; Boomsma, Jacobus J.			The Dynamics of Plant Cell-Wall Polysaccharide Decomposition in Leaf-Cutting Ant Fungus Gardens	PLOS ONE			English	Article							SYMBIOTIC FUNGUS; LEUCOAGARICUS-GONGYLOPHORUS; WASTE MANAGEMENT; DEGRADATION; METABOLISM; ENZYMES; SUBSTRATE; CULTIVAR; NESTS	The degradation of live plant biomass in fungus gardens of leaf-cutting ants is poorly characterised but fundamental for understanding the mutual advantages and efficiency of this obligate nutritional symbiosis. Controversies about the extent to which the garden-symbiont Leucocoprinus gongylophorus degrades cellulose have hampered our understanding of the selection forces that induced large scale herbivory and of the ensuing ecological footprint of these ants. Here we use a recently established technique, based on polysaccharide microarrays probed with antibodies and carbohydrate binding modules, to map the occurrence of cell wall polymers in consecutive sections of the fungus garden of the leaf-cutting ant Acromyrmex echinatior. We show that pectin, xyloglucan and some xylan epitopes are degraded, whereas more highly substituted xylan and cellulose epitopes remain as residuals in the waste material that the ants remove from their fungus garden. These results demonstrate that biomass entering leaf-cutting ant fungus gardens is only partially utilized and explain why disproportionally large amounts of plant material are needed to sustain colony growth. They also explain why substantial communities of microbial and invertebrate symbionts have evolved associations with the dump material from leaf-cutting ant nests, to exploit decomposition niches that the ant garden-fungus does not utilize. Our approach thus provides detailed insight into the nutritional benefits and shortcomings associated with fungus-farming in ants.	[Moller, Isabel E.; Willats, William G. T.] Univ Copenhagen, Dept Biol, Copenhagen Bioctr, Copenhagen, Denmark; [Licht, Henrik H. De Fine; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [Harholt, Jesper] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biochem, VKR Res Ctr Proact Plants,Sect Plant Glycobiol, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Moller, IE (corresponding author), Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Melbourne, Vic 3010, Australia.	imoller@unimelb.edu.au	de Fine Licht, Henrik Hjarvard/G-3307-2014; Moller, Isabel/C-2680-2008; Harholt, Jesper/F-3760-2011; Boomsma, Jacobus J/M-2785-2014; Harholt, Jesper/F-6865-2014	de Fine Licht, Henrik Hjarvard/0000-0003-3326-5729; Boomsma, Jacobus J/0000-0002-3598-1609; Harholt, Jesper/0000-0002-7984-0066; Willats, William/0000-0003-2064-4025	Danish National Research Foundation; Villum Kann Rasmussen Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Villum Kann Rasmussen Foundation(Villum Fonden)	The authors IEM, HHDFL, and JJB were supported by the Danish National Research Foundation. JH was supported by the Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril AB, 2004, APPL SOIL ECOL, V26, P243, DOI 10.1016/j.apsoil.2003.12.008; Abril AB, 2002, ECOL LETT, V5, P325, DOI 10.1046/j.1461-0248.2002.00327.x; Alonso-Simon A, 2010, BIOTECHNOL BIOENG, V105, P509, DOI 10.1002/bit.22546; BACCI M, 1995, BRAZ J MED BIOL RES, V28, P79; BACCI M, 1995, ANTON LEEUW INT J G, V67, P385, DOI 10.1007/BF00872939; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boomsma JJ, 2009, P NATL ACAD SCI USA, V106, P17611, DOI 10.1073/pnas.0910004106; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; Bucher EH, 2004, BIOTROPICA, V36, P327, DOI 10.1646/04005; Cherrett J.M., 1989, P93; COOKE RC, 1984, ECOLOGY SAPROTROPHIC; D'Ettorre P, 2002, J COMP PHYSIOL B, V172, P169, DOI 10.1007/s00360-001-0241-0; De Siqueira CG, 1998, APPL ENVIRON MICROB, V64, P4820; Deacon JW., 2005, FUNGAL BIOL; Erthal M, 2009, COMP BIOCHEM PHYS B, V152, P54, DOI 10.1016/j.cbpb.2008.09.086; Esquerre-Tugaye MT, 2000, PLANT PHYSIOL BIOCH, V38, P157, DOI 10.1016/S0981-9428(00)00161-3; Francois JM, 2006, NAT PROTOC, V1, P2995, DOI 10.1038/nprot.2006.457; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; Licht HHD, 2010, ECOL ENTOMOL, V35, P259, DOI 10.1111/j.1365-2311.2010.01193.x; Little AEF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-124; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MARTIN MM, 1969, ANN ENTOMOL SOC AM, V62, P1386, DOI 10.1093/aesa/62.6.1386; MATCHAM SE, 1985, APPL MICROBIOL BIOT, V21, P108; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Moutinho P, 2003, ECOLOGY, V84, P1265, DOI 10.1890/0012-9658(2003)084[1265:IOLANO]2.0.CO;2; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Murdoch L, 1999, PROTOPLASMA, V210, P59, DOI 10.1007/BF01314956; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; POULSEN M, 2006, INSECT SYMBIOSIS, V2, P57; Richard FJ, 2005, J COMP PHYSIOL B, V175, P297, DOI 10.1007/s00360-005-0485-1; Rodrigues A, 2009, ANTON LEEUW INT J G, V96, P331, DOI 10.1007/s10482-009-9350-7; Ronhede S, 2004, MYCOL RES, V108, P101, DOI 10.1017/S0953756203008931; Schiott M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-40; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Silva A, 2006, MICROBIOL RES, V161, P299, DOI 10.1016/j.micres.2005.11.001; Silva A, 2006, CURR MICROBIOL, V53, P68, DOI 10.1007/s00284-005-0431-1; Singh B, 2009, PLANT PHYSIOL, V150, P684, DOI 10.1104/pp.109.135459; SINSABAUGH RL, 1997, MYCOTA, V4, P347; Sorensen I, 2008, PLANT J, V54, P510, DOI 10.1111/j.1365-313X.2008.03453.x; Sorensen I, 2009, CARBOHYD RES, V344, P1872, DOI 10.1016/j.carres.2008.12.008; Sternberg LD, 2007, P ROY SOC B-BIOL SCI, V274, P315, DOI 10.1098/rspb.2006.3746; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Wirth R, 2003, HERBIVORY LEAF CUTTI	54	38	39	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17506	10.1371/journal.pone.0017506	http://dx.doi.org/10.1371/journal.pone.0017506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423735	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100011
J	Diaz-Albiter, H; Mitford, R; Genta, FA; Sant'Anna, MRV; Dillon, RJ				Diaz-Albiter, Hector; Mitford, Roanna; Genta, Fernando A.; Sant'Anna, Mauricio R. V.; Dillon, Rod J.			Reactive Oxygen Species Scavenging by Catalase Is Important for Female Lutzomyia longipalpis Fecundity and Mortality	PLOS ONE			English	Article							PROTEIN OXIDATIVE DAMAGE; LIFE-SPAN; VISCERAL LEISHMANIASIS; SUPEROXIDE-DISMUTASE; INORGANIC PEROXIDES; PEROXIREDOXIN GENE; ASCORBIC-ACID; CATTLE TICK; SAND FLIES; STRESS	The phlebotomine sand fly Lutzomyia longipalpis is the most important vector of American visceral leishmaniasis (AVL), the disseminated and most serious form of the disease in Central and South America. In the natural environment, most female L. longipalpis are thought to survive for less than 10 days and will feed on blood only once or twice during their lifetime. Successful transmission of parasites occurs when a Leishmania-infected female sand fly feeds on a new host. Knowledge of factors affecting sand fly longevity that lead to a reduction in lifespan could result in a decrease in parasite transmission. Catalase has been found to play a major role in survival and fecundity in many insect species. It is a strong antioxidant enzyme that breaks down toxic reactive oxygen species (ROS). Ovarian catalase was found to accumulate in the developing sand fly oocyte from 12 to 48 hours after blood feeding. Catalase expression in ovaries as well as oocyte numbers was found to decrease with age. This reduction was not found in flies when fed on the antioxidant ascorbic acid in the sugar meal, a condition that increased mortality and activation of the prophenoloxidase cascade. RNA interference was used to silence catalase gene expression in female Lu. longipalpis. Depletion of catalase led to a significant increase of mortality and a reduction in the number of developing oocytes produced after blood feeding. These results demonstrate the central role that catalase and ROS play in the longevity and fecundity of phlebotomine sand flies.	[Diaz-Albiter, Hector; Mitford, Roanna; Sant'Anna, Mauricio R. V.; Dillon, Rod J.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Genta, Fernando A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Genta, Fernando A.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Liverpool School of Tropical Medicine; University of Liverpool; Fundacao Oswaldo Cruz	Diaz-Albiter, H (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	r.j.dillon@liv.ac.uk	Genta, Fernando/F-1791-2011; Sant'Anna, Mauricio Roberto Via/AAQ-6084-2021; DIAZ-ALBITER, HECTOR/G-4327-2012; Sant'Anna, Mauricio Roberto Viana/AAQ-4093-2021	Genta, Fernando/0000-0001-9558-1116; Sant'Anna, Mauricio Roberto Viana/0000-0002-2504-0979; Dillon, Rod/0000-0002-3551-0030; Diaz-Albiter, Hector/0000-0003-2937-0569	Consejo Nacional de Ciencia y Tecnologia [207646]; Leverhulme Trust [F/00 808/C]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Leverhulme Trust(Leverhulme Trust)	This work was funded by Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) Fellow ref 207646; The Leverhulme Trust (www.leverhulme.co.uk) ref F/00 808/C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2002, OIKOS, V97, P371, DOI 10.1034/j.1600-0706.2002.970307.x; ALLEN RG, 1983, BIOCHEM J, V216, P503, DOI 10.1042/bj2160503; Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Citelli M, 2007, MOL BIOCHEM PARASIT, V151, P81, DOI 10.1016/j.molbiopara.2006.10.008; CORBYHARRIS V, PLOS PATHOGENS, V6; Coutinho-Abreu IV, 2010, MEM I OSWALDO CRUZ, V105, P1, DOI 10.1590/S0074-02762010000100001; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Emanuelsson O, 2003, J MOL BIOL, V330, P443, DOI 10.1016/S0022-2836(03)00553-9; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; FREEMAN BA, 1982, LAB INVEST, V47, P412; Freitas DRJ, 2007, COMP BIOCHEM PHYS A, V146, P688, DOI 10.1016/j.cbpa.2006.04.032; GENTA F, 2010, J INSECT PHYSL; GILLESPIE S, 2004, MICROBEVECTOR INTERA; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HU Z, 2009, COMP BIOCH PHYSL B; JARAMILLOGUTIER.G, ANOPHELES GAMBIAE OX; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955; Kim I, 2005, COMP BIOCHEM PHYS B, V140, P579, DOI 10.1016/j.cbpc.2004.12.005; KOUA D, 2008, NUCL ACIDS RES; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241; Logullo C, 2002, INSECT BIOCHEM MOLEC, V32, P1805, DOI 10.1016/S0965-1748(02)00162-5; MACKAY WJ, 1989, GENETICS, V122, P643; MAGALHAES DEBT, 2008, PHYSIOLOGY, V68, P134; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Miller MA, 2000, J BIOL CHEM, V275, P33883, DOI 10.1074/jbc.M003671200; MODI G, CARE MAINTENANCE PHL; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Morey M, 2003, J CELL SCI, V116, P4597, DOI 10.1242/jcs.00783; Myskova J, 2007, MICROBES INFECT, V9, P317, DOI 10.1016/j.micinf.2006.12.010; Costa CHN, 2008, CAD SAUDE PUBLICA, V24, P2959, DOI 10.1590/S0102-311X2008001200027; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; ORR CWM, 1967, BIOCHEMISTRY-US, V6, P2995, DOI 10.1021/bi00862a004; ORR CWM, 1967, BIOCHEMISTRY-US, V6, P3000, DOI 10.1021/bi00862a005; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; POMERANTZ SH, 1963, J BIOL CHEM, V238, P2351; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Soares RPP, 2003, AN ACAD BRAS CIENC, V75, P301, DOI 10.1590/S0001-37652003000300005; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Walker J. M, 2005, PROTEOMICS PROTOCOLS; WALSHE DP, 2009, ENEMY WITHIN INTERAC, P119; Wang Q, 2008, COMP BIOCHEM PHYS B, V149, P176, DOI 10.1016/j.cbpb.2007.09.005; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yan LJ, 2000, FREE RADICAL BIO MED, V29, P1143, DOI 10.1016/S0891-5849(00)00423-8; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046	64	57	63	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17486	10.1371/journal.pone.0017486	http://dx.doi.org/10.1371/journal.pone.0017486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408075	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000288170900021
J	Tjalsma, H; Laarakkers, CMM; van Swelm, RPL; Theurl, M; Theurl, I; Kemna, EH; van der Burgt, YEM; Venselaar, H; Dutilh, BE; Russel, FGM; Weiss, G; Masereeuw, R; Fleming, RE; Swinkels, DW				Tjalsma, Harold; Laarakkers, Coby M. M.; van Swelm, Rachel P. L.; Theurl, Milan; Theurl, Igor; Kemna, Erwin H.; van der Burgt, Yuri E. M.; Venselaar, Hanka; Dutilh, Bas E.; Russel, Frans G. M.; Weiss, Guenter; Masereeuw, Rosalinde; Fleming, Robert E.; Swinkels, Dorine W.			Mass Spectrometry Analysis of Hepcidin Peptides in Experimental Mouse Models	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS; GENE-EXPRESSION; IRON; LIVER; SERUM; HFE; URINE; BMP6; FERROPORTIN; REGULATOR	The mouse is a valuable model for unravelling the role of hepcidin in iron homeostasis, however, such studies still report hepcidin mRNA levels as a surrogate marker for bioactive hepcidin in its pivotal function to block ferroportin-mediated iron transport. Here, we aimed to assess bioactive mouse Hepcidin-1 (Hep-1) and its paralogue Hepcidin-2 (Hep-2) at the peptide level. To this purpose, fourier transform ion cyclotron resonance (FTICR) and tandem-MS was used for hepcidin identification, after which a time-of-flight (TOF) MS-based methodology was exploited to routinely determine Hep-1 and -2 levels in mouse serum and urine. This method was biologically validated by hepcidin assessment in: i) 3 mouse strains (C57Bl/6; DBA/2 and BABL/c) upon stimulation with intravenous iron and LPS, ii) homozygous Hfe knock out, homozygous transferrin receptor 2 (Y245X) mutated mice and double affected mice, and iii) mice treated with a sublethal hepatotoxic dose of paracetamol. The results showed that detection of Hep-1 was restricted to serum, whereas Hep-2 and its presumed isoforms were predominantly present in urine. Elevations in serum Hep-1 and urine Hep-2 upon intravenous iron or LPS were only moderate and varied considerably between mouse strains. Serum Hep-1 was decreased in all three hemochromatosis models, being lowest in the double affected mice. Serum Hep-1 levels correlated with liver hepcidin-1 gene expression, while acute liver damage by paracetamol depleted Hep-1 from serum. Furthermore, serum Hep-1 appeared to be an excellent indicator of splenic iron accumulation. In conclusion, Hep-1 and Hep-2 peptide responses in experimental mouse agree with the known biology of hepcidin mRNA regulators, and their measurement can now be implemented in experimental mouse models to provide novel insights in post-transcriptional regulation, hepcidin function, and kinetics.	[Tjalsma, Harold; Laarakkers, Coby M. M.; Kemna, Erwin H.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, NL-6525 ED Nijmegen, Netherlands; [van Swelm, Rachel P. L.; Russel, Frans G. M.; Masereeuw, Rosalinde] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands; [Theurl, Milan; Theurl, Igor; Weiss, Guenter] Med Univ Innsbruck, Dept Internal Med Clin Immunol & Infect Dis, Innsbruck, Austria; [Theurl, Milan] Innsbruck Med Univ, Dept Ophthalmol & Optometry, Innsbruck, Austria; [van der Burgt, Yuri E. M.] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands; [Venselaar, Hanka; Dutilh, Bas E.] Ctr Mol & Biomol Informat NCMLS, Nijmegen, Netherlands; [Fleming, Robert E.] St Louis Univ, Sch Med, Dept Pediat, Ctr Liver, St Louis, MO 63104 USA	Radboud University Nijmegen; Radboud University Nijmegen; Medical University of Innsbruck; Medical University of Innsbruck; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Saint Louis University	Tjalsma, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, NL-6525 ED Nijmegen, Netherlands.	d.swinkels@labgk.umcn.nl	Swinkels, Dorine W./H-8098-2014; Masereeuw, Roos/I-5276-2016; van der Burgt, Yuri/I-1149-2016; van Swelm, Rachel PL/P-6063-2015; Venselaar, Hanka/D-2009-2016; Dutilh, Bas E./B-9719-2011; Tjalsma, Harold/I-7146-2012; Russel, Frans G.M./B-3184-2014; Masereeuw, Roos/N-3582-2014	Swinkels, Dorine W./0000-0002-1040-9446; Masereeuw, Roos/0000-0002-1560-1074; van der Burgt, Yuri/0000-0003-0556-5564; Venselaar, Hanka/0000-0001-9824-6559; Dutilh, Bas E./0000-0003-2329-7890; Russel, Frans G.M./0000-0002-7959-2314; Weiss, Guenter/0000-0003-0709-2158; Theurl, Igor/0000-0003-3180-4784				Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Ilyin G, 2003, FEBS LETT, V542, P22, DOI 10.1016/S0014-5793(03)00329-6; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Koening CL, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-33; Krijt J, 2004, J HEPATOL, V40, P891, DOI 10.1016/j.jhep.2004.02.029; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Lou DQ, 2004, BLOOD, V103, P2816, DOI 10.1182/blood-2003-07-2524; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2005, GASTROENTEROLOGY, V128, P470, DOI 10.1053/j.gastro.2004.11.057; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Swinkels DW, 2006, CLIN CHEM, V52, P950, DOI 10.1373/clinchem.2006.068684; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; van Dijk BAC, 2008, BRIT J HAEMATOL, V142, P979, DOI 10.1111/j.1365-2141.2008.07273.x; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wenderfer SE, 2009, AM J NEPHROL, V30, P450, DOI 10.1159/000242430; Zasloff M, 2006, NAT MED, V12, P606, DOI 10.1038/nm0606-607; Zhang XL, 2008, KIDNEY INT, V74, P799, DOI 10.1038/ki.2008.316	36	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16762	10.1371/journal.pone.0016762	http://dx.doi.org/10.1371/journal.pone.0016762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408141	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170000008
J	Webster, KD; Crow, A; Fletcher, DA				Webster, Kevin D.; Crow, Ailey; Fletcher, Daniel A.			An AFM-Based Stiffness Clamp for Dynamic Control of Rigidity	PLOS ONE			English	Article							SINGLE-CELL RESPONSE; MECHANICS	Atomic force microscopy (AFM) has become a powerful tool for measuring material properties in biology and imposing mechanical boundary conditions on samples from single molecules to cells and tissues. Constant force or constant height can be maintained in an AFM experiment through feedback control of cantilever deflection, known respectively as a 'force clamp' or 'position clamp'. However, stiffness, the third variable in the Hookean relation F= kx that describes AFM cantilever deflection, has not been dynamically controllable in the same way. Here we present and demonstrate a 'stiffness clamp' that can vary the apparent stiffness of an AFM cantilever. This method, employable on any AFM system by modifying feedback control of the cantilever, allows rapid and reversible tuning of the stiffness exposed to the sample in a way that can decouple the role of stiffness from force and deformation. We demonstrated the AFM stiffness clamp on two different samples: a contracting fibroblast cell and an expanding polyacrylamide hydrogel. We found that the fibroblast, a cell type that secretes and organizes the extracellular matrix, exhibited a rapid, sub-second change in traction rate (dF/dt) and contraction velocity (dx/dt) in response to step changes in stiffness between 1-100 nN/mu m. This response was independent of the absolute contractile force and cell height, demonstrating that cells can react directly to changes in stiffness alone. In contrast, the hydrogel used in our experiment maintained a constant expansion velocity (dx/dt) over this range of stiffness, while the traction rate (dF/dt) changed with stiffness, showing that passive materials can also behave differently in different stiffness environments. The AFM stiffness clamp presented here, which is applicable to mechanical measurements on both biological and non-biological samples, may be used to investigate cellular mechanotransduction under a wide range of controlled mechanical boundary conditions.	[Webster, Kevin D.; Crow, Ailey; Fletcher, Daniel A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Webster, KD (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	fletch@berkeley.edu			NSF IGERT [DGE-0333455]; NIH [R01 GM072736]; NCI PS-OC [1U54CA143836-01]; NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072736] Funding Source: NIH RePORTER	NSF IGERT(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI PS-OC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NSF IGERT DGE-0333455 (www.nsf.gov), NIH R01 GM072736 (www.nih.gov), NCI PS-OC 1U54CA143836-01 (www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allioux-Guerin M, 2009, BIOPHYS J, V96, P238, DOI 10.1529/biophysj.108.134627; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Chaudhuri O, 2009, NAT METHODS, V6, P383, DOI [10.1038/NMETH.1320, 10.1038/nmeth.1320]; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Frey MT, 2009, SOFT MATTER, V5, P1918, DOI 10.1039/b818104g; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Jena BP, 2002, METHOD CELL BIOL, V68, P33; Jiang FX, 2010, BIOMATERIALS, V31, P1199, DOI 10.1016/j.biomaterials.2009.10.050; KEESE CR, 1991, EXP CELL RES, V195, P528, DOI 10.1016/0014-4827(91)90406-K; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Mitrossilis D, 2010, P NATL ACAD SCI USA, V107, P16518, DOI 10.1073/pnas.1007940107; Mitrossilis D, 2009, P NATL ACAD SCI USA, V106, P18243, DOI 10.1073/pnas.0903994106; Mizuno D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.168102; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; SHEETZ MP, 1997, LASER TWEEZERS CELL; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Wen JD, 2007, BIOPHYS J, V92, P2996, DOI 10.1529/biophysj.106.094052; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	28	31	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17807	10.1371/journal.pone.0017807	http://dx.doi.org/10.1371/journal.pone.0017807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408137	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000061
J	Mao, CH; Brown, CR; Griesenbeck, J; Boeger, H				Mao, Changhui; Brown, Christopher R.; Griesenbeck, Joachim; Boeger, Hinrich			Occlusion of Regulatory Sequences by Promoter Nucleosomes In Vivo	PLOS ONE			English	Article							HISTONE CHAPERONE ASF1; PHO5 PROMOTER; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; MAJOR DETERMINANT; CRYSTAL-STRUCTURE; DNA INTERACTIONS; CORE PARTICLE; YEAST PHO5; CHROMATIN	Nucleosomes are believed to inhibit DNA binding by transcription factors. Theoretical attempts to understand the significance of nucleosomes in gene expression and regulation are based upon this assumption. However, nucleosomal inhibition of transcription factor binding to DNA is not complete. Rather, access to nucleosomal DNA depends on a number of factors, including the stereochemistry of transcription factor- DNA interaction, the in vivo kinetics of thermal fluctuations in nucleosome structure, and the intracellular concentration of the transcription factor. In vitro binding studies must therefore be complemented with in vivo measurements. The inducible PHO5 promoter of yeast has played a prominent role in this discussion. It bears two binding sites for the transcriptional activator Pho4, which at the repressed promoter are positioned within a nucleosome and in the linker region between two nucleosomes, respectively. Earlier studies suggested that the nucleosomal binding site is inaccessible to Pho4 binding in the absence of chromatin remodeling. However, this notion has been challenged by several recent reports. We therefore have reanalyzed transcription factor binding to the PHO5 promoter in vivo, using 'chromatin endogenous cleavage' (ChEC). Our results unambiguously demonstrate that nucleosomes effectively interfere with the binding of Pho4 and other critical transcription factors to regulatory sequences of the PHO5 promoter. Our data furthermore suggest that Pho4 recruits the TATA box binding protein to the PHO5 promoter.	[Mao, Changhui; Brown, Christopher R.; Boeger, Hinrich] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Griesenbeck, Joachim] Univ Regensburg, Dept Biochem 3, Regensburg, Germany	University of California System; University of California Santa Cruz; University of Regensburg	Mao, CH (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	hboeger@ucsc.edu		Brown, Christopher/0000-0001-6076-4035; Griesenbeck, Joachim/0000-0002-7817-6095	National Institutes of Health [F32GM087867, GM078111-01]; DFG [GR 1706/4-1, GR 1706/5-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078111, F32GM087867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RB was supported by National Research Service Award (NRSA) grant F32GM087867 from the National Institutes of Health. JG was supported by two DFG travel grants, GR 1706/4-1 and GR 1706/5-1. HB acknowledges support from National Institutes of Health grant GM078111-01 and the Pew Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; BAUER WR, 1994, J MOL BIOL, V236, P685, DOI 10.1006/jmbi.1994.1180; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Carvin CD, 2003, P NATL ACAD SCI USA, V100, P7743, DOI 10.1073/pnas.1332672100; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; Eisfeld K, 1997, NUCLEIC ACIDS RES, V25, P3733, DOI 10.1093/nar/25.18.3733; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; FASCHER KD, 1993, J MOL BIOL, V231, P658, DOI 10.1006/jmbi.1993.1317; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Magbanua JPV, 1997, J BIOCHEM, V121, P1182; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; RHODES D, 1980, NATURE, V286, P573, DOI 10.1038/286573a0; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Terrell AR, 2002, J BIOL CHEM, V277, P31038, DOI 10.1074/jbc.M204662200; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; Wu WH, 1999, P NATL ACAD SCI USA, V96, P2764, DOI 10.1073/pnas.96.6.2764; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	46	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17521	10.1371/journal.pone.0017521	http://dx.doi.org/10.1371/journal.pone.0017521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408617	Green Published, Green Submitted, gold			2022-12-27	WOS:000287965200020
J	Badisco, L; Huybrechts, J; Simonet, G; Verlinden, H; Marchal, E; Huybrechts, R; Schoofs, L; De Loof, A; Broeck, JV				Badisco, Liesbeth; Huybrechts, Jurgen; Simonet, Gert; Verlinden, Heleen; Marchal, Elisabeth; Huybrechts, Roger; Schoofs, Liliane; De Loof, Arnold; Broeck, Jozef Vanden			Transcriptome Analysis of the Desert Locust Central Nervous System: Production and Annotation of a Schistocerca gregaria EST Database	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; NEUROPEPTIDE-F-RECEPTOR; CRUSTACEAN CARDIOACTIVE PEPTIDE; 2 CARDIOACCELERATORY PEPTIDES; FOLLICLE-STIMULATING-HORMONE; AFRICAN MALARIA MOSQUITO; PROHORMONE CONVERTASE 2; AMINO-ACID-SEQUENCE; CORPORA-CARDIACA; DROSOPHILA-MELANOGASTER	Background: The desert locust (Schistocerca gregaria) displays a fascinating type of phenotypic plasticity, designated as 'phase polyphenism'. Depending on environmental conditions, one genome can be translated into two highly divergent phenotypes, termed the solitarious and gregarious (swarming) phase. Although many of the underlying molecular events remain elusive, the central nervous system (CNS) is expected to play a crucial role in the phase transition process. Locusts have also proven to be interesting model organisms in a physiological and neurobiological research context. However, molecular studies in locusts are hampered by the fact that genome/transcriptome sequence information available for this branch of insects is still limited. Methodology: We have generated 34,672 raw expressed sequence tags (EST) from the CNS of desert locusts in both phases. These ESTs were assembled in 12,709 unique transcript sequences and nearly 4,000 sequences were functionally annotated. Moreover, the obtained S. gregaria EST information is highly complementary to the existing orthopteran transcriptomic data. Since many novel transcripts encode neuronal signaling and signal transduction components, this paper includes an overview of these sequences. Furthermore, several transcripts being differentially represented in solitarious and gregarious locusts were retrieved from this EST database. The findings highlight the involvement of the CNS in the phase transition process and indicate that this novel annotated database may also add to the emerging knowledge of concomitant neuronal signaling and neuroplasticity events. Conclusions: In summary, we met the need for novel sequence data from desert locust CNS. To our knowledge, we hereby also present the first insect EST database that is derived from the complete CNS. The obtained S. gregaria EST data constitute an important new source of information that will be instrumental in further unraveling the molecular principles of phase polyphenism, in further establishing locusts as valuable research model organisms and in molecular evolutionary and comparative entomology.	[Badisco, Liesbeth; Huybrechts, Jurgen; Simonet, Gert; Verlinden, Heleen; Marchal, Elisabeth; Huybrechts, Roger; Schoofs, Liliane; De Loof, Arnold; Broeck, Jozef Vanden] Katholieke Univ Leuven, Dept Anim Physiol & Neurobiol, Leuven, Belgium	KU Leuven	Badisco, L (corresponding author), Katholieke Univ Leuven, Dept Anim Physiol & Neurobiol, Leuven, Belgium.	jozef.vandenbroeck@bio.kuleuven.be	schoofs, liliane/ABD-2943-2020; Huybrechts, Roger R/D-1650-2009; Verlinden, Heleen/D-1033-2011; Schoofs, Liliane/F-2815-2010	Huybrechts, Roger R/0000-0003-3950-8920; Verlinden, Heleen/0000-0001-6721-3973; Marchal, Elisabeth/0000-0003-1310-4792; Vanden Broeck, Jozef/0000-0001-7653-0516; Schoofs, Liliane/0000-0002-1673-432X	K.U. Leuven Research Foundation [GOA 2005/06]; Research Foundation of Flanders (FWO-Flanders); Interuniversity Attraction Poles program [P6/14]; 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT); FWO	K.U. Leuven Research Foundation; Research Foundation of Flanders (FWO-Flanders)(FWO); Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWO(FWO)	This work was supported by grants from the K.U. Leuven Research Foundation (GOA 2005/06, www.kuleuven.be/bof), the Research Foundation of Flanders (FWO-Flanders, www.fwo.be) and the Interuniversity Attraction Poles program (Belgian Science Policy Grant P6/14, www.belspo.be). L.B., H.V. and E.M. were supported by a scholarship from the 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT) and J.H. obtained a postdoctoral research fellowship from the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Mena MA, 2009, CURR TOP MED CHEM, V9, P880; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AUDSLEY N, 1992, J EXP BIOL, V173, P261; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; AXELROD J, 1977, NATURE, V265, P501, DOI 10.1038/265501a0; Badisco L, 2008, J MOL ENDOCRINOL, V40, P137, DOI 10.1677/JME-07-0161; Badisco L, 2007, GEN COMP ENDOCR, V153, P64, DOI 10.1016/j.ygcen.2007.03.008; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bendena WG, 1999, ANN NY ACAD SCI, V897, P311, DOI 10.1111/j.1749-6632.1999.tb07902.x; BENJANNET S, 1995, FEBS LETT, V362, P151, DOI 10.1016/0014-5793(95)00228-2; BENJANNET S, 1995, J NEUROCHEM, V64, P2303; Berthier K, 2010, ADV INSECT PHYSIOL, V39, P1, DOI 10.1016/S0065-2806(10)39001-1; Boerjan B, 2010, NEUROPHARMACOLOGY, V58, P248, DOI 10.1016/j.neuropharm.2009.06.026; Boime I, 1999, RECENT PROG HORM RES, V54, P271; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; BOUREME D, 1989, J INSECT PHYSIOL, V35, P265, DOI 10.1016/0022-1910(89)90073-5; BOYAN G, 1995, DEVELOPMENT, V121, P75; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brierley DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000199; Broeck JV, 2001, ARCH INSECT BIOCHEM, V48, P1, DOI 10.1002/arch.1054; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Casida JE, 2009, CHEM RES TOXICOL, V22, P609, DOI 10.1021/tx8004949; Chen ME, 2006, ARCH INSECT BIOCHEM, V61, P195, DOI 10.1002/arch.20103; CHRISTENSON JG, 1972, P NATL ACAD SCI USA, V69, P343, DOI 10.1073/pnas.69.2.343; Claeys I, 2005, VITAM HORM, V73, P217, DOI 10.1016/S0083-6729(05)73007-7; Claeys I, 2006, BIOCHEM BIOPH RES CO, V341, P599, DOI 10.1016/j.bbrc.2006.01.011; Claeys I, 2005, INSECT MOL BIOL, V14, P415, DOI 10.1111/j.1365-2583.2005.00572.x; Claeys I, 2003, INSECT MOL BIOL, V12, P473, DOI 10.1046/j.1365-2583.2003.00431.x; Clynen E, 2003, BIOCHEM BIOPH RES CO, V300, P422, DOI 10.1016/S0006-291X(02)02869-3; Clynen E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-201; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Clynen E, 2009, ANN NY ACAD SCI, V1163, P60, DOI 10.1111/j.1749-6632.2008.03624.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORLESS CL, 1987, J CELL BIOL, V104, P1173, DOI 10.1083/jcb.104.5.1173; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; Cullen DA, 2010, J INSECT PHYSIOL, V56, P937, DOI 10.1016/j.jinsphys.2010.04.023; CURRY WJ, 1992, COMP BIOCHEM PHYS C, V101, P269, DOI 10.1016/0742-8413(92)90272-9; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028; Donini A, 2001, J INSECT PHYSIOL, V47, P277, DOI 10.1016/S0022-1910(00)00112-8; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; FOURNIER B, 1987, GEN COMP ENDOCR, V68, P49, DOI 10.1016/0016-6480(87)90059-1; FRAENKEL G, 1966, SCIENCE, V151, P91, DOI 10.1126/science.151.3706.91; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; Gade G, 2005, PHYSIOL ENTOMOL, V30, P103, DOI 10.1111/j.1365-3032.2005.00442.x; GADE G, 1984, H-S Z PHYSIOL CHEM, V365, P393, DOI 10.1515/bchm2.1984.365.1.393; Gade G, 2009, ANN NY ACAD SCI, V1163, P125, DOI 10.1111/j.1749-6632.2008.03625.x; Garczynski SF, 2005, PEPTIDES, V26, P99, DOI 10.1016/j.peptides.2004.07.014; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Garczynski SF, 2007, PEPTIDES, V28, P109, DOI 10.1016/j.peptides.2006.09.019; Geva N, 2010, NEUROBIOL LEARN MEM, V93, P175, DOI 10.1016/j.nlm.2009.09.008; GIRARDIE J, 1991, EUR J BIOCHEM, V202, P1121, DOI 10.1111/j.1432-1033.1991.tb16479.x; Girardie J, 1998, INSECT BIOCHEM MOLEC, V28, P641, DOI 10.1016/S0965-1748(98)00053-8; GIRARDIE J, 1989, FEBS LETT, V245, P4, DOI 10.1016/0014-5793(89)80179-6; Goldsworthy GJ, 1997, COMP BIOCHEM PHYS B, V117, P483, DOI 10.1016/S0305-0491(97)00186-7; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Hagele BF, 2000, J INSECT PHYSIOL, V46, P1295, DOI 10.1016/S0022-1910(00)00051-2; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; HIETTER H, 1991, INSECT BIOCHEM, V21, P259, DOI 10.1016/0020-1790(91)90015-7; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; Hoste B, 2002, ENTOMOL EXP APPL, V104, P281, DOI 10.1023/A:1021207518712; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; HUESMANN GR, 1995, FEBS LETT, V371, P311, DOI 10.1016/0014-5793(95)00929-4; Huising MO, 2005, ENDOCRINOLOGY, V146, P2165, DOI 10.1210/en.2004-1514; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huybrechts J, 2003, PHYSIOL ENTOMOL, V28, P46, DOI 10.1046/j.1365-3032.2003.00321.x; Hwang JR, 2000, J BIOL CHEM, V275, P17886, DOI 10.1074/jbc.M000032200; ICHIYAMA A, 1970, J BIOL CHEM, V245, P1699; Isaac RE, 2002, PEPTIDES, V23, P725, DOI 10.1016/S0196-9781(01)00653-2; Isaac RE, 1998, BIOCHEM J, V330, P61, DOI 10.1042/bj3300061; Ja WW, 2007, NAT CHEM BIOL, V3, P415, DOI 10.1038/nchembio.2007.2; Ja WW, 2009, PROTEIN SCI, V18, P2203, DOI 10.1002/pro.221; Janssen T, 2001, INSECT MOL BIOL, V10, P183, DOI 10.1046/j.1365-2583.2001.00257.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; KATAOKA H, 1989, P NATL ACAD SCI USA, V86, P2976, DOI 10.1073/pnas.86.8.2976; KAY I, 1991, BIOL CHEM H-S, V372, P929, DOI 10.1515/bchm3.1991.372.2.929; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kloppenburg P, 2008, ANNU REV ENTOMOL, V53, P179, DOI 10.1146/annurev.ento.53.103106.093408; Knoepfel Thomas, 2008, V44, P163, DOI 10.1007/400_2007_035; Kumar CG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-176; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; LAGUEUX M, 1992, INSECT BIOCHEM MOLEC, V22, P511, DOI 10.1016/0965-1748(92)90027-C; Lamango NS, 1996, ARCH BIOCHEM BIOPHYS, V330, P238, DOI 10.1006/abbi.1996.0249; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LEHMBERG E, 1991, BIOCHEM BIOPH RES CO, V179, P1036, DOI 10.1016/0006-291X(91)91923-Z; Lester RL, 2005, J INSECT PHYSIOL, V51, P737, DOI 10.1016/j.jinsphys.2005.03.015; LEUNG PS, 1992, REGUL PEPTIDES, V41, P71, DOI 10.1016/0167-0115(92)90515-V; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Macdonald LE, 2005, P NATL ACAD SCI USA, V102, P2496, DOI 10.1073/pnas.0409849102; Macins A, 1999, ARCH INSECT BIOCHEM, V40, P107, DOI 10.1002/(SICI)1520-6327(1999)40:2&lt;107::AID-ARCH5&gt;3.0.CO;2-B; Macours N, 2004, INT REV CYTOL, V239, P47, DOI 10.1016/S0074-7696(04)39002-9; Macours N, 2004, INSECT BIOCHEM MOLEC, V34, P501, DOI 10.1016/j.ibmb.2004.03.007; Macours N, 2003, J INSECT PHYSIOL, V49, P739, DOI 10.1016/S0022-1910(03)00110-0; Macours N, 2003, INSECT MOL BIOL, V12, P233, DOI 10.1046/j.1365-2583.2003.00406.x; MARSHALL J, 1988, BIOCHEM SOC T, V16, P463, DOI 10.1042/bst0160463; MARSHALL J, 1990, EMBO J, V9, P4391, DOI 10.1002/j.1460-2075.1990.tb07889.x; MAULE AG, 1992, PARASITOLOGY, V105, P505, DOI 10.1017/S0031182000074680; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; Mercer AR, 1996, J NEUROBIOL, V29, P49, DOI 10.1002/(SICI)1097-4695(199601)29:1<49::AID-NEU4>3.0.CO;2-7; Meredith J, 1996, J EXP BIOL, V199, P1053; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; MINTH CD, 1984, P NATL ACAD SCI-BIOL, V81, P4577, DOI 10.1073/pnas.81.14.4577; Molina Y, 2008, DEV NEUROBIOL, V68, P950, DOI 10.1002/dneu.20633; Molina Y, 2007, BRAIN BEHAV EVOLUT, V70, P137, DOI 10.1159/000102975; MOREAU R, 1988, ARCH INSECT BIOCHEM, V8, P135, DOI 10.1002/arch.940080207; Morris MB, 2009, INT J BIOCHEM CELL B, V41, P721, DOI 10.1016/j.biocel.2008.04.025; MURPHYULLRICH JE, 1991, J CELL BIOL, V115, P1127, DOI 10.1083/jcb.115.4.1127; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; PAEMEN L, 1991, PEPTIDES, V12, P7, DOI 10.1016/0196-9781(91)90158-L; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; PENER MP, 1991, ADV INSECT PHYSL; Phillips JE, 1996, J EXP ZOOL, V275, P292, DOI 10.1002/(SICI)1097-010X(19960701)275:4&lt;292::AID-JEZ7&gt;3.0.CO;2-K; PRATT GE, 1989, BIOCHEM BIOPH RES CO, V163, P1243, DOI 10.1016/0006-291X(89)91111-X; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Querat B, 2000, BIOL REPROD, V63, P222, DOI 10.1095/biolreprod63.1.222; Rahman MM, 2008, J INSECT PHYSIOL, V54, P543, DOI 10.1016/j.jinsphys.2007.12.003; Rahman MM, 2003, COMP BIOCHEM PHYS A, V135, P221, DOI 10.1016/S1095-6433(03)00050-3; Rahman MM, 2002, PEPTIDES, V23, P1907, DOI 10.1016/S0196-9781(02)00175-4; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Riveros AJ, 2010, BRAIN BEHAV EVOLUT, V75, P138, DOI 10.1159/000306506; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Rosenblatt S, 1997, BIOCHEM J, V324, P311, DOI 10.1042/bj3240311; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAGE H, 1989, J MOL CELL CARDIOL, V21, P13, DOI 10.1016/0022-2828(89)90833-X; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Schoofs L, 1998, BRAIN RES, V785, P215, DOI 10.1016/S0006-8993(97)01398-X; SCHOOFS L, 1990, FEBS LETT, V261, P397, DOI 10.1016/0014-5793(90)80601-E; Schoofs L, 1997, PEPTIDES, V18, P145, DOI 10.1016/S0196-9781(96)00236-7; SCHOOFS L, 1993, INSECT BIOCHEM MOLEC, V23, P859, DOI 10.1016/0965-1748(93)90104-Z; SCHOOFS L, 1990, REGUL PEPTIDES, V31, P199, DOI 10.1016/0167-0115(90)90006-I; SCHULZAELLEN MF, 1989, NEURON, V2, P1369, DOI 10.1016/0896-6273(89)90075-5; Seidah N G, 1992, NIDA Res Monogr, V126, P132; SEIDAH NG, 1991, ENZYME, V45, P271, DOI 10.1159/000468901; SEIDAH NG, 1994, METHOD ENZYMOL, V244, P175; Siegert KJ, 1999, FEBS LETT, V447, P237, DOI 10.1016/S0014-5793(99)00299-9; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; SONG H, 2011, PSYCHE IN PRESS; Song Hojun, 2005, Journal of Orthoptera Research, V14, P235, DOI 10.1665/1082-6467(2005)14[235:PPOTEO]2.0.CO;2; Song H, 2008, CLADISTICS, V24, P515, DOI 10.1111/j.1096-0031.2007.00190.x; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; STANGIER J, 1987, P NATL ACAD SCI USA, V84, P575, DOI 10.1073/pnas.84.2.575; STANGIER J, 1989, J COMP PHYSIOL B, V159, P5, DOI 10.1007/BF00692677; STONE JV, 1976, NATURE, V263, P207, DOI 10.1038/263207a0; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Towner P, 1997, VISION RES, V37, P495, DOI 10.1016/S0042-6989(96)00198-8; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; TUBLITZ NJ, 1985, J EXP BIOL, V116, P395; TUBLITZ NJ, 1985, J EXP BIOL, V114, P381; TUBLITZ NJ, 1985, J EXP BIOL, V114, P365; TUBLITZ NJ, 1985, SCIENCE, V228, P1013, DOI 10.1126/science.4001929; Uvarov B, 1977, GRASSHOPPERS LOCUSTS; Uvarov BP, 1966, GRASSHOPPERS LOCUSTS; Van der Horst DJ, 2001, INT REV CYTOL, V211, P179, DOI 10.1016/S0074-7696(01)11019-3; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Van Loy T, 2007, GEN COMP ENDOCR, V153, P59, DOI 10.1016/j.ygcen.2006.12.004; Vanden Broeck J J, 1996, Int Rev Cytol, V164, P189; VandenBroeck J, 1996, MOL CELL ENDOCRINOL, V122, P191, DOI 10.1016/0303-7207(96)03890-7; VANDENBROECK J, 1995, J NEUROCHEM, V64, P2387; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; VANHEMS E, 1990, EUR J NEUROSCI, V2, P776, DOI 10.1111/j.1460-9568.1990.tb00468.x; Veelaert D, 1997, ENDOCRINOLOGY, V138, P138, DOI 10.1210/en.138.1.138; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P161, DOI 10.1016/j.ibmb.2008.10.014; Verleyen P, 2009, PEPTIDES, V30, P522, DOI 10.1016/j.peptides.2008.12.006; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Verlinden H, 2009, GEN COMP ENDOCR, V162, P79, DOI 10.1016/j.ygcen.2008.11.016; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; WASSARMAN DA, 1991, NATURE, V349, P463, DOI 10.1038/349463a0; Weaver RJ, 2009, ANN NY ACAD SCI, V1163, P316, DOI 10.1111/j.1749-6632.2009.04459.x; Wegener C, 2002, PEPTIDES, V23, P605, DOI 10.1016/S0196-9781(01)00665-9; Wegener C, 1999, ARCH INSECT BIOCHEM, V40, P203, DOI 10.1002/(SICI)1520-6327(1999)40:4&lt;203::AID-ARCH5&gt;3.0.CO;2-C; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; WILMORE PJ, 1975, CHROMOSOMA, V51, P337, DOI 10.1007/BF00326320; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; WOODHEAD AP, 1989, P NATL ACAD SCI USA, V86, P5997, DOI 10.1073/pnas.86.15.5997; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Wu RX, 2006, J MOL MED, V84, P241, DOI 10.1007/s00109-005-0026-0; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; ZHU XR, 1995, J CELL BIOL, V129, P1641, DOI 10.1083/jcb.129.6.1641	225	74	78	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17274	10.1371/journal.pone.0017274	http://dx.doi.org/10.1371/journal.pone.0017274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445293	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300006
J	Billard, MJ; Gruver, AL; Sempowski, GD				Billard, Matthew J.; Gruver, Amanda L.; Sempowski, Gregory D.			Acute Endotoxin-Induced Thymic Atrophy Is Characterized By Intrathymic Inflammatory and Wound Healing Responses	PLOS ONE			English	Article							T-CELL-ACTIVATION; DOUBLE-POSITIVE THYMOCYTES; LEUKEMIA INHIBITORY FACTOR; NF-KAPPA-B; HELPER-CELLS; MATRIX METALLOPROTEINASES; NEGATIVE SELECTION; ACTIN CYTOSKELETON; LEPTIN PROTECTS; MICE	Background: Productive thymopoiesis is essential for a robust and healthy immune system. Thymus unfortunately is acutely sensitive to stress resulting in involution and decreased T cell production. Thymic involution is a complication of many clinical settings, including infection, malnutrition, starvation, and irradiation or immunosuppressive therapies. Systemic rises in glucocorticoids and inflammatory cytokines are known to contribute to thymic atrophy. Little is known, however, about intrathymic mechanisms that may actively contribute to thymus atrophy or initiate thymic recovery following stress events. Methodology/Principal Findings: Phenotypic, histologic and transcriptome/pathway analysis of murine thymic tissue during the early stages of endotoxemia-induced thymic involution was performed to identify putative mechanisms that drive thymic involution during stress. Thymus atrophy in this murine model was confirmed by down-regulation of genes involved in T cell development, cell activation, and cell cycle progression, correlating with observed phenotypic and histologic thymus involution. Significant gene changes support the hypothesis that multiple key intrathymic pathways are differentially activated during stress-induced thymic involution. These included direct activation of thymus tissue by LPS through TLR signaling, local expression of inflammatory cytokines, inhibition of T cell signaling, and induction of wound healing/tissue remodeling. Conclusions/Significance: Taken together, these observations demonstrated that in addition to the classic systemic response, a direct intrathymic response to endotoxin challenge concurrently contributes to thymic involution during endotoxemia. These findings are a substantial advancement over current understanding of thymus response to stress and may lead to the development of novel therapeutic approaches to ameliorate immune deficiency associated with stress events.	[Billard, Matthew J.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Gruver, Amanda L.; Sempowski, Gregory D.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA; [Gruver, Amanda L.; Sempowski, Gregory D.] Duke Univ, Dept Pathol, Dept Med, Durham, NC 27706 USA	Duke University; Duke University; Duke University	Billard, MJ (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA.	gsem@duke.edu		Sempowski, Gregory/0000-0003-0391-6594	NIH (Regional Biocontainment Laboratory at Duke University Medical Center) [RO1 AG25150, NO1 HHSN266200500019C, UC6 AI058607]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC6AI058607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025150] Funding Source: NIH RePORTER	NIH (Regional Biocontainment Laboratory at Duke University Medical Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was made possible by the following NIH grants and contracts: RO1 AG25150, NO1 HHSN266200500019C, and UC6 AI058607 (Regional Biocontainment Laboratory at Duke University Medical Center). Publication content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Brownlie R, 2009, IMMUNITY, V31, P174, DOI 10.1016/j.immuni.2009.08.002; Buhlmann JE, 2003, J IMMUNOL, V170, P5421, DOI 10.4049/jimmunol.170.11.5421; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Chambers CA, 1997, P NATL ACAD SCI USA, V94, P9296, DOI 10.1073/pnas.94.17.9296; Chendil D, 2002, CANCER BIOL THER, V1, P152, DOI 10.4161/cbt.61; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geiman TM, 2000, P NATL ACAD SCI USA, V97, P4772, DOI 10.1073/pnas.97.9.4772; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gravestein LA, 1996, J EXP MED, V184, P675, DOI 10.1084/jem.184.2.675; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Gruber T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000046; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gruver AL, 2009, J ENDOCRINOL, V203, P75, DOI 10.1677/JOE-09-0179; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hick RW, 2006, J IMMUNOL, V177, P169, DOI 10.4049/jimmunol.177.1.169; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Huang F, 2006, IMMUNITY, V25, P571, DOI 10.1016/j.immuni.2006.08.021; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inoue KI, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/101659; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Kwon H, 2004, J IMMUNOL, V173, P6645, DOI 10.4049/jimmunol.173.11.6645; Laky K, 2006, IMMUNOL REV, V209, P274, DOI 10.1111/j.0105-2896.2006.00358.x; Liepinsh DJ, 2009, EUR J IMMUNOL, V39, P2906, DOI 10.1002/eji.200839191; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Lores P, 1997, ONCOGENE, V15, P601, DOI 10.1038/sj.onc.1201378; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Mastorakos G, 2006, ANN NY ACAD SCI, V1088, P373, DOI 10.1196/annals.1366.021; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; MULLERHERMELINK HK, 1987, AM J PATHOL, V129, P242; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; *R PROJ RDCT, 2009, R LANG ENV STAT COMP; Saluk-Juszczak Joanna, 2005, Postepy Biochem, V51, P280; Savino W, 1999, NEUROIMMUNOMODULAT, V6, P126, DOI 10.1159/000026372; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Sempowski GD, 2002, EUR J IMMUNOL, V32, P3066, DOI 10.1002/1521-4141(200211)32:11<3066::AID-IMMU3066>3.0.CO;2-J; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sohn SJ, 2003, CURR OPIN IMMUNOL, V15, P209, DOI 10.1016/S0952-7915(03)00004-9; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Takahashi S, 2005, EUR J IMMUNOL, V35, P399, DOI 10.1002/eji.200324746; Takeoka Y, 1999, J AUTOIMMUN, V13, P325, DOI 10.1006/jaut.1999.0325; Torres-Collado AX, 2006, J BIOL CHEM, V281, P17827, DOI 10.1074/jbc.M513465200; Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035; Wagner DH, 1996, J EXP MED, V184, P1631, DOI 10.1084/jem.184.5.1631; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WANG SD, 1994, J IMMUNOL, V152, P5014; Wang X, 2006, SCAND J IMMUNOL, V64, P287, DOI 10.1111/j.1365-3083.2006.01813.x	64	45	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17940	10.1371/journal.pone.0017940	http://dx.doi.org/10.1371/journal.pone.0017940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437240	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100047
J	Goh, L; Chen, GB; Cutcutache, I; Low, B; Teh, BT; Rozen, S; Tan, P				Goh, Liang; Chen, Geng Bo; Cutcutache, Ioana; Low, Benjamin; Teh, Bin Tean; Rozen, Steve; Tan, Patrick			Assessing Matched Normal and Tumor Pairs in Next-Generation Sequencing Studies	PLOS ONE			English	Article							SOMATIC MUTATIONS; CANCER GENOME; ASSOCIATION	Next generation sequencing technology has revolutionized the study of cancers. Through matched normal-tumor pairs, it is now possible to identify genome-wide germline and somatic mutations. The generation and analysis of the data requires rigorous quality checks and filtering, and the current analytical pipeline is constantly undergoing improvements. We noted however that in analyzing matched pairs, there is an implicit assumption that the sequenced data are matched, without any quality check such as those implemented in association studies. There are serious implications in this assumption as identification of germline and rare somatic variants depend on the normal sample being the matched pair. Using a genetics concept on measuring relatedness between individuals, we demonstrate that the matchedness of tumor pairs can be quantified and should be included as part of a quality protocol in analysis of sequenced data. Despite the mutation changes in cancer samples, matched tumor-normal pairs are still relatively similar in sequence compared to non-matched pairs. We demonstrate that the approach can be used to assess the mutation landscape between individuals.	[Goh, Liang; Chen, Geng Bo; Low, Benjamin; Tan, Patrick] Duke Natl Univ Singapore, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore; [Goh, Liang] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Goh, Liang] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Cutcutache, Ioana; Rozen, Steve] Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders Program, Singapore, Singapore; [Teh, Bin Tean] Natl Canc Ctr, Cellular & Mol Res Natl Canc Ctr Singapore, Van Andel Res Inst, Translat Canc Res Lab, Singapore, Singapore; [Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; [Tan, Patrick] Canc Sci Inst Singapore, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); Van Andel Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Goh, L (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore.	liang.goh@duke-nus.edu.sg	; Rozen, Steven G./J-5939-2013	Teh, Bin Tean/0000-0003-1514-1124; Rozen, Steven G./0000-0002-4288-0056	Khoo Discovery Award [KDP/2008/0002, KDP/2009/0006]; Singapore Biomedical Research Council [BMRC 05/1/31/19/423]; National Medical Research Council [NMRC TCR/0001/2007]	Khoo Discovery Award; Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LG is supported by Khoo Discovery Award KDP/2008/0002 and KDP/2009/0006. PT is supported by Singapore Biomedical Research Council BMRC 05/1/31/19/423 and National Medical Research Council NMRC TCR/0001/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LI YJ, 2010, OPHTHALMOLOGY; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberson EDO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006711; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Zang ZJ, 2011, CANCER RES, V71, P29, DOI 10.1158/0008-5472.CAN-10-1749	17	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17810	10.1371/journal.pone.0017810	http://dx.doi.org/10.1371/journal.pone.0017810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445261	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100032
J	Madsen, KM; Udatha, GDBRK; Semba, S; Otero, JM; Koetter, P; Nielsen, J; Ebizuka, Y; Kushiro, T; Panagiotou, G				Madsen, Karina M.; Udatha, Gupta D. B. R. K.; Semba, Saori; Otero, Jose M.; Koetter, Peter; Nielsen, Jens; Ebizuka, Yutaka; Kushiro, Tetsuo; Panagiotou, Gianni			Linking Genotype and Phenotype of Saccharomyces cerevisiae Strains Reveals Metabolic Engineering Targets and Leads to Triterpene Hyper-Producers	PLOS ONE			English	Article							BETA-AMYRIN SYNTHASE; PROTEIN STABILITY; SQUALENE SYNTHASE; CRYSTAL-STRUCTURE; PREDICTION; ACID; ENZYME; BIOSYNTHESIS; EVOLUTION; SEQUENCE	Background: Metabolic engineering is an attractive approach in order to improve the microbial production of drugs. Triterpenes is a chemically diverse class of compounds and many among them are of interest from a human health perspective. A systematic experimental or computational survey of all feasible gene modifications to determine the genotype yielding the optimal triterpene production phenotype is a laborious and time-consuming process. Methodology/Principal Findings: Based on the recent genome-wide sequencing of Saccharomyces cerevisiae CEN. PK 113-7D and its phenotypic differences with the S288C strain, we implemented a strategy for the construction of a beta-amyrin production platform. The genes Erg8, Erg9 and HFA1 contained non-silent SNPs that were computationally analyzed to evaluate the changes that cause in the respective protein structures. Subsequently, Erg8, Erg9 and HFA1 were correlated with the increased levels of ergosterol and fatty acids in CEN. PK 113-7D and single, double, and triple gene over-expression strains were constructed. Conclusions: The six out of seven gene over-expression constructs had a considerable impact on both ergosterol and beta-amyrin production. In the case of beta-amyrin formation the triple over-expression construct exhibited a nearly 500% increase over the control strain making our metabolic engineering strategy the most successful design of triterpene microbial producers.	[Madsen, Karina M.; Otero, Jose M.; Panagiotou, Gianni] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Semba, Saori; Ebizuka, Yutaka; Kushiro, Tetsuo; Panagiotou, Gianni] Univ Tokyo, Bunkyo Ku, Grad Sch Pharmaceut Sci, Tokyo 113, Japan; [Koetter, Peter] Goethe Univ Frankfurt, Inst Microbiol, Frankfurt, Germany; [Udatha, Gupta D. B. R. K.; Otero, Jose M.; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Panagiotou, Gianni] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark; University of Tokyo; Goethe University Frankfurt; Chalmers University of Technology; Technical University of Denmark	Madsen, KM (corresponding author), Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark.	gpa@bio.dtu.dk	Panagiotou, Ioannis/B-7083-2013; Nielsen, Jens/Q-1347-2017	Kushiro, Tetsuo/0000-0002-7598-4791; Nielsen, Jens/0000-0002-9955-6003; Udatha, D.B.R.K. Gupta/0000-0003-0163-9407	Danish Research Council for Production and Technology Sciences; Swedish Research Council	Danish Research Council for Production and Technology Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors would like to thank the Danish Research Council for Production and Technology Sciences and the Swedish Research Council for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Amin N, 2004, PROTEIN ENG DES SEL, V17, P787, DOI 10.1093/protein/gzh091; Andreassi JL, 2009, BIOCHEMISTRY-US, V48, P6461, DOI 10.1021/bi900537u; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Carr TP, 2006, ADV FOOD NUTR RES, V51, P165, DOI 10.1016/S1043-4526(06)51003-4; Cheng TMK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000135; Dai MH, 2007, PROTEIN ENG DES SEL, V20, P69, DOI 10.1093/protein/gzl056; Daum G, 1999, YEAST, V15, P601, DOI 10.1002/(SICI)1097-0061(199905)15:7<601::AID-YEA390>3.0.CO;2-N; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Doss CGP, 2009, NEW BIOTECHNOL, V25, P214, DOI 10.1016/j.nbt.2009.01.004; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; ESCHENMOSER A, 1955, HELV CHIM ACTA, V38, P1890, DOI 10.1002/hlca.19550380728; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Gilis D, 2000, PROTEIN ENG, V13, P849, DOI 10.1093/protein/13.12.849; Gong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009186; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Houten SM, 2001, MOL GENET METAB, V72, P273, DOI 10.1006/mgme.2000.3133; Jackson BE, 2003, ORG LETT, V5, P1629, DOI 10.1021/ol034231x; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Kirby J, 2008, FEBS J, V275, P1852, DOI 10.1111/j.1742-4658.2008.06343.x; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lee SY, 2009, DRUG DISCOV TODAY, V14, P78, DOI 10.1016/j.drudis.2008.08.004; Lee S, 2008, J BACTERIOL, V190, P3808, DOI 10.1128/JB.01939-07; LEE SY, 1999, METAB ENG, P1; Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Morita M, 2000, EUR J BIOCHEM, V267, P3453, DOI 10.1046/j.1432-1327.2000.01357.x; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Newman JRS, 2006, NATURE, V444, P561, DOI 10.1038/nature05407; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nielsen KF, 2000, J CHROMATOGR A, V898, P227, DOI 10.1016/S0021-9673(00)00873-6; Otero JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-723; Panagiotou G, 2006, METAB ENG, V8, P474, DOI 10.1016/j.ymben.2006.04.004; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Randles LG, 2006, J BIOL CHEM, V281, P24216, DOI 10.1074/jbc.M603593200; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Shimada H, 1998, APPL ENVIRON MICROB, V64, P2676; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Stephanopoulos G, 2004, NAT BIOTECHNOL, V22, P1261, DOI 10.1038/nbt1016; TOH H, 1993, EUR J BIOCHEM, V215, P687, DOI 10.1111/j.1432-1033.1993.tb18080.x; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Withers ST, 2007, APPL MICROBIOL BIOT, V73, P980, DOI 10.1007/s00253-006-0593-1; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	76	37	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14763	10.1371/journal.pone.0014763	http://dx.doi.org/10.1371/journal.pone.0014763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445244	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100003
J	Garrido, D; Kim, JH; German, JB; Raybould, HE; Mills, DA				Garrido, Daniel; Kim, Jae Han; German, J. Bruce; Raybould, Helen E.; Mills, David A.			Oligosaccharide Binding Proteins from Bifidobacterium longum subsp infantis Reveal a Preference for Host Glycans	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; INTESTINAL EPITHELIAL-CELLS; BLOOD-GROUP; ESCHERICHIA-COLI; GENOME SEQUENCE; CACO-2 CELLS; SHIGA TOXIN; GLYCOSPHINGOLIPIDS; LACTOBACILLUS; MICROBIOTA	Bifidobacterium longum subsp. infantis (B. infantis) is a common member of the infant intestinal microbiota, and it has been characterized by its foraging capacity for human milk oligosaccharides (HMO). Its genome sequence revealed an overabundance of the Family 1 of solute binding proteins (F1SBPs), part of ABC transporters and associated with the import of oligosaccharides. In this study we have used the Mammalian Glycan Array to determine the specific affinities of these proteins. This was correlated with binding protein expression induced by different prebiotics including HMO. Half of the F1SBPs in B. infantis were determined to bind mammalian oligosaccharides. Their affinities included different blood group structures and mucin oligosaccharides. Related to HMO, other proteins were specific for oligomers of lacto-N-biose (LNB) and polylactosamines with different degrees of fucosylation. Growth on HMO induced the expression of specific binding proteins that import HMO isomers, but also bind blood group and mucin oligosaccharides, suggesting coregulated transport mechanisms. The prebiotic inulin induced other family 1 binding proteins with affinity for intestinal glycans. Most of the host glycan F1SBPs in B. infantis do not have homologs in other bifidobacteria. Finally, some of these proteins were found to be adherent to intestinal epithelial cells in vitro. In conclusion, this study represents further evidence for the particular adaptations of B. infantis to the infant gut environment, and helps to understand the molecular mechanisms involved in this process.	[Garrido, Daniel; German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Garrido, Daniel; Kim, Jae Han; German, J. Bruce; Raybould, Helen E.; Mills, David A.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Garrido, Daniel; Kim, Jae Han; German, J. Bruce; Raybould, Helen E.; Mills, David A.] Univ Calif Davis, Funct Glycobiol Program, Davis, CA 95616 USA; [Garrido, Daniel; Kim, Jae Han; German, J. Bruce; Mills, David A.] Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Davis, CA 95616 USA; [Kim, Jae Han; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Raybould, Helen E.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Garrido, D (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.	damills@ucdavis.edu	Garrido, Daniel/F-8229-2013; Mills, David Andrew/G-2282-2011; Mills, David/GXF-1821-2022	Garrido, Daniel/0000-0002-4982-134X; Mills, David Andrew/0000-0003-1913-9865; kim, Jaehan/0000-0001-9719-9957	University of California; California Dairy Research Foundation; United States Department of Agriculture National Research Initiative [2008-35200-18776]; National Institutes of Health-National Institute of Child Health & Human Development [1R01HD061923]; Fulbright-Conicyt; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061923] Funding Source: NIH RePORTER	University of California(University of California System); California Dairy Research Foundation; United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); National Institutes of Health-National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fulbright-Conicyt; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible in part by grant support from the University of California Discovery Grant Program, the California Dairy Research Foundation, United States Department of Agriculture National Research Initiative-Cooperative State Research, Education, and Extension Service Award 2008-35200-18776 and National Institutes of Health-National Institute of Child Health & Human Development award 1R01HD061923. DG is the recipient of a Fulbright-Conicyt scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Asakuma S, 2007, BIOSCI BIOTECH BIOCH, V71, P1447, DOI 10.1271/bbb.60529; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Barboza M, 2009, APPL ENVIRON MICROB, V75, P7319, DOI 10.1128/AEM.00842-09; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bouhnik Y, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-8; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; Coppa GV, 2006, PEDIATR RES, V59, P377, DOI 10.1203/01.pdr.0000200805.45593.17; CROCIANI F, 1994, INT J FOOD MICROBIOL, V24, P199, DOI 10.1016/0168-1605(94)90119-8; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Falguieres T, 2008, MOL CANCER THER, V7, P2498, DOI 10.1158/1535-7163.MCT-08-0430; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; FINNE J, 1989, J BIOL CHEM, V264, P5720; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Gonzalez R, 2008, APPL ENVIRON MICROB, V74, P4686, DOI 10.1128/AEM.00122-08; Guglielmetti S, 2008, APPL ENVIRON MICROB, V74, P4695, DOI 10.1128/AEM.00124-08; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; HOLGERSSON J, 1988, BIOCHIMIE, V70, P1565, DOI 10.1016/0300-9084(88)90292-1; HOLGERSSON J, 1991, J BIOCHEM-TOKYO, V110, P120, DOI 10.1093/oxfordjournals.jbchem.a123530; KARLSSON KA, 1981, J BIOL CHEM, V256, P3512; KERANEN A, 1975, BIOCHIM BIOPHYS ACTA, V409, P320, DOI 10.1016/0005-2760(75)90028-4; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kleessen B, 1995, ACTA PAEDIATR, V84, P1347, DOI 10.1111/j.1651-2227.1995.tb13567.x; Kogelberg H, 2004, EUR J BIOCHEM, V271, P1172, DOI 10.1111/j.1432-1033.2004.04021.x; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; LARSON G, 1987, FEBS LETT, V214, P41, DOI 10.1016/0014-5793(87)80009-1; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; MACHER BA, 1980, J BIOL CHEM, V255, P2092; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Miller-Podraza H, 2005, J BIOL CHEM, V280, P19695, DOI 10.1074/jbc.M412688200; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; MORGAN WTJ, 1969, BRIT MED BULL, V25, P30, DOI 10.1093/oxfordjournals.bmb.a070666; NEWBURG DS, 1992, J INFECT DIS, V166, P832, DOI 10.1093/infdis/166.4.832; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; ORLANDI PA, 1994, BIOCHEMISTRY-US, V33, P12886, DOI 10.1021/bi00209a021; Parche S, 2006, J BACTERIOL, V188, P1260, DOI 10.1128/JB.188.4.1260-1265.2006; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; PODOLSKY DK, 1985, J BIOL CHEM, V260, P5510; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Ruas-Madiedo P, 2008, APPL ENVIRON MICROB, V74, P1936, DOI 10.1128/AEM.02509-07; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Ventura M, 2001, FEMS MICROBIOL ECOL, V36, P113, DOI 10.1111/j.1574-6941.2001.tb00831.x; Ventura M, 2007, INT J FOOD MICROBIOL, V120, P2, DOI 10.1016/j.ijfoodmicro.2007.06.011; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Wu AM, 2003, J BIOMED SCI, V10, P676, DOI 10.1159/000073954; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhang GY, 2009, APPL ENVIRON MICROB, V75, P1080, DOI 10.1128/AEM.01416-08; ZIVKOVIC AM, 2010, P NATL ACAD IN PRESS	72	147	151	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17315	10.1371/journal.pone.0017315	http://dx.doi.org/10.1371/journal.pone.0017315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423604	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900006
J	Darpel, KE; Langner, KFA; Nimtz, M; Anthony, SJ; Brownlie, J; Takamatsu, HH; Mellor, PS; Mertens, PPC				Darpel, Karin E.; Langner, Kathrin F. A.; Nimtz, Manfred; Anthony, Simon J.; Brownlie, Joe; Takamatsu, Haru-Hisa; Mellor, Philip S.; Mertens, Peter P. C.			Saliva Proteins of Vector Culicoides Modify Structure and Infectivity of Bluetongue Virus Particles	PLOS ONE			English	Article							HOST IMMUNE-RESPONSE; VARIIPENNIS DIPTERA; GLAND EXTRACTS; FUNCTIONAL-CHARACTERIZATION; SONORENSIS DIPTERA; MOSQUITO SALIVA; AEDES-AEGYPTI; CELL-LINES; CERATOPOGONIDAE; NUBECULOSUS	Bluetongue virus (BTV) and epizootic haemorrhagic disease virus (EHDV) are related orbiviruses, transmitted between their ruminant hosts primarily by certain haematophagous midge vectors (Culicoides spp.). The larger of the BTV outer-capsid proteins, 'VP2', can be cleaved by proteases (including trypsin or chymotrypsin), forming infectious subviral particles (ISVP) which have enhanced infectivity for adult Culicoides, or KC cells (a cell-line derived from C. sonorensis). We demonstrate that VP2 present on purified virus particles from 3 different BTV strains can also be cleaved by treatment with saliva from adult Culicoides. The saliva proteins from C. sonorensis (a competent BTV vector), cleaved BTV-VP2 more efficiently than those from C. nubeculosus (a less competent / non-vector species). Electrophoresis and mass spectrometry identified a trypsin-like protease in C. sonorensis saliva, which was significantly reduced or absent from C. nubeculosus saliva. Incubating purified BTV-1 with C. sonorensis saliva proteins also increased their infectivity for KC cells similar to 10 fold, while infectivity for BHK cells was reduced by 2-6 fold. Treatment of an 'eastern' strain of EHDV-2 with saliva proteins of either C. sonorensis or C. nubeculosus cleaved VP2, but a 'western' strain of EHDV-2 remained unmodified. These results indicate that temperature, strain of virus and protein composition of Culicoides saliva (particularly its protease content which is dependent upon vector species), can all play a significant role in the efficiency of VP2 cleavage, influencing virus infectivity. Saliva of several other arthropod species has previously been shown to increase transmission, infectivity and virulence of certain arboviruses, by modulating and/or suppressing the mammalian immune response. The findings presented here, however, demonstrate a novel mechanism by which proteases in Culicoides saliva can also directly modify the orbivirus particle structure, leading to increased infectivity specifically for Culicoides cells and, in turn, efficiency of transmission to the insect vector.	[Darpel, Karin E.; Anthony, Simon J.; Takamatsu, Haru-Hisa; Mellor, Philip S.; Mertens, Peter P. C.] AFRC, Inst Anim Hlth, Pirbright Lab, Vector Borne Dis Programme, Woking GU24 0NF, Surrey, England; [Langner, Kathrin F. A.] Univ Vet Med, Immunol Unit, Hannover, Germany; [Nimtz, Manfred] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Brownlie, Joe] Univ London, Dept Pathol & Infect Dis, Royal Vet Coll, Hatfield, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research; University of London; University of London Royal Veterinary College	Darpel, KE (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Vector Borne Dis Programme, Woking GU24 0NF, Surrey, England.	karin.darpel@bbsrc.ac.uk	Darpel, Karin/HIK-2423-2022	Mertens, Peter/0000-0002-3438-3738; Darpel, Karin/0000-0002-1488-3233	BBSRC [BB/F00852X/1]; IAH; BBSRC [BBS/E/I/00001441, BBS/E/I/00001445] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00852X/1, BBS/E/I/00001445, BBS/E/I/00001441] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); IAH; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly founded by BBSRC grant BB/F00852X/1 awarded to HHT and PPM. KED was for part of this work also funded by an IAH studentship (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; ANTHONY SJ, 2009, VIRUS GENES IN PRESS; Bishop JV, 2006, AM J TROP MED HYG, V75, P532, DOI 10.4269/ajtmh.2006.75.532; BOORMAN J, 1974, B ENTOMOL RES, V64, P371, DOI 10.1017/S0007485300031254; Campbell CL, 2005, INSECT MOL BIOL, V14, P121, DOI 10.1111/j.1365-2583.2004.00537.x; CROSS ML, 1994, TROP MED PARASITOL, V45, P119; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Darpel K.E., 2007, THESIS U LONDON; Darpel KE, 2009, BIOL ANIM INFECT, P265, DOI 10.1016/B978-012369368-6.50016-2; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; FU H, THESIS U HERTFORDSHI; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hassan SS, 1999, J VIROL, V73, P9832, DOI 10.1128/JVI.73.12.9832-9842.1999; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; HOCKING B, 1971, ANNU REV ENTOMOL, V16, P1, DOI 10.1146/annurev.en.16.010171.000245; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; JENNINGS DM, 1987, ARCH VIROL, V95, P177, DOI 10.1007/BF01310778; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langner KFA, 2007, J MED ENTOMOL, V44, P238, DOI 10.1603/0022-2585(2007)44[238:CAAOSP]2.0.CO;2; Limesand KH, 2003, J MED ENTOMOL, V40, P199, DOI 10.1603/0022-2585-40.2.199; Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x; LUDWIG GV, 1989, VIROLOGY, V171, P108, DOI 10.1016/0042-6822(89)90516-3; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S., 2010, PLOS ONE, V5; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; MACLACHLAN NJ, 1994, COMP IMMUNOL MICROB, V17, P197, DOI 10.1016/0147-9571(94)90043-4; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MELLOR PS, 1971, T ROY SOC TROP MED H, V65, P199, DOI 10.1016/0035-9203(71)90218-5; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Russell CL, 2009, INSECT MOL BIOL, V18, P383, DOI 10.1111/j.1365-2583.2009.00882.x; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; Swist SL, 2002, J MED ENTOMOL, V39, P900, DOI 10.1603/0022-2585-39.6.900; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Tan BH, 2001, J VIROL, V75, P3937, DOI 10.1128/JVI.75.8.3937-3947.2001; Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Wellby MP, 1996, B ENTOMOL RES, V86, P715, DOI 10.1017/S0007485300039237; Wilson AD, 2008, VET IMMUNOL IMMUNOP, V122, P94, DOI 10.1016/j.vetimm.2007.10.011; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; WITTMANN EJ, THESIS U BRISTOL; [No title captured], DOI DOI 10.1007/BF01863914	52	29	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17545	10.1371/journal.pone.0017545	http://dx.doi.org/10.1371/journal.pone.0017545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423801	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400014
J	Duning, T; Schiffbauer, H; Warnecke, T; Mohammadi, S; Floel, A; Kolpatzik, K; Kugel, H; Schneider, A; Knecht, S; Deppe, M; Schabitz, WR				Duning, Thomas; Schiffbauer, Hagen; Warnecke, Tobias; Mohammadi, Siawoosh; Floel, Agnes; Kolpatzik, Katja; Kugel, Harald; Schneider, Armin; Knecht, Stefan; Deppe, Michael; Schaebitz, Wolf Ruediger			G-CSF Prevents the Progression of Structural Disintegration of White Matter Tracts in Amyotrophic Lateral Sclerosis: A Pilot Trial	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DIFFUSION TENSOR MRI; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; WHOLE-BRAIN; SENSITIVITY; INVOLVEMENT; IMPAIRMENT; ALS	Background: The hematopoietic protein Granulocyte-colony stimulating factor (G-CSF) has neuroprotective and regenerative properties. The G-CSF receptor is expressed by motoneurons, and G-CSF protects cultured motoneuronal cells from apoptosis. It therefore appears as an attractive and feasible drug candidate for the treatment of amyotrophic lateral sclerosis (ALS). The current pilot study was performed to determine whether treatment with G-CSF in ALS patients is feasible. Methods: Ten patients with definite ALS were entered into a double-blind, placebo-controlled, randomized trial. Patients received either 10 mu g/kg BW G-CSF or placebo subcutaneously for the first 10 days and from day 20 to 25 of the study. Clinical outcome was assessed by changes in the ALS functional rating scale (ALSFRS), a comprehensive neuropsychological test battery, and by examining hand activities of daily living over the course of the study (100 days). The total number of adverse events (AE) and treatment-related AEs, discontinuation due to treatment-related AEs, laboratory parameters including leukocyte, erythrocyte, and platelet count, as well as vital signs were examined as safety endpoints. Furthermore, we explored potential effects of G-CSF on structural cerebral abnormalities on the basis of voxel-wise statistics of Diffusion Tensor Imaging (DTI), brain volumetry, and voxel-based morphometry. Results: Treatment was well-tolerated. No significant differences were found between groups in clinical tests and brain volumetry from baseline to day 100. However, DTI analysis revealed significant reductions of fractional anisotropy (FA) encompassing diffuse areas of the brain when patients were compared to controls. On longitudinal analysis, the placebo group showed significant greater and more widespread decline in FA than the ALS patients treated with G-CSF. Conclusions: Subcutaneous G-CSF treatment in ALS patients appears as feasible approach. Although exploratory analysis of clinical data showed no significant effect, DTI measurements suggest that the widespread and progressive microstructural neural damage in ALS can be modulated by G-CSF treatment. These findings may carry significant implications for further clinical trials on ALS using growth factors.	[Duning, Thomas; Warnecke, Tobias; Mohammadi, Siawoosh; Kolpatzik, Katja; Knecht, Stefan; Deppe, Michael; Schaebitz, Wolf Ruediger] Univ Hosp Muenster, Dept Neurol, Munster, Germany; [Schiffbauer, Hagen; Kugel, Harald] Univ Hosp Muenster, Dept Clin Radiol, Munster, Germany; [Floel, Agnes] Charite, Dept Neurol, D-13353 Berlin, Germany; [Floel, Agnes] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Schneider, Armin] SYGNIS Biosci, Heidelberg, Germany; [Schaebitz, Wolf Ruediger] EVK Bielefeld, Dept Neurol, Bielefeld, Germany	University of Munster; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Duning, T (corresponding author), Univ Hosp Muenster, Dept Neurol, Munster, Germany.	duningt@uni-muenster.de	Mohammadi, Siawoosh/AAG-8251-2022; Mohammadi, Siawoosh/H-9539-2012; Mohammadi, Siawoosh/AFL-8250-2022; Kugel, Harald/A-4963-2013; Floel, Agnes/A-9426-2017; Deppe, Michael/C-5780-2017	Mohammadi, Siawoosh/0000-0003-1311-9636; Mohammadi, Siawoosh/0000-0003-1311-9636; Mohammadi, Siawoosh/0000-0003-1311-9636; Kugel, Harald/0000-0002-4349-1984; Deppe, Michael/0000-0002-8372-9678; Schneider, Armin/0000-0003-0296-0059; Knecht, Stefan/0000-0003-1056-9228	pharmacy of the University of Mainz, Germany; SYGNIS Bioscience, Heidelberg, Germany	pharmacy of the University of Mainz, Germany; SYGNIS Bioscience, Heidelberg, Germany	This investigator-initiated trial was supported by institutional grants (for the randomized filling of G-CSF by the pharmacy of the University of Mainz, Germany) from SYGNIS Bioscience, Heidelberg, Germany. One of the authors (Armin Schneider) is employed by SYGNIS Bioscience, who was involved in the organization of the research project and critical review of the manuscript, and G-CSF was provided by SYGNIS Bioscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; AGOSTA F, 2010, AJNR AM J NEURORADIO; Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x; Alon G, 2003, NEUROREHABILITATION, V18, P215; [Anonymous], 1996, Arch Neurol, V53, P141; Brooks BR, 2009, ANN NEUROL, V65, pS17, DOI 10.1002/ana.21544; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Canu E, 2009, J ALZHEIMERS DIS; Cashman N, 2008, MUSCLE NERVE, V37, P620, DOI 10.1002/mus.20951; Charlton RA, 2010, J NEUROL NEUROSUR PS, V81, P13, DOI 10.1136/jnnp.2008.167288; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Dengler R, 2005, NEURODEGENER DIS, V2, P177, DOI 10.1159/000089623; Deppe M, 2008, NEUROLOGY, V71, P1981, DOI 10.1212/01.wnl.0000336969.98241.17; Duning T, 2009, J NEUROL NEUROSUR PS, V80, P432, DOI 10.1136/jnnp.2008.153148; Fein G, 2006, NEUROIMAGE, V30, P1187, DOI 10.1016/j.neuroimage.2005.10.054; FILIPPI M, 2010, EUR J NEUROL; GIORDANA MT, 2010, NEUROL SCI; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Grosskreutz J, 2008, AMYOTROPH LATERAL SC, V9, P238, DOI 10.1080/17482960802163622; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Iwata Nobue K., 2007, Brain and Nerve (Tokyo), V59, P1053; Kavcic V, 2008, ALZHEIMERS DEMENT, V4, P381, DOI 10.1016/j.jalz.2008.07.001; KIM SH, 2010, J NEUROIMAGING; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Mascalchi M, 2005, RADIOL MED, V109, P155; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Minnerup J, 2008, STROKE, V39, P1855, DOI 10.1161/STROKEAHA.107.506816; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Muller MJ, 2007, NEUROBIOL AGING, V28, P398, DOI 10.1016/j.neurobiolaging.2006.01.009; NEFUSSY B, 2009, AMYOTROPH LATERAL SC, P1, DOI DOI 10.1080/17482960902933809; Ng MC, 2008, J MAGN RESON IMAGING, V27, P8, DOI 10.1002/jmri.21217; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Pyra T, 2010, AMYOTROPH LATERAL SC, V11, P157, DOI 10.3109/17482960902756473; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schiavone F, 2009, J MAGN RESON IMAGING, V29, P23, DOI 10.1002/jmri.21572; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Senda J, 2009, AMYOTROPH LATERAL SC, V10, P288, DOI 10.3109/17482960802651717; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Stanton BR, 2009, ARCH NEUROL-CHICAGO, V66, P109, DOI 10.1001/archneurol.2008.527; SWASH M, 1988, J NEUROL NEUROSUR PS, V51, P165, DOI 10.1136/jnnp.51.2.165; Tanaka M, 2006, J NEUROPATH EXP NEUR, V65, P816, DOI 10.1097/01.jnen.0000232025.84238.e1; TARELLA C, 2009, CYTOTHERAPY; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; van der Graaff MM, 2009, NEUROMUSCULAR DISORD, V19, P53, DOI 10.1016/j.nmd.2008.10.002; Yamasaki R, 2010, J NEUROIMMUNOL, V229, P51, DOI 10.1016/j.jneuroim.2010.07.002; Zhang YF., 2008, ACTA AGR JIANGXI, V6, P1; Zoccolella S, 2009, NEUROPSYCH DIS TREAT, V5, P577	53	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17770	10.1371/journal.pone.0017770	http://dx.doi.org/10.1371/journal.pone.0017770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423758	gold, Green Published, Green Submitted			2022-12-27	WOS:000288512400027
J	McDuff, FKE; Turner, SD				McDuff, Fiona Kate Elizabeth; Turner, Suzanne Dawn			Aberrant Anaplastic Lymphoma Kinase Activity Induces a p53 and Rb-Dependent Senescence-Like Arrest in the Absence of Detectable p53 Stabilization	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; LARGE-CELL LYMPHOMA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; RECEPTOR TYROSINE KINASE; EML4-ALK FUSION GENE; NPM-ALK; ACTIVATING MUTATIONS; HEALTHY-INDIVIDUALS; SUPPRESSOR P53; LUNG-CANCER	Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in a variety of tumor types, most notably in Anaplastic Large Cell Lymphoma (ALCL) where a chromosomal translocation generates the oncogenic fusion protein, Nucleophosmin-ALK (NPM-ALK). Whilst much is known regarding the mechanism of transformation by NPM-ALK, the existence of cellular defence pathways to prevent this pathological process has not been investigated. Employing the highly tractable primary murine embryonic fibroblast (MEF) system we show that cellular transformation is not an inevitable consequence of NPM-ALK activity but is combated by p53 and Rb. Activation of p53 and/or Rb by NPM-ALK triggers a potent proliferative block with features reminiscent of senescence. While loss of p53 alone is sufficient to circumvent NPM-ALK-induced senescence and permit cellular transformation, sole loss of Rb permits continued proliferation but not transformation due to p53-imposed restraints. Furthermore, NPM-ALK attenuates p53 activity in an Rb and MDM2 dependent manner but this activity is not sufficient to bypass senescence. These data indicate that senescence may constitute an effective barrier to ALK-induced malignancies that ultimately must be overcome for tumor development.	[McDuff, Fiona Kate Elizabeth; Turner, Suzanne Dawn] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 1QP, England	University of Cambridge	McDuff, FKE (corresponding author), Univ Cambridge, Dept Pathol, Div Mol Histopathol, Tennis Court Rd, Cambridge CB2 1QP, England.	sdt36@cam.ac.uk	Turner, Suzanne Dawn/K-4405-2013	Turner, Suzanne Dawn/0000-0002-8439-4507	Leukaemia and Lymphoma Research [09004]; Wellcome Trust; Cancer Research UK [C19666]	Leukaemia and Lymphoma Research; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This study was sponsored with funding from Leukaemia and Lymphoma Research (09004 to sdt; http://www.beatbloodcancers.org/), Wellcome Trust (PhD studentship to FKEM; http://www.wellcome.ac.uk/), and Cancer Research UK (C19666 to sdt; http://www.cancerresearch-uk.org/charities/cancer-research-uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERNAUX C, 1995, BLOOD, V86, P3118; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cui YX, 2009, BLOOD, V113, P5217, DOI 10.1182/blood-2008-06-160168; Debelenko LV, 2003, LAB INVEST, V83, P1255, DOI 10.1097/01.LAB.0000088856.49388.EA; Dirks WG, 2002, INT J CANCER, V100, P49, DOI 10.1002/ijc.10435; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Garcia MJ, 2002, BRIT J HAEMATOL, V119, P877, DOI 10.1046/j.1365-2141.2002.03870_3.x; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Ma ZG, 2003, GENE CHROMOSOME CANC, V37, P98, DOI 10.1002/gcc.10177; Maes B, 2001, AM J PATHOL, V158, P2185, DOI 10.1016/S0002-9440(10)64690-1; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Quina AS, 2000, GENE CHROMOSOME CANC, V29, P266, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1030>3.0.CO;2-#; Rassidakis GZ, 2005, LEUKEMIA, V19, P1663, DOI 10.1038/sj.leu.2403840; Rassidakis GZ, 2004, AM J PATHOL, V164, P2259, DOI 10.1016/S0002-9440(10)63782-0; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Summers KE, 2001, J CLIN ONCOL, V19, P420, DOI 10.1200/JCO.2001.19.2.420; TODARO GJ, 1963, J CELL COMPAR PHYSL, V62, P257, DOI 10.1002/jcp.1030620305; Trumper L, 1998, BRIT J HAEMATOL, V103, P1138; Turner SD, 2005, LEUKEMIA, V19, P1128, DOI 10.1038/sj.leu.2403797; Turner SD, 2003, ONCOGENE, V22, P7750, DOI 10.1038/sj.onc.1207048; Turner SD, 2006, ANTICANCER RES, V26, P3275; Yasukawa M, 2001, BLOOD, V98, P486, DOI 10.1182/blood.V98.2.486	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17854	10.1371/journal.pone.0017854	http://dx.doi.org/10.1371/journal.pone.0017854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423761	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400034
J	Li, Q; Qin, SZ; Rao, LL; Zhang, WC; Ying, XP; Guo, XY; Guo, CY; Ding, JH; Li, S; Luo, J				Li, Qi; Qin, Shaozheng; Rao, Li-Lin; Zhang, Wencai; Ying, Xiaoping; Guo, Xiuyan; Guo, Chunyan; Ding, Jinghong; Li, Shu; Luo, Jing			Can Sophie's Choice Be Adequately Captured by Cold Computation of Minimizing Losses? An fMRI Study of Vital Loss Decisions	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; TASK-DIFFICULTY; NEGATIVE AFFECT; PROSPECT-THEORY; WORKING-MEMORY; LOSS AVERSION; VALUES; PAIN; ACTIVATION; CONFLICT	The vast maojority of decision-making research is performed under the assumption of the value maxing principle. This principle implies that when making decisions, individuals try to optimize outcomes on the basis of cold mathematical equations. However, decisions are emotion-laden rather thatn cool and analytic when they tap into life-threatening considerations. Using functional magnetic resonance imaging (fMRI), this study investigated the neural mechanisms underlying vital loss decisions. Participants were asked to make a forced choice between two losses across three conditions: both losses are trivial (trivial-trivial), both losses are viral (vital-vital), or one loss is trivial and the other is vital (vital-trivial). Out results revealed that the amygdala was more active and correlated positively with self-reported negative emotion associated with choice during vital-vital loss decisions, when compared to trivial-trivial loss decisions. The rostral anterior cingulate cortex was also more active and correlated positively with self-reported positive emotion of choice diring vital-trivial loss decisions. Out findings suggest that vital loss decisions involve emotions and cannot be adequately captured by cold computation of minimizing losses. This research will shed light on how people make vital loss decisions.	[Li, Qi; Rao, Li-Lin; Zhang, Wencai; Li, Shu; Luo, Jing] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Li, Qi; Rao, Li-Lin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Guo, Chunyan; Ding, Jinghong; Luo, Jing] Capital Normal Univ, Learning & Cognit Lab, Beijing, Peoples R China; [Qin, Shaozheng] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Ying, Xiaoping] Chinese Acad Social Sci, Inst Sociol, Ctr Social Psychol Studies, Beijing, Peoples R China; [Guo, Xiuyan] Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Normal University; Stanford University; Chinese Academy of Social Sciences; Fudan University	Li, Q (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	lishu@psych.ac.cn; luoj@psych.ac.cn	Qin, Shaozheng/AAD-2107-2019	Qin, Shaozheng/0000-0002-1859-2150; li, shu/0000-0003-4402-1674	National Basic Research Program of China [2011CB711000, 2010CB833904]; National Natural Science Foundation of China [70871110, 307707890]; National Hi-Tech Research and Development Program of China [2008AA022604]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was partially supported by the National Basic Research Program of China (Grant No. 2011CB711000; 2010CB833904), the National Natural Science Foundation of China (Grant No. 70871110; 307707890), and the National Hi-Tech Research and Development Program of China (Grant No. 2008AA022604). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui M, 2007, MANAGE SCI, V53, P1659, DOI 10.1287/mnsc.1070.0711; Altamura M, 2007, PSYCHIAT RES-NEUROIM, V154, P103, DOI 10.1016/j.pscychresns.2006.08.002; Baron J, 1997, ORGAN BEHAV HUM DEC, V70, P1, DOI 10.1006/obhd.1997.2690; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; BIGGS SF, 1985, MANAGE SCI, V31, P970, DOI 10.1287/mnsc.31.8.970; Bjork JM, 2008, NEUROIMAGE, V42, P1609, DOI 10.1016/j.neuroimage.2008.06.035; Bleichrodt H, 1999, J MATH PSYCHOL, V43, P238, DOI 10.1006/jmps.1999.1257; BUSS DM, 1995, AM PSYCHOL, V50, P164, DOI 10.1037/0003-066X.50.3.164; Chandrasekhar PVS, 2008, NEUROIMAGE, V39, P1472, DOI 10.1016/j.neuroimage.2007.10.027; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; COOMBS CH, 1984, J MATH PSYCHOL, V28, P1, DOI 10.1016/0022-2496(84)90018-X; Crivello F, 2002, HUM BRAIN MAPP, V16, P228, DOI 10.1002/hbm.10047; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Derbyshire SWG, 2004, NEUROIMAGE, V23, P392, DOI 10.1016/j.neuroimage.2004.04.033; Dolmatov IY, 2009, CELL TISSUE RES, V336, P41, DOI 10.1007/s00441-009-0761-6; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Fujiwara J, 2009, NEUROIMAGE, V44, P1163, DOI 10.1016/j.neuroimage.2008.09.050; Gould RL, 2003, NEUROIMAGE, V20, P1006, DOI 10.1016/S1053-8119(03)00365-3; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Grouzet FME, 2005, J PERS SOC PSYCHOL, V89, P800, DOI 10.1037/0022-3514.89.5.800; Gu XS, 2007, BEHAV BRAIN RES, V181, P218, DOI 10.1016/j.bbr.2007.04.008; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Guyer AE, 2008, ARCH GEN PSYCHIAT, V65, P1303, DOI 10.1001/archpsyc.65.11.1303; Hanselmann M, 2008, JUDGM DECIS MAK, V3, P51; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kasser T, 2008, PSYCHOL INQ, V19, P174, DOI 10.1080/10478400802592331; KEENEY RL, 1976, DECISIONS MULTIPLE O, P224; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Luce MF, 1999, J MARKETING RES, V36, P143, DOI 10.2307/3152089; Luce MF, 1997, J EXP PSYCHOL LEARN, V23, P384, DOI 10.1037/0278-7393.23.2.384; Luce MF, 2000, ORGAN BEHAV HUM DEC, V81, P274, DOI 10.1006/obhd.1999.2872; MEHREZ A, 1989, MED DECIS MAKING, V9, P142, DOI 10.1177/0272989X8900900209; Mellers BA, 2001, CURR DIR PSYCHOL SCI, V10, P210, DOI 10.1111/1467-8721.00151; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Morrone JV, 2000, PERS INDIV DIFFER, V29, P199, DOI 10.1016/S0191-8869(99)00187-7; Naya DE, 2007, COMP BIOCHEM PHYS A, V146, P189, DOI 10.1016/j.cbpa.2006.10.014; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Osaka N, 2004, BEHAV BRAIN RES, V153, P123, DOI 10.1016/j.bbr.2003.11.013; Pfister HR, 2008, JUDGM DECIS MAK, V3, P5; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith APR, 2006, NEURON, V49, P631, DOI 10.1016/j.neuron.2005.12.025; Stone DN, 1997, ORGAN BEHAV HUM DEC, V70, P159, DOI 10.1006/obhd.1997.2703; Tanner C, 2004, PSYCHON B REV, V11, P185, DOI 10.3758/BF03206481; Tetlock PE, 2000, J PERS SOC PSYCHOL, V78, P853, DOI 10.1037/0022-3514.78.5.853; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Touryan SR, 2007, SOC NEUROSCI-UK, V2, P14, DOI 10.1080/17470910601046829; Von Neumann J., 1944, THEORY GAMES EC BEHA; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Xu LJ, 2009, BRAIN RES, V1261, P65, DOI 10.1016/j.brainres.2008.12.061; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; YUAN L, 1990, MODERN FREQUENCY DIC; Zeelenberg M, 2007, J CONSUM PSYCHOL, V17, P3, DOI 10.1207/s15327663jcp1701_3; [No title captured]	67	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17544	10.1371/journal.pone.0017544	http://dx.doi.org/10.1371/journal.pone.0017544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412428	Green Submitted, gold, Green Published			2022-12-27	WOS:000288247800013
J	Bradshaw, CR; Surendranath, V; Henschel, R; Mueller, MS; Habermann, BH				Bradshaw, Charles Richard; Surendranath, Vineeth; Henschel, Robert; Mueller, Matthias Stefan; Habermann, Bianca Hermine			HMMerThread: Detecting Remote, Functional Conserved Domains in Entire Genomes by Combining Relaxed Sequence-Database Searches with Fold Recognition	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; HIDDEN MARKOV-MODELS; VIRUS CORE PROTEIN; KINASE-ANCHORING PROTEIN-2; VHS DOMAIN; TRANSCRIPTIONAL REPRESSION; FAMILIES DATABASE; ENDOSOME DYNAMICS; CRYSTAL-STRUCTURE; GENE ONTOLOGY	Conserved domains in proteins are one of the major sources of functional information for experimental design and genome-level annotation. Though search tools for conserved domain databases such as Hidden Markov Models (HMMs) are sensitive in detecting conserved domains in proteins when they share sufficient sequence similarity, they tend to miss more divergent family members, as they lack a reliable statistical framework for the detection of low sequence similarity. We have developed a greatly improved HMMerThread algorithm that can detect remotely conserved domains in highly divergent sequences. HMMerThread combines relaxed conserved domain searches with fold recognition to eliminate false positive, sequence-based identifications. With an accuracy of 90%, our software is able to automatically predict highly divergent members of conserved domain families with an associated 3-dimensional structure. We give additional confidence to our predictions by validation across species. We have run HMMerThread searches on eight proteomes including human and present a rich resource of remotely conserved domains, which adds significantly to the functional annotation of entire proteomes. We find similar to 4500 cross-species validated, remotely conserved domain predictions in the human proteome alone. As an example, we find a DNA-binding domain in the C-terminal part of the A-kinase anchor protein 10 (AKAP10), a PKA adaptor that has been implicated in cardiac arrhythmias and premature cardiac death, which upon stress likely translocates from mitochondria to the nucleus/nucleolus. Based on our prediction, we propose that with this HLH-domain, AKAP10 is involved in the transcriptional control of stress response. Further remotely conserved domains we discuss are examples from areas such as sporulation, chromosome segregation and signalling during immune response. The HMMerThread algorithm is able to automatically detect the presence of remotely conserved domains in proteins based on weak sequence similarity. Our predictions open up new avenues for biological and medical studies. Genome-wide HMMerThread domains are available at http://vm1-hmmerthread.age.mpg.de.	[Habermann, Bianca Hermine] Max Planck Inst Mol Cell Biol & Genet, Bioinformat Lab, Scionics, Dresden, Saxony, Germany; [Henschel, Robert; Mueller, Matthias Stefan] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp ZIH, Dresden, Saxony, Germany; [Henschel, Robert] Indiana Univ, Pervas Technol Inst, Bloomington, IN USA	Max Planck Society; Technische Universitat Dresden; Indiana University System; Indiana University Bloomington	Bradshaw, CR (corresponding author), Univ Cambridge, Core Bioinformat Grp, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England.	BHabermann@age.mpg.de	Habermann, Bianca/N-4886-2016	Habermann, Bianca/0000-0002-2457-7504; Bradshaw, Charles/0000-0002-3528-458X; Surendranath, Vineeth/0000-0003-1593-6461	BMBF [0313082H]; EU [027269]; Max Planck Society	BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	CRB was supported by BMBF Grant 0313082H "Hepatosys," and VS was supported by EU Grant 027269 "Sealife." This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAUER A, 1994, PROTEINS, V18, P254, DOI 10.1002/prot.340180306; Bradshaw CR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-466; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Burns-Hamuro LL, 2004, METHOD ENZYMOL, V390, P354; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eggers CT, 2009, J BIOL CHEM, V284, P32869, DOI 10.1074/jbc.M109.022582; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gebauer D, 2004, BIOCHEMISTRY-US, V43, P14873, DOI 10.1021/bi049498y; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hadano S, 2004, FEBS LETT, V575, P64, DOI 10.1016/j.febslet.2004.07.092; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hofmann K, 2000, Brief Bioinform, V1, P167, DOI 10.1093/bib/1.2.167; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kim D, 2003, PROTEIN ENG, V16, P641, DOI 10.1093/protein/gzg081; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee S, 2001, VIROLOGY, V283, P167, DOI 10.1006/viro.2001.0892; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lohi O, 2002, FEBS LETT, V513, P19, DOI 10.1016/S0014-5793(01)03287-2; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; McGuffin LJ, 2004, NUCLEIC ACIDS RES, V32, pD196, DOI 10.1093/nar/gkh043; McNairn AJ, 2008, TRENDS GENET, V24, P382, DOI 10.1016/j.tig.2008.06.002; Mochizuki K, 2008, J CELL SCI, V121, P2148, DOI 10.1242/jcs.031799; Mooney C, 2009, PROTEINS, V77, P181, DOI 10.1002/prot.22429; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Oyen M, 2004, CURR GENET, V45, P76, DOI 10.1007/s00294-003-0462-8; Peters JM, 2009, MOL CELL, V34, P1, DOI 10.1016/j.molcel.2009.03.011; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; RAY RB, 1995, VIRUS RES, V37, P209, DOI 10.1016/0168-1702(95)00034-N; Ray RB, 1997, J BIOL CHEM, V272, P10983; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schultz J, 1997, PROTEIN SCI, V6, P249; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Skolnick J, 2004, PROTEINS, V56, P502, DOI 10.1002/prot.20106; Skolnick J, 2001, PROTEINS, V42, P319; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Suzuki-Utsunomiya K, 2007, BIOCHEM BIOPH RES CO, V354, P491, DOI 10.1016/j.bbrc.2006.12.229; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Verni F, 2000, GENETICS, V154, P1693; Wang JW, 2001, J IMMUNOL, V166, P4586, DOI 10.4049/jimmunol.166.7.4586; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2005, PROTEINS, V61, P91, DOI 10.1002/prot.20724; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	95	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17568	10.1371/journal.pone.0017568	http://dx.doi.org/10.1371/journal.pone.0017568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423752	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100014
J	Guo, N; Parry, EM; Li, LS; Kembou, F; Lauder, N; Hussain, MA; Berggren, PO; Armanios, M				Guo, Nini; Parry, Erin M.; Li, Luo-Sheng; Kembou, Frant; Lauder, Naudia; Hussain, Mehboob A.; Berggren, Per-Olof; Armanios, Mary			Short Telomeres Compromise beta-Cell Signaling and Survival	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DYSKERATOSIS-CONGENITA; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; REPLICATION; TETRAHYMENA; MUTATIONS; APOPTOSIS; LOCI; RNA	The genetic factors that underlie the increasing incidence of diabetes with age are poorly understood. We examined whether telomere length, which is inherited and known to shorten with age, plays a role in the age-dependent increased incidence of diabetes. We show that in mice with short telomeres, insulin secretion is impaired and leads to glucose intolerance despite the presence of an intact beta-cell mass. In ex vivo studies, short telomeres induced cell-autonomous defects in beta-cells including reduced mitochondrial membrane hyperpolarization and Ca2+ influx which limited insulin release. To examine the mechanism, we looked for evidence of apoptosis but found no baseline increase in beta-cells with short telomeres. However, there was evidence of all the hallmarks of senescence including slower proliferation of beta-cells and accumulation of p16(INK4a). Specifically, we identified gene expression changes in pathways which are essential for Ca2+-mediated exocytosis. We also show that telomere length is additive to the damaging effect of endoplasmic reticulum stress which occurs in the late stages of type 2 diabetes. This additive effect manifests as more severe hyperglycemia in Akita mice with short telomeres which had a profound loss of beta-cell mass and increased beta-cell apoptosis. Our data indicate that short telomeres can affect beta-cell metabolism even in the presence of intact beta-cell number, thus identifying a novel mechanism of telomere-mediated disease. They implicate telomere length as a determinant of beta-cell function and diabetes pathogenesis.	[Guo, Nini] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Parry, Erin M.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD USA; [Parry, Erin M.; Kembou, Frant; Armanios, Mary] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Li, Luo-Sheng; Berggren, Per-Olof] Karolinska Inst, Roft Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Lauder, Naudia; Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Armanios, Mary] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Guo, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	marmani1@jhmi.edu		Parry, Erin/0000-0002-3382-9769; Berggren, Per-Olof/0000-0001-8991-413X	National Institutes of Health [GM007309, CA118416, AG27406]; Maryland Stem Cell Foundation; Sidney Kimmel Foundation; Doris Duke Charitable Foundation; Swedish Research Council; Family Erling-Persson Foundation; NATIONAL CANCER INSTITUTE [K08CA118416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Foundation; Sidney Kimmel Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health: A Ruth L. Kirschstein Award, GM007309, CA118416, AG27406 and awards from the Maryland Stem Cell, Sidney Kimmel, and Doris Duke Charitable Foundations. The in vitro islet work was supported by the Swedish Research Council and the Family Erling-Persson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Elder DA, 2008, PEDIATR BLOOD CANCER, V51, P256, DOI 10.1002/pbc.21589; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Gribbin J, 2009, RESP MED, V103, P927, DOI 10.1016/j.rmed.2008.11.001; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Healy JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000771; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; KUHLOW D, AGING ALBANY NY, V2, P650; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; *PREV CFDCA, 2008, NAT DIAB FACT SHEET; REICHEL M, 1992, PEDIATR DERMATOL, V9, P103, DOI 10.1111/j.1525-1470.1992.tb01223.x; SALPEA KD, 2009, ATHEROSCLEROSIS; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; STEIER W, 1972, BLOOD-J HEMATOL, V39, P510, DOI 10.1182/blood.V39.4.510.510; STEIN KM, 1993, CIRCULATION, V88, P127, DOI 10.1161/01.CIR.88.1.127; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Uhlen Per, 2004, Sci STKE, V2004, ppl15, DOI 10.1126/stke.2582004pl15; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100	50	75	78	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17858	10.1371/journal.pone.0017858	http://dx.doi.org/10.1371/journal.pone.0017858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423765	gold, Green Submitted, Green Published			2022-12-27	WOS:000288219100041
J	Singer, F; Stern, G; Thamrin, C; Fuchs, O; Riedel, T; Gustafsson, P; Frey, U; Latzin, P				Singer, Florian; Stern, Georgette; Thamrin, Cindy; Fuchs, Oliver; Riedel, Thomas; Gustafsson, Per; Frey, Urs; Latzin, Philipp			Tidal Volume Single Breath Washout of Two Tracer Gases - A Practical and Promising Lung Function Test	PLOS ONE			English	Article							PERIPHERAL AIRWAY INVOLVEMENT; ULTRASONIC FLOW SENSOR; VENTILATION DISTRIBUTION; SULFUR-HEXAFLUORIDE; NITROGEN WASHOUT; DISEASE; DIFFUSION; INFANTS; ASTHMA; VARIABILITY	Background: Small airway disease frequently occurs in chronic lung diseases and may cause ventilation inhomogeneity (VI), which can be assessed by washout tests of inert tracer gas. Using two tracer gases with unequal molar mass (MM) and diffusivity increases specificity for VI in different lung zones. Currently washout tests are underutilised due to the time and effort required for measurements. The aim of this study was to develop and validate a simple technique for a new tidal single breath washout test (SBW) of sulfur hexafluoride (SF6) and helium (He) using an ultrasonic flowmeter (USFM). Methods: The tracer gas mixture contained 5% SF6 and 26.3% He, had similar total MM as air, and was applied for a single tidal breath in 13 healthy adults. The USFM measured MM, which was then plotted against expired volume. USFM and mass spectrometer signals were compared in six subjects performing three SBW. Repeatability and reproducibility of SBW, i.e., area under the MM curve (AUC), were determined in seven subjects performing three SBW 24 hours apart. Results: USFM reliably measured MM during all SBW tests (n = 60). MM from USFM reflected SF6 and He washout patterns measured by mass spectrometer. USFM signals were highly associated with mass spectrometer signals, e.g., for MM, linear regression r-squared was 0.98. Intra-subject coefficient of variation of AUC was 6.8%, and coefficient of repeatability was 11.8%. Conclusion: The USFM accurately measured relative changes in SF6 and He washout. SBW tests were repeatable and reproducible in healthy adults. We have developed a fast, reliable, and straightforward USFM based SBW method, which provides valid information on SF6 and He washout patterns during tidal breathing.	[Singer, Florian; Stern, Georgette; Thamrin, Cindy; Fuchs, Oliver; Latzin, Philipp] Univ Childrens Hosp Bern, Dept Paediat, Div Resp Med, Bern, Switzerland; [Riedel, Thomas] Univ Childrens Hosp Bern, Dept Paediat, Paediat & Neonatal Intens Care Unit, Bern, Switzerland; [Gustafsson, Per] Cent Hosp Skovde, Dept Paediat, S-54185 Skovde, Sweden; [Frey, Urs] Univ Childrens Hosp Basel, Dept Paediat, Basel, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Basel	Singer, F (corresponding author), Univ Childrens Hosp Bern, Dept Paediat, Div Resp Med, Bern, Switzerland.	philipp.latzin@insel.ch	Singer, Florian/AAO-1460-2021; Singer, Florian/O-7651-2015; Latzin, Philipp/F-2206-2017	Singer, Florian/0000-0003-3471-5664; Singer, Florian/0000-0003-3471-5664; Thamrin, Cindy/0000-0003-3284-3558; Riedel, Thomas/0000-0002-7153-5251; Latzin, Philipp/0000-0002-5239-1571	Confederation's Innovation Promotion Agency [11661.1]; Eco Medics AG [2009/030058A1]	Confederation's Innovation Promotion Agency; Eco Medics AG	The work for this report was funded by the Confederation's Innovation Promotion Agency (CTI; http://www.bbt.admin.ch/kti/) grant no. 11661.1 PFLS-LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The current authors would like to thank Mr. Rudolf Isler for his extremely valuable input in the development of the method and his skilful technical assistance, and Eco Medics AG for supporting this study with their patented equipment (patent no. WO 2009/030058A1, priority date 09/07/2007).	Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; Aurora P, 2010, THORAX, V65, P373, DOI 10.1136/thx.2009.132100; AURORA P, 2010, AM J RESP CRIT CARE, DOI DOI 10.1164/RCCM.200911-16460C; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BUESS C, 1986, J APPL PHYSIOL, V61, P1195, DOI 10.1152/jappl.1986.61.3.1195; CHINN S, 1991, THORAX, V46, P454, DOI 10.1136/thx.46.6.454; Coates AL, 2000, PEDIATR PULM, V30, P1, DOI 10.1002/1099-0496(200007)30:1<1::AID-PPUL1>3.0.CO;2-Q; Contoli M, 2010, ALLERGY, V65, P141, DOI 10.1111/j.1398-9995.2009.02242.x; CRAWFORD ABH, 1985, J APPL PHYSIOL, V59, P838, DOI 10.1152/jappl.1985.59.3.838; CRAWFORD ABH, 1989, J APPL PHYSIOL, V66, P2502, DOI 10.1152/jappl.1989.66.6.2502; Dutrieue B, 1999, J APPL PHYSIOL, V86, P1594, DOI 10.1152/jappl.1999.86.5.1594; Estenne M, 2000, AM J RESP CRIT CARE, V162, P1047, DOI 10.1164/ajrccm.162.3.9912063; Frey U, 2000, EUR RESPIR J, V16, P1016, DOI 10.1183/09031936.00.16510160; Fuchs O, 2011, EUR RESPIR J, V37, P1208, DOI 10.1183/09031936.00125510; Fuchs SI, 2008, PEDIATR PULM, V43, P731, DOI 10.1002/ppul.20825; Fuchs SI, 2006, PEDIATR PULM, V41, P1218, DOI 10.1002/ppul.20524; Gronkvist M, 2002, J APPL PHYSIOL, V92, P634, DOI 10.1152/japplphysiol.00161.2001; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson PM, 2007, PEDIATR PULM, V42, P168, DOI 10.1002/ppul.20554; Gustafsson PM, 2003, PEDIATR PULM, V35, P42, DOI 10.1002/ppul.10221; Gustafsson PM, 2003, EUR RESPIR J, V21, P1033, DOI 10.1183/09031936.03.00049302; LACQUET LM, 1982, B EUR PHYSIOPATH RES, V18, P239; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; Latzin P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004635; PAIVA M, 1981, RESP PHYSIOL, V44, P325, DOI 10.1016/0034-5687(81)90027-X; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pillow JJ, 2004, EUR RESPIR J, V23, P763, DOI 10.1183/09031936.04.00091504; Riedel T, 2009, INTENS CARE MED, V35, P144, DOI 10.1007/s00134-008-1299-x; Robinson PD, 2009, RESPIRATION, V78, P339, DOI 10.1159/000225373; Schibler A, 2002, EUR RESPIR J, V20, P912, DOI 10.1183/09031936.02.00226002; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Stanescu D, 1998, CHEST, V114, P416; Tang Y, 2007, BRIT J ANAESTH, V98, P828, DOI 10.1093/bja/aem090; TECULESCU DB, 1987, CLIN PHYSIOL, V7, P247, DOI 10.1111/j.1475-097X.1987.tb00166.x; TECULESCU DB, 1993, CLIN PHYSIOL, V13, P35, DOI 10.1111/j.1475-097X.1993.tb00315.x; Thamrin C, 2007, PEDIATR PULM, V42, P920, DOI 10.1002/ppul.20683; Tiddens HAWM, 2010, PEDIATR PULM, V45, P107, DOI 10.1002/ppul.21154; Van Muylem A, 2000, PEDIATR PULM, V30, P3, DOI 10.1002/1099-0496(200007)30:1<3::AID-PPUL2>3.0.CO;2-L; VANMUYLEM A, 1992, AM REV RESPIR DIS, V146, P1167, DOI 10.1164/ajrccm/146.5_Pt_1.1167; Verbanck S, 2004, AM J RESP CRIT CARE, V170, P414, DOI 10.1164/rccm.200401-037OC; WORTH H, 1978, RESP PHYSIOL, V32, P155, DOI 10.1016/0034-5687(78)90106-8; Yablonskiy DA, 2009, J APPL PHYSIOL, V107, P1258, DOI 10.1152/japplphysiol.00386.2009	42	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17588	10.1371/journal.pone.0017588	http://dx.doi.org/10.1371/journal.pone.0017588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423739	gold, Green Published, Green Submitted			2022-12-27	WOS:000288219100018
J	Dang, TNH; Thi, PTL; Wolbers, M; Quang, TC; Van, MHN; Vu, TNT; Thi, PTL; Hoan, PN; Thi, HCT; Xuan, SD; Song, DT; Thi, THH; Truong, H; Campbell, J; Van, VCN; Tran, CN; Van, DN; Thi, HN; Spratt, BG; Tinh, HT; Farrar, J; Schultsz, C				Dang Trung Nghia Ho; Thi Phuong Tu Le; Wolbers, Marcel; Quang Thai Cao; Van Minh Hoang Nguyen; Vu Thieu Nga Tran; Thi Phuong Thao Le; Hoan Phu Nguyen; Thi Hong Chau Tran; Xuan Sinh Dinh; Song Diep To; Thi Thanh Hang Hoang; Truong Hoang; Campbell, James; Van Vinh Chau Nguyen; Tran Chinh Nguyen; Van Dung Nguyen; Thi Hoa Ngo; Spratt, Brian G.; Tinh Hien Tran; Farrar, Jeremy; Schultsz, Constance			Risk Factors of Streptococcus suis Infection in Vietnam. A Case-Control Study	PLOS ONE			English	Article							MENINGITIS	Background: Streptococcus suis infection, an emerging zoonosis, is an increasing public health problem across South East Asia and the most common cause of acute bacterial meningitis in adults in Vietnam. Little is known of the risk factors underlying the disease. Methods and Findings: A case-control study with appropriate hospital and matched community controls for each patient was conducted between May 2006 and June 2009. Potential risk factors were assessed using a standardized questionnaire and investigation of throat and rectal S. suis carriage in cases, controls and their pigs, using real-time PCR and culture of swab samples. We recruited 101 cases of S. suis meningitis, 303 hospital controls and 300 community controls. By multivariate analysis, risk factors identified for S. suis infection as compared to either control group included eating "high risk" dishes, including such dishes as undercooked pig blood and pig intestine (OR1 = 2.22; 95% CI = [1.15-4.28] and OR2 = 4.44; 95% CI = [2.15-9.15]), occupations related to pigs (OR1 = 3.84; 95% CI = [1.32-11.11] and OR2 = 5.52; 95% CI = [1.49-20.39]), and exposures to pigs or pork in the presence of skin injuries (OR1 = 7.48; 95% CI = [1.97-28.44] and OR2 = 15.96; 95% CI = [2.97-85.72]). S. suis specific DNA was detected in rectal and throat swabs of 6 patients and was cultured from 2 rectal samples, but was not detected in such samples of 1522 healthy individuals or patients without S. suis infection. Conclusions: This case control study, the largest prospective epidemiological assessment of this disease, has identified the most important risk factors associated with S. suis bacterial meningitis to be eating 'high risk' dishes popular in parts of Asia, occupational exposure to pigs and pig products, and preparation of pork in the presence of skin lesions. These risk factors can be addressed in public health campaigns aimed at preventing S. suis infection.	[Dang Trung Nghia Ho; Thi Phuong Tu Le; Wolbers, Marcel; Quang Thai Cao; Van Minh Hoang Nguyen; Vu Thieu Nga Tran; Thi Phuong Thao Le; Thi Thanh Hang Hoang; Campbell, James; Thi Hoa Ngo; Tinh Hien Tran; Farrar, Jeremy; Schultsz, Constance] Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam; [Dang Trung Nghia Ho; Thi Thanh Hang Hoang; Truong Hoang] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam; [Van Dung Nguyen] Subdept Anim Hlth Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Spratt, Brian G.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London	Dang, TNH (corresponding author), Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam.	schultsz@gmail.com	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X; Ngo, Hoa/0000-0001-9320-4050; Van Nguyen, Dung/0000-0002-0590-0679	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust Major Overseas Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JP, 1988, REV INFECT DIS, V10, P131; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Harrell FE, 2001, REGRESSION MODELING; Ip M, 2007, DIAGN MICR INFEC DIS, V57, P15, DOI 10.1016/j.diagmicrobio.2006.05.011; KAY R, 1995, QJM-INT J MED, V88, P39; KHADTHASRIMA HTN, 2007, HUMAN STREPTOCOCCUS; Ma Y, 2009, PHILOS T R SOC B, V364, P2725, DOI 10.1098/rstb.2009.0093; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; NGA TVT, DIAGN MICRO IN PRESS; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Strangmann E, 2002, INT J HYG ENVIR HEAL, V205, P385, DOI 10.1078/1438-4639-00165; Walsh B., 1992, Reviews in Medical Microbiology, V3, P65; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Wisselink HJ, 1999, VET MICROBIOL, V67, P143, DOI 10.1016/S0378-1135(99)00036-X; Yu Hong-jie, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P636; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; STAT YB VIET NAM 200	17	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17604	10.1371/journal.pone.0017604	http://dx.doi.org/10.1371/journal.pone.0017604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408132	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000045
J	Trulsson, M; Yu, H; Gisselsson, L; Chao, YX; Urbano, A; Aits, S; Mossberg, AK; Svanborg, C				Trulsson, Maria; Yu, Hao; Gisselsson, Lennart; Chao, Yinxia; Urbano, Alexander; Aits, Sonja; Mossberg, Ann-Kristin; Svanborg, Catharina			HAMLET Binding to alpha-Actinin Facilitates Tumor Cell Detachment	PLOS ONE			English	Article							APOPTOSIS-LIKE MECHANISM; GENE AMPLIFICATION; FOURIER HOLOGRAPHY; ALPHA-ACTININ-4; LACTALBUMIN; PROTEIN; CANCER; ANOIKIS; SITE; TUMORIGENICITY	Cell adhesion is tightly regulated by specific molecular interactions and detachment from the extracellular matrix modifies proliferation and survival. HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) is a protein-lipid complex with tumoricidal activity that also triggers tumor cell detachment in vitro and in vivo, suggesting that molecular interactions defining detachment are perturbed in cancer cells. To identify such interactions, cell membrane extracts were used in Far-western blots and HAMLET was shown to bind alpha-actinins; major F-actin cross-linking proteins and focal adhesion constituents. Synthetic peptide mapping revealed that HAMLET binds to the N-terminal actin-binding domain as well as the integrin-binding domain of alpha-actinin-4. By co-immunoprecipitation of extracts from HAMLET-treated cancer cells, an interaction with alpha-actinin-1 and -4 was observed. Inhibition of alpha-actinin-1 and alpha-actinin-4 expression by siRNA transfection increased detachment, while alpha-actinin-4-GFP over-expression significantly delayed rounding up and detachment of tumor cells in response to HAMLET. In response to HAMLET, adherent tumor cells rounded up and detached, suggesting a loss of the actin cytoskeletal organization. These changes were accompanied by a reduction in beta 1 integrin staining and a decrease in FAK and ERK1/2 phosphorylation, consistent with a disruption of integrin-dependent cell adhesion signaling. Detachment per se did not increase cell death during the 22 hour experimental period, regardless of alpha-actinin-4 and alpha-actinin-1 expression levels but adherent cells with low alpha-actinin levels showed increased death in response to HAMLET. The results suggest that the interaction between HAMLET and alpha-actinins promotes tumor cell detachment. As alpha-actinins also associate with signaling molecules, cytoplasmic domains of transmembrane receptors and ion channels, additional alpha-actinin-dependent mechanisms are discussed.	[Trulsson, Maria; Yu, Hao; Aits, Sonja; Mossberg, Ann-Kristin; Svanborg, Catharina] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Gisselsson, Lennart] Phase Holog Imaging AB, Lund, Sweden; [Chao, Yinxia; Urbano, Alexander] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	Lund University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Trulsson, M (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	catharina.svanborg@med.lu.se	Aits, Sonja/D-1496-2011	Aits, Sonja/0000-0002-1321-0678; Chao, Yinxia/0000-0003-1185-3511	Sharon D. Lund Foundation; American Cancer Society; Swedish Cancer Society; Swedish Pediatric Cancer Foundation; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society	Sharon D. Lund Foundation; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Swedish Pediatric Cancer Foundation; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society	This study was supported by the Sharon D. Lund Foundation grant and the American Cancer Society, the Swedish Cancer Society, the Swedish Pediatric Cancer Foundation, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, the HJ Forssman Foundation for Medical Research and the Royal Physiographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; BARON MD, 1987, BIOCHEM SOC T, V15, P796, DOI 10.1042/bst0150796; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Craig DH, 2008, NEOPLASIA, V10, P217, DOI 10.1593/neo.07945; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; ENDO T, 1982, J BIOCHEM, V92, P1457, DOI 10.1093/oxfordjournals.jbchem.a134070; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Franzot G, 2005, J MOL BIOL, V348, P151, DOI 10.1016/j.jmb.2005.01.002; Fu L, 2007, CANCER-AM CANCER SOC, V110, P2672, DOI 10.1002/cncr.23110; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GLUCK U, 1993, P NATL ACAD SCI USA, V90, P383, DOI 10.1073/pnas.90.2.383; Gonzalez AM, 2001, J CELL SCI, V114, P4197; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Gustafsson M, 2004, OPT LASER ENG, V41, P553, DOI 10.1016/S0143-8166(02)00214-2; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Kelly DF, 2005, J STRUCT BIOL, V149, P290, DOI 10.1016/j.jsb.2004.11.010; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kohler C, 1999, EXP CELL RES, V249, P260, DOI 10.1006/excr.1999.4472; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; MONTEIRO J, EUR J CANC, V46, P1198; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Nikolopoulos SN, 2000, ONCOGENE, V19, P380, DOI 10.1038/sj.onc.1203310; OTEY CA, 1993, J BIOL CHEM, V268, P21193; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; REN JS, 1993, J BIOL CHEM, V268, P19292; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SCHNARS U, 2005, DIGITAL HOLOGRAPHY D, V9, P164; Sebesta M, 2005, OPT LETT, V30, P471, DOI 10.1364/OL.30.000471; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	56	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17179	10.1371/journal.pone.0017179	http://dx.doi.org/10.1371/journal.pone.0017179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408150	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000014
J	Guo, SJ; Sun, F; Guo, ZY; Li, W; Alfano, A; Chen, HG; Magyar, CE; Huang, JT; Chai, TC; Qiu, SP; Qiu, Y				Guo, Shengjie; Sun, Feng; Guo, Zhiyong; Li, Wei; Alfano, Alan; Chen, Hegang; Magyar, Clara E.; Huang, Jiaoti; Chai, Toby C.; Qiu, Shaopeng; Qiu, Yun			Tyrosine Kinase ETK/BMX Is Up-Regulated in Bladder Cancer and Predicts Poor Prognosis in Patients with Cystectomy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROSTATE-CANCER; FACTOR RECEPTOR; EXPRESSION; SRC; ACTIVATION; SUPPRESSOR; DOMAIN; RISK; ETK	Deregulation of the non-receptor tyrosine kinase ETK/BMX has been reported in several solid tumors. In this report, we demonstrated that ETK expression is progressively increased during bladder cancer progression. We found that downregulation of ETK in bladder cancer cells attenuated STAT3 and AKT activity whereas exogenous overexpression of ETK had opposite effects, suggesting that deregulation of ETK may attribute to the elevated activity of STAT3 and AKT frequently detected in bladder cancer. The survival, migration and invasion of bladder cancer cells were significantly compromised when ETK expression was knocked down by a specific shRNA. In addition, we showed that ETK localizes to mitochondria in bladder cancer cells through interacting with Bcl-XL and regulating ROS production and drug sensitivity. Therefore, ETK may play an important role in regulating survival, migration and invasion by modulating multiple signaling pathways in bladder cancer cells. Immunohistochemistry analysis on tissue microarrays containing 619 human bladder tissue samples shows that ETK is significantly upregulated during bladder cancer development and progression and ETK expression level predicts the survival rate of patients with cystectomy. Taken together, our results suggest that ETK may potentially serve as a new drug target for bladder cancer treatment as well as a biomarker which could be used to identify patients with higher mortality risk, who may be benefited from therapeutics targeting ETK activity.	[Guo, Shengjie; Sun, Feng; Guo, Zhiyong; Li, Wei; Alfano, Alan; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA; [Guo, Shengjie; Sun, Feng; Guo, Zhiyong; Li, Wei; Alfano, Alan; Qiu, Yun] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Chai, Toby C.] Univ Maryland, Sch Med, Div Urol, Baltimore, MD 21201 USA; [Guo, Shengjie; Qiu, Shaopeng] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Magyar, Clara E.; Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Sun Yat Sen University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Guo, SJ (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA.	urology@vip.163.com; yqiu@som.umaryland.edu		Chai, Toby/0000-0002-1119-546X; Huang, Jiaoti/0000-0003-1195-1998	NIH [CA106504]; DOD [W81XWH-08-1-0174]; China National Natural Science Foundation [30872584]; Guangdong Natural Science Foundation [8251008901000018]; NATIONAL CANCER INSTITUTE [R01CA106504] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (CA106504) and DOD (W81XWH-08-1-0174) grants to Y.Q., China National Natural Science Foundation (30872584) and Guangdong Natural Science Foundation (8251008901000018) to S. Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2003, J BIOL CHEM, V278, P35636, DOI 10.1074/jbc.M306438200; Chau CH, 2005, AM J PHYSIOL-CELL PH, V289, pC444, DOI 10.1152/ajpcell.00410.2004; Chen CL, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-78; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Chiang GJ, 2005, BJU INT, V96, P416, DOI 10.1111/j.1464-410X.2005.05642.x; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; HARTGE P, 1990, J NATL CANCER I, V82, P1636, DOI 10.1093/jnci/82.20.1636; Huang WT, 2009, KAOHSIUNG J MED SCI, V25, P640, DOI 10.1016/S1607-551X(09)70569-8; ISHIKAWA J, 1989, INT J CANCER, V44, P1000, DOI 10.1002/ijc.2910440610; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JEMAL A, 2010, CA CANC J CLIN; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Klatte T, 2009, CANCER-AM CANCER SOC, V115, P1448, DOI 10.1002/cncr.24163; KURANAMI M, 1991, CANCER RES, V51, P4631; LEE I, 2010, MOL CANC THER; Mitra AP, 2009, J CLIN ONCOL, V27, P3929, DOI 10.1200/JCO.2008.18.5744; Mookerjee A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-267; NEAL DE, 1990, CANCER, V65, P1619, DOI 10.1002/1097-0142(19900401)65:7<1619::AID-CNCR2820650728>3.0.CO;2-Q; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Salvi M, 2002, BBA-MOL CELL RES, V1589, P181, DOI 10.1016/S0167-4889(02)00174-X; SMITH K, 1989, CANCER RES, V49, P5810; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Wen X, 1999, J BIOL CHEM, V274, P38204, DOI 10.1074/jbc.274.53.38204; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200	31	22	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17778	10.1371/journal.pone.0017778	http://dx.doi.org/10.1371/journal.pone.0017778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408190	Green Published, gold, Green Submitted			2022-12-27	WOS:000288099800037
J	Qian, JF; Hintze, A; Adami, C				Qian, Jifeng; Hintze, Arend; Adami, Christoph			Colored Motifs Reveal Computational Building Blocks in the C. elegans Brain	PLOS ONE			English	Article							NETWORK MOTIFS; EVOLUTIONARY CONSERVATION; NERVOUS-SYSTEM; CONNECTIVITY; SPECIFICITY; LOCOMOTION; NEURONS	Background: Complex networks can often be decomposed into less complex sub-networks whose structures can give hints about the functional organization of the network as a whole. However, these structural motifs can only tell one part of the functional story because in this analysis each node and edge is treated on an equal footing. In real networks, two motifs that are topologically identical but whose nodes perform very different functions will play very different roles in the network. Methodology/Principal Findings: Here, we combine structural information derived from the topology of the neuronal network of the nematode C. elegans with information about the biological function of these nodes, thus coloring nodes by function. We discover that particular colorations of motifs are significantly more abundant in the worm brain than expected by chance, and have particular computational functions that emphasize the feed-forward structure of information processing in the network, while evading feedback loops. Interneurons are strongly over-represented among the common motifs, supporting the notion that these motifs process and transduce the information from the sensor neurons towards the muscles. Some of the most common motifs identified in the search for significant colored motifs play a crucial role in the system of neurons controlling the worm's locomotion. Conclusions/Significance: The analysis of complex networks in terms of colored motifs combines two independent data sets to generate insight about these networks that cannot be obtained with either data set alone. The method is general and should allow a decomposition of any complex networks into its functional (rather than topological) motifs as long as both wiring and functional information is available.	[Qian, Jifeng; Hintze, Arend; Adami, Christoph] Keck Grad Inst, Claremont, CA USA; [Adami, Christoph] Michigan State Univ, BEACON Ctr Evolut Act, E Lansing, MI 48824 USA; [Adami, Christoph] CALTECH, Pasadena, CA 91125 USA	Claremont Colleges; Keck Graduate Institute; Michigan State University; California Institute of Technology	Qian, JF (corresponding author), Keck Grad Inst, Claremont, CA USA.	adami@kgi.edu	Adami, Chris/A-9675-2011	Adami, Chris/0000-0002-2915-9504; Hintze, Arend/0000-0002-4872-1961	National Science Foundation [FIBR-0527023]; NSF's BEACON Center for Evolution in Action [DBI-0939454]	National Science Foundation(National Science Foundation (NSF)); NSF's BEACON Center for Evolution in Action	This work was supported in part by the National Science Foundation's Frontiers in Biological Research Grant FIBR-0527023 and NSF's BEACON Center for Evolution in Action, under contract No. DBI-0939454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHACOSO TB, 1992, AYS NEUROANATOMY G E; Alon U, 2007, INTRO SYSTEMS BIOL D; Barabasi A-L., 2002, LINKED EVERYTHING IS; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Callebaut W, 2005, MODULARITY UNDERSTAN; Chase Daniel L, 2007, WormBook, P1; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; HALL DH, 1991, J NEUROSCI, V11, P1; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Karbowski J, 2008, J COMPUT NEUROSCI, V24, P253, DOI 10.1007/s10827-007-0054-6; Lee WP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-89; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ., 2006, STRUCTURE DYNAMICS N; NIEBUR E, 1993, MATH BIOSCI, V118, P51, DOI 10.1016/0025-5564(93)90033-7; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Rice JJ, 2005, P NATL ACAD SCI USA, V102, P3173, DOI 10.1073/pnas.0500130102; Richmond Janet E, 2006, WormBook, P1, DOI 10.1895/wormbook.1.112.1; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; VARSHNEY LR, 2009, ARXIV09072373V4QBION; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; White EL, 2002, J NEUROCYTOL, V31, P195, DOI 10.1023/A:1024109606722; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1985, TRENDS NEUROSCI, V8, P277, DOI 10.1016/0166-2236(85)90102-X; *WORMATLAS, 2002, WORM DAT BEH STRUCT; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	36	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17013	10.1371/journal.pone.0017013	http://dx.doi.org/10.1371/journal.pone.0017013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408227	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000288099800010
J	Ulery, BD; Kumar, D; Ramer-Tait, AE; Metzger, DW; Wannemuehler, MJ; Narasimhan, B				Ulery, Bret D.; Kumar, Devender; Ramer-Tait, Amanda E.; Metzger, Dennis W.; Wannemuehler, Michael J.; Narasimhan, Balaji			Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases	PLOS ONE			English	Article							YERSINIA-PESTIS; POLYANHYDRIDE MICROSPHERES; IMMUNE-RESPONSE; BIOERODIBLE POLYANHYDRIDES; AFFINITY MATURATION; POLYMER CHEMISTRY; PNEUMONIC PLAGUE; DRUG DELIVERY; V-ANTIGEN; RELEASE	Despite the successes provided by vaccination, many challenges still exist with respect to controlling new and re-emerging infectious diseases. Innovative vaccine platforms composed of adaptable adjuvants able to appropriately modulate immune responses, induce long-lived immunity in a single dose, and deliver immunogens in a safe and stable manner via multiple routes of administration are needed. This work describes the development of a novel biodegradable polyanhydride nanoparticle-based vaccine platform administered as a single intranasal dose that induced long-lived protective immunity against respiratory disease caused by Yesinia pestis, the causative agent of pneumonic plague. Relative to the responses induced by the recombinant protein F1-V alone and MPLA-adjuvanted F1-V, the nanoparticle-based vaccination regimen induced an immune response that was characterized by high titer and high avidity IgG1 anti-F1-V antibody that persisted for at least 23 weeks post-vaccination. After challenge, no Y. pestis were recovered from the lungs, livers, or spleens of mice vaccinated with the nanoparticle-based formulation and histopathological appearance of lung, liver, and splenic tissues from these mice post-vaccination was remarkably similar to uninfected control mice.	[Ulery, Bret D.; Narasimhan, Balaji] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Kumar, Devender; Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Ramer-Tait, Amanda E.; Wannemuehler, Michael J.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA	Iowa State University; Albany Medical College; Iowa State University	Narasimhan, B (corresponding author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.	nbalaji@iastate.edu	Metzger, Dennis W/I-2771-2019; Narasimhan, Balaji/A-5487-2008; Ramer-Tait, Amanda/B-4542-2008	Metzger, Dennis W/0000-0002-8000-9907; Narasimhan, Balaji/0000-0002-7955-5353; Ramer-Tait, Amanda/0000-0003-0950-7548; Kumar, Devender/0000-0001-5260-8606	US Department of Defense-Office of Naval Research (ONR) [N00014-06-1-1176]; Aileen S. Andrew Foundation	US Department of Defense-Office of Naval Research (ONR)(Office of Naval Research); Aileen S. Andrew Foundation	The authors acknowledge financial support from the US Department of Defense-Office of Naval Research (ONR Award no. N00014-06-1-1176). BDU acknowledges financial support from the Aileen S. Andrew Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airhart CL, 2008, VACCINE, V26, P5554, DOI 10.1016/j.vaccine.2008.08.007; Anderson GW, 1998, AM J TROP MED HYG, V58, P793, DOI 10.4269/ajtmh.1998.58.793; Carrillo-Conde B, 2010, J BIOMED MATER RES A, V95A, P40, DOI 10.1002/jbm.a.32815; Carrillo-Conde B, 2010, ACTA BIOMATER, V6, P3110, DOI 10.1016/j.actbio.2010.01.040; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Chiuchiolo MJ, 2006, J INFECT DIS, V194, P1249, DOI 10.1086/507644; Cowan C, 2005, INFECT IMMUN, V73, P6127, DOI 10.1128/IAI.73.9.6127-6137.2005; Dandekar P, 2010, J AEROSOL MED PULM D, V23, P343, DOI 10.1089/jamp.2009.0784; Determan AS, 2006, BIOMATERIALS, V27, P3312, DOI 10.1016/j.biomaterials.2006.01.054; Determan AS, 2004, J CONTROL RELEASE, V100, P97, DOI 10.1016/j.jconrel.2004.08.006; DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217; Elvin SJ, 2006, VACCINE, V24, P4433, DOI 10.1016/j.vaccine.2005.12.016; GIRARD G., 1963, BIOL MED [PARIS], V52, P631; Glynn A, 2005, VACCINE, V23, P1957, DOI 10.1016/j.vaccine.2004.10.025; Haffkine W.M., 1897, BMJ-BRIT MED J, V1, P1461, DOI [10.1136/bmj.1.1902.1461, DOI 10.1136/BMJ.1.1902.1461]; Kipper MJ, 2006, J BIOMED MATER RES A, V76A, P798, DOI 10.1002/jbm.a.30545; Lambert PH, 2005, NAT MED, V11, pS54, DOI 10.1038/nm1216; Lee LH, 2003, VACCINE, V21, P2190, DOI 10.1016/S0264-410X(03)00025-2; LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106; Mett V, 2007, VACCINE, V25, P3014, DOI 10.1016/j.vaccine.2007.01.017; Park YS, 2008, INFECT IMMUN, V76, P1952, DOI 10.1128/IAI.01722-07; Petersen LK, 2009, BIOMATERIALS, V30, P5131, DOI 10.1016/j.biomaterials.2009.05.069; Pitt M.L., 2004, PUBL WORKSH AN MOD C; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; ROSEN HB, 1983, BIOMATERIALS, V4, P131, DOI 10.1016/0142-9612(83)90054-6; Siegrist CA, 2004, VACCINE, V23, P615, DOI 10.1016/j.vaccine.2004.07.014; TABATA Y, 1993, PHARMACEUT RES, V10, P487, DOI 10.1023/A:1018929531410; TAMADA J, 1992, J BIOMAT SCI-POLYM E, V3, P315, DOI 10.1163/156856292X00402; Thomas RJ, 2009, INFECT IMMUN, V77, P1315, DOI 10.1128/IAI.01473-08; Torres MP, 2007, BIOMATERIALS, V28, P108, DOI 10.1016/j.biomaterials.2006.08.047; Torres MP, 2006, J BIOMED MATER RES A, V76A, P102, DOI 10.1002/jbm.a.30510; Ulery BD, 2009, PHARM RES-DORDR, V26, P683, DOI 10.1007/s11095-008-9760-7; Uppada JB, 2009, MED MICROBIOL IMMUN, V198, P247, DOI 10.1007/s00430-009-0124-7; Wang Y, 2000, EUR J IMMUNOL, V30, P2226, DOI 10.1002/1521-4141(2000)30:18<2226::AID-IMMU2226>3.0.CO;2-M; Zepp F, 2010, VACCINE, V28, pC14, DOI 10.1016/j.vaccine.2010.07.020; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9	36	89	91	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17642	10.1371/journal.pone.0017642	http://dx.doi.org/10.1371/journal.pone.0017642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408610	Green Published, gold			2022-12-27	WOS:000287965200033
J	Hausmann, A; Haszprunar, G; Hebert, PDN				Hausmann, Axel; Haszprunar, Gerhard; Hebert, Paul D. N.			DNA Barcoding the Geometrid Fauna of Bavaria (Lepidoptera): Successes, Surprises, and Questions	PLOS ONE			English	Article							LIFE	Background The State of Bavaria is involved in a research program that will lead to the construction of a DNA barcode library for all animal species within its territorial boundaries. The present study provides a comprehensive DNA barcode library for the Geometridae, one of the most diverse of insect families. Methodology/Principal Findings This study reports DNA barcodes for 400 Bavarian geometrid species, 98 per cent of the known fauna, and approximately one per cent of all Bavarian animal species. Although 98.5% of these species possess diagnostic barcode sequences in Bavaria, records from neighbouring countries suggest that species-level resolution may be compromised in up to 3.5% of cases. All taxa which apparently share barcodes are discussed in detail. One case of modest divergence (1.4%) revealed a species overlooked by the current taxonomic system: Eupithecia goossensiata Mabille, 1869 stat.n. is raised from synonymy with Eupithecia absinthiata (Clerck, 1759) to species rank. Deep intraspecific sequence divergences (>2%) were detected in 20 traditionally recognized species. Conclusions/Significance The study emphasizes the effectiveness of DNA barcoding as a tool for monitoring biodiversity. Open access is provided to a data set that includes records for 1,395 geometrid specimens (331 species) from Bavaria, with 69 additional species from neighbouring regions. Taxa with deep intraspecific sequence divergences are undergoing more detailed analysis to ascertain if they represent cases of cryptic diversity.	[Hausmann, Axel; Haszprunar, Gerhard] Zool Collect State Bavaria, Dept Entomol, Munich, Germany; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Guelph	Hausmann, A (corresponding author), Zool Collect State Bavaria, Dept Entomol, Munich, Germany.	axel.hausmann@zsm.mwn.de	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	Genome Canada through the Ontario Genomics Institute; Ontario Ministry of Research and Innovation; Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany)	Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany)	This study represents a contribution to WG1.9 of the International Barcode of Life Project. Sequence analysis was supported by Genome Canada through the Ontario Genomics Institute, while informatics support was provided through a grant from the Ontario Ministry of Research and Innovation. The collection and processing of specimens were funded as one component of the "Barcoding Fauna Bavarica" project by the Bavarian Ministry of Science, Research and Art (Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst, Munich, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke M, 2010, PROJECT BARCODING FA; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Dapporto L, 2010, J ZOOL SYST EVOL RES, V48, P229, DOI 10.1111/j.1439-0469.2009.00550.x; DeWaard Jeremy R., 2008, V410, P275; Ebert G, 1991, SCHMETTERLINGE BADEN, V1-10, P1991; Embacher Gernot, 2005, Nachrichtenblatt der Bayerischen Entomologen, V54, P73; Gaedike R, 1999, ENT NACHR BER S5, P216; Gossner Martin M., 2009, Mitteilungen Muenchener Entomologischen Gesellschaft, V99, P135; Handfield D, 2006, CAN ENTOMOL, V138, P853; Haslberger A, 2011, NACHRBL BAY IN PRESS, V60; Haszprunar Gerhard, 2009, Nachrichtenblatt der Bayerischen Entomologen, V58, P45; Hausmann A, 2004, FAUNA EUROPE; Hausmann A., 2001, GEOMETRID MOTHS EURO, V1, P1, DOI DOI 10.1007/978-1-4757-3423-2_; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huemer P, 2009, ZOOTAXA, P1; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Kandul NP, 2004, SYST BIOL, V53, P278, DOI 10.1080/10635150490423692; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Mironov V, 2004, GEOMETRID MOTHS EURO, V4; Mitchell A, 2008, AUST J ENTOMOL, V47, P169, DOI 10.1111/j.1440-6055.2008.00645.x; Monteiro A, 2001, MOL PHYLOGENET EVOL, V18, P264, DOI 10.1006/mpev.2000.0872; Osthelder L, 1925, MITT MUNCH ENT GES, P15; Ratnasingham S, 2010, BOLD BARCODE LIFE DA; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Scoble MJ, ONLINE LIST VALID NO; Segerer A.H., 2010, NOTA LEPIDOPTEROLOGI, V33, P197; Tenaillon MI, 2008, J EVOLUTION BIOL, V21, P541, DOI 10.1111/j.1420-9101.2007.01490.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	33	151	166	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17134	10.1371/journal.pone.0017134	http://dx.doi.org/10.1371/journal.pone.0017134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21423340	Green Submitted, Green Published, gold			2022-12-27	WOS:000287367600042
J	Fossati, A; Dolfini, D; Donati, G; Mantovani, R				Fossati, Andrea; Dolfini, Diletta; Donati, Giacomo; Mantovani, Roberto			NF-Y Recruits Ash2L to Impart H3K4 Trimethylation on CCAAT Promoters	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; TRANSCRIPTION FACTOR; HUMAN GENOME; METHYLATION; LEUKEMIA; GENES; MLL; COMPLEX; DIFFERENTIATION; BINDING	Background: Different histone post-translational modifications (PTMs) are crucial in the regulation of chromatin, including methylations of H3 at Lysine 4 by the MLL complex. A relevant issue is how this is causally correlated to the binding of specific transcription factors (TFs) in regulatory regions. NF-Y is a TF that regulates 30% of mammalian promoters containing the widespread CCAAT element. We and others established that the presence of H3K4me3 is dependent upon the binding of NF-Y. Here, we investigate the mechanisms of H3K4me3 deposition by NF-Y. Methods: We employed Chromatin Immunoprecipitation in cells in which Ash2L and NF-Y subunits were knocked down by RNAi, to monitor the presence of histones PTMs and components of the MLL complex. We performed gene expression profiling of Ash2L-knocked down cells and analyzed the regulated genes. We performed ChIPs in leukemic cells in which MLL1 is devoid of the methyltransferase domain and fused to the AF4 gene. Results: Knock down of the Ash2L subunit of MLL leads to a decrease in global H3K4me3 with a concomitant increase in H3K79me2. Knock down of NF-Y subunits prevents promoter association of Ash2L, but not MLL1, nor WDR5, and H3K4me3 drops dramatically. Endogenous NF-Y and Ash2L specifically interact in vivo. Analysis of the promoters of Ash2L regulated genes, identified by transcriptional profiling, suggests that a handful TF binding sites are moderately enriched, among which the CCAAT box. Finally, leukemic cells carrying the MLL-AF4 translocation show a decrease of H3K4me3, absence of Ash2L and increase in H3K79me2, while NF-Y binding was not significantly affected. Conclusions: Three types of conclusions are reached: (i) H3K4 methylation is not absolutely required for NF-Y promoter association. (ii) NF-Y acts upstream of H3K4me3 deposition by recruiting Ash2L. (iii) There is a general cross-talk between H3K4me3 and H3K79me2 which is independent from the presence of MLL oncogenic fusions.	[Fossati, Andrea; Dolfini, Diletta; Donati, Giacomo; Mantovani, Roberto] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy	University of Milan	Fossati, A (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy.	mantor@unimi.it	Fossati, Andrea/AAN-3814-2020; DOLFINI, DILETTA/D-8286-2017	Fossati, Andrea/0000-0001-9368-4058; DOLFINI, DILETTA/0000-0002-5346-6096; DONATI, Giacomo/0000-0002-0370-8288	Associazione Italiana per la Ricerca sul Cancro (AIRC); Cassa di Risparmio delle Provincie Lombarde CARIPLO-Nobel	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cassa di Risparmio delle Provincie Lombarde CARIPLO-Nobel	The work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) and Cassa di Risparmio delle Provincie Lombarde CARIPLO-Nobel grants to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; DOMASHENKO AD, 2010, BLOOD IN PRESS; Donati G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002066; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Gatta R, 2008, NUCLEIC ACIDS RES, V36, P6592, DOI 10.1093/nar/gkn699; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Imbriano C, 2001, J BIOL CHEM, V276, P26332, DOI 10.1074/jbc.M101553200; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Neff T, 2009, LEUKEMIA, V23, P1243, DOI 10.1038/leu.2009.40; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Sinha S, 2008, GENOME RES, V18, P477, DOI 10.1101/gr.6828808; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Tan CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008535; Tsutsumi S, 2003, CANCER RES, V63, P4882; van Wageningen S, 2008, HAEMATOL-HEMATOL J, V93, P1580, DOI 10.3324/haematol.12425; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102	39	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17220	10.1371/journal.pone.0017220	http://dx.doi.org/10.1371/journal.pone.0017220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445285	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300005
J	Graham, ME; Prescott, GR; Johnson, JR; Jones, M; Walmesley, A; Haynes, LP; Morgan, A; Burgoyne, RD; Barclay, JW				Graham, Margaret E.; Prescott, Gerald R.; Johnson, James R.; Jones, Mathew; Walmesley, Alice; Haynes, Lee P.; Morgan, Alan; Burgoyne, Robert D.; Barclay, Jeff W.			Structure-Function Study of Mammalian Munc18-1 and C. elegans UNC-18 Implicates Domain 3b in the Regulation of Exocytosis	PLOS ONE			English	Article							PROTEIN-KINASE-C; MEMBRANE-FUSION; SYNAPTIC-TRANSMISSION; VESICLE DOCKING; BINDING; SNARE; SYNTAXIN; RELEASE; MUTAGENESIS; DEFECTS	Munc18-1 is an essential synaptic protein functioning during multiple stages of the exocytotic process including vesicle recruitment, docking and fusion. These functions require a number of distinct syntaxin-dependent interactions; however, Munc18-1 also regulates vesicle fusion via syntaxin-independent interactions with other exocytotic proteins. Although the structural regions of the Munc18-1 protein involved in closed-conformation syntaxin binding have been thoroughly examined, regions of the protein involved in other interactions are poorly characterised. To investigate this we performed a random transposon mutagenesis, identifying domain 3b of Munc18-1 as a functionally important region of the protein. Transposon insertion in an exposed loop within this domain specifically disrupted Mint1 binding despite leaving affinity for closed conformation syntaxin and binding to the SNARE complex unaffected. The insertion mutation significantly reduced total amounts of exocytosis as measured by carbon fiber amperometry in chromaffin cells. Introduction of the equivalent mutation in UNC-18 in Caenorhabditis elegans also reduced neurotransmitter release as assessed by aldicarb sensitivity. Correlation between the two experimental methods for recording changes in the number of exocytotic events was verified using a previously identified gain of function Munc18-1 mutation E466K (increased exocytosis in chromaffin cells and aldicarb hypersensitivity of C. elegans). These data implicate a novel role for an exposed loop in domain 3b of Munc18-1 in transducing regulation of vesicle fusion independent of closed-conformation syntaxin binding.	[Graham, Margaret E.; Prescott, Gerald R.; Johnson, James R.; Jones, Mathew; Walmesley, Alice; Haynes, Lee P.; Morgan, Alan; Burgoyne, Robert D.; Barclay, Jeff W.] Univ Liverpool, Inst Translat Med, Physiol Lab, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Graham, ME (corresponding author), Univ Liverpool, Inst Translat Med, Physiol Lab, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	barclayj@liv.ac.uk	Burgoyne, Robert D/P-6641-2019; Morgan, Alan/AAI-8875-2020; Burgoyne, Robert/C-6706-2008; Johnson, James R/D-9721-2014; Johnson, James R/A-8174-2012	Burgoyne, Robert D/0000-0002-9219-0387; Burgoyne, Robert/0000-0002-9219-0387; Johnson, James R/0000-0002-8849-0993; Barclay, Jeff W/0000-0003-4320-2094; Morgan, Alan/0000-0002-0346-1289	Wellcome Trust; BBSRC; National Institutes of Health National Center for Research Resources (NCRR); Biotechnology and Biological Sciences Research Council [BB/E006477/1] Funding Source: researchfish; BBSRC [BB/E006477/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust and BBSRC. GRP was supported by a Wellcome Trust Prize Studentship. The C. elegans strain used in this work was provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay JW, 2008, BIOPHYS J, V94, P1084, DOI 10.1529/biophysj.107.111203; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Boyd A, 2008, GENETICS, V180, P165, DOI 10.1534/genetics.108.090423; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Bracher A, 2001, J MOL BIOL, V306, P7, DOI 10.1006/jmbi.2000.4347; BRENNER S, 1974, GENETICS, V77, P71; Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Craig TJ, 2004, J BIOCHEM BIOPH METH, V60, P49, DOI 10.1016/j.jbbm.2004.04.015; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; GengyoAndo K, 1996, J NEUROSCI, V16, P6695; GOFF SP, 1991, METHOD ENZYMOL, V208, P586; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Graham ME, 2009, MOL BIOL CELL, V20, P43, DOI 10.1091/mbc.E08-07-0689; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Hafez I, 2005, P NATL ACAD SCI USA, V102, P13879, DOI 10.1073/pnas.0504098102; Hallet B, 1997, NUCLEIC ACIDS RES, V25, P1866, DOI 10.1093/nar/25.9.1866; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HU SH, 2011, P NATL ACAD IN PRESS; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lee HY, 2004, J BIOL CHEM, V279, P16339, DOI 10.1074/jbc.M310976200; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nonet ML, 1997, J NEUROSCI, V17, P8061; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Sassa T, 1999, J NEUROSCI, V19, P4772; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Tsuboi T, 2006, MOL BIOL CELL, V17, P2101, DOI 10.1091/mbc.E05-11-1047; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber M, 2010, MOL BIOL CELL, V21, P1362, DOI 10.1091/mbc.E09-07-0546; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247	59	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17999	10.1371/journal.pone.0017999	http://dx.doi.org/10.1371/journal.pone.0017999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445306	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300028
J	Dibaj, P; Steffens, H; Zschuntzsch, J; Nadrigny, F; Schomburg, ED; Kirchhoff, F; Neusch, C				Dibaj, Payam; Steffens, Heinz; Zschuentzsch, Jana; Nadrigny, Fabien; Schomburg, Eike D.; Kirchhoff, Frank; Neusch, Clemens			In Vivo Imaging Reveals Distinct Inflammatory Activity of CNS Microglia versus PNS Macrophages in a Mouse Model for ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; WILD-TYPE MICROGLIA; SPINAL-CORD-INJURY; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; AXONAL-TRANSPORT; NERVOUS-SYSTEM; SOD1 MUTANTS; GLIAL-CELLS	Mutations in the enzyme superoxide dismutase-1 (SOD1) cause hereditary variants of the fatal motor neuronal disease Amyotrophic lateral sclerosis (ALS). Pathophysiology of the disease is non-cell-autonomous: neurotoxicity is derived not only from mutant motor neurons but also from mutant neighbouring non-neuronal cells. In vivo imaging by two-photon laser-scanning microscopy was used to compare the role of microglia/macrophage-related neuroinflammation in the CNS and PNS using ALS-linked transgenic SOD1(G93A) mice. These mice contained labeled projection neurons and labeled microglia/macrophages. In the affected lateral spinal cord (in contrast to non-affected dorsal columns), different phases of microglia-mediated inflammation were observed: highly reactive microglial cells in preclinical stages (in 60-day-old mice the reaction to axonal transection was similar to 180% of control) and morphologically transformed microglia that have lost their function of tissue surveillance and injury-directed response in clinical stages (reaction to axonal transection was lower than 50% of control). Furthermore, unlike CNS microglia, macrophages of the PNS lack any substantial morphological reaction while preclinical degeneration of peripheral motor axons and neuromuscular junctions was observed. We present in vivo evidence for a different inflammatory activity of microglia and macrophages: an aberrant neuroinflammatory response of microglia in the CNS and an apparently mainly neurodegenerative process in the PNS.	[Dibaj, Payam; Steffens, Heinz; Nadrigny, Fabien; Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Steffens, Heinz; Schomburg, Eike D.] Univ Gottingen, Inst Physiol, Gottingen, Germany; [Zschuentzsch, Jana] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany; [Nadrigny, Fabien] Inst Francois Magendie, U862, Bordeaux, France; [Kirchhoff, Frank] Univ Saarland, Dept Neurol, D-6650 Homburg, Germany; [Neusch, Clemens] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany	Max Planck Society; University of Gottingen; University of Gottingen; UDICE-French Research Universities; Universite de Bordeaux; Saarland University; Ulm University	Dibaj, P (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	cneusch@gwdg.de	Kirchhoff, Frank/B-9335-2008; Dibaj, Payam/GQH-9423-2022; Dibaj, Payam/AAS-5479-2021	Kirchhoff, Frank/0000-0002-2324-2761; Dibaj, Payam/0000-0003-1585-6330; 	Deutsche Forschungsgemeinschaft [NE-767/3-3, SCHO37/16]; Tom-Wahlig-Foundation; "Fondation pour la Recherche Medicale" (FRM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tom-Wahlig-Foundation; "Fondation pour la Recherche Medicale" (FRM)(Fondation pour la Recherche Medicale)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (NE-767/3-3 to CN and SCHO37/16 to EDS) and the Tom-Wahlig-Foundation (to CN and FK). FN was supported by "Fondation pour la Recherche Medicale" (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Banks RW, 2009, J ANAT, V214, P859, DOI 10.1111/j.1469-7580.2009.01072.x; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2008, M S-MED SCI, V24, P124, DOI 10.1051/medsci/2008242124; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; CHEN K, 2009, BRAIN STRUCT FUNCT; Chen LC, 2004, AMYOTROPH LATERAL SC, V5, P164, DOI 10.1080/14660820410017091; Chiu IM, 2009, P NATL ACAD SCI USA, V106, P20960, DOI 10.1073/pnas.0911405106; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; D'Ambrosi N, 2009, J IMMUNOL, V183, P4648, DOI 10.4049/jimmunol.0901212; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davalos D, 2008, J NEUROSCI METH, V169, P1, DOI 10.1016/j.jneumeth.2007.11.011; Dibaj P, 2010, J NEUROSCI RES, V88, P2431, DOI 10.1002/jnr.22402; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Duan YL, 2009, DEV NEUROBIOL, V69, P60, DOI 10.1002/dneu.20689; Fendrick SE, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-9; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2005, NEUROBIOL DIS, V19, P293, DOI 10.1016/j.nbd.2005.01.008; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Graber DJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-8; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; HEADS T, 1991, ACTA NEUROPATHOL, V82, P316, DOI 10.1007/BF00308818; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Hoffmann A, 2008, GLIA, V56, P1162, DOI 10.1002/glia.20687; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Neusch C, 2007, MUSCLE NERVE, V35, P712, DOI 10.1002/mus.20768; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pradat PF, 2009, MOVEMENT DISORD, V24, P2143, DOI 10.1002/mds.22762; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Synofzik M, 2010, J NEUROL NEUROSUR PS, V81, P764, DOI 10.1136/jnnp.2009.181719; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, CURR OPIN NEUROL, V8, P294, DOI 10.1097/00019052-199508000-00008; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yamanaka K, 2006, ANN NEUROL, V60, P95, DOI 10.1002/ana.20888; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073	58	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17910	10.1371/journal.pone.0017910	http://dx.doi.org/10.1371/journal.pone.0017910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437247	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100043
J	Cicek, M; Vrabel, A; Sturchio, C; Pederson, L; Hawse, JR; Subramaniam, M; Spelsberg, TC; Oursler, MJ				Cicek, Muzaffer; Vrabel, Anne; Sturchio, Catherine; Pederson, Larry; Hawse, John R.; Subramaniam, Malayannan; Spelsberg, Thomas C.; Oursler, Merry Jo			TGF-beta Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling Pathways	PLOS ONE			English	Article							FINGER TRANSCRIPTION FACTOR; CALCIUM-SENSING RECEPTOR; KAPPA-B PATHWAYS; NUCLEAR-FACTOR; INHIBITORY LECTIN; MICE DISPLAY; ACTIVATION; INDUCTION; GROWTH; RANKL	TGF-beta Inducible Early Gene-1 (TIEG1) is a Kruppel-like transcription factor (KLF10) that was originally cloned from human osteoblasts as an early response gene to TGF-beta treatment. As reported previously, TIEG1(-/-) mice have decreased cortical bone thickness and vertebral bone volume and have increased spacing between the trabeculae in the femoral head relative to wildtype controls. Here, we have investigated the role of TIEG1 in osteoclasts to further determine their potential role in mediating this phenotype. We have found that TIEG1(-/-) osteoclast precursors differentiated more slowly compared to wildtype precursors in vitro and high RANKL doses are able to overcome this defect. We also discovered that TIEG1(-/-) precursors exhibit defective RANKL-induced phosphorylation and accumulation of NFATc1 and the NFATc1 target gene DC-STAMP. Higher RANKL concentrations reversed defective NFATc1 signaling and restored differentiation. After differentiation, wildtype osteoclasts underwent apoptosis more quickly than TIEG1(-/-) osteoclasts. We observed increased AKT and MEK/ERK signaling pathway activation in TIEG1(-/-) osteoclasts, consistent with the roles of these kinases in promoting osteoclast survival. Adenoviral delivery of TIEG1 (AdTIEG1) to TIEG1(-/-) cells reversed the RANKL-induced NFATc1 signaling defect in TIEG1(-/-) precursors and eliminated the differentiation and apoptosis defects. Suppression of TIEG1 with siRNA in wildtype cells reduced differentiation and NFATc1 activation. Together, these data provide evidence that TIEG1 controls osteoclast differentiation by reducing NFATc1 pathway activation and reduces osteoclast survival by suppressing AKT and MEK/ERK signaling.	[Cicek, Muzaffer; Hawse, John R.; Subramaniam, Malayannan; Spelsberg, Thomas C.; Oursler, Merry Jo] Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Vrabel, Anne; Sturchio, Catherine; Pederson, Larry; Oursler, Merry Jo] Mayo Clin Coll Med, Endocrine Res Unit, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Cicek, M (corresponding author), Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA.	cicek.muzaffer@mayo.edu			National Institutes of Health [AR52004]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (AR52004) to M.J. Oursler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensamoun SF, 2006, BONE, V39, P1244, DOI 10.1016/j.bone.2006.05.021; BLOK LJ, 1995, MOL ENDOCRINOL, V9, P1610, DOI 10.1210/me.9.11.1610; Bradley EW, 2008, J CELL PHYSIOL, V217, P752, DOI 10.1002/jcp.21550; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Chalaux E, 1999, FEBS LETT, V457, P478, DOI 10.1016/S0014-5793(99)01051-0; Cicek M, 2007, CANCER RES, V67, P10106, DOI 10.1158/0008-5472.CAN-07-1362; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Crotti TN, 2008, J CELL PHYSIOL, V215, P636, DOI 10.1002/jcp.21344; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Hawse JR, 2008, BONE, V42, P1025, DOI 10.1016/j.bone.2008.02.004; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; JAWORSKI ZFG, 1981, J ANAT, V133, P397; Jiang L, 2009, CANCER LETT, V274, P101, DOI 10.1016/j.canlet.2008.09.017; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448; Kawaguchi N, 2000, EXP CELL RES, V260, P284, DOI 10.1006/excr.2000.5020; Kim HH, 2003, EXP CELL RES, V289, P368, DOI 10.1016/S0014-4827(03)00288-X; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Michigami T, 2001, CANCER RES, V61, P1637; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Nakamura A, 2007, BONE, V40, P305, DOI 10.1016/j.bone.2006.09.001; OURSLER M, 2010, J CELLULAR IN PRESS; Oursler MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC156, DOI 10.1152/ajpcell.00092.2004; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; SUBRAMANIAM M, BIOCH BIOPHYS RES CO, V392, P72; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Sutherland KA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2681; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tau KR, 1998, ENDOCRINOLOGY, V139, P1346, DOI 10.1210/en.139.3.1346; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhou H, 2002, J BIOL CHEM, V277, P48808, DOI 10.1074/jbc.M209059200	47	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17522	10.1371/journal.pone.0017522	http://dx.doi.org/10.1371/journal.pone.0017522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423731	gold, Green Published, Green Submitted			2022-12-27	WOS:000288512400013
J	Fujimura, A; Michiue, H; Nishiki, T; Ohmori, I; Wei, FY; Matsui, H; Tomizawa, K				Fujimura, Atsushi; Michiue, Hiroyuki; Nishiki, Tei-ichi; Ohmori, Iori; Wei, Fan-Yan; Matsui, Hideki; Tomizawa, Kazuhito			Expression of a Constitutively Active Calcineurin Encoded by an Intron-Retaining mRNA in Follicular Keratinocytes	PLOS ONE			English	Article							PROTEIN PHOSPHATASE; CYCLOSPORINE-A; CYCLIN G2; NFAT; INHIBITION; ACTIVATION; RETENTION; GROWTH; SKIN; DISEASE	Hair growth is a highly regulated cyclical process. Immunosuppressive immunophilin ligands such as cyclosporin A (CsA) and FK506 are known as potent hair growth modulatory agents in rodents and humans that induce active hair growth and inhibit hair follicle regression. The immunosuppressive effectiveness of these drugs has been generally attributed to inhibition of T cell activation through well-characterized pathways. Specifically, CsA and FK506 bind to intracellular proteins, principally cyclophilin A and FKBP12, respectively, and thereby inhibit the phosphatase calcineurin (Cn). The calcineurin (Cn)/NFAT pathway has an important, but poorly understood, role in the regulation of hair follicle development. Here we show that a novel-splicing variant of calcineurin A beta CnA beta-FK, which is encoded by an intron-retaining mRNA and is deficient in the autoinhibitory domain, is predominantly expressed in mature follicular keratinocytes but not in the proliferating keratinocytes of rodents. CnA beta-FK was weakly sensitive to Ca2+ and dephosphorylated NFATc2 under low Ca2+ levels in keratinocytes. Inhibition of Cn/NFAT induced hair growth in nude mice. Cyclin G2 was identified as a novel target of the Cn/NFATc2 pathway and its expression in follicular keratinocytes was reduced by inhibition of Cn/NFAT. Overexpression of cyclin G2 arrested the cell cycle in follicular keratinocytes in vitro and the Cn inhibitor, cyclosporin A, inhibited nuclear localization of NFATc2, resulting in decreased cyclin G2 expression in follicular keratinocytes of rats in vivo. We therefore suggest that the calcineurin/NFAT pathway has a unique regulatory role in hair follicle development.	[Fujimura, Atsushi; Michiue, Hiroyuki; Nishiki, Tei-ichi; Ohmori, Iori; Matsui, Hideki] Okayama Univ, Dept Physiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Kumamoto, Japan; [Tomizawa, Kazuhito] Japan Sci Technol Agcy JST, PREST, Kawaguchi, Saitama, Japan	Okayama University; Kumamoto University; Japan Science & Technology Agency (JST)	Fujimura, A (corresponding author), Okayama Univ, Dept Physiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	tomikt@kumamoto-u.ac.jp	OHMORI, Iori/B-2292-2011; MICHIUE, Hiroyuki/B-2320-2011; Fujimura, Atsushi/AAA-4458-2021; Tomizawa, Kazuhito/F-2405-2015; Wei, Fan-Yan/AAD-8461-2021	OHMORI, Iori/0000-0001-6823-2762; Tomizawa, Kazuhito/0000-0002-5663-2627; Fujimura, Atsushi/0000-0002-8638-5460; Wei, Fan-Yan/0000-0002-4843-724X	Ministry of Education, Science, Sports, Culture and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan and by a Grant-in-aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gafter-Gvili A, 2003, AM J PHYSIOL-CELL PH, V284, pC1593, DOI 10.1152/ajpcell.00537.2002; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; GUERINI D, 1989, P NATL ACAD SCI USA, V86, P9183, DOI 10.1073/pnas.86.23.9183; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hirano M, 2008, J PROTEOME RES, V7, P2471, DOI 10.1021/pr800025t; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; JIANG H, 1995, J INVEST DERMATOL, V104, P523, DOI 10.1111/1523-1747.ep12606018; KAHAN BD, 1987, TRANSPLANTATION, V43, P197, DOI 10.1097/00007890-198702000-00007; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Lara-Pezzi E, 2007, J CELL BIOL, V179, P1205, DOI 10.1083/jcb.200704179; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Takenobu T, 2002, MOL CANCER THER, V1, P1043; Taniguchi I, 2007, P NATL ACAD SCI USA, V104, P13684, DOI 10.1073/pnas.0704922104; Tarrio R, 2008, P NATL ACAD SCI USA, V105, P7223, DOI 10.1073/pnas.0802941105; TOMIZAWA K, 1995, MOL BRAIN RES, V28, P122, DOI 10.1016/0169-328X(94)00199-O; Wu Hai-Yan, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P207, DOI 10.2174/1568015054863873; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17685	10.1371/journal.pone.0017685	http://dx.doi.org/10.1371/journal.pone.0017685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423799	Green Submitted, gold, Green Published			2022-12-27	WOS:000288512400020
J	Liao, QY; Cowling, BJ; Lam, WWT; Fielding, R				Liao, Qiuyan; Cowling, Benjamin J.; Lam, Wendy Wing Tak; Fielding, Richard			Factors Affecting Intention to Receive and Self-Reported Receipt of 2009 Pandemic (H1N1) Vaccine in Hong Kong: A Longitudinal Study	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PLANNED BEHAVIOR; INFLUENZA VACCINE; IMPLEMENTATION INTENTIONS; A/H1N1 VACCINATION; COVERAGE RATES; OLDER CHINESE; OMISSION BIAS; METAANALYSIS; PERCEPTIONS	Background: Vaccination was a core component for mitigating the 2009 influenza pandemic (pH1N1). However, a vaccination program's efficacy largely depends on population compliance. We examined general population decision-making for pH1N1 vaccination using a modified Theory of Planned Behaviour (TBP). Methodology: We conducted a longitudinal study, collecting data before and after the introduction of pH1N1 vaccine in Hong Kong. Structural equation modeling (SEM) tested if a modified TPB had explanatory utility for vaccine uptake among adults. Principal Findings: Among 896 subjects who completed both the baseline and the follow-up surveys, 7% (67/896) reported being "likely/very likely/certain'' to be vaccinated (intent) but two months later only 0.8% (7/896) reported having received pH1N1 vaccination. Perception of low risk from pH1N1 (60%) and concerns regarding adverse effects of the vaccine (37%) were primary justifications for avoiding pH1N1 vaccination. Greater perceived vaccine benefits (beta = 0.15), less concerns regarding vaccine side-effects (beta = 20.20), greater adherence to social norms of vaccination (beta = 0.39), anticipated higher regret if not vaccinated (beta = 0.47), perceived higher self-efficacy for vaccination (beta = 0.12) and history of seasonal influenza vaccination (beta = 0.12) were associated with higher intention to receive the pH1N1 vaccine, which in turn predicted self-reported vaccination uptake (beta = 0.30). Social norm (beta = 0.70), anticipated regret (beta = 0.19) and vaccination intention (beta = 0.31) were positively associated with, and accounted for 70% of variance in vaccination planning, which, in turn subsequently predicted self-reported vaccination uptake (beta = 0.36) accounting for 36% of variance in reported vaccination behaviour. Conclusions/Significance: Perceived low risk from pH1N1 and perceived high risk from pH1N1 vaccine inhibited pH1N1 vaccine uptake. Both the TPB and the additional components contributed to intended vaccination uptake but social norms and anticipated regret predominantly associated with vaccination intention and planning. Vaccination planning is a more significant proximal determinant of uptake of pH1N1 vaccine than is intention. Intention alone is an unreliable predictor of future vaccine uptake.	[Liao, Qiuyan; Lam, Wendy Wing Tak; Fielding, Richard] Univ Hong Kong, Hlth Behav Res Grp, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Liao, Qiuyan; Cowling, Benjamin J.; Lam, Wendy Wing Tak; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Cowling, Benjamin J.] Univ Hong Kong, Infect Dis Res Grp, Dept Community Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Liao, QY (corresponding author), Univ Hong Kong, Hlth Behav Res Grp, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	fielding@hku.hk	Cowling, Benjamin John/C-4263-2009; Lam, Wendy Wing Tak/C-4319-2009	Cowling, Benjamin John/0000-0002-6297-7154; Liao, Qiuyan/0000-0002-1105-6857; Lam, Wendy Wing Tak/0000-0003-2383-0149	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR [PHE-01]; Harvard Center for Communicable Disease Dynamics from the US National Institutes of Health Models of Infectious Disease [1 U54 GM088558]; Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; Harvard Center for Communicable Disease Dynamics from the US National Institutes of Health Models of Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong University Grants Committee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received financial support from the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (grant no. PHE-01), the Harvard Center for Communicable Disease Dynamics from the US National Institutes of Health Models of Infectious Disease Agent Study program (grant no. 1 U54 GM088558), and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2003, BRIT J SOC PSYCHOL, V42, P495, DOI 10.1348/014466603322595248; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1980, UNDERSTANDING ATTITU; Ajzen I., 1988, ATTITUDES PERSONALIT; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; ASCH DA, 1994, MED DECIS MAKING, V14, P118, DOI 10.1177/0272989X9401400204; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brown KF, 2010, VACCINE, V28, P4181, DOI 10.1016/j.vaccine.2010.04.012; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chernoff RA, 2005, AIDS EDUC PREV, V17, P91, DOI 10.1521/aeap.17.3.91.62902; Clayton DA, 2008, INT J ENVIRON HEAL R, V18, P83, DOI 10.1080/09603120701358424; Cohen J., 1988, STAT POWER ANAL BEHA; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; CREWAL R, 2004, MARK SCI, V23, P519; *CTR HLTH PROT HON, 2010, HUM SWIN INFL VACC P; *CTR HLTH PROT HON, 2009, PUBL PLAN HUM SWIN I; *CTR HLTH PROT HON, 2009, NUMB NOT NOT INF DIS; *CTR HLTH PROT HON, 2010, STAT HUM SWIN INFL V; Department of health hong kong, 2009, HUM SWIN INFL VACC P; Dittmann S, 2001, VACCINE, V19, P2446, DOI 10.1016/S0264-410X(00)00470-9; Edmonds BMT, 2011, MATERN CHILD HLTH J, V15, P1203, DOI 10.1007/s10995-010-0693-5; Fishbein M., 1975, BELIEF ATTITUDE INTE; Gallagher S, 2006, J PUBLIC HEALTH-UK, V28, P139, DOI 10.1093/pubmed/fdl008; Gaygisiz U, 2010, VACCINE, V29, P329, DOI 10.1016/j.vaccine.2010.10.030; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Harris KM, 2009, J GEN INTERN MED, V24, P1311, DOI 10.1007/s11606-009-1126-2; *HONG KONG CENS ST, 2006, MAIN TABL 2006 POP C; Horney JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011226; Kaboli F, 2010, INFECT CONT HOSP EP, V31, P1017, DOI 10.1086/655465; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Kwon Y, 2010, VACCINE, V29, P161, DOI 10.1016/j.vaccine.2010.10.063; Kwong EWY, 2009, J CLIN NURS, V18, P960, DOI 10.1111/j.1365-2702.2008.02548.x; Lau JTF, 2010, VACCINE, V28, P4632, DOI 10.1016/j.vaccine.2010.04.076; Lau JTF, 2009, BRIT MED J, V338, pb4164, DOI DOI 10.1136/bmj.b4164; Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Maltezou HC, 2010, J INFECTION, V61, P252, DOI 10.1016/j.jinf.2010.06.004; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Offit PA, 2003, PEDIATRICS, V112, P1394, DOI 10.1542/peds.112.6.1394; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Sheeran P, 1999, J APPL SOC PSYCHOL, V29, P2107, DOI 10.1111/j.1559-1816.1999.tb02298.x; Sheeran P., 2002, EUR REV SOC PSYCHOL, P1, DOI DOI 10.1080/14792772143000003; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Stohr K, 2004, SCIENCE, V306, P2195, DOI 10.1126/science.1108165; Syed Q, 2003, J EPIDEMIOL COMMUN H, V57, P855, DOI 10.1136/jech.57.11.855; Sypsa V, 2009, EUROSURVEILLANCE, V14; Szucs TD, 2005, VACCINE, V23, P5055, DOI 10.1016/j.vaccine.2005.06.005; Tang CSK, 2005, J AGING HEALTH, V17, P490, DOI 10.1177/0898264305277966; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; UNDERWOOD C, 2006, J ADOLESC HLTH, V55; Valle P.O., 2005, ENVIRON BEHAV, V37, P364, DOI DOI 10.1177/0013916504272563; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; WHO, 2009, PAND INFL VACC MAN P; *WHO, 2009, PREP 2 WAV LESS CURR; *WHO, 2009, SAF PAND H1N1 2009 V; *WHO, 2009, WHO REC PAND H1N1 VA; Zijtregtop EAM, 2009, VACCINE, V28, P207, DOI 10.1016/j.vaccine.2009.09.099	75	116	118	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17713	10.1371/journal.pone.0017713	http://dx.doi.org/10.1371/journal.pone.0017713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	733FF	21412418	gold, Green Published			2022-12-27	WOS:000288247800026
J	Yang, L; Chiu, SS; Chan, KP; Chan, KH; Wong, WHS; Peiris, JSM; Wong, CM				Yang, Lin; Chiu, Susan S.; Chan, King-Pan; Chan, Kwok-Hung; Wong, Wilfred Hing-Sang; Peiris, J. S. Malik; Wong, Chit-Ming			Validation of Statistical Models for Estimating Hospitalization Associated with Influenza and Other Respiratory Viruses	PLOS ONE			English	Article							SYNCYTIAL-VIRUS; AIR-POLLUTION; DEATHS; MORTALITY; CHILDREN	Background: Reliable estimates of disease burden associated with respiratory viruses are keys to deployment of preventive strategies such as vaccination and resource allocation. Such estimates are particularly needed in tropical and subtropical regions where some methods commonly used in temperate regions are not applicable. While a number of alternative approaches to assess the influenza associated disease burden have been recently reported, none of these models have been validated with virologically confirmed data. Even fewer methods have been developed for other common respiratory viruses such as respiratory syncytial virus (RSV), parainfluenza and adenovirus. Methods and Findings: We had recently conducted a prospective population-based study of virologically confirmed hospitalization for acute respiratory illnesses in persons < 18 years residing in Hong Kong Island. Here we used this dataset to validate two commonly used models for estimation of influenza disease burden, namely the rate difference model and Poisson regression model, and also explored the applicability of these models to estimate the disease burden of other respiratory viruses. The Poisson regression models with different link functions all yielded estimates well correlated with the virologically confirmed influenza associated hospitalization, especially in children older than two years. The disease burden estimates for RSV, parainfluenza and adenovirus were less reliable with wide confidence intervals. The rate difference model was not applicable to RSV, parainfluenza and adenovirus and grossly underestimated the true burden of influenza associated hospitalization. Conclusion: The Poisson regression model generally produced satisfactory estimates in calculating the disease burden of respiratory viruses in a subtropical region such as Hong Kong.	[Yang, Lin; Chan, King-Pan; Wong, Chit-Ming] Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Chiu, Susan S.; Wong, Wilfred Hing-Sang] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Chan, King-Pan; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yang, L (corresponding author), Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	malik@hkucc.hku.hk; hrmrwcm@hkucc.hku.hk	Wong, Wilfred/Q-8751-2019; YANG, Lin/F-9601-2014; Chan, Kwok Hung/ABD-5399-2021; Yang, Lin/E-5183-2011	YANG, Lin/0000-0002-5964-3233; Wong, Hing Sang Wilfred/0000-0001-8396-2368	Research Grants Council of Hong Kong [HKU 7396/03M]; University Grants Committee of the Hong Kong Special Administrative Region Government [AoE/M-12/-06]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Committee of the Hong Kong Special Administrative Region Government	This work is supported by the Research Grants Council of Hong Kong (HKU 7396/03M) and the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/-06) of the Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chiu SS, 2010, PEDIATR INFECT DIS J, V29, P1088, DOI 10.1097/INF.0b013e3181e9de24; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Gilca R, 2009, AM J EPIDEMIOL, V170, P925, DOI 10.1093/aje/kwp195; Glezen WP, 2003, JAMA-J AM MED ASSOC, V289, P2500, DOI 10.1001/jama.289.19.2500-a; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jackson ML, 2009, ANN EPIDEMIOL, V19, P681, DOI 10.1016/j.annepidem.2009.06.009; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Panozzo C. A., 2008, Morbidity and Mortality Weekly Report, V57, P1355; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Schwartz J, 1996, J EPIDEMIOL COMMUN H, V50, pS3, DOI 10.1136/jech.50.Suppl_1.S3; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315	25	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17882	10.1371/journal.pone.0017882	http://dx.doi.org/10.1371/journal.pone.0017882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412433	gold, Green Published			2022-12-27	WOS:000288247800036
J	Huttunen, R; Hurme, M; Aittoniemi, J; Huhtala, H; Vuento, R; Laine, J; Jylhava, J; Syrjanen, J				Huttunen, Reetta; Hurme, Mikko; Aittoniemi, Janne; Huhtala, Heini; Vuento, Risto; Laine, Janne; Jylhava, Juulia; Syrjanen, Jaana			High Plasma Level of Long Pentraxin 3 (PTX3) Is Associated with Fatal Disease in Bacteremic Patients: A Prospective Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INNATE IMMUNITY; PULMONARY INFECTION; TRANSGENIC MICE; SEPSIS; SEVERITY; MARKER	Introduction: Long pentraxin 3 (PTX3) is an acute-phase protein secreted by various cells, including leukocytes and endothelial cells. Like C-reactive protein (CRP), it belongs to the pentraxin superfamily. Recent studies indicate that high levels of PTX3 may be associated with mortality in sepsis. The prognostic value of plasma PTX3 in bacteremic patients is unknown. Methods: Plasma PTX3 levels were measured in 132 patients with bacteremia caused by Staphylococcus aureus, Streptococcus pneumoniae, beta-hemolytic streptococcae and Escherichia coli, using a commercial solid-phase enzyme-linked immunosorbent assay (ELISA). Values were measured on days 1-4 after positive blood culture, on day 13-18 and on recovery. Results: The maximum PTX3 values on days 1-4 were markedly higher in nonsurvivors compared to survivors (44.8 vs 6.4 ng/ml, p < 0.001) and the AUC(ROC) in the prediction of case fatality was 0.82 (95% CI 0.73-0.91). PTX3 at a cut-off level of 15 ng/ml showed 72% sensitivity and 81% specificity for fatal disease. High PTX3 (> 15 ng/ml) was associated with hypotension (MAP < 70 mmHg)(OR 7.9; 95% CI 3.3-19.0) and high SOFA score (>= 4)(OR 13.2; 95% CI 4.9-35.4). The CRP level (maximum value on days 1 to 4) did not predict case fatality at any cut-off level in the ROC curve (p = 0.132). High PTX3 (> 15 ng/ml) remained an independent risk factor for case fatality in a logistic regression model adjusted for potential confounders. Conclusions: PTX3 proved to be a specific independent prognostic biomarker in bacteremia. PTX3 during the first days after diagnosis showed better prognostic value as compared to CRP, a widely used biomarker in clinical settings. PTX3 measurement offers a novel opportunity for the prognostic stratification of bacteremia patients.	[Huttunen, Reetta; Laine, Janne; Syrjanen, Jaana] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Huttunen, Reetta; Syrjanen, Jaana] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Hurme, Mikko; Aittoniemi, Janne; Vuento, Risto] Pirkanmaa Hosp Dist, Ctr Lab Med, Tampere, Finland; [Hurme, Mikko; Jylhava, Juulia] Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Pirkanmaa Hospital District; Tampere University; Tampere University	Huttunen, R (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	reetta.huttunen@uta.fi		Syrjanen, Jaana/0000-0002-7335-573X; Hurme, Mikko/0000-0002-8614-1044; Jylhava, Juulia/0000-0003-0250-4491	Tampere University Hospital (Pirkanmaa Hospital District); Finnish Medical Foundation; Orion-Farmos Research Foundation	Tampere University Hospital (Pirkanmaa Hospital District); Finnish Medical Foundation; Orion-Farmos Research Foundation	This work was financially supported by the Competitive Research Funding of Tampere University Hospital (Pirkanmaa Hospital District), the Finnish Medical Foundation, and the Orion-Farmos Research Foundation. The authors' work was independent of the funders (the funding sources had no involvement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BOYD JC, 1997, SCAND J CLIN LAB INV, V227, P46; BrunBuisson C, 1996, AM J RESP CRIT CARE, V154, P617, DOI 10.1164/ajrccm.154.3.8810595; de Kruif MD, 2010, J INFECTION, V60, P122, DOI 10.1016/j.jinf.2009.11.010; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Huttunen R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-13; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; MCCABE WR, 1962, ARCH INTERN MED, V110, P856, DOI 10.1001/archinte.1962.03620240038007; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Silvestre J, 2009, INTENS CARE MED, V35, P909, DOI 10.1007/s00134-009-1402-y; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004	22	49	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17653	10.1371/journal.pone.0017653	http://dx.doi.org/10.1371/journal.pone.0017653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423699	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100020
J	Lochlainn, SO; Bowen, HC; Fray, RG; Hammond, JP; King, GJ; White, PJ; Graham, NS; Broadley, MR				Lochlainn, Seosamh O.; Bowen, Helen C.; Fray, Rupert G.; Hammond, John P.; King, Graham J.; White, Philip J.; Graham, Neil S.; Broadley, Martin R.			Tandem Quadruplication of HMA4 in the Zinc (Zn) and Cadmium (Cd) Hyperaccumulator Noccaea caerulescens	PLOS ONE			English	Article							THLASPI-CAERULESCENS; METAL HYPERACCUMULATION; P-1B-TYPE ATPASE; GENES; HOMEOSTASIS; ATHMA4; EXPRESSION; HISTORY; TRANSLOCATION; CONSTRUCTION	Zinc (Zn) and cadmium (Cd) hyperaccumulation may have evolved twice in the Brassicaceae, in Arabidopsis halleri and in the Noccaea genus. Tandem gene duplication and deregulated expression of the Zn transporter, HMA4, has previously been linked to Zn/Cd hyperaccumulation in A. halleri. Here, we tested the hypothesis that tandem duplication and deregulation of HMA4 expression also occurs in Noccaea. A Noccaea caerulescens genomic library was generated, containing 36,864 fosmid pCC1FOS (TM) clones with insert sizes similar to 20-40 kbp, and screened with a PCR-generated HMA4 genomic probe. Gene copy number within the genome was estimated through DNA fingerprinting and pooled fosmid pyrosequencing. Gene copy numbers within individual clones was determined by PCR analyses with novel locus specific primers. Entire fosmids were then sequenced individually and reads equivalent to 20-fold coverage were assembled to generate complete whole contigs. Four tandem HMA4 repeats were identified in a contiguous sequence of 101,480 bp based on sequence overlap identities. These were flanked by regions syntenous with up and downstream regions of AtHMA4 in Arabidopsis thaliana. Promoter-reporter beta-glucuronidase (GUS) fusion analysis of a NcHMA4 in A. thaliana revealed deregulated expression in roots and shoots, analogous to AhHMA4 promoters, but distinct from AtHMA4 expression which localised to the root vascular tissue. This remarkable consistency in tandem duplication and deregulated expression of metal transport genes between N. caerulescens and A. halleri, which last shared a common ancestor > 40 mya, provides intriguing evidence that parallel evolutionary pathways may underlie Zn/Cd hyperaccumulation in Brassicaceae.	[Lochlainn, Seosamh O.; Fray, Rupert G.; Hammond, John P.; Graham, Neil S.; Broadley, Martin R.] Univ Nottingham, Plant & Crop Sci Div, Loughborough, Leics, England; [Bowen, Helen C.] Univ Warwick, Warwick HRI, Wellesbourne, Warwick, England; [King, Graham J.] Rothamsted Res, Harpenden, Herts, England; [King, Graham J.] So Cross Univ, Lismore, NSW 2480, Australia; [White, Philip J.] Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	University of Nottingham; University of Warwick; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Southern Cross University; James Hutton Institute	Lochlainn, SO (corresponding author), Univ Nottingham, Plant & Crop Sci Div, Loughborough, Leics, England.	martin.broadley@nottingham.ac.uk	White, Philip John/C-5860-2008; Broadley, Martin/AAW-4638-2021; King, Graham J/AAW-3368-2020; Fray, Rupert G/A-9059-2016; Hammond, John P/A-1876-2012; broadley, martin r/E-9081-2011; Graham, Neil/C-5489-2008	White, Philip John/0000-0003-0827-288X; Broadley, Martin/0000-0003-3964-7226; King, Graham J/0000-0002-5975-6051; Fray, Rupert G/0000-0002-3935-8945; Hammond, John P/0000-0002-6241-3551; broadley, martin r/0000-0003-3964-7226; Graham, Neil/0000-0001-9080-8967	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBSSE200613215]; Scottish Government Rural and Environment Research and Analysis Directorate	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Rural and Environment Research and Analysis Directorate	Seosamh O Lochlainn was funded by a UK Biotechnology and Biological Sciences Research Council (BBSRC) Studentship (BBSSE200613215). Rothamsted Research is an institute of the BBSRC. The Scottish Crop Research Institute is funded by the Scottish Government Rural and Environment Research and Analysis Directorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Bernard C, 2004, FEBS LETT, V569, P140, DOI 10.1016/j.febslet.2004.05.036; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Dubois S, 2003, NEW PHYTOL, V157, P633, DOI 10.1046/j.1469-8137.2003.00684.x; Frey B, 2000, PLANT CELL ENVIRON, V23, P675, DOI 10.1046/j.1365-3040.2000.00590.x; Hammond JP, 2006, NEW PHYTOL, V170, P239, DOI 10.1111/j.1469-8137.2006.01662.x; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Haydon MJ, 2007, NEW PHYTOL, V174, P499, DOI 10.1111/j.1469-8137.2007.02051.x; Higgins K, 2001, P NATL ACAD SCI USA, V98, P2928, DOI 10.1073/pnas.031358898; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jimenez-Ambriz G, 2007, NEW PHYTOL, V173, P199, DOI 10.1111/j.1469-8137.2006.01923.x; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Koch M, 1998, BIOCHEM SYST ECOL, V26, P823, DOI 10.1016/S0305-1978(98)00057-X; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kupper H, 2000, PLANTA, V212, P75, DOI 10.1007/s004250000366; Lochlainn SO, 2011, NEW PHYTOL, V189, P409, DOI 10.1111/j.1469-8137.2010.03554.x; Lombi E, 2000, NEW PHYTOL, V145, P11, DOI 10.1046/j.1469-8137.2000.00560.x; Ma JF, 2005, PLANTA, V220, P731, DOI 10.1007/s00425-004-1392-5; Macnair MR, 2003, ADV BOT RES, V40, P63, DOI 10.1016/S0065-2296(05)40002-6; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mills RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013388; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; MUNAMENHOF K, 1994, SYSTEMATIC BOT, V19, P73; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nyren Pal, 2007, V373, P1; Papoyan A, 2004, PLANT PHYSIOL, V136, P3814, DOI 10.1104/pp.104.044503; Peer WA, 2003, NEW PHYTOL, V159, P421, DOI 10.1046/j.1469-8137.2003.00822.x; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pollard AJ, 1996, NEW PHYTOL, V132, P113, DOI 10.1111/j.1469-8137.1996.tb04515.x; Riley R., 1956, NEW PHYTOL, V55, P319, DOI DOI 10.1111/J.1469-8137.1956.TB05291.X; Roze D, 2004, GENETICS, V167, P1001, DOI 10.1534/genetics.103.025148; Sambrook J, 2001, MOL CLONING LAB MANU; Santuari L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r4; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; TAYLOR SI, 2004, EVOLUTION ZINC HYPER; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Wang XB, 2009, MAR BIOTECHNOL, V11, P236, DOI 10.1007/s10126-008-9137-2; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x	52	94	93	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17814	10.1371/journal.pone.0017814	http://dx.doi.org/10.1371/journal.pone.0017814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423774	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100037
J	Angulo, S; Morales, A; Danese, S; Llacuna, L; Masamunt, MC; Pultz, N; Cifone, MG; De Simone, C; Delgado, S; Vila, J; Panes, J; Donskey, C; Fernandez-Checa, JC; Fiocchi, C; Sans, M				Angulo, Sandra; Morales, Albert; Danese, Silvio; Llacuna, Laura; Carme Masamunt, Maria; Pultz, Nicole; Cifone, Maria Grazia; De Simone, Claudio; Delgado, Salvadora; Vila, Jordi; Panes, Julian; Donskey, Curtis; Fernandez-Checa, Jose C.; Fiocchi, Claudio; Sans, Miquel			Probiotic Sonicates Selectively Induce Mucosal Immune Cells Apoptosis through Ceramide Generation via Neutral Sphingomyelinase	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESCHERICHIA-COLI NISSLE-1917; ELECTRON-TRANSPORT CHAIN; CROHNS-DISEASE; T-CELLS; ULCERATIVE-COLITIS; LYMPHOPROLIFERATIVE SYNDROME; MITOCHONDRIAL GLUTATHIONE; ALKALINE SPHINGOMYELINASE; MAINTAINING REMISSION	Background: Probiotics appear to be beneficial in inflammatory bowel disease, but their mechanism of action is incompletely understood. We investigated whether probiotic-derived sphingomyelinase mediates this beneficial effect. Methodology/Principal Findings: Neutral sphingomyelinase (NSMase) activity was measured in sonicates of the probiotic L. brevis (LB) and S. thermophilus (ST) and the non-probiotic E. coli (EC) and E. faecalis (EF). Lamina propria mononuclear cells (LPMC) were obtained from patients with Crohn's disease (CD) and Ulcerative Colitis (UC), and peripheral blood mononuclear cells (PBMC) from healthy volunteers, analysing LPMC and PBMC apoptosis susceptibility, reactive oxygen species (ROS) generation and JNK activation. In some experiments, sonicates were preincubated with GSH or GW4869, a specific NSMase inhibitor. NSMase activity of LB and ST was 10-fold that of EC and EF sonicates. LB and ST sonicates induced significantly more apoptosis of CD and UC than control LPMC, whereas EC and EF sonicates failed to induce apoptosis. Pre-stimulation with anti-CD3/CD28 induced a significant and time-dependent increase in LB-induced apoptosis of LPMC and PBMC. Exposure to LB sonicates resulted in JNK activation and ROS production by LPMC. NSMase activity of LB sonicates was completely abrogated by GW4869, causing a dose-dependent reduction of LB-induced apoptosis. LB and ST selectively induced immune cell apoptosis, an effect dependent on the degree of cell activation and mediated by bacterial NSMase. Conclusions: These results suggest that induction of immune cell apoptosis is a mechanism of action of some probiotics, and that NSMase-mediated ceramide generation contributes to the therapeutic effects of probiotics.	[Angulo, Sandra; Carme Masamunt, Maria; Panes, Julian; Sans, Miquel] CIBERehd, Dept Gastroenterol, Hosp Clin, IDIBAPS, Barcelona, Spain; [Morales, Albert; Llacuna, Laura; Fernandez-Checa, Jose C.] CIBERehd, Liver Unit, Hosp Clin, IDIBAPS, Barcelona, Spain; [Morales, Albert; Llacuna, Laura; Fernandez-Checa, Jose C.] CSIC, Dept Cell Death & Proliferat, IIBB, Barcelona, Spain; [Danese, Silvio] Ist Clin Humanitas, Div Gastroenterol, Milan, Italy; [Pultz, Nicole; Donskey, Curtis] VA Med Ctr, Infect Dis Sect, Louis Stokes Cleveland Dept, Cleveland, OH USA; [Cifone, Maria Grazia; De Simone, Claudio] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Delgado, Salvadora] CIBERehd, Dept Gastrointestinal Surg, Hosp Clin, IDIBAPS, Barcelona, Spain; [Vila, Jordi] CIBERehd, Dept Clin Microbiol, Hosp Clin, IDIBAPS, Barcelona, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90033 USA; [Fiocchi, Claudio] Cleveland Clin Fdn, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); IRCCS Humanitas Research Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of L'Aquila; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Southern California; Cleveland Clinic Foundation	Angulo, S (corresponding author), CIBERehd, Dept Gastroenterol, Hosp Clin, IDIBAPS, Barcelona, Spain.	checa229@yahoo.com; msans@clinic.ub.es	Danese, Silvio/ABH-9571-2020; Morales, Albert/E-2988-2013; Fernández-Checa, José Carlos/L-8342-2014; Cifone, Maria Grazia/I-3750-2019; Cifone, Maria Grazia/ABH-1984-2021; Vila, Jordi/P-3613-2016; Panes, Julian/H-5991-2015	Danese, Silvio/0000-0001-7341-1351; Morales, Albert/0000-0001-8702-2269; Fernández-Checa, José Carlos/0000-0003-3422-2990; Cifone, Maria Grazia/0000-0002-9923-5445; Vila, Jordi/0000-0002-8025-3926; Masamunt, M Carme/0000-0001-8736-1623; Panes, Julian/0000-0002-4971-6902	Ministerio de Ciencia e Innovacion [SAF2005-00280, SAF2008-03676, FIS2009-00056, SAF2009-11417]; Fundacion Ramon Areces; National Institutes of Health [DK30399, DK50984]; United States National Institute for Alcohol Abuse and Alcoholism [P50 AA 11999]; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050984, R37DK030399, R01DK030399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Institute for Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The funding sources included grants from Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Ministerio de Ciencia e Innovacion (SAF2005-00280 and SAF2008-03676 to MS, FIS2009-00056 to AM, SAF2009-11417 to JCF), Fundacion Ramon Areces (to MS), the National Institutes of Health (DK30399 and DK50984 to CF) and the Research Center for Liver and Pancreatic Diseases funded by the United States National Institute for Alcohol Abuse and Alcoholism (P50 AA 11999 to JCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Boirivant M, 1999, GASTROENTEROLOGY, V116, P557, DOI 10.1016/S0016-5085(99)70177-0; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Coll O, 2007, J LIPID RES, V48, P1924, DOI 10.1194/jlr.M700069-JLR200; Di Marzio L, 2001, NUTR CANCER, V40, P185, DOI 10.1207/S15327914NC402_16; Doering J, 2004, GUT, V53, P1632, DOI 10.1136/gut.2003.037911; Dotan I, 2005, CURR OPIN GASTROEN, V21, P426; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Frustaci A, 2006, MODERN PATHOL, V19, P755, DOI 10.1038/modpathol.3800594; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Ina K, 1999, J IMMUNOL, V163, P1081; Itoh J, 2001, GUT, V49, P35, DOI 10.1136/gut.49.1.35; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; Loidl A, 2002, J LIPID RES, V43, P815; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Martin SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Murosaki S, 1997, MICROBIOL IMMUNOL, V41, P139, DOI 10.1111/j.1348-0421.1997.tb01179.x; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Ruvolo PP, 2001, LEUKEMIA, V15, P1153, DOI 10.1038/sj.leu.2402197; Salinas I, 2008, VET MICROBIOL, V128, P167, DOI 10.1016/j.vetmic.2007.10.011; Sanchez AM, 2007, APOPTOSIS, V12, P2013, DOI 10.1007/s10495-007-0119-z; Schrezenmeir J, 2001, AM J CLIN NUTR, V73, p361S, DOI 10.1093/ajcn/73.2.361s; Shen C, 2005, ALIMENT PHARM THER, V21, P251, DOI 10.1111/j.1365-2036.2005.02309.x; Soo I, 2008, CAN J GASTROENTEROL, V22, P237, DOI 10.1155/2008/520383; Sturm A, 2005, INFECT IMMUN, V73, P1452, DOI 10.1128/IAI.73.3.1452-1465.2005; Sturm A, 2004, GUT, V53, P1624, DOI 10.1136/gut.2003.033613; Sturm A, 2004, J IMMUNOL, V173, P3889, DOI 10.4049/jimmunol.173.6.3889; Sturm A, 2002, J CLIN INVEST, V109, P1481, DOI 10.1172/JCI14967; Sturm A, 2002, GUT, V50, P148, DOI 10.1136/gut.50.2.148; van den Brande JMH, 2007, INFLAMM BOWEL DIS, V13, P118, DOI 10.1002/ibd.20000; Van den Brande JMH, 2006, GASTROENTEROLOGY, V131, P1362, DOI 10.1053/j.gastro.2006.08.054; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; West GA, 1996, GASTROENTEROLOGY, V110, P1683, DOI 10.1053/gast.1996.v110.pm8964392; Won JS, 2006, FREE RADICAL BIO MED, V40, P1875, DOI 10.1016/j.freeradbiomed.2006.01.035; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang M, 2004, CELL MOL IMMUNOL, V1, P447; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	47	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e16953	10.1371/journal.pone.0016953	http://dx.doi.org/10.1371/journal.pone.0016953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408067	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900006
J	El-Khatib, Z; Katzenstein, D; Marrone, G; Laher, F; Mohapi, L; Petzold, M; Morris, L; Ekstrom, AM				El-Khatib, Ziad; Katzenstein, David; Marrone, Gaetano; Laher, Fatima; Mohapi, Lerato; Petzold, Max; Morris, Lynn; Ekstrom, Anna Mia			Adherence to Drug-Refill Is a Useful Early Warning Indicator of Virologic and Immunologic Failure among HIV Patients on First-Line ART in South Africa	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; ANTIRETROVIRAL THERAPY ADHERENCE; SUB-SAHARAN AFRICA; VIRAL LOAD; RESISTANCE; ADULTS; CARE; INFECTION; LEVEL	Background: Affordable strategies to prevent treatment failure on first-line regimens among HIV patients are essential for the long-term success of antiretroviral therapy (ART) in sub-Saharan Africa. WHO recommends using routinely collected data such as adherence to drug-refill visits as early warning indicators. We examined the association between adherence to drug-refill visits and long-term virologic and immunologic failure among non-nucleoside reverse transcriptase inhibitor (NNRTI) recipients in South Africa. Methods: In 2008, 456 patients on NNRTI-based ART for a median of 44 months (range 12-99 months; 1,510 person-years) were enrolled in a retrospective cohort study in Soweto. Charts were reviewed for clinical characteristics before and during ART. Multivariable logistic regression and Kaplan-Meier survival analysis assessed associations with virologic (two repeated VL>50 copies/ml) and immunologic failure (as defined by WHO). Results: After a median of 15 months on ART, 19% (n = 88) and 19% (n = 87) had failed virologically and immunologically respectively. A cumulative adherence of <95% to drug-refill visits was significantly associated with both virologic and immunologic failure (p<0.01). In the final multivariable model, risk factors for virologic failure were incomplete adherence (OR 2.8, 95% CI 1.2-6.7), and previous exposure to single-dose nevirapine or any other antiretrovirals (adj. OR 2.1, 95% CI 1.2-3.9), adjusted for age and sex. In Kaplan-Meier analysis, the virologic failure rate by month 48 was 19% vs. 37% among adherent and non-adherent patients respectively (logrank p value = 0.02). Conclusion: One in five failed virologically after a median of 15 months on ART. Adherence to drug-refill visits works as an early warning indicator for both virologic and immunologic failure.	[El-Khatib, Ziad; Marrone, Gaetano; Petzold, Max; Ekstrom, Anna Mia] Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden; [El-Khatib, Ziad; Morris, Lynn] NICD, AIDS Virus Res Unit, Johannesburg, South Africa; [Katzenstein, David] Stanford Univ, Div Infect Dis, Palo Alto, CA 94304 USA; [Laher, Fatima; Mohapi, Lerato] Univ Witwatersrand, PHRU, Soweto, South Africa; [Petzold, Max] Nord Sch Publ Hlth NHV, Gothenburg, Sweden	Karolinska Institutet; National Institute for Communicable Diseases (NICD); Stanford University; University of Witwatersrand	El-Khatib, Z (corresponding author), Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden.	ziad.khatib@gmail.com	Franzeck, Fabian C/B-5055-2011; Morris, Lynn/V-3941-2018; El-Khatib, Ziad/B-5161-2017	Morris, Lynn/0000-0003-3961-7828; El-Khatib, Ziad/0000-0003-0756-7280; Marrone, Gaetano/0000-0002-2991-1663; El-Khatib, Ziad/0000-0002-0711-5404; katzenstein, david/0000-0002-8593-4560	Swedish International Development Cooperation Agency; Karolinska Institutet; HIV/TB Research Fogarty International Center/NIH [2 U2R TW006878]; Freeman-Spogli Institute at Stanford University; FOGARTY INTERNATIONAL CENTER [U2RTW006878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066922] Funding Source: NIH RePORTER	Swedish International Development Cooperation Agency; Karolinska Institutet(Karolinska Institutet); HIV/TB Research Fogarty International Center/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Freeman-Spogli Institute at Stanford University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Swedish International Development Cooperation Agency to National Institute for Communicable Diseases (NICD) and Karolinska Institutet; The Karolinska Institutet (PhD student grant to ZEK and senior research grant to AME); Sven Gard's Fund for Virology Research, African Programme for Training in HIV/TB Research Fogarty International Center/NIH 2 U2R TW006878 and the Freeman-Spogli Institute at Stanford University to ZEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-89; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Cambiano V, 2010, HIV MED, V11, P216, DOI 10.1111/j.1468-1293.2009.00771.x; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Datay MI, 2010, JAIDS-J ACQ IMM DEF, V54, P489, DOI 10.1097/QAI.0b013e3181d91788; EGGER M, 2007, OUTCOMES ANTIRETROVI; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; ELKHATIB Z, 2009, MED REV S AFRICAN AD; ELKHATIB Z, 2004, QUESTIONNAIRE DESIGN; ELKHATIB Z, 2010, DRUG RESIST IN PRESS; *EPIDATA FDN, 2008, EPIDATA DAT ENTR DOC; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; HATANO H, 2010, AIDS; Hedt BL, 2008, ANTIVIR THER, V13, P69; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Jackson JB, 2000, AIDS, V14, pF111, DOI 10.1097/00002030-200007280-00001; Kagee A, 2010, GLOB PUBLIC HEALTH, V1-15; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Kuritzkes DR, 2004, AIDS PATIENT CARE ST, V18, P259, DOI 10.1089/108729104323076007; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Madge S, 2008, HIV MED, V9, P208, DOI 10.1111/j.1468-1293.2008.00548.x; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Martinson NA, 2009, AIDS, V23, P809, DOI 10.1097/QAD.0b013e328323ad49; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; NATTRASS N, 2006, SO AFRICAN J HIV MED; Paredes R, 2004, MIL DRUG TH, P53; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phillips AN, 2001, AIDS, V15, P2385, DOI 10.1097/00002030-200112070-00006; PRISM G, 2005, VERSION 4 0C; REWARI BB, 2010, J ACQUIR IMMUNE 1001; RICHARD T, 2010, LANCET, DOI DOI 10.1016/S0140-6736(10)61997-6; Rothman KJ., 1982, EPIDEMIOLOGIC ANAL P; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; *STATACORP LP, 2008, STAT SE 10 1; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; WHO, 2010, ANT THER HIV INF AD; *WHO, 2006, HIV DRUG RES EARL WA; World Health Organization, 2008, PRIM HLTH CAR MOR NE, P1; World Health Organization, 2004, SCAL ANT THER RES LT	53	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17518	10.1371/journal.pone.0017518	http://dx.doi.org/10.1371/journal.pone.0017518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408071	gold, Green Published, Green Submitted			2022-12-27	WOS:000288170900024
J	Iser, WB; Wilson, MA; Wood, WH; Becker, K; Wolkow, CA				Iser, Wendy B.; Wilson, Mark A.; Wood, William H., III; Becker, Kevin; Wolkow, Catherine A.			Co-Regulation of the DAF-16 Target Gene, cyp-35B1/dod-13, by HSF-1 in C. elegans Dauer Larvae and daf-2 Insulin Pathway Mutants	PLOS ONE			English	Article							HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LIFE-SPAN; INTERACTING GENES; FAMILY-MEMBER; LONGEVITY; TRANSCRIPTION; RECEPTOR; PROTEIN; LONG	Insulin/IGF-I-like signaling (IIS) has both cell autonomous and non-autonomous functions. In some cases, targets through which IIS regulates cell-autonomous functions, such as cell growth and metabolism, have been identified. In contrast, targets for many non-autonomous IIS functions, such as C. elegans dauer morphogenesis, remain elusive. Here, we report the use of genomic and genetic approaches to identify potential non-autonomous targets of C. elegans IIS. First, we used transcriptional microarrays to identify target genes regulated non-autonomously by IIS in the intestine or in neurons. C. elegans IIS controls expression of a number of stress response genes, which were differentially regulated by tissue-restricted IIS. In particular, expression of sod-3, a MnSOD enzyme, was not regulated by tissue-restricted IIS on the microarrays, while expression of hsp-16 genes was rescued back to wildtype by tissue restricted IIS. One IIS target regulated non-autonomously by age-1 was cyp-35B1/dod-13, encoding a cytochrome P450. Genetic analysis of the cyp-35B1 promoter showed both DAF-16 and HSF-1 are direct regulators. Based on these findings, we propose that hsf-1 may participate in the pathways mediating non-autonomous activities of age-1 in C. elegans.	[Iser, Wendy B.; Wilson, Mark A.; Wolkow, Catherine A.] NIA Intramural Res Program, Invertebrate Mol Genet Unit, Lab Neurosci, Res Resources Branch,NIH Biomed Res Ctr, Baltimore, MD USA; [Wood, William H., III; Becker, Kevin] NIA Intramural Res Program, Gene Express & Genom Unit, Res Resources Branch, NIH Biomed Res Ctr, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Iser, WB (corresponding author), NIA Intramural Res Program, Invertebrate Mol Genet Unit, Lab Neurosci, Res Resources Branch,NIH Biomed Res Ctr, Baltimore, MD USA.	wolkowca@mail.nih.gov		Becker, Kevin/0000-0002-6794-6656	NIA [AG000320]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [Z01AG000320, ZICAG000616] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was carried out with funding from the NIA Intramural Research Program (AG000320) and from an Ellison Medical Foundation New Scholar in Aging award (www.ellisonfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; BRENNER S, 1974, GENETICS, V77, P71; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garigan D, 2002, GENETICS, V161, P1101; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gems D, 1998, GENETICS, V150, P129; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; GOTTLIEB S, 1994, GENETICS, V137, P107; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Iser WB, 2007, DEV BIOL, V303, P434, DOI 10.1016/j.ydbio.2006.04.467; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SH, 2003, J BIOL CHEM, V278, P28038, DOI 10.1074/jbc.M302192200; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; THOMAS JH, 1993, GENETICS, V134, P1105; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; VOWELS JJ, 1992, GENETICS, V130, P105; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	45	16	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17369	10.1371/journal.pone.0017369	http://dx.doi.org/10.1371/journal.pone.0017369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408062	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170900012
J	Anselmo, A; Flori, L; Jaffrezic, F; Rutigliano, T; Cecere, M; Cortes-Perez, N; Lefevre, F; Rogel-Gaillard, C; Giuffra, E				Anselmo, Anna; Flori, Laurence; Jaffrezic, Florence; Rutigliano, Teresa; Cecere, Maria; Cortes-Perez, Naima; Lefevre, Francois; Rogel-Gaillard, Claire; Giuffra, Elisabetta			Co-Expression of Host and Viral MicroRNAs in Porcine Dendritic Cells Infected by the Pseudorabies Virus	PLOS ONE			English	Article							LATENCY-ASSOCIATED TRANSCRIPT; DEEP-SEQUENCING DATA; GENOMIC ORGANIZATION; GENE-EXPRESSION; IMMUNITY; IDENTIFICATION; ANNOTATION; PROTEINS; TARGETS; INNATE	MicroRNAs are small non-coding RNAs approximately 22 nt long that modulate gene expression in animals and plants. It has been recently demonstrated that herpesviruses encode miRNAs to control the post-transcriptional regulation of expression from their own genomes and possibly that of their host, thus adding an additional layer of complexity to the physiological cross-talk between host and pathogen. The present study focussed on the interactions between porcine dendritic cells (DCs) and the Pseudorabies virus (PRV), an alpha-herpesvirus causing Aujeszky's disease in pigs. A catalogue of porcine and viral miRNAs, expressed eight hours post-infection, was established by deep sequencing. An average of 2 million reads per sample with a size of 21-24 nucleotides was obtained from six libraries representing three biological replicates of infected and mock-infected DCs. Almost 95% of reads mapped to the draft pig genome sequence and pig miRNAs previously annotated in dedicated databases were detected by sequence alignment. In silico prediction allowed the identification of unknown porcine as well as of five miRNAs transcribed by the Large Latency Transcript (LLT) of PRV. The gene target prediction of the viral miRNAs and the Ingenuity Pathway Analysis of differentially expressed pig miRNAs were conducted to contextualize the identified small RNA molecules and functionally characterize their involvement in the post-transcriptional regulation of gene expression. The results support a role for PRV miRNAs in the maintenance of the host cell latency state through the down-regulation of immediate-early viral genes which is similar to other herpesviruses. The differentially expressed swine miRNAs identified a unique network of target genes with highly significant functions in the development and function of the nervous system and in infectious mechanisms, suggesting that the modulation of both host and viral miRNAs is necessary for the establishment of PRV latency.	[Anselmo, Anna; Rutigliano, Teresa; Cecere, Maria; Giuffra, Elisabetta] Polo Univ, Lodi, Italy; [Flori, Laurence; Jaffrezic, Florence; Rogel-Gaillard, Claire; Giuffra, Elisabetta] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Flori, Laurence; Jaffrezic, Florence; Cortes-Perez, Naima; Rogel-Gaillard, Claire; Giuffra, Elisabetta] AgroParisTech, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Lefevre, Francois] INRA, UR Virol & Immunol Mol 892, Jouy En Josas, France; [Rogel-Gaillard, Claire] CEA, DSV, IRCM, SREIT,Lab Radiobiol & Etud Genome, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Anselmo, A (corresponding author), Polo Univ, Lodi, Italy.	elisabetta.giuffra@jouy.inra.fr	Cortes-Perez, Naima/AAG-7100-2022; Cortes-Perez, Naima/AFL-1772-2022; Giuffra, Elisabetta/I-3201-2013; Giuffra, Elisabetta/J-8080-2014; Flori, Laurence/H-3683-2013; Cortes-Perez, Naima G/AAE-8967-2019	Cortes-Perez, Naima/0000-0003-4189-7304; Cortes-Perez, Naima/0000-0003-4189-7304; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; Giuffra, Elisabetta/0000-0001-9568-2056; Anselmo, Anna/0000-0002-5279-8670	EU [FOOD-CT-2004-506416]	EU(European Commission)	Work was supported by FP6 EADGENE network of excellence (EU Contract No. FOOD-CT-2004-506416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bai Zhi-Qiang, 2008, Virol Sin, V23, P459, DOI 10.1007/s12250-008-2997-9; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Brukman A, 2006, J VIROL, V80, P10871, DOI 10.1128/JVI.01308-06; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Cekaite Lina, 2010, Front Biosci (Elite Ed), V2, P818; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Das S, 2009, MOL BIOL EVOL, V26, P1179, DOI 10.1093/molbev/msp035; Derfuss T, 2002, CURR TOP MICROBIOL, V269, P257; Flori L, 2008, DEV BIOLOGICALS, V132, P99, DOI 10.1159/000317149; Flori L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-123; Freer G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000384; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glazov EA, 2010, J GEN VIROL, V91, P32, DOI 10.1099/vir.0.014290-0; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Heidari M, 2010, VIRAL IMMUNOL, V23, P309, DOI 10.1089/vim.2009.0079; Ji J, 2008, J GEN VIROL, V89, P2761, DOI 10.1099/vir.0.2008/002923-0; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Kent JR, 2003, J NEUROVIROL, V9, P285, DOI 10.1080/13550280390200994; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; McCullough KC, 2009, VET IMMUNOL IMMUNOP, V128, P7, DOI 10.1016/j.vetimm.2008.10.290; Moens U, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/419539; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Riteau B, 2006, J GEN VIROL, V87, P1109, DOI 10.1099/vir.0.81609-0; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Song WJ, 2010, CANCER SCI, V101, P1754, DOI 10.1111/j.1349-7006.2010.01577.x; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Umbach JL, 2010, J VIROL, V84, P1189, DOI 10.1128/JVI.01712-09; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288	52	34	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17374	10.1371/journal.pone.0017374	http://dx.doi.org/10.1371/journal.pone.0017374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408164	Green Published, gold			2022-12-27	WOS:000288170000026
J	Wijsman, CA; van Heemst, D; Rozing, MP; Slagboom, PE; Beekman, M; de Craen, AJM; Maier, AB; Westendorp, RGJ; Blom, HJ; Mooijaart, SP				Wijsman, Carolien A.; van Heemst, Diana; Rozing, Maarten P.; Slagboom, P. Eline; Beekman, Marian; de Craen, Anton J. M.; Maier, Andrea B.; Westendorp, Rudi G. J.; Blom, Henk J.; Mooijaart, Simon P.			Homocysteine and Familial Longevity: The Leiden Longevity Study	PLOS ONE			English	Article							PLASMA TOTAL HOMOCYSTEINE; S-ADENOSYLHOMOCYSTEINE; GLUTATHIONE METABOLISM; CARDIOVASCULAR-DISEASE; NONAGENARIAN SIBLINGS; RISK FACTOR; LIFE-SPAN; MORTALITY; HYPERHOMOCYSTEINEMIA; DETERMINANTS	Homocysteine concentrations are a read-out of methionine metabolism and have been related to changes in lifespan in animal models. In humans, high homocysteine concentrations are an important predictor of age related disease. We aimed to explore the association of homocysteine with familial longevity by testing whether homocysteine is lower in individuals that are genetically enriched for longevity. We measured concentrations of total homocysteine in 1907 subjects from the Leiden Longevity Study consisting of 1309 offspring of nonagenarian siblings, who are enriched with familial factors promoting longevity, and 598 partners thereof as population controls. We found that homocysteine was related to age, creatinine, folate, vitamin B levels and medical history of hypertension and stroke in both groups (all p < 0.001). However, levels of homocysteine did not differ between offspring enriched for longevity and their partners, and no differences in the age-related rise in homocysteine levels were found between groups (p for interaction 0.63). The results suggest that homocysteine metabolism is not likely to predict familial longevity.	[Wijsman, Carolien A.; van Heemst, Diana; Rozing, Maarten P.; de Craen, Anton J. M.; Maier, Andrea B.; Westendorp, Rudi G. J.; Mooijaart, Simon P.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Slagboom, P. Eline; Beekman, Marian] Leiden Univ, Med Ctr, Dept Med Stat, Sect Mol Epidemiol, Leiden, Netherlands; [Slagboom, P. Eline] NCHA, Leiden, Netherlands; [Blom, Henk J.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Wijsman, CA (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	c.a.wijsman@lumc.nl	Mooijaart, Simon P./A-5306-2008; Maier, Andrea B./Q-5548-2019; Rozing, Maarten/AHC-7454-2022; Maier, Andrea/W-7060-2019; Slagboom, P. Eline/R-4790-2016; Beekman, Marian/L-3004-2019	Mooijaart, Simon P./0000-0003-3106-3568; Maier, Andrea/0000-0001-7206-1724; Slagboom, P. Eline/0000-0002-2875-4723; Beekman, Marian/0000-0003-0585-6206; Blom, Henk/0000-0001-5202-9241	SenterNovem [IGE01014, IGE5007]; Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO) [05040202]; EU [FP6 036894]	SenterNovem; Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	This study was supported by the Innovation Oriented Research Program on Genomics (SenterNovem; IGE01014 and IGE5007), the Centre for Medical Systems Biology (CMSB), the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO; 05040202), and the EU funded Network of Excellence Lifespan (FP6 036894). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Ayyadevara S, 2005, AGING CELL, V4, P257, DOI 10.1111/j.1474-9726.2005.00168.x; Becker A, 2003, ATHEROSCLEROSIS, V169, P323, DOI 10.1016/S0021-9150(03)00199-0; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Blom HJ, 2000, EUR J PEDIATR, V159, pS208, DOI 10.1007/PL00014405; Bostom AG, 1999, ANN INTERN MED, V131, P352, DOI 10.7326/0003-4819-131-5-199909070-00006; Brown-Borg HM, 2005, EXP GERONTOL, V40, P115, DOI 10.1016/j.exger.2004.11.004; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Connolly GM, 2010, NEPHRON CLIN PRACT, V114, pC5, DOI 10.1159/000242443; Dangour AD, 2008, J NUTR, V138, P1121, DOI 10.1093/jn/138.6.1121; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Kerins DM, 2001, AM J CLIN NUTR, V74, P723; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Marti-Carvajal AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006786.pub2; Muntjewerff JW, 2005, AM J MED GENET B, V135B, P69, DOI 10.1002/ajmg.b.30179; Nygard O, 1998, AM J CLIN NUTR, V67, P263, DOI 10.1093/ajcn/67.2.263; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Rozing MP, 2010, J GERONTOL A-BIOL, V65, P365, DOI 10.1093/gerona/glp200; Rozing MP, 2010, J AM GERIATR SOC, V58, P564, DOI 10.1111/j.1532-5415.2010.02725.x; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Selhub J, 2006, J NUTR, V136, p1726S, DOI 10.1093/jn/136.6.1726S; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Smulders YM, 2011, J INHERIT METAB DIS, V34, P93, DOI 10.1007/s10545-010-9151-1; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; van Hecke MV, 2008, CLIN SCI, V114, P479, DOI 10.1042/CS20070275; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Zhang WL, 2010, CLIN SCI, V118, P187, DOI 10.1042/CS20090142	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17543	10.1371/journal.pone.0017543	http://dx.doi.org/10.1371/journal.pone.0017543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408159	Green Published, gold			2022-12-27	WOS:000288170000036
J	Minguez, P; Dopazo, J				Minguez, Pablo; Dopazo, Joaquin			Assessing the Biological Significance of Gene Expression Signatures and Co-Expression Modules by Studying Their Network Properties	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORKS; GENOMIC DATA; MICROARRAY EXPERIMENTS; FUNCTION PREDICTION; STATISTICAL TESTS; SYSTEMS BIOLOGY; DATABASE; TOOL; ONTOLOGY; CANCER	Microarray experiments have been extensively used to define signatures, which are sets of genes that can be considered markers of experimental conditions (typically diseases). Paradoxically, in spite of the apparent functional role that might be attributed to such gene sets, signatures do not seem to be reproducible across experiments. Given the close relationship between function and protein interaction, network properties can be used to study to what extent signatures are composed of genes whose resulting proteins show a considerable level of interaction (and consequently a putative common functional role). We have analysed 618 signatures and 507 modules of co-expression in cancer looking for significant values of four main protein-protein interaction (PPI) network parameters: connection degree, cluster coefficient, betweenness and number of components. A total of 3904 gene ontology (GO) modules, 146 KEGG pathways, and 263 Biocarta pathways have been used as functional modules of reference. Co-expression modules found in microarray experiments display a high level of connectivity, similar to the one shown by conventional modules based on functional definitions (GO, KEGG and Biocarta). A general observation for all the classes studied is that the networks formed by the modules improve their topological parameters when an external protein is allowed to be introduced within the paths (up to the 70% of GO modules show network parameters beyond the random expectation). This fact suggests that functional definitions are incomplete and some genes might still be missing. Conversely, signatures are clearly not capturing the altered functions in the corresponding studies. This is probably because the way in which the genes have been selected in the signatures is too conservative. These results suggest that gene selection methods which take into account relationships among genes should be superior to methods that assume independence among genes outside their functional contexts.	[Minguez, Pablo; Dopazo, Joaquin] Ctr Invest Principe Felipe, Dept Bioinformat & Genom, Valencia, Spain; [Dopazo, Joaquin] CIBER Enfermedades Raras CIBERER, Valencia, Spain; [Dopazo, Joaquin] CIPF, INB, Valencia, Spain	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center	Minguez, P (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	jdopazo@cipf.es	Miguez, Pablo/D-4822-2013; Dopazo, Joaquin/A-9270-2014	Miguez, Pablo/0000-0003-4099-9421; Dopazo, Joaquin/0000-0003-3318-120X	Spanish Ministry of Science and Innovation (MICINN) [BIO2008-04212]; GVA-FEDER [PROMETEO/2010/001]; National Institute of Bioinformatics; CIBER de Enfermedades Raras; ISCIII, MICINN; Red Tematica de Investigacion Cooperativa en Cancer (RTICC), ISCIII, MICINN [RD06/0020/1019]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); GVA-FEDER; National Institute of Bioinformatics; CIBER de Enfermedades Raras; ISCIII, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), ISCIII, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work is supported by grants BIO2008-04212 from the Spanish Ministry of Science and Innovation (MICINN) and PROMETEO/2010/001 from the GVA-FEDER. The authors also thank the support of the National Institute of Bioinformatics (www.inab.org) and the CIBER de Enfermedades Raras, both initiatives of the ISCIII, MICINN. This work is also partly supported by a grant (RD06/0020/1019) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), ISCIII, MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Deng MH, 2004, BIOINFORMATICS, V20, P895, DOI 10.1093/bioinformatics/btg500; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dopazo J, 2006, OMICS, V10, P398, DOI 10.1089/omi.2006.10.398; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926; Hernandez P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-185; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Mateos A, 2002, GENOME RES, V12, P1703, DOI 10.1101/gr.192502; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Minguez P, 2009, NUCLEIC ACIDS RES, V37, pW109, DOI 10.1093/nar/gkp402; Montaner D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-197; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wei P, 2008, BIOINFORMATICS, V24, P404, DOI 10.1093/bioinformatics/btm612; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; 2011, MICROARRAY DATABASE; COEXPRESSION CANC MO	47	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17474	10.1371/journal.pone.0017474	http://dx.doi.org/10.1371/journal.pone.0017474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408226	gold, Green Published, Green Submitted			2022-12-27	WOS:000288099800015
J	Rube, CE; Fricke, A; Widmann, TA; Furst, T; Madry, H; Pfreundschuh, M; Rube, C				Ruebe, Claudia E.; Fricke, Andreas; Widmann, Thomas A.; Fuerst, Tobias; Madry, Henning; Pfreundschuh, Michael; Ruebe, Christian			Accumulation of DNA Damage in Hematopoietic Stem and Progenitor Cells during Human Aging	PLOS ONE			English	Article							STRAND BREAK REPAIR; TELOMERE LENGTH; CELLULAR SENESCENCE; DYSFUNCTION; EXERCISE; TISSUES; AGE	Background: Accumulation of DNA damage leading to adult stem cell exhaustion has been proposed to be a principal mechanism of aging. Here we tested this hypothesis in healthy individuals of different ages by examining unrepaired DNA double-strand breaks (DSBs) in hematopoietic stem/progenitor cells matured in their physiological microenvironment. Methodology/Principal Findings: To asses DNA damage accumulation and repair capacities, gamma H2AX-foci were examined before and after exposure to ionizing irradiation. Analyzing CD34+ and CD34- stem/progenitor cells we observed an increase of endogenous gamma H2AX-foci levels with advancing donor age, associated with an age-related decline in telomere length. Using combined immunofluorescence and telomere-fluorescence in-situ hybridization we show that gamma H2AX-foci co-localize consistently with other repair factors such as pATM, MDC1 and 53BP1, but not significantly with telomeres, strongly supporting the telomere-independent origin for the majority of foci. The highest inter-individual variations for non-telomeric DNA damage were observed in middle-aged donors, whereas the individual DSB repair capacity appears to determine the extent of DNA damage accrual. However, analyzing different stem/progenitor subpopulations obtained from healthy elderly (> 70 years), we observed an only modest increase in DNA damage accrual, most pronounced in the primitive CD34+CD38--enriched subfraction, but sustained DNA repair efficiencies, suggesting that healthy lifestyle may slow down the natural aging process. Conclusions/Significance: Based on these findings we conclude that age-related non-telomeric DNA damage accrual accompanies physiological stem cell aging in humans. Moreover, aging may alter the functional capacity of human stem cells to repair DSBs, thereby deteriorating an important genome protection mechanism leading to exceeding DNA damage accumulation. However, the great inter-individual variations in middle-aged individuals suggest that additional cell-intrinsic mechanisms and/or extrinsic factors contribute to the age-associated DNA damage accumulation.	[Ruebe, Claudia E.; Fricke, Andreas; Fuerst, Tobias; Ruebe, Christian] Univ Saarland, Dept Radiat Oncol, D-6650 Homburg, Germany; [Widmann, Thomas A.; Pfreundschuh, Michael] Univ Saarland, Dept Internal Med 1, D-6650 Homburg, Germany; [Madry, Henning] Univ Saarland, Dept Orthopaed Surg, D-6650 Homburg, Germany	Saarland University; Saarland University; Saarland University	Rube, CE (corresponding author), Univ Saarland, Dept Radiat Oncol, D-6650 Homburg, Germany.	claudia.ruebe@uks.eu	Fricke, Andreas/V-7478-2018; Madry, Henning/AAP-7115-2020	Fricke, Andreas/0000-0003-4915-4564	Saarland University [HOMFOR 2006/77]; Deutsche Forschungsgemeinschaft [RU 821/3-1]	Saarland University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by research funding from Saarland University (HOMFOR 2006/77) and in part from Deutsche Forschungsgemeinschaft (RU 821/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 2008, SCAND J GASTROENTERO, V43, P971, DOI 10.1080/00365520701766111; Baerlocher GM, 2002, CYTOMETRY, V47, P89, DOI 10.1002/cyto.10053; Banath JP, 2009, EXP CELL RES, V315, P1505, DOI 10.1016/j.yexcr.2008.12.007; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Engelhardt M, 2002, LEUKEMIA, V16, P1603, DOI 10.1038/sj.leu.2402620; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hofer T, 2008, REJUV RES, V11, P793, DOI 10.1089/rej.2008.0712; Jeggo PA, 2009, HEALTH PHYS, V97, P416, DOI 10.1097/HP.0b013e3181aff9c8; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Ju ZY, 2008, BIOCHIMIE, V90, P24, DOI 10.1016/j.biochi.2007.09.006; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kappei D, 2008, MECH AGEING DEV, V129, P17, DOI 10.1016/j.mad.2007.10.009; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Lichtman MA, 2004, SEMIN ONCOL, V31, P185, DOI 10.1053/j.seminoncol.2003.12.029; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; O'Callaghan NJ, 2009, REJUV RES, V12, P169, DOI 10.1089/rej.2008.0819; ORLOWSKI C, CHROMOSOMA; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Reichenbach J, 2006, CLIN EXP IMMUNOL, V146, P381, DOI 10.1111/j.1365-2249.2006.03221.x; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; RUBE CE, DNA REPAIR AMST; Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Song Z, AGING CELL, V9, P607; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Widmann TA, 2005, EXP HEMATOL, V33, P1257, DOI 10.1016/j.exphem.2005.05.019; Widmann T, 2008, EXP HEMATOL, V36, P104, DOI 10.1016/j.exphem.2007.08.028; Xiao M, 2000, LEUKEMIA LYMPHOMA, V38, P489, DOI 10.3109/10428190009059267	40	213	215	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17487	10.1371/journal.pone.0017487	http://dx.doi.org/10.1371/journal.pone.0017487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408175	gold, Green Published, Green Submitted			2022-12-27	WOS:000288099800018
J	Muyskens, JB; Guillemin, K				Muyskens, Jonathan B.; Guillemin, Karen			Helicobacter pylori CagA Disrupts Epithelial Patterning by Activating Myosin Light Chain	PLOS ONE			English	Article							VIRULENCE FACTOR CAGA; KINASE RHO-KINASE; TYROSINE PHOSPHATASE; DROSOPHILA; CELLS; PHOSPHORYLATION; CARCINOGENESIS; POLARITY; EXPRESSION; OOGENESIS	Helicobacter pylori infection is a leading cause of ulcers and gastric cancer. We show that expression of the H. pylori virulence factor CagA in a model Drosophila melanogaster epithelium induces morphological disruptions including ectopic furrowing. We find that CagA alters the distribution and increases the levels of activated myosin regulatory light chain (MLC), a key regulator of epithelial integrity. Reducing MLC activity suppresses CagA-induced disruptions. A CagA mutant lacking EPIYA motifs (CagA(EPISA)) induces less epithelial disruption and is not targeted to apical foci like wild-type CagA. In a cell culture model in which CagA(EPISA) and CagA have equivalent subcellular localization, CagA(EPISA) is equally potent in activating MLC. Therefore, in our transgenic system, CagA is targeted by EPIYA motifs to a specific apical region of the epithelium where it efficiently activates MLC to disrupt epithelial integrity.	[Muyskens, Jonathan B.; Guillemin, Karen] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Muyskens, JB (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	guillemin@molbio.uoregon.edu		Guillemin, Karen/0000-0001-6004-9955	National Institutes of Health (NIH) [RO1 DK075667]; American Recovery and Reinvestment Act (ARRA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075667] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act (ARRA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institutes of Health (NIH) grant number RO1 DK075667 to K. G. and by American Recovery and Reinvestment Act (ARRA) funds to J.M. through the above grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard JD, 1996, DEVELOPMENT, V122, P1137; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Botham CM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000064; Bourzac KM, 2007, INFECT IMMUN, V75, P1203, DOI 10.1128/IAI.01702-06; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Cohen D, 2007, MOL BIOL CELL, V18, P2203, DOI 10.1091/mbc.E07-02-0095; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; Hamlet MRJ, 2001, GENETICS, V159, P1073; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lapointe TK, 2010, CELL MICROBIOL, V12, P692, DOI 10.1111/j.1462-5822.2010.01429.x; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pignoni F, 1997, P NATL ACAD SCI USA, V94, P9220, DOI 10.1073/pnas.94.17.9220; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wong K, 2007, J CELL BIOL, V179, P1141, DOI 10.1083/jcb.200706167; Wroblewski LE, 2009, GASTROENTEROLOGY, V136, P236, DOI 10.1053/j.gastro.2008.10.011; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107	37	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17856	10.1371/journal.pone.0017856	http://dx.doi.org/10.1371/journal.pone.0017856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445303	Green Submitted, Green Published, gold			2022-12-27	WOS:000288613300016
J	Georgiades, K; Raoult, D				Georgiades, Kalliopi; Raoult, Didier			Genomes of the Most Dangerous Epidemic Bacteria Have a Virulence Repertoire Characterized by Fewer Genes but More Toxin-Antitoxin Modules	PLOS ONE			English	Article							VI SECRETION SYSTEM; RICKETTSIA-PROWAZEKII; ESCHERICHIA-COLI; EVOLUTION; IDENTIFICATION; RNAS; EXPRESSION; PATHOGENS; DEATH; YEAST	Background: We conducted a comparative genomic study based on a neutral approach to identify genome specificities associated with the virulence capacity of pathogenic bacteria. We also determined whether virulence is dictated by rules, or if it is the result of individual evolutionary histories. We systematically compared the genomes of the 12 most dangerous pandemic bacteria for humans ("bad bugs") to their closest non-epidemic related species ("controls"). Methodology/Principal Findings: We found several significantly different features in the "bad bugs", one of which was a smaller genome that likely resulted from a degraded recombination and repair system. The 10 Cluster of Orthologous Group (COG) functional categories revealed a significantly smaller number of genes in the "bad bugs", which lacked mostly transcription, signal transduction mechanisms, cell motility, energy production and conversion, and metabolic and regulatory functions. A few genes were identified as virulence factors, including secretion system proteins. Five "bad bugs" showed a greater number of poly (A) tails compared to the controls, whereas an elevated number of poly (A) tails was found to be strongly correlated to a low GC% content. The "bad bugs" had fewer tandem repeat sequences compared to controls. Moreover, the results obtained from a principal component analysis (PCA) showed that the "bad bugs" had surprisingly more toxin-antitoxin modules than did the controls. Conclusions/Significance: We conclude that pathogenic capacity is not the result of "virulence factors" but is the outcome of a virulent gene repertoire resulting from reduced genome repertoires. Toxin-antitoxin systems could participate in the virulence repertoire, but they may have developed independently of selfish evolution.	[Georgiades, Kalliopi; Raoult, Didier] Univ Mediterranee, Fac Med, URMITE, CNRS IRD UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Georgiades, K (corresponding author), Univ Mediterranee, Fac Med, URMITE, CNRS IRD UMR 6236, Marseille, France.	didier.raoult@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Audic S, 2007, PLOS GENET, V3, P1454, DOI 10.1371/journal.pgen.0030138; AUDOLY G, 2010, TOXIC EFFEC IN PRESS; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; BALLOUX F, 2010, BACTERIAL POPULATION, P114; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Cohan FM, 2002, GENETICA, V116, P359, DOI 10.1023/A:1021232409545; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; Dagan T, 2006, MOL BIOL EVOL, V23, P310, DOI 10.1093/molbev/msj036; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; DATE C, 2003, MOL BIOL EVOL, V20, P1188; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; Denoeud F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-4; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Eldredge N., 1972, P82; Feil E. J, 2010, BACTERIAL POPULATION, P19, DOI DOI 10.1002/9780470600122.CH2; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Georgiades K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00151; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Goulard C, 2010, J BACTERIOL, V192, P3669, DOI 10.1128/JB.00336-10; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Krehenbrink M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-55; Kristoffersen P, 2000, APPL ENVIRON MICROB, V66, P5524, DOI 10.1128/AEM.66.12.5524-5526.2000; Le Fleche P, 2001, BMC Microbiol, V1, P2; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Medina M, 2010, GENOMICS, V95, P129, DOI 10.1016/j.ygeno.2009.12.004; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Miyata ST, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00117; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Picardeau M, 2003, FEMS MICROBIOL LETT, V229, P277, DOI 10.1016/S0378-1097(03)00848-6; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakharkar KR, 2004, INT J SYST EVOL MICR, V54, P1937, DOI 10.1099/ijs.0.63090-0; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Storz G, 2006, COLD SPRING HARB SYM, V71, P269, DOI 10.1101/sqb.2006.71.033; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ten Bokum AMC, 2008, TRENDS MICROBIOL, V16, P436, DOI 10.1016/j.tim.2008.06.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Wixon J, 2001, COMPAR FUNCT GENOM, V2, P44, DOI 10.1002/cfg.70; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Yamamoto TAM, 2002, FEBS LETT, V519, P191, DOI 10.1016/S0014-5793(02)02764-3; Zomorodipour A, 1999, FEBS LETT, V452, P11, DOI 10.1016/S0014-5793(99)00563-3	70	86	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17962	10.1371/journal.pone.0017962	http://dx.doi.org/10.1371/journal.pone.0017962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437250	gold, Green Published, Green Submitted			2022-12-27	WOS:000288545100050
J	Li, XX; Zhang, MY; Zhang, HY				Li, Xiaoxue; Zhang, Mingyan; Zhang, Hongyu			RNA Interference of Four Genes in Adult Bactrocera dorsalis by Feeding Their dsRNAs	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ORIENTAL FRUIT-FLY; ANTIVIRAL IMMUNITY; C-ELEGANS; EXPRESSION; INGESTION; PATHWAY; RESISTANCE; INFLUENZA; PROTEINS	Background: RNA interference (RNAi) is a powerful method to inhibit gene expression in a sequence specific manner. Recently silencing the target gene through feeding has been successfully carried out in many insect species. Methodology/Principal Findings: Escherichia coli strain HT115 was genetically engineered to express dsRNA targeting genes that encode ribosomal protein Rpl19, V type ATPase D subunit, the fatty acid elongase Noa and a small GTPase Rab11. qRT-PCR showed that mRNA level of four target genes was reduced compared to ds-egfp control by feeding either engineered bacteria or dsRNAs. The maximum down-regulation of each gene varied from 35% to 100%. Tissue specific examination indicated that RNAi could be observed not only in midgut but also in other tissues like the ovary, nervous system and fat body. Silencing of rab11 through ingestion of dsRNA killed 20% of adult flies. Egg production was affected through feeding ds-noa and ds-rab11 compared to ds-egfp group. Adult flies were continuously fed with dsRNA and bacteria expressing dsRNA for 14 days and up-regulations of target genes were observed during this process. The transcripts of noa showed up-regulation compared to ds-egfp control group in four tissues on day 7 after continuous feeding either dsRNA or engineered bacteria. The maximum over-expression is 21 times compared to ds-egfp control group. Up-regulation of rab11 mRNA level could be observed in testes on day 7 after continuous bacteria treatment and in midgut on day 2 after ds-rab11 treatment. This phenomenon could also be observed in rpl19 groups. Conclusions: Our results suggested that it is feasible to silence genes by feeding dsRNA and bacteria expressing dsRNA in Bactrocera dorsalis. Additionally the over-expression of the target gene after continuously feeding dsRNA or bacteria was observed.	[Li, Xiaoxue] Huazhong Agr Univ, State Key Lab Agr Microbiol, Hubei Key Lab Insect Resource Applicat & Sustaina, Wuhan, Hubei, Peoples R China; Huazhong Agr Univ, Inst Urban & Hort Pests, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Li, XX (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Hubei Key Lab Insect Resource Applicat & Sustaina, Wuhan, Hubei, Peoples R China.	hongyu.zhang@mail.hzau.edu.cn			earmarked fund for Modern Agro-industry Technology Research System (MATS); Special Fund for Agro-scientific Research in the Public Interest [200903047]	earmarked fund for Modern Agro-industry Technology Research System (MATS); Special Fund for Agro-scientific Research in the Public Interest	This work is supported by the earmarked fund for Modern Agro-industry Technology Research System (MATS) and Special Fund for Agro-scientific Research in the Public Interest (grant number 200903047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; BINZ L, 2008, CHINESE AGR SCI B, V24, P391; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang JH, 2003, J VIROL, V77, P11910, DOI 10.1128/JVI.77.22.11910-11917.2003; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; FEO S, 1992, GENOMICS, V13, P201, DOI 10.1016/0888-7543(92)90221-D; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Geley S, 2004, EXP GERONTOL, V39, P985, DOI 10.1016/j.exger.2004.03.040; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Giansanti MG, 2007, MOL BIOL CELL, V18, P5034, DOI 10.1091/mbc.E07-05-0415; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Griebler M, 2008, J INSECT PHYSIOL, V54, P997, DOI 10.1016/j.jinsphys.2008.04.019; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Hannon, 2003, RNAI GUIDE GENE SILE; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Haque SJ, 1998, SEMIN ONCOL, V25, P14; HOISSONA B, 2006, FEBS LETT, V580, P1988; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jung A, 2007, J CELL SCI, V120, P2924, DOI 10.1242/jcs.006551; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Solis CF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008424; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tiwari AK, 2008, CELL BIOL INT, V32, P1158, DOI 10.1016/j.cellbi.2008.04.002; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zheng ZM, 2005, ANN NY ACAD SCI, V1058, P105, DOI 10.1196/annals.1359.019; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	45	124	133	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17788	10.1371/journal.pone.0017788	http://dx.doi.org/10.1371/journal.pone.0017788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445257	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100031
J	Li, JW; Vandal, O; Sant'Angelo, DB				Li, Jianwei; Vandal, Omar; Sant'Angelo, Derek B.			TCR Affinity for Self-Ligands Influences the Development and Function of Encephalitogenic T Cells	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RECEPTOR TRANSGENIC MICE; MULTIPLE-SCLEROSIS; NEGATIVE SELECTION; POSITIVE SELECTION; ANTIGEN RECEPTOR; D10 TCR; REPERTOIRE; MHC	The specificity and affinity of self-reactive T cells is likely to impact the development of autoimmune-disease causing T cells in the thymus as well as their function in the periphery. We identified a naturally occurring, low affinity variant of an MBP Ac1-11/I-A(u) specific TCR that is known to induce EAE. Thymocytes in mice carrying the transgenes for this low affinity TCR were poorly positively selected, as compared to their high affinity TCR expressing counterparts. Nonetheless, CD4 T cells bearing the low affinity TCR accumulated in the periphery of the mice. Unlike mice expressing the high affinity TCR, these mice very rarely developed disease. However, if endogenous TCR expression was eliminated by breeding to RAG1 deficient mice, 100% of the mice carrying either the high or the low affinity versions of the TCR developed EAE. Intriguingly, while the incidence of EAE increased, the age of onset of disease in both mice was identical. These data suggest disease onset occurs during a short window of mouse development.	[Li, Jianwei; Vandal, Omar; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Li, JW (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	santangd@mskcc.org			National Institutes of Health (NIH) [R01 AI-41574, T32 CA 09149]; Rudin Family Foundation; Leonard and Claire Tow Charitable Trust; NATIONAL CANCER INSTITUTE [T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041574] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rudin Family Foundation; Leonard and Claire Tow Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D.B.S. and O.V. were supported by National Institutes of Health (NIH) Grant R01 AI-41574, the Rudin Family Foundation and the Leonard and Claire Tow Charitable Trust. J.L. was supported by NIH training grant T32 CA 09149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Anderton S, 1999, IMMUNOL REV, V169, P123, DOI 10.1111/j.1600-065X.1999.tb01311.x; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; BEVAN MJ, 1994, SCIENCE, V264, P796, DOI 10.1126/science.8171333; Blander JM, 2000, J EXP MED, V191, P2065, DOI 10.1084/jem.191.12.2065; Brabb T, 1997, J IMMUNOL, V159, P497; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Cohen I R, 1993, Int Rev Immunol, V9, P243, DOI 10.3109/08830189309051209; Dao T, 2003, J IMMUNOL, V170, P48, DOI 10.4049/jimmunol.170.1.48; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Golub R, 2001, EUR J IMMUNOL, V31, P2919, DOI 10.1002/1521-4141(2001010)31:10<2919::AID-IMMU2919>3.0.CO;2-N; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; Janeway CA, 1997, CURR BIOL, V7, pR299, DOI 10.1016/S0960-9822(06)00142-4; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; KUMAR V, 1989, ANNU REV IMMUNOL, V7, P657, DOI 10.1146/annurev.iy.07.040189.003301; Kurschus FC, 2006, INT IMMUNOL, V18, P151, DOI 10.1093/intimm/dxh357; KYEWSKI B, 2006, ANNU REV IMMUNOL; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lo D, 1997, IMMUNOL RES, V16, P3, DOI 10.1007/BF02786320; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; McHeyzer-Williams LJ, 2004, IMMUNITY, V20, P231, DOI 10.1016/S1074-7613(04)00028-7; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Sant'Angelo DB, 2002, P NATL ACAD SCI USA, V99, P6931, DOI 10.1073/pnas.102182499; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Sercarz EE, 2000, J AUTOIMMUN, V14, P275, DOI 10.1006/jaut.2000.0380; Smiley ST, 1997, SCAND J IMMUNOL, V45, P726, DOI 10.1046/j.1365-3083.1997.d01-445.x; STAERZ UD, 1985, J IMMUNOL, V134, P3994; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2003, IMMUNOL REV, V191, P97, DOI 10.1034/j.1600-065X.2003.00006.x; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Targoni OS, 1998, J EXP MED, V187, P2055, DOI 10.1084/jem.187.12.2055; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; van den Elzen P, 2004, AUTOIMMUN REV, V3, P524, DOI 10.1016/j.autrev.2004.07.008; Wang FP, 1998, P NATL ACAD SCI USA, V95, P11834, DOI 10.1073/pnas.95.20.11834; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; 1995, IMMUNOGENETICS, V42, P451	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17702	10.1371/journal.pone.0017702	http://dx.doi.org/10.1371/journal.pone.0017702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437282	Green Published, gold, Green Submitted			2022-12-27	WOS:000288514600009
J	Fushing, H; McAssey, MP; Beisner, B; McCowan, B				Fushing, Hsieh; McAssey, Michael P.; Beisner, Brianne; McCowan, Brenda			Ranking Network of a Captive Rhesus Macaque Society: A Sophisticated Corporative Kingdom	PLOS ONE			English	Article							DOMINANCE ORDER; HIERARCHIES	We develop a three-step computing approach to explore a hierarchical ranking network for a society of captive rhesus macaques. The computed network is sufficiently informative to address the question: Is the ranking network for a rhesus macaque society more like a kingdom or a corporation? Our computations are based on a three-step approach. These steps are devised to deal with the tremendous challenges stemming from the transitivity of dominance as a necessary constraint on the ranking relations among all individual macaques, and the very high sampling heterogeneity in the behavioral conflict data. The first step simultaneously infers the ranking potentials among all network members, which requires accommodation of heterogeneous measurement error inherent in behavioral data. Our second step estimates the social rank for all individuals by minimizing the network-wide errors in the ranking potentials. The third step provides a way to compute confidence bounds for selected empirical features in the social ranking. We apply this approach to two sets of conflict data pertaining to two captive societies of adult rhesus macaques. The resultant ranking network for each society is found to be a sophisticated mixture of both a kingdom and a corporation. Also, for validation purposes, we reanalyze conflict data from twenty longhorn sheep and demonstrate that our three-step approach is capable of correctly computing a ranking network by eliminating all ranking error.	[Fushing, Hsieh; McAssey, Michael P.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [McCowan, Brenda] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Fushing, H (corresponding author), Univ Calif Davis, Dept Stat, Davis, CA 95616 USA.	bjmccowan@ucdavis.edu			NSF [HSD 0826844, DMS-1007219]; NIH [1R01AG025218-01A2, R24 RR024396, PR51 RR000169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR024396, P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025218] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011136, P51OD011107] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [0826844] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1007219] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding: The first two authors are supported in part by the NSF under Grant No. HSD 0826844 and DMS-1007219, and by the NIH under Grant No. 1R01AG025218-01A2. The last two authors are supported in part by the NIH under Grant Nos. R24 RR024396 (BM) and PR51 RR000169 (CNPRC Base Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ES, 2005, ANIM BEHAV, V69, P1191, DOI 10.1016/j.anbehav.2004.08.011; BEISNER BA, 2010, AM J PRIMAT IN PRESS; Bonabeau E, 1996, B MATH BIOL, V58, P661, DOI 10.1007/BF02459478; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; HASS CC, 1991, J ZOOL, V225, P509, DOI 10.1111/j.1469-7998.1991.tb03832.x; Hemelrijk CK, 2005, BEHAVIOUR, V142, P1037, DOI 10.1163/156853905774405290; Isbell LA, 2002, BEHAVIOUR, V139, P177, DOI 10.1163/156853902760102645; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Thierry B, SOCIAL EPIGENESIS; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	14	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17817	10.1371/journal.pone.0017817	http://dx.doi.org/10.1371/journal.pone.0017817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423627	Green Published, gold			2022-12-27	WOS:000288513900036
J	Leach, MC; Coulter, CA; Richardson, CA; Flecknell, PA				Leach, Matthew C.; Coulter, Claire A.; Richardson, Claire A.; Flecknell, Paul A.			Are We Looking in the Wrong Place? Implications for Behavioural-Based Pain Assessment in Rabbits (Oryctolagus cuniculi) and Beyond?	PLOS ONE			English	Article							BRITISH VETERINARY ATTITUDES; POSTOPERATIVE PAIN; PERIOPERATIVE ANALGESIA; FACE; KETOPROFEN; MELOXICAM; FIXATION; AUTISM; SCALE; EYES	Background: Successful observation of behaviour depends upon knowing both which behaviours to look for and focusing on the appropriate areas of the body to observe them. Behaviour based scoring systems have become increasingly widely used to assess animal pain and distress. Although studies are available demonstrating which behaviours need to be observed, there has been little attempt to assess how effectively observers apply such information when viewing an animal's behaviour. Methodology/Principal Findings: This study used historical video recordings of New Zealand white rabbits (Oryctolagus cuniculi) considered to be experiencing varying degrees of post-operative pain to assess the pattern of observation and the ability to assess pain exhibited by both experienced and inexperienced human participants (n = 151). Eye tracking equipment was used to identify how quickly, how frequently, for how long different areas of the rabbit's body were attended to by the participants. Simple visual analgoue scoring was used to assess the pain experienced in each sequence. The results demonstrate that irrespective of their experience or gender, observers focus first, more frequently and for longer on the face, compared to the abdomen, ears, back and hindquarters of the rabbit and that participants were poor at identifying rabbits in pain. Observing the back and hindquarters was correlated with 'correct' assessments and observing the face was correlated with 'incorrect' assessments. Conclusions: In conclusion, irrespective of experience and gender, observers focused on the face when using behaviour to assess pain and were unable to effectively identify rabbits in pain. Focusing on the face is unlikely to be effective when using behavioural indicators of pain since they involve other body areas. Alternatively, if animals exhibit pain-related facial expressions, then it could improve our ability to assess pain. In addition, these results have potential implications for the use of behaviour to assess how rabbits and potentially other species feel.	[Leach, Matthew C.; Coulter, Claire A.; Richardson, Claire A.; Flecknell, Paul A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Leach, MC (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.c.leach@ncl.ac.uk	Holtet, Astrid/B-9316-2012	Flecknell, Paul/0000-0002-1075-1129	Animal Free Research Foundation, Switzerland	Animal Free Research Foundation, Switzerland	This study was funded by the Animal Free Research Foundation, Switzerland (www.animalfree-research.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Blignaut PJ, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P165, DOI 10.1145/1344471.1344514; Capner CA, 1999, VET REC, V145, P95; COLLEWIJN H, 1998, VISION RES PRACTICAL, P245; Cornelissen PL, 2009, EVOL HUM BEHAV, V30, P417, DOI 10.1016/j.evolhumbehav.2009.04.003; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Deyo KS, 2004, PAIN, V107, P16, DOI 10.1016/S0304-3959(03)00263-X; Ekman P., 2002, FACIAL ACTION CODING; Firth AM, 1999, J AM VET MED ASSOC, V214, P651; Focquaert F, 2007, PERS INDIV DIFFER, V43, P619, DOI 10.1016/j.paid.2007.01.004; Gliga T, 2007, PROG BRAIN RES, V164, P323, DOI 10.1016/S0079-6123(07)64018-7; Golarai G, 2006, CLIN NEUROSCI RES, V6, P145, DOI 10.1016/j.cnr.2006.08.001; Grahm MJ, 1997, VET J, V153, P87, DOI 10.1016/S1090-0233(97)80013-5; Holton L, 2001, VET REC, V148, P525, DOI 10.1136/vr.148.17.525; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lascelles BDX, 1999, VET REC, V145, P601, DOI 10.1136/vr.145.21.601; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; Liu BS, 2007, LECT NOTES ARTIF INT, V4562, P741; Maeder A, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P727, DOI 10.1109/ISIMP.2004.1434167; Meffert RH, 1999, LAB ANIM SCI, V49, P650; Molony V, 1995, APPL ANIM BEHAV SCI, V46, P33, DOI 10.1016/0168-1591(95)00635-4; Pradhan AK, 2006, TRANSPORT RES REC, P58, DOI 10.3141/1969-10; Price J, 2003, VET ANAESTH ANALG, V30, P124, DOI 10.1046/j.1467-2995.2003.00139.x; Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Slingsby LS, 1998, VET REC, V143, P185, DOI 10.1136/vr.143.7.185; Treuting J, 2006, SMPTE MOTION IMAG J, V115, P31, DOI 10.5594/J11499; Turner PV, 2006, COMPARATIVE MED, V56, P63; Wemelsfelder F, 2001, ACTA AGR SCAND A-AN, V51, P21, DOI 10.1080/090647001300004763; Wiseman ML, 2001, VET REC, V149, P423, DOI 10.1136/vr.149.14.423; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003	31	43	43	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e13347	10.1371/journal.pone.0013347	http://dx.doi.org/10.1371/journal.pone.0013347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423605	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900001
J	von Schack, D; Agostino, MJ; Murray, BS; Li, YZ; Reddy, PS; Chen, J; Choe, SE; Strassle, BW; Li, C; Bates, B; Zhang, L; Hu, HJ; Kotnis, S; Bingham, B; Liu, W; Whiteside, GT; Samad, TA; Kennedy, JD; Ajit, SK				von Schack, David; Agostino, Michael J.; Murray, B. Stuart; Li, Yizheng; Reddy, Padmalatha S.; Chen, Jin; Choe, Sung E.; Strassle, Brian W.; Li, Christine; Bates, Brian; Zhang, Lynn; Hu, Huijuan; Kotnis, Smita; Bingham, Brendan; Liu, Wei; Whiteside, Garth T.; Samad, Tarek A.; Kennedy, Jeffrey D.; Ajit, Seena K.			Dynamic Changes in the MicroRNA Expression Profile Reveal Multiple Regulatory Mechanisms in the Spinal Nerve Ligation Model of Neuropathic Pain	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; TACTILE ALLODYNIA; PROTEIN-SYNTHESIS; P2X(4) RECEPTORS; GENE-EXPRESSION; UP-REGULATION; RAT; INJURY; IDENTIFICATION; SPECIFICITY	Neuropathic pain resulting from nerve lesions or dysfunction represents one of the most challenging neurological diseases to treat. A better understanding of the molecular mechanisms responsible for causing these maladaptive responses can help develop novel therapeutic strategies and biomarkers for neuropathic pain. We performed a miRNA expression profiling study of dorsal root ganglion (DRG) tissue from rats four weeks post spinal nerve ligation (SNL), a model of neuropathic pain. TaqMan low density arrays identified 63 miRNAs whose level of expression was significantly altered following SNL surgery. Of these, 59 were downregulated and the ipsilateral L4 DRG, not the injured L5 DRG, showed the most significant downregulation suggesting that miRNA changes in the uninjured afferents may underlie the development and maintenance of neuropathic pain. TargetScan was used to predict mRNA targets for these miRNAs and it was found that the transcripts with multiple predicted target sites belong to neurologically important pathways. By employing different bioinformatic approaches we identified neurite remodeling as a significantly regulated biological pathway, and some of these predictions were confirmed by siRNA knockdown for genes that regulate neurite growth in differentiated Neuro2A cells. In vitro validation for predicted target sites in the 3'-UTR of voltage-gated sodium channel Scn11a, alpha 2/delta1 subunit of voltage-dependent Ca-channel, and purinergic receptor P2rx ligand-gated ion channel 4 using luciferase reporter assays showed that identified miRNAs modulated gene expression significantly. Our results suggest the potential for miRNAs to play a direct role in neuropathic pain.	[von Schack, David; Agostino, Michael J.; Murray, B. Stuart; Li, Yizheng; Reddy, Padmalatha S.; Choe, Sung E.; Li, Christine; Bates, Brian; Zhang, Lynn; Liu, Wei] Pfizer Global Res & Dev, Biol Technol, Cambridge, MA USA; [Chen, Jin; Strassle, Brian W.; Hu, Huijuan; Kotnis, Smita; Bingham, Brendan; Whiteside, Garth T.; Samad, Tarek A.; Kennedy, Jeffrey D.; Ajit, Seena K.] Pfizer Global Res & Dev, Neurosci Discovery, Princeton, NJ USA; [Ajit, Seena K.] Drexel Univ, Dept Physiol & Pharmacol, Coll Med, Philadelphia, PA 19104 USA	Pfizer; Pfizer; Drexel University	von Schack, D (corresponding author), Pfizer Global Res & Dev, Biol Technol, Cambridge, MA USA.	seena.ajit@drexelmed.edu	Ajit, Seena/AAA-5114-2022	Whiteside, Garth/0000-0001-8128-0806; Agostino, Michael/0000-0003-3204-8175; Hu, Huijuan/0000-0003-2306-2514; Choe, Sung/0000-0001-9140-4198	Wyeth Research	Wyeth Research(Wyeth)	This work was funded by Wyeth Research and all authors were employees of Wyeth Research at the time. Wyeth was acquired by Pfizer in October 2009. The funders therefore had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Ali Z, 1999, J NEUROPHYSIOL, V81, P455, DOI 10.1152/jn.1999.81.2.455; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Campbell JN, 2001, MUSCLE NERVE, V24, P1261, DOI 10.1002/mus.1143; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gold MS, 2000, PAIN, V84, P117, DOI 10.1016/S0304-3959(99)00309-7; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jang JH, 2007, EXP NEUROL, V204, P288, DOI 10.1016/j.expneurol.2006.11.004; JI RR, 2004, SCI STKE; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Komori N, 2007, PHYSIOL GENOMICS, V29, P215, DOI 10.1152/physiolgenomics.00255.2006; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai M, 2005, CEREBROVASC DIS, V20, P49, DOI 10.1159/000086281; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YB, 2000, PAIN, V85, P493, DOI 10.1016/S0304-3959(00)00250-5; LIU NK, 2009, EXP NEUROL; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Martino S, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/654346; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Murray BS, 2010, MOL BIOSYST, V6, P1853, DOI 10.1039/c003961f; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Schmitt AB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-8; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHEEN K, 1993, BRAIN RES, V610, P62, DOI 10.1016/0006-8993(93)91217-G; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Taylor CP, 2009, PAIN, V142, P13, DOI 10.1016/j.pain.2008.11.019; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Vanderluit JL, 2000, EUR J NEUROSCI, V12, P3469, DOI 10.1046/j.1460-9568.2000.00241.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yoon YW, 1996, PAIN, V64, P27, DOI 10.1016/0304-3959(95)00096-8; Yun SJ, 2010, J CELL PHYSIOL, V225, P337, DOI 10.1002/jcp.22294	56	108	108	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17670	10.1371/journal.pone.0017670	http://dx.doi.org/10.1371/journal.pone.0017670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423802	gold, Green Published, Green Submitted			2022-12-27	WOS:000288512400018
J	Gray, JG; Dudas, S; Czub, S				Gray, John G.; Dudas, Sandor; Czub, Stefanie			A Study on the Analytical Sensitivity of 6 BSE Tests Used by the Canadian BSE Reference Laboratory	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRION PROTEIN; RAPID TESTS; DIAGNOSIS; CATTLE; EPIDEMIOLOGY	Bovine spongiform encephalopathy (BSE) surveillance programs have been employed in numerous countries to monitor BSE prevalence and to protect animal and human health. Since 1999, the European Commission (EC) authorized the evaluation and approval of 20 molecular based tests for the rapid detection of the pathological prion protein (PrPsc) in BSE infection. The diagnostic sensitivity, convenience, and speed of these tests have made molecular diagnostics the preferred method for BSE surveillance. The aim of this study was to determine the analytical sensitivity of 4 commercially available BSE rapid-test kits, including the Prionics (R)-Check WESTERN, the Prionics (R) Check-PrioSTRIP (TM), the BioRad (R) TeSeE (TM) ELISA, and the IDEXX (R) HerdChek (TM) EIA. Performances of these tests were then compared to 2 confirmatory tests, including the BioRad (R) TeSeE (TM) Western Blot and the modified Scrapie Associated Fibrils (SAF)/OIE Immunoblot. One 50% w/v homogenate was made from experimentally generated C-type BSE brain tissues in ddH(2)O. Homogenates were diluted through a background of BSE-negative brainstem homogenate. Masses of both positive and negative tissues in each dilution were calculated to maintain the appropriate tissue amounts for each test platform. Specific concentrated homogenization buffer was added accordingly to maintain the correct buffer condition for each test. ELISA-based tests were evaluated using their respective software/detection platforms. Blot-protocols were evaluated by manual measurements of blot signal density. Detection limitations were determined by fitted curves intersecting the manufacturers' positive/negative criteria. The confirmatory SAF Immunoblot displayed the highest analytical sensitivity, followed by the IDEXX (R) HerdChek (TM) EIA, Bio-Rad (R) TeSeE (TM) Western Blot, the Bio-Rad (R) TeSeE (TM) ELISA, PrionicsH-Check PrioSTRIP (TM), and PrionicsH-Check WESTERN (TM), respectively. Although the tests performed at different levels of sensitivity, the most sensitive and least sensitive of the rapid tests were separated by 2 logs in analytical sensitivity, meeting European performance requirements. All rapid tests appear suitable for targeted BSE surveillance programs, as implemented in Canada.	[Gray, John G.; Dudas, Sandor; Czub, Stefanie] Canadian Food Inspect Agcy, Lethbridge Lab, Lethbridge, AB, Canada	Canadian Food Inspection Agency	Gray, JG (corresponding author), Canadian Food Inspect Agcy, Lethbridge Lab, Lethbridge, AB, Canada.	stefanie.czub@inspection.gc.ca						Adam D, 2001, NATURE, V411, P728, DOI 10.1038/35081261; Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; [Anonymous], 2010, EFSA J, V8, P1591; Bennion BJ, 2002, CLIN CHEM, V48, P2105; *BIOR BIOR LAB, 2006, TESEE W BLOT INSTR M; *BIOR LAB, 2003, TESEE PUR DET KIT US; Bounias M, 2002, SCI TOTAL ENVIRON, V297, P1, DOI 10.1016/S0048-9697(02)00140-7; Braun U, 1999, VET REC, V145, P198, DOI 10.1136/vr.145.7.198; Budka H., 2008, TRENDS FOOD SCI TECH, V19, pS34; Buschmann A, 2004, J VIROL METHODS, V117, P27, DOI 10.1016/j.jviromet.2003.11.017; Castilla J, 2004, CURR MOL MED, V4, P397, DOI 10.2174/1566524043360654; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CZUB S, 2008, DETECTION PATHOLOGIC; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; *EUR COMM, 1999, OFFICIAL J L, V147, P1; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Heim D, 2005, MEAT SCI, V70, P555, DOI 10.1016/j.meatsci.2004.07.014; *IDEXX LAB, 2007, BOV SPONG ENC ANT TE; Lane A, 2003, CLIN CHEM, V49, P1774, DOI 10.1373/49.10.1774; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981; Polak MP, 2008, ARCH VIROL, V153, P69, DOI 10.1007/s00705-007-1062-6; Polak MP, 2003, B VET I PULAWY, V47, P89; *PRION AG, 2001, BOV SPONG ENC BSE AN; *PRION AG, 2001, PRION CHECK WESTERN; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Schaller O, 1999, ACTA NEUROPATHOL, V98, P437, DOI 10.1007/s004010051106; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; 2005, EFSA J, V17, P1	29	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17633	10.1371/journal.pone.0017633	http://dx.doi.org/10.1371/journal.pone.0017633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412419	gold, Green Published, Green Submitted			2022-12-27	WOS:000288247800020
J	Kitt, KN; Nelson, WJ				Kitt, Khameeka N.; Nelson, W. James			Rapid Suppression of Activated Rac1 by Cadherins and Nectins during De Novo Cell-Cell Adhesion	PLOS ONE			English	Article							RHO-FAMILY GTPASES; ADHERENS JUNCTIONS; TRANS-INTERACTIONS; CDC42 GTPASES; ACTIN; MOLECULES; DOMAIN; ESTABLISHMENT; LAMELLIPODIA; SUFFICIENT	Cell-cell adhesion in simple epithelia involves the engagement of E-cadherin and nectins, and the reorganization of the actin cytoskeleton and membrane dynamics by Rho GTPases, particularly Rac1. However, it remains unclear whether E-cadherin and nectins up-regulate, maintain or suppress Rac1 activity during cell-cell adhesion. Roles for Rho GTPases are complicated by cell spreading and integrin-based adhesions to the extracellular matrix that occur concurrently with cell-cell adhesion, and which also require Rho GTPases. Here, we designed a simple approach to examine Rac1 activity upon cell-cell adhesion by MDCK epithelial cells, without cell spreading or integrin-based adhesion. Upon initiation of cell-cell contact in 3-D cell aggregates, we observed an initial peak of Rac1 activity that rapidly decreased by similar to 66% within 5 minutes, and further decreased to a low baseline level after 30 minutes. Inhibition of E-cadherin engagement with DECMA-1 Fab fragments or competitive binding of soluble E-cadherin, or nectin2alpha extracellular domain completely inhibited Rac1 activity. These results indicate that cadherins and nectins cooperate to induce and then rapidly suppress Rac1 activity during initial cell-cell adhesion, which may be important in inhibiting the migratory cell phenotype and allowing the establishment of initially weak cell-cell adhesions.	[Kitt, Khameeka N.; Nelson, W. James] Stanford Univ, Dept Biol, James H Clark Ctr, Bio X Program, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, James H Clark Ctr, Bio X Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Kitt, KN (corresponding author), Stanford Univ, Dept Biol, James H Clark Ctr, Bio X Program, Stanford, CA 94305 USA.	wjnelson@stanford.edu			National Institutes of Health (NIH) [GM35527]; National Cancer Institute [CA09302]; DHHS;  [NIH 5R37-GM35527-24]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R37GM035527] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DHHS; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by a National Institutes of Health (NIH) grant (GM35527) to WJN and a Minority Supplement on Parent Grant NIH 5R37-GM35527-24 (WJN) awarded to KNK. Currently, PHS Grant Number CA09302 awarded by the National Cancer Institute, DHHS supports KNK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Drees Frauke, 2004, V294, P303; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata Masaki, 2002, Methods Mol Biol, V189, P121; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Honda T, 2003, GENES CELLS, V8, P481, DOI 10.1046/j.1365-2443.2003.00649.x; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hoshino T, 2004, MOL BIOL CELL, V15, P1077, DOI 10.1091/mbc.E03-05-0321; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kovacs EM, 2008, CURR BIOL, V18, pR667, DOI 10.1016/j.cub.2008.06.024; Kuroda S, 1997, BIOCHEM BIOPH RES CO, V240, P430, DOI 10.1006/bbrc.1997.7675; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; Miyoshi J, 2007, AM J NEPHROL, V27, P590, DOI 10.1159/000108103; Nakagawa M, 2001, J CELL SCI, V114, P1829; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Ogita H, 2006, METHOD ENZYMOL, V406, P415, DOI 10.1016/S0076-6879(06)06030-7; Perez TD, 2008, J BIOL CHEM, V283, P5014, DOI 10.1074/jbc.M705209200; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Stewart DB, 2000, J BIOL CHEM, V275, P20707, DOI 10.1074/jbc.M000467200; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Troyanovsky S, 2005, EUR J CELL BIOL, V84, P225, DOI 10.1016/j.ejcb.2004.12.009; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	44	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17841	10.1371/journal.pone.0017841	http://dx.doi.org/10.1371/journal.pone.0017841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412440	Green Published, Green Submitted, gold			2022-12-27	WOS:000288247800034
J	Wang, SA; Xu, LA; Jonas, JB; You, QS; Wang, YX; Yang, H				Wang, Shuang; Xu, Liang; Jonas, Jost B.; You, Qi Sheng; Wang, Ya Xing; Yang, Hua			Prevalence and Associated Factors of Dyslipidemia in the Adult Chinese Population	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; DENSITY-LIPOPROTEIN CHOLESTEROL; SINO-MONICA PROJECT; RISK-FACTORS; CARDIOVASCULAR-DISEASES; HDL-CHOLESTEROL; GLOBAL BURDEN; PART I; MORTALITY; CORONARY	To determine the prevalence, associated factors, awareness and control of dyslipidemia in Chinese living in Greater Beijing, we measured the serum cholesterol concentration in 3251 Chinese adults (age: 45 to 89 years) as participants of the population-based Beijing Eye Study 2006. Additional information on treatment of dyslipidemia was obtained using a standard questionnaire. The mean concentrations of total, HDL cholesterol, LDL cholesterol and triglycerides were 4.92 +/- 1.01 mmol/L, 1.61 +/- 0.36 mmol/L, 2.88 +/- 0.85 mmol/L, and 1.76 +/- 1.29 mmol/L, respectively. Prevalence of dyslipidemia was 56.1 +/- 0.9%%. Presence of dyslipidemia was significantly associated with increasing age (odds ratio (OR): 1.02; 95% confidence interval (CI): 1.01, 1.03), female gender (OR:1.51; 95% CI: 1.25, 1.83), urban region (OR: 1.82; 95% CI: 1.30, 2.55), body mass index (OR: 1.13; 95% CI: 1.10, 1.15), income (OR: 1.11; 95% CI: 1.02, 1.21), blood glucose concentration (OR: 1.10; 95% CI: 1.05, 1.16), diastolic blood pressure (OR: 1.02; 95% CI: 1.01, 1.03), and smoking (OR:1.23; 1.01, 1.51). Among those who had dyslipidemia, the proportion of subjects who were aware, treated and controlled was 50.9%, 23.8%, and 39.91%, respectively. The awareness rate was associated with urban region (P = 0.001; OR: 6.50), body mass index (P = 0.001; OR: 1.06), and income (P = 0.02; OR: 1.14). The data suggest that dyslipidemia may be present in about 56% of the population aged 45+ years in Greater Beijing. Factors likely associated with dyslipidemia were higher age, female gender, urban region, higher body mass index, higher income, higher blood concentration of glucose, higher diastolic blood pressure, and smoking. In the examined study population, treatment rate was 24% with about 60% of the treated subjects still having uncontrolled dyslipidemia.	[Wang, Shuang; Xu, Liang; Jonas, Jost B.; You, Qi Sheng; Wang, Ya Xing; Yang, Hua] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Wang, SA (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@gmail.com; Jost.Jonas@augen.ma.uni-heidelberg.de	You, Qisheng/AAG-7153-2020	You, Qisheng/0000-0003-0743-7320				[Anonymous], 5 CENS CHIN POP YEAR; [Anonymous], 1997, CHIN J CARDIOL, V25, P169; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; *BEIJ MUN STAT BUR, 2001, BEIJ STAT YB 2001; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; IRVING S, 1992, CIRCULATION, V85, P1083; Jia W P, 2002, Obes Rev, V3, P157; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Kang Wei-ming, 2009, Chinese Medical Sciences Journal, V24, P142; Li YH, 2002, NUTR METAB CARDIOVAS, V12, P118; Li ZY, 2005, CLIN CHEM, V51, P144, DOI 10.1373/clinchem.2004.038646; Liang Li-rong, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P363, DOI 10.3760/cma.j.issn.0253-3758.2009.04.017; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Rodgers A, 1998, LANCET, V352, P1801; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; TAO SC, 1989, INT J EPIDEMIOL, V18, pS159; VERSCHUREN WMM, 1994, INT J EPIDEMIOL, V23, P948, DOI 10.1093/ije/23.5.948; Wu Yang-feng, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P420; WU ZS, 1988, ACTA MED SCAND, P60; Wu ZS, 2004, EUR J CARDIOV PREV R, V11, P275, DOI 10.1097/01.hjr.0000136566.89429.63; Wu ZS, 2001, CIRCULATION, V103, P462; Xu L, 2008, EXP CLIN ENDOCR DIAB, V116, P69, DOI 10.1055/s-2007-985381; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Xu L, 2008, AM J HYPERTENS, V21, P1117, DOI 10.1038/ajh.2008.247; Yao C, 1993, Zhonghua Liu Xing Bing Xue Za Zhi, V14, P19; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zhang L, 2010, J EPIDEMIOL, V20, P237, DOI 10.2188/jea.JE20090119; Zhao WH, 2007, BIOMED ENVIRON SCI, V20, P329; ZHOU BF, 1995, INT J EPIDEMIOL, V24, P528, DOI 10.1093/ije/24.3.528	32	75	81	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17326	10.1371/journal.pone.0017326	http://dx.doi.org/10.1371/journal.pone.0017326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423741	gold, Green Published, Green Submitted			2022-12-27	WOS:000288219100006
J	Cappelletti, PA; dos Santos, RF; do Amaral, AM; Homem, RA; Souza, TD; Machado, MA; Farah, CS				Cappelletti, Paola A.; dos Santos, Rafael Freitas; do Amaral, Alexandre M.; Homem, Rafael Augusto; Souza, Thais dos Santos; Machado, Marcos A.; Farah, Chuck S.			Structure-Function Analysis of the HrpB2-HrcU Interaction in the Xanthomonas citri Type III Secretion System	PLOS ONE			English	Article							ENCODES 8 PROTEINS; SUBSTRATE-SPECIFICITY; FLAGELLAR HOOK; HYPERSENSITIVE RESPONSE; HOST-PLANT; SALMONELLA; PATHOGENICITY; YSCU; EXPORT; GENE	Bacterial type III secretion systems deliver protein virulence factors to host cells. Here we characterize the interaction between HrpB2, a small protein secreted by the Xanthomonas citri subsp. citri type III secretion system, and the cytosolic domain of the inner membrane protein HrcU, a paralog of the flagellar protein FlhB. We show that a recombinant fragment corresponding to the C-terminal cytosolic domain of HrcU produced in E. coli suffers cleavage within a conserved Asn264-Pro265-Thr266-His267 (NPTH) sequence. A recombinant HrcU cytosolic domain with N264A, P265A, T266A mutations at the cleavage site (HrcU(AAAH)) was not cleaved and interacted with HrpB2. Furthermore, a polypeptide corresponding to the sequence following the NPTH cleavage site also interacted with HrpB2 indicating that the site for interaction is located after the NPTH site. Non-polar deletion mutants of the hrcU and hrpB2 genes resulted in a total loss of pathogenicity in susceptible citrus plants and disease symptoms could be recovered by expression of HrpB2 and HrcU from extrachromossomal plasmids. Complementation of the Delta hrcU mutant with HrcU(AAAH) produced canker lesions similar to those observed when complemented with wild-type HrcU. HrpB2 secretion however, was significantly reduced in the Delta hrcU mutant complemented with HrcU(AAAH), suggesting that an intact and cleavable NPTH site in HrcU is necessary for total functionally of T3SS in X. citri subsp. citri. Complementation of the Delta hrpB2 X. citri subsp. citri strain with a series of hrpB2 gene mutants revealed that the highly conserved HrpB2 C-terminus is essential for T3SS-dependent development of citrus canker symptoms in planta.	[Cappelletti, Paola A.; dos Santos, Rafael Freitas; Souza, Thais dos Santos; Farah, Chuck S.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [do Amaral, Alexandre M.] EMBRAPA Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [do Amaral, Alexandre M.; Homem, Rafael Augusto; Machado, Marcos A.] Ctr APTA Citros Sylvio Moreira IAC, Sao Paulo, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Instituto Agronomico de Campinas (IAC)	Cappelletti, PA (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	chsfarah@iq.usp.br	4, INCT/H-4499-2013; Machado, Marcos/G-3582-2012; Citros, Inct/I-2442-2013; Farah, Chuck Shaker/G-5565-2012; Inbeqmedi, Inct/I-1929-2013	Machado, Marcos/0000-0001-9780-3990; Farah, Chuck Shaker/0000-0003-3110-6302; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/59243-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by research grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant # 2005/59243-3) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to C. S. F. and a graduate student scholarship to P. A. C. from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Aldon D, 2000, EMBO J, V19, P2304, DOI 10.1093/emboj/19.10.2304; Alegria MC, 2004, J BACTERIOL, V186, P6186, DOI 10.1128/JB.186.18.6186-6197.2004; ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994; Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; BONAS U, 1991, MOL PLANT MICROBE IN, V15, P109; Brito B, 2002, MOL PLANT MICROBE IN, V15, P109, DOI 10.1094/MPMI.2002.15.2.109; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2009, PLANT PHYSIOL, V150, P1656, DOI 10.1104/pp.109.139089; Buttner D, 2006, CURR OPIN MICROBIOL, V9, P193, DOI 10.1016/j.mib.2006.02.006; Buttner D, 2006, MOL MICROBIOL, V59, P513, DOI 10.1111/j.1365-2958.2005.04924.x; COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Deane JE, 2008, MOL MICROBIOL, V69, P267, DOI 10.1111/j.1365-2958.2008.06293.x; DEFEYTER R, 1993, MOL PLANT MICROBE IN, V6, P225, DOI 10.1094/MPMI-6-225; DUNGER G, 2005, PLANT PATHOL, V54, P8; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; HIROSHI S, 2007, J BACTERIOL, V189, P3271; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lorenz C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000094; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Marenda M, 1998, MOL MICROBIOL, V27, P437, DOI 10.1046/j.1365-2958.1998.00692.x; Marguerettaz M, 2011, MOL PLANT MICROBE IN, V24, P246, DOI 10.1094/MPMI-08-10-0188; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Oh C, 1999, MOL PLANT MICROBE IN, V12, P633, DOI 10.1094/MPMI.1999.12.7.633; Paulucci AA, 2002, J BIOL CHEM, V277, P39574, DOI 10.1074/jbc.M204749200; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; Riordan KE, 2008, MOL MICROBIOL, V68, P1485, DOI 10.1111/j.1365-2958.2008.06247.x; Rong W, 2010, MOL PLANT PATHOL, V11, P783, DOI 10.1111/j.1364-3703.2010.00642.x; Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUZUKI T, 1981, J BACTERIOL, V148, P973, DOI 10.1128/JB.148.3.973-979.1981; SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204; Szczesny R, 2010, NEW PHYTOL, V187, P1058, DOI 10.1111/j.1469-8137.2010.03346.x; Tahara ST, 2003, PROTEOMICS, V3, P95, DOI 10.1002/pmic.200390014; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x; Wiesand U, 2009, J MOL BIOL, V385, P854, DOI 10.1016/j.jmb.2008.10.034; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832	63	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17614	10.1371/journal.pone.0017614	http://dx.doi.org/10.1371/journal.pone.0017614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408079	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900030
J	Singh, A; Beveridge, AJ; Singh, N				Singh, Ajay; Beveridge, Alim J.; Singh, Neena			Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CEREBROSPINAL-FLUID; DIFFERENTIAL-DIAGNOSIS; TAU-PROTEIN; GEL-ELECTROPHORESIS; IRON; MARKERS; 14-3-3-PROTEIN; ALZHEIMERS; FERRITIN	Sporadic Creutzfeldt-Jakob-disease (sCJD) is a fatal neurodegenerative condition that escapes detection until autopsy. Recently, brain iron dyshomeostasis accompanied by increased transferrin (Tf) was reported in sCJD cases. The consequence of this abnormality on cerebrospinal-fluid (CSF) levels of Tf is uncertain. We evaluated the accuracy of CSF Tf, a 'new' biomarker, as a pre-mortem diagnostic test for sCJD when used alone or in combination with the 'current' biomarker totaltau (T-tau). Levels of total-Tf (T-Tf), isoforms of Tf (Tf-1 and Tf-b2), and iron saturation of Tf were quantified in CSF collected 0.3-36 months before death (duration) from 99 autopsy confirmed sCJD (CJD+) and 75 confirmed cases of dementia of non-CJD origin (CJD-). Diagnostic accuracy was estimated by non-parametric tests, logistic regression, and receiver operating characteristic (ROC) analysis. Area under the ROC curve (AUC), sensitivity, specificity, positive and negative predictive values (PV), and likelihood ratios (LR) of each biomarker and biomarker combination were calculated. We report that relative to CJD-, CJD+ cases had lower median CSF T-Tf (125,7093 vs. 217,7893) and higher T-tau (11530 vs. 1266) values. AUC was 0.90 (95% confidence interval (CI), 0.85-0.94) for T-Tf, and 0.93 (95% CI, 0.89-0.97) for T-Tf combined with T-tau. With cut-offs defined to achieve a sensitivity of,85%, T-Tf identified CJD+ cases with a specificity of 71.6% (95% CI, 59.1-81.7), positive LR of 3.0 (95% CI, 2.1-4.5), negative LR of 0.2 (95% CI, 0.1-0.3), and accuracy of 80.1%. The effect of patient age and duration was insignificant. T-Tf combined with T-tau identified CJD+ with improved specificity of 87.5% (95% CI, 76.3-94.1), positive LR of 6.8 (95% CI, 3.5-13.1), negative LR of 0.2 (95% CI, 0.1-0.3), positive-PV of 91.0%, negative-PV of 80.0%, and accuracy of 86.2%. Thus, CSF T-Tf, a new biomarker, when combined with the current biomarker T-tau, is a reliable pre-mortem diagnostic test for sCJD.	[Singh, Ajay; Singh, Neena] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Beveridge, Alim J.] Case Western Reserve Univ, Dept Org Behav, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Singh, A (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	neena.singh@case.edu	Beveridge, 'Alim/I-2098-2012; Beveridge, 'Alim/GRS-5863-2022	Beveridge, 'Alim/0000-0001-6454-585X	National Institutes of Health [R21AG109106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076139, R21NS077438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by funds from National Institutes of Health grant R21AG109106 to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aksamit AJ, 2003, ARCH NEUROL-CHICAGO, V60, P803, DOI 10.1001/archneur.60.6.803; Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Baldeiras IE, 2009, J NEUROL, V256, P1540, DOI 10.1007/s00415-009-5160-0; Brechlin P, 2008, PROTEOMICS, V8, P4357, DOI 10.1002/pmic.200800375; Castellani RJ, 2004, NEUROLOGY, V63, P436, DOI 10.1212/01.WNL.0000135153.96325.3B; Clardy SL, 2006, J LAB CLIN MED, V147, P67, DOI 10.1016/j.lab.2005.06.011; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; Connor JR, 2008, CURR NEUROL NEUROSCI, V8, P162, DOI 10.1007/s11910-008-0026-x; Cuadrado-Corrales N, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-25; DUGUID JR, 1989, P NATL ACAD SCI USA, V86, P7260, DOI 10.1073/pnas.86.18.7260; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430; Gmitterova K, 2009, NEUROBIOL AGING, V30, P1842, DOI 10.1016/j.neurobiolaging.2008.01.007; Gorogh T, 2005, CLIN CHEM, V51, P1704, DOI 10.1373/clinchem.2005.054916; Green AJE, 2001, NEUROLOGY, V56, P986, DOI 10.1212/WNL.56.7.986; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Jesse S, 2009, J ALZHEIMERS DIS, V17, P541, DOI 10.3233/JAD-2009-1075; Kapaki E, 2001, J NEUROL NEUROSUR PS, V71, P401, DOI 10.1136/jnnp.71.3.401; Kell D., 2009, NATURE, V460, P6; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kim BH, 2007, NEUROSCI LETT, V422, P158, DOI 10.1016/j.neulet.2007.05.061; KURT S, 2002, NEUROLOGY TODAY, V2, P19; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mizuno S, 2005, J SLEEP RES, V14, P43, DOI 10.1111/j.1365-2869.2004.00403.x; Moos T, 2000, CELL MOL NEUROBIOL, V20, P77, DOI 10.1023/A:1006948027674; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Otto M, 2003, RESTOR NEUROL NEUROS, V21, P191; Otto M, 2002, NEUROLOGY, V58, P192, DOI 10.1212/WNL.58.2.192; Otto M, 1997, NEUROSCI LETT, V225, P210, DOI 10.1016/S0304-3940(97)00215-2; Otto M, 2008, METHODS, V44, P289, DOI 10.1016/j.ymeth.2007.06.012; Pennington C, 2009, NEUROSCI LETT, V455, P56, DOI 10.1016/j.neulet.2009.02.067; Piubelli C, 2006, PROTEOMICS, V6, pS256, DOI 10.1002/pmic.200500294; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sanchez-Juan P, 2006, NEUROLOGY, V67, P637, DOI 10.1212/01.wnl.0000230159.67128.00; Sanchez-Juan P, 2007, J NEUROL, V254, P901, DOI 10.1007/s00415-006-0472-9; Satoh K, 2007, DEMENT GERIATR COGN, V24, P207, DOI 10.1159/000107082; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Skinningsrud Anders, 2008, Cerebrospinal Fluid Res, V5, P14, DOI 10.1186/1743-8454-5-14; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Sussmuth SD, 2001, NEUROSCI LETT, V300, P95, DOI 10.1016/S0304-3940(01)01556-7; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th Ed., P659; Van Everbroeck B, 2005, CLIN NEUROL NEUROSUR, V107, P355, DOI 10.1016/j.clineuro.2004.12.002; Van Everbroeck B, 2004, J NEUROL, V251, P298, DOI 10.1007/s00415-004-0311-9; Van Everbroeck B, 2003, J NEUROL NEUROSUR PS, V74, P1210, DOI 10.1136/jnnp.74.9.1210; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799; WHO, 1998, EM OTH COMM DIS SURV, P1; Wiltfang J, 2005, WORLD J BIOL PSYCHIA, V6, P69, DOI 10.1080/15622970510029786; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	55	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e16804	10.1371/journal.pone.0016804	http://dx.doi.org/10.1371/journal.pone.0016804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408069	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900004
J	Wallace, P; Murray, E; McCambridge, J; Khadjesari, Z; White, IR; Thompson, SG; Kalaitzaki, E; Godfrey, C; Linke, S				Wallace, Paul; Murray, Elizabeth; McCambridge, Jim; Khadjesari, Zarnie; White, Ian R.; Thompson, Simon G.; Kalaitzaki, Eleftheria; Godfrey, Christine; Linke, Stuart			On-line Randomized Controlled Trial of an Internet Based Psychologically Enhanced Intervention for People with Hazardous Alcohol Consumption	PLOS ONE			English	Article							CLINICAL-TRIALS; QUESTIONNAIRE; RELIABILITY; AUDIT	Background: Interventions delivered via the Internet have the potential to address the problem of hazardous alcohol consumption at minimal incremental cost, with potentially major public health implications. It was hypothesised that providing access to a psychologically enhanced website would result in greater reductions in drinking and related problems than giving access to a typical alcohol website simply providing information on potential harms of alcohol. DYD-RCT Trial registration: ISRCTN 31070347. Methodology/Principal Findings: A two-arm randomised controlled trial was conducted entirely on-line through the Down Your Drink (DYD) website. A total of 7935 individuals who screened positive for hazardous alcohol consumption were recruited and randomized. At entry to the trial, the geometric mean reported past week alcohol consumption was 46.0 (SD 31.2) units. Consumption levels reduced substantially in both groups at the principal 3 month assessment point to an average of 26.0 (SD 22.3) units. Similar changes were reported at 1 month and 12 months. There were no significant differences between the groups for either alcohol consumption at 3 months (intervention: control ratio of geometric means 1.03, 95% CI 0.97 to 1.10) or for this outcome and the main secondary outcomes at any of the assessments. The results were not materially changed following imputation of missing values, nor was there any evidence that the impact of the intervention varied with baseline measures or level of exposure to the intervention. Conclusions/Significance: Findings did not provide support for the hypothesis that access to a psychologically enhanced website confers additional benefit over standard practice and indicate the need for further research to optimise the effectiveness of Internet-based behavioural interventions. The trial demonstrates a widespread and potentially sustainable demand for Internet based interventions for people with hazardous alcohol consumption, which could be delivered internationally.	[Wallace, Paul; Murray, Elizabeth; Khadjesari, Zarnie] UCL, E Hlth Unit, Res Dept Primary Care & Populat Hlth, London, England; [McCambridge, Jim] Univ London London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 7HT, England; [White, Ian R.; Thompson, Simon G.] Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge, England; [Kalaitzaki, Eleftheria] Royal Canc Hosp, Inst Canc Res, London, England; [Godfrey, Christine] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Linke, Stuart] Camden & Islington NHS Trust, Dept Psychol, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; MRC Biostatistics Unit; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of York - UK	Wallace, P (corresponding author), UCL, E Hlth Unit, Res Dept Primary Care & Populat Hlth, London, England.	p.wallace@ucl.ac.uk		Murray, Elizabeth/0000-0002-8932-3695; White, Ian/0000-0002-6718-7661; Godfrey, Christine/0000-0001-6290-5532; McCambridge, Jim/0000-0002-5461-7001; Linke, Stuart/0000-0003-2515-3946; Khadjesari, Zarnie/0000-0002-2958-9555	National Prevention Research Initiative; British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Executive Health Department; Welsh Assembly Government; UK Medical Research Council [U.1052.00.006, U.1052.00.001]; Alcohol Education and Research Council; charity Drinkaware; MRC [MC_U105260792, MC_U122797163, G0501298, MC_U105260558] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U105260792, G0501298, MC_U105260558, MC_U122797163] Funding Source: researchfish	National Prevention Research Initiative(Diabetes UK); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Executive Health Department; Welsh Assembly Government; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alcohol Education and Research Council; charity Drinkaware; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the National Prevention Research Initiative, which includes the following funding partners: British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Executive Health Department; and the Welsh Assembly Government. IRW and SGT are funded by the UK Medical Research Council (grant codes U.1052.00.006 and U.1052.00.001). The Alcohol Education and Research Council provided additional funding to assist with developing the intervention site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Since June 2009, PGW has received payments from the charity Drinkaware in his capacity as its Chief Medical Advisor. PGW has no other competing interests and the authors confirm that this does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Anderson P.Anderson, 2008, ALCOHOL EUROPE PUBLI; Armitage CJ, 2000, PSYCHOL HEALTH, V15, P173, DOI 10.1080/08870440008400299; Bewick BM, 2008, PREV MED, V47, P17, DOI 10.1016/j.ypmed.2008.01.005; Bland JM, 1996, BRIT MED J, V312, P1079; Bull SS, 2004, AIDS CARE, V16, P931, DOI 10.1080/09540120412331292507; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; *CHIEF MED OFF STA, 2001, ANN REP CHIEF MED OF; CUNNINGHAM JA, 2010, ALCOHOL ALCOHOL; Cunningham JA, 2009, ADDICTION, V104, P2023, DOI 10.1111/j.1360-0443.2009.02726.x; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; DRUMMOND C, 2005, 2004 NATL ALCOHOL NE; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; Evans C, 2002, BRIT J PSYCHIAT, V180, P51, DOI 10.1192/bjp.180.1.51; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Fischer-Lapp K, 1999, CONTROL CLIN TRIALS, V20, P531, DOI 10.1016/S0197-2456(99)00027-6; Internet world stats, 2009, INT WORLD STATS US P; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; KHADJESARI Z, 2010, ADDICTION; Khadjesari Z, 2009, ADDICT BEHAV, V34, P337, DOI 10.1016/j.addbeh.2008.11.010; KIND P, 1999, 172 U YORK CTR HLTH; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Linke S, 2004, ALCOHOL ALCOHOLISM, V39, P29, DOI 10.1093/alcalc/agh004; Linke S, 2008, ALCOHOL ALCOHOLISM, V43, P669, DOI 10.1093/alcalc/agn066; Linke S, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e10; McAlindon T, 2003, BMJ-BRIT MED J, V327, P484, DOI 10.1136/bmj.327.7413.484; McCambridge J, 2008, ADDICTION, V103, P241, DOI 10.1111/j.1360-0443.2007.02080.x; Murray E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-306; O'Meara Susan, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000265.pub3, DOI 10.1002/14651858.CD000265.PUB3, DOI 10.1002/14651858.CD004274.PUB3]; Paul J, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e5; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Riper H, 2008, ADDICTION, V103, P218, DOI 10.1111/j.1360-0443.2007.02063.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shahab L, 2009, ADDICTION, V104, P1792, DOI 10.1111/j.1360-0443.2009.02710.x; White IR, 2007, CLIN TRIALS, V4, P125, DOI 10.1177/1740774507077849; Whitford JL, 2009, AM J DRUG ALCOHOL AB, V35, P55, DOI 10.1080/00952990802295212; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; WILLIAMS BTR, 1994, DRUG ALCOHOL DEPEN, V35, P239, DOI 10.1016/0376-8716(94)90080-9	39	71	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e14740	10.1371/journal.pone.0014740	http://dx.doi.org/10.1371/journal.pone.0014740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FR	21408060	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000288170900001
J	Zebelo, SA; Bertea, CM; Bossi, S; Occhipinti, A; Gnavi, G; Maffei, ME				Zebelo, Simon Atsbaha; Bertea, Cinzia M.; Bossi, Simone; Occhipinti, Andrea; Gnavi, Giorgio; Maffei, Massimo E.			Chrysolina herbacea Modulates Terpenoid Biosynthesis of Mentha aquatica L.	PLOS ONE			English	Article							ESSENTIAL OIL BIOSYNTHESIS; PLANT DEFENSE; MONOTERPENE BIOSYNTHESIS; ISOPRENOID BIOSYNTHESIS; FUNCTIONAL EXPRESSION; MINTHOSTACHYS-MOLLIS; CHEMICAL-COMPOSITION; GLANDULAR TRICHOMES; VOLATILE EMISSIONS; INSECT HERBIVORY	Interactions between herbivorous insects and plants storing terpenoids are poorly understood. This study describes the ability of Chrysolina herbacea to use volatiles emitted by undamaged Mentha aquatica plants as attractants and the plant's response to herbivory, which involves the production of deterrent molecules. Emitted plant volatiles were analyzed by GC-MS. The insect's response to plant volatiles was tested by Y-tube olfactometer bioassays. Total RNA was extracted from control plants, mechanically damaged leaves, and leaves damaged by herbivores. The terpenoid quantitative gene expressions (qPCR) were then assayed. Upon herbivory, M. aquatica synthesizes and emits (+)-menthofuran, which acts as a deterrent to C. herbacea. Herbivory was found to up-regulate the expression of genes involved in terpenoid biosynthesis. The increased emission of (+)-menthofuran was correlated with the upregulation of (+)-menthofuran synthase.	[Zebelo, Simon Atsbaha; Bertea, Cinzia M.; Bossi, Simone; Occhipinti, Andrea; Gnavi, Giorgio; Maffei, Massimo E.] Univ Turin, Plant Physiol Unit, Dept Plant Biol, Innovat Ctr, Turin, Italy	University of Turin	Zebelo, SA (corresponding author), Univ Turin, Plant Physiol Unit, Dept Plant Biol, Innovat Ctr, Turin, Italy.	massimo.maffei@unito.it	Zebelo, Simon/T-7086-2017; Maffei, Massimo E/K-9593-2015; Bertea, Cinzia Margherita/AAH-6434-2019; Occhipinti, Andrea/E-4607-2017; G., Gnavi/B-8624-2014	Maffei, Massimo E/0000-0001-6814-2353; Occhipinti, Andrea/0000-0003-2723-6374; G., Gnavi/0000-0003-4725-5337; Bertea, Cinzia Margherita/0000-0003-2919-0445; Bossi, Simone/0000-0003-4736-519X	doctorate school of Pharmaceutical and Biomolecular Sciences of the University of Turin	doctorate school of Pharmaceutical and Biomolecular Sciences of the University of Turin	Financial support came from the doctorate school of Pharmaceutical and Biomolecular Sciences of the University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Banchio E, 2005, J CHEM ECOL, V31, P719, DOI 10.1007/s10886-005-3540-1; Banchio E, 2007, BIOCHEM SYST ECOL, V35, P68, DOI 10.1016/j.bse.2006.08.007; Bertea CM, 2001, ARCH BIOCHEM BIOPHYS, V390, P279, DOI 10.1006/abbi.2001.2378; Bienkowski AO, 2009, ZOOL ZH, V88, P1471; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Burse A, 2009, PHYTOCHEMISTRY, V70, P1899, DOI 10.1016/j.phytochem.2009.08.002; Chen MS, 2008, INSECT SCI, V15, P101, DOI 10.1111/j.1744-7917.2008.00190.x; Cogni R, 2009, BIOL J LINN SOC, V97, P494, DOI 10.1111/j.1095-8312.2009.01234.x; Croteau RB, 2005, NATURWISSENSCHAFTEN, V92, P562, DOI 10.1007/s00114-005-0055-0; Dancewicz K, 2008, J CHEM ECOL, V34, P530, DOI 10.1007/s10886-008-9448-9; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2010, TRENDS PLANT SCI, V15, P115, DOI 10.1016/j.tplants.2010.01.007; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; FARRELL BD, 1994, AM ZOOL, V34, P57, DOI 10.1093/icb/34.1.57; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Gershenzon J, 2000, PLANT PHYSIOL, V122, P205, DOI 10.1104/pp.122.1.205; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; HORWOOD AR, BRIT WILD FLOWERS TH; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Jager AK, 2007, S AFR J BOT, V73, P518, DOI 10.1016/j.sajb.2007.04.061; Jerkovic I, 2001, CROAT CHEM ACTA, V74, P431; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Laurent P, 2005, TOP CURR CHEM, V240, P167; Laurent P, 2003, EUR J ORG CHEM, V2003, P2733, DOI 10.1002/ejoc.200300008; Luciano P, 2007, FORENSIC SCI INT-GEN, V1, P262, DOI 10.1016/j.fsigen.2007.06.003; Lupien S, 1999, ARCH BIOCHEM BIOPHYS, V368, P181, DOI 10.1006/abbi.1999.1298; MAFFEI M, 1989, NEW PHYTOL, V111, P707, DOI 10.1111/j.1469-8137.1989.tb02366.x; Maffei ME, 2010, S AFR J BOT, V76, P612, DOI 10.1016/j.sajb.2010.03.003; Maffei ME, 2007, PHYTOCHEMISTRY, V68, P2946, DOI 10.1016/j.phytochem.2007.07.016; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Mahmoud SS, 2003, P NATL ACAD SCI USA, V100, P14481, DOI 10.1073/pnas.2436325100; Mahmoud SS, 2002, TRENDS PLANT SCI, V7, P366, DOI 10.1016/S1360-1385(02)02303-8; MALINGRE TM, 1974, PHYTOCHEMISTRY, V13, P1531, DOI 10.1016/0031-9422(74)80322-5; Mantyla E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002832; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; McConkey ME, 2000, PLANT PHYSIOL, V122, P215, DOI 10.1104/pp.122.1.215; Mithofer A, 2009, ANNU PLANT REV, V34, P261, DOI 10.1111/b.9781405175326.2009.00009.x; Mkaddem M, 2009, J FOOD SCI, V74, pM358, DOI 10.1111/j.1750-3841.2009.01272.x; Mora FD, 2009, NAT PROD COMMUN, V4, P997; Mucciarelli M, 2001, PHYTOCHEMISTRY, V57, P91, DOI 10.1016/S0031-9422(00)00393-9; Ntalli NG, 2010, J AGR FOOD CHEM, V58, P7856, DOI 10.1021/jf100797m; Olsen HT, 2008, J ETHNOPHARMACOL, V117, P500, DOI 10.1016/j.jep.2008.02.015; Pare PW, 1997, PLANT PHYSIOL, V114, P1161, DOI 10.1104/pp.114.4.1161; PASTEELS JM, 1990, J CHEM ECOL, V16, P211, DOI 10.1007/BF01021280; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Ringer KL, 2005, PLANT PHYSIOL, V137, P863, DOI 10.1104/pp.104.053298; Ringer KL, 2003, ARCH BIOCHEM BIOPHYS, V418, P80, DOI 10.1016/S0003-9861(03)00390-4; Rios-Estepa R, 2008, P NATL ACAD SCI USA, V105, P2818, DOI 10.1073/pnas.0712314105; Rozen S, 2000, Methods Mol Biol, V132, P365; Ribeiro VLS, 2010, BIORESOURCE TECHNOL, V101, P2506, DOI 10.1016/j.biortech.2009.11.016; Scharf ME, 2006, PEST MANAG SCI, V62, P655, DOI 10.1002/ps.1222; Scriber JM, 2002, ENTOMOL EXP APPL, V104, P217, DOI 10.1023/A:1021292604205; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; STRONG DR, 1984, INSECTS PLANTS; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Valladares GR, 2002, J AGR FOOD CHEM, V50, P4059, DOI 10.1021/jf011608+; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Van Staden J, 2007, PLANTA MED, V73, P928; Wang H, 2008, J CHEM ECOL, V34, P330, DOI 10.1007/s10886-008-9433-3; WARREN PH, 1993, ECOGRAPHY, V16, P11, DOI 10.1111/j.1600-0587.1993.tb00053.x; Zhao YX, 2003, J APPL ENTOMOL, V127, P80, DOI 10.1046/j.1439-0418.2003.00687.x	71	30	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17195	10.1371/journal.pone.0017195	http://dx.doi.org/10.1371/journal.pone.0017195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408066	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900007
J	Daveson, AJ; Jones, DM; Gaze, S; McSorley, H; Clouston, A; Pascoe, A; Cooke, S; Speare, R; Macdonald, GA; Anderson, R; McCarthy, JS; Loukas, A; Croese, J				Daveson, A. James; Jones, Dianne M.; Gaze, Soraya; McSorley, Henry; Clouston, Andrew; Pascoe, Andrew; Cooke, Sharon; Speare, Richard; Macdonald, Graeme A.; Anderson, Robert; McCarthy, James S.; Loukas, Alex; Croese, John			Effect of Hookworm Infection on Wheat Challenge in Celiac Disease - A Randomised Double-Blinded Placebo Controlled Trial	PLOS ONE			English	Article							TRICHURIS-SUIS THERAPY; NECATOR-AMERICANUS; HYGIENE HYPOTHESIS; ULCERATIVE-COLITIS; IMMUNE MODULATION; AUTOIMMUNE; HELMINTHS; RESPONSES; SERIES; SAFE	Background and Aims: The association between hygiene and prevalence of autoimmune disease has been attributed in part to enteric helminth infection. A pilot study of experimental infection with the hookworm Necator americanus was undertaken among a group of otherwise healthy people with celiac disease to test the potential of the helminth to suppress the immunopathology induced by gluten. Methods: In a 21-week, double-blinded, placebo-controlled study, we explored the effects of N. americanus infection in 20 healthy, helminth-naive adults with celiac disease well controlled by diet. Staged cutaneous inoculations with 10 and 5 infective 3(rd) stage hookworm larvae or placebo were performed at week-0 and -12 respectively. At week-20, a five day oral wheat challenge equivalent to 16 grams of gluten per day was undertaken. Primary outcomes included duodenal Marsh score and quantification of the immunodominant alpha-gliadin peptide (QE65)-specific systemic interferon-gamma-producing cells by ELISpot pre- and post-wheat challenge. Results: Enteric colonisation with hookworm established in all 10 cases, resulting in transiently painful enteritis in 5. Chronic infection was asymptomatic, with no effect on hemoglobin levels. Although some duodenal eosinophilia was apparent, hookworm-infected mucosa retained a healthy appearance. In both groups, wheat challenge caused deterioration in both primary and several secondary outcomes. Conclusions: Experimental N. americanus infection proved to be safe and enabled testing its effect on a range of measures of the human autoimmune response. Infection imposed no obvious benefit on pathology.	[Daveson, A. James; Jones, Dianne M.; Clouston, Andrew; Macdonald, Graeme A.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Gaze, Soraya; McSorley, Henry; Macdonald, Graeme A.; McCarthy, James S.; Loukas, Alex; Croese, John] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Gaze, Soraya; McSorley, Henry; Speare, Richard; Loukas, Alex; Croese, John] James Cook Univ, Townsville, Qld 4811, Australia; [Clouston, Andrew] Envoi Specialist Pathologists, Brisbane, Qld, Australia; [Cooke, Sharon; Croese, John] Townsville Hosp, Townsville, Qld, Australia; [Anderson, Robert] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [McCarthy, James S.] Univ Queensland, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; James Cook University; Walter & Eliza Hall Institute; University of Queensland	Daveson, AJ (corresponding author), Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	jcroese@bigpond.com	Daveson, Alfred/C-7136-2011; Gaze, Soraya/B-9419-2013; Gaze, Soraya T/B-3085-2013; McCarthy, James S/C-1681-2009; Daveson, A James M/O-8692-2017; Clouston, Andrew D/E-7199-2011; Loukas, Alex/B-7355-2014; Macdonald, Graeme A/K-4167-2013	Gaze, Soraya/0000-0001-8600-2389; Gaze, Soraya T/0000-0001-8600-2389; Daveson, A James M/0000-0002-6042-5102; Clouston, Andrew D/0000-0002-9601-7952; Loukas, Alex/0000-0002-0896-8441; Macdonald, Graeme A/0000-0003-0929-110X; McCarthy, James/0000-0001-6596-9718; Anderson, Robert/0000-0002-0764-7267; Speare, Rick/0000-0002-9993-1213; McSorley, Henry/0000-0003-1300-7407	Broad Foundation	Broad Foundation	The study was funded by the Broad Medical Research Program of The Broad Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Prof. Andrew Clouston is a principal of and clinical pathologist at Envoi Specialist Pathologists, Brisbane, QLD, Australia, which processed tissue sections for histological grading. Prof. Clouston contributed to the interpretation and grading of the histology, and the preparation of the manuscript. Neither Prof. Clouston nor Envoi Specialist Pathologists has any patent or financial interest in the product of this clinical trial.	Altmann DM, 2009, IMMUNOLOGY, V126, P1, DOI 10.1111/j.1365-2567.2008.03006.x; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Aoyama H, 2007, AM J TROP MED HYG, V76, P972; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bager P, 2010, J ALLERGY CLIN IMMUN, V125, P123, DOI 10.1016/j.jaci.2009.08.006; BEAVER PC, 1988, AM J TROP MED HYG, V39, P369, DOI 10.4269/ajtmh.1988.39.369; Blount D, 2009, AM J TROP MED HYG, V81, P911, DOI 10.4269/ajtmh.2009.09-0237; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; Croese J, 2006, GASTROENTEROLOGY, V131, P402, DOI 10.1053/j.gastro.2006.05.019; Elliott DE, 2009, ADV EXP MED BIOL, V666, P157; Feary J, 2009, CLIN EXP ALLERGY, V39, P1060, DOI 10.1111/j.1365-2222.2009.03187.x; Feary JR, 2010, CLIN EXP ALLERGY, V40, P299, DOI 10.1111/j.1365-2222.2009.03433.x; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Jackson JA, 2009, IMMUNOLOGY, V126, P18, DOI 10.1111/j.1365-2567.2008.03010.x; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Leffler DA, 2009, CLIN GASTROENTEROL H, V7, P1328, DOI 10.1016/j.cgh.2009.07.031; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; MAXWELL C, 1987, AM J TROP MED HYG, V37, P126, DOI 10.4269/ajtmh.1987.37.126; Mortimer K, 2006, AM J TROP MED HYG, V75, P914, DOI 10.4269/ajtmh.2006.75.914; Musgrove P, 2009, HEALTH AFFAIR, V28, P1691, DOI 10.1377/hlthaff.28.6.1691; PALMER ED, 1955, AM J TROP MED HYG, V4, P756, DOI 10.4269/ajtmh.1955.4.756; Quinnell RJ, 2004, PARASITE IMMUNOL, V26, P443, DOI 10.1111/j.0141-9838.2004.00727.x; Ruyssers NE, 2010, WORLD J GASTROENTERO, V16, P703, DOI 10.3748/wjg.v16.i6.703; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Tye-Din Jason, 2008, Curr Gastroenterol Rep, V10, P458, DOI 10.1007/s11894-008-0085-9; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Wright V, 2005, CLIN EXP IMMUNOL, V142, P398, DOI 10.1111/j.1365-2249.2005.02945.x	34	150	152	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17366	10.1371/journal.pone.0017366	http://dx.doi.org/10.1371/journal.pone.0017366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408161	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000288170000025
J	Nikitina, L; Ahammer, H; Blaschitz, A; Gismondi, A; Glasner, A; Schimek, MG; Dohr, G; Sedlmayr, P				Nikitina, Liudmila; Ahammer, Helmut; Blaschitz, Astrid; Gismondi, Angela; Glasner, Andreas; Schimek, Michael G.; Dohr, Gottfried; Sedlmayr, Peter			A New Method for Morphometric Analysis of Tissue Distribution of Mobile Cells in Relation to Immobile Tissue Structures	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; UTERINE LEUKOCYTES; HUMAN ENDOMETRIUM; PREGNANCY; RECRUITMENT; UTERUS; ACCUMULATION; MECHANISMS	The distribution of cells in stained tissue sections provides information that may be analyzed by means of morphometric computation. We developed an algorithm for automated analysis for the purpose of answering questions pertaining to the relative densities of wandering cells in the vicinity of comparatively immobile tissue structures such as vessels or tumors. As an example, we present the analysis of distribution of CD56-positive cells and of CXCR3-positive cells (relative densities of peri-vascular versus non-vascular cell populations) in relation to the endothelium of capillaries and venules of human parietal decidua tissue of first trimester pregnancy. In addition, the distibution of CD56-positive cells (mostly uterine NK cells) in relation to spiral arteries is analyzed. The image analysis is based on microphotographs of two-color immunohistological stainings. Discrete distances (10-50 mm) from the fixed structures were chosen for the purpose of definining the extent of neighborhood areas. For the sake of better comparison of cell distributions at different overall cell densities a model of random distribution of "cells" in relation to neighborhood areas and rest decidua of a specific sample was built. In the chosen instances, we found increased perivascular density of CD56-positive cells and of CXCR3-positive cells. In contrast, no accumulation of CD56-positive cells was found in the neighborhood of spiral arteries.	[Nikitina, Liudmila; Blaschitz, Astrid; Dohr, Gottfried; Sedlmayr, Peter] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Ahammer, Helmut] Med Univ Graz, Inst Biophys, Graz, Austria; [Gismondi, Angela] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Schimek, Michael G.] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz; Sapienza University Rome; Medical University of Graz	Nikitina, L (corresponding author), Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland.	peter.sedlmayr@medunigraz.at	Dohr, Gottfried/E-8070-2010	Ahammer, Helmut/0000-0001-5400-294X	the European Commission (Network of Excellence, "The Control of Embryo Implantation (EMBIC)") [FP6-512040]	the European Commission (Network of Excellence, "The Control of Embryo Implantation (EMBIC)")(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the European Commission (Network of Excellence, "The Control of Embryo Implantation (EMBIC)", FP6-512040, lead researcher involved: P. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; BULMER JN, 1991, HUM REPROD, V6, P791, DOI 10.1093/oxfordjournals.humrep.a137430; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; Chantakru S, 2001, J REPROD IMMUNOL, V49, P33, DOI 10.1016/S0165-0378(00)00076-0; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hazan AD, 2010, AM J PATHOL, V177, P1017, DOI 10.2353/ajpath.2010.091105; Kam EPY, 1999, HUM REPROD, V14, P2131, DOI 10.1093/humrep/14.8.2131; King A, 2000, HUM REPROD UPDATE, V6, P28, DOI 10.1093/humupd/6.1.28; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Olert J, 2001, PATHOL RES PRACT, V197, P823, DOI 10.1078/0344-0338-00166; Santoni A, 2008, AM J REPROD IMMUNOL, V59, P417, DOI 10.1111/j.1600-0897.2008.00598.x; Sentman CL, 2004, J IMMUNOL, V173, P6760, DOI 10.4049/jimmunol.173.11.6760; Trowsdale J, 2008, SEMIN IMMUNOL, V20, P317, DOI 10.1016/j.smim.2008.06.002; Trundley A, 2004, TISSUE ANTIGENS, V63, P1, DOI 10.1111/j.1399-0039.2004.00170.x; van den Heuvel MJ, 2005, IMMUNOL INVEST, V34, P273, DOI 10.1081/IMM-200064488	16	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e15086	10.1371/journal.pone.0015086	http://dx.doi.org/10.1371/journal.pone.0015086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408197	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000003
J	Chitteti, BR; Liu, YL; Srour, EF				Chitteti, Brahmananda Reddy; Liu, Yunlong; Srour, Edward F.			Genomic and Proteomic Analysis of the Impact of Mitotic Quiescence on the Engraftment of Human CD34(+) Cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; STEM-CELL; GENE-EXPRESSION; BONE-MARROW; REPOPULATING CAPACITY; STEM/PROGENITOR CELLS; MICROARRAY; PROTEIN; MODEL; DIFFERENTIATION	It is well established that in adults, long-term repopulating hematopoietic stem cells (HSC) are mitotically quiescent cells that reside in specialized bone marrow (BM) niches that maintain the dormancy of HSC. Our laboratory demonstrated that the engraftment potential of human HSC (CD34(+) cells) from BM and mobilized peripheral blood (MPB) is restricted to cells in the G0 phase of cell cycle but that in the case of umbilical cord blood (UCB) -derived CD34(+) cells, cell cycle status is not a determining factor in the ability of these cells to engraft and sustain hematopoiesis. We used this distinct in vivo behavior of CD34(+) cells from these tissues to identify genes associated with the engraftment potential of human HSC. CD34(+) cells from BM, MPB, and UCB were fractionated into G0 and G1 phases of cell cycle and subjected in parallel to microarray and proteomic analyses. A total of 484 target genes were identified to be associated with engraftment potential of HSC. System biology modeling indicated that the top four signaling pathways associated with these genes are Integrin signaling, p53 signaling, cytotoxic T lymphocyte-mediated apoptosis, and Myc mediated apoptosis signaling. Our data suggest that a continuum of functions of hematopoietic cells directly associated with cell cycle progression may play a major role in governing the engraftment potential of stem cells. While proteomic analysis identified a total of 646 proteins in analyzed samples, a very limited overlap between genomic and proteomic data was observed. These data provide a new insight into the genetic control of engraftment of human HSC from distinct tissues and suggest that mitotic quiescence may not be the requisite characteristic of engrafting stem cells, but instead may be the physiologic status conducive to the expression of genetic elements favoring engraftment.	[Chitteti, Brahmananda Reddy; Srour, Edward F.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Liu, Yunlong] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA; [Srour, Edward F.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Srour, Edward F.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Chitteti, BR (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA.	esrour@iupui.edu			National Institutes of Health (NIH) [R01 HL55716]; National Cancer Institute (NCI) [P30 CA082709]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055716] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01 HL55716 (EFS). The Flow Cytometry Research Facility is partially funded by National Cancer Institute (NCI) P30 CA082709. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chulada PC, 2000, CANCER RES, V60, P4705; Colvin GA, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2006.09.005; DAWN PGF, 2007, PROTEOMICS CLIN APPL; de Haan G, 2002, BLOOD, V100, P2056, DOI 10.1182/blood-2002-03-0808; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Evangelou A, 2002, ENDOCRINOLOGY, V143, P3897, DOI 10.1210/en.2002-220156; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Gothot A, 1998, EXP HEMATOL, V26, P562; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Higgs Richard E., 2008, V428, P209; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kim YC, 2009, P NATL ACAD SCI USA, V106, P8278, DOI 10.1073/pnas.0903390106; Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013; Ladd AC, 1997, BLOOD, V90, P658, DOI 10.1182/blood.V90.2.658.658_658_668; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; Liu F, 2006, PROTEOMICS, V6, P2673, DOI 10.1002/pmic.200500032; Mielcarek M, 1997, STEM CELLS, V15, P229, DOI 10.1002/stem.5530150831; Nunes SS, 2008, J CELL PHYSIOL, V214, P828, DOI 10.1002/jcp.21281; Nunez C, 2006, J BACTERIOL, V188, P2792, DOI 10.1128/JB.188.8.2792-2800.2006; OGAWA M, 1993, BLOOD, V81, P2844; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Quesenberry PJ, 2006, CURR OPIN HEMATOL, V13, P216, DOI 10.1097/01.moh.0000231417.08031.ac; Quesenberry PJ, 2002, BLOOD, V100, P4266, DOI 10.1182/blood-2002-04-1246; Rakeman AS, 2006, DEVELOPMENT, V133, P3075, DOI 10.1242/dev.02473; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Roeder I, 2002, EXP HEMATOL, V30, P853, DOI 10.1016/S0301-472X(02)00832-9; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Sheng QH, 2006, NAT GENET, V38, P1223, DOI 10.1038/ng1106-1223; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; SNODGRASS R, 1987, EMBO J, V6, P3955, DOI 10.1002/j.1460-2075.1987.tb02737.x; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; Tao W, 2004, STEM CELLS, V22, P1003, DOI 10.1634/stemcells.22-6-1003; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Wang HB, 2002, J CLIN ENDOCR METAB, V87, P2629, DOI 10.1210/jc.87.6.2629; Wang ZQ, 2007, BIOCHEM BIOPH RES CO, V355, P312, DOI 10.1016/j.bbrc.2007.01.129; Wilpshaar J, 2000, BLOOD, V96, P2100; Wilpshaar J, 2002, BLOOD, V100, P120, DOI 10.1182/blood.V100.1.120; Yamauchi M, 2007, CANCER SCI, V98, P1491, DOI 10.1111/j.1349-7006.2007.00534.x; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2; Zhan QM, 1999, ONCOGENE, V18, P297, DOI 10.1038/sj.onc.1202310	58	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17498	10.1371/journal.pone.0017498	http://dx.doi.org/10.1371/journal.pone.0017498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408179	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800020
J	Kristiansen, T; Drinkwater, KF; Lough, RG; Sundby, S				Kristiansen, Trond; Drinkwater, Kenneth F.; Lough, R. Gregory; Sundby, Svein			Recruitment Variability in North Atlantic Cod and Match-Mismatch Dynamics	PLOS ONE			English	Article							GADUS-MORHUA; HABITAT SELECTION; CLASS STRENGTH; CLIMATE-CHANGE; LIFE-HISTORY; FISH EGGS; LARVAL; GROWTH; SIZE; TEMPERATURE	Background: Fisheries exploitation, habitat destruction, and climate are important drivers of variability in recruitment success. Understanding variability in recruitment can reveal mechanisms behind widespread decline in the abundance of key species in marine and terrestrial ecosystems. For fish populations, the match-mismatch theory hypothesizes that successful recruitment is a function of the timing and duration of larval fish abundance and prey availability. However, the underlying mechanisms of match-mismatch dynamics and the factors driving spatial differences between high and low recruitment remain poorly understood. Methodology/Principal Findings: We used empirical observations of larval fish abundance, a mechanistic individual-based model, and a reanalysis of ocean temperature data from 1960 to 2002 to estimate the survival of larval cod (Gadus morhua). From the model, we quantified how survival rates changed during the warmest and coldest years at four important cod spawning sites in the North Atlantic. The modeled difference in survival probability was not large for any given month between cold or warm years. However, the cumulative effect of higher growth rates and survival through the entire spawning season in warm years was substantial with 308%, 385%, 154%, and 175% increases in survival for Georges Bank, Iceland, North Sea, and Lofoten cod stocks, respectively. We also found that the importance of match-mismatch dynamics generally increased with latitude. Conclusions/Significance: Our analyses indicate that a key factor for enhancing survival is the duration of the overlap between larval and prey abundance and not the actual timing of the peak abundance. During warm years, the duration of the overlap between larval fish and their prey is prolonged due to an early onset of the spring bloom. This prolonged season enhances cumulative growth and survival, leading to a greater number of large individuals with enhanced potential for survival to recruitment.	[Kristiansen, Trond; Drinkwater, Kenneth F.; Sundby, Svein] Inst Marine Res, N-5024 Bergen, Norway; [Kristiansen, Trond; Drinkwater, Kenneth F.; Sundby, Svein] Bjerknes Ctr Climate Res, Bergen, Norway; [Lough, R. Gregory] NOAA, Natl Marine Fisheries Serv, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA	Institute of Marine Research - Norway; Bjerknes Centre for Climate Research; National Oceanic Atmospheric Admin (NOAA) - USA	Kristiansen, T (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	tk@trondkristiansen.com		Sundby, Svein/0000-0002-0815-9740; Kristiansen, Trond/0000-0001-6121-297X	Norwegian Research Council [178239]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was supported by the Norwegian Research Council through project ARCWARM #178239 to T. K. and K. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2010, CLIM RES, V41, P15, DOI 10.3354/cr00838; Bonnet D, 2005, PROG OCEANOGR, V65, P1, DOI 10.1016/j.pocean.2005.02.002; BRANDER KM, 1994, ICES J MAR SCI, V51, P71, DOI 10.1006/jmsc.1994.1007; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buckley LJ, 2010, MAR ECOL PROG SER, V405, P57, DOI 10.3354/meps08503; Carton JA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002817; Cheung WWL, 2008, MAR ECOL PROG SER, V365, P187, DOI 10.3354/meps07414; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; CUSHING DH, 1996, D21385 OLDENDORF LUH, P1; Daewel U, 2008, J PLANKTON RES, V30, P1, DOI 10.1093/plankt/fbm094; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT WORLD FISH AQ S; Fiksen O, 2002, MAR ECOL PROG SER, V243, P151, DOI 10.3354/meps243151; Folkvord A, 2005, CAN J FISH AQUAT SCI, V62, P1037, DOI 10.1139/F05-008; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hare JA, 1997, ECOLOGY, V78, P2415; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Heath MR, 2007, FISH OCEANOGR, V16, P169, DOI 10.1111/j.1365-2419.2006.00423.x; HENSON SA, 2009, J GEOPHYS RES-OCEANS, P114; HINRICHSEN HH, 2010, SURVIVAL PROBABILITY; Houde ED, 1997, J FISH BIOL, V51, P52, DOI 10.1111/j.1095-8649.1997.tb06093.x; Houde ED, 1987, AM FISH SOC S, V2, P17; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; ICES, 2005, ICES COD PRACT INTR, P1; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Kaartvedt S, 2000, ICES J MAR SCI, V57, P1819, DOI 10.1006/jmsc.2000.0964; Kjesbu OS, 1996, CAN J FISH AQUAT SCI, V53, P610, DOI 10.1139/cjfas-53-3-610; Kristiansen T, 2009, BEHAV ECOL, V20, P490, DOI 10.1093/beheco/arp023; Kristiansen T, 2007, CAN J FISH AQUAT SCI, V64, P136, DOI 10.1139/F06-176; Kuzmina SI, 2008, TELLUS A, V60, P289, DOI [10.1111/j.1600-0870.2008.00303.x, 10.1111/J.1600-0870.2008.00303.X]; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Levitus S., 1994, NOAA ATLAS NESDIS, V4; Lough RG, 2010, FISH OCEANOGR, V19, P159, DOI 10.1111/j.1365-2419.2010.00535.x; Lough RG, 2005, FISH OCEANOGR, V14, P241, DOI 10.1111/j.1365-2419.2005.00330.x; MACKENZIE BR, 1993, MAR ECOL PROG SER, V94, P207, DOI 10.3354/meps094207; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Meekan MG, 2006, MAR ECOL PROG SER, V317, P237, DOI 10.3354/meps317237; MILLER TJ, 1997, EARLY LIFE HIST RECR; Mueter FJ, 2009, PROG OCEANOGR, V81, P93, DOI 10.1016/j.pocean.2009.04.018; Orlova EL, 2005, ICES J MAR SCI, V62, P1281, DOI 10.1016/j.icesjms.2005.05.020; Ottersen G, 2000, ICES J MAR SCI, V57, P339, DOI 10.1006/jmsc.1999.0529; Ottersen G, 2006, FISH OCEANOGR, V15, P230, DOI 10.1111/j.1365-2419.2006.00404.x; Paradis AR, 1996, CAN J FISH AQUAT SCI, V53, P1226, DOI 10.1139/cjfas-53-6-1226; Peck MA, 2006, ENVIRON BIOL FISH, V75, P419, DOI 10.1007/s10641-006-0031-3; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; POPE JG, 1994, PHILOS T ROY SOC B, V343, P41, DOI 10.1098/rstb.1994.0006; RICHARDSON AJ, 2004, SCIENCE, P305; Siegel DA, 2002, SCIENCE, V296, P730, DOI 10.1126/science.1069174; Skartveit A, 1998, SOL ENERGY, V63, P173, DOI 10.1016/S0038-092X(98)00067-X; Stock CA, 2008, J MARINE SYST, V74, P134, DOI 10.1016/j.jmarsys.2007.12.004; SUNDBY S, 1994, ICES MAR SC, V198, P393; SUNDBY S, 1989, RAP PROCES, V191, P351; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Vollset KW, 2009, J EXP MAR BIOL ECOL, V379, P16, DOI 10.1016/j.jembe.2009.08.013	58	109	109	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17456	10.1371/journal.pone.0017456	http://dx.doi.org/10.1371/journal.pone.0017456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408215	Green Submitted, Green Published, gold			2022-12-27	WOS:000288099800012
J	Kayali, G; Webby, RJ; Ducatez, MF; El Shesheny, RA; Kandeil, AM; Govorkova, EA; Mostafa, A; Ali, MA				Kayali, Ghazi; Webby, Richard J.; Ducatez, Mariette F.; El Shesheny, Rabeh A.; Kandeil, Ahmed M.; Govorkova, Elena A.; Mostafa, Ahmed; Ali, Mohamed A.			The Epidemiological and Molecular Aspects of Influenza H5N1 Viruses at the Human-Animal Interface in Egypt	PLOS ONE			English	Article							A H5N1; NEURAMINIDASE INHIBITORS; CASE-FATALITY; INFECTION; VIRULENCE; INDONESIA; OUTBREAKS; DIARRHEA; DISEASE; BIRD	With 119 confirmed cases between March 2006 and December 2010, Egypt ranks second among countries reporting human H5N1 influenza virus infections. In 2009-2010, Egypt reported 68 new human cases and became the new epicenter for H5N1 infections. We conducted an epidemiological and molecular analysis in order to better understand the situation in Egypt. The onset of new cases peaked annually during the winter and spring months, with majority of cases reported in the Nile Delta region. Most cases were less than 18 years old (62%) and females (60%). The overall case-fatality rate was 34% and significantly increased by age. There was a significant difference between the case-fatality rates among females and males. We observed a significant drop (p = 0.004) in case fatality rate in 2009 (10%) as compared to higher rates (36%-56%) in other years. Hospitalization within 2 or 3 days after onset of symptoms significantly decreased mortality. Molecular analysis showed that variations do occur among viruses isolated from birds as well as from humans in Egypt, and these mutations were especially noted in 2009 viruses. As the epidemiological profile of Egyptian cases differs from other countries, there is an urgent need to conduct prospective studies to enhance our understanding of incidence, prevalence, and determinants of virulence of human infections with avian H5N1 influenza viruses.	[Kayali, Ghazi; Webby, Richard J.; Ducatez, Mariette F.; Govorkova, Elena A.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [El Shesheny, Rabeh A.; Kandeil, Ahmed M.; Mostafa, Ahmed; Ali, Mohamed A.] Natl Res Ctr, Virol Lab, Div Environm Res, Cairo, Egypt	St Jude Children's Research Hospital; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Kayali, G (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.	ghazi.kayali@stjude.org	Kandeil, Ahmed/N-5473-2019; Kandeil, Ahmed Mohamed/B-3345-2016; Mostafa, Ahmed/S-7462-2016; Ali, Mohamed A/N-8768-2017; El-shesheny, Rabeh/S-7927-2016; Webby, Richard J/N-5657-2018	Kandeil, Ahmed/0000-0003-3253-6961; Kandeil, Ahmed Mohamed/0000-0003-3253-6961; Mostafa, Ahmed/0000-0002-2878-5714; Ali, Mohamed A/0000-0002-5615-3212; El-shesheny, Rabeh/0000-0002-8798-2240; Govorkova, Elena/0000-0001-9067-5682	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700005C]; American Lebanese Syrian Associated Charities	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN266200700005C, and by the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2006, ANTIVIR THER, V11, P971; Al-Azemi A, 2008, EMERG INFECT DIS, V14, P958, DOI 10.3201/eid1406.080056; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P410; Arabi Y, 2007, CRIT CARE MED, V35, P1397, DOI 10.1097/01.CCM.0000262940.34596.4B; Arafa A, 2010, AVIAN DIS, V54, P345, DOI 10.1637/8927-051509-ResNote.1; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; DUDLEY JP, 2009, EUROSURVEILL, V14; *EG CAB, 2006, AN POULTR IND STRUCT; FASINA FO, EUROSURVEILL, V15, P19473; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hui DSC, 2008, RESPIROLOGY, V13, pS10, DOI 10.1111/j.1440-1843.2008.01247.x; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kandeel A, 2010, EMERG INFECT DIS, V16, P1101, DOI 10.3201/eid1607.091695; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Li FCK, 2008, J EPIDEMIOL COMMUN H, V62, P555, DOI 10.1136/jech.2007.064030; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Nicoll Angus, 2006, Euro Surveill, V11, P74; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Slomka MJ, 2007, AVIAN DIS, V51, P227, DOI 10.1637/7674-063006R1.1; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; WEBSTER RG, 1993, INTERVIROLOGY, V35, P16, DOI 10.1159/000150292; WHO, 2009, H5N1 AV INFL TIM MAJ; WHO, 2006, WKLY EPIDEMIOL REC, V81, P249; Wiwanitkit V, 2005, GUT, V54, P1506, DOI 10.1136/gut.2005.072488; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; World Health Organization, 2009, EP PAND AL RESP; World Health Organization, 2009, WHO INF LAB DIAGN PA; WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180, DOI 10.1128/JCM.33.5.1180-1184.1995; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985	42	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17730	10.1371/journal.pone.0017730	http://dx.doi.org/10.1371/journal.pone.0017730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445292	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300011
J	Fan, YF; Fan, YB; Li, ZY; Lv, CS; Luo, DL				Fan, Yifang; Fan, Yubo; Li, Zhiyu; Lv, Changsheng; Luo, Donglin			Natural Gaits of the Non-Pathological Flat Foot and High-Arched Foot	PLOS ONE			English	Article							EVOLUTION; FOOTPRINT	There has been a controversy as to whether or not the non-pathological flat foot and high-arched foot have an effect on human walking activities. The 3D foot scanning system was employed to obtain static footprints from subjects adopting a half-weight-bearing stance. Based upon their footprints, the subjects were divided into two groups: the flat-footed and the high-arched. The plantar pressure measurement system was used to measure and record the subjects' successive natural gaits. Two indices were proposed: distribution of vertical ground reaction force (VGRF) of plantar and the rate of change of footprint areas. Using these two indices to compare the natural gaits of the two subject groups, we found that (1) in stance phase, there is a significant difference (p < 0.01) in the distributions of VGRF of plantar; (2) in a stride cycle, there is also a significant difference (p < 0.01) in the rate of change of footprint area. Our analysis suggests that when walking, the VGRF of the plantar brings greater muscle tension to the flat-footed while a smaller rate of change of footprint area brings greater stability to the high-arched.	[Fan, Yifang; Lv, Changsheng; Luo, Donglin] Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China; [Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing, Peoples R China; [Li, Zhiyu] Jinan Univ, Coll Foreign Studies, Guangzhou, Guangdong, Peoples R China	Guangzhou Sport University; Beihang University; Jinan University	Fan, YF (corresponding author), Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China.	tfyf@gipe.edu.cn; yubofan@buaa.edu.cn	Fan, Yifang/V-6281-2019	Fan, Yifang/0000-0001-5338-9847	National Natural Science Foundation of China [10772053, 10925208, 10972061]; Natural Science Research of Guangdong Higher Education [06Z019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Research of Guangdong Higher Education	This project was funded by National Natural Science Foundation of China under the grant 10772053, 10925208, 10972061 and by Key Project of Natural Science Research of Guangdong Higher Education Grant No 06Z019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAN CW, 1994, MAYO CLIN PROC, V69, P448, DOI 10.1016/S0025-6196(12)61642-5; Chen CH, 2006, ARCH PHYS MED REHAB, V87, P235, DOI 10.1016/j.apmr.2005.10.014; Chen MJL, 2003, AM J PHYS MED REHAB, V82, P842, DOI 10.1097/01.PHM.0000087455.38062.79; Chesnin KJ, 2000, GAIT POSTURE, V12, P128, DOI 10.1016/S0966-6362(00)00071-0; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Colne P, 2008, GAIT POSTURE, V28, P164, DOI 10.1016/j.gaitpost.2007.11.006; Dowling AM, 2001, INT J OBESITY, V25, P845, DOI 10.1038/sj.ijo.0801598; Esterman A, 2005, MIL MED, V170, P623, DOI 10.7205/MILMED.170.7.623; Fan YF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/58003; FAN YF, 2010, DYNAMIC PRINCIPLES C; Gefen A, 2001, CLIN BIOMECH, V16, P921, DOI 10.1016/S0268-0033(01)00074-2; Igbigbi P S, 2002, J Foot Ankle Surg, V41, P394; Kanatli U, 2001, J PEDIATR ORTHOPED, V21, P225, DOI 10.1097/00004694-200103000-00018; Lin CJ, 2001, J PEDIATR ORTHOPED, V21, P378, DOI 10.1097/00004694-200105000-00022; Mochimaru M, 2000, ERGONOMICS, V43, P1301, DOI 10.1080/001401300421752; NATTIV A, 2000, WOMEN SPORT TRACK FI; Orlin MN, 2000, PHYS THER, V80, P399, DOI 10.1093/ptj/80.4.399; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Reid SM, 2010, GAIT POSTURE, V31, P197, DOI 10.1016/j.gaitpost.2009.10.005; SALTZMAN CL, 1995, J ORTHOP SPORT PHYS, V21, P354, DOI 10.2519/jospt.1995.21.6.354; SUSMAN RL, 1983, FOOT ANKLE, V3, P365, DOI 10.1177/107110078300300605; Walczak Michal, 2003, Chir Narzadow Ruchu Ortop Pol, V68, P261; Wang WJ, 2004, J BIOMECH, V37, P1831, DOI 10.1016/j.jbiomech.2004.02.036; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; Younger AS, 2005, FOOT ANKLE INT, V26, P820, DOI 10.1177/107110070502601006	25	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17749	10.1371/journal.pone.0017749	http://dx.doi.org/10.1371/journal.pone.0017749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445254	gold, Green Submitted, Green Published			2022-12-27	WOS:000288545100028
J	Shaner, PJL; Macko, SA				Shaner, Pei-Jen L.; Macko, Stephen A.			Trophic Shifts of a Generalist Consumer in Response to Resource Pulses	PLOS ONE			English	Article							STABLE-ISOTOPES; PEROMYSCUS-LEUCOPUS; CALLORHINUS-URSINUS; FOOD-HABITS; NITROGEN; CARBON; DIET; MAMMALS; RODENT; TISSUE	Trophic shifts of generalist consumers can have broad food-web and biodiversity consequences through altered trophic flows and vertical diversity. Previous studies have used trophic shifts as indicators of food-web responses to perturbations, such as species invasion, and spatial or temporal subsidies. Resource pulses, as a form of temporal subsidies, have been found to be quite common among various ecosystems, affecting organisms at multiple trophic levels. Although diet switching of generalist consumers in response to resource pulses is well documented, few studies have examined if the switch involves trophic shifts, and if so, the directions and magnitudes of the shifts. In this study, we used stable carbon and nitrogen isotopes with a Bayesian multi-source mixing model to estimate proportional contributions of three trophic groups (i.e. producer, consumer, and fungus-detritivore) to the diets of the White-footed mouse (Peromyscus leucopus) receiving an artificial seed pulse or a naturally-occurring cicadas pulse. Our results demonstrated that resource pulses can drive trophic shifts in the mice. Specifically, the producer contribution to the mouse diets was increased by 32% with the seed pulse at both sites examined. The consumer contribution to the mouse diets was also increased by 29% with the cicadas pulse in one of the two grids examined. However, the pattern was reversed in the second grid, with a 13% decrease in the consumer contribution with the cicadas pulse. These findings suggest that generalist consumers may play different functional roles in food webs under perturbations of resource pulses. This study provides one of the few highly quantitative descriptions on dietary and trophic shifts of a key consumer in forest food webs, which may help future studies to form specific predictions on changes in trophic interactions following resource pulses.	[Shaner, Pei-Jen L.] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Shaner, Pei-Jen L.; Macko, Stephen A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	National Taiwan Normal University; University of Virginia	Shaner, PJL (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	pshaner@ntnu.edu.tw	Shaner, Pei-Jen/B-2955-2012; Macko, Stephen/K-4588-2015	Shaner, Pei-Jen/0000-0001-8112-4299	National Science Foundation [NSF DEB 0411027]	National Science Foundation(National Science Foundation (NSF))	The study was partially supported by a National Science Foundation Dissertation Improvement Grant (NSF DEB 0411027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	CLARIDGE AW, 1994, AUST J ECOL, V19, P251, DOI 10.1111/j.1442-9993.1994.tb00489.x; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Davidson DL, 2001, FUNCT ECOL, V15, P575, DOI 10.1046/j.0269-8463.2001.00569.x; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Elias SP, 2004, J MAMMAL, V85, P743, DOI 10.1644/BER-025; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Johnson CN, 1996, TRENDS ECOL EVOL, V11, P503, DOI 10.1016/S0169-5347(96)10053-7; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kurle CM, 2002, MAR ECOL PROG SER, V236, P289, DOI 10.3354/meps236289; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; MacAvoy SE, 2005, CAN J ZOOL, V83, P631, DOI 10.1139/Z05-038; MacAvoy SE, 2006, OECOLOGIA, V150, P190, DOI 10.1007/s00442-006-0522-0; Marcello GJ, 2008, J ANIM ECOL, V77, P41, DOI 10.1111/j.1365-2656.2007.01310.x; MASER C, 1978, ECOLOGY, V59, P799, DOI 10.2307/1938784; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; McCracken KE, 1999, J MAMMAL, V80, P1288, DOI 10.2307/1383179; Mcilwee AP, 1998, FUNCT ECOL, V12, P223, DOI 10.1046/j.1365-2435.1998.00181.x; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Moreno R, 2010, MAR BIOL, V157, P545, DOI 10.1007/s00227-009-1340-9; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ostfeld RS, 1996, BIOSCIENCE, V46, P323, DOI 10.2307/1312946; PAINE RT, 1980, J ANIM ECOL, V49, P667; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; PULLIAM HR, 1975, AM NAT, V109, P765, DOI 10.1086/283041; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Schmidt KA, 2003, ECOLOGY, V84, P406, DOI 10.1890/0012-9658(2003)084[0406:SPIFEP]2.0.CO;2; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Schnurr JL, 2002, OIKOS, V96, P402, DOI 10.1034/j.1600-0706.2002.960302.x; Sears ALW, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P359; Shaner PJ, 2007, ECOLOGY, V88, P87, DOI 10.1890/0012-9658(2007)88[87:GDADSI]2.0.CO;2; Stancampiano Anthony J., 1995, Proceedings of the Oklahoma Academy of Science, V75, P45; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Storm Jonathan J., 2007, Proceedings of the Indiana Academy of Science, V116, P196; Thebault E, 2003, P NATL ACAD SCI USA, V100, P14949, DOI 10.1073/pnas.2434847100; Vandegrift KJ, 2009, J ANIM ECOL, V78, P202, DOI 10.1111/j.1365-2656.2008.01456.x; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; WHITAKER JO, 1966, J MAMMAL, V47, P473, DOI 10.2307/1377688; Wise DH, 2006, ECOL APPL, V16, P865, DOI 10.1890/1051-0761(2006)016[0865:USITRS]2.0.CO;2; WOLFF JO, 1985, J MAMMAL, V66, P795, DOI 10.2307/1380812; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2006, P ROY SOC B-BIOL SCI, V273, P2993, DOI 10.1098/rspb.2006.3676; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; YONEYAMA T, 1983, Radioisotopes, V32, P330	55	13	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17970	10.1371/journal.pone.0017970	http://dx.doi.org/10.1371/journal.pone.0017970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437248	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100051
J	Tao, J; Shi, JA; Yan, L; Chen, Y; Duan, YH; Ye, P; Feng, Q; Zhang, JW; Shu, XQ; Ji, YH				Tao, Jie; Shi, Jian; Yan, Li; Chen, Ying; Duan, Yan Hong; Ye, Pin; Feng, Qi; Zhang, Jian Wei; Shu, Xue Qin; Ji, Yong Hua			Enhancement Effects of Martentoxin on Glioma BK Channel and BK Channel (alpha+beta 1) Subtypes	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; ACTION-POTENTIAL REPOLARIZATION; CA2+-ACTIVATED K+ CHANNEL; CA1 PYRAMIDAL NEURONS; SMOOTH-MUSCLE; BETA-SUBUNIT; CALCIUM; CELLS; CONDUCTANCE; EXPRESSION	Background: BK channels are usually activated by membrane depolarization and cytoplasmic Ca(2+). Especially, the activity of BK channel (alpha+beta 4) can be modulated by martentoxin, a 37 residues peptide, with Ca(2+) -dependent manner. gBK channel (glioma BK channel) and BK channel (alpha+beta 1) possessed higher Ca(2+) sensitivity than other known BK channel subtypes. Methodology and Principal Findings: The present study investigated the modulatory characteristics of martentoxin on these two BK channel subtypes by electrophysiological recordings, cell proliferation and Ca(2+) imaging. In the presence of cytoplasmic Ca(2+), martentoxin could enhance the activities of both gBK and BK channel (alpha+beta 1) subtypes in dose-dependent manner with EC(50) of 46.7 nM and 495 nM respectively, while not shift the steady-state activation of these channels. The enhancement ratio of martentoxin on gBK and BK channel (alpha+beta 1) was unrelated to the quantitive change of cytoplasmic Ca(2+) concentrations though the interaction between martentoxin and BK channel (alpha+beta 1) was accelerated under higher cytoplasmic Ca(2+). The selective BK pore blocker iberiotoxin could fully abolish the enhancement of these two BK subtypes induced by martentoxin, suggesting that the auxiliary beta subunit might contribute to the docking for martentoxin. However, in the absence of cytoplasmic Ca(2+), the activity of gBK channel would be surprisingly inhibited by martentoxin while BK channel (alpha+beta 1) couldn't be affected by the toxin. Conclusions and Significance: Thus, the results shown here provide the novel evidence that martentoxin could increase the two Ca(2+) -hypersensitive BK channel subtypes activities in a new manner and indicate that beta subunit of these BK channels plays a vital role in this enhancement by martentoxin.	[Tao, Jie; Shi, Jian; Yan, Li; Chen, Ying; Duan, Yan Hong; Ye, Pin; Feng, Qi; Zhang, Jian Wei; Shu, Xue Qin; Ji, Yong Hua] Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai, Peoples R China	Shanghai University	Tao, J (corresponding author), Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai, Peoples R China.	yhji@staff.shu.edu.cn	Ji, Yonghua/B-7769-2014; Tao, Jie/AAF-7766-2020		National Basic Research Program of China [2010CB529806]; National Nature Sciences Foundation of China [30772554]; Shanghai Municipal Education Commission; National Laboratory of Biomacromolecules [O5SY021097]; Institute of Biophysics, Chinese Academy of Sciences, Shanghai University	National Basic Research Program of China(National Basic Research Program of China); National Nature Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); National Laboratory of Biomacromolecules; Institute of Biophysics, Chinese Academy of Sciences, Shanghai University(Shanghai UniversityChinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China (grant 2010CB529806), the National Nature Sciences Foundation of China (grant 30772554), and the Leading Academic Discipline Project of Shanghai Municipal Education Commission "Molecular Physiology," National Laboratory of Biomacromolecules (grant O5SY021097), Institute of Biophysics, Chinese Academy of Sciences and Innovation Fund for Graduate Student, Shanghai University. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brenner S, 2000, CLIN DERMATOL, V18, P711, DOI 10.1016/S0738-081X(00)00154-1; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hurley BR, 1999, AM J PHYSIOL-GASTR L, V276, pG843, DOI 10.1152/ajpgi.1999.276.4.G843; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Ji YH, 2003, J NEUROCHEM, V84, P325, DOI 10.1046/j.1471-4159.2003.01516.x; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Kraft R, 2003, PFLUG ARCH EUR J PHY, V446, P248, DOI 10.1007/s00424-003-1012-4; Lingle C J, 1996, Ion Channels, V4, P261; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; MACDERMOTT AB, 1982, NATURE, V300, P185, DOI 10.1038/300185a0; MARTY A, 1989, TRENDS NEUROSCI, V12, P420, DOI 10.1016/0166-2236(89)90090-8; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Navarro-Antolin J, 2005, CIRCULATION, V112, P1309, DOI 10.1161/CIRCULATIONAHA.104.529404; Nelson MT, 2004, J CLIN INVEST, V113, P955, DOI 10.1172/JCI200421388; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Olsen ML, 2005, J NEUROSCI RES, V81, P179, DOI 10.1002/jnr.20543; PALLOTTA BS, 1985, J GEN PHYSIOL, V86, P601, DOI 10.1085/jgp.86.5.601; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Poolos NP, 1999, J NEUROSCI, V19, P5205; Ransom CB, 2002, GLIA, V38, P281, DOI 10.1002/glia.10064; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; SHI J, 2008, BIOPHYS J; Shi J, 2008, BIOPHYS J, V94, P3706, DOI 10.1529/biophysj.107.122150; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang B, 2006, J GEN PHYSIOL, V127, P449, DOI 10.1085/jgp.200509436; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Wiecha J, 1998, J VASC RES, V35, P363, DOI 10.1159/000025606; Yoshida J, 2004, HUM GENE THER, V15, P77, DOI 10.1089/10430340460732472; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e15896	10.1371/journal.pone.0015896	http://dx.doi.org/10.1371/journal.pone.0015896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445248	gold, Green Published, Green Submitted			2022-12-27	WOS:000288545100007
J	Kujjo, LL; Chang, EA; Pereira, RJG; Dhar, S; Marrero-Rosado, B; Sengupta, S; Wang, HB; Cibelli, JB; Perez, GI				Kujjo, Loro L.; Chang, Eun A.; Pereira, Ricardo J. G.; Dhar, Shilpa; Marrero-Rosado, Brenda; Sengupta, Satyaki; Wang, Hongbing; Cibelli, Jose B.; Perez, Gloria I.			Chemotherapy-Induced Late Transgenerational Effects in Mice	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; RING-SHAPED NUCLEI; CHILDHOOD-CANCER; ANTICANCER DRUGS; FEMALE SURVIVORS; BONE-MARROW; DOXORUBICIN; FERTILITY; APOPTOSIS; GENE	To our knowledge, there is no report on long-term reproductive and developmental side effects in the offspring of mothers treated with a widely used chemotherapeutic drug such as doxorubicin (DXR), and neither is there information on transmission of any detrimental effects to several filial generations. Therefore, the purpose of the present paper was to examine the long-term effects of a single intraperitoneal injection of DXR on the reproductive and behavioral performance of adult female mice and their progeny. C57BL/6 female mice (generation zero; G0) were treated with either a single intraperitoneal injection of DXR (G0-DXR) or saline (G0-CON). Data were collected on multiple reproductive parameters and behavioral analysis for anxiety, despair and depression. In addition, the reproductive capacity and health of the subsequent six generations were evaluated. G0-DXR females developed despair-like behaviors; delivery complications; decreased primordial follicle pool; and early lost of reproductive capacity. Surprisingly, the DXR-induced effects in oocytes were transmitted transgenerationally; the most striking effects being observed in G4 and G6, constituting: increased rates of neonatal death; physical malformations; chromosomal abnormalities (particularly deletions on chromosome 10); and death of mothers due to delivery complications. None of these effects were seen in control females of the same generations. Long-term effects of DXR in female mice and their offspring can be attributed to genetic alterations or cell-killing events in oocytes or, presumably, to toxicosis in non-ovarian tissues. Results from the rodent model emphasize the need for retrospective and long-term prospective studies of survivors of cancer treatment and their offspring.	[Kujjo, Loro L.; Pereira, Ricardo J. G.; Dhar, Shilpa; Marrero-Rosado, Brenda; Sengupta, Satyaki; Wang, Hongbing; Cibelli, Jose B.; Perez, Gloria I.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Kujjo, Loro L.] Michigan State Univ, Dept Human Anat, E Lansing, MI 48824 USA; [Chang, Eun A.; Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Cibelli, Jose B.; Perez, Gloria I.] LARCel, Programa Andaluz Terapia Celular & Med Regenerat, Seville, Spain	Michigan State University; Michigan State University; Michigan State University	Kujjo, LL (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	perezg@msu.edu	Perez, Gloria I/GMX-1286-2022; Sengupta, Satyaki/AAD-6065-2022; Pereira, Ricardo/C-7200-2012	Pereira, Ricardo/0000-0003-3908-1007; Cibelli, Jose/0000-0002-2176-3854	Department of Physiology at Michigan State University; Fundacion Progreso y Salud (Seville, Spain);  [05-IRGP-400 MSU]	Department of Physiology at Michigan State University; Fundacion Progreso y Salud (Seville, Spain); 	This work was supported by 05-IRGP-400 MSU, the Department of Physiology at Michigan State University, and Fundacion Progreso y Salud (Seville, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Aluise CD, 2010, ADV EXP MED BIOL, V678, P147; Bath LE, 2002, BJOG-INT J OBSTET GY, V109, P107, DOI 10.1111/j.1471-0528.2002.t01-1-01007.x; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; Bishop JB, 1997, FUND APPL TOXICOL, V40, P191, DOI 10.1006/faat.1997.2379; Bishop JB, 2002, ADV EXP MED BIOL, V518, P1; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Chinnery PF, 1993, GENEREVIEWS; CHINNERY PF, 2010, MITOCHONDRIAL DISORD; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Critchley HOD, 2007, NAT CLIN PRACT ONCOL, V4, P84, DOI 10.1038/ncponc0697; Critchley Hilary O D, 2005, J Natl Cancer Inst Monogr, P64; Dalvi A, 1999, PSYCHOPHARMACOLOGY, V147, P14, DOI 10.1007/s002130051131; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Falkenberg JH, 2002, MUSCLE NERVE, V25, P735, DOI 10.1002/mus.10082; Fox E, 2009, J NATL CANCER I, V101, P1105, DOI 10.1093/jnci/djp238; Grady MC, 2006, MATERN CHILD HLTH J, V10, pS165, DOI 10.1007/s10995-006-0103-1; Green DM, 2007, PEDIATR BLOOD CANCER, V48, P718, DOI 10.1002/pbc.21116; Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839; Green DM, 2009, J CLIN ONCOL, V27, P2677, DOI 10.1200/JCO.2008.20.1541; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Heck K E, 1997, Matern Child Health J, V1, P81, DOI 10.1023/A:1026218322723; Hofhaus G, 1999, BIOL CHEM, V380, P871, DOI 10.1515/BC.1999.107; Jacquet P, 1998, CANCER CHEMOTH PHARM, V41, P147; JANSEN CE, 2010, SUPPORT CARE CANC; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Kasapovic J, 2010, CLIN BIOCHEM, V43, P1287, DOI 10.1016/j.clinbiochem.2010.08.009; KATOH MA, 1990, MUTAT RES, V230, P205, DOI 10.1016/0027-5107(90)90058-C; Kujjo LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009204; Lai HC, 2010, EUR J PHARMACOL, V644, P176, DOI 10.1016/j.ejphar.2010.07.010; LANGENHUIJSEN MMAC, 1984, BRIT J HAEMATOL, V58, P227, DOI 10.1111/j.1365-2141.1984.tb06080.x; LISTED NA, 1992, ONCOLOGY WILLISTON P, V6, P84; Madanat-Harjuoja LM, 2010, INT J CANCER, V127, P1669, DOI 10.1002/ijc.25157; Mariotto AB, 2009, CANCER EPIDEM BIOMAR, V18, P1033, DOI 10.1158/1055-9965.EPI-08-0988; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; McLoon LK, 2001, INVEST OPHTH VIS SCI, V42, P1254; Montaigne D, 2011, MITOCHONDRION, V11, P22, DOI 10.1016/j.mito.2010.06.001; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Nagar S, 2010, ADV EXP MED BIOL, V678, P124; NAGY A, 2008, KARYOTYPING MOUSE CE; Nakayama K, 2008, NAT CLIN PRACT ONCOL, V5, P78, DOI 10.1038/ncponc1016; Oktay K, 2008, CURR OPIN OBSTET GYN, V20, P408, DOI 10.1097/GCO.0b013e328307ebad; Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901; Patel N, 2010, TOXICOL APPL PHARM, V245, P143, DOI 10.1016/j.taap.2010.02.002; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 2000, NATURE, V403, P500, DOI 10.1038/35000651; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Perez GI, 2007, P NATL ACAD SCI USA, V104, P5229, DOI 10.1073/pnas.0608557104; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rowan K, 2010, J NATL CANCER I, V102, P294, DOI 10.1093/jnci/djq053; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Salooja N, 2001, LANCET, V358, P271, DOI 10.1016/S0140-6736(01)05482-4; Schover LR, 2008, J CLIN ONCOL, V26, P753, DOI 10.1200/JCO.2007.14.1655; Schover LR, 2009, J CLIN ONCOL, V27, P321, DOI 10.1200/JCO.2008.19.7749; Signore LB, 2010, LANCET, V376, P624, DOI 10.1016/S0140-6736(10)60752-0; Signorello LB, 2006, JNCI-J NATL CANCER I, V98, P1453, DOI 10.1093/jnci/djj394; St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002; STAVEM P, 1985, BRIT J HAEMATOL, V59, P559, DOI 10.1111/j.1365-2141.1985.tb07346.x; Stovall M, 2004, INT J RADIAT ONCOL, V60, P542, DOI 10.1016/j.ijrobp.2004.03.017; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Takai Y, 2003, ENDOCRINOLOGY, V144, P69, DOI 10.1210/en.2002-220814; Ting AY, 2010, J ASSIST REPROD GEN, V27, P591, DOI 10.1007/s10815-010-9463-y; TRASLER JM, 1986, BIOL REPROD, V34, P275, DOI 10.1095/biolreprod34.2.275; Veitia RA, 2007, STEM CELLS, V25, P1334, DOI 10.1634/stemcells.2006-0770; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Winther JF, 2008, J CLIN ONCOL, V26, P4340, DOI 10.1200/JCO.2007.15.2884; Witt KL, 1996, MUTAT RES-FUND MOL M, V355, P209, DOI 10.1016/0027-5107(96)00029-2; Wyrobek AJ, 2007, ENVIRON MOL MUTAGEN, V48, P71, DOI 10.1002/em.20284	76	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17877	10.1371/journal.pone.0017877	http://dx.doi.org/10.1371/journal.pone.0017877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437292	gold, Green Published, Green Submitted			2022-12-27	WOS:000288514600014
J	Martino, NA; Lange-Consiglio, A; Cremonesi, F; Valentini, L; Caira, M; Guaricci, AC; Ambruosi, B; Sciorsci, RL; Lacalandra, GM; Reshkin, SJ; Dell'Aquila, ME				Martino, Nicola Antonio; Lange-Consiglio, Anna; Cremonesi, Fausto; Valentini, Luisa; Caira, Michele; Guaricci, Antonio Ciro; Ambruosi, Barbara; Sciorsci, Raffaele Luigi; Lacalandra, Giovanni Michele; Reshkin, Stephan Joel; Dell'Aquila, Maria Elena			Functional Expression of the Extracellular Calcium Sensing Receptor (CaSR) in Equine Umbilical Cord Matrix Size-Sieved Stem Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OUTWARD K+ CHANNEL; VITAMIN-D-RECEPTOR; CA2+-SENSING RECEPTOR; CALCIMIMETIC COMPOUND; PARATHYROID-GLAND; AMNIOTIC-FLUID; CA2+ RECEPTOR; UP-REGULATION; NPS R-467	Background: The present study investigates the effects of high external calcium concentration ([Ca2+](o)) and the calcimimetic NPS R-467, a known calcium-sensing receptor (CaSR) agonist, on growth/proliferation of two equine size-sieved umbilical cord matrix mesenchymal stem cell (eUCM-MSC) lines. The involvement of CaSR on observed cell response was analyzed at both the mRNA and protein level. Methodology/Principal Findings: A large (> 8 mu m in diameter) and a small (< 8 mu m) cell line were cultured in medium containing: 1) low [Ca2+](o) (0.37 mM); 2) high [Ca2+](o) (2.87 mM); 3) NPS R-467 (3 mu M) in presence of high [Ca2+](o) and 4) the CaSR antagonist NPS 2390 (10 mu M for 30 min.) followed by incubation in presence of NPS R-467 in medium with high [Ca2+](o). Growth/proliferation rates were compared between groups. In large cells, the addition of NPS R-467 significantly increased cell growth whereas increasing [Ca2+](o) was not effective in this cell line. In small cells, both higher [Ca2+](o) and NPS R-467 increased cell growth. In both cell lines, preincubation with the CaSR antagonist NPS 2390 significantly inhibited the agonistic effect of NPS R-467. In both cell lines, increased [Ca2+](o) and/or NPS R-467 reduced doubling time values. Treatment with NPS R-467 down-regulated CaSR mRNA expression in both cell lines. In large cells, NPS R-467 reduced CaSR labeling in the cytosol and increased it at cortical level. Conclusions/Significance: In conclusion, calcium and the calcimimetic NPS R-467 reduce CaSR mRNA expression and stimulate cell growth/proliferation in eUCM-MSC. Their use as components of media for eUCM-MSC culture could be beneficial to obtain enough cells for down-stream purposes.	[Martino, Nicola Antonio; Valentini, Luisa; Caira, Michele; Guaricci, Antonio Ciro; Ambruosi, Barbara; Sciorsci, Raffaele Luigi; Lacalandra, Giovanni Michele; Dell'Aquila, Maria Elena] Univ Bari, Dept Anim Prod, Fac Biotechnol Sci, Bari, Italy; [Lange-Consiglio, Anna; Cremonesi, Fausto] Univ Milan, Fac Vet Med, Reprod Unit, Large Anim Hosp, Lodi, Italy; [Reshkin, Stephan Joel] Univ Bari, Fac Sci, Dept Gen & Environm Physiol, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Milan; Universita degli Studi di Bari Aldo Moro	Martino, NA (corresponding author), Univ Bari, Dept Anim Prod, Fac Biotechnol Sci, Bari, Italy.	nicmartino@libero.it	Cremonesi, Fausto/J-2506-2014; Reshkin, Stephan/AAI-6680-2020; Lange-Consiglio, Anna/AAI-4146-2021; LACALANDRA, Giovanni Michele/P-4661-2014; Martino, Nicola/AAP-9891-2020; Martino, Nicola Antonio/N-4096-2014	Cremonesi, Fausto/0000-0001-8399-4626; Reshkin, Stephan/0000-0001-9757-5908; Lange-Consiglio, Anna/0000-0002-7748-3413; CAIRA, Michele/0000-0002-0394-9153; Martino, Nicola Antonio/0000-0001-6853-2757; Sciorsci, Raffaele Luigi/0000-0002-1141-3084; Dell'Aquila, Maria Elena/0000-0003-3629-7005; Valentini, Luisa/0000-0002-0030-5141; Lacalandra, Giovanni M/0000-0001-9109-3561	"Progetto di Ricerca finanziabile con Fondi di Ateneo per l'anno 2009". (Resp. Sci. Maria Elena Dell'Aquila) Universita degli Studi di Bari "Aldo Moro" [COD. ORBA09UDWX]; Academic Center of Excellence "Comparative Genomics: Genes Involved in Physiopathological Processes in the Biomedical And Agricultural Fields" University of Bari "Aldo Moro" Italy	"Progetto di Ricerca finanziabile con Fondi di Ateneo per l'anno 2009". (Resp. Sci. Maria Elena Dell'Aquila) Universita degli Studi di Bari "Aldo Moro"; Academic Center of Excellence "Comparative Genomics: Genes Involved in Physiopathological Processes in the Biomedical And Agricultural Fields" University of Bari "Aldo Moro" Italy	This work was supported by "Progetto di Ricerca finanziabile con Fondi di Ateneo per l'anno 2009". (Resp. Sci. Maria Elena Dell'Aquila) Universita degli Studi di Bari "Aldo Moro" (COD. ORBA09UDWX). This work was supported by the Academic Center of Excellence "Comparative Genomics: Genes Involved in Physiopathological Processes in the Biomedical And Agricultural Fields" University of Bari "Aldo Moro" Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom M, 2008, BONE, V42, P483, DOI 10.1016/j.bone.2007.10.025; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bhagavathula N, 2005, BRIT J CANCER, V93, P1364, DOI 10.1038/sj.bjc.6602852; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; Carrillo-Lopez N, 2008, NEPHROL DIAL TRANSPL, V23, P3479, DOI 10.1093/ndt/gfn338; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chattopadhyay N, 2004, ENDOCRINOLOGY, V145, P3451, DOI 10.1210/en.2003-1127; Chattopadhyay N, 1999, J NEUROCHEM, V72, P1915, DOI 10.1046/j.1471-4159.1999.0721915.x; Chattopadhyay N, 1998, GLIA, V24, P449, DOI 10.1002/(SICI)1098-1136(199812)24:4<449::AID-GLIA10>3.3.CO;2-0; Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003; Chen RA, 2004, AM J PHYSIOL-RENAL, V286, pF1005, DOI 10.1152/ajprenal.00013.2004; Chikatsu N, 2000, J BIOL CHEM, V275, P7553, DOI 10.1074/jbc.275.11.7553; Choi SA, 2010, REPROD FERT DEVELOP, V22, P346, DOI 10.1071/RDv22n1Ab380; Consiglio AL, 2010, REPROD FERT DEVELOP, V22, P349; Corradetti B, 2010, REPROD FERT DEVELOP, V22, P347; Cremonesi F, 2008, VET RES COMMUN, V32, pS139, DOI 10.1007/s11259-008-9116-0; De Santis T, 2009, REPRODUCTION, V138, P439, DOI 10.1530/REP-09-0078; Dell'Aquila ME, 2006, FERTIL STERIL, V85, P1240, DOI 10.1016/j.fertnstert.2005.11.033; Diao YZ, 2009, J BIOMED MATER RES A, V91A, P123, DOI 10.1002/jbm.a.32186; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fu-Jiang C, 2009, CHINESE MED J-PEKING, V122, P225, DOI 10.3760/cma.j.issn.0366-6999.2009.02.021; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Hammerland LG, 1998, MOL PHARMACOL, V53, P1083; Hauache OM, 2000, ENDOCRINOLOGY, V141, P4156, DOI 10.1210/en.141.11.4156; Hinrichs K, 2007, THERIOGENOLOGY, V68, P521, DOI 10.1016/j.theriogenology.2007.04.046; Hobson SA, 2003, MOL CELL ENDOCRINOL, V200, P189, DOI 10.1016/S0303-7207(01)00749-3; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; HUANG SX, 1995, BIOCHEM J, V310, P881, DOI 10.1042/bj3100881; Iacono E, 2010, REPROD FERT DEVELOP, V22, P348, DOI 10.1071/RDv22n1Ab384; Jung SY, 2005, EXP MOL MED, V37, P91, DOI 10.1038/emm.2005.13; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Koch TG, 2009, CAN VET J, V50, P155; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Lavreysen H, 2003, MOL PHARMACOL, V63, P1082, DOI 10.1124/mol.63.5.1082; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x; McNeil L, 1998, AM J OBSTET GYNECOL, V178, P305, DOI 10.1016/S0002-9378(98)80017-3; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Mendoza FJ, 2009, AM J PHYSIOL-RENAL, V296, pF605, DOI 10.1152/ajprenal.90272.2008; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Noeske T, 2006, QSAR COMB SCI, V25, P134, DOI 10.1002/qsar.200510139; Pappa KI, 2009, REGEN MED, V4, P423, DOI 10.2217/RME.09.12; Park KS, 2007, STEM CELLS, V25, P2044, DOI 10.1634/stemcells.2006-0735; Passeri S, 2009, CELL BIOL INT, V33, P100, DOI 10.1016/j.cellbi.2008.10.012; Pereira WC, 2008, J TISSUE ENG REGEN M, V2, P394, DOI 10.1002/term.107; Racz GZ, 2002, GUT, V51, P705, DOI 10.1136/gut.51.5.705; Rho GJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3942, DOI [10.2735/3503, 10.2741/3503]; Roussanne MC, 2001, EUR J CLIN INVEST, V31, P610, DOI 10.1046/j.1365-2362.2001.00809.x; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Shih YRV, 2009, CELL PROLIFERAT, V42, P461, DOI 10.1111/j.1365-2184.2009.00614.x; Straub SG, 2000, J BIOL CHEM, V275, P18777, DOI 10.1074/jbc.M000090200; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P1211, DOI 10.1210/en.2003-0749; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Tu CL, 1999, J INVEST DERMATOL, V113, P340, DOI 10.1046/j.1523-1747.1999.00698.x; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang LM, 2009, TISSUE ENG PT A, V15, P2259, DOI 10.1089/ten.tea.2008.0393; Xing WJ, 2010, MOL CELL BIOCHEM, V343, P13, DOI 10.1007/s11010-010-0493-7; Yamaguchi T, 2002, BIOCHEM BIOPH RES CO, V299, P532, DOI 10.1016/S0006-291X(02)02690-6; Yamaguchi T, 2001, AM J PHYSIOL-CELL PH, V280, pC382, DOI 10.1152/ajpcell.2001.280.2.C382; Zeidan-Chulia Fares, 2009, Eur J Dent, V3, P240; Zhang ZX, 2002, J BIOL CHEM, V277, P33736, DOI 10.1074/jbc.M200978200; Zucconi E, 2010, STEM CELLS DEV, V19, P395, DOI 10.1089/scd.2008.0314	74	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17714	10.1371/journal.pone.0017714	http://dx.doi.org/10.1371/journal.pone.0017714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437284	Green Published, gold			2022-12-27	WOS:000288514600010
J	Rizzo, C; Ronca, R; Fiorentino, G; Verra, F; Mangano, V; Poinsignon, A; Sirima, SB; Nebie, I; Lombardo, F; Remoue, F; Coluzzi, M; Petrarca, V; Modiano, D; Arca, B				Rizzo, Cinzia; Ronca, Raffaele; Fiorentino, Gabriella; Verra, Federica; Mangano, Valentina; Poinsignon, Anne; Sirima, Sodiomon Bienvenu; Nebie, Issa; Lombardo, Fabrizio; Remoue, Franck; Coluzzi, Mario; Petrarca, Vincenzo; Modiano, David; Arca, Bruno			Humoral Response to the Anopheles gambiae Salivary Protein gSG6: A Serological Indicator of Exposure to Afrotropical Malaria Vectors	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTIBODY-RESPONSE; IMMUNE-RESPONSE; GLAND ANTIGENS; SIALOME; TRANSMISSION; MOSQUITOS; INSIGHT; MARKER; TOOL	Salivary proteins injected by blood feeding arthropods into their hosts evoke a saliva-specific humoral response which can be useful to evaluate exposure to bites of disease vectors. However, saliva of hematophagous arthropods is a complex cocktail of bioactive factors and its use in immunoassays can be misleading because of potential cross-reactivity to other antigens. Toward the development of a serological marker of exposure to Afrotropical malaria vectors we expressed the Anopheles gambiae gSG6, a small anopheline-specific salivary protein, and we measured the anti-gSG6 IgG response in individuals from a malaria hyperendemic area of Burkina Faso, West Africa. The gSG6 protein was immunogenic and anti-gSG6 IgG levels and/or prevalence increased in exposed individuals during the malaria transmission/rainy season. Moreover, this response dropped during the intervening low transmission/dry season, suggesting it is sensitive enough to detect variation in vector density. Members of the Fulani ethnic group showed higher anti-gSG6 IgG response as compared to Mossi, a result consistent with the stronger immune reactivity reported in this group. Remarkably, anti-gSG6 IgG levels among responders were high in children and gradually declined with age. This unusual pattern, opposite to the one observed with Plasmodium antigens, is compatible with a progressive desensitization to mosquito saliva and may be linked to the continued exposure to bites of anopheline mosquitoes. Overall, the humoral anti-gSG6 IgG response appears a reliable serological indicator of exposure to bites of the main African malaria vectors (An. gambiae, Anopheles arabiensis and, possibly, Anopheles funestus) and it may be exploited for malaria epidemiological studies, development of risk maps and evaluation of anti-vector measures. In addition, the gSG6 protein may represent a powerful model system to get a deeper understanding of molecular and cellular mechanisms underlying the immune tolerance and progressive desensitization to insect salivary allergens.	[Rizzo, Cinzia; Verra, Federica; Mangano, Valentina; Lombardo, Fabrizio; Coluzzi, Mario; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy; [Rizzo, Cinzia; Petrarca, Vincenzo; Modiano, David] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Ronca, Raffaele; Fiorentino, Gabriella; Arca, Bruno] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy; [Poinsignon, Anne; Remoue, Franck] Inst Rech Dev, Biol & Control Vectors UR016, Montpellier, France; [Petrarca, Vincenzo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Naples Federico II; Institut de Recherche pour le Developpement (IRD); Sapienza University Rome	Rizzo, C (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.	bruno.arca@unina.it	Fiorentino, Gabriella/E-2843-2017; mangano, valentina/I-2456-2012; Lombardo, Fabrizio/J-8511-2014; Arca, Bruno/C-8383-2012	Fiorentino, Gabriella/0000-0002-4089-3822; Lombardo, Fabrizio/0000-0002-8563-0612; Nebie, Issa/0000-0003-3051-3600; Poinsignon, Anne/0000-0003-2921-4486; Arca, Bruno/0000-0002-4029-0984; Ronca, Raffaele/0000-0003-2217-3378; Mangano, Valentina D/0000-0002-2021-6162; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211	BioMalPar European Network of Excellence [LSHP-CT-2004-503578]; EU [242095]; Fondazione "Compagnia di San Paolo" (Torino) through the Italian Malaria Network	BioMalPar European Network of Excellence; EU(European Commission); Fondazione "Compagnia di San Paolo" (Torino) through the Italian Malaria Network(Compagnia di San Paolo)	This work was initially funded by the BioMalPar European Network of Excellence (LSHP-CT-2004-503578) and continued as part of the EU-funded EVIMalaR NoE (242095). RR and FV were supported by Fondazione "Compagnia di San Paolo" (Torino) through the Italian Malaria Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-121; Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; ESPOSITO F, 1988, T ROY SOC TROP MED H, V82, P827, DOI 10.1016/0035-9203(88)90007-7; FEINGOLD BF, 1968, ANNU REV ENTOMOL, V13, P137, DOI 10.1146/annurev.en.13.010168.001033; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Lombardo F., 2006, Parassitologia (Rome), V48, P573; Lombardo F, 2009, INSECT BIOCHEM MOLEC, V39, P457, DOI 10.1016/j.ibmb.2009.04.006; MELLANBY K, 1946, NATURE, V158, P554, DOI 10.1038/158554c0; Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D, 1998, AM J TROP MED HYG, V59, P336, DOI 10.4269/ajtmh.1998.59.336; Nascimento RJ, 2001, AM J TROP MED HYG, V65, P219, DOI 10.4269/ajtmh.2001.65.219; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P284, DOI 10.1016/S0091-6749(98)70395-1; Peng ZK, 2004, INT ARCH ALLERGY IMM, V133, P198, DOI 10.1159/000076787; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Trevejo RT, 2005, AM J TROP MED HYG, V72, P481, DOI 10.4269/ajtmh.2005.72.481; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004	40	56	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17980	10.1371/journal.pone.0017980	http://dx.doi.org/10.1371/journal.pone.0017980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437289	Green Published, Green Submitted, gold			2022-12-27	WOS:000288514600020
J	Francis, SMS; Larsen, JE; Pavey, SJ; Duhig, EE; Clarke, BE; Bowman, RV; Hayward, NK; Fong, KM; Yang, IA				Francis, Santiyagu M. Savarimuthu; Larsen, Jill E.; Pavey, Sandra J.; Duhig, Edwina E.; Clarke, Belinda E.; Bowman, Rayleen V.; Hayward, Nick K.; Fong, Kwun M.; Yang, Ian A.			Genes and Gene Ontologies Common to Airflow Obstruction and Emphysema in the Lungs of Patients with COPD	PLOS ONE			English	Article							EXPRESSION; PATHOGENESIS; TISSUE; DISEASE; SMOKERS; CELLS	Chronic obstructive pulmonary disease (COPD) is a major public health problem with increasing prevalence worldwide. The primary aim of this study was to identify genes and gene ontologies associated with COPD severity. Gene expression profiling was performed on total RNA extracted from lung tissue of 18 former smokers with COPD. Class comparison analysis on mild (n = 9, FEV1 80-110% predicted) and moderate (n = 9, FEV1 50-60% predicted) COPD patients identified 46 differentially expressed genes (p<0.01), of which 14 genes were technically confirmed by quantitative real-time-PCR. Biological replication in an independent test set of 58 lung samples confirmed the altered expression of ten genes with increasing COPD severity, with eight of these genes (NNMT, THBS1, HLA-DPB1, IGHD, ETS2, ELF1, PTGDS and CYRBD1) being differentially expressed by greater than 1.8 fold between mild and moderate COPD, identifying these as candidate determinants of COPD severity. These genes belonged to ontologies potentially implicated in COPD including angiogenesis, cell migration, proliferation and apoptosis. Our secondary aim was to identify gene ontologies common to airway obstruction, indicated by impaired FEV1 and KCO. Using gene ontology enrichment analysis we have identified relevant biological and molecular processes including regulation of cell-matrix adhesion, leukocyte activation, cell and substrate adhesion, cell adhesion, angiogenesis, cell activation that are enriched among genes involved in airflow obstruction. Exploring the functional significance of these genes and their gene ontologies will provide clues to molecular changes involved in severity of COPD, which could be developed as targets for therapy or biomarkers for early diagnosis.	[Francis, Santiyagu M. Savarimuthu; Larsen, Jill E.; Bowman, Rayleen V.; Fong, Kwun M.; Yang, Ian A.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Duhig, Edwina E.; Clarke, Belinda E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld 4032, Australia; [Francis, Santiyagu M. Savarimuthu; Larsen, Jill E.; Pavey, Sandra J.; Bowman, Rayleen V.; Fong, Kwun M.; Yang, Ian A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Hayward, Nick K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Prince Charles Hospital; Prince Charles Hospital; University of Queensland; QIMR Berghofer Medical Research Institute	Francis, SMS (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia.	ss.francis@uqconnect.edu.au	hayward, nick/AAV-8802-2020; hayward, nicholas k/C-1367-2015; Bowman, Rayleen V/G-4144-2013; Larsen, Jill E/G-3787-2010; Fong, Kwun M/G-6369-2010; Yang, Ian A/B-9609-2008; Pavey, Sandra/B-3662-2011	hayward, nicholas k/0000-0003-4760-1033; Larsen, Jill E/0000-0001-7806-3931; Yang, Ian A/0000-0001-8338-1993; Fong, Kwun/0000-0002-6507-1403; Pavey, Sandra/0000-0003-4519-5932	Prince Charles Hospital Foundation; National Health and Medical Research Council (NHMRC)	Prince Charles Hospital Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The Prince Charles Hospital Foundation and The National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bhattacharya S, 2009, AM J RESP CELL MOL, V40, P359, DOI 10.1165/rcmb.2008-0114OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cotes JE, 1993, LUNG FUNCTION; Debigare R, 2008, COPD, V5, P75, DOI 10.1080/15412550801940457; Dennery PA, 2003, FREE RADICAL BIO MED, V34, P124, DOI 10.1016/S0891-5849(02)01295-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Francis SMS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-81; Golpon HA, 2004, AM J RESP CELL MOL, V31, P595, DOI 10.1165/rcmb.2004-0008OC; Gosselink JV, 2010, AM J RESP CRIT CARE, V181, P1329, DOI 10.1164/rccm.200812-1902OC; HOGG JC, 1994, THORAX, V49, P473, DOI 10.1136/thx.49.5.473; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Joo M, 2007, J IMMUNOL, V179, P2565, DOI 10.4049/jimmunol.179.4.2565; Kim HC, 2010, AM J RESP CRIT CARE, V181, P797, DOI 10.1164/rccm.200906-0936OC; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Oudijk EJD, 2005, THORAX, V60, P538, DOI 10.1136/thx.2004.034009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Spira A, 2004, AM J RESP CELL MOL, V31, P601, DOI 10.1165/rcmb.2004-0273OC; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verducci JS, 2006, PHYSIOL GENOMICS, V25, P355, DOI 10.1152/physiolgenomics.00314.2004; Wang IM, 2008, AM J RESP CRIT CARE, V177, P402, DOI 10.1164/rccm.200703-390OC; Yang IA, 2003, GENES IMMUN, V4, P269, DOI 10.1038/sj.gene.6363961; Yang IA, 2009, RESPIROLOGY, V14, P313, DOI 10.1111/j.1440-1843.2009.01483.x; Zeskind Julie E, 2008, Proc Am Thorac Soc, V5, P834, DOI 10.1513/pats.200807-074TH; Zupo S, 2002, BLOOD, V99, P2277, DOI 10.1182/blood-2001-11-0126	28	19	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17442	10.1371/journal.pone.0017442	http://dx.doi.org/10.1371/journal.pone.0017442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423603	gold, Green Published, Green Submitted			2022-12-27	WOS:000288513900009
J	Guo, CP; Liu, KW; Luo, HB; Chen, HB; Zheng, Y; Sun, SN; Zhang, QA; Huang, LQ				Guo, Cai-ping; Liu, Ke-wei; Luo, Hai-bo; Chen, Hong-bo; Zheng, Yi; Sun, Shen-nan; Zhang, Qian; Huang, Laiqiang			Potent Anti-Tumor Effect Generated by a Novel Human Papillomavirus (HPV) Antagonist Peptide Reactivating the pRb/E2F Pathway	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RETINOBLASTOMA TUMOR-SUPPRESSOR; TYPE-16 E7 ONCOPROTEIN; CERVICAL-CARCINOMA; PROTEIN; GENE; CISPLATIN; BIND; PRB; TRANSCRIPTION	Human papillomavirus type 16 (HPV16) E7 is a viral oncoprotein believed to play a major role in cervical cancer. In this study, an antagonist peptide against HPV16E7 protein was first identified from screening the c7c phage display peptide library. The binding specificity and affinity of the selected peptide to HPV16E7 were tested by competitive enzyme-linked immunosorbent assay (ELISA). The antagonist peptide showed obvious anti-tumor efficacy both in cell lines and animal tumor models. Significant cell proliferation inhibition with high specificity was noted when HPV16-positive cells were treated with the peptide. This anti-tumor efficacy was resulted from overriding the activities of HPV16E7 and reactivating the pRb/E2F pathway, as shown by a series of experiments. Flow cytometry analysis revealed that the selected peptide induced G1 arrest in a dose-dependent manner. Competitive ELISA, pull down, and Co-IP experiments indicated that the selected peptide disrupted the interaction between HPV16E7 and pRb proteins both in vitro and in vivo. Luciferase reporter assay verified that transcription activities of E2F were suppressed by the peptide through restoration of pRb. RT-PCR and Western blot revealed that it reduced cyclins A, D1, and E1 expression, and led to HPV16E7 protein degradation, but pRb protein stabilization. The current study suggests that this specific peptide may serve as a potential therapeutic agent for HPV16-positive cervical cancer.	[Guo, Cai-ping; Luo, Hai-bo; Chen, Hong-bo; Zheng, Yi; Sun, Shen-nan; Zhang, Qian; Huang, Laiqiang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Guo, Cai-ping; Liu, Ke-wei; Chen, Hong-bo; Zheng, Yi; Sun, Shen-nan; Zhang, Qian; Huang, Laiqiang] Tsinghua Univ, Ctr Biotech & BioMed, Shenzhen Key Lab Gene & Antibody Therapy, Shenzhen 518057, Guangdong, Peoples R China; [Guo, Cai-ping; Liu, Ke-wei; Chen, Hong-bo; Zheng, Yi; Sun, Shen-nan; Zhang, Qian; Huang, Laiqiang] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Guangdong, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Guo, CP (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	huanglq@tsinghua.edu.cn			Guangdong Province Natural Science Fund [06301451]; China MOST [2005CCA03500]; China NSFC [30671034]; Shenzhen Municipal Government	Guangdong Province Natural Science Fund(National Natural Science Foundation of Guangdong Province); China MOST(Ministry of Science and Technology, China); China NSFC(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government	This work was supported by grants to LQH from Guangdong Province Natural Science Fund (No. 06301451) and in part from China MOST National "973" Key Research Program (No. 2005CCA03500), China NSFC (No. 30671034), and from Shenzhen Municipal Government for the Shenzhen Key Lab of Gene & Antibody Therapy and for Upgrading the Building of the Shenzhen National Key Lab of Health Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Avvakumov N, 2003, ONCOGENE, V22, P3833, DOI 10.1038/sj.onc.1206562; BANKS L, 1990, ONCOGENE, V5, P833; BANKS L, 1990, ONCOGENE, V5, P1383; Berezutskaya E, 1997, CELL GROWTH DIFFER, V8, P1277; BONOMI P, 1985, J CLIN ONCOL, V3, P1079, DOI 10.1200/JCO.1985.3.8.1079; Boyer SN, 1996, CANCER RES, V56, P4620; Burnett AF, 2000, GYNECOL ONCOL, V76, P63, DOI 10.1006/gyno.1999.5657; Caldeira S, 2005, METH MOLEC MED, V119, P363; Chu NR, 2000, CLIN EXP IMMUNOL, V121, P216, DOI 10.1046/j.1365-2249.2000.01293.x; CLEMENS KE, 1995, VIROLOGY, V214, P289, DOI 10.1006/viro.1995.9926; De Falco G, 2003, ONCOGENE, V22, P6214, DOI 10.1038/sj.onc.1206637; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; Dona MG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-25; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Helt AM, 2001, J VIROL, V75, P6737, DOI 10.1128/JVI.75.15.6737-6747.2001; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Huang SM, 2002, J VIROL, V76, P8710, DOI 10.1128/JVI.76.17.8710-8721.2002; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; Jares P, 1996, AM J PATHOL, V148, P1591; Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Kohashi K, 2008, J CANCER RES CLIN, V134, P1097, DOI 10.1007/s00432-008-0385-3; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Liu XF, 2008, VIROLOGY, V375, P611, DOI 10.1016/j.virol.2008.02.025; Long HJ, 2005, J CLIN ONCOL, V23, P4626, DOI 10.1200/JCO.2005.10.021; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Nauenburg S, 2001, FASEB J, V15, P592; Nie CL, 2008, CHINESE J CANCER RES, V20, P301, DOI 10.1007/s11670-008-0301-z; Nishimura A, 2006, MICROBES INFECT, V8, P984, DOI 10.1016/j.micinf.2005.10.015; Niwa H, 2003, CLIN CANCER RES, V9, P5028; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; PARKIN DM, 2006, VACCINE S3, V24, pCH2; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Rose PG, 1999, J CLIN ONCOL, V17, P2676, DOI 10.1200/JCO.1999.17.9.2676; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SCHIFFMAN MH, 1995, CANCER-AM CANCER SOC, V76, P1888, DOI 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H; SHILLITOE EJ, 1994, CANCER GENE THER, V1, P193; Sima N, 2007, GYNECOL ONCOL, V106, P299, DOI 10.1016/j.ygyno.2007.04.039; Stanley Margaret, 2003, J Natl Cancer Inst Monogr, P117; STEELE C, 1991, Critical Reviews in Oral Biology and Medicine, V2, P153; TOM R, 2008, TRANSFECTION ADHEREN; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006; WU EW, 1993, J VIROL, V67, P2402, DOI 10.1128/JVI.67.4.2402-2407.1993; *XJ XZS, 2009, PROG BIOCHEM BIOPHYS, V36, P6; Zhang BY, 2006, P NATL ACAD SCI USA, V103, P437, DOI 10.1073/pnas.0510012103	56	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17734	10.1371/journal.pone.0017734	http://dx.doi.org/10.1371/journal.pone.0017734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423621	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900019
J	Li, CH; Wang, E; Wang, J				Li, Chunhe; Wang, Erkang; Wang, Jin			Potential Landscape and Probabilistic Flux of a Predator Prey Network	PLOS ONE			English	Article							DISSIPATION COST; ENERGY LANDSCAPE; ROBUSTNESS	Predator-prey system, as an essential element of ecological dynamics, has been recently studied experimentally with synthetic biology. We developed a global probabilistic landscape and flux framework to explore a synthetic predator-prey network constructed with two Escherichia coli populations. We developed a self consistent mean field method to solve multidimensional problem and uncovered the potential landscape with Mexican hat ring valley shape for predator-prey oscillations. The landscape attracts the system down to the closed oscillation ring. The probability flux drives the coherent oscillations on the ring. Both the landscape and flux are essential for the stable and coherent oscillations. The landscape topography characterized by the barrier height from the top of Mexican hat to the closed ring valley provides a quantitative measure of global stability of system. The entropy production rate for the energy dissipation is less for smaller environmental fluctuations or perturbations. The global sensitivity analysis based on the landscape topography gives specific predictions for the effects of parameters on the stability and function of the system. This may provide some clues for the global stability, robustness, function and synthetic network design.	[Li, Chunhe; Wang, Erkang; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA; [Li, Chunhe] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, CH (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	ekwang@ciac.jl.cn; jin.wang.1@stonybrook.edu	Li, Chunhe/C-8132-2011; , 汪尔康/P-1748-2019	Li, Chunhe/0000-0002-9127-3930; 	National Science Foundation; National Natural Science Foundation of China [90713022, 20735003]; 973 project [2009CB930100, 2010CB833600]	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China)	Funding: J.W. acknowledges support from the National Science Foundation. C. H. L. and E. K. W. are supported by the National Natural Science Foundation of China (Grants 90713022 and 20735003) and the 973 project 2009CB930100 and 2010CB833600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao P, 2004, J PHYS A-MATH GEN, V37, pL25, DOI 10.1088/0305-4470/37/3/L01; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Han B, 2007, BIOPHYS J, V92, P3755, DOI 10.1529/biophysj.106.094821; Hatano T, 2001, PHYS REV LETT, V86, P3463, DOI 10.1103/PhysRevLett.86.3463; Hornos JEM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051907; Hu G., 1994, STOCHASTIC FORCES NO, P68; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim KY, 2007, PLOS COMPUT BIOL, V3, P565, DOI 10.1371/journal.pcbi.0030060; Kim KY, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2424933; Lapidus S, 2008, P NATL ACAD SCI USA, V105, P6039, DOI 10.1073/pnas.0708708105; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; May R.M., 1974, STABILITY COMPLEXITY; Murray, 2002, MATH BIOL I INTRO IN; QIAN H, 2001, PHYS REV E, V65, P61025; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; Van Kampen N. G., 1992, STOCHASTIC PROCESSES, P120; VOLTERRA V, 1931, ANIMAL ECOLOGY, V2, P409; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Yoda M, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2539037	26	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17888	10.1371/journal.pone.0017888	http://dx.doi.org/10.1371/journal.pone.0017888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423576	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900041
J	Zhang, ZJ; Chen, DM; Liu, WB; Racine, JS; Ong, S; Chen, Y; Zhao, GM; Jiang, QW				Zhang, Zhijie; Chen, Dongmei; Liu, Wenbao; Racine, Jeffrey S.; Ong, SengHuat; Chen, Yue; Zhao, Genming; Jiang, Qingwu			Nonparametric Evaluation of Dynamic Disease Risk: A Spatio-Temporal Kernel Approach	PLOS ONE			English	Article							SPATIAL RELATIVE RISK; GEOGRAPHICAL EPIDEMIOLOGY; DENSITY-ESTIMATION; BINARY REGRESSION; CROSS-VALIDATION; DISTRIBUTIONS; CHINA; SCHISTOSOMIASIS; ESTIMATORS; REGIONS	Quantifying the distributions of disease risk in space and time jointly is a key element for understanding spatio-temporal phenomena while also having the potential to enhance our understanding of epidemiologic trajectories. However, most studies to date have neglected time dimension and focus instead on the "average'' spatial pattern of disease risk, thereby masking time trajectories of disease risk. In this study we propose a new idea titled "spatio-temporal kernel density estimation (stKDE)'' that employs hybrid kernel (i.e., weight) functions to evaluate the spatio-temporal disease risks. This approach not only can make full use of sample data but also "borrows'' information in a particular manner from neighboring points both in space and time via appropriate choice of kernel functions. Monte Carlo simulations show that the proposed method performs substantially better than the traditional (i.e., frequency-based) kernel density estimation (trKDE) which has been used in applied settings while two illustrative examples demonstrate that the proposed approach can yield superior results compared to the popular trKDE approach. In addition, there exist various possibilities for improving and extending this method.	[Zhang, Zhijie; Chen, Dongmei; Liu, Wenbao] Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada; [Zhang, Zhijie; Zhao, Genming; Jiang, Qingwu] Fudan Univ, Dept Epidemiol, Shanghai 200433, Peoples R China; [Racine, Jeffrey S.] McMaster Univ, Dept Econ, Hamilton, ON, Canada; [Ong, SengHuat] Univ Malaya, Dept Math Sci, Kuala Lumpur, Malaysia; [Chen, Yue] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Queens University - Canada; Fudan University; McMaster University; Universiti Malaya; University of Ottawa	Zhang, ZJ (corresponding author), Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada.	epistat@gmail.com; chendm@queensu.ca	ONG, Seng Huat/B-9454-2010; Racine, Jeffrey/N-9476-2014	ONG, Seng Huat/0000-0002-4288-7637; zhang, zhijie/0000-0002-1276-787X; Jiang, Qingwu/0000-0001-8921-3317; Racine, Jeffrey/0000-0002-5680-3705	National Important Technologies Project of China [2008ZX10004-011]; Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada [PIV-005]	National Important Technologies Project of China; Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada	This research was supported by a grant from the National Important Technologies Project of China [grant number 2008ZX10004-011] and a grant from the Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada [grant number PIV-005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan JJ, 2008, ENVIRON HEALTH PERSP, V116, P1111, DOI 10.1289/ehp.10814; Bailey T, 1995, INTERACTIVE SPATIAL; Beale L, 2008, ENVIRON HEALTH PERSP, V116, P1105, DOI 10.1289/ehp.10816; Benschop J, 2008, VET RES, V39, DOI 10.1051/vetres:2007040; Berke O, 2003, J VET MED B, V50, P322, DOI 10.1046/j.1439-0450.2003.00689.x; BITHELL JF, 1991, STAT MED, V10, P1745, DOI 10.1002/sim.4780101112; BITHELL JF, 1990, STAT MED, V9, P691, DOI 10.1002/sim.4780090616; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Clark AB, 2004, COMPUT STAT DATA AN, V47, P63, DOI 10.1016/j.csda.2003.10.014; Davies TM, 2010, STAT MED, V29, P2423, DOI 10.1002/sim.3995; Diggle P.J., 1995, BERNOULLI, V1, DOI [10.2307/3318678, DOI 10.2307/3318678, 10.1002/sim.4780142106]; Griffith DA, 2010, J GEOGR SYST, V12, P111, DOI 10.1007/s10109-010-0120-x; Hall P, 2004, J AM STAT ASSOC, V99, P1015, DOI 10.1198/016214504000000548; Hayfield T., 2008, J STAT SOFTW, P27; Hazelton ML, 2008, STAT MED, V27, P2269, DOI 10.1002/sim.3047; Hazelton ML, 2007, COMPUT STAT DATA AN, V51, P4393, DOI 10.1016/j.csda.2006.06.012; Hazelton ML, 2009, BIOMETRICAL J, V51, P98, DOI 10.1002/bimj.200810495; KELSALL JE, 1995, STAT MED, V14, P2335, DOI 10.1002/sim.4780142106; Kelsall JE, 1998, J ROY STAT SOC C-APP, V47, P559, DOI 10.1111/1467-9876.00128; Kulldorff M., 2009, SATSCANTM V8 0 SOFTW; Li Q, 2004, STAT SINICA, V14, P485; Li Q, 2003, J MULTIVARIATE ANAL, V86, P266, DOI 10.1016/S0047-259X(02)00025-8; Li Q., 2007, NONPARAMETRIC ECONOM; Lo C.P., 2007, CONCEPTS TECHNIQUES, V2nd; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Mugdadi AR, 2004, COMPUT STAT DATA AN, V47, P49, DOI 10.1016/j.csda.2003.10.013; Orem Jackson, 2007, Afr Health Sci, V7, P166; Ouyang D, 2006, J NONPARAMETR STAT, V18, P69, DOI 10.1080/10485250600569002; Prince MI, 2001, HEPATOLOGY, V34, P1083, DOI 10.1053/jhep.2001.29760; Racine J, 2004, J ECONOMETRICS, V119, P99, DOI 10.1016/S0304-4076(03)00157-X; Rowlingson B., 2010, SPLANCS SPATIAL SPAC; Sabel CE, 2000, SOC SCI MED, V50, P1121, DOI 10.1016/S0277-9536(99)00360-3; Simonoff J.S., 1996, SMOOTING METHODS STA, V2nd; Turlach B.A., 1993, BANDWIDTH SELECTION; Wand MP., 1994, KERNEL SMOOTHING; WANG MC, 1981, BIOMETRIKA, V68, P301, DOI 10.1093/biomet/68.1.301; Ward M, 2008, GEOJOURNAL LIB, V94, P257, DOI 10.1007/978-1-4020-8507-9_13; Wheeler DC, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-13; Wikle CK, 2002, STAT MODEL, V2, P299, DOI 10.1191/1471082x02st036oa; Zhang ZJ, 2009, PARASITOLOGY, V136, P737, DOI 10.1017/S0031182009005885; Zhang ZJ, 2008, ACTA TROP, V107, P217, DOI 10.1016/j.actatropica.2008.04.027; Zhang ZJ, 2009, T ROY SOC TROP MED H, V103, P1045, DOI 10.1016/j.trstmh.2008.11.012	42	13	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17381	10.1371/journal.pone.0017381	http://dx.doi.org/10.1371/journal.pone.0017381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423612	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900008
J	Novakova, M; Dolezal, T				Novakova, Milena; Dolezal, Tomas			Expression of Drosophila Adenosine Deaminase in Immune Cells during Inflammatory Response	PLOS ONE			English	Article							EXTRACELLULAR ADENOSINE; GROWTH-FACTORS; HEMATOPOIESIS; SYSTEM; PROLIFERATION; MACROPHAGES; BLOOD; ADA2	Extra-cellular adenosine is an important regulator of inflammatory responses. It is generated from released ATP by a cascade of ectoenzymes and degraded by adenosine deaminase (ADA). There are two types of enzymes with ADA activity: ADA1 and ADGF/ADA2. ADA2 activity originates from macrophages and dendritic cells and is associated with inflammatory responses in humans and rats. Drosophila possesses a family of six ADGF proteins with ADGF-A being the main regulator of extracellular adenosine during larval stages. Herein we present the generation of a GFP reporter for ADGF-A expression by a precise replacement of the ADGF-A coding sequence with GFP using homologous recombination. We show that the reporter is specifically expressed in aggregating hemocytes (Drosophila immune cells) forming melanotic capsules; a characteristic of inflammatory response. Our vital reporter thus confirms ADA expression in sites of inflammation in vivo and demonstrates that the requirement for ADA activity during inflammatory response is evolutionary conserved from insects to vertebrates. Our results also suggest that ADA activity is achieved specifically within sites of inflammation by an uncharacterized post-transcriptional regulation based mechanism. Utilizing various mutants that induce melanotic capsule formation and also a real immune challenge provided by parasitic wasps, we show that the acute expression of the ADGF-A protein is not driven by one specific signaling cascade but is rather associated with the behavior of immune cells during the general inflammatory response. Connecting the exclusive expression of ADGF-A within sites of inflammation, as presented here, with the release of energy stores when the ADGF-A activity is absent, suggests that extra-cellular adenosine may function as a signal for energy allocation during immune response and that ADGF-A/ADA2 expression in such sites of inflammation may regulate this role.	[Novakova, Milena; Dolezal, Tomas] Univ S Bohemia, Fac Sci, Dept Mol Biol, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Novakova, M (corresponding author), Univ S Bohemia, Fac Sci, Dept Mol Biol, Ceske Budejovice, Czech Republic.	tomas.dolezal@prf.jcu.cz	Dolezal, Tomas/AAF-2350-2020; Doležal, Tomáš/EXQ-6090-2022; Novakova, Milena/AAD-7503-2021	Dolezal, Tomas/0000-0001-5217-4465; 	Grant Agency of the Academy of Sciences of the Czech Republic [KJB501410602]; Grant Agency of the Czech Republic [204/09/1463]; Ministry of Education, Youth and Sports of the Czech Republic [MSM6007665801]; Grant Agency of the University of South Bohemia	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the University of South Bohemia	Funding was provided by KJB501410602, Grant Agency of the Academy of Sciences of the Czech Republic (http://www.gaav.cz/); 204/09/1463, Grant Agency of the Czech Republic (http://www.gacr.cz/); MSM6007665801, Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/); and the Grant Agency of the University of South Bohemia (http://www.jcu.cz/research/gaju). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich MB, 2000, BIOCHEM BIOPH RES CO, V272, P311, DOI 10.1006/bbrc.2000.2773; Antonioli L, 2008, INFLAMM BOWEL DIS, V14, P566, DOI 10.1002/ibd.20316; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Carroll Dana, 2008, V435, P63, DOI 10.1007/978-1-59745-232-8_5; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Conlon BA, 2004, CLIN EXP IMMUNOL, V138, P14, DOI 10.1111/j.1365-2249.2004.02591.x; Cortes D., 2009, Autonomic & Autacoid Pharmacology, V29, P157, DOI 10.1111/j.1474-8665.2009.00443.x; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Franco R, 1997, PROG NEUROBIOL, V52, P283, DOI 10.1016/S0301-0082(97)00013-0; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Homma K, 1996, J BIOL CHEM, V271, P13770, DOI 10.1074/jbc.271.23.13770; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; NIEDZWICKI JG, 1991, BIOCHEM PHARMACOL, V41, P1615, DOI 10.1016/0006-2952(91)90162-X; NIEDZWICKI JG, 1991, AM J HEMATOL, V37, P152, DOI 10.1002/ajh.2830370303; Qiu P, 1998, DEVELOPMENT, V125, P1909; RATECH H, 1981, ENZYME, V26, P74, DOI 10.1159/000459153; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; Sankar N, 2002, NUCLEIC ACIDS RES, V30, P4339, DOI 10.1093/nar/gkf564; Valdes Luis, 2003, Eur J Intern Med, V14, P77, DOI 10.1016/S0953-6205(03)00018-9; Zavialov AV, 2010, J LEUKOCYTE BIOL, V88, P279, DOI 10.1189/jlb.1109764; Zavialov AV, 2010, J BIOL CHEM, V285, P12367, DOI 10.1074/jbc.M109.083527; Zavialov AV, 2005, BIOCHEM J, V391, P51, DOI 10.1042/BJ20050683; Zuberova M, 2010, DIS MODEL MECH, V3, P773, DOI 10.1242/dmm.005389; Zurovec M, 2002, P NATL ACAD SCI USA, V99, P4403, DOI 10.1073/pnas.062059699	31	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17741	10.1371/journal.pone.0017741	http://dx.doi.org/10.1371/journal.pone.0017741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412432	Green Submitted, Green Published, gold			2022-12-27	WOS:000288247800027
J	Maibach, EW; Leiserowitz, A; Roser-Renouf, C; Mertz, CK				Maibach, Edward W.; Leiserowitz, Anthony; Roser-Renouf, Connie; Mertz, C. K.			Identifying Like-Minded Audiences for Global Warming Public Engagement Campaigns: An Audience Segmentation Analysis and Tool Development	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNICATION; PREFERENCES	Background: Achieving national reductions in greenhouse gas emissions will require public support for climate and energy policies and changes in population behaviors. Audience segmentation - a process of identifying coherent groups within a population - can be used to improve the effectiveness of public engagement campaigns. Methodology/Principal Findings: In Fall 2008, we conducted a nationally representative survey of American adults (n = 2,164) to identify audience segments for global warming public engagement campaigns. By subjecting multiple measures of global warming beliefs, behaviors, policy preferences, and issue engagement to latent class analysis, we identified six distinct segments ranging in size from 7 to 33% of the population. These six segments formed a continuum, from a segment of people who were highly worried, involved and supportive of policy responses (18%), to a segment of people who were completely unconcerned and strongly opposed to policy responses (7%). Three of the segments (totaling 70%) were to varying degrees concerned about global warming and supportive of policy responses, two (totaling 18%) were unsupportive, and one was largely disengaged (12%), having paid little attention to the issue. Certain behaviors and policy preferences varied greatly across these audiences, while others did not. Using discriminant analysis, we subsequently developed 36-item and 15-item instruments that can be used to categorize respondents with 91% and 84% accuracy, respectively. Conclusions/Significance: In late 2008, Americans supported a broad range of policies and personal actions to reduce global warming, although there was wide variation among the six identified audiences. To enhance the impact of campaigns, government agencies, non-profit organizations, and businesses seeking to engage the public can selectively target one or more of these audiences rather than address an undifferentiated general population. Our screening instruments are available to assist in that process.	[Maibach, Edward W.; Roser-Renouf, Connie] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA; [Leiserowitz, Anthony] Yale Univ, Yale Project Climate Change, New Haven, CT USA; [Mertz, C. K.] Decis Res, Eugene, OR USA	George Mason University; Yale University	Maibach, EW (corresponding author), George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA.	emaibach@gmu.edu	Leiserowitz, Anthony/ABE-6529-2020; Leiserowitz, Anthony/HGB-4208-2022; Maibach, Edward/A-7102-2009	Leiserowitz, Anthony/0000-0001-5349-409X; Maibach, Edward/0000-0003-3409-9187	Yale Center for Environmental Law and Policy; Betsy and Jessie Fink Foundation; 11th Hour Project; Pacific Foundation; Robert Wood Johnson Foundation	Yale Center for Environmental Law and Policy; Betsy and Jessie Fink Foundation; 11th Hour Project(Ministry of Education, China - 111 Project); Pacific Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was funded by the Yale Center for Environmental Law and Policy; the Betsy and Jessie Fink Foundation; the 11th Hour Project; the Pacific Foundation; and by a Robert Wood Johnson Foundation Investigator Award in Health Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlof K., 2008, GLOB STUD REV, V4, P4; Andreasen AlanR., 1995, MARKETING SOCIAL CHA; [Anonymous], 2009, PROT HLTH CLIM CHANG; [Anonymous], 2002, NEW TOOLS ENV PROTEC; Australian Public Service Commission, 2007, TACKL WICK PROBL PUB; Conklin, 2006, DIALOGUE MAPPING BUI; Dahlstrom MF, 2010, COMMUN RES, V37, P857, DOI 10.1177/0093650210362683; Dibb S., 1999, J STRATEGIC MARKETIN, V7, P107, DOI DOI 10.1080/096525499346477; Dowd Matthew J., 2006, APPLEBEES AM SUCCESS; HITZHUSEN G, 2010, CLIMATE CHANGE ED FA; Hornik R., 2002, PUBLIC HLTH COMMUNIC; Kotler P, 2008, SOCIAL MARKETING INF; Kotler P., 2008, MANAGEMENT MARKETING, V12th; LEISEROWITZ A, 2010, CONNECTIONS CLIMATE; Leiserowitz A., 2010, GLOBAL WARMINGS 6 AM; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Magidson J., 2002, CAN J MARKET RES, V20, P37, DOI DOI 10.1017/CBO9780511499531.004; MAGIDSON J, 2002, SAGE HDB QUANTITATIV, P175; Maibach E W, 1996, J Health Psychol, V1, P261, DOI 10.1177/135910539600100302; Maibach E, 2009, SCI COMMUN, V30, P299, DOI 10.1177/1075547008329202; Maibach EW, 2008, AM J PREV MED, V35, P488, DOI 10.1016/j.amepre.2008.08.016; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; Maibach EW, 2006, J HEALTH COMMUN, V11, P717, DOI 10.1080/10810730600934633; McDonald M., 1995, MARKET SEGMENTATION; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; *NAT AC, 2010, WORKSH CLIM CHANG ED; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Ockwell D, 2009, SCI COMMUN, V30, P305, DOI 10.1177/1075547008328969; PHIPPS M, 2010, GLOBAL WARMINGS 6 AM; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Slater MD, 1995, DESIGNING HLTH MESSA, P186; Smith R, 2009, STRATEGIC PLANNING P; Weir MR, 2000, ARCH INTERN MED, V160, P481, DOI 10.1001/archinte.160.4.481; [No title captured]	34	172	175	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17571	10.1371/journal.pone.0017571	http://dx.doi.org/10.1371/journal.pone.0017571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732VZ	21423743	gold, Green Published			2022-12-27	WOS:000288219100015
J	Arstikaitis, P; Gauthier-Campbell, C; Huang, K; El-Husseini, A; Murphy, TH				Arstikaitis, Pamela; Gauthier-Campbell, Catherine; Huang, Kun; El-Husseini, Alaa; Murphy, Timothy H.			Proteins That Promote Filopodia Stability, but Not Number, Lead to More Axonal-Dendritic Contacts	PLOS ONE			English	Article							INHIBITORY SYNAPSE FORMATION; DEVELOPMENTAL REGULATION; POSTSYNAPTIC PROTEIN; MOLECULAR-MECHANISMS; RAPID FORMATION; IN-VIVO; SPINE; PLASTICITY; MOTILITY; AUTISM	Dendritic filopodia are dynamic protrusions that are thought to play an active role in synaptogenesis and serve as precursors to spine synapses. However, this hypothesis is largely based on a temporal correlation between filopodia formation and synaptogenesis. We investigated the role of filopodia in synapse formation by contrasting the roles of molecules that affect filopodia elaboration and motility, versus those that impact synapse induction and maturation. We used a filopodia inducing motif that is found in GAP-43, as a molecular tool, and found this palmitoylated motif enhanced filopodia number and motility, but reduced the probability of forming a stable axon-dendrite contact. Conversely, expression of neuroligin-1 (NLG-1), a synapse inducing cell adhesion molecule, resulted in a decrease in filopodia motility, but an increase in the number of stable axonal contacts. Moreover, RNAi knockdown of NLG-1 reduced the number of presynaptic contacts formed. Postsynaptic scaffolding proteins such as Shank1b, a protein that induces the maturation of spine synapses, increased the rate at which filopodia transformed into spines by stabilization of the initial contact with axons. Taken together, these results suggest that increased filopodia stability and not density, may be the rate-limiting step for synapse formation.	[Arstikaitis, Pamela] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Arstikaitis, P (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	thmurphy@interchange.ubc.ca	Murphy, Timothy H/I-4982-2014; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490	Canadian Institutes of Health Research [MOP12675]; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; EJLB Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); EJLB Foundation	This work was supported by funding from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to PA, to THM (MOP12675), and to AEH; the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to CGC; the Michael Smith Foundation for Health Research to AEH; and the EJLB Foundation (http://www.ejlb.qc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; ARSTIKAITIS P, 2008, MOL BIOL CELL; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Brocco MA, 2010, EUR J NEUROSCI, V31, P195, DOI 10.1111/j.1460-9568.2009.07064.x; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Dailey ME, 1996, J NEUROSCI, V16, P2983; Decourt B, 2009, J NEUROSCI RES, V87, P1057, DOI 10.1002/jnr.21937; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Evers JF, 2006, DEV BIOL, V297, P214, DOI 10.1016/j.ydbio.2006.05.012; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Fiala JC, 1998, J NEUROSCI, V18, P8900; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kohsaka H, 2009, DEVELOPMENT, V136, P1127, DOI 10.1242/dev.027920; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; KWINTER DM, 2009, J VIS EXP; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Niell CM, 2004, ANNU REV PHYSIOL, V66, P771, DOI 10.1146/annurev.physiol.66.082602.095217; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Portera-Cailliau C, 2001, REV NEUROLOGIA, V33, P1158, DOI 10.33588/rn.3312.2001338; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Ramakers GMJ, 2000, NEUROSCI LETT, V286, P53, DOI 10.1016/S0304-3940(00)01081-8; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Swedlow JR, 2002, CELL STRUCT FUNCT, V27, P335, DOI 10.1247/csf.27.335; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Wong WT, 2000, J NEUROSCI, V20, P5024; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Yan J, 2008, PSYCHIAT GENET, V18, P204, DOI 10.1097/YPG.0b013e3282fb7fe6; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009; Zhang WD, 2000, HIPPOCAMPUS, V10, P512, DOI 10.1002/1098-1063(2000)10:5<512::AID-HIPO2>3.0.CO;2-M; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, NEUROSCIENTIST, V7, P365, DOI 10.1177/107385840100700505	64	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16998	10.1371/journal.pone.0016998	http://dx.doi.org/10.1371/journal.pone.0016998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408225	Green Published, gold, Green Submitted			2022-12-27	WOS:000288099800009
J	Novitsky, V; Wang, R; Margolin, L; Baca, J; Rossenkhan, R; Moyo, S; van Widenfelt, E; Essex, M				Novitsky, Vladimir; Wang, Rui; Margolin, Lauren; Baca, Jeannie; Rossenkhan, Raabya; Moyo, Sikhulile; van Widenfelt, Erik; Essex, M.			Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection	PLOS ONE			English	Article							DYNAMICS; IDENTIFICATION; INOCULATION; SEQUENCES; LOAD; TIME	To address whether sequences of viral gag and env quasispecies collected during the early post-acute period can be utilized to determine multiplicity of transmitted HIV's, recently developed approaches for analysis of viral evolution in acute HIV-1 infection [1,2] were applied. Specifically, phylogenetic reconstruction, inter-and intra-patient distribution of maximum and mean genetic distances, analysis of Poisson fitness, shape of highlighter plots, recombination analysis, and estimation of time to the most recent common ancestor (tMRCA) were utilized for resolving multiplicity of HIV-1 transmission in a set of viral quasispecies collected within 50 days post-seroconversion (p/s) in 25 HIV-infected individuals with estimated time of seroconversion. The decision on multiplicity of HIV infection was made based on the model's fit with, or failure to explain, the observed extent of viral sequence heterogeneity. The initial analysis was based on phylogeny, inter-patient distribution of maximum and mean distances, and Poisson fitness, and was able to resolve multiplicity of HIV transmission in 20 of 25 (80%) cases. Additional analysis involved distribution of individual viral distances, highlighter plots, recombination analysis, and estimation of tMRCA, and resolved 4 of the 5 remaining cases. Overall, transmission of a single viral variant was identified in 16 of 25 (64%) cases, and transmission of multiple variants was evident in 8 of 25 (32%) cases. In one case multiplicity of HIV-1 transmission could not be determined. In primary HIV-1 subtype C infection, samples collected within 50 days p/s and analyzed by a single-genome amplification/sequencing technique can provide reliable identification of transmission multiplicity in 24 of 25 (96%) cases. Observed transmission frequency of a single viral variant and multiple viral variants were within the ranges of 64% to 68%, and 32% to 36%, respectively.	[Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; Essex, M.] Harvard Univ, Sch Publ Hlth, Harvard Sch Publ Hlth AIDS Initiat, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Novitsky, Vladimir; Rossenkhan, Raabya; Moyo, Sikhulile; van Widenfelt, Erik; Essex, M.] Botswana Harvard AIDS Inst, Gaborone, Botswana; [Wang, Rui] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health	Novitsky, V (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Sch Publ Hlth AIDS Initiat, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	Moyo, Sikhulile/E-1464-2015; Wang, Rui/X-1699-2019	Moyo, Sikhulile/0000-0003-3821-4592; Wang, Rui/0000-0001-5007-193X	NIH [R01 AI057027, D43 TW000004, R37 AI24643]; AAMC FIC/Ellison Overseas Fellowships in Global Health and Clinical Research; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024643] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAMC FIC/Ellison Overseas Fellowships in Global Health and Clinical Research(Lawrence Ellison Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary HIV-1 subtype C infection study in Botswana, the Tshedimoso study, was supported and funded by NIH grant R01 AI057027. This work was supported in part by the NIH grants D43 TW000004 (RR) and R37 AI24643 (RW), and also through the AAMC FIC/Ellison Overseas Fellowships in Global Health and Clinical Research (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Drummond AJ, 2010, GENEIOUS V5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Greenier JL, 2001, J VIROL, V75, P3753, DOI 10.1128/JVI.75.8.3753-3765.2001; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Lemey P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-126; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2010, VIROLOGY, V403, P37, DOI 10.1016/j.virol.2010.04.001; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; RAMBAUT A, 2008, BIOTECHNIQUES, V48, P405; Ritola K, 2004, J VIROL, V78, P11208, DOI 10.1128/JVI.78.20.11208-11218.2004; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sagar M, 2004, J VIROL, V78, P7279, DOI 10.1128/JVI.78.13.7279-7283.2004; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929	39	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16714	10.1371/journal.pone.0016714	http://dx.doi.org/10.1371/journal.pone.0016714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21415914	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700029
J	Immel, TA; Groth, U; Huhn, T; Ohlschlager, P				Immel, Timo A.; Groth, Ulrich; Huhn, Thomas; Oehlschlaeger, Peter			Titanium Salan Complexes Displays Strong Antitumor Properties In Vitro and In Vivo in Mice	PLOS ONE			English	Article							PLATINUM COMPLEXES; TITANOCENE DICHLORIDE; ANTICANCER DRUGS; CANCER-TREATMENT; METAL-COMPLEXES; CERVICAL-CANCER; HYDROLYSIS; DNA; VACCINATION; WOMEN	The anticancer activity of titanium complexes has been known since the groundbreaking studies of Kopf and Kopf-Maier on titanocen dichloride. Unfortunately, possibly due to their fast hydrolysis, derivatives of titanocen dichloride failed in clinical studies. Recently, the new family of titanium salan complexes containing tetradentate ONNO ligands with anti-cancer properties has been discovered. These salan complexes are much more stabile in aqueous media. In this study we describe the biological activity of two titanium salan complexes in a mouse model of cervical cancer. High efficiency of this promising complex family was demonstrated for the first time in vivo. From these data we conclude that titanium salan complexes display very strong antitumor properties exhibiting only minor side effects. Our results may influence the chemotherapy with metallo therapeutics in the future.	[Immel, Timo A.; Groth, Ulrich; Huhn, Thomas] Univ Konstanz, Dept Chem, Constance, Germany; [Immel, Timo A.; Groth, Ulrich; Huhn, Thomas] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Oehlschlaeger, Peter] Univ Konstanz, Dept Immunol, Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz	Immel, TA (corresponding author), Univ Konstanz, Dept Chem, Constance, Germany.	peter.oehlschlaeger@uni-konstanz.de	Huhn, Thomas/A-2708-2009	Huhn, Thomas/0000-0001-6292-4215	Konstanz Research School Chemical Biology (KoRS-CB)	Konstanz Research School Chemical Biology (KoRS-CB)	This work was supported by Konstanz Research School Chemical Biology (KoRS-CB). Support for TAI was provided by a personal scholarship of KoRS-CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013; Caruso F, 2004, MINI-REV MED CHEM, V4, P49, DOI 10.2174/1389557043487565; Coluccia M, 2007, ANTI-CANCER AGENT ME, V7, P111, DOI 10.2174/187152007779314080; Desoize B, 2004, ANTICANCER RES, V24, P1529; Eger S, 2010, INORG CHEM, V49, P1292, DOI 10.1021/ic9022163; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Galanski M, 2005, CURR MED CHEM, V12, P2075, DOI 10.2174/0929867054637626; Gatta G, 1998, EUR J CANCER, V34, P2218, DOI 10.1016/S0959-8049(98)00326-8; GIRALDI T, 1977, CANCER RES, V37, P2662; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Immel TA, 2010, J INORG BIOCHEM, V104, P863, DOI 10.1016/j.jinorgbio.2010.04.003; Immel TA, 2010, CHEM-EUR J, V16, P2775, DOI 10.1002/chem.200902312; Immel TA, 2009, CHEMMEDCHEM, V4, P738, DOI 10.1002/cmdc.200900038; Jakupec MA, 2003, REV PHYSIOL BIOCH P, V146, P1, DOI 10.1007/s10254-002-0001-x; Jakupec MA, 2008, DALTON T, P183, DOI 10.1039/b712656p; KOPF H, 1981, J ORGANOMET CHEM, V216, P185, DOI 10.1016/S0022-328X(00)85759-9; Lummen G, 1998, CANCER CHEMOTH PHARM, V42, P415, DOI 10.1007/s002800050838; Melendez E, 2002, CRIT REV ONCOL HEMAT, V42, P309, DOI 10.1016/S1040-8428(01)00224-4; Ohlschlager P, 2011, INT J CANCER, V128, P473, DOI 10.1002/ijc.25344; Ohlschlager P, 2009, INT J CANCER, V125, P189, DOI 10.1002/ijc.24333; Ohlschlager P, 2006, VACCINE, V24, P2880, DOI 10.1016/j.vaccine.2005.12.061; Ohlschlager P, 2003, J VIROL, V77, P4635, DOI 10.1128/JVI.77.8.4635-4645.2003; Ott I, 2007, ARCH PHARM, V340, P117, DOI 10.1002/ardp.200600151; Perez-Regadera J, 2010, INT J GYNECOL CANCER, V20, P164, DOI 10.1111/IGC.0b013e3181ad3e11; Pisani S, 1999, EUR J GYNAECOL ONCOL, V20, P69; Schilling T, 1996, Invest New Drugs, V13, P327; Strohfeldt K, 2008, CHEM SOC REV, V37, P1174, DOI 10.1039/b707310k; TONEY JH, 1985, J AM CHEM SOC, V107, P947, DOI 10.1021/ja00290a033; Tshuva EY, 2009, COORDIN CHEM REV, V253, P2098, DOI 10.1016/j.ccr.2008.11.015	29	39	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17869	10.1371/journal.pone.0017869	http://dx.doi.org/10.1371/journal.pone.0017869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445304	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300019
J	Courtland, HW; Elis, S; Wu, YJ; Sun, H; Rosen, CJ; Jepsen, KJ; Yakar, S				Courtland, Hayden-William; Elis, Sebastien; Wu, Yingjie; Sun, Hui; Rosen, Clifford J.; Jepsen, Karl J.; Yakar, Shoshana			Serum IGF-1 Affects Skeletal Acquisition in a Temporal and Compartment-Specific Manner	PLOS ONE			English	Article							GROWTH-FACTOR-I; BONE-MINERAL DENSITY; INBRED STRAINS; GENETIC-VARIATION; BINDING-PROTEIN; HORMONE; MICE; TAMOXIFEN; CULTURES; MEN	Insulin-like growth factor-1 (IGF-1) plays a critical role in the development of the growing skeleton by establishing both longitudinal and transverse bone accrual. IGF-1 has also been implicated in the maintenance of bone mass during late adulthood and aging, as decreases in serum IGF-1 levels appear to correlate with decreases in bone mineral density (BMD). Although informative, mouse models to date have been unable to separate the temporal effects of IGF-1 depletion on skeletal development. To address this problem, we performed a skeletal characterization of the inducible LID mouse (iLID), in which serum IGF-1 levels are depleted at selected ages. We found that depletion of serum IGF-1 in male iLID mice prior to adulthood (4 weeks) decreased trabecular bone architecture and significantly reduced transverse cortical bone properties (Ct.Ar, Ct.Th) by 16 weeks (adulthood). Likewise, depletion of serum IGF-1 in iLID males at 8 weeks of age, resulted in significantly reduced transverse cortical bone properties (Ct.Ar, Ct.Th) by 32 weeks (late adulthood), but had no effect on trabecular bone architecture. In contrast, depletion of serum IGF-1 after peak bone acquisition (at 16 weeks) resulted in enhancement of trabecular bone architecture, but no significant changes in cortical bone properties by 32 weeks as compared to controls. These results indicate that while serum IGF-1 is essential for bone accrual during the postnatal growth phase, depletion of IGF-1 after peak bone acquisition (16 weeks) is compartment-specific and does not have a detrimental effect on cortical bone mass in the older adult mouse.	[Courtland, Hayden-William; Elis, Sebastien; Wu, Yingjie; Sun, Hui; Yakar, Shoshana] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Jepsen, Karl J.] Mt Sinai Sch Med, Leni & Peter W May Dept Orthopaed, New York, NY USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Maine Medical Center	Courtland, HW (corresponding author), Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA.	shoshana.yakar@mssm.edu	Elis, Sebastien/K-6158-2019		NIAMS NIH HHS [R01 AR045433, R01 AR044927] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045433, R01AR044927] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CANALIS E, 1995, ENDOCRINOLOGY, V136, P1348, DOI 10.1210/en.136.4.1348; Canalis Ernesto, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P155; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; Gillberg P, 2002, CALCIFIED TISSUE INT, V70, P22, DOI 10.1007/s002230020048; HILL PA, 1995, ENDOCRINOLOGY, V136, P124, DOI 10.1210/en.136.1.124; HOLLY J, 2004, NOVART FDN SYMP, V262, P26; HOLLY J, 2004, NOVART FDN SYMP, V262, P265; Holly Jeff, 2004, Novartis Found Symp, V262, P19; Jepsen K, 2009, MAMM GENOME, V20, P21, DOI 10.1007/s00335-008-9158-1; JIANG J, 2006, BONE; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Langlois JA, 1998, J CLIN ENDOCR METAB, V83, P4257, DOI 10.1210/jc.83.12.4257; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Maheshwari H, 1996, J CLIN ENDOCR METAB, V81, P995, DOI 10.1210/jc.81.3.995; MALET C, 1988, CANCER RES, V48, P7193; MCCARTHY TL, 1989, ENDOCRINOLOGY, V124, P301, DOI 10.1210/endo-124-1-301; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patel MBR, 2005, BONE, V37, P833, DOI 10.1016/j.bone.2005.06.016; Price C, 2005, J BONE MINER RES, V20, P1983, DOI 10.1359/JBMR.050707; Resch A, 1998, ACTA ONCOL, V37, P661, DOI 10.1080/028418698430007; Rhee EJ, 2004, J BONE MINER METAB, V22, P392, DOI 10.1007/s00774-003-0500-0; Richman C, 2001, J BONE MINER RES, V16, P386, DOI 10.1359/jbmr.2001.16.2.386; Rosen CJ, 1997, BONE, V21, P217, DOI 10.1016/S8756-3282(97)00143-9; Rydziel S, 1997, J CELL BIOCHEM, V67, P176, DOI 10.1002/(SICI)1097-4644(19971101)67:2<176::AID-JCB3>3.0.CO;2-U; Shoba L, 1999, MOL CELL ENDOCRINOL, V152, P125, DOI 10.1016/S0303-7207(99)00045-3; Starnes LM, 2007, GENESIS, V45, P229, DOI 10.1002/dvg.20294; TURNER RT, 1988, ENDOCRINOLOGY, V122, P1146, DOI 10.1210/endo-122-3-1146; Wang YM, 2006, J BONE MINER RES, V21, P1350, DOI 10.1359/JBMR.060610; Wergedal JE, 2005, BONE, V36, P111, DOI 10.1016/j.bone.2004.09.012; WU PBY, CANC RES IN PRESS; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yakar S, 2006, J ENDOCRINOL, V189, P289, DOI 10.1677/joe.1.06657; Yakar S, 2009, J BONE MINER RES, V24, P1481, DOI [10.1359/JBMR.090226, 10.1359/jbmr.090226]; Yakar S, 2009, FASEB J, V23, P709, DOI 10.1096/fj.08-118976; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	38	35	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e14762	10.1371/journal.pone.0014762	http://dx.doi.org/10.1371/journal.pone.0014762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445249	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100002
J	Stuckey, DW; Di Gregorio, A; Clements, M; Rodriguez, TA				Stuckey, Daniel W.; Di Gregorio, Aida; Clements, Melanie; Rodriguez, Tristan A.			Correct Patterning of the Primitive Streak Requires the Anterior Visceral Endoderm	PLOS ONE			English	Article							EARLY MOUSE EMBRYO; DIPHTHERIA-TOXIN; GENETIC ABLATION; FOREBRAIN FORMATION; NODAL ANTAGONISTS; TRANSGENIC MICE; NEURAL PLATE; EXPRESSION; EPIBLAST; AXIS	Anterior-posterior axis specification in the mouse requires signalling from a specialised extra-embryonic tissue called the anterior visceral endoderm (AVE). AVE precursors are induced at the distal tip of the embryo and move to the prospective anterior. Embryological and genetic analysis has demonstrated that the AVE is required for anterior patterning and for correctly positioning the site of primitive streak formation by inhibiting Nodal activity. We have carried out a genetic ablation of the Hex-expressing cells of the AVE (Hex-AVE) by knocking the Diphtheria toxin subunit A into the Hex locus in an inducible manner. Using this model we have identified that, in addition to its requirement in the anterior of the embryo, the Hex-AVE sub-population has a novel role between 5.5 and 6.5dpc in patterning the primitive streak. Embryos lacking the Hex-AVE display delayed initiation of primitive streak formation and miss-patterning of the anterior primitive streak. We demonstrate that in the absence of the Hex-AVE the restriction of Bmp2 expression to the proximal visceral endoderm is also defective and expression of Wnt3 and Nodal is not correctly restricted to the posterior epiblast. These results, coupled with the observation that reducing Nodal signalling in Hex-AVE ablated embryos increases the frequency of phenotypes observed, suggests that these primitive streak patterning defects are due to defective Nodal signalling. Together, our experiments demonstrate that the AVE is not only required for anterior patterning, but also that specific sub-populations of this tissue are required to pattern the posterior of the embryo.	[Stuckey, Daniel W.; Di Gregorio, Aida; Clements, Melanie; Rodriguez, Tristan A.] Univ London Imperial Coll Sci Technol & Med, Mol Embryol Grp, MRC, Ctr Clin Sci, London, England	Imperial College London	Stuckey, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Mol Embryol Grp, MRC, Ctr Clin Sci, London, England.	tristan.rodriguez@csc.mrc.ac.uk		Rodriguez, Tristan/0000-0002-3415-8493	Medical Research Council; Lister Institute of Preventive Medicine; MRC [MC_U120081320] Funding Source: UKRI; Medical Research Council [MC_U120081320] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute of Preventive Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) and the Lister Institute of Preventive Medicine ( http://www.lister-institute.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1998, DEVELOPMENT, V125, P5091; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; HARRISON GS, 1991, HUM GENE THER, V2, P53, DOI 10.1089/hum.1991.2.1-53; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Kimura C, 2001, DEV BIOL, V235, P12, DOI 10.1006/dbio.2001.0289; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; Martinez-Barbera JP, 2001, INT J DEV BIOL, V45, P327; MAXWELL IH, 1986, CANCER RES, V46, P4660; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Miura S, 2007, DEV DYNAM, V236, P1602, DOI 10.1002/dvdy.21166; MORSUT L, DEVELOPMENT; Nagy A., 2003, MANIPULATING MOUSE E; Norris DP, 2002, DEVELOPMENT, V129, P3455; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Perea-Gomez A, 1999, DEVELOPMENT, V126, P4499; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Rhinn M, 1998, DEVELOPMENT, V125, P845; Rivera-Perez JA, 2003, DEV BIOL, V261, P470, DOI 10.1016/S0012-1606(03)00302-6; Rodriguez TA, 2001, DEV BIOL, V234, P304, DOI 10.1006/dbio.2001.0265; Shawlot W, 1999, DEVELOPMENT, V126, P4925; Srinivas S, 2004, DEVELOPMENT, V131, P1157, DOI 10.1242/dev.01005; Srinivas S, 2006, GENESIS, V44, P565, DOI 10.1002/dvg.20249; Tam PPL, 1999, DEVELOPMENT, V126, P5171; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Varlet I, 1997, DEVELOPMENT, V124, P1033; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17620	10.1371/journal.pone.0017620	http://dx.doi.org/10.1371/journal.pone.0017620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445260	gold, Green Published			2022-12-27	WOS:000288545100020
J	Damrauer, SM; Studer, P; da Silva, CG; Longo, CR; Ramsey, HE; Csizmadia, E; Shrikhande, GV; Scali, ST; Libermann, TA; Bhasin, MK; Ferran, C				Damrauer, Scott M.; Studer, Peter; da Silva, Cleide G.; Longo, Christopher R.; Ramsey, Haley E.; Csizmadia, Eva; Shrikhande, Gautam V.; Scali, Salvatore T.; Libermann, Towia A.; Bhasin, Manoj K.; Ferran, Christiane			A20 Modulates Lipid Metabolism and Energy Production to Promote Liver Regeneration	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; NF-KAPPA-B; GENE-EXPRESSION PATTERNS; PARTIAL-HEPATECTOMY; PROTECTS MICE; MOUSE-LIVER; MECHANISMS; DISRUPTION; INJURY; MASS	Background: Liver Regeneration is clinically of major importance in the setting of liver injury, resection or transplantation. We have demonstrated that the NF-kappa B inhibitory protein A20 significantly improves recovery of liver function and mass following extended liver resection (LR) in mice. In this study, we explored the Systems Biology modulated by A20 following extended LR in mice. Methodology and Principal Findings: We performed transcriptional profiling using Affymetrix-Mouse 430.2 arrays on liver mRNA retrieved from recombinant adenovirus A20 (rAd.A20) and rAd.beta galactosidase treated livers, before and 24 hours after 78% LR. A20 overexpression impacted 1595 genes that were enriched for biological processes related to inflammatory and immune responses, cellular proliferation, energy production, oxidoreductase activity, and lipid and fatty acid metabolism. These pathways were modulated by A20 in a manner that favored decreased inflammation, heightened proliferation, and optimized metabolic control and energy production. Promoter analysis identified several transcriptional factors that implemented the effects of A20, including NF-kappa B, CEBPA, OCT-1, OCT-4 and EGR1. Interactive scale-free network analysis captured the key genes that delivered the specific functions of A20. Most of these genes were affected at basal level and after resection. We validated a number of A20's target genes by real-time PCR, including p21, the mitochondrial solute carriers SLC25a10 and SLC25a13, and the fatty acid metabolism regulator, peroxisome proliferator activated receptor alpha. This resulted in greater energy production in A20-expressing livers following LR, as demonstrated by increased enzymatic activity of cytochrome c oxidase, or mitochondrial complex IV. Conclusion: This Systems Biology-based analysis unravels novel mechanisms supporting the pro-regenerative function of A20 in the liver, by optimizing energy production through improved lipid/fatty acid metabolism, and down-regulated inflammation. These findings support pursuit of A20-based therapies to improve patients' outcomes in the context of extreme liver injury and extensive LR for tumor treatment or donation.	[Damrauer, Scott M.; Studer, Peter; da Silva, Cleide G.; Longo, Christopher R.; Ramsey, Haley E.; Csizmadia, Eva; Shrikhande, Gautam V.; Scali, Salvatore T.; Ferran, Christiane] Harvard Univ, Sch Med, Div Vasc Surg, Vasc Biol Res Ctr, Boston, MA USA; [Damrauer, Scott M.; Studer, Peter; da Silva, Cleide G.; Longo, Christopher R.; Ramsey, Haley E.; Csizmadia, Eva; Shrikhande, Gautam V.; Scali, Salvatore T.; Ferran, Christiane] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr,Transplant Inst, Boston, MA 02115 USA; [Libermann, Towia A.; Bhasin, Manoj K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol,Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Damrauer, SM (corresponding author), Massachusetts Gen Hosp, Div Vasc Surg, Boston, MA 02114 USA.	mbhasin@bidmc.harvard.edu; cferran@bidmc.harvard.edu	Angolano, Cleide/AAZ-4154-2021	Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X; Damrauer, Scott/0000-0001-8009-1632	NIH [RO1 DK063275, RO1 HL080130, HL057791, T32 HL07734]; Juvenile Diabetes Research Foundation [1-2007-567]; National Swiss Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080130, T32HL007734, R01HL057791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Swiss Foundation(Swiss National Science Foundation (SNSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	research was supported by NIH grants RO1 DK063275, RO1 HL080130, HL057791 and Juvenile Diabetes Research Foundation grant 1-2007-567 to CF. SMD, CRL, GVS, STS, are recipients of a fellowship award from the NIH T32 HL07734. PS is the recipient of a grant from the National Swiss Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Arai M, 2003, J BIOL CHEM, V278, P29813, DOI 10.1074/jbc.M212648200; Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; Banz Y, 2007, TRANSPL INT, V20, P722, DOI 10.1111/j.1432-2277.2007.00512.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brasaemle DL, 2006, SCIENCE, V313, P1581, DOI 10.1126/science.1133253; Campbell JS, 2001, J CLIN INVEST, V107, P1285, DOI 10.1172/JCI11867; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Cooper JT, 1997, TRANSPL P, V29, P881, DOI 10.1016/S0041-1345(96)00185-6; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; COORNAERT B, 2008, J BIOL CHEM; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; de Jonge J, 2009, AM J TRANSPLANT, V9, P758, DOI 10.1111/j.1600-6143.2009.02557.x; De Paepe B, 2009, CURR PROTOC HUM GENE, VChapter 19, pUnit192; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Ezaki H, 2009, BIOCHEM BIOPH RES CO, V378, P68, DOI 10.1016/j.bbrc.2008.10.176; Farrell GC, 2004, HEPATOLOGY, V40, P1252, DOI 10.1002/hep.20522; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Ferran C, 1998, BLOOD, V91, P2249, DOI 10.1182/blood.V91.7.2249.2249_2249_2258; Garnier D, 2009, HEPATOLOGY, V50, P1946, DOI 10.1002/hep.23225; Gazit V, 2010, HEPATOLOGY, V52, P2109, DOI 10.1002/hep.23920; Glantzounis GK, 2005, LIVER TRANSPLANT, V11, P1031, DOI 10.1002/lt.20504; Guo FZ, 2006, PROTEOMICS, V6, P3075, DOI 10.1002/pmic.200500322; Haberberger TC, 2000, GENE THER, V7, P903, DOI 10.1038/sj.gt.3301181; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ilyin GP, 2003, AM J PHYSIOL-GASTR L, V285, pG115, DOI 10.1152/ajpgi.00309.2002; Inderbitzin DT, 2007, BRIT J SURG, V94, P599, DOI 10.1002/bjs.5666; Inderbitzin D, 2007, J GASTROINTEST SURG, V11, P280, DOI 10.1007/s11605-007-0096-0; Inderbitzin D, 2007, METHODS, V43, P46, DOI 10.1016/j.ymeth.2007.03.010; Klune JR, 2008, J LEUKOCYTE BIOL, V83, P558, DOI 10.1189/jlb.0607406; Kunter U, 2005, KIDNEY INT, V68, P1520, DOI 10.1111/j.1523-1755.2005.00564.x; LAHERTY CD, 1993, J BIOL CHEM, V268, P5032; Leclercq IA, 2003, GASTROENTEROLOGY, V124, P1451, DOI 10.1016/S0016-5085(03)00270-1; Leclercq IA, 2006, LAB INVEST, V86, P1161, DOI 10.1038/labinvest.3700474; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Li JN, 2009, AM J PATHOL, V175, P947, DOI 10.2353/ajpath.2009.090043; Li W, 2001, HEPATOLOGY, V33, P1377, DOI 10.1053/jhep.2001.24431; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo CR, 2005, HEPATOLOGY, V42, P156, DOI 10.1002/hep.20741; Mann DV, 2001, HEPATOLOGY, V34, P557, DOI 10.1053/jhep.2001.27012; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mizuarai S, 2005, J BIOL CHEM, V280, P32434, DOI 10.1074/jbc.M503152200; Nagata Y, 2005, EXP CELL RES, V305, P277, DOI 10.1016/j.yexcr.2004.12.028; NAKATANI T, 1982, CLIN SCI, V62, P295, DOI 10.1042/cs0620295; NAKATANI T, 1981, J LAB CLIN MED, V97, P887; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Okaya T, 2004, AM J PHYSIOL-GASTR L, V286, pG606, DOI 10.1152/ajpgi.00191.2003; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Otu HH, 2007, J BIOL CHEM, V282, P11197, DOI 10.1074/jbc.M608441200; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Ramsey HE, 2009, LIVER TRANSPLANT, V15, P1613, DOI 10.1002/lt.21879; Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462; Skrtic S, 2005, LIVER INT, V25, P33, DOI 10.1111/j.1478-3231.2004.0998.x; Stoupis C, 2007, EUR RADIOL, V17, P401, DOI 10.1007/s00330-006-0359-2; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Yang SQ, 2001, HEPATOLOGY, V34, P694, DOI 10.1053/jhep.2001.28054; Yang XX, 2010, AM J PATHOL, V176, P733, DOI 10.2353/ajpath.2010.090524; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	72	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17715	10.1371/journal.pone.0017715	http://dx.doi.org/10.1371/journal.pone.0017715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437236	Green Published, Green Submitted, gold			2022-12-27	WOS:000288514600011
J	Boswell, CA; Ferl, GZ; Mundo, EE; Bumbaca, D; Schweiger, MG; Theil, FP; Fielder, PJ; Khawli, LA				Boswell, C. Andrew; Ferl, Gregory Z.; Mundo, Eduardo E.; Bumbaca, Daniela; Schweiger, Michelle G.; Theil, Frank-Peter; Fielder, Paul J.; Khawli, Leslie A.			Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow	PLOS ONE			English	Article							PHARMACOKINETIC PBPK MODEL; HUMAN TUMOR XENOGRAFTS; MONOCLONAL-ANTIBODIES; RAT-TUMORS; MICE; CELLS; PERMEABILITY; BINDING; TC-99M; MOUSE	Background: The identification of clinically meaningful and predictive models of disposition kinetics for cancer therapeutics is an ongoing pursuit in drug development. In particular, the growing interest in preclinical evaluation of anti-angiogenic agents alone or in combination with other drugs requires a complete understanding of the associated physiological consequences. Methodology/Principal Findings: Technescan (TM) PYP (TM), a clinically utilized radiopharmaceutical, was used to measure tissue vascular volumes in beige nude mice that were naive or administered a single intravenous bolus dose of a murine anti-vascular endothelial growth factor (anti-VEGF) antibody (10 mg/kg) 24 h prior to assay. Anti-VEGF had no significant effect (p>0.05) on the fractional vascular volumes of any tissues studied; these findings were further supported by single photon emission computed tomographic imaging. In addition, apart from a borderline significant increase (p = 0.048) in mean hepatic blood flow, no significant anti-VEGF-induced differences were observed (p>0.05) in two additional physiological parameters, interstitial fluid volume and the organ blood flow rate, measured using indium-111-pentetate and rubidium-86 chloride, respectively. Areas under the concentration-time curves generated by a physiologically-based pharmacokinetic model changed substantially (>25%) in several tissues when model parameters describing compartmental volumes and blood flow rates were switched from literature to our experimentally derived values. However, negligible changes in predicted tissue exposure were observed when comparing simulations based on parameters measured in naive versus anti-VEGF-administered mice. Conclusions/Significance: These observations may foster an enhanced understanding of anti-VEGF effects in murine tissues and, in particular, may be useful in modeling antibody uptake alone or in combination with anti-VEGF.	[Boswell, C. Andrew; Ferl, Gregory Z.; Mundo, Eduardo E.; Bumbaca, Daniela; Theil, Frank-Peter; Fielder, Paul J.; Khawli, Leslie A.] Genentech Inc, Dept Pharmacokinet & Pharmacodynam Sci, San Francisco, CA 94080 USA; [Schweiger, Michelle G.] Genentech Inc, Dept Investigat Safety Assessment, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Boswell, CA (corresponding author), Genentech Inc, Dept Pharmacokinet & Pharmacodynam Sci, San Francisco, CA 94080 USA.	boswell.andy@gene.com		Ferl, Gregory/0000-0002-9943-1569; Boswell, Charles/0000-0002-0426-9846	Roche	Roche(Roche Holding)	Competing Interests: The authors have read the journal's policy and have the following conflicts: All authors are paid employees of Genentech, a member of the Roche Group, and hold financial interest in Roche in the form of stocks and/or options. Two drugs mentioned in this manuscript, trastuzumab and bevacizumab, are marketed by Genentech/Roche. In addition, CAB serves as an Academic Editor for PLoS ONE. None of these financial or competing interests alters the authors' adherence to all PLoS ONE policies on sharing data and materials.	ATKINS HL, 1980, RADIOLOGY, V136, P501, DOI 10.1148/radiology.136.2.7403531; Bagri A, CLIN CANC RES, V16, P3887; BAXTER LT, 1994, CANCER RES, V54, P1517; BAXTER LT, 1995, CANCER RES, V55, P4611; BISCHOFF KB, 1970, J PHARM SCI-US, V59, P149, DOI 10.1002/jps.2600590203; BJORKMAN S, 1994, J PHARMACOKINET BIOP, V22, P381, DOI 10.1007/BF02353862; Blumenthal RD, 2000, EUR J CANCER, V36, P1876, DOI 10.1016/S0959-8049(00)00177-5; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Boswell CA, 2009, J LABELLED COMPD RAD, V52, pS102; Boswell CA, 2010, MOL PHARMACEUT, V7, P1848, DOI 10.1021/mp100183k; Boswell CA, 2009, PROTEINS PEPTIDES PR; Boswell CA, MOL IMAGING PROBES C; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; CHERRY SR, 1990, J NUCL MED, V31, P1307; Davda JP, 2008, INT IMMUNOPHARMACOL, V8, P401, DOI 10.1016/j.intimp.2007.10.023; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Ferl GZ, 2005, ANN BIOMED ENG, V33, P1640, DOI 10.1007/s10439-005-7410-3; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Garg A, 2007, J PHARMACOKINET PHAR, V34, P687, DOI 10.1007/s10928-007-9065-1; Green AJ, 2001, PHYS MED BIOL, V46, P1679, DOI 10.1088/0031-9155/46/6/307; GULLINO PM, 1962, J NATL CANCER I, V28, P211; HAMMERSLEY PAG, 1987, EUR J NUCL MED, V13, P90; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Levitt David G, 2003, BMC Clin Pharmacol, V3, P3, DOI 10.1186/1472-6904-3-3; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Nestorov I, 2007, EXPERT OPIN DRUG MET, V3, P235, DOI 10.1517/17425255.3.2.235; O'Connor JPB, 2009, CLIN CANCER RES, V15, P6674, DOI 10.1158/1078-0432.CCR-09-0731; OCONNOR SW, 1984, CANCER RES, V44, P3719; Park S, 2005, J PHARMACOL EXP THER, V312, P1249, DOI 10.1124/jpet.104.076216; PAVEL DG, 1977, J NUCL MED, V18, P305; REHANI MM, 1980, J NUCL MED, V21, P676; SANDS H, 1985, CANCER LETT, V27, P15, DOI 10.1016/0304-3835(85)90004-7; SANDS H, 1988, CANCER RES, V48, P188; Scheer MGW, 2008, EUR J CANCER, V44, P1835, DOI 10.1016/j.ejca.2008.05.026; SHOCKLEY TR, 1992, CANCER RES, V52, P357; SMITH TD, 1976, J NUCL MED, V17, P126; SRIVASTAVA SC, 1984, SEMIN NUCL MED, V14, P68, DOI 10.1016/S0001-2998(84)80022-7; SUNG C, 1990, CANCER RES, V50, P7382; WANG P, 1993, AM J PHYSIOL, V264, pH1166, DOI 10.1152/ajpheart.1993.264.4.H1166; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; ZANELLI GD, 1974, CANCER RES, V34, P1451	41	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17874	10.1371/journal.pone.0017874	http://dx.doi.org/10.1371/journal.pone.0017874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21436893	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900038
J	Emmanuel, C; Gava, N; Kennedy, C; Balleine, RL; Sharma, R; Wain, G; Brand, A; Hogg, R; Etemadmoghadam, D; George, J; Birrer, MJ; Clarke, CL; Chenevix-Trench, G; Bowtell, DDL; Harnett, PR; Defazio, A				Emmanuel, Catherine; Gava, Natalie; Kennedy, Catherine; Balleine, Rosemary L.; Sharma, Raghwa; Wain, Gerard; Brand, Alison; Hogg, Russell; Etemadmoghadam, Dariush; George, Joshy; Birrer, Michael J.; Clarke, Christine L.; Chenevix-Trench, Georgia; Bowtell, David D. L.; Harnett, Paul R.; deFazio, Anna		Australian Ovarian Canc Study Grp	Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC MARKER; RNA-BINDING PROTEIN; SEROUS OVARIAN; CONSTITUTIVE ACTIVATION; SURVIVIN EXPRESSION; INCESSANT OVULATION; MITOTIC CHECKPOINT; SIGNALING PATHWAY; MUTATION CARRIERS; LIPOCALIN NGAL	Molecular events leading to epithelial ovarian cancer are poorly understood but ovulatory hormones and a high number of life-time ovulations with concomitant proliferation, apoptosis, and inflammation, increases risk. We identified genes that are regulated during the estrous cycle in murine ovarian surface epithelium and analysed these profiles to identify genes dysregulated in human ovarian cancer, using publically available datasets. We identified 338 genes that are regulated in murine ovarian surface epithelium during the estrous cycle and dysregulated in ovarian cancer. Six of seven candidates selected for immunohistochemical validation were expressed in serous ovarian cancer, inclusion cysts, ovarian surface epithelium and in fallopian tube epithelium. Most were overexpressed in ovarian cancer compared with ovarian surface epithelium and/or inclusion cysts (EpCAM, EZH2, BIRC5) although BIRC5 and EZH2 were expressed as highly in fallopian tube epithelium as in ovarian cancer. We prioritised the 338 genes for those likely to be important for ovarian cancer development by in silico analyses of copy number aberration and mutation using publically available datasets and identified genes with established roles in ovarian cancer as well as novel genes for which we have evidence for involvement in ovarian cancer. Chromosome segregation emerged as an important process in which genes from our list of 338 were over-represented including two (BUB1, NCAPD2) for which there is evidence of amplification and mutation. NUAK2, upregulated in ovarian surface epithelium in proestrus and predicted to have a driver mutation in ovarian cancer, was examined in a larger cohort of serous ovarian cancer where patients with lower NUAK2 expression had shorter overall survival. In conclusion, defining genes that are activated in normal epithelium in the course of ovulation that are also dysregulated in cancer has identified a number of pathways and novel candidate genes that may contribute to the development of ovarian cancer.	[Emmanuel, Catherine; Gava, Natalie; Kennedy, Catherine; Wain, Gerard; Brand, Alison; Hogg, Russell; Harnett, Paul R.; deFazio, Anna] Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia; [Emmanuel, Catherine; Gava, Natalie; Kennedy, Catherine; Balleine, Rosemary L.; Clarke, Christine L.; Harnett, Paul R.; deFazio, Anna] Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Emmanuel, Catherine; Gava, Natalie; Kennedy, Catherine; Balleine, Rosemary L.; Clarke, Christine L.; Harnett, Paul R.; deFazio, Anna] Univ Sydney, Westmead, NSW 2145, Australia; [Sharma, Raghwa] Westmead Hosp, Dept Anat Pathol, Westmead, NSW 2145, Australia; [Etemadmoghadam, Dariush; George, Joshy; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Melbourne, Australia; [Chenevix-Trench, Georgia] Queensland Inst Med Res, Div Genet & Populat Hlth, Canc Genet Lab, Brisbane, Qld 4006, Australia; [Bowtell, David D. L.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Birrer, Michael J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute; University of Melbourne; Harvard University; Harvard Medical School	Emmanuel, C (corresponding author), Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia.	catherine_emmanuel@wmi.usyd.edu.au	George, Joshy/K-4841-2019; Chenevix-Trench, Georgia/AAV-2014-2020; DeFazio, Anna/O-2385-2019; deFazio, Anna/D-3939-2013; Bowtell, David/H-1007-2016; Harnett, Paul R/D-4090-2014	Chenevix-Trench, Georgia/0000-0002-1878-2587; DeFazio, Anna/0000-0003-0057-4744; deFazio, Anna/0000-0003-0057-4744; Bowtell, David/0000-0001-9089-7525; Harnett, Paul R/0000-0001-7021-0642; George, Joshy/0000-0001-8510-8229; Brand, Alison/0000-0001-7975-6326; Clarke, Christine/0000-0001-7568-111X	National Health and Medical Research Council (NHMRC) [389867]; Marsha Rivkin Centre for Ovarian Cancer; U.S. Army Medical Research and Material Command [DAMD17-01-1-0729]; Cancer Council Victoria; Queensland Cancer Fund; Cancer Council New South Wales; Cancer Council South Australia; Cancer Foundation of Western Australia; Cancer Council Tasmania	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Marsha Rivkin Centre for Ovarian Cancer; U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Queensland Cancer Fund; Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Council Tasmania(Cancer Council Tasmania)	This study was funded by a National Health and Medical Research Council (NHMRC) project grant 389867 (nhmrc.gov.au) and by a Marsha Rivkin Centre for Ovarian Cancer Pilot Award (marsharivkin.org). RLB is a Cancer Institute NSW Fellow. The Australian Ovarian Cancer Study is supported by the U.S. Army Medical Research and Material Command under DAMD17-01-1-0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania and the NHMRC. The Australasian Biospecimens Network - Oncology is funded by the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto-Ishida E, 2004, ENDOCRINOLOGY, V145, P2014, DOI 10.1210/en.2003-1199; Armaiz-Pena GN, 2009, CLIN CANCER RES, V15, P2971, DOI 10.1158/1078-0432.CCR-08-2525; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Banks E, 1997, INT J GYNECOL CANCER, V7, P425, DOI 10.1046/j.1525-1438.1997.09756.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; BLAUSTEIN A, 1982, CANCER, V49, P722, DOI 10.1002/1097-0142(19820215)49:4<722::AID-CNCR2820490421>3.0.CO;2-C; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Burges A, 2007, CLIN CANCER RES, V13, P3899, DOI 10.1158/1078-0432.CCR-06-2769; Byrne JA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-497; Caldas H, 2006, MOL CANCER THER, V5, P693, DOI 10.1158/1535-7163.MCT-05-0423; CASAGRANDE JT, 1979, LANCET, V2, P170; Choi JH, 2007, ENDOCR REV, V28, P440, DOI 10.1210/er.2006-0036; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Drapkin R, 2004, HUM PATHOL, V35, P1014, DOI 10.1016/j.humpath.2004.04.014; FATHALLA MF, 1971, LANCET, V2, P163; Ferrandina G, 2005, BRIT J CANCER, V92, P271, DOI 10.1038/sj.bjc.6602332; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gaval N, 2008, J MOL ENDOCRINOL, V40, P281, DOI 10.1677/JME-07-0149; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gyorffy B, 2009, BREAST CANCER RES TR, V118, P433, DOI 10.1007/s10549-008-0242-8; Hamid AA, 2003, INT J GYNECOL PATHOL, V22, P240, DOI 10.1097/01.PGP.0000070851.25718.EC; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Jernstrom H, 2005, MOL GENET METAB, V86, P320, DOI 10.1016/j.ymgme.2005.06.007; Jordan SJ, 2008, INT J CANCER, V122, P1598, DOI 10.1002/ijc.23287; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Lee EA, 2004, MOL CANCER THER, V3, P661; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lee YK, 2009, BRIT J CANCER, V101, P504, DOI 10.1038/sj.bjc.6605161; Legembre P, 2004, J BIOL CHEM, V279, P46742, DOI 10.1074/jbc.M404334200; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Moilanen J, 2003, GYNECOL ONCOL, V90, P273, DOI 10.1016/S0090-8258(03)00262-2; Nabilsi NH, 2010, J ENDOCRINOL, V207, P237, DOI 10.1677/JOE-10-0128; Nishizuka S, 2003, CANCER RES, V63, P5243; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Reisman DN, 2003, CANCER RES, V63, P560; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Shahzad MMK, 2009, CANCER BIOL THER, V8, P1027, DOI 10.4161/cbt.8.11.8523; Sheikh MS, 1997, J BIOL CHEM, V272, P26720, DOI 10.1074/jbc.272.42.26720; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Shimizu Y, 1998, CANCER-AM CANCER SOC, V82, P893, DOI 10.1002/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Steinmetz R, 2004, MOL ENDOCRINOL, V18, P2570, DOI 10.1210/me.2004-0082; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Su D, 2009, CYTOTHERAPY, V11, P642, DOI 10.1080/14653240902878308; Sui L, 2002, INT J ONCOL, V21, P315; Takai N, 2002, INT J MOL MED, V10, P211; Tone AA, 2008, CLIN CANCER RES, V14, P4067, DOI 10.1158/1078-0432.CCR-07-4959; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tringler B, 2004, APPL IMMUNOHISTO M M, V12, P40; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urzua U, 2006, J CELL PHYSIOL, V206, P594, DOI 10.1002/jcp.20522; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vergote I, 2000, J NATL CANCER I, V92, P1534, DOI 10.1093/jnci/92.18.1534; Watrin E, 2005, MOL CELL BIOL, V25, P740, DOI 10.1128/MCB.25.2.740-750.2005; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wong AKC, 2000, CANCER RES, V60, P6171; Zhang L, 2005, CANCER RES, V65, P925; Zheng WX, 2000, GYNECOL ONCOL, V76, P80, DOI 10.1006/gyno.1999.5628	71	28	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17617	10.1371/journal.pone.0017617	http://dx.doi.org/10.1371/journal.pone.0017617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423607	Green Published, gold			2022-12-27	WOS:000288513900014
J	Meijer, HJG; Hassen, HH; Govers, F				Meijer, Harold J. G.; Hassen, Hussen Harrun; Govers, Francine			Phytophthora infestans Has a Plethora of Phospholipase D Enzymes Including a Subclass That Has Extracellular Activity	PLOS ONE			English	Article							ACTIVATION	In eukaryotes phospholipase D (PLD) is involved in many cellular processes. Currently little is known about PLDs in oomycetes. Here we report that the oomycete plant pathogen Phytophthora infestans has a large repertoire of PLDs divided over six subfamilies: PXPH-PLD, PXTM-PLD, TM-PLD, PLD-likes, and type A and B sPLD-likes. Since the latter have signal peptides we developed a method using metabolically labelled phospholipids to monitor if P. infestans secretes PLD. In extracellular medium of ten P. infestans strains PLD activity was detected as demonstrated by the production of phosphatidic acid and the PLD specific marker phosphatidylalcohol.	[Meijer, Harold J. G.; Hassen, Hussen Harrun; Govers, Francine] Wageningen Univ, Plant Sci Grp, Phytopathol Lab, Wageningen, Netherlands; [Govers, Francine] CBSG, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Meijer, HJG (corresponding author), Wageningen Univ, Plant Sci Grp, Phytopathol Lab, Wageningen, Netherlands.	Harold.Meijer@wur.nl	Meijer, HJG/AFN-5216-2022; Meijer, Harold/G-5703-2012; Govers, Francine/A-5616-2009; Meijer, Harold/S-3891-2019	Meijer, HJG/0000-0002-0883-219X; Govers, Francine/0000-0001-5311-929X; Meijer, Harold/0000-0002-0883-219X	Dutch Technology Foundation STW; applied science division of NWO; Ministry of Economic Affairs; Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Dutch Technology Foundation STW(Technologiestichting STW); applied science division of NWO(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs; Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Dutch Technology Foundation STW, applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs, in the framework of a VIDI project (HM) and by the Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (FG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Chae YC, 2005, J BIOL CHEM, V280, P3723, DOI 10.1074/jbc.M406987200; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Ho AYY, 2009, FUNCT PLANT BIOL, V36, P190, DOI 10.1071/FP08222; Lamour KH, 2006, MOL PLANT MICROBE IN, V19, P1359, DOI 10.1094/MPMI-19-1359; Latijnhouwers M, 2002, MOL PLANT MICROBE IN, V15, P939, DOI 10.1094/MPMI.2002.15.9.939; Madrid E, 2010, J EXP BOT, V61, P747, DOI 10.1093/jxb/erp339; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1337, DOI 10.1094/MPMI-19-1337; Meijer HJG, 2005, GENE, V350, P173, DOI 10.1016/j.gene.2005.02.012; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Pleskot R, 2010, PLANT J, V62, P494, DOI 10.1111/j.1365-313X.2010.04168.x; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Zambonelli C, 2005, PROG NUCLEIC ACID RE, V79, P133, DOI 10.1016/S0079-6603(04)79003-0	16	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17767	10.1371/journal.pone.0017767	http://dx.doi.org/10.1371/journal.pone.0017767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423760	Green Submitted, Green Published, gold			2022-12-27	WOS:000288512400026
J	Chen, JM; Guan, RZ; Chang, SX; Du, TQ; Zhang, HS; Xing, H				Chen, Jianmei; Guan, Rongzhan; Chang, Shengxin; Du, Tongqing; Zhang, Hongsheng; Xing, Han			Substoichiometrically Different Mitotypes Coexist in Mitochondrial Genomes of Brassica napus L	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CYTOPLASMIC MALE-STERILITY; ARABIDOPSIS-THALIANA; DNA; GENES; HETEROPLASMY; EVOLUTION; REVERSION; FERTILE; HYBRIDS	Cytoplasmic male sterility (CMS) has been identified in numerous plant species. Brassica napus CMS plants, such as Polima (pol), MI, and Shaan 2A, have been identified independently by different researchers with different materials in conventional breeding processes. How this kind of CMS emerges is unclear. Here, we report the mitochondrial genome sequence of the prevalent mitotype in the most widely used pol-CMS line, which has a length of 223,412 bp and encodes 34 proteins, 3 ribosomal RNAs, and 18 tRNAs, including two near identical copies of trnH. Of these 55 genes, 48 were found to be identical to their equivalents in the "nap" cytoplasm. The nap mitotype carries only one copy of trnH, and the sequences of five of the six remaining genes are highly similar to their equivalents in the pol mitotype. Forty-four open reading frames (ORFs) with unknown function were detected, including two unique to the pol mitotype (orf122 and orf132). At least five rearrangement events are required to account for the structural differences between the pol and nap sequences. The CMS-related orf224 neighboring region (similar to 5 kb) rearranged twice. PCR profiling based on mitotype-specific primer pairs showed that both mitotypes are present in B. napus cultivars. Quantitative PCR showed that the pol cytoplasm consists mainly of the pol mitotype, and the nap mitotype is the main genome of nap cytoplasm. Large variation in the copy number ratio of mitotypes was found, even among cultivars sharing the same cytoplasm. The coexistence of mitochondrial mitotypes and substoichiometric shifting can explain the emergence of CMS in B. napus.	[Chen, Jianmei; Guan, Rongzhan; Chang, Shengxin; Du, Tongqing; Zhang, Hongsheng; Xing, Han] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China	Nanjing Agricultural University	Chen, JM (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China.	rapeseed@njau.edu.cn; rapeseed@njau.edu.cn		Guan, Rongzhan/0000-0001-9177-6610	National Basic Research Program of China (973 Program) [2011CB109300]; National Natural Science Foundation of China [30970289]; National Key Technology R&D Program in China [2010BAD01B02]; Ministry of Agriculture of China for Transgenic Research [2009ZX08009-040B]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program in China(National Key Technology R&D Program); Ministry of Agriculture of China for Transgenic Research	This work was supported by the National Basic Research Program of China (973 Program) (2011CB109300); National Natural Science Foundation of China (30970289); National Key Technology R&D Program (2010BAD01B02) in China; and the Ministry of Agriculture of China for Transgenic Research (2009ZX08009-040B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Arrieta-Montiel M, 2001, GENETICS, V158, P851; Bellaoui M, 1998, MOL GEN GENET, V257, P177, DOI 10.1007/s004380050637; BLAND MM, 1985, THEOR APPL GENET, V69, P535, DOI 10.1007/BF00251100; Carlsson J, 2008, MITOCHONDRION, V8, P74, DOI 10.1016/j.mito.2007.09.006; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Feng X, 2009, THEOR APPL GENET, V118, P1361, DOI 10.1007/s00122-009-0986-5; FU S, 1989, Acta Agronomica Sinica, V15, P305; Fu T. D., 1981, Cruciferae Newsletter, P6; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hattori N, 2002, GENETICS, V160, P1619; HE SC, 1996, P NATL ACAD SCI USA, V93, P1176; Janska H, 1998, PLANT CELL, V10, P1163, DOI 10.1105/tpc.10.7.1163; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; LHOMME Y, 1993, NUCLEIC ACIDS RES, V21, P1903, DOI 10.1093/nar/21.8.1903; Li D.R., 1980, SHAANXI J AGR SCI, V1, P26; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Scotti N, 2004, CURR GENET, V45, P378, DOI 10.1007/s00294-004-0496-6; Shiga T., 1973, JPN J BREED, V23, P187, DOI DOI 10.1270/JSBBS1951.23.187; Shiga T., 1971, JAPANESE J BREED, V21, P16; SINGH M, 1991, PLANT CELL, V3, P1349, DOI 10.1105/tpc.3.12.1349; SMALL I, 1989, CELL, V58, P69, DOI 10.1016/0092-8674(89)90403-0; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON KF, 1972, HEREDITY, V29, P253, DOI 10.1038/hdy.1972.89; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361; Yang GuangSheng, 1998, Scientia Agricultura Sinica, V31, P27	40	78	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17662	10.1371/journal.pone.0017662	http://dx.doi.org/10.1371/journal.pone.0017662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423700	Green Submitted, Green Published, gold			2022-12-27	WOS:000288219100022
J	Martins-Silva, C; De Jaeger, X; Guzman, MS; Lima, RDF; Santos, MS; Kushmerick, C; Gomez, MV; Caron, MG; Prado, MAM; Prado, VF				Martins-Silva, Cristina; De Jaeger, Xavier; Guzman, Monica S.; Lima, Ricardo D. F.; Santos, Magda S.; Kushmerick, Christopher; Gomez, Marcus V.; Caron, Marc G.; Prado, Marco A. M.; Prado, Vania F.			Novel Strains of Mice Deficient for the Vesicular Acetylcholine Transporter: Insights on Transcriptional Regulation and Control of Locomotor Behavior	PLOS ONE			English	Article							CHOLINERGIC GENE LOCUS; INDUCED HYPERACTIVITY; KNOCKOUT MICE; EXPRESSION; NEURONS; IDENTIFICATION; RECEPTORS; TARGETS; LACKING; MICROINJECTIONS	Defining the contribution of acetylcholine to specific behaviors has been challenging, mainly because of the difficulty in generating suitable animal models of cholinergic dysfunction. We have recently shown that, by targeting the vesicular acetylcholine transporter (VAChT) gene, it is possible to generate genetically modified mice with cholinergic deficiency. Here we describe novel VAChT mutant lines. VAChT gene is embedded within the first intron of the choline acetyltransferase (ChAT) gene, which provides a unique arrangement and regulation for these two genes. We generated a VAChT allele that is flanked by loxP sequences and carries the resistance cassette placed in a ChAT intronic region (FloxNeo allele). We show that mice with the FloxNeo allele exhibit differential VAChT expression in distinct neuronal populations. These mice show relatively intact VAChT expression in somatomotor cholinergic neurons, but pronounced decrease in other cholinergic neurons in the brain. VAChT mutant mice present preserved neuromuscular function, but altered brain cholinergic function and are hyperactive. Genetic removal of the resistance cassette rescues VAChT expression and the hyperactivity phenotype. These results suggest that release of ACh in the brain is normally required to "turn down" neuronal circuits controlling locomotion.	[Martins-Silva, Cristina; De Jaeger, Xavier; Guzman, Monica S.; Prado, Marco A. M.; Prado, Vania F.] Univ Western Ontario, Mol Brain Res Grp, Dept Anat & Cell Biol, London, ON, Canada; [Martins-Silva, Cristina; De Jaeger, Xavier; Guzman, Monica S.; Prado, Marco A. M.; Prado, Vania F.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [De Jaeger, Xavier; Santos, Magda S.; Gomez, Marcus V.] Univ Fed Minas Gerais, Sch Med, Program Mol Pharmacol, Belo Horizonte, MG, Brazil; [Lima, Ricardo D. F.; Kushmerick, Christopher] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Duke University	Martins-Silva, C (corresponding author), Univ Fed Espirito Santo, Dept Physiol, Vitoria, Espirito Santo, Spain.	mprado@robarts.ca; vprado@robarts.ca	de Freitas Lima, Ricardo/T-7825-2017; santos, magda s/J-4509-2015; Kushmerick, Christopher/G-3578-2012; Prado, Vania Ferreira/K-7630-2013; Gomez, Marcus Vinicius/I-4081-2012; Prado, Marco Antonio Maximo/K-7638-2013; Martins-Silva, Cristina/F-8053-2016; Lima, Ricardo/G-2946-2013	de Freitas Lima, Ricardo/0000-0003-0250-5945; santos, magda s/0000-0003-0626-3015; Prado, Vania Ferreira/0000-0003-4994-6393; Gomez, Marcus Vinicius/0000-0002-6082-930X; Prado, Marco Antonio Maximo/0000-0002-3028-5778; De Jaeger, Xavier/0000-0003-2511-5659	Canadian Institutes of Health Research (CIHR) [MOP-89919]; Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF); University of Western Ontario; National Institutes of Health (NIH); CAPES (Brazil); CNPq; FAPEMIG (Brazil)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); University of Western Ontario; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (CIHR; MOP-89919; for V.F.P. & M.A.M.P), Canadian Foundation for Innovation (CFI), the Ontario Research Fund (ORF) and the University of Western Ontario (V.F.P. & M.A.M.P.). M.G.C. received support from the National Institutes of Health (NIH). X. De J. received a PhD fellowship from CAPES (Brazil). C.K. was funded by CNPq and FAPEMIG (Brazil). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFONSO A, 1994, J NEUROSCI, V14, P2290; ALFONSO A, 1994, J MOL BIOL, V241, P627, DOI 10.1006/jmbi.1994.1538; Balla A, 2001, NEUROPSYCHOPHARMACOL, V25, P157, DOI 10.1016/S0893-133X(01)00230-5; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; BYMASTER FP, 1993, J PHARMACOL EXP THER, V267, P16; CERVINI R, 1995, J BIOL CHEM, V270, P24654, DOI 10.1074/jbc.270.42.24654; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; de Castro BM, 2009, GENES BRAIN BEHAV, V8, P23, DOI 10.1111/j.1601-183X.2008.00439.x; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; DICHIARA G, 1994, TRENDS NEUROSCI, V17, P228, DOI 10.1016/0166-2236(94)90005-1; Eiden LE, 1998, J NEUROCHEM, V70, P2227; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gerber DJ, 2001, P NATL ACAD SCI USA, V98, P15312, DOI 10.1073/pnas.261583798; Gil-Bea FJ, 2007, BEHAV NEUROSCI, V121, P340, DOI 10.1037/0735-7044.121.2.340; Gomeza J, 2001, LIFE SCI, V68, P2457, DOI 10.1016/S0024-3205(01)01039-6; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Granon S, 2006, ACTA PAEDIATR, V95, P645, DOI 10.1080/08035250600719747; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Guidine PAM, 2008, NEUROSCI LETT, V436, P201, DOI 10.1016/j.neulet.2008.03.020; Harper DG, 2004, NEUROBIOL AGING, V25, P771, DOI 10.1016/j.neurobiolaging.2003.04.009; Harper DG, 2005, AM J GERIAT PSYCHIAT, V13, P359, DOI 10.1176/appi.ajgp.13.5.359; Kitamoto T, 1998, J BIOL CHEM, V273, P2706, DOI 10.1074/jbc.273.5.2706; KITAMOTO T, 1995, J NEUROBIOL, V28, P70, DOI 10.1002/neu.480280107; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lee MH, 2002, J NEUROSCI, V22, P5291; Lima RD, 2010, J NEUROCHEM, V113, P943, DOI 10.1111/j.1471-4159.2010.06657.x; LONNERBERG P, 1995, P NATL ACAD SCI USA, V92, P4046, DOI 10.1073/pnas.92.9.4046; Lonnerberg P, 1996, J BIOL CHEM, V271, P33358, DOI 10.1074/jbc.271.52.33358; Mattsson A, 2005, NEUROREPORT, V16, P1815, DOI 10.1097/01.wnr.0000185018.29316.87; Maubourguet N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000229; Mehler-Wex C, 2006, NEUROTOX RES, V10, P167, DOI 10.1007/BF03033354; Misawa H, 2003, GENESIS, V37, P44, DOI 10.1002/gene.10224; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; MOLINENGO L, 1989, PHARMACOL BIOCHEM BE, V32, P1075, DOI 10.1016/0091-3057(89)90085-3; MUSEO E, 1990, PHARMACOL BIOCHEM BE, V37, P113, DOI 10.1016/0091-3057(90)90050-R; MUSEO E, 1990, PHARMACOL BIOCHEM BE, V35, P735, DOI 10.1016/0091-3057(90)90316-A; Naciff JM, 1999, J NEUROCHEM, V72, P17, DOI 10.1046/j.1471-4159.1999.0720017.x; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Panagis G, 1996, BRAIN RES, V730, P133; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; REAVILL C, 1990, BRIT J PHARMACOL, V99, P273, DOI 10.1111/j.1476-5381.1990.tb14693.x; SALVATERRA PM, 1993, PROG BRAIN RES, V98, P167; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Scarr E, 2009, NEUROSIGNALS, V17, P298, DOI 10.1159/000231896; Schutz B, 2003, J NEUROCHEM, V87, P1174, DOI 10.1046/j.1471-4159.2003.02095.x; Schutz B, 2000, NEUROSCIENCE, V96, P707, DOI 10.1016/S0306-4522(99)00587-4; SHANNON HE, 1990, J PHARMACOL EXP THER, V255, P549; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; UKAI M, 1994, GEN PHARMACOL, V25, P433, DOI 10.1016/0306-3623(94)90193-7; VIANNA MR, BRAZ J MED BIOL RES, V34, P233; Weisman D, 2006, VITAM HORM, V74, P505, DOI 10.1016/S0083-6729(06)74020-1; Wess J, 2003, LIFE SCI, V72, P2047, DOI 10.1016/S0024-3205(03)00082-1; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; YASUYAMA K, 1995, CELL TISSUE RES, V282, P193, DOI 10.1007/BF00319111	60	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17611	10.1371/journal.pone.0017611	http://dx.doi.org/10.1371/journal.pone.0017611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423695	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100019
J	Erlwein, O; Robinson, MJ; Kaye, S; Wills, G; Izui, S; Wessely, S; Weber, J; Cleare, A; Collier, D; McClure, MO				Erlwein, Otto; Robinson, Mark J.; Kaye, Steve; Wills, Gillian; Izui, Shozo; Wessely, Simon; Weber, Jonathan; Cleare, Anthony; Collier, David; McClure, Myra O.			Investigation into the Presence of and Serological Response to XMRV in CFS Patients	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; MURINE LEUKEMIA-VIRUS; PROSTATE-CANCER; GAMMARETROVIRUS; IDENTIFICATION; PREVALENCE; TUMORS; BLOOD	The novel human gammaretrovirus xenotropic murine leukemia virus-related virus (XMRV), originally described in prostate cancer, has also been implicated in chronic fatigue syndrome (CFS). When later reports failed to confirm the link to CFS, they were often criticised for not using the conditions described in the original study. Here, we revisit our patient cohort to investigate the XMRV status in those patients by means of the original PCR protocol which linked the virus to CFS. In addition, sera from our CFS patients were assayed for the presence of xenotropic virus envelope protein, as well as a serological response to it. The results further strengthen our contention that there is no evidence for an association of XMRV with CFS, at least in the UK.	[Erlwein, Otto; Robinson, Mark J.; Kaye, Steve; Wills, Gillian; Weber, Jonathan; McClure, Myra O.] Univ London Imperial Coll Sci Technol & Med, Jefferiss Res Trust Labs, Infect Dis Sect, Wright Fleming Inst,Fac Med, London, England; [Izui, Shozo] Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland; [Wessely, Simon; Cleare, Anthony] Kings Coll London, Dept Psychol Med, Inst Psychiat, London WC2R 2LS, England; [Collier, David] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England	Imperial College London; University of Geneva; University of London; King's College London; University of London; King's College London	Erlwein, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Jefferiss Res Trust Labs, Infect Dis Sect, Wright Fleming Inst,Fac Med, London, England.	m.mcclure@imperial.ac.uk	Cleare, Anthony/AAN-5418-2021; Collier, David A/D-1649-2011; Wessely, Simon C/A-8713-2008	Collier, David A/0000-0003-4087-1559; Wessely, Simon Charles/0000-0002-6743-9929; McClure, Myra/0000-0002-5494-407X	NIHR Biomedical Research Centre; Medical Research Council [G9817803B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish	NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; IZUI S, 1983, CLIN EXP IMMUNOL, V71, P45; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Martinez-Fierro ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-326; MIKOVITS J, 2010, VIRULENCE, V1, P1; PORTIS JL, 1982, VIROLOGY, V126, P96; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sharpe M, 1997, GEN HOSP PSYCHIAT, V19, P185, DOI 10.1016/S0163-8343(97)80315-5; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJ, BMJ, V340, pc1018; Wilson A, 2001, AUST NZ J PSYCHIAT, V35, P520, DOI 10.1046/j.1440-1614.2001.00888.x	24	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17592	10.1371/journal.pone.0017592	http://dx.doi.org/10.1371/journal.pone.0017592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408077	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900029
J	Harrison, JS; Mondor, EB				Harrison, John Scott; Mondor, Edward B.			Evidence for an Invasive Aphid "Superclone": Extremely Low Genetic Diversity in Oleander Aphid (Aphis nerii) Populations in the Southern United States	PLOS ONE			English	Article							GENOTYPIC DIVERSITY; ASEXUAL POPULATIONS; REPRODUCTIVE MODE; SITOBION-AVENAE; GOSSYPII GLOVER; INSECT PEST; F HOMOPTERA; EVOLUTION; LINEAGES; DIFFERENTIATION	Background: The importance of genetic diversity in successful biological invasions is unclear. In animals, but not necessarily plants, increased genetic diversity is generally associated with successful colonization and establishment of novel habitats. The Oleander aphid, Aphis nerii, though native to the Mediterranean region, is an invasive pest species throughout much of the world. Feeding primarily on Oleander (Nerium oleander) and Milkweed (Asclepias spp.) under natural conditions, these plants are unlikely to support aphid populations year round in the southern US. The objective of this study was to describe the genetic variation within and among US populations of A. nerii, during extinction/recolonization events, to better understand the population ecology of this invasive species. Methodology/Principal Findings: We used five microsatellite markers to assess genetic diversity over a two year period within and among three aphid populations separated by small (100 km) and large (3,700 km) geographic distances on two host plant species. Here we provide evidence for A. nerii "superclones". Genotypic variation was absent in all populations (i.e., each population consisted of a single multilocus genotype (MLG) or "clone") and the genetic composition of only one population completely changed across years. There was no evidence of sexual reproduction or host races on different plant species. Conclusions/Significance: Aphis nerii is a well established invasive species despite having extremely low genetic diversity. As this aphid appears to be obligatorily asexual, it may share more similarities with clonally reproducing invasive plants, than with other animals. Patterns of temporal and geographic genetic variation, viewed in the context of its population dynamics, have important implications for the management of invasive pests and the evolutionary biology of asexual species.	[Harrison, John Scott; Mondor, Edward B.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	University System of Georgia; Georgia Southern University	Harrison, JS (corresponding author), Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA.	sharrison@georgiasouthern.edu			Georgia Southern University; NSF-STEP [DUE-0622460]	Georgia Southern University; NSF-STEP	This work was supported by Georgia Southern University and Advisement and Scholarship Promoting Inquiry-based Research Experiences in STEM (ASPIRES) funded through NSF-STEP grant (DUE-0622460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlroth P, 2003, OECOLOGIA, V137, P617, DOI 10.1007/s00442-003-1344-y; AKIMOTO S, 1990, OECOLOGIA, V83, P162, DOI 10.1007/BF00317747; Balloux F, 2003, GENETICS, V164, P1635; BLACKMAN R.L., 1984, ORIENT INSECTS; Brisson JA, 2006, BIOESSAYS, V28, P747, DOI 10.1002/bies.20436; Butlin RK, 2000, TRENDS ECOL EVOL, V15, P389, DOI 10.1016/S0169-5347(00)01937-6; Calabrese PP, 2001, GENETICS, V159, P839; Corrie AM, 2002, HEREDITY, V88, P203, DOI 10.1038/sj.hdy.6800028; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; Dedryver CA, 2008, B ENTOMOL RES, V98, P159, DOI 10.1017/S0007485307005500; Delmotte F, 2003, EVOLUTION, V57, P1291, DOI 10.1111/j.0014-3820.2003.tb00337.x; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; Fuller SJ, 1999, MOL ECOL, V8, P1867, DOI 10.1046/j.1365-294x.1999.00782.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GROETERS FR, 1989, EVOL ECOL, V3, P327, DOI 10.1007/BF02285263; GROETERS FR, 1989, EVOL ECOL, V3, P313, DOI 10.1007/BF02285262; GROETERS FR, 1993, OECOLOGIA, V93, P406, DOI 10.1007/BF00317885; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haack L, 2000, MOL ECOL, V9, P2055, DOI 10.1046/j.1365-294X.2000.01108.x; Halkett F, 2008, MOL ECOL, V17, P2998, DOI 10.1111/j.1365-294X.2008.03798.x; HALL RW, 1980, ENVIRON ENTOMOL, V9, P338, DOI 10.1093/ee/9.3.338; Kanbe T, 2009, MOL ECOL, V18, P801, DOI 10.1111/j.1365-294X.2008.04077.x; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Lockwood JL, 2007, INVASION ECOLOGY; LOXDALE HD, 1993, BIOL REV, V68, P291, DOI 10.1111/j.1469-185X.1993.tb00998.x; LOXDALE HD, B ENTOMOLOG IN PRESS, V100, P613; Loxdale H, 2010, ECOL ENTOMOL, V35, DOI 10.1111/j.1365-2311.2009.01151.x; Lushai G, 2003, BIOL J LINN SOC, V79, P193, DOI 10.1046/j.1095-8312.2003.00189.x; Lushai G, 2002, GENET RES, V79, P1, DOI 10.1017/S0016672301009582; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Massonnet B, 2002, MOL ECOL, V11, P2511, DOI 10.1046/j.1365-294X.2002.01633.x; Meselson M, 2007, SCIENCE, V318, P202, DOI 10.1126/science.1150197; Michel AP, 2009, ENVIRON ENTOMOL, V38, P1301, DOI 10.1603/022.038.0442; Miller NJ, 2005, HEREDITY, V94, P556, DOI 10.1038/sj.hdy.6800658; Muller C, 2004, BIOL J LINN SOC, V83, P219, DOI 10.1111/j.1095-8312.2004.00383.x; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Ruiz-Montoya L, 2003, HEREDITY, V91, P415, DOI 10.1038/sj.hdy.6800338; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Simon JC, 2010, CR BIOL, V333, P488, DOI 10.1016/j.crvi.2010.03.003; STODDART JA, 1988, GENETICS, V118, P705; STOETZEL MB, 1990, FLA ENTOMOL, V73, P580, DOI 10.2307/3495272; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; TAKADA H, 1993, APPL ENTOMOL ZOOL, V28, P199, DOI 10.1303/aez.28.199; TAKADA H, 1992, APPL ENTOMOL ZOOL, V27, P117, DOI 10.1303/aez.27.117; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanlerberghe-Masutti F, 1998, MOL ECOL, V7, P905, DOI 10.1046/j.1365-294x.1998.00421.x; Vanlerberghe-Masutti F, 1999, MOL ECOL, V8, P693, DOI 10.1046/j.1365-294x.1999.00876.x; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Vialatte A, 2005, P ROY SOC B-BIOL SCI, V272, P1075, DOI 10.1098/rspb.2004.3033; Vorburger C, 2006, J EVOLUTION BIOL, V19, P97, DOI 10.1111/j.1420-9101.2005.00985.x; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; Ward SM, 2008, INVAS PLANT SCI MANA, V1, P98, DOI 10.1614/IPSM-07-022.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x	60	46	46	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17524	10.1371/journal.pone.0017524	http://dx.doi.org/10.1371/journal.pone.0017524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408073	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900025
J	Gopal, U; Bohonowych, JE; Lema-Tome, C; Liu, A; Garrett-Mayer, E; Wang, BC; Isaacs, JS				Gopal, Udhayakumar; Bohonowych, Jessica E.; Lema-Tome, Carla; Liu, Angen; Garrett-Mayer, Elizabeth; Wang, Bingcheng; Isaacs, Jennifer S.			A Novel Extracellular Hsp90 Mediated Co-Receptor Function for LRP1 Regulates EphA2 Dependent Glioblastoma Cell Invasion	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; GENE-EXPRESSION; MIGRATION; ACTIVATION; HYPOXIA; AKT; HSP90-ALPHA; MOTILITY; KINASE; DOMAIN	Background: Extracellular Hsp90 protein (eHsp90) potentiates cancer cell motility and invasion through a poorly understood mechanism involving ligand mediated function with its cognate receptor LRP1. Glioblastoma multiforme (GBM) represents one of the most aggressive and lethal brain cancers. The receptor tyrosine kinase EphA2 is overexpressed in the majority of GBM specimens and is a critical mediator of GBM invasiveness through its AKT dependent activation of EphA2 at S897 (P-EphA2(S897)). We explored whether eHsp90 may confer invasive properties to GBM via regulation of EphA2 mediated signaling. Principal Findings: We find that eHsp90 signaling is essential for sustaining AKT activation, P-EphA2(S897), lamellipodia formation, and concomitant GBM cell motility and invasion. Furthermore, eHsp90 promotes the recruitment of LRP1 to EphA2 in an AKT dependent manner. A finding supported by biochemical methodology and the dual expression of LRP1 and P-EphA2(S897) in primary and recurrent GBM tumor specimens. Moreover, hypoxia mediated facilitation of GBM motility and invasion is dependent upon eHsp90-LRP1 signaling. Hypoxia dramatically elevated surface expression of both eHsp90 and LRP1, concomitant with eHsp90 dependent activation of src, AKT, and EphA2. Significance: We herein demonstrate a novel crosstalk mechanism involving eHsp90-LRP1 dependent regulation of EphA2 function. We highlight a dual role for eHsp90 in transducing signaling via LRP1, and in facilitating LRP1 co-receptor function for EphA2. Taken together, our results demonstrate activation of the eHsp90-LRP1 signaling axis as an obligate step in the initiation and maintenance of AKT signaling and EphA2 activation, thereby implicating this pathway as an integral component contributing to the aggressive nature of GBM.	[Gopal, Udhayakumar; Bohonowych, Jessica E.; Isaacs, Jennifer S.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Lema-Tome, Carla] Wake Forest Univ, Brain Tumor Ctr Excellence, Winston Salem, NC 27109 USA; [Liu, Angen] Med Univ S Carolina, Hollings Canc Ctr Tissue Biorepository, Charleston, SC 29425 USA; [Garrett-Mayer, Elizabeth] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA; [Wang, Bingcheng] Case Western Reserve Univ, Metrohlth Med Ctr, Rammelkamp Ctr Res, Cleveland, OH USA; [Wang, Bingcheng] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Medical University of South Carolina; Wake Forest University; Medical University of South Carolina; Medical University of South Carolina; Case Western Reserve University; MetroHealth System; Case Western Reserve University	Gopal, U (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA.	isaacsj@musc.edu	Gopal, Udhayakumar/K-9092-2019	gopal, Udhayakumar/0000-0003-2110-0601; Garrett-Mayer, Elizabeth/0000-0003-4709-0333	institutional startup funds; American Cancer Society [IRG-97-219-05]; National Cancer Institute [CA13795-01]; NATIONAL CANCER INSTITUTE [R01CA135297, R01CA152371] Funding Source: NIH RePORTER	institutional startup funds; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by institutional startup funds, the American Cancer Society (IRG-97-219-05), and the National Cancer Institute (CA13795-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai B, 2009, MOL CANCER RES, V7, P1021, DOI 10.1158/1541-7786.MCR-08-0582; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Bohonowych JE, 2010, J ONCOL, V2010, DOI 10.1155/2010/412985; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; CHEN JS, 2010, J BIOL CHEM; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Glas M, 2010, ANN NEUROL, V68, P264, DOI 10.1002/ana.22036; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Isaacs JS, 2005, EXPERT OPIN INV DRUG, V14, P569, DOI 10.1517/13543784.14.6.569; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LOPES MBS, 1994, FEBS LETT, V338, P301, DOI 10.1016/0014-5793(94)80288-2; Luo LY, 2002, BRIT J CANCER, V87, P339, DOI 10.1038/sj.bjc.6600439; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Oliver L, 2009, Curr Mol Pharmacol, V2, P263; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qin Z, 2010, VIROLOGY, V403, P92, DOI 10.1016/j.virol.2010.03.052; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; ULLRICH SJ, 1986, P NATL ACAD SCI USA, V83, P3121, DOI 10.1073/pnas.83.10.3121; Wang LF, 2008, ONCOL REP, V19, P151; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Weaver AM, 1997, J BIOL CHEM, V272, P14372, DOI 10.1074/jbc.272.22.14372; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Woodley DT, 2009, J CELL SCI, V122, P1495, DOI 10.1242/jcs.047894; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W	48	97	106	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17649	10.1371/journal.pone.0017649	http://dx.doi.org/10.1371/journal.pone.0017649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408136	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170000050
J	Mollema, NJ; Yuan, Y; Jelcick, AS; Sachs, AJ; von Alpen, D; Schorderet, D; Escher, P; Haider, NB				Mollema, Nissa J.; Yuan, Yang; Jelcick, Austin S.; Sachs, Andrew J.; von Alpen, Desiree; Schorderet, Daniel; Escher, Pascal; Haider, Neena B.			Nuclear Receptor Rev-erb Alpha (Nr1d1) Functions in Concert with Nr2e3 to Regulate Transcriptional Networks in the Retina	PLOS ONE			English	Article							GOLDMANN-FAVRE-SYNDROME; S-CONE SYNDROME; THYROID-HORMONE RECEPTOR; DEVELOPING MOUSE RETINA; PHOTORECEPTOR DEVELOPMENT; REPRESSES TRANSCRIPTION; RESPONSE ELEMENT; CIRCADIAN CLOCK; GENE; DEGENERATION	The majority of diseases in the retina are caused by genetic mutations affecting the development and function of photoreceptor cells. The transcriptional networks directing these processes are regulated by genes such as nuclear hormone receptors. The nuclear hormone receptor gene Rev-erb alpha/Nr1d1 has been widely studied for its role in the circadian cycle and cell metabolism, however its role in the retina is unknown. In order to understand the role of Rev-erb alpha/Nr1d1 in the retina, we evaluated the effects of loss of Nr1d1 to the developing retina and its co-regulation with the photoreceptor-specific nuclear receptor gene Nr2e3 in the developing and mature retina. Knock-down of Nr1d1 expression in the developing retina results in pan-retinal spotting and reduced retinal function by electroretinogram. Our studies show that NR1D1 protein is co-expressed with NR2E3 in the outer neuroblastic layer of the developing mouse retina. In the adult retina, NR1D1 is expressed in the ganglion cell layer and is co-expressed with NR2E3 in the outer nuclear layer, within rods and cones. Several genes co-targeted by NR2E3 and NR1D1 were identified that include: Nr2c1, Recoverin, Rgr, Rarres2, Pde8a, and Nupr1. We examined the cyclic expression of Nr1d1 and Nr2e3 over a twenty-four hour period and observed that both nuclear receptors cycle in a similar manner. Taken together, these studies reveal a novel role for Nr1d1, in conjunction with its cofactor Nr2e3, in regulating transcriptional networks critical for photoreceptor development and function.	[Mollema, Nissa J.; Yuan, Yang; Jelcick, Austin S.; Sachs, Andrew J.; Haider, Neena B.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [von Alpen, Desiree; Schorderet, Daniel; Escher, Pascal] Inst Res Opthalmol, Dept Ophthalmol, Sion, Switzerland; [von Alpen, Desiree; Schorderet, Daniel; Escher, Pascal] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Schorderet, Daniel] Ecole Polytech Fed Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Haider, Neena B.] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Nebraska System; University of Nebraska Medical Center	Mollema, NJ (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	nhaider@unmc.edu			National Institutes of Health [EY017653, 5P20 RR018788-02]; Hope for Vision; Swiss National Foundation [3100A0-122269/1]; Gottfried-und-Julia-Bangerter-Rhyner-Stiftung; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Gottfried-und-Julia-Bangerter-Rhyner-Stiftung; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY017653 and 5P20 RR018788-02 (NBH), Hope for Vision (NBH), The Swiss National Foundation Grant (3100A0-122269/1 PE, DFS), and the Gottfried-und-Julia-Bangerter-Rhyner-Stiftung Grant (PE, DFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Bandah D, 2009, ARCH OPHTHALMOL-CHIC, V127, P297, DOI 10.1001/archophthalmol.2008.615; Bernal S, 2008, CLIN GENET, V73, P360, DOI 10.1111/j.1399-0004.2008.00963.x; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chavala SH, 2005, BRIT J OPHTHALMOL, V89, P1065, DOI 10.1136/bjo.2005.068130; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Donovan SL, 2006, NAT PROTOC, V1, P2710, DOI 10.1038/nprot.2006.454; Egea PF, 2000, FEBS LETT, V476, P62, DOI 10.1016/S0014-5793(00)01672-0; Escher P, 2009, HUM MUTAT, V30, P342, DOI 10.1002/humu.20858; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; FULLER PJ, 1991, FASEB J, V5, P3092, DOI 10.1096/fasebj.5.15.1743440; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2008, MAMM GENOME, V19, P145, DOI 10.1007/s00335-008-9092-2; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jones G, 1999, J NEUROSCI, V19, P3376; Kachi S, 2005, GENE THER, V12, P843, DOI 10.1038/sj.gt.3302475; Laitinen S, 2005, BIOCHIMIE, V87, P21, DOI 10.1016/j.biochi.2004.12.006; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Liu H, 2008, J NEUROSCI, V28, P749, DOI 10.1523/JNEUROSCI.4832-07.2008; Marmor MF, 2006, DOC OPHTHALMOL, V113, P213, DOI 10.1007/s10633-006-9031-z; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Pachydaki SI, 2009, ARCH OPHTHALMOL-CHIC, V127, P71, DOI 10.1001/archophthalmol.2008.534; Peng GH, 2005, VISUAL NEUROSCI, V22, P575, DOI 10.1017/S0952523805225063; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pircher P, 2005, AM J PHYSIOL-REG I, V288, pR482, DOI 10.1152/ajpregu.00690.2003; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; SPANJAARD RA, 1994, MOL ENDOCRINOL, V8, P286, DOI 10.1210/me.8.3.286; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Wright Alan F, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9285; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	50	51	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17494	10.1371/journal.pone.0017494	http://dx.doi.org/10.1371/journal.pone.0017494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408158	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000034
J	Kowalczuk, L; Touchard, E; Omri, S; Jonet, L; Klein, C; Valamanes, F; Berdugo, M; Bigey, P; Massin, P; Jeanny, JC; Behar-Cohen, F				Kowalczuk, Laura; Touchard, Elodie; Omri, Samy; Jonet, Laurent; Klein, Christophe; Valamanes, Fatemeh; Berdugo, Marianne; Bigey, Pascal; Massin, Pascale; Jeanny, Jean-Claude; Behar-Cohen, Francine			Placental Growth Factor Contributes to Micro-Vascular Abnormalization and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy	PLOS ONE			English	Article							FACTOR GENE-EXPRESSION; HIGH-AFFINITY BINDING; FACTOR-I; TUMOR-GROWTH; ANGIOGENESIS; VEGF; NEOVASCULARIZATION; PATHOGENESIS; HYPOXIA; PLGF	Objective: There are controversies regarding the pro-angiogenic activity of placental growth factor (PGF) in diabetic retinopathy (DR). For a better understanding of its role on the retina, we have evaluated the effect of a sustained PGF overexpression in rat ocular media, using ciliary muscle electrotransfer (ET) of a plasmid encoding rat PGF-1 (pVAX2-rPGF-1). Materials and Methods: pVAX2-rPGF-1 ET in the ciliary muscle (200 V/cm) was achieved in non diabetic and diabetic rat eyes. Control eyes received saline or naked plasmid ET. Clinical follow up was carried out over three months using slit lamp examination and fluorescein angiography. After the control of rPGF-1 expression, PGF-induced effects on retinal vasculature and on the blood-external barrier were evaluated respectively by lectin and occludin staining on flat-mounts. Ocular structures were visualized through histological analysis. Results: After fifteen days of rPGF-1 over-expression in normal eyes, tortuous and dilated capillaries were observed. At one month, microaneurysms and moderate vascular sprouts were detected in mid retinal periphery in vivo and on retinal flat-mounts. At later stages, retinal pigmented epithelial cells demonstrated morphological abnormalities and junction ruptures. In diabetic retinas, PGF expression rose between 2 and 5 months, and, one month after ET, rPGF-1 over-expression induced glial activation and proliferation. Conclusion: This is the first demonstration that sustained intraocular PGF production induces vascular and retinal changes similar to those observed in the early stages of diabetic retinopathy. PGF and its receptor Flt-1 may therefore be looked upon as a potential regulatory target at this stage of the disease.	[Kowalczuk, Laura; Touchard, Elodie; Omri, Samy; Jonet, Laurent; Valamanes, Fatemeh; Berdugo, Marianne; Jeanny, Jean-Claude; Behar-Cohen, Francine] INSERM U872, Paris, France; [Kowalczuk, Laura; Touchard, Elodie; Omri, Samy; Jonet, Laurent; Klein, Christophe; Valamanes, Fatemeh; Berdugo, Marianne; Jeanny, Jean-Claude; Behar-Cohen, Francine] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Kowalczuk, Laura; Touchard, Elodie; Omri, Samy; Jonet, Laurent; Klein, Christophe; Valamanes, Fatemeh; Berdugo, Marianne; Jeanny, Jean-Claude; Behar-Cohen, Francine] Univ Paris 05, UMR S 872, Paris, France; [Valamanes, Fatemeh] Fdn Adolphe De Rothschild, Paris, France; [Bigey, Pascal] INSERM U640, Paris, France; [Bigey, Pascal] CNRS UMR8151, Paris, France; [Bigey, Pascal] Univ Paris 05, Chem & Genet Pharmacol Lab, Fac Pharm, Paris, France; [Bigey, Pascal] Ecole Natl Super Chim Paris ENSCP Chim ParisTech, Paris, France; [Massin, Pascale] Univ Paris 07, Hop Lariboisiere, AP HP, Dept Ophthalmol, Paris, France; [Behar-Cohen, Francine] Hop Hotel Dieu, AP HP, F-75181 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Kowalczuk, L (corresponding author), INSERM U872, Paris, France.	francine.behar@gmail.com	Kowalczuk, Laura/AAF-6230-2020	klein, christophe/0000-0001-8015-287X; bigey, pascal/0000-0002-6795-8569; Kowalczuk, Laura/0000-0003-0268-9430; Omri, Samy/0000-0002-2054-8298	ANR Emergence	ANR Emergence(French National Research Agency (ANR))	The work was supported by ANR Emergence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Arevalo JF, 2008, BRIT J OPHTHALMOL, V92, P213, DOI 10.1136/bjo.2007.127142; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bloquel C, 2006, FASEB J, V20, P389, DOI 10.1096/fj.05-4737fje; Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x; Campochiaro PA, 2006, GENE THER, V13, P559, DOI 10.1038/sj.gt.3302653; Cao RH, 2010, P NATL ACAD SCI USA, V107, P856, DOI 10.1073/pnas.0911661107; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; El Sanharawi M, 2010, PROG RETIN EYE RES, V29, P443, DOI 10.1016/j.preteyeres.2010.04.001; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Feeney SA, 2003, INVEST OPHTH VIS SCI, V44, P839, DOI 10.1167/iovs.02-0040; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; FRANK RN, 2005, RETINA, P1241; GARNER A, 1993, EYE, V7, P250, DOI 10.1038/eye.1993.58; Gigante B, 2006, FASEB J, V20, P970, DOI 10.1096/fj.05-4481fje; Green CJ, 2001, CANCER RES, V61, P2696; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Jacob M, 2004, IEEE T PATTERN ANAL, V26, P1007, DOI 10.1109/TPAMI.2004.44; Khaliq A, 1998, LAB INVEST, V78, P109; Kowalczuk L, 2009, INVEST OPHTH VIS SCI, V50, P1761, DOI 10.1167/iovs.08-3027; Lebherz C, 2005, DIABETES, V54, P1141, DOI 10.2337/diabetes.54.4.1141; Lin YL, 2007, J LEUKOCYTE BIOL, V82, P1473, DOI 10.1189/jlb.0307164; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Mitamura Y, 2002, DIABETES CARE, V25, P2352, DOI 10.2337/diacare.25.12.2352; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Odorisio T, 2002, J CELL SCI, V115, P2559; Paques M, 2006, VISION RES, V46, P1336, DOI 10.1016/j.visres.2005.09.037; PARK JE, 1994, J BIOL CHEM, V269, P25646; Parravano M, 2009, COCHRANE DB SYST REV, V4; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Rakoczy PE, 2003, DIABETES, V52, P857, DOI 10.2337/diabetes.52.3.857; Roh MI, 2009, OPHTHALMOLOGY, V116, P80, DOI 10.1016/j.ophtha.2008.09.036; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Schwesinger C, 2001, AM J PATHOL, V158, P1161, DOI 10.1016/S0002-9440(10)64063-1; Selvaraj SK, 2003, BLOOD, V102, P1515, DOI 10.1182/blood-2002-11-3423; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; Shen WY, 2006, DIABETOLOGIA, V49, P1690, DOI 10.1007/s00125-006-0274-8; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Spirin KS, 1999, CURR EYE RES, V18, P490, DOI 10.1076/ceyr.18.6.490.5267; Torry RJ, 2009, J HEART LUNG TRANSPL, V28, P183, DOI 10.1016/j.healun.2008.11.917; Touchard E, 2009, GENE THER, V16, P862, DOI 10.1038/gt.2009.43; TOUCHARD E, 2010, J GENE MED; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Viglietto G, 1996, ONCOGENE, V13, P577; Vinores SA, 2006, J CELL PHYSIOL, V206, P749, DOI 10.1002/jcp.20525; Wirostko B, 2008, PROG RETIN EYE RES, V27, P608, DOI 10.1016/j.preteyeres.2008.09.002; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yonekura H, 1999, J BIOL CHEM, V274, P35172, DOI 10.1074/jbc.274.49.35172; Yoo SA, 2009, ARTHRITIS RHEUM-US, V60, P345, DOI 10.1002/art.24289; Ziche M, 1997, LAB INVEST, V76, P517	56	56	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17462	10.1371/journal.pone.0017462	http://dx.doi.org/10.1371/journal.pone.0017462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408222	Green Submitted, Green Published, gold			2022-12-27	WOS:000288099800013
J	Noel, G; Stevenson, S; Moukhles, H				Noel, Geoffroy; Stevenson, Sarah; Moukhles, Hakima			A High Throughput Screen Identifies Chemical Modulators of the Laminin-Induced Clustering of Dystroglycan and Aquaporin-4 in Primary Astrocytes	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; DYSTROPHIN-ASSOCIATED GLYCOPROTEIN; FOCAL CEREBRAL-ISCHEMIA; WATER TRANSPORT; BETA-DYSTROGLYCAN; MATRIX METALLOPROTEINASES; ALPHA-SYNTROPHIN; TRANSGENIC MICE; GLIAL-CELLS; RAT-BRAIN	Background: Aquaporin-4 (AQP4) constitutes the principal water channel in the brain and is clusteredat the perivascular astrocyte endfeet. This specific distribution of AQP4 plays a major role in maintaining water homeostasis in the brain. A growing body of evidence points to a role ofthe dystroglycan complex and its interaction with perivascular laminin in the clusteringof AQP4 atperivascular astrocyte endfeet. Indeed, mice lacking components of this complex or in which laminin-dystroglycan interaction is disrupted show a delayed onset of brain edema due to a redistribution of AQP4 away from astrocyte endfeet. It is therefore important to identify inhibitory drugs of laminin-dependent AQP4 clustering which may prevent or reduce brain edema. Methodolgy/Principal Findings: In the present study we used primary rat astrocyte cultures toscreen a library of > 3,500 chemicals and identified 6 drugs that inhibit the laminin-induced clustering of dystroglycan and AQP4. Detailed analysis of the inhibitory drug, chloranil, revealed that its inhibition of the clustering is due to the metalloproteinase-2-mediated beta-dystroglycan shedding and subsequent loss of laminin interaction with dystroglycan. Furthermore, chemical variants of chloranil induced a similar effect on beta-dystroglycan and this was prevented by the antioxidant N-acetylcysteine. Conclusion/Significance: These findings reveal the mechanism of action of chloranil in preventing the laminin-induced clustering of dystroglycan and AQP4 and validate the use of high-throughput screening as a tool to identify drugs that modulate AQP4 clustering and that could be tested in models of brain edema.	[Noel, Geoffroy; Stevenson, Sarah; Moukhles, Hakima] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Noel, G (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	moukhles@interchange.ubc.ca		Noel, Geoffroy/0000-0003-2192-7756	Canadian Institutes of Health Research (CIHR); Muscular Dystrophy Canada (MDC); Amyotrophic Lateral Sclerosis (ALS) Society of Canada; University Graduate Fellowship; Edward Squires Memorial Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Canada (MDC); Amyotrophic Lateral Sclerosis (ALS) Society of Canada; University Graduate Fellowship; Edward Squires Memorial Scholarship	This work was supported by grants from the Canadian Institutes of Health Research (CIHR), Muscular Dystrophy Canada (MDC), Amyotrophic Lateral Sclerosis (ALS) Society of Canada to H. M., and a University Graduate Fellowship and Edward Squires Memorial Scholarship to GN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKO H, 1988, Neurological Research, V10, P145; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Dahlhaus M, 1996, ARCH TOXICOL, V70, P457, DOI 10.1007/s002040050299; Detmers FJM, 2006, J BIOL CHEM, V281, P14207, DOI 10.1074/jbc.M513072200; Dibas A, 2008, MOL VIS, V14, P1770; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng XC, 2009, J NEUROSCI RES, V87, P1150, DOI 10.1002/jnr.21927; Fischer R, 1997, GLIA, V20, P51; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; HARTMANN A, 1986, EUR NEUROL, V25, P7, DOI 10.1159/000116058; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P418, DOI 10.1016/j.bmc.2007.12.038; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P425, DOI 10.1016/j.bmc.2008.12.013; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Kim SR, 2001, TOXICOL SCI, V62, P176, DOI 10.1093/toxsci/62.1.176; KIMLEE MH, 1992, GLIA, V5, P56, DOI 10.1002/glia.440050109; Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628; Leonardo CC, 2009, NEUROSCIENCE, V160, P755, DOI 10.1016/j.neuroscience.2009.02.080; Leone L, 2005, J NEUROPATH EXP NEUR, V64, P1007, DOI 10.1097/01.jnen.0000187053.59018.3c; LEYBAERT L, 1994, EXP BRAIN RES, V100, P369, DOI 10.1007/BF02738397; Li Zheng, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010045; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; MAKINEN PL, 1988, BIOCHEM BIOPH RES CO, V153, P74, DOI 10.1016/S0006-291X(88)81191-4; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Mehler MF, 2000, BRAIN RES REV, V32, P277, DOI 10.1016/S0165-0173(99)00090-9; Meli DN, 2003, J INFECT DIS, V187, P1411, DOI 10.1086/374644; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Milner R, 2008, J CEREBR BLOOD F MET, V28, P812, DOI 10.1038/sj.jcbfm.9600585; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; Nielsen S, 1997, J NEUROSCI, V17, P171; Noel G, 2009, J BIOL CHEM, V284, P19694, DOI 10.1074/jbc.M109.010090; Paggi P, 2006, J PHYSIOL-PARIS, V99, P119, DOI 10.1016/j.jphysparis.2005.12.004; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rurak J, 2007, J NEUROCHEM, V103, P1940, DOI 10.1111/j.1471-4159.2007.04886.x; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Siraki AG, 2004, TOXICOL SCI, V81, P148, DOI 10.1093/toxsci/kfh182; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tait MJ, 2010, NEUROSCIENCE, V167, P60, DOI 10.1016/j.neuroscience.2010.01.053; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; WORTON R, 1995, SCIENCE, V270, P755, DOI 10.1126/science.270.5237.755; Yamada H, 2001, HUM MOL GENET, V10, P1563, DOI 10.1093/hmg/10.15.1563; Yang BX, 2008, BIOORGAN MED CHEM, V16, P7489, DOI 10.1016/j.bmc.2008.06.005; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhong D, 2006, BIOCHEM BIOPH RES CO, V345, P867, DOI 10.1016/j.bbrc.2006.05.004; Zumkeller M, 1996, NEUROSURG REV, V19, P253, DOI 10.1007/BF00314841	65	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17559	10.1371/journal.pone.0017559	http://dx.doi.org/10.1371/journal.pone.0017559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408176	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800024
J	Peng, HM; Wen, JG; Li, HW; Chang, J; Zhou, XB				Peng, Huiming; Wen, Jianguo; Li, Hongwei; Chang, Jeff; Zhou, Xiaobo			Drug Inhibition Profile Prediction for NF kappa B Pathway in Multiple Myeloma	PLOS ONE			English	Article							PATHOGENESIS; COMBINATIONS	Nuclear factor kappa B (NF kappa B) activation plays a crucial role in anti-apoptotic responses in response to the apoptotic signaling during tumor necrosis factor (TNF alpha) stimulation in Multiple Myeloma (MM). Although several drugs have been found effective for the treatment of MM by mainly inhibiting NF kappa B pathway, there are not any quantitative or qualitative results of comparison assessment on inhibition effect between different drugs either used alone or in combinations. Computational modeling is becoming increasingly indispensable for applied biological research mainly because it can provide strong quantitative predicting power. In this study, a novel computational pathway modeling approach is employed to comparably assess the inhibition effects of specific drugs used alone or in combinations on the NF kappa B pathway in MM and to predict the potential synergistic drug combinations.	[Peng, Huiming; Zhou, Xiaobo] Methodist Hosp, Res Inst, Dept Radiol, Houston, TX 77030 USA; [Peng, Huiming; Wen, Jianguo; Chang, Jeff; Zhou, Xiaobo] Weill Cornell Med Coll, Houston, TX USA; [Peng, Huiming; Li, Hongwei] China Univ Geosci, Sch Math & Phys, Wuhan 430074, Peoples R China; [Wen, Jianguo; Chang, Jeff] Methodist Hosp, Res Inst, Dept Pathol, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; China University of Geosciences; The Methodist Hospital System; The Methodist Hospital - Houston	Peng, HM (corresponding author), Methodist Hosp, Res Inst, Dept Radiol, 6535 Fannin, Houston, TX 77030 USA.	XZhou@tmhs.org	Peng, Huiming/D-1184-2011		NIH [1R01LM010185-01]; Institute for Biomedical Imaging Sciences - IBIS foundation; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Biomedical Imaging Sciences - IBIS foundation; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work is funded by NIH 1R01LM010185-01 (Zhou & Chang) and The Institute for Biomedical Imaging Sciences - IBIS foundation (Zhou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goryanin I, 2004, METABOLIC ENGINEERING IN THE POST GENOMIC ERA, P321; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2001, ONCOGENE, V20, P4519, DOI 10.1038/sj.onc.1204623; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; HOOKE R, 1961, J ASSOC COMPUT MACH, V8, P221; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li ZW, 2008, CURR OPIN HEMATOL, V15, P391, DOI 10.1097/MOH.0b013e328302c7f4; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Moehren G, 2002, BIOCHEMISTRY-US, V41, P306, DOI 10.1021/bi011506c; Park SG, 2006, FEBS LETT, V580, P822, DOI 10.1016/j.febslet.2006.01.004; Schilling M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.91; Smith A, 2002, NATURE, V418, P453, DOI 10.1038/418453a; Sung MH, 2004, MOL PHARMACOL, V66, P70, DOI 10.1124/mol.66.1.70; van de Donk NWCJ, 2005, LEUKEMIA, V19, P2177, DOI 10.1038/sj.leu.2403970; Weinberg R, 2007, BIOL CANC GARLAND SC; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Wen JG, 2010, LEUKEMIA RES, V34, P85, DOI 10.1016/j.leukres.2009.05.024; Younes H, 2007, CLIN CANCER RES, V13, P3771, DOI 10.1158/1078-0432.CCR-06-2921; YOUNG M, 2008, PREDICTION ATTRACTIO; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; Zinner RG, 2009, MOL CANCER THER, V8, P521, DOI 10.1158/1535-7163.MCT-08-0937	28	81	82	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e14750	10.1371/journal.pone.0014750	http://dx.doi.org/10.1371/journal.pone.0014750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408099	Green Published, gold, Green Submitted			2022-12-27	WOS:000288099800001
J	Robyr, D; Friedli, M; Gehrig, C; Arcangeli, M; Marin, M; Guipponi, M; Farinelli, L; Barde, I; Verp, S; Trono, D; Antonarakis, SE				Robyr, Daniel; Friedli, Marc; Gehrig, Corinne; Arcangeli, Melanie; Marin, Marilyn; Guipponi, Michel; Farinelli, Laurent; Barde, Isabelle; Verp, Sonia; Trono, Didier; Antonarakis, Stylianos E.			Chromosome Conformation Capture Uncovers Potential Genome-Wide Interactions between Human Conserved Non-Coding Sequences	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; IN-VIVO; EXPRESSION; ENHANCER; DISRUPTION; LIMB; DNA	Comparative analyses of various mammalian genomes have identified numerous conserved non-coding (CNC) DNA elements that display striking conservation among species, suggesting that they have maintained specific functions throughout evolution. CNC function remains poorly understood, although recent studies have identified a role in gene regulation. We hypothesized that the identification of genomic loci that interact physically with CNCs would provide information on their functions. We have used circular chromosome conformation capture (4C) to characterize interactions of 10 CNCs from human chromosome 21 in K562 cells. The data provide evidence that CNCs are capable of interacting with loci that are enriched for CNCs. The number of trans interactions varies among CNCs; some show interactions with many loci, while others interact with few. Some of the tested CNCs are capable of driving the expression of a reporter gene in the mouse embryo, and associate with the oligodendrocyte genes OLIG1 and OLIG2. Our results underscore the power of chromosome conformation capture for the identification of targets of functional DNA elements and raise the possibility that CNCs exert their functions by physical association with defined genomic regions enriched in CNCs. These CNC-CNC interactions may in part explain their stringent conservation as a group of regulatory sequences.	[Robyr, Daniel; Friedli, Marc; Gehrig, Corinne; Arcangeli, Melanie; Marin, Marilyn; Guipponi, Michel; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Robyr, Daniel; Friedli, Marc; Gehrig, Corinne; Arcangeli, Melanie; Marin, Marilyn; Guipponi, Michel; Antonarakis, Stylianos E.] Univ Hosp Geneva, Geneva, Switzerland; [Farinelli, Laurent] FASTERIS SA, Plan Les Ouates, Switzerland; [Barde, Isabelle; Verp, Sonia; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Robyr, D (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Daniel.Robyr@unige.ch; Stylianos.Antonarakis@unige.ch	Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823	Lejeune Foundation; Swiss National Science Foundation; EU; European Research Council; NCCR Frontiers in Genetics	Lejeune Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); European Research Council(European Research Council (ERC)European Commission); NCCR Frontiers in Genetics(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Lejeune Foundation to DR, the Swiss National Science Foundation, the EU FP6 Integrated projects AnEUploidy, the European Research Council and the NCCR Frontiers in Genetics to SEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Attanasio C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r168; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chen CTL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003946; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sauvain MO, 2008, J VIROL, V82, P7111, DOI 10.1128/JVI.00623-08; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	42	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17634	10.1371/journal.pone.0017634	http://dx.doi.org/10.1371/journal.pone.0017634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408183	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800029
J	Zheng, XD; Yang, XQ; Tao, Y				Zheng, Xiu-Deng; Yang, Xiao-Qian; Tao, Yi			Bistability, Probability Transition Rate and First-Passage Time in an Autoactivating Positive-Feedback Loop	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; NOISE; MULTISTABILITY; EXPRESSION	A hallmark of positive-feedback regulation is bistability, which gives rise to distinct cellular states with high and low expression levels, and that stochasticity in gene expression can cause random transitions between two states, yielding bimodal population distribution (Kaern et al., 2005, Nat Rev Genet 6: 451-464). In this paper, the probability transition rate and first-passage time in an autoactivating positive-feedback loop with bistability are investigated, where the gene expression is assumed to be disturbed by both additive and multiplicative external noises, the bimodality in the stochastic gene expression is due to the bistability, and the bistability determines that the potential of the Fokker-Planck equation has two potential wells. Our main goal is to illustrate how the probability transition rate and first-passage time are affected by the maximum transcriptional rate, the intensities of additive and multiplicative noises, and the correlation of additive and multiplicative noises. Our main results show that (i) the increase of the maximum transcription rate will be useful for maintaining a high gene expression level; (ii) the probability transition rate from one potential well to the other one will increase with the increase of the intensity of additive noise; (iii) the increase of multiplicative noise strength will increase the amount of probability in the left potential well; and (iv) positive (or negative) cross-correlation between additive and multiplicative noises will increase the amount of probability in the left (or right) potential well.	[Zheng, Xiu-Deng; Tao, Yi] Chinese Acad Sci, Inst Zool, Ctr Computat & Evolutionary Biol, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Yang, Xiao-Qian] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Zheng, Xiu-Deng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zheng, XD (corresponding author), Chinese Acad Sci, Inst Zool, Ctr Computat & Evolutionary Biol, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	yitao@ioz.ac.cn		Tao, Yi/0000-0002-0749-6614; Zheng, Xiu-Deng/0000-0003-1143-0797	Chinese Academy of Sciences [A0790]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the "Hundred Talent Program of Chinese Academy of Sciences" (A0790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; [Anonymous], 2001, PROBABILITY RANDOM V; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bennett MR, 2007, BIOPHYS J, V92, P3501, DOI 10.1529/biophysj.106.095638; Denisov SI, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046132; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hu G., 1992, STOCHASTIC FORCES NO; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; PAULSON J, 2004, SCIENCE, V307, P1962; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Scott M, 2007, P NATL ACAD SCI USA, V104, P7402, DOI 10.1073/pnas.0610468104; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; VANKAMPEN NG, 1992, STOCHASTIC PROCESS T; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899	21	24	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17104	10.1371/journal.pone.0017104	http://dx.doi.org/10.1371/journal.pone.0017104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445288	gold, Green Published, Green Submitted			2022-12-27	WOS:000288613300004
J	Das, D; Herve, M; Feuerhelm, J; Farr, CL; Chiu, HJ; Elsliger, MA; Knuth, MW; Klock, HE; Miller, MD; Godzik, A; Lesley, SA; Deacon, AM; Mengin-Lecreulx, D; Wilson, IA				Das, Debanu; Herve, Mireille; Feuerhelm, Julie; Farr, Carol L.; Chiu, Hsiu-Ju; Elsliger, Marc-Andre; Knuth, Mark W.; Klock, Heath E.; Miller, Mitchell D.; Godzik, Adam; Lesley, Scott A.; Deacon, Ashley M.; Mengin-Lecreulx, Dominique; Wilson, Ian A.			Structure and Function of the First Full-Length Murein Peptide Ligase (Mpl) Cell Wall Recycling Protein	PLOS ONE			English	Article							MESO-DIAMINOPIMELATE LIGASE; ESCHERICHIA-COLI; ALANINE LIGASE; THERMOTOGA-MARITIMA; ATOMIC STRUCTURES; CRYSTAL-STRUCTURE; D-GLUTAMATE; CLUSTAL-W; BIOSYNTHESIS; SYNTHETASES	Bacterial cell walls contain peptidoglycan, an essential polymer made by enzymes in the Mur pathway. These proteins are specific to bacteria, which make them targets for drug discovery. MurC, MurD, MurE and MurF catalyze the synthesis of the peptidoglycan precursor UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-diaminopimelyl-D-alanyl-D-alanine by the sequential addition of amino acids onto UDP-N-acetylmuramic acid (UDP-MurNAc). MurC-F enzymes have been extensively studied by biochemistry and X-ray crystallography. In Gram-negative bacteria, similar to 30-60% of the bacterial cell wall is recycled during each generation. Part of this recycling process involves the murein peptide ligase (Mpl), which attaches the breakdown product, the tripeptide L-alanyl-gamma-D-glutamyl-meso-diaminopimelate, to UDP-MurNAc. We present the crystal structure at 1.65 angstrom resolution of a full-length Mpl from the permafrost bacterium Psychrobacter arcticus 273-4 (PaMpl). Although the Mpl structure has similarities to Mur enzymes, it has unique sequence and structure features that are likely related to its role in cell wall recycling, a function that differentiates it from the MurC-F enzymes. We have analyzed the sequence-structure relationships that are unique to Mpl proteins and compared them to MurC-F ligases. We have also characterized the biochemical properties of this enzyme (optimal temperature, pH and magnesium binding profiles and kinetic parameters). Although the structure does not contain any bound substrates, we have identified similar to 30 residues that are likely to be important for recognition of the tripeptide and UDP-MurNAc substrates, as well as features that are unique to Psychrobacter Mpl proteins. These results provide the basis for future mutational studies for more extensive function characterization of the Mpl sequence-structure relationships.	[Das, Debanu; Feuerhelm, Julie; Farr, Carol L.; Chiu, Hsiu-Ju; Elsliger, Marc-Andre; Knuth, Mark W.; Klock, Heath E.; Miller, Mitchell D.; Godzik, Adam; Lesley, Scott A.; Deacon, Ashley M.; Wilson, Ian A.] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA USA; [Das, Debanu; Chiu, Hsiu-Ju; Miller, Mitchell D.; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Herve, Mireille; Mengin-Lecreulx, Dominique] Univ Paris 11, Lab Enveloppes Bacteriennes & Antibiot, Orsay, France; [Herve, Mireille; Mengin-Lecreulx, Dominique] CNRS, Inst Biochim & Biophys Mole & Cellulaire, F-91405 Orsay, France; [Feuerhelm, Julie; Knuth, Mark W.; Klock, Heath E.; Lesley, Scott A.] Novartis Res Fdn, Prot Sci Dept, Genom Inst, San Diego, CA USA; [Farr, Carol L.; Elsliger, Marc-Andre; Lesley, Scott A.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Godzik, Adam] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, La Jolla, CA USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Novartis; Scripps Research Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Das, D (corresponding author), SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA USA.	dominique.mengin-lecreulx@u-psud.fr; wilson@scripps.edu	Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; MENGIN-LECREULX, Dominique/0000-0003-3205-0275; Elsliger, Marc Andre/0000-0002-1989-7626; Miller, Mitchell/0000-0003-1626-4943	Department of Energy; Office of Biological and Environmental Research; National Institutes of Health (National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences); National Institutes of Health; National Institute of General Medical Sciences; Protein Structure Initiative; CNRS [UMR 8619];  [U54 GM094586];  [GM074898]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, U54GM074898] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health (National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)NIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Protein Structure Initiative; CNRS(Centre National de la Recherche Scientifique (CNRS)); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Psychrobacter arcticus 273-4 (Psychrobacter sp 273-4) was a gift from Drs. Tamara Cole and Jim Tiedje, Michigan State University, East Lansing, MI, USA. We thank the members of the JCSG high-throughput structural biology pipeline for their contribution to this work. We also thank Dr. Clyde Smith at SSRL for helpful discussions during the preparation of the manuscript and Dr. Didier Blanot at Universite Paris-Sud, Laboratoire des Enveloppes Bacteriennes et Antibiotiques, for his support and constructive criticism. Portions of this research were performed at the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory. The SSRL is a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health (National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.; This work was supported by National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative, Grants U54 GM094586 and GM074898, and by the CNRS (UMR 8619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Babic A, 2007, PROCEEDINGS OF THE 5TH JOINT MEETING ON MEDICINAL CHEMISTRY, P1; Babic A, 2007, TETRAHEDRON LETT, V48, P4403, DOI 10.1016/j.tetlet.2007.04.098; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Basavannacharya C, 2010, TUBERCULOSIS, V90, P16, DOI 10.1016/j.tube.2009.10.007; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; BLANOT D, 1983, PEPTIDES, V1982, P311; Bolanos-Garcia VM, 2006, BBA-GEN SUBJECTS, V1760, P1304, DOI 10.1016/j.bbagen.2006.03.027; Bouhss A, 1999, BIOCHEMISTRY-US, V38, P12240, DOI 10.1021/bi990517r; Bouhss A, 1997, BIOCHEMISTRY-US, V36, P11556, DOI 10.1021/bi970797f; Bouhss A, 2002, METHOD ENZYMOL, V354, P189; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dementin S, 2001, EUR J BIOCHEM, V268, P5800, DOI 10.1046/j.0014-2956.2001.02524.x; Deva T, 2006, ACTA CRYSTALLOGR D, V62, P1466, DOI 10.1107/S0907444906038376; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eveland SS, 1997, BIOCHEMISTRY-US, V36, P6223, DOI 10.1021/bi9701078; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Gomez MJ, 2006, ANTIMICROB AGENTS CH, V50, P3562, DOI 10.1128/AAC.00579-06; Gordon E, 2001, J BIOL CHEM, V276, P10999, DOI 10.1074/jbc.M009835200; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Herve M, 2007, J BACTERIOL, V189, P3987, DOI 10.1128/JB.00087-07; Jin HY, 1996, BIOCHEMISTRY-US, V35, P1423, DOI 10.1021/bi952334k; Kleywegt GJ, 2000, ACTA CRYSTALLOGR D, V56, P249, DOI 10.1107/S0907444999016364; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kotnik M, 2007, CURR PHARM DESIGN, V13, P2283; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1973, J MOL BIOL, V80, P601, DOI 10.1016/0022-2836(73)90199-X; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; LUGTENBERG EJ, 1972, J BACTERIOL, V110, P26, DOI 10.1128/JB.110.1.26-34.1972; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MenginLecreulx D, 1996, J BACTERIOL, V178, P5347, DOI 10.1128/jb.178.18.5347-5352.1996; Mol CD, 2003, J BACTERIOL, V185, P4152, DOI 10.1128/JB.185.14.4152-4162.2003; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pennartz A, 2009, ANTIMICROB AGENTS CH, V53, P2991, DOI 10.1128/AAC.01520-07; SACHS H, 1953, J AM CHEM SOC, V75, P4608, DOI 10.1021/ja01114a528; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Schmidt DMZ, 2001, BIOCHEMISTRY-US, V40, P15707, DOI 10.1021/bi011640x; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith CA, 2006, J MOL BIOL, V362, P640, DOI 10.1016/j.jmb.2006.07.066; Spraggon G, 2004, PROTEINS, V55, P1078, DOI 10.1002/prot.20034; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Ye YZ, 2005, BIOINFORMATICS, V21, P2362, DOI 10.1093/bioinformatics/bti353	66	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17624	10.1371/journal.pone.0017624	http://dx.doi.org/10.1371/journal.pone.0017624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445265	gold, Green Published, Green Submitted			2022-12-27	WOS:000288545100022
J	Lavallard, VJ; Bonnafous, S; Patouraux, S; Saint-Paul, MC; Rousseau, D; Anty, R; Le Marchand-Brustel, Y; Tran, A; Gual, P				Lavallard, Vanessa Jeannette; Bonnafous, Stephanie; Patouraux, Stephanie; Saint-Paul, Marie-Christine; Rousseau, Deborah; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe			Serum Markers of Hepatocyte Death and Apoptosis Are Non Invasive Biomarkers of Severe Fibrosis in Patients with Alcoholic Liver Disease	PLOS ONE			English	Article							POLYPEPTIDE-SPECIFIC ANTIGEN; NONALCOHOLIC STEATOHEPATITIS; NONINVASIVE BIOMARKER; CELL APOPTOSIS; CYTOKERATIN-18; HEPATITIS; INJURY; EXPRESSION; NECROSIS; OBESITY	Background: Quantification of hepatotocyte death is useful to evaluate the progression of alcoholic liver diseases. Our aims were to quantify and correlate the circulating levels of Cytokeratin 18 (CK18) and its caspases-generated fragment to disease severity in heavy alcoholics. Methodology/Principal Findings: CK18 and CK18-fragment were evaluated in the serum of 143 heavy alcoholics. Serum levels of markers of hepatocyte death (CK18), apoptosis (CK18 fragment) and necrosis (CK18 -CK18 fragment) increased in patients with severe fibrosis compared to patients with mild fibrosis. These markers strongly correlated with Mallory-Denk bodies, hepatocyte ballooning, fibrosis and with hepatic TNF alpha and TGF beta assessed in the liver of 24 patients. Elevated levels of serum hepatocyte death and apoptotic markers were independent risk factors in predicting severe fibrosis in a model combining alkaline phosphatase, bilirubin, prothrombin index, hyaluronate, hepatocyte death and apoptotic markers. The level of markers of hepatocyte death and apoptosis had an area under the receiving operator curve that predicted severe fibrosis of 0.84 and 0.76, respectively. Conclusion/Significance: Death of hepatocytes can be easily evaluated with serum markers and correlated with severe fibrosis in heavy alcohol drinkers. These biomarkers could be useful to rapidly evaluate liver injuries and the efficacy of therapies.	[Lavallard, Vanessa Jeannette; Bonnafous, Stephanie; Patouraux, Stephanie; Saint-Paul, Marie-Christine; Rousseau, Deborah; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Fac Med Nice, INSERM, Team 8, U895, F-06034 Nice, France; [Lavallard, Vanessa Jeannette; Patouraux, Stephanie; Saint-Paul, Marie-Christine; Rousseau, Deborah; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Lavallard, Vanessa Jeannette; Bonnafous, Stephanie; Anty, Rodolphe; Le Marchand-Brustel, Yannick; Tran, Albert; Gual, Philippe] Univ Nice, Digest Ctr, Ctr Hosp, Nice, France; [Patouraux, Stephanie; Saint-Paul, Marie-Christine] Univ Nice, Ctr Biol, Ctr Hosp, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Lavallard, VJ (corresponding author), Fac Med Nice, INSERM, Team 8, U895, U210, F-06034 Nice, France.	gual@unice.fr	Gual, Philippe/M-8787-2017; Gual, Philippe/P-9833-2019	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; Albert, TRAN/0000-0003-0003-5361; Anty, Rodolphe/0000-0001-8194-9805; Anty, Rodolphe/0000-0002-8053-1957; Lavallard, Vanessa/0000-0001-7328-7549; patouraux, stephanie/0000-0001-6004-7685	Institut National de la Sante et de la Recherche Medicale (France); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice); Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough; Association pour la Recherche sur le Cancer (France); Fondation Recherche Medicale; Centre Hospitalier Universitaire of Nice	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice; Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice); Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough(Merck & CompanySchering Plough Corporation); Association pour la Recherche sur le Cancer (France)(Fondation ARC pour la Recherche sur le Cancer); Fondation Recherche Medicale; Centre Hospitalier Universitaire of Nice	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (France), the University of Nice, the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice), and charities (Association Francaise pour l'Etude du Foie (AFEF)/Schering-Plough to PG). VJL was successively supported by the Programme Hospitalier de Recherche Clinique (Centre Hospitalier Universitaire of Nice) and the Association pour la Recherche sur le Cancer ( France). SP was supported by the Fondation Recherche Medicale. YLMB and PG are the recipients of an Interface Grant from the Centre Hospitalier Universitaire of Nice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anty R, 2010, ALIMENT PHARM THER, V32, P1315, DOI 10.1111/j.1365-2036.2010.04480.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bechmann LP, 2010, J HEPATOL, V53, P639, DOI 10.1016/j.jhep.2010.04.029; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Diab DL, 2008, CLIN GASTROENTEROL H, V6, P1249, DOI 10.1016/j.cgh.2008.07.016; Feldstein AE, 2005, FRONT BIOSCI-LANDMRK, V10, P3093, DOI 10.2741/1765; Feldstein A, 2009, J CLIN GASTROENTEROL, V43, P374, DOI 10.1097/MCG.0b013e318178d91f; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Gonzalez-Quintela A, 2006, ALCOHOL, V38, P45, DOI 10.1016/j.alcohol.2006.01.003; Gonzalez-Quintela A, 2009, DIGEST DIS SCI, V54, P648, DOI 10.1007/s10620-008-0371-2; Gonzalez-Quintela A, 2006, LIVER INT, V26, P1217, DOI 10.1111/j.1478-3231.2006.01380.x; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Li XH, 2010, HEPATOLOGY, V51, P1865, DOI 10.1002/hep.23433; Linder S, 2004, CANCER LETT, V214, P1, DOI 10.1016/j.canlet.2004.06.032; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Luft T, 2007, BLOOD, V110, P4535, DOI 10.1182/blood-2006-10-049817; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Natori S, 2001, J HEPATOL, V34, P248, DOI 10.1016/S0168-8278(00)00089-1; Naveau S, 2009, HEPATOLOGY, V49, P97, DOI 10.1002/hep.22576; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; Olofsson MH, 2007, CLIN CANCER RES, V13, P3198, DOI 10.1158/1078-0432.CCR-07-0009; Orrego H, 1987, GASTROENTEROLOGY, V92, P208, DOI 10.1016/0016-5085(87)90861-4; Purohit V, 2006, HEPATOLOGY, V43, P872, DOI 10.1002/hep.21107; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Taieb J, 1998, LANCET, V351, P1930, DOI 10.1016/S0140-6736(05)78614-1; Volkmann X, 2006, HEPATOLOGY, V43, P1311, DOI 10.1002/hep.21186; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Yilmaz Y, 2009, ALIMENT PHARM THER, V30, P1103, DOI 10.1111/j.1365-2036.2009.04148.x; Younossi ZM, 2008, OBES SURG, V18, P1430, DOI 10.1007/s11695-008-9506-y	36	45	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17599	10.1371/journal.pone.0017599	http://dx.doi.org/10.1371/journal.pone.0017599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445263	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100018
J	Sun, LA; Hu, FB; Yu, ZJ; Li, HX; Liu, HY; Wang, XD; Yu, DX; Wu, HY; Zhang, G; Zong, G; Liu, Y; Lin, X				Sun, Liang; Hu, Frank B.; Yu, Zhijie; Li, Huaixing; Liu, Huaiyu; Wang, Xiangdong; Yu, Danxia; Wu, Hongyu; Zhang, Geng; Zong, Geng; Liu, Yong; Lin, Xu			Lean Body Mass, Interleukin 18, and Metabolic Syndrome in Apparently Healthy Chinese	PLOS ONE			English	Article							FAT-FREE MASS; INSULIN-RESISTANCE; CIRCULATING IL-18; WEIGHT-LOSS; OBESITY; EXPRESSION; CYTOKINE; RISK; ASSOCIATION; SENSITIVITY	Objective: We aimed to investigate how lean body mass is related to circulating Interleukin 18 (IL-18) and its association with metabolic syndrome (MetS) among apparently healthy Chinese. Methods: A population-based sample of 1059 Chinese men and women aged 35-54 years was used to measure plasma IL-18, glucose, insulin, lipid profile, inflammatory markers and high-molecular-weight (HMW)-adiponectin. Fat mass index (FMI) and lean mass index (LMI) were measured by dual-energy X-ray absorptiometry. MetS was defined by the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian-Americans. Results: Circulating IL-18 was positively correlated with LMI after adjustment for FMI (correlation coefficient = 0.11, P < 0.001). The association with the MetS (odds ratio 3.43, 95% confidence interval 2.01-5.85) was substantially higher in the highest than the lowest quartile of IL-18 after multiple adjustments including body mass index. In the stratified multivariable regression analyses, the positive association between IL-18 and MetS was independent of tertiles of FMI, inflammatory markers and HMW-adiponectin, but significantly interacted with tertile of LMI (P for interaction = 0.010). Conclusion: Elevated plasma IL-18 was associated with higher MetS prevalence in apparently healthy Chinese, independent of traditional risk factors, FMI, inflammatory markers and HMW-adiponectin. More studies are needed to clarify the role of lean mass in IL-18 secretion and its associated cardio-metabolic disorders.	[Sun, Liang; Yu, Zhijie; Li, Huaixing; Yu, Danxia; Wu, Hongyu; Zhang, Geng; Zong, Geng; Liu, Yong; Lin, Xu] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Sun, Liang; Yu, Zhijie; Li, Huaixing; Yu, Danxia; Wu, Hongyu; Zhang, Geng; Zong, Geng; Liu, Yong; Lin, Xu] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Yu, Zhijie] Chinese Acad Sci, Shanghai Inst Biol Sci, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Shanghai, Peoples R China; [Liu, Huaiyu] Shanghai Luwan Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wang, Xiangdong] Shanghai Zhabei Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Sun, LA (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	xlin@sibs.ac.cn	Zong, Geng/ABG-6946-2021; Wang, Xiangdong/AAF-9148-2020	Yu, Danxia/0000-0002-1710-9382	National Natural Science Foundation of China [30930081, 81021002]; Ministry of Science and Technology of China [2011CB504002, 2009AA022704, 2008DFA31960]; Chinese Academy of Sciences [KSCX2-EW-R-10]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2008006]; Novo Nordisk A/S	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Novo Nordisk A/S(Novo Nordisk)	This study was supported by the National Natural Science Foundation of China (30930081 and 81021002), the Ministry of Science and Technology of China (2011CB504002, 2009AA022704 and 2008DFA31960), the Chinese Academy of Sciences (KSCX2-EW-R-10), the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006) and the Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Bosch M, 2005, DIABETOLOGIA, V48, P1841, DOI 10.1007/s00125-005-1859-3; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Esposito K, 2002, J CLIN ENDOCR METAB, V87, P3864, DOI 10.1210/jc.2002-????; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Evans J, 2007, EUR J ENDOCRINOL, V157, P633, DOI 10.1530/EJE-07-0463; Fain JN, 2006, METABOLISM, V55, P1113, DOI 10.1016/j.metabol.2006.04.008; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Herder C, 2006, DIABETES CARE, V29, P174, DOI 10.2337/diacare.29.1.174-a; Hivert MF, 2009, DIABETOLOGIA, V52, P2101, DOI 10.1007/s00125-009-1455-z; Hung J, 2005, ARTERIOSCL THROM VAS, V25, P1268, DOI 10.1161/01.ATV.0000163843.70369.12; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kojima H, 1999, J IMMUNOL, V162, P5063; Krogh-Madsen R, 2006, AM J PHYSIOL-ENDOC M, V291, pE108, DOI 10.1152/ajpendo.00471.2005; Lepper PM, 2007, J AM COLL CARDIOL, V50, P25, DOI 10.1016/j.jacc.2007.02.070; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Nistala Ravi, 2006, J Cardiometab Syndr, V1, P47, DOI 10.1111/j.0197-3118.2006.05455.x; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Skurk T, 2005, EUR J ENDOCRINOL, V152, P863, DOI 10.1530/eje.1.01897; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Wells JCK, 2001, ARCH DIS CHILD, V85, P67, DOI 10.1136/adc.85.1.67; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; You TJ, 2004, J CLIN ENDOCR METAB, V89, P5517, DOI 10.1210/jc.2004-0480; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P2043, DOI 10.1161/ATVBAHA.107.149484	30	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18104	10.1371/journal.pone.0018104	http://dx.doi.org/10.1371/journal.pone.0018104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437204	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100068
J	Rhea, CK; Silver, TA; Hong, SL; Ryu, JH; Studenka, BE; Hughes, CML; Haddad, JM				Rhea, Christopher K.; Silver, Tobin A.; Hong, S. Lee; Ryu, Joong Hyun; Studenka, Breanna E.; Hughes, Charmayne M. L.; Haddad, Jeffrey M.			Noise and Complexity in Human Postural Control: Interpreting the Different Estimations of Entropy	PLOS ONE			English	Article							OF-PRESSURE TRAJECTORIES; TIME-SERIES; APPROXIMATE ENTROPY; SAMPLE ENTROPY; DYNAMICS; QUANTIFICATION; PERFORMANCE	Background: Over the last two decades, various measures of entropy have been used to examine the complexity of human postural control. In general, entropy measures provide information regarding the health, stability and adaptability of the postural system that is not captured when using more traditional analytical techniques. The purpose of this study was to examine how noise, sampling frequency and time series length influence various measures of entropy when applied to human center of pressure (CoP) data, as well as in synthetic signals with known properties. Such a comparison is necessary to interpret data between and within studies that use different entropy measures, equipment, sampling frequencies or data collection durations. Methods and Findings: The complexity of synthetic signals with known properties and standing CoP data was calculated using Approximate Entropy (ApEn), Sample Entropy (SampEn) and Recurrence Quantification Analysis Entropy (RQAEn). All signals were examined at varying sampling frequencies and with varying amounts of added noise. Additionally, an increment time series of the original CoP data was examined to remove long-range correlations. Of the three measures examined, ApEn was the least robust to sampling frequency and noise manipulations. Additionally, increased noise led to an increase in SampEn, but a decrease in RQAEn. Thus, noise can yield inconsistent results between the various entropy measures. Finally, the differences between the entropy measures were minimized in the increment CoP data, suggesting that long-range correlations should be removed from CoP data prior to calculating entropy. Conclusions: The various algorithms typically used to quantify the complexity (entropy) of CoP may yield very different results, particularly when sampling frequency and noise are different. The results of this study are discussed within the context of the neural noise and loss of complexity hypotheses.	[Rhea, Christopher K.] Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA; [Silver, Tobin A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Hong, S. Lee] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Ryu, Joong Hyun; Haddad, Jeffrey M.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Studenka, Breanna E.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Hughes, Charmayne M. L.] Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, Bielefeld, Germany; [Haddad, Jeffrey M.] Purdue Univ, Ctr Aging & Life Course, W Lafayette, IN 47907 USA	University of North Carolina; University of North Carolina Greensboro; University of Massachusetts System; University of Massachusetts Amherst; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Bielefeld; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rhea, CK (corresponding author), Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA.	ckrhea@uncg.edu	Hong, S./B-2390-2008	Hong, S./0000-0001-6044-2482	Department of Veterans Affairs Center for Restorative and Regenerative Medicine (RRD) [A3772C]; Purdue University College of Liberal Arts Research Incentive	Department of Veterans Affairs Center for Restorative and Regenerative Medicine (RRD); Purdue University College of Liberal Arts Research Incentive	Funding for this project was provided by Department of Veterans Affairs Center for Restorative and Regenerative Medicine (RR&D A3772C) and the Purdue University College of Liberal Arts Research Incentive Grant in the form of salary support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barahona M, 1996, NATURE, V381, P215, DOI 10.1038/381215a0; BELTRAMI E, 1999, WHAT RANDOM CHANCE O; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Farmer SF, 1999, J PHYSIOL-LONDON, V517, P3, DOI 10.1111/j.1469-7793.1999.0003z.x; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Govindan RB, 2007, PHYSICA A, V376, P158, DOI 10.1016/j.physa.2006.10.077; Haran F J, 2008, J Neurol Phys Ther, V32, P186, DOI 10.1097/NPT.0b013e31818dee39; Harbourne RT, 2009, PHYS THER, V89, P267, DOI 10.2522/ptj.20080130; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Ho KKL, 1997, CIRCULATION, V96, P842; Kelso S., 1995, DYNAMIC PATTERNS SEL; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Li SC, 2001, GERONTOLOGY, V47, P100, DOI 10.1159/000052782; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Mazaheri M, 2010, MED ENG PHYS, V32, P808, DOI 10.1016/j.medengphy.2010.04.019; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Newell KM, 1997, EXP BRAIN RES, V113, P158, DOI 10.1007/BF02454152; Pellecchia G. L., 2005, TUTORIALS CONT NONLI, P95; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 1999, AM J PHYSIOL-ENDOC M, V277, pE948, DOI 10.1152/ajpendo.1999.277.5.E948; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; ROERDINK M, 2010, HUM MOVEMEN IN PRESS; ROSENSTEIN MT, 1994, PHYSICA D, V73, P82, DOI 10.1016/0167-2789(94)90226-7; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; West B, 2006, MED WENT WRONG REDIS; Yamada N, 1995, HUM MOVEMENT SCI, V14, P711, DOI 10.1016/0167-9457(95)00032-1	35	75	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17696	10.1371/journal.pone.0017696	http://dx.doi.org/10.1371/journal.pone.0017696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437281	Green Published, gold			2022-12-27	WOS:000288514600008
J	Ciavarra, G; Ho, AT; Cobrinik, D; Zacksenhaus, E				Ciavarra, Giovanni; Ho, Andrew T.; Cobrinik, David; Zacksenhaus, Eldad			Critical Role of the Rb Family in Myoblast Survival and Fusion	PLOS ONE			English	Article							RETINOBLASTOMA GENE FAMILY; CELL-CYCLE CONTROL; SKELETAL-MUSCLE; TUMOR-SUPPRESSOR; P107 PROTEINS; MICE LACKING; DIFFERENTIATION; PRB; BINDING; MOUSE	The tumor suppressor Rb is thought to control cell proliferation, survival and differentiation. We recently showed that differentiating Rb-deficient mouse myoblasts can fuse to form short myotubes that quickly collapse through a mechanism involving autophagy, and that autophagy inhibitors or hypoxia could rescue the defect leading to long, twitching myotubes. Here we determined the contribution of pRb relatives, p107 and p130, to this process. We show that chronic or acute inactivation of Rb plus p107 or p130 increased myoblast cell death and reduced myotube formation relative to Rb loss alone. Treatment with autophagy antagonists or hypoxia extended survival of double-knockout myotubes, which appeared indistinguishable from control fibers. In contrast, triple mutations in Rb, p107 and p130, led to substantial increase in myoblast death and to elongated bi-nuclear myocytes, which seem to derive from nuclear duplication, as opposed to cell fusion. Under hypoxia, some rare, abnormally thin triple knockout myotubes survived and twitched. Thus, mutation of p107 or p130 reduces survival of Rb-deficient myoblasts during differentiation but does not preclude myoblast fusion or necessitate myotube degeneration, whereas combined inactivation of the entire Rb family produces a distinct phenotype, with drastically impaired myoblast fusion and survival.	[Ciavarra, Giovanni; Ho, Andrew T.; Zacksenhaus, Eldad] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Cobrinik, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Zacksenhaus, Eldad] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON, Canada	University of Toronto; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Ciavarra, G (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	zacksenhaus@utoronto.ca	Zacksenhaus, Eldad/AAD-3584-2020; Ho, Andrew Tri Van/D-9681-2019	Ho, Andrew Tri Van/0000-0002-5501-6419	Canadian Institutes of Health Research [MOP-93674]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number: MOP-93674. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Berman SD, 2009, P NATL ACAD SCI USA, V106, P14932, DOI 10.1073/pnas.0902408106; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Bremner R, 2010, CANCER RES, V70, P6114, DOI 10.1158/0008-5472.CAN-10-0358; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burkhart DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001003; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Carnac G, 2000, CURR BIOL, V10, P543, DOI 10.1016/S0960-9822(00)00471-1; Castano E, 1998, MOL CELL BIOL, V18, P5380, DOI 10.1128/MCB.18.9.5380; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; CIAVARRA G, 2010, J CELL BIOL IN PRESS; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Ho AT, 2004, EMBO J, V23, P460, DOI 10.1038/sj.emboj.7600039; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jiang Z, 2002, J CELL BIOL, V156, P185, DOI 10.1083/jcb.200106084; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Jiang Z, 2001, J BIOL CHEM, V276, P593, DOI 10.1074/jbc.M005474200; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LeCouter JE, 1998, DEVELOPMENT, V125, P4669; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; MacLellan WR, 2000, MOL CELL BIOL, V20, P8903, DOI 10.1128/MCB.20.23.8903-8915.2000; Macleod K, 1999, CURR OPIN GENET DEV, V9, P31, DOI 10.1016/S0959-437X(99)80005-7; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Scime A, 2010, J CELL BIOL, V190, P651, DOI 10.1083/jcb.201005076; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; Takahashi C, 2003, MOL CELL BIOL, V23, P5256, DOI 10.1128/MCB.23.15.5256-5268.2003; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Ullah Z, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-10; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Vooijs M, 2002, ONCOGENE, V21, P4635, DOI 10.1038/sj.onc.1205575; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wirt SE, 2010, J CELL BIOL, V191, P809, DOI 10.1083/jcb.201003048; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; ZHU LG, 1995, MOL CELL BIOL, V15, P3552	65	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17682	10.1371/journal.pone.0017682	http://dx.doi.org/10.1371/journal.pone.0017682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423694	gold, Green Submitted, Green Published			2022-12-27	WOS:000288219100025
J	Hartlerode, A; Odate, S; Shim, I; Brown, J; Scully, R				Hartlerode, Andrea; Odate, Shobu; Shim, Inbo; Brown, Jenifer; Scully, Ralph			Cell Cycle-Dependent Induction of Homologous Recombination by a Tightly Regulated I-SceI Fusion Protein	PLOS ONE			English	Article							STRAND BREAK REPAIR; SISTER-CHROMATID RECOMBINATION; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; ESTROGEN-RECEPTOR; BINDING DOMAINS; GENE CONVERSION; DNA-DAMAGE; BRCA1; MAINTENANCE	Double-strand break repair is executed by two major repair pathways: non-homologous end joining (NHEJ) and homologous recombination (HR). Whereas NHEJ contributes to the repair of ionizing radiation (IR)-induced double strand breaks (DSBs) throughout the cell cycle, HR acts predominantly during the S and G2 phases of the cell cycle. The rare-cutting restriction endonuclease, I-SceI, is in common use to study the repair of site-specific chromosomal DSBs in vertebrate cells. To facilitate analysis of I-SceI-induced DSB repair, we have developed a stably expressed I-SceI fusion protein that enables precise temporal control of I-SceI activation, and correspondingly tight control of the timing of onset of site-specific chromosome breakage. I-SceI-induced HR showed a strong, positive linear correlation with the percentage of cells in S phase, and was negatively correlated with the G1 fraction. Acute depletion of BRCA1, a key regulator of HR, disrupted the relationship between S phase fraction and I-SceI-induced HR, consistent with the hypothesis that BRCA1 regulates HR during S phase.	[Hartlerode, Andrea] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Hartlerode, A (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	rscully@bidmc.harvard.edu	Scully, Ralph/F-5008-2013		NIH [R01CA095175, R01GM073894, R21CA144022]; NATIONAL CANCER INSTITUTE [R01CA095175, RC1CA145867, R21CA144022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073894] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH R01CA095175; R01GM073894; R21CA144022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gonzalez-Barrera S, 2003, MOL CELL, V11, P1661, DOI 10.1016/S1097-2765(03)00183-7; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hunter NL, 2005, GENESIS, V41, P99, DOI 10.1002/gene.20101; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackman J, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0803s00; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; KADYK LC, 1992, GENETICS, V132, P387; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; MATTIONI T, 1994, METHOD CELL BIOL, V43, P335; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Moure CM, 2003, J MOL BIOL, V334, P685, DOI 10.1016/j.jmb.2003.09.068; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nagaraju G, 2006, MOL CELL BIOL, V26, P8075, DOI 10.1128/MCB.01235-06; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Rao S, 1998, ONCOGENE, V17, P2393, DOI 10.1038/sj.onc.1202322; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; SAINTIGNY Y, 2006, ONCOGENE; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	38	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e16501	10.1371/journal.pone.0016501	http://dx.doi.org/10.1371/journal.pone.0016501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408059	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900003
J	Becker, SI				Becker, Stefanie I.			Determinants of Dwell Time in Visual Search: Similarity or Perceptual Difficulty?	PLOS ONE			English	Article							EYE-MOVEMENT CONTROL; ATTENTION; SELECTION; CONTRAST; COLOR	The present study examined the factors that determine the dwell times in a visual search task, that is, the duration the gaze remains fixated on an object. It has been suggested that an item's similarity to the search target should be an important determiner of dwell times, because dwell times are taken to reflect the time needed to reject the item as a distractor, and such discriminations are supposed to be harder the more similar an item is to the search target. In line with this similarity view, a previous study shows that, in search for a target ring of thin line-width, dwell times on thin linewidth Landolt C's distractors were longer than dwell times on Landolt C's with thick or medium linewidth. However, dwell times may have been longer on thin Landolt C's because the thin line-width made it harder to detect whether the stimuli had a gap or not. Thus, it is an open question whether dwell times on thin line-width distractors were longer because they were similar to the target or because the perceptual decision was more difficult. The present study de-coupled similarity from perceptual difficulty, by measuring dwell times on thin, medium and thick line-width distractors when the target had thin, medium or thick line-width. The results showed that dwell times were longer on target-similar than target-dissimilar stimuli across all target conditions and regardless of the line-width. It is concluded that prior findings of longer dwell times on thin linewidth-distractors can clearly be attributed to target similarity. As will be discussed towards the end, the finding of similarity effects on dwell times has important implications for current theories of visual search and eye movement control.	Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	University of Queensland	Becker, SI (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	s.becker@psy.uq.edu.au		Becker, Stefanie/0000-0003-4198-5056	University of Queensland	University of Queensland(University of Queensland)	The present research was funded by two University of Queensland grants awarded to Stefanie I. Becker, a post-doctoral UQ fellowship and an early career researcher grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, EYE MOVEMENTS THEIR; Bauer B, 1996, VISION RES, V36, P1439, DOI 10.1016/0042-6989(95)00207-3; Becker SI, 2010, J EXP PSYCHOL GEN, V139, P247, DOI 10.1037/a0018808; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DZMURA M, 1991, VISION RES, V31, P951, DOI 10.1016/0042-6989(91)90203-H; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Hooge ITC, 1998, VISION RES, V38, P1295, DOI 10.1016/S0042-6989(97)00287-3; Hooge LTC, 1996, PERCEPT PSYCHOPHYS, V58, P969, DOI 10.3758/BF03206825; JACOBS AM, 1986, PERCEPT PSYCHOPHYS, V39, P47, DOI 10.3758/BF03207583; LEGGE GE, 1987, VISION RES, V37, P1165; Nasanen R, 2001, VISION RES, V41, P1817, DOI 10.1016/S0042-6989(01)00056-6; Navalpakkam V, 2006, J VISION, V6, P1180, DOI 10.1167/6.11.4; RAYNER K, 1987, PERCEPT PSYCHOPHYS, V42, P87, DOI 10.3758/BF03211517; RAYNER K, 1987, PSYCHOL BULL, V85, P618; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Remington RW, 2001, PSYCHOL SCI, V12, P511, DOI 10.1111/1467-9280.00394; Roufs JAJ, 1997, DISPLAYS, V18, P37, DOI 10.1016/S0141-9382(97)00003-6; Shen JY, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P65, DOI 10.1016/B978-044451020-4/50005-0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Williams CC, 2007, PERCEPT PSYCHOPHYS, V69, P372, DOI 10.3758/BF03193758; Zelinsky GJ, 1997, J EXP PSYCHOL HUMAN, V23, P244, DOI 10.1037/0096-1523.23.1.244; Zelinsky GJ, 1996, VISION RES, V36, P2177, DOI 10.1016/0042-6989(95)00300-2	22	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17740	10.1371/journal.pone.0017740	http://dx.doi.org/10.1371/journal.pone.0017740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FI	21408139	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170000057
J	Cachat, J; Stewart, A; Utterback, E; Hart, P; Gaikwad, S; Wong, K; Kyzar, E; Wu, N; Kalueff, AV				Cachat, Jonathan; Stewart, Adam; Utterback, Eli; Hart, Peter; Gaikwad, Siddharth; Wong, Keith; Kyzar, Evan; Wu, Nadine; Kalueff, Allan V.			Three-Dimensional Neurophenotyping of Adult Zebrafish Behavior	PLOS ONE			English	Article							MEDAKA ORYZIAS-LATIPES; LARVAL ZEBRAFISH; SUBLETHAL TREATMENTS; SWIMMING BEHAVIOR; VIDEO TRACKING; MODEL SYSTEM; DANIO-RERIO; OPEN-FIELD; FISH; RESPONSES	The use of adult zebrafish (Danio rerio) in neurobehavioral research is rapidly expanding. The present large-scale study applied the newest video-tracking and data-mining technologies to further examine zebrafish anxiety-like phenotypes. Here, we generated temporal and spatial three-dimensional (3D) reconstructions of zebrafish locomotion, globally assessed behavioral profiles evoked by several anxiogenic and anxiolytic manipulations, mapped individual endpoints to 3D reconstructions, and performed cluster analysis to reconfirm behavioral correlates of high- and low-anxiety states. The application of 3D swim path reconstructions consolidates behavioral data (while increasing data density) and provides a novel way to examine and represent zebrafish behavior. It also enables rapid optimization of video tracking settings to improve quantification of automated parameters, and suggests that spatiotemporal organization of zebrafish swimming activity can be affected by various experimental manipulations in a manner predicted by their anxiolytic or anxiogenic nature. Our approach markedly enhances the power of zebrafish behavioral analyses, providing innovative framework for high-throughput 3D phenotyping of adult zebrafish behavior.	[Cachat, Jonathan] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Neurosci Program, Tulane Neurophenotyping Platform & Zebrafish Neur, New Orleans, LA 70112 USA	Tulane University; Tulane University	Cachat, J (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	avkalueff@gmail.com	Kalueff, Allan V/B-3647-2010; Cachat, Jonathan/AAW-1165-2021; Kalueff, Allan/AAB-8620-2022; Cachat, Jonathan M/B-3719-2010	Kalueff, Allan V/0000-0002-7525-1950; Cachat, Jonathan/0000-0002-6504-0869; Kalueff, Allan/0000-0002-7525-1950; Cachat, Jonathan M/0000-0002-6504-0869; Hart, Peter/0000-0003-1843-9102; Kyzar, Evan/0000-0002-7688-0281; Gaikwad, Siddharth/0000-0001-6437-7016	Tulane University [8k2009b]; Zebrafish Neuroscience Research Consortium (ZNRC) [2010-77]; National Institute on Drug Abuse/National Institutes of Health (NIDA/NIH); LA Board of Regents [LAB548530]	Tulane University; Zebrafish Neuroscience Research Consortium (ZNRC); National Institute on Drug Abuse/National Institutes of Health (NIDA/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); LA Board of Regents	This study was supported by Tulane University Intramural Research program (#8k2009b), Zebrafish Neuroscience Research Consortium (ZNRC) (#2010-77), National Institute on Drug Abuse/National Institutes of Health (NIDA/NIH) Drug Supply Program, and LA Board of Regents P-Fund grant (LAB548530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Alsop D, 2009, GEN COMP ENDOCR, V161, P62, DOI 10.1016/j.ygcen.2008.09.011; [Anonymous], ZEBRAFISH NEUROBEHAV; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Best J D, 2008, Neuropsychiatr Dis Treat, V4, P567; Blaser RE, 2010, BEHAV BRAIN RES, V208, P56, DOI 10.1016/j.bbr.2009.11.009; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Bleakley BH, 2006, BEHAV GENET, V36, P783, DOI 10.1007/s10519-005-9044-5; Budick SA, 2000, J EXP BIOL, V203, P2565; BURNE T, 2010, BIG IDEAS SMALL BRAI; Cachat J.M., 2010, ZEBRAFISH MODELS NEU; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Chatterjee D, 2009, BEHAV BRAIN RES, V200, P208, DOI 10.1016/j.bbr.2009.01.016; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Chon TS, 2005, ENVIRON MONIT ASSESS, V101, P1; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Delcourt J, 2006, BEHAV RES METHODS, V38, P704, DOI 10.3758/BF03193904; Delcourt J, 2009, BEHAV RES METHODS, V41, P228, DOI 10.3758/BRM.41.1.228; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; Dodge S, 2009, COMPUT ENVIRON URBAN, V33, P419, DOI 10.1016/j.compenvurbsys.2009.07.008; Echevarria DJ., 2008, INT J COMP PSYCHOL, V21, P19; Eddins D, 2010, NEUROTOXICOL TERATOL, V32, P99, DOI 10.1016/j.ntt.2009.02.005; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Fan CY, 2010, NEUROTOXICOL TERATOL, V32, P91, DOI 10.1016/j.ntt.2009.04.065; FERO K, 2010, ZEBRAFISH MODELS NEU; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; FUIMAN LA, 1988, ANIM BEHAV, V36, P250, DOI 10.1016/S0003-3472(88)80268-9; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008; Gomez-Laplaza LM, 2010, BEHAV BRAIN RES, V208, P509, DOI 10.1016/j.bbr.2009.12.031; Graham N, 2004, ICES J MAR SCI, V61, P1036, DOI 10.1016/j.icesjms.2004.06.006; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Hicks C, 2006, J NEUROBIOL, V66, P977, DOI 10.1002/neu.20290; HUSE I, 1990, AQUACULT ENG, V9, P131, DOI 10.1016/0144-8609(90)90016-S; Jadot C, 2005, J FISH BIOL, V67, P589, DOI 10.1111/j.0022-1112.2005.00761.x; Kane AS, 2004, WATER RES, V38, P3993, DOI 10.1016/j.watres.2004.06.028; Kato S, 2004, J NEUROSCI METH, V134, P1, DOI 10.1016/j.jneumeth.2003.09.028; Kwak IS, 2002, ENVIRON POLLUT, V120, P671, DOI 10.1016/S0269-7491(02)00183-5; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Laube P., 2009, BEHAV MONITORING INT; LEE S, 2005, COMPUTER ANAL IMAGES; Levin ED, 2004, NEUROTOXICOL TERATOL, V26, P731, DOI 10.1016/j.ntt.2004.06.010; Levin ED, 2006, NEUROTOXICOL TERATOL, V28, P709, DOI 10.1016/j.ntt.2006.09.016; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; MacIver MA, 2000, J NEUROSCI METH, V95, P133, DOI 10.1016/S0165-0270(99)00161-2; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; McGonnell IM, 2006, J ENDOCRINOL, V189, P425, DOI 10.1677/joe.1.06683; MCHENRY MJ, 1995, J EXP BIOL, V198, P2293; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Morris JA, 2009, PROG BRAIN RES, V179, P97, DOI 10.1016/S0079-6123(09)17911-6; Nimkerdphol K, 2008, J BIOSCI BIOENG, V105, P486, DOI 10.1263/jbb.105.486; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Panula P., 2010, NEUROBIOL DIS; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Park YS, 2005, AQUAT TOXICOL, V71, P215, DOI 10.1016/j.aquatox.2004.11.002; Patullo BW, 2007, BEHAV RES METHODS, V39, P783, DOI 10.3758/BF03192969; PAULL GC, 2010, DOMINANCE HIERARCHIE; Peitsaro N, 2007, BIOCHEM PHARMACOL, V73, P1205, DOI 10.1016/j.bcp.2007.01.014; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Redolat Rosa, 2009, Curr Drug Abuse Rev, V2, P230; Renier C, 2007, PHARMACOGENET GENOM, V17, P237, DOI 10.1097/FPC.0b013e3280119d62; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; ROSSANCHEZ G, 2010, TURK 20 INT C PATT R; Rubinstein AL, 2006, EXPERT OPIN DRUG MET, V2, P231, DOI 10.1517/17425255.2.2.231; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Salas C, 2006, ZEBRAFISH, V3, P157, DOI 10.1089/zeb.2006.3.157; Sarrazin AF, 2010, J NEUROSCI, V30, P8234, DOI 10.1523/JNEUROSCI.5137-09.2010; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Shannon W, 2003, PHARMACOGENOMICS, V4, P41, DOI 10.1517/phgs.4.1.41.22581; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Stewart A., 2010, INT J COMP PSYCHOL, V23, P104, DOI [10.1016/j.pnpbp.2010.11.035, DOI 10.1016/J.PNPBP.2013.11.014)]; Suzuki K, 2003, FISH RES, V60, P3, DOI 10.1016/S0165-7836(02)00081-4; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; Webb KJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r81; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wong K, 2010, BRAIN RES, V1348, P209, DOI 10.1016/j.brainres.2010.06.012; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Wright D, 2003, NATURWISSENSCHAFTEN, V90, P374, DOI 10.1007/s00114-003-0443-2; Xi YW, 2010, EUR J NEUROSCI, V31, P623, DOI 10.1111/j.1460-9568.2010.07091.x	90	185	190	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17597	10.1371/journal.pone.0017597	http://dx.doi.org/10.1371/journal.pone.0017597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408171	Green Submitted, Green Published, gold			2022-12-27	WOS:000288099800027
J	Gouya, G; Sturm, G; Lamina, C; Zitt, E; Freistatter, O; Struck, J; Wolzt, M; Knoll, F; Lins, F; Lhotta, K; Neyer, U; Kronenberg, F				Gouya, Ghazaleh; Sturm, Gisela; Lamina, Claudia; Zitt, Emanuel; Freistaetter, Otto; Struck, Joachim; Wolzt, Michael; Knoll, Florian; Lins, Friederike; Lhotta, Karl; Neyer, Ulrich; Kronenberg, Florian			The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; REFLECTS CARDIAC DYSFUNCTION; HEMODIALYSIS-PATIENTS; MIDREGIONAL PROADRENOMEDULLIN; IMMUNOLUMINOMETRIC ASSAY; CARDIOVASCULAR-DISEASE; PLASMA-CONCENTRATION; FOLLOW-UP; A-TYPE; MARKERS	High levels of the plasma peptides mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) are associated with clinical outcomes in the general population. Data in patients with chronic kidney disease are sparse. We therefore investigated the association of MR-proANP and MR-proADM levels with all-cause and cardiovascular (CV) mortality, CV events and peripheral arterial disease in 201 incident dialysis patients of the INVOR-Study prospectively followed for a period of up to more than 7 years. The overall mortality rate was 43%, thereof 43% due to CV events. Both baseline MR-proANP and MR-proADM were associated with higher risk of all-cause (HR = 1.44, p = 0.001 and HR = 1.32, p = 0.002, respectively) and CV mortality (HR = 1.75, p < 0.001 and HR = 1.41, p = 0.007, respectively) after adjustment for age, sex, previous CV events, diabetes mellitus and time-dependent type of renal replacement therapy. We then stratified patients in high risk (both peptides in the upper tertile), intermediate risk (only one of the two peptides in the upper tertile) and low risk (none in the upper tertile). Although demographic, clinical and laboratory variables were similar among the intermediate and high risk group, to be with both parameters in the upper tertile was associated with a 3-fold higher risk for all-cause (HR = 2.87, p < 0.001) and CV mortality (HR = 3.58, p = 0.001). In summary, among incident dialysis patients MR-proANP and MR-proADM were shown to be associated with all-cause and CV mortality, with the highest risk when both parameters were in the upper tertiles.	[Gouya, Ghazaleh; Wolzt, Michael] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Sturm, Gisela; Lamina, Claudia; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Zitt, Emanuel; Knoll, Florian; Lhotta, Karl; Neyer, Ulrich] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria; [Freistaetter, Otto; Lins, Friederike; Lhotta, Karl; Neyer, Ulrich] VIVIT, Feldkirch, Austria; [Struck, Joachim] BRAHMS GmbH, Res Dept, Hennigsdorf, Germany	Medical University of Vienna; Medical University of Innsbruck; Thermo Fisher Scientific; Brahms AG	Gouya, G (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria.	Florian.Kronenberg@i-med.ac.at	Kronenberg, Florian/B-1736-2008; Lamina, Claudia/F-7608-2010; Zitt, Emanuel/ABE-1926-2020	Kronenberg, Florian/0000-0003-2229-1120; Lamina, Claudia/0000-0002-5398-5806; Zitt, Emanuel/0000-0001-6944-6041; Wolzt, Michael/0000-0001-6049-1890; Knoll, Florian/0000-0001-5357-8656				Ala-Kopsala M, 2004, CLIN CHEM, V50, P1576, DOI 10.1373/clinchem.2004.032490; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Dieplinger B, 2009, KIDNEY INT, V75, P408, DOI 10.1038/ki.2008.560; Franz M, 2001, KIDNEY INT, V59, P1928, DOI 10.1046/j.1523-1755.2001.0590051928.x; Goto T, 2002, NEPHRON, V92, P610, DOI 10.1159/000064100; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; Kronenberg F, 1999, J AM SOC NEPHROL, V10, P1027; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Kwan BCH, 2007, J AM SOC NEPHROL, V18, P1246, DOI 10.1681/ASN.2006091006; Lewis LK, 1998, CLIN CHEM, V44, P571; Lo CS, 2009, J CELL PHYSIOL, V219, P776, DOI 10.1002/jcp.21728; Maier C, 2009, DIABETES CARE, V32, P1890, DOI 10.2337/dc08-2168; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Meeran K, 1997, J CLIN ENDOCR METAB, V82, P95, DOI 10.1210/jc.82.1.95; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Moertl D, 2009, J AM COLL CARDIOL, V53, P1783, DOI 10.1016/j.jacc.2009.01.057; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Nakatani T, 2003, BLOOD PURIFICAT, V21, P395, DOI 10.1159/000073442; Nishikimi T, 2007, CURR MED CHEM, V14, P1689, DOI 10.2174/092986707780830943; Odar-Cederlof I, 2003, ASAIO J, V49, P74, DOI 10.1097/01.MAT.0000044738.93079.F0; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; Rutten JHW, 2006, PERITON DIALYSIS INT, V26, P598; Schwaiger JP, 2006, KIDNEY INT, V70, P543, DOI 10.1038/sj.ki.5001589; Schwaiger JP, 2006, AM J KIDNEY DIS, V47, P888, DOI 10.1053/j.ajkd.2006.01.011; Sturm G, 2010, NEPHROL DIAL TRANSPL, V25, P2715, DOI 10.1093/ndt/gfq101; Yoshihara F, 2005, KIDNEY INT, V68, P1355, DOI 10.1111/j.1523-1755.2005.00534.x; Yoshihara F, 2007, NEPHROL DIAL TRANSPL, V22, P2263, DOI 10.1093/ndt/gfm029; Zoccali C, 2001, J AM SOC NEPHROL, V12, P1508, DOI 10.1681/ASN.V1271508	30	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17803	10.1371/journal.pone.0017803	http://dx.doi.org/10.1371/journal.pone.0017803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408188	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800041
J	Marchant, I; Nony, P; Cucherat, M; Boissel, JP; Thomas, SR; Bejan-Angoulvant, T; Laugerotte, A; Kahoul, R; Gueyffier, F				Marchant, Ivanny; Nony, Patrice; Cucherat, Michel; Boissel, Jean-Pierre; Thomas, S. Randall; Bejan-Angoulvant, Theodora; Laugerotte, Alexandra; Kahoul, Riad; Gueyffier, Francois			The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; CLINICAL-PRACTICE; EUROPEAN GUIDELINES; TASK-FORCE; PREVENTION; SCORE; RECOMMENDATIONS; STRATEGIES; BENEFIT	Background: The prediction of the public health impact of a preventive strategy provides valuable support for decision-making. International guidelines for hypertension management have introduced the level of absolute cardiovascular risk in the definition of the treatment target population. The public health impact of implementing such a recommendation has not been measured. Methodology/Principal Findings: We assessed the efficiency of three treatment scenarios according to historical and current versions of practice guidelines on a Realistic Virtual Population representative of the French population aged from 35 to 64 years: 1) BP >= 160/95 mm Hg; 2) BP >= 140/90 mm Hg and 3) BP >= 140/ 90 mm Hg plus increased CVD risk. We compared the eligibility following the ESC guidelines with the recently observed proportion of treated amongst hypertensive individuals reported by the Etude Nationale Nutrition Sante survey. Lowering the threshold to define hypertension multiplied by 2.5 the number of eligible individuals. Applying the cardiovascular risk rule reduced this number significantly: less than 1/4 of hypertensive women under 55 years and less than 1/3 of hypertensive men below 45 years of age. This was the most efficient strategy. Compared to the simulated guidelines application, men of all ages were undertreated (between 32 and 60%), as were women over 55 years (70%). By contrast, younger women were over-treated (over 200%). Conclusion: The global CVD risk approach to decide for treatment is more efficient than the simple blood pressure level. However, lack of screening rather than guideline application seems to explain the low prescription rates among hypertensive individuals in France. Multidimensional analyses required to obtain these results are possible only through databases at the individual level: realistic virtual populations should become the gold standard for assessing the impact of public health policies at the national level.	[Marchant, Ivanny] Univ Valparaiso, Escuela Med, Dept Preclin, Valparaiso, Chile; [Marchant, Ivanny; Nony, Patrice; Bejan-Angoulvant, Theodora; Laugerotte, Alexandra; Gueyffier, Francois] IMTh Inst Theoret Med, Lyon, France; [Marchant, Ivanny; Nony, Patrice; Cucherat, Michel; Bejan-Angoulvant, Theodora; Laugerotte, Alexandra; Kahoul, Riad; Gueyffier, Francois] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69365 Lyon, France; [Bejan-Angoulvant, Theodora; Laugerotte, Alexandra; Gueyffier, Francois] EPICIME, CIC 201, INSERM, Lyon, France; [Nony, Patrice; Bejan-Angoulvant, Theodora; Gueyffier, Francois] Ctr Hosp Univ Lyon, Hop L Pradel, Serv Pharmacol Clin, Lyon, France; [Thomas, S. Randall] Univ Paris Sud, CNRS, UMR8081, IR4M, Orsay, France; [Boissel, Jean-Pierre; Kahoul, Riad] Novadiscovery, Lyon, France; [Boissel, Jean-Pierre; Kahoul, Riad] Novacare, Lyon, France	Universidad de Valparaiso; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay	Marchant, I (corresponding author), Univ Valparaiso, Escuela Med, Dept Preclin, Valparaiso, Chile.	ivanny.marchant@uv.cl	Gueyffier, François/B-8545-2008; Cucherat, Michel/B-2343-2008; nony, patrice/F-8128-2011	Gueyffier, François/0000-0002-9921-0977; Cucherat, Michel/0000-0003-2150-5932; Kahoul, Riad/0000-0002-6181-7466; Bejan-Angoulvant, Theodora/0000-0002-0018-9996	Facultad de Medicina, Universidad de Valparaiso, Chile; Ministere des Affaires Etrangeres, France; Societe Franc,aise de Pharmacologie et de Therapeutique; Agence Nationale de la Recherche	Facultad de Medicina, Universidad de Valparaiso, Chile; Ministere des Affaires Etrangeres, France; Societe Franc,aise de Pharmacologie et de Therapeutique; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Facultad de Medicina, Universidad de Valparaiso, Chile, (MECESUP UVA 106-www.mecesup.cl); the Ministere des Affaires Etrangeres, France, (Bourse Charcot-www.diplomatie.gouv.fr); the Societe Franc,aise de Pharmacologie et de Therapeutique (www.pharmacol-fr.org) and the Agence Nationale de la Recherche (BIMBO project, Grant SYSCOMM Nr 002, ANR-www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ANAES, 2004, METH EV RISQ CARD GL; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; GODETTHOBIE H, 2008, MEAN BLOOD PRESSURE, P478; Gourdy P, 2001, DIABETES METAB, V27, P347; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Gueyffier F, 1996, J HUM HYPERTENS, V10, P1; *I NAT STAT ET EC, 2004, STRUCT AG POP FEM MA; *INS CEPIDC, 2008, PRINC CAUS DEC; Kassai B, 2003, J CLIN EPIDEMIOL, V56, P977, DOI 10.1016/S0895-4356(03)00159-8; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Marchant I, 2009, EUR J CARDIOV PREV R, V16, P609, DOI 10.1097/HJR.0b013e32832da006; Marques-Vidal P, 2008, EUR J CARDIOV PREV R, V15, P402, DOI 10.1097/HJR.0b013e3282fb040f; Marshall T, 2003, BMJ-BRIT MED J, V327, P1264, DOI 10.1136/bmj.327.7426.1264; Marshall T, 2002, BMJ-BRIT MED J, V325, P197, DOI 10.1136/bmj.325.7357.197; Massol J, 2007, THERAPIE, V62, P427, DOI 10.2515/therapie:2007071; MOULD D, 2003, SIMULATION DESIGNING, P33; Probstfield JL, 2003, AM J CARDIOL, V91, p22G, DOI 10.1016/S0002-9149(03)00229-7; PYORALA K, 1994, ATHEROSCLEROSIS, V110, P121, DOI 10.1016/0021-9150(94)90200-3; Pyorala K, 1998, EUR HEART J, V19, P1413; R Core Team, 2021, R LANGUAGE ENV STAT; RICHARD JL, 1988, REV EPIDEMIOL SANTE, V36, P325; ROCCELLA EJ, 1985, HYPERTENSION, V7, P457; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; ZANCHETTI A, 1993, HYPERTENSION, V22, P392	26	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17508	10.1371/journal.pone.0017508	http://dx.doi.org/10.1371/journal.pone.0017508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408615	Green Published, Green Submitted, gold			2022-12-27	WOS:000287965200018
J	Nanthakumar, N; Meng, D; Goldstein, AM; Zhu, WS; Lu, L; Uauy, R; Llanos, A; Claud, EC; Walker, WA				Nanthakumar, Nanda; Meng, Di; Goldstein, Allan M.; Zhu, Weishu; Lu, Lei; Uauy, Ricardo; Llanos, Adolfo; Claud, Erika C.; Walker, W. Allan			The Mechanism of Excessive Intestinal Inflammation in Necrotizing Enterocolitis: An Immature Innate Immune Response	PLOS ONE			English	Article							EPITHELIAL-CELLS; ENDOTOXIN TOLERANCE; BACTERIAL LIGANDS; UP-REGULATION; CORTICOSTEROIDS; ENTEROCYTES; EXPRESSION	Necrotizing enterocolitis (NEC) is a devastating neonatal intestinal inflammatory disease, occurring primarily in premature infants, causing significant morbidity and mortality. The pathogenesis of NEC is associated with an excessive inflammatory IL-8 response. In this study, we hypothesized that this excessive inflammatory response is related to an immature expression of innate immune response genes. To address this hypothesis, intestinal RNA expression analysis of innate immune response genes was performed after laser capture microdissection of resected ileal epithelium from fetuses, NEC patients and children and confirmed in ex vivo human intestinal xenografts. Changes in mRNA levels of toll-like receptors (TLR)-2 and -4, their signaling molecules and transcription factors (MyD88, TRAF-6 and NF kappa B1) and negative regulators (SIGIRR, IRAK-M, A-20 and TOLLIP) and the effector IL-8 were characterized by qRT-PCR. The expression of TLR2, TLR4, MyD88, TRAF-6, NFkB1 and IL-8 mRNA was increased while SIGIRR, IRAK-M, A-20 and TOLLIP mRNA were decreased in fetal vs. mature human enterocytes and further altered in NEC enterocytes. Similar changes in mRNA expression were observed in immature, but not mature, human intestinal xenografts. Confirmation of gene expression was also validated with selective protein measurements and with suggested evidence that immature TRL4 enterocyte surface expression was internalized in mature enterocytes. Cortisone, an intestinal maturation factor, treatment corrected the mRNA differences only in the immature intestinal xenograft. Using specific siRNA to attenuate expression of primary fetal enterocyte cultures, both TOLLIP and A-20 were confirmed to be important when knocked down by exhibiting the same excessive inflammatory response seen in the NEC intestine. We conclude that the excessive inflammatory response of the immature intestine, a hallmark of NEC, is due to a developmental immaturity in innate immune response genes.	[Nanthakumar, Nanda; Meng, Di; Zhu, Weishu; Lu, Lei; Walker, W. Allan] Harvard Univ, Sch Med, Dev Gastroenterol Lab, Boston, MA 02115 USA; [Goldstein, Allan M.] Harvard Univ, Sch Med, Pediat Surg Res Lab, MassGen Hosp Children, Boston, MA USA; [Uauy, Ricardo; Llanos, Adolfo] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile; [Claud, Erika C.] Univ Chicago, Dept Pediat & Med, Sect Neonatol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universidad de Chile; University of Chicago	Nanthakumar, N (corresponding author), Harvard Univ, Sch Med, Dev Gastroenterol Lab, Boston, MA 02115 USA.	wwalker@partners.org			National Institutes of Health (NIH) [R01 HD059126, R01-HD012437, R01 DK070260, P01 DK033506, P30 DK040561, R01 DK080914, R01 HD059123, R21 HD055237, R21 AT004044]; March of Dimes Basil O'Connor Starter Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437, R01HD059126, R01HD059123] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055237] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK043351, R01DK080914, R01DK070260, P01DK033506] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor Starter Award(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health (NIH): R01 HD059126 (Nanda Nanthakumar); R01-HD012437, R01 DK070260, P01 DK033506 and P30 DK040561 (W. Allan Walker); R01 DK080914 (Allan Goldstein); R01 HD059123, R21 HD055237, R21 AT004044 and the March of Dimes Basil O'Connor Starter Award (Erika Claud). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, GASTROENTEROLOGY, V138, P39, DOI 10.1053/j.gastro.2009.11.031; CAPLAN MS, 2005, SEMIN PEDIATR SURG, V14, P14; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Doyle LW, 2000, J PAEDIATR CHILD H, V36, P101, DOI 10.1046/j.1440-1754.2000.00481.x; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; Grave GD, 2007, PEDIATR RES, V62, P510, DOI 10.1203/PDR.0b013e318142580a; HALAC E, 1990, J PEDIATR-US, V117, P132, DOI 10.1016/S0022-3476(05)72461-6; Harada K, 2006, LIVER INT, V26, P935, DOI 10.1111/j.1478-3231.2006.01325.x; Hayes EJ, 2008, OBSTET GYNECOL, V111, P921, DOI 10.1097/AOG.0b013e318169ce2d; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu L, 2008, GASTROENTEROLOGY, V135, P185, DOI 10.1053/j.gastro.2008.03.038; Lu L, 2009, AM J PHYSIOL-GASTR L, V296, pG1221, DOI 10.1152/ajpgi.90686.2008; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P50; Ohnuma K, 2005, MOL CELL BIOL, V25, P7743, DOI 10.1128/MCB.25.17.7743-7757.2005; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; Weng M, 2007, PEDIATR RES, V62, P542, DOI 10.1203/PDR.0b013e318155a422; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012	28	230	238	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17776	10.1371/journal.pone.0017776	http://dx.doi.org/10.1371/journal.pone.0017776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445298	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000288613300015
J	Bocchi, L; Savi, M; Graiani, G; Rossi, S; Agnetti, A; Stillitano, F; Lagrasta, C; Baruffi, S; Berni, R; Frati, C; Vassalle, M; Squarcia, U; Cerbai, E; Macchi, E; Stilli, D; Quaini, F; Musso, E				Bocchi, Leonardo; Savi, Monia; Graiani, Gallia; Rossi, Stefano; Agnetti, Aldo; Stillitano, Francesca; Lagrasta, Costanza; Baruffi, Silvana; Berni, Roberta; Frati, Caterina; Vassalle, Mario; Squarcia, Umberto; Cerbai, Elisabetta; Macchi, Emilio; Stilli, Donatella; Quaini, Federico; Musso, Ezio			Growth Factor-Induced Mobilization of Cardiac Progenitor Cells Reduces the Risk of Arrhythmias, in a Rat Model of Chronic Myocardial Infarction	PLOS ONE			English	Article							STEM-CELLS; HEART-FAILURE; LIMINAL LENGTH; SOCIAL STRESS; THERAPY; TRANSPLANTATION; REGENERATE; ACTIVATION; EXPRESSION; INJECTION	Heart repair by stem cell treatment may involve life-threatening arrhythmias. Cardiac progenitor cells (CPCs) appear best suited for reconstituting lost myocardium without posing arrhythmic risks, being commissioned towards cardiac phenotype. In this study we tested the hypothesis that mobilization of CPCs through locally delivered Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 to heal chronic myocardial infarction (MI), lowers the proneness to arrhythmias. We used 133 adult male Wistar rats either with one-month old MI and treated with growth factors (GFs, n = 60) or vehicle (V, n = 55), or sham operated (n = 18). In selected groups of animals, prior to and two weeks after GF/V delivery, we evaluated stress-induced ventricular arrhythmias by telemetry-ECG, cardiac mechanics by echocardiography, and ventricular excitability, conduction velocity and refractoriness by epicardial multiple-lead recording. Invasive hemodynamic measurements were performed before sacrifice and eventually the hearts were subjected to anatomical, morphometric, immunohistochemical, and molecular biology analyses. When compared with untreated MI, GFs decreased stress-induced arrhythmias and concurrently prolonged the effective refractory period (ERP) without affecting neither the duration of ventricular repolarization, as suggested by measurements of QTc interval and mRNA levels for K-channel alpha-subunits Kv4.2 and Kv4.3, nor the dispersion of refractoriness. Further, markers of cardiomyocyte reactive hypertrophy, including mRNA levels for K-channel alpha-subunit Kv1.4 and beta-subunit KChIP2, interstitial fibrosis and negative structural remodeling were significantly reduced in peri-infarcted/remote ventricular myocardium. Finally, analyses of BrdU incorporation and distribution of connexin43 and N-cadherin indicated that cytokines generated new vessels and electromechanically-connected myocytes and abolished the correlation of infarct size with deterioration of mechanical function. In conclusion, local injection of GFs ameliorates electromechanical competence in chronic MI. Reduced arrhythmogenesis is attributable to prolongation of ERP resulting from improved intercellular coupling via increased expression of connexin43, and attenuation of unfavorable remodeling.	[Bocchi, Leonardo; Savi, Monia; Rossi, Stefano; Baruffi, Silvana; Berni, Roberta; Macchi, Emilio; Stilli, Donatella; Musso, Ezio] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy; [Graiani, Gallia; Lagrasta, Costanza; Frati, Caterina] Univ Parma, Dipartimento Patol & Med Lab, I-43100 Parma, Italy; [Agnetti, Aldo; Squarcia, Umberto] Univ Parma, Dipartimento Eta Evolut, I-43100 Parma, Italy; [Stillitano, Francesca; Cerbai, Elisabetta] Univ Florence, Dipartimento Farmacol Preclin & Clin, Florence, Italy; [Vassalle, Mario] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY USA; [Quaini, Federico] Univ Parma, Dipartimento Med Interna & Sci Biomed, I-43100 Parma, Italy; [Agnetti, Aldo; Lagrasta, Costanza; Squarcia, Umberto; Macchi, Emilio; Stilli, Donatella; Quaini, Federico; Musso, Ezio] Univ Parma, Ctr Interdipartimentale Cellule Staminali Cardiac, I-43100 Parma, Italy	University of Parma; University of Parma; University of Parma; University of Florence; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Parma; University of Parma	Bocchi, L (corresponding author), Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy.	ezio.musso@unipr.it	Savi, Monia/B-9562-2015; Cerbai, Elisabetta/J-2663-2013; Stilli, Donatella/M-5630-2018; Rossi, Stefano/L-2556-2016	Savi, Monia/0000-0002-7895-7756; Cerbai, Elisabetta/0000-0001-7839-1361; Rossi, Stefano/0000-0003-0346-8410; Frati, Caterina/0000-0002-3343-6471; BOCCHI, Leonardo/0000-0003-4799-2804; Quaini, Federico/0000-0003-2377-4810; Stillitano, Francesca/0000-0003-1898-5058; Graiani, Gallia/0000-0003-1926-7568	Italian Ministry of Education, University and Research [PRIN 062944 2005]; European Commission [NMP-214539 2007]; Italian Ministry of Health; Fondazione Cassa di Risparmio di Parma; Ente Cassa di Risparmio di Firenze; Compagnia di San Paolo; Istituto Nazionale di Ricerche Cardiovascolari	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cassa di Risparmio di Parma(Fondazione Cariparma); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Compagnia di San Paolo(Compagnia di San Paolo); Istituto Nazionale di Ricerche Cardiovascolari	This study was supported by the following grants: Italian Ministry of Education, University and Research PRIN 062944 2005, European Commission CORDIS FP7-BIOSCENT, NMP-214539 2007, Italian Ministry of Health THEAPPL 2008, and funding by "Fondazione Cassa di Risparmio di Parma", "Ente Cassa di Risparmio di Firenze", "Compagnia di San Paolo", and "Istituto Nazionale di Ricerche Cardiovascolari." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Camm AJ, 1996, CIRCULATION, V93, P1043; Chamuleau SAF, 2009, NETH HEART J, V17, P199, DOI 10.1007/BF03086247; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; DODGE HT, 1969, AM J CARDIOL, V23, P528, DOI 10.1016/0002-9149(69)90006-X; Duffy HS, 2008, NEW ENGL J MED, V358, P1397, DOI 10.1056/NEJMcibr0708922; FOZZARD HA, 1972, J PHYSIOL-LONDON, V226, P593, DOI 10.1113/jphysiol.1972.sp009999; Fozzard HA, 2001, J CARDIOVASC ELECTR, V12, P836, DOI 10.1046/j.1540-8167.2001.00836.x; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Fuller MS, 2000, CIRCULATION, V102, P685, DOI 10.1161/01.CIR.102.6.685; Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040; Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124; KJEKSHUS J, 1990, AM J CARDIOL, V65, pI42; Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007; Kuhlmann MT, 2006, J EXP MED, V203, P87, DOI 10.1084/jem.20051151; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Ly HQ, 2009, CIRCULATION, V119, P1824, DOI 10.1161/CIRCULATIONAHA.108.812701; Macchi E, 1998, AM J PHYSIOL-HEART C, V275, pH1886, DOI 10.1152/ajpheart.1998.275.5.H1886; Macia E, 2009, CIRCULATION, V119, P1814, DOI 10.1161/CIRCULATIONAHA.108.779900; Marban E, 2010, CIRCULATION, V121, P1981, DOI 10.1161/CIRCULATIONAHA.110.952580; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Martinez M, 1998, AGGRESSIVE BEHAV, V24, P241; Menasche P, 2009, CIRCULATION, V119, P2735, DOI 10.1161/CIRCULATIONAHA.108.812693; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mills WR, 2007, J MOL CELL CARDIOL, V42, P304, DOI 10.1016/j.yjmcc.2006.09.011; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; OGAWA S, 1991, CARDIOVASC RES, V25, P378, DOI 10.1093/cvr/25.5.378; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; OLIVETTI G, 1991, CIRC RES, V68, P856, DOI 10.1161/01.RES.68.3.856; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Pak HN, 2003, J CARDIOVASC ELECTR, V14, P841, DOI 10.1046/j.1540-8167.2003.03124.x; Pollick C, 1995, J Am Soc Echocardiogr, V8, P602, DOI 10.1016/S0894-7317(05)80373-6; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011; Stilli D, 2004, EXP PHYSIOL, V89, P387, DOI 10.1113/expphysiol.2003.027110; Stilli D, 2007, BASIC RES CARDIOL, V102, P488, DOI 10.1007/s00395-007-0665-0; Tozakidou M, 2010, J MOL CELL CARDIOL, V48, P140, DOI 10.1016/j.yjmcc.2009.08.027; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; van der Heyden MAG, 2006, CARDIOVASC RES, V71, P430, DOI 10.1016/j.cardiores.2006.04.012; van Rijen HVM, 2006, ADV CARDIOL, V42, P150, DOI 10.1159/000092567; Wang DG, 2011, INT J CARDIOL, V152, P314, DOI 10.1016/j.ijcard.2010.07.025	56	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17750	10.1371/journal.pone.0017750	http://dx.doi.org/10.1371/journal.pone.0017750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445273	gold, Green Published, Green Submitted			2022-12-27	WOS:000288545100029
J	Walenda, T; Bokermann, G; Jost, E; Galm, O; Schellenberg, A; Koch, CM; Piroth, DM; Drescher, W; Brummendorf, TH; Wagner, W				Walenda, Thomas; Bokermann, Gudrun; Jost, Edgar; Galm, Oliver; Schellenberg, Anne; Koch, Carmen M.; Piroth, Daniela M.; Drescher, Wolf; Bruemmendorf, Tim H.; Wagner, Wolfgang			Serum after Autologous Transplantation Stimulates Proliferation and Expansion of Human Hematopoietic Progenitor Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; MESENCHYMAL STROMAL CELLS; FREE CULTURE-SYSTEM; STEM-CELLS; BONE-MARROW; PERIPHERAL-BLOOD; STEM/PROGENITOR CELLS; SELF-RENEWAL; DIVISION	Regeneration after hematopoietic stem cell transplantation (HSCT) depends on enormous activation of the stem cell pool. So far, it is hardly understood how these cells are recruited into proliferation and self-renewal. In this study, we have addressed the question if systemically released factors are involved in activation of hematopoietic stem and progenitor cells (HPC) after autologous HSCT. Serum was taken from patients before chemotherapy, during neutropenia and after hematopoietic recovery. Subsequently, it was used as supplement for in vitro culture of CD34(+) cord blood HPC. Serum taken under hematopoietic stress (4 to 11 days after HSCT) significantly enhanced proliferation, maintained primitive immunophenotype (CD34(+), CD133(+), CD45(-)) for more cell divisions and increased colony forming units (CFU) as well as the number of cobblestone area-forming cells (CAFC). The stimulatory effect decays to normal levels after hematopoietic recovery (more than 2 weeks after HSCT). Chemokine profiling revealed a decline of several growth-factors during neutropenia, including platelet-derived growth factors PDGF-AA, PDGF-AB and PDGF-BB, whereas expression of monocyte chemotactic protein-1 (MCP-1) increased. These results demonstrate that systemically released factors play an important role for stimulation of hematopoietic regeneration after autologous HSCT. This feedback mechanism opens new perspectives for in vivo stimulation of the stem cell pool.	[Walenda, Thomas; Bokermann, Gudrun; Schellenberg, Anne; Koch, Carmen M.; Wagner, Wolfgang] RWTH Aachen Univ Med Sch, Helmholtz Inst Biomed Engn, Aachen, Germany; [Jost, Edgar; Galm, Oliver; Bruemmendorf, Tim H.] RWTH Aachen Univ Med Sch, Dept Hematol & Oncol, Aachen, Germany; [Piroth, Daniela M.] RWTH Aachen Univ Med Sch, Dept Gynecol, Aachen, Germany; [Drescher, Wolf] RWTH Aachen Univ Med Sch, Dept Orthoped, Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Walenda, T (corresponding author), RWTH Aachen Univ Med Sch, Helmholtz Inst Biomed Engn, Aachen, Germany.	wwagner@ukaachen.de		Wagner, Wolfgang/0000-0002-1971-3217	German Ministry of Education and Research (BMBF); Stem Cell Network North Rhine Westphalia	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Stem Cell Network North Rhine Westphalia	This work was supported by the German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine'' (CB-HERMES), and by the Stem Cell Network North Rhine Westphalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PZ, 2010, MOL BIOSYST, V6, P1207, DOI 10.1039/b922637k; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Chen YM, 1996, JPN J CLIN ONCOL, V26, P18, DOI 10.1093/oxfordjournals.jjco.a023173; da Silva CL, 2005, EXP HEMATOL, V33, P828, DOI 10.1016/j.exphem.2005.03.017; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Frederik W, 2010, STEM CELL RES, V4, P129, DOI 10.1016/j.scr.2009.12.004; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gotze KS, 2007, EXP HEMATOL, V35, P1408, DOI 10.1016/j.exphem.2007.05.016; Goncalves R, 2006, EXP HEMATOL, V34, P1353, DOI 10.1016/j.exphem.2006.05.024; Gratwohl A, 2009, BONE MARROW TRANSPL, V43, P275, DOI 10.1038/bmt.2009.7; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Ho AD, 2007, CURR OPIN HEMATOL, V14, P330, DOI 10.1097/MOH.0b013e3281900f12; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Hsu HC, 2002, ONCOLOGY-BASEL, V63, P64, DOI 10.1159/000065722; Huang GP, 2007, CELL TRANSPLANT, V16, P579, DOI 10.3727/000000007783465073; Huang S, 1998, EXP HEMATOL, V26, P1162; Klaus J, 2007, EUR J HAEMATOL, V78, P21, DOI 10.1111/j.0902-4441.2006.t01-1-EJH2895.x; Kurita M, 2008, PLAST RECONSTR SURG, V122, P438, DOI 10.1097/PRS.0b013e31817d618d; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NOROOZI AA, 2010, GROWTH FACTORS; Olivieri A, 1998, HAEMATOLOGICA, V83, P329; Oostendorp RAJ, 2000, BLOOD, V95, P855, DOI 10.1182/blood.V95.3.855.003k41_855_862; PLOEMACHER RE, 1989, BLOOD, V74, P2755; SARRIS AH, 1993, J EXP MED, V178, P1127, DOI 10.1084/jem.178.3.1127; Sauvageau G, 2010, SCIENCE, V329, P1291, DOI 10.1126/science.1195173; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Su RJ, 2002, BRIT J HAEMATOL, V117, P735, DOI 10.1046/j.1365-2141.2002.03500.x; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; WALENDA T, 2011, EXPT HEMATO IN PRESS; Walenda T, 2010, J CELL MOL MED, V14, P337, DOI 10.1111/j.1582-4934.2009.00776.x; Wang SR, 2007, TRANSFUSION, V47, P2207, DOI 10.1111/j.1537-2995.2007.01448.x; Weissinger Eva M., 2009, V506, P437, DOI 10.1007/978-1-59745-409-4_29; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yoshimura C, 2000, VOX SANG, V78, P106, DOI 10.1046/j.1423-0410.2000.7820106.x; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18012	10.1371/journal.pone.0018012	http://dx.doi.org/10.1371/journal.pone.0018012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437259	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100057
J	Arisue, N; Kawai, S; Hirai, M; Palacpac, NMQ; Jia, M; Kaneko, A; Tanabe, K; Horii, T				Arisue, Nobuko; Kawai, Satoru; Hirai, Makoto; Palacpac, Nirianne M. Q.; Jia, Mozhi; Kaneko, Akira; Tanabe, Kazuyuki; Horii, Toshihiro			Clues to Evolution of the SERA Multigene Family in 18 Plasmodium Species	PLOS ONE			English	Article							SERINE-REPEAT-ANTIGEN; PHYLOGENETIC ANALYSIS; EXPRESSION PATTERNS; AOTUS MONKEYS; FALCIPARUM; MALARIA; PROTEIN; PROTEASES; SEQUENCE; ORIGIN	SERA gene sequences were newly determined from 11 primate Plasmodium species including two human parasites, P. ovale and P. malariae, and the evolutionary history of SERA genes was analyzed together with 7 known species. All have one each of Group I to III cysteine-type SERA genes and varying number of Group IV serine-type SERA genes in tandem cluster. Notably, Group IV SERA genes were ascertained in all mammalian parasite lineages; and in two primate parasite lineages gene events such as duplication, truncation, fragmentation and gene loss occurred at high frequency in a manner that mimics the birth-and-death evolution model. Transcription profile of individual SERA genes varied greatly among rodent and monkey parasites. Results support the lineage-specific evolution of the Plasmodium SERA gene family. These findings provide further impetus for studies that could clarify/provide proof-of-concept that duplications of SERA genes were associated with the parasites' expansion of host range and the evolutionary conundrums of multigene families in Plasmodium.	[Arisue, Nobuko; Palacpac, Nirianne M. Q.; Jia, Mozhi; Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Osaka, Japan; [Kawai, Satoru] Dokkyo Univ, Sch Med, Lab Trop Med & Parasitol, Shimotsuga, Tochigi, Japan; [Hirai, Makoto] Gunma Univ, Grad Sch Med, Dept Parasitol, Gunma, Japan; [Kaneko, Akira] Osaka City Univ, Grad Sch Med, Dept Parasitol, Osaka 558, Japan; [Kaneko, Akira] Karolinska Inst, Isl Malaria Grp, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kaneko, Akira] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Osaka, Japan	Osaka University; Dokkyo Medical University; Gunma University; Osaka Metropolitan University; Karolinska Institutet; Nagasaki University; Osaka University	Arisue, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Osaka, Japan.	horii@biken.osaka-u.ac.jp		Palacpac, Nirianne Marie/0000-0003-4098-3972; Horii, Toshihiro/0000-0002-3000-2045; , Akira/0000-0003-2411-3352	Ministry of Education, Culture, Sports, Science and Technology [21570238, 20390120, 18073013]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: This work was supported by the Ministry of Education, Culture, Sports, Science and Technology grant (21570238 to N. A.; 20390120 to K. T.; 18073013 to T. H.) [http://www.mext.go.jp/english/]. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arisue N, 2007, J MOL EVOL, V65, P82, DOI 10.1007/s00239-006-0253-1; BZIK DJ, 1988, MOL BIOCHEM PARASIT, V30, P279, DOI 10.1016/0166-6851(88)90097-7; Chen XF, 1997, GENE, V185, P195, DOI 10.1016/S0378-1119(96)00637-3; COATNEY GR, 1971, PRIMATE MALARIAS; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; DELPLACE P, 1987, MOL BIOCHEM PARASIT, V23, P193, DOI 10.1016/0166-6851(87)90026-0; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Duval L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005520; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; FOODEN J, 1994, INT J PRIMATOL, V15, P573, DOI 10.1007/BF02735972; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garzon-Ospina D, 2010, MOL PHYLOGENET EVOL, V55, P399, DOI 10.1016/j.ympev.2010.02.017; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Hayakawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007412; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Horii T, 2010, PARASITOL INT, V59, P380, DOI 10.1016/j.parint.2010.05.002; INSELBURG J, 1993, INFECT IMMUN, V61, P2048, DOI 10.1128/IAI.61.5.2048-2052.1993; INSELBURG J, 1993, INFECT IMMUN, V61, P2041, DOI 10.1128/IAI.61.5.2041-2047.1993; Janssen CS, 2004, NUCLEIC ACIDS RES, V32, P5712, DOI 10.1093/nar/gkh907; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; Li J, 2002, MOL BIOCHEM PARASIT, V120, P177, DOI 10.1016/S0166-6851(01)00452-2; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Okech BA, 2001, AM J TROP MED HYG, V65, P912, DOI 10.4269/ajtmh.2001.65.912; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Palacpac NMQ, 2006, MOL BIOCHEM PARASIT, V150, P353, DOI 10.1016/j.molbiopara.2006.07.006; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Ricklefs RE, 2010, SCIENCE, V329, P226, DOI 10.1126/science.1188954; Sugiyama T, 1996, VACCINE, V14, P1069, DOI 10.1016/0264-410X(95)00238-V; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Ziegler T, 2007, MOL PHYLOGENET EVOL, V42, P807, DOI 10.1016/j.ympev.2006.11.015	48	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17775	10.1371/journal.pone.0017775	http://dx.doi.org/10.1371/journal.pone.0017775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423628	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900029
J	Sester, U; Fousse, M; Dirks, J; Mack, U; Prasse, A; Singh, M; Lalvani, A; Sester, M				Sester, Urban; Fousse, Mathias; Dirks, Jan; Mack, Ulrich; Prasse, Antje; Singh, Mahavir; Lalvani, Ajit; Sester, Martina			Whole-Blood Flow-Cytometric Analysis of Antigen-Specific CD4 T-Cell Cytokine Profiles Distinguishes Active Tuberculosis from Non-Active States	PLOS ONE			English	Article							INFECTED INDIVIDUALS; M. TUBERCULOSIS; RAPID DIAGNOSIS; IFN-GAMMA; IMMUNITY; DISEASE; CORRELATE	T-cell based IFN-gamma release assays do not permit distinction of active tuberculosis (TB) from successfully treated disease or latent M. tuberculosis infection. We postulated that IFN-gamma and IL-2 cytokine profiles of antigen-specific T cells measured by flow-cytometry ex vivo might correlate with TB disease activity in vivo. Tuberculin (PPD), ESAT-6 and CFP-10 were used as stimuli to determine antigen-specific cytokine profiles in CD4 T cells from 24 patients with active TB and 28 patients with successfully treated TB using flow-cytometry. Moreover, 25 individuals with immunity consistent with latent M. tuberculosis infection and BCG-vaccination, respectively, were recruited. Although the frequency of cytokine secreting PPD reactive CD4 T cells was higher in patients with active TB compared to patients with treated TB (median 0.81% vs. 0.39% of CD4 T cells, p = 0.02), the overlap in frequencies precluded distinction between the groups on an individual basis. When assessing cytokine profiles, PPD specific CD4 T cells secreting both IFN-gamma and IL-2 predominated in treated TB, latent infection and BCG-vaccination, whilst in active TB the cytokine profile was shifted towards cells secreting IFN-gamma only (p<0.0001). Cytokine profiles of ESAT-6 or CFP-10 reactive CD4 T cells did not differ between the groups. Receiver operator characteristics (ROC) analysis revealed that frequencies of PPD specific IFN-gamma/IL-2 dual-positive T cells below 56% were an accurate marker for active TB (specificity 100%, sensitivity 70%) enabling effective discrimination from non-active states. In conclusion, a frequency lower than 56% IFN-gamma/IL-2 dual positive PPD-specific circulating CD4 T-cells is strongly indicative of active TB.	[Sester, Urban] Univ Saarland, Dept Internal Med 4, D-6650 Homburg, Germany; [Fousse, Mathias; Dirks, Jan; Sester, Martina] Univ Saarland, Inst Virol, Dept Transplant & Infect Immunol, D-6650 Homburg, Germany; [Mack, Ulrich] Univ Saarland, Dept Internal Med 5, D-6650 Homburg, Germany; [Prasse, Antje] Univ Med Ctr Freiburg, Dept Pneumol, Freiburg, Germany; [Singh, Mahavir] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Singh, Mahavir] Lionex Diagnost & Therapeut GmbH, Braunschweig, Germany; [Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, TB Res Unit, Dept Resp Med, Natl Heart & Lung Inst, London, England	Saarland University; Saarland University; Saarland University; University of Freiburg; Helmholtz Association; Helmholtz-Center for Infection Research; Lionex Diagnostics & Therapeutics GmbH; Imperial College London	Sester, U (corresponding author), Univ Saarland, Dept Internal Med 4, D-6650 Homburg, Germany.	martina.sester@uks.eu	Prasse, Antje/AAM-7521-2021; Sester, Martina/AAA-3383-2022; Prasse, Antje/AAY-6279-2020	Prasse, Antje/0000-0002-7336-7458; Lalvani, Ajit/0000-0002-2396-246X; Sester, Urban/0000-0003-4007-5595; Sester, Martina/0000-0001-5482-0002	Else Kroner Fresenius Stiftung; HOMFOR	Else Kroner Fresenius Stiftung; HOMFOR	Funding: Financial support was given in part by grants from the Else Kroner Fresenius Stiftung and from "HOMFOR" to M. S. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mahavir Singh is the owner and director of LIONEX.	Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Dinser R, 2008, RHEUMATOLOGY, V47, P212, DOI 10.1093/rheumatology/kem351; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Hinks TSC, 2009, INFECT IMMUN, V77, P5486, DOI 10.1128/IAI.01436-08; Jafari C, 2008, EUR RESPIR J, V31, P261, DOI 10.1183/09031936.00096707; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Sester M, 2004, KIDNEY INT, V65, P1826, DOI 10.1111/j.1523-1755.2004.00586.x; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Sester U, 2008, AM J TRANSPLANT, V8, P1486, DOI 10.1111/j.1600-6143.2008.02279.x; Sester U, 2009, EUR RESPIR J, V34, P702, DOI 10.1183/09031936.00013409; Sester U, 2006, NEPHROL DIAL TRANSPL, V21, P3258, DOI 10.1093/ndt/gfl416; Siawaya JFD, 2009, CYTOKINE, V47, P132, DOI 10.1016/j.cyto.2009.05.016; Strassburg A, 2008, EUR RESPIR J, V31, P1132, DOI 10.1183/09031936.00083707; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Thomas MM, 2008, INT J TUBERC LUNG D, V12, P651; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139	26	95	101	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17813	10.1371/journal.pone.0017813	http://dx.doi.org/10.1371/journal.pone.0017813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423578	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900035
J	Yin, RX; Li, YY; Liu, WY; Zhang, L; Wu, JZ				Yin, Rui-Xing; Li, Yi-Yang; Liu, Wan-Ying; Zhang, Lin; Wu, Jin-Zhen			Interactions of the Apolipoprotein A5 Gene Polymorphisms and Alcohol Consumption on Serum Lipid Levels	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POSTPRANDIAL LIPOPROTEIN METABOLISM; PLASMA TRIGLYCERIDE LEVELS; ALL-CAUSE MORTALITY; HEI-YI-ZHUANG; AV GENE; ARTERY-DISEASE; APOA5 GENE; CHOLESTEROL LEVELS; HDL CHOLESTEROL	Background: Little is known about the interactions of apolipoprotein (Apo) A5 gene polymorphisms and alcohol consumption on serum lipid profiles. The present study was undertaken to detect the interactions of ApoA5-1131T > C, c.553G > T and c.457G > A polymorphisms and alcohol consumption on serum lipid levels. Methodology/Principal Findings: A total of 516 nondrinkers and 514 drinkers were randomly selected from our previous stratified randomized cluster samples. Genotyping was performed by polymerase chain reaction and restriction fragment length polymorphism. The levels of serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), ApoA1 and ApoB were higher in drinkers than in nondrinkers (P < 0.05-0.001). The genotypic and allelic frequencies of three loci were not different between the two groups. The interactions between -1131T > C genotypes and alcohol consumption on ApoB levels (P < 0.05) and the ApoA1/ApoB ratio (P < 0.01), between c.553G > T genotypes and alcohol consumption on low-density lipoprotein cholesterol (LDL-C) levels (P < 0.05) and the ApoA1/ApoB ratio (P < 0.05), and between c.457G > A genotypes and alcohol consumption on TG levels (P < 0.001) were detected by factorial regression analysis after controlling for potential confounders. Four haplotypes (T-G-G, C-G-G, T-A-G and C-G-T) had frequencies ranging from 0.06 to 0.87. Three haplotypes (C-G-G, T-A-G, and C-G-T) were significantly associated with serum lipid parameters. The -1131T > C genotypes were correlated with TG, and c.553G > T and c.457G > A genotypes were associated with HDL-C levels in nondrinkers (P < 0.05 for all). For drinkers, the -1131T > C genotypes were correlated with TC, TG, LDL-C, ApoB levels and the ApoA1/ApoB ratio (P < 0.01 for all); c.553G > T genotypes were correlated with TC, TG, HDL-C and LDL-C levels (P < 0.05-0.01); and c.457G > A genotypes were associated with TG, LDL-C, ApoA1 and ApoB levels (P < 0.05-0.01). Conclusions: The differences in some serum lipid parameters between the drinkers and nondrinkers might partly result from different interactions of the ApoA5 gene polymorphisms and alcohol consumption.	[Yin, Rui-Xing; Li, Yi-Yang; Liu, Wan-Ying; Zhang, Lin; Wu, Jin-Zhen] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiol, Inst Cardiovasc Dis, Nanning, Guangxi, Peoples R China; [Li, Yi-Yang] Guangxi Natl Hosp, Dept Cardiol, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Yin, RX (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiol, Inst Cardiovasc Dis, Nanning, Guangxi, Peoples R China.	yinruixing@yahoo.com.cn			National Natural Science Foundation of China [30360038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30360038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Aouizerat BE, 2003, J LIPID RES, V44, P1167, DOI 10.1194/jlr.M200480-JLR200; Austin MA, 2004, BBA-MOL BASIS DIS, V1688, P1, DOI 10.1016/j.bbadis.2003.10.003; Baum L, 2003, CLIN GENET, V63, P377, DOI 10.1034/j.1399-0004.2003.00063.x; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; Chaaba Raja, 2005, Lipids Health Dis, V4, P1, DOI 10.1186/1476-511X-4-1; Chen ES, 2006, CLIN CHEM LAB MED, V44, P32, DOI 10.1515/CCLM.2006.007; Chien KL, 2008, CLIN CHIM ACTA, V390, P56, DOI 10.1016/j.cca.2007.12.014; Chien KL, 2008, CLIN CHIM ACTA, V388, P78, DOI 10.1016/j.cca.2007.10.006; CHOUDHURY SR, 1994, INT J EPIDEMIOL, V23, P940, DOI 10.1093/ije/23.5.940; Corella D, 2001, AM J CLIN NUTR, V73, P736; Dallinga-Thie GM, 2006, DIABETOLOGIA, V49, P1505, DOI 10.1007/s00125-006-0261-0; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Endo K, 2002, HUM GENET, V111, P570, DOI 10.1007/s00439-002-0825-0; Evans D, 2003, J MOL MED-JMM, V81, P645, DOI 10.1007/s00109-003-0465-4; Gaziano JM, 1999, AM J CARDIOL, V83, P52, DOI 10.1016/S0002-9149(98)00782-6; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Havasi V, 2006, J MOL NEUROSCI, V29, P177, DOI 10.1385/JMN:29:2:177; Horinek A, 2003, ATHEROSCLEROSIS, V167, P369, DOI 10.1016/S0021-9150(03)00022-4; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Huang MC, 2008, KAOHSIUNG J MED SCI, V24, P171, DOI 10.1016/S1607-551X(08)70114-1; Hubacek JA, 2004, PHYSIOL RES, V53, P225; Hubacek JA, 2007, CLIN CHEM LAB MED, V45, P316, DOI 10.1515/CCLM.2007.056; Hubacek JA, 2009, PHARMACOGENOMICS, V10, P945, DOI 10.2217/PGS.09.17; HUMPHRIES S, 1989, ATHEROSCLEROSIS, V75, P249, DOI 10.1016/0021-9150(89)90183-4; IRVING S, 1992, CIRCULATION, V85, P1083; Ishihara M, 2005, J LIPID RES, V46, P2015, DOI 10.1194/jlr.D500018-JLR200; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Kluger M, 2008, J INHERIT METAB DIS, V31, P281, DOI 10.1007/s10545-008-0863-4; Koppes LLJ, 2005, J STUD ALCOHOL, V66, P713, DOI 10.15288/jsa.2005.66.713; Lai CQ, 2004, J LIPID RES, V45, P2096, DOI 10.1194/jlr.M400192-JLR200; Lai CQ, 2003, J LIPID RES, V44, P2365, DOI 10.1194/jlr.M300251-JLR200; Lee KWJ, 2004, ATHEROSCLEROSIS, V176, P165, DOI 10.1016/j.atherosclerosis.2004.04.024; Li GP, 2004, CLIN GENET, V65, P470, DOI 10.1111/j.1399-0004.2004.00251.x; Liu HK, 2005, METABOLISM, V54, P568, DOI 10.1016/j.metabol.2004.11.009; Martin S, 2003, BBA-MOL BASIS DIS, V1637, P217, DOI 10.1016/S0925-4439(03)00033-4; Masana L, 2003, CLIN CHEM LAB MED, V41, P517, DOI 10.1515/CCLM.2003.078; Moreno R, 2006, ATHEROSCLEROSIS, V189, P163, DOI 10.1016/j.atherosclerosis.2005.11.029; Moreno-Luna R, 2007, J CLIN ENDOCR METAB, V92, P2280, DOI 10.1210/jc.2006-1802; Nabika T, 2002, ATHEROSCLEROSIS, V165, P201, DOI 10.1016/S0021-9150(02)00252-6; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; Parker DR, 1996, AM J PUBLIC HEALTH, V86, P1022, DOI 10.2105/AJPH.86.7.1022; Pennacchio LA, 2003, ARTERIOSCL THROM VAS, V23, P529, DOI 10.1161/01.ATV.0000054194.78240.45; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Puddey IB, 1999, NEUROEPIDEMIOLOGY, V18, P292, DOI 10.1159/000026224; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Ribalta J, 2002, CLIN CHEM, V48, P1597; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ruidavets J.-B., 2002, Journal of Epidemiology and Community Health, V56, P24, DOI 10.1136/jech.56.1.24; SAVOLAINEN MJ, 1995, CURR OPIN LIPIDOL, V6, P243, DOI 10.1097/00041433-199508000-00009; Seda O, 2003, PHYSIOL RES, V52, P141; Shanker J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-33; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Szalai C, 2004, ATHEROSCLEROSIS, V173, P109, DOI 10.1016/j.atherosclerosis.2003.12.003; Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; Tang YB, 2006, ATHEROSCLEROSIS, V185, P433, DOI 10.1016/j.atherosclerosis.2005.06.026; Theobald H, 2000, J STUD ALCOHOL, V61, P652, DOI 10.15288/jsa.2000.61.652; van der Vliet HN, 2002, BIOCHEM BIOPH RES CO, V295, P1156, DOI 10.1016/S0006-291X(02)00808-2; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; Volcik KA, 2008, ANN EPIDEMIOL, V18, P101, DOI 10.1016/j.annepidem.2007.07.103; Wannamethee SG, 1999, AM J PUBLIC HEALTH, V89, P685, DOI 10.2105/AJPH.89.5.685; Yin RX, 2006, HYPERTENS RES, V29, P423, DOI 10.1291/hypres.29.423; Yin RX, 2006, EUR J CARDIOV PREV R, V13, P977, DOI 10.1097/01.hjr.0000239476.79428.25; Yin RX, 2006, J INVEST MED, V54, P191, DOI 10.2310/6650.2006.05050; Yin RX, 2006, ARCH MED RES, V37, P787, DOI 10.1016/j.arcmed.2005.12.005; Yin RX, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-86; Yin RX, 2009, PUBLIC HEALTH NUTR, V12, P553, DOI 10.1017/S1368980008002437; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Zhou B., 2002, ZHONGHUA LIU XING BI, V1, P5; Zhou YJ, 2008, ALCOHOL, V42, P583, DOI 10.1016/j.alcohol.2008.08.004	74	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17954	10.1371/journal.pone.0017954	http://dx.doi.org/10.1371/journal.pone.0017954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423763	gold, Green Submitted, Green Published			2022-12-27	WOS:000288512400042
J	Kuppers, DA; Hwang, HC; Jackson, AL; Linsley, PS; Clurman, BE; Fero, ML				Kuppers, Daniel A.; Hwang, Harry C.; Jackson, Aimee L.; Linsley, Peter S.; Clurman, Bruce E.; Fero, Matthew L.			Effect of Xpcl1 Activation and p27Kip1 Loss on Gene Expression in Murine Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMAS; VIRUS-INDUCED LYMPHOMAS; MICROARRAY EXPERIMENTS; TUMOR SUPPRESSION; NONCODING RNA; T-CELL; MICRORNAS; P27(KIP1); LEUKEMIA; CLUSTER	Mice lacking the p27(Kip1) Cdk inhibitor (Cdkn1b) exhibit increased susceptibility to lymphomas from the Maloney murine leukemia virus (M-MuLV), and exhibit a high frequency of viral integrations at Xpcl1 (Kis2), a locus on the X-chromosome. Xpcl1 encodes miR-106a similar to 363, a cluster of microRNAs that are expressed in response to adjacent retroviral integrations. We report the first large-scale profile of microRNA expression in MuLV-induced lymphomas, in combination with microarray gene expression analysis. The source material was T-cell lymphomas induced by M-MuLV in p27(Kip1) knockout mice and normal thymus. Surprisingly, the overall levels of miRNA expression were equivalent in lymphomas and normal thymus. Nonetheless, the expression of specific microRNAs was altered in tumors. The miR-106a similar to 363 miRNA were over-expressed in lymphomas, particularly those with viral integrations at the Xpcl1 locus. In contrast, p27(Kip1) deletion itself was associated with a different pattern of microRNA expression. Gene expression was dramatically altered in lymphomas, yet paralleled data from T-cell lymphomas induced by other mechanisms. Genes with altered expression in association with the p27(Kip1) null genotype were of similar functional classes to those associated with Xpcl1 integration, but with the opposite pattern of expression. Thus, the effect of p27(Kip1) deletion may be to oppose an anti-oncogenic effect of Xpcl1 rather than enhancing its oncogenic functions. A subset of miR-106a similar to 363 target genes was consistently reduced in lymphomas with Xpcl1 integrations, particularly genes with cell cycle and immune functions. We identify four predicted target genes of miR-106a similar to 363 miRNA, including N-Myc (Mycn), and the TGF-beta receptor (Tgfbr2) using 3'UTR reporter assays. Still, bioinformatic miRNA target predictions were poor predictors of altered gene expression in lymphomas with Xpcl1 integration. Confirmation of miR-106a similar to 363 gene targeting relevant to the tumor phenotype requires in vivo validation, because only a subset of predicted targets are consistently reduced in tumors that overexpress miR-106a similar to 363.	[Kuppers, Daniel A.; Hwang, Harry C.; Clurman, Bruce E.; Fero, Matthew L.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Jackson, Aimee L.; Linsley, Peter S.] Rosetta Inpharmat, Seattle, WA USA	Fred Hutchinson Cancer Center; Merck & Company	Kuppers, DA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	mfero@fhcrc.org	Clurman, Bruce/AAV-3854-2021	Jackson, Aimee/0000-0002-3786-7391; Fero, Matthew/0000-0002-9967-4659	National Cancer Institute [R01CA100053, R01CA084069, K08HL073670]; NIH; NATIONAL CANCER INSTITUTE [R01CA084069, R01CA100053, R01CA102742] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL073670] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Cancer Institute R01CA100053 (MLF), R01CA084069 (BEC), K08HL073670 (HCH) http://www.cancer.gov/, Rosetta Inpharmatics, Inc. (PSL, ALJ) provided materials and technical support for microarray processing and miRNA QPCR. The funders had no role in data analysis, the decision to publish, or preparation of the manuscript.; Salary support in the form of research grants from the NIH and NCI was provided to M. Fero, H. Hwang, B. Clurman. Both Regulus Inc. and Rosetta Inpharmatics, Inc (a subsidiary of Merck Inc.) have approved or pending patents involving miRNA and microarray technology. The Fred Hutchinson Cancer Research Center holds patents on p27-deficient mouse models. All individuals received salary support from their host institutions. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Garrett-Engele CM, 2007, PLOS GENET, V3, P2415, DOI 10.1371/journal.pgen.0030219; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landais S, 2005, J VIROL, V79, P11443, DOI 10.1128/JVI.79.17.11443-11456.2005; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lum AM, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-5; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Megason SG, 2002, DEVELOPMENT, V129, P2087; MELLORS RC, 1956, ANN NY ACAD SCI, V63, P1177, DOI 10.1111/j.1749-6632.1956.tb32129.x; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Muth D, 2010, CANCER RES, V70, P3791, DOI 10.1158/0008-5472.CAN-09-1245; Petrocelli T, 2001, BREAST CANCER RES, V3, P356, DOI 10.1186/bcr322; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; SHIVDASANI RA, 2006, BLOOD; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; VASMEL WLE, 1989, INT J CANCER, V43, P1112, DOI 10.1002/ijc.2910430626; von BERTALANFFY LUDWIN, 1957, CALIFORNIA MED, V87, P248; Wang JB, 2002, BIOINFORMATICS, V18, P1139, DOI 10.1093/bioinformatics/18.8.1139; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WU J, 2009, METHOD MOL BIOL, P205	44	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e14758	10.1371/journal.pone.0014758	http://dx.doi.org/10.1371/journal.pone.0014758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412408	Green Published, Green Submitted, gold			2022-12-27	WOS:000288247800003
J	Lee, JY; Zhou, ZP; Taub, PJ; Ramcharan, M; Li, YH; Akinbiyi, T; Maharam, ER; Leong, DJ; Laudier, DM; Ruike, T; Torina, PJ; Zaidi, M; Majeska, RJ; Schaffler, MB; Flatow, EL; Sun, HB				Lee, Jonathan Y.; Zhou, Zuping; Taub, Peter J.; Ramcharan, Melissa; Li, Yonghui; Akinbiyi, Takintope; Maharam, Edward R.; Leong, Daniel J.; Laudier, Damien M.; Ruike, Takuya; Torina, Phillip J.; Zaidi, Mone; Majeska, Robert J.; Schaffler, Mitchell B.; Flatow, Evan L.; Sun, Hui B.			BMP-12 Treatment of Adult Mesenchymal Stem Cells In Vitro Augments Tendon-Like Tissue Formation and Defect Repair In Vivo	PLOS ONE			English	Article							GENE-TRANSFER; ROOF PLATE; DIFFERENTIATION; EXPRESSION; FAMILY; PROLIFERATION; OSTEOBLASTS; TENOMODULIN; TENOCYTES; GROWTH	We characterized the differentiation of rat bone marrow-derived mesenchymal stem cells (BM-MSCs) into tenocyte-like cells in response to bone morphogenetic protein-12 (BMP-12). BM-MSCs were prepared from Sprague-Dawley rats and cultured as monolayers. Recombinant BMP-12 treatment (10 ng/ml) of BM-MSCs for 12 hours in vitro markedly increased expression of the tenocyte lineage markers scleraxis (Scx) and tenomodulin (Tnmd) over 14 days. Treatment with BMP-12 for a further 12-hour period had no additional effect. Colony formation assays revealed that similar to 80% of treated cells and their progeny were Scx-and Tnmd-positive. BM-MSCs seeded in collagen scaffolds and similarly treated with a single dose of BMP-12 also expressed high levels of Scx and Tnmd, as well as type I collagen and tenascin-c. Furthermore, when the treated BM-MSC-seeded scaffolds were implanted into surgically created tendon defects in vivo, robust formation of tendon-like tissue was observed after 21 days as evidenced by increased cell number, elongation and alignment along the tensile axis, greater matrix deposition and the elevated expression of tendon markers. These results indicate that brief stimulation with BMP-12 in vitro is sufficient to induce BM-MSC differentiation into tenocytes, and that this phenotype is sustained in vivo. This strategy of pretreating BM-MSCs with BMP-12 prior to in vivo transplantation may be useful in MSC-based tendon reconstruction or tissue engineering.	[Lee, Jonathan Y.; Zhou, Zuping; Ramcharan, Melissa; Li, Yonghui; Akinbiyi, Takintope; Maharam, Edward R.; Leong, Daniel J.; Laudier, Damien M.; Ruike, Takuya; Majeska, Robert J.; Schaffler, Mitchell B.; Flatow, Evan L.; Sun, Hui B.] Mt Sinai Sch Med, Leni & Peter W May Dept Orthopaed, New York, NY USA; [Lee, Jonathan Y.; Taub, Peter J.; Torina, Phillip J.] Mt Sinai Sch Med, Div Plast Surg, New York, NY USA; [Ramcharan, Melissa; Leong, Daniel J.; Majeska, Robert J.; Schaffler, Mitchell B.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [Zaidi, Mone] Mt Sinai Sch Med, Mt Sinai Bone Program, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; City College of New York (CUNY); Icahn School of Medicine at Mount Sinai	Lee, JY (corresponding author), Mt Sinai Sch Med, Leni & Peter W May Dept Orthopaed, New York, NY USA.	Herb.Sun@mssm.edu		Akinbiyi, Takintope/0000-0002-7208-9054	National Institutes of Health [AR47628, AR52743]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052743, R03AR047628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the National Institutes of Health to Hui B. Sun (AR47628 and AR52743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P1425, DOI 10.2106/00004623-200308000-00002; Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41; Inada M, 1996, BIOCHEM BIOPH RES CO, V222, P317, DOI 10.1006/bbrc.1996.0742; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Lee EH, 2006, J BONE JOINT SURG BR, V88B, P841, DOI 10.1302/0301-620X.88B7.17305; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Lo LC, 2005, P NATL ACAD SCI USA, V102, P7192, DOI 10.1073/pnas.0502581102; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Lou JR, 2001, J ORTHOPAED RES, V19, P1199, DOI 10.1016/S0736-0266(01)00042-0; Noel D, 2004, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74; Pennisi E, 2002, SCIENCE, V295, P1011, DOI 10.1126/science.295.5557.1011; Pereira RC, 2000, J CELL PHYSIOL, V182, P239, DOI 10.1002/(SICI)1097-4652(200002)182:2<239::AID-JCP13>3.0.CO;2-W; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Settle S, 2001, DEV BIOL, V234, P138, DOI 10.1006/dbio.2001.0244; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; Wang QW, 2005, J BIOSCI BIOENG, V100, P418, DOI 10.1263/jbb.100.418; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403; Yu Y, 2007, ARTHROSCOPY, V23, P205, DOI 10.1016/j.arthro.2006.08.023	31	28	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17531	10.1371/journal.pone.0017531	http://dx.doi.org/10.1371/journal.pone.0017531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412429	gold, Green Published			2022-12-27	WOS:000288247800011
J	Wang, XV; Verhaak, RGW; Purdom, E; Spellman, PT; Speed, TP				Wang, Xin Victoria; Verhaak, Roel G. W.; Purdom, Elizabeth; Spellman, Paul T.; Speed, Terence P.			Unifying Gene Expression Measures from Multiple Platforms Using Factor Analysis	PLOS ONE			English	Article							PROBE LEVEL DATA; MICROARRAY DATA; REPRODUCIBILITY; DISCOVERY; GENOME	In the Cancer Genome Atlas (TCGA) project, gene expression of the same set of samples is measured multiple times on different microarray platforms. There are two main advantages to combining these measurements. First, we have the opportunity to obtain a more precise and accurate estimate of expression levels than using the individual platforms alone. Second, the combined measure simplifies downstream analysis by eliminating the need to work with three sets of expression measures and to consolidate results from the three platforms. We propose to use factor analysis (FA) to obtain a unified gene expression measure (UE) from multiple platforms. The UE is a weighted average of the three platforms, and is shown to perform well in terms of accuracy and precision. In addition, the FA model produces parameter estimates that allow the assessment of the model fit. The R code is provided in File S2. Gene-level FA measurements for the TCGA data sets are available from http://tcga-data.nci.nih.gov/docs/publications/unified_expression/.	[Wang, Xin Victoria] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Wang, Xin Victoria] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Verhaak, Roel G. W.] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA USA; [Purdom, Elizabeth] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Spellman, Paul T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Speed, Terence P.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Wang, XV (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	vwang@jimmy.harvard.edu	Verhaak, Roel/ABE-7058-2020		National Institutes of Health [U24 CA126551]; Dutch Cancer Society KWF; NATIONAL CANCER INSTITUTE [U24CA126551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society KWF(KWF Kankerbestrijding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [U24 CA126551 to XVW, EP, PTS, and TPS] and Dutch Cancer Society KWF [fellowship to RGWV]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomew DKM, 1999, LATENT VARIABLE MODE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; EFRON B, 1997, INTRO BOOTSTRAP; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; *ILL, 2008, DIG GEN EXPR TAG PRO; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; *NAT CANC I, 2009, TCGA DAT PRIM; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-419; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Scharpf RB, 2009, J AM STAT ASSOC, V104, P1295, DOI 10.1198/jasa.2009.ap07611; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smyth G., 2003, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Verhaak RGW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-105; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265	24	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17691	10.1371/journal.pone.0017691	http://dx.doi.org/10.1371/journal.pone.0017691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21436879	Green Submitted, Green Published, gold			2022-12-27	WOS:000288247800025
J	Whitney, HM; Poetes, R; Steiner, U; Chittka, L; Glover, BJ				Whitney, Heather M.; Poetes, Rosa; Steiner, Ullrich; Chittka, Lars; Glover, Beverley J.			Determining the Contribution of Epidermal Cell Shape to Petal Wettability Using Isogenic Antirrhinum Lines	PLOS ONE			English	Article							FORAGING BUMBLEBEES; PLANT-SURFACES; FLOWER COLOR; SCENT MARK; WATER; MAJUS; INSPIRATION; POLLINATION; REPELLENT; WETNESS	The petal epidermis acts not only as a barrier to the outside world but also as a point of interaction between the flower and potential pollinators. The presence of conical petal epidermal cells has previously been shown to influence the attractiveness of the flower to pollinating insects. Using Antirrhinum isogenic lines differing only in the presence of a single epidermal structure, conical cells, we were able to investigate how the structure of the epidermis influences petal wettability by measuring the surface contact angle of water drops. Conical cells have a significant impact on how water is retained on the flower surface, which may have indirect consequences for pollinator behaviour. We discuss how the petal epidermis is a highly multifunctional one and how a battery of methods, including the use of isogenic lines, is required to untangle the impacts of specific epidermal properties in an ecological context.	[Whitney, Heather M.; Glover, Beverley J.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Whitney, Heather M.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Poetes, Rosa; Steiner, Ullrich] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Chittka, Lars] Univ London, Sch Biol & Chem Sci, London, England	University of Cambridge; University of Bristol; University of Cambridge; University of London	Whitney, HM (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	heather.whitney@bristol.ac.uk	Chittka, Lars/C-3110-2012; Steiner, Ullrich/K-4777-2013	Chittka, Lars/0000-0001-8153-1732; Steiner, Ullrich/0000-0001-5936-339X; Whitney, Heather/0000-0001-6450-8266	NERC [NE/C000552/1]; Cambridge University Research Exchange; Natural Environment Research Council [NE/C000552/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Cambridge University Research Exchange(University of Cambridge); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	HMW was supported by a NERC grant NE/C000552/1 (to BJG and LC) and by the Cambridge University Research Exchange. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal B, 2010, OECOLOGIA, V162, P1, DOI 10.1007/s00442-009-1437-3; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Brewer CA, 1997, PLANT CELL ENVIRON, V20, P1, DOI 10.1046/j.1365-3040.1997.d01-15.x; BREWER CA, 1991, PLANT CELL ENVIRON, V14, P955, DOI 10.1111/j.1365-3040.1991.tb00965.x; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Comba L, 2000, PLANT CELL ENVIRON, V23, P639, DOI 10.1046/j.1365-3040.2000.00580.x; Dyer AG, 2007, ARTHROPOD-PLANT INTE, V1, P45, DOI 10.1007/s11829-007-9002-7; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; EVANS KJ, 1992, PHYTOPATHOLOGY, V82, P890, DOI 10.1094/Phyto-82-890; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Glover BJ, 1998, HEREDITY, V80, P778, DOI 10.1046/j.1365-2540.1998.00345.x; Goulson D, 2000, J CHEM ECOL, V26, P2897, DOI 10.1023/A:1026406330348; Holder CD, 2007, BIOTROPICA, V39, P767, DOI 10.1111/j.1744-7429.2007.00303.x; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Koch K, 2008, SOFT MATTER, V4, P1943, DOI 10.1039/b804854a; Koch K, 2009, PHILOS T R SOC A, V367, P1487, DOI 10.1098/rsta.2009.0022; Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Saleh N, 2006, ANIM BEHAV, V71, P847, DOI 10.1016/j.anbehav.2005.06.014; SCHMITT U, 1990, OECOLOGIA, V82, P137, DOI 10.1007/BF00318545; van der Wal P, 2007, SOFT MATTER, V3, P426, DOI 10.1039/b613947g; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Whitney Heather M., 2009, Communicative & Integrative Biology, V2, P505; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051	25	25	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17576	10.1371/journal.pone.0017576	http://dx.doi.org/10.1371/journal.pone.0017576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423738	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100016
J	Hartfield, EM; Rinaldi, F; Glover, CP; Wong, LF; Caldwell, MA; Uney, JB				Hartfield, Elizabeth M.; Rinaldi, Federica; Glover, Colin P.; Wong, Liang-Fong; Caldwell, Maeve A.; Uney, James B.			Connexin 36 Expression Regulates Neuronal Differentiation from Neural Progenitor Cells	PLOS ONE			English	Article							GAP-JUNCTIONS; CX36; PROLIFERATION; COMMUNICATION; SPECIFICATION; HEMICHANNELS; MIGRATION; MEMBRANE; SURVIVAL; MOBILITY	Background: Gap junction communication has been shown in glial and neuronal cells and it is thought they mediate inter- and intra-cellular communication. Connexin 36 (Cx36) is expressed extensively in the developing brain, with levels peaking at P14 after which its levels fall and its expression becomes entirely neuronal. These and other data have led to the hypothesis that Cx36 may direct neuronal coupling and neurogenesis during development. Methodology/Principal Findings: To investigate Cx36 function we used a neurosphere model of neuronal cell development and developed lentiviral Cx36 knockdown and overexpression strategies. Cx36 knockdown was confirmed by western blotting, immunocytochemistry and functionally by fluorescence recovery after photobleaching (FRAP). We found that knockdown of Cx36 in neurosphere neuronal precursors significantly reduced neuronal coupling and the number of differentiated neurons. Correspondingly, the lentiviral mediated overexpression of Cx36 significantly increased the number of neurons derived from the transduced neurospheres. The number of oligodendrocytes was also significantly increased following transduction with Cx36 indicating they may support neuronal differentiation. Conclusions/Significance: Our data suggests that astrocytic and neuronal differentiation during development are governed by mechanisms that include the differential expression of Cx36.	[Hartfield, Elizabeth M.; Rinaldi, Federica; Wong, Liang-Fong; Caldwell, Maeve A.; Uney, James B.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Labs Integrated Neurosci & Endocrinol, Bristol, Avon, England; [Glover, Colin P.] GlaxoSmithKline, Neurosci CEDD, Harlow, Essex, England	University of Bristol; GlaxoSmithKline	Hartfield, EM (corresponding author), Univ Oxford, Oxford Parkinsons Dis Ctr, Dept Physiol Anat & Genet, Oxford, England.	maeve.caldwell@bristol.ac.uk; james.uney@bristol.ac.uk	Caldwell, Maeve/HHN-1986-2022	Caldwell, Maeve/0000-0001-7442-711X	MRC; GSK; Wellcome Trust; BBSRC; Neurosciences CEDD GlaxoSmithKline; GlaxoSmithKline; Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GSK(GlaxoSmithKline); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Neurosciences CEDD GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The MRC and GSK provided the studentship that funded EH. Grants from the Wellcome Trust and BBSRC to JBU also helped support this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for the research was also provided by Neurosciences CEDD GlaxoSmithKline to Colin Glover who is an employee of Neurosciences CEDD GlaxoSmithKline. This funder therefore had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; GlaxoSmithKline provided some funding toward the studentship. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cheng AW, 2004, DEV BIOL, V272, P203, DOI 10.1016/j.ydbio.2004.04.031; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Fraga C, 2002, HISTOCHEM CELL BIOL, V117, P547, DOI 10.1007/s00418-002-0413-3; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gulisano M, 2000, NEUROREPORT, V11, P3823, DOI 10.1097/00001756-200011270-00045; Harper SQ, 2005, METH MOL B, V309, P219; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Laux-Fenton WT, 2003, CORNEA, V22, P457, DOI 10.1097/00003226-200307000-00012; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Parekkadan B, 2008, NEUROSCI LETT, V438, P190, DOI 10.1016/j.neulet.2008.03.094; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Prime G, 2000, DEV BRAIN RES, V119, P111, DOI 10.1016/S0165-3806(99)00132-7; Rozental R, 1998, J NEUROSCI, V18, P1753; Santiago MF, 2010, J BIOL CHEM, V285, P11836, DOI 10.1074/jbc.M109.058750; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; TODOROVA MG, 2004, J CELL PHYSL, V214, P354; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Windoffer R, 2000, CELL TISSUE RES, V299, P347, DOI 10.1007/s004419900162; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	37	37	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e14746	10.1371/journal.pone.0014746	http://dx.doi.org/10.1371/journal.pone.0014746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408068	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900002
J	Sankhala, RS; Damai, RS; Swamy, MJ				Sankhala, Rajeshwer S.; Damai, Rajani S.; Swamy, Musti J.			Correlation of Membrane Binding and Hydrophobicity to the Chaperone-Like Activity of PDC-109, the Major Protein of Bovine Seminal Plasma	PLOS ONE			English	Article							ALPHA-CRYSTALLIN; MODEL MEMBRANES; PHOSPHORYLCHOLINE; FLUORESCENCE; SPECIFICITY; BSP-A1/-A2; MECHANISM; LIGANDS; EFFLUX; DOMAIN	The major protein of bovine seminal plasma, PDC-109 binds to choline phospholipids present on the sperm plasma membrane upon ejaculation and plays a crucial role in the subsequent events leading to fertilization. PDC-109 also shares significant similarities with small heat shock proteins and exhibits chaperone-like activity (CLA). Although the polydisperse nature of this protein has been shown to be important for its CLA, knowledge of other factors responsible for such an activity is scarce. Since surface exposure of hydrophobic residues is known to be an important factor which modulates the CLA of chaperone proteins, in the present study we have probed the surface hydrophobicity of PDC-109 using bisANS and ANS. Further, effect of phospholipids on the structure and chaperone-like activity of PDC-109 was studied. Presence of DMPC was found to increase the CLA of PDC-109 significantly, which could be due to the considerable exposure of hydrophobic regions on the lipid-protein recombinants, which can interact productively with the nonnative structures of target proteins, resulting in their protection. However, inclusion of DMPG instead of DMPC did not significantly alter the CLA of PDC-109, which could be due to the lower specificity of PDC-109 for DMPG as compared to DMPC. Cholesterol incorporation into DMPC membranes led to a decrease in the CLA of PDC-109-lipid recombinants, which could be attributed to reduced accessibility of hydrophobic surfaces to the substrate protein(s). These results underscore the relevance of phospholipid binding and hydrophobicity to the chaperone-like activity of PDC-109.	[Sankhala, Rajeshwer S.; Damai, Rajani S.; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Sankhala, RS (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	mjssc@uohyd.ernet.in	Swamy, Musti/B-9418-2009	Swamy, Musti/0000-0002-3108-3633	Department of Science and Technology (India) [SR/SO/BB/0067/2007]	Department of Science and Technology (India)(Department of Science & Technology (India))	This work was supported by research grant No. SR/SO/BB/0067/2007 from the Department of Science and Technology (India) to MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan V, 2008, BBA-PROTEINS PROTEOM, V1784, P891, DOI 10.1016/j.bbapap.2008.03.002; Anbazhagan V, 2005, FEBS LETT, V579, P2933, DOI 10.1016/j.febslet.2005.04.046; ANBAZHAGAN V, 2010, THERMODYNAMICS UNPUB; BAKER ME, 1985, BIOCHEM BIOPH RES CO, V130, P1010, DOI 10.1016/0006-291X(85)91715-2; Bhattacharyya M, 2004, J BIOL CHEM, V279, P55080, DOI 10.1074/jbc.M406418200; Calvete JJ, 1996, PROTEIN EXPRES PURIF, V8, P48, DOI 10.1006/prep.1996.0073; CHANDONNET L, 1990, MOL REPROD DEV, V26, P313, DOI 10.1002/mrd.1080260404; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Damai RS, 2010, IUBMB LIFE, V62, P841, DOI 10.1002/iub.394; Damai RS, 2009, BBA-PROTEINS PROTEOM, V1794, P1725, DOI 10.1016/j.bbapap.2009.08.010; DAS KP, 1995, BIOCHEM J, V311, P367, DOI 10.1042/bj3110367; Datta SA, 1999, J BIOL CHEM, V274, P34773, DOI 10.1074/jbc.274.49.34773; DESNOYERS L, 1992, J BIOL CHEM, V267, P10149; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; ESCH FS, 1983, BIOCHEM BIOPH RES CO, V113, P861, DOI 10.1016/0006-291X(83)91078-1; Gasset M, 1997, EUR J BIOCHEM, V250, P735, DOI 10.1111/j.1432-1033.1997.00735.x; Gasset M, 2000, ARCH BIOCHEM BIOPHYS, V374, P241, DOI 10.1006/abbi.1999.1593; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Greube A, 2001, BIOCHEMISTRY-US, V40, P8326, DOI 10.1021/bi010552+; Guha S, 1998, J BIOL CHEM, V273, P30077, DOI 10.1074/jbc.273.46.30077; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hawe A, 2011, J PHARM SCI-US, V100, P1294, DOI 10.1002/jps.22368; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2004, EXP EYE RES, V79, P817, DOI 10.1016/j.exer.2004.05.007; Kavitha M, 2009, J PHOTOCH PHOTOBIO B, V94, P59, DOI 10.1016/j.jphotobiol.2008.10.002; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kumarasamy A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003175; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Lassiseraye D, 2008, BBA-BIOMEMBRANES, V1778, P502, DOI 10.1016/j.bbamem.2007.10.025; LIANG JN, 1991, EXP EYE RES, V53, P61, DOI 10.1016/0014-4835(91)90145-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mancek-Keber M, 2006, FASEB J, V20, P1836, DOI 10.1096/fj.06-5862com; MANJUNATH P, 1987, BIOSCIENCE REP, V7, P231, DOI 10.1007/BF01124794; MANJUNATH P, 1987, BIOCHEM J, V241, P685, DOI 10.1042/bj2410685; Manjunath P, 2002, BIOL REPROD, V67, P1250, DOI 10.1095/biolreprod67.4.1250; Moreau R, 1998, BIOCHEM BIOPH RES CO, V246, P148, DOI 10.1006/bbrc.1998.8513; Qu J, 2009, BIOCHEMISTRY-US, V48, P4926, DOI 10.1021/bi9004039; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Ramakrishnan M, 2001, BIOPHYS J, V81, P2215, DOI 10.1016/S0006-3495(01)75869-9; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; ROBERTS DD, 1982, J BIOL CHEM, V257, P1274; Sankhala RS, 2010, BIOCHEMISTRY-US, V49, P3908, DOI 10.1021/bi100051d; Scolari S, 2010, BIOCHEMISTRY-US, V49, P9027, DOI 10.1021/bi101257c; SEIDAH NG, 1987, BIOCHEM J, V243, P195, DOI 10.1042/bj2430195; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Shivaji S., 1990, PROTEINS SEMINAL PLA, P1; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Swamy MJ, 2004, CURR SCI INDIA, V87, P203; Tannert A, 2007, EUR BIOPHYS J BIOPHY, V36, P461, DOI 10.1007/s00249-006-0105-3; Therien I, 1998, BIOL REPROD, V59, P768, DOI 10.1095/biolreprod59.4.768; Thomas CJ, 2003, BIOPHYS J, V84, P3037, DOI 10.1016/S0006-3495(03)70029-0; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Yanagimachi R., 1994, P189	55	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17330	10.1371/journal.pone.0017330	http://dx.doi.org/10.1371/journal.pone.0017330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408153	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000021
J	van Eijk, R; Licht, J; Schrumpf, M; Yazdi, MT; Ruano, D; Forte, GI; Nederlof, PM; Veselic, M; Rabe, KF; Annema, JT; Smit, V; Morreau, H; van Wezel, T				van Eijk, Ronald; Licht, Jappe; Schrumpf, Melanie; Yazdi, Mehrdad Talebian; Ruano, Dina; Forte, Giusi I.; Nederlof, Petra M.; Veselic, Maud; Rabe, Klaus F.; Annema, Jouke T.; Smit, Vincent; Morreau, Hans; van Wezel, Tom			Rapid KRAS, EGFR, BRAF and PIK3CA Mutation Analysis of Fine Needle Aspirates from Non-Small-Cell Lung Cancer Using Allele-Specific qPCR	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATION; ENDOSCOPIC ULTRASOUND; PCR; ADENOCARCINOMA; AMPLIFICATION; GUIDELINES; DIAGNOSIS; THERAPY; NSCLC	Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) and Trans-esophageal Ultrasound Scanning with Fine Needle Aspiration (EUS-FNA) are important, novel techniques for the diagnosis and staging of non-small cell lung cancer (NSCLC) that have been incorporated into lung cancer staging guidelines. To guide and optimize treatment decisions, especially for NSCLC patients in stage III and IV, EGFR and KRAS mutation status is often required. The concordance rate of the mutation analysis between these cytological aspirates and histological samples obtained by surgical staging is unknown. Therefore, we studied the extent to which allele-specific quantitative real-time PCR with hydrolysis probes could be reliably performed on EBUS and EUS fine needle aspirates by comparing the results with histological material from the same patient. We analyzed a series of 43 NSCLC patients for whom cytological and histological material was available. We demonstrated that these standard molecular techniques can be accurately applied on fine needle cytological aspirates from NSCLC patients. Importantly, we show that all mutations detected in the histological material of primary tumor were also identified in the cytological samples. We conclude that molecular profiling can be reliably performed on fine needle cytology aspirates from NSCLC patients.	[van Eijk, Ronald; Licht, Jappe; Schrumpf, Melanie; Ruano, Dina; Forte, Giusi I.; Veselic, Maud; Smit, Vincent; Morreau, Hans; van Wezel, Tom] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Yazdi, Mehrdad Talebian; Rabe, Klaus F.; Annema, Jouke T.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Nederlof, Petra M.] Netherlands Canc Inst NKI AVL, Dept Pathol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	van Eijk, R (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands.	t.van_wezel@lumc.nl	Smit, Vincent/AAD-1811-2022; van Wezel, Tom/Z-3092-2019; van Wezel, Tom/AAL-5626-2021; Rabe, Klaus F./AAW-6296-2021; van Wezel, Tom/A-9599-2008	Smit, Vincent/0000-0003-3730-5652; van Wezel, Tom/0000-0001-5773-7730; Rabe, Klaus F./0000-0002-7020-1401; van Wezel, Tom/0000-0001-5773-7730; Forte, Giusi Irma/0000-0003-0161-9828; van Eijk, Ronald/0000-0001-7955-6295	Leiden University Medical Center	Leiden University Medical Center	This work was funded by the Leiden University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annema JT, 2005, JAMA-J AM MED ASSOC, V294, P931, DOI 10.1001/jama.294.8.931; Annema JT, 2005, J CLIN ONCOL, V23, P8357, DOI 10.1200/JCO.2005.01.1965; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; BOLDRINI L, 2007, J THORACIC ONCOLOGY, V2; Brose MS, 2002, CANCER RES, V62, P6997; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Horiike A, 2007, CHEST, V131, P1628, DOI 10.1378/chest.06-1673; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Jang Tae Won, 2009, Korean Journal of Internal Medicine, V24, P48, DOI [10.3904/kjim.2009.24.1.48, 10.3904/kjim.2009.24.1.43]; Kalikaki A, 2008, BRIT J CANCER, V99, P923, DOI 10.1038/sj.bjc.6604629; Kotoula V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007746; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Lim EH, 2009, J THORAC ONCOL, V4, P12, DOI 10.1097/JTO.0b013e3181913e28; Micames CG, 2007, CHEST, V131, P539, DOI 10.1378/chest.06-1437; Molina JR, 2006, CHEST, V130, P1211, DOI 10.1378/chest.130.4.1211; MOLINAVILA MA, 2008, J THORACIC ONCOLOGY, V3; Monaco SE, 2010, HUM PATHOL, V41, P94, DOI 10.1016/j.humpath.2009.06.019; MOTOI N, 2008, AM J SURG PATHOLOGY, V32; Nakajima T, 2007, CHEST, V132, P597, DOI 10.1378/chest.07-0095; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rossi G, 2009, INT J SURG PATHOL, V17, P206, DOI 10.1177/1066896909336178; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Sasaki H, 2007, ONCOL REP, V18, P623; Tournoy KG, 2009, LUNG CANCER, V63, P45, DOI 10.1016/j.lungcan.2008.04.004; van Eijk R, 2010, J MOL DIAGN, V12, P27, DOI 10.2353/jmoldx.2010.090028; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zou ZQ, 2009, INT J MOL MED, V24, P97, DOI 10.3892/ijmm_00000212	36	137	138	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17791	10.1371/journal.pone.0017791	http://dx.doi.org/10.1371/journal.pone.0017791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408138	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170000060
J	Lee, SH; Ooi, SK; Mahadi, NM; Tan, MW; Nathan, S				Lee, Song-Hua; Ooi, Soon-Keat; Mahadi, Nor Muhammad; Tan, Man-Wah; Nathan, Sheila			Complete Killing of Caenorhabditis elegans by Burkholderia pseudomallei Is Dependent on Prolonged Direct Association with the Viable Pathogen	PLOS ONE			English	Article							MODEL HOST; MELIOIDOSIS; VIRULENCE; INFECTION; DIVERSITY; DISEASE	Background: Burkholderia pseudomallei is the causative agent of melioidosis, a disease of significant morbidity and mortality in both human and animals in endemic areas. Much remains to be known about the contributions of genotypic variations within the bacteria and the host, and environmental factors that lead to the manifestation of the clinical symptoms of melioidosis. Methodology/Principal Findings: In this study, we showed that different isolates of B. pseudomallei have divergent ability to kill the soil nematode Caenorhabditis elegans. The rate of nematode killing was also dependent on growth media: B. pseudomallei grown on peptone-glucose media killed C. elegans more rapidly than bacteria grown on the nematode growth media. Filter and bacteria cell-free culture filtrate assays demonstrated that the extent of killing observed is significantly less than that observed in the direct killing assay. Additionally, we showed that B. pseudomallei does not persistently accumulate within the C. elegans gut as brief exposure to B. pseudomallei is not sufficient for C. elegans infection. Conclusions/Significance: A combination of genetic and environmental factors affects virulence. In addition, we have also demonstrated that a Burkholderia-specific mechanism mediating the pathogenic effect in C. elegans requires proliferating B. pseudomallei to continuously produce toxins to mediate complete killing.	[Lee, Song-Hua; Ooi, Soon-Keat; Nathan, Sheila] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Ukm Bangi, Selangor, Malaysia; [Mahadi, Nor Muhammad; Nathan, Sheila] Malaysia Genome Inst, UKM MTDC Technol Ctr, Ukm Bangi, Selangor, Malaysia; [Tan, Man-Wah] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Tan, Man-Wah] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Stanford University; Stanford University	Lee, SH (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Ukm Bangi, Selangor, Malaysia.	sheila@ukm.my	Nathan, Sheila/C-1182-2011	Nathan, Sheila/0000-0002-2132-2346	Ministry of Science, Technology & Innovation, Malaysia	Ministry of Science, Technology & Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The project was funded by the Ministry of Science, Technology & Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Ashcroft N, 2002, GENESIS, V33, P1, DOI 10.1002/gene.10083; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Balaji V, 2004, INDIAN J MED RES, V119, P101; Bleich A, 2005, PATHOBIOLOGY, V72, P293, DOI 10.1159/000091327; BRENNER S, 1974, GENETICS, V77, P71; Chaowagul W, 2000, ACTA TROP, V74, P133, DOI 10.1016/S0001-706X(99)00062-5; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Gan YH, 2002, MOL MICROBIOL, V44, P1185, DOI 10.1046/j.1365-2958.2002.02957.x; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; JANSSON HB, 1994, J NEMATOL, V26, P430; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lee SH, 2007, DIAGN MICR INFEC DIS, V58, P263, DOI 10.1016/j.diagmicrobio.2007.01.002; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Ou KL, 2005, J BACTERIOL, V187, P4276, DOI 10.1128/JB.187.12.4276-4285.2005; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; TITBALL RW, 2008, T ROYAL SOC TROP S1, V102, P111; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WIXTON J, 2000, YEAST, V17, P37	34	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16707	10.1371/journal.pone.0016707	http://dx.doi.org/10.1371/journal.pone.0016707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408228	Green Published, gold, Green Submitted			2022-12-27	WOS:000288099800006
J	Veziris, N; Ibrahim, M; Lounis, N; Andries, K; Jarlier, V				Veziris, Nicolas; Ibrahim, Murad; Lounis, Nacer; Andries, Koen; Jarlier, Vincent			Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; MICROBIAL ENUMERATION TECHNIQUE; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; MOUSE TISSUES; MOXIFLOXACIN; PYRAZINAMIDE; INFECTION; THERAPY; R207910	Rationale: The sterilizing activity of the regimen used to treat multidrug resistant tuberculosis (MDR TB) has not been studied in a mouse model. Objective and Methods: Swiss mice were intravenously inoculated with 6 log10 of Mycobacterium tuberculosis (TB) strain H37Rv, treated with second- line drug combinations with or without the diarylquinoline TMC207, and then followed without treatment for 3 more months to determine relapse rates (modified Cornell model). Measurements: Bactericidal efficacy was assessed by quantitative lung colony- forming unit (CFU) counts. Sterilizing efficacy was assessed by measuring bacteriological relapse rates 3 months after the end of treatment. Main Results: The relapse rate observed after 12 months treatment with the WHO recommended MDR TB regimen (amikacin, ethionamide, pyrazinamide and moxifloxacin) was equivalent to the relapse rate observed after 6 months treatment with the recommended drug susceptible TB regimen (rifampin, isoniazid and pyrazinamide). When TMC207 was added to this MDR TB regimen, the treatment duration needed to reach the same relapse rate dropped to 6 months. A similar relapse rate was also obtained with a 6- month completely oral regimen including TMC207, moxifloxacin and pyrazinamide but excluding both amikacin and ethionamide. Conclusions: In this murine model the duration of the WHO MDR TB treatment could be reduced to 12 months instead of the recommended 18- 24 months. The inclusion of TMC207 in the WHO MDR TB treatment regimen has the potential to further shorten the treatment duration and at the same time to simplify treatment by eliminating the need to include an injectable aminoglycoside. dd	[Veziris, Nicolas; Ibrahim, Murad; Jarlier, Vincent] Univ Paris 06, EA 1541, Lab Bacteriol Hyg, Paris, France; [Veziris, Nicolas; Ibrahim, Murad; Jarlier, Vincent] Hop La Pitie Salpetriere, AP HP, Lab Bacteriol Hyg, Paris, France; [Veziris, Nicolas; Ibrahim, Murad; Jarlier, Vincent] Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France; [Ibrahim, Murad] Al Quds Univ Abu Dies, Fac Med, Dept Microbiol & Immunol, Jerusalem, Israel; [Lounis, Nacer; Andries, Koen] Tibotec BVBA, Dept Antimicrobial Res, Beerse, Belgium	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Johnson & Johnson	Veziris, N (corresponding author), Univ Paris 06, EA 1541, Lab Bacteriol Hyg, Paris, France.	nicolas.veziris@upmc.fr	Ibrahim, Murad/AAC-5781-2019; veziris, nicolas/O-9783-2017	veziris, nicolas/0000-0001-5660-6544	Johnson and Johnson, Beerse, Belgium; Universite Paris 6 [EA 1541]	Johnson and Johnson, Beerse, Belgium(Johnson & JohnsonJohnson & Johnson USA); Universite Paris 6	This work was partly supported by Johnson and Johnson, Beerse, Belgium (128106 euros grant). KA and NL are employees of Tibotec BVBA, a subsidiary of Johnson and Johnson, and participated in the design of the study, analysis of the results and writing of the manuscipt. The laboratory is supported by annual grant EA 1541 from Universite Paris 6, Pierre-et-Marie Curie.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Andries K, 2010, ANTIMICROB AGENTS CH, V54, P4540, DOI 10.1128/AAC.00934-10; Davies GR, 2007, ANTIMICROB AGENTS CH, V51, P403, DOI 10.1128/AAC.01246-06; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; DYEC, 2006, LANCET, V367, P938; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; GROSSET J, 1992, ANTIMICROB AGENTS CH, V36, P548, DOI 10.1128/AAC.36.3.548; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Grosset J, 1998, MYCOBACTERIA, VII, P51; GRUMBACH F, 1965, ETUDES CHIMIOTHERAPI, P31; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Ibrahim M, 2009, AM J RESP CRIT CARE, V180, P553, DOI 10.1164/rccm.200807-1152OC; LECOEUR HF, 1989, AM REV RESPIR DIS, V140, P1189, DOI 10.1164/ajrccm/140.5.1189; Lenaerts AJ, 2004, TUBERCULOSIS, V84, P361, DOI 10.1016/j.tube.2004.03.002; Lounis N, 1997, ANTIMICROB AGENTS CH, V41, P607, DOI 10.1128/AAC.41.3.607; Lounis N, 2006, ANTIMICROB AGENTS CH, V50, P3543, DOI 10.1128/AAC.00766-06; Lubasch A, 2000, ANTIMICROB AGENTS CH, V44, P2600, DOI 10.1128/AAC.44.10.2600-2603.2000; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; MCNEELEY DF, 2010, TMC207 VERSUS PLACEB; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Poissy J, 2010, ANTIMICROB AGENTS CH, V54, P4765, DOI 10.1128/AAC.00968-10; Rosenthal IM, 2005, AM J RESP CRIT CARE, V172, P1457, DOI 10.1164/rccm.200507-1072OC; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; TRUFFOTPERNOT C, 1991, TUBERCLE, V72, P57, DOI 10.1016/0041-3879(91)90025-N; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Veziris N, 2003, ANTIMICROB AGENTS CH, V47, P3117, DOI 10.1128/AAC.47.10.3117-3122.2003; VEZIRIS N, 2007, R207910 CONTAINING R; Williams B, 2007, AM J RESP CRIT CARE, V175, P6, DOI 10.1164/rccm.200609-1376ED; World Health Organization, 2006, GUID PROGR MAN DRUG; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	34	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17556	10.1371/journal.pone.0017556	http://dx.doi.org/10.1371/journal.pone.0017556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408613	gold, Green Published, Green Submitted			2022-12-27	WOS:000287965200025
J	Weissenmayer, BA; Prendergast, JGD; Lohan, AJ; Loftus, BJ				Weissenmayer, Barbara A.; Prendergast, James G. D.; Lohan, Amanda J.; Loftus, Brendan J.			Sequencing Illustrates the Transcriptional Response of Legionella pneumophila during Infection and Identifies Seventy Novel Small Non-Coding RNAs	PLOS ONE			English	Article							INTRACELLULAR MULTIPLICATION; SECRETION SYSTEM; 6S RNA; GENE; ACANTHAMOEBA; ACTIVATION; EXPRESSION; PATHWAYS; PROTEIN; AMEBAS	Second generation sequencing has prompted a number of groups to re-interrogate the transcriptomes of several bacterial and archaeal species. One of the central findings has been the identification of complex networks of small non-coding RNAs that play central roles in transcriptional regulation in all growth conditions and for the pathogen's interaction with and survival within host cells. Legionella pneumophila is a Gram-negative facultative intracellular human pathogen with a distinct biphasic lifestyle. One of its primary environmental hosts in the free-living amoeba Acanthamoeba castellanii and its infection by L. pneumophila mimics that seen in human macrophages. Here we present analysis of strand specific sequencing of the transcriptional response of L. pneumophila during exponential and post-exponential broth growth and during the replicative and transmissive phase of infection inside A. castellanii. We extend previous microarray based studies as well as uncovering evidence of a complex regulatory architecture underpinned by numerous non-coding RNAs. Over seventy new non-coding RNAs could be identified; many of them appear to be strain specific and in configurations not previously reported. We discover a family of non-coding RNAs preferentially expressed during infection conditions and identify a second copy of 6S RNA in L. pneumophila. We show that the newly discovered putative 6S RNA as well as a number of other non-coding RNAs show evidence for antisense transcription. The nature and extent of the non-coding RNAs and their expression patterns suggests that these may well play central roles in the regulation of Legionella spp. specific traits and offer clues as to how L. pneumophila adapts to its intracellular niche. The expression profiles outlined in the study have been deposited into Genbank's Gene Expression Omnibus (GEO) database under the series accession GSE27232.	[Weissenmayer, Barbara A.; Lohan, Amanda J.; Loftus, Brendan J.] UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Prendergast, James G. D.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University College Dublin; University of Edinburgh	Loftus, BJ (corresponding author), UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland.	brendan.loftus@ucd.ie	GenePool, The/D-8812-2012	Lohan, Amanda/0000-0002-3574-7572; loftus, brendan/0000-0001-8871-8356; Prendergast, James/0000-0001-8916-018X	Irish Science Foundation (SFI) [05/RP1/B908, 05/RP1/908/EC07]	Irish Science Foundation (SFI)(Science Foundation Ireland)	This work was funded by the Irish Science Foundation (SFI) grants 05/RP1/B908 & 05/RP1/908/EC07 awarded to BJL (http://www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2010, J BACTERIOL, V192, P446, DOI 10.1128/JB.00610-09; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Alsam S, 2006, J MED MICROBIOL, V55, P689, DOI 10.1099/jmm.0.46497-0; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Berghoff BA, 2009, MOL MICROBIOL, V74, P1497, DOI 10.1111/j.1365-2958.2009.06949.x; Berk SG, 2006, ENVIRON SCI TECHNOL, V40, P7440, DOI 10.1021/es0604257; Brantl S, 2009, FUTURE MICROBIOL, V4, P85, DOI 10.2217/17460913.4.1.85; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cianciotto NP, 2001, INT J MED MICROBIOL, V291, P331, DOI 10.1078/1438-4221-00139; Cirillo SLG, 2002, MICROBIOL-SGM, V148, P1667, DOI 10.1099/00221287-148-6-1667; Conover GM, 2008, CELL MICROBIOL, V10, P514, DOI 10.1111/j.1462-5822.2007.01066.x; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Faucher SP, 2010, P NATL ACAD SCI USA, V107, P7533, DOI 10.1073/pnas.0911764107; Ferhat M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007732; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Harada E, 2010, J BACTERIOL, V192, P2892, DOI 10.1128/JB.01535-09; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Jules M, 2007, FEBS LETT, V581, P2829, DOI 10.1016/j.febslet.2007.05.026; KEEN MG, 1984, CURR MICROBIOL, V11, P81, DOI 10.1007/BF01567708; Kim EH, 2009, FEMS MICROBIOL LETT, V301, P164, DOI 10.1111/j.1574-6968.2009.01813.x; Kohler R, 2000, MOL GEN GENET, V262, P1060, DOI 10.1007/PL00008649; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Molmeret M, 2004, MICROBES INFECT, V6, P129, DOI 10.1016/j.micinf.2003.11.004; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Muto A, 1998, TRENDS BIOCHEM SCI, V23, P25, DOI 10.1016/S0968-0004(97)01159-6; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Rasis M, 2009, MOL MICROBIOL, V72, P995, DOI 10.1111/j.1365-2958.2009.06705.x; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Rossier O, 2008, APPL ENVIRON MICROB, V74, P753, DOI 10.1128/AEM.01944-07; Rubin CJ, 2005, INT J SYST EVOL MICR, V55, P2039, DOI 10.1099/ijs.0.63656-0; SAHR T, 2009, MOL MICROBIOL; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Svenningsen SL, 2009, EMBO J, V28, P429, DOI 10.1038/emboj.2008.300; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor M, 2009, MICROB ECOL, V58, P538, DOI 10.1007/s00248-009-9514-z; TESH MJ, 1981, J CLIN MICROBIOL, V13, P865, DOI 10.1128/JCM.13.5.865-869.1981; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109	54	66	68	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17570	10.1371/journal.pone.0017570	http://dx.doi.org/10.1371/journal.pone.0017570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21408607	Green Published, gold, Green Submitted			2022-12-27	WOS:000287965200028
J	Muscarella, RA; Murray, KL; Ortt, D; Russell, AL; Fleming, TH				Muscarella, Robert A.; Murray, Kevin L.; Ortt, Derek; Russell, Amy L.; Fleming, Theodore H.			Exploring Demographic, Physical, and Historical Explanations for the Genetic Structure of Two Lineages of Greater Antillean Bats	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; LONG-DISTANCE DISPERSAL; POPULATION-STRUCTURE; EROPHYLLA-SEZEKORNI; PUERTO-RICO; LANDSCAPE GENETICS; MIGRATION RATES; EXTINCTION RISK; FLOW; PHYLLOSTOMIDAE	Observed patterns of genetic structure result from the interactions of demographic, physical, and historical influences on gene flow. The particular strength of various factors in governing gene flow, however, may differ between species in biologically relevant ways. We investigated the role of demographic factors (population size and sex-biased dispersal) and physical features (geographic distance, island size and climatological winds) on patterns of genetic structure and gene flow for two lineages of Greater Antillean bats. We used microsatellite genetic data to estimate demographic characteristics, infer population genetic structure, and estimate gene flow among island populations of Erophylla sezekorni/E. bombifrons and Macrotus waterhousii (Chiroptera: Phyllostomidae). Using a landscape genetics approach, we asked if geographic distance, island size, or climatological winds mediate historical gene flow in this system. Samples from 13 islands spanning Erophylla's range clustered into five genetically distinct populations. Samples of M. waterhousii from eight islands represented eight genetically distinct populations. While we found evidence that a majority of historical gene flow between genetic populations was asymmetric for both lineages, we were not able to entirely rule out incomplete lineage sorting in generating this pattern. We found no evidence of contemporary gene flow except between two genetic populations of Erophylla. Both lineages exhibited significant isolation by geographic distance. Patterns of genetic structure and gene flow, however, were not explained by differences in relative effective population sizes, island area, sex-biased dispersal (tested only for Erophylla), or surface-level climatological winds. Gene flow among islands appears to be highly restricted, particularly for M. waterhousii, and we suggest that this species deserves increased taxonomic attention and conservation concern.	[Muscarella, Robert A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Muscarella, Robert A.; Murray, Kevin L.; Fleming, Theodore H.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Ortt, Derek] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Ortt, Derek] ImpactWeather, Houston, TX USA; [Russell, Amy L.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA	Columbia University; University of Miami; University of Miami; Grand Valley State University	Muscarella, RA (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	bob.muscarella@gmail.com	Russell, Amy L/B-2222-2010		National Geographic Society [7959-05]; United States National Science Foundation [DEB-05-05866]; Department of Biology; College of Arts and Sciences at the University of Miami	National Geographic Society(National Geographic Society); United States National Science Foundation(National Science Foundation (NSF)); Department of Biology; College of Arts and Sciences at the University of Miami	We thank the National Geographic Society (grant 7959-05) (http://www.nationalgeographic.com/field/grants-programs/cre.html), the United States National Science Foundation (DEB-05-05866) (http://www.nsf.gov/), the Department of Biology (W. Evoy Fund) (http://www.bio. miami.edu/), and the College of Arts and Sciences at the University of Miami (http://www.as.miami.edu/) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; ANDERSON S, 1969, Mammalian Species, V1, P1; Austerlitz F, 2007, HEREDITY, V99, P193, DOI 10.1038/sj.hdy.6800983; Baker RJ, 2003, OCCAS PAP MUS TEXAS, V230, P1; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P., 2004, MIGRATE DOCUMENTATIO; BELL GP, 1985, BEHAV ECOL SOCIOBIOL, V16, P343, DOI 10.1007/BF00295547; Calsbeek R, 2003, NATURE, V426, P552, DOI 10.1038/nature02143; Carstens BC, 2004, MOL ECOL, V13, P2557, DOI 10.1111/j.1365-294X.2004.02250.x; CAVIEDES C, 1991, GEOJOURNAL, V23; *CLARK LABS, 2006, IDRISI AND; Consuegra S, 2005, CONSERV GENET, V6, P823, DOI 10.1007/s10592-005-9042-4; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2007, B MATH BIOL, V69, P797, DOI 10.1007/s11538-006-9161-1; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Fleming Theodore H., 2009, P116; Fleming TH, 2009, BIOTROPICA, V41, P250, DOI 10.1111/j.1744-7429.2008.00466.x; Fraser DJ, 2004, MOL ECOL, V13, P67, DOI 10.1046/j.1365-294X.2003.02038.x; FREELAND JR, 2006, MOL ECOLOGY; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; GANNON MR, 1994, BIOTROPICA, V26, P320, DOI 10.2307/2388854; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GRIFFITHS TA, 1988, BIOTROPICA, V20, P240, DOI 10.2307/2388240; HADLEY G, 1735, PHILOS T R SOC LOND, V34, P58; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Hare MP, 2005, EVOLUTION, V59, P2509, DOI 10.1554/05-150.1; Heaney LR, 2007, J BIOGEOGR, V34, P753, DOI 10.1111/j.1365-2699.2007.01692.x; Hedges SB, 1996, ANNU REV ECOL SYST, V27, P163, DOI 10.1146/annurev.ecolsys.27.1.163; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; JENNESS J, 2004, DISTANCE BEARING MAT; Jennings NV, 2004, ACTA CHIROPTEROL, V6, P75, DOI 10.3161/001.006.0106; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Jones KE, 2001, ANIM CONSERV, V4, P59, DOI 10.1017/S1367943001001068; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Kawecki TJ, 2002, AM NAT, V160, P333, DOI 10.1086/341519; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; MAC ARTHUR ROBERT H., 1967; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; MORGAN GS, 2001, BIOGEOGRAPHY W INDIE, P368; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Murray KL, 2008, MOL ECOL RESOUR, V8, P596, DOI 10.1111/j.1471-8286.2007.02007.x; Murray KL, 2008, J MAMMAL, V89, P1391, DOI 10.1644/08-MAMM-S-068.1; Norberg U., 1990, VERTEBRATE FLIGHT ME; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Nowak RM, 1994, WALKERS BATS WORLD; Palstra FP, 2007, MOL ECOL, V16, P4504, DOI 10.1111/j.1365-294X.2007.03541.x; Pritchard JK, 2000, GENETICS, V155, P945; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Renner S, 2004, INT J PLANT SCI, V165, pS23, DOI 10.1086/383334; Roberts TE, 2006, MOL ECOL, V15, P2183, DOI 10.1111/j.1365-294X.2006.02928.x; RODRIGUEZDURAN A, 1995, COMP BIOCHEM PHYS A, V110, P347, DOI 10.1016/0300-9629(94)00174-R; Russell AL, 2008, J BIOGEOGR, V35, P995, DOI 10.1111/j.1365-2699.2008.01891.x; Safi K, 2004, CONSERV BIOL, V18, P1293, DOI 10.1111/j.1523-1739.2004.00155.x; SAHLEY CT, 1993, J MAMMAL, V74, P594, DOI 10.2307/1382278; Shamoun-Baranes J, 2007, J EXP BIOL, V210, P82, DOI 10.1242/jeb.02612; Simmons N. B., 2005, ORDER CHIROPTERA, P312; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Soto-Centeno JA, 2006, J MAMMAL, V87, P19, DOI 10.1644/05-MAMM-041R1.1; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Telschow A, 2006, J EVOLUTION BIOL, V19, P869, DOI 10.1111/j.1420-9101.2005.01049.x; VALDIVIESO D, 1968, COMP BIOCHEM PHYSIOL, V27, P133, DOI 10.1016/0010-406X(68)90760-3; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vuilleumier S, 2006, P ROY SOC B-BIOL SCI, V273, P1637, DOI 10.1098/rspb.2006.3469; Wares JP, 2001, EVOLUTION, V55, P295; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westberg E, 2009, J BIOGEOGR, V36, P1398, DOI 10.1111/j.1365-2699.2008.01973.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilson GA, 2003, GENETICS, V163, P1177; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x	80	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17704	10.1371/journal.pone.0017704	http://dx.doi.org/10.1371/journal.pone.0017704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445291	Green Published, gold			2022-12-27	WOS:000288613300010
J	Wills, J; Credle, J; Haggerty, T; Lee, JH; Oaks, AW; Sidhu, A				Wills, Jonathan; Credle, Joel; Haggerty, Thomas; Lee, Jae-Hoon; Oaks, Adam W.; Sidhu, Anita			Tauopathic Changes in the Striatum of A53T alpha-Synuclein Mutant Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							LEWY-BODY-DISEASE; ALZHEIMERS-DISEASE; TAU-PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; DEMENTIA COMPLEX; BODIES; BRAIN; PATHOLOGY; MUTATION; GENE	Tauopathic pathways lead to degenerative changes in Alzheimer's disease and there is evidence that they are also involved in the neurodegenerative pathology of Parkinson's disease [PD]. We have examined tauopathic changes in striatum of the alpha-synuclein (alpha-Syn) A53T mutant mouse. Elevated levels of alpha-Syn were observed in striatum of the adult A53T alpha-Syn mice. This was accompanied by increases in hyperphosphorylated Tau [ p-Tau], phosphorylated at Ser202, Ser262 and Ser396/404, which are the same toxic sites also seen in Alzheimer's disease. There was an increase in active p-GSK-3 beta, hyperphosphorylated at Tyr216, a major and primary kinase known to phosphorylate Tau at multiple sites. The sites of hyperphosphorylation of Tau in the A53T mutant mice were similar to those seen in post-mortem striata from PD patients, attesting to their pathophysiological relevance. Increases in p-Tau were not due to alterations on protein phosphatases in either A53T mice or in human PD, suggesting lack of involvement of these proteins in tauopathy. Extraction of striata with Triton X-100 showed large increases in oligomeric forms of alpha-Syn suggesting that alpha-Syn had formed aggregates the mutant mice. In addition, increased levels of p-GSK-3 beta and pSer396/404 were also found associated with aggregated alpha-Syn. Differential solubilization to measure protein binding to cytoskeletal proteins demonstrated that p-Tau in the A53T mutant mouse were unbound to cytoskeletal proteins, consistent with dissociation of p-Tau from the microtubules upon hyperphosphorylation. Interestingly, alpha-Syn remained tightly bound to the cytoskeleton, while p-GSK-3 beta was seen in the cytoskeleton-free fractions. Immunohistochemical studies showed that alpha-Syn, pSer396/404 Tau and p-GSK-3 beta co-localized with one another and was aggregated and accumulated into large inclusion bodies, leading to cell death of Substantia nigral neurons. Together, these data demonstrate an elevated state of tauopathy in striata of the A53T alpha-Syn mutant mice, suggesting that tauopathy is a common feature of synucleinopathies.	[Wills, Jonathan; Credle, Joel; Haggerty, Thomas; Lee, Jae-Hoon; Oaks, Adam W.; Sidhu, Anita] Georgetown Univ, Dept Biochem Mol & Cellular Biol, Washington, DC 20057 USA	Georgetown University	Wills, J (corresponding author), Georgetown Univ, Dept Biochem Mol & Cellular Biol, Washington, DC 20057 USA.	sidhua@georgetown.edu			National Institute on Aging, Arizona Alzheimer's Disease Core Center [P30 AG19610]; Arizona Department of Health Services, Arizona Alzheimer's Research Center [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901]; Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research; National Institute on Aging [R01 NIA AGO28108]; NATIONAL INSTITUTE ON AGING [R01AG028108, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging, Arizona Alzheimer's Disease Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services, Arizona Alzheimer's Research Center; Arizona Biomedical Research Commission; Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Brain Donation Program is supported by the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011 and 05-901 to the Arizona Parkinson's Disease Consortium), and the Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research. This study was supported by a National Institute on Aging grant R01 NIA AGO28108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha A, 2000, J CELL SCI, V113, P3737; Arai Y, 2001, BRAIN RES, V888, P287, DOI 10.1016/S0006-8993(00)03082-1; Barroso-Chinea P, 2005, EUR J NEUROSCI, V21, P1815, DOI 10.1111/j.1460-9568.2005.04024.x; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2006, NEUROTOX RES, V10, P1, DOI 10.1007/BF03033329; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Forman MS, 2002, AM J PATHOL, V160, P1725, DOI 10.1016/S0002-9440(10)61119-4; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Griffin WST, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-5; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hofer A, 2005, J NEURAL TRANSM, V112, P1249, DOI 10.1007/s00702-004-0263-3; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Iseki E, 1999, NEUROSCI LETT, V265, P9, DOI 10.1016/S0304-3940(99)00178-0; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jeannotte AM, 2008, J NEUROCHEM, V105, P1668, DOI 10.1111/j.1471-4159.2008.05258.x; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Jellinger KA, 2004, J NEURAL TRANSM, V111, P1219, DOI 10.1007/s00702-004-0138-7; Joyce JN, 2002, BRAIN RES, V955, P138, DOI 10.1016/S0006-8993(02)03396-6; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kozikowski AP, 2006, CHEMMEDCHEM, V1, P256, DOI 10.1002/cmdc.200500039; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kwok JBJ, 2005, ANN NEUROL, V58, P829, DOI 10.1002/ana.20691; LEI P, 2010, INT J BIOCH CEL 0801; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Szpak GM, 2001, FOLIA NEUROPATHOL, V39, P63; Tsuboi Y, 2003, NEUROPATH APPL NEURO, V29, P503, DOI 10.1046/j.1365-2990.2003.00453.x; Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Yamaguchi K, 2005, ACTA NEUROPATHOL, V110, P298, DOI 10.1007/s00401-005-1042-4; Yamazaki M, 2000, J NEUROPATH EXP NEUR, V59, P585, DOI 10.1093/jnen/59.7.585; Zhong J, 1999, FEBS LETT, V453, P224, DOI 10.1016/S0014-5793(99)00715-2; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200	48	59	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17953	10.1371/journal.pone.0017953	http://dx.doi.org/10.1371/journal.pone.0017953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445308	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300024
J	Lucero, ME; Unc, A; Cooke, P; Dowd, S; Sun, SL				Lucero, Mary E.; Unc, Adrian; Cooke, Peter; Dowd, Scot; Sun, Shulei			Endophyte Microbiome Diversity in Micropropagated Atriplex canescens and Atriplex torreyi var griffithsii	PLOS ONE			English	Article							BOUTELOUA-ERIOPODA TORR.; DARK SEPTATE FUNGI; ENHANCED SPECIFICITY; BACTERIAL DIVERSITY; FOURWING SALTBUSH; TALL FESCUE; GROWTH; IDENTIFICATION; AMPLIFICATION; PRODUCTIVITY	Microbial diversity associated with micropropagated Atriplex species was assessed using microscopy, isolate culturing, and sequencing. Light, electron, and confocal microscopy revealed microbial cells in aseptically regenerated leaves and roots. Clone libraries and tag-encoded FLX amplicon pyrosequencing (TEFAP) analysis amplified sequences from callus homologous to diverse fungal and bacterial taxa. Culturing isolated some seed borne endophyte taxa which could be readily propagated apart from the host. Microbial cells were observed within biofilm-like residues associated with plant cell surfaces and intercellular spaces. Various universal primers amplified both plant and microbial sequences, with different primers revealing different patterns of fungal diversity. Bacterial and fungal TEFAP followed by alignment with sequences from curated databases revealed 7 bacterial and 17 ascomycete taxa in A. canescens, and 5 bacterial taxa in A. torreyi. Additional diversity was observed among isolates and clone libraries. Micropropagated Atriplex retains a complex, intimately associated microbiome which includes diverse strains well poised to interact in manners that influence host physiology. Microbiome analysis was facilitated by high throughput sequencing methods, but primer biases continue to limit recovery of diverse sequences from even moderately complex communities.	[Lucero, Mary E.] ARS, USDA, Las Cruces, NM USA; [Cooke, Peter] New Mexico State Univ, Electron Microscopy Lab, Las Cruces, NM 88003 USA; [Dowd, Scot] Res & Testing Labs LLC, Lubbock, TX USA; [Sun, Shulei] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA	United States Department of Agriculture (USDA); New Mexico State University; University of California System; University of California San Diego	Lucero, ME (corresponding author), ARS, USDA, Las Cruces, NM USA.	malucero@nmsu.edu	Unc, Adrian/AAE-8345-2019; Dowd, Scot E/M-5386-2017; Unc, Adrian/F-1382-2010	Unc, Adrian/0000-0002-7265-9758; Dowd, Scot E/0000-0002-6296-1427; Unc, Adrian/0000-0002-7265-9758	USDA-ARS [6235-11210-005-00]; New Mexico State Office of the Bureau of Land Management [6235-11210-006-56]; International Arid Lands Consortium (IALC) [09R-05]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); New Mexico State Office of the Bureau of Land Management; International Arid Lands Consortium (IALC)	This work was funded by USDA-ARS National Program 215, Projects 6235-11210-005-00, summarized at http://www.ars.usda.gov/research/projects/projects.htm?ACCN_NO=406494. Funding was also received from a cooperative agreement with the New Mexico State Office of the Bureau of Land Management (project 6235-11210-006-56), summarized at http://www.ars.usda.gov/research/projects/projects.htm?ACCN_NO=412128. Research was also funded by the International Arid Lands Consortium (IALC) Project 09R-05, summarized at http://alic.arid.arizona.edu/ialc/ialc4.asp?proj=09R-05, through a competitive grant process. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Scot Dowd directs a commercial sequencing facility, and received payment (from Lucero, using funds from USDA-ARS National Program 215, Projects 6235-11210-005-00 and 6235-11210-006-56) for samples processed at the facility. The payment was based on the number of samples processed, and did not depend on successful endophyte detection. Lucero and Dowd worked together to identify some of the primers that were used to sequence some of the endophytes. Others were sequenced using standard proprietary primers from Research and Testing Labs.	ABREUTARAZI MF, 2009, WORLD J MICROB BIOT, P1; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Afkhami ME, 2008, AM NAT, V172, P405, DOI 10.1086/589893; Asghari HR, 2005, PLANT SOIL, V273, P245, DOI 10.1007/s11104-004-7942-6; Bacon CW, 1997, CROP SCI, V37, P1415, DOI 10.2135/cropsci1997.0011183X003700050001x; Barrow Jerry R, 2008, Commun Integr Biol, V1, P69; Barrow JR, 2004, IN VITRO CELL DEV-PL, V40, P608, DOI 10.1079/IVP2004584; Barrow JR, 2002, J ARID ENVIRON, V51, P449, DOI 10.1006/jare.2001.0925; Barrow JR, 2001, MYCORRHIZA, V11, P199, DOI 10.1007/s005720100111; Barrow JR, 1997, ARID SOIL RES REHAB, V11, P307, DOI 10.1080/15324989709381484; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Braun K, 2003, MYCOL RES, V107, P980, DOI 10.1017/S095375620300813X; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Cibils AF, 2000, J ARID ENVIRON, V46, P383, DOI 10.1006/jare.2000.0692; Clay K, 1996, RES POPUL ECOL, V38, P191, DOI 10.1007/BF02515727; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Almeida CV, 2009, WORLD J MICROB BIOT, V25, P1757, DOI 10.1007/s11274-009-0073-8; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Eberl L., 2007, BIOFILM MODE LIFE ME, V12, P215; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fett WF, 2005, FOOD MICROBIOL, V22, P253, DOI 10.1016/j.fm.2004.03.004; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gibbens RP, 2005, J ARID ENVIRON, V61, P651, DOI 10.1016/j.jaridenv.2004.10.001; Glenn E, 1998, J ARID ENVIRON, V38, P45, DOI 10.1006/jare.1997.0320; GOBEL UB, 1995, J MICROBIOL METH, V23, P117, DOI 10.1016/0167-7012(95)00025-G; Handelsman J., 2007, NEW SCI METAGENOMICS, DOI 10.17226/11902; ISHAK HD, 2011, MICROB ECOL, P1; KARIMI SH, 1989, BOT GAZ, V150, P68, DOI 10.1086/337749; Kluger CG, 2008, J TROP ECOL, V24, P351, DOI 10.1017/S0266467408005026; Kowalchuk GA, 2010, ENVIRONMENTAL MOLECULAR MICROBIOLOGY, P131; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; Larena I, 1999, J BIOTECHNOL, V75, P187, DOI 10.1016/S0168-1656(99)00154-6; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Lucero M, 2008, PLANT SCI, V174, P570, DOI 10.1016/j.plantsci.2008.02.012; Lucero ME, 2008, RANGELAND ECOL MANAG, V61, P124, DOI 10.2111/06-144R3.1; Lucero ME, 2006, J ARID ENVIRON, V65, P276, DOI 10.1016/j.jaridenv.2005.08.014; Mandyam K., 2005, STUD MYCOL, V53, P173, DOI [10.3114/sim.53.1.173, DOI 10.3114/SIM.53.1.173]; Mano H, 2008, MICROBES ENVIRON, V23, P109, DOI 10.1264/jsme2.23.109; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; MCARTHUR ED, 1992, EVOLUTION, V46, P1708, DOI [10.2307/2410025, 10.1111/j.1558-5646.1992.tb01163.x]; McKeon C, 2006, J ARID ENVIRON, V64, P1, DOI 10.1016/j.jaridenv.2005.04.008; MILLER RM, 1983, NEW PHYTOL, V95, P241, DOI 10.1111/j.1469-8137.1983.tb03490.x; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Muller P, 2009, PLANT CELL TISS ORG, V98, P35, DOI 10.1007/s11240-009-9536-8; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Petroski Richard J., 1992, Natural Toxins, V1, P84, DOI 10.1002/nt.2620010205; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Piotrowski JS, 2008, ADV AGRON, V97, P111, DOI 10.1016/S0065-2113(07)00003-X; RALPHS MH, 2007, J CHEM ECOL, P1; Reyes-Vera I., 2010, Native Plants Journal, V11, P53, DOI 10.2979/NPJ.2010.11.1.53; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Rudgers JA, 2004, ECOL LETT, V7, P42, DOI 10.1046/j.1461-0248.2003.00543.x; Rudgers Jennifer A., 2007, Fungal Biology Reviews, V21, P107, DOI 10.1016/j.fbr.2007.05.002; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; SANDERSON SC, 2004, FOURWING SALTBUSH AT, P1; Sawalha MF, 2008, INT J ENVIRON POLLUT, V34, P28, DOI 10.1504/IJEP.2008.020780; Sawalha MF, 2007, J CHEM THERMODYN, V39, P488, DOI 10.1016/j.jct.2006.07.020; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sipos R, 2010, METHODS MOL BIOL, V599, P37, DOI 10.1007/978-1-60761-439-5_3; Spatafora J., 2005, MYCOL RES, V109, P755, DOI DOI 10.1017/S0953756205243551; STUTZ HC, 1978, GREAT BASIN NATURALI; Thomas P, 2007, CAN J MICROBIOL, V53, P380, DOI 10.1139/W06-141; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; WAGNER WL, 1978, MANUAL SALTBUSHES AT; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wink M, 2008, NAT PROD COMMUN, V3, P1205; Zhuang J, 2005, AGRON J, V97, P711, DOI 10.2134/agronj2004.0108	76	54	60	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17693	10.1371/journal.pone.0017693	http://dx.doi.org/10.1371/journal.pone.0017693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437280	Green Published, gold			2022-12-27	WOS:000288514600006
J	Cheriyan, J; Kumar, P; Mayadevi, M; Surolia, A; Omkumar, RV				Cheriyan, John; Kumar, Parimal; Mayadevi, Madhavan; Surolia, Avadhesha; Omkumar, Ramakrishnapillai V.			Calcium/Calmodulin Dependent Protein Kinase II Bound to NMDA Receptor 2B Subunit Exhibits Increased ATP Affinity and Attenuated Dephosphorylation	PLOS ONE			English	Article							POSTSYNAPTIC DENSITY; SYNAPTIC PLASTICITY; NR2B SUBUNIT; BINDING; CALMODULIN; CAMKII; MECHANISM; SWITCH; ACTIVATION; MEMORY	Calcium/calmodulin dependent protein kinase II (CaMKII) is implicated to play a key role in learning and memory. NR2B subunit of N-methyl-D-aspartate receptor (NMDAR) is a high affinity binding partner of CaMKII at the postsynaptic membrane. NR2B binds to the T-site of CaMKII and modulates its catalysis. By direct measurement using isothermal titration calorimetry (ITC), we show that NR2B binding causes about 11 fold increase in the affinity of CaMKII for ATP gamma S, an analogue of ATP. ITC data is also consistent with an ordered binding mechanism for CaMKII with ATP binding the catalytic site first followed by peptide substrate. We also show that dephosphorylation of phospho-Thr(286)-alpha-CaMKII is attenuated when NR2B is bound to CaMKII. This favors the persistence of Thr(286) autophosphorylated state of CaMKII in a CaMKII/phosphatase conjugate system in vitro. Overall our data indicate that the NR2B- bound state of CaMKII attains unique biochemical properties which could help in the efficient functioning of the proposed molecular switch supporting synaptic memory.	[Cheriyan, John; Mayadevi, Madhavan; Omkumar, Ramakrishnapillai V.] Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram, Kerala, India; [Kumar, Parimal; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Cheriyan, J (corresponding author), Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram, Kerala, India.	omkumar@rgcb.res.in	Kumar, Parimal/AAG-9653-2019		Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology; Department of Science and Technology, Government of India; University Grants Commission; Council of Scientific and Industrial Research of the Government of India	Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research of the Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by research grants from the Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology and Department of Science and Technology, Government of India. AS is a J.C. Bose Fellow of the Department of Science and Technology, Government of India. JC and PK received grants from the University Grants Commission and Council of Scientific and Industrial Research of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DR, 2007, BIOORG MED CHEM LETT, V17, P147, DOI 10.1016/j.bmcl.2006.09.070; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BOWDEN AC, 1995, FUNDAMENTALS ENZYME, P23; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; KATOH T, 1991, BIOCHIM BIOPHYS ACTA, V1091, P205, DOI 10.1016/0167-4889(91)90063-4; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; KWIATKOWSKI AP, 1990, BIOCHEMISTRY-US, V29, P153, DOI 10.1021/bi00453a019; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Praseeda M, 2004, BIOCHEM J, V378, P391, DOI 10.1042/BJ20030741; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; SHENK, 1999, SCIENCE, V284, P162; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Wu K, 1997, P NATL ACAD SCI USA, V94, P13273, DOI 10.1073/pnas.94.24.13273; Yoshimura Y, 1996, J BIOCHEM, V119, P268; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	30	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e16495	10.1371/journal.pone.0016495	http://dx.doi.org/10.1371/journal.pone.0016495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423658	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000288513900003
J	Mihaila, C; Schramm, J; Strathmann, FG; Lee, DL; Gelein, RM; Luebke, AE; Mayer-Proschel, M				Mihaila, Camelia; Schramm, Jordan; Strathmann, Frederick G.; Lee, Dawn L.; Gelein, Robert M.; Luebke, Anne E.; Mayer-Proeschel, Margot			Identifying a Window of Vulnerability during Fetal Development in a Maternal Iron Restriction Model	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; BRAIN-STEM RESPONSE; DEFICIENCY ANEMIA; HORMONE-LEVELS; MOTOR-ACTIVITY; HUMAN INFANTS; TRANSFERRIN; PREGNANCY; SUPPLEMENTATION; GENERATION	It is well acknowledged from observations in humans that iron deficiency during pregnancy can be associated with a number of developmental problems in the newborn and developing child. Due to the obvious limitations of human studies, the stage during gestation at which maternal iron deficiency causes an apparent impairment in the offspring remains elusive. In order to begin to understand the time window(s) during pregnancy that is/are especially susceptible to suboptimal iron levels, which may result in negative effects on the development of the fetus, we developed a rat model in which we were able to manipulate and monitor the dietary iron intake during specific stages of pregnancy and analyzed the developing fetuses. We established four different dietary-feeding protocols that were designed to render the fetuses iron deficient at different gestational stages. Based on a functional analysis that employed Auditory Brainstem Response measurements, we found that maternal iron restriction initiated prior to conception and during the first trimester were associated with profound changes in the developing fetus compared to iron restriction initiated later in pregnancy. We also showed that the presence of iron deficiency anemia, low body weight, and changes in core body temperature were not defining factors in the establishment of neural impairment in the rodent offspring. Our data may have significant relevance for understanding the impact of suboptimal iron levels during pregnancy not only on the mother but also on the developing fetus and hence might lead to a more informed timing of iron supplementation during pregnancy.	[Mihaila, Camelia; Strathmann, Frederick G.; Mayer-Proeschel, Margot] Univ Rochester, Dept Biomed Genet, Rochester, NY 14627 USA; [Schramm, Jordan; Luebke, Anne E.; Mayer-Proeschel, Margot] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Luebke, Anne E.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Lee, Dawn L.] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY USA; [Gelein, Robert M.] Univ Rochester, Dept Environm Med, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Mihaila, C (corresponding author), Univ Rochester, Dept Biomed Genet, Rochester, NY 14627 USA.	Anne_Luebke@urmc.rochester.edu; Margot_Mayer-Proschel@urmc.rochester.edu	lee, dawn/GRJ-7459-2022	Schramm, Jordan/0000-0002-0896-1071; Luebke, Anne/0000-0001-5651-0278	NIH [R01HD059739, NIH R01NS39511]; Environment Health Science Center (EHSC) at the University of Rochester; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD059739] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Environment Health Science Center (EHSC) at the University of Rochester; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was funded by the NIH grants R01HD059739 and NIH R01NS39511, and was in part supported by the Environment Health Science Center (EHSC) at the University of Rochester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarin C, 2003, PEDIATR RES, V53, P217, DOI 10.1203/01.PDR.0000047657.23156.55; Amin SB, 2010, J PEDIATR-US, V156, P377, DOI 10.1016/j.jpeds.2009.09.049; Angulo-Kinzler RM, 2002, EARLY HUM DEV, V70, P85, DOI 10.1016/S0378-3782(02)00092-0; Angulo-Kinzler RM, 2002, EARLY HUM DEV, V66, P67, DOI 10.1016/S0378-3782(01)00238-9; Banhidy F., 2010, NUTRITION; Baynes R D, 1996, Curr Opin Hematol, V3, P145; BEARD J, 1984, AM J PHYSIOL, V247, pR114, DOI 10.1152/ajpregu.1984.247.1.R114; BEARD J, 1989, J NUTR, V119, P772, DOI 10.1093/jn/119.5.772; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; BEARD J, 1982, LIFE SCI, V30, P691, DOI 10.1016/0024-3205(82)90285-5; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Beard JL, 2002, BEHAV BRAIN RES, V134, P517, DOI 10.1016/S0166-4328(02)00092-X; BEARD JL, 1993, PROG FOOD NUTR SCI, V17, P183; Beard J, 2007, J NUTR, V137, p524S, DOI 10.1093/jn/137.2.524S; Bourque SL, 2008, J NUTR, V138, P931, DOI 10.1093/jn/138.5.931; Brigham D, 1996, CRIT REV FOOD SCI, V36, P747, DOI 10.1080/10408399609527748; Brunette KE, 2010, DEV NEUROSCI-BASEL, V32, P238, DOI 10.1159/000314341; Burhans MS, 2005, NUTR NEUROSCI, V8, P31, DOI 10.1080/10284150500047070; Cankaya Hakan, 2003, Acta Paediatrica Taiwanica, V44, P21; Carlson ES, 2010, J NEURODEV DISORD, V2, P133, DOI 10.1007/s11689-010-9049-0; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Chong WS, 2005, HUM REPROD, V20, P3532, DOI 10.1093/humrep/dei246; Church MW, 2009, NEUROTOXICOL TERATOL, V31, P26, DOI 10.1016/j.ntt.2008.09.001; Conrad ME, 2000, AM J PHYSIOL-GASTR L, V279, pG767, DOI 10.1152/ajpgi.2000.279.4.G767; Conrad ME, 2001, AM J HEMATOL, V67, P215, DOI 10.1002/ajh.1114; Corapci F, 2006, J DEV BEHAV PEDIATR, V27, P371, DOI 10.1097/00004703-200610000-00001; Cutmore TRH, 2004, CLIN NEUROPHYSIOL, V115, P998, DOI 10.1016/j.clinph.2003.12.013; DALLMAN PR, 1986, ACTA PAEDIATR SCAND, P59; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; Deregnier RA, 2007, DEV NEUROPSYCHOL, V31, P379, DOI 10.1080/87565640701229524; DILLMAN E, 1980, AM J PHYSIOL, V239, pR377, DOI 10.1152/ajpregu.1980.239.5.R377; Ece A, 1999, PEDIATR INT, V41, P168, DOI 10.1046/j.1442-200X.1999.4121036.x; Eden Alvin N, 2005, Paediatr Drugs, V7, P347, DOI 10.2165/00148581-200507060-00003; El Guindi W, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P506; Badaracco ME, 2010, BIOFACTORS, V36, P98, DOI 10.1002/biof.90; Emamghorashi F, 2004, East Mediterr Health J, V10, P808; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; FAIRBANKS VF, 1994, MAYO CLIN PROC, V69, P889, DOI 10.1016/S0025-6196(12)61794-7; Felt BT, 2006, BEHAV BRAIN RES, V171, P261, DOI 10.1016/j.bbr.2006.04.001; Florentino Rodolfo F., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P31; Focht SJ, 1997, NEUROSCIENCE, V79, P255, DOI 10.1016/S0306-4522(96)00607-0; Gambling L, 2004, J PHYSIOL-LONDON, V561, P195, DOI 10.1113/jphysiol.2004.068825; Gambling L, 2001, BIOCHEM J, V356, P883, DOI 10.1042/0264-6021:3560883; Georgieff Michael K, 2006, Minn Med, V89, P44; Georgieff MK, 2002, J PEDIATR-US, V141, P405, DOI 10.1067/mpd.2002.127090; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Gregori N, 2002, J NEUROSCI, V22, P248, DOI 10.1523/JNEUROSCI.22-01-00248.2002; Hall J W 3rd, 1997, Adv Otorhinolaryngol, V53, P21; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Hartfield DS, 2009, CLIN PEDIATR, V48, P420, DOI 10.1177/0009922809331800; Hartfield DS, 1997, PEDIATR NEUROL, V16, P50, DOI 10.1016/S0887-8994(96)00290-1; Ito T, 2004, HEARING RES, V191, P119, DOI 10.1016/j.heares.2003.12.019; Jaime-Perez JC, 2005, ARCH MED RES, V36, P598, DOI 10.1016/j.arcmed.2005.03.023; KARP RJ, 1989, B NEW YORK ACAD MED, V65, P1085; Knipper M, 1998, DEVELOPMENT, V125, P3709; Kurekci AE, 2006, TURKISH J PEDIATR, V48, P334; Kwik-Uribe CL, 2000, J NUTR, V130, P2821, DOI 10.1093/jn/130.11.2821; Kwik-Uribe CL, 2000, J NUTR, V130, P2040, DOI 10.1093/jn/130.8.2040; Lee HS, 2006, EUR J CLIN NUTR, V60, P1130, DOI 10.1038/sj.ejcn.1602429; Legatt AD, 2002, J CLIN NEUROPHYSIOL, V19, P396, DOI 10.1097/00004691-200210000-00003; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Love AL, 2008, AM J HEMATOL, V83, P403, DOI 10.1002/ajh.21106; LOZOFF B, 1986, PROG HEMATOL, V14, P23; Lozoff B, 1987, Hematol Oncol Clin North Am, V1, P449; LOZOFF B, 1989, B NEW YORK ACAD MED, V65, P1050; Lozoff B, 2003, PEDIATRICS, V112, P846; LOZOFF B, 1987, PEDIATRICS, V79, P981; Lozoff B, 2000, PEDIATR RES, V48, P137, DOI 10.1203/00006450-200008000-00003; Lozoff B, 2008, J PEDIATR-US, V152, P696, DOI 10.1016/j.jpeds.2007.09.048; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lukowski AF, 2010, NUTR NEUROSCI, V13, P54, DOI 10.1179/147683010X12611460763689; Maison SF, 2009, JARO-J ASSOC RES OTO, V10, P50, DOI 10.1007/s10162-008-0138-7; Melamed Nir, 2007, Archives of Gynecology and Obstetrics, V276, P601, DOI 10.1007/s00404-007-0388-3; Morath DJ, 2002, DEV NEUROSCI-BASEL, V24, P197, DOI 10.1159/000065688; Morath DJ, 2001, DEV BIOL, V237, P232, DOI 10.1006/dbio.2001.0352; MUNOZ C, 1994, EUR CYTOKINE NETW, V5, P401; Naghii Mohammad R., 2006, Nutrition and Health (Bicester), V18, P133; Nguyen Patricia, 2008, BMC Pregnancy Childbirth, V8, P17, DOI 10.1186/1471-2393-8-17; Noben-Trauth K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011459; Park HJ, 2009, HEARING RES, V257, P53, DOI 10.1016/j.heares.2009.08.001; Ponton CW, 1996, EAR HEARING, V17, P402, DOI 10.1097/00003446-199610000-00006; Reeves PG, 2006, J NUTR BIOCHEM, V17, P635, DOI 10.1016/j.jnutbio.2006.04.004; Roncagliolo M, 1998, AM J CLIN NUTR, V68, P683, DOI 10.1093/ajcn/68.3.683; Sarici SU, 2001, PEDIATR NEUROL, V24, P205, DOI 10.1016/S0887-8994(00)00270-8; Schmidt AT, 2007, BEHAV NEUROSCI, V121, P475, DOI 10.1037/0735-7044.121.3.475; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Shafir T, 2008, EARLY HUM DEV, V84, P479, DOI 10.1016/j.earlhumdev.2007.12.009; SHAW NA, 1995, PROG NEUROBIOL, V47, P95, DOI 10.1016/0301-0082(95)00021-M; Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011; Singla PN, 1997, J TROP PEDIATRICS, V43, P89, DOI 10.1093/tropej/43.2.89; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Sweet DG, 2001, ARCH DIS CHILD-FETAL, V84, pF40, DOI 10.1136/fn.84.1.F40; Tanaka C, 2009, HEARING RES, V250, P10, DOI 10.1016/j.heares.2008.12.010; TANG F, 1988, HORM METAB RES, V20, P616, DOI 10.1055/s-2007-1010899; Unger EL, 2007, J NUTR, V137, P118, DOI 10.1093/jn/137.1.118; VANGELDER W, 1995, J NEUROCHEM, V64, P2708; VANGELDER W, 1995, COMP BIOCHEM PHYS B, V111, P171, DOI 10.1016/0305-0491(94)00255-S; Wachs TD, 2005, DEV PSYCHOBIOL, V46, P141, DOI 10.1002/dev.20049; WALTER T, 1994, BAILLIERE CLIN HAEM, V7, P815, DOI 10.1016/S0950-3536(05)80126-X; Wang Y, 2005, J NEUROPHYSIOL, V94, P1814, DOI 10.1152/jn.00374.2005; Wu HP, 2010, HEARING RES, V267, P71, DOI 10.1016/j.heares.2010.03.082; Wu LL, 2008, BEHAV BRAIN RES, V188, P263, DOI 10.1016/j.bbr.2007.11.003; Xanthakos SA, 2009, PEDIATR CLIN N AM, V56, P1105, DOI 10.1016/j.pcl.2009.07.002; Zhou B, 2001, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V15, P173; Zhou GD, 2001, MUTAT RES-FUND MOL M, V479, P71, DOI 10.1016/S0027-5107(01)00148-8; Zimmermann MB, 2002, THYROID, V12, P867, DOI 10.1089/105072502761016494	107	38	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17483	10.1371/journal.pone.0017483	http://dx.doi.org/10.1371/journal.pone.0017483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423661	gold, Green Published, Green Submitted			2022-12-27	WOS:000288513900010
J	Lopatina, T; Kalinina, N; Karagyaur, M; Stambolsky, D; Rubina, K; Revischin, A; Pavlova, G; Parfyonova, Y; Tkachuk, V				Lopatina, Tatiana; Kalinina, Natalia; Karagyaur, Maxim; Stambolsky, Dmitry; Rubina, Kseniya; Revischin, Alexander; Pavlova, Galina; Parfyonova, Yelena; Tkachuk, Vsevolod			Adipose-Derived Stem Cells Stimulate Regeneration of Peripheral Nerves: BDNF Secreted by These Cells Promotes Nerve Healing and Axon Growth De Novo	PLOS ONE			English	Article							RAT SPINAL-CORD; STROMAL CELLS; BONE-MARROW; SYMPATHETIC NEURONS; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; IFATS COLLECTION; SCHWANN-CELLS; PC12 CELLS; IN-VITRO	Transplantation of adipose-derived mesenchymal stem cells (ASCs) induces tissue regeneration by accelerating the growth of blood vessels and nerve. However, mechanisms by which they accelerate the growth of nerve fibers are only partially understood. We used transplantation of ASCs with subcutaneous matrigel implants (well-known in vivo model of angiogenesis) and model of mice limb reinnervation to check the influence of ASC on nerve growth. Here we show that ASCs stimulate the regeneration of nerves in innervated mice's limbs and induce axon growth in subcutaneous matrigel implants. To investigate the mechanism of this action we analyzed different properties of these cells and showed that they express numerous genes of neurotrophins and extracellular matrix proteins required for the nerve growth and myelination. Induction of neural differentiation of ASCs enhances production of brain-derived neurotrophic factor (BDNF) as well as ability of these cells to induce nerve fiber growth. BDNF neutralizing antibodies abrogated the stimulatory effects of ASCs on the growth of nerve sprouts. These data suggest that ASCs induce nerve repair and growth via BDNF production. This stimulatory effect can be further enhanced by culturing the cells in neural differentiation medium prior to transplantation.	[Lopatina, Tatiana; Kalinina, Natalia; Karagyaur, Maxim; Stambolsky, Dmitry; Rubina, Kseniya; Parfyonova, Yelena; Tkachuk, Vsevolod] Lomonosov Moscow State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia; [Revischin, Alexander; Pavlova, Galina] Russian Acad Sci, Inst Gene Biol, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Lopatina, T (corresponding author), Lomonosov Moscow State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia.	t.lopatina@gmail.com	Tkachuk, Vsevolod/AAE-1136-2022; Tkachuk, Vsevolod A/J-9357-2012; Parfyonova, Yelena V/B-9307-2014; Kalinina, Natalia I./L-6475-2013; Rubina, Kseniya A/A-8208-2014; Stambolsky, Dmitry/A-8358-2014; Pavlova, Galina/AAO-4691-2020; Revishchin, Alexander/AAO-4863-2020; Rubina, Kseniya/AAL-2675-2021; Karagyaur, Maxim N/A-8385-2014; Kalinina, Natalia/AAN-6763-2020	Parfyonova, Yelena V/0000-0002-0969-5780; Kalinina, Natalia I./0000-0003-3497-9619; Rubina, Kseniya A/0000-0002-7166-7406; Stambolsky, Dmitry/0000-0001-6983-9697; Pavlova, Galina/0000-0002-6885-6601; Rubina, Kseniya/0000-0002-7166-7406; Karagyaur, Maxim N/0000-0003-4289-3428; Kalinina, Natalia/0000-0003-3497-9619; Lopatina, Tatiana/0000-0002-8198-8887; Tkachuk, Vsevolod/0000-0002-7492-747X; Revishchin, Alexandr/0000-0002-6007-6440	Russian Government [02.740.11.0093];  [SS-3755.2010.7]	Russian Government; 	This study was supported by grants from Russian Government No 02.740.11.0093 and Russian President SS-3755.2010.7 (both to V.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Balezina O. P., 2004, Uspekhi Fiziologicheskikh Nauk, V35, P37; Balezina OP, 2005, B EXP BIOL MED+, V139, P4, DOI 10.1007/s10517-005-0196-3; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Efimenko A Iu, 2010, Tsitologiia, V52, P144; Fuhrmann T, 2010, NEUROSCI LETT, V474, P37, DOI 10.1016/j.neulet.2010.03.002; Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; INAGAKI N, 1995, EUR J NEUROSCI, V7, P1125, DOI 10.1111/j.1460-9568.1995.tb01102.x; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Koda M, 2007, EUR SPINE J, V16, P2206, DOI 10.1007/s00586-007-0499-3; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Mantovani C, 2010, REGEN MED, V5, P403, DOI 10.2217/RME.10.15; McDonald DM, 1996, ADV EXP MED BIOL, V410, P453; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; PASSANITI A, 1992, LAB INVEST, V67, P519; Plant GW, 2002, J NEUROSCI, V22, P6083; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rubina Kseniya, 2007, Angiogenesis, V10, P183, DOI 10.1007/s10456-007-9072-2; Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359; Traktuev DO, 2006, TSITOLOGIYA, V48, P83; Vard'ya I V, 2000, Dokl Biol Sci, V371, P112; Walsh S, 2009, NEUROSURGERY, V65, pA80, DOI 10.1227/01.NEU.0000335651.93926.2F; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wong M, 2011, EARLY CHILD DEV CARE, V181, P1199, DOI 10.1080/03004430.2010.520712; Xu YF, 2008, BRAIN RES, V1239, P49, DOI 10.1016/j.brainres.2008.08.088; Yu WM, 2007, MOL NEUROBIOL, V35, P288, DOI 10.1007/s12035-007-0026-x; Yuan QJ, 2009, J BRACHIAL PLEX PERI, V4, DOI 10.1186/1749-7221-4-18; Yuan Y, 2010, BRAIN RES BULL, V81, P25, DOI 10.1016/j.brainresbull.2009.07.013; Zhang XM, 2010, MOL BIOL REP, V37, P1197, DOI 10.1007/s11033-009-9489-3; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	38	204	221	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17899	10.1371/journal.pone.0017899	http://dx.doi.org/10.1371/journal.pone.0017899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423756	Green Published, gold			2022-12-27	WOS:000288512400037
J	Fernandes, VC; Martins, EMN; Boeloni, JN; Coitinho, JB; Serakides, R; Goes, AM				Fernandes, Viviane C.; Martins, Estefania M. N.; Boeloni, Jankerle N.; Coitinho, Juliana B.; Serakides, Rogeria; Goes, Alfredo M.			Additive Effect of rPb27 Immunization and Chemotherapy in Experimental Paracoccidioidomycosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RECOMBINANT 27-KILODALTON; ANTIGENIC PROTEIN; BRASILIENSIS; MICE; SERODIAGNOSIS; RESISTANCE; INFECTION; CELLS; DNA	Paracoccidioidomycosis, PCM, the major systemic mycosis in Latin America, is caused by the termally dimorphic fungus Paracoccidioides brasiliensis and requires extended periods of chemotherapy with a significant frequency of relapsing disease. The search for new alternatives of treatment is necessary. rPb27 is an antigenic protein from P. brasiliensis that already showed a significant protective activity as a vaccine for PCM in experimental models. The cDNA of rPb27 was subcloned into a pET-DEST 42 plasmid, expressed in E. coli with a his-tag and purified by affinity chromatography. Immunization with this recombinant protein and chemotherapy were used together in an attempt to improve treatment of PCM. For this, BALB/c mice were challenged with pathogenic P. brasiliensis strain and after immunized with rPb27, in the presence of Corynebacterium parvum and Al(OH)(3), some groups were also treated with fluconazole. After 40 days of treatment, the combined drug/rPb27 administration controlled PCM in the liver and spleen, with long lasting protection, and largely preserved tissues structures of these organs. Additionally, in the lungs after 40 days of treatment there was a significant reduction in the fungal load and size of lesions. At the same time, the levels of TNF-alpha were higher than infectedonly mice. Moreover, significant levels of anti-rPb27 specific IgG1, IgG2a and IgG2b isotypes were detected in the sera of mice immunized with rPb27 fluconazole treated or not. These results showed an additive protective effect of rPb27 immunization and chemotherapy, suggesting that an rPb27-based vaccine can be used to enhance PCM antifungal treatment.	[Fernandes, Viviane C.; Coitinho, Juliana B.; Goes, Alfredo M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Martins, Estefania M. N.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Boeloni, Jankerle N.; Serakides, Rogeria] Univ Fed Minas Gerais, Dept Clin & Cirurgia Vet, Escola Vet, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Fernandes, VC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	cfernandes.viviane@gmail.com	Coitinho, Juliana Barbosa/AAI-4742-2021; Martins, Estefânia Mara do Nascimento/GQI-4671-2022; Serakides, Rogéria/C-7571-2016	Coitinho, Juliana Barbosa/0000-0002-5892-050X; Serakides, Rogéria/0000-0001-5374-6242	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais	This work was supported by Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais. Viviane C. Fernandes is a PhD student with a scholarship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1976, AM J PATHOL, V84, P164; Araujo SD, 2009, BRAZ J INFECT DIS, V13, P394, DOI 10.1590/S1413-86702009000500017; CANO LE, 1995, INFECT IMMUN, V63, P1777, DOI 10.1128/IAI.63.5.1777-1783.1995; Chakrabarti A., 2005, Journal of Postgraduate Medicine, V51, P16; de Almeida SM, 2004, J INFECTION, V48, P193, DOI 10.1016/j.jinf.2003.08.012; Dias MFRG, 2004, MED MYCOL, V42, P43, DOI 10.1080/13693780310001610074; Diez S, 2003, J CLIN MICROBIOL, V41, P1536, DOI 10.1128/JCM.41.4.1536-1542.2003; Diniz SN, 2004, VACCINE, V22, P485, DOI 10.1016/j.vaccine.2003.07.017; Hahn RC, 2003, MYCOSES, V46, P342; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Marques AF, 2006, ANTIMICROB AGENTS CH, V50, P2814, DOI 10.1128/AAC.00220-06; Marques AF, 2008, MICROBES INFECT, V10, P1251, DOI 10.1016/j.micinf.2008.07.027; McEwen JG, 1996, FUNGAL GENET BIOL, V20, P125, DOI 10.1006/fgbi.1996.0027; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Ortiz BL, 1996, CLIN DIAGN LAB IMMUN, V3, P239, DOI 10.1128/CDLI.3.2.239-241.1996; Ortiz BL, 1998, CLIN DIAGN LAB IMMUN, V5, P826, DOI 10.1128/CDLI.5.6.826-830.1998; Paniago Anamaria Mello Miranda, 2003, Rev. Soc. Bras. Med. Trop., V36, P455, DOI 10.1590/S0037-86822003000400004; Pereira Ricardo M., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P37, DOI 10.1590/S0036-46652004000100007; Pereira Ricardo Mendes, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P127, DOI 10.1590/S0036-46652004000300002; PINZAN CF, PLOS ONE, V5; Reis BS, 2008, VACCINE, V26, P5461, DOI 10.1016/j.vaccine.2008.07.097; Ribeiro AM, 2010, VACCINE, V28, P1528, DOI 10.1016/j.vaccine.2009.11.062; San-Blas G, 2008, MYCOPATHOLOGIA, V165, P183, DOI 10.1007/s11046-007-9040-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Visbal G., 2005, Current Drug Targets - Infectious Disorders, V5, P211, DOI 10.2174/1568005054880118	30	22	22	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17885	10.1371/journal.pone.0017885	http://dx.doi.org/10.1371/journal.pone.0017885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423771	gold, Green Published, Green Submitted			2022-12-27	WOS:000288219100043
J	Lightfield, J; Fram, NR; Ely, B				Lightfield, John; Fram, Noah R.; Ely, Bert			Across Bacterial Phyla, Distantly-Related Genomes with Similar Genomic GC Content Have Similar Patterns of Amino Acid Usage	PLOS ONE			English	Article							OPTIMAL-GROWTH TEMPERATURE; CYTOSINE CONTENT; BASE COMPOSITION; CODON USAGE; PROKARYOTES; PROTEINS; GUANINE; G+C; DNA	The GC content of bacterial genomes ranges from 16% to 75% and wide ranges of genomic GC content are observed within many bacterial phyla, including both Gram negative and Gram positive phyla. Thus, divergent genomic GC content has evolved repeatedly in widely separated bacterial taxa. Since genomic GC content influences codon usage, we examined codon usage patterns and predicted protein amino acid content as a function of genomic GC content within eight different phyla or classes of bacteria. We found that similar patterns of codon usage and protein amino acid content have evolved independently in all eight groups of bacteria. For example, in each group, use of amino acids encoded by GC-rich codons increased by approximately 1% for each 10% increase in genomic GC content, while the use of amino acids encoded by AT-rich codons decreased by a similar amount. This consistency within every phylum and class studied led us to conclude that GC content appears to be the primary determinant of the codon and amino acid usage patterns observed in bacterial genomes. These results also indicate that selection for translational efficiency of highly expressed genes is constrained by the genomic parameters associated with the GC content of the host genome.	[Lightfield, John; Fram, Noah R.; Ely, Bert] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Lightfield, J (corresponding author), Ripon Coll, Ripon, WI USA.	ely@sc.edu		Fram, Noah/0000-0002-0234-9922	National Science Foundation (nsf.gov) [DBI-0451403, EF-0826792]	National Science Foundation (nsf.gov)(National Science Foundation (NSF))	This work was funded in part by National Science Foundation (nsf.gov) grants DBI-0451403 and EF-0826792 to BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBU E, 1956, ANN I PASTEUR, V91, P212; BELOZERSKY AN, 1958, NATURE, V182, P111, DOI 10.1038/182111a0; Bohlin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008113; Chen LL, 2003, BIOCHEM BIOPH RES CO, V306, P310, DOI 10.1016/S0006-291X(03)00973-2; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Fryxell KJ, 2008, NOVA HEDWIGIA BIEHEF, V133, P285; Gu X, 1998, GENETICA, V102-3, P383, DOI 10.1023/A:1017028102013; Knight RD, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-4-research0010; Lobry JR, 1997, GENE, V205, P309, DOI 10.1016/S0378-1119(97)00403-4; Musto H, 2005, BIOCHEM BIOPH RES CO, V330, P357, DOI 10.1016/j.bbrc.2005.02.133; Musto H, 2004, FEBS LETT, V573, P73, DOI 10.1016/j.febslet.2004.07.056; Musto H, 2006, BIOCHEM BIOPH RES CO, V347, P1, DOI 10.1016/j.bbrc.2006.06.054; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; SUEOKA N, 1962, P NATL ACAD SCI USA, V48, P582, DOI 10.1073/pnas.48.4.582; SUEOKA N, 1961, P NATL ACAD SCI USA, V47, P1141, DOI 10.1073/pnas.47.8.1141; Wilquet V, 1999, RES MICROBIOL, V150, P21, DOI 10.1016/S0923-2508(99)80043-6	19	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17677	10.1371/journal.pone.0017677	http://dx.doi.org/10.1371/journal.pone.0017677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423704	gold, Green Published			2022-12-27	WOS:000288219100024
J	Franz, R; Soliva, CR; Kreuzer, M; Hatt, JM; Furrer, S; Hummel, J; Clauss, M				Franz, Ragna; Soliva, Carla R.; Kreuzer, Michael; Hatt, Jean-Michel; Furrer, Samuel; Hummel, Juergen; Clauss, Marcus			Methane Output of Tortoises: Its Contribution to Energy Loss Related to Herbivore Body Mass	PLOS ONE			English	Article							MAMMALIAN HERBIVORES; TRANSIT-TIME; FOOD-INTAKE; XEROBATES-AGASSIZII; CELLULOSE DIGESTION; SAUROPOD DINOSAURS; GEOCHELONE-NIGRA; HEALTHY-SUBJECTS; CHELONIA-MYDAS; IGUANA-IGUANA	An increase in body mass (M) is traditionally considered advantageous for herbivores in terms of digestive efficiency. However, recently increasing methane losses with increasing M were described in mammals. To test this pattern in non-mammal herbivores, we conducted feeding trails with 24 tortoises of various species (M range 0.52-180 kg) fed a diet of grass hay ad libitum and salad. Mean daily dry matter and gross energy intake measured over 30 consecutive days scaled to M0.75 (95% CI 0.64-0.87) and M0.77 (95% CI 0.66-0.88), respectively. Methane production was measured over two consecutive days in respiration chambers and scaled to M1.03 (95% CI 0.84-1.22). When expressed as energy loss per gross energy intake, methane losses scaled to 0.70 (95% CI 0.47-1.05) M0.29(95% CI 0.14-0.45). This scaling overlaps in its confidence intervals to that calculated for nonruminant mammals 0.79 (95% CI 0.63-0.99) M0.15(95% CI 0.09-0.20), but is lower than that for ruminants. The similarity between nonruminant mammals and tortoises suggest a common evolution of the gut fauna in ectotherms and endotherms, and that the increase in energetic losses due to methane production with increasing body mass is a general allometric principle in herbivores. These findings add evidence to the view that large body size itself does not necessarily convey a digestive advantage.	[Franz, Ragna; Hatt, Jean-Michel; Clauss, Marcus] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Vetsuisse Fac, Zurich, Switzerland; [Soliva, Carla R.; Kreuzer, Michael] Swiss Fed Inst Technol, Inst Plant Anim & Agroecosyst Sci, Zurich, Switzerland; [Furrer, Samuel] Zurich Zoo, Zurich, Switzerland; [Hummel, Juergen] Rhein Freidrich Wilhelms Univ Bonn, Inst Anim Sci, D-53113 Bonn, Germany	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn	Franz, R (corresponding author), Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Vetsuisse Fac, Zurich, Switzerland.	mclauss@vetclinics.uzh.ch	Clauss, Marcus/A-4710-2008; Clauss, Marcus/M-8702-2019; Clauss, Marcus/GRR-7996-2022; Hatt, Jean-Michel/C-3850-2015; Kreuzer, Michael/E-7697-2015	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Kreuzer, Michael/0000-0002-9978-1171; Hatt, Jean-Michel/0000-0002-7043-7430; Hummel, Jurgen/0000-0002-8876-7745	DFG (German Research Foundation) [CL 182/5-1]	DFG (German Research Foundation)(German Research Foundation (DFG))	This study was funded by DFG (German Research Foundation) grant CL 182/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1997, OFF METH AN; BARBOZA PS, 1995, J COMP PHYSIOL B, V165, P193; Barboza PS, 2000, J MAMMAL, V81, P473, DOI 10.1644/1545-1542(2000)081&lt;0473:SSIDDA&gt;2.0.CO;2; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Bennett A.F., 1976, P127; BJORNDAL KA, 1979, COMP BIOCHEM PHYS A, V63, P127, DOI 10.1016/0300-9629(79)90638-8; Chatterjee S, 2007, AM J GASTROENTEROL, V102, P837, DOI 10.1111/j.1572-0241.2007.01072.x; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Clauss M, 2009, COMP BIOCHEM PHYS A, V154, P376, DOI 10.1016/j.cbpa.2009.07.016; CLOAREC D, 1990, GUT, V31, P300, DOI 10.1136/gut.31.3.300; Codron D, 2007, J ANIM ECOL, V76, P526, DOI 10.1111/j.1365-2656.2007.01222.x; CRUTZEN P J, 1986, Tellus Series B Chemical and Physical Meteorology, V38, P271; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; ElOufir L, 1996, GUT, V38, P870, DOI 10.1136/gut.38.6.870; FENCHEL TM, 1979, APPL ENVIRON MICROB, V37, P348, DOI 10.1128/AEM.37.2.348-350.1979; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; FOLEY WJ, 1992, J ZOOL, V226, P387, DOI 10.1111/j.1469-7998.1992.tb07486.x; Franz R, 2010, EVOL ECOL RES, V12, P727; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P94, DOI 10.1016/j.cbpa.2010.09.007; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; Franz R, 2009, P ROY SOC B-BIOL SCI, V276, P1731, DOI 10.1098/rspb.2008.1735; Fritz J, 2010, J EXP ZOOL PART A, V313A, P579, DOI 10.1002/jez.629; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; GAULIN SJC, 1979, HUM ECOL, V7, P1, DOI 10.1007/BF00889349; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; Goel G, 2009, BRIT J NUTR, V101, P1484, DOI 10.1017/S0007114508076198; Hackstein JHP, 1996, EVOLUTION, V50, P559, DOI [10.2307/2410831, 10.1111/j.1558-5646.1996.tb03868.x]; Hailey A, 1997, CAN J ZOOL, V75, P787, DOI 10.1139/z97-100; Hatt JM, 2005, ZOO BIOL, V24, P185, DOI 10.1002/zoo.20039; Hatt JM, 2002, HERPETOL J, V12, P45; Hwang L, 2010, DIGEST DIS SCI, V55, P398, DOI 10.1007/s10620-009-0778-4; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; KARASOV WH, 1986, J COMP PHYSIOL B, V156, P599, DOI 10.1007/BF00691047; KIRKWOOD JK, 1996, BSAVA MANUAL COMPANI, P235; Low K, 2010, J CLIN GASTROENTEROL, V44, P547, DOI 10.1097/MCG.0b013e3181c64c90; Mackie RI, 2004, PHYSIOL BIOCHEM ZOOL, V77, P127, DOI 10.1086/383498; Martin C, 2010, ANIMAL, V4, P351, DOI 10.1017/S1751731109990620; McBee R.H., 1982, P77; McCrabb GJ, 1997, AUST J AGR RES, V48, P323, DOI 10.1071/A96119; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MEIENBERGER C, 1993, PHYSIOL ZOOL, V66, P847, DOI 10.1086/physzool.66.5.30163827; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NAGY KA, 1977, COPEIA, P355; OKINE EK, 1989, J ANIM SCI, V67, P3388; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Parra R., 1978, P205; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Pimentel M, 2006, DIGEST DIS SCI, V51, P1297, DOI 10.1007/s10620-006-9104-6; Pimentel M, 2006, AM J PHYSIOL-GASTR L, V290, pG1089, DOI 10.1152/ajpgi.00574.2004; Pinares-Patino CS, 2003, J AGR SCI-CAMBRIDGE, V140, P205, DOI 10.1017/S0021859603003046; PRINS RA, 1991, RUMEN ECOSYSTEM MICR, P109; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; SAWYER MS, 1974, J ANIM SCI, V38, P908, DOI 10.2527/jas1974.384908x; Smith FA, 2010, NAT GEOSCI, V3, P374, DOI 10.1038/ngeo877; Soares ACF, 2005, J CLIN GASTROENTEROL, V39, P512, DOI 10.1097/01.mcg.0000165665.94777.bd; Soliva C. R., 2007, P15, DOI 10.1007/978-1-4020-6133-2_2; STEPHEN AM, 1986, BRIT J NUTR, V56, P349, DOI 10.1079/BJN19860116; Tomkins NW, 2009, ANIM PROD SCI, V49, P1053, DOI 10.1071/EA08223; TROYER K, 1984, PHYSIOL ZOOL, V57, P1; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN	64	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17628	10.1371/journal.pone.0017628	http://dx.doi.org/10.1371/journal.pone.0017628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408074	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900032
J	Meng, JH; Adkin, CF; Xu, SW; Muntoni, F; Morgan, JE				Meng, Jinhong; Adkin, Carl F.; Xu, Shi-wen; Muntoni, Francesco; Morgan, Jennifer E.			Contribution of Human Muscle-Derived Cells to Skeletal Muscle Regeneration in Dystrophic Host Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN MYOBLAST TRANSPLANTATION; ENDOTHELIAL PROGENITOR CELLS; DUCHENNE MUSCULAR-DYSTROPHY; SIDE POPULATION CELLS; SATELLITE CELLS; MYOGENIC DIFFERENTIATION; SELF-RENEWAL; MDX MOUSE; IN-VITRO	Background: Stem cell transplantation is a promising potential therapy for muscular dystrophies, but for this purpose, the cells need to be systemically-deliverable, give rise to many muscle fibres and functionally reconstitute the satellite cell niche in the majority of the patient's skeletal muscles. Human skeletal muscle-derived pericytes have been shown to form muscle fibres after intra-arterial transplantation in dystrophin-deficient host mice. Our aim was to replicate and extend these promising findings. Methodology/Principal Findings: Isolation and maintenance of human muscle derived cells (mdcs) was performed as published for human pericytes. Mdscs were characterized by immunostaining, flow cytometry and RT-PCR; also, their ability to differentiate into myotubes in vitro and into muscle fibres in vivo was assayed. Despite minor differences between human mdcs and pericytes, mdscs contributed to muscle regeneration after intra-muscular injection in mdx nu/nu mice, the CD56+ sub-population being especially myogenic. However, in contrast to human pericytes delivered intra-arterially in mdx SCID hosts, mdscs did not contribute to muscle regeneration after systemic delivery in mdx nu/nu hosts. Conclusions/Significance: Our data complement and extend previous findings on human skeletal muscle-derived stem cells, and clearly indicate that further work is necessary to prepare pure cell populations from skeletal muscle that maintain their phenotype in culture and make a robust contribution to skeletal muscle regeneration after systemic delivery in dystrophic mouse models. Small differences in protocols, animal models or outcome measurements may be the reason for differences between our findings and previous data, but nonetheless underline the need for more detailed studies on muscle-derived stem cells and independent replication of results before use of such cells in clinical trials.	[Meng, Jinhong; Adkin, Carl F.; Muntoni, Francesco; Morgan, Jennifer E.] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Xu, Shi-wen] UCL, Ctr Rheumatol, Dept Med, London, England	University of London; University College London; University of London; University College London	Meng, JH (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	j.morgan@ich.ucl.ac.uk			International Collaborative Effort for DMD (ICE); Wellcome Trust [084241/Z/07/Z]; Medical Research Council [G0900872]; Duchenne Parent Project, Netherlands; MRC Centre for Neuromuscular Diseases Biobank; Medical Research Council [G0601943] Funding Source: researchfish; MRC [G0900872, G0601943] Funding Source: UKRI	International Collaborative Effort for DMD (ICE); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Duchenne Parent Project, Netherlands(Netherlands Government); MRC Centre for Neuromuscular Diseases Biobank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the International Collaborative Effort for DMD (ICE), the Wellcome Trust (http://www.wellcome.ac.uk/) grant number 084241/Z/07/Z, and the Medical Research Council (http://www.mrc.ac.uk/index.htm) grant number G0900872. J.M. was funded by the International Collaborative Effort for DMD (ICE) and the Medical Research Council, and J.E.M. holds a Wellcome Trust University award. J.E.M. and F. M. are PIs of the MRC Centre for Neuromuscular Diseases. C. A. was funded by the Duchenne Parent Project, Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of the MRC Centre for Neuromuscular Diseases Biobank is gratefully acknowledged. We thank Dr. Francesco Conti for his critical reading of the manuscript, and Dr. Ayad Eddaoudi and Mr. Prabhjoat Chana for their help with FACS sorting and analysis. We also thank Dr. Geraldine Edge and Mr. Paolo De Coppi for their help in obtaining the muscle biopsies.	Abuzakouk M, 1996, J IMMUNOL METHODS, V194, P211, DOI 10.1016/0022-1759(96)00038-5; Allegra A, 2009, J NEPHROL, V22, P463; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BELLESISLES M, 1993, EUR J HISTOCHEM, V37, P375; Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Brimah K, 2004, HUM GENE THER, V15, P1109, DOI 10.1089/hum.2004.15.1109; Cao BH, 2004, CELL CYCLE, V3, P104; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Chan J, 2007, STEM CELLS, V25, P875, DOI 10.1634/stemcells.2006-0694; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2006, CURR OPIN PHARMACOL, V6, P301, DOI 10.1016/j.coph.2006.01.006; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Cooper RN, 2001, HUM GENE THER, V12, P823, DOI 10.1089/104303401750148784; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; De B. C, 2003, J CELL BIOL, V160, P909; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Eberli D, 2009, METHODS, V47, P98, DOI 10.1016/j.ymeth.2008.10.016; Ehrhardt J, 2007, NEUROMUSCULAR DISORD, V17, P631, DOI 10.1016/j.nmd.2007.04.009; FIDZIANSKA A, 1995, FOLIA NEUROPATHOL, V33, P125; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617; Grounds MD, 2007, NEUROMUSCULAR DISORD, V17, P206, DOI 10.1016/j.nmd.2007.01.007; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Huard Johnny, 2003, Birth Defects Research, V69, P230, DOI 10.1002/bdrc.10020; Ieronimakis N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010920; Jankowski RJ, 2001, HUM GENE THER, V12, P619, DOI 10.1089/104303401300057306; Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Law P K, 1992, Cell Transplant, V1, P235; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Mastrandrea F, 2008, EUR ANN ALLERGY CLIN, V40, P90; MENDELL JR, 1990, ADV EXP MED BIOL, V280, P287; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Meng JH, 2010, NEUROMUSCULAR DISORD, V20, P6, DOI 10.1016/j.nmd.2009.11.007; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MORETTA A, 1989, INT J CANCER, P48; Morosetti R, 2007, STEM CELLS, V25, P3173, DOI 10.1634/stemcells.2007-0465; Morosetti R, 2006, P NATL ACAD SCI USA, V103, P16995, DOI 10.1073/pnas.0603386103; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pisani DF, 2010, STEM CELLS, V28, P753, DOI 10.1002/stem.317; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Quinlan JG, 1997, MUSCLE NERVE, V20, P1016, DOI 10.1002/(SICI)1097-4598(199708)20:8<1016::AID-MUS12>3.0.CO;2-T; Ramalho-Santos Miguel, 2007, Cell Stem Cell, V1, P35, DOI 10.1016/j.stem.2007.05.013; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Silva-Barbosa SD, 2005, CELL TRANSPLANT, V14, P457, DOI 10.3727/000000005783982837; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tonlorenzi Rossana, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02b01s3; TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Vauchez K, 2009, MOL THER, V17, P1948, DOI 10.1038/mt.2009.204; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334	64	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17454	10.1371/journal.pone.0017454	http://dx.doi.org/10.1371/journal.pone.0017454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408080	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900018
J	Liu, XQ; Zhang, N; Li, X; Moran, MS; Yuan, CZ; Yan, S; Jiang, LY; Ma, TT; Haffty, BG; Yang, QF				Liu, Xianqiang; Zhang, Ning; Li, Xiao; Moran, Meena S.; Yuan, Cunzhong; Yan, Shi; Jiang, Liyu; Ma, Tingting; Haffty, Bruce G.; Yang, Qifeng			Identification of Novel Variants of Metadherin in Breast Cancer	PLOS ONE			English	Article							ASTROCYTE ELEVATED GENE-1; TUMOR PROGRESSION; EXPRESSION; PROTEIN; METASTASIS; ACTIVATION; SURVIVAL; ENVELOPE	Metadherin (MTDH, also known as AEG-1, and Lyric) has been demonstrated to play a potential role in several significant aspects of tumor progression. It has been reported that overexpression of MTDH is associated with progression of disease and poorer prognosis in breast cancer. However, there are no studies to date assessing variants of the MTDH gene and their potential relationship with breast cancer susceptibility. Thus, we investigated all variants of the MTDH gene and explored the association of the variants with breast cancer development. Our cohort consisted of full-length gene sequencing of 108 breast cancer cases and 100 healthy controls; variants were detected in 11 breast cancer cases and 13 controls. Among the variants detected, 9 novel variants were discovered and 2 were found to be associated with the susceptibility of breast cancer. However, additional studies need to be conducted in larger sample sizes to validate these findings and to further investigate whether these variants are prognostic in breast cancer patients.	[Liu, Xianqiang; Zhang, Ning; Jiang, Liyu; Ma, Tingting; Yang, Qifeng] Shandong Univ, Sch Med, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Liu, Xianqiang] Shandong Univ, Affiliated Jinan Cent Hosp, Dept Surg, Jinan 250100, Shandong, Peoples R China; [Moran, Meena S.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Haffty, Bruce G.] UMDNJ Robert Wood Johnson Sch Med, Dept Radiat Oncol, New Brunswick, NJ USA; [Haffty, Bruce G.] Canc Inst New Jersey, New Brunswick, NJ USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Liu, XQ (corresponding author), Shandong Univ, Sch Med, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	Zhang, Ning/GNP-1966-2022; yang, qiang/GYJ-0971-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Li, Xiao/0000-0001-9504-605X; Yuan, Cunzhong/0000-0002-8785-2139; Yang, Qifeng/0000-0003-0576-8513	Program for New Century Excellent Talents in University; Chinese Ministry of Education [108080]; National Natural Science Foundation of China [30772133, 81072150]; Independent Innovation Foundation of Shandong University (IIFSDU) [2009JQ007]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University (IIFSDU)	This project is supported by the Program for New Century Excellent Talents in University, the Key Project of Chinese Ministry of Education (No. 108080), the National Natural Science Foundation of China (No. 30772133; No. 81072150) and the Independent Innovation Foundation of Shandong University (IIFSDU, No. 2009JQ007) to Prof. Q. Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; KIM DH, 1995, INT J CANCER, V60, P812, DOI 10.1002/ijc.2910600615; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Poon TCW, 2006, GASTROENTEROLOGY, V131, P1262, DOI 10.1053/j.gastro.2006.08.014; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Su P, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-38; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460	21	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17582	10.1371/journal.pone.0017582	http://dx.doi.org/10.1371/journal.pone.0017582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408129	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170000041
J	Senchenko, VN; Krasnov, GS; Dmitriev, AA; Kudryavtseva, AV; Anedchenko, EA; Braga, EA; Pronina, IV; Kondratieva, TT; Ivanov, SV; Zabarovsky, ER; Lerman, MI				Senchenko, Vera N.; Krasnov, George S.; Dmitriev, Alexey A.; Kudryavtseva, Anna V.; Anedchenko, Ekaterina A.; Braga, Eleonora A.; Pronina, Irina V.; Kondratieva, Tatiana T.; Ivanov, Sergey V.; Zabarovsky, Eugene R.; Lerman, Michael I.			Differential Expression of CHL1 Gene during Development of Major Human Cancers	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; TUMOR-SUPPRESSOR; CALL GENE; BREAST; L1; METASTASIS; PATTERNS; REGIONS; LUNG; POLYMORPHISM	Background: CHL1 gene (also known as CALL) on 3p26.3 encodes a one-pass trans-membrane cell adhesion molecule (CAM). Previously CAMs of this type, including L1, were shown to be involved in cancer growth and metastasis. Methodology/Principal Findings: We used Clontech Cancer Profiling Arrays (19 different types of cancers, 395 samples) to analyze expression of the CHL1 gene. The results were further validated by RT-qPCR for breast, renal and lung cancer. Cancer Profiling Arrays revealed differential expression of the gene: down-regulation/silencing in a majority of primary tumors and up-regulation associated with invasive/metastatic growth. Frequent down-regulation (> 40% of cases) was detected in 11 types of cancer (breast, kidney, rectum, colon, thyroid, stomach, skin, small intestine, bladder, vulva and pancreatic cancer) and frequent up-regulation (> 40% of cases) - in 5 types (lung, ovary, uterus, liver and trachea) of cancer. Using real-time quantitative PCR (RT-qPCR) we found that CHL1 expression was decreased in 61% of breast, 60% of lung, 87% of clear cell and 89% papillary renal cancer specimens (P < 0.03 for all the cases). There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P = 0.02) without association with tumor progression. Conclusions/Significance: Our results suggested that CHL1 is involved in the development of different human cancers. Initially, during the primary tumor growth CHL1 could act as a putative tumor suppressor and is silenced to facilitate in situ tumor growth for 11 cancer types. We also suggested that re-expression of the gene on the edge of tumor mass might promote local invasive growth and enable further metastatic spread in ovary, colon and breast cancer. Our data also supported the role of CHL1 as a potentially novel specific biomarker in the early pathogenesis of two major histological types of renal cancer.	[Senchenko, Vera N.; Krasnov, George S.; Dmitriev, Alexey A.; Kudryavtseva, Anna V.; Anedchenko, Ekaterina A.; Zabarovsky, Eugene R.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Lab Struct & Funct Genom, Moscow, Russia; [Braga, Eleonora A.; Pronina, Irina V.] Russian State Genet Ctr GosNIIgenetika, Lab Mol Diag, Moscow, Russia; [Kondratieva, Tatiana T.] Russian Acad Med Sci, Blokhin Canc Res Ctr, Moscow, Russia; [Ivanov, Sergey V.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY USA; [Zabarovsky, Eugene R.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Lerman, Michael I.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; New York University; NYU Langone Medical Center; Karolinska Institutet; Sodersjukhuset Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Senchenko, VN (corresponding author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Lab Struct & Funct Genom, Moscow, Russia.	eugzab@ki.se	Dmitriev, Alexey A./D-6109-2011; Braga, Eleonora A./P-5574-2016; Kudryavtseva, Anna V/C-9032-2014; Krasnov, George S/Q-2591-2017; Zabarovsky, Eugene R/A-6645-2010; Krasnov, George S/E-6529-2014; Pronina, Irina/ABD-8018-2021; Pronina, Irina Valerievna/G-3951-2014; Senchenko, Vera N/C-8992-2014	Dmitriev, Alexey A./0000-0002-6827-9584; Kudryavtseva, Anna V/0000-0002-3722-8207; Krasnov, George S/0000-0002-6493-8378; Krasnov, George S/0000-0002-6493-8378; Pronina, Irina/0000-0002-0423-7801; Pronina, Irina Valerievna/0000-0002-0423-7801; Senchenko, Vera N/0000-0002-3119-515X; Braga, Eleonora/0000-0001-5188-4094; Ivanov, Sergey/0000-0001-9770-7237	Russian Foundation for Basic Research [08-04-01577, 10-04-01213]; Russian Ministry of Education and Science [02.740.11.5227, 16.740.11.0173]; Swedish Cancer Society; Swedish Research Council; Swedish Institute; Karolinska Institute; National Cancer Institute, Center for Cancer Research; NCI	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute; Karolinska Institute(Karolinska Institutet); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants 08-04-01577 and 10-04-01213 from the Russian Foundation for Basic Research; State Contracts 02.740.11.5227 and 16.740.11.0173 with the Russian Ministry of Education and Science; grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Institute and Karolinska Institute and National Cancer Institute, Center for Cancer Research, Intramural Research Program of NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anedchenko EA, 2008, MOL BIOL+, V42, P859, DOI 10.1134/S0026893308060058; Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; CHEN LC, 1994, CANCER RES, V54, P3021; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lindlof A, 2008, BIOINFORM BIOL INSIG, V2, P215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machesky LM, 2009, CANCER CELL, V16, P5, DOI 10.1016/j.ccr.2009.06.009; Maddaluno L, 2009, J EXP MED, V206, P623, DOI 10.1084/jem.20081211; Manderson EN, 2009, INT J GYNECOL CANCER, V19, P513, DOI 10.1111/IGC.0b013e3181a3cd38; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Murphy J, 2009, EXPERT REV MOL DIAGN, V9, P187, DOI 10.1586/14737159.9.2.187; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Protopopov A, 2003, CANCER RES, V63, P404; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rokman A, 2005, HUM GENET, V116, P43, DOI 10.1007/s00439-004-1214-7; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Safran M, 2002, BIOINFORMATICS, V18, P1542, DOI 10.1093/bioinformatics/18.11.1542; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sausville EA, 2004, EUR J CANCER, V40, P2544, DOI 10.1016/j.ejca.2004.08.006; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; SPIESSL B, 1989, TNM ATLAS ILLUSTRATE, V14, P341; Stoeck A, 2006, CANCER LETT, V239, P212, DOI 10.1016/j.canlet.2005.08.005; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Thies A, 2002, EUR J CANCER, V38, P1708, DOI 10.1016/S0959-8049(02)00105-3; Travis WD, 1999, HISTOLOGICAL TYPING; Wei MH, 1996, CANCER RES, V56, P1487; Wei MH, 1998, HUM GENET, V103, P355, DOI 10.1007/s004390050829; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zeechini S, 2008, CANCER RES, V68, P1110, DOI 10.1158/0008-5472.CAN-07-2897	54	68	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e15612	10.1371/journal.pone.0015612	http://dx.doi.org/10.1371/journal.pone.0015612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408220	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800003
J	Tu, DQ; Li, YQ; Song, HK; Toms, AV; Gould, CJ; Ficarro, SB; Marto, JA; Goode, BL; Eck, MJ				Tu, Daqi; Li, Yiqun; Song, Hyun Kyu; Toms, Angela V.; Gould, Christopher J.; Ficarro, Scott B.; Marto, Jarrod A.; Goode, Bruce L.; Eck, Michael J.			Crystal Structure of a Coiled-Coil Domain from Human ROCK I	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; MYOSIN LIGHT-CHAIN; SMOOTH-MUSCLE CONTRACTION; SERINE/THREONINE KINASE; PROTEIN-KINASE; STRESS FIBERS; PHOSPHORYLATION; BINDING; ACTIVATION; CYTOKINESIS	The small GTPase Rho and one of its targets, Rho-associated kinase (ROCK), participate in a variety of actin-based cellular processes including smooth muscle contraction, cell migration, and stress fiber formation. The ROCK protein consists of an N-terminal kinase domain, a central coiled-coil domain containing a Rho binding site, and a C-terminal pleckstrin homology domain. Here we present the crystal structure of a large section of the central coiled-coil domain of human ROCK I (amino acids 535-700). The structure forms a parallel alpha-helical coiled-coil dimer that is structurally similar to tropomyosin, an actin filament binding protein. There is an unusual discontinuity in the coiled-coil; three charged residues (E613, R617 and D620) are positioned at what is normally the hydrophobic core of coiled-coil packing. We speculate that this conserved irregularity could function as a hinge that allows ROCK to adopt its autoinhibited conformation.	[Tu, Daqi; Toms, Angela V.; Ficarro, Scott B.; Marto, Jarrod A.; Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tu, Daqi; Li, Yiqun; Toms, Angela V.; Ficarro, Scott B.; Marto, Jarrod A.; Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Song, Hyun Kyu] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Gould, Christopher J.; Goode, Bruce L.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Gould, Christopher J.; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Korea University; Brandeis University; Brandeis University	Tu, DQ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu	Song, Hyun Kyu/D-6763-2016	Song, Hyun Kyu/0000-0001-5684-4059	National Institutes of Health (NIH) [GM071834]; Ministry of Education, Science and Technology [R33-10108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM071834, T32GM007596, R01GM071834] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) grant GM071834 to M.J.E. and by WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-10108) to M.J.E. and H.K.S.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chiba Y, 1999, BRIT J PHARMACOL, V127, P597, DOI 10.1038/sj.bjp.0702585; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freedman SJ, 2003, J BIOL CHEM, V278, P13462, DOI 10.1074/jbc.M210483200; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Leung T, 1996, MOL CELL BIOL, V16, P5313; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nakajima M, 2003, EUR J PHARMACOL, V459, P113, DOI 10.1016/S0014-2999(02)02869-8; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sato M, 2000, CIRC RES, V87, P195, DOI 10.1161/01.RES.87.3.195; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086	48	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18080	10.1371/journal.pone.0018080	http://dx.doi.org/10.1371/journal.pone.0018080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445309	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300035
J	Canning-Clode, J; Fofonoff, P; Riedel, GF; Torchin, M; Ruiz, GM				Canning-Clode, Joao; Fofonoff, Paul; Riedel, Gerhardt F.; Torchin, Mark; Ruiz, Gregory M.			The Effects of Copper Pollution on Fouling Assemblage Diversity: A Tropical-Temperate Comparison	PLOS ONE			English	Article							FUNCTIONAL-DIVERSITY; PROPAGULE PRESSURE; MARINE COMMUNITIES; CHESAPEAKE BAY; INVASION; BIODIVERSITY; DISTURBANCE; RICHNESS; PATTERNS; POPULATIONS	Background: The invasion of habitats by non-indigenous species (NIS) occurs at a global scale and can generate significant ecological, evolutionary, economic and social consequences. Estuarine and coastal ecosystems are particularly vulnerable to pollution from numerous sources due to years of human-induced degradation and shipping. Pollution is considered as a class of disturbance with anthropogenic roots and recent studies have concluded that high frequencies of disturbance may facilitate invasions by increasing the availability of resources. Methodology/Principal Findings: To examine the effects of heavy metal pollution as disturbance in shaping patterns of exotic versus native diversity in marine fouling communities we exposed fouling communities to different concentrations of copper in one temperate (Virginia) and one tropical (Panama) region. Diversity was categorized as total, native and nonindigenous and we also incorporated taxonomic and functional richness. Our findings indicate that total fouling diversity decreased with increasing copper pollution, whether taxonomic or functional diversity is considered. Both native and nonindigenous richness decreased with increasing copper concentrations at the tropical site whereas at the temperate site, non-indigenous richness was too low to detect any effect. Conclusions/Significance: Non-indigenous richness decreased with increasing metal concentrations, contradicting previous investigations that evaluate the influence of heavy metal pollution on diversity and invasibility of fouling assemblages. These results provide first insights on how the invasive species pool in a certain region may play a key role in the disturbance vs. non-indigenous diversity relationship.	[Canning-Clode, Joao; Fofonoff, Paul; Riedel, Gerhardt F.; Ruiz, Gregory M.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Canning-Clode, Joao] Ctr Marine & Environm Res, CIIMAR, CIMAR, Oporto, Portugal; [Torchin, Mark] Smithsonian Trop Res Inst, Panama City, Panama	Smithsonian Institution; Smithsonian Environmental Research Center; Universidade do Porto; Smithsonian Institution; Smithsonian Tropical Research Institute	Canning-Clode, J (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	canning-clodej@si.edu	Canning-Clode, Joao/I-4343-2019; Canning Clode, João/G-5142-2011	Canning-Clode, Joao/0000-0003-2143-6535; Canning Clode, João/0000-0003-2143-6535; Ruiz, Gregory/0000-0003-2499-441X	Marine Science Network (MSN)	Marine Science Network (MSN)	The funding was provided by a Marine Science Network (MSN) fellowship award to JCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tovar-Hernandez MA, 2009, SYST BIODIVERS, V7, P319, DOI 10.1017/S1477200009990041; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; BOCK P, 2010, RECENT FOSSIL BRYOZO; Britton-Simmons KH, 2006, OIKOS, V113, P395, DOI 10.1111/j.2006.0030-1299.14203.x; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; CALDER DALE R., 1966, CHESAPEAKE SCI, V7, P223, DOI 10.2307/1350443; Canning-Clode J, 2010, GLOBAL ECOL BIOGEOGR, V19, P875, DOI 10.1111/j.1466-8238.2010.00560.x; Celesti-Grapow L, 2006, DIVERS DISTRIB, V12, P490, DOI 10.1111/j.1366-9516.2006.00282.x; Clark GF, 2005, MAR ECOL PROG SER, V298, P9, DOI 10.3354/meps298009; Clarke K.R., 1994, CHANGE MARINE COMMUN, V2, P117; Clarke K.R., 2006, PRIMER V6 USER MANUA; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CROOKS J, 2010, BIOL INVASIONS, DOI DOI 10.1007/S10530-10010-19799-10533; da Rocha RM, 2005, REV BRAS ZOOL, V22, P1170, DOI 10.1590/S0101-81752005000400052; Elton C., 1958; Floerl O, 2004, ECOL APPL, V14, P1724, DOI 10.1890/03-5399; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; FOFONOFF P, CARLTON J NATL EXOTI; Fraser C.M., 1944, HYDROIDS ATLANTIC CO; GOLLASCH S, 2006, BRIDGING DIVIDES MAR; Gosner K, 1978, FIELD GUIDE ATLANTIC; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; HALL A, 1981, BOT MAR, V24, P223, DOI 10.1515/botm.1981.24.4.223; Hall LW, 1998, ENVIRON TOXICOL CHEM, V17, P1172, DOI [10.1897/1551-5028(1998)017&lt;1172:ERAOCA&gt;2.3.CO;2, 10.1002/etc.5620170626]; HARTMAN WILLARD D., 1958, PEADBODY MUS NAT HIST BULL, V12, P155; Henry D.P., 1975, Zoologische Verh Leiden, VNo. 141, P1; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2007, ECOL LETT, V10, P849, DOI 10.1111/j.1461-0248.2007.01075.x; Johnston EL, 2002, MAR ECOL PROG SER, V226, P103, DOI 10.3354/meps226103; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Johnston Emma L., 2009, V204, P133; JONES MB, 1975, MAR BIOL, V30, P13, DOI 10.1007/BF00393748; KNIGHTJONES P, 1977, J MAR BIOL ASSOC UK, V57, P453, DOI 10.1017/S002531540002186X; KNIGHTJONES P, 1979, J ZOOL, V189, P419; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kott P, 2002, ZOOL J LINN SOC-LOND, V134, P359, DOI 10.1046/j.1096-3642.2002.00009.x; Lockwood J, 2006, INVASION ECOLOGY; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Mackey RL, 2001, ECOLOGY, V82, P3479, DOI 10.1890/0012-9658(2001)082[3479:TDDRII]2.0.CO;2; Mackie JA, 2006, MAR BIOL, V149, P285, DOI 10.1007/s00227-005-0196-x; Marins FO, 2010, ZOOLOGIA-CURITIBA, V27, P213, DOI 10.1590/S1984-46702010000200009; McCann LD, 2007, B MAR SCI, V80, P319; Minchin D, 2003, BIOFOULING, V19, P111, DOI 10.1080/0892701021000057891; *NAT MUS NAT HIST, 2002, INV ZOOL COLL DAT; OSBURN RC, 1944, CHESAPEAKE BIOL LAB, V63, P1; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Pettengill JB, 2007, BIOFOULING, V23, P161, DOI 10.1080/08927010701218952; Piola RF, 2006, MAR BIOL, V148, P997, DOI 10.1007/s00227-005-0156-5; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; Piola RF, 2006, MAR ECOL PROG SER, V311, P103, DOI 10.3354/meps311103; Piola RF, 2009, BIOFOULING, V25, P633, DOI 10.1080/08927010903063065; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; Prieur-Richard AH, 2000, ECOL LETT, V3, P412, DOI 10.1046/j.1461-0248.2000.00157.x; Raffaelli DG, 2006, MAR ECOL PROG SER, V311, P285, DOI 10.3354/meps311285; Raghukumar S, 2003, CURR SCI INDIA, V84, P884; Rice SA, 2008, INVERTEBR BIOL, V127, P45, DOI 10.1111/j.1744-7410.2007.00104.x; Riedel GF, 2000, ESTUARIES, V23, P521, DOI 10.2307/1353143; Riedel GF, 2002, CHEMOSPHERE, V49, P27, DOI 10.1016/S0045-6535(02)00195-9; Rocha LA, 2005, MOL ECOL, V14, P3921, DOI 10.1111/j.1365-294X.2005.02698.x; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 1997, AM ZOOL, V37, P621; Ruiz GM, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P347, DOI 10.5479/si.097884601X.26; RUSSELL G, 1973, P 3 INT C MAR CORR F, P719; Ryland JS., 1991, NOAA TECHNICAL REPOR, V99, P1; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; *SMITHS TROP RES I, 2010, BOC TOR SPEC DAT; SNELL TW, 1991, ECOTOX ENVIRON SAFE, V21, P308, DOI 10.1016/0147-6513(91)90070-6; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Ten Hove HA, 2009, ZOOTAXA, P1; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; Valdivia N, 2009, J SEA RES, V61, P216, DOI 10.1016/j.seares.2008.12.001; VANNAME WG, 1945, B AM MUS NAT HIST, V84, P1; WAHL M, 2009, HARD BOTTOM COMMUNIT; Zea S, 2009, SPONGE GUIDE PICTURE	80	52	53	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18026	10.1371/journal.pone.0018026	http://dx.doi.org/10.1371/journal.pone.0018026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437262	Green Published, Green Submitted, gold			2022-12-27	WOS:000288545100063
J	Cerqueira, GM; Souza, NM; Araujo, ER; Barros, AT; Morais, ZM; Vasconcellos, LA; Nascimento, ALTO				Cerqueira, Gustavo M.; Souza, Natalie M.; Araujo, Eduardo R.; Barros, Aline T.; Morais, Zenaide M.; Vasconcellos, Lvio A.; Nascimento, Ana L. T. O.			Development of Transcriptional Fusions to Assess Leptospira interrogans Promoter Activity	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; OUTER-MEMBRANE PROTEINS; INTERNATIONAL MULTICENTER EVALUATION; PROTECTIVE IMMUNITY; RECOMBINANT LIPL32; HEME OXYGENASE; DIPSTICK ASSAY; LIG GENES; EXPRESSION; SEROVAR	Background: Leptospirosis is a zoonotic infectious disease that affects both humans and animals. The existing genetic tools for Leptospira spp. have improved our understanding of the biology of this spirochete as well as the interaction of pathogenic leptospires with the mammalian host. However, new tools are necessary to provide novel and useful information to the field. Methodology and Principal Findings: A series of promoter-probe vectors carrying a reporter gene encoding green fluorescent protein (GFP) were constructed for use in L. biflexa. They were tested by constructing transcriptional fusions between the lipL41, Leptospiral Immunoglobulin-like A (ligA) and Sphingomielynase 2 (sph2) promoters from L. interrogans and the reporter gene. ligA and sph2 promoters were the most active, in comparison to the lipL41 promoter and the non-induced controls. The results obtained are in agreement with LigA expression from the L. interrogans Fiocruz L1-130 strain. Conclusions: The novel vectors facilitated the in vitro evaluation of L. interrogans promoter activity under defined growth conditions which simulate the mammalian host environment. The fluorescence and rt-PCR data obtained closely reflected transcriptional regulation of the promoters, thus demonstrating the suitability of these vectors for assessing promoter activity in L. biflexa.	[Cerqueira, Gustavo M.; Souza, Natalie M.; Araujo, Eduardo R.; Barros, Aline T.; Nascimento, Ana L. T. O.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Morais, Zenaide M.; Vasconcellos, Lvio A.] Fac Med Vet & Zootecnia, Lab Zoonoses Bacterianas VPS, Sao Paulo, Brazil; [Nascimento, Ana L. T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Interunidades Biotecnol, BR-05508 Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo	Cerqueira, GM (corresponding author), Monash Univ, Dept Microbiol, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia.	cerqueiragm@yahoo.com.br	Cerqueira, Gustavo/B-7180-2015; Nascimento, Ana L. T. O./E-8488-2012	Cerqueira, Gustavo/0000-0002-3029-6899; Nascimento, Ana L. T. O./0000-0003-4851-0870	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Butantan	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan	Gustavo M. Cerqueira holds a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). Ana L.T.O. Nascimento would like to acknowledge the support from FAPESP, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Butantan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, HUM LEPT GUID DIAGN; Artiushin S, 2004, INFECT IMMUN, V72, P742, DOI 10.1128/IAI.72.2.742-749.2004; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Aviat F, 2010, APPL ENVIRON MICROB, V76, P8135, DOI 10.1128/AEM.02199-10; Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999; Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BOLIN CA, 1989, AM J VET RES, V50, P161; Bomfim MRQ, 2005, VET MICROBIOL, V109, P89, DOI 10.1016/j.vetmic.2005.05.002; Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; CARLSON JPE, 2009, J BACTERIOL, V191, P10; Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; Chang YF, 2007, VACCINE, V25, P8190, DOI 10.1016/j.vaccine.2007.09.020; Chong PK, 2007, PROTEOMICS, V7, P424, DOI 10.1002/pmic.200600746; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Dey S, 2004, VET MICROBIOL, V103, P99, DOI 10.1016/j.vetmic.2004.07.018; Dong HY, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-223; Effler PV, 2002, J CLIN MICROBIOL, V40, P1464, DOI 10.1128/JCM.40.4.1464-1469.2002; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; FAISAL SM, 2009, VACCINE; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Faisal SM, 2009, VACCINE, V27, P6537, DOI 10.1016/j.vaccine.2009.08.051; Faisal SM, 2009, VACCINE, V27, P6129, DOI 10.1016/j.vaccine.2009.08.029; Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 1999, INFECT IMMUN, V67, P6572; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; HORZEMPA J, 2008, APPL ENVIRON MICROB, V74, P10; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; IGARASHI K, 2000, BIOCHEM BIOPH RES CO, V271, P6; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208; LI S, 2009, INNATE IMMUN; Lin X, 2008, CLIN VACCINE IMMUNOL, V15, P1711, DOI 10.1128/CVI.00189-08; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2002, INFECT IMMUN, V70, P323, DOI 10.1128/IAI.70.1.323-334.2002; Matsunaga J, 2007, MICROBIOL-SGM, V153, P3390, DOI 10.1099/mic.0.2007/007948-0; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0; MATYS V, 2003, NUCLEIC ACIDS RES, V31, P5; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Monahan AM, 2008, INFECT IMMUN, V76, P4952, DOI 10.1128/IAI.00511-08; Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010; Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001; Nally JE, 2001, INFECT IMMUN, V69, P7616, DOI 10.1128/IAI.69.12.7616-7624.2001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Oliveira TR, 2008, CLIN VACCINE IMMUNOL, V15, P1715, DOI 10.1128/CVI.00214-08; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Patarakul K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-31; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; REESE MG, 2001, COMPUTATIONAL CHEM, V26, P6; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000; SEGAL GM, 1987, KIDNEY INT, V31, P72, DOI 10.1038/ki.1987.11; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Smits HL, 1999, J CLIN MICROBIOL, V37, P2904, DOI 10.1128/JCM.37.9.2904-2909.1999; Smits HL, 2000, TROP MED INT HEALTH, V5, P124, DOI 10.1046/j.1365-3156.2000.00525.x; Smits HL, 2001, TROP MED INT HEALTH, V6, P114, DOI 10.1046/j.1365-3156.2001.00675.x; Smits HL, 2001, CLIN DIAGN LAB IMMUN, V8, P166, DOI 10.1128/CDLI.8.1.166-169.2001; Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8; Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; SUZUKI I, 2006, J EXP BOT, V57, P6; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; WEISBURG WG, 1991, J BACTERIOL, V173, P7; Xue F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000857; YAN W, VACCINE, V28, P2277; Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006	102	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17409	10.1371/journal.pone.0017409	http://dx.doi.org/10.1371/journal.pone.0017409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445252	gold, Green Published, Green Accepted			2022-12-27	WOS:000288545100013
J	Phuong, THN; Nakamura, T; Hori, E; Urakawa, S; Uwano, T; Zhao, JJ; Li, RX; Bac, ND; Hamashima, T; Ishii, Y; Matsushima, T; Ono, T; Sasahara, M; Nishijo, H				Phuong Thi Hong Nguyen; Nakamura, Tomoya; Hori, Etsuro; Urakawa, Susumu; Uwano, Teruko; Zhao, Juanjuan; Li, Ruixi; Nguyen Duy Bac; Hamashima, Takeru; Ishii, Yoko; Matsushima, Takako; Ono, Taketoshi; Sasahara, Masakiyo; Nishijo, Hisao			Cognitive and Socio-Emotional Deficits in Platelet-Derived Growth Factor Receptor-beta Gene Knockout Mice	PLOS ONE			English	Article							GENOME-WIDE SCAN; SUSCEPTIBILITY LOCUS; ANIMAL-MODEL; B-CHAIN; PREPULSE INHIBITION; MOUSE MODELS; FACTOR PDGF; SCHIZOPHRENIA; RAT; NEURONS	Platelet-derived growth factor (PDGF) is a potent mitogen. Extensive in vivo studies of PDGF and its receptor (PDGFR) genes have reported that PDGF plays an important role in embryogenesis and development of the central nervous system (CNS). Furthermore, PDGF and the beta subunit of the PDGF receptor (PDGFR-beta) have been reported to be associated with schizophrenia and autism. However, no study has reported on the effects of PDGF deletion on mice behavior. Here we generated novel mutant mice (PDGFR-beta KO) in which PDGFR-beta was conditionally deleted in CNS neurons using the Cre/loxP system. Mice without the Cre transgene but with floxed PDGFR-beta were used as controls. Both groups of mice reached adulthood without any apparent anatomical defects. These mice were further examined by conducting several behavioral tests for spatial memory, social interaction, conditioning, prepulse inhibition, and forced swimming. The test results indicated that the PDGFR-beta KO mice show deficits in all of these areas. Furthermore, an immunohistochemical study of the PDGFR-beta KO mice brain indicated that the number of parvalbumin (calcium-binding protein)-positive (i.e., putatively gamma-aminobutyric acid-ergic) neurons was low in the amygdala, hippocampus, and medial prefrontal cortex. Neurophysiological studies indicated that sensory-evoked gamma oscillation was low in the PDGFR-beta KO mice, consistent with the observed reduction in the number of parvalbumin-positive neurons. These results suggest that PDGFR-beta plays an important role in cognitive and socioemotional functions, and that deficits in this receptor may partly underlie the cognitive and socioemotional deficits observed in schizophrenic and autistic patients.	[Phuong Thi Hong Nguyen; Urakawa, Susumu; Ono, Taketoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Judo Physiotherapy, Toyama 930, Japan; [Hamashima, Takeru; Ishii, Yoko; Matsushima, Takako; Sasahara, Masakiyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 930, Japan	University of Toyama; University of Toyama	Phuong, THN (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Judo Physiotherapy, Toyama 930, Japan.	nishijo@med.u-toyama.ac.jp			CREST (Core Research for Evolutional Science and Technology); JST (Japan Science and Technology Agency) Japan; JSPS (Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture [22240051]; Grants-in-Aid for Scientific Research [22240051] Funding Source: KAKEN	CREST (Core Research for Evolutional Science and Technology)(Core Research for Evolutional Science and Technology (CREST)); JST (Japan Science and Technology Agency) Japan(Japan Science & Technology Agency (JST)); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by CREST (Core Research for Evolutional Science and Technology), JST (Japan Science and Technology Agency), Japan, JSPS (Japan Society for the Promotion of Science) Asian Core Program, and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (A) (22240051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JD, 2004, NEUROPSYCHOPHARMACOL, V29, P1080, DOI 10.1038/sj.npp.1300394; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bannon Anthony W, 2007, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0809s41; Behrens MM, 2009, NEUROPHARMACOLOGY, V57, P193, DOI 10.1016/j.neuropharm.2009.06.002; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CHENG B, 1995, J NEUROSCI, V15, P7095; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; Devlin B, 2002, MOL PSYCHIATR, V7, P689, DOI 10.1038/sj.mp.4001056; ELISABETH B, 2009, NEUROSCIENCE, V10, P132; Fejgin K, 2009, NEUROPSYCHOPHARMACOL, V34, P1673, DOI 10.1038/npp.2008.225; Fendt M, 2000, NEUROSCIENCE, V98, P55, DOI 10.1016/S0306-4522(00)00086-5; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gaigg SB, 2007, NEUROPSYCHOLOGIA, V45, P2125, DOI 10.1016/j.neuropsychologia.2007.01.012; Gao ZY, 2005, J BIOL CHEM, V280, P9375, DOI 10.1074/jbc.M413081200; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hall MH, 2011, SCHIZOPHRENIA BULL, V37, P778, DOI 10.1093/schbul/sbp134; Hanlon FM, 2006, SCHIZOPHR RES, V87, P67, DOI 10.1016/j.schres.2006.05.021; Hauser J, 2005, MOL PSYCHIATR, V10, P201, DOI 10.1038/sj.mp.4001554; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Herzberg I, 2006, HUM MOL GENET, V15, P3146, DOI 10.1093/hmg/ddl254; Hof PR., 2000, COMP CYTOARCHITECTON; Hofer E, 2001, SCHIZOPHR RES, V51, P127, DOI 10.1016/S0920-9964(00)00118-3; Ishii Y, 2008, MOL CELL NEUROSCI, V37, P507, DOI 10.1016/j.mcn.2007.11.006; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Kajizuka M, 2010, PROG NEURO-PSYCHOPH, V34, P154, DOI 10.1016/j.pnpbp.2009.10.017; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Kim HJ, 2008, SCHIZOPHR RES, V103, P201, DOI 10.1016/j.schres.2008.04.031; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Kurokawa M, 2003, CELL MOL NEUROBIOL, V23, P121, DOI 10.1023/A:1022956403708; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Lei SB, 1999, J BIOL CHEM, V274, P30617, DOI 10.1074/jbc.274.43.30617; Leicht G, 2010, BIOL PSYCHIAT, V67, P224, DOI 10.1016/j.biopsych.2009.07.033; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nabeshima T, 2006, ANN NY ACAD SCI, V1086, P160, DOI 10.1196/annals.1377.003; NEETA PN, 2005, J NEUROSCI, V25, P4659; O'Tuathaigh CMP, 2010, SCHIZOPHRENIA BULL, V36, P271, DOI 10.1093/schbul/sbp125; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; OTHBERG A, 1995, EXP BRAIN RES, V105, P111; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Phillips JM, 2007, NEUROSCIENCE, V144, P1314, DOI 10.1016/j.neuroscience.2006.11.003; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Pollack MH, 2008, PROG NEURO-PSYCHOPH, V32, P739, DOI 10.1016/j.pnpbp.2007.11.023; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Rojas DC, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-66; SASAHARA A, 1992, DEV BRAIN RES, V68, P41, DOI 10.1016/0165-3806(92)90246-S; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; Sasahara M, 1998, ONCOGENE, V16, P1571, DOI 10.1038/sj.onc.1201679; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Schmajuk NA, 2005, BEHAV NEUROSCI, V119, P1546, DOI 10.1037/0735-7044.119.6.1546; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Shioda N, 2009, NEUROSCI RES, V65, pS67, DOI 10.1016/j.neures.2009.09.217; Silverman JM, 1996, AM J MED GENET, V67, P162, DOI 10.1002/(SICI)1096-8628(19960409)67:2<162::AID-AJMG6>3.0.CO;2-U; Sklar P, 2004, MOL PSYCHIATR, V9, P213, DOI 10.1038/sj.mp.4001418; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; SMITS A, 1993, EUR J NEUROSCI, V5, P986, DOI 10.1111/j.1460-9568.1993.tb00950.x; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stahl SM, 2007, ACTA PSYCHIAT SCAND, V115, P4, DOI 10.1111/j.1600-0447.2006.00947.x; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; Suzuki M, 2005, BRAIN, V128, P2109, DOI 10.1093/brain/awh554; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; Tandon R, 2009, SCHIZOPHR RES, V110, P1, DOI 10.1016/j.schres.2009.03.005; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; VUKMIR V, 2001, PEDIATR RES, V50, P236; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302	81	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18004	10.1371/journal.pone.0018004	http://dx.doi.org/10.1371/journal.pone.0018004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437241	gold, Green Submitted, Green Published			2022-12-27	WOS:000288545100055
J	Shaw, PJA; Shackleton, K				Shaw, Peter J. A.; Shackleton, Kyle			Carnivory in the Teasel Dipsacus fullonum - The Effect of Experimental Feeding on Growth and Seed Set	PLOS ONE			English	Article							NITROGEN; PLANTS; PREY; NUTRITION; FITNESS; DROSERA	The teasel, Dipsacus fullonum is known to catch invertebrates in its water filled leaf bases, but experimental testing of reproductive benefits of this have been lacking. We report the effects of insect supplementation/ removal and water removal during spring/summer on Dipsacus in two field populations. There were no significant treatment effects on biomass, but addition of dead dipteran larvae to leaf bases caused a 30% increase in seed set and the seed mass: biomass ratio. This study provides the first empirical evidence for reproductive benefit from carnivory in Dipsacus fullonum.	[Shaw, Peter J. A.; Shackleton, Kyle] Roehampton Univ, Dept Life Sci, Whitelands Coll, London, England	Roehampton University	Shaw, PJA (corresponding author), Roehampton Univ, Dept Life Sci, Whitelands Coll, London, England.	p.shaw@roehampton.ac.uk		shaw, peter/0000-0002-6621-2204				Adamec L, 1997, BOT REV, V63, P273, DOI 10.1007/BF02857953; CHANDLER GE, 1976, NEW PHYTOL, V76, P129, DOI 10.1111/j.1469-8137.1976.tb01445.x; Christy M., 1923, J BOT BRIT FOREIGN, V61, P33; Darwin C., 1875, CARNIVOROUS PLANTS; DARWIN F, 1877, P ROY SOC LONDON, V26, P245; *ECOFACT, 1999, RES REP, V2; Ellison AM, 2001, TRENDS ECOL EVOL, V16, P623, DOI 10.1016/S0169-5347(01)02269-8; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Hanslin HM, 1996, OECOLOGIA, V106, P370, DOI 10.1007/BF00334564; Juniper B. E., 1989, CARNIVOROUS PLANTS; Lloyd F.E., 1942, CARNIVOROUS PLANTS; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MEYERS DG, 1982, P ACAD NAT SCI PHILA, V134, P1; PRIMACK RB, 1989, ANNU REV ECOL SYST, V20, P367, DOI 10.1146/annurev.es.20.110189.002055; SIMONS P, 1981, CARNIVOROUS PLANT NE, V10, P65; SLACK A, CARNIVOROUS PLANTS; THUM M, 1989, OECOLOGIA, V81, P401, DOI 10.1007/BF00377091; Wakefield AE, 2005, ECOLOGY, V86, P1737, DOI 10.1890/04-1673; WERNER PA, 1975, OECOLOGIA, V20, P197, DOI 10.1007/BF00347472; WERNER PA, 1975, CAN J PLANT SCI, V55, P783, DOI 10.4141/cjps75-122	20	5	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17935	10.1371/journal.pone.0017935	http://dx.doi.org/10.1371/journal.pone.0017935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445274	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100045
J	Andersson, IE; Andersson, CD; Batsalova, T; Dzhambazov, B; Holmdahl, R; Kihlberg, J; Linusson, A				Andersson, Ida E.; Andersson, C. David; Batsalova, Tsvetelina; Dzhambazov, Balik; Holmdahl, Rikard; Kihlberg, Jan; Linusson, Anna			Design of Glycopeptides Used to Investigate Class II MHC Binding and T-Cell Responses Associated with Autoimmune Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ANCHOR-SUBSTITUTED VARIANT; PEPTIDE MIMETIC INHIBITORS; SCORING FUNCTIONS; ANTIGEN PRESENTATION; MOLECULAR DOCKING; LIGAND; COMPLEX; MODEL; DETERMINANT	The glycopeptide fragment CII259-273 from type II collagen (CII) binds to the murine A(q) and human DR4 class II Major Histocompatibility Complex (MHC II) proteins, which are associated with development of murine collagen-induced arthritis (CIA) and rheumatoid arthritis (RA), respectively. It has been shown that CII259-273 can be used in therapeutic vaccination of CIA. This glycopeptide also elicits responses from T-cells obtained from RA patients, which indicates that it has an important role in RA as well. We now present a methodology for studies of (glyco) peptide-receptor interactions based on a combination of structure-based virtual screening, ligand-based statistical molecular design and biological evaluations. This methodology included the design of a CII259-273 glycopeptide library in which two anchor positions crucial for binding in pockets of A(q) and DR4 were varied. Synthesis and biological evaluation of the designed glycopeptides provided novel structure-activity relationship (SAR) understanding of binding to A(q) and DR4. Glycopeptides that retained high affinities for these MHC II proteins and induced strong responses in panels of T-cell hybridomas were also identified. An analysis of all the responses revealed groups of glycopeptides with different response patterns that are of high interest for vaccination studies in CIA. Moreover, the SAR understanding obtained in this study provides a platform for the design of second-generation glycopeptides with tuned MHC affinities and T-cell responses.	[Andersson, Ida E.; Andersson, C. David; Kihlberg, Jan] Umea Univ, Dept Chem, Umea, Sweden; [Batsalova, Tsvetelina; Dzhambazov, Balik; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Kihlberg, Jan; Linusson, Anna] AstraZeneca R&D, Molndal, Sweden	Umea University; Karolinska Institutet; AstraZeneca	Andersson, IE (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	anna.linusson@chem.umu.se	Batsalova, Tsvetelina G/W-6340-2018; Batsalova, Tsvetelina/AAS-7000-2021; Kihlberg, Jan/S-4739-2019; Holmdahl, Rikard/AAI-7682-2020; Batsalova, Tsvetelina/K-3026-2016; Dzhambazov, Balik/H-1220-2015	Batsalova, Tsvetelina/0000-0002-6560-1945; Dzhambazov, Balik/0000-0001-8052-5840	Swedish Research Council [dnr 2008-3672]; Swedish Strategic Science Foundation (SSF); Umea University; JC Kempe Foundation (SJCKMS); EU [HEALTH-F2-2008-223404]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Science Foundation (SSF)(Swedish Foundation for Strategic Research); Umea University; JC Kempe Foundation (SJCKMS); EU(European Commission)	Funding: This work was supported by the Swedish Research Council (dnr 2008-3672), the Swedish Strategic Science Foundation (SSF), the Biotechnology Fund at Umea University, the JC Kempe Foundation (SJCKMS), and the EU project Masterswitch HEALTH-F2-2008-223404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EC, 1998, P NATL ACAD SCI USA, V95, P7574, DOI 10.1073/pnas.95.13.7574; Andersson IE, 2007, J MED CHEM, V50, P5627, DOI 10.1021/jm0705410; Andersson IE, 2010, ORG BIOMOL CHEM, V8, P2931, DOI 10.1039/c003640d; Backlund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A; Backlund J, 2002, P NATL ACAD SCI USA, V99, P9960, DOI 10.1073/pnas.132254199; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; Boots AMH, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2269; Bowers K.J., 2006, P ACM IEEE C SUP SC0, DOI 10.1109/SC.2006.54; Box G.E., 1987, EMPIRICAL MODEL BUIL, VVolume 424; Broddefalk J, 1998, J AM CHEM SOC, V120, P7676, DOI 10.1021/ja980489k; BRUNSBERG U, 1994, EUR J IMMUNOL, V24, P1698, DOI 10.1002/eji.1830240736; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Haan EC, 2005, MOL IMMUNOL, V42, P355, DOI 10.1016/j.molimm.2004.07.044; de Haan EC, 2002, BIOORGAN MED CHEM, V10, P1939, DOI 10.1016/S0968-0896(01)00434-5; deAguiar PF, 1995, CHEMOMETR INTELL LAB, V30, P199, DOI 10.1016/0169-7439(94)00076-X; Desmond Molecular Dynamics System, 2010, 22 DE SHAW RES; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; DUMOUCHEL W, 1994, TECHNOMETRICS, V36, P37, DOI 10.2307/1269197; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Eriksson L, 1996, J CHEMOMETR, V10, P483; Evensen E, 2007, J COMPUT AID MOL DES, V21, P395, DOI 10.1007/s10822-007-9119-x; Falcioni F, 1999, NAT BIOTECHNOL, V17, P562, DOI 10.1038/9865; Feher M, 2006, DRUG DISCOV TODAY, V11, P421, DOI 10.1016/j.drudis.2006.03.009; Ford ML, 2003, J IMMUNOL, V171, P1247, DOI 10.4049/jimmunol.171.3.1247; Gad M, 2003, EUR J IMMUNOL, V33, P1624, DOI 10.1002/eji.200323698; GOLD, 2006, CAMBR CRYST DAT; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hanson GJ, 1996, BIOORG MED CHEM LETT, V6, P1931, DOI 10.1016/0960-894X(96)00348-4; HILL CM, 1994, J IMMUNOL, V152, P2890; Holm B, 2002, CHEMBIOCHEM, V3, P1209, DOI 10.1002/1439-7633(20021202)3:12<1209::AID-CBIC1209>3.0.CO;2-0; Holm L, 2005, BIOORGAN MED CHEM, V13, P473, DOI 10.1016/j.bmc.2004.10.011; Holm L, 2007, J MED CHEM, V50, P2049, DOI 10.1021/jm061209b; Holm L, 2006, BIOORGAN MED CHEM, V14, P5921, DOI 10.1016/j.bmc.2006.05.023; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jacobsson M, 2003, J MED CHEM, V46, P5781, DOI 10.1021/jm030896t; Jensen T, 2001, EUR J IMMUNOL, V31, P3197, DOI 10.1002/1521-4141(200111)31:11<3197::AID-IMMU3197>3.0.CO;2-5; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kirchmair J, 2006, J CHEM INF MODEL, V46, P1848, DOI 10.1021/ci060084g; Kjellen P, 1998, EUR J IMMUNOL, V28, P755, DOI 10.1002/(SICI)1521-4141(199802)28:02<755::AID-IMMU755>3.0.CO;2-2; KRCHNAK V, 1988, INT J PEPT PROT RES, V32, P415; Larsson A, 2005, J MED CHEM, V48, P935, DOI 10.1021/jm040818l; Lindgren F, 1996, J CHEMOMETR, V10, P521; Linusson A, 1998, MOL DIVERS, V4, P103, DOI 10.1023/A:1026416430656; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Margot CD, 2005, J IMMUNOL, V174, P3352, DOI 10.4049/jimmunol.174.6.3352; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; McGann MR, 2003, BIOPOLYMERS, V68, P76, DOI 10.1002/bip.10207; MICHAELSSON E, 1992, EUR J IMMUNOL, V22, P1819, DOI 10.1002/eji.1830220722; MYERS LK, 1993, J IMMUNOL, V150, P4652; Myers LK, 1998, J IMMUNOL, V161, P3589; Myers LK, 2002, ARTHRITIS RHEUM, V46, P3369, DOI 10.1002/art.10687; Nurbo J, 2007, J PEPT SCI, V13, P822, DOI 10.1002/psc.906; Oda A, 2006, J CHEM INF MODEL, V46, P380, DOI 10.1021/ci050283k; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Perola E, 2004, PROTEINS, V56, P235, DOI 10.1002/prot.20088; Rognan D, 1999, J MED CHEM, V42, P4650, DOI 10.1021/jm9910775; Rosloniec EF, 1996, CELL IMMUNOL, V172, P21, DOI 10.1006/cimm.1996.0210; Ryan KR, 2004, CELL IMMUNOL, V227, P70, DOI 10.1016/j.cellimm.2004.01.003; Sakurai Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2043; Smith AB, 1999, J AM CHEM SOC, V121, P9286, DOI 10.1021/ja991251e; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; STJOHN RC, 1975, TECHNOMETRICS, V17, P15; Syed BM, 2004, TETRAHEDRON, V60, P5571, DOI 10.1016/j.tet.2004.04.081; Tang B, 2009, CLIN IMMUNOL, V133, P145, DOI 10.1016/j.clim.2009.06.006; Terp GE, 2001, J MED CHEM, V44, P2333, DOI 10.1021/jm001090l; Tong JC, 2004, PROTEIN SCI, V13, P2523, DOI 10.1110/ps.04631204; Verkhivker GM, 2000, J COMPUT AID MOL DES, V14, P731, DOI 10.1023/A:1008158231558; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wei HY, 2005, J CHEM INF MODEL, V45, P1343, DOI 10.1021/ci050140y; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Xing L, 2004, J COMPUT AID MOL DES, V18, P333, DOI 10.1023/B:JCAM.0000047812.39758.ab; Zavala-Ruiz Z, 2003, J BIOL CHEM, V278, P44904, DOI 10.1074/jbc.M307652200	80	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17881	10.1371/journal.pone.0017881	http://dx.doi.org/10.1371/journal.pone.0017881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423632	gold, Green Submitted, Green Published			2022-12-27	WOS:000288513900039
J	da Rocha, AF; Rocha, FT; Massad, E				da Rocha, Armando Freitas; Rocha, Fabio Theoto; Massad, Eduardo			The Brain as a Distributed Intelligent Processing System: An EEG Study	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SEX-DIFFERENCES; FUNCTIONAL CONNECTIVITY; NEURAL EFFICIENCY; NETWORKS; NEUROSCIENCE; PERFORMANCE; AGE	Background: Various neuroimaging studies, both structural and functional, have provided support for the proposal that a distributed brain network is likely to be the neural basis of intelligence. The theory of Distributed Intelligent Processing Systems (DIPS), first developed in the field of Artificial Intelligence, was proposed to adequately model distributed neural intelligent processing. In addition, the neural efficiency hypothesis suggests that individuals with higher intelligence display more focused cortical activation during cognitive performance, resulting in lower total brain activation when compared with individuals who have lower intelligence. This may be understood as a property of the DIPS. Methodology and Principal Findings: In our study, a new EEG brain mapping technique, based on the neural efficiency hypothesis and the notion of the brain as a Distributed Intelligence Processing System, was used to investigate the correlations between IQ evaluated with WAIS (Whechsler Adult Intelligence Scale) and WISC (Wechsler Intelligence Scale for Children), and the brain activity associated with visual and verbal processing, in order to test the validity of a distributed neural basis for intelligence. Conclusion: The present results support these claims and the neural efficiency hypothesis.	[da Rocha, Armando Freitas; Rocha, Fabio Theoto] RANI, Sao Paulo, Brazil; [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Universidade de Sao Paulo	da Rocha, AF (corresponding author), RANI, Sao Paulo, Brazil.	edmassad@usp.br	Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011	Massad, Eduardo/0000-0002-7200-2916; 				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; CHANDRASEKARAN B, 1981, IEEE T SYST MAN CYB, V11, P1, DOI 10.1109/TSMC.1981.4308573; Colom R, 2004, PERS INDIV DIFFER, V36, P75, DOI 10.1016/S0191-8869(03)00053-9; DAVIS R, 1983, ARTIF INTELL, V20, P63, DOI 10.1016/0004-3702(83)90015-2; Deary IJ, 1997, TRENDS NEUROSCI, V20, P365, DOI 10.1016/S0166-2236(97)01070-9; Doppelmayr M, 2005, NEUROSCI LETT, V381, P309, DOI 10.1016/j.neulet.2005.02.037; Doppelmayr M, 2002, INTELLIGENCE, V30, P289, DOI 10.1016/S0160-2896(01)00101-5; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fink A, 2006, INT J PSYCHOPHYSIOL, V62, P46, DOI 10.1016/j.ijpsycho.2006.01.001; Grabner RH, 2006, BRAIN RES BULL, V69, P422, DOI 10.1016/j.brainresbull.2006.02.009; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; HEWITT C, 1991, IEEE T SYST MAN CYB, V21, P1409, DOI 10.1109/21.135685; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jackson DN, 2006, INTELLIGENCE, V34, P479, DOI 10.1016/j.intell.2006.03.005; Jausovec N, 2000, INTELLIGENCE, V28, P213, DOI 10.1016/S0160-2896(00)00037-4; Jausovec N, 2005, BRAIN COGNITION, V59, P277, DOI 10.1016/j.bandc.2005.08.001; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; LESSER VR, 1991, IEEE T SYST MAN CYB, V21, P1347, DOI 10.1109/21.135681; Lynn R, 1999, INTELLIGENCE, V27, P1, DOI 10.1016/S0160-2896(99)00009-4; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Neubauer AC, 1997, PERS INDIV DIFFER, V22, P885, DOI 10.1016/S0191-8869(97)00003-2; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; Njemanze PC, 2005, BRAIN LANG, V92, P234, DOI 10.1016/j.bandl.2004.06.104; Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rocha AF, 1997, PROG NEUROBIOL, V53, P121, DOI 10.1016/S0301-0082(97)00015-4; Rocha AF, 2004, BRAIN; Rocha AF, 1992, LECT NOTES ARTIFICIA; Rocha AF, 2002, PROGR NEUROBIOLOGY, V64, P555; Rocha FT, 2005, COGNITIVE BRAIN RES, V22, P359, DOI 10.1016/j.cogbrainres.2004.09.008; Schmid RG, 2002, CLIN NEUROPHYSIOL, V113, P1647, DOI 10.1016/S1388-2457(02)00212-2; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Stauder JEA, 2003, INTELLIGENCE, V31, P257, DOI 10.1016/S0160-2896(02)00136-8; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Wats DJ, 1999, SMALL WORLDS DYNAMIC	42	11	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17355	10.1371/journal.pone.0017355	http://dx.doi.org/10.1371/journal.pone.0017355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423657	Green Published, gold			2022-12-27	WOS:000288513900007
J	Aruna, M; Dasgupta, S; Sirisha, PVS; Bhaskar, SA; Tarakeswari, S; Singh, L; Reddy, BM				Aruna, Meka; Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Bhaskar, Sadaranga Andal; Tarakeswari, Surapaneni; Singh, Lalji; Reddy, B. Mohan			Role of Androgen Receptor CAG Repeat Polymorphism and X-Inactivation in the Manifestation of Recurrent Spontaneous Abortions in Indian Women	PLOS ONE			English	Article							CHROMOSOME INACTIVATION; TRINUCLEOTIDE REPEATS; GENE; INFERTILITY; MISCARRIAGE; LENGTH	The aim of the present study was to investigate the role of CAG repeat polymorphism and X-chromosome Inactivation (XCI) pattern in Recurrent Spontaneous Abortions among Indian women which has not been hitherto explored. 117 RSA cases and 224 Controls were included in the study. Cases were recruited from two different hospitals - Lakshmi Fertility Clinic, Nellore and Fernandez Maternity Hospital, Hyderabad. Controls were roughly matched for age, ethnicity and socioeconomic status. The CAG repeats of the Androgen Receptor gene were genotyped using a PCR-based assay and were analysed using the GeneMapper software to determine the CAG repeat length. XCI analysis was also carried out to assess the inactivation percentages. RSA cases had a significantly greater frequency of allele sizes in the polymorphic range above 19 repeats (p = 0.006), which is the median value of the controls, and in the biallelic mean range above 21 repeats (p = 0.002). We found no evidence of abnormal incidence of skewed X-inactivation. We conclude that longer CAG repeat lengths are associated with increased odds for RSA with statistical power estimated to be similar to 90%.	[Aruna, Meka; Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Reddy, B. Mohan] Indian Stat Inst, Mol Anthropol Grp, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India; [Bhaskar, Sadaranga Andal] Lakshmi Fertil Clin & Res Ctr, Nellore, Andhra Pradesh, India; [Tarakeswari, Surapaneni] Fernandez Hosp, Hyderabad, Andhra Pradesh, India; [Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Statistical Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Aruna, M (corresponding author), Indian Stat Inst, Mol Anthropol Grp, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in			Indian Statistical Institute, Kolkata, India	Indian Statistical Institute, Kolkata, India	Indian Statistical Institute, Kolkata, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beever CL, 2003, AM J HUM GENET, V72, P399, DOI 10.1086/346119; Bussen S, 1999, HUM REPROD, V14, P18, DOI 10.1093/humrep/14.1.18; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; CLIFFORD K, 1995, HUM REPROD, V10, P694, DOI 10.1093/oxfordjournals.humrep.a136015; Cram DS, 2000, MOL HUM REPROD, V6, P861, DOI 10.1093/molehr/6.9.861; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; Ferk P, 2008, FERTIL STERIL, V90, P860, DOI 10.1016/j.fertnstert.2007.07.1291; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Hogge WA, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.012; HUSSAIN M A, 1976, Bangladesh Medical Research Council Bulletin, V2, P120; Jaaskelainen J, 2005, FERTIL STERIL, V83, P1724, DOI 10.1016/j.fertnstert.2004.11.080; Kim JJ, 2008, FERTIL STERIL, V90, P2318, DOI 10.1016/j.fertnstert.2007.10.030; Kim JW, 2004, J KOREAN MED SCI, V19, P258, DOI 10.3346/jkms.2004.19.2.258; Lanasa MC, 1999, AM J HUM GENET, V65, P252, DOI 10.1086/302441; Lanasa MC, 2000, SEMIN REPROD MED, V18, P97, DOI 10.1055/s-2000-13480; Liu QR, 2008, ENDOCRINE, V33, P165, DOI 10.1007/s12020-008-9069-7; Meka Aruna, 2006, International Journal of Human Genetics, V6, P109; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Mohlig M, 2006, EUR J ENDOCRINOL, V155, P127, DOI 10.1530/eje.1.02195; Pasquier E, 2007, HUM REPROD, V22, P2829, DOI 10.1093/humrep/dem264; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Reddy BM, 2005, HUM BIOL, V77, P803, DOI 10.1353/hub.2006.0018; REISS HE, 1998, REPROD MED A Z; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangha KK, 1999, AM J HUM GENET, V65, P913, DOI 10.1086/302552; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Sharma R, 1992, Indian J Matern Child Health, V3, P36; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Sullivan AE, 2003, OBSTET GYNECOL, V101, P1236, DOI 10.1016/S0029-7844(03)00345-4; TULPPALA M, 1993, BRIT J OBSTET GYNAEC, V100, P348, DOI 10.1111/j.1471-0528.1993.tb12978.x; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Xita N, 2008, HUM REPROD, V23, P693, DOI 10.1093/humrep/dem382	33	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17718	10.1371/journal.pone.0017718	http://dx.doi.org/10.1371/journal.pone.0017718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423805	gold, Green Submitted, Green Published			2022-12-27	WOS:000288512400021
J	Hashemi, J; Worrall, C; Vasilcanu, D; Fryknas, M; Sulaiman, L; Karimi, M; Weng, WH; Lui, WO; Rudduck, C; Axelson, M; Jernberg-Wiklund, H; Girnita, L; Larsson, O; Larsson, C				Hashemi, Jamileh; Worrall, Claire; Vasilcanu, Daiana; Fryknas, Marten; Sulaiman, Luqman; Karimi, Mohsen; Weng, Wen-Hui; Lui, Weng-Onn; Rudduck, Christina; Axelson, Magnus; Jernberg-Wiklund, Helena; Girnita, Leonard; Larsson, Olle; Larsson, Catharina			Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)	PLOS ONE			English	Article							GROWTH-FACTOR-I; RECEPTOR TYROSINE KINASE; MOUSE MODEL; INHIBITOR; PROLIFERATION; NORMALIZATION; PROGRESSION; MECHANISMS; EXPRESSION; PROFILES	Background: Picropodophyllin (PPP) is a promising novel anti-neoplastic agent that efficiently kills tumor cells in vitro and causes tumor regression and increased survival in vivo. We have previously reported that PPP treatment induced moderate tolerance in two out of 10 cell lines only, and here report the acquired genomic and expression alterations associated with PPP selection over 1.5 years of treatment. Methodology/Principal Findings: Copy number alterations monitored using metaphase and array-based comparative genomic hybridization analyses revealed largely overlapping alterations in parental and maximally tolerant cells. Gain/amplification of the MYC and PVT1 loci in 8q24.21 were verified on the chromosome level. Abnormalities observed in connection to PPP treatment included regular gains and losses, as well as homozygous losses in 10q24.1-q24.2 and 12p12.3-p13.2 in one of the lines and amplification at 5q11.2 in the other. Abnormalities observed in both tolerant derivatives include amplification/gain of 5q11.2, gain of 11q12.1-q14.3 and gain of 13q33.3-qter. Using Nexus software analysis we combined the array-CGH data with data from gene expression profilings and identified genes that were altered in both inputs. A subset of genes identified as downregulated (ALDH1A3, ANXA1, TLR4 and RAB5A) or upregulated (COX6A1, NFIX, ME1, MAPK and TAP2) were validated by siRNA in the tolerant or parental cells to alter sensitivity to PPP and confirmed to alter sensitivity to PPP in further cell lines. Conclusions: Long-term PPP selection lead to altered gene expression in PPP tolerant cells with increase as well as decrease of genes involved in cell death such as PTEN and BCL2. In addition, acquired genomic copy number alterations were observed that were often reflected by altered mRNA expression levels for genes in the same regions.	[Hashemi, Jamileh; Sulaiman, Luqman; Karimi, Mohsen; Weng, Wen-Hui; Lui, Weng-Onn; Rudduck, Christina; Axelson, Magnus; Larsson, Catharina] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Karolinska Univ Hosp, Stockholm, Sweden; [Worrall, Claire; Vasilcanu, Daiana; Girnita, Leonard; Larsson, Olle] Karolinska Inst, Dept Oncol Pathol, Karolinska Univ Hosp, Stockholm, Sweden; [Fryknas, Marten; Jernberg-Wiklund, Helena] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Hashemi, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Karolinska Univ Hosp, CMM L8 01, Stockholm, Sweden.	Jamileh.Hashemi@ki.se	Weng, Wen Hui/AAV-7260-2021; Lui, Weng-Onn/G-6703-2013; Girnita, Leonard/A-4168-2008; Lui, Weng-Onn/X-5957-2019	Lui, Weng-Onn/0000-0003-4717-4473; Girnita, Leonard/0000-0003-0280-9500; Lui, Weng-Onn/0000-0003-4717-4473; Jernberg Wiklund, Helena/0000-0002-9319-7986	Swedish Cancer Society; Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council; Swedish Children Cancer Society; Cancer Society in Stockholm; Gustav V Jubilee Foundation; Stockholm County Council; Lund University; Knut & Alice Wallenberg Foundation; IngaBritt and Arne Lundberg Foundation; Governmental Funding of Clinical Research within the National Health Services (ALF)	Swedish Cancer Society(Swedish Cancer Society); Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Gustav V Jubilee Foundation; Stockholm County Council(Stockholm County Council); Lund University; Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Governmental Funding of Clinical Research within the National Health Services (ALF)	Work was supported by the Swedish Cancer Society, Goran Gustafsson Foundation for Research in Natural Sciences and Medicine, Swedish Research Council, Swedish Children Cancer Society, Cancer Society in Stockholm, Gustav V Jubilee Foundation, and Stockholm County Council. The SCIBLU Genomics center is supported by grants from Lund University, the Knut & Alice Wallenberg Foundation, the IngaBritt and Arne Lundberg Foundation and by Governmental Funding of Clinical Research within the National Health Services (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Autio R, 2003, BIOINFORMATICS, V19, P1714, DOI 10.1093/bioinformatics/btg230; Cadoret A, 2005, INT J CANCER, V114, P668, DOI 10.1002/ijc.20805; Colon E, 2007, ENDOCRINOLOGY, V148, P128, DOI 10.1210/en.2006-0835; Conti L, 2007, BLOOD, V109, P2496, DOI 10.1182/blood-2006-07-034231; Duan ZF, 2009, MOL CANCER THER, V8, P2122, DOI 10.1158/1535-7163.MCT-09-0115; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2620, DOI 10.1167/iovs.07-0742; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2337, DOI 10.1167/iovs.07-0819; Eun SY, 2008, BIOCHEM BIOPH RES CO, V373, P58, DOI 10.1016/j.bbrc.2008.05.178; GENSLER WJ, 1966, J ORG CHEM, V31, P3224, DOI 10.1021/jo01348a030; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Hannelius U, 2007, TWIN RES HUM GENET, V10, P604, DOI 10.1375/twin.10.4.604; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Menu E, 2007, INT J CANCER, V121, P1857, DOI 10.1002/ijc.22845; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Pang ST, 2006, PROSTATE, V66, P157, DOI 10.1002/pros.20328; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Roberti A, 2006, J CELL PHYSIOL, V207, P571, DOI 10.1002/jcp.20515; Saal LH, 2002, GENOME BIOL, V3; SalazarOnfray F, 1997, CANCER RES, V57, P4348; *SCN, 1995, INT SYST HUM CYT NOM; Strathdee G, 2007, DIS MARKERS, V23, P43, DOI 10.1155/2007/610815; Vasilcanu D, 2006, ONCOGENE, V25, P3186, DOI 10.1038/sj.onc.1209339; Vasilcanu R, 2008, MOL PHARMACOL, V73, P930, DOI 10.1124/mol.107.040014; Weng WH, 2005, INT J ONCOL, V26, P5; Yang MCK, 2001, PHYSIOL GENOMICS, V7, P45, DOI 10.1152/physiolgenomics.00020.2001; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yin SC, 2010, NEURO-ONCOLOGY, V12, P19, DOI 10.1093/neuonc/nop008; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	41	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14757	10.1371/journal.pone.0014757	http://dx.doi.org/10.1371/journal.pone.0014757			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423728	gold, Green Published, Green Submitted			2022-12-27	WOS:000288512400004
J	Halford, WP; Puschel, R; Gershburg, E; Wilber, A; Gershburg, S; Rakowski, B				Halford, William P.; Pueschel, Ringo; Gershburg, Edward; Wilber, Andrew; Gershburg, Svetlana; Rakowski, Brandon			A Live-Attenuated HSV-2 ICP0(-) Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; SIMPLEX-VIRUS; GUINEA-PIGS; IMMUNE-RESPONSES; MUCOSAL IMMUNITY; VARICELLA VACCINATION; ADJUVANT ACTIVITY; TYPE-2 VACCINE; ADVERSE EVENTS; INFECTION	Glycoprotein D (gD-2) is the entry receptor of herpes simplex virus 2 (HSV-2), and is the immunogen in the pharmaceutical industry's lead HSV-2 vaccine candidate. Efforts to prevent genital herpes using gD-2 subunit vaccines have been ongoing for 20 years at a cost in excess of $100 million. To date, gD-2 vaccines have yielded equivocal protection in clinical trials. Therefore, using a small animal model, we sought to determine if a live-attenuated HSV-2 ICP0(-) virus would elicit better protection against genital herpes than a gD-2 subunit vaccine. Mice immunized with gD-2 and a potent adjuvant (alum+monophosphoryl lipid A) produced high titers of gD-2 antibody. While gD-2-immunized mice possessed significant resistance to HSV-2, only 3 of 45 gD-2-immunized mice survived an overwhelming challenge of the vagina or eyes with wildtype HSV-2 (MS strain). In contrast, 114 of 115 mice immunized with a live HSV-2 ICP0(-) virus, 0 Delta NLS, survived the same HSV-2 MS challenges. Likewise, 0 Delta NLS-immunized mice shed an average 125-fold less HSV-2 MS challenge virus per vagina relative to gD-2-immunized mice. In vivo imaging demonstrated that a luciferase-expressing HSV-2 challenge virus failed to establish a detectable infection in 0 Delta DNLS-immunized mice, whereas the same virus readily infected naive and gD-2-immunized mice. Collectively, these results suggest that a HSV-2 vaccine might be more likely to prevent genital herpes if it contained a live-attenuated HSV-2 virus rather than a single HSV-2 protein.	[Halford, William P.; Pueschel, Ringo; Gershburg, Edward; Wilber, Andrew; Gershburg, Svetlana; Rakowski, Brandon] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA	Southern Illinois University System; Southern Illinois University	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu	Wilber, Andrew/I-9259-2019	Wilber, Andrew/0000-0002-8457-599X; Gershburg, Edward/0000-0003-3584-9947	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health [R21 AI81072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072] Funding Source: NIH RePORTER	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine, as well as a grant from the National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine (R21 AI81072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1990, J INFECT DIS, V162, P1043, DOI 10.1093/infdis/162.5.1043; ALLEN E M, 1990, Viral Immunology, V3, P207, DOI 10.1089/vim.1990.3.207; Aurelian L, 1999, VACCINE, V17, P1951, DOI 10.1016/S0264-410X(98)00470-8; BEHBEHANI AM, 1983, MICROBIOL REV, V47, P455, DOI 10.1128/MMBR.47.4.455-509.1983; Bernstein D I, 2001, Herpes, V8, P8; Bernstein DI, 2010, VACCINE, V28, P3748, DOI 10.1016/j.vaccine.2009.10.025; Bernstein DI, 2009, CLIN VACCINE IMMUNOL, V16, P699, DOI 10.1128/CVI.00370-08; BOBROWSKI PJ, 1991, INT J DERMATOL, V30, P29, DOI 10.1111/j.1365-4362.1991.tb05875.x; Bourne N, 2005, J INFECT DIS, V192, P2117, DOI 10.1086/498247; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Boursnell MEG, 1997, J INFECT DIS, V175, P16, DOI 10.1093/infdis/175.1.16; Brans R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-163; Brittle EE, 2008, J VIROL, V82, P8431, DOI 10.1128/JVI.00551-08; CENTIFANTOFITZGERALD YM, 1982, INFECT IMMUN, V35, P1125, DOI 10.1128/IAI.35.3.1125-1132.1982; CENTIFANTOFITZGERALD YM, 1985, P SOC EXP BIOL MED, V179, P55; Cohen J, 2010, SCIENCE, V330, P304, DOI 10.1126/science.330.6002.304; Cunningham A L, 2001, Herpes, V8 Suppl 1, p6A; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P449, DOI 10.1016/0035-9203(52)90062-X; Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020; Dunning R., 1800, SOME OBSERVATIONS VA; DUPAN RM, 1968, AM J DIS CHILD, V115, P658, DOI 10.1001/archpedi.1968.02100010660004; Eo SK, 2001, J IMMUNOL, V166, P5473, DOI 10.4049/jimmunol.166.9.5473; Eo SK, 2001, EXPERT OPIN BIOL TH, V1, P213, DOI 10.1517/14712598.1.2.213; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Galea SA, 2008, J INFECT DIS, V197, pS165, DOI 10.1086/522125; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Girard MP, 2006, VACCINE, V24, P4062, DOI 10.1016/j.vaccine.2006.02.031; *GLAXOSMITHKLINE, 2010, GSK PROV UPD HERP TR; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; HAARR L, 1994, APMIS, V102, P321, DOI 10.1111/j.1699-0463.1994.tb04882.x; Halford WP, 2007, FUTURE VIROL, V2, P1, DOI 10.2217/17460794.2.1.1; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2011, VIRUSES AND INTERFERON: CURRENT RESEARCH, P85; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Halford WP, 2005, J THEOR BIOL, V234, P439, DOI 10.1016/j.jtbi.2004.12.007; Higgins TJ, 2000, J INFECT DIS, V182, P1311, DOI 10.1086/315879; HILLEMAN MR, 1966, CLIN PHARMACOL THER, V7, P752; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Hosken N, 2006, J VIROL, V80, P5509, DOI 10.1128/JVI.02659-05; JENNNER E, 1798, INQUIRY CAUSES EFFEC; Jonsson MK, 2004, SCAND J INFECT DIS, V36, P93, DOI 10.1080/00365540310018905; Karem KL, 1997, J GEN VIROL, V78, P427, DOI 10.1099/0022-1317-78-2-427; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Krause PR, 2000, NAT MED, V6, P451, DOI 10.1038/74715; Kuklin N, 1997, J VIROL, V71, P3138, DOI 10.1128/JVI.71.4.3138-3145.1997; Kumaraguru U, 1998, Expert Opin Investig Drugs, V7, P219, DOI 10.1517/13543784.7.2.219; Laing KJ, 2010, J CLIN IMMUNOL, V30, P703, DOI 10.1007/s10875-010-9441-2; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008837; MAINGAY JP, 1988, MICROBIOL SCI, V5, P211; MANICKAN E, 1995, J VIROL, V69, P4711, DOI 10.1128/JVI.69.8.4711-4716.1995; Mansoor O, 1997, NEW ZEAL MED J, V110, P270; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; MCDERMOTT MR, 1984, J VIROL, V51, P747, DOI 10.1128/JVI.51.3.747-753.1984; MEIGNIER B, 1988, J INFECT DIS, V158, P602, DOI 10.1093/infdis/158.3.602; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Nicola AV, 1996, J VIROL, V70, P3815, DOI 10.1128/JVI.70.6.3815-3822.1996; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; PAOLETTI E, 1984, P NATL ACAD SCI-BIOL, V81, P193, DOI 10.1073/pnas.81.1.193; PARR MB, 1994, LAB INVEST, V70, P369; Pollara G, 2004, CURR OPIN INFECT DIS, V17, P199, DOI 10.1097/00001432-200406000-00005; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Reszka NJ, 2010, VACCINE, V28, P2754, DOI 10.1016/j.vaccine.2010.01.030; Ruprecht RM, 2000, J HUMAN VIROL, V3, P88; SABIN AB, 1953, AMA AM J DIS CHILD, V86, P301, DOI 10.1001/archpedi.1953.02050080311006; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; SCHWARZ AJF, 1962, AM J DIS CHILD, V103, P386, DOI 10.1001/archpedi.1962.02080020398042; Sengupta N, 2008, EUR J PEDIATR, V167, P47, DOI 10.1007/s00431-007-0424-0; Solomon L, 2003, SEX TRANSM INFECT, V79, P456, DOI 10.1136/sti.79.6.456; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Spector FC, 1998, J INFECT DIS, V177, P1143, DOI 10.1086/515278; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P1913, DOI 10.1001/jama.284.15.1913; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; TAKAHASHI M, 1975, BIKEN J, V18, P25; Thompson HSG, 1998, VACCINE, V16, P1993, DOI 10.1016/S0264-410X(98)00088-7; Toka FN, 2004, IMMUNOL REV, V199, P100, DOI 10.1111/j.0105-2896.2004.0147.x; WATSON RJ, 1982, SCIENCE, V218, P381, DOI 10.1126/science.6289440; Wattigney WA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e83; WEIR JP, 1989, J GEN VIROL, V70, P2587, DOI 10.1099/0022-1317-70-10-2587; WILDY P, 1973, CANCER RES, V33, P1465; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; Zimmerman DH, 2005, FRONT BIOSCI, V10, P790, DOI 10.2741/1572	90	74	78	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17748	10.1371/journal.pone.0017748	http://dx.doi.org/10.1371/journal.pone.0017748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412438	Green Submitted, Green Published, gold			2022-12-27	WOS:000288247800028
J	Berisha, SZ; Serre, D; Schauer, P; Kashyap, SR; Smith, JD				Berisha, Stela Z.; Serre, David; Schauer, Philip; Kashyap, Sangeeta R.; Smith, Jonathan D.			Changes in Whole Blood Gene Expression in Obese Subjects with Type 2 Diabetes Following Bariatric Surgery: a Pilot Study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; WEIGHT-LOSS; LIPOCALIN-2; ADIPOCYTOKINES; INFLAMMATION	Background: A pilot study was performed in order to investigate the effects of bariatric surgery on whole blood gene expression profiles in obese subjects with type 2 diabetes. Methodology/Principal Findings: Whole blood from eleven obese subjects with type 2 diabetes was collected in PAXgene tubes prior to and 6-12 months after bariatric surgery. Total RNA was isolated, amplified, labeled and hybridized to Illumina gene expression microarrays. Clinical and expression data were analyzed using a paired t-test, and correlations between changes in clinical trait and transcript levels were calculated. Pathways were identified using Ingenuity Pathway Analysis and DAVID gene ontology software. Overall, bariatric surgery resulted in significant reduction of body mass index, fasting plasma glucose, fasting plasma insulin, and normalization of glycosylated hemoglobin levels. The expression levels of 204 transcripts, representing 200 unique genes, were significantly altered after bariatric surgery. Among the significantly regulated genes were GGT1, CAMP, DEFA1, LCN2, TP53, PDSS1, OLR1, CNTNAP5, DHCR24, HHAT and SARDH, which have been previously implicated in lipid metabolism, obesity and/or type 2 diabetes. Selected findings were replicated by quantitative real-time-PCR. The changes in expression of seven transcripts, WDR35, FLF45244, DHCR24, TIGD7, TOPBP1, TSHZ1, and FAM8A1 were strongly correlated with the changes in body weight, fasting plasma glucose and glycosylated hemoglobin content. The top pathways associated with gene expression changes after bariatric surgery was lipid metabolism, small molecule biochemistry and gene expression. Two antimicrobial peptides were among the transcripts with the largest changes in gene expression after bariatric surgery. Conclusions/Significance: Data from this pilot study suggest that whole blood expression levels of specific transcripts may be useful as biomarkers associated with susceptibility for type 2 diabetes and/or therapeutic response.	[Berisha, Stela Z.; Smith, Jonathan D.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Berisha, Stela Z.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Serre, David] Cleveland Clin, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44106 USA; [Serre, David; Smith, Jonathan D.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin Lerner Coll Med, Cleveland, OH 44106 USA; [Schauer, Philip] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44106 USA; [Kashyap, Sangeeta R.] Cleveland Clin, Dept Diabet Endocrinol & Metab, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Berisha, SZ (corresponding author), Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA.	kashyas@ccf.org; smithj4@ccf.org	Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Schauer, Philip/0000-0002-4029-7537; Kashyap, Sangeeta/0000-0002-7489-6650	National Institute of Health [P50-HL077107, R01-HL098193]; National Center for Research Resources [5K12RR023264]; Clinical and Translational Science Award [1UL1RR024989]; Cleveland State University; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990, K12RR023264, UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107, R01HL098193] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science Award; Cleveland State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health Grants P50-HL077107 and R01-HL098193 (http://www.nih.gov/) to J.D.S, by National Center for Research Resources Multidisciplinary Clinical Research Career Development Programs Grant 5K12RR023264 (http://www.ncrr.nih.gov/index.asp) and Clinical and Translational Science Award Grant 1UL1RR024989 (http://www.ctsaweb.org/) to S.R.K.. S.Z.B. was supported by Cellular and Molecular Medicine Coordinating Committee Research Assistantship from Cleveland State University (http://www.csuohio.edu/sciences/dept/biology/cmms/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2005, DIABETES METAB, V31, P542, DOI 10.1016/S1262-3636(07)70229-X; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145; BURIAN D, 2007, DOTFAAAM079; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS3, DOI 10.1331/JAPhA.2009.09077; Compher C, 2008, JPEN-PARENTER ENTER, V32, P645, DOI 10.1177/0148607108326070; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; Gagliardi L, 2007, CURR DIABETES REV, V3, P95, DOI 10.2174/157339907780598207; Ghosh S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-56; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Hindle AK, 2009, SURG ENDOSC, V23, P1292, DOI 10.1007/s00464-008-0152-1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANCO M, 2010, OBES SURG       0409; Manco M, 2007, J CLIN ENDOCR METAB, V92, P483, DOI 10.1210/jc.2006-0960; Mathurin P, 2009, GASTROENTEROLOGY, V137, P532, DOI 10.1053/j.gastro.2009.04.052; McGrath KCY, 2009, ARTERIOSCL THROM VAS, V29, P877, DOI 10.1161/ATVBAHA.109.184663; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Otis M, 2008, J STEROID BIOCHEM, V109, P224, DOI 10.1016/j.jsbmb.2008.03.010; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Strasak AM, 2008, ARTERIOSCL THROM VAS, V28, P1857, DOI 10.1161/ATVBAHA.108.170597; Tan KCB, 2008, J LIPID RES, V49, P1438, DOI 10.1194/jlr.M700551-JLR200; Visvikis A, 2001, EUR J BIOCHEM, V268, P317; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	38	65	65	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e16729	10.1371/journal.pone.0016729	http://dx.doi.org/10.1371/journal.pone.0016729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423737	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100002
J	Tran, TNN; Signoli, M; Fozzati, L; Aboudharam, G; Raoult, D; Drancourt, M				Tran, Thi-Nguyen-Ny; Signoli, Michel; Fozzati, Luigi; Aboudharam, Gerard; Raoult, Didier; Drancourt, Michel			High Throughput, Multiplexed Pathogen Detection Authenticates Plague Waves in Medieval Venice, Italy	PLOS ONE			English	Article							YERSINIA-PESTIS DNA; RAPID DIAGNOSTIC-TEST; BARTONELLA-QUINTANA; SKELETAL FINDS; DENTAL-PULP; F1 ANTIGEN; BODY LOUSE; REMAINS; IDENTIFICATION; ORIENTALIS	Background: Historical records suggest that multiple burial sites from the 14th-16(th) centuries in Venice, Italy, were used during the Black Death and subsequent plague epidemics. Methodology/Principal Findings: High throughput, multiplexed real-time PCR detected DNA of seven highly transmissible pathogens in 173 dental pulp specimens collected from 46 graves. Bartonella quintana DNA was identified in five (2.9%) samples, including three from the 16th century and two from the 15th century, and Yersinia pestis DNA was detected in three (1.7%) samples, including two from the 14th century and one from the 16th century. Partial glpD gene sequencing indicated that the detected Y. pestis was the Orientalis biotype. Conclusions: These data document for the first time successive plague epidemics in the medieval European city where quarantine was first instituted in the 14th century.	[Tran, Thi-Nguyen-Ny; Aboudharam, Gerard; Raoult, Didier; Drancourt, Michel] Univ Mediterranee, URMITE, UMR CNRS IRD 198 6236, Fac Med,IFR48, Marseille, France; [Signoli, Michel] Univ Mediterranee, EFS, UMR CNRS 6578, Marseille, France; [Fozzati, Luigi] Soprintendenza Archeol Veneto, Venice, Italy	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Tran, TNN (corresponding author), Univ Mediterranee, URMITE, UMR CNRS IRD 198 6236, Fac Med,IFR48, Marseille, France.	Michel.Drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Aboudharam G, 2000, MICROB PATHOGENESIS, V28, P249, DOI 10.1006/mpat.1999.0343; Ayyadurai S, 2010, EMERG INFECT DIS, V16, P892, DOI 10.3201/eid1605.091280; Bianucci R, 2008, AM J PHYS ANTHROPOL, V136, P361, DOI 10.1002/ajpa.20818; Bianucci R, 2007, CR BIOL, V330, P747, DOI 10.1016/j.crvi.2007.07.007; Bianucci R, 2009, J ARCHAEOL SCI, V36, P616, DOI 10.1016/j.jas.2008.10.007; Biraben JN., 1975, HOMMES PESTE FRANCE; Blanc G, 1941, CR HEBD ACAD SCI, V213, P849; Blanc G, 1942, B ACAD NAT MED PARIS, V126, P446; BLANC G, 1945, ARCH I PASTEUR MAROC, V5, P349; BRACHET JL, 1847, MEMOIRE PESTE QUARAN; Brouqui P, 1999, NEW ENGL J MED, V340, P184, DOI 10.1056/NEJM199901213400303; Cannons A, 2006, INFEC AGENT, P1, DOI 10.1109/INTLEC.2006.251633; Cerutti N., 2007, PLAGUE EPIDEMICS SOC, P238; DONAT R, 2008, VILARNAU VILLAGE MOY; Drancourt M, 2006, LANCET INFECT DIS, V6, P234, DOI 10.1016/S1473-3099(06)70438-8; Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; DRANCOURT M, 2010, EMERG INFEC IN PRESS; Drancourt M, 2007, EMERG INFECT DIS, V13, P332, DOI 10.3201/eid1302.060197; Duncan CJ, 2005, POSTGRAD MED J, V81, P315, DOI 10.1136/pgmj.2004.024075; ELL SR, 1989, REV INFECT DIS, V11, P128; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; GAMBARO L, 2007, PLAGUE EPIDEMICS SOC, P97; Gensini GF, 2004, J INFECTION, V49, P257, DOI 10.1016/j.jinf.2004.03.002; Hadjouis Djillai, 2008, Biometrie Humaine et Anthropologie, V26, P69; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Houhamdi L, 2006, J INFECT DIS, V194, P1589, DOI 10.1086/508995; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pusch CM, 2004, LANCET INFECT DIS, V4, P484, DOI 10.1016/S1473-3099(04)01099-0; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Raoult D, 2006, J INFECT DIS, V193, P112, DOI 10.1086/498534; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; SIGNOLI M, 2009, FOUILLES LAZZARETO V, P333; STEIN A, 1995, LANCET, V345, P450, DOI 10.1016/S0140-6736(95)90430-1; Teh WL, 1923, J HYG-CAMBRIDGE, V21, P289; Twigg G., 1985, BLACK DEATH BIOL REA; Wiechmann I, 2005, AM J PHYS ANTHROPOL, V126, P48, DOI 10.1002/ajpa.10276; Wiechmann I, 2010, EMERG INFECT DIS, V16, P1806, DOI 10.3201/eid1611.100598; Wood J, 2003, LANCET INFECT DIS, V3, P327, DOI 10.1016/S1473-3099(03)00651-0	42	42	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e16735	10.1371/journal.pone.0016735	http://dx.doi.org/10.1371/journal.pone.0016735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	732VZ	21423736	Green Published, Green Submitted, gold			2022-12-27	WOS:000288219100003
J	Mouquet, N; Matthiessen, B; Miller, T; Gonzalez, A				Mouquet, Nicolas; Matthiessen, Birte; Miller, Tom; Gonzalez, Andrew			Extinction Debt in Source-Sink Metacommunities	PLOS ONE			English	Article							HABITAT DESTRUCTION; SPATIAL HETEROGENEITY; FRAGMENTED LANDSCAPES; SPECIES RICHNESS; DYNAMICS; COEXISTENCE; BIODIVERSITY; FOREST; COMPETITION; RELAXATION	In an increasingly modified world, understanding and predicting the consequences of landscape alteration on biodiversity is a challenge for ecologists. To this end, metacommunity theory has developed to better understand the complexity of local and regional interactions that occur across larger landscapes. While metacommunity ecology has now provided several alternative models of species coexistence at different spatial scales, predictions regarding the consequences of landscape alteration have been done exclusively for the competition-colonization trade off model (CC). In this paper we investigate the effects of landscape perturbation on source-sink metacommunities. We show that habitat destruction perturbs the equilibria among species competitive effects within the metacommunity, driving both direct extinctions and an indirect extinction debt. As in CC models, we found a time lag for extinction following habitat destruction that varied in length depending upon the relative importance of direct and indirect effects. However, in contrast to CC models, we found that the less competitive species are more affected by habitat destruction. The best competitors can sometimes even be positively affected by habitat destruction, which corresponds well with the results of field studies. Our results are complementary to those results found in CC models of metacommunity dynamics. From a conservation perspective, our results illustrate that landscape alteration jeopardizes species coexistence in patchy landscapes through complex indirect effects and delayed extinctions patterns.	[Mouquet, Nicolas] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Matthiessen, Birte] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Miller, Tom] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; State University System of Florida; Florida State University; McGill University	Mouquet, N (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, Pl Eugene Bataillon, Montpellier, France.	nmouquet@univ-montp2.fr	Gonzalez, Andrew/F-2247-2010; MOUQUET, Nicolas/AAL-1440-2021; Matthiessen, Birte/U-5459-2017	Gonzalez, Andrew/0000-0001-6075-8081; Matthiessen, Birte/0000-0001-9673-1876; Mouquet, Nicolas/0000-0003-1840-6984	CNRS; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Program; Fonds Quebecois de la Recherche sur la Nature et les Technologies; National Science Foundation [DEB 0716891];  [ANR-BACH-09-JCJC-0110-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); National Science Foundation(National Science Foundation (NSF)); 	NM was supported by the CNRS and a research grant ANR-BACH-09-JCJC-0110-01. AG was supported by grants from the Natural Sciences and Engineering Research Council of Canada, and the Canada Research Chair Program, and a team grant from Fonds Quebecois de la Recherche sur la Nature et les Technologies. TM has support from the National Science Foundation (DEB 0716891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; Boughton DA, 1999, ECOLOGY, V80, P2727; Brown J. H., 1998, BIOGEOGRAPHY; Crowder LB, 2000, B MAR SCI, V66, P799; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Eklof A, 2006, J ANIM ECOL, V75, P239, DOI 10.1111/j.1365-2656.2006.01041.x; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Gonzalez A, 2000, ECOL LETT, V3, P441, DOI 10.1046/j.1461-0248.2000.00171.x; Gonzalez A., 2009, BIODIVERSITY ECOSYST; Gouhier TC, 2010, AM NAT, V175, pE16, DOI 10.1086/649579; Gravel D, 2010, ECOLOGY, V91, P2172, DOI 10.1890/09-0843.1; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I., 1999, METAPOPULATION ECOLO; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Holt Robert D., 1996, P313; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; Klausmeier CA, 2001, ECOL LETT, V4, P57, DOI 10.1046/j.1461-0248.2001.00195.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; MAC ARTHUR ROBERT H., 1967; MASSOL F, ECOLOGY LET IN PRESS; McCarthy MA, 1997, CONSERV BIOL, V11, P221, DOI 10.1046/j.1523-1739.1997.95381.x; Melbourne BA, 2004, BIODIVERS CONSERV, V13, P275, DOI 10.1023/B:BIOC.0000004321.58196.d8; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2006, OIKOS, V113, P481, DOI 10.1111/j.2006.0030-1299.14582.x; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Muko S, 2000, THEOR POPUL BIOL, V57, P273, DOI 10.1006/tpbi.2000.1456; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Rozdilsky ID, 2001, ECOL RES, V16, P983, DOI 10.1046/j.1440-1703.2001.00446.x; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; STONE L, 1995, P ROY SOC B-BIOL SCI, V261, P381, DOI 10.1098/rspb.1995.0163; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 1997, AM NAT, V149, P407, DOI 10.1086/285998; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182	49	16	16	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17567	10.1371/journal.pone.0017567	http://dx.doi.org/10.1371/journal.pone.0017567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408133	gold, Green Published, Green Accepted			2022-12-27	WOS:000288170000039
J	Foresta, C; Patassini, C; Bertoldo, A; Menegazzo, M; Francavilla, F; Barzon, L; Ferlin, A				Foresta, Carlo; Patassini, Cristina; Bertoldo, Alessandro; Menegazzo, Massimo; Francavilla, Felice; Barzon, Luisa; Ferlin, Alberto			Mechanism of Human Papillomavirus Binding to Human Spermatozoa and Fertilizing Ability of Infected Spermatozoa	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HEPARAN-SULFATE; DNA	Human papillomaviruses (HPVs) are agents of the most common sexually transmitted diseases in females and males. Precise data about the presence, mechanism of infection and clinical significance of HPV in the male reproductive tract and especially in sperm are not available. Here we show that HPV can infect human sperm, it localizes at the equatorial region of sperm head through interaction between the HPV capsid protein L1 and syndecan-1. Sperm transfected with HPV E6/E7 genes and sperm exposed to HPV L1 capsid protein are capable to penetrate the oocyte and transfer the virus into oocytes, in which viral genes are then activated and transcribed. These data show that sperm might function as vectors for HPV transfer into the oocytes, and open new perspectives on the role of HPV infection in males and are particularly intriguing in relation to assisted reproduction techniques.	[Foresta, Carlo; Patassini, Cristina; Bertoldo, Alessandro; Menegazzo, Massimo; Ferlin, Alberto] Univ Padua, Sect Clin Pathol, Padua, Italy; [Foresta, Carlo; Patassini, Cristina; Bertoldo, Alessandro; Menegazzo, Massimo; Ferlin, Alberto] Univ Padua, Ctr Male Gamete Cryopreservat, Dept Histol Microbiol & Med Biotechnol, Padua, Italy; [Francavilla, Felice] Univ Aquila, Androl Unit, Dept Internal Med, I-67100 Laquila, Italy; [Barzon, Luisa] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Microbiol & Virol, Padua, Italy	University of Padua; University of Padua; University of L'Aquila; University of Padua	Foresta, C (corresponding author), Univ Padua, Sect Clin Pathol, Padua, Italy.	carlo.foresta@unipd.it	Ferlin, Alberto/AAO-3541-2020; Barzon, Luisa/K-7961-2016	Ferlin, Alberto/0000-0001-5817-8141; Barzon, Luisa/0000-0003-0720-8456; FRANCAVILLA, Felice/0000-0003-1255-4062	University of Padova; Hospital of Padova	University of Padova; Hospital of Padova	This work was funded by the University of Padova and the Hospital of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aynaud O, 2002, INT J STD AIDS, V13, P547, DOI 10.1258/095646202760159666; Bocharova E N, 2007, Dokl Biol Sci, V412, P82, DOI 10.1134/S0012496607010279; Bocharova E N, 2003, Dokl Biol Sci, V391, P379, DOI 10.1023/A:1025179307236; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1118; Combita AL, 2001, FEMS MICROBIOL LETT, V204, P183, DOI 10.1111/j.1574-6968.2001.tb10883.x; Drobni P, 2003, VIROLOGY, V310, P163, DOI 10.1016/S0042-6822(03)00114-4; Flores R, 2008, CANCER EPIDEM BIOMAR, V17, P3573, DOI 10.1158/1055-9965.EPI-08-0467; Foresta C, 2010, INT J ANDROL, V33, P28; FORESTA C, 2010, FERTIL STERIL   0105; Foresta C, 2010, FERTIL STERIL, V93, P802, DOI 10.1016/j.fertnstert.2008.10.050; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Horvath CAJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-11; JDOORBAR J, 2005, J CLIN VIROL S, V32, pS7; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kadze R, 2002, ASIAN J ANDROL, V4, P169; Kotronias D, 1998, IN VIVO, V12, P391; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9; Lee CA, 2002, GYNECOL ONCOL, V85, P511, DOI 10.1006/gyno.2002.6662; Letian Tan, 2010, Virol J, V7, P2, DOI 10.1186/1743-422X-7-2; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; LOWY DR, 1994, P NATL ACAD SCI USA, V91, P2436, DOI 10.1073/pnas.91.7.2436; Martorell M, 2005, ARCH PATHOL LAB MED, V129, P1132; Nielson CM, 2007, CANCER EPIDEM BIOMAR, V16, P1107, DOI 10.1158/1055-9965.EPI-06-0997; Perez-Andino J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005847; Piomboni P, 2000, MOL REPROD DEV, V56, P238, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;238::AID-MRD5&gt;3.0.CO;2-1; Rintala MAM, 2004, INT J STD AIDS, V15, P740, DOI 10.1258/0956462042395122; RODEN RBS, 1994, J VIROL, V68, P7260, DOI 10.1128/JVI.68.11.7260-7266.1994; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Svec A, 2003, ARCH PATHOL LAB MED, V127, P1471; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th	35	86	107	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e15036	10.1371/journal.pone.0015036	http://dx.doi.org/10.1371/journal.pone.0015036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408100	Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800002
J	Vanpouille-Box, C; Lacoeuille, F; Roux, J; Aube, C; Garcion, E; Lepareur, N; Oberti, F; Bouchet, F; Noiret, N; Garin, E; Benoit, JP; Couturier, O; Hindre, F				Vanpouille-Box, Claire; Lacoeuille, Franck; Roux, Jerome; Aube, Christophe; Garcion, Emmanuel; Lepareur, Nicolas; Oberti, Frederic; Bouchet, Francis; Noiret, Nicolas; Garin, Etienne; Benoit, Jean-Pierre; Couturier, Olivier; Hindre, Francois			Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DRUG ELUTING BEADS; RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; CHITOSAN NANOPARTICLES; MICROSPHERES; RADIOEMBOLIZATION; BIODISTRIBUTION; FORMULATION; LIPIODOL	Background: Due to their nanometric scale (50 nm) along with their biomimetic properties, lipid nanocapsules loaded with Rhenium-188 (LNC(188)Re-SSS) constitute a promising radiopharmaceutical carrier for hepatocellular carcinoma treatment as its size may improve tumor penetration in comparison with microspheres devices. This study was conducted to confirm the feasibility and to assess the efficacy of internal radiation with LNC(188)Re-SSS in a chemically induced hepatocellular carcinoma rat model. Methodology/Principal Findings: Animals were treated with an injection of LNC(188)Re-SSS (80 MBq or 120 MBq). The treated animals (80 MBq, n = 12; 120 MBq, n = 11) were compared with sham (n = 12), blank LNC (n = 7) and (188)Re-perrhenate (n = 4) animals. The evaluation criteria included rat survival, tumor volume assessment, and vascular endothelial growth factor quantification. Following treatment with LNC(188)Re-SSS (80 MBq) therapeutic efficiency was demonstrated by an increase in the median survival from 54 to 107% compared with control groups with up to 7 long-term survivors in the LNC(188)Re-SSS group. Decreased vascular endothelial growth factor expression in the treated rats could indicate alterations in the angiogenesis process. Conclusions/Significance: Overall, these results demonstrate that internal radiation with LNC(188)Re-SSS is a promising new strategy for hepatocellular carcinoma treatment.	[Vanpouille-Box, Claire; Lacoeuille, Franck; Garcion, Emmanuel; Benoit, Jean-Pierre; Couturier, Olivier; Hindre, Francois] Univ Angers, LUNAM Univ, INSERM U646, Angers, France; [Lacoeuille, Franck; Bouchet, Francis; Couturier, Olivier] CHU Angers, Dept Nucl Med, Angers, France; [Roux, Jerome] Univ Angers, LUNAM Univ, SCAHU, UFR Med, Angers, France; [Lepareur, Nicolas; Garin, Etienne] CRLCC Eugene Marquis, Dept Med Imaging, Rennes, France; [Noiret, Nicolas] European Univ Brittany, Rennes, France; [Aube, Christophe] CHU Angers, Dept Radiol, Angers, France; [Aube, Christophe; Oberti, Frederic] Univ Angers, LUNAM Univ, Lab HIFI, UPRES EA3589, Angers, France; [Lepareur, Nicolas] ENSCR, UMR CNRS 6226, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; UNICANCER; Centre Eugene Marquis; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole Nationale Superieure de Chimie de Rennes (ENSCR)	Vanpouille-Box, C (corresponding author), Univ Angers, LUNAM Univ, INSERM U646, Angers, France.	francois.hindre@univ-angers.fr	Lepareur, Nicolas/N-8914-2019; Vanpouille-Box, Claire/F-7137-2011; Lepareur, Nicolas/K-7174-2018; Vanpouille-Box, Claire/AAO-5355-2021; hindré, françois/K-5613-2015; Benoit, Jean-Pierre/K-4387-2015; Couturier, Olivier F/L-6635-2015; GARCION, Emmanuel/K-5417-2015; LACOEUILLE, Franck/K-4430-2015	Lepareur, Nicolas/0000-0001-9860-5451; Lepareur, Nicolas/0000-0001-9860-5451; GARCION, Emmanuel/0000-0003-0887-272X; LACOEUILLE, Franck/0000-0002-7070-7664; couturier, olivier-francois/0000-0002-4900-7807; Garin, Etienne/0000-0003-1416-2863; Hindre, Francois/0000-0002-2727-7996; BENOIT, Jean-Pierre/0000-0002-6178-7199; Vanpouille-Box, Claire/0000-0001-7213-0670	Maine et Loire	Maine et Loire	This work was funded by "the Canceropole Grand Ouest" and "La Ligue Contre le Cancer" of "Maine et Loire." Claire Vanpouille-Box was a fellow from Angers Loire Metropole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballot S, 2006, EUR J NUCL MED MOL I, V33, P602, DOI 10.1007/s00259-005-0007-0; Brown DB, 2009, J VASC INTERV RADIOL, V20, pS425, DOI 10.1016/j.jvir.2009.04.021; Cha CH, 2010, CURR PROB SURG, V47, P10, DOI 10.1067/j.cpsurg.2009.09.003; Cheng JCH, 2002, RADIOTHER ONCOL, V63, P41, DOI 10.1016/S0167-8140(02)00061-0; Dai LC, 2009, WORLD J GASTROENTERO, V15, P1966, DOI 10.3748/wjg.15.1966; Dancey JE, 2000, J NUCL MED, V41, P1673; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; DEUTSCH E, 1986, NUCL MED BIOL, V13, P465, DOI 10.1016/0883-2897(86)90027-9; Dhanasekaran R, 2010, J SURG ONCOL, V101, P476, DOI 10.1002/jso.21522; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Garin E, 2005, LAB ANIM-UK, V39, P314, DOI 10.1258/0023677054307051; Gibaud S, 1996, J PHARM SCI, V85, P944, DOI 10.1021/js960032d; Hafeli UO, 1999, INT J RADIAT ONCOL, V44, P189, DOI 10.1016/S0360-3016(98)00554-9; Heurtault B, 2002, PHARMACEUT RES, V19, P875, DOI 10.1023/A:1016121319668; Hsieh BT, 1999, NUCL MED BIOL, V26, P967, DOI 10.1016/S0969-8051(99)00074-8; Jin-no K, 1998, J GASTROENTEROL, V33, P376, DOI 10.1007/s005350050099; Kulik LM, 2006, J SURG ONCOL, V94, P572, DOI 10.1002/jso.20609; Kumar A, 2007, RADIOLOGY, V243, P509, DOI 10.1148/radiol.2432051246; Lacoeuille F, 2007, INT J PHARM, V344, P143, DOI 10.1016/j.ijpharm.2007.06.014; Lau WY, 1998, INT J RADIAT ONCOL, V40, P583, DOI 10.1016/S0360-3016(97)00818-3; Lepareur N, 2004, J LABELLED COMPD RAD, V47, P857, DOI 10.1002/jlcr.863; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Malagari K, 2008, ABDOM IMAGING, V33, P512, DOI 10.1007/s00261-007-9334-x; Malagari K, 2008, CARDIOVASC INTER RAD, V31, P269, DOI 10.1007/s00270-007-9226-z; Salem R, 2005, J VASC INTERV RADIOL, V16, P1627; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Wang Q, 2010, NANOMED-NANOTECHNOL, V6, P371, DOI 10.1016/j.nano.2009.07.006; Wunderlich G, 2005, APPL RADIAT ISOTOPES, V62, P745, DOI 10.1016/j.apradiso.2004.11.003; Xu YL, 2009, ANTICANCER RES, V29, P5103; Xu ZH, 2009, BIOMATERIALS, V30, P226, DOI 10.1016/j.biomaterials.2008.09.014; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Zeng ZC, 2002, EUR J NUCL MED MOL I, V29, P1657, DOI 10.1007/s00259-002-0996-x	33	32	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e16926	10.1371/journal.pone.0016926	http://dx.doi.org/10.1371/journal.pone.0016926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408224	Green Published, gold			2022-12-27	WOS:000288099800008
J	Wang, EF; Bhattacharyya, S; Szabolcs, A; Rodriguez-Aguayo, C; Jennings, NB; Lopez-Berestein, G; Mukherjee, P; Sood, AK; Bhattacharya, R				Wang, Enfeng; Bhattacharyya, Sanjib; Szabolcs, Annamaria; Rodriguez-Aguayo, Cristian; Jennings, Nicholas B.; Lopez-Berestein, Gabriel; Mukherjee, Priyabrata; Sood, Anil K.; Bhattacharya, Resham			Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer	PLOS ONE			English	Article							SMALL INTERFERING RNA; LEUKEMIC STEM-CELLS; SELF-RENEWAL; TELOMERASE ACTIVITY; OXIDATIVE STRESS; EPITHELIAL-CELLS; POOR-PROGNOSIS; EXPRESSION; APOPTOSIS; CARCINOMA	Undoubtedly ovarian cancer is a vexing, incurable disease for patients with recurrent cancer and therapeutic options are limited. Although the polycomb group gene, Bmi-1 that regulates the self-renewal of normal stem and progenitor cells has been implicated in the pathogenesis of many human malignancies, yet a role for Bmi-1 in influencing chemotherapy response has not been addressed before. Here we demonstrate that silencing Bmi-1 reduces intracellular GSH levels and thereby sensitizes chemoresistant ovarian cancer cells to chemotherapeutics such as cisplatin. By exacerbating ROS production in response to cisplatin, Bmi-1 silencing activates the DNA damage response pathway, caspases and cleaves PARP resulting in the induction apoptosis in ovarian cancer cells. In an in vivo orthotopic mouse model of chemoresistant ovarian cancer, knockdown of Bmi-1 by nanoliposomal delivery significantly inhibits tumor growth. While cisplatin monotherapy was inactive, combination of Bmi-1 silencing along with cisplatin almost completely abrogated ovarian tumor growth. Collectively these findings establish Bmi-1 as an important new target for therapy in chemoresistant ovarian cancer.	[Wang, Enfeng; Bhattacharyya, Sanjib; Szabolcs, Annamaria; Mukherjee, Priyabrata; Bhattacharya, Resham] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Jennings, Nicholas B.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, EF (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	bhattacharya.resham@mayo.edu	Bhattacharyya, Sanjib/F-1577-2013	RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Bhattacharyya, Sanjib/0000-0001-8738-7188	Marsha Rivkin Pilot Award [CA136494, CA135011, P50 CA083639, U54 CA151668]; NATIONAL CANCER INSTITUTE [R01CA135011, R01CA136494, P50CA083639, U54CA151668] Funding Source: NIH RePORTER	Marsha Rivkin Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Marsha Rivkin Pilot Award (RB), CA136494, CA135011 (PM) and P50 CA083639, U54 CA151668 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, CHEM BIODIVERS, V7, P543, DOI 10.1002/cbdv.200800340; Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Armstrong DK, 2002, ONCOLOGIST, V7, P20, DOI 10.1634/theoncologist.7-suppl_5-20; Arrigo AP, 1999, FREE RADICAL BIO MED, V27, P936, DOI 10.1016/S0891-5849(99)00175-6; BHATTACHARYA R, 2009, CANC RES; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Borges HL, 2008, CELL RES, V18, P17, DOI 10.1038/cr.2007.110; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Dimri GP, 2002, CANCER RES, V62, P4736; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; FernandezCheca JC, 1997, AM J PHYSIOL-GASTR L, V273, pG7, DOI 10.1152/ajpgi.1997.273.1.G7; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HAUPT Y, 1993, ONCOGENE, V8, P3161; Hayry V, 2008, NEUROPATH APPL NEURO, V34, P555, DOI 10.1111/j.1365-2990.2008.00949.x; Helm CW, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-2; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Liu JH, 2008, J SURG ONCOL, V97, P267, DOI 10.1002/jso.20934; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mangala LS, 2009, CLIN CANCER RES, V15, P3770, DOI 10.1158/1078-0432.CCR-08-2306; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Raaphorst FM, 2003, TRENDS IMMUNOL, V24, P522, DOI 10.1016/S1471-4906(03)00241-2; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Sawa M, 2005, INT J HEMATOL, V82, P42, DOI 10.1532/IJH97.05013; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Silva J, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1760; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Vrzalikova K, 2008, J CANCER RES CLIN, V134, P1037, DOI 10.1007/s00432-008-0361-y; Wang H, 2008, J CANCER RES CLIN, V134, P535, DOI 10.1007/s00432-007-0316-8; Yang GF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-133; Zhang F., 2008, Experimental Oncology, V30, P70; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	51	71	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17918	10.1371/journal.pone.0017918	http://dx.doi.org/10.1371/journal.pone.0017918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445297	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300022
J	Andley, UP; Hamilton, PD; Ravi, N; Weihl, CC				Andley, Usha P.; Hamilton, Paul D.; Ravi, Nathan; Weihl, Conrad C.			A Knock-In Mouse Model for the R120G Mutation of alpha B-Crystallin Recapitulates Human Hereditary Myopathy and Cataracts	PLOS ONE			English	Article							DESMIN-RELATED CARDIOMYOPATHY; POSTERIOR POLAR CATARACT; HEAT-SHOCK PROTEINS; A-CRYSTALLIN; MOLECULAR CHAPERONE; CONGENITAL CATARACT; MISSENSE MUTATION; LENS DEVELOPMENT; BETA-CRYSTALLIN; GENE CRYAA	An autosomal dominant missense mutation in alpha B-crystallin (alpha B-R120G) causes cataracts and desmin-related myopathy, but the underlying mechanisms are unknown. Here, we report the development of an alpha B-R120G crystallin knock-in mouse model of these disorders. Knock-in alpha B-R120G mice were generated and analyzed with slit lamp imaging, gel permeation chromatography, immunofluorescence, immunoprecipitation, histology, and muscle strength assays. Wild-type, age-matched mice were used as controls for all studies. Both heterozygous and homozygous mutant mice developed myopathy. Moreover, homozygous mutant mice were significantly weaker than wild-type control littermates at 6 months of age. Cataract severity increased with age and mutant gene dosage. The total mass, precipitation, and interaction with the intermediate filament protein vimentin, as well as light scattering of alpha B-crystallin, also increased in mutant lenses. In skeletal muscle, alpha B-R120G co-aggregated with desmin, became detergent insoluble, and was ubiquitinated in heterozygous and homozygous mutant mice. These data suggest that the cataract and myopathy pathologies in alpha B-R120G knock-in mice share common mechanisms, including increased insolubility of alpha B-crystallin and co-aggregation of alpha B-crystallin with intermediate filament proteins. These knock-in alpha B-R120G mice are a valuable model of the developmental and molecular biological mechanisms that underlie the pathophysiology of human hereditary cataracts and myopathy.	[Andley, Usha P.; Ravi, Nathan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Hamilton, Paul D.; Ravi, Nathan] Vet Affairs Med Ctr, Dept Res, St Louis, MO USA; [Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); US Department of Veterans Affairs; Veterans Health Administration (VHA); Washington University (WUSTL)	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	andley@vision.wustl.edu		Andley, Usha/0000-0001-7049-7591	National Institutes of Health [R01EY05681, R01AG031867, 5K08AG026271, EY02687]; RPB Inc.; Muscular Dystrophy Association; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin [P30 AR057235]; NATIONAL EYE INSTITUTE [P30EY002687, R01EY005681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG026271, R01AG031867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB Inc.; Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health [R01EY05681 to U.P.A. and R01AG031867, 5K08AG026271 to C. C. W., Core Grant EY02687 to the Department of Ophthalmology and Visual Sciences at Washington University], RPB Inc. [an unrestricted grant to the Department of Ophthalmology and Visual Sciences at Washington University], the Muscular Dystrophy Association [to C. C. W.], and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin [P30 AR057235 to the Washington University Center for Musculoskeletal Research]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Andley UP, 2001, FASEB J, V15, P221, DOI 10.1096/fj.00-0296com; Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Andley Usha P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000111; Andley UP, 2010, EXP EYE RES, V90, P699, DOI 10.1016/j.exer.2010.02.009; Andley UP, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-4; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; BATEMAN BJ, 1998, GENETICS EYE DIS, P1; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Graw J, 2004, INT J DEV BIOL, V48, P1031, DOI 10.1387/ijdb.041854jg; Head MW, 2000, NEUROREPORT, V11, P361, DOI 10.1097/00001756-200002070-00028; Head MW, 2000, NEUROPATH APPL NEURO, V26, P304, DOI 10.1046/j.1365-2990.2000.00269.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Moore AT, 2004, BRIT J OPHTHALMOL, V88, P2, DOI 10.1136/bjo.88.1.2; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; PIETROWSKI D, 1994, GENE, V144, P171, DOI 10.1016/0378-1119(94)90375-1; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Richter L, 2008, AM J MED GENET A, V146A, P833, DOI 10.1002/ajmg.a.32236; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sandilands A, 2004, EXP EYE RES, V78, P109, DOI 10.1016/j.exer.2003.09.001; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Schroder R, 2009, BRAIN PATHOL, V19, P483, DOI 10.1111/j.1750-3639.2009.00289.x; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Sitterding SM, 2008, ANN DIAGN PATHOL, V12, P33, DOI 10.1016/j.anndiagpath.2007.02.004; Skvorak K, 2006, GENESIS, V44, P345, DOI 10.1002/dvg.20222; Song SH, 2008, MOL VIS, V14, P1282; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; Vanita V, 2006, MOL VIS, V12, P518; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Watson GW, 2010, BIOCHEM BIOPH RES CO, V401, P192, DOI 10.1016/j.bbrc.2010.09.023; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	60	43	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17671	10.1371/journal.pone.0017671	http://dx.doi.org/10.1371/journal.pone.0017671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445271	Green Submitted, gold, Green Published			2022-12-27	WOS:000288545100025
J	Zilliges, Y; Kehr, JC; Meissner, S; Ishida, K; Mikkat, S; Hagemann, M; Kaplan, A; Borner, T; Dittmann, E				Zilliges, Yvonne; Kehr, Jan-Christoph; Meissner, Sven; Ishida, Keishi; Mikkat, Stefan; Hagemann, Martin; Kaplan, Aaron; Boerner, Thomas; Dittmann, Elke			The Cyanobacterial Hepatotoxin Microcystin Binds to Proteins and Increases the Fitness of Microcystis under Oxidative Stress Conditions	PLOS ONE			English	Article							BOUND MICROCYSTINS; LIGHT; STRAIN; GENE; BIOSYNTHESIS; AVAILABILITY; COMPETITION; IMPACT; TOXINS; LR	Microcystins are cyanobacterial toxins that represent a serious threat to drinking water and recreational lakes worldwide. Here, we show that microcystin fulfils an important function within cells of its natural producer Microcystis. The microcystin deficient mutant Delta mcyB showed significant changes in the accumulation of proteins, including several enzymes of the Calvin cycle, phycobiliproteins and two NADPH-dependent reductases. We have discovered that microcystin binds to a number of these proteins in vivo and that the binding is strongly enhanced under high light and oxidative stress conditions. The nature of this binding was studied using extracts of a microcystin-deficient mutant in vitro. The data obtained provided clear evidence for a covalent interaction of the toxin with cysteine residues of proteins. A detailed investigation of one of the binding partners, the large subunit of RubisCO showed a lower susceptibility to proteases in the presence of microcystin in the wild type. Finally, the mutant defective in microcystin production exhibited a clearly increased sensitivity under high light conditions and after hydrogen peroxide treatment. Taken together, our data suggest a protein-modulating role for microcystin within the producing cell, which represents a new addition to the catalogue of functions that have been discussed for microbial secondary metabolites.	[Zilliges, Yvonne] Humboldt Univ, Inst Biol, Dept Mol Ecol, Berlin, Germany; [Kehr, Jan-Christoph; Meissner, Sven; Dittmann, Elke] Univ Potsdam, Inst Biochem & Biol, Dept Microbiol Potsdam Golm, Potsdam, Germany; [Ishida, Keishi] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Mikkat, Stefan] Univ Rostock, Fac Med, Core Facil Proteome Anal, Rostock, Germany; [Hagemann, Martin] Univ Rostock, Inst Biol, Dept Plant Physiol, Rostock, Germany; [Kaplan, Aaron] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, Jerusalem, Israel; [Boerner, Thomas] Humboldt Univ, Dept Genet, Inst Biol, Berlin, Germany	Humboldt University of Berlin; University of Potsdam; Hans Knoll Institute (HKI); University of Rostock; University of Rostock; Hebrew University of Jerusalem; Humboldt University of Berlin	Zilliges, Y (corresponding author), Humboldt Univ, Inst Biol, Dept Mol Ecol, Berlin, Germany.	editt@uni-potsdam.de	Kaplan, Aaron/GLN-5655-2022; Dittmann, Elke/B-4742-2018	Dittmann, Elke/0000-0002-7549-7918; Borner, Thomas/0000-0001-9548-3348; Kaplan, Aaron/0000-0002-0815-5731	German Israeli Foundation (GIF); German Ministry of Science (BMBF)	German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); German Ministry of Science (BMBF)(Federal Ministry of Education & Research (BMBF))	E.D., T.B. and A.K. were supported by a grant of the German Israeli Foundation (GIF) and the German Ministry of Science (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Borner T, 2005, AQUAT ECOL SER, V3, P25; Brandes HK, 1996, PLANT PHYSIOL, V111, P50003; Briand E, 2008, ENVIRON MICROBIOL, V10, P3337, DOI 10.1111/j.1462-2920.2008.01730.x; CREIGHTON TE, 1980, NATURE, V287, P468, DOI 10.1038/287468b0; Davies J, 2006, J IND MICROBIOL BIOT, V33, P496, DOI 10.1007/s10295-006-0112-5; Dittmann E, 2006, MOL NUTR FOOD RES, V50, P7, DOI 10.1002/mnfr.200500162; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; Perez-Perez ME, 2009, MOL PLANT, V2, P270, DOI 10.1093/mp/ssn070; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; Hesse K, 2001, FEMS MICROBIOL ECOL, V37, P39, DOI 10.1111/j.1574-6941.2001.tb00851.x; Jahnichen S, 2007, APPL ENVIRON MICROB, V73, P6994, DOI 10.1128/AEM.01253-07; Juttner F, 2008, TOXICON, V51, P388, DOI 10.1016/j.toxicon.2007.10.013; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; Kehr JC, 2006, MOL MICROBIOL, V59, P893, DOI 10.1111/j.1365-2958.2005.05001.x; Kuhn I, 2000, J BACTERIOL, V182, P4640, DOI 10.1128/JB.182.16.4640-4643.2000; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Marin-Navarro J, 2006, PLANT CELL ENVIRON, V29, P898, DOI 10.1111/j.1365-3040.2005.01469.x; Moreno J, 2008, J EXP BOT, V59, P1605, DOI 10.1093/jxb/erm310; Paerl H W, 2001, ScientificWorldJournal, V1, P76; PAERL HW, 1985, APPL ENVIRON MICROB, V49, P1046, DOI 10.1128/AEM.49.5.1046-1052.1985; Pearson LA, 2004, APPL ENVIRON MICROB, V70, P6370, DOI 10.1128/AEM.70.11.6370-6378.2004; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Rohrlack T, 1999, APPL ENVIRON MICROB, V65, P737; Rohrlack T, 2001, APPL ENVIRON MICROB, V67, P3523, DOI 10.1128/AEM.67.8.3523-3529.2001; RUNNEGAR M, 1995, BIOCHEM BIOPH RES CO, V216, P162, DOI 10.1006/bbrc.1995.2605; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; SUGIYAMA T, 1968, ARCH BIOCHEM BIOPHYS, V125, P98, DOI 10.1016/0003-9861(68)90643-7; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Vela L, 2008, TOXICOL IN VITRO, V22, P1714, DOI 10.1016/j.tiv.2008.07.008; Weller MG, 2001, ANAL SCI, V17, P1445, DOI 10.2116/analsci.17.1445; Zilliges Y, 2008, J BACTERIOL, V190, P2871, DOI 10.1128/JB.01867-07	36	272	277	10	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17615	10.1371/journal.pone.0017615	http://dx.doi.org/10.1371/journal.pone.0017615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445264	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100019
J	Yang, B; Wang, JW; Tang, B; Liu, YF; Guo, CD; Yang, PH; Yu, TA; Li, R; Zhao, JM; Zhang, L; Dai, YP; Li, N				Yang, Bin; Wang, Jianwu; Tang, Bo; Liu, Yufang; Guo, Chengdong; Yang, Penghua; Yu, Tian; Li, Rong; Zhao, Jianmin; Zhang, Lei; Dai, Yunping; Li, Ning			Characterization of Bioactive Recombinant Human Lysozyme Expressed in Milk of Cloned Transgenic Cattle	PLOS ONE			English	Article							MAMMARY-GLAND; HUMAN-SERUM; PROTEINS; GOATS; LACTOFERRIN; CLONING; YEAST; GENE; COW; PH	Background: There is great potential for using transgenic technology to improve the quality of cow milk and to produce biopharmaceuticals within the mammary gland. Lysozyme, a bactericidal protein that protects human infants from microbial infections, is highly expressed in human milk but is found in only trace amounts in cow milk. Methodology/Principal Findings: We have produced 17 healthy cloned cattle expressing recombinant human lysozyme using somatic cell nuclear transfer. In this study, we just focus on four transgenic cattle which were natural lactation. The expression level of the recombinant lysozyme was up to 25.96 mg/L, as measured by radioimmunoassay. Purified recombinant human lysozyme showed the same physicochemical properties, such as molecular mass and bacterial lysis, as its natural counterpart. Moreover, both recombinant and natural lysozyme had similar conditions for reactivity as well as for pH and temperature stability during in vitro simulations. The gross composition of transgenic and non-transgenic milk, including levels of lactose, total protein, total fat, and total solids were not found significant differences. Conclusions/Significance: Thus, our study not only describes transgenic cattle whose milk offers the similar nutritional benefits as human milk but also reports techniques that could be further refined for production of active human lysozyme on a large scale.	[Yang, Bin; Wang, Jianwu; Liu, Yufang; Guo, Chengdong; Yang, Penghua; Yu, Tian; Dai, Yunping; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Tang, Bo; Li, Rong; Zhao, Jianmin; Zhang, Lei] Beijing GenProt Biotechnol Co, Beijing, Peoples R China	China Agricultural University	Yang, B (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglbau@public3.bta.net.cn			State High-Tech Research Development Program of China [2007AA100501]; GenProtein Biotechnology Company	State High-Tech Research Development Program of China; GenProtein Biotechnology Company	This work was supported by a grant from the State High-Tech Research Development Program of China (2007AA100501). This study also was financially supported in part by GenProtein Biotechnology Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bowen WH, 2005, PEDIATRICS, V116, P921, DOI 10.1542/peds.2004-2462; Brundige DR, 2008, J NUTR, V138, P921, DOI 10.1093/jn/138.5.921; Brundige DR, 2010, TRANSGENIC RES, V19, P563, DOI 10.1007/s11248-009-9334-4; CHANDAN RC, 1964, NATURE, V204, P76, DOI 10.1038/204076a0; Clark AJ, 1998, J MAMMARY GLAND BIOL, V3, P337, DOI 10.1023/A:1018723712996; DAVIES RC, 1969, BIOCHIM BIOPHYS ACTA, V178, P294, DOI 10.1016/0005-2744(69)90397-0; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Gong GC, 2004, SCI CHINA SER C, V47, P183, DOI 10.1360/03yc0015; HANKIEWICZ J, 1974, CLIN CHIM ACTA, V57, P205, DOI 10.1016/0009-8981(74)90398-2; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Huang E, 2009, FOOD BIOPROCESS TECH, V2, P222, DOI 10.1007/s11947-008-0062-1; Huang JM, 2002, TRANSGENIC RES, V11, P229, DOI 10.1023/A:1015663706259; ITO Y, 1993, EUR J BIOCHEM, V213, P649, DOI 10.1111/j.1432-1033.1993.tb17805.x; Iwata T, 2004, BIOTECHNOL LETT, V26, P1803, DOI 10.1007/s10529-004-4614-9; Jackson KA, 2010, TRANSGENIC RES, V19, P977, DOI 10.1007/s11248-010-9371-z; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kim HR, 2009, REPROD DOMEST ANIM, V44, P714, DOI 10.1111/j.1439-0531.2007.01058.x; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Krepulat F, 2005, ONCOGENE, V24, P4645, DOI 10.1038/sj.onc.1208557; Laible G, 2007, THERIOGENOLOGY, V67, P166, DOI 10.1016/j.theriogenology.2006.09.028; Larsen MR, 2006, BIOTECHNIQUES, V40, P790, DOI 10.2144/000112201; Lee BH, 2008, J MICROBIOL BIOTECHN, V18, P1386; Lee-Huang S, 2005, BIOCHEMISTRY-US, V44, P4648, DOI 10.1021/bi0477081; Levy J, 1998, NUTRITION, V14, P641, DOI 10.1016/S0899-9007(98)00007-0; Li B, 2006, FEBS LETT, V580, P1877, DOI 10.1016/j.febslet.2006.02.051; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1535S; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Maga EA, 1995, J DAIRY SCI, V78, P2645, DOI 10.3168/jds.S0022-0302(95)76894-1; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; MASON DY, 1975, J CLIN PATHOL, V28, P124, DOI 10.1136/jcp.28.2.124; Montagne P, 2001, ADV EXP MED BIOL, V501, P241; MURAKI M, 1988, PROTEIN ENG, V2, P49, DOI 10.1093/protein/2.1.49; Niemann H, 2003, ANIM REPROD SCI, V79, P291, DOI 10.1016/S0378-4320(03)00169-6; Ogundele MO, 1998, MEDIAT INFLAMM, V7, P363, DOI 10.1080/09629359890893; PARRY RM, 1969, ARCH BIOCHEM BIOPHYS, V130, P59, DOI 10.1016/0003-9861(69)90009-5; PEETERS TL, 1978, CLIN CHEM, V24, P2155; PETERS CWB, 1989, EUR J BIOCHEM, V182, P507, DOI 10.1111/j.1432-1033.1989.tb14857.x; Piccinini R, 2005, VET RES, V36, P747, DOI 10.1051/vetres:2005030; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; Ranieri ML, 2009, J DAIRY SCI, V92, P4823, DOI 10.3168/jds.2009-2144; Sabikhi L, 2007, ADV FOOD NUTR RES, V53, P161, DOI 10.1016/S1043-4526(07)53005-6; Samaranayake YH, 1997, APMIS, V105, P875, DOI 10.1111/j.1699-0463.1997.tb05097.x; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Tian XC, 2005, P NATL ACAD SCI USA, V102, P6261, DOI 10.1073/pnas.0500140102; VASSTRAND EN, 1980, SCAND J DENT RES, V88, P219; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang J, 2008, J DAIRY SCI, V91, P4466, DOI 10.3168/jds.2008-1189; Wilken LR, 2006, BIOTECHNOL PROGR, V22, P745, DOI 10.1021/bp0600536; Williams A, 2008, NUCLEIC ACIDS RES, V36, P2320, DOI 10.1093/nar/gkn085; Wuensch A, 2007, BIOL REPROD, V76, P983, DOI 10.1095/biolreprod.106.058776; Xiong RS, 2008, BIOTECHNOL APPL BIOC, V51, P129, DOI 10.1042/BA20070205; Xue QG, 2004, COMP BIOCHEM PHYS B, V139, P11, DOI 10.1016/j.cbpc.2004.05.011; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yu Z, 2006, J DAIRY SCI, V89, P2911, DOI 10.3168/jds.S0022-0302(06)72563-2; AGR QUALITY STANDARD	58	79	95	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17593	10.1371/journal.pone.0017593	http://dx.doi.org/10.1371/journal.pone.0017593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436886	Green Submitted, gold, Green Published			2022-12-27	WOS:000288514000004
J	Aporntewan, C; Phokaew, C; Piriyapongsa, J; Ngamphiw, C; Ittiwut, C; Tongsima, S; Mutirangura, A				Aporntewan, Chatchawit; Phokaew, Chureerat; Piriyapongsa, Jittima; Ngamphiw, Chumpol; Ittiwut, Chupong; Tongsima, Sissades; Mutirangura, Apiwat			Hypomethylation of Intragenic LINE-1 Represses Transcription in Cancer Cells through AGO2	PLOS ONE			English	Article							GENE-EXPRESSION; METHYLATION LEVEL; DNA HYPOMETHYLATION; L1 RETROTRANSPOSON; CARCINOMA; IDENTIFICATION; ASSOCIATION; HEAD; DIFFERENTIATION; PREDICTION	In human cancers, the methylation of long interspersed nuclear element -1 (LINE-1 or L1) retrotransposons is reduced. This occurs within the context of genome wide hypomethylation, and although it is common, its role is poorly understood. L1s are widely distributed both inside and outside of genes, intragenic and intergenic, respectively. Interestingly, the insertion of active full-length L1 sequences into host gene introns disrupts gene expression. Here, we evaluated if intragenic L1 hypomethylation influences their host gene expression in cancer. First, we extracted data from L1base (http://l1base.molgen.mpg.de), a database containing putatively active L1 insertions, and compared intragenic and intergenic L1 characters. We found that intragenic L1 sequences have been conserved across evolutionary time with respect to transcriptional activity and CpG dinucleotide sites for mammalian DNA methylation. Then, we compared regulated mRNA levels of cells from two different experiments available from Gene Expression Omnibus (GEO), a database repository of high throughput gene expression data, (http://www.ncbi.nlm.nih.gov/geo) by chi-square. The odds ratio of down-regulated genes between demethylated normal bronchial epithelium and lung cancer was high (p<1E(-27); OR = 3.14; 95% CI = 2.54-3.88), suggesting cancer genome wide hypomethylation down-regulating gene expression. Comprehensive analysis between L1 locations and gene expression showed that expression of genes containing L1s had a significantly higher likelihood to be repressed in cancer and hypomethylated normal cells. In contrast, many mRNAs derived from genes containing L1s are elevated in Argonaute 2 (AGO2 or EIF2C2)-depleted cells. Hypomethylated L1s increase L1 mRNA levels. Finally, we found that AGO2 targets intronic L1 pre-mRNA complexes and represses cancer genes. These findings represent one of the mechanisms of cancer genome wide hypomethylation altering gene expression. Hypomethylated intragenic L1s are a nuclear siRNA mediated cis-regulatory element that can repress genes. This epigenetic regulation of retrotransposons likely influences many aspects of genomic biology.	[Aporntewan, Chatchawit] Chulalongkorn Univ, Fac Sci, Dept Math, Bangkok, Thailand; [Phokaew, Chureerat] Chulalongkorn Univ, Fac Grad Sch, Inter Dept Program BioMed Sci, Bangkok, Thailand; [Piriyapongsa, Jittima; Ngamphiw, Chumpol; Tongsima, Sissades] Genome Inst, Natl Ctr Genet Engn & Biotechnol, Thailand Sci Pk, Pathumtani, Thailand; [Ittiwut, Chupong; Mutirangura, Apiwat] Chulalongkorn Univ, Ctr Excellence Mol Genet Canc & Human Dis, Fac Med, Dept Anat, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Aporntewan, C (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Math, Bangkok, Thailand.	mapiwat@chula.ac.th	Tongsima, Sissades/F-4891-2011; Piriyapongsa, Jittima/F-7581-2012; Ngamphiw, Chumpol/ABB-6488-2021; Mutirangura, Apiwat/C-8197-2009	Tongsima, Sissades/0000-0002-1491-1839; Ngamphiw, Chumpol/0000-0002-8581-397X; 	Thailand Research Fund (TRF); National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science and Technology Development Agency (NSTDA); Four Seasons Hotel Bangkok; Thai Red Cross Society 4th Cancer Care Charity; Chulalongkorn University; Royal Golden Jubilee Ph.D. grant [PHD/0190/2550]; French embassy in Thailand	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science and Technology Development Agency (NSTDA); Four Seasons Hotel Bangkok; Thai Red Cross Society 4th Cancer Care Charity; Chulalongkorn University(Chulalongkorn University); Royal Golden Jubilee Ph.D. grant; French embassy in Thailand	Funding: This study is supported in part by the Thailand Research Fund (TRF), the National Center for Genetic Engineering and Biotechnology (BIOTEC), the National Science and Technology Development Agency (NSTDA), Four Seasons Hotel Bangkok and the Thai Red Cross Society 4th Cancer Care Charity and Chulalongkorn University. Chureerat Phokaew is supported by a Royal Golden Jubilee Ph.D. grant (PHD/0190/2550), French embassy in Thailand and Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Herman JG, 2005, COLD SH Q B, V70, P329, DOI 10.1101/sqb.2005.70.036; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; Kim BY, 2004, BBA-MOL BASIS DIS, V1739, P50, DOI 10.1016/j.bbadis.2004.07.004; KONGRUTTANACHOK N, MOL CANC, V9, P70; Kuriakose MA, 2004, CELL MOL LIFE SCI, V61, P1372, DOI 10.1007/s00018-004-4069-0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Mecham BH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh071; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mutirangura A, 2007, ASIAN BIOMED, V1, P121; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Pornthanakasem W, 2004, BIOTECHNIQUES, V37, P750, DOI 10.2144/04375BM07; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Rangwala SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r100; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schulz WA, 2006, CURR TOP MICROBIOL, V310, P211; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; Shuangshoti S, 2007, ASIAN PAC J CANCER P, V8, P307; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Subbalekha K, 2009, ORAL ONCOL, V45, P184, DOI 10.1016/j.oraloncology.2008.05.002; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Thanasupawat T, 2009, ASIAN BIOMED, V3, P279; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	68	79	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17934	10.1371/journal.pone.0017934	http://dx.doi.org/10.1371/journal.pone.0017934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423624	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900045
J	Arandjelovic, M; Head, J; Rabanal, LI; Schubert, G; Mettke, E; Boesch, C; Robbins, MM; Vigilant, L				Arandjelovic, Mimi; Head, Josephine; Rabanal, Luisa I.; Schubert, Grit; Mettke, Elisabeth; Boesch, Christophe; Robbins, Martha M.; Vigilant, Linda			Non-Invasive Genetic Monitoring of Wild Central Chimpanzees	PLOS ONE			English	Article							KIBALE NATIONAL-PARK; POPULATION-SIZE; GOUALOUGO TRIANGLE; DNA AMPLIFICATION; PATERNITY; IDENTIFICATION; DECLINE; FIELD; RELATEDNESS; GORILLAS	Background: An assessment of population size and structure is an important first step in devising conservation and management plans for endangered species. Many threatened animals are elusive, rare and live in habitats that prohibit directly counting individuals. For example, a well-founded estimate of the number of great apes currently living in the wild is lacking. Developing methods to obtain accurate population estimates for these species is a priority for their conservation management. Genotyping non-invasively collected faecal samples is an effective way of evaluating a species' population size without disruption, and can also reveal details concerning population structure. Methodology/Principal Findings: We opportunistically collected wild chimpanzee faecal samples for genetic capture-recapture analyses over a four-year period in a 132 km 2 area of Loango National Park, Gabon. Of the 444 samples, 46% yielded sufficient quantities of DNA for genotyping analysis and the consequent identification of 121 individuals. Using genetic capture-recapture, we estimate that 283 chimpanzees (range: 208-316) inhabited the research area between February 2005 and July 2008. Since chimpanzee males are patrilocal and territorial, we genotyped samples from males using variable Y-chromosome microsatellite markers and could infer that seven chimpanzee groups are present in the area. Genetic information, in combination with field data, also suggested the occurrence of repeated cases of intergroup violence and a probable group extinction. Conclusions/Significance: The poor amplification success rate resulted in a limited number of recaptures and hence only moderate precision (38%, measured as the entire width of the 95% confidence interval), but this was still similar to the best results obtained using intensive nest count surveys of apes (40% to 63%). Genetic capture-recapture methods applied to apes can provide a considerable amount of novel information on chimpanzee population size and structure with minimal disturbance to the animals and represent a powerful complement to traditional field-based methods.	[Arandjelovic, Mimi; Head, Josephine; Rabanal, Luisa I.; Schubert, Grit; Mettke, Elisabeth; Boesch, Christophe; Robbins, Martha M.; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	Max Planck Society	Arandjelovic, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	arandjel@eva.mpg.de		Arandjelovic, Mimi/0000-0001-8920-9684	Societe pour la Conservation et le Developpement (SCD); Wildlife Conservation Society (WCS); Max Planck Society	Societe pour la Conservation et le Developpement (SCD); Wildlife Conservation Society (WCS); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the Societe pour la Conservation et le Developpement (SCD), Wildlife Conservation Society (WCS), and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; ARANDJELOVIC M, 2010, BIOL CONSERVATION; Arrendal J, 2007, CONSERV GENET, V8, P1097, DOI 10.1007/s10592-006-9266-y; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boesch C, 2008, SCIENCE AND CONSERVATION IN AFRICAN FORESTS: THE BENEFITS OF LONG-TERM RESEARCH, P184; Boesch C, 2007, INT J PRIMATOL, V28, P1025, DOI 10.1007/s10764-007-9201-1; Boyko RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010754; Bradley BJ, 2001, CONSERV GENET, V2, P179, DOI 10.1023/A:1011847528045; Butynski Thomas M., 2001, P3; Campbell G, 2008, CURR BIOL, V18, pR903, DOI 10.1016/j.cub.2008.08.015; Constable JL, 2001, MOL ECOL, V10, P1279, DOI 10.1046/j.1365-294X.2001.01262.x; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Erler A, 2004, MOL ECOL, V13, P2921, DOI 10.1111/j.1365-294X.2004.02304.x; Eves Heather E., 2008, P327, DOI 10.1007/978-0-387-70721-1_17; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOODALL J, 1979, GREAT APES; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; GOOSSENS B, 2000, CONSERVATION GENETIC, V1; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Hajkova P, 2009, CONSERV GENET, V10, P1667, DOI 10.1007/s10592-008-9745-4; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Herbinger I, 2001, INT J PRIMATOL, V22, P143, DOI 10.1023/A:1005663212997; Inoue E, 2008, AM J PHYS ANTHROPOL, V137, P256, DOI 10.1002/ajpa.20865; K?hl H., 2008, BEST PRACTICE GUIDEL; Kalinowski ST, 2006, J WILDLIFE MANAGE, V70, P1148, DOI 10.2193/0022-541X(2006)70[1148:IIADOG]2.0.CO;2; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kouakou CY, 2009, AM J PRIMATOL, V71, P447, DOI 10.1002/ajp.20673; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Leal M. E., 2001, Systematics and Geography of Plants, V71, P1073, DOI 10.2307/3668739; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; MARCHESI P, 1995, PRIMATES, V36, P591, DOI 10.1007/BF02382880; McGrew WC, 2004, AM J PRIMATOL, V63, P87, DOI 10.1002/ajp.20041; MCKELVEY KS, 2004, J WILDLIFE MANAGEMEN, V68; Melin AD, 2010, AM J PRIMATOL, V72, P61; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Mitani JC, 2008, CURR BIOL, V18, pR166, DOI 10.1016/j.cub.2007.12.022; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Mittermeier Russell A., 2009, Primate Conservation, V24, P1; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; Morgan D, 2003, INT J PRIMATOL, V24, P369, DOI 10.1023/A:1023005417897; MORIN PA, 1993, PRIMATES, V34, P347, DOI 10.1007/BF02382630; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Murray CM, 2008, CURR BIOL, V18, P20, DOI 10.1016/j.cub.2007.11.044; NISHIDA T, 1985, Z TIERPSYCHOL, V67, P284; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Oates J.F., 1996, AFRICAN PRIMATES STA; PAETKAU D, 2003, MOL ECOLOGY, V12; Petit E, 2006, CONSERV BIOL, V20, P1062, DOI 10.1111/j.1523-1739.2006.00417.x; Pettorelli N, 2010, ANIM CONSERV, V13, P131, DOI 10.1111/j.1469-1795.2009.00309.x; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; REED JZ, 1997, MOL ECOLOGY, V6; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; Sanz C, 2004, AM NAT, V164, P567, DOI 10.1086/424803; Sanz C, 2007, J APPL ECOL, V44, P263, DOI 10.1111/j.1365-2664.2007.01278.x; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Soulu M., 2001, CONSERVATION BIOL RE; Stumpf R., 2010, PRIMATES PERSPECTIVE; Thompson ME, 2006, INT J PRIMATOL, V27, P1601, DOI 10.1007/s10764-006-9098-0; UEHARA S, 1994, PRIMATES, V35, P275, DOI 10.1007/BF02382725; Vallet D, 2008, CONSERV GENET, V9, P677, DOI 10.1007/s10592-007-9361-8; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Walsh PD, 2005, ECOL APPL, V15, P1342, DOI 10.1890/03-5283; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Watts DP, 2000, PRIMATES, V41, P357, DOI 10.1007/BF02557646; Watts DP, 2004, INT J PRIMATOL, V25, P507, DOI 10.1023/B:IJOP.0000023573.56625.59; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042	82	48	49	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e14761	10.1371/journal.pone.0014761	http://dx.doi.org/10.1371/journal.pone.0014761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423611	gold, Green Published, Green Submitted			2022-12-27	WOS:000288513900002
J	Yamamoto, M; Cid, E; Bru, S; Yamamoto, F				Yamamoto, Miyako; Cid, Emili; Bru, Samuel; Yamamoto, Fumiichiro			Rare and Frequent Promoter Methylation, Respectively, of TSHZ2 and 3 Genes That Are Both Downregulated in Expression in Breast and Prostate Cancers	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DNA METHYLATION; PROTEIN EXPRESSION; HOMEOBOX GENES; TEASHIRT GENE; HUMAN GENOME; HUMAN COLON; RT-PCR; DROSOPHILA; TRANSCRIPTION	Background: Neoplastic cells harbor both hypomethylated and hypermethylated regions of DNA. Whereas hypomethylation is found mainly in repeat sequences, regional hypermethylation has been linked to the transcriptional silencing of certain tumor suppressor genes. We attempted to search for candidate genes involved in breast/prostate carcinogenesis, using the criteria that they should be expressed in primary cultures of normal breast/prostate epithelial cells but are frequently downregulated in breast/prostate cancer cell lines and that their promoters are hypermethylated. Methodology/Principal Findings: We identified several dozens of candidates among 194 homeobox and related genes using Systematic Multiplex RT-PCR and among 23,000 known genes and 23,000 other expressed sequences in the human genome by DNA microarray hybridization. An additional examination, by real-time qRT-PCR of clinical specimens of breast cancer, further narrowed the list of the candidates. Among them, the most frequently downregulated genes in tumors were NP_775756 and ZNF537, from the homeobox gene search and the genome-wide search, respectively. To our surprise, we later discovered that these genes belong to the same gene family, the 3-member Teashirt family, bearing the new names of TSHZ2 and TSHZ3. We subsequently determined the methylation status of their gene promoters. The TSHZ3 gene promoter was found to be methylated in all the breast/prostate cancer cell lines and some of the breast cancer clinical specimens analyzed. The TSHZ2 gene promoter, on the other hand, was unmethylated except for the MDA-MB-231 breast cancer cell line. The TSHZ1 gene was always expressed, and its promoter was unmethylated in all cases. Conclusions/Significance: TSHZ2 and TSHZ3 genes turned out to be the most interesting candidates for novel tumor suppressor genes. Expression of both genes is downregulated. However, differential promoter methylation suggests the existence of distinctive mechanisms of transcriptional inactivation for these genes.	[Yamamoto, Miyako; Yamamoto, Fumiichiro] BIMR, La Jolla, CA USA; [Yamamoto, Miyako; Cid, Emili; Bru, Samuel; Yamamoto, Fumiichiro] Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain		Yamamoto, M (corresponding author), BIMR, La Jolla, CA USA.	fyamamoto@imppc.org	Yamamoto, Fumiichiro/F-1478-2016; Cid, Emili/F-7207-2016; ravegnini, gloria/K-1330-2016; Yamamoto, Miyako/F-1722-2016	Yamamoto, Fumiichiro/0000-0001-9690-7034; Cid, Emili/0000-0002-5025-352X; ravegnini, gloria/0000-0002-7774-402X; Yamamoto, Miyako/0000-0001-9516-1402	NIH [1R01CA087069]; DOD BCRP at BIMR [W81XWH-05-1-0317]; IMPPC; NATIONAL CANCER INSTITUTE [R01CA087069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP at BIMR; IMPPC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant 1R01CA087069 and the DOD BCRP grant W81XWH-05-1-0317 at BIMR and by the institutional start-up fund at IMPPC to FY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Ahuja N, 1998, CANCER RES, V58, P5489; AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; BIGGIN MD, 1989, CELL, V58, P433, DOI 10.1016/0092-8674(89)90424-8; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Core N, 2007, DEV BIOL, V308, P407, DOI 10.1016/j.ydbio.2007.05.038; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; Dostal A, 2009, J CRANIO MAXILL SURG, V37, P272, DOI 10.1016/j.jcms.2008.12.002; EE HC, 1995, AM J PATHOL, V147, P586; El Ghouzzi V, 2003, HUM MOL GENET, V12, P357, DOI 10.1093/hmg/ddg029; Erkner A, 1999, DEV BIOL, V215, P221, DOI 10.1006/dbio.1999.9452; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; FRIEDMANN Y, 1994, CANCER RES, V54, P5981; Gallet A, 1999, EMBO J, V18, P2208, DOI 10.1093/emboj/18.8.2208; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; Hayashi H, 2007, HUM GENET, V120, P701, DOI 10.1007/s00439-006-0254-6; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jenkins D, 2010, NEPHROL DIAL TRANSPL, V25, P54, DOI 10.1093/ndt/gfp453; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; KAMPS MP, 1990, MOL CELL BIOL, V10, P5464, DOI 10.1128/MCB.10.10.5464; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; Koebernick K, 2006, DEV BIOL, V298, P312, DOI 10.1016/j.ydbio.2006.06.041; KONGSUWAN K, 1988, EMBO J, V7, P2131, DOI 10.1002/j.1460-2075.1988.tb03052.x; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; MATHIES LD, 1994, DEVELOPMENT, V120, P2799; MAULBECKER CC, 1993, CELL GROWTH DIFFER, V4, P431; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Pan D, 1998, P NATL ACAD SCI USA, V95, P15508, DOI 10.1073/pnas.95.26.15508; Polakis P, 2000, GENE DEV, V14, P1837; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; RENUCCI A, 1992, EMBO J, V11, P1459, DOI 10.1002/j.1460-2075.1992.tb05190.x; Rots NY, 1998, MOL CELL BIOL, V18, P1911, DOI 10.1128/MCB.18.4.1911; RUBIN H, 1985, CANCER RES, V45, P2935; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WEINBERG RA, 1995, ANN NY ACAD SCI, V758, P331, DOI 10.1111/j.1749-6632.1995.tb24838.x; Yamamoto F, 2001, ELECTROPHORESIS, V22, P1946, DOI 10.1002/1522-2683(200106)22:10<1946::AID-ELPS1946>3.0.CO;2-Y; Yamamoto F, 2008, GENE EXPRESSION, V14, P217, DOI 10.3727/105221608786883816; Yamamoto M, 2003, ELECTROPHORESIS, V24, P2295, DOI 10.1002/elps.200305459; Yamamoto M, 2004, ELECTROPHORESIS, V25, P2201, DOI 10.1002/elps.200305952; Yamamoto M, 2003, GENE EXPRESSION, V11, P199, DOI 10.3727/000000003108749071; Yamamoto M, 2006, ELECTROPHORESIS, V27, P2529, DOI 10.1002/elps.200500875; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; ZAPPAVIGNA V, 1991, EMBO J, V10, P4177, DOI 10.1002/j.1460-2075.1991.tb04996.x	54	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17149	10.1371/journal.pone.0017149	http://dx.doi.org/10.1371/journal.pone.0017149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423795	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400009
J	Binder, MD; Xiao, JH; Kemper, D; Ma, GZM; Murray, SS; Kilpatrick, TJ				Binder, Michele D.; Xiao, Junhua; Kemper, Dennis; Ma, Gerry Z. M.; Murray, Simon S.; Kilpatrick, Trevor J.			Gas6 Increases Myelination by Oligodendrocytes and Its Deficiency Delays Recovery following Cuprizone-Induced Demyelination	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; MULTIPLE-SCLEROSIS; C57BL/6 MICE; REMYELINATION; SURVIVAL; PATHWAY; AXL; GROWTH; CELLS; CNS	Multiple sclerosis (MS) is a complex demyelinating disease of the central nervous system. Current research has shown that at least in some cases, the primary insult in MS could be directed at the oligodendrocyte, and that the earliest immune responses are primarily via innate immune cells. We have identified a family of receptor protein tyrosine kinases, known as the TAM receptors (Tyro3, Axl and Mertk), as potentially important in regulating both the oligodendrocyte and immune responses. We have previously shown that Gas6, a ligand for the TAM receptors, can affect the severity of demyelination in mice, with a loss of signalling via Gas6 leading to decreased oligodendrocyte survival and increased microglial activation during cuprizone-induced demyelination. We hypothesised TAM receptor signalling would also influence the extent of recovery in mice following demyelination. A significant effect of the absence of Gas6 was detected upon remyelination, with a lower level of myelination after 4 weeks of recovery in comparison with wild-type mice. The delay in remyelination was accompanied by a reduction in oligodendrocyte numbers. To understand the molecular mechanisms that drive the observed effects, we also examined the effect of exogenous Gas6 in in vitro myelination assays. We found that Gas6 significantly increased myelination in a dose-dependent manner, suggesting that TAM receptor signalling could be directly involved in myelination by oligodendrocytes. The reduced rate of remyelination in the absence of Gas6 could thus result from a lack of Gas6 at a critical time during myelin production after injury. These findings establish Gas6 as an important regulator of both CNS demyelination and remyelination.	[Binder, Michele D.; Xiao, Junhua; Kemper, Dennis; Ma, Gerry Z. M.; Murray, Simon S.; Kilpatrick, Trevor J.] Univ Melbourne, Multiple Sclerosis Div, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Binder, Michele D.; Xiao, Junhua; Ma, Gerry Z. M.; Murray, Simon S.; Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Murray, Simon S.] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne	Binder, MD (corresponding author), Univ Melbourne, Multiple Sclerosis Div, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	mbinder@florey.edu.au	Xiao, Junhua/AAC-6898-2022	Xiao, Junhua/0000-0002-4320-2855; Murray, Simon/0000-0001-6671-192X; Kilpatrick, Trevor/0000-0003-3999-085X; Binder, Michele/0000-0002-4494-6717	National Health and Medical Research Council Australia [566830, 454330]; Australian Postgraduate Award; Multiple Sclerosis Research Australia; Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria, Australia	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Multiple Sclerosis Research Australia; Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria, Australia	This work was supported by a grant from the National Health and Medical Research Council Australia (grant number 566830). GZMM is supported by an Australian Postgraduate Award. JX is the recipient of a Betty Cuthbert Fellowship (#454330) from National Health and Medical Research Council Australia and Multiple Sclerosis Research Australia. The Florey Neuroscience Institutes is supported by funding provided from the Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; BARRES BA, 1993, DEVELOPMENT, V118, P283; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Emery B, 2006, P NATL ACAD SCI USA, V103, P7859, DOI 10.1073/pnas.0602574103; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Hesse A, 2010, NEUROBIOL DIS, V37, P362, DOI 10.1016/j.nbd.2009.10.016; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Irvine KA, 2006, J NEUROIMMUNOL, V175, P69, DOI 10.1016/j.jneuroim.2006.03.002; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; KLEITMAN NW, 1991, TISSUE CULTURE METHO, P337; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Ma GZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016964; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Paxinos G., 2001, MOUSE BRAIN STEREOTA; RESCIGNO J, 1991, ONCOGENE, V6, P1909; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shankar SL, 2003, J NEUROSCI, V23, P4208; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; Taylor LC, 2010, J NEUROSCI RES, V88, P391, DOI 10.1002/jnr.22215; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009	29	42	43	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17727	10.1371/journal.pone.0017727	http://dx.doi.org/10.1371/journal.pone.0017727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423702	Green Published, gold			2022-12-27	WOS:000288219100031
J	Hidaka, S; Teramoto, W; Sugita, Y; Manaka, Y; Sakamoto, S; Suzuki, Y				Hidaka, Souta; Teramoto, Wataru; Sugita, Yoichi; Manaka, Yuko; Sakamoto, Shuichi; Suzuki, Yoiti			Auditory Motion Information Drives Visual Motion Perception	PLOS ONE			English	Article							SENSORY MODALITIES; SOUND; VENTRILOQUIST; INTEGRATION; DIRECTION; CAPTURE; VISION	Background: Vision provides the most salient information with regard to the stimulus motion. However, it has recently been demonstrated that static visual stimuli are perceived as moving laterally by alternating left-right sound sources. The underlying mechanism of this phenomenon remains unclear; it has not yet been determined whether auditory motion signals, rather than auditory positional signals, can directly contribute to visual motion perception. Methodology/Principal Findings: Static visual flashes were presented at retinal locations outside the fovea together with a lateral auditory motion provided by a virtual stereo noise source smoothly shifting in the horizontal plane. The flash appeared to move by means of the auditory motion when the spatiotemporal position of the flashes was in the middle of the auditory motion trajectory. Furthermore, the lateral auditory motion altered visual motion perception in a global motion display where different localized motion signals of multiple visual stimuli were combined to produce a coherent visual motion perception. Conclusions/Significance: These findings suggest there exist direct interactions between auditory and visual motion signals, and that there might be common neural substrates for auditory and visual motion processing.	[Hidaka, Souta] Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan; [Hidaka, Souta; Teramoto, Wataru] Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan; [Teramoto, Wataru; Sakamoto, Shuichi; Suzuki, Yoiti] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Sugita, Yoichi] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan; [Manaka, Yuko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Rikkyo University; Tohoku University; Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Hidaka, S (corresponding author), Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan.	hidaka@rikkyo.ac.jp	Suzuki, Yoiti/AAC-3765-2019; Hidaka, Souta/L-6393-2019	Hidaka, Souta/0000-0001-6727-5322	Ministry of Education, Science, and Culture, Japan [19001004]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Specially Promoted Research (19001004) of the Ministry of Education, Science, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIGGS RM, 1972, J EXP PSYCHOL, V92, P83, DOI 10.1037/h0032148; Calvert G., 2004, HDB MULTISENSORY PRO; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Hidaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008188; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; Macmillan N. A., 2004, DETECTION THEORY USE; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; RAMACHANDRAN VS, 1987, NATURE, V328, P645, DOI 10.1038/328645a0; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Sanabria D, 2007, EXP BRAIN RES, V178, P415, DOI 10.1007/s00221-007-0919-y; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Soto-Faraco S, 2004, J EXP PSYCHOL HUMAN, V30, P330, DOI 10.1037/0096-1523.30.2.330; Soto-Faraco S, 2004, CURR DIR PSYCHOL SCI, V13, P29, DOI 10.1111/j.0963-7214.2004.01301008.x; Soto-Faraco S, 2003, NEUROPSYCHOLOGIA, V41, P1847, DOI 10.1016/S0028-3932(03)00185-4; Soto-Faraco S, 2002, COGNITIVE BRAIN RES, V14, P139, DOI 10.1016/S0926-6410(02)00068-X; Teramoto W, 2010, NEUROSCI LETT, V479, P221, DOI 10.1016/j.neulet.2010.05.065; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; Welch R.B, 1986, HDB PERCEPTION HUMAN, V1; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5	26	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17499	10.1371/journal.pone.0017499	http://dx.doi.org/10.1371/journal.pone.0017499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FR	21408078	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900022
J	Dupont, E; Stevens, L; Cochon, L; Falempin, M; Bastide, B; Canu, MH				Dupont, Erwan; Stevens, Laurence; Cochon, Laetitia; Falempin, Maurice; Bastide, Bruno; Canu, Marie-Helene			ERK Is Involved in the Reorganization of Somatosensory Cortical Maps in Adult Rats Submitted to Hindlimb Unloading	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; HYPODYNAMIA-HYPOKINESIA; SYNAPTIC PLASTICITY; BARREL CORTEX; PROTEIN; KINASE; ACTIVATION; SUSPENSION; CASCADE; SYSTEM	Sensorimotor restriction by a 14-day period of hindlimb unloading (HU) in the adult rat induces a reorganization of topographic maps and receptive fields. However, the underlying mechanisms are still unclear. Interest was turned towards a possible implication of intracellular MAPK signaling pathway since Extracellular-signal-Regulated Kinase 1/2 (ERK1/2) is known to play a significant role in the control of synaptic plasticity. In order to better understand the mechanisms underlying cortical plasticity in adult rats submitted to a sensorimotor restriction, we analyzed the time-course of ERK1/2 activation by immunoblot and of cortical reorganization by electrophysiological recordings, on rats submitted to hindlimb unloading over four weeks. Immunohistochemistry analysis provided evidence that ERK1/2 phosphorylation was increased in layer III neurons of the somatosensory cortex. This increase was transient, and parallel to the changes in hindpaw cortical map area (layer IV). By contrast, receptive fields were progressively enlarged from 7 to 28 days of hindlimb unloading. To determine whether ERK1/2 was involved in cortical remapping, we administered a specific ERK1/2 inhibitor (PD-98059) through osmotic mini-pump in rats hindlimb unloaded for 14 days. Results demonstrate that focal inhibition of ERK1/2 pathway prevents cortical reorganization, but had no effect on receptive fields. These results suggest that ERK1/2 plays a role in the induction of cortical plasticity during hindlimb unloading.	[Dupont, Erwan; Stevens, Laurence; Cochon, Laetitia; Falempin, Maurice; Bastide, Bruno; Canu, Marie-Helene] Univ Lille Nord France, Lille, France; [Dupont, Erwan; Stevens, Laurence; Cochon, Laetitia; Falempin, Maurice; Bastide, Bruno; Canu, Marie-Helene] Univ Lille 1, IFR 114, EA 4488, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Dupont, E (corresponding author), Univ Lille Nord France, Lille, France.	erwan.dupont@univ-lille1.fr	CANU, Marie-Hélène/AAW-7356-2020	Bastide, bruno/0000-0002-7544-463X; CANU, Marie-Helene/0000-0003-4035-9619; Dupont, Erwan/0000-0003-0777-9734	Centre National d'Etudes Spatiales [8941]; Fonds Europeen de Developpement Regional [0066019F]; Nord-Pas de Calais regional council [06-1912]	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Fonds Europeen de Developpement Regional; Nord-Pas de Calais regional council(Region Hauts-de-France)	This study was supported by the Centre National d'Etudes Spatiales (Grant 8941), by the Fonds Europeen de Developpement Regional (Grant 0066019F), and by the Nord-Pas de Calais regional council (Grant 06-1912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ALFORD EK, 1987, EXP NEUROL, V96, P635, DOI 10.1016/0014-4886(87)90225-1; Boggio EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000604; Canu MH, 2007, EXP NEUROL, V203, P521, DOI 10.1016/j.expneurol.2006.09.005; Canu MH, 2006, EXP BRAIN RES, V173, P623, DOI 10.1007/s00221-006-0401-2; Canu MH, 2003, BRAIN RES, V978, P162, DOI 10.1016/S0006-8993(03)02804-X; DAmelio F, 1996, J NEUROSCI RES, V44, P532; De-Doncker L, 2005, J EXP BIOL, V208, P4585, DOI 10.1242/jeb.01931; Derkinderen P, 1999, NEUROREPORT, V10, pR24; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Diamond ME, 1999, J NEUROBIOL, V41, P64, DOI 10.1002/(SICI)1097-4695(199910)41:1<64::AID-NEU9>3.0.CO;2-N; Dupont E, 2005, MOL BRAIN RES, V133, P78, DOI 10.1016/j.molbrainres.2004.09.019; Dupont E, 2002, BRAIN RES, V926, P51, DOI 10.1016/S0006-8993(01)03293-0; Dupont E, 2001, NEUROSCI LETT, V309, P121, DOI 10.1016/S0304-3940(01)02050-X; DUPONT E, 2011, AM J PHYSL IN PRESS; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Huang W, 1998, J NEUROPHYSIOL, V80, P3261, DOI 10.1152/jn.1998.80.6.3261; Kawano F, 2004, AM J PHYSIOL-REG I, V287, pR76, DOI 10.1152/ajpregu.00694.2003; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Langlet C, 1999, NEUROSCI LETT, V266, P145, DOI 10.1016/S0304-3940(99)00296-7; Langlet C, 2001, BRAIN RES, V905, P72, DOI 10.1016/S0006-8993(01)02507-0; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Molina-Luna K, 2008, NEUROIMAGE, V40, P1748, DOI 10.1016/j.neuroimage.2007.11.018; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Ratto GM, 2006, ADV EXP MED BIOL, V557, P122; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; Rosselet C, 2006, J NEUROSCI, V26, P10667, DOI 10.1523/JNEUROSCI.3253-06.2006; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; STRATTON KR, 1989, P NATL ACAD SCI USA, V86, P2498, DOI 10.1073/pnas.86.7.2498; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Van der Zee EA, 1999, PROG NEUROBIOL, V58, P409, DOI 10.1016/S0301-0082(98)00092-6; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xerri C, 2008, BEHAV BRAIN RES, V192, P26, DOI 10.1016/j.bbr.2008.02.038	41	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17564	10.1371/journal.pone.0017564	http://dx.doi.org/10.1371/journal.pone.0017564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408155	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170000038
J	Zhao, YJ; Zhang, YH; Cao, Y; Qi, JX; Mao, LW; Xue, YF; Gao, F; Peng, H; Wang, XW; Gao, GF; Ma, YH				Zhao, Yueju; Zhang, Yunhua; Cao, Yang; Qi, Jianxun; Mao, Liangwei; Xue, Yanfen; Gao, Feng; Peng, Hao; Wang, Xiaowei; Gao, George F.; Ma, Yanhe			Structural Analysis of Alkaline beta-Mannanase from Alkaliphilic Bacillus sp N16-5: Implications for Adaptation to Alkaline Conditions	PLOS ONE			English	Article							PRELIMINARY-X-RAY; CRYSTAL-STRUCTURE; CONFORMATIONAL FLEXIBILITY; ALPHA-AMYLASE; GENE CLONING; BLUE MUSSEL; PH; SEQUENCE; XYLANASE; ENZYMES	Significant progress has been made in isolating novel alkaline beta-mannanases, however, there is a paucity of information concerning the structural basis for alkaline tolerance displayed by these beta-mannanases. We report the catalytic domain structure of an industrially important beta-mannanase from the alkaliphilic Bacillus sp. N16-5 (BSP165 MAN) at a resolution of 1.6 angstrom. This enzyme, classified into subfamily 8 in glycosyl hydrolase family 5 (GH5), has a pH optimum of enzymatic activity at pH 9.5 and folds into a classic (beta/alpha)(8)-barrel. In order to gain insight into molecular features for alkaline adaptation, we compared BSP165 MAN with previously reported GH5 beta-mannanases. It was revealed that BSP165 MAN and other subfamily 8 beta-mannanases have significantly increased hydrophobic and Arg residues content and decreased polar residues, comparing to beta-mannanases of subfamily 7 or 10 in GH5 which display optimum activities at lower pH. Further, extensive structural comparisons show alkaline beta-mannanases possess a set of distinctive features. Position and length of some helices, strands and loops of the TIM barrel structures are changed, which contributes, to a certain degree, to the distinctly different shaped (beta/alpha)(8)-barrels, thus affecting the catalytic environment of these enzymes. The number of negatively charged residues is increased on the molecular surface, and fewer polar residues are exposed to the solvent. Two amino acid substitutions in the vicinity of the acid/base catalyst were proposed to be possibly responsible for the variation in pH optimum of these homologous enzymes in subfamily 8 of GH5, identified by sequence homology analysis and pK(a) calculations of the active site residues. Mutational analysis has proved that Gln91 and Glu226 are important for BSP165 MAN to function at high pH. These findings are proposed to be possible factors implicated in the alkaline adaptation of GH5 beta-mannanases and will help to further understanding of alkaline adaptation mechanism.	[Zhao, Yueju; Zhang, Yunhua; Xue, Yanfen; Wang, Xiaowei; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Zhao, Yueju; Cao, Yang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cao, Yang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Qi, Jianxun; Gao, Feng; Peng, Hao; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Mao, Liangwei] Hubei Univ, Coll Life Sci, Wuhan 430062, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Hubei University	Zhao, YJ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	mayanhe@im.ac.cn	Wang, Xiaowei/K-8352-2013; MA, YAN/HHN-2912-2022; Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021	Mao, Liangwei/0000-0002-4325-4962	National Natural Science Foundation of China (NSFC) [30621005]; Ministry of Sciences and Technology of China [2007CB707801, 2003CB716001, 2006 AA020201, 2007AA021306]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (NSFC: 30621005) and from the Ministry of Sciences and Technology of China (973 programs 2007CB707801 and 2003CB716001, 863 programs 2006 AA020201 and 2007AA021306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AKINO T, 1987, APPL MICROBIOL BIOT, V26, P323; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P1490, DOI 10.1107/S0907444904014313; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Besir H, 2005, FEBS LETT, V579, P6595, DOI 10.1016/j.febslet.2005.10.052; BETTIOL JP, 2002, Patent No. 6376445; Coughlan S, 2001, BBA-PROTEIN STRUCT M, V1544, P10, DOI 10.1016/S0167-4838(00)00200-4; Dekker R F, 1976, Adv Carbohydr Chem Biochem, V32, P277; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P97, DOI 10.1110/ps.041029805; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fang TY, 1998, PROTEIN ENG, V11, P383, DOI 10.1093/protein/11.5.383; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P667, DOI 10.1142/S0219720008003618; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatada Y, 2005, EXTREMOPHILES, V9, P497, DOI 10.1007/s00792-005-0460-5; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Horikoshi K, 2004, P JPN ACAD B-PHYS, V80, P166, DOI 10.2183/pjab.80.166; Ito S, 1998, EXTREMOPHILES, V2, P185, DOI 10.1007/s007920050059; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kansoh AL, 2004, ANTON LEEUW INT J G, V85, P103, DOI 10.1023/B:ANTO.0000020281.73208.62; KIM JR, 2002, J KOREAN CHEM SOC, V46, P432; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUNTZ ID, 1971, J AM CHEM SOC, V93, P514, DOI 10.1021/ja00731a036; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7888, DOI 10.1128/AEM.71.12.7888-7896.2005; Li YN, 2008, J MICROBIOL BIOTECHN, V18, P160; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; Mamo G, 2009, BIOCHIMIE, V91, P1187, DOI 10.1016/j.biochi.2009.06.017; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCCLEARY BV, 1983, CARBOHYD RES, V111, P297, DOI 10.1016/0008-6215(83)88314-1; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 2001, PROTEIN ENG, V14, P505, DOI 10.1093/protein/14.7.505; Petersen MTN, 2001, J BIOTECHNOL, V85, P115, DOI 10.1016/S0168-1656(00)00360-6; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shirai T, 1997, PROTEIN ENG, V10, P627, DOI 10.1093/protein/10.6.627; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Shirai T, 2007, PROTEINS, V66, P600, DOI 10.1002/prot.21255; Singh S, 2003, FEMS MICROBIOL REV, V27, P3, DOI 10.1016/S0168-6445(03)00018-4; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu BZ, 2002, J BIOTECHNOL, V92, P267, DOI 10.1016/S0168-1656(01)00367-4; YANG AS, 1993, J MOL BIOL, V231, P459, DOI 10.1006/jmbi.1993.1294; Yang JH, 2008, J BIOTECHNOL, V133, P294, DOI 10.1016/j.jbiotec.2007.10.008; YANG P, 2008, APPL BIOCHEM BIOTECH, P1559; Zhao YJ, 2008, ACTA CRYSTALLOGR F, V64, P957, DOI 10.1107/S1744309108028571	62	32	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14608	10.1371/journal.pone.0014608	http://dx.doi.org/10.1371/journal.pone.0014608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21436878	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100002
J	Piper, ME; Sorenson, DR; Gerrard, SR				Piper, Mary E.; Sorenson, Dorothy R.; Gerrard, Sonja R.			Efficient Cellular Release of Rift Valley Fever Virus Requires Genomic RNA	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED PROTEIN; NUCLEOCAPSID PROTEIN; MATRIX PROTEIN; M-SEGMENT; S RNA; EXPRESSION STRATEGY; FUNCTIONAL-ANALYSIS; GLYCOPROTEINS GN; CYTOPLASMIC TAIL; INFLUENZA-VIRUS	The Rift Valley fever virus is responsible for periodic, explosive epizootics throughout sub-Saharan Africa. The development of therapeutics targeting this virus is difficult due to a limited understanding of the viral replicative cycle. Utilizing a virus-like particle system, we have established roles for each of the viral structural components in assembly, release, and virus infectivity. The envelope glycoprotein, Gn, was discovered to be necessary and sufficient for packaging of the genome, nucleocapsid protein and the RNA-dependent RNA polymerase into virus particles. Additionally, packaging of the genome was found to be necessary for the efficient release of particles, revealing a novel mechanism for the efficient generation of infectious virus. Our results identify possible conserved targets for development of anti-phlebovirus therapies.	[Piper, Mary E.; Gerrard, Sonja R.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Sorenson, Dorothy R.] Univ Michigan, Microscopy & Image Anal Lab, Ann Arbor, MI 48109 USA; [Gerrard, Sonja R.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Piper, ME (corresponding author), Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA.	srgerrard@gmail.com		Piper, Mary/0000-0003-2699-3840	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Regional Center of Excellence for Bio-defense; Emerging Infectious Diseases Research (RCE) [1-U54-AI-057153]; Rackham Graduate School at the University of Michigan; Ruth L. Kirschstein National Research Service [GM007315-32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Regional Center of Excellence for Bio-defense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emerging Infectious Diseases Research (RCE); Rackham Graduate School at the University of Michigan(University of Michigan System); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program (NIH award 1-U54-AI-057153) and the Rackham Graduate School at the University of Michigan. MEP is the recipient of a Ruth L. Kirschstein National Research Service Award, Grant No. GM007315-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarino CG, 2007, J VIROL, V81, P5246, DOI 10.1128/JVI.02778-06; BESSELAAR TG, 1992, ARCH VIROL, V125, P239, DOI 10.1007/BF01309641; Ciancanelli MJ, 2006, J VIROL, V80, P12070, DOI 10.1128/JVI.01743-06; Coronel EC, 1999, J VIROL, V73, P7035, DOI 10.1128/JVI.73.8.7035-7038.1999; DENG MY, 1994, APPL ENVIRON MICROB, V60, P1927, DOI 10.1128/AEM.60.6.1927-1933.1994; Flick K, 2004, J VIROL, V78, P11726, DOI 10.1128/JVI.78.21.11726-11738.2004; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Garry Courtney E, 2004, Theor Biol Med Model, V1, P10, DOI 10.1186/1742-4682-1-10; Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hartlieb B, 2006, VIROLOGY, V344, P64, DOI 10.1016/j.virol.2005.09.018; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Ikegami T, 2007, J VIROL, V81, P8421, DOI 10.1128/JVI.02641-06; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009; JIN H, 1993, J VIROL, V67, P1396, DOI 10.1128/JVI.67.3.1396-1404.1993; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; KAKACH LT, 1989, VIROLOGY, V170, P505, DOI 10.1016/0042-6822(89)90442-X; Kukkonen SKJ, 2004, J GEN VIROL, V85, P1181, DOI 10.1099/vir.0.19748-0; Li M, 2009, J VIROL, V83, P7261, DOI 10.1128/JVI.00421-09; Liu L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-82; LOPEZ N, 1995, J VIROL, V69, P3972, DOI 10.1128/JVI.69.7.3972-3979.1995; Lowen AC, 2005, J VIROL, V79, P12861, DOI 10.1128/JVI.79.20.12861-12870.2005; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; MEEGAN JM, 1979, VET REC, V105, P124, DOI 10.1136/vr.105.6.124; MEEGAN JM, 1988, ARBOVIRUSES EPIDEMIO, P51; Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Nugent CI, 1999, J VIROL, V73, P427, DOI 10.1128/JVI.73.1.427-435.1999; Overby AK, 2007, J VIROL, V81, P3198, DOI 10.1128/JVI.02655-06; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; PHILIPPE B, 1989, B SOC PATHOL EXOT, V82, P611; Piper ME, 2010, VIRUSES-BASEL, V2, P731, DOI 10.3390/v2030731; Plassmeyer ML, 2007, VIROLOGY, V358, P273, DOI 10.1016/j.virol.2006.08.050; Plassmeyer ML, 2005, VIROLOGY, V338, P121, DOI 10.1016/j.virol.2005.04.026; Pohl C, 2007, J GEN VIROL, V88, P1243, DOI 10.1099/vir.0.82578-0; Ramanathan HN, 2007, J VIROL, V81, P8634, DOI 10.1128/JVI.00418-07; Ravkov EV, 2001, J VIROL, V75, P1808, DOI 10.1128/JVI.75.4.1808-1815.2001; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; Shi XH, 2009, J GEN VIROL, V90, P2483, DOI 10.1099/vir.0.013540-0; SIMONS JF, 1990, J VIROL, V64, P247, DOI 10.1128/JVI.64.1.247-255.1990; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; SUZICH JA, 1990, J VIROL, V64, P1549, DOI 10.1128/JVI.64.4.1549-1555.1990; Swenson DL, 2004, FEMS IMMUNOL MED MIC, V40, P27, DOI 10.1016/S0928-8244(03)00273-6; Venter PA, 2007, J VIROL, V81, P613, DOI 10.1128/JVI.01668-06; Venter PA, 2005, J VIROL, V79, P6239, DOI 10.1128/JVI.79.10.6239-6248.2005; WASMOEN TL, 1988, VIROLOGY, V166, P275, DOI 10.1016/0042-6822(88)90174-2; WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06	59	44	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18070	10.1371/journal.pone.0018070	http://dx.doi.org/10.1371/journal.pone.0018070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445316	Green Submitted, gold, Green Published			2022-12-27	WOS:000288613300033
J	Venner, S; Pelisson, PF; Bel-Venner, MC; Debias, F; Rajon, E; Menu, F				Venner, Samuel; Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Debias, Francois; Rajon, Etienne; Menu, Frederic			Coexistence of Insect Species Competing for a Pulsed Resource: Toward a Unified Theory of Biodiversity in Fluctuating Environments	PLOS ONE			English	Article							PROLONGED DIAPAUSE; COMMUNITY DYNAMICS; DESERT ANNUALS; NEUTRALITY; ECOLOGY; NICHE; DIVERSITY; PERSPECTIVES; MAINTENANCE; MECHANISMS	Background: One major challenge in understanding how biodiversity is organized is finding out whether communities of competing species are shaped exclusively by species-level differences in ecological traits (niche theory), exclusively by random processes (neutral theory of biodiversity), or by both processes simultaneously. Communities of species competing for a pulsed resource are a suitable system for testing these theories: due to marked fluctuations in resource availability, the theories yield very different predictions about the timing of resource use and the synchronization of the population dynamics between the competing species. Accordingly, we explored mechanisms that might promote the local coexistence of phytophagous insects (four sister species of the genus Curculio) competing for oak acorns, a pulsed resource. Methodology/Principal Findings: We analyzed the time partitioning of the exploitation of oak acorns by the four weevil species in two independent communities, and we assessed the level of synchronization in their population dynamics. In accordance with the niche theory, overall these species exhibited marked time partitioning of resource use, both within a given year and between different years owing to different dormancy strategies between species, as well as distinct demographic patterns. Two of the four weevil species, however, consistently exploited the resource during the same period of the year, exhibited a similar dormancy pattern, and did not show any significant difference in their population dynamics. Conclusions/Significance: The marked time partitioning of the resource use appears as a keystone of the coexistence of these competing insect species, except for two of them which are demographically nearly equivalent. Communities of consumers of pulsed resources thus seem to offer a promising avenue for developing a unifying theory of biodiversity in fluctuating environments which might predict the co-occurrence, within the same community, of species that are ecologically either very similar, or very different.	[Venner, Samuel; Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Debias, Francois; Menu, Frederic] Univ Lyon 1, F-69622 Villeurbanne, France; [Venner, Samuel; Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Debias, Francois; Menu, Frederic] Univ Lyon, Lyon, France; [Venner, Samuel; Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Debias, Francois; Menu, Frederic] CNRS, Lab Biometrie & Biol Evolut, UMR5558, Villeurbanne, France; [Rajon, Etienne] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; University of Arizona	Venner, S (corresponding author), Univ Lyon 1, F-69622 Villeurbanne, France.	samuel.venner@univ-lyon1.fr	MENU, Frédéric/C-3107-2016; Venner, Samuel/ABC-7739-2020; Rajon, Etienne/AAE-3868-2020; Rajon, Etienne/E-7764-2010	Venner, Samuel/0000-0001-7127-3733; Rajon, Etienne/0000-0003-0658-8311	French National Research Agency (ANR) [JC09_470585]; CNRS; Envirhonalp (Sante et Environnement Cluster)	French National Research Agency (ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Envirhonalp (Sante et Environnement Cluster)	This work was funded by the French National Research Agency (ANR: CoCoReCo project JC09_470585), by the CNRS and by Envirhonalp (Sante et Environnement Cluster). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Coutin R., 1992, Memoires de la Societe Royale Belge d'Entomologie, V35, P259; Gewin V, 2006, PLOS BIOL, V4, P1306, DOI 10.1371/journal.pbio.0040278; GIBSON P, 1969, MISC PUBLS ENT SOC A, V6, P239; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hedlin A. F., 1980, CONE SEED INSECTS N; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Hughes J, 2004, MOL PHYLOGENET EVOL, V32, P601, DOI 10.1016/j.ympev.2004.02.007; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Liebhold A, 2004, OIKOS, V104, P156, DOI 10.1111/j.0030-1299.2004.12722.x; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maeto K, 2003, OECOLOGIA, V137, P392, DOI 10.1007/s00442-003-1381-6; MENU F, 1993, OECOLOGIA, V93, P367, DOI 10.1007/BF00317880; Menu F, 2000, AM NAT, V155, P724, DOI 10.1086/303355; Menu F, 2002, OECOLOGIA, V132, P167, DOI 10.1007/s00442-002-0969-6; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; OBERLI F, 2001, THESIS U LYONL FRANC; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; Pelisson PF, 2011, ENTOMOL EXP APPL, V138, P77, DOI 10.1111/j.1570-7458.2010.01077.x; Rajon E, 2009, J EVOLUTION BIOL, V22, P2094, DOI 10.1111/j.1420-9101.2009.01825.x; Schauff ME, 1986, USDA MISC PUBL, V1443; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; SHMIDA A, 1984, VEGETATIO, V58, P29; Siepielski AM, 2010, ECOLOGY, V91, P847, DOI 10.1890/09-0609.1; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Venable DL, 2008, ECOLOGY, V89, P2218, DOI 10.1890/07-0386.1; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Verhulst J, 2008, OECOLOGIA, V156, P95, DOI 10.1007/s00442-008-0980-7; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1	43	40	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e18039	10.1371/journal.pone.0018039	http://dx.doi.org/10.1371/journal.pone.0018039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445318	Green Published, gold, Green Submitted			2022-12-27	WOS:000288613300030
J	Ji, SC; Wang, X; Yun, SH; Jeon, HJ; Lee, HJ; Kim, H; Lim, HM				Ji, Sang Chun; Wang, Xun; Yun, Sang Hoon; Jeon, Heung Jin; Lee, Hee Jung; Kim, Hackjin; Lim, Heon M.			In Vivo Transcription Dynamics of the Galactose Operon: A Study on the Promoter Transition from P1 to P2 at Onset of Stationary Phase	PLOS ONE			English	Article							MESSENGER-RNA DECAY; ESCHERICHIA-COLI; CYCLIC-AMP; GENE-EXPRESSION; RECEPTOR PROTEIN; SIGMA-FACTOR; GAL OPERON; POLYMERASE; BINDING; ACTIVATION	Quantitative analyses of the 5' end of gal transcripts indicate that transcription from the galactose operon P1 promoter is higher during cell division. When cells are no longer dividing, however, transcription is initiated more often from the P2 promoter. Escherichia coli cells divide six times before the onset of the stationary phase when grown in LB containing 0.5% galactose at 37 degrees C. Transcription from the two promoters increases, although at different rates, during early exponential phase (until the third cell division, OD(600) 0.4), and then reaches a plateau. The steady-state transcription from P1 continues in late exponential phase (the next three cell divisions, OD(600) 3.0), after which transcription from this promoter decreases. However, steady-state transcription from P2 continues 1 h longer into the stationary phase, before decreasing. This longer steady-state P2 transcription constitutes the promoter transition from P1 to P2 at the onset of the stationary phase. The intracellular cAMP concentration dictates P1 transcription dynamics; therefore, promoter transition may result from a lack of cAMP-CRP complex binding to the gal operon. The decay rate of gal-specific transcripts is constant through the six consecutive cell divisions that comprise the exponential growth phase, increases at the onset of the stationary phase, and is too low to be measured during the stationary phase. These data suggest that a regulatory mechanism coordinates the synthesis and decay of gal mRNAs to maintain the observed gal transcription. Our analysis indicates that the increase in P1 transcription is the result of cAMP-CRP binding to increasing numbers of galactose operons in the cell population.	[Ji, Sang Chun; Wang, Xun; Yun, Sang Hoon; Jeon, Heung Jin; Lee, Hee Jung; Lim, Heon M.] Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon, South Korea; [Kim, Hackjin] Chungnam Natl Univ, Dept Chem, Coll Nat Sci, Taejon 305764, South Korea	Chungnam National University; Chungnam National University	Ji, SC (corresponding author), Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon, South Korea.	hmlim@cnu.ac.kr	Ji, Sang Chun/Y-6863-2019; Ji, Sang Chun/C-5383-2012; Park, DongNyuk/F-5737-2013	Ji, Sang Chun/0000-0003-2858-1057; Lim, Heon/0000-0003-1711-2589	Korean government [MOST R01-2006-000-10902-0]; Korea Research Foundation [KRF-2008-2581]	Korean government(Korean Government); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MOST R01-2006-000-10902-0) and by the Korea Research Foundation grant (KRF-2008-2581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1979, NATURE, V279, P492, DOI 10.1038/279492a0; ADHYA S, 2003, SCI STKE, pPE22; Adhya S, 1987, ESCHERICHIA COLI SAL, P1503; Aki T, 1997, EMBO J, V16, P3666, DOI 10.1093/emboj/16.12.3666; Belyaeva TA, 1998, J MOL BIOL, V277, P789, DOI 10.1006/jmbi.1998.1666; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Cavanagh AT, 2008, MOL MICROBIOL, V67, P1242, DOI 10.1111/j.1365-2958.2008.06117.x; CHOY HE, 1992, P NATL ACAD SCI USA, V89, P11264, DOI 10.1073/pnas.89.23.11264; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FRITZ HJ, 1983, EMBO J, V2, P2129, DOI 10.1002/j.1460-2075.1983.tb01713.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GUIDIRONTANI C, 1984, MOL GEN GENET, V195, P96, DOI 10.1007/BF00332730; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; IRANI M, 1989, J BACTERIOL, V171, P1623, DOI 10.1128/jb.171.3.1623-1630.1989; IRANI MH, 1983, CELL, V32, P783, DOI 10.1016/0092-8674(83)90064-8; Jain V, 2006, J MICROBIOL, V44, P1; Ji SC, 2010, BMB REP, V43, P474, DOI 10.5483/BMBRep.2010.43.7.474; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; JOSEPH E, 1981, J BACTERIOL, V146, P149, DOI 10.1128/JB.146.1.149-154.1981; Lee HJ, 2008, J MOL BIOL, V378, P318, DOI 10.1016/j.jmb.2008.02.067; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; MUSSO RE, 1977, CELL, V12, P847, DOI 10.1016/0092-8674(77)90283-5; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; QUEEN C, 1981, CELL, V25, P241, DOI 10.1016/0092-8674(81)90249-X; Roy S, 1998, J BIOL CHEM, V273, P14059, DOI 10.1074/jbc.273.23.14059; Roy S, 2004, EMBO J, V23, P869, DOI 10.1038/sj.emboj.7600098; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 1989, MOL CLONING LAB; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Sharma UK, 2008, J BACTERIOL, V190, P3434, DOI 10.1128/JB.01792-07; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; ULLMANN A, 1979, P NATL ACAD SCI USA, V76, P3194, DOI 10.1073/pnas.76.7.3194; WELPLY JK, 1980, J BACTERIOL, V142, P732, DOI 10.1128/JB.142.2.732-734.1980; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Yuan AH, 2008, MOL MICROBIOL, V70, P1136, DOI 10.1111/j.1365-2958.2008.06462.x	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17646	10.1371/journal.pone.0017646	http://dx.doi.org/10.1371/journal.pone.0017646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445255	gold, Green Published, Green Submitted			2022-12-27	WOS:000288545100023
J	Johnson, CJ; Herbst, A; Duque-Velasquez, C; Vanderloo, JP; Bochsler, P; Chappell, R; McKenzie, D				Johnson, Chad J.; Herbst, Allen; Duque-Velasquez, Camilo; Vanderloo, Joshua P.; Bochsler, Phil; Chappell, Rick; McKenzie, Debbie			Prion Protein Polymorphisms Affect Chronic Wasting Disease Progression	PLOS ONE			English	Article							WHITE-TAILED DEER; INFLUENCE SUSCEPTIBILITY; GENE; PRNP; PATTERNS; SCRAPIE	Analysis of the PRNP gene in cervids naturally infected with chronic wasting disease (CWD) suggested that PRNP polymorphisms affect the susceptibility of deer to infection. To test this effect, we orally inoculated 12 white-tailed deer with CWD agent. Three different PRNP alleles, wild-type (wt; glutamine at amino acid 95 and glycine at 96), Q95H (glutamine to histidine at amino acid position 95) and G96S (glycine to serine at position 96) were represented in the study cohort with 5 wt/wt, 3 wt/G96S, and 1 each wt/Q95H and Q95H/G96S. Two animals were lost to follow-up due to intercurrent disease. The inoculum was prepared from Wisconsin hunter-harvested homozygous wt/wt animals. All infected deer presented with clinical signs of CWD; the orally infected wt/wt had an average survival period of 693 days post inoculation (dpi) and G96S/wt deer had an average survival period of 956 dpi. The Q95H/wt and Q95H/G96S deer succumbed to CWD at 1,508 and 1,596 dpi respectively. These data show that polymorphisms in the PRNP gene affect CWD incubation period. Deer heterozygous for the PRNP alleles had extended incubation periods with the Q95H allele having the greatest effect.	[Johnson, Chad J.; Vanderloo, Joshua P.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Herbst, Allen; Duque-Velasquez, Camilo; McKenzie, Debbie] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Herbst, Allen; Duque-Velasquez, Camilo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Bochsler, Phil] Univ Wisconsin, Wisconsin Vet Diagnost Lab, Madison, WI USA; [Chappell, Rick] Univ Wisconsin, Dept Biostat & Med Bioinformat, Madison, WI USA; [McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Alberta; University of Alberta; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Alberta	Johnson, CJ (corresponding author), Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA.	Debbie.mckenzie@ualberta.ca	McKenzie, Debbie/G-4459-2015	McKenzie, Debbie/0000-0002-9291-6977; Herbst, Allen/0000-0001-6601-1245	DoD's National Prion Research Program; Alberta Prion Research Institute	DoD's National Prion Research Program; Alberta Prion Research Institute	This work was funded by the DoD's National Prion Research Program and the Alberta Prion Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; CARLSON GA, 1994, PHILOS T R SOC B, V343, P363, DOI 10.1098/rstb.1994.0030; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; O'Neill GT, 2005, J ANIM BREED GENET, V122, P86, DOI 10.1111/j.1439-0388.2005.00520.x; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Prusiner SB, 1991, BRAIN PATHOL, V1, P297, DOI 10.1111/j.1750-3639.1991.tb00673.x; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Tranulis MA, 2002, APMIS, V110, P33, DOI 10.1034/j.1600-0463.2002.100105.x; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264	16	76	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17450	10.1371/journal.pone.0017450	http://dx.doi.org/10.1371/journal.pone.0017450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445256	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100015
J	Genetos, DC; Yellowley, CE; Loots, GG				Genetos, Damian C.; Yellowley, Clare E.; Loots, Gabriela G.			Prostaglandin E-2 Signals Through PTGER2 to Regulate Sclerostin Expression	PLOS ONE			English	Article							MEF2 TRANSCRIPTION FACTORS; FRIZZLED-RELATED PROTEIN-1; LOCAL BONE-FORMATION; VAN-BUCHEM-DISEASE; PARATHYROID-HORMONE; GENE-EXPRESSION; OSTEOBLASTIC CELLS; SELECTIVE AGONIST; ANABOLIC ACTIONS; CLONE MC3T3-E1	The Wnt signaling pathway is a robust regulator of skeletal homeostasis. Gain-of-function mutations promote high bone mass, whereas loss of Lrp5 or Lrp6 co-receptors decrease bone mass. Similarly, mutations in antagonists of Wnt signaling influence skeletal integrity, in an inverse relation to Lrp receptor mutations. Loss of the Wnt antagonist Sclerostin (Sost) produces the generalized skeletal hyperostotic condition of sclerosteosis, which is characterized by increased bone mass and density due to hyperactive osteoblast function. Here we demonstrate that prostaglandin E-2 (PGE(2)), a paracrine factor with pleiotropic effects on osteoblasts and osteoclasts, decreases Sclerostin expression in osteoblastic UMR106.01 cells. Decreased Sost expression correlates with increased expression of Wnt/TCF target genes Axin2 and Tcf3. We also show that the suppressive effect of PGE(2) is mediated through a cyclic AMP/PKA pathway. Furthermore, selective agonists for the PGE(2) receptor EP2 mimic the effect of PGE(2) upon Sost, and siRNA reduction in Ptger2 prevents PGE(2)-induced Sost repression. These results indicate a functional relationship between prostaglandins and the Wnt/beta-catenin signaling pathway in bone.	[Genetos, Damian C.; Yellowley, Clare E.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA; [Loots, Gabriela G.] Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Livermore, CA USA	University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Genetos, DC (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA.	dgenetos@ucdavis.edu	Genetos, Damian/AAF-5953-2021; Loots, Gabriela G/AGA-4868-2022; Genetos, Damian C/A-6480-2012	Genetos, Damian/0000-0002-8599-2867; Loots, Gabriela G/0000-0001-9546-5561; 	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R03AR057547]; National Institute of Aging [R01AG022305]; National Institute of Diabetes and Digestive and Kidney Diseases [DK075730]; Alliance for Better Bone Health; U. S. Department of Energy by Lawrence Livermore National Laboratory [AC52-07NA27344]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022305] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Alliance for Better Bone Health; U. S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project described was supported by Award Number R03AR057547 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (DCG), R01AG022305 from the National Institute of Aging (CEY), DK075730 from the National Institute of Diabetes and Digestive and Kidney Diseases (GGL), and a grant from The Alliance for Better Bone Health (DCG). This work performed under the auspices of the U. S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Axelrad TW, 2007, INJURY, V38, pS49, DOI 10.1016/j.injury.2007.02.010; Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Burd TA, 2003, J BONE JOINT SURG BR, V85B, P700, DOI 10.1302/0301-620X.85B5.13970; Cameron KO, 2009, BIOORG MED CHEM LETT, V19, P2075, DOI 10.1016/j.bmcl.2009.01.059; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; CHYUN YS, 1984, PROSTAGLANDINS, V27, P97, DOI 10.1016/0090-6980(84)90223-5; Collette NM, 2010, DEV BIOL, V342, P169, DOI 10.1016/j.ydbio.2010.03.021; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; FEYEN JHM, 1985, PROSTAGLANDINS, V30, P827, DOI 10.1016/0090-6980(85)90011-5; FLANAGAN AM, 1992, ENDOCRINOLOGY, V130, P443, DOI 10.1210/en.130.1.443; Forwood MR, 1996, J BONE MINER RES, V11, P1688; GARDINER PJ, 1986, BRIT J PHARMACOL, V87, P45, DOI 10.1111/j.1476-5381.1986.tb10155.x; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Gerstenfeld Louis C, 2004, Expert Opin Drug Saf, V3, P131, DOI 10.1517/14740338.3.2.131; Giannoudis PV, 2000, J BONE JOINT SURG BR, V82B, P655, DOI 10.1302/0301-620X.82B5.9899; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HAKEDA Y, 1985, J BIOCHEM, V97, P97, DOI 10.1093/oxfordjournals.jbchem.a135072; HAKEDA Y, 1986, J CELL PHYSIOL, V128, P155, DOI 10.1002/jcp.1041280204; Hamamura K, 2008, J BONE MINER METAB, V26, P231, DOI 10.1007/s00774-007-0825-1; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6; JORGENSEN HRI, 1988, ACTA ORTHOP SCAND, V59, P464, DOI 10.3109/17453678809149406; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P1157, DOI 10.1210/en.135.3.1157; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; KleinNulend J, 1997, J BONE MINER RES, V12, P45, DOI 10.1359/jbmr.1997.12.1.45; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Lee CM, 2007, J CELL PHYSIOL, V212, P182, DOI 10.1002/jcp.21017; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li M, 2003, J BONE MINER RES, V18, P2033, DOI 10.1359/jbmr.2003.18.11.2033; LI X, 2010, J BONE MINER RES; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Maciel FMB, 1997, J RHEUMATOL, V24, P2429; Minamizaki T, 2009, BONE, V44, P1177, DOI 10.1016/j.bone.2009.02.010; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Papanicolaou SE, 2009, BIORHEOLOGY, V46, P389, DOI 10.3233/BIR-2009-0550; Paralkar VM, 2003, P NATL ACAD SCI USA, V100, P6736, DOI 10.1073/pnas.1037343100; PARTRIDGE NC, 1983, CANCER RES, V43, P4308; PEAD MJ, 1989, CALCIFIED TISSUE INT, V45, P34, DOI 10.1007/BF02556658; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Suda M, 1996, ENDOCRINOLOGY, V137, P1698, DOI 10.1210/en.137.5.1698; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Wadhwa S, 2002, J BONE MINER RES, V17, P266, DOI 10.1359/jbmr.2002.17.2.266; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963	69	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17772	10.1371/journal.pone.0017772	http://dx.doi.org/10.1371/journal.pone.0017772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436889	Green Submitted, Green Published, gold			2022-12-27	WOS:000288514000008
J	Kim, HM; Wangemann, P				Kim, Hyoung-Mi; Wangemann, Philine			Epithelial Cell Stretching and Luminal Acidification Lead to a Retarded Development of Stria Vascularis and Deafness in Mice Lacking Pendrin	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; ENLARGED VESTIBULAR AQUEDUCT; KCNJ10 PROTEIN EXPRESSION; ENDOLYMPHATIC SAC; POSTNATAL-DEVELOPMENT; H+-ATPASE; ORGAN; FLUID; CONTRIBUTES; INHIBITION	Loss-of-function mutations of SLC26A4/pendrin are among the most prevalent causes of deafness. Deafness and vestibular dysfunction in the corresponding mouse model, Slc26a4(-/-), are associated with an enlargement and acidification of the membranous labyrinth. Here we relate the onset of expression of the HCO3- transporter pendrin to the luminal pH and to enlargement-associated epithelial cell stretching. We determined expression with immunocytochemistry, cell stretching by digital morphometry and pH with double-barreled ion-selective electrodes. Pendrin was first expressed in the endolymphatic sac at embryonic day (E) 11.5, in the cochlear hook-region at E13.5, in the utricle and saccule at E14.5, in ampullae at E16.5, and in the upper turn of the cochlea at E17.5. Epithelial cell stretching in Slc26a4(-/-) mice began at E14.5. pH changes occurred first in the cochlea at E15.5 and in the endolymphatic sac at E17.5. At postnatal day 2, stria vascularis, outer sulcus and Reissner's membrane epithelial cells, and utricular and saccular transitional cells were stretched, whereas sensory cells in the cochlea, utricle and saccule did not differ between Slc26a4(+/-) and Slc26a4(-/-) mice. Structural development of stria vascularis, including vascularization, was retarded in Slc26a4(-/-) mice. In conclusion, the data demonstrate that the enlargement and stretching of non-sensory epithelial cells precedes luminal acidification in the cochlea and the endolymphatic sac. Stretching and luminal acidification may alter cell-to-cell communication and lead to the observed retarded development of stria vascularis, which may be an important step on the path to deafness in Slc26a4(-/-) mice, and possibly in humans, lacking functional pendrin expression.	[Kim, Hyoung-Mi; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	Kansas State University	Kim, HM (corresponding author), Pochon CHA Univ, Coll Med, Dept Otolaryngol, Seoul, South Korea.	wange@vet.ksu.edu	Wangemann, Philine/N-2826-2013		 [KSU-SMILE];  [NIH-R01-DC00212];  [NIH-P20-RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000212, R01DC001098] Funding Source: NIH RePORTER	; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the following grants: KSU-SMILE, NIH-R01-DC00212, and NIH-P20-RR017686. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1999, AM J MED GENET, V82, P322, DOI 10.1002/(SICI)1096-8628(19990212)82:4<322::AID-AJMG9>3.0.CO;2-0; Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Colvin IB, 2006, LARYNGOSCOPE, V116, P2027, DOI 10.1097/01.mlg.0000240908.88759.fe; Couloigner V, 1999, ACTA OTO-LARYNGOL, V119, P200; Couloigner V, 2000, AM J PHYSIOL-REG I, V279, pR1695, DOI 10.1152/ajpregu.2000.279.5.R1695; Dou HW, 2004, J HISTOCHEM CYTOCHEM, V52, P1377, DOI 10.1369/jhc.3A6228.2004; Dou HW, 2003, HEARING RES, V180, P76, DOI 10.1016/S0378-5955(03)00108-4; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; FRASER GR, 1965, ANN HUM GENET, V28, P201; Inoshita A, 2008, NEUROSCIENCE, V156, P1039, DOI 10.1016/j.neuroscience.2008.08.027; Ishida T, 2006, CELL STRUCT FUNCT, V31, P77, DOI 10.1247/csf.06013; Jabba SV, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-37; Kim HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014041; Kim SH, 2009, AM J PHYSIOL-CELL PH, V296, pC544, DOI 10.1152/ajpcell.00338.2008; Kim YH, 2007, AM J PHYSIOL-RENAL, V293, pF1314, DOI 10.1152/ajprenal.00155.2007; Kudo T, 2003, HUM MOL GENET, V12, P995, DOI 10.1093/hmg/ddg116; Luxon LM, 2003, INT J AUDIOL, V42, P82, DOI 10.3109/14992020309078339; MARCUS DC, 1985, HEARING RES, V17, P79, DOI 10.1016/0378-5955(85)90133-9; Nakaya K, 2007, AM J PHYSIOL-RENAL, V292, pF1314, DOI 10.1152/ajprenal.00432.2006; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Pech V, 2010, J AM SOC NEPHROL, V21, P1928, DOI 10.1681/ASN.2009121257; Peters TA, 2003, HEARING RES, V176, P94, DOI 10.1016/S0378-5955(02)00748-7; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Royaux IE, 2003, JARO-J ASSOC RES OTO, V4, P394, DOI 10.1007/s10162-002-3052-4; RUGH R, 1968, MOUSE ITS REPROD DEV, P430; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; THALMANN I, 1992, HEARING RES, V63, P37, DOI 10.1016/0378-5955(92)90071-T; Theiler K., 1972, HOUSE MOUSE; TSUJIKAWA S, 1992, ORL J OTO-RHINO-LARY, V54, P198, DOI 10.1159/000276298; Wang YF, 2009, BIOCHEM BIOPH RES CO, V385, P33, DOI 10.1016/j.bbrc.2009.05.023; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79	37	43	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17949	10.1371/journal.pone.0017949	http://dx.doi.org/10.1371/journal.pone.0017949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423764	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400041
J	Mahmoudi, B; Sanchez, JC				Mahmoudi, Babak; Sanchez, Justin C.			Symbiotic Brain-Machine Interface through Value-Based Decision Making	PLOS ONE			English	Article							BASAL GANGLIA; CORTICAL CONTROL; MOTOR CORTEX; MICROSTIMULATION; PLASTICITY; PREDICTION; NEURONS; SIGNALS; RAT	Background: In the development of Brain Machine Interfaces (BMIs), there is a great need to enable users to interact with changing environments during the activities of daily life. It is expected that the number and scope of the learning tasks encountered during interaction with the environment as well as the pattern of brain activity will vary over time. These conditions, in addition to neural reorganization, pose a challenge to decoding neural commands for BMIs. We have developed a new BMI framework in which a computational agent symbiotically decoded users' intended actions by utilizing both motor commands and goal information directly from the brain through a continuous Perception-Action-Reward Cycle (PARC). Methodology: The control architecture designed was based on Actor-Critic learning, which is a PARC-based reinforcement learning method. Our neurophysiology studies in rat models suggested that Nucleus Accumbens (NAcc) contained a rich representation of goal information in terms of predicting the probability of earning reward and it could be translated into an evaluative feedback for adaptation of the decoder with high precision. Simulated neural control experiments showed that the system was able to maintain high performance in decoding neural motor commands during novel tasks or in the presence of reorganization in the neural input. We then implanted a dual micro-wire array in the primary motor cortex (M1) and the NAcc of rat brain and implemented a full closed-loop system in which robot actions were decoded from the single unit activity in M1 based on an evaluative feedback that was estimated from NAcc. Conclusions: Our results suggest that adapting the BMI decoder with an evaluative feedback that is directly extracted from the brain is a possible solution to the problem of operating BMIs in changing environments with dynamic neural signals. During closed-loop control, the agent was able to solve a reaching task by capturing the action and reward interdependency in the brain.	[Mahmoudi, Babak; Sanchez, Justin C.] Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA	University of Miami	Mahmoudi, B (corresponding author), Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA.	b.mahmoudi@gmail.com	Mahmoudi, Babak/HHY-7302-2022		Defense Advanced Research Project Agency (DARPA) [N66001-10-C-2008]	Defense Advanced Research Project Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The work was funded by Defense Advanced Research Project Agency (DARPA) contract N66001-10-C-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2004, TRENDS COGN SCI, V8, P486, DOI 10.1016/j.tics.2004.09.009; Bower G.H., 1981, THEORIES LEARNING; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Cohen MX, 2008, COGN AFFECT BEHAV NE, V8, P113, DOI 10.3758/CABN.8.2.113; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; DiGiovanna J, 2009, IEEE T BIO-MED ENG, V56, P54, DOI 10.1109/TBME.2008.926699; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Doya K, 2007, HFSP J, V1, P30, DOI [10.2976/1.2732246/10.2976/1, 10.2976/1.2732246]; FERRETTI V, P NATL ACAD SCI, V107, P7945; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; Grossberg S., 1982, STUDIES MIND BRAIN N; Haykin S. S., 2001, NEURAL NETWORKS COMP; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Johnson-Frey SH, 2003, NEURON, V39, P201, DOI 10.1016/S0896-6273(03)00424-0; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kim HK, 2006, IEEE T BIO-MED ENG, V53, P1164, DOI 10.1109/TBME.2006.870235; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Mahmoudi B, 2009, IEEE ENG MED BIO, P3365, DOI 10.1109/IEMBS.2009.5332825; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Montagne G, 2003, Q J EXP PSYCHOL-A, V56, P551, DOI 10.1080/02724980244000620; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Nixon PD, 2004, EUR J NEUROSCI, V20, P3165, DOI 10.1111/j.1460-9568.2004.03788.x; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PRINCIPE JC, 1993, IEEE T SIGNAL PROCES, V41, P649, DOI 10.1109/78.193206; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Samejima K, 2007, ANN NY ACAD SCI, V1104, P213, DOI 10.1196/annals.1390.024; Sanchez J., 2007, BRAIN MACHINE INTERF; SANCHEZ JC, 2006, HDB NEURAL ENG; Sanchez JC, 2006, IEEE T NEUR SYS REH, V14, P217, DOI 10.1109/TNSRE.2006.875581; Sanchez JC, 2009, NEURAL NETWORKS, V22, P305, DOI 10.1016/j.neunet.2009.03.015; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Shenoy KV, 2003, NEUROREPORT, V14, P591, DOI 10.1097/00001756-200303240-00013; Struthers WM, 2005, EXP BRAIN RES, V167, P136, DOI 10.1007/s00221-005-0061-7; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662	50	62	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14760	10.1371/journal.pone.0014760	http://dx.doi.org/10.1371/journal.pone.0014760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423797	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400006
J	Adlard, PA; Bica, L; White, AR; Nurjono, M; Filiz, G; Crouch, PJ; Donnelly, PS; Cappai, R; Finkelstein, DI; Bush, AI				Adlard, Paul A.; Bica, Laura; White, Anthony R.; Nurjono, Milawaty; Filiz, Gulay; Crouch, Peter J.; Donnelly, Paul S.; Cappai, Roberto; Finkelstein, David I.; Bush, Ashley I.			Metal Ionophore Treatment Restores Dendritic Spine Density and Synaptic Protein Levels in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA; TRANSGENIC MICE; MOLECULAR-BASIS; KINASE-II; ABNORMALITIES; ACCUMULATION; PLASTICITY; RECEPTORS; COGNITION; DEFICITS	We have previously demonstrated that brief treatment of APP transgenic mice with metal ionophores (PBT2, Prana Biotechnology) rapidly and markedly improves learning and memory. To understand the potential mechanisms of action underlying this phenomenon we examined hippocampal dendritic spine density, and the levels of key proteins involved in learning and memory, in young (4 months) and old (14 months) female Tg2576 mice following brief (11 days) oral treatment with PBT2 (30 mg/kg/d). Transgenic mice exhibited deficits in spine density compared to littermate controls that were significantly rescued by PBT2 treatment in both the young (+17%, p<0.001) and old (+32%, p<0.001) animals. There was no effect of PBT2 on spine density in the control animals. In the transgenic animals, PBT2 treatment also resulted in significant increases in brain levels of CamKII (+57%, p = 0.005), spinophilin (+37%, p = 0.04), NMDAR1A (+126%, p = 0.02), NMDAR2A (+70%, p = 0.05), pro-BDNF (+19%, p = 0.02) and BDNF (+19%, p = 0.04). While PBT2-treatment did not significantly alter neurite-length in vivo, it did increase neurite outgrowth (+200%, p = 0.006) in cultured cells, and this was abolished by co-incubation with the transition metal chelator, diamsar. These data suggest that PBT2 may affect multiple aspects of snaptic health/efficacy. In Alzheimer's disease therefore, PBT2 may restore the uptake of physiological metal ions trapped within extracellular beta-amyloid aggregates that then induce biochemical and anatomical changes to improve cognitive function.	[Adlard, Paul A.; Nurjono, Milawaty; Filiz, Gulay; Finkelstein, David I.; Bush, Ashley I.] Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic, Australia; [Adlard, Paul A.; Finkelstein, David I.] Mental Hlth Res Inst, Synapt Neurobiol Lab, Parkville, Vic, Australia; [Adlard, Paul A.; Bica, Laura; White, Anthony R.; Crouch, Peter J.; Cappai, Roberto; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Bica, Laura; White, Anthony R.; Crouch, Peter J.; Finkelstein, David I.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Donnelly, Paul S.; Cappai, Roberto] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Donnelly, Paul S.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Adlard, PA (corresponding author), Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic, Australia.	p.adlard@mhri.edu.au	Bush, Ashley/Y-2457-2019; Finkelstein, David/B-9617-2009; Bush, Ashley I/A-1186-2007; White, Anthony/P-5596-2016; Cappai, Roberto/B-3347-2010	Bush, Ashley/0000-0001-8259-9069; Finkelstein, David/0000-0002-8167-4917; Bush, Ashley I/0000-0001-8259-9069; Crouch, Peter/0000-0002-7777-4747; White, Anthony/0000-0003-1802-9891; Cappai, Roberto/0000-0002-9505-8496	Australian Research Council; National Health and Medical Research Council; Alzheimer's Association (USA)	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Association (USA)(Alzheimer's Association)	This work was supported by funds from the Australian Research Council, the National Health and Medical Research Council, and the Alzheimer's Association (USA). PBT2 was kindly provided by Prana Biotechnology Ltd (www.pranabio.com). These funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Alpar A, 2006, BRAIN RES, V1099, P189, DOI 10.1016/j.brainres.2006.04.109; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; BOTTOMLEY GA, 1994, AUST J CHEM, V47, P143, DOI 10.1071/CH9940143; CATALA I, 1988, HUM NEUROBIOL, V6, P255; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; DERUITER JP, 1987, BRAIN RES, V402, P217, DOI 10.1016/0006-8993(87)90028-X; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jourdain P, 2003, J NEUROSCI, V23, P10645; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Shimada A, 1998, J NEUROSCI, V18, P8559; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335	34	102	105	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17669	10.1371/journal.pone.0017669	http://dx.doi.org/10.1371/journal.pone.0017669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412423	Green Published, gold			2022-12-27	WOS:000288247800023
J	Blaser, C; Wittwer, M; Grandgirard, D; Leib, SL				Blaser, Cornelia; Wittwer, Matthias; Grandgirard, Denis; Leib, Stephen L.			Adjunctive Dexamethasone Affects the Expression of Genes Related to Inflammation, Neurogenesis and Apoptosis in Infant Rat Pneumococcal Meningitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INDUCED LEUCINE-ZIPPER; ACTIVATED PROTEIN-KINASE; ALPHA CONVERTING-ENZYME; DENTATE GYRUS; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; HIPPOCAMPAL APOPTOSIS; BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID	Streptococcus pneumoniae is the most common pathogen causing non-epidemic bacterial meningitis worldwide. The immune response and inflammatory processes contribute to the pathophysiology. Hence, the anti-inflammatory dexamethasone is advocated as adjuvant treatment although its clinical efficacy remains a question at issue. In experimental models of pneumococcal meningitis, dexamethasone increased neuronal damage in the dentate gyrus. Here, we investigated expressional changes in the hippocampus and cortex at 72 h after infection when dexamethasone was given to infant rats with pneumococcal meningitis. Nursing Wistar rats were intracisternally infected with Streptococcus pneumoniae to induce experimental meningitis or were sham-infected with pyrogen-free saline. Besides antibiotics, animals were either treated with dexamethasone or saline. Expressional changes were assessed by the use of GeneChip (R) Rat Exon 1.0 ST Arrays and quantitative real-time PCR. Protein levels of brain-derived neurotrophic factor, cytokines and chemokines were evaluated in immunoassays using Luminex xMAP (R) technology. In infected animals, 213 and 264 genes were significantly regulated by dexamethasone in the hippocampus and cortex respectively. Separately for the cortex and the hippocampus, Gene Ontology analysis identified clusters of biological processes which were assigned to the predefined categories "inflammation'', "growth'', "apoptosis'' and others. Dexamethasone affected the expression of genes and protein levels of chemokines reflecting diminished activation of microglia. Dexamethasone-induced changes of genes related to apoptosis suggest the downregulation of the Akt-survival pathway and the induction of caspase-independent apoptosis. Signalling of pro-neurogenic pathways such as transforming growth factor pathway was reduced by dexamethasone resulting in a lack of pro-survival triggers. The anti-inflammatory properties of dexamethasone were observed on gene and protein level in experimental pneumococcal meningitis. Further dexamethasone-induced expressional changes reflect an increase of pro-apoptotic signals and a decrease of pro-neurogenic processes. The findings may help to identify potential mechanisms leading to apoptosis by dexamethasone in experimental pneumococcal meningitis.	[Blaser, Cornelia; Grandgirard, Denis; Leib, Stephen L.] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Wittwer, Matthias] Spiez Lab, Spiez, Switzerland	University of Bern	Blaser, C (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	stephen.leib@ifik.unibe.ch	Leib, Stephen/M-3786-2019; Wittwer, Matthias/K-4512-2014; Leib, Stephen L/A-7866-2011; Grandgirard, Denis/AAB-8786-2020; Kummer, Juerg/B-3322-2011	Leib, Stephen/0000-0002-1106-6123; Wittwer, Matthias/0000-0003-4713-8392; Leib, Stephen L/0000-0002-1106-6123; Grandgirard, Denis/0000-0002-4151-5196; 	Swiss National Science Foundation [310030-116257]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financially supported by the Swiss National Science Foundation (Nr. 310030-116257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison J, 2006, LARYNGOSCOPE, V116, P279, DOI 10.1097/01.mlg.0000197315.79394.36; Andersen CO, 2007, DAN MED BULL, V54, P189; [Anonymous], 2010, R LANG ENV STAT COMP; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Boku S, 2009, NEUROPSYCHOPHARMACOL, V34, P805, DOI 10.1038/npp.2008.198; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Braun JS, 2001, J INFECT DIS, V184, P1300, DOI 10.1086/324013; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Byts N, 2006, NEUROCHEM RES, V31, P1219, DOI 10.1007/s11064-006-9149-0; Coimbra RS, 2007, PEDIATR RES, V62, P291, DOI 10.1203/PDR.0b013e318123fb7c; Coimbra RS, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-15; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diab A, 1999, INFECT IMMUN, V67, P2590, DOI 10.1128/IAI.67.5.2590-2601.1999; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Ehrenreich H, 2005, P NATL ACAD SCI USA, V102, P862, DOI 10.1073/pnas.0406008102; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Gehre F, 2008, J INTERN MED, V264, P143, DOI 10.1111/j.1365-2796.2008.01930.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gianinazzi C, 2003, ACTA NEUROPATHOL, V105, P499, DOI 10.1007/s00401-003-0672-7; Gillett A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007773; Grandgirard D, 2007, DEV NEUROSCI-BASEL, V29, P134, DOI 10.1159/000096218; Grandgirard D, 2010, ANTIMICROB AGENTS CH, V54, P1323, DOI 10.1128/AAC.00812-09; Guan Y, 2004, MOL ENDOCRINOL, V18, P214, DOI 10.1210/me.2003-0014; Hanisch UK, 2001, EUR J IMMUNOL, V31, P2104, DOI 10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Horvat A, 2001, J NEUROSCI, V21, P865, DOI 10.1523/JNEUROSCI.21-03-00865.2001; Hu XY, 2003, J IMMUNOL, V170, P4833, DOI 10.4049/jimmunol.170.9.4833; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Inoue K, 2007, CELL ADHES MIGR, V1, P131, DOI 10.4161/cam.1.3.4937; Irazuzta J, 2005, INTENS CARE MED, V31, P146, DOI 10.1007/s00134-004-2462-7; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kalesnikoff J, 2003, Rev Physiol Biochem Pharmacol, V149, P87; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kim HH, 2007, LARYNGOSCOPE, V117, P1209, DOI 10.1097/MLG.0b013e318058195f; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Klein M, 2008, INFECTION, V36, P2, DOI 10.1007/s15010-007-7153-1; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Klein M, 2006, MICROBES INFECT, V8, P974, DOI 10.1016/j.micinf.2005.10.013; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Koedel U, 2010, CURR OPIN INFECT DIS, V23, P217, DOI 10.1097/QCO.0b013e328337f49e; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Leib SL, 2003, PEDIATR RES, V54, P353, DOI 10.1203/01.PDR.0000079185.67878.72; Leib SL, 2001, BRAIN, V124, P1734, DOI 10.1093/brain/124.9.1734; Li L, 2003, J CHILD NEUROL, V18, P828, DOI 10.1177/088307380301801202; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Liu M, 2009, NEUROSCIENCE, V163, P296, DOI 10.1016/j.neuroscience.2009.06.027; Marsh HN, 2003, J CELL BIOL, V163, P999, DOI 10.1083/jcb.200309036; Meli DN, 2004, J NEUROIMMUNOL, V151, P6, DOI 10.1016/j.jneuroim.2004.01.026; Mundy WR, 2010, TOXICOLOGY, V270, P121, DOI 10.1016/j.tox.2010.02.004; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Ohnaka K, 2005, BIOCHEM BIOPH RES CO, V329, P177, DOI 10.1016/j.bbrc.2005.01.117; Rappaport JM, 1999, J INFECT DIS, V179, P264, DOI 10.1086/314531; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Sanagi T, 2008, J NEUROCHEM, V106, P1841, DOI 10.1111/j.1471-4159.2008.05529.x; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sarnoylenko A, 2008, CELL SIGNAL, V20, P154, DOI 10.1016/j.cellsig.2007.10.006; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SCHUKNECHT HF, 1970, ARCH KLIN EXP OHR, V195, P207, DOI 10.1007/BF00302950; Schutte M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003007; SELLNER J, 2010, BACTERIAL INFECT CEN, P1; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soverchia L, 2005, ADDICT BIOL, V10, P5, DOI 10.1080/13556210412331327803; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Spreer A, 2006, PEDIATR RES, V60, P210, DOI 10.1203/01.pdr.0000227553.47378.9f; Swartz MN, 2004, NEW ENGL J MED, V351, P1826, DOI 10.1056/NEJMp048246; Takagi Y, 2002, J CEREBR BLOOD F MET, V22, P1311, DOI 10.1097/01.WCB.0000034148.72481.F4; Takanohashi A, 2005, GLIA, V51, P266, DOI 10.1002/glia.20203; Tarozzo G, 2002, EUR J NEUROSCI, V15, P1663, DOI 10.1046/j.1460-9568.2002.02007.x; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; Taylor JM, 2005, J NEUROCHEM, V92, P283, DOI 10.1111/j.1471-4159.2004.02863.x; van de Beek D, 2010, LANCET NEUROL, V9, P254, DOI 10.1016/S1474-4422(10)70023-5; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Wittwer M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-176; Yachi K, 2007, BRAIN RES, V1159, P141, DOI 10.1016/j.brainres.2007.05.024; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Yu S, 2010, ANN NEUROL, V67, P21, DOI 10.1002/ana.21812; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Zhu Y, 2004, NEUROSCIENCE, V123, P897, DOI 10.1016/j.neuroscience.2003.10.037; Zysk G, 1996, J NEUROPATH EXP NEUR, V55, P722, DOI 10.1097/00005072-199606000-00006; [No title captured]; [No title captured]; [No title captured]	93	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17840	10.1371/journal.pone.0017840	http://dx.doi.org/10.1371/journal.pone.0017840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412436	Green Published, gold, Green Submitted			2022-12-27	WOS:000288247800033
J	Suri, S; Watts, DJ				Suri, Siddharth; Watts, Duncan J.			Cooperation and Contagion in Web-Based, Networked Public Goods Experiments	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; GROUP-SIZE; EVOLUTION; MAINTENANCE; PROVISION; DYNAMICS; BEHAVIOR; GAMES	A longstanding idea in the literature on human cooperation is that cooperation should be reinforced when conditional cooperators are more likely to interact. In the context of social networks, this idea implies that cooperation should fare better in highly clustered networks such as cliques than in networks with low clustering such as random networks. To test this hypothesis, we conducted a series of web-based experiments, in which 24 individuals played a local public goods game arranged on one of five network topologies that varied between disconnected cliques and a random regular graph. In contrast with previous theoretical work, we found that network topology had no significant effect on average contributions. This result implies either that individuals are not conditional cooperators, or else that cooperation does not benefit from positive reinforcement between connected neighbors. We then tested both of these possibilities in two subsequent series of experiments in which artificial seed players were introduced, making either full or zero contributions. First, we found that although players did generally behave like conditional cooperators, they were as likely to decrease their contributions in response to low contributing neighbors as they were to increase their contributions in response to high contributing neighbors. Second, we found that positive effects of cooperation were contagious only to direct neighbors in the network. In total we report on 113 human subjects experiments, highlighting the speed, flexibility, and cost-effectiveness of web-based experiments over those conducted in physical labs.	[Suri, Siddharth; Watts, Duncan J.] Yahoo Res, Microecon & Social Syst, New York, NY USA		Suri, S (corresponding author), Yahoo Res, Microecon & Social Syst, New York, NY USA.	suri@yahoo-inc.com; djw@yahoo-inc.com	Watts, Duncan J/J-6483-2012		Yahoo! Inc.	Yahoo! Inc.	Both authors are full-time employees of Yahoo! Inc., which funded the research. According to PLoS ONE policy, therefore, Yahoo! Inc. is deemed to have played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Eshel I, 1998, AM ECON REV, V88, P157; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; GLANCE NS, 1993, J MATH SOCIOL, V17, P281, DOI 10.1080/0022250X.1993.9990112; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heal G, 2005, J CONFLICT RESOLUT, V49, P201, DOI 10.1177/0022002704272833; HORTON JJ, 2010, W15961 NBER; Howe J., 2008, CROWDSOURCING WHY PO; Ipeirotis P. G., 2010, P ACM SIGKDD WORKSH, P64, DOI [10.1145/1837885.1837906, DOI 10.1145/1837885.1837906]; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; JUDD JS, 2008, P 9 ACM C EL COMM AC, P150; Kearns M, 2006, SCIENCE, V313, P824, DOI 10.1126/science.1127207; Kearns M, 2009, P NATL ACAD SCI USA, V106, P1347, DOI 10.1073/pnas.0808147106; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; MARWELL G, 1979, AM J SOCIOL, V84, P1335, DOI 10.1086/226937; Mason W., 2010, CONDUCTING BEHAV RES; Mason W., 2010, SIGKDD EXPLORATIONS, V11, P100, DOI [DOI 10.1145/1809400.1809422, 10.1145/1600150.1600175]; MAY R, 1995, LECT NOTES COMPUTER, V929, P747; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Ostrom E, 1999, ANNU REV POLIT SCI, V2, P493, DOI 10.1146/annurev.polisci.2.1.493; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rapoport A., 1965, PRISONERS DILEMMA ST; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SIEGEL S., 1956, NONPARAMETRIC STAT B; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Ule A, 2009, SCIENCE, V326, P1701, DOI 10.1126/science.1178883; von Ahn L, 2006, COMPUTER, V39, P92, DOI 10.1109/MC.2006.196; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120	47	232	234	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e16836	10.1371/journal.pone.0016836	http://dx.doi.org/10.1371/journal.pone.0016836			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	733FF	21412431	Green Submitted, Green Published, gold			2022-12-27	WOS:000288247800004
J	Bird, AD; Flecknoe, SJ; Tan, KH; Olsson, PF; Antony, N; Mantamadiotis, T; Hooper, SB; Cole, TJ				Bird, A. Daniel; Flecknoe, Sharon J.; Tan, Kheng H.; Olsson, P. Fredrik; Antony, Nisha; Mantamadiotis, Theo; Hooper, Stuart B.; Cole, Timothy J.			cAMP Response Element Binding Protein Is Required for Differentiation of Respiratory Epithelium during Murine Development	PLOS ONE			English	Article							FETAL LUNG DEVELOPMENT; TRANSCRIPTION FACTOR-I; DEVELOPING MOUSE LUNG; PROBE LEVEL DATA; GENE-EXPRESSION; CELL PHENOTYPES; MICE LACKING; CREB; SHEEP; LOCALIZATION	The cAMP response element binding protein 1 (Creb1) transcription factor regulates cellular gene expression in response to elevated levels of intracellular cAMP. Creb1(-/-) fetal mice are phenotypically smaller than wildtype littermates, predominantly die in utero and do not survive after birth due to respiratory failure. We have further investigated the respiratory defect of Creb1(-/-) fetal mice during development. Lungs of Creb1(-/-) fetal mice were pale in colour and smaller than wildtype controls in proportion to their reduced body size. Creb1(-/-) lungs also did not mature morphologically beyond E16.5 with little or no expansion of airway luminal spaces, a phenotype also observed with the Creb1(-/-) lung on a Crem(-/-) genetic background. Creb1 was highly expressed throughout the lung at all stages examined, however activation of Creb1 was detected primarily in distal lung epithelium. Cell differentiation of E17.5 Creb1(-/-) lung distal epithelium was analysed by electron microscopy and showed markedly reduced numbers of type-I and type-II alveolar epithelial cells. Furthermore, immunomarkers for specific lineages of proximal epithelium including ciliated, non-ciliated (Clara), and neuroendocrine cells showed delayed onset of expression in the Creb1(-/-) lung. Finally, gene expression analyses of the E17.5 Creb1(-/-) lung using whole genome microarray and qPCR collectively identified respiratory marker gene profiles and provide potential novel Creb1-regulated genes. Together, these results demonstrate a crucial role for Creb1 activity for the development and differentiation of the conducting and distal lung epithelium.	[Bird, A. Daniel; Tan, Kheng H.; Olsson, P. Fredrik; Antony, Nisha; Cole, Timothy J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Flecknoe, Sharon J.; Hooper, Stuart B.] Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Mantamadiotis, Theo] Univ Patras, Dept Med, Patras, Greece	Monash University; Monash University; University of Patras	Bird, AD (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	daniel.bird@monash.edu	Bird, Anthony/AAM-6018-2021; Mantamadiotis, Theo/AAM-1346-2020; Mantamadiotis, Theo/W-9010-2019	Bird, Anthony/0000-0003-3012-7160; Mantamadiotis, Theo/0000-0003-3971-5380; Hooper, Stuart/0000-0003-1676-4825	National Health and Medical Research Council of Australia [384100]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a program grant of the National Health and Medical Research Council of Australia (ID no. 384100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; ALCORN DG, 1981, ANAT REC, V201, P655, DOI 10.1002/ar.1092010410; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; DAMOREBRUNO MA, 1992, AM J PHYSIOL, V262, pL40, DOI 10.1152/ajplung.1992.262.1.L40; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Dave V, 2004, J BIOL CHEM, V279, P34578, DOI 10.1074/jbc.M404296200; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; FITZGERALD ML, 2006, J LIPID RES; Flecknoe S, 2000, AM J PHYSIOL-LUNG C, V278, pL1180, DOI 10.1152/ajplung.2000.278.6.L1180; Flecknoe SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL1207, DOI 10.1152/ajplung.00375.2003; Flecknoe SJ, 2003, AM J PHYSIOL-LUNG C, V285, pL664, DOI 10.1152/ajplung.00306.2002; Flecknoe SJ, 2002, J PHYSIOL-LONDON, V542, P245, DOI 10.1113/jphysiol.2001.014274; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FORBES LR, CLIN EXP ALLERGY, V40, P547; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; He YC, 2002, J BIOL CHEM, V277, P19530, DOI 10.1074/jbc.M201126200; He YC, 2000, J BIOL CHEM, V275, P31051, DOI 10.1074/jbc.M003499200; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kramer BW, 2009, SEMIN FETAL NEONAT M, V14, P2, DOI 10.1016/j.siny.2008.08.011; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Liu Yuru, 2002, Gene Expression Patterns, V2, P229, DOI 10.1016/S1567-133X(02)00057-1; Long FX, 2001, DEVELOPMENT, V128, P541; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Markart P, 2004, AM J RESP CRIT CARE, V169, P454, DOI 10.1164/rccm.200305-669OC; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Matus M, 2007, FASEB J, V21, P1884, DOI 10.1096/fj.06-7915com; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Sozo F, 2006, PEDIATR RES, V59, P151, DOI 10.1203/01.pdr.0000190574.94285.a2; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tichelaar JW, 1999, J HISTOCHEM CYTOCHEM, V47, P823, DOI 10.1177/002215549904700612; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wong CJ, 1996, PEDIATR RES, V39, P930, DOI 10.1203/00006450-199606000-00002; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	51	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17843	10.1371/journal.pone.0017843	http://dx.doi.org/10.1371/journal.pone.0017843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408140	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000062
J	Hauri, AM; Westbrock, HJ; Claus, H; Geis, S; Giernat, S; Forssbohm, M; Uphoff, H				Hauri, Anja M.; Westbrock, Hans-Juergen; Claus, Herman; Geis, Steffen; Giernat, Siegfried; Forssbohm, Michael; Uphoff, Helmut			Electronic Outbreak Surveillance in Germany: A First Evaluation for Nosocomial Norovirus Outbreaks	PLOS ONE			English	Article							GASTROENTERITIS; COMPLETENESS; DISEASES; EUROPE; SYSTEM	Background: In Germany, surveillance for infectious disease outbreaks is integrated into an electronic surveillance system. For 2007, the national surveillance database contains case-based information on 201,224 norovirus cases, three-quarters of which are linked to outbreaks. We evaluated the data quality of the national database in reflecting nosocomial norovirus outbreak (NNO) data available in 19 Hessian local public health authorities (LPHAs) and the influence of differences between LPHA's follow-up procedures for laboratory notifications of Norovirus positive stool samples on outbreak under-ascertainment. Methods: Data on NNO beginning in 2007 and notified to the 19 LPHAs were extracted from the national database, investigated regarding internal validity and compared to data collected from LPHAs for a study on NNO control. LPHAs were questioned whether they routinely contacted all persons for whom a laboratory diagnosis of norovirus infection was notified. The number of outbreaks per 1,000 hospital beds and the number of cases within NNOs for acute care and rehabilitation hospitals were compared between counties with and without complete follow-up. Results: The national database contained information on 155 NNOs, including 3,115 cases. Cases were missed in the national database in 58 (37%) of the outbreaks. Information on hospitalisation was incorrect for an estimated 47% of NNO cases. Information on county of infection was incorrect for 24% (199/820) of cases being forwarded between LPHAs for data entry. Reported NNO incidence and number of NNO cases in acute care hospitals was higher in counties with complete follow-up (incidence-rate ratio (IRR) 2.7, 95% CI 1.4-5.7, p-value 0.002 and IRR 2.1, 95% CI 1.9-2.4, p-value 0.001, respectively). Conclusions: Many NNOs are not notified by hospitals and differences in LPHA procedures have an impact on the number of outbreaks captured in the surveillance system. Forwarding of case-by-case data on Norovirus outbreak cases from the local to the state and national level should not be required.	[Hauri, Anja M.; Westbrock, Hans-Juergen; Geis, Steffen; Uphoff, Helmut] Hesse State Hlth Off, Dillenburg, Germany; [Claus, Herman; Geis, Steffen] Robert Koch Inst, D-1000 Berlin, Germany; [Geis, Steffen] Robert Koch Inst, Postgrad Training Appl Epidemiol PAE, D-1000 Berlin, Germany; [Giernat, Siegfried] Publ Hlth Author, Main Kinzig Kreis, Gelnhausen, Germany; [Forssbohm, Michael] Publ Hlth Author, Wiesbaden, Germany	Robert Koch Institute; Robert Koch Institute	Hauri, AM (corresponding author), Hesse State Hlth Off, Dillenburg, Germany.	anja.hauri@hlpug.hessen.de		Claus, Hermann/0000-0002-0120-1846				[Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; Doyle TJ, 2009, EPIDEMIOL INFECT, V137, P617, DOI 10.1017/S0950268808000630; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Faensen D, 2006, Euro Surveill, V11, P7, DOI 10.2807/esm.11.04.00614-en; Gray JJ, 2007, CLIN VACCINE IMMUNOL, V14, P1349, DOI 10.1128/CVI.00214-07; Hauri AM, 2004, GESUNDHEITSWESEN, V66, P779, DOI 10.1055/s-2004-813822; HAURI AM, 2008, 2 EUR SCI C APPL INF; Jajosky RA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-29; Jansson A, 2005, EPIDEMIOL INFECT, V133, P401, DOI 10.1017/S0950268804003632; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P161; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; LESCANO AG, 2008, BMC P S3, V14; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Lopman BA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-108; Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x; *NAT DIS SURV CTR, COMP INF DIS REP CID; National Electronic Disease Surveillance System Working Group, 2001, J Public Health Manag Pract, V7, P43; Pillaye J, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-31; *R KOCH I, 2008, INF JB 2007; *R KOCH I, 2004, FALLD R KOCH I UB ER; *R KOCH I, R KOCH I SURVSTAT; *R KOCH I, 2010, EPIDEMIOLOGISCHES B, V49, P497; *R KOCH I, 2010, INF JB MELD KRANKH 2; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Verhoef LPB, 2009, EMERG INFECT DIS, V15, P31, DOI 10.3201/eid1501.080673; 2006, BUNDESGESETZBLATT 1	28	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17341	10.1371/journal.pone.0017341	http://dx.doi.org/10.1371/journal.pone.0017341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408157	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000022
J	Norghauer, JM; Nock, CA; Grogan, J				Norghauer, Julian M.; Nock, Charles A.; Grogan, James			The Importance of Tree Size and Fecundity for Wind Dispersal of Big-Leaf Mahogany	PLOS ONE			English	Article							SWIETENIA-MACROPHYLLA KING; LONG-DISTANCE DISPERSAL; RAIN-FOREST TREE; SEED DISPERSAL; RECRUITMENT LIMITATION; SPATIAL-PATTERNS; WOODY-PLANTS; ECOLOGY; MANAGEMENT; CONSEQUENCES	Seed dispersal by wind is a critical yet poorly understood process in tropical forest trees. How tree size and fecundity affect this process at the population level remains largely unknown because of insufficient replication across adults. We measured seed dispersal by the endangered neotropical timber species big-leaf mahogany (Swietenia macrophylla King, Meliaceae) in the Brazilian Amazon at 25 relatively isolated trees using multiple 1-m wide belt transects extended 100 m downwind. Tree diameter and fecundity correlated positively with increased seed shadow extent; but in combination large, high fecundity trees contributed disproportionately to longer-distance dispersal events (> 60 m). Among three empirical models fitted to seed density vs. distance in one dimension, the Student-t (2Dt) generally fit best (compared to the negative exponential and inverse power). When seedfall downwind was modelled in two dimensions using a normalised sample, it peaked furthest downwind (c. 25 m) for large, high-fecundity trees; with the inverse Gaussian and Weibull functions providing comparable fits that were slightly better than the lognormal. Although most seeds fell within 30 m of parent trees, relatively few juveniles were found within this distance, resulting in juvenile-to-seed ratios peaking at c. 35-45 m. Using the 2Dt model fits to predict seed densities downwind, coupled with known fecundity data for 2000-2009, we evaluated potential Swietenia regeneration near adults (<= 30 m dispersal) and beyond 30 m. Mean seed arrival into canopy gaps > 30 m downwind was more than 3x greater for large, high fecundity trees than small, high-fecundity trees. Tree seed production did not necessarily scale up proportionately with diameter, and was not consistent across years, and this resulting intraspecific variation can have important consequences for local patterns of dispersal in forests. Our results have important implications for management and conservation of big-leaf mahogany populations, and may apply to other threatened wind-dispersed Meliaceae trees.	[Norghauer, Julian M.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Nock, Charles A.] Univ Quebec Montreal UQAM, Dept Biol Sci, Ctr Etud Foret, Montreal, PQ, Canada; [Grogan, James] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	University of Toronto; University of Quebec; University of Quebec Montreal; Yale University	Norghauer, JM (corresponding author), Univ Toronto, Fac Forestry, Toronto, ON, Canada.	julian.norghauer@ips.unibe.ch		Norghauer, Julian/0000-0002-6484-6879	OAS (Organisation of American States); USDA Forest Service's International Institute of Tropical Forestry; University of Toronto; Faculty of Forestry	OAS (Organisation of American States); USDA Forest Service's International Institute of Tropical Forestry(United States Department of Agriculture (USDA)United States Forest Service); University of Toronto(University of Toronto); Faculty of Forestry	This study was partly funded by a Grant for Graduate Research Abroad from OAS (Organisation of American States) to JMN, and from the USDA Forest Service's International Institute of Tropical Forestry to JG. JMN is grateful for a University of Toronto Fellowship and V. J. Nordin Prize from the Faculty of Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGSPURGER CK, 1983, AM J BOT, V70, P1031, DOI 10.2307/2442812; AUGSPURGER CK, 1983, OIKOS, V40, P189, DOI 10.2307/3544582; AUGSPURGER CK, 1992, ECOLOGY, V73, P1270, DOI 10.2307/1940675; BECKER P, 1985, OIKOS, V44, P382, DOI 10.2307/3565778; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; BULLOCK SH, 1982, OECOLOGIA, V55, P238, DOI 10.1007/BF00384493; Camara-Cabrales L, 2009, J TROP FOR SCI, V21, P235; Carson WP., 2008, TROPICAL FOREST COMM, P210; Chapman CA, 2005, J TROP ECOL, V21, P31, DOI 10.1017/S0266467404001993; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; CONNELL J H, 1971, P298; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Dauer JT, 2007, J APPL ECOL, V44, P105, DOI 10.1111/j.1365-2664.2006.01256.x; Dyer RJ, 2007, MOL ECOL, V16, P4881, DOI 10.1111/j.1365-294X.2007.03581.x; Greene DF, 2004, J ECOL, V92, P758, DOI 10.1111/j.0022-0477.2004.00921.x; Grogan J, 2006, BIOTROPICA, V38, P219, DOI 10.1111/j.1744-7429.2006.00121.x; Grogan J, 2005, CONSERV BIOL, V19, P973; Grogan J, 2008, FOREST ECOL MANAG, V255, P269, DOI 10.1016/j.foreco.2007.09.048; Grogan James, 2006, Acta Amaz., V36, P483, DOI 10.1590/S0044-59672006000400009; Grogan J, 2010, CONSERV LETT, V3, P12, DOI 10.1111/j.1755-263X.2009.00082.x; Gullison RE, 1996, BOT J LINN SOC, V122, P9; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; Horn HS, 2001, ECOL RES, V16, P877, DOI 10.1046/j.1440-1703.2001.00456.x; HOUSE SM, 1992, J ECOL, V80, P57, DOI 10.2307/2261063; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1985, ECOLOGY, V66, P781, DOI 10.2307/1940539; HOWE HF, 1979, ECOLOGY, V60, P180, DOI 10.2307/1936479; Jansen PA, 2008, ECOGRAPHY, V31, P43, DOI 10.1111/j.2007.0906-7590.05156.x; JANZEN D H, 1978, P83; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Lamb FB., 1966, MAHOGANY TROPICAL AM; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Makana JR, 2004, OIKOS, V106, P67, DOI 10.1111/j.0030-1299.2004.13084.x; Martin PH, 2010, OIKOS, V119, P807, DOI 10.1111/j.1600-0706.2009.17941.x; Medjibe V, 2002, FOREST ECOL MANAG, V170, P249, DOI 10.1016/S0378-1127(01)00769-1; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Muller-Landau Helene C., 2005, P267, DOI 10.1017/CBO9780511541971.012; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2000, ECOLOGY, V81, P2156, DOI 10.1890/0012-9658(2000)081[2156:SVISDA]2.0.CO;2; Norghauer JM, 2008, J ECOL, V96, P103, DOI 10.1111/j.1365-2745.2007.01325.x; Norghauer JM, 2010, ECOLOGY, V91, P2303, DOI 10.1890/09-0071.1; Norghauer JM, 2010, OECOLOGIA, V162, P405, DOI 10.1007/s00442-009-1476-9; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2020, R LANG ENV STAT COMP; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Schulze M, 2008, FOREST ECOL MANAG, V256, P1443, DOI 10.1016/j.foreco.2008.02.051; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; SINHA A, 1992, BIOTROPICA, V24, P519, DOI 10.2307/2389014; Skarpaas O, 2004, J ECOL, V92, P747, DOI 10.1111/j.0022-0477.2004.00915.x; Skarpaas O, 2005, J APPL ECOL, V42, P731, DOI 10.1111/j.1365-2664.2005.01056.x; Snook LK, 2005, FOREST ECOL MANAG, V206, P221, DOI 10.1016/j.foreco.2004.11.003; Svenning JC, 2005, J ECOL, V93, P853, DOI 10.1111/j.1365-2745.2005.01016.x; Thomas SC, 1996, EVOL ECOL, V10, P517, DOI 10.1007/BF01237882; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; ZIMMERMAN JK, 2008, TROPICAL FOREST COMM, P89	62	14	14	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17488	10.1371/journal.pone.0017488	http://dx.doi.org/10.1371/journal.pone.0017488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408184	gold, Green Submitted, Green Published			2022-12-27	WOS:000288099800019
J	Wang, SF; Fouquet, S; Chapon, M; Salmon, H; Regnier, F; Labroquere, K; Badoual, C; Damotte, D; Validire, P; Maubec, E; Delongchamps, NB; Cazes, A; Gibault, L; Garcette, M; Dieu-Nosjean, MC; Zerbib, M; Avril, MF; Prevost-Blondel, A; Randriamampita, C; Trautmann, A; Bercovici, N				Wang, Shu-Fang; Fouquet, Stephane; Chapon, Maxime; Salmon, Helene; Regnier, Fabienne; Labroquere, Karine; Badoual, Cecile; Damotte, Diane; Validire, Pierre; Maubec, Eve; Delongchamps, Nicolas B.; Cazes, Aurelie; Gibault, Laure; Garcette, Marylene; Dieu-Nosjean, Marie-Caroline; Zerbib, Marc; Avril, Marie-Francoise; Prevost-Blondel, Armelle; Randriamampita, Clotilde; Trautmann, Alain; Bercovici, Nadege			Early T Cell Signalling Is Reversibly Altered in PD-1(+) T Lymphocytes Infiltrating Human Tumors	PLOS ONE			English	Article							PROGRAMMED DEATH-1; MELANOMA PATIENTS; OVARIAN-CANCER; LUNG-CANCER; RECEPTOR; TOLERANCE; ANERGY; RECOGNITION; ACTIVATION; CARCINOMA	To improve cancer immunotherapy, a better understanding of the weak efficiency of tumor-infiltrating T lymphocytes (TIL) is necessary. We have analyzed the functional state of human TIL immediately after resection of three types of tumors (NSCLC, melanoma and RCC). Several signalling pathways (calcium, phosphorylation of ERK and Akt) and cytokine secretion are affected to different extents in TIL, and show a partial spontaneous recovery within a few hours in culture. The global result is an anergy that is quite distinct from clonal anergy induced in vitro, and closer to adaptive tolerance in mice. PD-1 (programmed death -1) is systematically expressed by TIL and may contribute to their anergy by its mere expression, and not only when it interacts with its ligands PD-L1 or PD-L2, which are not expressed by every tumor. Indeed, the TCR-induced calcium and ERK responses were reduced in peripheral blood T cells transfected with PD-1. Inhibition by sodium stibogluconate of the SHP-1 and SHP-2 phosphatases that associate with several inhibitory receptors including PD-1, relieves part of the anergy apparent in TIL or in PD-1-transfected T cells. This work highlights some of the molecular modifications contributing to functional defects of human TIL.	[Wang, Shu-Fang; Fouquet, Stephane; Chapon, Maxime; Salmon, Helene; Regnier, Fabienne; Labroquere, Karine; Garcette, Marylene; Avril, Marie-Francoise; Prevost-Blondel, Armelle; Randriamampita, Clotilde; Trautmann, Alain; Bercovici, Nadege] INSERM, U1016, Inst Cochin, Paris, France; [Wang, Shu-Fang; Fouquet, Stephane; Chapon, Maxime; Salmon, Helene; Regnier, Fabienne; Labroquere, Karine; Garcette, Marylene; Avril, Marie-Francoise; Prevost-Blondel, Armelle; Randriamampita, Clotilde; Trautmann, Alain; Bercovici, Nadege] CNRS, UMR8104, Paris, France; [Badoual, Cecile] Univ Paris 05, PARCC, INSERM, U970, Paris, France; [Badoual, Cecile; Cazes, Aurelie] Hop Europeen Georges Pompidou, AP HP, Serv Anat Pathol, Paris, France; [Damotte, Diane; Dieu-Nosjean, Marie-Caroline] INSERM, U872, Ctr Rech Cordeliers, Lab Microenvironm Immunitaire & Tumeurs, Paris, France; [Damotte, Diane; Dieu-Nosjean, Marie-Caroline] Univ Paris 06, UMR S872, Paris, France; [Damotte, Diane; Dieu-Nosjean, Marie-Caroline] Univ Paris 05, UMR S872, Paris, France; [Damotte, Diane] Hop Hotel Dieu, AP HP, Serv Anat Pathol, F-75181 Paris, France; [Validire, Pierre] Inst Mutualiste Montsouris, Serv Anat Pathol, Paris, France; [Maubec, Eve] UnivParis Diderot, Hop Bichat, AP HP, Serv Dermatol, Paris, France; [Delongchamps, Nicolas B.; Zerbib, Marc] Hop Cochin, AP HP, Serv Urol, F-75674 Paris, France; [Cazes, Aurelie] Univ Paris 05, Coll France, INSERM, U833, Paris, France; [Gibault, Laure] Univ Paris 05, Grp Hosp Cochin St Vincent de Paul, Serv Anat & Cytol Pathol, Paris, France; [Avril, Marie-Francoise] Hop Cochin, AP HP, Serv Dermatol, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Wang, SF (corresponding author), INSERM, U1016, Inst Cochin, Paris, France.	alain.trautmann@inserm.fr; nadege.bercovici@inserm.fr	Dieu-Nosjean, Marie-Caroline/N-3736-2017; Maubec, Eve/V-4296-2017; Prevost-Blondel, Armelle/N-7643-2017; bercovici, nadege/P-5239-2017; Delongchamps, Nicolas Barry/AAE-8651-2020; Dieu-Nosjean, Marie-Caroline/AAD-3695-2022	Maubec, Eve/0000-0003-1658-6686; Dieu-Nosjean, Marie-Caroline/0000-0002-1697-8914; Badoual, Cecile/0000-0002-1143-3085; RENAULT, Shufang/0000-0001-9234-1002; Prevost-Blondel, Armelle/0000-0002-7268-5905; Randriamampita, Clotilde/0000-0001-8594-7831	CNRS; INSERM; Ligue Nationale Contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by CNRS, INSERM and Ligue Nationale Contre le Cancer. NB was supported by an INSERM grant, S-FW by a post-doctoral fellowship from Ligue Nationale contre le Cancer, SF by a CNRS post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Attig S, 2009, CANCER RES, V69, P8412, DOI 10.1158/0008-5472.CAN-09-0852; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; Broderick L, 2006, CLIN IMMUNOL, V118, P159, DOI 10.1016/j.clim.2005.09.008; Broderick L, 2006, J IMMUNOL, V177, P3082, DOI 10.4049/jimmunol.177.5.3082; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Dong HD, 2006, CELL MOL IMMUNOL, V3, P179; Fourcade J, 2009, J IMMUNOL, V182, P5240, DOI 10.4049/jimmunol.0803245; Fourmentraux-Neves E, 2008, BLOOD, V112, P2381, DOI 10.1182/blood-2007-12-127779; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Frey AB, 2008, IMMUNOL REV, V222, P192, DOI 10.1111/j.1600-065X.2008.00606.x; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rivas MN, 2009, J IMMUNOL, V183, P4284, DOI 10.4049/jimmunol.0901408; Sabil SD, 2007, CURR OPIN IMMUNOL, V19, P658, DOI 10.1016/j.coi.2007.08.005; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Sundar S, 2002, CURR OPIN INFECT DIS, V15, P593, DOI 10.1097/00001432-200212000-00007; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Wong RM, 2007, INT IMMUNOL, V19, P1223, DOI 10.1093/intimm/dxm091; Woo EY, 2001, CANCER RES, V61, P4766; Zea AH, 1995, CLIN CANCER RES, V1, P1327; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	36	51	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17621	10.1371/journal.pone.0017621	http://dx.doi.org/10.1371/journal.pone.0017621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408177	Green Published, gold, Green Submitted			2022-12-27	WOS:000288099800028
J	White, S; Ohnesorg, T; Notini, A; Roeszler, K; Hewitt, J; Daggag, H; Smith, C; Turbitt, E; Gustin, S; van den Bergen, J; Miles, D; Western, P; Arboleda, V; Schumacher, V; Gordon, L; Bell, K; Bengtsson, H; Speed, T; Hutson, J; Warne, G; Harley, V; Koopman, P; Vilain, E; Sinclair, A				White, Stefan; Ohnesorg, Thomas; Notini, Amanda; Roeszler, Kelly; Hewitt, Jacqueline; Daggag, Hinda; Smith, Craig; Turbitt, Erin; Gustin, Sonja; van den Bergen, Jocelyn; Miles, Denise; Western, Patrick; Arboleda, Valerie; Schumacher, Valerie; Gordon, Lavinia; Bell, Katrina; Bengtsson, Henrik; Speed, Terry; Hutson, John; Warne, Garry; Harley, Vincent; Koopman, Peter; Vilain, Eric; Sinclair, Andrew			Copy Number Variation in Patients with Disorders of Sex Development Due to 46,XY Gonadal Dysgenesis	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; TRANSLOCATION BREAKPOINTS; DETERMINATION REVEALS; TESTIS DETERMINATION; KB UPSTREAM; ARRAY-CGH; SOX9; MUTATIONS	Disorders of sex development (DSD), ranging in severity from mild genital abnormalities to complete sex reversal, represent a major concern for patients and their families. DSD are often due to disruption of the genetic programs that regulate gonad development. Although some genes have been identified in these developmental pathways, the causative mutations have not been identified in more than 50% 46,XY DSD cases. We used the Affymetrix Genome-Wide Human SNP Array 6.0 to analyse copy number variation in 23 individuals with unexplained 46, XY DSD due to gonadal dysgenesis (GD). Here we describe three discrete changes in copy number that are the likely cause of the GD. Firstly, we identified a large duplication on the X chromosome that included DAX1 (NR0B1). Secondly, we identified a rearrangement that appears to affect a novel gonad-specific regulatory region in a known testis gene, SOX9. Surprisingly this patient lacked any signs of campomelic dysplasia, suggesting that the deletion affected expression of SOX9 only in the gonad. Functional analysis of potential SRY binding sites within this deleted region identified five putative enhancers, suggesting that sequences additional to the known SRY-binding TES enhancer influence human testis-specific SOX9 expression. Thirdly, we identified a small deletion immediately downstream of GATA4, supporting a role for GATA4 in gonad development in humans. These CNV analyses give new insights into the pathways involved in human gonad development and dysfunction, and suggest that rearrangements of non-coding sequences disturbing gene regulation may account for significant proportion of DSD cases.	[White, Stefan; Ohnesorg, Thomas; Notini, Amanda; Roeszler, Kelly; Hewitt, Jacqueline; Daggag, Hinda; Smith, Craig; Turbitt, Erin; Gustin, Sonja; van den Bergen, Jocelyn; Miles, Denise; Western, Patrick; Gordon, Lavinia; Bell, Katrina; Hutson, John; Warne, Garry; Sinclair, Andrew] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [White, Stefan; Hewitt, Jacqueline; Miles, Denise; Hutson, John; Warne, Garry; Sinclair, Andrew] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Schumacher, Valerie; Vilain, Eric] Univ Calif Los Angeles, Dept Med Genet, Los Angeles, CA USA; [Schumacher, Valerie] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Bengtsson, Henrik; Speed, Terry] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Harley, Vincent] Prince Henrys Inst Med Res, Melbourne, Vic, Australia; [Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Walter & Eliza Hall Institute; Prince Henry's Institute of Medical Research; University of Queensland	White, S (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	evilain@ucla.edu; andrew.sinclair@mcri.edu.au	Sinclair, Andrew H/A-3598-2010; Koopman, Peter A/C-9416-2009; Hewitt, Jacqueline/F-6082-2012; Arboleda, Valerie A/C-9608-2011; Turbitt, Erin/F-7419-2015; Harley, Vincent/B-8092-2018; Gordon, Lavinia/L-1310-2016	Sinclair, Andrew H/0000-0003-2741-7992; Koopman, Peter A/0000-0001-6939-0914; Arboleda, Valerie A/0000-0002-9687-9122; Turbitt, Erin/0000-0002-6650-9702; Harley, Vincent/0000-0002-2405-1262; Western, Patrick/0000-0002-7587-8227; Gordon, Lavinia/0000-0003-3469-8489; Smith, Craig/0000-0002-1670-5545; Hewitt, Jacqueline/0000-0002-3809-8475; Roeszler, Kelly/0000-0002-9809-1507; Ohnesorg, Thomas/0000-0001-9225-8911	Australian National Health and Medical Research Council [334314, 491293, 546478]; Helen Macpherson Smith Trust; Doris Duke Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044513] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Helen Macpherson Smith Trust; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was provided by the Australian National Health and Medical Research Council www.nhmrc.gov.au (334314 to AS, PK and VH; 491293 and 546478 to SW), the Helen Macpherson Smith Trust www.hmstrust.org.au (AS), and the Doris Duke Charitable Foundation www.ddcf.org (EV, VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Barbaro M, 2008, CLIN GENET, V73, P453, DOI 10.1111/j.1399-0004.2008.00980.x; Barbaro M, 2007, J CLIN ENDOCR METAB, V92, P3305, DOI 10.1210/jc.2007-0505; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bouma GJ, 2007, P NATL ACAD SCI USA, V104, P14994, DOI 10.1073/pnas.0701677104; Bouma GJ, 2005, DEVELOPMENT, V132, P3045, DOI 10.1242/dev.01890; Cameron FJ, 1997, HUM MUTAT, V9, P388; Canto P, 2004, J CLIN ENDOCR METAB, V89, P4480, DOI 10.1210/jc.2004-0863; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Domenice S, 2004, BRAZ J MED BIOL RES, V37, P145, DOI 10.1590/S0100-879X2004000100020; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Georg I, 2010, SEX DEV, V4, P321, DOI 10.1159/000320142; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hill-Harfe KL, 2005, AM J HUM GENET, V76, P663, DOI 10.1086/429254; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; KWOK C, 1995, AM J HUM GENET, V57, P1028; Kyuno J, 2008, MECH DEVELOP, V125, P571, DOI 10.1016/j.mod.2008.03.001; Lecointre C, 2009, AM J MED GENET A, V149A, P1183, DOI 10.1002/ajmg.a.32830; Ledig S, 2010, HUM REPROD, V25, P2637, DOI 10.1093/humrep/deq167; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; Lourenco D, 2011, P NATL ACAD SCI USA, V108, P1597, DOI 10.1073/pnas.1010257108; Ludbrook LM, 2004, TRENDS ENDOCRIN MET, V15, P116, DOI 10.1016/j.tem.2004.02.002; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Meeks JJ, 2003, NAT GENET, V34, P32, DOI 10.1038/ng1141; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Ohnesorg T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-412; Pearlman A, 2010, AM J HUM GENET, V87, P898, DOI 10.1016/j.ajhg.2010.11.003; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Pop R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013185; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schumacher V, 2008, MOL REPROD DEV, V75, P1484, DOI 10.1002/mrd.20889; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smyk M, 2007, AM J MED GENET A, V143A, P866, DOI 10.1002/ajmg.a.31631; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Velagaleti GVN, 2005, AM J HUM GENET, V76, P652, DOI 10.1086/429252; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Warne GL, 2009, MED J AUSTRALIA, V190, P612, DOI 10.5694/j.1326-5377.2009.tb02586.x; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; White SJ, 2004, METHOD CELL BIOL, V75, P751; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	63	90	94	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17793	10.1371/journal.pone.0017793	http://dx.doi.org/10.1371/journal.pone.0017793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408189	Green Published, gold			2022-12-27	WOS:000288099800040
J	Kashyap, MP; Singh, AK; Kumar, V; Tripathi, VK; Srivastava, RK; Agrawal, M; Khanna, VK; Yadav, S; Jain, SK; Pant, AB				Kashyap, Mahendra Pratap; Singh, Abhishek Kumar; Kumar, Vivek; Tripathi, Vinay Kumar; Srivastava, Ritesh Kumar; Agrawal, Megha; Khanna, Vinay Kumar; Yadav, Sanjay; Jain, Swatantra Kumar; Pant, Aditya Bhushan			Monocrotophos Induced Apoptosis in PC12 Cells: Role of Xenobiotic Metabolizing Cytochrome P450s	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; GLUTATHIONE-S-TRANSFERASE; IN-VITRO; RODENT LIVER; HEPG2 CELLS; RAT-BRAIN; GST P1-1; STRESS; ACTIVATION	Monocrotophos (MCP) is a widely used organophosphate (OP) pesticide. We studied apoptotic changes and their correlation with expression of selected cytochrome P450s (CYPs) in PC12 cells exposed to MCP. A significant induction in reactive oxygen species (ROS) and decrease in glutathione (GSH) levels were observed in cells exposed to MCP. Following the exposure of PC12 cells to MCP (10(-5) M), the levels of protein and mRNA expressions of caspase-3/9, Bax, Bcl(2), P-53, P-21, GSTP1-1 were significantly upregulated, whereas the levels of Bclw, Mcl1 were downregulated. A significant induction in the expression of CYP1A1/1A2, 2B1/2B2, 2E1 was also observed in PC12 cells exposed to MCP (10(-5) M), whereas induction of CYPs was insignificant in cells exposed to 10(-6) M concentration of MCP. We believe that this is the first report showing altered expressions of selected CYPs in MCP-induced apoptosis in PC12 cells. These apoptotic changes were mitochondria mediated and regulated by caspase cascade. Our data confirm the involvement of specific CYPs in MCP-induced apoptosis in PC12 cells and also identifies possible cellular and molecular mechanisms of organophosphate pesticide-induced apoptosis in neuronal cells.	[Kashyap, Mahendra Pratap; Singh, Abhishek Kumar; Kumar, Vivek; Tripathi, Vinay Kumar; Srivastava, Ritesh Kumar; Agrawal, Megha; Khanna, Vinay Kumar; Yadav, Sanjay; Pant, Aditya Bhushan] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Kashyap, Mahendra Pratap; Singh, Abhishek Kumar; Kumar, Vivek; Tripathi, Vinay Kumar; Srivastava, Ritesh Kumar; Agrawal, Megha; Khanna, Vinay Kumar; Yadav, Sanjay; Pant, Aditya Bhushan] CSIR, New Delhi, India; [Jain, Swatantra Kumar] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; Jamia Hamdard University	Kashyap, MP (corresponding author), Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India.	abpant@rediffmail.com	Srivastava, Ritesh/V-6029-2019; Yadav, Sanjay/E-2902-2010; Singh, Abhishek K/G-4032-2011; Kashyap, Mahendra/G-4305-2011	Kashyap, Mahendra/0000-0001-7924-4793; Agrawal, Megha/0000-0001-5280-7699; Singh, Abhishek Kumar/0000-0002-3186-9898	Council of Scientific and Industrial Research, New Delhi [SIP-08]; University Grant Commission, New Delhi [GAP-155]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, New Delhi(University Grants Commission, India)	Financial support by Council of Scientific and Industrial Research, New Delhi, (SIP-08) is acknowledged. University Grant Commission, New Delhi is acknowledged for providing the fellowship to Mr. M.P. Kashyap (GAP-155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardini S, 2002, J CELL BIOCHEM, V86, P340, DOI 10.1002/jcb.10219; Bernardini S, 2000, J CELL BIOCHEM, V77, P645, DOI 10.1002/(SICI)1097-4644(20000615)77:4<645::AID-JCB12>3.3.CO;2-0; Bernardini S, 2006, ANN HEMATOL, V85, P681, DOI 10.1007/s00277-006-0139-8; Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532; Cederbaum AI, 2006, MT SINAI J MED, V73, P657; Chan JYH, 2006, NEUROPHARMACOLOGY, V51, P1109, DOI 10.1016/j.neuropharm.2006.06.024; Chen Q, 1998, MOL PHARMACOL, V53, P638, DOI 10.1124/mol.53.4.638; Chen ZH, 2004, CARCINOGENESIS, V25, P2005, DOI 10.1093/carcin/bgh183; Costa LG, 2006, CLIN CHIM ACTA, V366, P1, DOI 10.1016/j.cca.2005.10.008; Dostalek M, 2008, J BIOL CHEM, V283, P17147, DOI 10.1074/jbc.M802447200; Fujita K, 2001, MUTAT RES-FUND MOL M, V483, P35, DOI 10.1016/S0027-5107(01)00223-8; Galluzzi L, 2008, CELL CYCLE, V7, P1949, DOI 10.4161/cc.7.13.6222; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gong PF, 2006, HEPATOLOGY, V43, P144, DOI 10.1002/hep.21004; Hashizume T, 2009, MUTAT RES-GEN TOX EN, V677, P1, DOI 10.1016/j.mrgentox.2009.03.009; Hewitt R, 2007, ENVIRON HEALTH PERSP, V115, P129, DOI 10.1289/ehp.9361; Huk OL, 2004, J ARTHROPLASTY, V19, P84, DOI 10.1016/j.arth.2004.09.011; Johri A, 2008, TOXICOL APPL PHARM, V231, P10, DOI 10.1016/j.taap.2008.03.019; Kapoor N, 2006, LIFE SCI, V79, P1514, DOI 10.1016/j.lfs.2006.04.023; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; Kaur P, 2007, NEUROTOXICOLOGY, V28, P1208, DOI 10.1016/j.neuro.2007.08.001; Kim JY, 2007, ENDOCRINOLOGY, V148, P5112, DOI 10.1210/en.2007-0096; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KUMAR S, 2009, BIOCHEM PHARMACOL, V79, P1182; Li Q, 2009, TOXICOLOGY, V255, P53, DOI 10.1016/j.tox.2008.10.003; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Loft S, 1998, FREE RADICAL RES, V29, P525, DOI 10.1080/10715769800300571; Lupp A, 2006, INT J CLIN PHARM TH, V44, P225; Mari M, 2001, HEPATOLOGY, V33, P652, DOI 10.1053/jhep.2001.22521; Masoud A, 2009, CELL MOL NEUROBIOL, V29, P1245, DOI 10.1007/s10571-009-9420-4; McConnachie LA, 2007, TOXICOL SCI, V99, P628, DOI 10.1093/toxsci/kfm165; Moore PD, 2010, ENVIRON TOXICOL, V25, P221, DOI 10.1002/tox.20492; Namazi M R, 2009, J Autoimmune Dis, V6, P4, DOI 10.1186/1740-2557-6-4; Naraharisetti SB, 2009, ENVIRON TOXICOL PHAR, V28, P213, DOI 10.1016/j.etap.2009.04.006; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Perera PMS, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-73; Perez-Maldonado IN, 2005, ENVIRON RES, V98, P177, DOI 10.1016/j.envres.2004.11.001; Ramakrishna V, 2008, ACTA DIABETOL, V45, P41, DOI 10.1007/s00592-007-0018-3; Raza H, 2006, TOXICOL APPL PHARM, V216, P309, DOI 10.1016/j.taap.2006.06.001; Sarabia L, 2009, ECOTOX ENVIRON SAFE, V72, P938, DOI 10.1016/j.ecoenv.2008.04.022; Saulsbury MD, 2008, TOXICOLOGY, V244, P98, DOI 10.1016/j.tox.2007.10.020; Shenouda J, 2009, TOXICOL APPL PHARM, V241, P135, DOI 10.1016/j.taap.2009.08.014; Siddiqui MA, 2010, TOXICOL IN VITRO, V24, P1681, DOI 10.1016/j.tiv.2010.05.019; Singh Mohan, 2004, Indian Journal of Experimental Biology, V42, P292; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; Slotkin TA, 2009, ENVIRON HEALTH PERSP, V117, P587, DOI 10.1289/ehp.0800251; Srivastava RK, 2011, NANOTOXICOLOGY, V5, P195, DOI 10.3109/17435390.2010.503944; Wang XY, 2004, NEUROBIOL DIS, V16, P179, DOI 10.1016/j.nbd.2004.01.014; Zhao MR, 2009, CHEM RES TOXICOL, V22, P504, DOI 10.1021/tx800358b	51	41	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17757	10.1371/journal.pone.0017757	http://dx.doi.org/10.1371/journal.pone.0017757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445290	gold, Green Published, Green Submitted			2022-12-27	WOS:000288613300012
J	Friman, VP; Hiltunen, T; Jalasvuori, M; Lindstedt, C; Laanto, E; Ormala, AM; Laakso, J; Mappes, J; Bamford, JKH				Friman, Ville-Petri; Hiltunen, Teppo; Jalasvuori, Matti; Lindstedt, Carita; Laanto, Elina; Ormala, Anni-Maria; Laakso, Jouni; Mappes, Johanna; Bamford, Jaana K. H.			High Temperature and Bacteriophages Can Indirectly Select for Bacterial Pathogenicity in Environmental Reservoirs	PLOS ONE			English	Article							SERRATIA-MARCESCENS; ESCHERICHIA-COLI; DECREASED VIRULENCE; RESISTANT MUTANTS; SHIGA TOXIN; EVOLUTION; PHAGE; ADAPTATION; EXPRESSION; PROTOZOA	The coincidental evolution hypothesis predicts that traits connected to bacterial pathogenicity could be indirectly selected outside the host as a correlated response to abiotic environmental conditions or different biotic species interactions. To investigate this, an opportunistic bacterial pathogen, Serratia marcescens, was cultured in the absence and presence of the lytic bacteriophage PPV (Podoviridae) at 25 degrees C and 37 degrees C for four weeks (N = 5). At the end, we measured changes in bacterial phage-resistance and potential virulence traits, and determined the pathogenicity of all bacterial selection lines in the Parasemia plantaginis insect model in vivo. Selection at 37 degrees C increased bacterial motility and pathogenicity but only in the absence of phages. Exposure to phages increased the phage-resistance of bacteria, and this was costly in terms of decreased maximum population size in the absence of phages. However, this small-magnitude growth cost was not greater with bacteria that had evolved in high temperature regime, and no trade-off was found between phage-resistance and growth rate. As a result, phages constrained the evolution of a temperature-mediated increase in bacterial pathogenicity presumably by preferably infecting the highly motile and virulent bacteria. In more general perspective, our results suggest that the traits connected to bacterial pathogenicity could be indirectly selected as a correlated response by abiotic and biotic factors in environmental reservoirs.	[Friman, Ville-Petri; Hiltunen, Teppo; Lindstedt, Carita; Ormala, Anni-Maria; Laakso, Jouni; Mappes, Johanna] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland; [Jalasvuori, Matti; Laanto, Elina; Ormala, Anni-Maria; Bamford, Jaana K. H.] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Virus Res, Jyvaskyla, Finland; [Jalasvuori, Matti; Laanto, Elina; Ormala, Anni-Maria; Bamford, Jaana K. H.] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland; [Friman, Ville-Petri; Laakso, Jouni] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki	Friman, VP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	vifriman@jyu.fi	Laanto, Elina/ABA-8049-2020; Laakso, Jouni/I-7794-2013; Mappes, Johanna/AAZ-3627-2021; Hiltunen, Teppo/A-4308-2015	Laakso, Jouni/0000-0001-8245-9912; Hiltunen, Teppo/0000-0001-7206-2399; Friman, Ville-Petri/0000-0002-1592-157X; Mappes, Johanna/0000-0002-1117-5629; Laanto, Elina/0000-0003-4172-3128	Academy of Finland (Centre of Excellence in Evolution Research) [218349]; Academy of Finland (Centre of excellence in Virus Research) [1213467, 1106993, 1130724]	Academy of Finland (Centre of Excellence in Evolution Research)(Academy of Finland); Academy of Finland (Centre of excellence in Virus Research)(Academy of Finland)	This study was funded by the Academy of Finland (Centre of Excellence in Evolution Research; grant 218349, Centre of excellence in Virus Research; grant 1213467 and projects No. 1106993 and 1130724 for JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; BAMFORD JKH, 1991, VIROLOGY, V181, P348, DOI 10.1016/0042-6822(91)90501-2; BENNETT AF, 1992, EVOLUTION, V46, P16, DOI 10.1111/j.1558-5646.1992.tb01981.x; BENNETT AF, 1990, NATURE, V346, P79, DOI 10.1038/346079a0; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brockhurst MA, 2004, P ROY SOC B-BIOL SCI, V271, P107, DOI 10.1098/rspb.2003.2556; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brussow H, 2007, MOL MICROBIOL, V65, P583, DOI 10.1111/j.1365-2958.2007.05826.x; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Case RJ, 2010, ENV MICROB IN PRESS; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002; Ducel G, 2002, PREVENTION HOSP ACQU; Duriez P, 2008, APPL ENVIRON MICROB, V74, P3935, DOI 10.1128/AEM.02710-07; Ellis CN, 2010, APPL ENVIRON MICROB, V76, P2387, DOI 10.1128/AEM.01930-09; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Halpern M, 2007, ENVIRON MICROBIOL, V9, P584, DOI 10.1111/j.1462-2920.2006.01174.x; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; HEIERSON A, 1986, J BACTERIOL, V167, P18, DOI 10.1128/jb.167.1.18-24.1986; HINNEN R, 1974, EUR J BIOCHEM, V50, P1, DOI 10.1111/j.1432-1033.1974.tb03867.x; Iino T, 1967, J Virol, V1, P445; Inglis RF, 2009, P NATL ACAD SCI USA, V106, P5703, DOI 10.1073/pnas.0810850106; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Lai HC, 2005, J BACTERIOL, V187, P3407, DOI 10.1128/JB.187.10.3407-3414.2005; Lainhart W, 2009, J BACTERIOL, V191, P5116, DOI 10.1128/JB.00508-09; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; LENSKI RE, 1988, ADV MICROB ECOL, V10, P1; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; LEVIN BR, 1990, PARASITOLOGY, V100, pS103, DOI 10.1017/S0031182000073054; Liu JH, 2000, J BIOMED SCI, V7, P475, DOI 10.1159/000025483; Malik-Kale P, APPL ENV MICROBIOL, V73, P3123; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; MAUCHLINE WS, 1994, INFECT IMMUN, V62, P2995, DOI 10.1128/IAI.62.7.2995-2997.1994; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; MEYNELL EW, 1961, J GEN MICROBIOL, V25, P253, DOI 10.1099/00221287-25-2-253; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; PARUCHURI DK, 1987, J BACTERIOL, V169, P61, DOI 10.1128/jb.169.1.61-65.1987; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Sambrook J, 2001, MOL CLONING LAB MANU; Samuel ADT, 1999, P NATL ACAD SCI USA, V96, P9863, DOI 10.1073/pnas.96.17.9863; Santander J, 2007, ELECTRON J BIOTECHN, V10, P627, DOI 10.2225/vol10-issue4-fulltext-14; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Wei JR, 2006, INT J MED MICROBIOL, V296, P117, DOI 10.1016/j.ijmm.2006.01.033	61	42	45	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17651	10.1371/journal.pone.0017651	http://dx.doi.org/10.1371/journal.pone.0017651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423610	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900015
J	Kaulfurst-Soboll, H; Mertens, M; Brehler, R; von Schaewen, A				Kaulfuerst-Soboll, Heidi; Mertens, Melanie; Brehler, Randolf; von Schaewen, Antje			Reduction of Cross-Reactive Carbohydrate Determinants in Plant Foodstuff: Elucidation of Clinical Relevance and Implications for Allergy Diagnosis	PLOS ONE			English	Article							IMMUNOGLOBULIN-E ANTIBODIES; SKIN PRICK TESTS; TOMATO FRUIT; REDUCED ALLERGENICITY; STRONGLY AFFECT; IGE ANTIBODIES; ACID INVERTASE; ORAL CHALLENGE; POSITIVE SKIN; IN-VIVO	Background: A longstanding debate in allergy is whether or not specific immunoglobulin-E antibodies (sIgE), recognizing cross-reactive carbohydrate determinants (CCD), are able to elicit clinical symptoms. In pollen and food allergy, >= 20% of patients display in-vitro CCD reactivity based on presence of alpha 1,3-fucose and/or beta 1,2-xylose residues on N-glycans of plant (xylose/fucose) and insect (fucose) glycoproteins. Because the allergenicity of tomato glycoallergen Lyc e 2 was ascribed to N-glycan chains alone, this study aimed at evaluating clinical relevance of CCD-reduced foodstuff in patients with carbohydrate-specific IgE (CCD-sIgE). Methodology/Principal Findings: Tomato and/or potato plants with stable reduction of Lyc e 2 (tomato) or CCD formation in general were obtained via RNA interference, and gene-silencing was confirmed by immunoblot analyses. Two different CCD-positive patient groups were compared: one with tomato and/or potato food allergy and another with hymenopteravenom allergy (the latter to distinguish between CCD- and peptide-specific reactions in the food-allergic group). Non-allergic and CCD-negative food-allergic patients served as controls for immunoblot, basophil activation, and ImmunoCAP analyses. Basophil activation tests (BAT) revealed that Lyc e 2 is no key player among other tomato (glyco) allergens. CCD-positive patients showed decreased (re) activity with CCD-reduced foodstuff, most obvious in the hymenoptera venom-allergic but less in the food-allergic group, suggesting that in-vivo reactivity is primarily based on peptide- and not CCD-sIgE. Peptide epitopes remained unaffected in CCD-reduced plants, because CCD-negative patient sera showed reactivity similar to wild-type. In-house-made ImmunoCAPs, applied to investigate feasibility in routine diagnosis, confirmed BAT results at the sIgE level. Conclusions/Significance: CCD-positive hymenoptera venom-allergic patients (control group) showed basophil activation despite no allergic symptoms towards tomato and potato. Therefore, this proof-of-principle study demonstrates feasibility of CCD-reduced foodstuff to minimize 'false-positive results' in routine serum tests. Despite confirming low clinical relevance of CCD antibodies, we identified one patient with ambiguous in-vitro results, indicating need for further component-resolved diagnosis.	[Kaulfuerst-Soboll, Heidi; von Schaewen, Antje] Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany; [Mertens, Melanie; Brehler, Randolf] Univ Munster, Dept Dermatol, D-4400 Munster, Germany	University of Munster; University of Munster	Kaulfurst-Soboll, H (corresponding author), Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany.	schaewen@uni-muenster.de			Deutsche Forschungsgemeinschaft [DFG-SCHA 541/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG-SCHA 541/9) to AvS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Bassler OY, 2009, J PROTEOME RES, V8, P1111, DOI 10.1021/pr800186d; Ballmer-Weber BK, 2001, J ALLERGY CLIN IMMUN, V108, P301, DOI 10.1067/mai.2001.116430; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Bublin M, 2003, FASEB J, V17, P1697, DOI 10.1096/fj.02-0872fje; Chen S, 2003, PLANT J, V36, P731, DOI 10.1046/j.1365-313X.2003.01914.x; Ebo DG, 2004, CLIN EXP ALLERGY, V34, P137, DOI 10.1111/j.1365-2222.2004.01837.x; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Foetisch K, 2003, J ALLERGY CLIN IMMUN, V111, P889, DOI 10.1067/mai.2003.173; Foetisch K, 2001, EUR FOOD RES TECHNOL, V213, P259, DOI 10.1007/s002170100343; Fotisch K, 1999, INT ARCH ALLERGY IMM, V120, P30, DOI 10.1159/000024217; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; Iacovacci P., 2002, Clinical and Experimental Allergy, V32, P1620, DOI 10.1046/j.1365-2222.2002.01516.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; KLANN E, 1992, PLANT PHYSIOL, V99, P351, DOI 10.1104/pp.99.1.351; Kondo Y, 2001, INT ARCH ALLERGY IMM, V126, P294, DOI 10.1159/000049526; Le LQ, 2006, J ALLERGY CLIN IMMUN, V118, P1176, DOI 10.1016/j.jaci.2006.06.031; Le LQ, 2006, PLANT BIOTECHNOL J, V4, P231, DOI 10.1111/j.1467-7652.2005.00175.x; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Ling HQ, 1998, PLANT CELL REP, V17, P843, DOI 10.1007/s002990050495; Lorenz Y, 2006, J ALLERGY CLIN IMMUN, V118, P711, DOI 10.1016/j.jaci.2006.05.014; Luttkopf D, 2000, J ALLERGY CLIN IMMUN, V106, P390, DOI 10.1067/mai.2000.108711; Majamaa H, 2001, PEDIAT ALLERG IMM-UK, V12, P283, DOI 10.1034/j.1399-3038.2001.00096.x; Mari A, 1999, J ALLERGY CLIN IMMUN, V103, P1005, DOI 10.1016/S0091-6749(99)70171-5; Mari A, 2002, INT ARCH ALLERGY IMM, V129, P286, DOI 10.1159/000067591; Mari A, 2008, ALLERGY, V63, P891, DOI 10.1111/j.1398-9995.2008.01703.x; Mertens M, 2010, CLIN EXP ALLERGY, V40, P1333, DOI 10.1111/j.1365-2222.2010.03535.x; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; OHYAMA A, 1992, JPN J GENET, V67, P491, DOI 10.1266/jjg.67.491; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; PARK WD, 1983, PLANT PHYSIOL, V71, P156, DOI 10.1104/pp.71.1.156; Petersen A, 1996, J ALLERGY CLIN IMMUN, V98, P805, DOI 10.1016/S0091-6749(96)70130-6; Pots AM, 1999, J AGR FOOD CHEM, V47, P4587, DOI 10.1021/jf981180n; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; RUDESCHKO O, 1995, ALLERGY, V50, P262, DOI 10.1111/j.1398-9995.1995.tb01144.x; Sander I, 2005, INT ARCH ALLERGY IMM, V136, P39, DOI 10.1159/000082583; Seppala U, 1999, J ALLERGY CLIN IMMUN, V103, P165, DOI 10.1016/S0091-6749(99)70541-5; Seppala U, 2001, ALLERGY, V56, P619, DOI 10.1034/j.1398-9995.2001.00058.x; SONNEWALD U, 1989, PLANTA, V179, P171, DOI 10.1007/BF00393687; Strasser R, 2004, GLYCOCONJUGATE J, V21, P275, DOI 10.1023/B:GLYC.0000045099.29038.04; Turner JD, 2005, MICROBES INFECT, V7, P990, DOI 10.1016/j.micinf.2005.03.036; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; vanderVeen MJ, 1997, J ALLERGY CLIN IMMUN, V100, P327, DOI 10.1016/S0091-6749(97)70245-8; VONKROGH G, 1981, J AM ACAD DERMATOL, V5, P328, DOI 10.1016/S0190-9622(81)70099-9; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Weangsripanaval T, 2003, BIOSCI BIOTECH BIOCH, V67, P1299, DOI 10.1271/bbb.67.1299; Wenderoth I, 2000, PLANT PHYSIOL, V123, P1097, DOI 10.1104/pp.123.3.1097; Westphal S, 2003, EUR J BIOCHEM, V270, P1327, DOI 10.1046/j.1432-1033.2003.03503.x	51	18	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17800	10.1371/journal.pone.0017800	http://dx.doi.org/10.1371/journal.pone.0017800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423762	Green Published, Green Submitted, gold			2022-12-27	WOS:000288512400030
J	Mendez, V; Agullo, L; Gonzalez, M; Seeger, M				Mendez, Valentina; Agullo, Loreine; Gonzalez, Myriam; Seeger, Michael			The Homogentisate and Homoprotocatechuate Central Pathways Are Involved in 3-and 4-Hydroxyphenylacetate Degradation by Burkholderia xenovorans LB400	PLOS ONE			English	Article							2-PROTEIN COMPONENT ENZYME; ESCHERICHIA-COLI; PSEUDOMONAS-PUTIDA; MOLECULAR CHARACTERIZATION; BACTERIAL-DEGRADATION; CATABOLIC PATHWAY; KLEBSIELLA-PNEUMONIAE; ASPERGILLUS-NIDULANS; AROMATIC-COMPOUNDS; STRESS-PROTEINS	Background: Genome characterization of the model PCB-degrading bacterium Burkholderia xenovorans LB400 revealed the presence of eleven central pathways for aromatic compounds degradation, among them, the homogentisate and the homoprotocatechuate pathways. However, the functionality of these central pathways in strain LB400 has not been assessed and related peripheral pathways has not been described. Methodology/Principal Findings: The aims of this study were to determine the functionality of the homogentisate and homoprotocatechuate central pathways in B. xenovorans LB400 and to establish their role in 3-hydroxyphenylacetate (3-HPA) and 4-hydroxyphenylacetate (4-HPA) catabolism. Strain LB400 was able to grow using 3-HPA and 4-HPA as sole carbon source. A genomic search in LB400 suggested the presence of mhaAB and hpaBC genes clusters encoding proteins of the 3-hydroxyphenylacetate and 4-hydroxyphenylacetate peripheral pathways. LB400 cells grown with 3-HPA and 4-HPA degraded homogentisate and homoprotocatechuate and showed homogentisate 1,2-dioxygenase and homoprotocatechuate 2,3-dioxygenase activities. Transcriptional analyses by RT-PCR showed the expression of two chromosomally-encoded homogentisate dioxygenases (BxeA2725 and BxeA3900) and the hpaD gene encoding the homoprotocatechuate 2,3-dioxygenase during 3-HPA and 4-HPA degradation. The proteome analyses by two-dimensional polyacrilamide gel electrophoresis of B. xenovorans LB400 grown in 3-HPA and 4-HPA showed the induction of fumarylacetoacetate hydrolase HmgB (BxeA3899). Conclusions/Significance: This study revealed that strain LB400 used both homogentisate and homoprotocatechuate ring-cleavage pathways for 3-hydroxyphenylacetate and 4-hydroxyphenylacetate catabolism and that these four catabolic routes are functional, confirming the metabolic versatility of B. xenovorans LB400.	[Mendez, Valentina] Univ Tecn Federico Santa Maria, Dept Quim, Lab Microbiol Mol & Biotecnol Ambiental, Valparaiso, Chile; Univ Tecn Federico Santa Maria, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria	Mendez, V (corresponding author), Univ Tecn Federico Santa Maria, Dept Quim, Lab Microbiol Mol & Biotecnol Ambiental, Valparaiso, Chile.	michael.seeger@usm.cl	Seeger, Michael/B-3774-2012; Agullo, Loreine/AAH-2424-2019; Seeger, Michael/AFK-3436-2022	Agullo Carvajal, Loreine Joselyn/0000-0003-4789-2686	FONDECYT [1070507, 7090079, 1020221]; MILENIO [P04/007-F]; Center for Nanotechnology and Systems Biology; USM [130836, 130948]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MILENIO; Center for Nanotechnology and Systems Biology; USM	M.S. gratefully acknowledges financial support from FONDECYT (1070507, 7090079 and 1020221) (http://www.fondecyt.cl), MILENIO P04/007-F (MIDEPLAN) (http://www.iniciativamilenio.cl) Center for Nanotechnology and Systems Biology (http://www.usm.cl) and USM (130836, 130948) (http://www.usm.cl) grants. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agullo L, 2007, FEMS MICROBIOL LETT, V267, P167, DOI 10.1111/j.1574-6968.2006.00554.x; Arias-Barrau E, 2005, J BIOL CHEM, V280, P26435, DOI 10.1074/jbc.M501988200; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Camara B, 2009, J BACTERIOL, V191, P4905, DOI 10.1128/JB.00331-09; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; CHAPMAN PJ, 1962, J GEN MICROBIOL, V28, P251, DOI 10.1099/00221287-28-2-251; COOPER RA, 1980, J BACTERIOL, V143, P302, DOI 10.1128/JB.143.1.302-306.1980; Diaz E, 2004, INT MICROBIOL, V7, P173; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; FERNANDEZCANON JM, 1995, J BIOL CHEM, V270, P21199, DOI 10.1074/jbc.270.36.21199; FernandezCanon JM, 1997, ANAL BIOCHEM, V245, P218, DOI 10.1006/abio.1996.9957; Gibello A, 1997, ARCH MICROBIOL, V167, P160, DOI 10.1007/s002030050429; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; MARTIN M, 1991, J GEN MICROBIOL, V137, P621, DOI 10.1099/00221287-137-3-621; Martinez P, 2007, ARCH MICROBIOL, V188, P289, DOI 10.1007/s00203-007-0247-4; Saavedra JM, 2010, APPL MICROBIOL BIOT, V87, P1543, DOI 10.1007/s00253-010-2575-6; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mohamed MES, 2002, ARCH MICROBIOL, V178, P180, DOI 10.1007/s00203-002-0438-y; NOGALES P, 2009, BMC SYSTEMS BIOL, V2, P79; OLIVERA ER, 1994, EUR J BIOCHEM, V221, P375, DOI 10.1111/j.1432-1033.1994.tb18749.x; Perez-Pantoja D, 2003, J BACTERIOL, V185, P1534, DOI 10.1128/JB.185.5.1534-1542.2003; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; PRIETO MA, 1994, J BIOL CHEM, V269, P22823; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; ROPER DI, 1993, MOL GEN GENET, V237, P241, DOI 10.1007/BF00282806; Sanchez-Amat A, 1998, COMP BIOCHEM PHYS B, V119, P557, DOI 10.1016/S0305-0491(98)00028-5; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 1999, APPL ENVIRON MICROB, V65, P3614; Seeger M, 2010, J SOIL SCI PLANT NUT, V10, P320, DOI 10.4067/S0718-95162010000100007; Seeger M, 2009, MICROBIOLOGY HYDROCA, P1179; SEEGMILLER J, 1961, J BIOL CHEM, V236, P774; SPARNINS VL, 1974, J BACTERIOL, V120, P159, DOI 10.1128/JB.120.1.159-167.1974; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	41	36	37	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17583	10.1371/journal.pone.0017583	http://dx.doi.org/10.1371/journal.pone.0017583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423751	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100017
J	Sajid, A; Arora, G; Gupta, M; Upadhyay, S; Nandicoori, VK; Singh, Y				Sajid, Andaleeb; Arora, Gunjan; Gupta, Meetu; Upadhyay, Sandeep; Nandicoori, Vinay K.; Singh, Yogendra			Phosphorylation of Mycobacterium tuberculosis Ser/Thr Phosphatase by PknA and PknB	PLOS ONE			English	Article							2C PROTEIN PHOSPHATASES; SERINE/THREONINE PHOSPHATASE; REGULATORY PROTEIN; RECEPTOR-KINASE; 3RD METAL; SUBSTRATE; VIRULENCE; TYROSINE; MECHANISM; DEPHOSPHORYLATES	Background: The integrated functions of 11 Ser/Thr protein kinases (STPKs) and one phosphatase manipulate the phosphorylation levels of critical proteins in Mycobacterium tuberculosis. In this study, we show that the lone Ser/Thr phosphatase (PstP) is regulated through phosphorylation by STPKs. Principal Findings: PstP is phosphorylated by PknA and PknB and phosphorylation is influenced by the presence of Zn2+-ions and inorganic phosphate (Pi). PstP is differentially phosphorylated on the cytosolic domain with Thr(137), Thr(141), Thr(174) and Thr(290) being the target residues of PknB while Thr(137) and Thr(174) are phosphorylated by PknA. The Mn2+-ion binding residues Asp(38) and Asp(229) are critical for the optimal activity of PstP and substitution of these residues affects its phosphorylation status. Native PstP and its phosphatase deficient mutant PstP(c)(D38G) are phosphorylated by PknA and PknB in E. coli and addition of Zn2+/Pi in the culture conditions affect the phosphorylation level of PstP. Interestingly, the phosphorylated phosphatase is more active than its unphosphorylated equivalent. Conclusions and Significance: This study establishes the novel mechanisms for regulation of mycobacterial Ser/Thr phosphatase. The results indicate that STPKs and PstP may regulate the signaling through mutually dependent mechanisms. Consequently, PstP phosphorylation may play a critical role in regulating its own activity. Since, the equilibrium between phosphorylated and non-phosphorylated states of mycobacterial proteins is still unexplained, understanding the regulation of PstP may help in deciphering the signal transduction pathways mediated by STPKs and the reversibility of the phenomena.	[Sajid, Andaleeb; Arora, Gunjan; Gupta, Meetu; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi, India; [Upadhyay, Sandeep; Nandicoori, Vinay K.] Natl Inst Immunol, New Delhi 110067, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sajid, A (corresponding author), CSIR, Inst Genom & Integrat Biol, Delhi, India.	ysingh@igib.res.in	Arora, Gunjan/AAL-3448-2020; Sajid, Andaleeb/AAI-2960-2020; Upadhyay, Sandeep/ABF-5956-2020; Upadhyay, Sandeep/X-5218-2019	Arora, Gunjan/0000-0003-0575-6205; Sajid, Andaleeb/0000-0001-6248-4985; Upadhyay, Sandeep/0000-0001-5958-5419; Nandicoori, Vinay/0000-0002-5682-4178	Council of Scientific and Industrial Research [NWP-0038]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	Financial support to the work was provided by Council of Scientific and Industrial Research (NWP-0038). AS is a Senior Research Fellow of University Grants Commission, India. GA and MG are Senior Research Fellows of Council of Scientific and Industrial Research, India. SU is a Junior Research Fellow of Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Awano K, 2008, BIOCHEMISTRY-US, V47, P7248, DOI 10.1021/bi800067p; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bukczynska P, 2004, BIOCHEM J, V380, P939, DOI 10.1042/BJ20031780; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chopra P, 2003, BIOCHEM BIOPH RES CO, V311, P112, DOI 10.1016/j.bbrc.2003.09.173; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dahche H, 2009, EXTREMOPHILES, V13, P371, DOI 10.1007/s00792-008-0211-5; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Doehn U, 2004, BIOCHEM J, V382, P425, DOI 10.1042/BJ20040948; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Halbedel S, 2006, J BIOL CHEM, V281, P26253, DOI 10.1074/jbc.M605010200; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Jan G, 2009, MICROBES INFECT, V11, P935, DOI 10.1016/j.micinf.2009.06.002; Jang JC, 2007, MOL MICROBIOL, V64, P347, DOI 10.1111/j.1365-2958.2007.05654.x; Jiang LH, 2010, MOL PLANT PATHOL, V11, P277, DOI 10.1111/j.1364-3703.2009.00598.x; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; KOBAYASHI T, 1993, BIOCHEM BIOPH RES CO, V195, P484, DOI 10.1006/bbrc.1993.2069; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Miyahara A, 2008, J BIOL CHEM, V283, P25381, DOI 10.1074/jbc.M800400200; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Sugiura T, 2009, BIOMETALS, V22, P469, DOI 10.1007/s10534-009-9204-9; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Travis SM, 1997, P NATL ACAD SCI USA, V94, P11055, DOI 10.1073/pnas.94.20.11055; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; van der Knaap E, 1999, PLANT PHYSIOL, V120, P559, DOI 10.1104/pp.120.2.559; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang JY, 1998, J BACTERIOL, V180, P6764, DOI 10.1128/JB.180.24.6764-6768.1998; Zhao SM, 2000, J BACTERIOL, V182, P1053, DOI 10.1128/JB.182.4.1053-1061.2000	54	34	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17871	10.1371/journal.pone.0017871	http://dx.doi.org/10.1371/journal.pone.0017871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21423706	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900052
J	Comley, LH; Wishart, TM; Baxter, B; Murray, LM; Nimmo, A; Thomson, D; Parson, SH; Gillingwater, TH				Comley, Laura H.; Wishart, Thomas M.; Baxter, Becki; Murray, Lyndsay M.; Nimmo, Ailish; Thomson, Derek; Parson, Simon H.; Gillingwater, Thomas H.			Induction of Cell Stress in Neurons from Transgenic Mice Expressing Yellow Fluorescent Protein: Implications for Neurodegeneration Research	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; WALLERIAN DEGENERATION; IN-VIVO; MOUSE MODEL; PATHOLOGY; WLD(S); GENE; CORTEX; GFP	Background: Mice expressing fluorescent proteins in neurons are one of the most powerful tools in modern neuroscience research and are increasingly being used for in vivo studies of neurodegeneration. However, these mice are often used under the assumption that the fluorescent proteins present are biologically inert. Methodology/Principal Findings: Here, we show that thy1-driven expression of yellow fluorescent protein (YFP) in neurons triggers multiple cell stress responses at both the mRNA and protein levels in vivo. The presence of YFP in neurons also subtly altered neuronal morphology and modified the time-course of dying-back neurodegeneration in experimental axonopathy, but not in Wallerian degeneration triggered by nerve injury. Conclusions/Significance: We conclude that fluorescent protein expressed in thy1-YFP mice is not biologically inert, modifies molecular and cellular characteristics of neurons in vivo, and has diverse and unpredictable effects on neurodegeneration pathways.	[Comley, Laura H.; Wishart, Thomas M.; Baxter, Becki; Murray, Lyndsay M.; Nimmo, Ailish; Thomson, Derek; Parson, Simon H.; Gillingwater, Thomas H.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Lothian, Scotland; [Comley, Laura H.; Wishart, Thomas M.; Baxter, Becki; Murray, Lyndsay M.; Nimmo, Ailish; Thomson, Derek; Parson, Simon H.; Gillingwater, Thomas H.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Lothian, Scotland	University of Edinburgh; University of Edinburgh	Comley, LH (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Lothian, Scotland.	T.Gillingwater@ed.ac.uk	Gillingwater, Thomas/G-2880-2011	Gillingwater, Thomas/0000-0002-0306-5577; wishart, thomas/0000-0002-1973-6654; Nimmo, Ailish/0000-0001-6044-5827; Parson, Simon/0000-0002-8848-8738	BBSRC; Anatomical Society of Great Britain Ireland; SMA Trust; Wellcome Trust	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Anatomical Society of Great Britain Ireland; SMA Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by funding from the BBSRC (LHC/THG), the Anatomical Society of Great Britain & Ireland (LMM/BB/SHP/THG), the SMA Trust (THG) and the Wellcome Trust (THG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Detrait ER, 2002, MOL THER, V5, P723, DOI 10.1006/mthe.2002.0609; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mi WQ, 2005, BRAIN, V128, P405, DOI 10.1093/brain/awh368; Murray LM, 2010, NEUROMUSCULAR DISORD, V20, P740, DOI 10.1016/j.nmd.2010.06.013; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Murray LM, 2008, J ANAT, V213, P633, DOI 10.1111/j.1469-7580.2008.01007.x; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Wishart TM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r101; Wright AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015108; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	22	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17639	10.1371/journal.pone.0017639	http://dx.doi.org/10.1371/journal.pone.0017639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408118	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000049
J	Miller, SJ; Joshi, BP; Feng, Y; Gaustad, A; Fearon, ER; Wang, TD				Miller, Sharon J.; Joshi, Bishnu P.; Feng, Ying; Gaustad, Adam; Fearon, Eric R.; Wang, Thomas D.			In Vivo Fluorescence-Based Endoscopic Detection of Colon Dysplasia in the Mouse Using a Novel Peptide Probe	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; COLORECTAL-CANCER; PHAGE DISPLAY; BINDING PEPTIDE; UNITED-KINGDOM; FLAT ADENOMAS; MICE; SELECTION; LIBRARY; MODEL	Colorectal cancer (CRC) is a major cause of cancer-related deaths in much of the world. Most CRCs arise from pre-malignant (dysplastic) lesions, such as adenomatous polyps, and current endoscopic screening approaches with white light do not detect all dysplastic lesions. Thus, new strategies to identify such lesions, including non-polypoid lesions, are needed. We aim to identify and validate novel peptides that specifically target dysplastic colonic epithelium in vivo. We used phage display to identify a novel peptide that binds to dysplastic colonic mucosa in vivo in a genetically engineered mouse model of colo-rectal tumorigenesis, based on somatic Apc (adenomatous polyposis coli) gene inactivation. Binding was confirmed using confocal microscopy on biopsied adenomas and excised adenomas incubated with peptide ex vivo. Studies of mice where a mutant Kras allele was somatically activated in the colon to generate hyperplastic epithelium were also performed for comparison. Several rounds of in vivo T7 library biopanning isolated a peptide, QPIHPNNM. The fluorescent-labeled peptide bound to dysplastic lesions on endoscopic analysis. Quantitative assessment revealed the fluorescent-labeled peptide (target/background: 2.17 +/- 0.61) binds similar to 2-fold greater to the colonic adenomas when compared to the control peptide (target/background: 1.14 +/- 0.15), p < 0.01. The peptide did not bind to the non-dysplastic (hyperplastic) epithelium of the Kras mice. This work is first to image fluorescence-labeled peptide binding in vivo that is specific towards colonic dysplasia on wide-area surveillance. This finding highlights an innovative strategy for targeted detection to localize premalignant lesions that can be generalized to the epithelium of hollow organs.	[Miller, Sharon J.; Joshi, Bishnu P.; Feng, Ying; Fearon, Eric R.; Wang, Thomas D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gaustad, Adam; Wang, Thomas D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Fearon, Eric R.; Wang, Thomas D.] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Miller, SJ (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	thomaswa@umich.edu		Miller, Sharon/0000-0002-1768-5945	National Institutes of Health (NIH) [U54 CA13642, P50 CA93990, R01 CA142750, P30 DK34933, R01 CA082223]; Department of Defense (DOD) [W81XWH-09-2-0014]; NATIONAL CANCER INSTITUTE [P50CA093990, U54CA136429, R01CA142750, R01CA082223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge funding support from National Institutes of Health (NIH) U54 CA13642, P50 CA93990, R01 CA142750, P30 DK34933 (pilot award), R01 CA082223, and the Department of Defense (DOD) Award W81XWH-09-2-0014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol A, 2008, NAT METHODS, V5, P231, DOI 10.1038/NMETH.1182; Alencar H, 2007, RADIOLOGY, V244, P232, DOI 10.1148/radiol.2441052114; American Cancer Society (ACS), CANC FACTS FIG; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Brammer LA, 2008, ANAL BIOCHEM, V373, P88, DOI 10.1016/j.ab.2007.10.015; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Deo S, 2000, J AM CHEM SOC, V122, P174, DOI 10.1021/ja992238x; Essler M, 2002, P NATL ACAD SCI USA, V99, P2252, DOI 10.1073/pnas.251687998; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fujii T, 1998, ENDOSCOPY, V30, P437, DOI 10.1055/s-2007-1001304; Gualco Gabriela, 2006, Ann Diagn Pathol, V10, P333, DOI 10.1016/j.anndiagpath.2006.03.003; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hart AR, 1998, GUT, V43, P229, DOI 10.1136/gut.43.2.229; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Hurlstone DP, 2003, AM J GASTROENTEROL, V98, P2543, DOI 10.1016/S0002-9270(03)00664-6; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Joshi BP, 2007, BIOORG MED CHEM LETT, V17, P6425, DOI 10.1016/j.bmcl.2007.10.008; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Judge Thomas A, 2002, Gastrointest Endosc Clin N Am, V12, P495, DOI 10.1016/S1052-5157(02)00014-4; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kelly KA, 2003, NEOPLASIA, V5, P437, DOI 10.1016/S1476-5586(03)80046-5; Kelly KA, 2006, NEOPLASIA, V8, P1011, DOI 10.1593/neo.06610; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Kubo N, 2008, J DRUG TARGET, V16, P396, DOI [10.1080/10611860802088796, 10.1080/10611860802088796 ]; Lee SM, 2007, MOL CANCER RES, V5, P11, DOI 10.1158/1541-7786.MCR-06-0069; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Li M, 2010, GASTROENTEROLOGY, V139, P1472, DOI 10.1053/j.gastro.2010.07.007; Lin HY, 2006, FASEB J, V20, P1742, DOI 10.1096/fj.06-5743fje; Ludtke JJ, 2007, DRUG DELIV, V14, P357, DOI 10.1080/10717540601098765; Mandava S, 2004, PROTEOMICS, V4, P1439, DOI 10.1002/pmic.200300680; McGuire MJ, 2004, J MOL BIOL, V342, P171, DOI 10.1016/j.jmb.2004.06.029; Newton JR, 2006, NEOPLASIA, V8, P772, DOI 10.1593/neo.06331; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Rasmussen UB, 2002, CANCER GENE THER, V9, P606, DOI 10.1038/sj.cgt.7700476; Ruoslahti E, 2005, CURR PHARM DESIGN, V11, P3655, DOI 10.2174/138161205774580787; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Walkup GK, 1997, J AM CHEM SOC, V119, P3443, DOI 10.1021/ja9642121; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zhang YD, 2007, J BIOMOL SCREEN, V12, P429, DOI 10.1177/1087057106299164; Zou J, 2004, MOL BIOL REP, V31, P121, DOI 10.1023/B:MOLE.0000031459.14448.af; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	52	63	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17384	10.1371/journal.pone.0017384	http://dx.doi.org/10.1371/journal.pone.0017384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408169	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000027
J	Ferte, C; Soria, JC; Penel, N				Ferte, Charles; Soria, Jean-Charles; Penel, Nicolas			Dose-Levels and First Signs of Efficacy in Contemporary Oncology Phase 1 Clinical Trials	PLOS ONE			English	Article							AGENTS; INHIBITOR; ANTITUMOR; DESIGN; ESCALATION; SORAFENIB; THERAPY	Purpose: Phase 1 trials play a crucial role in oncology by translating laboratory science into efficient therapies. Molecular targeted agents (MTA) differ from traditional cytotoxics in terms of both efficacy and toxicity profiles. Recent reports suggest that higher doses are not essential to produce the optimal anti-tumor effect. This study aimed to assess if MTA could achieve clinical benefit at much lower dose than traditional cytotoxics in dose seeking phase 1 trials. Patients and Methods: We reviewed 317 recent phase 1 oncology trials reported in the literature between January 1997 and January 2009. First sign of efficacy, maximum tolerated dose (MTD) and their associated dose level were recorded in each trial. Results: Trials investigating conventional cytotoxics alone, MTA alone and combination of both represented respectively 63.0% (201/317), 23.3% (74/317) and 13.7% (42/317) of all trials. The MTD was reached in 65.9% (209/317) of all trials and was mostly observed at the fifth dose level. First sign of efficacy was less frequently observed at the first three dose-levels for MTA as compared to conventional cytotoxics or combinations regimens (48.3% versus 63.2% and 61.3%). Sign of efficacy was observed in the same proportion whatever the treatment type (73-82%). MTD was less frequently established in trials investigating MTA alone (51.3%) or combinations (42.8%) as compared to conventional cytotoxic agents (75.6%). Conclusion: First sign of efficacy was less frequently reported at the early dose-levels and MTD was less frequently reached in trials investigating molecular targeted therapy alone. Similar proportion of trials reported clinical benefit.	[Ferte, Charles; Penel, Nicolas] Ctr Oscar Lambret, Dept Cancerol Gen, F-59020 Lille, France; [Ferte, Charles; Soria, Jean-Charles] Inst Gustave Roussy, Dept Med, SITEP, Phase Unit 1, Villejuif, France; [Penel, Nicolas] Univ Lille 2, Equipe Accueil Sante Publ Epidemiol & Modelisat M, Lille, France	UNICANCER; Centre Oscar Lambret; UNICANCER; Gustave Roussy; Universite de Lille - ISITE; Universite de Lille	Ferte, C (corresponding author), Ctr Oscar Lambret, Dept Cancerol Gen, F-59020 Lille, France.	chferte@hotmail.com	Soria, Jean-Charles/F-3619-2014	PENEL, Nicolas/0000-0001-5243-1548				Azad NS, 2008, J CLIN ONCOL, V26, P3709, DOI 10.1200/JCO.2007.10.8332; Booth CM, 2008, EUR J CANCER, V44, P19, DOI 10.1016/j.ejca.2007.07.034; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; Dent SF, 1996, ANN ONCOL, V7, P561; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Gelmon KA, 1999, J NATL CANCER I, V91, P1281, DOI 10.1093/jnci/91.15.1281; George S, 2009, EUR J CANCER, V45, P1959, DOI 10.1016/j.ejca.2009.02.011; Gomez-Roca CA, 2009, J CLIN ONCOL, V27; Grunwald HW, 2007, CANCER INVEST, V25, P124, DOI 10.1080/07357900701225331; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; ITOH K, 1994, CANCER CHEMOTH PHARM, V34, P451, DOI 10.1007/BF00685653; Jain RK, 2010, CLIN CANCER RES, V16, P1289, DOI 10.1158/1078-0432.CCR-09-2684; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KERR DJ, 1994, ANN ONCOL, V5, pS67, DOI 10.1093/annonc/5.suppl_4.S67; Korn EL, 2001, J CLIN ONCOL, V19, P265, DOI 10.1200/JCO.2001.19.1.265; Kumar R, 2007, MOL CANCER THER, V6, P2012, DOI 10.1158/1535-7163.MCT-07-0193; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Liu GZ, 2009, EUR J CANCER, V45, P3098, DOI 10.1016/j.ejca.2009.09.007; Newsome BW, 2008, BRIT J CLIN PHARMACO, V66, P6, DOI 10.1111/j.1365-2125.2008.03187.x; Parulekar WR, 2004, JNCI-J NATL CANCER I, V96, P990, DOI 10.1093/jnci/djh182; Penel N, 2010, INVEST NEW DRUG, V28, P839, DOI 10.1007/s10637-009-9317-6; PENTA JS, 1992, CANCER CHEMOTH PHARM, V31, P247, DOI 10.1007/BF00685555; PENTA JS, 1979, CANCER CHEMOTH PHARM, V31, P247; Postel-Vinay S, 2009, BRIT J CANCER, V100, P1373, DOI 10.1038/sj.bjc.6605030; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Simon R, 1997, JNCI-J NATL CANCER I, V89, P1138, DOI 10.1093/jnci/89.15.1138; Stupp R, 1998, ANN ONCOL, V9, P1233, DOI 10.1023/A:1008495919071; VONHOFF DD, 1991, INVEST NEW DRUG, V9, P115, DOI 10.1007/BF00194562; Wadman M, 2006, NATURE, V440, P388, DOI 10.1038/440388a	29	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e16633	10.1371/journal.pone.0016633	http://dx.doi.org/10.1371/journal.pone.0016633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21415927	Green Published, gold, Green Submitted			2022-12-27	WOS:000287933300001
J	Goldson, AJ; Fairweather-Tait, SJ; Armah, CN; Bao, YP; Broadley, MR; Dainty, JR; Furniss, C; Hart, DJ; Teucher, B; Hurst, R				Goldson, Andrew J.; Fairweather-Tait, Susan J.; Armah, Charlotte N.; Bao, Yongping; Broadley, Martin R.; Dainty, Jack R.; Furniss, Caroline; Hart, David J.; Teucher, Birgit; Hurst, Rachel			Effects of Selenium Supplementation on Selenoprotein Gene Expression and Response to Influenza Vaccine Challenge: A Randomised Controlled Trial	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE ACTIVITY; MESSENGER-RNA LEVELS; CANCER-PREVENTION; THIOREDOXIN REDUCTASE; PROTEIN-BIOSYNTHESIS; HEALTHY-VOLUNTEERS; DIETARY SELENIUM; CHEMICAL FORM; ADULTS; PLASMA	Background: The uncertainty surrounding dietary requirements for selenium (Se) is partly due to limitations in biomarkers of Se status that are related to health outcomes. In this study we determined the effect of different doses and forms of Se on gene expression of selenoprotein S (SEPS1), selenoprotein W (SEPW1) and selenoprotein R (SEPR), and responses to an immune function challenge, influenza vaccine, were measured in order to identify functional markers of Se status. Methods and Findings: A 12 week human dietary intervention study was undertaken in 119 volunteers who received placebo, 50, 100 or 200 mu g/day Se-enriched yeast (Se-yeast) or meals containing unenriched or Se-enriched onions (50 mu g/day). Gene expression was quantified in RNA samples extracted from human peripheral blood mononuclear cells (PBMC's) using quantitative RT-PCR. There was a significant increase in SEPW1 mRNA in the Se-enriched onion group (50 mu g/day) compared with the unenriched onion group. SEPR and SEPW1 did not change significantly over the duration of the supplementation period in the control or Se-yeast groups, except at week 10 when SEPW1 mRNA levels were significantly lower in the 200 mg/day Se-yeast group compared to the placebo group. Levels of SEPS1 mRNA increased significantly 7 days after the influenza vaccine challenge, the magnitude of the increase in SEPS1 gene expression was dose-dependent, with a significantly greater response with higher Se supplementation. Conclusions: This novel finding provides preliminary evidence for a role of SEPS1 in the immune response, and further supports the relationship between Se status and immune function.	[Goldson, Andrew J.; Armah, Charlotte N.; Dainty, Jack R.; Furniss, Caroline; Hart, David J.; Teucher, Birgit] Inst Food Res, Norwich, Norfolk, England; [Fairweather-Tait, Susan J.; Bao, Yongping; Hurst, Rachel] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Broadley, Martin R.] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of East Anglia; University of Nottingham	Goldson, AJ (corresponding author), Inst Food Res, Norwich Res Pk, Norwich, Norfolk, England.	R.hurst1@uea.ac.uk	Bao, Yongping/A-6951-2010; Fairweather-Tait, Susan J/K-4251-2012; Broadley, Martin/AAW-4638-2021; Teucher, Birgit/J-6380-2015; broadley, martin r/E-9081-2011	Bao, Yongping/0000-0002-6425-0370; Broadley, Martin/0000-0003-3964-7226; broadley, martin r/0000-0003-3964-7226; Hurst, Rachel/0000-0001-8066-324X; Fairweather-Tait, Susan/0000-0002-1413-5569; Dainty, Jack/0000-0002-0056-1233	UK Food Standards Agency [NO5059]; Institute of Food Research; University of East Anglia	UK Food Standards Agency; Institute of Food Research; University of East Anglia	The study was funded by the UK Food Standards Agency (grant NO5059), the Institute of Food Research and the University of East Anglia. The Se-yeast supplements and placebo tablets were donated by Pharma Nord, Denmark, and the influenza vaccines were supplied by Masta Ltd, U.K. and Solvay, Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESSON B, 1994, BBA-PROTEIN STRUCT M, V1204, P243, DOI 10.1016/0167-4838(94)90014-0; Arab L, 2004, P NUTR SOC, V63, P167, DOI 10.1079/PNS2003325; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; BAO YP, 1995, ANAL BIOCHEM, V224, P395, DOI 10.1006/abio.1995.1056; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Bendich A, 2001, DIETARY REFERENCE IN, DOI [10.1016/s0899-9007(00)00596-7, DOI 10.1016/S0899-9007(00)00596-7]; Bleys J, 2008, ARCH INTERN MED, V168, P404, DOI 10.1001/archinternmed.2007.74; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broome CS, 2004, AM J CLIN NUTR, V80, P154; Brown KM, 2000, CLIN SCI, V98, P593, DOI 10.1042/CS19990276; Burk RF, 2006, CANCER EPIDEM BIOMAR, V15, P804, DOI 10.1158/1055-9965.EPI-05-0950; Burk RF, 2001, BIOFACTORS, V14, P107, DOI 10.1002/biof.5520140115; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Combs GF, 2001, NUTR CANCER, V40, P6, DOI 10.1207/S15327914NC401_4; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; DEAGEN JT, 1993, ANAL BIOCHEM, V208, P176, DOI 10.1006/abio.1993.1025; DRABKIN DL, 1949, AM J MED SCI, V217, P710; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Elsom R, 2006, BRIT J NUTR, V96, P980, DOI 10.1017/BJN20061893; Gao Y, 2006, CYTOKINE, V33, P246, DOI 10.1016/j.cyto.2006.02.005; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; Hawkes WC, 2008, BIOL TRACE ELEM RES, V122, P107, DOI 10.1007/s12011-007-8066-7; Hoffmann PR, 2008, MOL NUTR FOOD RES, V52, P1273, DOI 10.1002/mnfr.200700330; Hurst R, 2008, CANCER LETT, V269, P117, DOI 10.1016/j.canlet.2008.04.025; Hurst R, 2010, AM J CLIN NUTR, V91, P923, DOI 10.3945/ajcn.2009.28169; IP C, 1991, CANCER RES, V51, P595; Jeong DW, 2002, FEBS LETT, V517, P225, DOI 10.1016/S0014-5793(02)02628-5; Kibriya MG, 2007, TOXICOL LETT, V169, P162, DOI 10.1016/j.toxlet.2007.01.006; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kotrebai M, 2000, ANALYST, V125, P71, DOI 10.1039/a906320j; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kussmann M, 2006, J BIOTECHNOL, V124, P758, DOI 10.1016/j.jbiotec.2006.02.014; Loseke S, 2003, J IMMUNOL METHODS, V276, P207, DOI 10.1016/S0022-1759(03)00072-3; MARMOT M, 2007, FOOD NUTR PHYS ACTIV, P109; NEVE J, 1995, J TRACE ELEM MED BIO, V9, P65, DOI 10.1016/S0946-672X(11)80013-1; NEVE J, 1988, AM J CLIN NUTR, V48, P139, DOI 10.1093/ajcn/48.1.139; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pagmantidis V, 2005, FEBS LETT, V579, P792, DOI 10.1016/j.febslet.2004.12.042; Pagmantidis V, 2008, AM J CLIN NUTR, V87, P181, DOI 10.1093/ajcn/87.1.181; Patching SG, 1999, J TRACE ELEM MED BIO, V13, P193, DOI 10.1016/S0946-672X(99)80037-6; R Development Core Team, R LANG ENV STAT COMP; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Rayman MP, 1997, BRIT MED J, V314, P387, DOI 10.1136/bmj.314.7078.387; Rooseboom M, 2002, CHEM-BIOL INTERACT, V140, P243, DOI 10.1016/S0009-2797(02)00039-X; *SDS, SDS US B, V2; Smith AD, 2002, METHOD ENZYMOL, V347, P113; Sunde RA, 2008, BRIT J NUTR, V99, pS37, DOI 10.1017/S0007114508006831; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; THOMSON CD, 1993, BRIT J NUTR, V69, P577, DOI 10.1079/BJN19930057; THOMSON CD, 1985, BIOCHEM INT, V10, P673; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xia YM, 2005, AM J CLIN NUTR, V81, P829, DOI 10.1093/ajcn/81.4.829; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	55	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e14771	10.1371/journal.pone.0014771	http://dx.doi.org/10.1371/journal.pone.0014771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445287	gold, Green Submitted, Green Published			2022-12-27	WOS:000288613300001
J	Yung, HW; Charnock-Jones, DS; Burton, GJ				Yung, Hong Wa; Charnock-Jones, D. Stephen; Burton, Graham J.			Regulation of AKT Phosphorylation at Ser473 and Thr308 by Endoplasmic Reticulum Stress Modulates Substrate Specificity in a Severity Dependent Manner	PLOS ONE			English	Article							PROTEIN-KINASE-B; RICTOR-MTOR COMPLEX; INDUCED APOPTOSIS; ACTIVATION; GRP78/BIP; CELLS; INSULIN; BINDING; ER; IDENTIFICATION	Endoplasmic reticulum (ER) stress is a common factor in the pathophysiology of diverse human diseases that are characterised by contrasting cellular behaviours, from proliferation in cancer to apoptosis in neurodegenerative disorders. Coincidently, dysregulation of AKT/PKB activity, which is the central regulator of cell growth, proliferation and survival, is often associated with the same diseases. Here, we demonstrate that ER stress modulates AKT substrate specificity in a severity-dependent manner, as shown by phospho-specific antibodies against known AKT targets. ER stress also reduces both total and phosphorylated AKT in a severity-dependent manner, without affecting activity of the upstream kinase PDK1. Normalisation to total AKT revealed that under ER stress phosphorylation of Thr308 is suppressed while that of Ser473 is increased. ER stress induces GRP78, and siRNA-mediated knock-down of GRP78 enhances phosphorylation at Ser473 by 3.6 fold, but not at Thr308. Substrate specificity is again altered. An in-situ proximity ligation assay revealed a physical interaction between GRP78 and AKT at the plasma membrane of cells following induction of ER stress. Staining was weak in cells with normal nuclear morphology but stronger in those displaying rounded, condensed nuclei. Co-immunoprecipitation of GRP78 and P-AKT(Ser473) confirmed the immuno-complex consists of non-phosphorylated AKT (Ser473 and Thr308). The interaction is likely specific as AKT did not bind to all molecular chaperones, and GRP78 did not bind to p70 S6 kinase. These findings provide one mechanistic explanation for how ER stress contributes to human pathologies demonstrating contrasting cell fates via modulation of AKT signalling.	[Yung, Hong Wa; Charnock-Jones, D. Stephen; Burton, Graham J.] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Charnock-Jones, D. Stephen] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Charnock-Jones, D. Stephen; Burton, Graham J.] Natl Inst Hlth Res, Cambridge Comprehens Biomed Res Ctr, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Yung, HW (corresponding author), Univ Cambridge, Ctr Trophoblast Res, Cambridge, England.	gjb2@cam.ac.uk	Charnock-Jones, D. Stephen/AAE-3391-2020; Charnock-Jones, D. Stephen/B-3743-2009	Charnock-Jones, D. Stephen/0000-0002-2936-4890; Charnock-Jones, D. Stephen/0000-0002-2936-4890	Wellcome Trust [084804/2/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (084804/2/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barati MT, 2006, J PROTEOME RES, V5, P1636, DOI 10.1021/pr0502469; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; LIN Y, 2010, LUNG CANC; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Merrick BA, 1996, BBA-PROTEIN STRUCT M, V1297, P57; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shu CV, 2008, J CELL PHYSIOL, V215, P627, DOI 10.1002/jcp.21340; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com; ZHANG Y, 2010, J BIOL CHEM; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	39	114	115	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17894	10.1371/journal.pone.0017894	http://dx.doi.org/10.1371/journal.pone.0017894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445305	gold, Green Published, Green Submitted			2022-12-27	WOS:000288613300020
J	Chen, SP; Fuh, JL; Wang, SJ; Tsai, SJ; Hong, CJ; Yang, AC				Chen, Shih-Pin; Fuh, Jong-Ling; Wang, Shuu-Jiun; Tsai, Shih-Jen; Hong, Chen-Jee; Yang, Albert C.			Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism Modulates Reversible Cerebral Vasoconstriction Syndromes	PLOS ONE			English	Article							BDNF; MEDIATOR	Background: Reversible cerebral vasoconstriction syndrome (RCVS) could be complicated by cerebral ischemic events. Hypothetical mechanisms of RCVS involve endothelial dysfunction and sympathetic overactivity, both of which were reported to be related to brain-derived neurotrophic factor (BDNF). The study investigated the association between functional BDNF Val66Met polymorphism and RCVS. Methods: Patients with RCVS and controls were prospectively recruited and genotyped for the BDNF Val66Met polymorphism. Magnetic resonance angiography (MRA) and transcranial color-coded Doppler sonography were employed to evaluate cerebral vasoconstriction. Genotyping results, clinical parameters, vasoconstriction scores, mean flow velocities of the middle cerebral artery (V-MCA), and Lindegaard indices were analyzed. Split-sample approach was employed to internally validate the data. Principal Findings: Ninety Taiwanese patients with RCVS and 180 age-and gender-matched normal controls of the same ethnicity completed the study. The genotype frequencies did not differ between patients and controls. Compared to patients with Met/Met homozygosity, patients with Val allele had higher mean vasoconstriction scores of all arterial segments (1.60 +/- 0.72 vs. 0.87 +/- 0.39, p < 0.001), V-MCA values (116.7 +/- 36.2 vs. 82.7 +/- 17.9 cm/s, p < 0.001), and LI (2.41 +/- 0.91 vs. 1.89 +/- 0.41, p = 0.001). None of the Met/Met homozygotes, but 38.9% of the Val carriers, had V-MCA values of > 120 cm/s (p < 0.001). Split-sample validation by randomization, age, entry time or residence of patients demonstrated concordant findings. Conclusions: Our findings link BDNF Val66Met polymorphism with the severity of RCVS for the first time and implicate possible pathogenic mechanisms for vasoconstriction in RCVS.	[Chen, Shih-Pin; Fuh, Jong-Ling; Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Chen, Shih-Pin; Fuh, Jong-Ling; Wang, Shuu-Jiun; Tsai, Shih-Jen; Hong, Chen-Jee; Yang, Albert C.] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Tsai, Shih-Jen; Hong, Chen-Jee] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wang, SJ (corresponding author), Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.	sjwang@vghtpe.gov.tw	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Fuh, Jong-Ling/0000-0001-9135-3351; Yang, Albert Chih-Chieh/0000-0003-2794-9649; Wang, Shuu-Jiun/0000-0001-5179-5358	National Science Council of Taiwan [97-2628-B-010-007-MY3]; Taipei Veterans General Hospital [V98C1-143, V99B1-002]; Ministry of Education	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education	This study was supported in part by grants from the National Science Council of Taiwan (97-2628-B-010-007-MY3 to S-JW), Taipei Veterans General Hospital (V98C1-143 to S-JW and V99B1-002 to S-PC), and Ministry of Education (Aim for the Top University Plan to S-JW). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-00007; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen SP, 2006, NEUROLOGY, V67, P2164, DOI 10.1212/01.wnl.0000249115.63436.6d; Chen SP, 2008, ANN NEUROL, V63, P751, DOI 10.1002/ana.21384; Chen SP, 2010, ANN NEUROL, V67, P648, DOI 10.1002/ana.21951; CROLL SD, 1994, EUR J NEUROSCI, V6, P1343, DOI 10.1111/j.1460-9568.1994.tb00325.x; Dodick DW, 2002, J NEUROL NEUROSUR PS, V72, P6, DOI 10.1136/jnnp.72.1.6; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Hong CJ, 2003, NEUROSCI LETT, V349, P206, DOI 10.1016/S0304-3940(03)00828-0; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jiang H, 2009, CLIN CHIM ACTA, V400, P3, DOI 10.1016/j.cca.2008.10.017; Kasselman LJ, 2006, J NEUROIMMUNOL, V175, P118, DOI 10.1016/j.jneuroim.2006.03.008; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kumar S, 2010, NEUROLOGY, V74, P893, DOI 10.1212/WNL.0b013e3181d55efa; Luo KR, 2010, PROG NEURO-PSYCHOPH, V34, P1433, DOI 10.1016/j.pnpbp.2010.07.033; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; PICARD RR, 1990, AM STAT, V44, P140, DOI 10.2307/2684155; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Slonimsky JD, 2003, MOL CELL NEUROSCI, V23, P648, DOI 10.1016/S1044-7431(03)00102-7; Springer J, 2004, REGUL PEPTIDES, V118, P19, DOI 10.1016/j.regpep.2003.10.020; Terracciano A, 2010, GENES BRAIN BEHAV, V9, P512, DOI 10.1111/j.1601-183X.2010.00579.x; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853; Zukowska Z, 2003, CAN J PHYSIOL PHARM, V81, P89, DOI 10.1139/Y03-006	27	38	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18024	10.1371/journal.pone.0018024	http://dx.doi.org/10.1371/journal.pone.0018024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437208	gold, Green Published, Green Submitted			2022-12-27	WOS:000288545100062
J	Dang, X; Bialasiewicz, S; Nissen, MD; Sloots, TP; Koralnik, IJ; Tan, CS				Dang, Xin; Bialasiewicz, Seweryn; Nissen, Michael D.; Sloots, Theo P.; Koralnik, Igor J.; Tan, Chen S.			Infrequent Detection of KI, WU and MC Polyomaviruses in Immunosuppressed Individuals with or without Progressive Multifocal Leukoencephalopathy	PLOS ONE			English	Article							MERKEL CELL-CARCINOMA; ASYMPTOMATIC REACTIVATION; CEREBROSPINAL-FLUID; JC VIRUS; NATALIZUMAB; INFECTION; ADULTS; BK	Conflicting prevalence of newly identified KI(KIPyV), WU(WUPyV) and Merkel Cell Carcinoma(MCPyV) polyomaviruses have been reported in progressive multifocal leukoencephalopathy(PML) patient samples, ranging from 0 to 14.3%. We analyzed the prevalence of these polyomaviruses in cerebrospinal fluid(CSF), peripheral blood mononuclear cells(PBMC), and bone marrow samples from PML patients, immunosuppressed individuals with or without HIV, and multiple sclerosis(MS) patients. Distinct PCR tests for KIPyV, WUPyV and MCPyV DNA performed in two independent laboratories detected low levels of MCPyV DNA only in 1/269 samples. The infrequent detections of these viruses in multiple samples from immunosuppressed individuals including those with PML suggest that their reactivation mechanisms may be different from that of JC polyomavirus (JCPyV) and that they do not play a role in the pathogenesis of PML.	[Dang, Xin; Koralnik, Igor J.; Tan, Chen S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Dang, Xin; Koralnik, Igor J.; Tan, Chen S.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div NeuroVirol, Boston, MA 02215 USA; [Bialasiewicz, Seweryn; Nissen, Michael D.; Sloots, Theo P.] Sir Albert Sakzewski Virus Res Ctr, Queensland Pediat Infect Dis Lab, Brisbane, Qld, Australia; [Bialasiewicz, Seweryn; Nissen, Michael D.; Sloots, Theo P.] Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Tan, Chen S.] Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Dang, X (corresponding author), Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	ctan@bidmc.harvard.edu	Sloots, Theo P/E-6118-2011; Nissen, Michael D/M-6823-2013; Bialasiewicz, Seweryn/F-1414-2010	Nissen, Michael D/0000-0003-1686-3313; Bialasiewicz, Seweryn/0000-0001-9474-6943	Public Health Service [R01 NS 047029, R01 NS 041198, K24 NS 060950]; Harvard Medical School Center for AIDS Research (CFAR), National Institutes of Health [P30 AI60354]; Queensland Children's Medical Research Institute [50006]; NIH [K08 NS 064215-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047029, R01NS041198, K24NS060950, K08NS064215] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Harvard Medical School Center for AIDS Research (CFAR), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Queensland Children's Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support was provided by Public Health Service R01 NS 047029, R01 NS 041198, K24 NS 060950 to I.J.K. The Harvard Medical School Center for AIDS Research (CFAR), a National Institutes of Health-funded program (P30 AI60354), NIH K08 NS 064215-01A1 to CST, and Queensland Children's Medical Research Institute Program Grant 50006 to M.D.N. and T. P. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Babakir-Mina M, 2010, EMERG INFECT DIS, V16, P1482, DOI 10.3201/eid1609.100211; Barzon L, 2009, J INFECT DIS, V200, P1755, DOI 10.1086/648095; Barzon L, 2009, J INFECT DIS, V200, P314, DOI 10.1086/599842; Barzon L, 2009, J CLIN VIROL, V45, P370, DOI 10.1016/j.jcv.2009.05.026; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; Bialasiewicz S, 2009, J CLIN VIROL, V45, P249, DOI 10.1016/j.jcv.2009.05.002; Chen YP, 2009, NEW ENGL J MED, V361, P1067, DOI 10.1056/NEJMoa0904267; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Focosi D, 2009, J CLIN VIROL, V45, P161, DOI 10.1016/j.jcv.2009.04.009; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gorelik L, 2009, NEW ENGL J MED, V361, P2487, DOI 10.1056/NEJMc0909622; Lam WY, 2010, J CLIN VIROL, V48, P11, DOI 10.1016/j.jcv.2010.01.017; Maggi F, 2010, J INFECT DIS, V201, P1276, DOI 10.1086/651379; Miller MA, 2009, EMERG INFECT DIS, V15, P1095, DOI 10.3201/eid1507.090150; Nguyen NL, 2009, EMERG INFECT DIS, V15, P1199, DOI 10.3201/eid1508.090270; Norja P, 2007, J CLIN VIROL, V40, P307, DOI 10.1016/j.jcv.2007.09.008; Sharp CP, 2009, J INFECT DIS, V199, P398, DOI 10.1086/596062	18	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e16736	10.1371/journal.pone.0016736	http://dx.doi.org/10.1371/journal.pone.0016736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436884	Green Published, Green Submitted, gold			2022-12-27	WOS:000288514000001
J	Chen, C; Dow, C; Wang, P; Sidney, J; Read, A; Harmsen, A; Samuel, JE; Peters, B				Chen, Chen; Dow, Courtney; Wang, Peng; Sidney, John; Read, Amanda; Harmsen, Allen; Samuel, James E.; Peters, Bjoern			Identification of CD4(+) T Cell Epitopes in C-burnetii Antigens Targeted by Antibody Responses	PLOS ONE			English	Article							NODE B-CELLS; Q-FEVER; GAMMA-INTERFERON; DENDRITIC CELLS; PHASE-I; VACCINE PROPHYLAXIS; PROTEIN MICROARRAY; IMMUNE-COMPLEXES; MICE; INFECTION	Coxiella burnetii is an obligate intracellular Gram-negative bacterium that causes acute Q fever and chronic infections in humans. A killed, whole cell vaccine is efficacious, but vaccination can result in severe local or systemic adverse reactions. Although T cell responses are considered pivotal for vaccine derived protective immunity, the epitope targets of CD4(+) T cell responses in C. burnetii vaccination have not been elucidated. Since mapping CD4(+) epitopes in a genome with over 2,000 ORFs is resource intensive, we focused on 7 antigens that were known to be targeted by antibody responses. 117 candidate peptides were selected from these antigens based on bioinformatics predictions of binding to the murine MHC class II molecule H-2IA(b). We screened these peptides for recognition by IFN-gamma producing CD4(+) T cell in phase I C. burnetii whole cell vaccine (PI-WCV) vaccinated C57BL/6 mice and identified 8 distinct epitopes from four different proteins. The identified epitope targets account for 8% of the total vaccination induced IFN-gamma producing CD4(+) T cells. Given that less than 0.4% of the antigens contained in C. burnetii were screened, this suggests that prioritizing antigens targeted by antibody responses is an efficient strategy to identify at least a subset of CD4(+) targets in large pathogens. Finally, we examined the nature of linkage between CD4(+) T cell and antibody responses in PI-WCV vaccinated mice. We found a surprisingly non-uniform pattern in the help provided by epitope specific CD4(+) T cells for antibody production, which can be specific for the epitope source antigen as well as non-specific. This suggests that a complete map of CD4(+) response targets in PI-WCV vaccinated mice will likely include antigens against which no antibody responses are made.	[Chen, Chen; Samuel, James E.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX 77840 USA; [Dow, Courtney; Wang, Peng; Sidney, John; Peters, Bjoern] La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA USA; [Read, Amanda; Harmsen, Allen] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; La Jolla Institute for Immunology; Montana State University System; Montana State University Bozeman	Chen, C (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX 77840 USA.	bpeters@liai.org		Chen, Chen/0000-0003-3862-062X	PSWRCE [U54 AI065359]; NIH [RO1A1057768, U54 AIO65359, U54 AI057156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, U54AI065359] Funding Source: NIH RePORTER	PSWRCE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	study was supported by PSWRCE grant U54 AI065359 to BP, and NIH RO1A1057768, U54 AIO65359, U54 AI057156 to JES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLAND JR, 1994, MED J AUSTRALIA, V160, P704, DOI 10.5694/j.1326-5377.1994.tb125909.x; Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Beare PA, 2008, CLIN VACCINE IMMUNOL, V15, P1771, DOI 10.1128/CVI.00300-08; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Brennan RE, 2004, INFECT IMMUN, V72, P6666, DOI 10.1128/IAI.72.11.6666-6675.2004; BRETT SJ, 1989, EUR J IMMUNOL, V19, P1303, DOI 10.1002/eji.1830190723; Bynoe MS, 2005, P NATL ACAD SCI USA, V102, P2898, DOI 10.1073/pnas.0409880102; Chen C, 2009, CLIN MICROBIOL INFEC; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Cookson BT, 1997, J IMMUNOL, V158, P4310; Darrah PA, 2007, NAT MED ADV ONLINE P; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; HENDRIX LR, 1990, ANN NY ACAD SCI, V590, P534, DOI 10.1111/j.1749-6632.1990.tb42263.x; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; KAZAR J, 1977, ACTA VIROL, V21, P422; KAZAR J, 1986, ACTA VIROL, V30, P499; LAKE P, 1976, IMMUNOL COMMUN, V5, P795, DOI 10.3109/08820137609047620; MARMION BP, 1984, LANCET, V2, P1411; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; Morisawa Y, 2001, PEDIATR INFECT DIS J, V20, P546, DOI 10.1097/00006454-200105000-00018; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Murphey C, 2006, CELL IMMUNOL, V242, P110, DOI 10.1016/j.cellimm.2006.10.002; NOVAK M, 1992, ACTA VIROL, V36, P39; ORMSBEE RA, 1964, J IMMUNOL, V92, P404; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Richards KA, 2007, J VIROL, V81, P7608, DOI 10.1128/JVI.02834-06; Roshick C, 2006, INFECT IMMUN, V74, P225, DOI 10.1128/IAI.74.1.225-238.2006; RUSSELL SM, 1979, NATURE, V280, P147, DOI 10.1038/280147a0; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sidney J, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1803s31; Southwood S, 1998, J IMMUNOL, V160, P3363; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Varghees S, 2002, INFECT IMMUN, V70, P6741, DOI 10.1128/IAI.70.12.6741-6750.2002; Vigil A, 2010, PROTEOMICS, V10, P2259, DOI 10.1002/pmic.201000064; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wykes M, 1998, J IMMUNOL, V161, P1313; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang GQ, 2005, INFECT IMMUN, V73, P1561, DOI 10.1128/IAI.73.3.1561-1567.2005; Zhang GQ, 2004, INFECT IMMUN, V72, P844, DOI 10.1128/IAI.72.2.844-852.2004; Zhang GQ, 2003, ANN NY ACAD SCI, V990, P510, DOI 10.1111/j.1749-6632.2003.tb07420.x; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372	56	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17712	10.1371/journal.pone.0017712	http://dx.doi.org/10.1371/journal.pone.0017712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423609	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900016
J	Chouquet, A; Paidassi, H; Ling, WL; Frachet, P; Houen, G; Arlaud, GJ; Gaboriaud, C				Chouquet, Anne; Paidassi, Helena; Ling, Wai Li; Frachet, Philippe; Houen, Gunnar; Arlaud, Gerard J.; Gaboriaud, Christine			X-Ray Structure of the Human Calreticulin Globular Domain Reveals a Peptide-Binding Area and Suggests a Multi-Molecular Mechanism	PLOS ONE			English	Article							CHAPERONE FUNCTION; IDENTIFICATION; CELLS; MOLECULES; SYSTEM	In the endoplasmic reticulum, calreticulin acts as a chaperone and a Ca2+-signalling protein. At the cell surface, it mediates numerous important biological effects. The crystal structure of the human calreticulin globular domain was solved at 1.55 angstrom resolution. Interactions of the flexible N-terminal extension with the edge of the lectin site are consistently observed, revealing a hitherto unidentified peptide-binding site. A calreticulin molecular zipper, observed in all crystal lattices, could further extend this site by creating a binding cavity lined by hydrophobic residues. These data thus provide a first structural insight into the lectin-independent binding properties of calreticulin and suggest new working hypotheses, including that of a multi-molecular mechanism.	[Chouquet, Anne; Paidassi, Helena; Ling, Wai Li; Gaboriaud, Christine] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Frachet, Philippe] UJF Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Arlaud, Gerard J.] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Statens Serum Institut; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Chouquet, A (corresponding author), CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France.	christine.gaboriaud@ibs.fr	Ling, Wai Li W/F-9823-2012; Paidassi, Helena/M-5739-2014; frachet, philippe/Q-2869-2019; Frachet, philippe/C-3797-2018	Ling, Wai Li W/0000-0002-4264-5750; frachet, philippe/0000-0002-1658-3859; Frachet, philippe/0000-0002-1658-3859; gaboriaud, christine/0000-0001-5308-0516; Paidassi, Helena/0000-0001-9915-4365; Houen, Gunnar/0000-0002-5948-4156	CNRS, CEA, Grenoble Universite 1; National Research Agency [ANR-09-PIRI-0021]	CNRS, CEA, Grenoble Universite 1(French Atomic Energy CommissionCentre National de la Recherche Scientifique (CNRS)); National Research Agency(French National Research Agency (ANR))	Funding: This work was supporting by CNRS, CEA, Grenoble Universite 1 and by the National Research Agency grant ANR-09-PIRI-0021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bricogne G., 2009, BUSTER; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Martins I, 2010, ANN NY ACAD SCI, V1209, P77, DOI 10.1111/j.1749-6632.2010.05740.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Paidassi H, 2011, J MOL BIOL IN PRESS; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856	32	65	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17886	10.1371/journal.pone.0017886	http://dx.doi.org/10.1371/journal.pone.0017886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423620	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900040
J	Rojas, LA; Yanez, C; Gonzalez, M; Lobos, S; Smalla, K; Seeger, M				Rojas, Luis A.; Yanez, Carolina; Gonzalez, Myriam; Lobos, Soledad; Smalla, Kornelia; Seeger, Michael			Characterization of the Metabolically Modified Heavy Metal-Resistant Cupriavidus metallidurans Strain MSR33 Generated for Mercury Bioremediation	PLOS ONE			English	Article							PLASMID-BEARING STRAIN; ESCHERICHIA-COLI; ALCALIGENES-EUTROPHUS; WASTE-WATER; RALSTONIA-METALLIDURANS; IONIC MERCURY; BACTERIA; SOIL; GENES; REMOVAL	Background: Mercury-polluted environments are often contaminated with other heavy metals. Therefore, bacteria with resistance to several heavy metals may be useful for bioremediation. Cupriavidus metallidurans CH34 is a model heavy metal-resistant bacterium, but possesses a low resistance to mercury compounds. Methodology/Principal Findings: To improve inorganic and organic mercury resistance of strain CH34, the IncP-1 beta plasmid pTP6 that provides novel merB, merG genes and additional other mer genes was introduced into the bacterium by biparental mating. The transconjugant Cupriavidus metallidurans strain MSR33 was genetically and biochemically characterized. Strain MSR33 maintained stably the plasmid pTP6 over 70 generations under non-selective conditions. The organomercurial lyase protein MerB and the mercuric reductase MerA of strain MSR33 were synthesized in presence of Hg2+. The minimum inhibitory concentrations (mM) for strain MSR33 were: Hg2+, 0.12 and CH3Hg+, 0.08. The addition of Hg2+ (0.04 mM) at exponential phase had not an effect on the growth rate of strain MSR33. In contrast, after Hg2+ addition at exponential phase the parental strain CH34 showed an immediate cessation of cell growth. During exposure to Hg2+ no effects in the morphology of MSR33 cells were observed, whereas CH34 cells exposed to Hg2+ showed a fuzzy outer membrane. Bioremediation with strain MSR33 of two mercury-contaminated aqueous solutions was evaluated. Hg2+ (0.10 and 0.15 mM) was completely volatilized by strain MSR33 from the polluted waters in presence of thioglycolate (5 mM) after 2 h. Conclusions/Significance: A broad-spectrum mercury-resistant strain MSR33 was generated by incorporation of plasmid pTP6 that was directly isolated from the environment into C. metallidurans CH34. Strain MSR33 is capable to remove mercury from polluted waters. This is the first study to use an IncP-1 beta plasmid directly isolated from the environment, to generate a novel and stable bacterial strain useful for mercury bioremediation.	[Rojas, Luis A.; Yanez, Carolina; Gonzalez, Myriam; Seeger, Michael] Univ Tecn Federico Santa Mari, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile; [Rojas, Luis A.; Yanez, Carolina; Gonzalez, Myriam; Seeger, Michael] Univ Tecn Federico Santa Mari, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile; [Rojas, Luis A.; Lobos, Soledad] Univ Valparaiso, Lab Espectroscopia, Fac Farm, Valparaiso, Chile; [Smalla, Kornelia] Inst Epidemiol & Pathogen Diagnost, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Braunschweig, Germany	Universidad de Valparaiso; Julius Kuhn-Institut	Rojas, LA (corresponding author), Univ Tecn Federico Santa Mari, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile.	michael.seeger@usm.cl	Rojas, Luis/K-4679-2019; Seeger, Michael/B-3774-2012; Seeger, Michael/AFK-3436-2022; Smalla, Kornelia/H-4002-2011; Yáñez, Carolina/F-6114-2013	Rojas, Luis/0000-0001-6935-8711; Yáñez, Carolina/0000-0003-3969-2078	MIDEPLAN [MILENIO P04/007-F]; USM [130522, 130836, 130948]; FONDECYT (CONICYT) [1070507]; CONICYT-BMBF; Nucleus Millennium EMBA; USM; PIIC-2009-USM	MIDEPLAN; USM; FONDECYT (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-BMBF(Federal Ministry of Education & Research (BMBF)); Nucleus Millennium EMBA; USM; PIIC-2009-USM	M.S. gratefully acknowledges financial support from MILENIO P04/007-F (MIDEPLAN) (http://www.iniciativamilenio.cl), USM 130522, 130836, and 130948 (http://www.usm.cl), and FONDECYT 1070507 (CONICYT) (http://www.fondecyt.cl) grants. M.S. and K.S. gratefully acknowledge CONICYT-BMBF grant. L.A.R. gratefully acknowledges Nucleus Millennium EMBA, USM and PIIC-2009-USM fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shanab RAI, 2007, CHEMOSPHERE, V68, P360, DOI 10.1016/j.chemosphere.2006.12.051; Baldrian P, 2000, APPL ENVIRON MICROB, V66, P2471, DOI 10.1128/AEM.66.6.2471-2478.2000; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; BHRIAIN NNN, 1983, J BACTERIOL, V155, P690, DOI 10.1128/JB.155.2.690-703.1983; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Champier L, 2004, MOL MICROBIOL, V52, P1475, DOI 10.1111/j.1365-2958.2004.04071.x; CHANG JS, 1994, BIOTECHNOL BIOENG, V44, P999, DOI 10.1002/bit.260440817; Deckwer WD, 2004, ENVIRON SCI TECHNOL, V38, P1858, DOI 10.1021/es0300517; DON RH, 1981, J BACTERIOL, V145, P681, DOI 10.1128/JB.145.2.681-686.1981; Fatta D, 2007, J HAZARD MATER, V145, P169, DOI 10.1016/j.jhazmat.2006.11.009; FOX B, 1982, J BIOL CHEM, V257, P2498; HORN JM, 1994, APPL ENVIRON MICROB, V60, P357, DOI 10.1128/AEM.60.1.357-362.1994; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kiyono M, 1999, J BACTERIOL, V181, P726, DOI 10.1128/JB.181.3.726-730.1999; Kiyono M, 2009, FEBS LETT, V583, P1127, DOI 10.1016/j.febslet.2009.02.039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lejon DPH, 2007, FEMS MICROBIOL ECOL, V61, P424, DOI 10.1111/j.1574-6941.2007.00365.x; Liebert CA, 1997, APPL ENVIRON MICROB, V63, P1066, DOI 10.1128/AEM.63.3.1066-1076.1997; Saavedra JM, 2010, APPL MICROBIOL BIOT, V87, P1543, DOI 10.1007/s00253-010-2575-6; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; MISRA TK, 1992, PLASMID, V27, P4, DOI 10.1016/0147-619X(92)90002-R; Monchy S, 2007, J BACTERIOL, V189, P7417, DOI 10.1128/JB.00375-07; MOORE MJ, 1990, ACCOUNTS CHEM RES, V23, P301, DOI 10.1021/ar00177a006; Morgante V, 2010, FEMS MICROBIOL ECOL, V71, P114, DOI 10.1111/j.1574-6941.2009.00790.x; NAKAMURA K, 1988, APPL ENVIRON MICROB, V54, P2871, DOI 10.1128/AEM.54.11.2871-2873.1988; Nakamura K, 1999, BIODEGRADATION, V10, P443, DOI 10.1023/A:1008329511391; Nascimento Andrea M A, 2003, Genet Mol Res, V2, P92; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; NIES A, 1990, J BIOL CHEM, V265, P5648; Oehmen A, 2009, J HAZARD MATER, V165, P1040, DOI 10.1016/j.jhazmat.2008.10.094; Okino S, 2000, BIOTECHNOL LETT, V22, P783, DOI 10.1023/A:1005653825272; Permina EA, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-49; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; Pukall R, 1996, FEMS MICROBIOL ECOL, V20, P53, DOI 10.1016/0168-6496(96)00021-9; RAY S, 1989, J BIOSCIENCE, V14, P173, DOI 10.1007/BF02703169; RITTER JA, 1992, WATER SCI TECHNOL, V25, P165, DOI 10.2166/wst.1992.0089; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAOUTER E, 1995, J IND MICROBIOL, V14, P343, DOI 10.1007/BF01569949; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; SCHOTTEL JL, 1978, J BIOL CHEM, V253, P4341; SEEGER M, 1993, FEMS MICROBIOL LETT, V108, P35; Silver S, 2005, J IND MICROBIOL BIOT, V32, P587, DOI 10.1007/s10295-005-0019-6; Smalla K, 2006, APPL ENVIRON MICROB, V72, P7253, DOI 10.1128/AEM.00922-06; SUMMERS AO, 1974, J BACTERIOL, V119, P242, DOI 10.1128/JB.119.1.242-249.1974; TOP E, 1990, APPL ENVIRON MICROB, V56, P2471, DOI 10.1128/AEM.56.8.2471-2479.1990; VAITUZIS Z, 1975, APPL MICROBIOL, V29, P275, DOI 10.1128/AEM.29.2.275-286.1975; Valls M, 2002, FEMS MICROBIOL REV, V26, P327, DOI 10.1111/j.1574-6976.2002.tb00618.x; von Canstein H, 1999, APPL ENVIRON MICROB, V65, P5279; Wagner-Dobler I, 2003, APPL MICROBIOL BIOT, V62, P124, DOI 10.1007/s00253-003-1322-7; Yurieva O, 1997, MOL MICROBIOL, V24, P321, DOI 10.1046/j.1365-2958.1997.3261688.x	54	66	69	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17555	10.1371/journal.pone.0017555	http://dx.doi.org/10.1371/journal.pone.0017555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423734	gold, Green Submitted, Green Published			2022-12-27	WOS:000288512400015
J	Talsma, D; Sikkens, JJ; Theeuwes, J				Talsma, Durk; Sikkens, Jonne J.; Theeuwes, Jan			Stay Tuned: What Is Special About Not Shifting Attention?	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SHORT-TERM-MEMORY; TOP-DOWN CONTROL; SPATIAL ATTENTION; SELECTIVE ATTENTION; NEURAL MECHANISMS; VISUAL-ATTENTION; VISUOSPATIAL ATTENTION; DIRECTING ATTENTION; BRAIN POTENTIALS	Background: When studying attentional orienting processes, brain activity elicited by symbolic cue is usually compared to a neutral condition in which no information is provided about the upcoming target location. It is generally assumed that when a neutral cue is provided, participants do not shift their attention. The present study sought to validate this assumption. We further investigated whether anticipated task demands had an impact on brain activity related to processing symbolic cues. Methodology/Principal Findings: Two experiments were conducted, during which event-related potentials were elicited by symbolic cues that instructed participants to shift their attention to a particular location on a computer screen. In Experiment 1, attention shift-inducing cues were compared to non-informative cues, while in both conditions participants were required to detect target stimuli that were subsequently presented at peripheral locations. In Experiment 2, a non-ambiguous "stay-central'' cue that explicitly required participants not to shift their attention was used instead. In the latter case, target stimuli that followed a stay-central cue were also presented at a central location. Both experiments revealed enlarged early latency contralateral ERP components to shift-inducing cues compared to those elicited by either non-informative (exp. 1) or stay-central cues (exp. 2). In addition, cueing effects were modulated by the anticipated difficulty of the upcoming target, particularly so in Experiment 2. A positive difference, predominantly over the posterior contralateral scalp areas, could be observed for stay-central cues, especially for those predicting that the upcoming target would be easy. This effect was not present for non-informative cues. Conclusions/Significance: We interpret our result in terms of a more rapid engagement of attention occurring in the presence of a more predictive instruction (i.e. stay-central easy target). Our results indicate that the human brain is capable of very rapidly identifying the difference between different types of instructions.	[Talsma, Durk; Sikkens, Jonne J.; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Talsma, Durk] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Vrije Universiteit Amsterdam; Ghent University	Talsma, D (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	durktals@gmail.com	Theeuwes, Jan/B-6862-2008; Theeuwes, Jan/ABF-3771-2020; Talsma, Durk/A-6072-2009	Talsma, Durk/0000-0002-3435-2317; Sikkens, Jonne/0000-0001-5481-5596; Theeuwes, Jan/0000-0002-5849-7721	Human Frontier Science Program [HFSP-RGP39/2005]	Human Frontier Science Program(Human Frontier Science Program)	This research was funded by a grant from Human Frontier Science Program (HFSP-RGP39/2005) to Jan Theeuwes (http://www.hfsp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CORBETTA M, 1993, J NEUROSCI, V13, P1202; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; EIMER M, 1993, ELECTROEN CLIN NEURO, V88, P408, DOI 10.1016/0168-5597(93)90017-J; Eimer M, 2003, PSYCHOPHYSIOLOGY, V40, P924, DOI 10.1111/1469-8986.00110; Eimer M, 2002, PSYCHOPHYSIOLOGY, V39, P437, DOI 10.1017/S0048577201393162; Foxe JJ, 2005, EXP BRAIN RES, V166, P370, DOI 10.1007/s00221-005-2378-7; Gherri E, 2007, CLIN NEUROPHYSIOL, V118, P2031, DOI 10.1016/j.clinph.2007.06.003; Goldman-Rakic P. S., 1994, Society for Neuroscience Abstracts, V20, P808; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRATTON G, 1990, ELECTROEN CLIN NEURO, V75, P419, DOI 10.1016/0013-4694(90)90087-Z; Green JJ, 2008, PSYCHOPHYSIOLOGY, V45, P579, DOI 10.1111/j.1469-8986.2008.00657.x; Grent-'T-Jong T, 2007, PLOS BIOL, V5, P114, DOI 10.1371/journal.pbio.0050012; Gutchess AH, 2007, J COGNITIVE NEUROSCI, V19, P1089, DOI 10.1162/jocn.2007.19.7.1089; Harter M R, 1989, J Cogn Neurosci, V1, P223, DOI 10.1162/jocn.1989.1.3.223; Herrero JL, 2009, NEUROREPORT, V20, P652, DOI 10.1097/WNR.0b013e328329a431; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Jolicoeur P, 2008, BRAIN RES, V1215, P160, DOI 10.1016/j.brainres.2008.03.059; JONIDES J, 1984, PSYCHOL BULL, V96, P29, DOI 10.1037/0033-2909.96.1.29; KENEMANS JL, 1991, PSYCHOPHYSIOLOGY, V28, P114, DOI 10.1111/j.1469-8986.1991.tb03397.x; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Klaver P, 1999, NEUROREPORT, V10, P2001, DOI 10.1097/00001756-199907130-00002; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MANGUN GR, 1994, COGNITIVE ELECTROPHY; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Munneke J, 2008, BRAIN RES, V1222, P184, DOI 10.1016/j.brainres.2008.05.039; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Praamstra P, 2005, J NEUROPHYSIOL, V94, P764, DOI 10.1152/jn.01052.2004; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Ristic J, 2007, PSYCHON B REV, V14, P964, DOI 10.3758/BF03194129; Slagter HA, 2005, PSYCHOPHYSIOLOGY, V42, P428, DOI 10.1111/j.1469-8986.2005.00304.x; Slagter HA, 2005, COGNITIVE BRAIN RES, V22, P333, DOI 10.1016/j.cogbrainres.2004.09.005; Talsma D, 2005, COGNITIVE BRAIN RES, V25, P117, DOI 10.1016/j.cogbrainres.2005.04.013; Talsma D, 2002, PSYCHOPHYSIOLOGY, V39, P689, DOI 10.1017/S004857720200152X; Talsma D, 2008, PSYCHOPHYSIOLOGY, V45, P216, DOI 10.1111/j.1469-8986.2007.00612.x; Talsma D, 2007, BRAIN RES, V1178, P92, DOI 10.1016/j.brainres.2007.07.099; Talsma D, 2010, J COGNITIVE NEUROSCI, V22, P761, DOI 10.1162/jocn.2009.21223; Tipples J, 2002, PSYCHON B REV, V9, P314, DOI 10.3758/BF03196287; van der Lubbe RHJ, 2006, BRAIN RES, V1072, P133, DOI 10.1016/j.brainres.2005.11.087; Van der Stigchel S, 2006, BRAIN RES, V1105, P32, DOI 10.1016/j.brainres.2006.02.089; Van Velzen J, 2003, PSYCHOPHYSIOLOGY, V40, P827, DOI 10.1111/1469-8986.00083; VANBOXTEL GJM, 1994, BIOL PSYCHOL, V38, P37, DOI 10.1016/0301-0511(94)90048-5; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; Woodruff CC, 2006, NEUROPSYCHOLOGIA, V44, P3000, DOI 10.1016/j.neuropsychologia.2006.06.019; WRIGHT MJ, 1995, BIOL PSYCHOL, V41, P183, DOI 10.1016/0301-0511(95)05128-7	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e16829	10.1371/journal.pone.0016829	http://dx.doi.org/10.1371/journal.pone.0016829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736RS	21423733	gold, Green Published			2022-12-27	WOS:000288512400007
J	Gong, L; Cullinane, M; Treerat, P; Ramm, G; Prescott, M; Adler, B; Boyce, JD; Devenish, RJ				Gong, Lan; Cullinane, Meabh; Treerat, Puthayalai; Ramm, Georg; Prescott, Mark; Adler, Ben; Boyce, John D.; Devenish, Rodney J.			The Burkholderia pseudomallei Type III Secretion System and BopA Are Required for Evasion of LC3-Associated Phagocytosis	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; INTRACELLULAR SHIGELLA; INFECTED MACROPHAGES; AUTOPHAGIC PATHWAY; MELIOIDOSIS; SURVIVAL; ESCAPE; CELLS; HOST; VIRULENCE	Burkholderia pseudomallei is the causative agent of melioidosis, a fatal infectious disease endemic in tropical regions worldwide, and especially prevalent in southeast Asia and northern Australia. This intracellular pathogen can escape from phagosomes into the host cytoplasm, where it replicates and infects adjacent cells. We previously demonstrated that, in response to B. pseudomallei infection of macrophage cell line RAW 264.7, a subset of bacteria co-localized with the autophagy marker protein, microtubule-associated protein light chain 3 (LC3), implicating autophagy in host cell defence against infection. Recent reports have suggested that LC3 can be recruited to both phagosomes and autophagosomes, thereby raising questions regarding the identity of the LC3-positive compartments in which invading bacteria reside and the mechanism of the autophagic response to B. pseudomallei infection. Electron microscopy analysis of infected cells demonstrated that the invading bacteria were either free in the cytosol, or sequestered in single-membrane phagosomes rather than double-membrane autophagosomes, suggesting that LC3 is recruited to B. pseudomallei-containing phagosomes. Partial or complete loss of function of type III secretion system cluster 3 (TTSS3) in mutants lacking the BopA (effector) or BipD (translocator) proteins respectively, resulted in delayed or no escape from phagosomes. Consistent with these observations, bopA and bipD mutants both showed a higher level of co-localization with LC3 and the lysosomal marker LAMP1, and impaired survival in RAW264.7 cells, suggesting enhanced killing in phagolysosomes. We conclude that LC3 recruitment to phagosomes stimulates killing of B. pseudomallei trapped in phagosomes. Furthermore, BopA plays an important role in efficient escape of B. pseudomallei from phagosomes.	[Gong, Lan; Ramm, Georg; Prescott, Mark; Devenish, Rodney J.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Cullinane, Meabh; Treerat, Puthayalai; Adler, Ben; Boyce, John D.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Gong, Lan; Treerat, Puthayalai; Adler, Ben; Boyce, John D.; Devenish, Rodney J.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Gong, L (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	John.Boyce@monash.edu; Rod.Devenish@monash.edu	Boyce, John D/F-5058-2012; Gong, Lan/O-7886-2019; Gong, Lan/J-6368-2016	Boyce, John D/0000-0002-8614-3074; Gong, Lan/0000-0003-3136-1565; Gong, Lan/0000-0003-3136-1565; Ramm, Georg/0000-0003-3596-2288; Cullinane, Meabh/0000-0003-4947-1826	Australian Research Council; National Health and Medical Research Council, Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the Australian Research Council and the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Burtnick MN, 2008, INFECT IMMUN, V76, P2991, DOI 10.1128/IAI.00263-08; CALYOV EE, 2010, ANNU REV MICROBIOL, V64, P495; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng Allen C, 2003, Commun Dis Intell Q Rep, V27, P272; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; Cullinane M, 2008, AUTOPHAGY, V4, P744, DOI 10.4161/auto.6246; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dorn BR, 2002, CELL MICROBIOL, V4, P1, DOI 10.1046/j.1462-5822.2002.00164.x; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harley VS, 1998, MICROBIOS, V96, P71; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kayath CA, 2010, MICROBES INFECT, V12, P956, DOI 10.1016/j.micinf.2010.06.006; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Lerena MC, 2010, CELL MICROBIOL, V12, P10, DOI 10.1111/j.1462-5822.2009.01403.x; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2006, CURR OPIN MICROBIOL, V9, P62, DOI 10.1016/j.mib.2005.12.007; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pei JM, 2009, PROTEINS, V77, P413, DOI 10.1002/prot.22447; PRUKSACHARTVUTHI S, 1990, J MED MICROBIOL, V31, P109, DOI 10.1099/00222615-31-2-109; Rodrigues PH, 2008, FRONT BIOSCI-LANDMRK, V13, P178, DOI 10.2741/2668; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Tan KS, 2010, J IMMUNOL, V184, P5160, DOI 10.4049/jimmunol.0902663; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Yoshimori T, 2009, CURR TOP MICROBIOL, V335, P217, DOI 10.1007/978-3-642-00302-8_10	50	115	120	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17852	10.1371/journal.pone.0017852	http://dx.doi.org/10.1371/journal.pone.0017852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412437	gold, Green Published, Green Submitted			2022-12-27	WOS:000288247800035
J	Sacca, F; Puorro, G; Antenora, A; Marsili, A; Denaro, A; Piro, R; Sorrentino, P; Pane, C; Tessa, A; Morra, VB; Cocozza, S; De Michele, G; Santorelli, FM; Filla, A				Sacca, Francesco; Puorro, Giorgia; Antenora, Antonella; Marsili, Angela; Denaro, Alessandra; Piro, Raffaele; Sorrentino, Pierpaolo; Pane, Chiara; Tessa, Alessandra; Morra, Vincenzo Brescia; Cocozza, Sergio; De Michele, Giuseppe; Santorelli, Filippo M.; Filla, Alessandro			A Combined Nucleic Acid and Protein Analysis in Friedreich Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design	PLOS ONE			English	Article							REAL-TIME PCR; FRATAXIN PROTEIN; POINT MUTATIONS; ONSET; GENE; QUANTIFICATION; IMMUNOASSAY; PHENOTYPE; EXPANSION; CARRIERS	Background: Friedreich's ataxia (FRDA) is the most common hereditary ataxia among caucasians. The molecular defect in FRDA is the trinucleotide GAA expansion in the first intron of the FXN gene, which encodes frataxin. No studies have yet reported frataxin protein and mRNA levels in a large cohort of FRDA patients, carriers and controls. Methodology/Principal Findings: We enrolled 24 patients with classic FRDA phenotype (cFA), 6 late onset FRDA (LOFA), all homozygous for GAA expansion, 5 pFA cases who harbored the GAA expansion in compound heterozygosis with FXN point mutations (namely, p.I154F, c.482+3delA, p.R165P), 33 healthy expansion carriers, and 29 healthy controls. DNA was genotyped for GAA expansion, mRNA/FXN was quantified in real-time, and frataxin protein was measured using lateral-flow immunoassay in peripheral blood mononuclear cells (PBMCs). Mean residual levels of frataxin, compared to controls, were 35.8%, 65.6%, 33%, and 68.7% in cFA, LOFA, pFA and healthy carriers, respectively. Comparison of both cFA and pFA with controls resulted in 100% sensitivity and specificity, but there was overlap between LOFA, carriers and controls. Frataxin levels correlated inversely with GAA1 and GAA2 expansions, and directly with age at onset. Messenger RNA expression was reduced to 19.4% in cFA, 50.4% in LOFA, 52.7% in pFA, 53.0% in carriers, as compared to controls (p<0.0001). mRNA levels proved to be diagnostic when comparing cFA with controls resulting in 100% sensitivity and specificity. In cFA and LOFA patients mRNA levels correlated directly with protein levels and age at onset, and inversely with GAA1 and GAA2. Conclusion/Significance: We report the first explorative study on combined frataxin and mRNA levels in PBMCs from a cohort of FRDA patients, carriers and healthy individuals. Lateral-flow immunoassay differentiated cFA and pFA patients from controls, whereas determination of mRNA in q-PCR was sensitive and specific only in cFA.	[Sacca, Francesco; Puorro, Giorgia; Antenora, Antonella; Marsili, Angela; Denaro, Alessandra; Piro, Raffaele; Sorrentino, Pierpaolo; Pane, Chiara; Morra, Vincenzo Brescia; De Michele, Giuseppe; Filla, Alessandro] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Tessa, Alessandra; Santorelli, Filippo M.] IRCCS Stella Maris, Pisa, Italy; [Cocozza, Sergio] Univ Naples Federico II, Dept Cellular & Mol Biol, Naples, Italy	University of Naples Federico II; IRCCS Fondazione Stella Maris; University of Naples Federico II	Sacca, F (corresponding author), Univ Naples Federico II, Dept Neurol Sci, Naples, Italy.	francesco.sacca@unina.it	Sorrentino, Pierpaolo/K-4311-2018; Tessa, Alessandra/K-2325-2016; Santorelli, Filippo M/ABE-5124-2020; Tessa, Alessandra/AAA-4442-2021	Sorrentino, Pierpaolo/0000-0002-9556-9800; Tessa, Alessandra/0000-0002-1445-6434; Santorelli, Filippo M/0000-0002-1359-9062; Tessa, Alessandra/0000-0002-1445-6434; Sacca, Francesco/0000-0002-1323-6317; Pane, Chiara/0000-0002-3459-2644	"Associazione il Cuore in un Dono" Cardito, Napoli; "Associazione Italiana per la lotta alle Sindromi Atassiche (AISA) sez. Campania", Napoli; Fondazione Cassa di Risparmio di Livorno; Italian Ministry of Health	"Associazione il Cuore in un Dono" Cardito, Napoli; "Associazione Italiana per la lotta alle Sindromi Atassiche (AISA) sez. Campania", Napoli(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Livorno; Italian Ministry of Health(Ministry of Health, Italy)	The study was supported in part by "Associazione il Cuore in un Dono" Cardito, Napoli (to AF), "Associazione Italiana per la lotta alle Sindromi Atassiche (AISA) sez. Campania", Napoli (to AF) and grants from Fondazione Cassa di Risparmio di Livorno and the Italian Ministry of Health (to FMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Bhidayasiri R, 2005, ARCH NEUROL-CHICAGO, V62, P1865, DOI 10.1001/archneur.62.12.1865; BOEHM T, 2010, NEUROL SCI      0527; Boesch S, 2007, ANN NEUROL, V62, P521, DOI 10.1002/ana.21177; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cagnoli C, 2004, J MOL DIAGN, V6, P96, DOI 10.1016/S1525-1578(10)60496-5; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Michele G, 2000, NEUROLOGY, V54, P496, DOI 10.1212/WNL.54.2.496; DeMichele G, 1996, NEUROLOGY, V47, P1260, DOI 10.1212/WNL.47.5.1260; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; Filla A, 2000, MOVEMENT DISORD, V15, P1255, DOI 10.1002/1531-8257(200011)15:6<1255::AID-MDS1031>3.0.CO;2-C; GAKH O, 2010, J BIOL CHEM     1002; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; MONTERMINI V, 1997, ANN NEUROL, V41, P675; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Ragno M, 1997, NEUROLOGY, V49, P1617, DOI 10.1212/WNL.49.6.1617; Sacca F, 2011, MOVEMENT DISORD, V26, P739, DOI 10.1002/mds.23435; Sparaco M, 2009, J NEUROL SCI, V287, P111, DOI 10.1016/j.jns.2009.08.052; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Steinkellner H, 2010, ANAL CHIM ACTA, V659, P129, DOI 10.1016/j.aca.2009.11.036; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019	26	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17627	10.1371/journal.pone.0017627	http://dx.doi.org/10.1371/journal.pone.0017627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412413	Green Published, gold, Green Submitted			2022-12-27	WOS:000288247800019
J	O'Brien, KB; Morrison, TE; Dundore, DY; Heise, MT; Schultz-Cherry, S				O'Brien, Kevin B.; Morrison, Thomas E.; Dundore, David Y.; Heise, Mark T.; Schultz-Cherry, Stacey			A Protective Role for Complement C3 Protein during Pandemic 2009 H1N1 and H5N1 Influenza A Virus Infection	PLOS ONE			English	Article							NATURAL ANTIBODY; VIRAL-INFECTIONS; INNATE; PATHOGENESIS; REPLICATION; INHIBITION; RESPONSES; SYSTEM; MODEL	Highly pathogenic H5N1 influenza infections are associated with enhanced inflammatory and cytokine responses, severe lung damage, and an overall dysregulation of innate immunity. C3, a member of the complement system of serum proteins, is a major component of the innate immune and inflammatory responses. However, the role of this protein in the pathogenesis of H5N1 infection is unknown. Here we demonstrate that H5N1 influenza virus infected mice had increased levels of C5a and C3 activation byproducts as compared to mice infected with either seasonal or pandemic 2009 H1N1 influenza viruses. We hypothesized that the increased complement was associated with the enhanced disease associated with the H5N1 infection. However, studies in knockout mice demonstrated that C3 was required for protection from influenza infection, proper viral clearance, and associated with changes in cellular infiltration. These studies suggest that although the levels of complement activation may differ depending on the influenza virus subtype, complement is an important host defense mechanism.	[O'Brien, Kevin B.; Dundore, David Y.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [O'Brien, Kevin B.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Morrison, Thomas E.] Univ Colorado Denver, Dept Microbiol, Aurora, CO USA; [Heise, Mark T.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Heise, Mark T.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Heise, Mark T.] Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC USA	University of Wisconsin System; University of Wisconsin Madison; St Jude Children's Research Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	O'Brien, KB (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	stacey.schultz-cherry@stjude.org	Schultz-Cherry, Stacey/N-2506-2018		University of Wisconsin-Madison; NIH [AR047190, AI059049]; NIH NIAID [HHSN266200700005C]; American Lebanese Syrian Associated Charities (ALSAC); Howard Hughes Medical Institute; Sigma Xi; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047190] Funding Source: NIH RePORTER	University of Wisconsin-Madison; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sigma Xi; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Howard Hughes Medical Institute Gilliam Fellowship, an Advanced Opportunity Fellowship (AOF) from the University of Wisconsin-Madison, and a Sigma Xi Grants-in-Aid-of-Research grant to K. O'Brien, NIH grant AR047190 to M. T. Heise, and NIH AI059049, and in part by the NIH NIAID contract number HHSN266200700005C and the American Lebanese Syrian Associated Charities (ALSAC) to S. Schultz-Cherry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gonzalez SF, 2008, VACCINE, V26, pI86, DOI 10.1016/j.vaccine.2008.11.057; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; HIRSCH RL, 1980, J IMMUNOL, V124, P2507; HIRSCH RL, 1980, J INFECT DIS, V141, P212, DOI 10.1093/infdis/141.2.212; JANEWAY CAJ, COMPLEMENT SYSTEM IN; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Morrison TE, 2008, CURR DRUG TARGETS, V9, P165; Morrison TE, 2008, J VIROL, V82, P11263, DOI 10.1128/JVI.01352-08; Morrison TE, 2007, J VIROL, V81, P5132, DOI 10.1128/JVI.02799-06; Morton D B, 2000, ILAR J, V41, P80; Nakayama Y, 2009, J IMMUNOL, V183, P2921, DOI 10.4049/jimmunol.0801191; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richmond JY, 1993, BIOSAFETY MICROBIOLO, P26; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	39	75	76	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17377	10.1371/journal.pone.0017377	http://dx.doi.org/10.1371/journal.pone.0017377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408070	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900013
J	Gleason, C; Foley, RC; Singh, KB				Gleason, Cynthia; Foley, Rhonda C.; Singh, Karam B.			Mutant Analysis in Arabidopsis Provides Insight into the Molecular Mode of Action of the Auxinic Herbicide Dicamba	PLOS ONE			English	Article							CLEAVERS GALIUM-APARINE; BOX PROTEIN TIR1; RESISTANT MUTANTS; ROOT GRAVITROPISM; PLANT DEVELOPMENT; RESPONSIVE GENES; INDUCED ETHYLENE; ACID; FAMILY; EXPRESSION	Herbicides that mimic the natural auxin indole-3-acetic acid are widely used in weed control. One common auxin-like herbicide is dicamba, but despite its wide use, plant gene responses to dicamba have never been extensively studied. To further understand dicamba's mode of action, we utilized Arabidopsis auxin-insensitive mutants and compared their sensitivity to dicamba and the widely-studied auxinic herbicide 2,4-dichlorophenoxyacetic acid (2,4-D). The mutant axr4-2, which has disrupted auxin transport into cells, was resistant to 2,4-D but susceptible to dicamba. By comparing dicamba resistance in auxin signalling F-box receptor mutants (tir1-1, afb1, afb2, afb3, and afb5), only tir1-1 and afb5 were resistant to dicamba, and this resistance was additive in the double tir1-1/afb5 mutant. Interestingly, tir1-1 but not afb5 was resistant to 2,4-D. Whole genome analysis of dicamba-induced gene expression showed that 10 hours after application, dicamba stimulated many stress-responsive and signalling genes, including those involved in biosynthesis or signalling of auxin, ethylene, and abscisic acid (ABA), with TIR1 and AFB5 required for the dicamba-responsiveness of some genes. Research into dicamba-regulated gene expression and the selectivity of auxin receptors has provided molecular insight into dicamba-regulated signalling and could help in the development of novel herbicide resistance in crop plants.	[Gleason, Cynthia; Foley, Rhonda C.; Singh, Karam B.] CSIRO Plant Ind, Ctr Environm & Life Sci, Wembley, WA, Australia; [Singh, Karam B.] Univ Western Australia, Inst Agr, Crawley, WA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Gleason, C (corresponding author), CSIRO Plant Ind, Ctr Environm & Life Sci, Wembley, WA, Australia.	karam.singh@csiro.au	Foley, Rhonda C/G-6716-2012; Singh, Karam B/C-3235-2012; Singh, Karam B/A-7790-2008	Singh, Karam B/0000-0002-2777-7448; 	Commonwealth Scientific and Industrial Research Organisation (CSIRO); Grains Research and Development Corporation [CSP00061]	Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Grains Research and Development Corporation(Grains R&D Corp)	This work was supported by Commonwealth Scientific and Industrial Research Organisation (CSIRO). Grains Research and Development Corporation (http://www.grdc.com.au/, Grant number CSP00061) provided funding for the microarray related aspects of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Calderon-Villalobos LI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005546; Chen WQ, 1996, PLANT J, V10, P955, DOI 10.1046/j.1365-313X.1996.10060955.x; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Cranston HJ, 2001, WEED SCI, V49, P164, DOI 10.1614/0043-1745(2001)049[0164:DRIK]2.0.CO;2; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Delker C, 2008, PLANTA, V227, P929, DOI 10.1007/s00425-008-0710-8; Delker C, 2010, PLANT CELL, V22, P2184, DOI 10.1105/tpc.110.073957; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dharmasiri S, 2006, SCIENCE, V312, P1218, DOI 10.1126/science.1122847; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Foley RC, 2006, PLANT PHYSIOL, V142, P245, DOI 10.1104/pp.106.079509; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Grossmann K, 2003, J PLANT GROWTH REGUL, V22, P109, DOI 10.1007/s00344-003-0020-0; Grossmann K, 2000, TRENDS PLANT SCI, V5, P506, DOI 10.1016/S1360-1385(00)01791-X; Grossmann K, 2001, J EXP BOT, V52, P1811, DOI 10.1093/jexbot/52.362.1811; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hansen H, 2000, PLANT PHYSIOL, V124, P1437, DOI 10.1104/pp.124.3.1437; HEAP I, 2010, INT SURVEY HERBICIDE; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; HOBBIE L, 1995, PLANT J, V7, P211, DOI 10.1046/j.1365-313X.1995.7020211.x; JASIENIUK M, 1995, WEED SCI, V43, P192, DOI 10.1017/S0043174500081054; Kelley KB, 2007, PESTIC BIOCHEM PHYS, V89, P1, DOI 10.1016/j.pestbp.2007.04.002; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kern AJ, 2005, WEED SCI, V53, P139, DOI 10.1614/WS-04-090R; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Kraft M, 2007, J EXP BOT, V58, P1497, DOI 10.1093/jxb/erm011; Lee DJ, 2009, J EXP BOT, V60, P3935, DOI 10.1093/jxb/erp230; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Nandula VK, 2002, WEED TECHNOL, V16, P50, DOI 10.1614/0890-037X(2002)016[0050:ROKKSI]2.0.CO;2; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Perl-Treves R, 2004, MOL PLANT MICROBE IN, V17, P70, DOI 10.1094/MPMI.2004.17.1.70; Powles SB, 2008, PEST MANAG SCI, V64, P360, DOI 10.1002/ps.1525; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; Preston C, 2009, WEED SCI, V57, P43, DOI 10.1614/WS-08-098.1; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Pufky John, 2003, Functional & Integrative Genomics, V3, P135, DOI 10.1007/s10142-003-0093-7; Raghavan Chitra, 2006, Functional & Integrative Genomics, V6, P60, DOI 10.1007/s10142-005-0012-1; Raghavan Chitra, 2005, Functional & Integrative Genomics, V5, P4, DOI 10.1007/s10142-004-0119-9; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; SAPPL PG, 2009, PLANT J; Smyth G, 2005, LIMMA LINEAR MODELS; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Taylor IB, 2000, J EXP BOT, V51, P1563, DOI 10.1093/jexbot/51.350.1563; Thatcher LF, 2007, J BIOL CHEM, V282, P28915, DOI 10.1074/jbc.M702207200; Uquillas C, 2004, MOL PLANT MICROBE IN, V17, P34, DOI 10.1094/MPMI.2004.17.1.34; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Wei YD, 2000, PEST MANAG SCI, V56, P377, DOI 10.1002/(SICI)1526-4998(200005)56:5<377::AID-PS154>3.3.CO;2-D; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yamamoto M, 1999, J PLANT RES, V112, P391, DOI 10.1007/PL00013892; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	62	48	48	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17245	10.1371/journal.pone.0017245	http://dx.doi.org/10.1371/journal.pone.0017245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408147	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170000017
J	Rakovic, A; Grunewald, A; Kottwitz, J; Bruggemann, N; Pramstaller, PP; Lohmann, K; Klein, C				Rakovic, Aleksandar; Gruenewald, Anne; Kottwitz, Jan; Brueggemann, Norbert; Pramstaller, Peter P.; Lohmann, Katja; Klein, Christine			Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts	PLOS ONE			English	Article							COMPLEX I DEFICIENCY; MITOCHONDRIAL-FUNCTION; DISEASE; DROSOPHILA; MITOPHAGY; DEGRADATION; MORPHOLOGY; FUSION; PROTEASOME; MUTANTS	PINK1 and Parkin mutations cause recessive Parkinson's disease (PD). In Drosophila and SH-SY5Y cells, Parkin is recruited by PINK1 to damaged mitochondria, where it ubiquitinates Mitofusins and consequently promotes mitochondrial fission and mitophagy. Here, we investigated the impact of mutations in endogenous PINK1 and Parkin on the ubiquitination of mitochondrial fusion and fission factors and the mitochondrial network structure. Treating control fibroblasts with mitochondrial membrane potential (Delta psi) inhibitors or H(2)O(2) resulted in ubiquitination of Mfn1/2 but not of OPA1 or Fis1. Ubiquitination of Mitofusins through the PINK1/Parkin pathway was observed within 1 h of treatment. Upon combined inhibition of Delta psi and the ubiquitin proteasome system (UPS), no ubiquitination of Mitofusins was detected. Regarding morphological changes, we observed a trend towards increased mitochondrial branching in PD patient cells upon mitochondrial stress. For the first time in PD patient-derived cells, we demonstrate that mutations in PINK1 and Parkin impair ubiquitination of Mitofusins. In the presence of UPS inhibitors, ubiquitinated Mitofusin is deubiquitinated by the UPS but not degraded, suggesting that the UPS is involved in Mitofusin degradation.	[Rakovic, Aleksandar; Gruenewald, Anne; Kottwitz, Jan; Brueggemann, Norbert; Lohmann, Katja; Klein, Christine] Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany; [Pramstaller, Peter P.] European Acad, Inst Med Genet, Bolzano, Italy	University of Lubeck; European Academy of Bozen-Bolzano	Rakovic, A (corresponding author), Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany.	christine.klein@neuro.uni-luebeck.de	Klein, Christine/AGK-8003-2022; Grünewald, Anne/ABD-1255-2021; Pramstaller, Peter P/C-2357-2008	Grünewald, Anne/0000-0002-4179-2994; Pramstaller, Peter P/0000-0002-9831-8302; Kottwitz, Jan/0000-0002-2993-4312; Klein, Christine/0000-0003-2102-3431	Medical Faculty of the University of Lubeck; Volkswagen Foundation; Hermann and Lilly Schilling Foundation; German Research Foundation (DFG) [GR 3731/1-1]; Hilde Ulrichs Foundation for Parkinson's Disease Research; EU [EU-LSHB-CT-2006-037544]; German 'Bundesministerium fur Bildung und Forschung' (NGFN plus) [PNP-01GS08135-3]	Medical Faculty of the University of Lubeck; Volkswagen Foundation(Volkswagen); Hermann and Lilly Schilling Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Hilde Ulrichs Foundation for Parkinson's Disease Research; EU(European Commission); German 'Bundesministerium fur Bildung und Forschung' (NGFN plus)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Medical Faculty of the University of Lubeck [to A. G.], the Volkswagen Foundation [to C. K.], the Hermann and Lilly Schilling Foundation [to C. K.], the German Research Foundation (DFG) [GR 3731/1-1 to A. G.], the Hilde Ulrichs Foundation for Parkinson's Disease Research [to C. K.], the EU Grant GENEPARK [EU-LSHB-CT-2006-037544 to C. K.], and the German 'Bundesministerium fur Bildung und Forschung' (NGFN plus) [PNP-01GS08135-3 to C. K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 1997, BRAIN RES, V764, P167, DOI 10.1016/S0006-8993(97)00453-8; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; GEGG ME, 2010, HUM MOL GENET; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Grunewald A, 2007, NEUROGENETICS, V8, P103, DOI 10.1007/s10048-006-0072-y; Hedrich K, 2006, ARCH NEUROL-CHICAGO, V63, P833, DOI 10.1001/archneur.63.6.833; Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103; Kaiser P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-233; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LUTZ AK, 2009, J BIOL CHEM; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moro E, 2008, NEUROLOGY, V70, P1186, DOI 10.1212/01.wnl.0000307748.11216.03; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Piccoli C, 2008, J MED GENET, V45, P596, DOI 10.1136/jmg.2008.058628; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Verma R, 2005, METHOD ENZYMOL, V398, P391, DOI 10.1016/S0076-6879(05)98032-4; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	44	159	166	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16746	10.1371/journal.pone.0016746	http://dx.doi.org/10.1371/journal.pone.0016746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408142	gold, Green Published, Green Submitted			2022-12-27	WOS:000288170000007
J	Hoff, DR; Ryan, GJ; Driver, ER; Ssemakulu, CC; De Groote, MA; Basaraba, RJ; Lenaerts, AJ				Hoff, Donald R.; Ryan, Gavin J.; Driver, Emily R.; Ssemakulu, Cornelius C.; De Groote, Mary A.; Basaraba, Randall J.; Lenaerts, Anne J.			Location of Intra- and Extracellular M. tuberculosis Populations in Lungs of Mice and Guinea Pigs during Disease Progression and after Drug Treatment	PLOS ONE			English	Article							AEROSOL INFECTION MODEL; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; ZIEHL-NEELSEN; PULMONARY TUBERCULOSIS; IN-VITRO; GRANULOMAS; MOUSE; EXPRESSION; METRONIDAZOLE	The lengthy treatment regimen for tuberculosis is necessary to eradicate a small sub-population of M. tuberculosis that persists in certain host locations under drug pressure. Limited information is available on persisting bacilli and their location within the lung during disease progression and after drug treatment. Here we provide a comprehensive histopathological and microscopic evaluation to elucidate the location of bacterial populations in animal models for TB drug development. To detect bacilli in tissues, a new combination staining method was optimized using auramine O and rhodamine B for staining acid-fast bacilli, hematoxylin QS for staining tissue and DAPI for staining nuclei. Bacillary location was studied in three animal models used in-house for TB drug evaluations: C57BL/6 mice, immunocompromised GKO mice and guinea pigs. In both mouse models, the bacilli were found primarily intracellularly in inflammatory lesions at most stages of disease, except for late stage GKO mice, which showed significant necrosis and extracellular bacilli after 25 days of infection. This is also the time when hypoxia was initially visualized in GKO mice by 2-piminidazole. In guinea pigs, the majority of bacteria in lungs are extracellular organisms in necrotic lesions and only few, if any, were ever visualized in inflammatory lesions. Following drug treatment in mice a homogenous bacillary reduction across lung granulomas was observed, whereas in guinea pigs the remaining extracellular bacilli persisted in lesions with residual necrosis. In summary, differences in pathogenesis between animal models infected with M. tuberculosis result in various granulomatous lesion types, which affect the location, environment and state of bacilli. The majority of M. tuberculosis bacilli in an advanced disease state were found to be extracellular in necrotic lesions with an acellular rim of residual necrosis. Drug development should be designed to target this bacillary population and should evaluate drug regimens in the appropriate animal models.	[Hoff, Donald R.; Ryan, Gavin J.; Driver, Emily R.; De Groote, Mary A.; Basaraba, Randall J.; Lenaerts, Anne J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ssemakulu, Cornelius C.] CSIR, CSIR Biosci, ZA-0001 Pretoria, South Africa	Colorado State University; Council for Scientific & Industrial Research (CSIR) - South Africa	Hoff, DR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	lenaerts@colostate.edu	Lenaerts, Anne/F-1353-2017	Ssemakalu, Cornelius/0000-0003-3895-2018	National Institutes of Health (NIH) [RO-1 AI061505-01A1, NO1 AI-95385]; Colorado State University, Fort Collins; Southern Research Institute, Birmingham, AL [N01-AI-95364]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095385, R01AI061505, N01AI095364] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State University, Fort Collins; Southern Research Institute, Birmingham, AL; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health (NIH) grant RO-1 AI061505-01A1 and the NIH Contracts NO1 AI-95385 at Colorado State University, Fort Collins, and N01-AI-95364 at the Southern Research Institute, Birmingham, AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2009, J INFECT DIS, V200, P1136, DOI 10.1086/605605; Al-Moamary MS, 1999, CHEST, V116, P726, DOI 10.1378/chest.116.3.726; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P122; Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002; Basaraba RJ, 2006, INFECT IMMUN, V74, P5397, DOI 10.1128/IAI.00332-06; Bishal WR, 2000, LANCET, V356, P2113, DOI 10.1016/S0140-6736(00)03485-1; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brooks JV, 1998, ANTIMICROB AGENTS CH, V42, P3047, DOI 10.1128/AAC.42.11.3047; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; CANCELA MMG, 1993, J COMP PATHOL, V109, P361, DOI 10.1016/S0021-9975(08)80299-X; Canetti G., 1955, TUBERCLE BACILLUS PU; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona Pere-Joan, 2007, Inflammation & Allergy Drug Targets, V6, P27; Cegielski JP, 1997, J CLIN MICROBIOL, V35, P3254, DOI 10.1128/JCM.35.12.3254-3257.1997; Converse PJ, 1996, INFECT IMMUN, V64, P4776, DOI 10.1128/IAI.64.11.4776-4787.1996; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Davies GR, 2007, ANTIMICROB AGENTS CH, V51, P403, DOI 10.1128/AAC.01246-06; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Ehlers S, 2009, INFECTION, V37, P87, DOI 10.1007/s15010-009-8450-7; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Goel Madhu Mati, 2007, Indian J Tuberc, V54, P24; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hanscheid T, 2007, LANCET INFECT DIS, V7, P236, DOI 10.1016/S1473-3099(07)70058-0; Hoff DR, 2008, ANTIMICROB AGENTS CH, V52, P4137, DOI 10.1128/AAC.00196-08; Jayaram R, 2004, ANTIMICROB AGENTS CH, V48, P2951, DOI 10.1128/AAC.48.8.2951-2957.2004; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Jeyanathan M, 2006, J CLIN MICROBIOL, V44, P2942, DOI 10.1128/JCM.00585-06; JOHNSON CM, 2005, ANTIMICROB AGENTS CH; Kelly BP, 1996, ANTIMICROB AGENTS CH, V40, P2809, DOI 10.1128/AAC.40.12.2809; KOJIMA K, 1989, AM J CLIN PATHOL, V92, P57, DOI 10.1093/ajcp/92.1.57; Kraft SL, 2004, INFECT IMMUN, V72, P5963, DOI 10.1128/IAI.72.10.5963-5971.2004; Kumar N, 1998, CYTOPATHOLOGY, V9, P208, DOI 10.1046/j.1365-2303.1998.00057.x; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJM, 2003, ANTIMICROB AGENTS CH, V47, P783, DOI 10.1128/AAC.47.2.783-785.2003; Lenaerts AJ, 2008, TRENDS MICROBIOL, V16, P48, DOI 10.1016/j.tim.2007.12.002; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nikonenko Boris V, 2008, Recent Pat Antiinfect Drug Discov, V3, P102, DOI 10.2174/157489108784746579; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Nuermberger E, 2008, SEMIN RESP CRIT CARE, V29, P542, DOI 10.1055/s-0028-1085705; *OJHAAEA, 2008, MOL MICROBI IN PRESS; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; OSTER G, 1951, CR HEBD ACAD SCI, V232, P1708; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pratt R., 2008, Morbidity and Mortality Weekly Report, V57, P281; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; ROSENTHAL IM, 2005, AM J RESP CRIT CARE; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; SALFINGER M, 1994, EUR J CLIN MICROBIOL, V13, P961, DOI 10.1007/BF02111498; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Sissons J, 2009, GENES IMMUN, V10, P37, DOI 10.1038/gene.2008.68; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; Somoskovi A, 2001, CHEST, V120, P250, DOI 10.1378/chest.120.1.250; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Turner OC, 2003, GRANULOMATOUS INFECTIONS AND INFLAMMATIONS: CELLULAR AND MOLECULAR MECHANISMS, P65; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2005, J PATHOL, V205, P633, DOI 10.1002/path.1728; van der Zanden AGM, 1998, J CLIN PATHOL-MOL PA, V51, P209, DOI 10.1136/mp.51.4.209; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Watrelot-Virieux D, 2006, J VET MED B, V53, P321, DOI 10.1111/j.1439-0450.2006.00957.x; WAYNE LG, 1994, ANTIMICROB AGENTS CH, V38, P2054, DOI 10.1128/AAC.38.9.2054; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919	86	77	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17550	10.1371/journal.pone.0017550	http://dx.doi.org/10.1371/journal.pone.0017550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445321	Green Submitted, gold, Green Published			2022-12-27	WOS:000288613300008
J	Ringner, M; Fredlund, E; Hakkinen, J; Borg, A; Staaf, J				Ringner, Markus; Fredlund, Erik; Hakkinen, Jari; Borg, Ake; Staaf, Johan			GOBO: Gene Expression-Based Outcome for Breast Cancer Online	PLOS ONE			English	Article							CYCLIN B1; INTEGRATIVE ANALYSIS; HISTOLOGIC GRADE; SIGNATURE; PREDICTOR; METASTASIS; SURVIVAL; SUBTYPES; STROMA; CHEMOTHERAPY	Microarray-based gene expression analysis holds promise of improving prognostication and treatment decisions for breast cancer patients. However, the heterogeneity of breast cancer emphasizes the need for validation of prognostic gene signatures in larger sample sets stratified into relevant subgroups. Here, we describe a multifunctional user-friendly online tool, GOBO (http://co.bmc.lu.se/gobo), allowing a range of different analyses to be performed in an 1881-sample breast tumor data set, and a 51-sample breast cancer cell line set, both generated on Affymetrix U133A microarrays. GOBO supports a wide range of applications including: 1) rapid assessment of gene expression levels in subgroups of breast tumors and cell lines, 2) identification of co-expressed genes for creation of potential metagenes, 3) association with outcome for gene expression levels of single genes, sets of genes, or gene signatures in multiple subgroups of the 1881-sample breast cancer data set. The design and implementation of GOBO facilitate easy incorporation of additional query functions and applications, as well as additional data sets irrespective of tumor type and array platform.	[Ringner, Markus; Fredlund, Erik; Hakkinen, Jari; Borg, Ake; Staaf, Johan] Lund Univ, Dept Oncol, Lund, Sweden; [Ringner, Markus; Fredlund, Erik; Hakkinen, Jari; Borg, Ake; Staaf, Johan] Skane Univ Hosp, Lund, Sweden; [Ringner, Markus; Fredlund, Erik; Borg, Ake; Staaf, Johan] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University	Ringner, M (corresponding author), Lund Univ, Dept Oncol, Lund, Sweden.	johan.staaf@med.lu.se	Häkkinen, Jari/AHH-4463-2022; Ringnér, Markus/G-3641-2011	Ringnér, Markus/0000-0001-5469-8940; Hakkinen, Jari/0000-0002-8466-9179	Swedish Cancer Society; Foundation for Strategic Research through the Lund Strategic Centre for Translational Cancer Research (CREATE Health); Swedish Research Council	Swedish Cancer Society(Swedish Cancer Society); Foundation for Strategic Research through the Lund Strategic Centre for Translational Cancer Research (CREATE Health); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The present study was supported by the Swedish Cancer Society, the Foundation for Strategic Research through the Lund Strategic Centre for Translational Cancer Research (CREATE Health), and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen K, 2009, BRIT J CANCER, V100, P1055, DOI 10.1038/sj.bjc.6604874; Agarwal R, 2009, CLIN CANCER RES, V15, P3654, DOI 10.1158/1078-0432.CCR-08-3293; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gene Expression Omnibus, GENE EXPRESSION OMNI; Gruvberger SK, 2003, BREAST CANCER RES, V5, P23, DOI 10.1186/bcr548; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Karn T, 2010, BREAST CANCER RES TR, V120, P567, DOI 10.1007/s10549-009-0416-z; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nimeus-Malmstrom E, 2010, INT J CANCER, V127, P961, DOI 10.1002/ijc.25091; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rody A, 2009, BREAST CANCER RES TR, V113, P457, DOI 10.1007/s10549-008-9964-x; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Urban P, 2006, J CLIN ONCOL, V24, P4245, DOI 10.1200/JCO.2005.05.1912; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	55	297	303	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e17911	10.1371/journal.pone.0017911	http://dx.doi.org/10.1371/journal.pone.0017911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	738BC	21445301	Green Published, Green Submitted, gold			2022-12-27	WOS:000288613300021
J	Power, P; Jeffery, D; Rehman, MA; Chatterji, A; Yankulov, K				Power, Patricia; Jeffery, Daniel; Rehman, Muhammad Attiq; Chatterji, Arjun; Yankulov, Krassimir			Sub-Telomeric core X and Y ' Elements in S.cerevisiae Suppress Extreme Variations in Gene Silencing	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; SACCHAROMYCES-CEREVISIAE; SUBTELOMERIC REGIONS; DNA-REPLICATION; TRANSCRIPTIONAL REPRESSION; PROTO-SILENCERS; LIFE-SPAN; ACETYLATION; CHROMATIN; HETEROCHROMATIN	Telomere Position Effect (TPE) is governed by strong repression signals emitted by telomeres via the Sir2/3/4 Histone Deacetylase complex. These signals are then relayed by weak proto-silencers residing in the subtelomeric core X and Y' elements. Subtelomeres also contain Sub-Telomeric Anti-silencing Regions (STARs). In this study we have prepared telomeres built of different combinations of core X, Y' and STARs and have analyzed them in strains lacking Histone-Acetyltransferase genes as well as in cdc6-1 and Delta rif1 strains. We show that core X and Y' dramatically reduce both positive and negative variations in TPE, that are caused by these mutations. We also show that the deletion of Histone-Acetyltransferase genes reduce the silencing activity of an ACS proto-silencer, but also reduce the anti-silencing activity of a STAR. We postulate that core X and Y' act as epigenetic "cushioning" cis-elements.	[Power, Patricia; Jeffery, Daniel; Rehman, Muhammad Attiq; Chatterji, Arjun; Yankulov, Krassimir] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Power, P (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	yankulov@uoguelph.ca	Rehman, Muhammad/L-1283-2019; Jeffery, Daniel/GVS-0791-2022	Rehman, Muhammad/0000-0002-2062-1969; Yankulov, Krassimir/0000-0001-9440-9234	National Science and Engineering Research Council of Canada (NSERC) (University of Guelph) [043230]	National Science and Engineering Research Council of Canada (NSERC) (University of Guelph)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the National Science and Engineering Research Council of Canada (NSERC) (University of Guelph grant # 043230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; AXELROD A, 1991, MOL CELL BIOL, V11, P1080, DOI 10.1128/MCB.11.2.1080; Boscheron C, 1996, EMBO J, V15, P2184, DOI 10.1002/j.1460-2075.1996.tb00572.x; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dillin A, 1997, GENETICS, V147, P1053; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; Ehrentraut S, 2010, P NATL ACAD SCI USA, V107, P5522, DOI 10.1073/pnas.0909169107; Fourel G, 2004, BIOESSAYS, V26, P523, DOI 10.1002/bies.20028; Fourel G, 2002, BIOESSAYS, V24, P828, DOI 10.1002/bies.10139; Fourel G, 2002, J BIOL CHEM, V277, P41736, DOI 10.1074/jbc.M202578200; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Howe L, 2002, MOL CELL BIOL, V22, P5047, DOI 10.1128/MCB.22.14.5047-5053.2002; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Koering CE, 2000, NUCLEIC ACIDS RES, V28, P2519, DOI 10.1093/nar/28.13.2519; Kozak ML, 2010, EMBO J, V29, P158, DOI 10.1038/emboj.2009.314; Lafon A, 2007, ONCOGENE, V26, P5373, DOI 10.1038/sj.onc.1210606; Lebrun E, 2001, GENETICS, V158, P167; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marcand S, 1997, CIBA F SYMP, V211, P76; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Muller HJ, 1930, GENETICS, V15, P283; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Rehman MA, 2006, GENETICS, V174, P1801, DOI 10.1534/genetics.106.063446; Rehman MA, 2009, CURR GENET, V55, P357, DOI 10.1007/s00294-009-0265-7; Rehman MA, 2009, MOL BIOL CELL, V20, P631, DOI 10.1091/mbc.E08-01-0099; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; WILEY EA, 1995, GENETICS, V139, P67; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Xu EY, 1999, GENETICS, V153, P25	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17523	10.1371/journal.pone.0017523	http://dx.doi.org/10.1371/journal.pone.0017523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437278	Green Submitted, Green Published, gold			2022-12-27	WOS:000288514600004
J	Syed, Z; Pelletier, J; Flounders, E; Chitolina, RF; Leal, WS				Syed, Zainulabeuddin; Pelletier, Julien; Flounders, Eric; Chitolina, Rodrigo F.; Leal, Walter S.			Generic Insect Repellent Detector from the Fruit Fly Drosophila melanogaster	PLOS ONE			English	Article							MOLECULAR-BASIS; BED NETS; DEET; RECEPTORS; MALARIA	Background: Insect repellents are prophylactic tools against a number of vector-borne diseases. There is growing demand for repellents outperforming DEET in cost and safety, but with the current technologies R&D of a new product takes almost 10 years, with a prohibitive cost of $30 million dollar in part due to the demand for large-scale synthesis of thousands of test compounds of which only 1 may reach the market. R&D could be expedited and cost dramatically reduced with a molecular/physiological target to streamline putative repellents for final efficacy and toxicological tests. Methodology: Using olfactory-based choice assay we show here that the fruit fly is repelled by not only DEET, but also IR3535 and picaridin thus suggesting they might have "generic repellent detector(s)," which may be of practical applications in new repellent screenings. We performed single unit recordings from all olfactory sensilla in the antennae and maxillary palps. Although the ab3A neuron in the wild type flies responded to picaridin, it was unresponsive to DEET and IR3535. By contrast, a neuron housed in the palp basiconic sensilla pb1 responded to DEET, IR3535, and picaridin, with apparent sensitivity higher than that of the DEET detectors in the mosquitoes Culex quinquefasciatus and Aedes aegypti. DmOr42a was transplanted from pb1 to the "empty neuron" and showed to be sensitive to the three insect repellents. Conclusions: For the first time we have demonstrated that the fruit fly avoids not only DEET but also IR3535 and picaridin, and identified an olfactory receptor neuron (ORN), which is sensitive to these three major insect repellents. We have also identified the insect repellent-sensitive receptor, DmOr42a. This generic detector fulfils the requirements for a simplified bioassay for early screening of test insect repellents.	[Syed, Zainulabeuddin; Pelletier, Julien; Flounders, Eric; Chitolina, Rodrigo F.; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis	Syed, Z (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; syed, zainulabeuddin/L-4961-2016	Leal, Walter/0000-0002-6800-1240; syed, zainulabeuddin/0000-0002-6235-7115; Leal Filho, Walter/0000-0002-1241-5225	National Science Foundation [0918177]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under FIPSE-CAPSE	National Science Foundation(National Science Foundation (NSF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under FIPSE-CAPSE(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the National Science Foundation (0918177). R. F. C. (Universidade Federal do Parana, Curitiba, Brazil) received an undergraduate scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under a FIPSE-CAPSE sponsored US-Brazil Higher Education Consortium Program. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; BECKER HJ, 1970, MOL GEN GENET, V107, P194, DOI 10.1007/BF00333634; Boeckh J, 1996, PESTIC SCI, V48, P359, DOI 10.1002/(SICI)1096-9063(199612)48:4&lt;359::AID-PS490&gt;3.0.CO;2-Z; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Faulde MK, 2010, PARASITOL RES, V106, P957, DOI 10.1007/s00436-010-1749-6; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; GOVERE JM, 2010, INSECT REPELLENTS PR, P147; Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Leal WS, 2010, NATURE, V464, P37, DOI 10.1038/464037a; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; MCCABE ET, 1954, J ORG CHEM, V19, P493, DOI 10.1021/jo01369a003; Moore Sarah J., 2007, P3; Moore SJ, 2007, J MED ENTOMOL, V44, P624, DOI 10.1603/0022-2585(2007)44[624:FEOTUP]2.0.CO;2; Nasci Roger S., 1996, P85; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pennetier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007896; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; STANCZYK NM, 2010, P NATL ACAD SCI US; Strickman D., 2007, INSECT REPELLENTS PR, P195; SYED Z, 2010, P NATL ACAD SCI US; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; 2004, IMPACT MALARIA LEADI	38	22	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17705	10.1371/journal.pone.0017705	http://dx.doi.org/10.1371/journal.pone.0017705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436880	gold, Green Published			2022-12-27	WOS:000288514000007
J	Vukov, J; Santos, FC; Pacheco, JM				Vukov, Jeromos; Santos, Francisco C.; Pacheco, Jorge M.			Incipient Cognition Solves the Spatial Reciprocity Conundrum of Cooperation	PLOS ONE			English	Article							STOCHASTIC STRATEGIES; EVOLUTIONARY GAMES; PRISONERS-DILEMMA	Background: From the simplest living organisms to human societies, cooperation among individuals emerges as a paradox difficult to explain and describe mathematically, although very often observed in reality. Evolutionary game theory offers an excellent toolbar to investigate this issue. Spatial structure has been one of the first mechanisms promoting cooperation; however, alone it only opens a narrow window of viability. Methodology/Principal Findings: Here we equip individuals with incipient cognitive abilities, and investigate the evolution of cooperation in a spatial world where retaliation, forgiveness, treason and mutualism may coexist, as individuals engage in Prisoner's Dilemma games. In the model, individuals are able to distinguish their partners and act towards them based on previous interactions. We show how the simplest level of cognition, alone, can lead to the emergence of cooperation. Conclusions/Significance: Despite the incipient nature of the individuals' cognitive abilities, cooperation emerges for unprecedented values of the temptation to cheat, being also robust to invasion by cheaters, errors in decision making and inaccuracy of imitation, features akin to many species, including humans.	[Vukov, Jeromos; Santos, Francisco C.; Pacheco, Jorge M.] Complexo Interdisciplinar Univ Lisboa, Ctr Matemat & Aplicacoes Fundamentais, Applicat Theoret Phys Grp, Lisbon, Portugal; [Santos, Francisco C.] Univ Nova Lisboa, Dept Informat, Caparica, Portugal; [Santos, Francisco C.] Univ Nova Lisboa, Ctr Artificial Intelligence, Caparica, Portugal; [Pacheco, Jorge M.] Univ Minho, Dept Matemat & Aplicacoes, Braga, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade do Minho	Vukov, J (corresponding author), Complexo Interdisciplinar Univ Lisboa, Ctr Matemat & Aplicacoes Fundamentais, Applicat Theoret Phys Grp, Lisbon, Portugal.	pacheco@cii.fc.ul.pt	Pacheco, Jorge M./O-8184-2019; Santos, Francisco C./W-7781-2019; Santos, Francisco C./D-2394-2010; Pacheco, Jorge M/B-6116-2008	Pacheco, Jorge M./0000-0002-2579-8499; Santos, Francisco C./0000-0002-9103-2862; Santos, Francisco C./0000-0002-9103-2862; Pacheco, Jorge M/0000-0002-2579-8499	Fundacao para a Ciencia e Tecnologia, Portugal	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Funding: JV, FCS and JMP acknowledge the support of Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, CHIMPANZEE POLITICS; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R, EVOLUTION COOPERATIO; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; DELLAROCAS C, 2003, 42974203 MIT; Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629; Dunbar R, 2003, SCIENCE, V302, P1160, DOI 10.1126/science.1092116; Dunbar RIM, 2009, ANN HUM BIOL, V36, P562, DOI 10.1080/03014460902960289; Forgas J. P., 2007, EVOLUTION SOCIAL MIN; Gintis Herbert, 2009, BOUNDS REASON GAME T; Glimcher PW, NEUROECONOMICS DECIS; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Maynard Smith J., 1982, pi; MOLANDER P, 1985, J CONFLICT RESOLUT, V29, P611, DOI 10.1177/0022002785029004004; NOWAK M, 1990, J THEOR BIOL, V142, P237, DOI 10.1016/S0022-5193(05)80224-3; NOWAK M, 1990, THEOR POPUL BIOL, V38, P93, DOI 10.1016/0040-5809(90)90005-G; NOWAK M, 1989, J THEOR BIOL, V137, P21, DOI 10.1016/S0022-5193(89)80146-8; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; NOWAK M, 1989, APPL MATH COMPUT, V30, P191, DOI 10.1016/0096-3003(89)90052-0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Sigmund K, 2002, SCI AM, V286, P82, DOI 10.1038/scientificamerican0102-82; SIGMUND K, 1995, GAMES LIFE EXPLORATI, P256; SIMON H, 1984, MODELS BOUNDED RATIO, V1, P502; SMITH JM, 1984, BEHAV BRAIN SCI, V7, P117, DOI 10.1017/S0140525X00026510; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Wingreen NS, 2006, PLOS BIOL, V4, P1486, DOI 10.1371/journal.pbio.0040299; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	36	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17939	10.1371/journal.pone.0017939	http://dx.doi.org/10.1371/journal.pone.0017939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423580	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900046
J	Drier, Y; Domany, E				Drier, Yotam; Domany, Eytan			Do Two Machine-Learning Based Prognostic Signatures for Breast Cancer Capture the Same Biological Processes?	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MICROARRAY DATA; DISCOVERY; METASTASIS; VALIDATION; PREDICTION; ONTOLOGY; ANNOTATION; SURVIVAL; DATABASE	The fact that there is very little if any overlap between the genes of different prognostic signatures for early-discovery breast cancer is well documented. The reasons for this apparent discrepancy have been explained by the limits of simple machine-learning identification and ranking techniques, and the biological relevance and meaning of the prognostic gene lists was questioned. Subsequently, proponents of the prognostic gene lists claimed that different lists do capture similar underlying biological processes and pathways. The present study places under scrutiny the validity of this claim, for two important gene lists that are at the focus of current large-scale validation efforts. We performed careful enrichment analysis, controlling the effects of multiple testing in a manner which takes into account the nested dependent structure of gene ontologies. In contradiction to several previous publications, we find that the only biological process or pathway for which statistically significant concordance can be claimed is cell proliferation, a process whose relevance and prognostic value was well known long before gene expression profiling. We found that the claims reported by others, of wider concordance between the biological processes captured by the two prognostic signatures studied, were found either to be lacking statistical rigor or were in fact based on addressing some other question.	[Drier, Yotam; Domany, Eytan] Weizmann Inst Sci, Dept Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Drier, Y (corresponding author), Weizmann Inst Sci, Dept Phys, Complex Syst, IL-76100 Rehovot, Israel.	eytan.domany@weizmann.ac.il	Drier, Yotam/K-5208-2012; DOMANY, EYTAN/K-1560-2012	Drier, Yotam/0000-0003-1725-2995; 	Leir Charitable Foundation; Weizmann-Mario Negri collaborative research grant; German Research Foundation (DIP)	Leir Charitable Foundation; Weizmann-Mario Negri collaborative research grant; German Research Foundation (DIP)(German Research Foundation (DFG))	This research was supported by the Leir Charitable Foundation, a Weizmann-Mario Negri collaborative research grant and by a grant from the German Research Foundation (DIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BUSSEY KJ, 2003, GENOME BIOL, V4, pNIL81; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; de Snoo F, 2009, SURG ONCOL, V18, P366, DOI 10.1016/j.suronc.2009.07.005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dunkler D, 2007, EUR J CANCER, V43, P745, DOI 10.1016/j.ejca.2006.11.018; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Farcomeni A, 2008, STAT METHODS MED RES, V17, P347, DOI 10.1177/0962280206079046; FISHER RA, 1970, STAT METHODS RES WOR, pR15; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim SJ, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-20; Koscielny S, 2008, CURR OPIN OBSTET GYN, V20, P47, DOI 10.1097/GCO.0b013e3282f39d9e; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pusztai L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2430; Radpour R, 2009, GENET TEST MOL BIOMA, V13, P565, DOI 10.1089/gtmb.2009.0060; Ransohoff DF, 2003, NEW ENGL J MED, V348, P1716; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shen RL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-28; Simon R, 2008, EUR J CANCER, V44, P2707, DOI 10.1016/j.ejca.2008.09.009; Sims AH, 2009, J CLIN PATHOL, V62, P879, DOI 10.1136/jcp.2008.060376; Sole X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004544; Sotiriou C, 2006, J CLIN ONCOL, V24, p4S; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi S, 2008, CANCER SCI, V99, P324, DOI 10.1111/j.1349-7006.2007.00691.x; TANAY A, THESIS TEL AVIV U; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Vegt B, 2009, CRIT REV ONCOL HEMAT, V70, P1, DOI 10.1016/j.critrevonc.2008.09.001; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182	62	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17795	10.1371/journal.pone.0017795	http://dx.doi.org/10.1371/journal.pone.0017795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423753	gold, Green Submitted, Green Published			2022-12-27	WOS:000288512400029
J	Broyd, SJ; Helps, SK; Sonuga-Barke, EJS				Broyd, Samantha J.; Helps, Suzannah K.; Sonuga-Barke, Edmund J. S.			Attention-Induced Deactivations in Very Low Frequency EEG Oscillations: Differential Localisation According to ADHD Symptom Status	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; ELECTROMAGNETIC TOMOGRAPHY; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; RESTING BRAIN; FLUCTUATIONS; DYSFUNCTION; CORTEX; ALPHA; THETA	Background: The default-mode network (DMN) is characterised by coherent very low frequency (VLF) brain oscillations. The cognitive significance of this VLF profile remains unclear, partly because of the temporally constrained nature of the blood oxygen-level dependent (BOLD) signal. Previously we have identified a VLF EEG network of scalp locations that shares many features of the DMN. Here we explore the intracranial sources of VLF EEG and examine their overlap with the DMN in adults with high and low ADHD ratings. Methodology/Principal Findings: DC-EEG was recorded using an equidistant 66 channel electrode montage in 25 adult participants with high-and 25 participants with low-ratings of ADHD symptoms during a rest condition and an attention demanding Eriksen task. VLF EEG power was calculated in the VLF band (0.02 to 0.2 Hz) for the rest and task condition and compared for high and low ADHD participants. sLORETA was used to identify brain sources associated with the attention-induced deactivation of VLF EEG power, and to examine these sources in relation to ADHD symptoms. There was significant deactivation of VLF EEG power between the rest and task condition for the whole sample. Using s-LORETA the sources of this deactivation were localised to medial prefrontal regions, posterior cingulate cortex/precuneus and temporal regions. However, deactivation sources were different for high and low ADHD groups: In the low ADHD group attention-induced VLF EEG deactivation was most significant in medial prefrontal regions while for the high ADHD group this deactivation was predominantly localised to the temporal lobes. Conclusions/Significance: Attention-induced VLF EEG deactivations have intracranial sources that appear to overlap with those of the DMN. Furthermore, these seem to be related to ADHD symptom status, with high ADHD adults failing to significantly deactivate medial prefrontal regions while at the same time showing significant attenuation of VLF EEG power in temporal lobes.	[Broyd, Samantha J.; Helps, Suzannah K.; Sonuga-Barke, Edmund J. S.] Univ Southampton, Sch Psychol, Inst Disorders Impulse & Attent, Dev Brain Behav Lab, Southampton, Hants, England; [Sonuga-Barke, Edmund J. S.] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	University of Southampton; Ghent University	Broyd, SJ (corresponding author), Univ Southampton, Sch Psychol, Inst Disorders Impulse & Attent, Dev Brain Behav Lab, Southampton, Hants, England.	ejb3@soton.ac.uk	Sonuga-Barke, Edmund j/D-9137-2011		Janssen Cilag; Shire; Qbtech; Flynn Pharma	Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Shire; Qbtech; Flynn Pharma	Professor Edmund Sonuga-Barke reports the following conflicts: Recent speaker board: Shire, UCB Pharma; current and recent consultancy: UCB Pharma, Shire; current and recent research support for other studies: Janssen Cilag, Shire, Qbtech, Flynn Pharma; advisory board: Shire, Flynn Pharma, UCB Pharma, Astra Zeneca; conference support: Shire. Samantha Broyd and Suzannah Helps have no competing interests. None of the authors are employed by a commercial company. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Banich MT, 2009, NEUROPSYCHOLOGIA, V47, P3095, DOI 10.1016/j.neuropsychologia.2009.07.005; BARKLEY PA, 1998, ATTENTION DEFICIT HY; BECKMANN CF, 2005, PHILOS T ROYAL SOC, V360; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Collett BR, 2003, J AM ACAD CHILD PSY, V42, P1015, DOI 10.1097/01.CHI.0000070245.24125.B6; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; FRISTON KJ, 1991, P ROY SOC B-BIOL SCI, V244, P101, DOI 10.1098/rspb.1991.0057; GASSER T, 1982, ELECTROEN CLIN NEURO, V53, P119, DOI 10.1016/0013-4694(82)90112-2; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Helps S, 2008, J NEURAL TRANSM, V115, P279, DOI 10.1007/s00702-007-0825-2; Helps SK, 2009, J PSYCHOPHYSIOL, V23, P191, DOI 10.1027/0269-8803.23.4.191; Helps SK, 2010, BRAIN RES, V1322, P134, DOI 10.1016/j.brainres.2010.01.057; KOBEL M, PSYCHIAT RE IN PRESS; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Meltzer JA, 2007, CLIN NEUROPHYSIOL, V118, P2419, DOI 10.1016/j.clinph.2007.07.023; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD., 2007, ARXIV 07103341 MATH; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; TRAVIS F, 2010, COGNITIVE PROCESSING, V11, P12; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	49	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17325	10.1371/journal.pone.0017325	http://dx.doi.org/10.1371/journal.pone.0017325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408092	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000288170000020
J	McDougal, JS; McNicholl, JM; Wasinrapee, P; Branson, BM; Martin, M; Tappero, JW; Mock, PA; Green, TA; Hu, DJ; Parekh, B				McDougal, J. Steven; McNicholl, Janet M.; Wasinrapee, Punneeporn; Branson, Bernard M.; Martin, Michael; Tappero, Jordan W.; Mock, Philip A.; Green, Timothy A.; Hu, Dale J.; Parekh, Bharat		Thai US Bed Assay Validat Working	Assessment of BED HIV-1 Incidence Assay in Seroconverter Cohorts: Effect of Individuals with Long-Term Infection and Importance of Stable Incidence	PLOS ONE			English	Article							INJECTION-DRUG USERS; VACCINE TRIAL; SUBTYPE E; BANGKOK; SURVEILLANCE; POPULATION	Background: Performance of the BED assay in estimating HIV-1 incidence has previously been evaluated by using longitudinal specimens from persons with incident HIV infections, but questions remain about its accuracy. We sought to assess its performance in three longitudinal cohorts from Thailand where HIV-1 CRF01_AE and subtype B' dominate the epidemic. Design: BED testing was conducted in two longitudinal cohorts with only incident infections (a military conscript cohort and an injection drug user cohort) and in one longitudinal cohort (an HIV-1 vaccine efficacy trial cohort) that also included long-term infections. Methods: Incidence estimates were generated conventionally (based on the number of annual serocoversions) and by using BED test results in the three cohorts. Adjusted incidence was calculated where appropriate. Results: For each longitudinal cohort the BED incidence estimates and the conventional incidence estimates were similar when only newly infected persons were tested, whether infected with CRF01_AE or subtype B9. When the analysis included persons with long-term infections (to mimic a true cross-sectional cohort), BED incidence estimates were higher, although not significantly, than the conventional incidence estimates. After adjustment, the BED incidence estimates were closer to the conventional incidence estimates. When the conventional incidence varied over time, as in the early phase of the injection drug user cohort, the difference between the two estimates increased, but not significantly. Conclusions: Evaluation of the performance of incidence assays requires the inclusion of a substantial number of cohort-derived specimens from individuals with long-term HIV infection and, ideally, the use of cohorts in which incidence remained stable. Appropriate adjustments of the BED incidence estimates generate estimates similar to those generated conventionally.	[McDougal, J. Steven; McNicholl, Janet M.; Branson, Bernard M.; Martin, Michael; Tappero, Jordan W.; Green, Timothy A.; Hu, Dale J.; Parekh, Bharat] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	McDougal, JS (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	jkm7@cdc.gov		PAREKH, BHARAT/0000-0002-1088-4263	US Centers for Disease Control and Prevention (CDC)	US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work was supported by the US Centers for Disease Control and Prevention (CDC). CDC investigators had significant roles in every phase of the work including design, data collection, analysis, manuscript writing, decisions to publish. The work was a collaboration between CDC investigators and investigators in Thailand who had collected informative specimens. Some of these specimens were collected using some CDC resources to support the cohort studies (BMA IDU and Vax003).	Ackers ML, 2003, J INFECT DIS, V187, P879, DOI 10.1086/368169; Brookmeyer R., 1994, AIDS EPIDEMIOLOGY QU; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Calzavara L, 2002, AIDS, V16, P1655, DOI 10.1097/00002030-200208160-00011; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kana Khunakorn, 2009, J Med Assoc Thai, V92 Suppl 1, pS112; Kellogg TA, 2005, JAIDS-J ACQ IMM DEF, V39, P112, DOI 10.1097/01.qai.0000144444.44518.a3; Killian MS, 2006, AIDS RES HUM RETROV, V22, P640, DOI 10.1089/aid.2006.22.640; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Nopkesorn T, 1998, J ACQ IMMUN DEF SYND, V18, P372, DOI 10.1097/00042560-199808010-00009; NOPKESORN T, 1993, AIDS, V7, P1233, DOI 10.1097/00002030-199309000-00013; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; PAREKH BS, 2010, AIDS RES HU IN PRESS; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2007, JAIDS-J ACQ IMM DEF, V44, P196, DOI 10.1097/01.qai.0000254323.86897.36; Rehle T, 2004, B WORLD HEALTH ORGAN, V82, P121; Rutherford GW, 2000, J ACQ IMMUN DEF SYND, V25, pS115, DOI 10.1097/00126334-200012152-00005; Saidel T, 1996, AM J EPIDEMIOL, V144, P214, DOI 10.1093/oxfordjournals.aje.a008916; Satten GA, 1999, BIOMETRICS, V55, P1224, DOI 10.1111/j.0006-341X.1999.01224.x; Stoneburner RL, 1996, AM J EPIDEMIOL, V144, P682, DOI 10.1093/oxfordjournals.aje.a008981; Subbarao S, 2000, AIDS RES HUM RETROV, V16, P699, DOI 10.1089/088922200308693; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vanichseni S, 2004, AIDS, V18, P311, DOI 10.1097/00002030-200401230-00022; Welte A, 2009, AIDS RES HUM RETROV, V25, P125, DOI 10.1089/aid.2008.0150	31	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e14748	10.1371/journal.pone.0014748	http://dx.doi.org/10.1371/journal.pone.0014748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21408214	Green Published, gold, Green Submitted			2022-12-27	WOS:000288025500002
J	Huo, XA; Qi, XA; Tang, FY; Zu, RQ; Li, LA; Wu, B; Qin, YF; Ji, H; Fu, JG; Wang, SJ; Tian, H; Hu, ZB; Yang, HT; Zhou, MH; Wang, H; Zhu, FC				Huo, Xiang; Qi, Xian; Tang, Fenyang; Zu, Rongqiang; Li, Liang; Wu, Bin; Qin, Yuanfang; Ji, Hong; Fu, Jianguang; Wang, Shenjiao; Tian, Hua; Hu, Zhibin; Yang, Haitao; Zhou, Minghao; Wang, Hua; Zhu, Fengcai			Seroprevalence of Pandemic (H1N1) 2009 in Pregnant Women in China: An Observational Study	PLOS ONE			English	Article							IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; INFLUENZA-VIRUS; IMMUNE-RESPONSES; RECOMMENDATIONS; PREVENTION; INFECTION	Background: We investigated the seropositive rates and persistence of antibody against pandemic (H1N1) 2009 virus (pH1N1) in pregnant women and voluntary blood donors after the second wave of the pandemic in Nanjing, China. Methodology/Principal Findings: Serum samples of unvaccinated pregnant women (n = 720) and voluntary blood donors (n = 320) were collected after the second wave of 2009 pandemic in Nanjing. All samples were tested against pH1N1 strain (A/California/7/2009) with hemagglutination inhibition assay. A significant decline in seropositive rates, from above 50% to about 20%, was observed in pregnant women and voluntary blood donors fifteen weeks after the second wave of the pandemic. A quarter of the samples were tested against a seasonal H1N1 strain (A/Brisbane/59/2007). The antibody titers against pH1N1 strain were found to correlate positively with those against seasonal H1N1 strain. The correlation was modest but statistically significant. Conclusions and Significance: The high seropositive rates in both pregnant women and voluntary blood donors suggested that the pH1N1 virus had widely spread in these two populations. Immunity derived from natural infection seemed not to be persistent well.	[Huo, Xiang; Qi, Xian; Tang, Fenyang; Zu, Rongqiang; Li, Liang; Wu, Bin; Qin, Yuanfang; Ji, Hong; Fu, Jianguang; Wang, Shenjiao; Tian, Hua; Yang, Haitao; Zhou, Minghao; Wang, Hua; Zhu, Fengcai] Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Peoples R China; [Hu, Zhibin] Nanjing Med Univ, Coll Publ Hlth, Nanjing, Peoples R China	Nanjing Medical University	Huo, XA (corresponding author), Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Peoples R China.	jszfc@vip.sina.com	zhou, minghao/GZA-7244-2022					Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Chen MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012474; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Fonseca V., 2009, Morbidity and Mortality Weekly Report, V58, P497; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Keynan Y, 2010, CLIN MICROBIOL INFEC, V16, P1179, DOI 10.1111/j.1469-0691.2010.03142.x; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lin JT, 2009, J INFECT DIS, V199, P184, DOI 10.1086/595832; Liu WT, 2010, CLIN INFECT DIS, V51, P251, DOI 10.1086/653680; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; MARGARETCHAN, 2009, WORLD NOW START 2009; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Moghadami M, 2010, IRAN J IMMUNOL, V7, P39, DOI IJIv7i1A5; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Saleeby E, 2009, OBSTET GYNECOL, V114, P885, DOI 10.1097/AOG.0b013e3181bb44bb; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Song JY, 2010, VACCINE, V28, P3929, DOI 10.1016/j.vaccine.2010.03.067; Tang Fen-yang, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P489; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; [No title captured]	31	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17995	10.1371/journal.pone.0017995	http://dx.doi.org/10.1371/journal.pone.0017995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437256	gold, Green Published, Green Submitted			2022-12-27	WOS:000288545100054
J	Meis, S; Stork, O; Munsch, T				Meis, Susanne; Stork, Oliver; Munsch, Thomas			Neuropeptide S-Mediated Facilitation of Synaptic Transmission Enforces Subthreshold Theta Oscillations within the Lateral Amygdala	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FEAR MEMORY; CONDITIONED FEAR; RECEPTOR; NEURONS; MECHANISMS; NETWORKS; PHARMACOLOGY; EXPRESSION; CIRCUITS	The neuropeptide S (NPS) receptor system modulates neuronal circuit activity in the amygdala in conjunction with fear, anxiety and the expression and extinction of previously acquired fear memories. Using in vitro brain slice preparations of transgenic GAD67-GFP (Delta neo) mice, we investigated the effects of NPS on neural activity in the lateral amygdala as a key region for the formation and extinction of fear memories. We are able to demonstrate that NPS augments excitatory glutamatergic synaptic input onto both projection neurons and interneurons of the lateral amygdala, resulting in enhanced spike activity of both types of cells. These effects were at least in part mediated by presynaptic mechanisms. In turn, inhibition of projection neurons by local interneurons was augmented by NPS, and subthreshold oscillations were strengthened, leading to their shift into the theta frequency range. These data suggest that the multifaceted effects of NPS on amygdaloid circuitry may shape behavior-related network activity patterns in the amygdala and reflect the peptide's potent activity in various forms of affective behavior and emotional memory.	[Meis, Susanne; Munsch, Thomas] Otto Von Guericke Univ, Inst Physiol, Magdeburg, Germany; [Meis, Susanne; Stork, Oliver; Munsch, Thomas] Ctr Behav Brain Sci, Magdeburg, Germany; [Stork, Oliver] Otto Von Guericke Univ, Inst Biol, Abt Genet & Mol Neurobiol, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Meis, S (corresponding author), Otto Von Guericke Univ, Inst Physiol, Magdeburg, Germany.	Thomas.munsch@med.ovgu.de		Stork, Oliver/0000-0003-4285-7507	Deutsche Forschungsgemeinschaft [SFB 426, TP B8, SFB 779, TP B5]; Federal State Saxony-Anhalt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal State Saxony-Anhalt	Supported by the Deutsche Forschungsgemeinschaft (SFB 426, TP B8, SFB 779, TP B5) and the Federal State Saxony-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badia-Elder NE, 2008, ALCOHOL CLIN EXP RES, V32, P1380, DOI 10.1111/j.1530-0277.2008.00713.x; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Behan M, 1999, J COMP NEUROL, V408, P532; Bruce S, 2009, J MED GENET, V46, P159, DOI 10.1136/jmg.2007.055137; Camarda V, 2008, J MED CHEM, V51, P655, DOI 10.1021/jm701204n; Castro AA, 2009, PHARMACOL BIOCHEM BE, V91, P636, DOI 10.1016/j.pbb.2008.10.015; Chung S, 2006, NEUROPEPTIDES, V40, P233, DOI 10.1016/j.npep.2006.04.002; Cline MA, 2007, COMP BIOCHEM PHYS A, V148, P657, DOI 10.1016/j.cbpa.2007.08.016; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; Dityatev AE, 2005, NEUROSCIENTIST, V11, P75, DOI 10.1177/1073858404270857; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Gupte J, 2004, P NATL ACAD SCI USA, V101, P1508, DOI 10.1073/pnas.0308250100; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Johnson LR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.003.2008; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Leonard SK, 2008, PSYCHOPHARMACOLOGY, V197, P601, DOI 10.1007/s00213-008-1080-4; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Meis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002695; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; Orsmark-Pietras C, 2008, HUM MOL GENET, V17, P1673, DOI 10.1093/hmg/ddn058; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Pape HC, 1998, J NEUROPHYSIOL, V79, P217, DOI 10.1152/jn.1998.79.1.217; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; Popescu AT, 2011, J NEUROPHYSIOL, V105, P687, DOI 10.1152/jn.00732.2010; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Smith Y, 2000, J COMP NEUROL, V416, P496; SPAMPANATO J, 2010, NEUROPHARMACOLOGY; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tancredi T, 2007, J MED CHEM, V50, P4501, DOI 10.1021/jm0706822; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	47	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18020	10.1371/journal.pone.0018020	http://dx.doi.org/10.1371/journal.pone.0018020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437203	Green Published, gold, Green Submitted			2022-12-27	WOS:000288545100060
J	Peng, R; Maklokova, VI; Chandrashekhar, JH; Lan, Q				Peng, Rong; Maklokova, Vilena I.; Chandrashekhar, Jayadevi H.; Lan, Que			In Vivo Functional Genomic Studies of Sterol Carrier Protein-2 Gene in the Yellow Fever Mosquito	PLOS ONE			English	Article							GERM-LINE TRANSFORMATION; AEDES-AEGYPTI MOSQUITOS; DIPTERA-CULICIDAE; EXPRESSION; DNA; ELEGANS; VECTOR; OOCYTE	A simple and efficient DNA delivery method to introduce extrachromosomal DNA into mosquito embryos would significantly aid functional genomic studies. The conventional method for delivery of DNA into insects is to inject the DNA directly into the embryos. Taking advantage of the unique aspects of mosquito reproductive physiology during vitellogenesis and an in vivo transfection reagent that mediates DNA uptake in cells via endocytosis, we have developed a new method to introduce DNA into mosquito embryos vertically via microinjection of DNA vectors in vitellogenic females without directly manipulating the embryos. Our method was able to introduce inducible gene expression vectors transiently into F0 mosquitoes to perform functional studies in vivo without transgenic lines. The high efficiency of expression knockdown was reproducible with more than 70% of the F0 individuals showed sufficient gene expression suppression(< 30% of the controls' levels). At the cohort level, AeSCP-2 expression knockdown in early instar larvae resulted in detectable phenotypes of the expression deficiency such as high mortality, lowered fertility, and distorted sex ratio after induction of AeSCP-2 siRNA expression in vivo. The results further confirmed the important role of AeSCP-2 in the development and reproduction of A. aegypti. In this study, we proved that extrachromosaomal transient expression of an inducible gene from a DNA vector vertically delivered via vitellogenic females can be used to manipulate gene expression in F0 generation. This new method will be a simple and efficient tool for in vivo functional genomic studies in mosquitoes.	[Peng, Rong] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Peng, Rong; Chandrashekhar, Jayadevi H.; Lan, Que] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Maklokova, Vilena I.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53706 USA	Central China Normal University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Peng, R (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.	qlan@entomology.wisc.edu			National Institutes of Health Research [5R01AI067422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067422] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Research Grant #5R01AI067422 to Q.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON WA, 1971, J CELL BIOL, V50, P201, DOI 10.1083/jcb.50.1.201; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Berkowitz Laura A, 2008, J Vis Exp, DOI 10.3791/833; Beserra EB, 2009, NEOTROP ENTOMOL, V38, P847, DOI 10.1590/S1519-566X2009000600020; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Briegel H, 2003, J INSECT PHYSIOL, V49, P249, DOI 10.1016/S0022-1910(02)00272-X; Christophers, 1960, AEDES AEGYPTI L YELL; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Dyer DH, 2008, J LIPID RES, V49, P644, DOI 10.1194/jlr.M700460-JLR200; Tejerina EF, 2009, ACTA TROP, V109, P45, DOI 10.1016/j.actatropica.2008.09.014; HICKEY WA, 1970, J MED ENTOMOL, V7, P727, DOI 10.1093/jmedent/7.6.727; Isoe J, 2007, INSECT MOL BIOL, V16, P83, DOI 10.1111/j.1365-2583.2006.00704.x; Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lan Q, 2004, INSECT MOL BIOL, V13, P519, DOI 10.1111/j.0962-1075.2004.00510.x; Lan Q, 1997, IN VITRO CELL DEV-AN, V33, P615; LANG CA, 1972, J NUTR, V102, P1057, DOI 10.1093/jn/102.8.1057; Larson RT, 2008, J MED ENTOMOL, V45, P439, DOI 10.1603/0022-2585(2008)45[439:LAOSCP]2.0.CO;2; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; Lobo NF, 2002, INSECT MOL BIOL, V11, P133, DOI 10.1046/j.1365-2583.2002.00317.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Radek JT, 2010, BIOCHEMISTRY-US, V49, P7532, DOI 10.1021/bi902026v; RAIKHEL AS, 1984, EUR J CELL BIOL, V35, P279; RAIKHEL AS, 1983, TISSUE CELL, V15, P281, DOI 10.1016/0040-8166(83)90023-X; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; SAS Institute, 1999, US GUID VERS 8; Snigirevskaya ES, 1997, CELL TISSUE RES, V290, P129, DOI 10.1007/s004410050915; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; SVOBODA JA, 1982, LIPIDS, V17, P220, DOI 10.1007/BF02535107; TAMURA T, 1990, JPN J GENET, V65, P401, DOI 10.1266/jjg.65.401; *WHO, 2008, DENG HAEM FEV DIAGN; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	34	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e18030	10.1371/journal.pone.0018030	http://dx.doi.org/10.1371/journal.pone.0018030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437205	gold, Green Published, Green Submitted			2022-12-27	WOS:000288545100065
J	Gassman, NR; Clodfelter, JE; McCauley, AK; Bonin, K; Salsbury, FR; Scarpinato, KD				Gassman, Natalie R.; Clodfelter, Jill E.; McCauley, Anita K.; Bonin, Keith; Salsbury, Freddie R., Jr.; Scarpinato, Karin D.			Cooperative Nuclear Localization Sequences Lend a Novel Role to the N-Terminal Region of MSH6	PLOS ONE			English	Article							DNA MISMATCH REPAIR; PROTEINS MSH2; IMPORTIN-ALPHA; CANCER; SIGNALS; MUTATIONS; IDENTIFICATION; TRANSLOCATION; BINDING; CELLS	Human mismatch repair proteins MSH2-MSH6 play an essential role in maintaining genetic stability and preventing disease. While protein functions have been extensively studied, the substantial amino-terminal region (NTR*) of MSH6 that is unique to eukaryotic proteins, has mostly evaded functional characterization. We demonstrate that a cluster of three nuclear localization signals (NLS) in the NTR direct nuclear import. Individual NLSs are capable of partially directing cytoplasmic protein into the nucleus; however only cooperative effects between all three NLSs efficiently transport MSH6 into the nucleus. In striking contrast to yeast and previous assumptions on required heterodimerization, human MSH6 does not determine localization of its heterodimeric partner, MSH2. A cancer-derived mutation localized between two of the three NLS significantly decreases nuclear localization of MSH6, suggesting altered protein localization can contribute to carcinogenesis. These results clarify the pending speculations on the functional role of the NTR in human MSH6 and identify a novel, cooperative nuclear localization signal.	[Gassman, Natalie R.; Clodfelter, Jill E.; Scarpinato, Karin D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA; [McCauley, Anita K.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Bonin, Keith; Salsbury, Freddie R., Jr.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Salsbury, Freddie R., Jr.; Scarpinato, Karin D.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Gassman, NR (corresponding author), NIEHS, Durham, NC USA.	kscarpin@wfubmc.edu	Bonin, Keith/A-3207-2014; Salsbury, FR/A-5923-2008	Bonin, Keith/0000-0002-7594-823X; Salsbury, FR/0000-0002-2699-829X; Gassman, Natalie/0000-0002-8488-2332	National Cancer Institute (NCI) [CA101829, 5R01CA12937]; Comprehensive Cancer Center; National Science Foundation [0722926]; NATIONAL CANCER INSTITUTE [R01CA101829, R01CA129373, P30CA012197] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Comprehensive Cancer Center; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was in part supported by a grant from the National Cancer Institute (NCI) (CA101829) and support from the Comprehensive Cancer Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the National Institutes of Health. FRS is partially supported by NCI grant 5R01CA12937. The Zeiss LSM 710 confocal microscope was funded by National Science Foundation MRI award number 0722926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Belvederesi L, 2008, HUM MUTAT, V29, pE296, DOI 10.1002/humu.20875; BOYER JC, 1995, CANCER RES, V55, P6063; Christmann M, 2002, NUCLEIC ACIDS RES, V30, P1959, DOI 10.1093/nar/30.9.1959; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; Clark AB, 2007, NUCLEIC ACIDS RES, V35, P4114, DOI 10.1093/nar/gkm409; Collavoli A, 2003, J MOL CELL CARDIOL, V35, P1191, DOI 10.1016/S0022-2828(03)00231-1; Cyr JL, 2008, J BIOL CHEM, V283, P31641, DOI 10.1074/jbc.M806018200; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DINGWALL C, 1989, J CELL SCI, P243; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; FRANGIONI JV, 1993, J CELL SCI, V105, P481; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hayes AP, 2009, DNA REPAIR, V8, P739, DOI 10.1016/j.dnarep.2009.02.003; Hessabi B, 2000, BIOCHEM BIOPH RES CO, V270, P695, DOI 10.1006/bbrc.2000.2491; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Knudsen NO, 2007, NUCLEIC ACIDS RES, V35, P2609, DOI 10.1093/nar/gkl1166; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kolodner RD, 1999, CANCER RES, V59, P5068; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leong V, 2009, MOL CARCINOGEN, V48, P742, DOI 10.1002/mc.20514; Lightfoot J, 1999, HUM MOL GENET, V8, P1007, DOI 10.1093/hmg/8.6.1007; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Mastrocola AS, 2010, DNA REPAIR, V9, P120, DOI 10.1016/j.dnarep.2009.11.003; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Moraru II, 2008, IET SYST BIOL, V2, P352, DOI 10.1049/iet-syb:20080102; Raevaara TE, 2005, GASTROENTEROLOGY, V129, P537, DOI 10.1053/j.gastro.2005.06.005; RICHARDSON WD, 1986, CELL, V44, P77, DOI 10.1016/0092-8674(86)90486-1; Ripperger T, 2010, HAEMATOL-HEMATOL J, V95, P841, DOI 10.3324/haematol.2009.015503; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schaff J, 1997, BIOPHYS J, V73, P1135, DOI 10.1016/S0006-3495(97)78146-3; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Swedlow JR, 2007, METHOD CELL BIOL, V81, P447, DOI 10.1016/S0091-679X(06)81021-6; Umar A, 1998, GENETICS, V148, P1637; Umar A, 1997, CANCER RES, V57, P3949; UNDERWOOD MR, 1990, EMBO J, V9, P91, DOI 10.1002/j.1460-2075.1990.tb08084.x; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Woods MO, 2007, HUM MUTAT, V28, P669, DOI 10.1002/humu.20502; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Zacksenhaus E, 1999, BBA-MOL CELL RES, V1451, P288, DOI 10.1016/S0167-4889(99)00103-2	48	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17907	10.1371/journal.pone.0017907	http://dx.doi.org/10.1371/journal.pone.0017907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437237	gold, Green Submitted, Green Published			2022-12-27	WOS:000288514600015
J	Ling, DJ; Salvaterra, PM				Ling, Daijun; Salvaterra, Paul M.			Robust RT-qPCR Data Normalization: Validation and Selection of Internal Reference Genes during Post-Experimental Data Analysis	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; PROTEIN; PCR; EXPRESSION; ELAV	Reverse transcription and real-time PCR (RT-qPCR) has been widely used for rapid quantification of relative gene expression. To offset technical confounding variations, stably-expressed internal reference genes are measured simultaneously along with target genes for data normalization. Statistic methods have been developed for reference validation; however normalization of RT-qPCR data still remains arbitrary due to pre-experimental determination of particular reference genes. To establish a method for determination of the most stable normalizing factor (NF) across samples for robust data normalization, we measured the expression of 20 candidate reference genes and 7 target genes in 15 Drosophila head cDNA samples using RT-qPCR. The 20 reference genes exhibit sample-specific variation in their expression stability. Unexpectedly the NF variation across samples does not exhibit a continuous decrease with pairwise inclusion of more reference genes, suggesting that either too few or too many reference genes may detriment the robustness of data normalization. The optimal number of reference genes predicted by the minimal and most stable NF variation differs greatly from 1 to more than 10 based on particular sample sets. We also found that GstD1, InR and Hsp70 expression exhibits an age-dependent increase in fly heads; however their relative expression levels are significantly affected by NF using different numbers of reference genes. Due to highly dependent on actual data, RT-qPCR reference genes thus have to be validated and selected at post-experimental data analysis stage rather than by pre-experimental determination.	[Ling, Daijun; Salvaterra, Paul M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Neurosci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Ling, DJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Neurosci, Duarte, CA 91010 USA.	dling@coh.org; psalv@coh.org			American Federation for Aging Research (AFAR); American Health Assistant Foundation (AHAF); Sidell-Kagan Foundation	American Federation for Aging Research (AFAR); American Health Assistant Foundation (AHAF); Sidell-Kagan Foundation	This work was supported by a postdoctoral fellowship from the American Federation for Aging Research (AFAR) to DL. The laboratory was supported by grants from the American Health Assistant Foundation (AHAF) and the Sidell-Kagan Foundation to PMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; MARTINMORRIS LE, 1990, DEVELOPMENT, V110, P185; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382	24	119	123	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17762	10.1371/journal.pone.0017762	http://dx.doi.org/10.1371/journal.pone.0017762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423626	gold, Green Published			2022-12-27	WOS:000288513900024
J	Godena, VK; Romano, G; Romano, M; Appocher, C; Klima, R; Buratti, E; Baralle, FE; Feiguin, F				Godena, Vinay K.; Romano, Giulia; Romano, Maurizio; Appocher, Chiara; Klima, Raffaella; Buratti, Emanuele; Baralle, Francisco E.; Feiguin, Fabian			TDP-43 Regulates Drosophila Neuromuscular Junctions Growth by Modulating Futsch/MAP1B Levels and Synaptic Microtubules Organization	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; IN-VIVO; POSTSYNAPTIC DIFFERENTIATION; FUNCTIONAL COMPONENTS; STRUCTURAL PLASTICITY; GENETIC DISSECTION; CFTR EXON-9; STABILITY; STABILIZATION	TDP-43 is an evolutionarily conserved RNA binding protein recently associated with the pathogenesis of different neurological diseases. At the moment, neither its physiological role in vivo nor the mechanisms that may lead to neurodegeneration are well known. Previously, we have shown that TDP-43 mutant flies presented locomotive alterations and structural defects at the neuromuscular junctions. We have now investigated the functional mechanism leading to these phenotypes by screening several factors known to be important for synaptic growth or bouton formation. As a result we found that alterations in the organization of synaptic microtubules correlate with reduced protein levels in the microtubule associated protein futsch/MAP1B. Moreover, we observed that TDP-43 physically interacts with futsch mRNA and that its RNA binding capacity is required to prevent futsch down regulation and synaptic defects.	[Godena, Vinay K.; Romano, Giulia; Appocher, Chiara; Klima, Raffaella; Buratti, Emanuele; Baralle, Francisco E.; Feiguin, Fabian] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Romano, Maurizio] Univ Trieste, Dept Life Sci, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste	Godena, VK (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	baralle@icgeb.org; feiguin@icgeb.org	Romano, Giulia/U-4156-2018; Buratti, Emanuele/K-4691-2016; Romano, Maurizio/G-9431-2012; Feiguin, Fabian/ABC-2514-2020	Romano, Giulia/0000-0003-0356-4947; Buratti, Emanuele/0000-0002-1356-9074; Romano, Maurizio/0000-0002-4820-2897; 	Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA)	Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA)	We thank Bloomington Drosophila Stock Center at Indiana University for fly stocks and Developmental Hybridoma Bank at Iowa University for antibodies. This work was supported by the Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA).	Akbergenova Y, 2007, BRAIN RES, V1178, P52, DOI 10.1016/j.brainres.2007.08.042; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; BURATTI E, 2010, RNA BIOL, V7; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; CHENPLOTKIN AS, NAT REV NEUROL, V6, P211; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kabashi E., HUM MOL GENET, V19, P671; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Lagier-Tourenne C, HUM MOL GENET, V19, pR46; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; MIGUEL L, 2010, NEUROBIOL DIS; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Rohrbough J, 2007, GENE DEV, V21, P2607, DOI 10.1101/gad.1574107; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Stewart BA, 1996, J NEUROSCI, V16, P3877; STRONG MJ, J NEUROL SCI, V288, P1; TAKEMURA R, 1992, J CELL SCI, V103, P953; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Zou B, 2008, BIOCHEM J, V414, P63, DOI 10.1042/BJ20071449	47	93	94	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17808	10.1371/journal.pone.0017808	http://dx.doi.org/10.1371/journal.pone.0017808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412434	gold, Green Published, Green Submitted			2022-12-27	WOS:000288247800031
J	Valverde-Islas, LE; Arrangoiz, E; Vega, E; Robert, L; Villanueva, R; Reynoso-Ducoing, O; Willms, K; Zepeda-Rodriguez, A; Fortoul, TI; Ambrosio, JR				Valverde-Islas, Laura E.; Arrangoiz, Esteban; Vega, Elio; Robert, Lilia; Villanueva, Rafael; Reynoso-Ducoing, Olivia; Willms, Kaethe; Zepeda-Rodriguez, Armando; Fortoul, Teresa I.; Ambrosio, Javier R.			Visualization and 3D Reconstruction of Flame Cells of Taenia solium (Cestoda)	PLOS ONE			English	Article							IN-VITRO; CYSTICERCI; ULTRASTRUCTURE; SYSTEM; ACTIN	Background: Flame cells are the terminal cells of protonephridial systems, which are part of the excretory systems of invertebrates. Although the knowledge of their biological role is incomplete, there is a consensus that these cells perform excretion/secretion activities. It has been suggested that the flame cells participate in the maintenance of the osmotic environment that the cestodes require to live inside their hosts. In live Platyhelminthes, by light microscopy, the cells appear beating their flames rapidly and, at the ultrastructural, the cells have a large body enclosing a tuft of cilia. Few studies have been performed to define the localization of the cytoskeletal proteins of these cells, and it is unclear how these proteins are involved in cell function. Methodology/Principal Findings: Parasites of two different developmental stages of T. solium were used: cysticerci recovered from naturally infected pigs and intestinal adults obtained from immunosuppressed and experimentally infected golden hamsters. Hamsters were fed viable cysticerci to recover adult parasites after one month of infection. In the present studies focusing on flame cells of cysticerci tissues was performed. Using several methods such as video, confocal and electron microscopy, in addition to computational analysis for reconstruction and modeling, we have provided a 3D visual rendition of the cytoskeletal architecture of Taenia solium flame cells. Conclusions/Significance: We consider that visual representations of cells open a new way for understanding the role of these cells in the excretory systems of Platyhelminths. After reconstruction, the observation of high resolution 3D images allowed for virtual observation of the interior composition of cells. A combination of microscopic images, computational reconstructions and 3D modeling of cells appears to be useful for inferring the cellular dynamics of the flame cell cytoskeleton.	[Valverde-Islas, Laura E.; Robert, Lilia; Villanueva, Rafael; Reynoso-Ducoing, Olivia; Willms, Kaethe; Ambrosio, Javier R.] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Zepeda-Rodriguez, Armando; Fortoul, Teresa I.] Univ Nacl Autonoma Mexico, Fac Med, Dept Biol Celular & Tisular, Mexico City 04510, DF, Mexico; [Vega, Elio] Univ Nacl Autonoma Mexico, Direcc Gen Comp & Tecnol Informac & Comunicac DGT, Dept Visualizac, Mexico City 04510, DF, Mexico; [Arrangoiz, Esteban] Univ Nacl Autonoma Mexico, Fac Med, Lab 3D, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Valverde-Islas, LE (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.	jrah@servidor.unam.mx	Fortoul, Teresa I./AAW-3936-2020; Ambrosio, Javier R/A-6099-2008	Fortoul, Teresa I./0000-0002-3507-1365; Ambrosio, Javier R/0000-0001-7441-0609	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM [IN201003, IN216107, IN200610]; DGAPA-IXTLI [0709008, IX200610]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [V43629-M, 080093]; CONACYT Mexico	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM(Universidad Nacional Autonoma de Mexico); DGAPA-IXTLI; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM (IN201003, IN216107 and IN200610), DGAPA-IXTLI (0709008 and IX200610) and from Consejo Nacional de Ciencia y Tecnologia (CONACYT) V43629-M and 080093. LEVI was supported by a doctoral fellowship from CONACYT Mexico and her Doctoral degree was obtained from Posgrado-UNAM, Doctorado en Ciencias Biomedicas, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2002, MOL BIOL CELL, P907; Ambrosio J, 1997, PARASITOLOGY, V114, P545; Ambrosio J, 1994, Arch Med Res, V25, P325; Ambrosio JR, 2003, CELL BIOL INT, V27, P727, DOI 10.1016/S1065-6995(03)00142-2; Arafa SZ, 2007, PARASITOL INT, V56, P297, DOI 10.1016/j.parint.2007.06.005; Bahia D, 2006, PARASITOLOGY, V133, P321, DOI 10.1017/S0031182006000400; Barnes D, 1987, ZOOLOGIA INVERTEBRAD, P179; BOAL D, 2002, MECH CELL, P323; Bray D, 2001, CELL MOVEMENTS MOL M; BRUSCA CR, 2003, INVERTEBRATES, P285; Cardenas-Ramirez L., 1982, P281; Coil W.H., 1991, P211; Cruz-Rivera M, 2006, CELL BIOL INT, V30, P598, DOI 10.1016/j.cellbi.2006.02.010; Darenfed H, 2005, BIOCHEM CELL BIOL, V83, P711, DOI 10.1139/O05-164; Iwasa JH, 2010, TRENDS CELL BIOL, V20, P699, DOI 10.1016/j.tcb.2010.08.005; KARP G, 2005, BIOL CELULAR MOL, P357; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; LEMULLOIS M, 1990, J CELL SCI, V95, P423; LODISH H, 2000, MOL CELL BIOL, P796; LUMSDEN DR, 1983, BIOL EUCESTODA, P177; MCCULLOUGH JS, 1991, PARASITOL RES, V77, P157, DOI 10.1007/BF00935430; McGill G, 2008, CELL, V133, P1127, DOI 10.1016/j.cell.2008.06.013; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Moreno MJ, 2001, FOLIA PARASIT, V48, P163, DOI 10.14411/fp.2001.027; Neusser TP, 2006, J MORPHOL, V267, P231, DOI 10.1002/jmor.10398; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Palomares F, 2006, J ANTIMICROB CHEMOTH, V57, P482, DOI 10.1093/jac/dki484; Rivera N, 2004, PARASITOL RES, V93, P283, DOI 10.1007/s00436-004-1127-3; ROHDE K, 1992, INT J PARASITOL, V22, P443, DOI 10.1016/0020-7519(92)90145-B; Roman G, 2000, B WORLD HEALTH ORGAN, V78, P399; Smyth J.D., 1989, PHYSL BIOCH CESTODES, P5; Tan HHC, 2003, PARASITOLOGY, V126, P235, DOI 10.1017/S0031182002002846; Vargas-Parada L, 1999, PARASITOL RES, V85, P88, DOI 10.1007/s004360050514; VOGE M, 1963, J PARASITOL, V49, P85, DOI 10.2307/3275681; Wahlberg MH, 1998, CELL TISSUE RES, V291, P561, DOI 10.1007/s004410051025; Willms K, 2005, PARASITOL RES, V96, P296, DOI 10.1007/s00436-005-1348-0	37	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e14754	10.1371/journal.pone.0014754	http://dx.doi.org/10.1371/journal.pone.0014754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412407	Green Published, Green Submitted, gold			2022-12-27	WOS:000288247800001
J	Xia, JH; He, XP; Bai, ZY; Yue, GH				Xia, Jun Hong; He, Xiao Ping; Bai, Zhi Yi; Yue, Gen Hua			Identification and Characterization of 63 MicroRNAs in the Asian Seabass Lates calcarifer	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; CAENORHABDITIS-ELEGANS; ANIMAL DEVELOPMENT; RNA INTERFERENCE; GENE-EXPRESSION; CLONING; ZEBRAFISH; CONSERVATION; INFLAMMATION; BARRAMUNDI	Background: MicroRNAs (miRNAs) play an important role in the regulation of many fundamental biological processes. So far miRNAs have been only identified in a few fish species, although there are over 30,000 fish species living under different environmental conditions on the earth. Here, we described an approach to identify conserved miRNAs and characterized their expression patterns in different tissues for the first time in a food fish species Asian seabass (Lates calcarifer). Methodology/Principal Findings: By combining a bioinformatics analysis with an approach of homolog-based PCR amplification and sequencing, 63 novel miRNAs belonging to 29 conserved miRNA families were identified. Of which, 59 miRNAs were conserved across 10-86 species (E value <= 10(-4)) and 4 miRNAs were conserved only in fish species. qRT-PCR analysis showed that miR-29, miR-103, miR-125 and several let-7 family members were strongly and ubiquitously expressed in all tissues tested. Interestingly, miR-1, miR-21, miR-183, miR-184 and miR-192 showed highly conserved tissue-specific expression patterns. Exposure of the Asian seabass to lipopolysaccharide (LPS) resulted in up-regulation of over 50% of the identified miRNAs in spleen suggesting the importance of the miRNAs in acute inflammatory immune responses. Conclusions/Significance: The approach used in this study is highly effective for identification of conserved miRNAs. The identification of 63 miRNAs and determination of the spatial expression patterns of these miRNAs are valuable resources for further studies on post-transcriptional gene regulation in Asian seabass and other fish species. Further identification of the target genes of these miRNAs would shed new light on their regulatory roles of microRNAs in fish.	[Xia, Jun Hong; He, Xiao Ping; Bai, Zhi Yi; Yue, Gen Hua] Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore	National University of Singapore	Xia, JH (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	Ministry of National Development	Ministry of National Development	This study is funded by Ministry of National Development for the project "To ensure self-sufficiency of safe seafood for Singapore through the development of aquaculture genomic tools for marker-assisted selective breeding of tropical marine foodfish''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BENSI G, 1987, GENE, V52, P95, DOI 10.1016/0378-1119(87)90398-2; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bromage ES, 1999, DIS AQUAT ORGAN, V36, P177, DOI 10.3354/dao036177; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Calix M., 2018, EUROPEAN RED LIST SA; CARSON J, 1993, J FISH DIS, V16, P209, DOI 10.1111/j.1365-2761.1993.tb01250.x; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; GRIFFITHSJONES S, 2006, MIRBASE MICRORNA SEQ, pD140; GRIFFITHSJONES S, 2008, MIRBASE TOOLS MICROR, pD154; GRIFFITHSJONES S, 2004, MICRORNA REGISTRY, pD109; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2002, J CELL BIOL, V156, P17, DOI 10.1083/jcb.200111033; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; Jia WZ, 2008, CHINESE SCI BULL, V53, P169, DOI 10.1007/s11434-008-0106-y; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee IH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1165; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; MAUVIEL A, 1988, BIOCHEM BIOPH RES CO, V156, P1209, DOI 10.1016/S0006-291X(88)80761-7; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Sonkoly E, 2009, J CELL MOL MED, V13, P24, DOI 10.1111/j.1582-4934.2008.00534.x; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Takada S, 2007, NAT PROTOC, V2, P3136, DOI 10.1038/nprot.2007.457; Tani S, 2010, GENE, V449, P41, DOI 10.1016/j.gene.2009.09.005; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-356; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; 1998, CLONTECHNIQUES, V13, P12	79	44	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17537	10.1371/journal.pone.0017537	http://dx.doi.org/10.1371/journal.pone.0017537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412421	gold, Green Published, Green Submitted			2022-12-27	WOS:000288247800012
J	Hu, L; Huang, T; Liu, XJ; Cai, YD				Hu, Lele; Huang, Tao; Liu, Xiao-Jun; Cai, Yu-Dong			Predicting Protein Phenotypes Based on Protein-Protein Interaction Network	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; HIV-1 DRUG SUSCEPTIBILITY; SACCHAROMYCES-CEREVISIAE; INTERACTION MAP; BREAST-CANCER; YEAST; GENOTYPE; GENES; IDENTIFICATION; LOCATION	Background: Identifying associated phenotypes of proteins is a challenge of the modern genetics since the multifactorial trait often results from contributions of many proteins. Besides the high-through phenotype assays, the computational methods are alternative ways to identify the phenotypes of proteins. Methodology/Principal Findings: Here, we proposed a new method for predicting protein phenotypes in yeast based on protein-protein interaction network. Instead of only the most likely phenotype, a series of possible phenotypes for the query protein were generated and ranked acording to the tethering potential score. As a result, the first order prediction accuracy of our method achieved 65.4% evaluated by Jackknife test of 1,267 proteins in budding yeast, much higher than the success rate (15.4%) of a random guess. And the likelihood of the first 3 predicted phenotypes including all the real phenotypes of the proteins was 70.6%. Conclusions/Significance: The candidate phenotypes predicted by our method provided useful clues for the further validation. In addition, the method can be easily applied to the prediction of protein associated phenotypes in other organisms.	[Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Lele] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Liu, Xiao-Jun] Shihezi Univ, Coll Anim Sci & Technol, Shihezi City, Xinjiang, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shihezi University; Fudan University	Hu, L (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	xiaojun.liu@ed.ac.uk; cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	CYGD; STRING	CYGD; STRING	We thank CYGD and STRING for supply data to support not-for-profit research efforts.	Afjehi-Sadat L, 2007, NAT PROTOC, V2, P2318, DOI 10.1038/nprot.2007.317; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Cai HJ, 2006, GENETICS, V172, P1459, DOI 10.1534/genetics.105.053041; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Carter GW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100137; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Dwyer T, 2004, AM J EPIDEMIOL, V159, P826, DOI 10.1093/aje/kwh120; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foulkes AS, 2002, BIOMETRICS, V58, P145, DOI 10.1111/j.0006-341X.2002.00145.x; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaleta C, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-37; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin TY, 2010, INT J RADIAT ONCOL, V78, P246, DOI 10.1016/j.ijrobp.2010.03.002; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; Morton CO, 2007, MOL MICROBIOL, V65, P494, DOI 10.1111/j.1365-2958.2007.05801.x; Onuki Ritsuko, 2010, V22, P132, DOI 10.1142/9781848165786_0011; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Piruzyan L A, 2004, Dokl Biochem Biophys, V395, P84, DOI 10.1023/B:DOBI.0000025552.40172.db; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Ungar L, 2009, NUCLEIC ACIDS RES, V37, P3840, DOI 10.1093/nar/gkp259; Van Houtte M, 2009, J MED VIROL, V81, P1702, DOI 10.1002/jmv.21585; Vasilyev A. V., 2009, Voprosy Virusologii, V54, P17; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Watanabe M, 2009, CURR GENET, V55, P365, DOI 10.1007/s00294-009-0251-0; Whitfield PD, 2002, MOL GENET METAB, V75, P46, DOI 10.1006/mgme.2001.3269; Winzeler E A, 2000, Novartis Found Symp, V229, P105; Xu SG, 2007, J MICROBIOL, V45, P441; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	55	165	165	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17668	10.1371/journal.pone.0017668	http://dx.doi.org/10.1371/journal.pone.0017668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423698	gold, Green Published, Green Submitted			2022-12-27	WOS:000288219100023
J	Schnable, JC; Freeling, M				Schnable, James C.; Freeling, Michael			Genes Identified by Visible Mutant Phenotypes Show Increased Bias toward One of Two Subgenomes of Maize	PLOS ONE			English	Article							GENOME; GRASSES; ARABIDOPSIS; EVOLUTION; GENETICS; SORGHUM	Not all genes are created equal. Despite being supported by sequence conservation and expression data, knockout homozygotes of many genes show no visible effects, at least under laboratory conditions. We have identified a set of maize (Zea mays L.) genes which have been the subject of a disproportionate share of publications recorded at MaizeGDB. We manually anchored these "classical" maize genes to gene models in the B73 reference genome, and identified syntenic orthologs in other grass genomes. In addition to proofing the most recent version 2 maize gene models, we show that a subset of these genes, those that were identified by morphological phenotype prior to cloning, are retained at syntenic locations throughout the grasses at much higher levels than the average expressed maize gene, and are preferentially found on the maize1 subgenome even with a duplicate copy is still retained on the opposite subgenome. Maize1 is the subgenome that experienced less gene loss following the whole genome duplication in maize lineage 5-12 million years ago and genes located on this subgenome tend to be expressed at higher levels in modern maize. Links to the web based software that supported our syntenic analyses in the grasses should empower further research and support teaching involving the history of maize genetic research. Our findings exemplify the concept of "grasses as a single genetic system," where what is learned in one grass may be applied to another.	[Schnable, James C.; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schnable, JC (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	jschnable@berkeley.edu		Schnable, James/0000-0001-6739-5527	NSF [DBI-0701871]; Chang-Lin Tien Graduate Fellowship	NSF(National Science Foundation (NSF)); Chang-Lin Tien Graduate Fellowship	Funded by NSF DBI-0701871 to MF and Chang-Lin Tien Graduate Fellowship to JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; BENNETZEN JL, 1993, TRENDS GENET, V9, P259, DOI 10.1016/0168-9525(93)90001-X; Bennetzen JL, 1997, GENOME RES, V7, P301, DOI 10.1101/gr.7.4.301; Bomblies K, 2005, MOL BIOL EVOL, V22, P1082, DOI 10.1093/molbev/msi095; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; LAWRENCE CJ, 2008, INT J PLANT GENOMICS, DOI DOI 10.1155/2008/496957; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; MCCLINTOCK B, 1983, NATL LIB MED PROFILE; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; SCHNABLE JC, 2011, P NATL ACAD IN PRESS; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WEI F, ARIZONA GENOMICS WEB; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wilkerson MD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r58; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409	25	117	118	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17855	10.1371/journal.pone.0017855	http://dx.doi.org/10.1371/journal.pone.0017855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423772	Green Published, gold			2022-12-27	WOS:000288219100040
J	Kurikawa, T; Kaneko, K				Kurikawa, Tomoki; Kaneko, Kunihiko			Learning Shapes Spontaneous Activity Itinerating over Memorized States	PLOS ONE			English	Article							TRANSIENT DYNAMICS; NETWORKS; REPRESENTATIONS; REINFORCEMENT; SYSTEMS; NEURONS; TIME	Learning is a process that helps create neural dynamical systems so that an appropriate output pattern is generated for a given input. Often, such a memory is considered to be included in one of the attractors in neural dynamical systems, depending on the initial neural state specified by an input. Neither neural activities observed in the absence of inputs nor changes caused in the neural activity when an input is provided were studied extensively in the past. However, recent experimental studies have reported existence of structured spontaneous neural activity and its changes when an input is provided. With this background, we propose that memory recall occurs when the spontaneous neural activity changes to an appropriate output activity upon the application of an input, and this phenomenon is known as bifurcation in the dynamical systems theory. We introduce a reinforcement-learning-based layered neural network model with two synaptic time scales; in this network, I/O relations are successively memorized when the difference between the time scales is appropriate. After the learning process is complete, the neural dynamics are shaped so that it changes appropriately with each input. As the number of memorized patterns is increased, the generated spontaneous neural activity after learning shows itineration over the previously learned output patterns. This theoretical finding also shows remarkable agreement with recent experimental reports, where spontaneous neural activity in the visual cortex without stimuli itinerate over evoked patterns by previously applied signals. Our results suggest that itinerant spontaneous activity can be a natural outcome of successive learning of several patterns, and it facilitates bifurcation of the network when an input is provided.	[Kurikawa, Tomoki; Kaneko, Kunihiko] Univ Tokyo, Dept Basic Sci, Tokyo, Japan	University of Tokyo	Kurikawa, T (corresponding author), Univ Tokyo, Dept Basic Sci, Tokyo, Japan.	kurikawa@complex.c.u-tokyo.ac.jp			MEXT Japan [21120004]	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by Grants-in-Aid for scientific research (No. 21120004) from MEXT Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTO AG, 1981, BIOL CYBERN, V40, P201, DOI 10.1007/BF00453370; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gros C, 2009, COGN COMPUT, V1, P77, DOI 10.1007/s12559-008-9000-9; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Jordan M.I., 1990, ARTIFICIAL NEURAL NE, P112; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kurikawa T, 2010, LECT NOTES COMPUT SC, V6443, P155, DOI 10.1007/978-3-642-17537-4_20; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17432	10.1371/journal.pone.0017432	http://dx.doi.org/10.1371/journal.pone.0017432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408170	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000029
J	Yi, ZZ; Song, WB				Yi, Zhenzhen; Song, Weibo			Evolution of the Order Urostylida (Protozoa, Ciliophora): New Hypotheses Based on Multi-Gene Information and Identification of Localized Incongruence	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; NOV SPEC. CILIOPHORA; N-COMB. CILIOPHORA; ACTIN-I GENE; MOLECULAR PHYLOGENY; DIVISIONAL MORPHOGENESIS; MARINE CILIATE; YELLOW SEA; STICHOTRICHIA; SPIROTRICHEA	Previous systematic arrangement on the ciliate order Urostylida was mainly based on morphological data and only about 20% taxa were analyzed using molecular phylogenetic analyses. In the present investigation, 22 newly sequenced species for which alpha-tubulin, SSU rRNA genes or ITS1-5.8S-ITS2 region were sampled, refer to all families within the order. Following conclusions could be drawn: (1) the order Urostylida is not monophyletic, but a core group is always present; (2) among the family Urostylidae, six of 10 sequenced genera are rejected belonging to this family; (3) the genus Epiclintes is confirmed belonging to its own taxon; (4) the family Pseudokeronopsidae undoubtedly belongs to the core portion of urostylids; however, some or most of its members should be transferred to the family Urostylidae; (5) Bergeriellidae is confirmed to be a valid family; (6) the distinction of the taxon Acaudalia is not supported; (7) the morphology-based genus Anteholosticha is extremely polyphyletic; (8) ITS2 secondary structures of Pseudoamphisiella and Psammomitra are rather different from other urostylids; (9) partition addition bootstrap alteration (PABA) result shows that bootstrap values usually tend to increase as more gene partitions are included.	[Yi, Zhenzhen; Song, Weibo] Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Protozool, Qingdao, Peoples R China; [Yi, Zhenzhen] S China Normal Univ, Coll Life Sci, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Lab Protozool, Guangzhou, Guangdong, Peoples R China	Ocean University of China; South China Normal University	Yi, ZZ (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Protozool, Qingdao, Peoples R China.	wsong@ouc.edu.cn			Natural Science Foundation of China [31030059, 41006098]; Foundation for Distinguished Yong Talents in Higher Education of Guangdong, China [LYM10060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Yong Talents in Higher Education of Guangdong, China	This work was supported by the Natural Science Foundation of China (Project No. 31030059, 41006098). Its website is http://www.nsfc.gov.cn/Portal0/default124.htm. It was also supported by Foundation for Distinguished Yong Talents in Higher Education of Guangdong, China (Project No. LYM10060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2008, V88, P1; BAMFORTH SS, 1962, OFFICIAL PUBLICATION, V9, P34; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Berger H, 2003, EUR J PROTISTOL, V39, P373, DOI 10.1078/0932-4739-00006; BERGER H, 2006, MONOGR BIOL, V85, pR11; Berger H., 1999, MONOGRAPHIAE BIOL, V78, P1, DOI DOI 10.1007/978-94-011-4637-1; Bernhard D, 2001, MOL PHYLOGENET EVOL, V21, P86, DOI 10.1006/mpev.2001.0997; BORROR A, 1972, Acta Protozoologica, V10, P29; BORROR AC, 1983, ACTA PROTOZOOL, V22, P97; BORROR AC, 1979, J PROTOZOOL, V26, P544, DOI 10.1111/j.1550-7408.1979.tb04192.x; BORROR AC, 1972, J PROTOZOOL, V19, P1, DOI 10.1111/j.1550-7408.1972.tb03407.x; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; CALKINS GN, 1926, BIOL PROTOZOA; Cameron SL, 2001, MOL PHYLOGENET EVOL, V20, P302, DOI 10.1006/mpev.2001.0986; Carey P.G, 1992, MARINE INTERSTITIAL; Chen XR, 2010, INT J SYST EVOL MICR, V60, P234, DOI 10.1099/ijs.0.008037-0; Chen XM, 2010, EUR J PROTISTOL, V46, P43, DOI 10.1016/j.ejop.2009.08.002; CHIPPINDALE PT, 1994, SYST BIOL, V43, P278, DOI 10.2307/2413469; Coleman AW, 2005, J EUKARYOT MICROBIOL, V52, P68, DOI 10.1111/j.1550-7408.2005.3327r.x; CORLISS J O, 1979, P455; CORLISS JO, 1977, T AM MICROSC SOC, V96, P104, DOI 10.2307/3225971; CORLISS JO, 1961, INT SERIES MONOGRAPH; Croft KE, 2003, J MOL EVOL, V56, P341, DOI 10.1007/s00239-002-2405-2; Dalby AB, 2004, CHROMOSOMA, V112, P247, DOI 10.1007/s00412-003-0270-4; de Puytorac Pierre, 1994, P1; DeRijk P, 1997, NUCLEIC ACIDS RES, V25, P4679, DOI 10.1093/nar/25.22.4679; DINI F, 1995, CHECKLIST SPECIE FAU; EIGNER P, 1992, EUR J PROTISTOL, V28, P460, DOI 10.1016/S0932-4739(11)80011-8; Eigner P, 2001, J EUKARYOT MICROBIOL, V48, P70, DOI 10.1111/j.1550-7408.2001.tb00417.x; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FAUREFREMIET E, 1961, CR HEBD ACAD SCI, V252, P3515; Foissner W, 2004, EUR J PROTISTOL, V40, P265, DOI 10.1016/j.ejop.2004.05.004; Foissner W, 2008, ACTA PROTOZOOL, V47, P1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEMBERGER H, 1982, REVISION ORDNUMG HYP; Hewitt EA, 2003, MOL PHYLOGENET EVOL, V29, P258, DOI 10.1016/S1055-7903(03)00097-6; Hogan DJ, 2001, P NATL ACAD SCI USA, V98, P15101, DOI 10.1073/pnas.011578598; Hu XY, 2009, ACTA PROTOZOOL, V48, P203; Hu XZ, 2002, EUR J PROTISTOL, V38, P351, DOI 10.1078/0932-4739-00880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jankowski A., 1979, T ZOOL I LENINGR, V86, P48; JERKA-DZIADOSZ M, 1972, Acta Protozoologica, V10, P249; Kahl A., 1932, Tierwelt Deutschlands Jena, V25, P399; KALTENBACH A, 1960, WASS ABWASS WIEN, P151; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Levasseur C, 2001, SYST BIOL, V50, P881, DOI 10.1080/106351501753462858; Li LF, 2009, PROG NAT SCI-MATER, V19, P769, DOI 10.1016/j.pnsc.2008.06.027; Li LQ, 2008, EUR J PROTISTOL, V44, P208, DOI 10.1016/j.ejop.2008.01.001; Li LQ, 2007, J EUKARYOT MICROBIOL, V54, P527, DOI 10.1111/j.1550-7408.2007.00294.x; Li LQ, 2009, EUR J PROTISTOL, V45, P237, DOI 10.1016/j.ejop.2009.01.004; Liu WW, 2010, ZOOL J LINN SOC-LOND, V158, P697, DOI 10.1111/j.1096-3642.2009.00565.x; Lynn D.H., 2008, CILIATED PROTOZOA; LYNN DH, 2002, ILLUSTRATED GUIDE PR, V1; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; MIAO M, 2011, SCI CHINA C IN PRESS, V54; Nygren A, 2003, MOL PHYLOGENET EVOL, V29, P235, DOI 10.1016/S1055-7903(03)00095-2; NYLANDER JA, MRMODELTEST V2 EVOLU; OBERSCHMIDLEITN.R, 1996, BEITR NATURK OBEROST, V3, P3; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paiva TS, 2009, GENET MOL RES, V8, P223, DOI 10.4238/vol8-1gmr529; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Schmidt SL, 2007, J EUKARYOT MICROBIOL, V54, P201, DOI 10.1111/j.1550-7408.2007.00250.x; SHANG H, 2004, MOL PHYLOGENY SCUTIC; Shao C, 2007, J EUKARYOT MICROBIOL, V54, P392, DOI 10.1111/j.1550-7408.2007.00278.x; Shao C, 2007, ACTA PROTOZOOL, V46, P25; Shao C, 2008, ACTA PROTOZOOL, V47, P363; Shi X, 1999, PROGR PROTOZOOLOGY, P189; SHI X, 1999, PROGR PROTOZOOLOGY, P77; Shi Xin-Lu, 1999, Acta Zootaxonomica Sinica, V24, P241; Shi Xin-Lu, 1999, Acta Zootaxonomica Sinica, V24, P361; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Siebert S, 2005, BIOINFORMATICS, V21, P3352, DOI 10.1093/bioinformatics/bti550; Snoeyenbos-West OLO, 2002, INT J SYST EVOL MICR, V52, P1901, DOI 10.1099/00207713-52-5-1901; Song WB, 1997, ARCH PROTISTENKD, V147, P265, DOI 10.1016/S0003-9365(97)80053-X; Stoeck T, 2007, J EUKARYOT MICROBIOL, V54, P436, DOI 10.1111/j.1550-7408.2007.00283.x; Struck TH, 2006, SYST BIOL, V55, P1, DOI 10.1080/10635150500354910; Struder-Kypke MC, 2006, PROTIST, V157, P261, DOI 10.1016/j.protis.2006.03.003; Sung GH, 2007, MOL PHYLOGENET EVOL, V44, P1204, DOI 10.1016/j.ympev.2007.03.011; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TUFFRAU M, 1979, T AM MICROSC SOC, V98, P521, DOI 10.2307/3225902; TUFFRAU M, 1987, ANN SCI NAT ZOOL, V8, P111; Tuffrau M., 1994, TRAIT ZOOLOGIE INFUS, P83; Wicklow B.J., 1983, Dissertation Abstracts International B Sciences and Engineering, V43, P2135; WICKLOW BJ, 1990, EUR J PROTISTOL, V26, P182, DOI 10.1016/S0932-4739(11)80113-6; Yi Z, 2008, J ZOOL, V275, P268, DOI 10.1111/j.1469-7998.2008.00438.x; Yi ZZ, 2008, EUR J PROTISTOL, V44, P45, DOI 10.1016/j.ejop.2007.08.002; Yi ZZ, 2010, SYST BIODIVERS, V8, P149, DOI 10.1080/14772000903523493; Yi ZZ, 2009, ZOOL J LINN SOC-LOND, V157, P227, DOI 10.1111/j.1096-3642.2008.00524.x; Yi ZZ, 2009, PROG NAT SCI-MATER, V19, P581, DOI 10.1016/j.pnsc.2008.05.033; Yi ZZ, 2009, MOL PHYLOGENET EVOL, V50, P599, DOI 10.1016/j.ympev.2008.12.006; Yi ZZ, 2008, EUR J PROTISTOL, V44, P254, DOI 10.1016/j.ejop.2007.12.002; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	97	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17471	10.1371/journal.pone.0017471	http://dx.doi.org/10.1371/journal.pone.0017471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408166	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170000033
J	Deguchi, S				Deguchi, Shinji			Mechanism of and Threshold Biomechanical Conditions for Falsetto Voice Onset	PLOS ONE			English	Article							MYOELASTIC-AERODYNAMIC THEORY; COLLAPSIBLE-TUBE; FLOW SEPARATION; 2-MASS MODEL; VOCAL FOLDS; FUNDAMENTAL-FREQUENCY; NUMERICAL-ANALYSIS; AIR-FLOW; PHONATION; PRESSURE	The sound source of a voice is produced by the self-excited oscillation of the vocal folds. In modal voice production, a drastic increase in transglottal pressure after vocal fold closure works as a driving force that develops self-excitation. Another type of vocal fold oscillation with less pronounced glottal closure observed in falsetto voice production has been accounted for by the mucosal wave theory. The classical theory assumes a quasi-steady flow, and the expected driving force onto the vocal folds under wavelike motion is derived from the Bernoulli effect. However, wavelike motion is not always observed during falsetto voice production. More importantly, the application of the quasi-steady assumption to a falsetto voice with a fundamental frequency of several hundred hertz is unsupported by experiments. These considerations suggested that the mechanism of falsetto voice onset may be essentially different from that explained by the mucosal wave theory. In this paper, an alternative mechanism is submitted that explains how self-excitation reminiscent of the falsetto voice could be produced independent of the glottal closure and wavelike motion. This new explanation is derived through analytical procedures by employing only general unsteady equations of motion for flow and solids. The analysis demonstrated that a convective acceleration of a flow induced by rapid wall movement functions as a negative damping force, leading to the self-excitation of the vocal folds. The critical subglottal pressure and volume flow are expressed as functions of vocal fold biomechanical properties, geometry, and voice fundamental frequency. The analytically derived conditions are qualitatively and quantitatively reasonable in view of reported measurement data of the thresholds required for falsetto voice onset. Understanding of the voice onset mechanism and the explicit mathematical descriptions of thresholds would be beneficial for the diagnosis and treatment of voice diseases and the development of artificial vocal folds.	Tohoku Univ, Dept Biomed Engn, Sendai, Miyagi 980, Japan	Tohoku University	Deguchi, S (corresponding author), Tohoku Univ, Dept Biomed Engn, Sendai, Miyagi 980, Japan.	deguchi@bml.mech.tohoku.ac.jp		Deguchi, Shinji/0000-0002-0556-4599	Japan Ministry of Education, Culture, Sports, Science, and Technology [19700382]; Ono Acoustics Research Fund	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Acoustics Research Fund	This work was supported in part by Program for Exploring Advanced Interdisciplinary Frontiers and grant-in-aid for Scientific Research (19700382) from the Japan Ministry of Education, Culture, Sports, Science, and Technology (http://www.mext.go.jp/english/) and the Ono Acoustics Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour F, 2004, J ACOUST SOC AM, V116, P1710, DOI 10.1121/1.1779274; Alipour F, 2009, J SPEECH LANG HEAR R, V52, P465, DOI [10.1044/1092-4388(2008/07-0212), 10.1044/1092-4388(2008/07-0212]; Aronson A., 2009, CLIN VOICE DISORDERS; Bailey BJ, 2006, HEAD NECK SURG OTOLA; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; BERTRAM CD, 1982, J BIOMECH, V15, P39, DOI 10.1016/0021-9290(82)90033-1; Bertram CD, 2008, RESP PHYSIOL NEUROBI, V163, P256, DOI 10.1016/j.resp.2008.04.011; CANCELLI C, 1985, J FLUID MECH, V157, P375, DOI 10.1017/S0022112085002427; Daniloff R, 1980, PHYSL SPEECH HEARING; DEGUCHI S., 2006, J BIOMECH SCI ENG, V1, P246; Deguchi S, 2007, ANN OTO RHINOL LARYN, V116, P128, DOI 10.1177/000348940711600209; Deguchi S, 2009, J BIOMECH, V42, P824, DOI 10.1016/j.jbiomech.2009.01.027; DEJONCKERE P, 1981, ARCH INT PHYSIOL BIO, V89, P127, DOI 10.3109/13813458109073992; FLANAGAN JL, 1968, IEEE T ACOUST SPEECH, VAU16, P57, DOI 10.1109/TAU.1968.1161949; Fung Y.C., 2002, INTRO THEORY AEROELA; Fung Y.C., 1993, BIOMECHANICS MECH PR; Fung YC, 1990, BIOMECHANICS MOTION; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; HOLLIEN H, 1962, J SPEECH HEAR RES, V5, P237, DOI 10.1044/jshr.0503.237; Horacek J, 2005, J FLUID STRUCT, V20, P853, DOI 10.1016/j.jfluidstructs.2005.05.003; Horacek J, 2002, J FLUID STRUCT, V16, P931, DOI 10.1006/jfls.2002.0454; Hottinger DG, 2007, LARYNGOSCOPE, V117, P1695, DOI 10.1097/MLG.0b013e3180959e38; Hunter EJ, 2007, J APPL PHYSIOL, V103, P206, DOI 10.1152/japplphysiol.00892.2006; HYAKUTAKE T, 2006, J BIOMECH SCI ENG, V1, P290; Ikeda T, 2001, J BIOMECH ENG-T ASME, V123, P571, DOI 10.1115/1.1408939; Ikeda T, 1999, J BIOMECH ENG-T ASME, V121, P153, DOI 10.1115/1.2835097; IKEDA T, 1994, T JPN SOC MECH ENG-B, V60, P1226; ISHIZAKA K, 1972, AT&T TECH J, V51, P1233, DOI 10.1002/j.1538-7305.1972.tb02651.x; Ishizaka K, 1972, SCRL MONOGR, V8; Ishizaka K., 1968, J ACOUST SOC JPN, V24, P311, DOI [10.20697/jasj.24.5_311, DOI 10.20697/JASJ.24.5_311]; Ishizaka K., 1968, J ACOUST SOC JPN, V24, P312, DOI [10.20697/jasj.24.5_312, DOI 10.20697/JASJ.24.5_312]; Jiang JJ, 2007, J ACOUST SOC AM, V121, P2873, DOI 10.1121/1.2710961; Kaneko T., 1972, J JPN BRONCHOESOPHAG, V25, P133, DOI 10.2468/jbes.25.133; KATZ AI, 1969, BIOPHYS J, V9, P1261, DOI 10.1016/S0006-3495(69)86451-9; Krane M, 2007, J ACOUST SOC AM, V122, P3659, DOI 10.1121/1.2409485; Krane MH, 2006, J ACOUST SOC AM, V120, P1578, DOI 10.1121/1.2215408; Lucero JC, 1999, J ACOUST SOC AM, V105, P423, DOI 10.1121/1.424572; Lucero JC, 1996, J ACOUST SOC AM, V100, P3355, DOI 10.1121/1.416976; Matsuzaki Y, 1998, J BIOMECH ENG-T ASME, V120, P594, DOI 10.1115/1.2834749; MATSUZAKI Y, 1994, J BIOMECH ENG-T ASME, V116, P469, DOI 10.1115/1.2895798; Miller DG, 2005, FOLIA PHONIATR LOGO, V57, P278, DOI 10.1159/000087081; PELORSON X, 1994, J ACOUST SOC AM, V96, P3416, DOI 10.1121/1.411449; Plant RL, 2004, J ACOUST SOC AM, V116, P3640, DOI 10.1121/1.1812309; Regner MF, 2008, LARYNGOSCOPE, V118, P1313, DOI 10.1097/MLG.0b013e31816e2ec7; RUBIN HENRY J., 1960, LARYNGOSCOPE, V70, P1305; Sciamarella D, 2008, EUR J MECH B-FLUID, V27, P42, DOI 10.1016/j.euromechflu.2007.06.004; Sciamarella D, 2004, ACTA ACUST UNITED AC, V90, P746; SLOAN SH, 1993, LARYNGOSCOPE, V103, P947; Solomon NP, 2007, J VOICE, V21, P541, DOI 10.1016/j.jvoice.2006.04.002; STORY BH, 1995, J ACOUST SOC AM, V97, P1249, DOI 10.1121/1.412234; Svec JG, 1999, J ACOUST SOC AM, V106, P1523, DOI 10.1121/1.427149; Tao C, 2008, J ACOUST SOC AM, V123, P1637, DOI 10.1121/1.2832328; Titze IR, 2009, J SPEECH LANG HEAR R, V52, P1062, DOI 10.1044/1092-4388(2009/08-0110); TITZE IR, 1992, J ACOUST SOC AM, V91, P2926, DOI 10.1121/1.402928; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; TITZE IR, 1980, J SPEECH HEAR RES, V23, P495, DOI 10.1044/jshr.2303.495; Titze IR, 1994, PRINCIPLES VOICE PRO; Tokuda IT, 2007, J ACOUST SOC AM, V122, P519, DOI 10.1121/1.2741210; VANDENBERG J, 1958, J SPEECH HEAR RES, V1, P227, DOI 10.1044/jshr.0103.227; VERDOLINIMARSTON K, 1990, J VOICE, V4, P142, DOI 10.1016/S0892-1997(05)80139-0; WALSH C, 1995, J FLUID STRUCT, V9, P393, DOI 10.1006/jfls.1995.1022; Wang TG, 2010, J FORMOS MED ASSOC, V109, P62, DOI 10.1016/S0929-6646(10)60022-8; Washio S, 2008, P I MECH ENG C-J MEC, V222, P1695, DOI 10.1243/09544062JMES965; WOODSON G, 1998, OFFICE BASED SURG OT, P159; YOSHIKAWA S, 1995, J ACOUST SOC AM, V97, P1929, DOI 10.1121/1.412066; Zhang ZY, 2008, J ACOUST SOC AM, V124, P1689, DOI 10.1121/1.2957938; Zhang ZY, 2006, J ACOUST SOC AM, V120, P1558, DOI 10.1121/1.2225682; Zhuang P, 2009, LARYNGOSCOPE, V119, P811, DOI 10.1002/lary.20165	68	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17503	10.1371/journal.pone.0017503	http://dx.doi.org/10.1371/journal.pone.0017503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408178	Green Submitted, Green Published, gold			2022-12-27	WOS:000288099800021
J	Roellig, K; Drews, B; Goeritz, F; Hildebrandt, TB				Roellig, Kathleen; Drews, Barbara; Goeritz, Frank; Hildebrandt, Thomas Bernd			The Long Gestation of the Small Naked Mole-Rat (Heterocephalus glaber RUPPELL, 1842) Studied with Ultrasound Biomicroscopy and 3D-Ultrasonography	PLOS ONE			English	Article							MAMMALS; BATHYERGIDAE; EUSOCIALITY; EVOLUTION; COLONIES; BIRDS	The naked mole-rat (Heterocephalus glaber) is one of the two known mammalian species that live in a eusocial population structure. Here we investigate the exceptionally long gestation period of 70 days observed in the mole-rat queen. The course of seven successful pregnancies in two individuals was recorded in a colony of captive naked mole-rats using ultrasound biomicroscopy (UBM) and 3D-ultrasonography. We establish a catalogue of basic reference ultrasound data for this species by describing the ultrasonographic appearance of reproductive organs, calculating growth curves to predict gestational age and defining ultrasonographic milestones to characterize pregnancy stages. Mean litter size was 10.9+/-2.7, of which 7.2+/-1.5 survived the weaning period. Mean interbirth interval was 128.8+/-63.0 days. The reproductive success in our colony did not differ from previously published data. In the queen the active corpora lutea had an anechoic, fluid filled centre. Using UBM, pregnancy could be detected 53 days before parturition. The period of embryonic development is assumed to last until 30 days before parturition. Embryonic resorptions were detected frequently in the queen, indicating that this might be an ordinary event in this species. We discuss the extraordinary long gestation period of this small rodent and postulate that the long gestation is beneficial to both the eusocial structure and longevity. An increased litter size, twice as large as for other rodents of similar size, seemingly compensates for the doubling of pregnancy length. We demonstrate that the lifetime reproductive effort of a naked mole-rat queen is equivalent to the mass of offspring that would be produced if all of the females of a colony would be reproducing.	[Roellig, Kathleen; Drews, Barbara; Goeritz, Frank; Hildebrandt, Thomas Bernd] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung	Roellig, K (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	kathleen_roellig@gmx.de			Leibniz Institute for Zoo and Wildlife Research, Berlin	Leibniz Institute for Zoo and Wildlife Research, Berlin	This study was financed by the Leibniz Institute for Zoo and Wildlife Research, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braude S, 1998, J MAMMAL, V79, P360, DOI 10.2307/1382873; Braude S, 2000, BEHAV ECOL, V11, P7, DOI 10.1093/beheco/11.1.7; Brett R.A., 1991, P97; BUFFENSTEIN R, 1991, J THERM BIOL, V16, P227, DOI 10.1016/0306-4565(91)90030-6; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; BUFFENSTEIN R, 2002, SCI AGING KNOWLEDGE, V21, pPE7; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; Charnov EL, 2007, AM NAT, V170, pE129, DOI 10.1086/522840; Deuve JL, 2008, CHROMOSOME RES, V16, P57, DOI 10.1007/s10577-007-1200-8; Faulkes CG, 2010, J ZOOL, V282, P64, DOI 10.1111/j.1469-7998.2010.00713.x; FAULKES CG, 1990, J REPROD FERTIL, V88, P559; FAULKES CG, 1990, J REPROD FERTIL, V89, P317; Faulkes CG, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P369, DOI 10.1017/CBO9780511641954.015; Henry EC, 2007, J EXP BIOL, V210, P261, DOI 10.1242/jeb.02631; Hildebrandt TB, 1998, ZOOL-ANAL COMPLEX SY, V101, P200; Hildebrandt T, 2007, P ROY SOC B-BIOL SCI, V274, P323, DOI 10.1098/rspb.2006.3738; Jarvis J.U.M., 1991, P384; Jarvis Jennifer U.M., 2002, Mammalian Species, V706, P1, DOI 10.1644/1545-1410(2002)706<0001:HG>2.0.CO;2; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; Katsushima K, 2010, MOL ECOL RESOUR, V10, P222, DOI 10.1111/j.1755-0998.2009.02742.x; KAYANJA F I B, 1971, Zeitschrift fuer Saeugetierkunde, V36, P114; KIHLSTROM JE, 1972, COMP BIOCHEM PHYSIOL, V43, P673, DOI 10.1016/0300-9629(72)90254-X; KOCH R, 2004, THESIS SAINT LOUIS; Lacey E.A., 1991, P275; Martin R. D., 1975, PHYLOGENY PRIMATES M, P265; MICHENER CD, 1969, ANNU REV ENTOMOL, V14, P299, DOI 10.1146/annurev.en.14.010169.001503; MILLAR JS, 1983, ECOLOGY, V64, P631, DOI 10.2307/1937181; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Peil J, 1978, Gegenbaurs Morphol Jahrb, V124, P524; Reeve H., 1991, BIOL NAKED MOLE RAT, P337; Ricklefs RE, 2006, P ROY SOC B-BIOL SCI, V273, P2077, DOI 10.1098/rspb.2006.3544; Ricklefs RE, 2010, FUNCT ECOL, V24, P588, DOI 10.1111/j.1365-2435.2009.01684.x; Roellig K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1079; Roellig K, 2010, REPROD FERT DEVELOP, V22, P448, DOI 10.1071/RD09098; Sherman PW, 1999, J MAMMAL, V80, P720, DOI 10.2307/1383241; SHERMAN PW, BIOL NAKED MOLE RAT; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Sumbera R, 2003, J MAMMAL, V84, P278, DOI 10.1644/1545-1542(2003)084<0278:RBOASS>2.0.CO;2; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; [No title captured]	40	15	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17744	10.1371/journal.pone.0017744	http://dx.doi.org/10.1371/journal.pone.0017744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408185	Green Published, gold			2022-12-27	WOS:000288099800035
J	Yan, TC; Dudley, JA; Weir, RK; Grabowska, EM; Pena-Oliver, Y; Ripley, TL; Hunt, SP; Stephens, DN; Stanford, SC				Yan, Ting Carrie; Dudley, Julia A.; Weir, Ruth K.; Grabowska, Ewelina M.; Pena-Oliver, Yolanda; Ripley, Tamzin L.; Hunt, Stephen P.; Stephens, David N.; Stanford, S. Clare			Performance Deficits of NK1 Receptor Knockout Mice in the 5-Choice Serial Reaction-Time Task: Effects of d-Amphetamine, Stress and Time of Day	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FUNCTIONAL MAGNETIC-RESONANCE; MEDIAL PREFRONTAL CORTEX; HYPERACTIVITY DISORDER; SUBSTANCE-P; EXTRACELLULAR NORADRENALINE; SELECTIVE ATTENTION; RATS; ADHD; LESIONS	Background: The neurochemical status and hyperactivity of mice lacking functional substance P-preferring NK1 receptors (NK1R-/-) resemble abnormalities in Attention Deficit Hyperactivity Disorder (ADHD). Here we tested whether NK1R-/- mice express other core features of ADHD (impulsivity and inattentiveness) and, if so, whether they are diminished by d-amphetamine, as in ADHD. Prompted by evidence that circadian rhythms are disrupted in ADHD, we also compared the performance of mice that were trained and tested in the morning or afternoon. Methods and Results: The 5-Choice Serial Reaction-Time Task (5-CSRTT) was used to evaluate the cognitive performance of NK1R-/- mice and their wildtypes. After training, animals were tested using a long (LITI) and a variable (VITI) inter-trial interval: these tests were carried out with, and without, d-amphetamine pretreatment (0.3 or 1 mg/kg i.p.). NK1R-/- mice expressed greater omissions (inattentiveness), perseveration and premature responses (impulsivity) in the 5-CSRTT. In NK1R-/- mice, perseveration in the LITI was increased by injection-stress but reduced by d-amphetamine. Omissions by NK1R-/- mice in the VITI were unaffected by d-amphetamine, but premature responses were exacerbated by this psychostimulant. Omissions in the VITI were higher, overall, in the morning than the afternoon but, in the LITI, premature responses of NK1R-/- mice were higher in the afternoon than the morning. Conclusion: In addition to locomotor hyperactivity, NK1R-/- mice express inattentiveness, perseveration and impulsivity in the 5-CSRTT, thereby matching core criteria for a model of ADHD. Because d-amphetamine reduced perseveration in NK1R-/- mice, this action does not require functional NK1R. However, the lack of any improvement of omissions and premature responses in NK1R-/- mice given d-amphetamine suggests that beneficial effects of this psychostimulant in other rodent models, and ADHD patients, need functional NK1R. Finally, our results reveal experimental variables (stimulus parameters, stress and time of day) that could influence translational studies.	[Yan, Ting Carrie; Stanford, S. Clare] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Dudley, Julia A.; Grabowska, Ewelina M.; Pena-Oliver, Yolanda; Hunt, Stephen P.] UCL, Dept Cell & Dev Biol, London, England; [Pena-Oliver, Yolanda; Ripley, Tamzin L.; Stephens, David N.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of London; University College London; University of London; University College London; University of Sussex	Yan, TC (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	c.stanford@ucl.ac.uk	Stephens, David/G-2384-2012	Hunt, Stephen/0000-0001-9453-5505; Weir, Ruth/0000-0002-7268-7038; Stanford, Susan/0000-0002-5623-1751	Medical Research Council (UK) [G0801038 (p6818)]; MRC [G0801038] Funding Source: UKRI; Medical Research Council [G0801038] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK); Grant no. G0801038 (p6818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDERSON KJ, 1994, J PERS SOC PSYCHOL, V67, P334, DOI 10.1037/0022-3514.67.2.334; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bejerot S, 2010, J CLIN PSYCHIAT, V71, P1590, DOI 10.4088/JCP.09m05168pur; Bizarro L, 2004, BEHAV PHARMACOL, V15, P195, DOI 10.1097/01.fbp.0000131574.61491.50; Bizarro L, 2003, PSYCHOPHARMACOLOGY, V170, P271, DOI 10.1007/s00213-003-1543-6; Blokland A, 2005, BEHAV PHARMACOL, V16, P93, DOI 10.1097/00008877-200503000-00004; Body S, 2009, PSYCHOPHARMACOLOGY, V203, P547, DOI 10.1007/s00213-008-1400-8; *BRIT MED ASS, 2010, BRIT NAT FORM, V59, P217; Caci H, 2009, J ATTEN DISORD, V13, P36, DOI 10.1177/1087054708320439; Calcagno E, 2009, J NEUROCHEM, V108, P521, DOI 10.1111/j.1471-4159.2008.05789.x; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Dalley JW, 2002, NEUROPSYCHOPHARMACOL, V26, P716, DOI 10.1016/S0893-133X(01)00412-2; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; de Bruin NMWJ, 2006, PHYSIOL BEHAV, V89, P692, DOI 10.1016/j.physbeh.2006.08.009; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Finlay JM, 1997, NEUROCHEM RES, V22, P1387, DOI 10.1023/A:1022075324164; Fisher AS, 2007, EUR J NEUROSCI, V25, P1195, DOI 10.1111/j.1460-9568.2007.05369.x; Froger N, 2001, J NEUROSCI, V21, P8188, DOI 10.1523/JNEUROSCI.21-20-08188.2001; Gannon RL, 2005, EUR J PHARMACOL, V527, P86, DOI 10.1016/j.ejphar.2005.10.012; Harrison AA, 1997, PSYCHOPHARMACOLOGY, V133, P329, DOI 10.1007/s002130050410; Heal DJ, 2008, PHARMACOL BIOCHEM BE, V90, P184, DOI 10.1016/j.pbb.2008.03.016; Herpfer I, 2005, NEUROPHARMACOLOGY, V48, P706, DOI 10.1016/j.neuropharm.2004.12.016; Higgins GA, 2007, BEHAV BRAIN RES, V185, P32, DOI 10.1016/j.bbr.2007.07.013; Houghton S, 1999, J CHILD NEUROL, V14, P801, DOI 10.1177/088307389901401206; HUMBY T, 2005, CURRENT PROTOCOLS S, V31, pCH8; Koskinen T, 2000, NEUROPHARMACOLOGY, V39, P471, DOI 10.1016/S0028-3908(99)00159-8; KUCZENSKI R, 1989, J NEUROSCI, V9, P2051; MATTISON RE, 2010, J ATTEN DISORD; May DE, 2010, DRUGS, V70, P15, DOI 10.2165/11530540-000000000-00000; Mayorga AJ, 2000, BEHAV BRAIN RES, V109, P59, DOI 10.1016/S0166-4328(99)00165-5; MICK G, 1994, MOL BRAIN RES, V21, P157, DOI 10.1016/0169-328X(94)90388-3; Milstein JA, 2007, PSYCHOPHARMACOLOGY, V190, P51, DOI 10.1007/s00213-006-0594-x; Oades RD, 2008, PROG BRAIN RES, V172, P543, DOI 10.1016/S0079-6123(08)00926-6; Oliver YP, 2009, PSYCHOPHARMACOLOGY, V204, P679, DOI 10.1007/s00213-009-1500-0; Orsini C, 2004, PSYCHOPHARMACOLOGY, V172, P264, DOI 10.1007/s00213-003-1647-z; Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019; Piggins HD, 2001, J COMP NEUROL, V438, P50, DOI 10.1002/cne.1301; Pioli EY, 2008, NEUROSCIENCE, V153, P1213, DOI 10.1016/j.neuroscience.2008.01.084; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Pollier F, 2000, NEUROPSYCHOPHARMACOL, V22, P64, DOI 10.1016/S0893-133X(99)00092-5; Pum M, 2007, PSYCHOPHARMACOLOGY, V193, P375, DOI 10.1007/s00213-007-0791-2; Radonovich KJ, 2004, CHILD NEUROPSYCHOL, V10, P162, DOI 10.1080/09297040409609807; Renoldi G, 2006, J NEUROSCI RES, V84, P961, DOI 10.1002/jnr.20997; Sagvolden T, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-3; Schwabe K, 2004, BEHAV BRAIN RES, V153, P21, DOI 10.1016/j.bbr.2003.10.030; Sharp SI, 2009, NEUROPHARMACOLOGY, V57, P590, DOI 10.1016/j.neuropharm.2009.08.011; Singewald N, 2008, J NEUROCHEM, V106, P2476, DOI 10.1111/j.1471-4159.2008.05596.x; TANNOCK R, 1992, J CHILD PSYCHOL PSYC, V33, P1217, DOI 10.1111/j.1469-7610.1992.tb00940.x; Teicher MH, 2000, NAT MED, V6, P470, DOI 10.1038/74737; Toplak ME, 2003, J CHILD PSYCHOL PSYC, V44, P888, DOI 10.1111/1469-7610.00173; Tsutsui-Kimura I, 2009, BEHAV PHARMACOL, V20, P474, DOI 10.1097/FBP.0b013e3283305e65; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Van Veen MM, 2010, BIOL PSYCHIAT, V67, P1091, DOI 10.1016/j.biopsych.2009.12.032; Winstanley CA, 2003, PSYCHOPHARMACOLOGY, V170, P320, DOI 10.1007/s00213-003-1546-3; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Wood S, 2009, PSYCHOPHARMACOLOGY, V202, P197, DOI 10.1007/s00213-008-1185-9; Xu XH, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-48; Yan TC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/0269881108100255; Yan TC, 2009, NEUROPHARMACOLOGY, V57, P627, DOI 10.1016/j.neuropharm.2009.08.021; Yang SJ, 2007, PSYCHIAT RES, V153, P55, DOI 10.1016/j.psychres.2006.04.001	65	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17586	10.1371/journal.pone.0017586	http://dx.doi.org/10.1371/journal.pone.0017586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408181	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000288099800025
J	Yang, JJ; Xu, XH; Du, XY; Shi, CT; Fang, F				Yang, Jiongjiong; Xu, Xiaohong; Du, Xiaoya; Shi, Cuntong; Fang, Fang			Effects of Unconscious Processing on Implicit Memory for Fearful Faces	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; AMYGDALA RESPONSE; ANGRY FACES; ACTIVATION; AWARENESS; COGNITION; STIMULI; CONSCIOUSNESS; MODULATION; ATTENTION	Emotional stimuli can be processed even when participants perceive them without conscious awareness, but the extent to which unconsciously processed emotional stimuli influence implicit memory after short and long delays is not fully understood. We addressed this issue by measuring a subliminal affective priming effect in Experiment 1 and a long-term priming effect in Experiment 2. In Experiment 1, a flashed fearful or neutral face masked by a scrambled face was presented three times, then a target face (either fearful or neutral) was presented and participants were asked to make a fearful/neutral judgment. We found that, relative to a neutral prime face (neutral-fear face), a fearful prime face speeded up participants' reaction to a fearful target (fear-fear face), when they were not aware of the masked prime face. But this response pattern did not apply to the neutral target. In Experiment 2, participants were first presented with a masked faces six times during encoding. Three minutes later, they were asked to make a fearful/neutral judgment for the same face with congruent expression, the same face with incongruent expression or a new face. Participants showed a significant priming effect for the fearful faces but not for the neutral faces, regardless of their awareness of the masked faces during encoding. These results provided evidence that unconsciously processed stimuli could enhance emotional memory after both short and long delays. It indicates that emotion can enhance memory processing whether the stimuli are encoded consciously or unconsciously.	[Yang, Jiongjiong; Xu, Xiaohong; Du, Xiaoya; Shi, Cuntong; Fang, Fang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China	Peking University	Yang, JJ (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	yangjj@pku.edu.cn		Xu, Xiaohong (Violet)/0000-0002-4087-1623	National Science Foundation of China [30870769]; National Institutes of Health, USA [R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by grants from the National Science Foundation of China (30870769, J. Yang, 2009) and the Global Research Initiative Program, National Institutes of Health, USA (R01TW007897, J. Yang, 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bennett MR, 2005, PROG NEUROBIOL, V75, P29, DOI 10.1016/j.pneurobio.2004.11.002; Bentley P, 2003, J NEUROPHYSIOL, V90, P1171, DOI 10.1152/jn.00776.2002; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Dannlowski U, 2007, J PSYCHIATR NEUROSCI, V32, P423; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Draine SC, 1998, J EXP PSYCHOL GEN, V127, P286, DOI 10.1037/0096-3445.127.3.286; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Ghuman AS, 2006, EMOTION, V6, P215, DOI 10.1037/1528-3542.6.2.215; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Hermans D, 2003, COGNITION EMOTION, V17, P83, DOI 10.1080/02699930302276; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; Hermans D, 2003, CAN J EXP PSYCHOL, V57, P97, DOI 10.1037/h0087416; Irwin KR, 2010, SMART INNOV SYST TEC, V1, P17; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Kouider S, 2007, CEREB CORTEX, V17, P2019, DOI 10.1093/cercor/bhl110; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LOMBARDI WJ, 1987, PERS SOC PSYCHOL B, V13, P411, DOI 10.1177/0146167287133009; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Milders M, 2008, COGNITION EMOTION, V22, P63, DOI 10.1080/02699930701273849; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Ratcliff R, 1996, J EXP PSYCHOL GEN, V125, P403, DOI 10.1037/0096-3445.125.4.403; Rieth CA, 2010, J EXP PSYCHOL HUMAN, V36, P596, DOI 10.1037/a0018737; Ruys KI, 2008, PSYCHOL SCI, V19, P385, DOI 10.1111/j.1467-9280.2008.02097.x; Stoerig P, 2006, SCIENCE, V314, P1694, DOI 10.1126/science.1136956; Suslow T, 2006, BRAIN COGNITION, V61, P243, DOI 10.1016/j.bandc.2006.01.005; Sweeny TD, 2009, CONSCIOUS COGN, V18, P929, DOI 10.1016/j.concog.2009.07.011; Talmi D, 2008, LEARN MEMORY, V15, P172, DOI 10.1101/lm.722908; Thomas LA, 2005, COGNITION EMOTION, V19, P1027, DOI 10.1080/02699930500172440; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Whalen PJ, 1998, J NEUROSCI, V18, P411; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Zeelenberg R, 2004, J EXP PSYCHOL LEARN, V30, P270, DOI 10.1037/0278-7393.30.1.270	50	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2011	6	2							e14641	10.1371/journal.pone.0014641	http://dx.doi.org/10.1371/journal.pone.0014641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UR	21408105	gold, Green Published, Green Submitted			2022-12-27	WOS:000286835000001
J	Cui, YF; Xu, JC; Hargus, G; Jakovcevski, I; Schachner, M; Bernreuther, C				Cui, Yi-Fang; Xu, Jin-Chong; Hargus, Gunnar; Jakovcevski, Igor; Schachner, Melitta; Bernreuther, Christian			Embryonic Stem Cell-Derived L1 Overexpressing Neural Aggregates Enhance Recovery after Spinal Cord Injury in Mice	PLOS ONE			English	Article							ADHESION MOLECULE L1; FUNCTIONAL RECOVERY; BIOCHEMICAL-CHARACTERIZATION; NERVOUS-SYSTEM; ADULT MICE; H-REFLEX; MOUSE; RATS; TRANSPLANTATION; REGENERATION	An obstacle to early stem cell transplantation into the acutely injured spinal cord is poor survival of transplanted cells. Transplantation of embryonic stem cells as substrate adherent embryonic stem cell-derived neural aggregates (SENAs) consisting mainly of neurons and radial glial cells has been shown to enhance survival of grafted cells in the injured mouse brain. In the attempt to promote the beneficial function of these SENAs, murine embryonic stem cells constitutively overexpressing the neural cell adhesion molecule L1 which favors axonal growth and survival of grafted and imperiled cells in the inhibitory environment of the adult mammalian central nervous system were differentiated into SENAs and transplanted into the spinal cord three days after compression lesion. Mice transplanted with L1 overexpressing SENAs showed improved locomotor function when compared to mice injected with wild-type SENAs. L1 overexpressing SENAs showed an increased number of surviving cells, enhanced neuronal differentiation and reduced glial differentiation after transplantation when compared to SENAs not engineered to overexpress L1. Furthermore, L1 overexpressing SENAs rescued imperiled host motoneurons and parvalbumin-positive interneurons and increased numbers of catecholaminergic nerve fibers distal to the lesion. In addition to encouraging the use of embryonic stem cells for early therapy after spinal cord injury L1 overexpression in the microenvironment of the lesioned spinal cord is a novel finding in its functions that would make it more attractive for pre-clinical studies in spinal cord regeneration and most likely other diseases of the nervous system.	[Cui, Yi-Fang; Xu, Jin-Chong; Hargus, Gunnar; Jakovcevski, Igor; Schachner, Melitta; Bernreuther, Christian] Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Univ Krankenhaus Hamburg Eppendorf, Hamburg, Germany; [Cui, Yi-Fang] Leibniz Inst Primate Res, Clin Neurobiol Lab, German Primate Ctr, Gottingen, Germany; [Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08855 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Bernreuther, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Deutsches Primatenzentrum (DPZ); Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Hamburg; University Medical Center Hamburg-Eppendorf	Cui, YF (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Univ Krankenhaus Hamburg Eppendorf, Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de; c.bernreuther@uke.de		Jakovcevski, Igor/0000-0001-7673-9600	New Jersey Commission for Spinal Cord Research	New Jersey Commission for Spinal Cord Research	This work was supported by the New Jersey Commission for Spinal Cord Research (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; APPEL F, 1993, J NEUROSCI, V13, P4764; BARNES CD, 1979, PROG NEUROBIOL, V12, P1, DOI 10.1016/0301-0082(79)90008-X; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belegu V, 2007, NEUROSURG CLIN N AM, V18, P143, DOI 10.1016/j.nec.2006.10.012; Bernreuther C, 2006, J NEUROSCI, V26, P11532, DOI 10.1523/JNEUROSCI.2688-06.2006; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Celio M.R., 1984, NEUROSCI LETT S, V18, pS332; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; DAVIDOFF MS, 1986, HISTOCHEMISTRY, V84, P515, DOI 10.1007/BF00482985; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Dekkers J, 2002, DEV NEUROSCI-BASEL, V24, P283, DOI 10.1159/000066742; Di Giovanni S, 2006, EXPERT OPIN THER TAR, V10, P363, DOI 10.1517/14728222.10.3.363; Dihne M, 2003, J NEUROSCI, V23, P6638; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Fouad K, 2004, PROG NEUROBIOL, V73, P107, DOI 10.1016/j.pneurobio.2004.04.003; Gozariu M, 1998, BRAIN RES, V782, P343, DOI 10.1016/S0006-8993(97)01402-9; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Howard MJ, 2005, SOMATOSENS MOT RES, V22, P37, DOI 10.1080/08990220500084909; Hulley P, 1998, J NEUROSCI RES, V53, P129, DOI 10.1002/(SICI)1097-4547(19980715)53:2<129::AID-JNR1>3.0.CO;2-9; Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x; Jain KK, 2009, MOL BIOTECHNOL, V42, P367, DOI 10.1007/s12033-009-9166-8; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr DA, 2003, J NEUROSCI, V23, P5131; KIEHN O, 1992, J COMP NEUROL, V325, P527, DOI 10.1002/cne.903250406; Kimura H, 2005, NEUROL RES, V27, P812, DOI 10.1179/016164105X63629; LAVDAS AA, 2009, EXP NEUROL; Lee HJ, 2009, EXP NEUROL, V216, P365, DOI 10.1016/j.expneurol.2008.12.009; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LI D, 2010, J CELL BIOL; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Nishimune H, 2005, J NEUROSCI RES, V80, P593, DOI 10.1002/jnr.20517; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Pearse DD, 2006, J NEUROTRAUM, V23, P438, DOI 10.1089/neu.2006.23.437; RATHJEN FG, 1984, EMBO J, V3, P1; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Shapiro S, 1997, NEUROSURGERY, V40, P168, DOI 10.1097/00006123-199701000-00037; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Tewarie RSN, 2009, J SPINAL CORD MED, V32, P105, DOI 10.1080/10790268.2009.11760761; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955	58	63	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17126	10.1371/journal.pone.0017126	http://dx.doi.org/10.1371/journal.pone.0017126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21445247	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100010
J	Malek, R; Matta, J; Taylor, N; Perry, ME; Mendrysa, SM				Malek, Reem; Matta, Jennifer; Taylor, Natalie; Perry, Mary Ellen; Mendrysa, Susan M.			The p53 Inhibitor MDM2 Facilitates Sonic Hedgehog-Mediated Tumorigenesis and Influences Cerebellar Foliation	PLOS ONE			English	Article							EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NEURON PRECURSORS; TUMOR SUPPRESSION; MOUSE MODEL; N-MYC; CELL; MEDULLOBLASTOMA; PATHWAY; GROWTH	Disruption of cerebellar granular neuronal precursor (GNP) maturation can result in defects in motor coordination and learning, or in medulloblastoma, the most common childhood brain tumor. The Sonic Hedgehog (Shh) pathway is important for GNP proliferation; however, the factors regulating the extent and timing of GNP proliferation, as well as GNP differentiation and migration are poorly understood. The p53 tumor suppressor has been shown to negatively regulate the activity of the Shh effector, Gli1, in neural stem cells; however, the contribution of p53 to the regulation of Shh signaling in GNPs during cerebellar development has not been determined. Here, we exploited a hypomorphic allele of Mdm2 (Mdm2(puro)), which encodes a critical negative regulator of p53, to alter the level of wild-type MDM2 and p53 in vivo. We report that mice with reduced levels of MDM2 and increased levels of p53 have small cerebella with shortened folia, reminiscent of deficient Shh signaling. Indeed, Shh signaling in Mdm2-deficient GNPs is attenuated, concomitant with decreased expression of the Shh transducers, Gli1 and Gli2. We also find that Shh stimulation of GNPs promotes MDM2 accumulation and enhances phosphorylation at serine 166, a modification known to increase MDM2-p53 binding. Significantly, loss of MDM2 in Ptch1(+/-) mice, a model for Shh-mediated human medulloblastoma, impedes cerebellar tumorigenesis. Together, these results place MDM2 at a major nexus between the p53 and Shh signaling pathways in GNPs, with key roles in cerebellar development, GNP survival, cerebellar foliation, and MB tumorigenesis.	[Malek, Reem; Taylor, Natalie; Mendrysa, Susan M.] Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Matta, Jennifer] NCI, Lab Anim Sci Program, NIH, Frederick, MD 21701 USA; [Perry, Mary Ellen] NCI, Lab Prot Dynam & Signaling, NIH, Frederick, MD 21701 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Malek, R (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	mendrysa@purdue.edu			NIH, National Cancer Institute, Center for Cancer Research; Concern Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Concern Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer	This work was supported by the Intramural Program of the NIH, National Cancer Institute, Center for Cancer Research (M. E. P.) and by grants to S. M. M. from the Concern Foundation (www.concernfoundation.org) and Alex's Lemonade Stand Foundation for Childhood Cancer (www.alexslemonade.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barel D, 1998, CANCER GENET CYTOGEN, V103, P1, DOI 10.1016/S0165-4608(97)00258-6; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Chizhikov V, 2003, MOL GENET METAB, V80, P54, DOI 10.1016/j.ymgme.2003.08.019; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Cowan R, 1997, BRIT J CANCER, V76, P141, DOI 10.1038/bjc.1997.354; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; Huard JMT, 1999, DEVELOPMENT, V126, P1927; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kim JYH, 2003, DEV BIOL, V263, P50, DOI 10.1016/S0012-1606(03)00434-2; Kleihues P, 1997, AM J PATHOL, V150, P1; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; LUNA RMD, 1995, NATURE, V378, P203; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Marino S, 2000, GENE DEV, V14, P994; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Prykhozhij SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013549; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tavano A, 2007, BRAIN, V130, P2646, DOI 10.1093/brain/awm201; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wetmore C, 2001, CANCER RES, V61, P513; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399	68	33	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17884	10.1371/journal.pone.0017884	http://dx.doi.org/10.1371/journal.pone.0017884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437245	Green Submitted, gold, Green Published			2022-12-27	WOS:000288545100042
J	Liu, DY; Chang, XA; Liu, ZR; Chen, LN; Wang, RQ				Liu, Dengyu; Chang, Xiao; Liu, Zengrong; Chen, Luonan; Wang, Ruiqi			Bistability and Oscillations in Gene Regulation Mediated by Small Noncoding RNAs	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; POSITIVE-FEEDBACK; MESSENGER-RNA; MICRORNA; PROTEIN; EXPRESSION; NETWORK; MULTISTABILITY; DEGRADATION; ACTIVATION	The interplay of small noncoding RNAs (sRNAs), mRNAs, and proteins has been shown to play crucial roles in almost all cellular processes. As key post-transcriptional regulators of gene expression, the mechanisms and roles of sRNAs in various cellular processes still need to be fully understood. When participating in cellular processes, sRNAs mainly mediate mRNA degradation or translational repression. Here, we show how the dynamics of two minimal architectures is drastically affected by these two mechanisms. A comparison is also given to reveal the implication of the fundamental differences. This study may help us to analyze complex networks assembled by simple modules more easily. A better knowledge of the sRNA-mediated motifs is also of interest for bio-engineering and artificial control.	[Liu, Dengyu; Chang, Xiao; Liu, Zengrong; Wang, Ruiqi] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Liu, Dengyu] Jinggangshan Univ, Coll Phys & Math, Jian 343009, Jiangxi, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Key Lab Syst Biol, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Shanghai University; Jinggangshan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk	Wang, RQ (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	rqwang@shu.edu.cn			National Natural Science Foundation of China [10832006, 10701052]; Shanghai Pujiang Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by the National Natural Science Foundation of China (Grant No. 10832006 and Youth Research Grant No. 10701052) and the Shanghai Pujiang Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; LEVINE E, 2007, PLOS BIOL; Levine E, 2007, BIOPHYS J, V93, pL52, DOI 10.1529/biophysj.107.118448; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Saez-Rodriguez J, 2008, IET SYST BIOL, V2, P80, DOI 10.1049/iet-syb:20070012; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie ZR, 2007, BIOCHEM BIOPH RES CO, V358, P722, DOI 10.1016/j.bbrc.2007.04.207; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhdanov VP, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/28/285101; Zhdanov VP, 2009, BIOSYSTEMS, V95, P75, DOI 10.1016/j.biosystems.2008.07.002	36	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17029	10.1371/journal.pone.0017029	http://dx.doi.org/10.1371/journal.pone.0017029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437279	Green Published, gold, Green Submitted			2022-12-27	WOS:000288514600003
J	Yuan, ZD; Sun, XA; Liu, HD; Xie, JM				Yuan, Zhidong; Sun, Xiao; Liu, Hongde; Xie, Jianming			MicroRNA Genes Derived from Repetitive Elements and Expanded by Segmental Duplication Events in Mammalian Genomes	PLOS ONE			English	Article							COPY NUMBER; TRANSPOSABLE ELEMENTS; EVOLUTION; ARABIDOPSIS; MOUSE; EXPRESSION; SEQUENCES; IDENTIFICATION; BROWSER; RETROTRANSPOSONS	MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression by targeting mRNAs for translation repression or mRNA degradation. Many miRNAs are being discovered and studied, but in most cases their origin, evolution and function remain unclear. Here, we characterized miRNAs derived from repetitive elements and miRNA families expanded by segmental duplication events in the human, rhesus and mouse genomes. We applied a comparative genomics approach combined with identifying miRNA paralogs in segmental duplication pair data in a genome-wide study to identify new homologs of human miRNAs in the rhesus and mouse genomes. Interestingly, using segmental duplication pair data, we provided credible computational evidence that two miRNA genes are located in the pseudoautosomal region of the human Y chromosome. We characterized all the miRNAs whether they were derived from repetitive elements or not and identified significant differences between the repeat-related miRNAs (RrmiRs) and non-repeat-derived miRNAs in (1) their location in protein-coding and intergenic regions in genomes, (2) the minimum free energy of their hairpin structures, and (3) their conservation in vertebrate genomes. We found some lineage-specific RrmiR families and three lineage-specific expansion families, and provided evidence indicating that some RrmiR families formed and expanded during evolutionary segmental duplication events. We also provided computational and experimental evidence for the functions of the conservative RrmiR families in the three species. Together, our results indicate that repetitive elements contribute to the origin of miRNAs, and large segmental duplication events could prompt the expansion of some miRNA families, including RrmiR families. Our study is a valuable contribution to the knowledge of evolution and function of non-coding region in genome.	[Yuan, Zhidong; Sun, Xiao; Liu, Hongde] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Yuan, Zhidong; Xie, Jianming] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Peoples R China	Southeast University - China; Hunan University of Science & Technology	Yuan, ZD (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	xsun@seu.edu.cn			National Natural Science Foundation of China [61073141, 60971099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project No. 61073141 and No. 60971099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; BELL GI, 1992, COMPUT CHEM, V16, P135, DOI 10.1016/0097-8485(92)80040-7; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Devor EJ, 2009, GENE, V448, P187, DOI 10.1016/j.gene.2009.06.019; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; FAHLGREN N, 2010, PLANT CELL; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; He XJ, 2007, ACTA BIOCH BIOPH SIN, V39, P708, DOI 10.1111/j.1745-7270.2007.00324.x; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hikosaka A, 2004, J MOL EVOL, V59, P738, DOI 10.1007/s00239-004-2664-1; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jiang DH, 2006, CELL RES, V16, P507, DOI 10.1038/sj.cr.7310062; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Kozomara A, 2010, NUCL ACIDS RES; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee AS, 2008, HUM MOL GENET, V17, P1127, DOI 10.1093/hmg/ddn002; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; Meagher TR, 2005, NEW PHYTOL, V168, P71, DOI 10.1111/j.1469-8137.2005.01527.x; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nozawa M, 2010, GENOME BIOL EVOL, V2, P180, DOI 10.1093/gbe/evq009; Ogata H, 2002, GENOME RES, V12, P808, DOI 10.1101/gr.227602; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Pizzimenti S, 2009, FREE RADICAL BIO MED, V46, P282, DOI 10.1016/j.freeradbiomed.2008.10.035; R Core Team, 2020, R LANG ENV STAT COMP; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Smit A, 1996, REPEATMASKER OPEN 30; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Verduci L, 2010, J BIOL CHEM, V285, P39551, DOI 10.1074/jbc.M110.114736; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yuan ZD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-346; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	81	48	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17666	10.1371/journal.pone.0017666	http://dx.doi.org/10.1371/journal.pone.0017666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436881	gold, Green Submitted, Green Published			2022-12-27	WOS:000288514000005
J	Forsgren, J; Pedersen, C; Stromme, M; Engqvist, H				Forsgren, Johan; Pedersen, Christian; Stromme, Maria; Engqvist, Hakan			Synthetic Geopolymers for Controlled Delivery of Oxycodone: Adjustable and Nanostructured Porosity Enables Tunable and Sustained Drug Release	PLOS ONE			English	Article							PAIN; ADSORPTION; SYSTEMS	In this article we for the first time present a fully synthetic mesoporous geopolymer drug carrier for controlled release of opioids. Nanoparticulate precursor powders with different Al/Si-ratios were synthesized by a sol-gel route and used in the preparation of different geopolymers, which could be structurally tailored by adjusting the Al/Si-ratio and the curing temperatures. In particular, it was shown that the pore sizes of the geopolymers decreased with increasing Al/Si ratio and that completely mesoporous geopolymers could be produced from precursor particles with the Al/Si ratio 2:1. The mesoporosity was shown to be associated with a sustained and linear in vitro release profile of the opioid oxycodone. A clinically relevant release period of about 12 h was obtained by adjusting the size of the pellets. The easily fabricated and tunable geopolymers presented in this study constitute a novel approach in the development of controlled release formulations, not only for opioids, but whenever the clinical indication is best treated with a constant supply of drugs and when the mechanical stability of the delivery vehicle is crucial.	[Forsgren, Johan; Pedersen, Christian; Stromme, Maria; Engqvist, Hakan] Uppsala Univ, Dept Engn Sci, Uppsala, Sweden	Uppsala University	Forsgren, J (corresponding author), Uppsala Univ, Dept Engn Sci, Uppsala, Sweden.	maria.stromme@angstrom.uu.se		Engqvist, Hakan/0000-0001-9529-650X				Al-Ghananeem AM, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070123; [Anonymous], CANC PAIN REL GUID O; Aulton M.E., 2002, PHARM SCI DOSAGE FOR, Vsecond; Bakharev T, 2005, CEMENT CONCRETE RES, V35, P658, DOI 10.1016/j.cemconres.2004.06.005; Bernards DA, 2010, ADV MATER, V22, P2358, DOI 10.1002/adma.200903439; Bonica JJ, 1987, CHRONIC NONCANCER PA, P11; Brohede U, 2007, J PHARM SCI-US, V96, P3087, DOI 10.1002/jps.20915; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Casolco SR, 2008, SCRIPTA MATER, V58, P516, DOI 10.1016/j.scriptamat.2007.11.014; Cui XM, 2008, J POWER SOURCES, V184, P652, DOI 10.1016/j.jpowsour.2008.03.021; Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z; Duxson P, 2007, J MATER SCI, V42, P3044, DOI 10.1007/s10853-006-0535-4; El-Safy SA, 2005, ADV MATER, V17, P47, DOI 10.1002/adma.200401317; *FDA, 72005 FDA ALERT; Forsgren J, 2010, J PHARM SCI-US, V99, P219, DOI 10.1002/jps.21814; Gourlay GK, 1998, CLIN PHARMACOKINET, V35, P173, DOI 10.2165/00003088-199835030-00002; *ISO, 58332002 ISO; Jamstorp E, 2010, J CONTROL RELEASE, V146, P370, DOI 10.1016/j.jconrel.2010.05.029; Muijsers RBR, 2001, DRUGS, V61, P2289, DOI 10.2165/00003495-200161150-00014; Okada K, 1999, J MATER CHEM, V9, P1307, DOI 10.1039/a900611g; Oudadesse H, 2007, J MATER SCI, V42, P3092, DOI 10.1007/s10853-006-0524-7; POMONIS PJ, 2006, ENCY SURFACE COLLOID, P444; Rubio-Hernandez FJ, 2006, J COLLOID INTERF SCI, V298, P967, DOI 10.1016/j.jcis.2006.01.009; Shader RI, 2007, J CLIN PSYCHOPHARM, V27, P327, DOI 10.1097/JCP.0b013e318133fc23; TARAZONA P, 1987, MOL PHYS, V60, P573, DOI 10.1080/00268978700100381; TARAZONA P, 1985, PHYS REV A, V31, P2672, DOI 10.1103/PhysRevA.31.2672; Thommes M, 2006, LANGMUIR, V22, P756, DOI 10.1021/la051686h; Turner JA, 2007, CLIN J PAIN, V23, P180, DOI 10.1097/01.ajp.0000210955.93878.44; Walden M, 2007, DRUG DEV IND PHARM, V33, P1101, DOI 10.1080/03639040701377292; Weibel A, 2005, CHEM MATER, V17, P2378, DOI 10.1021/cm0403762; WEN H, 2010, ORAL CONTROLLED RELE; Zheng GJ, 2009, J MATER SCI, V44, P3991, DOI 10.1007/s10853-009-3549-x	32	11	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17759	10.1371/journal.pone.0017759	http://dx.doi.org/10.1371/journal.pone.0017759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423616	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900022
J	Tate, MD; Ioannidis, LJ; Croker, B; Brown, LE; Brooks, AG; Reading, PC				Tate, Michelle D.; Ioannidis, Lisa J.; Croker, Ben; Brown, Lorena E.; Brooks, Andrew G.; Reading, Patrick C.			The Role of Neutrophils during Mild and Severe Influenza Virus Infections of Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; POLYMORPHONUCLEAR LEUKOCYTES; MIGRATING NEUTROPHILS; ALVEOLAR MACROPHAGES; PULMONARY INFECTION; A VIRUS; REPLICATION; RECEPTOR; PATHOGENICITY; INVOLVEMENT	Neutrophils have been implicated in both protective and pathological responses following influenza virus infections. We have used mAb 1A8 (anti-Ly6G) to specifically deplete LyG6(high) neutrophils and induce neutropenia in mice infected with virus strains known to differ in virulence. Mice were also treated with mAb RB6-8C5 (anti-Ly6C/G or anti-Gr-1), a mAb widely used to investigate the role of neutrophils in mice that has been shown to bind and deplete additional leukocyte subsets. Using mAb 1A8, we confirm the beneficial role of neutrophils in mice infected with virus strains of intermediate (HKx31; H3N2) or high (PR8; H1N1) virulence whereas treatment of mice infected with an avirulent strain (BJx109; H3N2) did not affect disease or virus replication. Treatment of BJx109-infected mice with mAb RB6-8C5 was, however, associated with significant weight loss and enhanced virus replication indicating that other Gr-1(+) cells, not neutrophils, limit disease severity during mild influenza infections.	[Tate, Michelle D.; Ioannidis, Lisa J.; Brown, Lorena E.; Brooks, Andrew G.; Reading, Patrick C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Croker, Ben] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Reading, Patrick C.] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia	University of Melbourne; Walter & Eliza Hall Institute; World Health Organization	Tate, MD (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	preading@unimelb.edu.au		Brown, Lorena/0000-0001-9342-909X; Reading, Patrick/0000-0002-8860-5308; Croker, Ben/0000-0002-0885-3599; Brooks, Andrew/0000-0002-4085-9683; Tate, Michelle/0000-0002-0587-5514	The National Health and Medical Research Council (NH&MRC) of Australia [509230, 567122]; Australian Government Department of Health and Ageing	The National Health and Medical Research Council (NH&MRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This study was supported by Project Grant 509230 and Program Grant 567122 from The National Health and Medical Research Council (NH&MRC) of Australia. PCR is a NH&MRC R.D. Wright Research Fellow. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CASSIDY LF, 1988, J CLIN MICROBIOL, V26, P1267, DOI 10.1128/JCM.26.7.1267-1270.1988; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Egan CE, 2008, IMMUNOL RES, V40, P35, DOI 10.1007/s12026-007-0061-8; Ennis M, 2003, CURR ALLERGY ASTHM R, V3, P159, DOI 10.1007/s11882-003-0029-2; FRANKOVA V, 1975, ACTA VIROL, V19, P29; FUJISAWA H, 1987, J GEN VIROL, V68, P425, DOI 10.1099/0022-1317-68-2-425; Fujisawa H, 2001, MICROBIOL IMMUNOL, V45, P679, DOI 10.1111/j.1348-0421.2001.tb01302.x; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; Lomas-Neira J, 2006, AM J PHYSIOL-LUNG C, V290, pL51, DOI 10.1152/ajplung.00028.2005; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; Matsuzaki J, 2003, CELL IMMUNOL, V224, P98, DOI 10.1016/j.cellimm.2003.08.009; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; RATCLIFFE D, 1992, CELL MOL BIOL, V38, P63; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; RODGERS B, 1981, INFECT IMMUN, V31, P751, DOI 10.1128/IAI.31.2.751-757.1981; Sakai S, 2000, J VIROL, V74, P2472, DOI 10.1128/JVI.74.5.2472-2476.2000; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; TATE MD, 2010, IMMUNOL CEL IN PRESS; TATE MD, 2011, VIRAL IMMUN IN PRESS; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tumpey TM, 1996, J VIROL, V70, P898, DOI 10.1128/JVI.70.2.898-904.1996; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; Zhao YY, 2008, CLIN INFECT DIS, V47, P1575, DOI 10.1086/593196; Zhou JH, 2003, J IMMUNOL, V170, P3331, DOI 10.4049/jimmunol.170.6.3331	38	136	138	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17618	10.1371/journal.pone.0017618	http://dx.doi.org/10.1371/journal.pone.0017618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423798	Green Published, gold			2022-12-27	WOS:000288512400016
J	Roychoudhury, J; Sinha, R; Ali, N				Roychoudhury, Jayeeta; Sinha, Roma; Ali, Nahid			Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; AZAR DERMAL LEISHMANIASIS; IN-VITRO SUSCEPTIBILITY; NITRIC-OXIDE SYNTHASE; AMPHOTERICIN-B; ANTIMONY GLUCONATE; CATIONIC LIPOSOMES; KALA-AZAR; INTRACELLULAR INFECTION; IMMUNE-RESPONSES	Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment of visceral leishmaniasis (VL), has become a critical issue worldwide. Second-line and new drugs are also not devoid of limitations. Suitable drug-delivery systems can improve the mode of administration and action of the existing antimonials, thus increasing their clinical life. Methodology/Principal Findings: We investigated the efficacy of sodium stibogluconate (SSG) in phosphatidylcholine (PC)-stearylamine-bearing liposomes (PC-SA-SSG), PC-cholesterol liposomes (PC-Chol-SSG) and free amphotericin B (AmB) against SSG-resistant L. donovani strains in 8-wk infected BALB/c mice. Animals were sacrificed and parasites in liver, spleen and bone marrow were estimated 4-wk post-treatment by microscopic examination of stamp smears and limiting dilution assay. A set of PC-SA-SSG and AmB treated mice were further studied for protection against reinfection. Serum antibodies and cytokine profiles of ex-vivo cultured splenocytes were determined by ELISA. Uptake of free and liposomal SSG in intracellular amastigotes was determined by atomic absorption spectroscopy. Rhodamine 123 and 5-carboxyfluorescein, known substrates of Pgp and MRP transporter proteins, respectively, were used in free and liposomal forms for efflux studies to estimate intracellular drug retention. Unlike free and PC-Chol-SSG, PC-SA-SSG was effective in curing mice infected with two differentially originated SSG-unresponsive parasite strains at significantly higher levels than AmB. Successful therapy correlated with complete suppression of disease-promoting IL-10 and TGF-beta, upregulation of Th1 cytokines and expression of macrophage microbicidal NO. Cure due to elevated accumulation of SSG in intracellular parasites, irrespective of SSG-resistance, occurs as a result of increased drug retention and improved therapy when administered as PC-SA-SSG versus free SSG. Conclusions/Significance: The design of this single-dose combination therapy with PC-SA-SSG for VL, having reduced toxicity and long-term efficacy, irrespective of SSG-sensitivity may prove promising, not only to overcome SSG-resistance in Leishmania, but also for drugs with similar resistance-related problems in other diseases.	[Roychoudhury, Jayeeta; Sinha, Roma; Ali, Nahid] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roychoudhury, J (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	nali@iicb.res.in	bhattacharyya, Anirban/F-6067-2015; Sinha, Roma/B-3808-2010		Indian Council of Medical Research; University Grants Commission, Government of India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); University Grants Commission, Government of India(University Grants Commission, India)	This study was supported by grants from the Indian Council of Medical Research, and University Grants Commission, Government of India. JR was a Senior Research Fellow of Council for Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Afrin F, 2001, J PARASITOL, V87, P188, DOI 10.1645/0022-3395(2001)087[0188:LAOSBL]2.0.CO;2; Alexander J, 2000, EUR J IMMUNOL, V30, P2935, DOI 10.1002/1521-4141(200010)30:10&lt;2935::AID-IMMU2935&gt;3.0.CO;2-Q; ALVING CR, 1978, P NATL ACAD SCI USA, V75, P2959, DOI 10.1073/pnas.75.6.2959; ALVING CR, 1978, LIFE SCI, V22, P1021, DOI 10.1016/0024-3205(78)90270-9; Anderson CF, 2008, J IMMUNOL, V180, P4090, DOI 10.4049/jimmunol.180.6.4090; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; BAILLIE AJ, 1986, J PHARM PHARMACOL, V38, P502, DOI 10.1111/j.2042-7158.1986.tb04623.x; BANERJEE A, 2011, ANTIMICROB IN PRESS, DOI DOI 10.1128/AAC.00524-10); Banerjee A, 2008, J IMMUNOL, V181, P1386, DOI 10.4049/jimmunol.181.2.1386; Banerjee A, 2008, J ANTIMICROB CHEMOTH, V61, P103, DOI 10.1093/jac/dkm396; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhattacharyya A, 2002, J BIOSCIENCES, V27, P503, DOI 10.1007/BF02705047; BLACK CDV, 1977, T ROY SOC TROP MED H, V71, P550, DOI 10.1016/0035-9203(77)90155-9; CARTER KC, 1989, J PHARM PHARMACOL, V41, P87, DOI 10.1111/j.2042-7158.1989.tb06399.x; Carter KC, 2003, ANTIMICROB AGENTS CH, V47, P1529, DOI 10.1128/AAC.47.5.1529-1535.2003; Carter KC, 2001, ANTIMICROB AGENTS CH, V45, P3555, DOI 10.1128/AAC.45.12.3555-3559.2001; Chandra D, 2008, CLIN EXP IMMUNOL, V154, P224, DOI 10.1111/j.1365-2249.2008.03741.x; CHUNGE CN, 1990, T ROY SOC TROP MED H, V84, P221, DOI 10.1016/0035-9203(90)90263-E; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dey T, 2000, ANTIMICROB AGENTS CH, V44, P1739, DOI 10.1128/AAC.44.6.1739-1742.2000; DING AH, 1988, J IMMUNOL, V141, P2407; Feng GJ, 1999, J IMMUNOL, V163, P6403; Frezard F, 2009, MOLECULES, V14, P2317, DOI 10.3390/molecules14072317; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; HALDAR JP, 1983, INFECT IMMUN, V42, P702, DOI 10.1128/IAI.42.2.702-707.1983; HUNTER CA, 1988, J PHARM PHARMACOL, V40, P161, DOI 10.1111/j.2042-7158.1988.tb05210.x; Iwaoka S, 2006, J LEUKOCYTE BIOL, V79, P184, DOI 10.1189/jlb.0405181; Kang DI, 2009, DRUG DELIV, V16, P261, DOI 10.1080/10717540902937562; Kok JW, 2000, INT J CANCER, V87, P172, DOI 10.1002/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Maltezou HC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617521; Mamot C, 2003, DRUG RESIST UPDATE, V6, P271, DOI 10.1016/S1368-7646(03)00082-7; Mandal G, 2009, INDIAN J BIOCHEM BIO, V46, P86; Mastroianni A, 2004, Infez Med, V12, P197; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Melaku Y, 2007, AM J TROP MED HYG, V77, P89, DOI 10.4269/ajtmh.2007.77.89; Mora M, 2002, PHARMACEUT RES, V19, P1430, DOI 10.1023/A:1020440229102; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; MURRAY HW, 1989, J CLIN INVEST, V83, P1253, DOI 10.1172/JCI114009; Murray HW, 2005, J IMMUNOL, V174, P4916, DOI 10.4049/jimmunol.174.8.4916; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V240, P793, DOI 10.1006/bbrc.1997.7749; NEW RRC, 1978, NATURE, V272, P55, DOI 10.1038/272055a0; Olliaro PL, 2010, CURR OPIN INFECT DIS, V23, P595, DOI 10.1097/QCO.0b013e32833fca9d; Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6; Owais M., 2005, Current Drug Delivery, V2, P311, DOI 10.2174/156720105774370177; Padigel UM, 2003, J IMMUNOL, V171, P3705, DOI 10.4049/jimmunol.171.7.3705; Pal S, 2004, ANTIMICROB AGENTS CH, V48, P3591, DOI 10.1128/AAC.48.9.3591-3593.2004; Ranatunga D, 2009, P NATL ACAD SCI USA, V106, P17123, DOI 10.1073/pnas.0904955106; ROBERTS WL, 1993, ANAL BIOCHEM, V211, P1, DOI 10.1006/abio.1993.1223; Saha S, 2007, J IMMUNOL, V179, P5592, DOI 10.4049/jimmunol.179.8.5592; Stauber AL, 1956, RICE I PAM, V45, P80; Sundar S, 2008, CLIN INFECT DIS, V47, P1000, DOI 10.1086/591972; Sundar S, 2006, INDIAN J MED RES, V123, P345; Teng S, 2003, DRUG METAB DISPOS, V31, P1296, DOI 10.1124/dmd.31.11.1296; Valiathan R, 2006, EXP PARASITOL, V114, P103, DOI 10.1016/j.exppara.2006.02.015; WEBB MS, 1995, BBA-BIOMEMBRANES, V1238, P147, DOI 10.1016/0005-2736(95)00121-I	65	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e17376	10.1371/journal.pone.0017376	http://dx.doi.org/10.1371/journal.pone.0017376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423750	Green Submitted, Green Published, gold			2022-12-27	WOS:000288219100007
J	Nguyen, C; Berezne, A; Baubet, T; Mestre-Stanislas, C; Rannou, F; Papelard, A; Morell-Dubois, S; Revel, M; Guillevin, L; Poiraudeau, S; Mouthon, L				Nguyen, Christelle; Berezne, Alice; Baubet, Thierry; Mestre-Stanislas, Caroline; Rannou, Francois; Papelard, Agathe; Morell-Dubois, Sandrine; Revel, Michel; Guillevin, Loic; Poiraudeau, Serge; Mouthon, Luc		Grp Francais Rech Sclerodermie	Association of Gender with Clinical Expression, Quality of Life, Disability, and Depression and Anxiety in Patients with Systemic Sclerosis	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; FORM HEALTH SURVEY; HOSPITAL ANXIETY; ORGAN INVOLVEMENT; SCLERODERMA; SCALE; QUESTIONNAIRE; SYMPTOMS; VALIDATION; SURVIVAL	Objectives: To assess the association of gender with clinical expression, health-related quality of life (HRQoL), disability, and self-reported symptoms of depression and anxiety in patients with systemic sclerosis (SSc). Methods: SSc patients fulfilling the American College of Rheumatology and/or the Leroy and Medsger criteria were assessed for clinical symptoms, disability, HRQoL, self-reported symptoms of depression and anxiety by specific measurement scales. Results: Overall, 381 SSc patients (62 males) were included. Mean age and disease duration at the time of evaluation were 55.9 (13.3) and 9.5 (7.8) years, respectively. One-hundred-and-forty-nine (40.4%) patients had diffuse cutaneous SSc (dcSSc). On bivariate analysis, differences were observed between males and females for clinical symptoms and self-reported symptoms of depression and anxiety, however without reaching statistical significance. Indeed, a trend was found for higher body mass index (BMI) (25.0 [4.1] vs 23.0 [4.5], p = 0.013), more frequent dcSSc, echocardiography systolic pulmonary artery pressure >35 mmHg and interstitial lung disease in males than females (54.8% vs 37.2%, p = 0.010; 24.2% vs 10.5%, p = 0.003; and 54.8% vs 41.2%, p = 0.048, respectively), whereas calcinosis and self-reported anxiety symptoms tended to be more frequent in females than males (36.0% vs 21.4%, p = 0.036, and 62.3% vs 43.5%, p = 0.006, respectively). On multivariate analysis, BMI, echocardiography PAP>35 mmHg, and anxiety were the variables most closely associated with gender. Conclusions: In SSc patients, male gender tends to be associated with diffuse disease and female gender with calcinosis and self-reported symptoms of anxiety. Disease-associated disability and HRQoL were similar in both groups.	[Nguyen, Christelle; Berezne, Alice; Mestre-Stanislas, Caroline; Guillevin, Loic; Mouthon, Luc] Univ Paris 05, Fac Med Paris Descartes, Ctr Reference Vascularites Necrosantes & Sclerode, Hop Cochin,AP HP, Paris, France; [Nguyen, Christelle; Rannou, Francois; Papelard, Agathe; Revel, Michel; Poiraudeau, Serge] Univ Paris 05, Fac Med Paris Descartes, Inst Federatif Rech Handicap, Hop Cochin,AP HP,Serv Med Phys & Readaptat, Paris, France; [Baubet, Thierry] Univ Paris 13, EA 3413, Serv Psychopathol, Hop Avicenne,AP HP, Bobigny, France; [Morell-Dubois, Sandrine] Univ Lille 2, Serv Med Interne, Ctr Reference Sclerodermie Syst, Hop Claude Huriez, Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Nguyen, C (corresponding author), Univ Paris 05, Fac Med Paris Descartes, Ctr Reference Vascularites Necrosantes & Sclerode, Hop Cochin,AP HP, Paris, France.	luc.mouthon@cch.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016	Nguyen, MD, PhD, Christelle/0000-0001-7141-3230; Baubet, Thierry/0000-0002-4112-1592; Poiraudeau, Serge/0000-0002-1988-9124				Al-Dhaher FF, 2010, SEMIN ARTHRITIS RHEU, V39, P269, DOI 10.1016/j.semarthrit.2008.06.002; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Angelopoulos NV, 2001, PSYCHOTHER PSYCHOSOM, V70, P145, DOI 10.1159/000056240; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; Azad N, 2008, JCPSP-J COLL PHYSICI, V18, P569, DOI 09.2008/JCPSP.569573; Benrud-Larson LM, 2002, PAIN, V95, P267, DOI 10.1016/S0304-3959(01)00409-2; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BLACK CM, 1993, J INTERN MED, V234, P3, DOI 10.1111/j.1365-2796.1993.tb00697.x; Boulman N, 2005, SEMIN ARTHRITIS RHEU, V34, P805, DOI 10.1016/j.semarthrit.2005.01.016; Carreira PE, 2009, ANN RHEUM DIS, V68, P96; Chifflot H, 2008, SEMIN ARTHRITIS RHEU, V37, P223, DOI 10.1016/j.semarthrit.2007.05.003; Duruoz MT, 1996, J RHEUMATOL, V23, P1167; EVANS C, 1985, LANCET, V1, P1204; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; Gaultier JB, 2008, REV MED INTERNE, V29, P181, DOI 10.1016/j.revmed.2007.07.010; Georges C, 2005, CLIN RHEUMATOL, V24, P3, DOI 10.1007/s10067-004-0942-3; Haythornthwaite JA, 2003, RHEUM DIS CLIN N AM, V29, P427, DOI 10.1016/S0889-857X(03)00020-6; Hesselstrand R, 1998, ANN RHEUM DIS, V57, P682, DOI 10.1136/ard.57.11.682; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Hudson M, 2008, ARTHRIT RHEUM-ARTHR, V59, P279, DOI 10.1002/art.23344; Hudson M, 2009, ARTHRIT RHEUM-ARTHR, V61, P274, DOI 10.1002/art.24284; Hunzelmann N, 2008, RHEUMATOLOGY, V47, P1185, DOI 10.1093/rheumatology/ken179; Hyphantis TN, 2007, J PSYCHOSOM RES, V62, P47, DOI 10.1016/j.jpsychores.2006.07.028; Joven B, 2006, ANN RHEUM DIS, V65, P395; Legendre U, 2005, JOINT BONE SPINE, V72, P408, DOI 10.1016/j.jbspin.2003.11.008; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Matsuura E, 2003, J RHEUMATOL, V30, P1782; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Merkel PA, 2002, ARTHRITIS RHEUM-US, V46, P2410, DOI 10.1002/art.10486; MESTRESTANISLAS C, 2010, PRESSE MED; Mouthon L, 2007, ANN RHEUM DIS, V66, P1651, DOI 10.1136/ard.2007.070532; Mouthon L, 2010, ANN RHEUM DIS, V69, P214, DOI 10.1136/ard.2008.094193; Mouthon L, 2008, ARTHRIT RHEUM-ARTHR, V59, P968, DOI 10.1002/art.23819; Nguyen C, 2010, RHEUMATOLOGY, V49, P982, DOI 10.1093/rheumatology/kep400; Nguyen C, 2010, J RHEUMATOL, V37, P359, DOI 10.3899/jrheum.090632; Oliver JE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2585; PETERSGOLDEN M, 1984, MEDICINE, V63, P221, DOI 10.1097/00005792-198407000-00004; Poole J L, 1991, Arthritis Care Res, V4, P27, DOI 10.1002/art.1790040106; Ramjeet J, 2005, RHEUMATOLOGY, V44, P1166, DOI 10.1093/rheumatology/keh699; Rannou F, 2007, ARTHRIT RHEUM-ARTHR, V57, P94, DOI 10.1002/art.22468; Robertson LP, 2003, ANN RHEUM DIS, V62, P267, DOI 10.1136/ard.62.3.267; Roca RP, 1996, ARTHRITIS RHEUM, V39, P1035, DOI 10.1002/art.1780390623; Simeon CP, 1996, BRIT J RHEUMATOL, V35, P910; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Straszecka J, 1996, CLIN RHEUMATOL, V15, P621, DOI 10.1007/BF02238557; Tamby MC, 2003, AUTOIMMUN REV, V2, P152, DOI 10.1016/S1568-9972(03)00004-1; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P504, DOI 10.1002/art.23524; TUGWELL P, 1987, J RHEUMATOL, V14, P446; Waheed Abdul, 2006, JPMA Journal of the Pakistan Medical Association, V56, P243; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WYNN J, 1985, AM HEART J, V110, P123, DOI 10.1016/0002-8703(85)90525-3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17551	10.1371/journal.pone.0017551	http://dx.doi.org/10.1371/journal.pone.0017551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FR	21408076	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900027
J	Chatre, L; Ricchetti, M				Chatre, Laurent; Ricchetti, Miria			Nuclear Mitochondrial DNA Activates Replication in Saccharomyces cerevisiae	PLOS ONE			English	Article							CHROMOSOMAL REPLICATOR; CONSENSUS SEQUENCE; YEAST; ORIGINS; GENOME; ELEMENTS; TRANSFORMATION; PREDICTION; MUTATIONS; REGIONS	The nuclear genome of eukaryotes is colonized by DNA fragments of mitochondrial origin, called NUMTs. These insertions have been associated with a variety of germ-line diseases in humans. The significance of this uptake of potentially dangerous sequences into the nuclear genome is unclear. Here we provide functional evidence that sequences of mitochondrial origin promote nuclear DNA replication in Saccharomyces cerevisiae. We show that NUMTs are rich in key autonomously replicating sequence (ARS) consensus motifs, whose mutation results in the reduction or loss of DNA replication activity. Furthermore, 2D-gel analysis of the mrc1 mutant exposed to hydroxyurea shows that several NUMTs function as late chromosomal origins. We also show that NUMTs located close to or within ARS provide key sequence elements for replication. Thus NUMTs can act as independent origins, when inserted in an appropriate genomic context or affect the efficiency of pre-existing origins. These findings show that migratory mitochondrial DNAs can impact on the replication of the nuclear region they are inserted in.	[Chatre, Laurent; Ricchetti, Miria] Inst Pasteur, Dept Immunol, F-75724 Paris, France; [Chatre, Laurent; Ricchetti, Miria] Inst Pasteur, Unite Genet Mol Levures, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chatre, L (corresponding author), Inst Pasteur, Dept Immunol, F-75724 Paris, France.	mricch@pasteur.fr	Chatre, Laurent/S-5704-2019	Chatre, Laurent/0000-0001-9066-4342	PTR Institut Pasteur [217]; Association pour la Recherche sur le Cancer [4022]	PTR Institut Pasteur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by PTR Institut Pasteur [217]; and the Association pour la Recherche sur le Cancer [4022]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1990, MOL CELL BIOL, V10, P5442, DOI 10.1128/MCB.10.10.5442; Angeletti PC, 2002, J VIROL, V76, P3350, DOI 10.1128/JVI.76.7.3350-3358.2002; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BLANC H, 1980, P NATL ACAD SCI-BIOL, V77, P3942, DOI 10.1073/pnas.77.7.3942; Blanc H., 1982, MITOCHONDRIAL GENES, P279; Borensztajn K, 2002, BRIT J HAEMATOL, V117, P168, DOI 10.1046/j.1365-2141.2002.03397.x; Breier AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r22; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Crabbe L, 2010, NAT STRUCT MOL BIOL, V17, P1391, DOI 10.1038/nsmb.1932; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Donato JJ, 2006, PLOS GENET, V2, P1328, DOI 10.1371/journal.pgen.0020141; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Fukuhara H, 2006, FEMS YEAST RES, V6, P1281, DOI 10.1111/j.1567-1364.2006.00125.x; Goldin E, 2004, HUM MUTAT, V24, P460, DOI 10.1002/humu.20094; Hadler HI, 1998, J CELL BIOCHEM, V68, P100, DOI 10.1002/(SICI)1097-4644(19980101)68:1<100::AID-JCB10>3.0.CO;2-L; HINDLEY J, 1987, MOL CELL BIOL, V7, P504, DOI 10.1128/MCB.7.1.504; Huberman JA, 1999, METHODS, V18, P356, DOI 10.1006/meth.1999.0792; HYMAN BC, 1982, P NATL ACAD SCI-BIOL, V79, P1578, DOI 10.1073/pnas.79.5.1578; HYMAN BC, 1983, GENE, V26, P223, DOI 10.1016/0378-1119(83)90192-0; LENGLEZ S, GENOME RES; Lin S, 1997, MOL CELL BIOL, V17, P5473, DOI 10.1128/MCB.17.9.5473; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MARGULYS L, 1970, ORIGIN EUKARYOTIC CE; McCune HJ, 2008, GENETICS, V180, P1833, DOI 10.1534/genetics.108.094359; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Noutsos C, 2005, GENOME RES, V15, P616, DOI 10.1101/gr.3788705; Podnar M, 2007, J MOL EVOL, V64, P308, DOI 10.1007/s00239-005-0259-0; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; REID RA, 1983, TRENDS BIOCHEM SCI, V8, P190, DOI 10.1016/0968-0004(83)90205-0; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Ricchetti M, 2003, J MOL BIOL, V328, P847, DOI 10.1016/S0022-2836(03)00315-2; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; SACERDOT C, 2008, FEMS YEAST RES; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SHAY JW, 1991, ONCOGENE, V6, P1869; SIKORSKI RS, 1989, GENETICS, V122, P19; SRIENC F, 1985, MOL CELL BIOL, V5, P1676, DOI 10.1128/MCB.5.7.1676; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Theis JF, 1997, P NATL ACAD SCI USA, V94, P10786, DOI 10.1073/pnas.94.20.10786; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2; Van Brabant AJ, 1999, MOL CELL BIOL, V19, P4231; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917; Vartanian JP, 2002, P NATL ACAD SCI USA, V99, P7566, DOI 10.1073/pnas.112205999; WALKER SS, 1991, NUCLEIC ACIDS RES, V19, P6255, DOI 10.1093/nar/19.22.6255; Willett-Brozick JE, 2001, HUM GENET, V109, P216, DOI 10.1007/s004390100564; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17235	10.1371/journal.pone.0017235	http://dx.doi.org/10.1371/journal.pone.0017235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408151	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000016
J	Garcia, MC; Lee, JT; Ramsook, CB; Alsteens, D; Dufrene, YF; Lipke, PN				Garcia, Melissa C.; Lee, Janis T.; Ramsook, Caleen B.; Alsteens, David; Dufrene, Yves F.; Lipke, Peter N.			A Role for Amyloid in Cell Aggregation and Biofilm Formation	PLOS ONE			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; ALZHEIMERS-DISEASE; CONGO RED; ADHERENCE PROPERTIES; GENE; PROTEIN; YEAST; ADHESINS; BINDING	Cell adhesion molecules in Saccharomyces cerevisiae and Candida albicans contain amyloid-forming sequences that are highly conserved. We have now used site-specific mutagenesis and specific peptide perturbants to explore amyloid-dependent activity in the Candida albicans adhesin Als5p. A V326N substitution in the amyloid-forming region conserved secondary structure and ligand binding, but abrogated formation of amyloid fibrils in soluble Als5p and reduced cell surface thioflavin T fluorescence. When displayed on the cell surface, Als5p with this substitution prevented formation of adhesion nanodomains and formation of large cellular aggregates and model biofilms. In addition, amyloid nanodomains were regulated by exogenous peptides. An amyloid-forming homologous peptide rescued aggregation and biofilm activity of Als5p V326N cells, and V326N substitution peptide inhibited aggregation and biofilm activity in Als5p(WT) cells. Therefore, specific site mutation, inhibition by anti-amyloid peturbants, and sequence-specificity of pro-amyloid and anti-amyloid peptides showed that amyloid formation is essential for nanodomain formation and activation.	[Garcia, Melissa C.; Lee, Janis T.; Ramsook, Caleen B.; Lipke, Peter N.] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Alsteens, David; Dufrene, Yves F.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	City University of New York (CUNY) System; Brooklyn College (CUNY); Universite Catholique Louvain	Garcia, MC (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	plipke@brooklyn.cuny.edu	Alsteens, David/AAU-5475-2020; Lipke, Peter N./AAW-4914-2020; Alsteens, David A/F-2669-2014	Alsteens, David/0000-0001-9229-113X; Lipke, Peter N./0000-0003-1733-0690; Alsteens, David A/0000-0001-9229-113X; Garcia-Sherman, Melissa/0000-0003-1409-4397; Dufrene, Yves/0000-0002-7289-4248	National Institutes of Health (NIH) [SC1 GM 083756]; National Foundation for Scientific Research (FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Region Wallonne; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute francaise de Belgique; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM083756] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Region Wallonne; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute francaise de Belgique; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work at Brooklyn College was supported by National Institutes of Health (NIH) grant SC1 GM 083756. Work at the Universite catholique de Louvain was supported by the National Foundation for Scientific Research (FNRS), the Universite catholique de Louvain (Fonds Speciaux de Recherche), the Region Wallonne, the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the Research Department of the Communaute francaise de Belgique (Concerted Research Action). Y.F.D. and D.A. are Senior Research Associate and Research Fellow of the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; ALSTEENS D, 2010, P NATL ACAD SCI US; Alsteens D, 2009, ACS NANO, V3, P3063, DOI 10.1021/nn900778t; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P878; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; de Jong W, 2009, MOL MICROBIOL, V73, P1128, DOI 10.1111/j.1365-2958.2009.06838.x; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Eisert R, 2006, ANAL BIOCHEM, V353, P144, DOI 10.1016/j.ab.2006.03.015; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fowler Douglas M, 2006, PLoS Biol, V4, pe6; Frank AT, 2010, EUKARYOT CELL, V9, P405, DOI 10.1128/EC.00235-09; Gaur NK, 2004, MICROBIOL-SGM, V150, P277, DOI 10.1099/mic.0.26738-0; Gaur NK, 2002, CELL COMMUN ADHES, V9, P45, DOI 10.1080/15419060212187; Gaur NK, 1997, INFECT IMMUN, V65, P5289, DOI 10.1128/IAI.65.12.5289-5294.1997; Gaur NK, 1999, INFECT IMMUN, V67, P6040, DOI 10.1128/IAI.67.11.6040-6047.1999; Gonzalez M, 2010, YEAST, V27, P583, DOI 10.1002/yea.1797; Granic I, 2010, J ALZHEIMERS DIS, V19, P991, DOI 10.3233/JAD-2010-1297; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128; Hoyer LL, 2001, YEAST, V18, P49, DOI 10.1002/1097-0061(200101)18:1&lt;49::AID-YEA646&gt;3.0.CO;2-M; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Inbar P, 2006, BIOORG MED CHEM LETT, V16, P1076, DOI 10.1016/j.bmcl.2005.10.067; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; Kim YS, 2003, J BIOL CHEM, V278, P10842, DOI 10.1074/jbc.M212540200; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Lorenzo A, 1996, ANN NY ACAD SCI, V777, P89, DOI 10.1111/j.1749-6632.1996.tb34406.x; Loza L, 2004, YEAST, V21, P473, DOI 10.1002/yea.1111; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Nobbs AH, 2010, EUKARYOT CELL, V9, P1622, DOI 10.1128/EC.00103-10; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; SILVERMAN RJ, 2010, INFECT IMMUN; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; ten Cate JM, 2009, J DENT RES, V88, P105, DOI 10.1177/0022034508329273; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200	54	89	97	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17632	10.1371/journal.pone.0017632	http://dx.doi.org/10.1371/journal.pone.0017632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408122	Green Published, gold			2022-12-27	WOS:000288170000048
J	Lima-Camara, TN; Bruno, RV; Luz, PM; Castro, MG; Lourenco-de-Oliveira, R; Sorgine, MHF; Peixoto, AA				Lima-Camara, Tamara N.; Bruno, Rafaela V.; Luz, Paula M.; Castro, Marcia G.; Lourenco-de-Oliveira, Ricardo; Sorgine, Marcos H. F.; Peixoto, Alexandre A.			Dengue Infection Increases the Locomotor Activity of Aedes aegypti Females	PLOS ONE			English	Article							FEEDING-BEHAVIOR; VIRUS-INFECTION; CULICIDAE; DIPTERA; EXPRESSION; DROSOPHILA; MOSQUITOS; PARASITES; VECTORS; BRAZIL	Background: Aedes aegypti is the main vector of the virus causing Dengue fever, a disease that has increased dramatically in importance in recent decades, affecting many tropical and sub-tropical areas of the globe. It is known that viruses and other parasites can potentially alter vector behavior. We investigated whether infection with Dengue virus modifies the behavior of Aedes aegypti females with respect to their activity level. Methods/Principal Findings: We carried out intrathoracic Dengue 2 virus (DENV-2) infections in Aedes aegypti females and recorded their locomotor activity behavior. We observed an increase of up to,50% in the activity of infected mosquitoes compared to the uninfected controls. Conclusions: Dengue infection alters mosquito locomotor activity behavior. We speculate that the higher levels of activity observed in infected Aedes aegypti females might involve the circadian clock. Further studies are needed to assess whether this behavioral change could have implications for the dynamics of Dengue virus transmission.	[Lima-Camara, Tamara N.; Bruno, Rafaela V.; Peixoto, Alexandre A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil; [Luz, Paula M.] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin DST & AIDS, BR-21045900 Rio De Janeiro, Brazil; [Castro, Marcia G.; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, Brazil; [Sorgine, Marcos H. F.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Sorgine, Marcos H. F.; Peixoto, Alexandre A.] INCT EM, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Lima-Camara, TN (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil.	apeixoto@ioc.fiocruz.br	Bruno, Rafaela/AAQ-7611-2020; Camara, Tamara N Lima/G-3476-2016	Luz, Paula/0000-0001-9746-719X; Bruno, Rafaela/0000-0002-7082-9768	Howard Hughes Medical Institute; CNPq; Faperj; FIOCRUZ	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ	This work was supported by grants from the Howard Hughes Medical Institute, CNPq, Faperj, and FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Clements AN., 1999, SENSORY RECEPTION BE; Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013; Evans O, 2009, J EXP BIOL, V212, P1436, DOI 10.1242/jeb.028951; Gentile C, 2006, INSECT BIOCHEM MOLEC, V36, P878, DOI 10.1016/j.ibmb.2006.08.008; Gentile C, 2009, J BIOL RHYTHM, V24, P444, DOI 10.1177/0748730409349169; GRIMSTAD PR, 1980, J MED ENTOMOL, V17, P1, DOI 10.1093/jmedent/17.1.1; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Kuo TH, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-17; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee JE, 2008, CURR BIOL, V18, P195, DOI 10.1016/j.cub.2007.12.054; Linthicum KJ, 1996, MED VET ENTOMOL, V10, P87, DOI 10.1111/j.1365-2915.1996.tb00086.x; Miagostovich Marize P., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P17, DOI 10.1590/S0036-46652003000100004; MOORE J, 1993, J PARASITOL, V79, P1, DOI 10.2307/3283270; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; ROWLAND MW, 1986, PHYSIOL ENTOMOL, V11, P325, DOI 10.1111/j.1365-3032.1986.tb00420.x; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Saunders DS, 2002, INSECT CLOCKS; Schaub GA, 2006, INT J MED MICROBIOL, V296, P37, DOI 10.1016/j.ijmm.2005.12.004; Shirasu-Hiza MM, 2007, CURR BIOL, V17, pR353, DOI 10.1016/j.cub.2007.03.049; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292	34	78	80	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17690	10.1371/journal.pone.0017690	http://dx.doi.org/10.1371/journal.pone.0017690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408119	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170000055
J	Ludin, P; Nilsson, D; Maser, P				Ludin, Philipp; Nilsson, Daniel; Maeser, Pascal			Genome-Wide Identification of Molecular Mimicry Candidates in Parasites	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; COMPLEMENT C2 RECEPTOR; PLASMODIUM-FALCIPARUM; TRYPANOSOMA-CRUZI; HUMAN MALARIA; DRAFT GENOME; SPOROZOITE INVASION; SCHISTOSOMA-MANSONI; SEQUENCE; THROMBOSPONDIN	Among the many strategies employed by parasites for immune evasion and host manipulation, one of the most fascinating is molecular mimicry. With genome sequences available for host and parasite, mimicry of linear amino acid epitopes can be investigated by comparative genomics. Here we developed an in silico pipeline for genome-wide identification of molecular mimicry candidate proteins or epitopes. The predicted proteome of a given parasite was broken down into overlapping fragments, each of which was screened for close hits in the human proteome. Control searches were carried out against unrelated, free-living eukaryotes to eliminate the generally conserved proteins, and with randomized versions of the parasite proteins to get an estimate of statistical significance. This simple but computation-intensive approach yielded interesting candidates from human-pathogenic parasites. From Plasmodium falciparum, it returned a 14 amino acid motif in several of the PfEMP1 variants identical to part of the heparin-binding domain in the immunosuppressive serum protein vitronectin. And in Brugia malayi, fragments were detected that matched to periphilin-1, a protein of cell-cell junctions involved in barrier formation. All the results are publicly available by means of mimicDB, a searchable online database for molecular mimicry candidates from pathogens. To our knowledge, this is the first genome-wide survey for molecular mimicry proteins in parasites. The strategy can be adopted to any pair of host and pathogen, once appropriate negative control organisms are chosen. MimicDB provides a host of new starting points to gain insights into the molecular nature of host-pathogen interactions.	[Ludin, Philipp; Nilsson, Daniel; Maeser, Pascal] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Ludin, Philipp; Maeser, Pascal] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ludin, Philipp; Maeser, Pascal] Univ Basel, Basel, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Ludin, P (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	pascal.maeser@unibas.ch	Nilsson, Daniel/B-8365-2009	Nilsson, Daniel/0000-0001-5831-385X; Maser, Pascal/0000-0003-3122-1941	Swedish National Science Foundation; Swiss National Science Foundation	Swedish National Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Daniel Nilsson was supported by a fellowship of the Swedish National Science Foundation, and Pacal Maser was supported by a research professorship grant of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; BENISMAIL R, 1982, J PARASITOL, V68, P402, DOI 10.2307/3280949; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Biron DG, 2005, P ROY SOC B-BIOL SCI, V272, P2117, DOI 10.1098/rspb.2005.3213; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; DAMIAN RAYMOND T., 1962, JOUR PARASITOL, V48, P16; DAMIAN RT, 1964, AM NAT, V98, P129, DOI 10.1086/282313; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DELEON PP, 2005, REV INST MED TROP SP, V47, P159; Diaz A, 1997, J IMMUNOL, V158, P3779; DUVAUXMIRET O, 1992, P NATL ACAD SCI USA, V89, P778, DOI 10.1073/pnas.89.2.778; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gamulin V, 2000, BIOL J LINN SOC, V71, P821, DOI [10.1111/j.1095-8312.2000.tb01293.x, 10.1006/bijl.2000.0476]; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghansah TJ, 2002, J EUKARYOT MICROBIOL, V49, P383, DOI 10.1111/j.1550-7408.2002.tb00216.x; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Goodridge HS, 2005, IMMUNOLOGY, V115, P296, DOI 10.1111/j.1365-2567.2005.02167.x; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; HALL R, 1994, ADV PARASIT, V34, P81, DOI 10.1016/S0065-308X(08)60137-2; Han HJ, 2004, BIOCHEM BIOPH RES CO, V320, P563, DOI 10.1016/j.bbrc.2004.06.008; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; HIDE G, 1989, MOL BIOCHEM PARASIT, V36, P51, DOI 10.1016/0166-6851(89)90199-0; HOLMQUIST G, 1988, INFECT IMMUN, V56, P1545, DOI 10.1128/IAI.56.6.1545-1550.1988; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Inal JM, 2005, SPRINGER SEMIN IMMUN, V27, P320, DOI 10.1007/s00281-005-0009-9; Inal JM, 2005, J IMMUNOL, V174, P356, DOI 10.4049/jimmunol.174.1.356; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kazerounian S, 2003, J BIOL CHEM, V278, P36707, DOI 10.1074/jbc.M303896200; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lehr T, 2007, GLYCOBIOLOGY, V17, P82, DOI 10.1093/glycob/cwl048; Lu B, 2008, INFECT IMMUN, V76, P3530, DOI 10.1128/IAI.00411-08; Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597; Mauss ER, 1941, J IMMUNOL, V42, P71; Menard R, 2000, MICROBES INFECT, V2, P633, DOI 10.1016/S1286-4579(00)00362-2; Meri T, 2002, J INFECT DIS, V185, P1786, DOI 10.1086/340649; Michelson S, 2004, HUM IMMUNOL, V65, P465, DOI 10.1016/j.humimm.2004.02.002; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nyame AK, 1998, GLYCOBIOLOGY, V8, P615, DOI 10.1093/glycob/8.6.615; Oliver-Gonalez J, 1944, J INFECT DIS, V74, P173, DOI 10.1093/infdis/74.3.173; OLIVERGONZALEZ J, 1946, J INFECT DIS, V78, P232, DOI 10.1093/infdis/78.3.232; OUAISSI MA, 1986, SCIENCE, V234, P603, DOI 10.1126/science.3094145; OUAISSI MA, 1984, NATURE, V308, P380, DOI 10.1038/308380a0; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Ponce de León Patricia, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P107, DOI 10.1590/S0036-46652003000200011; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROBSON KJH, 1995, EMBO J, V14, P3883, DOI 10.1002/j.1460-2075.1995.tb00060.x; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; SHEAR HL, 1979, J EXP MED, V149, P1288, DOI 10.1084/jem.149.6.1288; SHERWOOD JA, 1987, AM J TROP MED HYG, V36, P228, DOI 10.4269/ajtmh.1987.36.228; SINGH B, 2010, MOL MICROBI IN PRESS; Spiliotis M, 2003, GENE, V323, P57, DOI 10.1016/j.gene.2003.09.007; SRINIVASAPPA J, 1986, J VIROL, V57, P397, DOI 10.1128/JVI.57.1.397-401.1986; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Wang SP, 1997, EMBO J, V16, P4107, DOI 10.1093/emboj/16.13.4107; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	83	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17546	10.1371/journal.pone.0017546	http://dx.doi.org/10.1371/journal.pone.0017546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408160	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170000037
J	Allen, LZ; Ishoey, T; Novotny, MA; McLean, JS; Lasken, RS; Williamson, SJ				Allen, Lisa Zeigler; Ishoey, Thomas; Novotny, Mark A.; McLean, Jeffrey S.; Lasken, Roger S.; Williamson, Shannon J.			Single Virus Genomics: A New Tool for Virus Discovery	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; FLOW-CYTOMETRY; MARINE VIRUSES; DNA-POLYMERASE; CELL; COMMUNITIES; SAMPLES; ENUMERATION; PROKARYOTES; SEQUENCES	Whole genome amplification and sequencing of single microbial cells has significantly influenced genomics and microbial ecology by facilitating direct recovery of reference genome data. However, viral genomics continues to suffer due to difficulties related to the isolation and characterization of uncultivated viruses. We report here on a new approach called 'Single Virus Genomics', which enabled the isolation and complete genome sequencing of the first single virus particle. A mixed assemblage comprised of two known viruses; E. coli bacteriophages lambda and T4, were sorted using flow cytometric methods and subsequently immobilized in an agarose matrix. Genome amplification was then achieved in situ via multiple displacement amplification (MDA). The complete lambda phage genome was recovered with an average depth of coverage of approximately 437X. The isolation and genome sequencing of uncultivated viruses using Single Virus Genomics approaches will enable researchers to address questions about viral diversity, evolution, adaptation and ecology that were previously unattainable.	[Allen, Lisa Zeigler; Ishoey, Thomas; Novotny, Mark A.; McLean, Jeffrey S.; Lasken, Roger S.; Williamson, Shannon J.] J Craig Venter Inst, San Diego, CA 92121 USA; [Allen, Lisa Zeigler] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	J. Craig Venter Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography	Allen, LZ (corresponding author), J Craig Venter Inst, San Diego, CA 92121 USA.	swilliamson@jcvi.org	McLean, Jeffrey S/A-8014-2012	McLean, Jeffrey S/0000-0001-9934-5137	J. Craig Venter Institute; Office of Science (BER), U.S. Department of Energy [De-FC02-02ER63453]	J. Craig Venter Institute; Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by the J. Craig Venter Institute and the Office of Science (BER), U.S. Department of Energy, Cooperative Agreement No. De-FC02-02ER63453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; BLAINEY PC, NUCL ACIDS RES; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brussaard Corina P. D., 2009, V501, P97, DOI 10.1007/978-1-60327-164-6_11; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Fuhrman JA, 1998, NATURE, V393, P410, DOI 10.1038/30839; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Ishey T, 2006, APPL MICROBIOL BIOT, V69, P510, DOI 10.1007/s00253-005-0014-x; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; LASKEN RS, 2005, METHODS EXPRESS, P119; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Luef B, 2009, FEMS MICROBIOL ECOL, V68, P372, DOI 10.1111/j.1574-6941.2009.00675.x; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; MENG X, 1995, NAT GENET, V9, P432, DOI 10.1038/ng0495-432; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Panelli S, 2005, BIOTECHNIQUES, V39, P174, DOI 10.2144/05392BM03; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Storrie-Lombardi M. C., 1994, Vistas in Astronomy, V38, P331, DOI 10.1016/0083-6656(94)90044-2; Tzvetkov MV, 2005, ELECTROPHORESIS, V26, P710, DOI 10.1002/elps.200410121; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Winget DM, 2008, APPL ENVIRON MICROB, V74, P2612, DOI 10.1128/AEM.02829-07; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	47	98	109	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2011	6	3							e17722	10.1371/journal.pone.0017722	http://dx.doi.org/10.1371/journal.pone.0017722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QW	21436882	Green Submitted, Green Published, gold			2022-12-27	WOS:000288810500010
J	Williams, C; Northstone, K; Sabates, R; Feinstein, L; Emond, A; Dutton, GN				Williams, Cathy; Northstone, Kate; Sabates, Ricardo; Feinstein, Leon; Emond, Alan; Dutton, Gordon N.			Visual Perceptual Difficulties and Under-Achievement at School in a Large Community-Based Sample of Children	PLOS ONE			English	Article							DORSAL-STREAM; OBJECT RECOGNITION; OCCIPITAL LESIONS; BALINTS-SYNDROME; IMPAIRMENT; AGE; SENSITIVITY; ATTENTION; PRETERM; INFANTS	Introduction: Difficulties with visual perception (VP) are often described in children with neurological or developmental problems. However, there are few data regarding the range of visual perceptual abilities in populations of normal children, or on the impact of these abilities on children's day-to-day functioning. Methods: Data were obtained for 4512 participants in an ongoing birth cohort study (Avon Longitudinal Study of Parents and Children; ALSPAC). The children's mothers responded to questions designed to elicit indications of visual perceptual difficulties or immaturity, when their children were aged 13 years. We examined associations with standardised school test results in reading and in mathematics at age 13-14 years (SATS-KS3), accounting for potential confounders including IQ. Results: Three underlying factors explained half the variance in the VP question responses. These correlated best with questions on interpreting cluttered scenes; guidance of movement and face recognition. The adjusted parameter estimates (95% CI) for the cluttered-scenes factor (0.05; 0.02 to 0.08; p < 0.001) suggested positive associations with the reading test results whilst that for the guidance-of-movement factor (0.03; 0.00 to 0.06; p = 0.026) suggested positive association with the mathematics results. The raw scores were associated with both test results. Discussion: VP abilities were widely distributed in this sample of 13-year old children. Lower levels of VP function were associated with under-achievement in reading and in mathematics. Simple interventions can help children with VP difficulties, so research is needed into practicable, cost-effective strategies for identification and assessment, so that support can be targeted appropriately.	[Williams, Cathy; Northstone, Kate; Emond, Alan] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Sabates, Ricardo] Univ Sussex, Dept Educ, Brighton, E Sussex, England; [Feinstein, Leon] Univ London, Inst Educ, London WC1N 1AZ, England; [Dutton, Gordon N.] Glasgow Caledonian Univ, Dept Visual Sci, Glasgow G4 0BA, Lanark, Scotland; [Dutton, Gordon N.] Glasgow Caledonian Univ, Royal Hosp Sick Children, Glasgow G4 0BA, Lanark, Scotland	University of Bristol; University of Sussex; University of London; University College London; UCL Institute of Education; Glasgow Caledonian University; Glasgow Caledonian University; University of Glasgow	Williams, C (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	Williams@bristol.ac.uk	Northstone, Kate/A-8165-2011; Sabates, Ricardo/AAM-7937-2020; Williams, Cathy/K-4919-2015	Northstone, Kate/0000-0002-0602-1983; Sabates, Ricardo/0000-0002-1433-5667; Williams, Cathy/0000-0002-9133-2021; Dutton, Gordon N/0000-0003-2516-5795	UK Medical Research Council [74882]; Wellcome Trust [076467]; University of Bristol; NIHR; Medical Research Council [G9815508] Funding Source: researchfish; National Institute for Health Research [CDF-2009-02-35] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The UK Medical Research Council (grant ref: 74882), the Wellcome Trust (grant ref: 076467) and the University of Bristol provide core support for ALSPAC. CW is supported by an NIHR Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2006, DEV MED CHILD NEUROL, V48, P836, DOI 10.1017/S0012162206001794; Atkinson J, 1997, NEUROREPORT, V8, P1919, DOI 10.1097/00001756-199705260-00025; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Atkinson J, 2001, DEV MED CHILD NEUROL, V43, P330, DOI 10.1017/S0012162201000615; BAYLIS GC, 1994, NEUROPSYCHOLOGIA, V32, P1273, DOI 10.1016/0028-3932(94)90109-0; Borowsky R, 2007, BRAIN TOPOGR, V20, P89, DOI 10.1007/s10548-007-0034-1; Borowsky R, 2006, BRAIN TOPOGR, V18, P233, DOI 10.1007/s10548-006-0001-2; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Braddick O, 2007, PROG BRAIN RES, V164, P151, DOI 10.1016/S0079-6123(07)64008-4; Braddick OJ, 2009, OPTOMETRY VISION SCI, V86, P577, DOI 10.1097/OPX.0b013e3181a76e84; Cooke RWI, 2004, ARCH DIS CHILD-FETAL, V89, pF249, DOI 10.1136/adc.2002.023374; *DIR, 2010, NAT CURR TEACH ASS K; Donders J, 2001, CHILD NEUROPSYCHOL, V7, P99, DOI 10.1076/chin.7.2.99.3126; Drummond SR, 2007, J AAPOS, V11, P497, DOI 10.1016/j.jaapos.2007.03.007; Fazzi E, 2004, BRAIN DEV-JPN, V26, P506, DOI 10.1016/j.braindev.2004.02.002; Galaburda AM, 2001, ARCH NEUROL-CHICAGO, V58, P1865, DOI 10.1001/archneur.58.11.1865; Gillen JA, 2003, DEV MED CHILD NEUROL, V45, P349, DOI 10.1017/S001212203000641; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gunn A, 2002, NEUROREPORT, V13, P843, DOI 10.1097/00001756-200205070-00021; HECAEN H, 1954, BRAIN, V77, P373, DOI 10.1093/brain/77.3.373; Houliston MJ, 1999, DEV MED CHILD NEUROL, V41, P298, DOI 10.1017/S0012162299000675; Jackson GM, 2009, PSYCHOL RES-PSYCH FO, V73, P263, DOI 10.1007/s00426-008-0210-2; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; LEVACIC R, 2005, RR679 UK GOV DEP ED; McKillop E., 2008, BRIT IRISH ORTHOPTIC, V5, P8; MONTERO J, 1982, ACTA NEUROL BELG, V82, P270; Newman C, 2001, DEV PSYCHOL, V37, P561, DOI 10.1037//0012-1649.37.4.561; Pagliano E, 2007, J CHILD NEUROL, V22, P282, DOI 10.1177/0883073807300529; Polderman TJC, 2006, ACTA NEUROL BELG, V106, P191; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Reijneveld SA, 2006, ARCH DIS CHILD-FETAL, V91, pF423, DOI 10.1136/adc.2006.093674; Saidkasimova S, 2007, J AAPOS, V11, P426, DOI 10.1016/j.jaapos.2007.04.015; SHAW DE, 1988, LANCET, V2, P207; Shmuelof L, 2005, NEURON, V47, P457, DOI 10.1016/j.neuron.2005.06.034; Smith AD, 2008, COGNITION, V107, P1102, DOI 10.1016/j.cognition.2007.10.008; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Stiers P, 1998, NEUROPEDIATRICS, V29, P80, DOI 10.1055/s-2007-973540; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wechsler D., 1992, WECHSLER INTELLIGENC; Williams E, 2008, DEV MED CHILD NEUROL, V50, P672, DOI 10.1111/j.1469-8749.2008.03042.x; World Health Organization, 1992, ICD 10 CLASSIFICATIO	45	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2011	6	3							e14772	10.1371/journal.pone.0014772	http://dx.doi.org/10.1371/journal.pone.0014772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	738BC	21445286	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000288613300002
J	Beebe, DW; Byars, KC				Beebe, Dean W.; Byars, Kelly C.			Adolescents with Obstructive Sleep Apnea Adhere Poorly to Positive Airway Pressure (PAP), but PAP Users Show Improved Attention and School Performance	PLOS ONE			English	Article							CHILDREN; THERAPY; METAANALYSIS; QUALITY; ADULTS	Background: Obstructive Sleep Apnea (OSA) is associated with medical and neurobehavioral morbidity across the lifespan. Positive airway pressure (PAP) treatment has demonstrated efficacy in treating OSA and has been shown to improve daytime functioning in adults, but treatment adherence can be problematic. There are nearly no published studies examining functional outcomes such as academic functioning in adolescents treated with PAP. This study was conducted as an initial step towards determining whether PAP treatment improves daytime functioning among adolescents with OSA. Methods: Self-reported academic grades, self-and parent-reported academic quality of life, and objectively-measured attention were assessed before and after PAP was clinically initiated in a sample of 13 obese adolescents with OSA, as well as 15 untreated obese Controls without OSA. Based on adherence data, the treated group was divided into PAP Users (n = 6) and Non-Adherent participants (n = 7). Results: Though demographically similar, the three groups significantly differed in how their academic performance and attention scores changed from baseline to follow-up. Non-Adherent participants showed worsening functioning over time, while PAP Users showed stable or improved functioning, similar to controls. Conclusion: Although many adolescents prescribed PAP for OSA are non-adherent to the treatment, those who adhere to treatment can display improved attention and academic functioning.	[Beebe, Dean W.; Byars, Kelly C.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Beebe, Dean W.; Byars, Kelly C.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Beebe, DW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA.	dean.beebe@cchmc.org			United States National Institutes of Health (NIH) [K23 HL075369, R01 HL092149, UL1 RR026314]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092149, K23HL075369] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the United States National Institutes of Health (NIH) grants K23 HL075369, R01 HL092149, and UL1 RR026314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archbold KH, 2009, CURR OPIN PULM MED, V15, P585, DOI 10.1097/MCP.0b013e3283319b3f; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P69, DOI 10.1093/jpepsy/jsj104; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Beebe DW, 2010, SLEEP, V33, P1447, DOI 10.1093/sleep/33.11.1447; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Costa DJ, 2009, OTOLARYNG HEAD NECK, V140, P455, DOI 10.1016/j.otohns.2008.12.038; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Gay P, 2006, SLEEP, V29, P381, DOI 10.1093/sleep/29.3.381; Gordon M, 1983, GORDON DIAGNOSTIC SY; Sanchez AI, 2009, SLEEP MED REV, V13, P223, DOI 10.1016/j.smrv.2008.07.002; Marcus CL, 2006, PEDIATRICS, V117, pE442, DOI 10.1542/peds.2005-1634; O'Donnell AR, 2006, SLEEP, V29, P651; Uong EC, 2007, PEDIATRICS, V120, pE1203, DOI 10.1542/peds.2006-2731; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351	15	39	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e16924	10.1371/journal.pone.0016924	http://dx.doi.org/10.1371/journal.pone.0016924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437285	Green Submitted, gold, Green Published			2022-12-27	WOS:000288514600001
J	Tadema, H; Kallenberg, CGM; Stegeman, CA; Heeringa, P				Tadema, Henko; Kallenberg, Cees G. M.; Stegeman, Coen A.; Heeringa, Peter			Reactivity against Complementary Proteinase-3 Is Not Increased in Patients with PR3-ANCA-Associated Vasculitis	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; ANTIRIBOSOMAL P AUTOANTIBODIES; STAPHYLOCOCCUS-AUREUS; SYSTEMIC VASCULITIS; MOLECULAR MIMICRY; NASAL CARRIAGE; AUTOIMMUNITY; INFECTIONS; ANTIBODIES; GRANULOMATOSIS	The etiology of anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitides (AAV) is unknown, but the association between infections and autoimmunity has been studied extensively. In 2004, a novel theory was proposed that could link infection and autoimmunity. This 'theory of autoantigen complementarity' was based on the serendipitous finding of antibodies against complementary-PR3 (cPR3) in patients with PR3-ANCA-associated vasculitis. cPR3 demonstrated homology to several bacterial proteins, and it was hypothesized that PR3-ANCA develop in response to anti-cPR3 antibodies, as a consequence of the anti-idiotypic network. These data have not been confirmed in other patient cohorts. We investigated the presence of anti-cPR3 antibodies in a Dutch cohort of PR3-ANCA-associated vasculitis patients. Anti-cPR3 reactivity was determined in serum using ELISA. Two separate batches of cPR3 were used to determine reactivity in two separate cohorts of PR3-ANCA-associated vasculitis patients. We found that anti-cPR3-reactivity was not increased in our PR3-ANCA-associated vasculitis patients, in comparison to control groups. Further research will be necessary to prove the concept of autoantigen complementarity in autoimmune diseases.	[Tadema, Henko; Kallenberg, Cees G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Tadema, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	h.tadema@reuma.umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; Stegeman, Coen/0000-0002-0224-0927	Dutch Arthritis Association [06-1-401]	Dutch Arthritis Association	This work was supported by the Dutch Arthritis Association (06-1-401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 1998, ARTHRITIS RHEUM, V41, P33, DOI 10.1002/1529-0131(199801)41:1<33::AID-ART5>3.0.CO;2-5; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Doria A, 2008, AUTOIMMUN REV, V8, P24, DOI 10.1016/j.autrev.2008.07.019; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Getts MT, 2010, CLIN EXP IMMUNOL, V160, P15, DOI 10.1111/j.1365-2249.2010.04132.x; Holtfreter S, 2006, J INFECT DIS, V193, P1275, DOI 10.1086/503048; JAYNE DRW, 1993, J AUTOIMMUN, V6, P207, DOI 10.1006/jaut.1993.1018; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Kallenberg CGM, 2008, AUTOIMMUN REV, V8, P29, DOI 10.1016/j.autrev.2008.07.020; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Pan ZJ, 1998, J CLIN INVEST, V102, P215, DOI 10.1172/JCI1969; Pendergraft WF, 2004, NAT MED, V10, P72, DOI 10.1038/nm968; Preston GA, 2005, CURR OPIN NEPHROL HY, V14, P217, DOI 10.1097/01.mnh.0000165886.93427.b1; ROSSI F, 1991, CLIN EXP IMMUNOL, V83, P298; SFRISO P, 2009, J LEUKOC BIOL; SHOENFELD Y, 1994, FASEB J, V8, P1296, DOI 10.1096/fasebj.8.15.8001742; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Vani J, 2009, MOL IMMUNOL, V46, P1250, DOI 10.1016/j.molimm.2008.11.019; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; Yang JJ, 2008, KIDNEY INT, V74, P1159, DOI 10.1038/ki.2008.309; Zycinska K, 2008, J PHYSIOL PHARMACOL, V59, P825	23	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2011	6	3							e17972	10.1371/journal.pone.0017972	http://dx.doi.org/10.1371/journal.pone.0017972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SO	21437233	Green Published, gold, Green Submitted			2022-12-27	WOS:000288514600019
J	Ayers, JW; Ribisl, K; Brownstein, JS				Ayers, John W.; Ribisl, Kurt; Brownstein, John S.			Using Search Query Surveillance to Monitor Tax Avoidance and Smoking Cessation following the United States' 2009 "SCHIP" Cigarette Tax Increase	PLOS ONE			English	Article							INTERNET; WEB; DISEASE; SMOKERS; SALES; DELIVERY; TRENDS	Smokers can use the web to continue or quit their habit. Online vendors sell reduced or tax-free cigarettes lowering smoking costs, while health advocates use the web to promote cessation. We examined how smokers' tax avoidance and smoking cessation Internet search queries were motivated by the United States' (US) 2009 State Children's Health Insurance Program (SCHIP) federal cigarette excise tax increase and two other state specific tax increases. Google keyword searches among residents in a taxed geography (US or US state) were compared to an untaxed geography (Canada) for two years around each tax increase. Search data were normalized to a relative search volume (RSV) scale, where the highest search proportion was labeled 100 with lesser proportions scaled by how they relatively compared to the highest proportion. Changes in RSV were estimated by comparing means during and after the tax increase to means before the tax increase, across taxed and untaxed geographies. The SCHIP tax was associated with an 11.8% (95% confidence interval [95% CI], 5.7 to 17.9; p<.001) immediate increase in cessation searches; however, searches quickly abated and approximated differences from pre-tax levels in Canada during the months after the tax. Tax avoidance searches increased 27.9% (95% CI, 15.9 to 39.9; p<.001) and 5.3% (95% CI, 3.6 to 7.1; p<.001) during and in the months after the tax compared to Canada, respectively, suggesting avoidance is the more pronounced and durable response. Trends were similar for state-specific tax increases but suggest strong interactive processes across taxes. When the SCHIP tax followed Florida's tax, versus not, it promoted more cessation and avoidance searches. Efforts to combat tax avoidance and increase cessation may be enhanced by using interventions targeted and tailored to smokers' searches. Search query surveillance is a valuable real-time, free and public method, that may be generalized to other behavioral, biological, informational or psychological outcomes manifested online.	[Ayers, John W.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Ayers, John W.] Ctr Behav Epidemiol & Community Hlth, San Diego, CA USA; [Ribisl, Kurt] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Ribisl, Kurt] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Brownstein, John S.] Harvard Univ, Sch Med, Boston, MA USA; [Brownstein, John S.] Childrens Hosp, Informat Program, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Ayers, JW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	jayers@jhsph.edu	Ribisl, Kurt M/C-4867-2015	Ribisl, Kurt M/0000-0003-3318-8524	Google.org; National Library of Medicine (National Institutes of Health)	Google.org; National Library of Medicine (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by research funding from Google.org and the National Library of Medicine (National Institutes of Health) to JSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MMWR-MORBID MORTAL W, V58, P1227; Askitas N., 2009, APPL EC Q, V55, P107, DOI [10.1016/1047-2797(94)90062-0, DOI 10.1016/1047-2797(94)90062-0, DOI 10.3790/AEQ.55.2.107]; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Bennett GG, 2009, ANNU REV PUBL HEALTH, V30, P273, DOI 10.1146/annurev.publhealth.031308.100235; BONNIC RJ, 2007, ENDING TOBACCO PROBL; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chriqui JF, 2008, NICOTINE TOB RES, V10, P253, DOI 10.1080/14622200701838232; Cobb NK, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e17; Cobb NK, 2010, AM J PREV MED, V38, pS429, DOI 10.1016/j.amepre.2009.12.001; Cobb NK, 2005, NICOTINE TOB RES, V7, P207, DOI 10.1080/14622200500055319; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Cook TD, 2008, J POLICY ANAL MANAG, V27, P724, DOI 10.1002/pam.20375; Cooper Crystale Purvis, 2005, J Med Internet Res, V7, pe36, DOI 10.2196/jmir.7.3.e36; Davis S., 2009, Morbidity and Mortality Weekly Report, V58, P221; Debrot K., 2010, Morbidity and Mortality Weekly Report, V59, P385; Etter JF, 2001, ARCH INTERN MED, V161, P2596, DOI 10.1001/archinte.161.21.2596; Eysenbach G, 2003, AMIA Annu Symp Proc, P225; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; FOX S, 2005, HLTH INFORM ONLINE; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; GIOVINO GA, 1994, MMWR-MORBID MORTAL W, V43, P986; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Goolsble A, 2010, AM ECON J-ECON POLIC, V2, P131, DOI 10.1257/pol.2.1.131; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1001; Herzog TA, 2007, HEALTH PSYCHOL, V26, P222, DOI 10.1037/0278-6133.26.2.222; Hrywna M, 2004, TOB CONTROL, V13, P296, DOI 10.1136/tc.2003.006783; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Kim AE, 2006, PUBLIC HEALTH REP, V121, P594, DOI 10.1177/003335490612100515; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lee K, 2008, PLOS MED, V5, P1308, DOI 10.1371/journal.pmed.0050189; Lenert L, 2003, J AM MED INFORM ASSN, V10, P16, DOI 10.1197/jamia.M1128; Mayhew DavidR., 2004, C ELECTORAL CONNECTI; Metzger KB, 2005, AM J PUBLIC HEALTH, V95, P1050, DOI 10.2105/AJPH.2004.048025; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Munoz RF, 2009, NICOTINE TOB RES, V11, P1025, DOI 10.1093/ntr/ntp090; Myung SK, 2009, ARCH INTERN MED, V169, P929, DOI 10.1001/archinternmed.2009.109; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Ribisl KM, 2001, TOB CONTROL, V10, P352, DOI 10.1136/tc.10.4.352; RIBISL KM, 2007, REDUCING TOBACCO USE; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Samet JM, 2009, JAMA-J AM MED ASSOC, V302, P681, DOI 10.1001/jama.2009.1155; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Stehr M, 2005, J HEALTH ECON, V24, P277, DOI 10.1016/j.jhealeco.2004.08.005; Stoddard JL, 2006, NICOTINE TOB RES, V8, pS77, DOI 10.1080/14622200601039147; Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376; West SG, 2008, AM J PUBLIC HEALTH, V98, P1359, DOI 10.2105/AJPH.2007.124446; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Zaller JohnR., 1992, NATURE ORIGINS MASS; ZAZA S, 2005, GUIDE COMMUNITY PREV, P1	52	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e16777	10.1371/journal.pone.0016777	http://dx.doi.org/10.1371/journal.pone.0016777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736SI	21436883	gold, Green Published, Green Submitted			2022-12-27	WOS:000288514000002
J	Corona, C; Frazzini, V; Silvestri, E; Lattanzio, R; La Sorda, R; Piantelli, M; Canzoniero, LMT; Ciavardelli, D; Rizzarelli, E; Sensi, SL				Corona, Carlo; Frazzini, Valerio; Silvestri, Elena; Lattanzio, Rossano; La Sorda, Rossana; Piantelli, Mauro; Canzoniero, Lorella M. T.; Ciavardelli, Domenico; Rizzarelli, Enrico; Sensi, Stefano L.			Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD Mice	PLOS ONE			English	Article							INCREASES BDNF LEVELS; TARGETING A-BETA; ZINC L-CARNOSINE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MEMORY DEFICITS; MOUSE MODEL; AMINO-ACID; PROTEIN; TAU	Background: The pathogenic road map leading to Alzheimer's disease (AD) is still not completely understood; however, a large body of studies in the last few years supports the idea that beside the classic hallmarks of the disease, namely the accumulation of amyloid-beta (A beta) and neurofibrillary tangles, other factors significantly contribute to the initiation and the progression of the disease. Among them, mitochondria failure, an unbalanced neuronal redox state, and the dyshomeostasis of endogenous metals like copper, iron, and zinc have all been reported to play an important role in exacerbating AD pathology. Given these factors, the endogenous peptide carnosine may be potentially beneficial in the treatment of AD because of its free-radical scavenger and metal chelating properties. Methodology: In this study, we explored the effect of L-carnosine supplementation in the 3xTg-AD mouse, an animal model of AD that shows both A beta- and tau-dependent pathology. Principal Findings: We found that carnosine supplementation in 3xTg-AD mice promotes a strong reduction in the hippocampal intraneuronal accumulation of A beta and completely rescues AD and aging-related mitochondrial dysfunctions. No effects were found on tau pathology and we only observed a trend toward the amelioration of cognitive deficits. Conclusions and Significance: Our data indicate that carnosine can be part of a combined therapeutic approach for the treatment of AD.	[Corona, Carlo; Frazzini, Valerio; Ciavardelli, Domenico; Sensi, Stefano L.] Univ G dAnnunzio, Ctr Excellence Aging CeSI, Mol Neurol Unit, Chieti, Italy; [Corona, Carlo; Frazzini, Valerio; Sensi, Stefano L.] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Silvestri, Elena; Canzoniero, Lorella M. T.] Univ Sannio, Dept Biol & Environm Sci, Benevento, Italy; [Lattanzio, Rossano; La Sorda, Rossana; Piantelli, Mauro] Univ G dAnnunzio, Dept Oncol & Neurosci, Chieti, Italy; [Rizzarelli, Enrico] Univ Catania, Dept Chem, Catania, Italy; [Sensi, Stefano L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Sannio; G d'Annunzio University of Chieti-Pescara; University of Catania; University of California System; University of California Irvine	Corona, C (corresponding author), Univ G dAnnunzio, Ctr Excellence Aging CeSI, Mol Neurol Unit, Chieti, Italy.	ssensi@uci.edu	Sensi, Stefano L./J-3164-2016; Rizzarelli, Enrico/M-6974-2017; Lattanzio, Rossano/K-1927-2018; Sensi, Stefano L./O-1335-2019; Frazzini, Valerio/R-3643-2016	Sensi, Stefano L./0000-0002-0710-2574; Rizzarelli, Enrico/0000-0001-5367-0823; Lattanzio, Rossano/0000-0001-9803-4476; Sensi, Stefano L./0000-0002-0710-2574; CANZONIERO, Lorella Maria Teresa/0000-0003-2255-5341; Frazzini, Valerio/0000-0003-1187-3352; Silvestri, Elena/0000-0002-0592-9033; Piantelli, Mauro/0000-0003-0154-482X	Italian Department of Education	Italian Department of Education	Funding: SLS and ER are supported by funds from the Italian Department of Education [Fondo per gli Investimenti della Ricerca di Base (FIRB) 2003; Progetti Ricerca Interesse Nazionale (PRIN) 2006 and PRIN 2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Atamna H, 2010, J ALZHEIMERS DIS, V20, pS439, DOI 10.3233/JAD-2010-100414; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Baran EJ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P789; Bellia F, 2009, ANTIOXID REDOX SIGN, V11, P2759, DOI 10.1089/ARS.2009.2738; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BOLDYREV AA, 1994, TRENDS NEUROSCI, V17, P468, DOI 10.1016/0166-2236(94)90134-1; Brownson C, 2000, FREE RADICAL BIO MED, V28, P1564, DOI 10.1016/S0891-5849(00)00270-7; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Calabrese V, 2005, NEUROCHEM RES, V30, P797, DOI 10.1007/s11064-005-6874-8; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Corona C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.73; Crouch PJ, 2007, REJUV RES, V10, P349, DOI 10.1089/rej.2007.0592; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Gazaryan IG, 2007, J BIOL CHEM, V282, P24373, DOI 10.1074/jbc.M611376200; Hipkiss AR, 1998, BBA-GEN SUBJECTS, V1380, P46, DOI 10.1016/S0304-4165(97)00123-2; HIPKISS AR, 1995, FEBS LETT, V371, P81, DOI 10.1016/0014-5793(95)00849-5; Hipkiss AR, 2001, MECH AGEING DEV, V122, P1431, DOI 10.1016/S0047-6374(01)00272-X; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Horning MS, 2000, BRAIN RES, V852, P56, DOI 10.1016/S0006-8993(99)02215-5; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lee JY, 2004, J BIOL CHEM, V279, P8602, DOI 10.1074/jbc.M309730200; Mineo P, 2002, RAPID COMMUN MASS SP, V16, P722, DOI 10.1002/rcm.633; Odashima M, 2002, DIGEST DIS SCI, V47, P2799, DOI 10.1023/A:1021029927386; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Preston JE, 1998, NEUROSCI LETT, V242, P105, DOI 10.1016/S0304-3940(98)00058-5; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; QUINN PJ, 1992, MOL ASPECTS MED, V13, P379, DOI 10.1016/0098-2997(92)90006-L; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Schagger H, 1996, Methods Enzymol, V264, P555, DOI 10.1016/S0076-6879(96)64048-8; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sensi SL, 2008, EXP GERONTOL, V43, P488, DOI 10.1016/j.exger.2007.10.018; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; Trombley PQ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P807; Trombley PQ, 1998, NEUROREPORT, V9, P3503, DOI 10.1097/00001756-199810260-00031; Ueda K, 2009, J PHARMACOL SCI, V110, P285, DOI 10.1254/jphs.09056FP; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	53	129	130	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17971	10.1371/journal.pone.0017971	http://dx.doi.org/10.1371/journal.pone.0017971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423579	Green Published, gold			2022-12-27	WOS:000288513900048
J	Hijazi, A; Haenlin, M; Waltzer, L; Roch, F				Hijazi, Assia; Haenlin, Marc; Waltzer, Lucas; Roch, Fernando			The Ly6 Protein Coiled Is Required for Septate Junction and Blood Brain Barrier Organisation in Drosophila	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; EPITHELIAL-CELLS; NEUREXIN IV; MELANOGASTER; ENCODES; FAMILY; GENE; DIFFERENTIATION; SUPERFAMILY; POLARITY	Background: Genetic analysis of the Drosophila septate junctions has greatly contributed to our understanding of the mechanisms controlling the assembly of these adhesion structures, which bear strong similarities with the vertebrate tight junctions and the paranodal septate junctions. These adhesion complexes share conserved molecular components and have a common function: the formation of paracellular barriers restraining the diffusion of solutes through epithelial and glial envelopes. Methodology/Principal Findings: In this work we characterise the function of the Drosophila cold gene, that codes for a protein belonging to the Ly6 superfamily of extracellular ligands. Analysis of cold mutants shows that this gene is specifically required for the organisation of the septate junctions in epithelial tissues and in the nervous system, where its contribution is essential for the maintenance of the blood-brain barrier. We show that cold acts in a cell autonomous way, and we present evidence indicating that this protein could act as a septate junction component. Conclusion/Significance: We discuss the specific roles of cold and three other Drosophila members of the Ly6 superfamily that have been shown to participate in a non-redundant way in the process of septate junction assembly. We propose that vertebrate Ly6 proteins could fulfill analogous roles in tight junctions and/or paranodal septate junctions.	[Hijazi, Assia; Haenlin, Marc; Waltzer, Lucas; Roch, Fernando] Univ Toulouse 3, Ctr Dev Biol, UPS, F-31062 Toulouse, France; [Hijazi, Assia; Haenlin, Marc; Waltzer, Lucas; Roch, Fernando] Ctr Dev Biol, CNRS, UMR 5547, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Hijazi, A (corresponding author), Univ Toulouse 3, Ctr Dev Biol, UPS, F-31062 Toulouse, France.	roch@cict.fr		Haenlin, Marc/0000-0003-2728-8457; Waltzer, Lucas/0000-0002-5361-727X	Lebanese CNRS; Association pour la Recherche sur le Cancer (ARC); CNRS	Lebanese CNRS; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS))	A. H. is recipient of PhD fellowships awarded by the Lebanese CNRS (www.cnrs.edu.lb) and the Association pour la Recherche sur le Cancer (ARC, http://www.arc-cancer.net/). This work has been supported by the CNRS (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Bamezai A, 2004, ARCH IMMUNOL THER EX, V52, P255; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Campos I, 2010, GENETICS, V184, P129, DOI 10.1534/genetics.109.110288; Carlson SD, 1997, J NEUROCYTOL, V26, P377, DOI 10.1023/A:1018564904170; Chou TB, 1996, GENETICS, V144, P1673; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Garza-Garcia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007123; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2005, DEV DYNAM, V233, P1056, DOI 10.1002/dvdy.20389; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Takashima S, 2001, MECH DEVELOP, V101, P79, DOI 10.1016/S0925-4773(00)00555-4; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Waltzer L, 2003, EMBO J, V22, P6516, DOI 10.1093/emboj/cdg622; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008	39	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17763	10.1371/journal.pone.0017763	http://dx.doi.org/10.1371/journal.pone.0017763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423573	Green Published, gold, Green Submitted			2022-12-27	WOS:000288513900025
J	Krueger, S; Giavalisco, P; Krall, L; Steinhauser, MC; Bussis, D; Usadel, B; Flugge, UI; Fernie, AR; Willmitzer, L; Steinhauser, D				Krueger, Stephan; Giavalisco, Patrick; Krall, Leonard; Steinhauser, Marie-Caroline; Buessis, Dirk; Usadel, Bjoern; Fluegge, Ulf-Ingo; Fernie, Alisdair R.; Willmitzer, Lothar; Steinhauser, Dirk			A Topological Map of the Compartmentalized Arabidopsis thaliana Leaf Metabolome	PLOS ONE			English	Article							MASS-SPECTROMETRY; HIGHER-PLANTS; INTRACELLULAR-LOCALIZATION; GLUCOSE PYROPHOSPHORYLASE; NONAQUEOUS FRACTIONATION; EPITHIOSPECIFIER PROTEIN; BRASSICA-OLERACEA; SUCROSE SYNTHESIS; AMINO-ACIDS; ADP-GLUCOSE	Background: The extensive subcellular compartmentalization of metabolites and metabolism in eukaryotic cells is widely acknowledged and represents a key factor of metabolic activity and functionality. In striking contrast, the knowledge of actual compartmental distribution of metabolites from experimental studies is surprisingly low. However, a precise knowledge of, possibly all, metabolites and their subcellular distributions remains a key prerequisite for the understanding of any cellular function. Methodology/Principal Findings: Here we describe results for the subcellular distribution of 1,117 polar and 2,804 lipophilic mass spectrometric features associated to known and unknown compounds from leaves of the model plant Arabidopsis thaliana. Using an optimized non-aqueous fractionation protocol in conjunction with GC/MS- and LC/MS-based metabolite profiling, 81.5% of the metabolic data could be associated to one of three subcellular compartments: the cytosol (including the mitochondria), vacuole, or plastids. Statistical analysis using a marker-'free' approach revealed that 18.5% of these metabolites show intermediate distributions, which can either be explained by transport processes or by additional subcellular compartments. Conclusion/Significance: Next to a functional and conceptual workflow for the efficient, highly resolved metabolite analysis of the fractionated Arabidopsis thaliana leaf metabolome, a detailed survey of the subcellular distribution of several compounds, in the graphical format of a topological map, is provided. This complex data set therefore does not only contain a rich repository of metabolic information, but due to thorough validation and testing by statistical methods, represents an initial step in the analysis of metabolite dynamics and fluxes within and between subcellular compartments.	[Krueger, Stephan; Fluegge, Ulf-Ingo] Univ Cologne, Inst Bot, D-5000 Cologne, Germany; [Buessis, Dirk] Max Planck Inst Mol Plant Physiol, GABI Managing Off, Potsdam, Germany	University of Cologne; Max Planck Society	Krueger, S (corresponding author), Univ Cologne, Inst Bot, Gyrhofstr 15, D-5000 Cologne, Germany.	steinhauser@mpimp-golm.mpg.de	Steinhauser, Dirk/J-6484-2012; Willmitzer, Lothar/F-7377-2011; Usadel, Björn/E-1932-2011	Usadel, Björn/0000-0003-0921-8041; steinhauser, dirk/0000-0001-7792-2896	University of Cologne; Federal Ministry of Education and Research (BMBF) [BMBF - 0315075]; Max Planck Society (MPG)	University of Cologne; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society (MPG)(Max Planck Society)	Funding: S.K and U.-I.F were funded and supported by the University of Cologne; D. B was funded by a grant (BMBF - 0315075) of the Federal Ministry of Education and Research (BMBF); P. G., L. K., M.-C. S, B. U., A. R. F., L. W., and D. S. by the Max Planck Society (MPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Agarwal R, 2009, MOL PLANT, V2, P32, DOI 10.1093/mp/ssn075; Andreasson E, 2001, PLANT PHYSIOL, V127, P1750, DOI 10.1104/pp.010334; Arnon DI, 1939, SCIENCE, V89, P512, DOI 10.1126/science.89.2318.512; Aubert S, 2004, J EXP BOT, V55, P2179, DOI 10.1093/jxb/erh235; Behrens M., 1932, H-S Z PHYSIOL CHEM, V209, P59; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benkeblia N, 2007, METABOLOMICS, V3, P297, DOI 10.1007/s11306-007-0078-y; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Burow M, 2007, PLANT MOL BIOL, V64, P173, DOI 10.1007/s11103-007-9143-1; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Cox TF, 1994, MONOGRAPHS STAT APPL; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Doniwa Y, 2007, PLANT BIOTECHNOL-NAR, V24, P441, DOI 10.5511/plantbiotechnology.24.441; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Echeverria E, 2000, PLANT PHYSIOL, V123, P1217, DOI 10.1104/pp.123.4.1217; Eisenreich W, 2007, PHYTOCHEMISTRY, V68, P2799, DOI 10.1016/j.phytochem.2007.09.028; ELBERS R, 1974, H-S Z PHYSIOL CHEM, V355, P378, DOI 10.1515/bchm2.1974.355.1.378; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Farre EM, 2008, METABOLOMICS, V4, P161, DOI 10.1007/s11306-008-0107-5; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; GERHARDT R, 1987, PLANT PHYSIOL, V83, P399, DOI 10.1104/pp.83.2.399; Goldberg D.M., 1987, METHODS ENZYMATIC AN, P258; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; HELL R, 1990, PLANTA, V180, P603, DOI 10.1007/BF02411460; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Ischebeck T, 2006, J BIOL CHEM, V281, P2470, DOI 10.1074/jbc.M509222200; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelly PJ, 1998, PLANTA, V206, P370, DOI 10.1007/s004250050412; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Krall L, 2009, J CHROMATOGR B, V877, P2952, DOI 10.1016/j.jchromb.2009.07.006; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Lawson CL, 1995, SIAM; LEHMANN S, 2010, AMINO ACIDS; Lin WL, 2008, PLANT SCI, V175, P233, DOI 10.1016/j.plantsci.2008.04.003; Linka N, 2010, MOL PLANT, V3, P21, DOI 10.1093/mp/ssp108; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Logan DC, 2010, BIOCHEM SOC T, V38, P789, DOI 10.1042/BST0380789; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; MARTINOIA E, 1994, ANNU REV PLANT PHYS, V45, P447, DOI 10.1146/annurev.pp.45.060194.002311; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; Nakabayashi R, 2009, PHYTOCHEMISTRY, V70, P1017, DOI 10.1016/j.phytochem.2009.03.021; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; Ohara K, 2004, PLANT J, V40, P734, DOI 10.1111/j.1365-313X.2004.02246.x; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ono E, 2006, PLANT J, V45, P133, DOI 10.1111/j.1365-313X.2005.02625.x; OPARKA KJ, 1992, ENV PLANT B, P91; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Paris N, 1996, CELL, V85, P563, DOI 10.1016/S0092-8674(00)81256-8; RAUCH U, 1994, CIRC RES, V75, P760, DOI 10.1161/01.RES.75.4.760; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Ripley B. D., 1996, PATTERN RECOGNITION; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; ROSA EAS, 1994, J SCI FOOD AGR, V66, P457, DOI 10.1002/jsfa.2740660406; Rosa EAS, 1996, J SCI FOOD AGR, V71, P237, DOI 10.1002/(SICI)1097-0010(199606)71:2&lt;237::AID-JSFA574&gt;3.0.CO;2-P; Sambrook J, 1989, MOL CLONING LABORATO; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schneider S, 2008, PLANT CELL, V20, P1073, DOI 10.1105/tpc.107.055632; SCHULTZ CJ, 1995, PLANT J, V7, P61, DOI 10.1046/j.1365-313X.1995.07010061.x; Schulze-Lefert P, 2004, CURR OPIN PLANT BIOL, V7, P377, DOI 10.1016/j.pbi.2004.05.004; Shannon JC, 1998, PLANT PHYSIOL, V117, P1235, DOI 10.1104/pp.117.4.1235; Shinbo Y, 2006, BIOTECH AGR FOREST, V57, P165; Sircar D, 2008, J PLANT PHYSIOL, V165, P407, DOI 10.1016/j.jplph.2007.05.005; SOBOLL S, 1980, BIOCHEM J, V192, P951, DOI 10.1042/bj1920951; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STITT M, 1982, PLANT PHYSIOL, V70, P971, DOI 10.1104/pp.70.4.971; Stitt M, 2003, CURR OPIN BIOTECH, V14, P136, DOI 10.1016/S0958-1669(03)00023-5; STITT M, 1983, PLANT PHYSIOL, V72, P767, DOI 10.1104/pp.72.3.767; SUSS KH, 1993, P NATL ACAD SCI USA, V90, P5514, DOI 10.1073/pnas.90.12.5514; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Taira M, 2004, PLANT CELL, V16, P2048, DOI 10.1105/tpc.104.022046; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Weber APM, 2007, FEBS LETT, V581, P2215, DOI 10.1016/j.febslet.2007.02.010; Werner E, 2008, ANAL CHEM, V80, P4918, DOI 10.1021/ac800094p; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996; WINTER H, 1993, PLANTA, V191, P180, DOI 10.1007/BF00199748; Wiseman JM, 2008, P NATL ACAD SCI USA, V105, P18120, DOI 10.1073/pnas.0801066105; Yamada K, 2009, PLANTA, V230, P1115, DOI 10.1007/s00425-009-1011-6; YAMAGA Y, 1993, PHYTOCHEMISTRY, V32, P633, DOI 10.1016/S0031-9422(00)95147-1; Yazaki K, 2005, CURR OPIN PLANT BIOL, V8, P301, DOI 10.1016/j.pbi.2005.03.011; Yazaki K, 2002, J BIOL CHEM, V277, P6240, DOI 10.1074/jbc.M106387200; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006; ZRENNER R, 1993, PLANTA, V190, P247, DOI 10.1007/BF00196618	98	78	78	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17806	10.1371/journal.pone.0017806	http://dx.doi.org/10.1371/journal.pone.0017806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423574	gold, Green Published, Green Submitted			2022-12-27	WOS:000288513900033
J	Lemjabbar-Alaoui, H; Sidhu, SS; Mengistab, A; Gallup, M; Basbaum, C				Lemjabbar-Alaoui, Hassan; Sidhu, Sukhvinder S.; Mengistab, Aklilu; Gallup, Marianne; Basbaum, Carol			TACE/ADAM-17 Phosphorylation by PKC-Epsilon Mediates Premalignant Changes in Tobacco Smoke-Exposed Lung Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; ALPHA-CONVERTING-ENZYME; GROWTH-FACTOR; FACTOR RECEPTOR; CANCER-CELLS; EPITHELIAL-CELLS; POTENTIAL ROLE; ACTIVATION; DELTA; PROLIFERATION	Background: Tobacco smoke predisposes humans and animals to develop lung tumors, but the molecular events responsible for this are poorly understood. We recently showed that signaling mechanisms triggered by smoke in lung cells could lead to the activation of a growth factor signaling pathway, thereby promoting hyperproliferation of lung epithelial cells. Hyperproliferation is considered a premalignant change in the lung, in that increased rates of DNA synthesis are associated with an increased number of DNA copying errors, events that are exacerbated in the presence of tobacco smoke carcinogens. Despite the existence of DNA repair mechanisms, a small percentage of these errors go unrepaired and can lead to tumorigenic mutations. The results of our previous study showed that an early event following smoke exposure was the generation of oxygen radicals through the activation of NADPH oxidase. Although it was clear that these radicals transduced signals through the epidermal growth factor receptor (EGFR), and that this was mediated by TACE-dependent cleavage of amphiregulin, it remained uncertain how oxygen radicals were able to activate TACE. Principal Findings: In the present study, we demonstrate for the first time that phosphorylation of TACE at serine/threonine residues by tobacco smoke induces amphiregulin release and EGFR activation. TACE phosphorylation is triggered in smoke-exposed lung cells by the ROS-induced activation of PKC through the action of SRC kinase. Furthermore, we identified PKC epsilon as the PKC isoform involved in smoke-induced TACE activation and hyperproliferation of lung cells. Conclusions: Our data elucidate new signaling paradigms by which tobacco smoke promotes TACE activation and hyperproliferation of lung cells.	[Lemjabbar-Alaoui, Hassan; Mengistab, Aklilu] Univ Calif San Francisco, Dept Surg, Ctr Comprehens Canc, Thorac Oncol Lab, San Francisco, CA 94143 USA; [Sidhu, Sukhvinder S.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care, San Francisco, CA USA; [Sidhu, Sukhvinder S.] Univ Calif San Francisco, Dept Med, Div Allergy Immunol, San Francisco, CA USA; [Gallup, Marianne; Basbaum, Carol] Univ Calif San Francisco, Cardiovasc Res Inst, Program Biomed Sci, San Francisco, CA 94143 USA; [Gallup, Marianne; Basbaum, Carol] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lemjabbar-Alaoui, H (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Comprehens Canc, Thorac Oncol Lab, San Francisco, CA 94143 USA.	hassan.alaoui@ucsf.edu		Sidhu, Sukhvinder/0000-0002-2999-4358	University of California [17RT-0216]; National Institutes of Health [R01 HD075602]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD075602] Funding Source: NIH RePORTER	University of California(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was performed with support from the Tobacco-Related Disease Research Program of the University of California Grant 17RT-0216 and the National Institutes of Health grant R01 HD075602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Basuroy S, 2010, AM J PHYSIOL-GASTR L, V299, pG186, DOI 10.1152/ajpgi.00368.2009; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2002, INFLAMM RES, V51, P83, DOI 10.1007/BF02684007; Carpenter G, 2000, SCI STKE, V2000, ppe1, DOI DOI 10.1126/SCISIGNAL.152000PE1; CHAKRAVARTHY BR, 1991, ANAL BIOCHEM, V196, P144, DOI 10.1016/0003-2697(91)90130-L; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Ding L, 2002, J BIOL CHEM, V277, P35305, DOI 10.1074/jbc.M201460200; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Duffy MJ, 2009, CLIN CHIM ACTA, V403, P31, DOI 10.1016/j.cca.2009.01.007; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gebremichael A, 1996, TOXICOL APPL PHARM, V141, P76; Gensch E, 2004, J BIOL CHEM, V279, P39085, DOI 10.1074/jbc.M406866200; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Karl PI, 1996, BIOCHEM J, V320, P831, DOI 10.1042/bj3200831; Kirkegaard T, 2004, CLIN EXP IMMUNOL, V135, P146, DOI 10.1111/j.1365-2249.2004.02348.x; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Leserer M, 2000, IUBMB LIFE, V49, P405; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; Madani S, 2001, FASEB J, V15, P2595, DOI 10.1096/fj.01-0753int; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Paulissen G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-127; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Proctor Robert N, 2004, Clin Lung Cancer, V5, P371, DOI 10.3816/CLC.2004.n.016; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; TANG EKY, 1992, BIOCHEM J, V283, P341, DOI 10.1042/bj2830341; Tazzari PL, 2008, CANCER RES, V68, P9394, DOI 10.1158/0008-5472.CAN-08-2815; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wheeler DL, 2003, CANCER RES, V63, P6547; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200; Zhang ZL, 2001, FASEB J, V15, P303	53	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17489	10.1371/journal.pone.0017489	http://dx.doi.org/10.1371/journal.pone.0017489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423656	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900011
J	Lindstedt, F; Lonsdorf, TB; Schalling, M; Kosek, E; Ingvar, M				Lindstedt, Fredrik; Lonsdorf, Tina B.; Schalling, Martin; Kosek, Eva; Ingvar, Martin			Perception of Thermal Pain and the Thermal Grill Illusion Is Associated with Polymorphisms in the Serotonin Transporter Gene	PLOS ONE			English	Article							RAT SPINAL-CORD; SKIN TEMPERATURE; DECREASED SENSITIVITY; 5-HT1A-LIKE RECEPTOR; ADJUSTMENT DISORDER; TREATMENT RESPONSE; REGULATORY REGION; MAJOR DEPRESSION; PERIPHERAL-NERVE; MICE LACKING	Aim: The main aim of this study was to assess if the perception of thermal pain thresholds is associated with genetically inferred levels of expression of the 5-HT transporter (5-HTT). Additionally, the perception of the so-called thermal grill illusion (TGI) was assessed. Forty-four healthy individuals (27 females, 17 males) were selected a-priori based on their 5-HTTLPR/rs25531 ('tri-allelic 5-HTTLPR') genotype, with inferred high or low 5-HTT expression. Thresholds for heat- and cold-pain were determined along with the sensory and affective dimensions of the TGI. Results: Thresholds to heat-and cold-pain correlated strongly (rho = -0.58, p<0.001). Individuals in the low 5-HTT-expressing group were significantly less sensitive to heat-pain (p = 0.02) and cold-pain (p = 0.03), compared to the high-expressing group. A significant gender-by-genotype interaction also emerged for cold-pain perception (p = 0.02); low 5-HTT-expressing females were less sensitive. The TGI was rated as significantly more unpleasant (affective-motivational dimension) than painful (sensory-discriminatory dimension), (p<0.001). Females in the low 5-HTT expressing group rated the TGI as significantly less unpleasant than high 5-HTT expressing females (p, 0.05), with no such differences among men. Conclusion/Significance: We demonstrate an association between inferred low 5-HTT expression and elevated thresholds to thermal pain in healthy non-depressed individuals. Despite the fact that reduced 5-HTT expression is a risk factor for chronic pain we found it to be related to hypoalgesia for threshold thermal pain. Low 5-HTT expression is, however, also a risk factor for depression where thermal insensitivity is often seen. Our results may thus contribute to a better understanding of the molecular underpinnings of such paradoxical hypoalgesia. The results point to a differential regulation of thermoafferent-information along the neuraxis on the basis of 5-HTT expression and gender. The TGI, suggested to rely on the central integration of thermoafferent-information, may prove a valuable tool in probing the affective-motivational dimension of these putative mechanisms.	[Lindstedt, Fredrik; Lonsdorf, Tina B.; Kosek, Eva; Ingvar, Martin] Karolinska Inst, Osher Ctr Integrat Med, Stockholm Brain Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lonsdorf, Tina B.] Univ Hosp Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Lonsdorf, Tina B.; Schalling, Martin] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Lonsdorf, Tina B.; Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden	Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet; Karolinska Institutet	Lindstedt, F (corresponding author), Karolinska Inst, Osher Ctr Integrat Med, Stockholm Brain Inst, Dept Clin Neurosci, Stockholm, Sweden.	fredrik.lindstedt@ki.se	Schalling, Martin/F-1518-2015; Lonsdorf, Tina/K-8657-2017	Schalling, Martin/0000-0001-5011-2922; Ingvar, Martin/0000-0002-9041-5714; Lonsdorf, Tina/0000-0003-1501-4846; Kosek, Eva/0000-0003-0488-8177	Osher foundation; Swedish Research Council [2009-2322, 2008-3307]; Karolinska Institutet; Karolinska University Hospital	Osher foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet)	This study was funded by the Osher foundation (www.osherfoundation.org) and the Swedish Research Council (www.vr.se), grant nr 2009-2322 (MI) and 2008-3307 (MS). The study was further supported by funds from Karolinska Institutet and Karolinska University Hospital (MS). The funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	ARNTZ A, 1991, BEHAV RES THER, V29, P41, DOI 10.1016/S0005-7967(09)80006-5; ARNTZ A, 1994, PAIN, V56, P307, DOI 10.1016/0304-3959(94)90169-4; Bar KR, 2006, EUR J PAIN, V10, P467, DOI 10.1016/j.ejpain.2005.07.001; Bar KJ, 2005, PAIN, V117, P97, DOI 10.1016/j.pain.2005.05.016; BENICIO NF, 2010, GENDER DIFFERENCES 1, V183, P157; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Berglund B, 2002, PAIN, V96, P177, DOI 10.1016/S0304-3959(01)00443-2; BERIC A, 1988, PAIN, V34, P109, DOI 10.1016/0304-3959(88)90155-8; Berna C, 2010, BIOL PSYCHIAT, V67, P1083, DOI 10.1016/j.biopsych.2010.01.014; Boettger MK, 2007, EUR J PAIN, V11, P819, DOI 10.1016/j.ejpain.2006.12.004; Boettger MK, 2011, PAIN, V152, P123, DOI 10.1016/j.pain.2010.10.003; Bouali S, 2003, EUR J NEUROSCI, V18, P2203, DOI 10.1046/j.1460-9568.2003.02960.x; Bouhassira D, 2005, PAIN, V114, P160, DOI 10.1016/j.pain.2004.12.014; Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y; Buono MJ, 2007, PHYSIOL MEAS, V28, P855, DOI 10.1088/0967-3334/28/8/008; Buskila D, 2007, BEST PRACT RES CL RH, V21, P535, DOI 10.1016/j.berh.2007.02.011; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; CHERYCROZE S, 1983, PAIN, V17, P109, DOI 10.1016/0304-3959(83)90137-9; Clauw Daniel J, 2009, Am J Med, V122, pS3, DOI 10.1016/j.amjmed.2009.09.006; Corruble E, 2000, PSYCHOPATHOLOGY, V33, P307, DOI 10.1159/000029163; Craig AD, 2008, PAIN, V135, P215, DOI 10.1016/j.pain.2008.01.022; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Dannlowski U, 2010, NEUROIMAGE, V53, P893, DOI 10.1016/j.neuroimage.2009.11.073; DAVIDSON PO, 1969, J PSYCHOSOM RES, V13, P83, DOI 10.1016/0022-3999(69)90023-3; Dickens C, 2003, PSYCHOSOM MED, V65, P369, DOI 10.1097/01.PSY.0000041622.69462.06; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Fortier E, 2010, NEUROSCI LETT, V485, P261, DOI 10.1016/j.neulet.2010.09.026; FREY BN, 2009, EUROPEAN PSYCHIAT, V24, pS681; Fruhstorfer H, 2003, EUR J PAIN, V7, P63, DOI 10.1016/S1090-3801(02)00056-3; FURMAN DJ, SOCIAL COGNITIVE AFF; Golimbet VE, 2010, MOL BIOL+, V44, P223, DOI 10.1134/S0026893310020068; Graff-Guerrero A, 2005, NEUROIMAGE, V25, P1197, DOI 10.1016/j.neuroimage.2004.12.020; Green BG, 2007, SOMATOSENS MOT RES, V24, P71, DOI 10.1080/08990220701388117; Hesketh PJ, 2006, SUPPORT CARE CANCER, V14, P354, DOI 10.1007/s00520-005-0914-4; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hodges MR, 2010, J APPL PHYSIOL, V108, P1425, DOI 10.1152/japplphysiol.01270.2009; Ito A, 2004, BONE, V35, P697, DOI 10.1016/j.bone.2004.04.012; Ito A, 2000, J NEUROSCI, V20, P6302, DOI 10.1523/JNEUROSCI.20-16-06302.2000; Jensen KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006016; Jochum T, 2007, BEHAV BRAIN RES, V183, P18, DOI 10.1016/j.bbr.2007.05.022; KARG K, 2011, ARCH GEN PSYCHIAT AR, V2010, P2189; Kayser V, 2007, PAIN, V130, P235, DOI 10.1016/j.pain.2006.11.015; Kern D, 2008, PAIN, V139, P653, DOI 10.1016/j.pain.2008.07.001; Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445; Kosek E, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-37; Kundermann B, 2009, J PSYCHIATR RES, V43, P1253, DOI 10.1016/j.jpsychires.2009.04.012; Kwang T, 2010, DEPRESS ANXIETY, V27, P746, DOI 10.1002/da.20708; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lothe A, 2009, NEUROIMAGE, V47, P482, DOI 10.1016/j.neuroimage.2009.04.067; Lowry CA, 2009, J PSYCHOPHARMACOL, V23, P392, DOI 10.1177/0269881108099956; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; LYNN B, 1977, PAIN, V3, P353, DOI 10.1016/0304-3959(77)90065-3; Maluchenko NV, 2009, B EXP BIOL MED+, V147, P462, DOI 10.1007/s10517-009-0559-2; MARLIER L, 1991, J NEUROCYTOL, V20, P310, DOI 10.1007/BF01235548; MARSTON OJ, 2011, EUROPEAN J IN PRESS; MATSUDA T, 1991, LIFE SCI, V48, P1627, DOI 10.1016/0024-3205(91)90122-R; Matsukawa T, 2000, CRIT CARE MED, V28, P532, DOI 10.1097/00003246-200002000-00041; McAllen RM, 2010, EUR J APPL PHYSIOL, V109, P27, DOI 10.1007/s00421-009-1295-z; McQueen JK, 1999, MOL BRAIN RES, V63, P241, DOI 10.1016/S0169-328X(98)00281-2; Millan MJ, 1995, BEHAV BRAIN RES, V73, P69; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Millan MJ, 1995, SEMIN NEUROSCI, V7, P409, DOI 10.1016/1044-5765(95)90005-5; Moalem G, 2005, NEUROSCIENCE, V134, P1399, DOI 10.1016/j.neuroscience.2005.05.046; Mogil JS, 1999, J NEUROSCI, V19; MOSKOWITZ M, 2006, FOCUS, V4, P465; Neziri AY, 2010, EUROPEAN J IN PRESS; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Noskova T, 2008, PROG NEURO-PSYCHOPH, V32, P1735, DOI 10.1016/j.pnpbp.2008.07.012; Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B; Oh EJ, 2000, J NEUROPHYSIOL, V84, P51, DOI 10.1152/jn.2000.84.1.51; Page NM, 2005, PEPTIDES, V26, P1356, DOI 10.1016/j.peptides.2005.03.030; Palm F, 2008, EUR J PAIN, V12, P790, DOI 10.1016/j.ejpain.2007.11.009; Pertovaara A, 1996, EXP BRAIN RES, V107, P497; Polgar E, 2002, NEUROSCIENCE, V109, P799, DOI 10.1016/S0306-4522(01)00304-9; POTVIN S, 2010, EUROPEAN J IN PRESS; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Price Donald D, 2002, Mol Interv, V2, P392, DOI 10.1124/mi.2.6.392; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Rucci P, 2009, AM J MED GENET B, V150B, P907, DOI 10.1002/ajmg.b.30917; Schwier C, 2010, J PAIN, V11, P287, DOI 10.1016/j.jpain.2009.07.012; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Simmons AN, 2009, INT J NEUROPSYCHOPH, V12, P1009, DOI 10.1017/S1461145709990149; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Strigo IA, 2008, PSYCHOSOM MED, V70, P338, DOI 10.1097/PSY.0b013e3181656a48; Suzuki R, 2004, TRENDS PHARMACOL SCI, V25, P613, DOI 10.1016/j.tips.2004.10.002; Thunberg T., 1896, UPPSALA L AKFOREN FO, V2, P489; Vigod SN, 2009, CURR OPIN PSYCHIATR, V22, P396, DOI 10.1097/YCO.0b013e3283297127; Vogel C, 2003, J NEUROSCI, V23, P708, DOI 10.1523/JNEUROSCI.23-02-00708.2003; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Wesseldijk F, 2008, ANESTH ANALG, V106, P1862, DOI 10.1213/ane.0b013e318172c2f4; Willis WD, 2001, ANN NY ACAD SCI, V933, P142; Wise TN, 2007, PAIN MED, V8, pS75, DOI 10.1111/j.1526-4637.2007.00352.x; Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011	101	56	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17752	10.1371/journal.pone.0017752	http://dx.doi.org/10.1371/journal.pone.0017752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423614	Green Published, gold			2022-12-27	WOS:000288513900020
J	Ridgway, CL; Sharp, SJ; Derom, C; Beunen, G; Fagard, R; Vlietinck, R; Ekelund, U; Loos, RJF				Ridgway, Charlotte L.; Sharp, Stephen J.; Derom, Catherine; Beunen, Gaston; Fagard, Robert; Vlietinck, Robert; Ekelund, Ulf; Loos, Ruth J. F.			The Contribution of Prenatal Environment and Genetic Factors to the Association between Birth Weight and Adult Grip Strength	PLOS ONE			English	Article							LATER BODY-COMPOSITION; MUSCLE STRENGTH; FAT DISTRIBUTION; PROSPECTIVE TWIN; LIVEBORN TWINS; SIZE; COHORT; AGE; ADOLESCENTS; MORTALITY	Low birth weight has been associated with reduced hand grip strength, which is a marker of future physical function and disease risk. The aim of this study was to apply a twin pair approach, using both 'individual' data and 'within-pair' differences, to investigate the influence of birth weight on hand grip strength and whether this association may be mediated through fat free mass (FFM). Participants from the East Flanders Prospective Twin Survey were included if born without congenital abnormalities, birth weight >500 g and >= 22 weeks of gestation. Follow up in adulthood (age: 18-34 year), included anthropometric measures and hand grip (n = 783 individuals, n = 326 same-sex twin pairs). Birth weight was positively associated with hand grip strength (beta = 2.60 kg, 95% CI 1.52, 3.67, p<0.001) and FFM (beta = 4.2, 95% CI 3.16, 5.24, p<0.001), adjusted for gestational age, sex and adult age. Using 'within-pair' analyses, the birth weight hand grip association was significant in DZ men only (beta = 5.82, 95% CI 0.67, 10.97, p = 0.028), which was attenuated following adjustment for FFM. Within-pair birth weight FFM associations were most pronounced in DZ men (beta = 11.20, 95% CI 7.18, 15.22, p<0.001). Our 'individual' analyses show that higher birth weight is associated with greater adult hand grip strength, which is mediated through greater adult FFM. The 'within-pair' analyses confirm this observation and furthermore show that, particularly in men, genetic factors may in part explain this association, as birth weight differences in DZ men result in greater differences in adult strength and FFM.	[Ridgway, Charlotte L.; Sharp, Stephen J.; Ekelund, Ulf; Loos, Ruth J. F.] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Derom, Catherine; Vlietinck, Robert] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Beunen, Gaston] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Biomed Kinesiol, Louvain, Belgium; [Fagard, Robert] Katholieke Univ Leuven, Dept Cardiovasc Dis, Hypertens & Cardiovasc Rehabil Unit, Louvain, Belgium	University of Cambridge; KU Leuven; KU Leuven; KU Leuven	Ridgway, CL (corresponding author), Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.	charlotte.ridgway@mrc-epid.cam.ac.uk	Loos, Ruth/GON-5877-2022; Ridgway, Charlotte/H-4378-2013; Loos, Ruth J F/Q-2862-2016; Curtis, Charlotte/AAV-1156-2020; Ekelund, Ulf/AAE-8471-2019	Ridgway, Charlotte/0000-0002-1022-3887; Loos, Ruth J F/0000-0002-8532-5087; Curtis, Charlotte/0000-0002-1022-3887; Ekelund, Ulf/0000-0003-2115-9267; Derom, Catherine/0000-0001-5574-796X	National Fund for Scientific Research, Belgium [3.0269.97]; Association for Scientific Research in Multiple Births; MRC [MC_U106179473, MC_U106188470] Funding Source: UKRI; Medical Research Council [MC_U106188470, MC_U106179473] Funding Source: researchfish	National Fund for Scientific Research, Belgium(Fonds de la Recherche Scientifique - FNRS); Association for Scientific Research in Multiple Births; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: The Prenatal Programming Twin Study was funded by a grant (nr.3.0269.97) from the National Fund for Scientific Research, Belgium. The East Flanders Prospective Twin Survey is partly supported by the Association for Scientific Research in Multiple Births. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 1998, MOTHERS BABIES HLTH; Chomtho S, 2008, AM J CLIN NUTR, V88, P1040, DOI 10.1093/ajcn/88.4.1040; Eriksson M, 2008, PAEDIATR PERINAT EP, V22, P379, DOI 10.1111/j.1365-3016.2008.00944.x; Freathy RM, 2009, DIABETES, V58, P1428, DOI 10.2337/db08-1739; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gale CR, 2001, J CLIN ENDOCR METAB, V86, P267, DOI 10.1210/jc.86.1.267; Gallagher D, 1998, APPL RADIAT ISOTOPES, V49, P733, DOI 10.1016/S0969-8043(97)00096-1; Grunnet L, 2007, J INTERN MED, V262, P96, DOI 10.1111/j.1365-2796.2007.01793.x; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; Kuh D, 2002, AM J EPIDEMIOL, V156, P627, DOI 10.1093/aje/kwf099; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Labayen I, 2006, J NUTR, V136, P147, DOI 10.1093/jn/136.1.147; Labayen I, 2008, OBESITY, V16, P1680, DOI 10.1038/oby.2008.258; Loos R, 1998, Twin Res, V1, P167, DOI 10.1375/twin.1.4.167; Loos RJF, 2005, PAEDIATR PERINAT EP, V19, P15, DOI 10.1111/j.1365-3016.2005.00611.x; Loos RJF, 2002, AM J CLIN NUTR, V75, P676, DOI 10.1093/ajcn/75.4.676; Loos RJF, 2001, INT J OBESITY, V25, P1537, DOI 10.1038/sj.ijo.0801743; Loos RJF, 2001, BRIT J OBSTET GYNAEC, V108, P943, DOI 10.1111/j.1471-0528.2001.00220.x; Nindl BC, 2002, J APPL PHYSIOL, V92, P1611, DOI 10.1152/japplphysiol.00892.2001; Ortega FB, 2009, J PEDIATR, V154, P61, DOI 10.1016/j.jpeds.2008.07.041; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rogers IS, 2006, AM J CLIN NUTR, V84, P739, DOI 10.1093/ajcn/84.4.739; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Saver AA, 2004, AM J CLIN NUTR, V80, P199; Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Vlietinck R, 1986, THESIS KATHOLIEKE U; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; World Health Organization, 2001, DEF IND FAM PLANN MA; YLIHARSILA H, 2007, INT J OBES LOND	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17955	10.1371/journal.pone.0017955	http://dx.doi.org/10.1371/journal.pone.0017955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423582	Green Published, Green Submitted, gold			2022-12-27	WOS:000288513900047
J	Ajoge, HO; Gordon, ML; de Oliveira, T; Green, TN; Ibrahim, S; Shittu, OS; Olonitola, SO; Ahmad, AA; Ndung'u, T				Ajoge, Hannah O.; Gordon, Michelle L.; de Oliveira, Tulio; Green, Taryn N.; Ibrahim, Sani; Shittu, Oladapo S.; Olonitola, Stephen O.; Ahmad, Aliyu A.; Ndung'u, Thumbi			Genetic Characteristics, Coreceptor Usage Potential and Evolution of Nigerian HIV-1 Subtype G and CRF02_AG Isolates	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; GAG PROTEIN; MOLECULAR EPIDEMIOLOGY; SEQUENCE-ANALYSIS; DRUG-RESISTANCE; VIRAL LOAD; OYO-STATE; DIVERSITY; STRAINS	HIV-1 CRF02_AG and subtype G (HIV-1G) account for most HIV infections in Nigeria, but their evolutionary trends have not been well documented. To better elucidate the dynamics of the epidemic in Nigeria we characterised the gag and env genes of North-Central Nigerian HIV-1 isolates from pregnant women. Of 28 samples sequenced in both genes, the predominant clades were CRF02_AG (39%) and HIV-1G (32%). Higher predicted proportion of CXCR4-tropic (X4) HIV-1G isolates was noted compared to CRF02_AG (p = 0.007, Fisher's exact test). Phylogenetic and Bayesian analysis conducted on our sequences and all the dated available Nigerian sequences on the Los Alamos data base showed that CRF02_AG and HIV-1G entered into Nigeria through multiple entries, with presence of HIV-1G dating back to early 1980s. This study underlines the genetic complexity of the HIV-1 epidemic in Nigeria, possible subtype-specific differences in co-receptor usage, and the evolutionary trends of the predominant HIV-1 strains in Nigeria, which may have implications for the design of biomedical interventions and better understanding of the epidemic.	[Ajoge, Hannah O.; Olonitola, Stephen O.; Ahmad, Aliyu A.] Ahmadu Bello Univ, Dept Microbiol, Zaria, Nigeria; [Ajoge, Hannah O.; Gordon, Michelle L.; Green, Taryn N.; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [de Oliveira, Tulio] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Ibrahim, Sani] Ahmadu Bello Univ, Dept Biochem, Zaria, Nigeria; [Shittu, Oladapo S.] Ahmadu Bello Univ, Ahmadu Bello Univ Teaching Hosp, Dept Gyneacol & Obstet, Zaria, Nigeria	Ahmadu Bello University; University of Kwazulu Natal; University of Kwazulu Natal; Ahmadu Bello University; Ahmadu Bello University	Ajoge, HO (corresponding author), Ahmadu Bello Univ, Dept Microbiol, Zaria, Nigeria.	ndungu@ukzn.ac.za		Gordon, Michelle/0000-0001-9945-1394; Ndung'u, Thumbi/0000-0003-2962-3992; Green, Taryn Natalie/0000-0001-9527-5960	Third World Academy of Sciences (TWAS); Hasso Plattner Foundation; South African Research Chair in Systems Biology of HIV/AIDS	Third World Academy of Sciences (TWAS); Hasso Plattner Foundation; South African Research Chair in Systems Biology of HIV/AIDS	HOA was supported by the Third World Organization for Women in Science (TWOWS) postgraduate fellowship from the Third World Academy of Sciences (TWAS). This study was supported by funding from the Hasso Plattner Foundation and the South African Research Chair in Systems Biology of HIV/AIDS to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIMIKU AG, 1994, AIDS RES HUM RETROV, V10, P1581, DOI 10.1089/aid.1994.10.1581; Agwale SM, 2006, AIDS RES HUM RETROV, V22, P22, DOI 10.1089/aid.2006.22.22; Agwale SM, 2002, VACCINE, V20, P2131, DOI 10.1016/S0264-410X(02)00059-2; Bibollet-Ruche F, 1998, AIDS RES HUM RETROV, V14, P1281, DOI 10.1089/aid.1998.14.1281; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Campbell GR, 2010, J BIOL CHEM, V285, P1681, DOI 10.1074/jbc.M109.049957; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Descamps D, 1998, AIDS, V12, P1109; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Entonu PE, 2007, BRAZ J INFECT DIS, V11, P579, DOI 10.1590/S1413-86702007000600011; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; *FED MIN HLTH, 2009, TECHN REP 2008 NAT H, P1; *FED MIN HLTH, 2006, TECHN REP 2005 NAT H, P1; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Gatanaga H, 2006, J BIOL CHEM, V281, P1241, DOI 10.1074/jbc.M505920200; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Gordon M, 2003, J VIROL, V77, P2587, DOI 10.1128/JVI.77.4.2587-2599.2003; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawkins CA, 2009, JAIDS-J ACQ IMM DEF, V52, P228, DOI 10.1097/QAI.0b013e3181b06125; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Howard TM, 1996, AIDS RES HUM RETROV, V12, P1413, DOI 10.1089/aid.1996.12.1413; HOWARD TM, 1994, AIDS RES HUM RETROV, V10, P1755, DOI 10.1089/aid.1994.10.1755; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; Klimas N, 2008, PSYCHOSOM MED, V70, P523, DOI 10.1097/PSY.0b013e31817ae69f; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; KORBER B, SODROSKI J NUMBERING; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; KORBER BTM, 1994, J VIROL, V68, P6730, DOI 10.1128/JVI.68.10.6730-6744.1994; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; LEWIS M, 2008, 15 C RETR OPP INF BO; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219; Marcelin AG, 2009, CURR OPIN HIV AIDS, V4, P531, DOI 10.1097/COH.0b013e328331d4b1; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; McCutchan FE, 1999, VIROLOGY, V254, P226, DOI 10.1006/viro.1998.9505; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; MORI J, 2007, 16 INT HIV DRUG RES; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Ojesina AI, 2007, AIDS RES HUM RETROV, V23, P1587, DOI 10.1089/aid.2007.0064; Ojesina AI, 2006, AIDS RES HUM RETROV, V22, P770, DOI 10.1089/aid.2006.22.770; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sankale JL, 2007, AIDS RES HUM RETROV, V23, P1020, DOI 10.1089/aid.2006.0304; Shaheen F, 2004, CURR OPIN INFECT DIS, V17, P7, DOI 10.1097/00001432-200402000-00003; Sing T, 2007, ANTIVIR THER, V12, P1097; Singh A, 2009, VIROLOGY, V393, P56, DOI 10.1016/j.virol.2009.07.021; Soulie C, 2008, AIDS, V22, P2212, DOI 10.1097/QAD.0b013e328313bf9c; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAMURA K, 2007, MOL BIO EVO, V24; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020; Triques K, 1999, VIROLOGY, V259, P99, DOI 10.1006/viro.1999.9720; van der Kuyl AC, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-67; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; LOS ALAMOS HIV SEQUE	83	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e17865	10.1371/journal.pone.0017865	http://dx.doi.org/10.1371/journal.pone.0017865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423811	Green Published, gold			2022-12-27	WOS:000288512400036
J	Oliver, SP; Hussey, NE; Turner, JR; Beckett, AJ				Oliver, Simon P.; Hussey, Nigel E.; Turner, John R.; Beckett, Alison J.			Oceanic Sharks Clean at Coastal Seamount	PLOS ONE			English	Article							LABROIDES-DIMIDIATUS; PROXIMATE CAUSE; FISH DIVERSITY; PARASITE; BEHAVIOR; ECOLOGY	Interactions between pelagic thresher sharks (Alopias pelagicus) and cleaner wrasse were investigated at a seamount in the Philippines. Cleaning associations between sharks and teleosts are poorly understood, but the observable interactions seen at this site may explain why these mainly oceanic sharks regularly venture into shallow coastal waters where they are vulnerable to disturbance from human activity. From 1,230 hours of observations recorded by remote video camera between July 2005 and December 2009, 97 cleaner-thresher shark events were analyzed, 19 of which were interrupted. Observations of pelagic thresher sharks interacting with cleaners at the seamount were recorded at all times of day but their frequency declined gradually from morning until evening. Cleaners showed preferences for foraging on specific areas of a thresher shark's body. For all events combined, cleaners were observed to conduct 2,757 inspections, of which 33.9% took place on the shark's pelvis, 23.3% on the pectoral fins, 22.3% on the caudal fin, 8.6% on the body, 8.3% on the head, 2.1% on the dorsal fin, and 1.5% on the gills respectively. Cleaners did not preferentially inspect thresher sharks by time of day or by shark sex, but there was a direct correlation between the amount of time a thresher shark spent at a cleaning station and the number of inspections it received. Thresher shark clients modified their behavior by "circular-stance-swimming,'' presumably to facilitate cleaner inspections. The cleaner-thresher shark association reflected some of the known behavioral trends in the cleaner-reef teleost system since cleaners appeared to forage selectively on shark clients. Evidence is mounting that in addition to acting as social refuges and foraging grounds for large visiting marine predators, seamounts may also support pelagic ecology by functioning as cleaning stations for oceanic sharks and rays.	[Oliver, Simon P.; Turner, John R.] Univ Wales, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Oliver, Simon P.; Beckett, Alison J.] Thresher Shark Res & Conservat Project, Malapascua Isl, Cebu, Philippines; [Hussey, Nigel E.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Beckett, Alison J.] Univ Liverpool, Sch Biomed Sci, Nuffield BD, Liverpool L69 3BX, Merseyside, England	University of Windsor; University of Liverpool	Oliver, SP (corresponding author), Univ Wales, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.	s.p.oliver@threshersharkproject.org	Oliver, Simon/AAK-1712-2020; Hussey, Nigel E/F-9699-2015	Oliver, Simon/0000-0002-2975-1233	Natural Environment Research Council (NERC)	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Work was supported in part by the Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Becker JHA, 2005, ANIM BEHAV, V70, P991, DOI 10.1016/j.anbehav.2005.01.004; BENZ GW, 1990, CAN J ZOOL, V68, P1180, DOI 10.1139/z90-175; BOEHLERT GW, 1987, ISLANDS, V43, P319; Bshary R, 2003, J ANIM ECOL, V72, P169, DOI 10.1046/j.1365-2656.2003.00683.x; Bshary R, 2002, MAR ECOL PROG SER, V235, P217, DOI 10.3354/meps235217; Bshary Redouan, 2008, P563; Caira JN, 2004, CRC MAR BIOL SER, P523; Carlson JK, 2004, CRC MAR BIOL SER, P203; Cheney KL, 2003, BEHAV ECOL, V14, P892, DOI 10.1093/beheco/arg079; CLARK E, 1975, NATL GEOGR, V147, P570; Compagno LJV., 1984, FAO FISH SYNOP, P20; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Cote IM, 1998, J FISH BIOL, V53, P256, DOI 10.1111/j.1095-8649.1998.tb01031.x; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; FOSTER SA, 1985, COPEIA, P875, DOI 10.2307/1445236; GRUBER SH, 1977, AM ZOOL, V17, P471; Grutter AS, 2008, J FISH BIOL, V73, P2094, DOI 10.1111/j.1095-8649.2008.02073.x; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 1997, J FISH BIOL, V50, P1303; Grutter AS, 2004, CURR BIOL, V14, P1080, DOI 10.1016/j.cub.2004.05.048; Grutter AS, 2003, CURR BIOL, V13, P64, DOI 10.1016/S0960-9822(02)01393-3; Grutter AS, 2002, J FISH BIOL, V61, P1098, DOI 10.1006/jfbi.2002.2121; Grutter AS, 2001, P ROY SOC B-BIOL SCI, V268, P1361, DOI 10.1098/rspb.2001.1658; Grutter AS, 1999, NATURE, V398, P672, DOI 10.1038/19443; Henderson AC, 2002, J NAT HIST, V36, P1995, DOI 10.1080/00222930110078834; Heupel MR, 1999, INT J PARASITOL, V29, P321, DOI 10.1016/S0020-7519(98)00218-5; KEYES RS, 1982, COPEIA, P225, DOI 10.2307/1444305; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Liu KM, 1999, COPEIA, P68; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; PAPERNA I, 1977, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V24, P195; PARKER T, 1994, BIOL BULL-US, V187, P336, DOI 10.2307/1542290; POTTS GW, 1973, ANIM BEHAV, V21, P250, DOI 10.1016/S0003-3472(73)80068-5; REED P, 2009, IFAS FA, V28, P1; Sazima I, 2000, COPEIA, P297; Sikkel PC, 2004, ANIM BEHAV, V68, P241, DOI 10.1016/j.anbehav.2003.10.023; Slater PJB, 1978, QUANTITATIVE ETHOLOG, P15; Stephens D.W., 1986, pi; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; WAHNBAECK C, 2007, MORE OCEANIC SHARKS; WEIHS D, 1981, COPEIA, P219, DOI 10.2307/1444062; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Yano K, 2000, ENVIRON BIOL FISH, V59, P329, DOI 10.1023/A:1007649227422	45	30	32	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14755	10.1371/journal.pone.0014755	http://dx.doi.org/10.1371/journal.pone.0014755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21423796	Green Submitted, Green Published, gold			2022-12-27	WOS:000288512400003
J	Moon, S; Kim, YG; Dong, LS; Lombardi, M; Haeggstrom, E; Jensen, RV; Hsiao, LL; Demirci, U				Moon, Sangjun; Kim, Yun-Gon; Dong, Lingsheng; Lombardi, Michael; Haeggstrom, Edward; Jensen, Roderick V.; Hsiao, Li-Li; Demirci, Utkan			Drop-on-Demand Single Cell Isolation and Total RNA Analysis	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION ANALYSIS; AMPLIFICATION; GENOME; PROVIDE; ARRAYS; SORTER	Technologies that rapidly isolate viable single cells from heterogeneous solutions have significantly contributed to the field of medical genomics. Challenges remain both to enable efficient extraction, isolation and patterning of single cells from heterogeneous solutions as well as to keep them alive during the process due to a limited degree of control over single cell manipulation. Here, we present a microdroplet based method to isolate and pattern single cells from heterogeneous cell suspensions (10% target cell mixture), preserve viability of the extracted cells (97.0 +/- 0.8%), and obtain genomic information from isolated cells compared to the non-patterned controls. The cell encapsulation process is both experimentally and theoretically analyzed. Using the isolated cells, we identified 11 stem cell markers among 1000 genes and compare to the controls. This automated platform enabling high-throughput cell manipulation for subsequent genomic analysis employs fewer handling steps compared to existing methods.	[Moon, Sangjun; Kim, Yun-Gon; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bio Acoust MEMS Med BAMM Lab,Ctr Bioengn, Boston, MA 02115 USA; [Dong, Lingsheng; Lombardi, Michael; Hsiao, Li-Li; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Haeggstrom, Edward] Univ Helsinki, Dept Phys, Elect Res Lab, Helsinki, Finland; [Jensen, Roderick V.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Demirci, Utkan] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Helsinki; Virginia Polytechnic Institute & State University; Harvard University; Massachusetts Institute of Technology (MIT)	Moon, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bio Acoust MEMS Med BAMM Lab,Ctr Bioengn, Boston, MA 02115 USA.	lhsiao@partners.org; udemirci@rics.bwh.harvard.edu			NIH [R21 EB007707]; W.H. Coulter Foundation; U.S. Army Medical Research Acquisition Activity Cooperative Agreement; U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD;  [RO1 A1081534];  [R21 AI087107]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.H. Coulter Foundation; U.S. Army Medical Research Acquisition Activity Cooperative Agreement; U.S. Army Medical Research & Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to acknowledge NIH R21 EB007707, and the W.H. Coulter Foundation Young Investigation Award. This was also partially supported by RO1 A1081534, R21 AI087107, and Integration of Medicine and Innovative Technology (CIMIT) under U.S. Army Medical Research Acquisition Activity Cooperative Agreement, as well as made possible by a research grant that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Fabbri R, 2001, HUM REPROD, V16, P411, DOI 10.1093/humrep/16.3.411; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Fu AY, 2002, ANAL CHEM, V74, P2451, DOI 10.1021/ac0255330; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Grinstead C. M., 1997, INTRO PROBABILITY; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106; Ino K, 2008, LAB CHIP, V8, P134, DOI 10.1039/b712330b; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Kvist T, 2007, APPL MICROBIOL BIOT, V74, P926, DOI 10.1007/s00253-006-0725-7; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lin LI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006710; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Ross Sheldon, 2008, 1 COURSE PROBABILITY; SA M, 2007, APPL STAT USING SPSS; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Song YS, 2010, P NATL ACAD SCI USA, V107, P4596, DOI 10.1073/pnas.0914059107; Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108; Svahn HA, 2007, LAB CHIP, V7, P544, DOI 10.1039/b704632b; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toriello NM, 2008, P NATL ACAD SCI USA, V105, P20173, DOI 10.1073/pnas.0806355106; Walker A, 2008, NAT REV MICROBIOL, V6, P176, DOI 10.1038/nrmicro1862; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Zeng Y, 2010, ANAL CHEM, V82, P3183, DOI 10.1021/ac902683t; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zipori D, 2005, STEM CELLS, V23, P719, DOI 10.1634/stemcells.2005-0030	40	42	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17455	10.1371/journal.pone.0017455	http://dx.doi.org/10.1371/journal.pone.0017455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412416	Green Published, gold, Green Submitted			2022-12-27	WOS:000288247800007
J	Samot, J; Moon, S; Shao, L; Zhang, XH; Xu, F; Song, Y; Keles, HO; Matloff, L; Markel, J; Demirci, U				Samot, Josh; Moon, Sangjun; Shao, Lei; Zhang, Xiaohui; Xu, Feng; Song, YoungSeok; Keles, Hasan Onur; Matloff, Laura; Markel, Jordan; Demirci, Utkan			Blood Banking in Living Droplets	PLOS ONE			English	Article							FREEZING-INJURY; CELLS; MODEL; VITRIFICATION; PRESERVATION; MECHANISM; DAMAGE	Blood banking has a broad public health impact influencing millions of lives daily. It could potentially benefit from emerging biopreservation technologies. However, although vitrification has shown advantages over traditional cryopreservation techniques, it has not been incorporated into transfusion medicine mainly due to throughput challenges. Here, we present a scalable method that can vitrify red blood cells in microdroplets. This approach enables the vitrification of large volumes of blood in a short amount of time, and makes it a viable and scalable biotechnology tool for blood cryopreservation.	[Samot, Josh; Moon, Sangjun; Shao, Lei; Zhang, Xiaohui; Xu, Feng; Song, YoungSeok; Keles, Hasan Onur; Matloff, Laura; Markel, Jordan; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bio Acoust MEMS Med BAMM Lab,Ctr Bioengn, Boston, MA 02115 USA; [Demirci, Utkan] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Samot, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bio Acoust MEMS Med BAMM Lab,Ctr Bioengn, Boston, MA 02115 USA.	udemirci@rics.bwh.harvard.edu	Xu, Feng/H-4468-2011; ZHANG, XIAOHUI/AHA-7028-2022; Zhang, Xiaohui/C-4569-2013; Keles, Hasan/A-4141-2012; Keles, Hasan Onur/L-3865-2018; Xu, Feng/C-7430-2011; Keles, Hasan Onur/AAJ-6014-2021	Xu, Feng/0000-0003-4351-0222; Keles, Hasan/0000-0001-8493-2582; Keles, Hasan Onur/0000-0002-1892-520X; Keles, Hasan Onur/0000-0001-8493-2582	NIH [R21 EB007707]; W.H. Coulter Foundation; Integration of Medicine and Innovative Technology (CIMIT) under U.S. Army Medical Research Acquisition Activity Cooperative Agreement; U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD;  [RO1 A1081534];  [R21 AI087107]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.H. Coulter Foundation; Integration of Medicine and Innovative Technology (CIMIT) under U.S. Army Medical Research Acquisition Activity Cooperative Agreement; U.S. Army Medical Research & Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to acknowledge NIH R21 EB007707, and the W.H. Coulter Foundation Young Investigation Award. This was also partially supported by RO1 A1081534, R21 AI087107, and Integration of Medicine and Innovative Technology (CIMIT) under U.S. Army Medical Research Acquisition Activity Cooperative Agreement, as well as made possible by a research grant that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, QRB QUAL REV B, V3, P22; Bernardin JD, 2004, J HEAT TRANS-T ASME, V126, P272, DOI 10.1115/1.1652045; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; Fuller B, 2004, LIFE IN THE FROZEN STATE, P505, DOI 10.1201/9780203647073.ch18; Hess JR, 2002, TRANSFUS MED REV, V16, P283, DOI 10.1053/tmrv.2002.35212; Hogman CF, 1998, VOX SANG, V74, P177; KRIJNEN HW, 1964, VOX SANG, V9, P559, DOI 10.1111/j.1423-0410.1964.tb03326.x; LOVELOCK JE, 1957, PROC R SOC SER B-BIO, V147, P427, DOI 10.1098/rspb.1957.0062; LUYET BJ, 1940, BIODYNAMICA, V3, P67; Malinauskas RA, 1997, ARTIF ORGANS, V21, P1255; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; MERYMAN HT, 1968, NATURE, V218, P333, DOI 10.1038/218333a0; MERYMAN HT, 1972, TRANSFUSION, V12, P145; PEGG DE, 1991, CRYOBIOLOGY, V28, P18, DOI 10.1016/0011-2240(91)90004-8; PEGG DE, 1988, BIOPHYS J, V54, P471, DOI 10.1016/S0006-3495(88)82980-1; PERT JH, 1964, BIBL HAEMATOL, V19, P7; ROWE AW, 1968, CRYOBIOLOGY, V5, P119, DOI 10.1016/S0011-2240(68)80154-3; Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004; Song YS, 2010, P NATL ACAD SCI USA, V107, P4596, DOI 10.1073/pnas.0914059107; Timmins NE, 2009, TRENDS BIOTECHNOL, V27, P415, DOI 10.1016/j.tibtech.2009.03.008; TULLIS JL, 1958, JAMA-J AM MED ASSOC, V168, P5; Whitaker BI, 2007, 2007 NATIONWIDE BLOO; WOLSTENHOLME GEW, 1970, FROZEN CELL; Xie H, 2007, INT J HEAT MASS TRAN, V50, P5328, DOI 10.1016/j.ijheatmasstransfer.2007.03.028; ZADEOPPEN AM, 1968, ACTA PHYSIOL SCAND, V73, P341, DOI 10.1111/j.1748-1716.1968.tb04113.x; 1977, QRB QUAL REV B, V3, P17	26	27	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2011	6	3							e17530	10.1371/journal.pone.0017530	http://dx.doi.org/10.1371/journal.pone.0017530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	733FF	21412411	Green Published, gold, Green Submitted			2022-12-27	WOS:000288247800010
J	Kinney, VC; Heemeyer, JL; Pessier, AP; Lannoo, MJ				Kinney, Vanessa C.; Heemeyer, Jennifer L.; Pessier, Allan P.; Lannoo, Michael J.			Seasonal Pattern of Batrachochytrium dendrobatidis Infection and Mortality in Lithobates areolatus: Affirmation of Vredenburg's "10,000 Zoospore Rule"	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; YELLOW-LEGGED FROG; ANTIMICROBIAL PEPTIDE DEFENSES; POPULATION DECLINES; NORTHERN QUEENSLAND; CUTANEOUS BACTERIA; EMERGING PATHOGEN; AMERICAN BULLFROG; RANA-CATESBEIANA; WILD FROGS	To fully comprehend chytridiomycosis, the amphibian disease caused by the chytrid fungus Batrachochytrium dendrobatidis (Bd), it is essential to understand how Bd affects amphibians throughout their remarkable range of life histories. Crawfish Frogs (Lithobates areolatus) are a typical North American pond-breeding species that forms explosive spring breeding aggregations in seasonal and semipermanent wetlands. But unlike most species, when not breeding Crawfish Frogs usually live singly-in nearly total isolation from conspecifics-and obligately in burrows dug by crayfish. Crayfish burrows penetrate the water table, and therefore offer Crawfish Frogs a second, permanent aquatic habitat when not breeding. Over the course of two years we sampled for the presence of Bd in Crawfish Frog adults. Sampling was conducted seasonally, as animals moved from post-winter emergence through breeding migrations, then back into upland burrow habitats. During our study, 53% of Crawfish Frog breeding adults tested positive for Bd in at least one sample; 27% entered breeding wetlands Bd positive; 46% exited wetlands Bd positive. Five emigrating Crawfish Frogs (12%) developed chytridiomycosis and died. In contrast, all 25 adult frogs sampled while occupying upland crayfish burrows during the summer tested Bd negative. One percent of postmetamorphic juveniles sampled were Bd positive. Zoospore equivalents/swab ranged from 0.8 to 24,436; five out of eight frogs with zoospore equivalents near or > 10,000 are known to have died. In summary, Bd infection rates in Crawfish Frog populations ratchet up from near zero during the summer to over 25% following overwintering; rates then nearly double again during and just after breeding-when mortality occurs-before the infection wanes during the summer. Bd-negative postmetamorphic juveniles may not be exposed again to this pathogen until they take up residence in crayfish burrows, or until their first breeding, some years later.	[Kinney, Vanessa C.; Heemeyer, Jennifer L.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA; [Pessier, Allan P.] San Diego Zoo Inst Conservat Res, Wildlife Dis Labs, San Diego, CA USA; [Lannoo, Michael J.] Indiana Univ Sch Med, Terre Haute Ctr Med Educ, Terre Haute, IN USA	Indiana State University; Zoological Society of San Diego; Indiana University System	Kinney, VC (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.	mlannoo@iupui.edu			Indiana Department of Natural Resources [E2-08-WDS13]; Indiana University School of Medicine; United States Department of Defense [09-426]	Indiana Department of Natural Resources; Indiana University School of Medicine; United States Department of Defense(United States Department of Defense)	Support for this project came from a State Wildlife Grant (E2-08-WDS13) awarded through the Indiana Department of Natural Resources (http://www.in.gov/dnr), start-up funds provided by Indiana University School of Medicine (http://www.medicine.iu.edu), and a United States Department of Defense Legacy grant (# 09-426; https://www.dodlegacy.org/legacy/index.aspx). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Michael J., 2008, Herpetological Review, V39, P324; Adams Michael J., 2007, Herpetological Review, V38, P430; Anchukaitis KJ, 2010, P NATL ACAD SCI USA, V107, P5036, DOI 10.1073/pnas.0908572107; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; BRIGGS CJ, 2010, PNAS0912886107; Chatfield Matthew W. H., 2009, Herpetological Review, V40, P176; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Davidson C, 2007, ENVIRON SCI TECHNOL, V41, P1771, DOI 10.1021/es0611947; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; Deguise Isabelle, 2009, Northwestern Naturalist, V90, P35; Di Rosa I, 2007, NATURE, V447, pE4, DOI 10.1038/nature05941; Fellers GM, 2001, COPEIA, P945, DOI 10.1643/0045-8511(2001)001[0945:OCITMY]2.0.CO;2; Frias-Alvarez P, 2008, ECOHEALTH, V5, P18, DOI 10.1007/s10393-008-0155-3; Gaertner James P., 2010, Herpetological Review, V41, P456; Gaertner JP, 2009, ECOHEALTH, V6, P20, DOI 10.1007/s10393-009-0229-x; Gaertner James P., 2009, Herpetological Review, V40, P184; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Goldberg Caren S., 2009, Herpetological Review, V40, P309; Grant EHC, 2008, APPL HERPETOL, V5, P233; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Heemeyer Jennifer L., 2010, Herpetological Review, V41, P168; Heemeyer Jennifer L., 2010, Herpetological Review, V41, P42; HEEMEYER JL, 2011, WINTERKILL IN PRESS, V42; Hillis DM, 2005, MOL PHYLOGENET EVOL, V34, P299, DOI 10.1016/j.ympev.2004.10.007; Hoffman AS, 2010, BIOSCIENCE, V60, P829, DOI 10.1525/bio.2010.60.10.9; Hossack BR, 2010, J HERPETOL, V44, P253, DOI 10.1670/09-058.1; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kiernan J.A, 1990, HISTOLOGICAL HISTOCH; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Lampo M, 2006, HERPETOL J, V16, P395; Lampo Margarita, 2008, Herpetological Review, V39, P449; Lannoo Michael J., 2009, Diversity, V1, P118; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, J HERPETOL, V37, P215, DOI 10.1670/0022-1511(2003)037[0215:CIWFFS]2.0.CO;2; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Marcum RD, 2010, DIS AQUAT ORGAN, V91, P17, DOI 10.3354/dao02235; MINTON SA, 2001, INDIAN ACAD SCI MONO, V3; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Carnaval ACOD, 2006, ECOHEALTH, V3, P41, DOI 10.1007/s10393-005-0008-2; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Parris MJ, 2004, COPEIA, P344, DOI 10.1643/CE-03-116R1; Pearl CA, 2007, J HERPETOL, V41, P145, DOI 10.1670/0022-1511(2007)41[145:OOTAPB]2.0.CO;2; Pessier A. P., 2010, MANUAL CONTROL INFEC; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Peterson JD, 2007, J WILDLIFE DIS, V43, P450, DOI 10.7589/0090-3558-43.3.450; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Redmer Michael, 2000, Journal of the Iowa Academy of Science, V107, P128; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richards Corinne L., 2008, Herpetological Review, V39, P200; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; Rosenblum EB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000550; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Rowley JJL, 2007, ECOHEALTH, V4, P31, DOI 10.1007/s10393-006-0075-z; Rowley JJL, 2006, ECOHEALTH, V3, P49, DOI 10.1007/s10393-005-0005-5; Sadinski Walt, 2010, Herpetological Review, V41, P170; Scalera Riccardo, 2008, Herpetological Review, V39, P199; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; SMITH HM, 1950, MISCELLANEOUS PUBLIC, V2; Smith KG, 2007, DIS AQUAT ORGAN, V74, P159, DOI 10.3354/dao074159; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; THOMPSON C, 1915, OCCASIONAL PAPERS MU, V9; VOORDOUW MJ, 2010, BMC ECOL, DOI DOI 10.1186/1472-6785-10-6; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; VREDENBURG VT, 2010, PNAS0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Waldman B., 2001, Surveillance (Wellington), V28, P9; Walker SF, 2007, DIS AQUAT ORGAN, V77, P105, DOI 10.3354/dao01850; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; WOODHAMS DC, 2007, HERP REV, V39, P66; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004	116	97	104	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2011	6	3							e16708	10.1371/journal.pone.0016708	http://dx.doi.org/10.1371/journal.pone.0016708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732VZ	21423745	Green Published, gold, Green Submitted			2022-12-27	WOS:000288219100001
J	Alborghetti, MR; Furlan, AS; Kobarg, J				Alborghetti, Marcos R.; Furlan, Ariane S.; Kobarg, Joerg			FEZ2 Has Acquired Additional Protein Interaction Partners Relative to FEZ1: Functional and Evolutionary Implications	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; AXONAL OUTGROWTH; NEURAL DIFFERENTIATION; INTERACTION NETWORK; NEURITE OUTGROWTH; 2-HYBRID SYSTEM; COILED COILS; ZETA-1 FEZ1; CELLS; FASCICULATION	Background: The FEZ (fasciculation and elongation protein zeta) family designation was purposed by Bloom and Horvitz by genetic analysis of C. elegans unc-76. Similar human sequences were identified in the expressed sequence tag database as FEZ1 and FEZ2. The unc-76 function is necessary for normal axon fasciculation and is required for axon-axon interactions. Indeed, the loss of UNC-76 function results in defects in axonal transport. The human FEZ1 protein has been shown to rescue defects caused by unc-76 mutations in nematodes, indicating that both UNC-76 and FEZ1 are evolutionarily conserved in their function. Until today, little is known about FEZ2 protein function. Methodology/ Principal Findings: Using the yeast two-hybrid system we demonstrate here conserved evolutionary features among orthologs and non-conserved features between paralogs of the FEZ family of proteins, by comparing the interactome profiles of the C-terminals of human FEZ1, FEZ2 and UNC-76 from C. elegans. Furthermore, we correlate our data with an analysis of the molecular evolution of the FEZ protein family in the animal kingdom. Conclusions/ Significance: We found that FEZ2 interacted with 59 proteins and that of these only 40 interacted with FEZ1. Of the 40 FEZ1 interacting proteins, 36 (90%), also interacted with UNC-76 and none of the 19 FEZ2 specific proteins interacted with FEZ1 or UNC-76. This together with the duplication of unc-76 gene in the ancestral line of chordates suggests that FEZ2 is in the process of acquiring new additional functions. The results provide also an explanation for the dramatic difference between C. elegans and D. melanogaster unc-76 mutants on one hand, which cause serious defects in the nervous system, and the mouse FEZ1 -/- knockout mice on the other, which show no morphological and no strong behavioural phenotype. Likely, the ubiquitously expressed FEZ2 can completely compensate the lack of neuronal FEZ1, since it can interact with all FEZ1 interacting proteins and additional 19 proteins.	[Alborghetti, Marcos R.; Furlan, Ariane S.; Kobarg, Joerg] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil; [Alborghetti, Marcos R.; Furlan, Ariane S.; Kobarg, Joerg] Univ Estadual Campinas, Inst Biol, Dept Bioquim, Programa Posgrad Biol Func & Mol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Alborghetti, MR (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil.	jorg.kobarg@lnbio.org.br	Alborghetti, Marcos/K-7547-2012; Kobarg, Jörg/T-4736-2019	Alborghetti, Marcos/0000-0003-4517-5579; Kobarg, Jörg/0000-0002-9419-0145	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Pesquisa e Desenvolvimento; LNBio-CNPEM	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); LNBio-CNPEM	This work was financially supported by Fundacao de Amparo a Pesquisa do Estado Sao Paulo, the Conselho Nacional de Pesquisa e Desenvolvimento and the LNBio-CNPEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Brunet-De Carvalho N, 2003, GROWTH FACTORS, V21, P139, DOI 10.1080/08977190310001621014; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fox A, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P391; Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050; Fujita T, 2004, BIOCHEM BIOPH RES CO, V313, P738, DOI 10.1016/j.bbrc.2003.12.006; Furuta M, 2004, DEV BRAIN RES, V152, P189, DOI 10.1016/j.devbrainres.2004.06.014; Gindhart JG, 2003, MOL BIOL CELL, V14, P3356, DOI 10.1091/mbc.E02-12-0800; Greene LA, 2005, NEUROCHEM RES, V30, P1347, DOI 10.1007/s11064-005-8807-y; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hennah W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004906; Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142; Kuroda S, 1999, J CELL BIOL, V144, P403, DOI 10.1083/jcb.144.3.403; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Lanza DCF, 2008, EXP CELL RES, V314, P2028, DOI 10.1016/j.yexcr.2008.02.012; Lanza DCF, 2010, MOL CELL BIOCHEM, V338, P35, DOI 10.1007/s11010-009-0317-9; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Makino T., 2007, V3, P13, DOI 10.1159/000107601; MATURANA AD, SCIENTIFICWORLDJOURN, V10, P1646; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Naghavi MH, 2005, GENE DEV, V19, P1105, DOI 10.1101/gad.1290005; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Sakae N, 2008, HUM MOL GENET, V17, P3191, DOI 10.1093/hmg/ddn215; SilosSantiago I, 1996, J NEUROBIOL, V31, P283, DOI 10.1002/(SICI)1097-4695(199611)31:3<283::AID-NEU2>3.0.CO;2-6; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; SU CW, 2006, J BIOL-LONDON, V5, pNIL5; Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200; WALHOUT AJM, 2000, SCIENCE, V287, P116; Whitehouse C, 2002, EUR J BIOCHEM, V269, P538, DOI 10.1046/j.0014-2956.2001.02681.x; Zechel C, 2005, MOL ENDOCRINOL, V19, P1629, DOI 10.1210/me.2004-0540	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17426	10.1371/journal.pone.0017426	http://dx.doi.org/10.1371/journal.pone.0017426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408165	Green Submitted, gold, Green Published			2022-12-27	WOS:000288170000028
J	Antenos, M; Lei, L; Xu, M; Malipatil, A; Kiesewetter, S; Woodruff, TK				Antenos, Monica; Lei, Lei; Xu, Min; Malipatil, Anjali; Kiesewetter, Sarah; Woodruff, Teresa K.			Role of PCSK5 Expression in Mouse Ovarian Follicle Development: Identification of the Inhibin alpha- and beta-Subunits as Candidate Substrates	PLOS ONE			English	Article							KEX2-LIKE PROCESSING ENDOPROTEASE; IN-VITRO CULTURE; GENE-EXPRESSION; PROPROTEIN CONVERTASES; ACTIVIN-A; RAT; SECRETION; FAMILY; CELLS; CYCLE	Inhibin and activin are essential dimeric glycoproteins belonging to the transforming growth factor-beta (TGF beta) superfamily. Inhibin is a heterodimer of alpha-and beta-subunits, whereas activin is a homodimer of beta-subunits. Production of inhibin is regulated during the reproductive cycle and requires the processing of pro-ligands to produce mature hormone. Furin is a subtilisin-like proprotein convertase (proconvertase) that activates precursor proteins by cleavage at basic sites during their transit through the secretory pathway and/or at the cell surface. We hypothesized that furin-like proconvertases are central regulators of inhibin alpha-and beta-subunit processing within the ovary. We analyzed the expression of the proconvertases furin, PCSK5, PCSK6, and PCSK7 in the developing mouse ovary by real-time quantitative RT-PCR. The data showed that proconvertase enzymes are temporally expressed in ovarian cells. With the transition from two-layer secondary to pre-antral follicle, only PCSK5 mRNA was significantly elevated. Activin A selectively enhanced expression of PCSK5 mRNA and decreased expression of furin and PCSK6 in cultured two-layer secondary follicles. Inhibition of proconvertase enzyme activity by dec-RVKR-chloromethylketone (CMK), a highly specific and potent competitive inhibitor of subtilisin-like proconvertases, significantly impeded both inhibin alpha-and beta-subunit maturation in murine granulosa cells. Overexpression of PC5/6 in furin-deficient cells led to increased inhibin alpha-and beta(B)-subunit maturation. Our data support the role of proconvertase PCSK5 in the processing of ovarian inhibin subunits during folliculogenesis and suggest that this enzyme may be an important regulator of inhibin and activin bioavailability.	[Antenos, Monica; Lei, Lei; Xu, Min; Malipatil, Anjali; Kiesewetter, Sarah; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Antenos, Monica; Lei, Lei; Xu, Min; Malipatil, Anjali; Kiesewetter, Sarah; Woodruff, Teresa K.] Northwestern Univ, Ctr Reprod Sci, Evanston, IL USA; [Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Antenos, M (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tkw@northwestern.edu	Antenos, Monica/J-8985-2017	Antenos, Monica/0000-0001-6350-2911; Woodruff, Teresa/0000-0002-1197-3399	National Institutes of Health [R01 HD37096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health grant R01 HD37096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Antenos M, 2008, J BIOL CHEM, V283, P33059, DOI 10.1074/jbc.M804190200; Bae JA, 2008, MOL CELL ENDOCRINOL, V289, P29, DOI 10.1016/j.mce.2008.04.006; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Burkart AD, 2005, ENDOCRINOLOGY, V146, P1909, DOI 10.1210/en.2004-0842; de Kretser DM, 2000, MOL CELL ENDOCRINOL, V161, P43, DOI 10.1016/S0303-7207(99)00222-1; Diaz FJ, 2008, BIOL REPROD, V78, P176, DOI 10.1095/biolreprod.107.063537; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Kenny HA, 2006, ENDOCRINOLOGY, V147, P51, DOI 10.1210/en.2005-0242; Kipp JL, 2007, ENDOCRINOLOGY, V148, P1968, DOI 10.1210/en.2006-1083; Knight PG, 2003, ANIM REPROD SCI, V78, P165, DOI 10.1016/S0378-4320(03)00089-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; Mather JP, 1997, P SOC EXP BIOL MED, V215, P209; MCLACHLAN RI, 1987, J CLIN ENDOCR METAB, V65, P954, DOI 10.1210/jcem-65-5-954; NAKAGAWA T, 1993, J BIOCHEM-TOKYO, V113, P132, DOI 10.1093/oxfordjournals.jbchem.a124015; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ogiwara K, 2004, J EXP ZOOL PART A, V301A, P449, DOI 10.1002/jez.a.20071; Pangas SA, 2002, J ENDOCRINOL, V172, P199, DOI 10.1677/joe.0.1720199; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SEIDAH NG, 1994, METHOD ENZYMOL, V244, P175; Smitz J, 1998, HUM REPROD, V13, P927, DOI 10.1093/humrep/13.4.927; Smitz J, 1998, MOL REPROD DEV, V50, P294, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;294::AID-MRD5&gt;3.0.CO;2-E; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Takumi I, 1998, MODERN PATHOL, V11, P232; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Thomas Fiona H, 2003, Reprod Biol Endocrinol, V1, P76, DOI 10.1186/1477-7827-1-76; West-Farrell ER, 2009, BIOL REPROD, V80, P432, DOI 10.1095/biolreprod.108.071142; WOODRUFF TK, 1990, ANNU REV PHYSIOL, V52, P807, DOI 10.1146/annurev.ph.52.030190.004111; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611; WOODRUFF TK, 1989, ENDOCRINOLOGY, V124, P2193, DOI 10.1210/endo-124-5-2193; Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739; Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	38	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17348	10.1371/journal.pone.0017348	http://dx.doi.org/10.1371/journal.pone.0017348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408162	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000024
J	Benlahrech, A; Gotch, F; Kelleher, P; Patterson, S				Benlahrech, Adel; Gotch, Frances; Kelleher, Peter; Patterson, Steven			Loss of NK Stimulatory Capacity by Plasmacytoid and Monocyte-Derived DC but Not Myeloid DC in HIV-1 Infected Patients	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS-INFECTION; NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; ANTIRETROVIRAL THERAPY; INTERFERON-ALPHA; MEDIATED LYSIS; 1-INFECTED INDIVIDUALS; TNF-ALPHA	Dendritic cells (DC) are potent inducers of natural killer (NK) cells. There are two distinct populations in blood, myeloid (mDC) and plasmacytoid (pDC) but they can also be generated In vitro from monocytes (mdDC). Although it is established that blood DC are lost in HIV-1 infection, the full impact of HIV-1 infection on DC-NK cell interactions remains elusive. We thus investigated the ability of pDC, mDC, and mdDC from viremic and anti-retroviral therapy-treated aviremic HIV-1+ patients to stimulate various NK cell functions. Stimulated pDC and mdDC from HIV-1+ patients showed reduced secretion of IFN-alpha and IL-12p70 respectively and their capacity to stimulate expression of CD25 and CD69, and IFN-gamma secretion in NK cells was also reduced. pDC activation of NK cell degranulation in response to a tumour cell line was severely reduced in HIV-1+ patients but the ability of mDC to activate NK cells was not affected by HIV-1 infection, with the exception of HLA-DR induction. No differences were observed between viremic and aviremic patients indicating that anti-retroviral therapy had minimal effect on restoration on pDC and mdDC-mediated activation of NK cells. Results from this study provide further insight into HIV-1 mediated suppression of innate immune functions.	[Benlahrech, Adel; Gotch, Frances; Kelleher, Peter; Patterson, Steven] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London, England	Imperial College London	Benlahrech, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London, England.	s.patterson@imperial.ac.uk		Patterson, Steven/0000-0003-0652-7797	Medical Research Council, UK; Algerian Embassy; MRC [G0501957, G0100482] Funding Source: UKRI; Medical Research Council [G0501957, G0100482] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Algerian Embassy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Medical Research Council, UK, and the Algerian Embassy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Amakata Y, 2001, CLIN EXP IMMUNOL, V124, P214, DOI 10.1046/j.1365-2249.2001.01550.x; Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f; BANDYOPADHYAY S, 1990, CLIN EXP IMMUNOL, V79, P430, DOI 10.1111/j.1365-2249.1990.tb08107.x; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Benlahrech A, 2009, SENSORS-BASEL, V9, P386, DOI 10.3390/s90100386; Buisson S, 2009, J INFECT DIS, V199, P1862, DOI 10.1086/599122; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chung AW, 2009, J IMMUNOL, V182, P1202, DOI 10.4049/jimmunol.182.2.1202; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Conry SJ, 2009, J VIROL, V83, P11175, DOI 10.1128/JVI.00753-09; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Douglas SD, 2001, AIDS RES HUM RETROV, V17, P543, DOI 10.1089/08892220151126643; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Ferlazzo G, 2005, IMMUNOL LETT, V101, P12, DOI 10.1016/j.imlet.2005.04.015; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Fortis C, 1999, EUR J IMMUNOL, V29, P3654, DOI 10.1002/(SICI)1521-4141(199911)29:11<3654::AID-IMMU3654>3.0.CO;2-B; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Grassi F, 1999, AIDS, V13, P759, DOI 10.1097/00002030-199905070-00004; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kamga I, 2005, J INFECT DIS, V192, P303, DOI 10.1086/430931; Killian MS, 2006, AIDS, V20, P1247, DOI 10.1097/01.aids.0000232231.34253.bd; Kottilil S, 2004, J INFECT DIS, V189, P1193, DOI 10.1086/382090; Kottilil Shyam, 2003, Indian Journal of Experimental Biology, V41, P1219; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Marshall JD, 2006, IMMUNOLOGY, V117, P38, DOI 10.1111/j.1365-2567.2005.02261.x; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Pacanowski M, 2004, J INFECT DIS, V190, P1889, DOI 10.1086/425020; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Reitano KN, 2009, AIDS RES HUM RETROV, V25, P1029, DOI 10.1089/aid.2008.0311; ROOK AH, 1983, J CLIN INVEST, V72, P398, DOI 10.1172/JCI110981; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Sabado RL, 2010, BLOOD, V116, P3839, DOI 10.1182/blood-2010-03-273763; Sacchi A, 2007, JAIDS-J ACQ IMM DEF, V46, P519, DOI 10.1097/QAI.0b013e31815b1278; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Siegal FP, 2001, AIDS, V15, P1603, DOI 10.1097/00002030-200109070-00002; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Tasca S, 2003, AIDS, V17, P2291, DOI 10.1097/00002030-200311070-00003; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; ULLUM H, 1995, J EXP MED, V182, P789, DOI 10.1084/jem.182.3.789; van der Meer A, 2001, TRANSPLANTATION, V72, P923, DOI 10.1097/00007890-200109150-00030; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Yonkers NL, 2009, CLIN IMMUNOL, V131, P288, DOI 10.1016/j.clim.2008.12.012	58	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17525	10.1371/journal.pone.0017525	http://dx.doi.org/10.1371/journal.pone.0017525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408163	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170000035
J	Li, SQ; Moffett, HF; Lu, J; Werner, L; Zhang, H; Ritz, J; Neuberg, D; Wucherpfennig, KW; Brown, JR; Novina, CD				Li, Shuqiang; Moffett, Howell F.; Lu, Jun; Werner, Lillian; Zhang, Hao; Ritz, Jerome; Neuberg, Donna; Wucherpfennig, Kai W.; Brown, Jennifer R.; Novina, Carl D.			MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							CLL PATIENTS; DISEASE PROGRESSION; MIRNA EXPRESSION; DOWN-REGULATION; PHENOTYPE; APOPTOSIS; LYMPHOMA; REVEALS; DIFFERENTIATION; PROLIFERATION	Chronic lymphocytic leukemia (CLL) is thought to be a disease of resting lymphocytes. However, recent data suggest that CLL cells may more closely resemble activated B cells. Using microRNA (miRNA) expression profiling of highly-enriched CLL cells from 38 patients and 9 untransformed B cells from normal donors before acute CpG activation and 5 matched B cells after acute CpG activation, we demonstrate an activated B cell status for CLL. Gene set enrichment analysis (GSEA) identified statistically-significant similarities in miRNA expression between activated B cells and CLL cells including upregulation of miR-34a, miR-155, and miR-342-3p and downregulation of miR-103, miR-181a and miR-181b. Additionally, decreased levels of two CLL signature miRNAs miR-29c and miR-223 are associated with ZAP70(+) and IgVH unmutated status and with shorter time to first therapy. These data indicate an activated B cell status for CLL cells and suggest that the direction of change of individual miRNAs may predict clinical course in CLL.	[Li, Shuqiang; Moffett, Howell F.; Wucherpfennig, Kai W.; Novina, Carl D.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Moffett, Howell F.] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Lu, Jun; Zhang, Hao; Novina, Carl D.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Werner, Lillian; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Ritz, Jerome; Brown, Jennifer R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ritz, Jerome; Brown, Jennifer R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Novina, Carl D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Li, SQ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	carl_novina@dfci.harvard.edu	Pillay, Nischalan/F-9536-2012; Ritz, Jerome/C-7929-2009	Ritz, Jerome/0000-0001-5526-4669; Moffett, Howell/0000-0002-7799-1688	NIH [PO1-CA081534, K23 CA115682]; NRSA [DFCI/NCI T32 CA70083]; Carreras International Leukemia; Doris Duke Clinical Scientist Development Awards; NATIONAL CANCER INSTITUTE [K23CA115682, P01CA081534, T32CA070083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carreras International Leukemia; Doris Duke Clinical Scientist Development Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders of the study include NIH grant (PO1-CA081534), NIH grant (K23 CA115682), NRSA Fellowship (DFCI/NCI T32 CA70083), Carreras International Leukemia and Doris Duke Clinical Scientist Development Awards.	Aalto Y, 2001, LEUKEMIA, V15, P1721, DOI 10.1038/sj.leu.2402282; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Ghia P, 2003, BLOOD, V101, P1262, DOI 10.1182/blood-2002-06-1801; Gobessi S, 2007, BLOOD, V109, P2032, DOI 10.1182/blood-2006-03-011759; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kusenda J, 2004, NEOPLASMA, V51, P97; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mraz M, 2009, LEUKEMIA, V23, P1159, DOI 10.1038/leu.2008.377; Mraz M, 2009, LEUKEMIA LYMPHOMA, V50, P506, DOI 10.1080/10428190902763517; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Ringshausen I, 2002, BLOOD, V100, P3741, DOI 10.1182/blood-2002-02-0539; Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schuh K, 1996, LEUKEMIA LYMPHOMA, V23, P583, DOI 10.3109/10428199609054868; Stamatopoulos B, 2009, BLOOD, V113, P5237, DOI 10.1182/blood-2008-11-189407; Stratowa C, 2001, INT J CANCER, V91, P474, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Volinia S., 2006, P NATL ACAD SCI US; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	43	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16956	10.1371/journal.pone.0016956	http://dx.doi.org/10.1371/journal.pone.0016956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408091	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170000012
J	Park, SB; Bin Jang, H; Nho, SW; Cha, IS; Hikima, J; Ohtani, M; Aoki, T; Jung, TS				Park, Seong Bin; Bin Jang, Ho; Nho, Seong Won; Cha, In Seok; Hikima, Jun-ichi; Ohtani, Maki; Aoki, Takashi; Jung, Tae Sung			Outer Membrane Vesicles as a Candidate Vaccine against Edwardsiellosis	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; NEISSERIA-MENINGITIDIS; JAPANESE FLOUNDER; VIBRIO-CHOLERAE; PROTEIN-A; TARDA; RELEASE; CELL; SECRETION	Infection with Edwardsiella tarda, a Gram-negative bacterium, causes high morbidity and mortality in both marine and freshwater fish. Outer membrane vesicles (OMVs) released from Gram-negative bacteria are known to play important roles in bacterial pathogenesis and host immune responses, but no such roles for E. tarda OMVs have yet been described. In the present study, we investigated the proteomic composition of OMVs and the immunostimulatory effect of OMVs in a natural host, as well as the efficacy of OMVs when used as a vaccine against E. tarda infection. A total of 74 proteins, from diverse subcellular fractions, were identified in OMVs. These included a variety of important virulence factors, such as hemolysin, OmpA, porin, GAPDH, EseB, EseC, EseD, EvpC, EvpP, lipoprotein, flagellin, and fimbrial protein. When OMVs were administrated to olive flounder, significant induction of mRNAs encoding IL-1 beta, IL-6, TNF alpha, and IFN gamma was observed, compared with the levels seen in fish injected with formalin-killed E. tarda. In a vaccine trial, olive flounder given OMVs were more effectively protected ( p,< 0.0001) than were control fish. Investigation of OMVs may be useful not only for understanding the pathogenesis of E. tarda but also in development of an effective vaccine against edwardsiellosis.	[Park, Seong Bin; Bin Jang, Ho; Nho, Seong Won; Cha, In Seok; Hikima, Jun-ichi; Ohtani, Maki; Aoki, Takashi; Jung, Tae Sung] Gyeongsang Natl Univ, Coll Vet Med, Aquatic Biotechnol Ctr, Jinju, South Korea	Gyeongsang National University	Park, SB (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Aquatic Biotechnol Ctr, Jinju, South Korea.	aoki@kaiyodai.ac.jp; jungts@gnu.ac.kr	Hikima, Jun-ichi/AAI-6983-2020; Jung, Tae Sung/G-8245-2017	Hikima, Jun-ichi/0000-0002-4184-7422; Jung, Tae Sung/0000-0001-6028-0946; Jang, Ho Bin/0000-0003-1316-316X	Ministry of Education, Science and Technology, of South Korea [R32-10253]	Ministry of Education, Science and Technology, of South Korea	This work was supported by a grant (no. R32-10253) from the World Class University Program funded by the Ministry of Education, Science and Technology, of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; Aoki M, 2007, VACCINE, V25, P561, DOI 10.1016/j.vaccine.2006.07.047; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bolton A, 2004, CAN J MICROBIOL, V50, P423, DOI [10.1139/w04-016, 10.1139/W04-016]; Castro N, 2008, FISH SHELLFISH IMMUN, V25, P208, DOI 10.1016/j.fsi.2008.05.008; DEVOE IW, 1973, J EXP MED, V138, P1156, DOI 10.1084/jem.138.5.1156; Egusa S., 1976, Fish Pathology, V10, P103; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Gonzalez S, 2006, VACCINE, V24, P1633, DOI 10.1016/j.vaccine.2005.09.050; HERMAN RL, 1986, T AM FISH SOC, V115, P232, DOI 10.1577/1548-8659(1986)115&lt;232:PCBTBE&gt;2.0.CO;2; Hirono I, 2004, IMMUNOGENETICS, V56, P38, DOI 10.1007/s00251-004-0657-2; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; JANDA JM, 1993, FEMS MICROBIOL LETT, V111, P275; JENDHOLM J, PLOS PATHOG, V6; Kadurugamuwa JL, 1999, MICROBIOL-SGM, V145, P2051, DOI 10.1099/13500872-145-8-2051; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kawai K, 2004, VACCINE, V22, P3411, DOI 10.1016/j.vaccine.2004.02.026; Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200; KONDO K, 1993, MICROBIOL IMMUNOL, V37, P149, DOI 10.1111/j.1348-0421.1993.tb03192.x; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kumar G, 2010, J APPL MICROBIOL, V108, P2214, DOI 10.1111/j.1365-2672.2009.04627.x; KUSUDA R, 1976, B JPN SOC SCI FISH, V42, P271; Kwon SR, 2006, FISH SHELLFISH IMMUN, V20, P621, DOI 10.1016/j.fsi.2005.08.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Mekuchi T, 1995, FISH PATHOL, V30, P251, DOI 10.3147/jsfp.30.251; MEYER FP, 1973, APPL MICROBIOL, V25, P155, DOI 10.1128/AEM.25.1.155-156.1973; Mohanty BR, 2007, J BIOSCIENCES, V32, P1331, DOI 10.1007/s12038-007-0143-8; Nakatsugawa T., 1983, Fish Pathology, V18, P99; Nevot M, 2006, ENVIRON MICROBIOL, V8, P1523, DOI 10.1111/j.1462-2920.2006.01043.x; NOUGAYREDE PH, 1994, EAFP B, V14, P128; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rao PSS, 2003, MICROBIOL-SGM, V149, P2635, DOI 10.1099/mic.0.26478-0; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Shin GW, 2006, DIS AQUAT ORGAN, V70, P71, DOI 10.3354/dao070071; Strauss EJ, 1997, INFECT IMMUN, V65, P3924, DOI 10.1128/IAI.65.9.3924-3932.1997; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Ullah M. A., 1983, Fish Pathology, V18, P65; van den Dobbelsteen GPJM, 2007, VACCINE, V25, P2491, DOI 10.1016/j.vaccine.2006.09.025; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wang B, 2010, MAR BIOTECHNOL, V12, P678, DOI 10.1007/s10126-009-9255-5; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	55	65	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17629	10.1371/journal.pone.0017629	http://dx.doi.org/10.1371/journal.pone.0017629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408115	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000047
J	Rehman, MT; Dey, P; Hassan, MI; Ahmad, F; Batra, JK				Rehman, Md Tabish; Dey, Punyatirtha; Hassan, Md Imtaiyaz; Ahmad, Faizan; Batra, Janendra K.			Functional Role of Glutamine 28 and Arginine 39 in Double Stranded RNA Cleavage by Human Pancreatic Ribonuclease	PLOS ONE			English	Article							CATALYTIC-PROPERTIES; BINDING; PROTEINS; DEGRADATION; STABILITY; VARIANTS; RESIDUES; FEATURES; MODEL; CHAIN	Human pancreatic ribonuclease (HPR), a member of RNase A superfamily, has a high activity on double stranded (ds) RNA. By virtue of this activity HPR appears to be involved in the host-defense against pathogenic viruses. To delineate the mechanism of dsRNA cleavage by HPR, we have investigated the role of glutamine 28 and arginine 39 of HPR in its activity on dsRNA. A non-basic residue glycine 38, earlier shown to be important for dsRNA cleavage by HPR was also included in the study in the context of glutamine 28 and arginine 39. Nine variants of HPR respectively containing Q28A, Q28L, R39A, G38D, Q28A/R39A, Q28L/R39A, Q28A/G38D, R39A/G38D and Q28A/G38D/R39A mutations were generated and functionally characterized. The far-UV CD-spectral analysis revealed all variants, except R39A, to have structures similar to that of HPR. The catalytic activity of all HPR variants on single stranded RNA substrate was similar to that of HPR, whereas on dsRNA, the catalytic efficiency of all single residue variants, except for the Q28L, was significantly reduced. The dsRNA cleavage activity of R39A/G38D and Q28A/G38D/R39A variants was most drastically reduced to 4% of that of HPR. The variants having reduced dsRNA cleavage activity also had reduction in their dsDNA melting activity and thermal stability. Our results indicate that in HPR both glutamine 28 and arginine 39 are important for the cleavage of dsRNA. Although these residues are not directly involved in catalysis, both arginine 39 and glutamine 28 appear to be facilitating a productive substrate-enzyme interaction during the dsRNA cleavage by HPR.	[Rehman, Md Tabish; Hassan, Md Imtaiyaz; Ahmad, Faizan] Ctr Interdisciplinary Res Basic Sci, New Delhi, India; [Dey, Punyatirtha; Batra, Janendra K.] Natl Inst Immunol, Immunochem Lab, New Delhi 110067, India	Jamia Millia Islamia; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Rehman, MT (corresponding author), Ctr Interdisciplinary Res Basic Sci, New Delhi, India.	janendra@nii.res.in	Batra, Janendra/GWQ-8031-2022; Hassan, Md Imtaiyaz/G-7072-2017; REHMAN, TABISH/H-8471-2012; Hassan, Mohammad/GZA-7507-2022; Ahmad, Faizan/AGH-4493-2022; Hassan, Imtaiyaz/ABF-6485-2020; Rehman, Md Tabish/AAC-8512-2019	Hassan, Md Imtaiyaz/0000-0002-3663-4940; REHMAN, TABISH/0000-0003-2341-900X; Hassan, Mohammad/0000-0002-1712-0004; Ahmad, Faizan/0000-0001-7021-7502; Hassan, Imtaiyaz/0000-0002-3663-4940; Rehman, Md Tabish/0000-0003-2341-900X; Batra, Janendra/0000-0003-2206-3398	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India [SP/SO/BB-01/2003]; Council of Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants to the National Institute of Immunology from the Department of Biotechnology, Government of India, and a grant number SP/SO/BB-01/2003 from the Department of Science and Technology, Government of India to JKB. MTR and PD were supported by senior research fellowships from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; ARUS A, 1981, BIOCHIM BIOPHYS ACTA, V680, P117; Bal HP, 1997, EUR J BIOCHEM, V245, P465, DOI 10.1111/j.1432-1033.1997.t01-1-00465.x; BIENTEMA JJ, 1997, RIBONUCLEASES STRUCT, P245; BOIX E, 1994, J BIOL CHEM, V269, P2529; BUCHNER J, 1992, ANAL BIOCHEM, V205, P263, DOI 10.1016/0003-2697(92)90433-8; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Dey P, 2007, BIOCHEM BIOPH RES CO, V360, P809, DOI 10.1016/j.bbrc.2007.06.141; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P12121, DOI 10.1021/bi980743l; Fisher BM, 1998, J BIOL CHEM, V273, P34134, DOI 10.1074/jbc.273.51.34134; FONTECILLACAMPS JC, 1994, J BIOL CHEM, V269, P21526; Gaur D, 2002, BIOCHEM BIOPH RES CO, V297, P390, DOI 10.1016/S0006-291X(02)02216-7; Gaur D, 2001, J BIOL CHEM, V276, P24978, DOI 10.1074/jbc.M102440200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; IRIE M, 1984, J BIOCHEM-TOKYO, V96, P89, DOI 10.1093/oxfordjournals.jbchem.a134833; IWAHASHI K, 1981, J BIOCHEM-TOKYO, V90, P1685, DOI 10.1093/oxfordjournals.jbchem.a133644; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Larson SB, 2010, ACTA CRYSTALLOGR F, V66, P113, DOI 10.1107/S174430910905194X; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; Libonati M, 2004, BIOCHEM J, V380, P311, DOI 10.1042/BJ20031922; LIBONATI M, 1992, MOL CELL BIOCHEM, V117, P139; Libonati M, 2001, METHOD ENZYMOL, V341, P234, DOI 10.1016/S0076-6879(01)41155-4; MCPHERSON A, 1986, SCIENCE, V232, P765, DOI 10.1126/science.3961503; MITSUI Y, 1978, BIOCHIM BIOPHYS ACTA, V536, P299; Nicholson AW, 1996, PROG NUCLEIC ACID RE, V52, P1, DOI 10.1016/S0079-6603(08)60963-0; Opitz JG, 1998, BIOCHEMISTRY-US, V37, P4023, DOI 10.1021/bi9722047; Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077; Pous J, 2000, J MOL BIOL, V303, P49, DOI 10.1006/jmbi.2000.4506; RICHARDS FM, 1971, ENZYMES, V4, P647; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; Zhang JZ, 2003, MOL BIOL EVOL, V20, P1310, DOI 10.1093/molbev/msg143; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852	36	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17159	10.1371/journal.pone.0017159	http://dx.doi.org/10.1371/journal.pone.0017159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408145	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000013
J	Zhou, XH; Wong, LL; Karakoti, AS; Seal, S; McGinnis, JF				Zhou, Xiaohong; Wong, Lily L.; Karakoti, Ajay S.; Seal, Sudipta; McGinnis, James F.			Nanoceria Inhibit the Development and Promote the Regression of Pathologic Retinal Neovascularization in the Vldlr Knockout Mouse	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; NADPH OXIDASE; SUBRETINAL NEOVASCULARIZATION; PHOTORECEPTOR DEGENERATION; PIGMENT EPITHELIUM; MODEL; MICE; PROTECTION; INJURY	Many neurodegenerative diseases are known to occur and progress because of oxidative stress, the presence of reactive oxygen species (ROS) in excess of the cellular defensive capabilities. Age related macular degeneration (AMD), diabetic retinopathy (DR) and inherited retinal degeneration share oxidative stress as a common node upstream of the blinding effects of these diseases. Knockout of the Vldlr gene results in a mouse that develops intraretinal and subretinal neovascular lesions within the first month of age and is an excellent model for a form of AMD called retinal angiomatous proliferation (RAP). Cerium oxide nanoparticles (nanoceria) catalytically scavenge ROS by mimicking the activities of superoxide dismutase and catalase. A single intravitreal injection of nanoceria into the Vldlr-/- eye was shown to inhibit: the rise in ROS in the Vldlr-/- retina, increases in vascular endothelial growth factor (VEGF) in the photoreceptor layer, and the formation of intraretinal and subretinal neovascular lesions. Of more therapeutic interest, injection of nanoceria into older mice (postnatal day 28) resulted in the regression of existing vascular lesions indicating that the pathologic neovessels require the continual production of excessive ROS. Our data demonstrate the unique ability of nanoceria to prevent downstream effects of oxidative stress in vivo and support their therapeutic potential for treatment of neurodegenerative diseases such as AMD and DR.	[Zhou, Xiaohong; Wong, Lily L.; Karakoti, Ajay S.; Seal, Sudipta; McGinnis, James F.] Univ Oklahoma, Coll Med, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK 73190 USA; [Karakoti, Ajay S.; Seal, Sudipta] Univ Cent Florida, Adv Mat Proc Anal Ctr, Mech Mat Aerosp Engn Nanosci & Technol Ctr, Orlando, FL 32816 USA; [McGinnis, James F.] Oklahoma Ctr Neurosci, Dept Ophthalmol & Cell Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University System of Florida; University of Central Florida	Zhou, XH (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab, Boston, MA 02115 USA.	lily-wong@ouhsc.edu; james-mcginnis@ouhsc.edu	Karakoti, Ajay/AGI-8160-2022; Wong, Li Lian/AAG-5568-2020; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AAY-5886-2020; Liu, Zhanjiang/R-9633-2019; Seal, Sudipta/A-7698-2012; Wong, Lily/D-7737-2011	Wong, Li Lian/0000-0001-9045-4556; KARAKOTI, AJAY/0000-0001-9081-2325; Na-Nakorn, Uthairat/0000-0002-0804-3561; Wong, Lily/0000-0003-0569-3398	NIH [P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724]; FFB [C-NP-0707-0404-UOK08]; NSF [CBET-0708172]; OCAST [HR06-075]; Presbyterian Health Foundation; Research to Prevent Blindness; RPB; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190, R01EY018724, R21EY018306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FFB; NSF(National Science Foundation (NSF)); OCAST; Presbyterian Health Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RPB; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from: NIH: P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724; FFB (http://www.blindness.org/): C-NP-0707-0404-UOK08; NSF: CBET-0708172; OCAST(http://www.ok.gov/ocast/Programs/Oklahoma_Health_Research_(OHR)/index.html): HR06-075, and unrestricted funds from Presbyterian Health Foundation (http://www.phfokc.com/research.htm) and Research to Prevent Blindness (http://www.rpbusa.org/rpb/) (RPB). JFM is a recipient of an RPB Senior Scientific Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L P, 1997, Curr Opin Ophthalmol, V8, P19; Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bhatti MT, 2006, CURR NEUROL NEUROSCI, V6, P403, DOI 10.1007/s11910-996-0021-z; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Butler D, 2006, ANTIOXID REDOX SIGN, V8, P185, DOI 10.1089/ars.2006.8.185; Cao W, 2000, J NEUROSCI RES, V60, P195, DOI 10.1002/(SICI)1097-4547(20000415)60:2<195::AID-JNR8>3.0.CO;2-7; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; FRIED R, 1975, J NEUROCHEM, V24, P433, DOI 10.1111/j.1471-4159.1975.tb07658.x; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hogg R, 2004, CURR EYE RES, V29, P387, DOI 10.1080/02713680490517890; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Kaluzny J J, 1996, Klin Oczna, V98, P145; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x; Korystov YN, 2007, RADIAT RES, V168, P226, DOI 10.1667/RR0925.1; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Lodi F, 2006, EUR J PHARMACOL, V544, P97, DOI 10.1016/j.ejphar.2006.06.028; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; OLIVEIRA CR, 1994, ANN NY ACAD SCI, V738, P130; Onyango Isaac G., 2006, Current Alzheimer Research, V3, P339, DOI 10.2174/156720506778249489; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Poon HF, 2004, J GERONTOL A-BIOL, V59, P478; Sacca SC, 2009, MUTAT RES-FUND MOL M, V667, P98, DOI 10.1016/j.mrfmmm.2008.11.002; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; STERNBERG P, 1993, INVEST OPHTH VIS SCI, V34, P3661; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; van Reyk DM, 2003, REDOX REP, V8, P187, DOI 10.1179/135100003225002673; Wu MY, 2008, INVEST OPHTH VIS SCI, V49, P2679, DOI 10.1167/iovs.07-1440; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200; Zhou XH, 2007, DEV NEUROBIOL, V67, P603, DOI 10.1002/dneu.20373	50	163	173	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16733	10.1371/journal.pone.0016733	http://dx.doi.org/10.1371/journal.pone.0016733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21423623	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600014
J	Parnell, G; McLean, A; Booth, D; Huang, S; Nalos, M; Tang, B				Parnell, Grant; McLean, Anthony; Booth, David; Huang, Stephen; Nalos, Marek; Tang, Benjamin			Aberrant Cell Cycle and Apoptotic Changes Characterise Severe Influenza A Infection - A Meta-Analysis of Genomic Signatures in Circulating Leukocytes	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; VIRAL LOAD; IMMUNE; DEATH	Influenza A infection is a global disease that has been responsible for four pandemics over the last one hundred years. However, it remains poorly understood as to why some infected individuals succumb to life threatening complications whilst others recover and are relatively unaffected. Using gene-expression analysis of circulating leukocytes, here we show that the progression towards severe influenza A infection is characterised by an abnormal transcriptional reprogramming of cell cycle and apoptosis pathways. In severely infected humans, leukocyte gene-expression profiles display opposing cell cycle activities; an increased aberrant DNA replication in the G(1)/S phase yet delayed progression in the G(2)/M phase. In mild infection, cell cycle perturbations are fewer and are integrated with an efficient apoptotic program. Importantly, the loss of integration between cell cycle perturbations and apoptosis marks the transition from a mild viral illness to a severe, life threatening infection. Our findings suggest that circulating immune cells may play a significant role in the evolution of the host response. Further study may reveal alternative host response factors previously unrecognized in the current disease model of influenza.	[Parnell, Grant; McLean, Anthony; Huang, Stephen; Nalos, Marek; Tang, Benjamin] Univ Sydney, Nepean Hosp, Western Clin Sch, Dept Intens Care Med, Sydney, NSW 2006, Australia; [Booth, David] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	Nepean Hospital; University of Sydney; University of Sydney; Westmead Institute for Medical Research	Parnell, G (corresponding author), Univ Sydney, Nepean Hosp, Western Clin Sch, Dept Intens Care Med, Sydney, NSW 2006, Australia.	gpar3109@uni.sydney.edu.au	Parnell, Grant/AAB-8155-2021; Huang, Stephen/O-6195-2019; Booth, David/A-7184-2012	Huang, Stephen/0000-0003-2518-0506; Booth, David/0000-0002-3801-0488; Parnell, Grant/0000-0002-2898-0253; Nalos, Marek/0000-0002-7977-9410	Nepean Institute of Critical Care Education and Research; Nepean Medical Research Foundation	Nepean Institute of Critical Care Education and Research; Nepean Medical Research Foundation	This work was supported by the Nepean Institute of Critical Care Education and Research and Nepean Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Heilman DW, 2005, CELL CYCLE, V4, P560; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; MEUNIER I, 2009, CRIT CARE MED S, V38; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; *WHO, 2010, WHO INFL FACT SHEETS; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	21	70	74	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17186	10.1371/journal.pone.0017186	http://dx.doi.org/10.1371/journal.pone.0017186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21826236	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170000015
J	Anderson, SC; Flemming, JM; Watson, R; Lotze, HK				Anderson, Sean C.; Flemming, Joanna Mills; Watson, Reg; Lotze, Heike K.			Rapid Global Expansion of Invertebrate Fisheries: Trends, Drivers, and Ecosystem Effects	PLOS ONE			English	Article							SEA-URCHIN FISHERIES; TROPHIC-LEVEL; FOOD WEBS; MANAGEMENT; COMMUNITIES; DEPLETION; COLLAPSE; RECOVERY; DECLINE; SCALE	Background: Worldwide, finfish fisheries are receiving increasing assessment and regulation, slowly leading to more sustainable exploitation and rebuilding. In their wake, invertebrate fisheries are rapidly expanding with little scientific scrutiny despite increasing socio-economic importance. Methods and Findings: We provide the first global evaluation of the trends, drivers, and population and ecosystem consequences of invertebrate fisheries based on a global catch database in combination with taxa-specific reviews. We also develop new methodologies to quantify temporal and spatial trends in resource status and fishery development. Since 1950, global invertebrate catches have increased 6-fold with 1.5 times more countries fishing and double the taxa reported. By 2004, 34% of invertebrate fisheries were over-exploited, collapsed, or closed. New fisheries have developed increasingly rapidly, with a decrease of 6 years (+/-3 years) in time to peak from the 1950s to 1990s. Moreover, some fisheries have expanded further and further away from their driving market, encompassing a global fishery by the 1990s. 71% of taxa (53% of catches) are harvested with habitat-destructive gear, and many provide important ecosystem functions including habitat, filtration, and grazing. Conclusions: Our findings suggest that invertebrate species, which form an important component of the basis of marine food webs, are increasingly exploited with limited stock and ecosystem-impact assessments, and enhanced management attention is needed to avoid negative consequences for ocean ecosystems and human well-being.	[Anderson, Sean C.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Watson, Reg] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	Dalhousie University; Dalhousie University; University of British Columbia	Anderson, SC (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	sean.anderson@dal.ca	Watson, Reg A/F-4850-2012; Anderson, Sean C./AFN-3267-2022	Watson, Reg A/0000-0001-7201-8865; Anderson, Sean C./0000-0001-9563-1937; Mills Flemming, Joanna/0000-0002-3517-3089; Watson, Jolanta/0000-0002-5027-9025; Lotze, Heike/0000-0001-6258-1304; Watson, Gregory/0000-0001-9843-9211	Natural Sciences and Engineering Research Council of Canada; Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations); University of British Columbia; Pew Environment Group; National Science Foundation; Gordon and Betty Moore Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations)(Alfred P. Sloan Foundation); University of British Columbia; Pew Environment Group; National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Financial support is acknowledged from the Natural Sciences and Engineering Research Council of Canada with grants to HKL and JMF; the Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations) with grants to HKL; and the Sea Around Us Project, a scientific collaboration between the University of British Columbia and the Pew Environment Group. This project was part of a National Center for Ecological Analysis and Synthesis working group funded by the National Science Foundation and the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SC, 2010, FISH FISH IN PRESS; Anderson SC, 2008, CAN J FISH AQUAT SCI, V65, P2553, DOI 10.1139/F08-156; Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; [Anonymous], 2005, DISCARDS WORLDS MARI; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Botsford LW, 2004, CAN J FISH AQUAT SCI, V61, P1325, DOI 10.1139/F04-131; Breen PA, 1997, MAR FRESHWATER RES, V48, P1103, DOI 10.1071/MF97141; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; *FAO, 2008, 516 UN FAO; FAO, 2009, STAT WORLD FISH AQ 2; Ferdouse F., 2004, ADV SEA CUCUMBER AQU, V463, P425; FROESE R, 2000, FISHBASE 2000 CONCEP; Hiddink JG, 2006, CAN J FISH AQUAT SCI, V63, P721, DOI 10.1139/F05-266; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jamieson G. S., 1998, CANADIAN SPECIAL PUB; JAMIESON GS, 1993, AM ZOOL, V33, P551; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; NEWELL RIE, 1988, ADV CHESAPEAKE BAY R, P29; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 2008, J BIOL RES-THESSALON, V9, P3; Perry RI, 1999, REV FISH BIOL FISHER, V9, P125, DOI 10.1023/A:1008946522213; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; PHILLIPS BF, 2007, FISHERIES MANAGEMENT, P231; Salomon AK, 2007, ECOL APPL, V17, P1752, DOI 10.1890/06-1369.1; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Shepherd SA, 1998, J SHELLFISH RES, V17, P839; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; Tillin HM, 2006, MAR ECOL PROG SER, V318, P31, DOI 10.3354/meps318031; Uthicke S, 2001, J EXP MAR BIOL ECOL, V265, P153, DOI 10.1016/S0022-0981(01)00329-X; Watson R, 2005, MAR POLICY, V29, P281, DOI 10.1016/j.marpol.2004.06.006; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; ZELLER D, 2007, RECONSTRUCTION MARIN, V15; [No title captured]	39	174	179	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e14735	10.1371/journal.pone.0014735	http://dx.doi.org/10.1371/journal.pone.0014735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21935401	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170000001
J	Wei, J; Wu, A; Kong, LY; Wang, YT; Fuller, G; Fokt, I; Melillo, G; Priebe, W; Heimberger, AB				Wei, Jun; Wu, Adam; Kong, Ling-Yuan; Wang, Yongtao; Fuller, Gregory; Fokt, Isabella; Melillo, Giovanni; Priebe, Waldemar; Heimberger, Amy B.			Hypoxia Potentiates Glioma-Mediated Immunosuppression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; IMMUNE DYSFUNCTION; SIGNAL TRANSDUCERS; INDUCIBLE FACTORS; TUMOR; MACROPHAGE; CANCER; EXPRESSION; HIF-1-ALPHA	Glioblastoma multiforme (GBM) is a lethal cancer that exerts potent immune suppression. Hypoxia is a predominant feature of GBM, but it is unclear to the degree in which tumor hypoxia contributes to this tumor-mediated immunosuppression. Utilizing GBM associated cancer stem cells (gCSCs) as a treatment resistant population that has been shown to inhibit both innate and adaptive immune responses, we compared immunosuppressive properties under both normoxic and hypoxic conditions. Functional immunosuppression was characterized based on production of immunosuppressive cytokines and chemokines, the inhibition of T cell proliferation and effector responses, induction of FoxP3+ regulatory T cells, effect on macrophage phagocytosis, and skewing to the immunosuppressive M2 phenotype. We found that hypoxia potentiated the gCSC-mediated inhibition of T cell proliferation and activation and especially the induction of FoxP3+T cells, and further inhibited macrophage phagocytosis compared to normoxia condition. These immunosuppressive hypoxic effects were mediated by signal transducer and activator of transcription 3 (STAT3) and its transcriptionally regulated products such as hypoxia inducible factor (HIF)-1 alpha and vascular endothelial growth factor (VEGF). Inhibitors of STAT3 and HIF-1 alpha down modulated the gCSCs' hypoxia-induced immunosuppressive effects. Thus, hypoxia further enhances GBM-mediated immunosuppression, which can be reversed with therapeutic inhibition of STAT3 and HIF-1 alpha and also helps to reconcile the disparate findings that immune therapeutic approaches can be used successfully in model systems but have yet to achieve generalized successful responses in the vast majority of GBM patients by demonstrating the importance of the tumor hypoxic environment.	[Wei, Jun; Wu, Adam; Kong, Ling-Yuan; Wang, Yongtao; Heimberger, Amy B.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Fuller, Gregory] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fokt, Isabella; Priebe, Waldemar] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Melillo, Giovanni] NCI, Frederick, MD 21701 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wei, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.	aheimber@mdanderson.org		Fuller, Gregory/0000-0001-9447-2647	Anthony Bullock III Foundation; Mitchell Foundation; Dr. Marnie Rose Foundation; U.S. National Institutes of Health [CA120813-03, A177225-01, P50 CA093459]; NATIONAL CANCER INSTITUTE [P50CA093459, R01CA120813] Funding Source: NIH RePORTER	Anthony Bullock III Foundation; Mitchell Foundation; Dr. Marnie Rose Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Anthony Bullock III Foundation (ABH), the Mitchell Foundation (ABH), the Dr. Marnie Rose Foundation (ABH), and the U.S. National Institutes of Health grants CA120813-03, A177225-01, P50 CA093459 (ABH), and P50 CA093459 (WP). The funding organizations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Iborra B, 2009, J IMMUNOL, V182, P3155, DOI 10.4049/jimmunol.0801710; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Biollaz G, 2009, EUR J IMMUNOL, V39, P1323, DOI 10.1002/eji.200838921; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Brault MS, 2005, J BIOMED BIOTECHNOL, P37, DOI 10.1155/JBB.2005.37; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; CRANE CA, NEURO ONCOL, V12, P7; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Faderl S, 2001, ANTICANCER RES, V21, P3777; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Johnson B, 2009, CURR MOL MED, V9, P702, DOI 10.2174/156652409788970634; Johnson BF, 2007, EXPERT OPIN BIOL TH, V7, P449, DOI 10.1517/14712598.7.4.449; Jordan JT, 2008, CANCER IMMUNOL IMMUN, V57, P123, DOI 10.1007/s00262-007-0336-x; Jung JI, 2005, FASEB J, V19, pA81; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; Kuklinski S, 2000, J NEUROSCI RES, V60, P45, DOI 10.1002/(SICI)1097-4547(20000401)60:1<45::AID-JNR5>3.0.CO;2-Y; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lucas T, 2008, FRONT BIOSCI, V13, P5580; MAEDA H, 1995, J IMMUNOL, V155, P4926; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Negus RPM, 1997, AM J PATHOL, V150, P1723; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Owegi Henry O, 2010, Biomed Sci Instrum, V46, P57; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sarwat AM, 2009, J NEURO-ONCOL, V92, P111, DOI 10.1007/s11060-008-9729-8; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Tabatabai G, 2006, BRAIN, V129, P2426, DOI 10.1093/brain/awl173; WEI J, CLIN CANC RES, V16, P461; WEI J, MOL CANC THER, V9, P67; WU A, NEURO ONCOL; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102	58	149	156	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16195	10.1371/journal.pone.0016195	http://dx.doi.org/10.1371/journal.pone.0016195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283755	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200035
J	Wong, LL; Peatman, E; Lu, JG; Kucuktas, H; He, SP; Zhou, CJ; Na-nakorn, U; Liu, ZJ				Wong, Li Lian; Peatman, Eric; Lu, Jianguo; Kucuktas, Huseyin; He, Shunping; Zhou, Chuanjiang; Na-nakorn, Uthairat; Liu, Zhanjiang			DNA Barcoding of Catfish: Species Authentication and Phylogenetic Assessment	PLOS ONE			English	Article							SILURIFORMES; SEQUENCE; TUNA	As the global market for fisheries and aquaculture products expands, mislabeling of these products has become a growing concern in the food safety arena. Molecular species identification techniques hold the potential for rapid, accurate assessment of proper labeling. Here we developed and evaluated DNA barcodes for use in differentiating United States domestic and imported catfish species. First, we sequenced 651 base-pair barcodes from the cytochrome oxidase I (COI) gene from individuals of 9 species (and an Ictalurid hybrid) of domestic and imported catfish in accordance with standard DNA barcoding protocols. These included domestic Ictalurid catfish, and representative imported species from the families of Clariidae and Pangasiidae. Alignment of individual sequences from within a given species revealed highly consistent barcodes (98% similarity on average). These alignments allowed the development and analyses of consensus barcode sequences for each species and comparison with limited sequences in public databases (GenBank and Barcode of Life Data Systems). Validation tests carried out in blinded studies and with commercially purchased catfish samples (both frozen and fresh) revealed the reliability of DNA barcoding for differentiating between these catfish species. The developed protocols and consensus barcodes are valuable resources as increasing market and governmental scrutiny is placed on catfish and other fisheries and aquaculture products labeling in the United States.	[Wong, Li Lian; Peatman, Eric; Lu, Jianguo; Kucuktas, Huseyin; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Auburn, AL 36849 USA; [He, Shunping; Zhou, Chuanjiang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Zhou, Chuanjiang] Southwest Univ, Sch Life Sci, Chongqing, Peoples R China; [Na-nakorn, Uthairat] Kasetsart Univ, Fac Fisheries, Dept Aquaculture, Bangkok, Thailand	Auburn University System; Auburn University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Southwest University - China; Kasetsart University	Wong, LL (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Karakoti, Ajay/AGI-8160-2022; Wong, Li Lian/AAG-5568-2020; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AAY-5886-2020; Liu, Zhanjiang/R-9633-2019; Seal, Sudipta/A-7698-2012; Wong, Lily/D-7737-2011	Wong, Li Lian/0000-0001-9045-4556; KARAKOTI, AJAY/0000-0001-9081-2325; Na-Nakorn, Uthairat/0000-0002-0804-3561; Wong, Lily/0000-0003-0569-3398	USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP) [2009-35205-05101]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190, R01EY018724, R21EY018306] Funding Source: NIH RePORTER	USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP)(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This project was supported in part by a grant from USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP award # 2009-35205-05101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BOONBRAHM M, 1977, EXPT HYBRIDIZATION F; Botti S, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-60; Costa FO., 2007, GENOMICS SOC POLICY, V3, P29; DAWNAY NR, 2007, VALIDATION IN PRESS; DONSAKUL T, 1989, P 27 KAS U C JAN 30, P421; Dugan KA, 2002, J FORENSIC SCI, V47, P811; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferraris Carl J. Jr., 1999, Proceedings of the California Academy of Sciences, V51, P1; *FISH BOL, 2010, FISH BARC LIF IN CAM; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GARCIAFRANCO M, 1993, THESIS TOKYO U FISHE; HANSON T, CATFISH DATABASE USD; Hardman M, 2005, MOL PHYLOGENET EVOL, V37, P700, DOI 10.1016/j.ympev.2005.04.029; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jondeung A, 2007, GENE, V387, P49, DOI 10.1016/j.gene.2006.08.001; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LEGRANDE WH, 1981, COPEIA, P33; Liu Z, 1998, MOL GEN GENET, V258, P260, DOI 10.1007/s004380050730; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Na-Nakorn U, 2002, J FISH BIOL, V60, P1051, DOI [10.1111/j.1095-8649.2002.tb02428.x, 10.1006/jfbi.2002.1906]; Nei M, 2000, MOL EVOLUTION PHYLOG; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SMITH EG, 2002, CAMBODIAN J AGR; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Teugels GG, 1999, CYBIUM, V23, P285; *USDA, 2002, CATF PROD; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005	35	163	173	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17812	10.1371/journal.pone.0017812	http://dx.doi.org/10.1371/journal.pone.0017812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423623	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900034
J	Yu, DX; Yu, ZJ; Sun, Q; Sun, LA; Li, HX; Song, J; Mi, M; Wu, HY; Lu, L; Liu, C; Zhang, G; Hu, FB; Lin, X				Yu, Danxia; Yu, Zhijie; Sun, Qi; Sun, Liang; Li, Huaixing; Song, Jun; Mi, Ming; Wu, Hongyu; Lu, Ling; Liu, Chen; Zhang, Geng; Hu, Frank B.; Lin, Xu			Effects of Body Fat on the Associations of High-Molecular-Weight Adiponectin, Leptin and Soluble Leptin Receptor with Metabolic Syndrome in Chinese	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RISK-FACTORS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; OBESITY; WOMEN; SENSITIVITY; HEALTH; ADIPOCYTOKINES	Background: Little is known regarding the associations between high-molecular-weight (HMW-) adiponectin, leptin and soluble leptin receptor (sOB-R) and metabolic syndrome (MetS) in Chinese. Also few studies elucidate the effects of inflammation and body fat mass on the relations. Methods: Plasma HMW-adiponectin, leptin and sOB-R were measured among 1055 Chinese men and women (35 similar to 54 yrs). Whole body and trunk fat mass were determined by Dual-energy X-ray absorptiometry. MetS was defined by the updated NCEP/ATPIII criterion for Asian-Americans. Results: HMW-adiponectin was inversely associated with MetS in multivariate model including fat mass index (FMI), inflammatory markers, leptin and sOB-R (OR in the highest quartile =0.30, 95%CI 0.18 similar to 0.50, P<.0001). Plasma sOB-R was also inversely associated with MetS independent of body fatness and inflammatory markers, whereas the association was somewhat attenuated after adjusting HMW-adiponectin (OR for the highest quartile =0.78, 95%CI 0.47 similar to 1.32, P = 0.15). In contrast, leptin was associated with increased odds of MetS independent of inflammatory markers, HMW-adiponectin, and sOB-R (OR for the highest quartile =2.64, 95%CI 1.35 similar to 5.18, P = 0.006), although further adjustment for FMI abolished this association. Conclusions: HMW-adiponectin exhibited strong inverse associations with MetS independent of body composition, inflammation, leptin and sOB-R; while the associations of leptin and sOB-R were largely explained by fat mass or HMW-adiponectin, respectively.	[Yu, Danxia; Yu, Zhijie; Sun, Liang; Li, Huaixing; Wu, Hongyu; Lu, Ling; Liu, Chen; Zhang, Geng; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Song, Jun; Mi, Ming] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard T.H. Chan School of Public Health; Shanghai Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health	Yu, DX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	xlin@sibs.ac.cn		Sun, Xinli/0000-0002-6592-6168; Yu, Danxia/0000-0002-1710-9382; Wang, Guo-Liang/0000-0001-8877-3064	Chinese Academy of Sciences [KSCX2-YW-R-116, KSCX2-EW-R-10]; Ministry of Science and Technology of China [2008DFA31960, 2009AA022704, 2011CB504002]; National Natural Science Foundation of China [30930081, 81021002]; Shanghai Institutes [SIBS2008006]; Unilever Corporate Research	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes; Unilever Corporate Research(Unilever)	This study was supported by grant from the Chinese Academy of Sciences (KSCX2-YW-R-116, KSCX2-EW-R-10); the Ministry of Science and Technology of China (2008DFA31960, 863 Program 2009AA022704, 973 program 2011CB504002); the National Natural Science Foundation of China (30930081, 81021002); the Chief Scientist Program of Shanghai Institutes and (SIBS2008006). Dr. Qi Sun was supported by a postdoctoral fellowship from the Unilever Corporate Research before September 2010. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; *COMM IR, 2009, GUID DAT PROC AN INT; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Franks PW, 2005, OBES RES, V13, P1476, DOI 10.1038/oby.2005.178; Furler SM, 2006, OBESITY, V14, P228, DOI 10.1038/oby.2006.29; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Ingelsson E, 2008, J CLIN ENDOCR METAB, V93, P3149, DOI 10.1210/jc.2008-0207; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koska J, 2008, AM J CLIN NUTR, V87, P295, DOI 10.1093/ajcn/87.2.295; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Oh DK, 2007, DIABETES OBES METAB, V9, P282, DOI 10.1111/j.1463-1326.2006.00610.x; Sepilian VP, 2006, FERTIL STERIL, V85, P1441, DOI 10.1016/j.fertnstert.2005.10.038; Shimamura M, 2004, BIOCHEM BIOPH RES CO, V322, P1080, DOI 10.1016/j.bbrc.2004.08.024; Soderberg S, 2007, INT J OBESITY, V31, P1126, DOI 10.1038/sj.ijo.0803561; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; SUN Q, 2009, LEPTIN SOLUBLE LEPTI, V59, P611; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Ukkola O, 2007, METABOLISM, V56, P1221, DOI 10.1016/j.metabol.2007.04.019; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Wang J, 2008, OBESITY, V16, P172, DOI 10.1038/oby.2007.42; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Yu ZJ, 2009, CIRCULATION, V119, P2969, DOI 10.1161/CIRCULATIONAHA.108.833574; Zhai F, 2006, NUTR HLTH STATUS CHI; Zhuo Q, 2009, DIABETES RES CLIN PR, V84, P27, DOI 10.1016/j.diabres.2008.12.019	41	66	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16818	10.1371/journal.pone.0016818	http://dx.doi.org/10.1371/journal.pone.0016818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347230	gold, Green Submitted, Green Published			2022-12-27	WOS:000287369200008
J	Pawlowski, DR; Metzger, DJ; Raslawsky, A; Howlett, A; Siebert, G; Karalus, RJ; Garrett, S; Whitehouse, CA				Pawlowski, David R.; Metzger, Daniel J.; Raslawsky, Amy; Howlett, Amy; Siebert, Gretchen; Karalus, Richard J.; Garrett, Stephanie; Whitehouse, Chris A.			Entry of Yersinia pestis into the Viable but Nonculturable State in a Low-Temperature Tap Water Microcosm	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIBRIO-VULNIFICUS; RESUSCITATION; SURVIVAL; CELLS; STARVATION; VIRULENCE; PERSISTENCE; POPULATION; RECOVERY	Yersinia pestis, the causative agent of plague, has caused several pandemics throughout history and remains endemic in the rodent populations of the western United States. More recently, Y. pestis is one of several bacterial pathogens considered to be a potential agent of bioterrorism. Thus, elucidating potential mechanisms of survival and persistence in the environment would be important in the event of an intentional release of the organism. One such mechanism is entry into the viable but non-culturable (VBNC) state, as has been demonstrated for several other bacterial pathogens. In this study, we showed that Y. pestis became nonculturable by normal laboratory methods after 21 days in a low-temperature tap water microcosm. We further show evidence that, after the loss of culturability, the cells remained viable by using a variety of criteria, including cellular membrane integrity, uptake and incorporation of radiolabeled amino acids, and protection of genomic DNA from DNase I digestion. Additionally, we identified morphological and ultrastructural characteristics of Y. pestis VBNC cells, such as cell rounding and large periplasmic spaces, by electron microscopy, which are consistent with entry into the VBNC state in other bacteria. Finally, we demonstrated resuscitation of a small number of the non-culturable cells. This study provides compelling evidence that Y. pestis persists in a low-temperature tap water microcosm in a viable state yet is unable to be cultured under normal laboratory conditions, which may prove useful in risk assessment and remediation efforts, particularly in the event of an intentional release of this organism.	[Pawlowski, David R.; Raslawsky, Amy; Howlett, Amy; Siebert, Gretchen; Karalus, Richard J.] CUBRC Inc, Buffalo, NY USA; [Garrett, Stephanie; Whitehouse, Chris A.] USA, Med Res Inst Infect Dis, Frederick, MD USA; [Pawlowski, David R.; Metzger, Daniel J.; Karalus, Richard J.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Pawlowski, DR (corresponding author), CUBRC Inc, Buffalo, NY USA.	pawlowski@cubrc.org		Guillou, Laure/0000-0003-1032-7958; Shahbazkia, Hamid Reza/0000-0002-5661-0612; Pawlowski, Jan/0000-0003-2421-388X; Christen, Richard/0000-0002-3396-4362	CUBRC [00291.01]; USAMRIID [114509]; Oak Ridge Institute for Science and Education	CUBRC; USAMRIID; Oak Ridge Institute for Science and Education(General Electric)	The authors acknowledge the CUBRC Internal Research and Development program (no. 00291.01) and the USAMRIID In-House Laboratory Research program (no. 114509) for financial support. This research was supported in part by an appointment to the Student Research Participation Program at USAMRIID by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Albertini MC, 2006, CYTOM PART A, V69A, P260, DOI 10.1002/cyto.a.20263; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Bjergbaek LA, 2005, J APPL MICROBIOL, V99, P1090, DOI 10.1111/j.1365-2672.2005.02706.x; Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x; Bogosian G, 2000, J BACTERIOL, V182, P5070, DOI 10.1128/JB.182.18.5070-5075.2000; Breneva N. V., 2006, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P7; Buzoleva LS, 2000, B EXP BIOL MED+, V129, P374, DOI 10.1007/BF02439275; Chaiyanan S, 2001, SYST APPL MICROBIOL, V24, P331, DOI 10.1078/0723-2020-00032; Chaiyanan S, 2007, ENVIRON MICROBIOL, V9, P393, DOI 10.1111/j.1462-2920.2006.01150.x; Czyzewska Izabela, 2003, Przegl Epidemiol, V57, P263; Du M, 2007, APPL ENVIRON MICROB, V73, P1349, DOI 10.1128/AEM.02243-06; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Forsman M, 2000, FEMS MICROBIOL ECOL, V31, P217, DOI 10.1111/j.1574-6941.2000.tb00686.x; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Garcia-Armisen T, 2004, J MICROBIOL METH, V58, P269, DOI 10.1016/j.mimet.2004.04.014; Halvorson HO, 1933, J BACTERIOL, V25, P101, DOI 10.1128/JB.25.2.101-121.1933; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Jang KI, 2007, J MICROBIOL BIOTECHN, V17, P202; Keep NH, 2006, CELL MOL LIFE SCI, V63, P2555, DOI 10.1007/s00018-006-6188-2; LINDER K, 1989, APPL ENVIRON MICROB, V55, P2837, DOI 10.1128/AEM.55.11.2837-2842.1989; Lleo MM, 2001, J APPL MICROBIOL, V91, P1095, DOI 10.1046/j.1365-2672.2001.01476.x; Mizunoe Y, 1999, ARCH MICROBIOL, V172, P63, DOI 10.1007/s002030050741; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; NOVITSKY JA, 1976, APPL ENVIRON MICROB, V32, P617, DOI 10.1128/AEM.32.4.617-622.1976; Oliver James D., 2005, Journal of Water and Health, V3, P249; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; OLIVER JD, 2005, FOODBORNE PATHOGENS; RAHMAN I, 1994, APPL ENVIRON MICROB, V60, P3573, DOI 10.1128/AEM.60.10.3573-3578.1994; Rose LJ, 2007, APPL ENVIRON MICROB, V73, P3437, DOI 10.1128/AEM.00051-07; Rose LJ, 2003, APPL ENVIRON MICROB, V69, P2166, DOI 10.1128/AEM.69.4.2166-2171.2003; ROSZAK DB, 1987, APPL ENVIRON MICROB, V53, P2889, DOI 10.1128/AEM.53.12.2889-2893.1987; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; SMITH JJ, 1994, APPL ENVIRON MICROB, V60, P2977, DOI 10.1128/AEM.60.8.2977-2984.1994; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Suchkov Iu G, 1997, Zh Mikrobiol Epidemiol Immunobiol, P42; Torosian SD, 2009, CAN J MICROBIOL, V55, P1125, DOI [10.1139/W09-061, 10.1139/w09-061]; Torosian SD, 2009, CAN J MICROBIOL, V55, P1119, DOI [10.1139/w09-060, 10.1139/W09-060]; Troitskaia V V, 1996, Zh Mikrobiol Epidemiol Immunobiol, P13; Whitesides MD, 1997, APPL ENVIRON MICROB, V63, P1002, DOI 10.1128/AEM.63.3.1002-1005.1997; WILM, 1897, HYGIENISCHE RUNDSCHA, V7, P285; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662	44	92	96	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17585	10.1371/journal.pone.0017585	http://dx.doi.org/10.1371/journal.pone.0017585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21436885	Green Submitted, Green Published, gold			2022-12-27	WOS:000288514000003
J	Chen, YJ; Huang, WC; Wei, YL; Hsu, SC; Yuan, P; Lin, HY; Wistuba, II; Lee, JJ; Yen, CJ; Su, WC; Chang, KY; Chang, WC; Chou, TC; Chou, CK; Tsai, CH; Hung, MC				Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Yuan, Ping; Lin, Heather Y.; Wistuba, Ignacio I.; Lee, J. Jack; Yen, Chia-Jui; Su, Wu-Chou; Chang, Kwang-Yu; Chang, Wen-Chang; Chou, Tse-Chuan; Chou, Chao-Kai; Tsai, Chang-Hai; Hung, Mien-Chie			Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR MUTATIONS; LUNG-CANCER PATIENTS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY; GENE-MUTATIONS; PHASE-II; ERLOTINIB; PROTEIN	Background: The sensitivity of non-small cell lung cancer (NSCLC) patients to EGFR tyrosine kinase inhibitors (TKIs) is strongly associated with activating EGFR mutations. Although not as sensitive as patients harboring these mutations, some patients with wild-type EGFR (wtEGFR) remain responsive to EGFR TKIs, suggesting that the existence of unexplored mechanisms renders most of wtEGFR-expressing cancer cells insensitive. Methodology/Principal Findings: Here, we show that acquired resistance of wtEGFR-expressing cancer cells to an EGFR TKI, gefitinib, is associated with elevated expression of breast cancer resistance protein (BCRP/ABCG2), which in turn leads to gefitinib efflux from cells. In addition, BCRP/ABCG2 expression correlates with poor response to gefitinib in both cancer cell lines and lung cancer patients with wtEGFR. Co-treatment with BCRP/ABCG2 inhibitors enhanced the anti-tumor activity of gefitinib. Conclusions/Significance: Thus, BCRP/ABCG2 expression may be a predictor for poor efficacy of gefitinib treatment, and targeting BCRP/ABCG2 may broaden the use of gefitinib in patients with wtEGFR.	[Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chou, Chao-Kai; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yuan, Ping; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lin, Heather Y.; Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Yen, Chia-Jui; Su, Wu-Chou] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chou, Tse-Chuan] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan; [Huang, Wei-Chien] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Kwang-Yu] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chou, Tse-Chuan] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Asia University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; Tatung University	Chen, YJ (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan.	whuang@mail.cmu.edu.tw; mhung@mdanderson.org	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council of Taiwan [NSC-96-2917-I-006-004, NSC-97-2320-B-039-033-MY3, NSC-98-3112-B-039-002]; National Health Research Institutes of Taiwan [NHRI-EX-98-9812BC, NSC-2632-B-001]; Cancer Center Research of Excellence [DOH-TD-C-111-005]; National Institutes of Health [NIH PO1 CA099031, NIH RO1 CA109311]; National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Cancer Center Research of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Science Council of Taiwan (NSC-96-2917-I-006-004 to Y.J. Chen; NSC-97-2320-B-039-033-MY3 and NSC-98-3112-B-039-002 to W.C. Huang), the National Health Research Institutes of Taiwan (NHRI-EX-98-9812BC to W.C. Huang), NSC-2632-B-001, and Cancer Center Research of Excellence (DOH-TD-C-111-005), National Institutes of Health (NIH PO1 CA099031 and NIH RO1 CA109311), National Breast Cancer Foundation, Inc., Kadoorie Charitable Foundation, and The University of Texas MD Anderson Cancer Center and CMUH Sister Institution Fund (to M.C. Hung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chang GC, 2006, J THORAC ONCOL, V1, P520, DOI 10.1097/01243894-200607000-00004; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Diestra JE, 2003, J UROLOGY, V170, P1383, DOI 10.1097/01.ju.0000074710.96154.c9; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; HUANG WC, 2011, J BIOL CHEM; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Lee DH, 2008, ANN ONCOL, V19, P2039, DOI 10.1093/annonc/mdn423; Lemos C, 2009, BRIT J CANCER, V100, P1120, DOI 10.1038/sj.bjc.6604980; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, BIOCHEM PHARMACOL, V77, P781, DOI 10.1016/j.bcp.2008.11.007; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Vasile E, 2008, J THORAC ONCOL, V3, P912, DOI 10.1097/JTO.0b013e318180275e; Wang XD, 2007, DRUG METAB DISPOS, V35, P268, DOI 10.1124/dmd.106.011684; Wu JY, 2008, AM J RESP CRIT CARE, V178, P847, DOI 10.1164/rccm.200803-389OC; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang CH, 2006, CANCER-AM CANCER SOC, V107, P1873, DOI 10.1002/cncr.22220; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhang SZ, 2005, DRUG METAB DISPOS, V33, P341, DOI 10.1124/dmd.104.002501; Zhang SZ, 2004, MOL PHARMACOL, V65, P1208, DOI 10.1124/mol.65.5.1208	43	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21428	10.1371/journal.pone.0021428	http://dx.doi.org/10.1371/journal.pone.0021428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21437249	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400036
J	Chen, YT; Ross, DS; Chiu, R; Zhou, XK; Chen, YY; Lee, PS; Hoda, SA; Simpson, AJ; Old, LJ; Caballero, O; Neville, AM				Chen, Yao-Tseng; Ross, Dara S.; Chiu, Rita; Zhou, Xi K.; Chen, Yunn-Yi; Lee, Peishan; Hoda, Syed A.; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro			Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers	PLOS ONE			English	Article							T-CELL RESPONSES; NY-ESO-1 EXPRESSION; PROTEIN EXPRESSION; ANTIBODY; IMMUNOGENICITY; IDENTIFICATION; CARCINOMA; FAMILY; GENES; CT45	Background: Cancer/testis (CT) antigens are protein antigens normally expressed only in germ cells of testis, and yet are expressed in a proportion of a wide variety of human cancers. CT antigens can elicit spontaneous immune responses in cancer patients with CT-positive cancers, and CT antigen-based therapeutic cancer vaccine trials are ongoing for "CT-rich" tumors. Although some previous studies found breast cancer to be "CT-poor", our recent analysis identified increased CT mRNA transcripts in the ER-negative subset of breast cancer. Methodology/Principal Findings: In this study, we performed a comprehensive immunohistochemical study to investigate the protein expression of eight CT genes in 454 invasive ductal carcinomas, including 225 ER/PR/HER2-negative (triple-negative) carcinomas. We found significantly more frequent expression of all eight CT antigens in ER-negative cancers, and five of them-MAGEA, CT7, NY-ESO-1, CT10 and CT45, were expressed in 12-24% of ER-negative cancers, versus 2-6% of ER-positive cancers (p < 0.001 to 0.003). In comparison, GAGE, SAGE1 and NXF2 were only expressed in 3-5% of ER-negative and 0-2% of ER-positive cancers. ER-negative cancers were also more likely to simultaneously co-express multiple CT antigens, with 27% (34/125) of ER-negative, CT-positive tumors expressing three or more CT antigens. HER2 status had no consistent effect on CT expression, and triple-negative carcinomas showed similar frequencies of MAGEA and NY-ESO-1 expression as ER-negative/HER2-positive carcinomas. More frequent CT expression was also found in tumors with higher nuclear grade (p < 0.001 to p = 0.01) and larger in size (> 2 cm). Conclusions/Significance: CT antigens are preferentially expressed in hormone receptor-negative and high-grade breast cancer. Considering the limited treatment options for ER/PR/HER2 triple-negative breast cancer, the potential of CT-based immunotherapy should be explored.	[Chen, Yao-Tseng; Ross, Dara S.; Hoda, Syed A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Chiu, Rita; Lee, Peishan; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro] Ludwig Inst Canc Res, New York Branch, New York, NY USA; [Zhou, Xi K.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Cornell University; Ludwig Institute for Cancer Research; Cornell University; University of California System; University of California San Francisco	Chen, YT (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.	ytchen@med.cornell.edu	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Ludwig Institute for Cancer Research < http://www.licr.org/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandic D, 2006, CROAT MED J, V47, P32; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 2010, P NATL ACAD SCI USA, V107, P3093, DOI 10.1073/pnas.0915050107; Chen YT, 2009, INT J CANCER, V124, P2893, DOI 10.1002/ijc.24296; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; CHEN YT, 1994, P NATL ACAD SCI USA, V91, P1004, DOI 10.1073/pnas.91.3.1004; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kurashige T, 2001, CANCER RES, V61, P4671; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Rimoldi D, 2000, INT J CANCER, V86, P749; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Zhuang Ran, 2006, Cancer Immun, V6, P7	29	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17876	10.1371/journal.pone.0017876	http://dx.doi.org/10.1371/journal.pone.0017876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437249	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100041
J	Zhou, JX; Brusch, L; Huang, S				Zhou, Joseph Xu; Brusch, Lutz; Huang, Sui			Predicting Pancreas Cell Fate Decisions and Reprogramming with a Hierarchical Multi-Attractor Model	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ROBUST DEVELOPMENT; NETWORK MODELS; STEM-CELLS; DIFFERENTIATION; EXPRESSION; ALPHA; DIVERSIFICATION; PRECURSORS; PLASTICITY	Cell fate reprogramming, such as the generation of insulin-producing beta cells from other pancreas cells, can be achieved by external modulation of key transcription factors. However, the known gene regulatory interactions that form a complex network with multiple feedback loops make it increasingly difficult to design the cell reprogramming scheme because the linear regulatory pathways as schemes of causal influences upon cell lineages are inadequate for predicting the effect of transcriptional perturbation. However, sufficient information on regulatory networks is usually not available for detailed formal models. Here we demonstrate that by using the qualitatively described regulatory interactions as the basis for a coarse-grained dynamical ODE (ordinary differential equation) based model, it is possible to recapitulate the observed attractors of the exocrine and beta, delta, alpha endocrine cells and to predict which gene perturbation can result in desired lineage reprogramming. Our model indicates that the constraints imposed by the incompletely elucidated regulatory network architecture suffice to build a predictive model for making informed decisions in choosing the set of transcription factors that need to be modulated for fate reprogramming.	[Zhou, Joseph Xu; Brusch, Lutz] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Zhou, Joseph Xu; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Zhou, Joseph Xu] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	Technische Universitat Dresden; University of Calgary; University of California System; University of California Santa Barbara	Zhou, JX (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany.	joseph.x.zhou@gmail.com	Yu, Hanry/C-1031-2013	Yu, Hanry/0000-0002-0339-3685; Mahara, Sylvia/0000-0001-7261-1423	German Ministry for Education and Research [0315259]; National Science Foundation [PHY05-51164]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF))	This research was partially supported by the German Ministry for Education and Research through grant no. 0315259. It was also supported in part by the National Science Foundation under Grant No. PHY05-51164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu Masahiko, 2006, Curr Stem Cell Res Ther, V1, P267, DOI 10.2174/157488806776956887; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Bokes P, 2009, MATH MED BIOL, V26, P117, DOI 10.1093/imammb/dqn026; Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Foster DV, 2009, J THEOR BIOL, V260, P589, DOI 10.1016/j.jtbi.2009.07.005; Fukuda A, 2008, DIABETES, V57, P2421, DOI 10.2337/db07-1558; Furusawa C, 2003, J THEOR BIOL, V224, P413, DOI 10.1016/S0022-5193(03)00189-9; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guney MA, 2009, BIRTH DEFECTS RES C, V87, P232, DOI 10.1002/bdrc.20156; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2001, PHARMACOGENOMICS, V2, P203, DOI 10.1517/14622416.2.3.203; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7; Kaneko K, 1999, J THEOR BIOL, V199, P243, DOI 10.1006/jtbi.1999.0952; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Mehta S, 2005, J HEPATO-BILIARY-PAN, V12, P208, DOI 10.1007/s00534-005-0981-4; Miyatsuka T, 2008, EXPERT OPIN THER TAR, V12, P1431, DOI [10.1517/14728222.12.11.1431, 10.1517/14728222.12.11.1431 ]; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; Offield MF, 1996, DEVELOPMENT, V122, P983; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; ZHOU Q, 2008, NATURE	57	110	115	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14752	10.1371/journal.pone.0014752	http://dx.doi.org/10.1371/journal.pone.0014752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21589872	gold, Green Published, Green Submitted			2022-12-27	WOS:000288512400002
